Psyllid ID: psy17270
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 429 | 2.2.26 [Sep-21-2011] | |||||||
| Q9V3D5 | 722 | Dual specificity tyrosine | yes | N/A | 0.722 | 0.429 | 0.647 | 1e-133 | |
| Q9NR20 | 520 | Dual specificity tyrosine | yes | N/A | 0.755 | 0.623 | 0.555 | 1e-122 | |
| Q8BI55 | 632 | Dual specificity tyrosine | yes | N/A | 0.717 | 0.487 | 0.566 | 1e-120 | |
| Q5U4C9 | 599 | Dual specificity tyrosine | no | N/A | 0.717 | 0.514 | 0.526 | 1e-109 | |
| Q92630 | 601 | Dual specificity tyrosine | no | N/A | 0.717 | 0.512 | 0.524 | 1e-108 | |
| Q5ZIU3 | 526 | Dual specificity tyrosine | yes | N/A | 0.841 | 0.686 | 0.471 | 1e-108 | |
| Q9XTF3 | 817 | Dual specificity tyrosine | yes | N/A | 0.715 | 0.375 | 0.523 | 1e-107 | |
| A8WJR8 | 815 | Dual specificity tyrosine | N/A | N/A | 0.715 | 0.376 | 0.523 | 1e-107 | |
| Q4V8A3 | 586 | Dual specificity tyrosine | no | N/A | 0.722 | 0.529 | 0.489 | 1e-101 | |
| Q922Y0 | 586 | Dual specificity tyrosine | no | N/A | 0.722 | 0.529 | 0.486 | 1e-100 |
| >sp|Q9V3D5|DYRK2_DROME Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Drosophila melanogaster GN=smi35A PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 475 bits (1222), Expect = e-133, Method: Compositional matrix adjust.
Identities = 230/355 (64%), Positives = 267/355 (75%), Gaps = 45/355 (12%)
Query: 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWY 73
+ HDHI +RYEILEVIGKGSFGQVIRALDHKTNTH
Sbjct: 189 IEHDHIAFRYEILEVIGKGSFGQVIRALDHKTNTHV------------------------ 224
Query: 74 LGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHM 133
A KI NKKRF +QA++E+ ILD LR+KDAD S+NVIHM
Sbjct: 225 ----AIKI-----------------IRNKKRFLNQAVVELNILDELREKDADGSHNVIHM 263
Query: 134 LEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHC 193
L+Y YFR HLCI+FELM+LNLYELIK+NNY GFS+ LIRRF S+V+CLRLL++ENIIHC
Sbjct: 264 LDYTYFRKHLCITFELMSLNLYELIKKNNYNGFSMSLIRRFCNSIVKCLRLLYKENIIHC 323
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253
DLKPEN+LLKQRGSSSIKVIDFGSSCY +++YTYIQSRFYRSPEVILGL YG IDMWS
Sbjct: 324 DLKPENILLKQRGSSSIKVIDFGSSCYVDRKIYTYIQSRFYRSPEVILGLQYGTAIDMWS 383
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
LGCILAELYTG PLFPGENEVEQLACIME+LG PP +I+ A RRRLFFDS+ PRCITN
Sbjct: 384 LGCILAELYTGFPLFPGENEVEQLACIMEVLGLPPKVLISVARRRRLFFDSRDAPRCITN 443
Query: 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368
+KGRKR PGSK +A +L C D+ F+DF+ +C WD +R+TPDEA HE+L+ S+
Sbjct: 444 TKGRKRSPGSKSLAHILHCQDRYFIDFLQRCLEWDPAERMTPDEAAHHEFLQPSA 498
|
In vitro; can phosphorylate exogenous substrates on Ser and Thr residues. May have a physiological role in development being involved in cellular growth and differentiation. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|Q9NR20|DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 438 bits (1127), Expect = e-122, Method: Compositional matrix adjust.
Identities = 211/380 (55%), Positives = 261/380 (68%), Gaps = 56/380 (14%)
Query: 10 FAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYL 69
F +VLHDHI YRYE+LE IGKGSFGQV + LDHK N
Sbjct: 91 FYLKVLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNE---------------------- 128
Query: 70 EIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYN 129
L A KI NKKRFH QAL+E++IL+ LRKKD D++YN
Sbjct: 129 ------LVALKI-----------------IRNKKRFHQQALMELKILEALRKKDKDNTYN 165
Query: 130 VIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN 189
V+HM ++FYFRNH CI+FEL+ +NLYEL+K NN+QGFSL ++RRF S+++CL++L E
Sbjct: 166 VVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQGFSLSIVRRFTLSVLKCLQMLSVEK 225
Query: 190 IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPI 249
IIHCDLKPEN++L Q+G +S+KVIDFGSSCY HQ+VYTYIQSRFYRSPEVILG PY I
Sbjct: 226 IIHCDLKPENIVLYQKGQASVKVIDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYDVAI 285
Query: 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309
DMWSLGCI AELYTG PLFPGENEVEQLACIME+LG PP I TASRR+ FFDSKG P+
Sbjct: 286 DMWSLGCITAELYTGYPLFPGENEVEQLACIMEVLGLPPAGFIQTASRRQTFFDSKGFPK 345
Query: 310 CITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369
ITN++G+KR P SKD+ VL+ D +F+DF+ +C W+ R+TPD+AL+H W+
Sbjct: 346 NITNNRGKKRYPDSKDLTMVLKTYDTSFLDFLRRCLVWEPSLRMTPDQALKHAWI----- 400
Query: 370 SSSSSSHHATDLRKSPSAHT 389
H + +L+ P T
Sbjct: 401 ------HQSRNLKPQPRPQT 414
|
Possible non-essential role in spermiogenesis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus GN=Dyrk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 431 bits (1109), Expect = e-120, Method: Compositional matrix adjust.
Identities = 200/353 (56%), Positives = 254/353 (71%), Gaps = 45/353 (12%)
Query: 12 FQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEI 71
+VLHDHI YRYE+LE+IGKGSFGQV + LDHK N
Sbjct: 208 MKVLHDHIAYRYEVLEMIGKGSFGQVAKCLDHKNNE------------------------ 243
Query: 72 WYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVI 131
L A KI NKKRFHHQAL+E++IL+ LR+KD D+++NV+
Sbjct: 244 ----LVALKI-----------------IRNKKRFHHQALVELKILEALRRKDKDNNHNVV 282
Query: 132 HMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENII 191
HM ++FYFRNHLCI+FEL+ +NLYEL+K N++ GF+L ++RRF FS+++CL +L+ E II
Sbjct: 283 HMKDFFYFRNHLCITFELLGINLYELMKNNSFHGFNLSIVRRFTFSILKCLHMLYVEKII 342
Query: 192 HCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDM 251
HCDLKPEN++L QRG ++KVIDFGSSCY HQ+VYTYIQSRFYRSPEVILG PY IDM
Sbjct: 343 HCDLKPENIVLYQRGQVTVKVIDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDM 402
Query: 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311
WSLGCI+AELYTG PLFPGENEVEQLACIME+LG PP TASRR++FFDSKG P+ I
Sbjct: 403 WSLGCIMAELYTGYPLFPGENEVEQLACIMEVLGLPPAHFTQTASRRQVFFDSKGLPKNI 462
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
N++G KR P SKD+ V++ D +F+DF+ +C W+ R+TP++AL+H W+
Sbjct: 463 NNNRGGKRYPDSKDLTMVVKTYDSSFLDFLRRCLVWEPSLRMTPEQALKHAWI 515
|
Possible non-essential role in spermiogenesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q5U4C9|DYRK2_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Mus musculus GN=Dyrk2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 395 bits (1014), Expect = e-109, Method: Compositional matrix adjust.
Identities = 196/372 (52%), Positives = 247/372 (66%), Gaps = 64/372 (17%)
Query: 12 FQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLE 70
QV HDH+ YRYE+L+VIGKGSFGQV++A DHK + H ALK
Sbjct: 209 VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV----------------- 251
Query: 71 IWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNV 130
N+KRFH QA E+RIL+HLRK+D D++ NV
Sbjct: 252 -----------------------------RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 282
Query: 131 IHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENI 190
IHMLE F FRNH+C++FEL+++NLYELIK+N +QGFSL L+R+FA S++QCL LH+ I
Sbjct: 283 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRI 342
Query: 191 IHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPID 250
IHCDLKPEN+LLKQ+G SSIKVIDFGSSCY HQRVYTYIQSRFYR+PEVILG YG PID
Sbjct: 343 IHCDLKPENILLKQQGRSSIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPID 402
Query: 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC 310
MWSLGCILAEL TG PL PGE+E +QLAC++E+LG P ++++ + R + F SKG PR
Sbjct: 403 MWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRY 462
Query: 311 ITNSK----------GRKRK------PGSKDMASVLR-CNDKAFVDFVTQCFNWDSKKRL 353
T + GR R+ P S++ + L+ C+D F+DF+ QC WD R+
Sbjct: 463 CTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 522
Query: 354 TPDEALRHEWLK 365
TP +ALRH WL+
Sbjct: 523 TPGQALRHPWLR 534
|
Serine/threonine-protein kinase involved in the control of mitotic transition and the regulation of cellular growth and/or development. Phosphorylates CRMP4/DPYSL3, EIF2B5, GYS1, p53/TP53, TAU/MAPT, STAT3 and KATNA1. Regulates p53/TP53 by phosphorylation on 'Ser-46' to induce apoptosis in response to DNA damage, functioning downstream of ATM. Inactivates GYS1 by phosphorylation at 'Ser-641', and potentially also a second phosphorylation site, thus regulating glycogen synthesis. Phosphorylates EIF2B5 at 'Ser-544', enabling its subsequent phosphorylation and inhibition by GSK3, and may play a more general role in the priming of GSK3 substrates. Mediates EDVP E3 ligase complex formation and is required for the phosphorylation and subsequent degradation of its downstream substrate, KATNA1. Phosphorylation of CRMP4/DPYSL3 promotes its subsequent phosphorylation by GSK3. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q92630|DYRK2_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Homo sapiens GN=DYRK2 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 393 bits (1009), Expect = e-108, Method: Compositional matrix adjust.
Identities = 195/372 (52%), Positives = 246/372 (66%), Gaps = 64/372 (17%)
Query: 12 FQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLE 70
QV HDH+ YRYE+L+VIGKGSFGQV++A DHK + H ALK
Sbjct: 211 VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV----------------- 253
Query: 71 IWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNV 130
N+KRFH QA E+RIL+HLRK+D D++ NV
Sbjct: 254 -----------------------------RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 284
Query: 131 IHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENI 190
IHMLE F FRNH+C++FEL+++NLYELIK+N +QGFSL L+R+FA S++QCL LH+ I
Sbjct: 285 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRI 344
Query: 191 IHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPID 250
IHCDLKPEN+LLKQ+G S IKVIDFGSSCY HQRVYTYIQSRFYR+PEVILG YG PID
Sbjct: 345 IHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPID 404
Query: 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC 310
MWSLGCILAEL TG PL PGE+E +QLAC++E+LG P ++++ + R + F SKG PR
Sbjct: 405 MWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRY 464
Query: 311 ITNSK----------GRKRK------PGSKDMASVLR-CNDKAFVDFVTQCFNWDSKKRL 353
T + GR R+ P S++ + L+ C+D F+DF+ QC WD R+
Sbjct: 465 CTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 524
Query: 354 TPDEALRHEWLK 365
TP +ALRH WL+
Sbjct: 525 TPGQALRHPWLR 536
|
Serine/threonine-protein kinase involved in the control of mitotic transition and the regulation of cellular growth and/or development. Phosphorylates CRMP4/DPYSL3, EIF2B5, GYS1, p53/TP53, TAU/MAPT, STAT3 and KATNA1. Regulates p53/TP53 by phosphorylation on 'Ser-46' to induce apoptosis in response to DNA damage, functioning downstream of ATM. Inactivates GYS1 by phosphorylation at 'Ser-641', and potentially also a second phosphorylation site, thus regulating glycogen synthesis. Phosphorylates EIF2B5 at 'Ser-544', enabling its subsequent phosphorylation and inhibition by GSK3, and may play a more general role in the priming of GSK3 substrates. Mediates EDVP E3 ligase complex formation and is required for the phosphorylation and subsequent degradation of its downstream substrate, KATNA1. Phosphorylation of CRMP4/DPYSL3 promotes its subsequent phosphorylation by GSK3. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q5ZIU3|DYRK2_CHICK Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Gallus gallus GN=DYRK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 391 bits (1005), Expect = e-108, Method: Compositional matrix adjust.
Identities = 207/439 (47%), Positives = 270/439 (61%), Gaps = 78/439 (17%)
Query: 12 FQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLE 70
QV HDHI YRYE+L+VIGKGSFGQV++A DHK + H ALK
Sbjct: 136 IQVPHDHIAYRYEVLKVIGKGSFGQVVKAYDHKMHQHVALKMV----------------- 178
Query: 71 IWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNV 130
N+KRFH QA E+RIL+HLRK+D D++ NV
Sbjct: 179 -----------------------------RNEKRFHRQAAEEIRILEHLRKQDKDNNMNV 209
Query: 131 IHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENI 190
IHMLE F FR+H+C++FEL+++NLYELIK+N +QGFSL L+R+FA S++QCL LH+ I
Sbjct: 210 IHMLENFTFRSHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRI 269
Query: 191 IHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPID 250
IHCDLKPEN+LLKQ+G S IKVIDFGSSCY HQRVYTYIQSRFYR+PEVILG YG PID
Sbjct: 270 IHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPID 329
Query: 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR- 309
MWSLGCILAEL TG PL PGE+E +QLAC++E+LG P ++++++ R + F SKG PR
Sbjct: 330 MWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSPKLLDSSKRAKNFVSSKGYPRY 389
Query: 310 ---------CITNSKGRKRK------PGSKDMASVLR-CNDKAFVDFVTQCFNWDSKKRL 353
I + GR R+ P S++ + L+ C+D F+DF+ QC WD R+
Sbjct: 390 CTITTLSDGSIILNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAIRM 449
Query: 354 TPDEALRHEWL-----------KSSSSSSSSSSHHATDLRKSPSAHTNMYRLYRGVPTKP 402
TP +ALRH WL K+S+ + S+ T + K P ++ +L +
Sbjct: 450 TPSQALRHPWLRRRLPKPPTGEKASAKRITESTGAITSISKLPPTSSSASKLRTNLAQMT 509
Query: 403 SAPADIDLNDSGTFLPPIL 421
A +I T LP ++
Sbjct: 510 DANGNIQQR---TVLPKLV 525
|
Serine/threonine-protein kinase involved in the control of mitotic transition and the regulation of cellular growth and/or development. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9XTF3|MBK2_CAEEL Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2 OS=Caenorhabditis elegans GN=mbk-2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 390 bits (1001), Expect = e-107, Method: Compositional matrix adjust.
Identities = 193/369 (52%), Positives = 246/369 (66%), Gaps = 62/369 (16%)
Query: 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWY 73
V+HDHI YRYE+L+VIGKGSFGQVI+A DHK Y
Sbjct: 452 VVHDHIAYRYEVLKVIGKGSFGQVIKAFDHKYQ-------------------------QY 486
Query: 74 LGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHM 133
+ L + N+KRFH QA E+RILDHLR++D+D ++N+IHM
Sbjct: 487 VALKLVR--------------------NEKRFHRQADEEIRILDHLRRQDSDGTHNIIHM 526
Query: 134 LEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHC 193
L+YF FRNH CI+FEL+++NLYELIKRN +QGFSL L+R+FA+S++ CL LL + +IHC
Sbjct: 527 LDYFNFRNHKCITFELLSINLYELIKRNKFQGFSLMLVRKFAYSMLLCLDLLQKNRLIHC 586
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253
DLKPENVLLKQ+G S IKVIDFGSSC+ QR+YTYIQSRFYR+PEVILG YG PIDMWS
Sbjct: 587 DLKPENVLLKQQGRSGIKVIDFGSSCFDDQRIYTYIQSRFYRAPEVILGTKYGMPIDMWS 646
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR-CIT 312
LGCILAEL TG PL PGE+E +QLA I+E+LG PP + + TA R R F SKG PR C
Sbjct: 647 LGCILAELLTGYPLLPGEDENDQLALIIELLGMPPPKSLETAKRARTFITSKGYPRYCTA 706
Query: 313 NS--------------KGRKR-KPGSKDMASVLR-CNDKAFVDFVTQCFNWDSKKRLTPD 356
S +G+ R P S+ ++ L+ D+ FVDF+ +C +WD + R+TP
Sbjct: 707 TSMPDGSVVLAGARSKRGKMRGPPASRSWSTALKNMGDELFVDFLKRCLDWDPETRMTPA 766
Query: 357 EALRHEWLK 365
+AL+H+WL+
Sbjct: 767 QALKHKWLR 775
|
Required for oocyte-to-zygote transition in which it phosphorylates oocyte proteins, including mei-1, oma-1, oma-2, mex-5, and mex-6, modifying their activity and/or stability following meiosis. Functions in both spindle positioning and in the posterior localization of cytoplasmic determinants, including pie-1, pos-1, and pgl-1, in early embryos. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|A8WJR8|MBK2_CAEBR Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2 OS=Caenorhabditis briggsae GN=mbk-2 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 389 bits (998), Expect = e-107, Method: Compositional matrix adjust.
Identities = 193/369 (52%), Positives = 246/369 (66%), Gaps = 62/369 (16%)
Query: 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWY 73
V+HDHI YRYE+L+VIGKGSFGQVI+A DHK Y
Sbjct: 451 VVHDHIAYRYEVLKVIGKGSFGQVIKAFDHKYQ-------------------------QY 485
Query: 74 LGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHM 133
+ L + N+KRFH QA E+RILDHLR++D+D ++N+IHM
Sbjct: 486 VALKLVR--------------------NEKRFHRQADEEIRILDHLRRQDSDGTHNIIHM 525
Query: 134 LEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHC 193
L+YF FRNH CI+FEL+++NLYELIKRN +QGFSL L+R+FA+S++ CL LL + +IHC
Sbjct: 526 LDYFNFRNHKCITFELLSINLYELIKRNKFQGFSLMLVRKFAYSMLLCLDLLQKNRLIHC 585
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253
DLKPENVLLKQ+G S IKVIDFGSSC+ QR+YTYIQSRFYR+PEVILG YG PIDMWS
Sbjct: 586 DLKPENVLLKQQGRSGIKVIDFGSSCFDDQRIYTYIQSRFYRAPEVILGTKYGMPIDMWS 645
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR-CIT 312
LGCILAEL TG PL PGE+E +QLA I+E+LG PP + + TA R R F SKG PR C
Sbjct: 646 LGCILAELLTGYPLLPGEDENDQLALIIELLGMPPPKSLETAKRARTFITSKGYPRYCTA 705
Query: 313 NS--------------KGRKRKPG-SKDMASVLR-CNDKAFVDFVTQCFNWDSKKRLTPD 356
S +G+ R P S+ ++ L+ D+ FVDF+ +C +WD + R+TP
Sbjct: 706 TSMPDGSVVLAGARSKRGKMRGPPESRSWSTALKNMGDELFVDFLKRCLDWDPETRMTPA 765
Query: 357 EALRHEWLK 365
+AL+H+WL+
Sbjct: 766 QALKHKWLR 774
|
Required for oocyte-to-zygote transition in which it phosphorylates oocyte proteins, including mei-1, oma-1, oma-2, mex-5, and mex-6, modifying their activity and/or stability following meiosis. Functions in both spindle positioning and in the posterior localization of cytoplasmic determinants, including pie-1, pos-1, and pgl-1, in early embryos. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q4V8A3|DYRK3_RAT Dual specificity tyrosine-phosphorylation-regulated kinase 3 OS=Rattus norvegicus GN=Dyrk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (943), Expect = e-101, Method: Compositional matrix adjust.
Identities = 182/372 (48%), Positives = 240/372 (64%), Gaps = 62/372 (16%)
Query: 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWY 73
V DH+ YRYE+L++IGKGSFGQV R DHK Y
Sbjct: 199 VPRDHLAYRYEVLKIIGKGSFGQVARVYDHKLRQ-------------------------Y 233
Query: 74 LGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHM 133
+ L + N+KRFH QA E+RIL+HL+K+D S NVIHM
Sbjct: 234 VALKMVR--------------------NEKRFHRQAAEEIRILEHLKKQDKTGSMNVIHM 273
Query: 134 LEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHC 193
LE F FRNH+C++FEL++++LYELIK+N +QGFS+ L+R+FA S++Q L LH+ IIHC
Sbjct: 274 LESFTFRNHVCMAFELLSIDLYELIKKNKFQGFSVQLVRKFAQSILQSLDALHKNKIIHC 333
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253
DLKPEN+LLK G S+ KVIDFGSSC+ +Q++YTYIQSRFYR+PE+ILG Y PID+WS
Sbjct: 334 DLKPENILLKHHGRSATKVIDFGSSCFEYQKLYTYIQSRFYRAPEIILGCRYSTPIDIWS 393
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR-CIT 312
GCILAEL TG PLFPGE+E +QLAC+ME+LG PP +++ + R + F +SKG PR C
Sbjct: 394 FGCILAELLTGQPLFPGEDEGDQLACMMELLGMPPQKLLEQSKRAKYFINSKGLPRYCSV 453
Query: 313 NSK---------GRKRK------PGSKDMASVLR-CNDKAFVDFVTQCFNWDSKKRLTPD 356
++ GR R+ PGSKD A+ L+ C+D F++F+ +C WD RLTP
Sbjct: 454 TTQTDGRVVLLGGRSRRGKKRGPPGSKDWAAALKGCDDYLFIEFLKRCLQWDPSARLTPA 513
Query: 357 EALRHEWLKSSS 368
+ALRH W+ S+
Sbjct: 514 QALRHPWISKSA 525
|
Negative regulator of EPO-dependent erythropoiesis, may place an upper limit on red cell production during stress erythropoiesis. Inhibits cell death due to cytokine withdrawal in hematopoietic progenitor cells. May act by regulating CREB/CRE signaling. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q922Y0|DYRK3_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 3 OS=Mus musculus GN=Dyrk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 366 bits (940), Expect = e-100, Method: Compositional matrix adjust.
Identities = 181/372 (48%), Positives = 239/372 (64%), Gaps = 62/372 (16%)
Query: 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWY 73
V DH+ YRYE+L++IGKGSFGQV R DHK Y
Sbjct: 199 VPRDHLAYRYEVLKIIGKGSFGQVARVYDHKLRQ-------------------------Y 233
Query: 74 LGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHM 133
+ L + N+KRFH QA E+RIL+HL+K+D S NVIHM
Sbjct: 234 VALKMVR--------------------NEKRFHRQAAEEIRILEHLKKQDKTGSMNVIHM 273
Query: 134 LEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHC 193
LE F FRNH+C++FEL++++LYELIK+N +QGFS+ L+R+FA S++Q L LH+ IIHC
Sbjct: 274 LESFTFRNHVCMAFELLSIDLYELIKKNKFQGFSVQLVRKFAQSILQSLDALHKNKIIHC 333
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253
DLKPEN+LLK G S+ KVIDFGSSC+ +Q++YTYIQSRFYR+PE+ILG Y PID+WS
Sbjct: 334 DLKPENILLKHHGRSATKVIDFGSSCFEYQKLYTYIQSRFYRAPEIILGCRYSTPIDIWS 393
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
GCILAEL TG PLFPGE+E +QLAC++E+LG PP +++ + R + F +SKG PR +
Sbjct: 394 FGCILAELLTGQPLFPGEDEGDQLACMIELLGMPPQKLLEQSKRAKYFINSKGLPRYCSV 453
Query: 314 S---------------KGRKR-KPGSKDMASVLR-CNDKAFVDFVTQCFNWDSKKRLTPD 356
S +G+KR PGSKD A+ L+ C D F++F+ +C WD RLTP
Sbjct: 454 STQTDGRVVLLGGRSRRGKKRGPPGSKDWATALKGCGDYLFIEFLKRCLQWDPSARLTPA 513
Query: 357 EALRHEWLKSSS 368
+ALRH W+ S+
Sbjct: 514 QALRHPWISKST 525
|
Negative regulator of EPO-dependent erythropoiesis, may place an upper limit on red cell production during stress erythropoiesis. Inhibits cell death due to cytokine withdrawal in hematopoietic progenitor cells. May act by regulating CREB/CRE signaling. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 429 | ||||||
| 345484982 | 661 | PREDICTED: dual specificity tyrosine-pho | 0.745 | 0.484 | 0.745 | 1e-159 | |
| 345484980 | 673 | PREDICTED: dual specificity tyrosine-pho | 0.745 | 0.475 | 0.745 | 1e-159 | |
| 242019366 | 612 | mitogen-activated protein kinase ERK-A, | 0.787 | 0.552 | 0.703 | 1e-154 | |
| 307197916 | 532 | Dual specificity tyrosine-phosphorylatio | 0.878 | 0.708 | 0.567 | 1e-153 | |
| 157119423 | 572 | Dual specificity tyrosine-phosphorylatio | 0.832 | 0.624 | 0.653 | 1e-152 | |
| 332023382 | 523 | Dual specificity tyrosine-phosphorylatio | 0.745 | 0.611 | 0.718 | 1e-152 | |
| 307168646 | 529 | Dual specificity tyrosine-phosphorylatio | 0.745 | 0.604 | 0.713 | 1e-151 | |
| 383860764 | 647 | PREDICTED: dual specificity tyrosine-pho | 0.738 | 0.489 | 0.713 | 1e-150 | |
| 328784208 | 644 | PREDICTED: dual specificity tyrosine-pho | 0.738 | 0.492 | 0.707 | 1e-150 | |
| 350414759 | 641 | PREDICTED: dual specificity tyrosine-pho | 0.736 | 0.492 | 0.685 | 1e-146 |
| >gi|345484982|ref|XP_001605197.2| PREDICTED: dual specificity tyrosine-phosphorylation-regulated kinase 2-like isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1461), Expect = e-159, Method: Compositional matrix adjust.
Identities = 273/366 (74%), Positives = 295/366 (80%), Gaps = 46/366 (12%)
Query: 45 TNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK-- 102
T A KYYG++LTEFER EIEKY EIWYLGL ACKIHGEE SQNGG+DD+NGSYNK
Sbjct: 137 TPEQATKYYGSKLTEFERAEIEKYSEIWYLGLSACKIHGEEGASQNGGYDDDNGSYNKVL 196
Query: 103 ------------------------------------------KRFHHQALIEVRILDHLR 120
KRFHHQALIEV+ILDHLR
Sbjct: 197 HDHISYRYEILEVIGKGSFGQVIRALDHKTGQHIAIKIIRNKKRFHHQALIEVKILDHLR 256
Query: 121 KKD--ADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178
KKD A+SS+NVIHMLEYFYFRNHLCISFELM+LNLYELIK+NNYQGFSL LIRRFA SL
Sbjct: 257 KKDLQANSSHNVIHMLEYFYFRNHLCISFELMSLNLYELIKKNNYQGFSLSLIRRFANSL 316
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 238
V CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE
Sbjct: 317 VNCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 376
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRR 298
VILGLPYG PIDMWSLGCILAELYTG PLFPGENEVEQLACIME+LG PPD++IN ASRR
Sbjct: 377 VILGLPYGTPIDMWSLGCILAELYTGYPLFPGENEVEQLACIMEVLGRPPDQLINHASRR 436
Query: 299 RLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358
RLFFDSKG PRC+TNSKG+KR+PGSK++ LRC D FVDFV++C WDSKKR+TP+EA
Sbjct: 437 RLFFDSKGIPRCVTNSKGKKRRPGSKNVMIALRCRDPLFVDFVSRCLEWDSKKRMTPEEA 496
Query: 359 LRHEWL 364
+RHEWL
Sbjct: 497 MRHEWL 502
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345484980|ref|XP_003425167.1| PREDICTED: dual specificity tyrosine-phosphorylation-regulated kinase 2-like isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1461), Expect = e-159, Method: Compositional matrix adjust.
Identities = 273/366 (74%), Positives = 295/366 (80%), Gaps = 46/366 (12%)
Query: 45 TNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK-- 102
T A KYYG++LTEFER EIEKY EIWYLGL ACKIHGEE SQNGG+DD+NGSYNK
Sbjct: 149 TPEQATKYYGSKLTEFERAEIEKYSEIWYLGLSACKIHGEEGASQNGGYDDDNGSYNKVL 208
Query: 103 ------------------------------------------KRFHHQALIEVRILDHLR 120
KRFHHQALIEV+ILDHLR
Sbjct: 209 HDHISYRYEILEVIGKGSFGQVIRALDHKTGQHIAIKIIRNKKRFHHQALIEVKILDHLR 268
Query: 121 KKD--ADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178
KKD A+SS+NVIHMLEYFYFRNHLCISFELM+LNLYELIK+NNYQGFSL LIRRFA SL
Sbjct: 269 KKDLQANSSHNVIHMLEYFYFRNHLCISFELMSLNLYELIKKNNYQGFSLSLIRRFANSL 328
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 238
V CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE
Sbjct: 329 VNCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 388
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRR 298
VILGLPYG PIDMWSLGCILAELYTG PLFPGENEVEQLACIME+LG PPD++IN ASRR
Sbjct: 389 VILGLPYGTPIDMWSLGCILAELYTGYPLFPGENEVEQLACIMEVLGRPPDQLINHASRR 448
Query: 299 RLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358
RLFFDSKG PRC+TNSKG+KR+PGSK++ LRC D FVDFV++C WDSKKR+TP+EA
Sbjct: 449 RLFFDSKGIPRCVTNSKGKKRRPGSKNVMIALRCRDPLFVDFVSRCLEWDSKKRMTPEEA 508
Query: 359 LRHEWL 364
+RHEWL
Sbjct: 509 MRHEWL 514
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242019366|ref|XP_002430132.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] gi|212515223|gb|EEB17394.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1416), Expect = e-154, Method: Compositional matrix adjust.
Identities = 275/391 (70%), Positives = 312/391 (79%), Gaps = 53/391 (13%)
Query: 45 TNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY---- 100
T + ALKYYG++LTE+E++EIEKY EIWYLGLDACKIHGE+ FDD+ GSY
Sbjct: 153 TPSEALKYYGSRLTEYEKSEIEKYSEIWYLGLDACKIHGED-------FDDDYGSYHKVL 205
Query: 101 ----------------------------------------NKKRFHHQALIEVRILDHLR 120
NKKRFHHQALIEV+ILDHLR
Sbjct: 206 HDHISYRYEILEVIGKGSFGQVIRALDHKTNQHVAIKIIRNKKRFHHQALIEVKILDHLR 265
Query: 121 KKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180
K+D S +NVIHMLEYFYFRNHLCISFELM+LNLYELIK+N+YQGFSL LIRRFA SLVQ
Sbjct: 266 KRDKYSLHNVIHMLEYFYFRNHLCISFELMSLNLYELIKKNSYQGFSLTLIRRFAHSLVQ 325
Query: 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVI 240
CLRLLH+ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVI
Sbjct: 326 CLRLLHKENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVI 385
Query: 241 LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL 300
LGLPYG IDMWSLGCILAELYTG PLFPGENE+EQLAC+MEILG PP++VI+ ASR+RL
Sbjct: 386 LGLPYGTAIDMWSLGCILAELYTGYPLFPGENEIEQLACVMEILGIPPEDVISNASRKRL 445
Query: 301 FFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360
FFDS+G PRCITNSKGRKRKPGSK++AS +RCNDK FVDF++QC WD+KKRL P++ALR
Sbjct: 446 FFDSRGNPRCITNSKGRKRKPGSKELASAIRCNDKQFVDFISQCLQWDAKKRLNPEDALR 505
Query: 361 HEWLKSSSSSSSSSSHHATDLRKSPSAHTNM 391
H+WLKSSS+SS + + + DLR+SPS N+
Sbjct: 506 HDWLKSSSTSSVTQT--SQDLRRSPSETGNL 534
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307197916|gb|EFN79015.1| Dual specificity tyrosine-phosphorylation-regulated kinase 2 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 547 bits (1410), Expect = e-153, Method: Compositional matrix adjust.
Identities = 290/511 (56%), Positives = 332/511 (64%), Gaps = 134/511 (26%)
Query: 45 TNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK-- 102
T A+KYYG++LTEFER EIEKY EIWYLGL A KIHGEE SQNGG+DDENGSYNK
Sbjct: 22 TPQEAVKYYGSRLTEFERAEIEKYSEIWYLGLSAHKIHGEEVSSQNGGYDDENGSYNKVL 81
Query: 103 ------------------------------------------KRFHHQALIEVRILDHLR 120
KRFHHQALIEVRIL+HLR
Sbjct: 82 HDHISYRYEILEVIGKGSFGQVIRALDHKTGQHIAIKIIRNKKRFHHQALIEVRILEHLR 141
Query: 121 KKD--ADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178
KKD A+SS+NVIHMLEYFYFRNHLCISFELM+LNLYELIK+NNYQGFSL LIRRFA SL
Sbjct: 142 KKDLEANSSHNVIHMLEYFYFRNHLCISFELMSLNLYELIKKNNYQGFSLSLIRRFANSL 201
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 238
+ CLRLL+RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE
Sbjct: 202 ISCLRLLYRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 261
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRR 298
VILGLPYG PIDMWSLGCILAELYTG PLFPGE+E+EQLACIME+LG PP+ +I+ ASRR
Sbjct: 262 VILGLPYGTPIDMWSLGCILAELYTGYPLFPGEDEIEQLACIMEVLGLPPEHIISHASRR 321
Query: 299 RLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358
RLFFD KG+PRC+TNSKG+KR GS++++ LRC+D FV+FV++C WD KKR+TPDEA
Sbjct: 322 RLFFDQKGSPRCVTNSKGKKRWAGSRNLSIALRCSDMLFVNFVSRCLEWDPKKRMTPDEA 381
Query: 359 LRHEWLK------------------------SSSSSSSSSSHHATDLRKSPSAHT----- 389
+RHEWL ++SS +S S HA + + SA
Sbjct: 382 MRHEWLNSSSSHVSSSSSAIASSTVNASANTTTSSVETSQSAHAQTVSVTVSAPRQRATT 441
Query: 390 ------NMYRLYRG---------------------------------------------- 397
MYRLY+G
Sbjct: 442 MEDPPYTMYRLYKGRKYVQKISTTSGDSGTDNGGGGGGGLVVKSKLNGSASSHALASSTQ 501
Query: 398 -VPTKPSAPADI------DLNDSGTFLPPIL 421
++ ++ DI +L+DSGTFLPPIL
Sbjct: 502 TATSRHASTGDIVASLDPNLDDSGTFLPPIL 532
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|157119423|ref|XP_001653374.1| Dual specificity tyrosine-phosphorylation-regulated kinase [Aedes aegypti] gi|108883157|gb|EAT47382.1| AAEL001504-PA [Aedes aegypti] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1403), Expect = e-152, Method: Compositional matrix adjust.
Identities = 264/404 (65%), Positives = 308/404 (76%), Gaps = 47/404 (11%)
Query: 45 TNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK-- 102
T + ALKY+G +LT++E+ EIEKY EI+YLGLDACKI+ + + N G+DD+NGSYNK
Sbjct: 107 TPSEALKYHGTRLTDYEKQEIEKYPEIYYLGLDACKINAKPGTALNSGYDDDNGSYNKVI 166
Query: 103 ------------------------------------------KRFHHQALIEVRILDHLR 120
KRFHHQAL+EVRILD LR
Sbjct: 167 HDHVCYRYEILEVIGKGSFGQVIRALDHKTNQHVAIKIIRNKKRFHHQALVEVRILDELR 226
Query: 121 KKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180
KKDAD +YNVIHML+YFYFRNHLCISFELM+LNLYELIK+NNYQGFSL LIRRF S+V+
Sbjct: 227 KKDADGAYNVIHMLDYFYFRNHLCISFELMSLNLYELIKKNNYQGFSLSLIRRFCNSIVK 286
Query: 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVI 240
CLRLL++ENIIHCDLKPENVLLKQRGSS IKVIDFGSSCYSH++VYTYIQSRFYRSPEVI
Sbjct: 287 CLRLLYQENIIHCDLKPENVLLKQRGSSLIKVIDFGSSCYSHRKVYTYIQSRFYRSPEVI 346
Query: 241 LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL 300
LGL YG PIDMWSLGCILAELYTG PLFPGENEVEQLACIME+LG PPD++INTA+RRRL
Sbjct: 347 LGLSYGTPIDMWSLGCILAELYTGYPLFPGENEVEQLACIMEVLGVPPDDLINTATRRRL 406
Query: 301 FFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360
FFDS+G PRCITNSKGRKRKPG+K ++ LRCND F+DFV++C WD KKR+TP+EA R
Sbjct: 407 FFDSRGIPRCITNSKGRKRKPGTKTISQALRCNDTVFIDFVSKCLEWDPKKRMTPEEAAR 466
Query: 361 HEWLKSSSSSSSSSSHHATDLRKSPSAHTNMYRLYRGVPTKPSA 404
HEWL+ S+SS+ SS + S + + M +L R P P+
Sbjct: 467 HEWLQPSASSTYVSSKSKEN---SDNQLSFMQKLQRSQPMTPNT 507
|
Source: Aedes aegypti Species: Aedes aegypti Genus: Aedes Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332023382|gb|EGI63627.1| Dual specificity tyrosine-phosphorylation-regulated kinase 2 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1398), Expect = e-152, Method: Compositional matrix adjust.
Identities = 263/366 (71%), Positives = 291/366 (79%), Gaps = 46/366 (12%)
Query: 45 TNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK-- 102
T A+KYYG++LTEFER EIEKY EIWYLGL A KIHGEE SQNGG+DDENGSYNK
Sbjct: 16 TPQEAVKYYGSRLTEFERAEIEKYSEIWYLGLSAHKIHGEEVSSQNGGYDDENGSYNKVL 75
Query: 103 ------------------------------------------KRFHHQALIEVRILDHLR 120
KRFHHQALIEVRIL+HLR
Sbjct: 76 HDHISYRYEILEVIGKGSFGQVIRALDHKTGQHIAIKIIRNKKRFHHQALIEVRILEHLR 135
Query: 121 KKD--ADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178
KKD +S +NVIHMLEYFYFRNHLCISFELM+LNLYELIK+NNYQGFSL LIRRFA SL
Sbjct: 136 KKDLEMNSQHNVIHMLEYFYFRNHLCISFELMSLNLYELIKKNNYQGFSLSLIRRFANSL 195
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 238
+ CLRLL+RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE
Sbjct: 196 ISCLRLLYRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 255
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRR 298
VILGL YGPPIDMWSLGCILAELYTG PLFPGE+E+EQLACIME+LG PP+ +IN ASRR
Sbjct: 256 VILGLTYGPPIDMWSLGCILAELYTGYPLFPGEDEIEQLACIMEVLGLPPEHIINHASRR 315
Query: 299 RLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358
RLFFD KG+PRC+TNSKG+KR GSK+++ LRC+D FV+FV++C WD KKR+TPDEA
Sbjct: 316 RLFFDQKGSPRCVTNSKGKKRWAGSKNLSMALRCSDMLFVNFVSRCLEWDPKKRMTPDEA 375
Query: 359 LRHEWL 364
+RHEWL
Sbjct: 376 MRHEWL 381
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307168646|gb|EFN61682.1| Dual specificity tyrosine-phosphorylation-regulated kinase 2 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1392), Expect = e-151, Method: Compositional matrix adjust.
Identities = 261/366 (71%), Positives = 292/366 (79%), Gaps = 46/366 (12%)
Query: 45 TNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK-- 102
T A+KYYG++LTEFER EIEKY EIWYLGL A KIHGEE SQNGG+DDENGSYNK
Sbjct: 22 TPQDAVKYYGSRLTEFERAEIEKYSEIWYLGLTAHKIHGEEVSSQNGGYDDENGSYNKVL 81
Query: 103 ------------------------------------------KRFHHQALIEVRILDHLR 120
KRFHHQALIEVRIL+HLR
Sbjct: 82 HDHISYRYEILEVIGKGSFGQVIRALDHKTGQHIAIKIIRNKKRFHHQALIEVRILEHLR 141
Query: 121 KKD--ADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178
KKD ++S +NVIHMLEYFYFRNHLCISFELM+LNLYELIK+NNYQGFSL LIRRFA SL
Sbjct: 142 KKDLESNSQHNVIHMLEYFYFRNHLCISFELMSLNLYELIKKNNYQGFSLSLIRRFANSL 201
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 238
+ CLRLL+RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE
Sbjct: 202 ISCLRLLYRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 261
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRR 298
VILGLPYG PIDMWSLGCILAELYTG PLFPGE+E+EQLACIME+LG PP+ +I+ A+RR
Sbjct: 262 VILGLPYGTPIDMWSLGCILAELYTGYPLFPGEDEIEQLACIMEVLGLPPEHIISHATRR 321
Query: 299 RLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358
RLFFD KG+PRC+TNSKG+KR GSK+++ LRC+D FV+FV++C WD KKR+TPDEA
Sbjct: 322 RLFFDQKGSPRCVTNSKGKKRWAGSKNLSMALRCSDMLFVNFVSRCLEWDPKKRMTPDEA 381
Query: 359 LRHEWL 364
+RHEWL
Sbjct: 382 MRHEWL 387
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383860764|ref|XP_003705859.1| PREDICTED: dual specificity tyrosine-phosphorylation-regulated kinase 2-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1385), Expect = e-150, Method: Compositional matrix adjust.
Identities = 261/366 (71%), Positives = 289/366 (78%), Gaps = 49/366 (13%)
Query: 45 TNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK-- 102
T+ ALKYYG++LTEFER EIEKY EIWYLGL A KIHGEE SQNGG+DDENGSYNK
Sbjct: 139 TSQEALKYYGSRLTEFERAEIEKYSEIWYLGLSAHKIHGEEGSSQNGGYDDENGSYNKVL 198
Query: 103 ------------------------------------------KRFHHQALIEVRILDHLR 120
KRFHHQAL+EV IL+HLR
Sbjct: 199 HDHISYRYEILEVIGKGSFGQVIRAWDHKTGHYIAIKIIRNKKRFHHQALVEVEILEHLR 258
Query: 121 KKD--ADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178
KKD A++S+NVIHMLEYFYFRNHLCI+FELM+LNLYELIK+NNY+GFSL LIRRFA SL
Sbjct: 259 KKDLDANASHNVIHMLEYFYFRNHLCITFELMSLNLYELIKKNNYKGFSLSLIRRFANSL 318
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 238
+ CLRLL+RE IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTY+QSRFYRSPE
Sbjct: 319 ISCLRLLYREKIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYLQSRFYRSPE 378
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRR 298
VILGLPYG PIDMWSLGCILAELYTGCPLFPGE+E+EQLACIME+LG PP+ +IN ASRR
Sbjct: 379 VILGLPYGTPIDMWSLGCILAELYTGCPLFPGEDEIEQLACIMEVLGLPPEHIINHASRR 438
Query: 299 RLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358
RLFF G PRCITNSKG+KR GSK++A LRC D FVDFV++C WD KKR+TPDEA
Sbjct: 439 RLFF---GNPRCITNSKGKKRWAGSKNLAIALRCTDTLFVDFVSRCLEWDPKKRMTPDEA 495
Query: 359 LRHEWL 364
+RHEWL
Sbjct: 496 MRHEWL 501
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328784208|ref|XP_396369.3| PREDICTED: dual specificity tyrosine-phosphorylation-regulated kinase 2-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 536 bits (1382), Expect = e-150, Method: Compositional matrix adjust.
Identities = 259/366 (70%), Positives = 287/366 (78%), Gaps = 49/366 (13%)
Query: 45 TNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK-- 102
T ALKYYG++LTEFER EIEKY EIWYLGL A KIHGEE SQNGG+DDENGSYNK
Sbjct: 133 TAPEALKYYGSRLTEFERNEIEKYSEIWYLGLSATKIHGEEGSSQNGGYDDENGSYNKVF 192
Query: 103 ------------------------------------------KRFHHQALIEVRILDHLR 120
KRFHHQAL+EV IL+HLR
Sbjct: 193 HDHISYRYEILEVIGKGSFGQVIRALDHKTGQYIAIKIIRNKKRFHHQALVEVEILEHLR 252
Query: 121 KKD--ADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178
KKD A++S+NVIHMLEYFYFRNHLCI+FELM+LNLYELIK+NNY+GFSL LIRRFA SL
Sbjct: 253 KKDLEANASHNVIHMLEYFYFRNHLCITFELMSLNLYELIKKNNYKGFSLSLIRRFANSL 312
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 238
+ CLRLL+RE IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTY+QSRFYRSPE
Sbjct: 313 ISCLRLLYREKIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYLQSRFYRSPE 372
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRR 298
VILGLPYG PIDMWSLGCILAELYTGCPLFPGE+E+EQLACIME+LG PP+ +IN ASRR
Sbjct: 373 VILGLPYGTPIDMWSLGCILAELYTGCPLFPGEDEIEQLACIMEVLGLPPEHIINHASRR 432
Query: 299 RLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358
RLFF G PRC+TNSKG+KR GS+++A LRC D FVDFV +C WD KKR+TPDEA
Sbjct: 433 RLFF---GDPRCVTNSKGKKRWAGSRNLAIALRCTDTLFVDFVRRCLEWDPKKRMTPDEA 489
Query: 359 LRHEWL 364
+RHEWL
Sbjct: 490 MRHEWL 495
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350414759|ref|XP_003490409.1| PREDICTED: dual specificity tyrosine-phosphorylation-regulated kinase 2-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1352), Expect = e-146, Method: Compositional matrix adjust.
Identities = 248/362 (68%), Positives = 286/362 (79%), Gaps = 46/362 (12%)
Query: 49 ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK------ 102
A KYYG++LT+FE EI+KY EIWYLGL A KI G++ +QNGG+DDE+GSYNK
Sbjct: 140 ARKYYGSRLTDFELAEIQKYSEIWYLGLSATKIRGKDGAAQNGGYDDEDGSYNKVFHDHI 199
Query: 103 --------------------------------------KRFHHQALIEVRILDHLRKKD- 123
KRFHHQAL+EV+ILDHLRKKD
Sbjct: 200 SYRYEILEVIGKGSFGQVIRALDHKTGQYIAIKIIRNKKRFHHQALVEVKILDHLRKKDL 259
Query: 124 -ADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCL 182
A++S+NVIHMLEYFYFRNHLCI+FELM+LNLYELIK+NNY+GFSL LIRRFA SLV CL
Sbjct: 260 EANASHNVIHMLEYFYFRNHLCITFELMSLNLYELIKKNNYKGFSLSLIRRFANSLVSCL 319
Query: 183 RLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG 242
RLL+RENIIHCDLKPENVLLKQRG SSIKVIDFGSSCYSHQRVYTY+QSRFYRSPEVILG
Sbjct: 320 RLLYRENIIHCDLKPENVLLKQRGCSSIKVIDFGSSCYSHQRVYTYLQSRFYRSPEVILG 379
Query: 243 LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFF 302
+ YG PIDMWSLGCILAELYTGCPLFPGE+E+EQLACIME+LG PP+ +I+ A+RRRLFF
Sbjct: 380 IQYGTPIDMWSLGCILAELYTGCPLFPGEDEIEQLACIMEVLGLPPEHIIDLATRRRLFF 439
Query: 303 DSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHE 362
D KG+PRC+TNSKG+KR GS+++A LRC D FVDFV +C WD +KR+TPDEA+RHE
Sbjct: 440 DPKGSPRCVTNSKGKKRWAGSRNLAIALRCTDTLFVDFVRRCLEWDPQKRMTPDEAMRHE 499
Query: 363 WL 364
WL
Sbjct: 500 WL 501
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 429 | ||||||
| ZFIN|ZDB-GENE-091015-3 | 634 | dyrk4 "dual-specificity tyrosi | 0.615 | 0.416 | 0.742 | 3.8e-129 | |
| FB|FBgn0016930 | 722 | smi35A "smell impaired 35A" [D | 0.617 | 0.367 | 0.735 | 1.9e-125 | |
| UNIPROTKB|E1BGJ6 | 637 | LOC100850226 "Uncharacterized | 0.615 | 0.414 | 0.662 | 1.4e-116 | |
| UNIPROTKB|F5H6L9 | 545 | DYRK4 "Dual-specificity tyrosi | 0.615 | 0.484 | 0.666 | 3.3e-115 | |
| UNIPROTKB|Q9NR20 | 520 | DYRK4 "Dual specificity tyrosi | 0.615 | 0.507 | 0.666 | 3.3e-115 | |
| UNIPROTKB|F1SL05 | 600 | DYRK4 "Uncharacterized protein | 0.615 | 0.44 | 0.662 | 4.2e-115 | |
| RGD|1306800 | 633 | Dyrk4 "dual-specificity tyrosi | 0.615 | 0.417 | 0.651 | 8.7e-115 | |
| UNIPROTKB|D4A0W8 | 597 | Dyrk4 "Protein Dyrk4" [Rattus | 0.615 | 0.442 | 0.651 | 8.7e-115 | |
| MGI|MGI:1330292 | 632 | Dyrk4 "dual-specificity tyrosi | 0.615 | 0.417 | 0.643 | 1.3e-113 | |
| ZFIN|ZDB-GENE-030131-2804 | 587 | dyrk2 "dual-specificity tyrosi | 0.538 | 0.393 | 0.619 | 5e-108 |
| ZFIN|ZDB-GENE-091015-3 dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1104 (393.7 bits), Expect = 3.8e-129, Sum P(2) = 3.8e-129
Identities = 196/264 (74%), Positives = 232/264 (87%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKR 160
NKKRFHHQAL+E++ILD +R++D D+ +NVIHM EYFYFRNHLCISFEL+ NLYELIK+
Sbjct: 245 NKKRFHHQALVELKILDAVRRRDRDNCHNVIHMKEYFYFRNHLCISFELLGANLYELIKK 304
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
NN+QGFSLGLIRRFA SL++CL++LH+E IIHCDLKPEN+LL QRG +IKV+DFGSSCY
Sbjct: 305 NNFQGFSLGLIRRFAHSLLKCLQMLHKEKIIHCDLKPENILLSQRGQGNIKVVDFGSSCY 364
Query: 221 SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
QRVYTYIQSRFYRSPEVILG PY IDMWSLGCILAELYTG PLFPGE+EVEQ+ACI
Sbjct: 365 EQQRVYTYIQSRFYRSPEVILGHPYSMAIDMWSLGCILAELYTGYPLFPGESEVEQIACI 424
Query: 281 MEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340
MEI+G PP++ + TASRRRLFFDSKG PR ITNSKG+KR+P SKD+ASVL+ ND F+DF
Sbjct: 425 MEIMGLPPNDFVQTASRRRLFFDSKGNPRNITNSKGKKRRPSSKDLASVLKTNDPLFLDF 484
Query: 341 VTQCFNWDSKKRLTPDEALRHEWL 364
+ +C WD KR+TPDEA++HEW+
Sbjct: 485 IQRCLVWDPTKRMTPDEAMQHEWI 508
|
|
| FB|FBgn0016930 smi35A "smell impaired 35A" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1078 (384.5 bits), Expect = 1.9e-125, Sum P(2) = 1.9e-125
Identities = 195/265 (73%), Positives = 229/265 (86%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKR 160
NKKRF +QA++E+ ILD LR+KDAD S+NVIHML+Y YFR HLCI+FELM+LNLYELIK+
Sbjct: 231 NKKRFLNQAVVELNILDELREKDADGSHNVIHMLDYTYFRKHLCITFELMSLNLYELIKK 290
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
NNY GFS+ LIRRF S+V+CLRLL++ENIIHCDLKPEN+LLKQRGSSSIKVIDFGSSCY
Sbjct: 291 NNYNGFSMSLIRRFCNSIVKCLRLLYKENIIHCDLKPENILLKQRGSSSIKVIDFGSSCY 350
Query: 221 SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
+++YTYIQSRFYRSPEVILGL YG IDMWSLGCILAELYTG PLFPGENEVEQLACI
Sbjct: 351 VDRKIYTYIQSRFYRSPEVILGLQYGTAIDMWSLGCILAELYTGFPLFPGENEVEQLACI 410
Query: 281 MEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340
ME+LG PP +I+ A RRRLFFDS+ PRCITN+KGRKR PGSK +A +L C D+ F+DF
Sbjct: 411 MEVLGLPPKVLISVARRRRLFFDSRDAPRCITNTKGRKRSPGSKSLAHILHCQDRYFIDF 470
Query: 341 VTQCFNWDSKKRLTPDEALRHEWLK 365
+ +C WD +R+TPDEA HE+L+
Sbjct: 471 LQRCLEWDPAERMTPDEAAHHEFLQ 495
|
|
| UNIPROTKB|E1BGJ6 LOC100850226 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1013 (361.7 bits), Expect = 1.4e-116, Sum P(2) = 1.4e-116
Identities = 175/264 (66%), Positives = 224/264 (84%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKR 160
NKKRFHHQAL+E++IL+ LR+KD D++YNV+HM ++FYFRNHLCI+FEL+ +NLYEL+K
Sbjct: 253 NKKRFHHQALVELKILEALRRKDKDNTYNVVHMKDFFYFRNHLCITFELLGINLYELMKN 312
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
N++QGFSL ++RRF S+++CL++L+ E IIHCDLKPEN++L Q+G S+KVIDFGSSCY
Sbjct: 313 NSFQGFSLSIVRRFTLSVLKCLQMLYMEKIIHCDLKPENIVLYQKGQVSVKVIDFGSSCY 372
Query: 221 SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
HQ+VYTYIQSRFYRSPEVILG PY IDMWSLGCI+AELYTG PLFPGENEVEQLACI
Sbjct: 373 EHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGENEVEQLACI 432
Query: 281 MEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340
ME+LG PP I TASRR++FFDSKG P+ ITN++G+KR P SKD+ +L+ D +F+DF
Sbjct: 433 MEVLGLPPSRFIQTASRRQMFFDSKGFPKNITNNRGKKRYPDSKDLTVLLKTCDTSFLDF 492
Query: 341 VTQCFNWDSKKRLTPDEALRHEWL 364
+ +C W+ R+TPD+AL+H W+
Sbjct: 493 LRRCLVWEPSLRMTPDQALKHAWI 516
|
|
| UNIPROTKB|F5H6L9 DYRK4 "Dual-specificity tyrosine-phosphorylation-regulated kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 999 (356.7 bits), Expect = 3.3e-115, Sum P(2) = 3.3e-115
Identities = 176/264 (66%), Positives = 220/264 (83%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKR 160
NKKRFH QAL+E++IL+ LRKKD D++YNV+HM ++FYFRNH CI+FEL+ +NLYEL+K
Sbjct: 252 NKKRFHQQALMELKILEALRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKN 311
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
NN+QGFSL ++RRF S+++CL++L E IIHCDLKPEN++L Q+G +S+KVIDFGSSCY
Sbjct: 312 NNFQGFSLSIVRRFTLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCY 371
Query: 221 SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
HQ+VYTYIQSRFYRSPEVILG PY IDMWSLGCI AELYTG PLFPGENEVEQLACI
Sbjct: 372 EHQKVYTYIQSRFYRSPEVILGHPYDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACI 431
Query: 281 MEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340
ME+LG PP I TASRR+ FFDSKG P+ ITN++G+KR P SKD+ VL+ D +F+DF
Sbjct: 432 MEVLGLPPAGFIQTASRRQTFFDSKGFPKNITNNRGKKRYPDSKDLTMVLKTYDTSFLDF 491
Query: 341 VTQCFNWDSKKRLTPDEALRHEWL 364
+ +C W+ R+TPD+AL+H W+
Sbjct: 492 LRRCLVWEPSLRMTPDQALKHAWI 515
|
|
| UNIPROTKB|Q9NR20 DYRK4 "Dual specificity tyrosine-phosphorylation-regulated kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 999 (356.7 bits), Expect = 3.3e-115, Sum P(2) = 3.3e-115
Identities = 176/264 (66%), Positives = 220/264 (83%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKR 160
NKKRFH QAL+E++IL+ LRKKD D++YNV+HM ++FYFRNH CI+FEL+ +NLYEL+K
Sbjct: 137 NKKRFHQQALMELKILEALRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKN 196
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
NN+QGFSL ++RRF S+++CL++L E IIHCDLKPEN++L Q+G +S+KVIDFGSSCY
Sbjct: 197 NNFQGFSLSIVRRFTLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCY 256
Query: 221 SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
HQ+VYTYIQSRFYRSPEVILG PY IDMWSLGCI AELYTG PLFPGENEVEQLACI
Sbjct: 257 EHQKVYTYIQSRFYRSPEVILGHPYDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACI 316
Query: 281 MEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340
ME+LG PP I TASRR+ FFDSKG P+ ITN++G+KR P SKD+ VL+ D +F+DF
Sbjct: 317 MEVLGLPPAGFIQTASRRQTFFDSKGFPKNITNNRGKKRYPDSKDLTMVLKTYDTSFLDF 376
Query: 341 VTQCFNWDSKKRLTPDEALRHEWL 364
+ +C W+ R+TPD+AL+H W+
Sbjct: 377 LRRCLVWEPSLRMTPDQALKHAWI 400
|
|
| UNIPROTKB|F1SL05 DYRK4 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1001 (357.4 bits), Expect = 4.2e-115, Sum P(2) = 4.2e-115
Identities = 175/264 (66%), Positives = 222/264 (84%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKR 160
NKKRFHHQAL+E++IL+ LR+KD D++YNV+HM ++FYFRNHLCI+FEL+ +NLYEL+K
Sbjct: 216 NKKRFHHQALVELKILEALRRKDKDNTYNVVHMKDFFYFRNHLCITFELLGINLYELMKT 275
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
N++QGFSL +IRRF S+++CL++L+ E IIHCDLKPEN++L Q+G ++KVIDFGSSCY
Sbjct: 276 NSFQGFSLSIIRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYQKGQVTVKVIDFGSSCY 335
Query: 221 SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
HQ+VYTYIQSRFYRSPEVILG PY IDMWSLGCI+AELYTG PLF GENEVEQLACI
Sbjct: 336 EHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFAGENEVEQLACI 395
Query: 281 MEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340
ME+LG PP I TASRR+ FFDSKG P+ ITN++G+KR P SKD+ VL+ D +F+DF
Sbjct: 396 MEVLGLPPTRFIQTASRRQTFFDSKGFPKNITNNRGKKRYPDSKDLTMVLKTYDTSFLDF 455
Query: 341 VTQCFNWDSKKRLTPDEALRHEWL 364
+ +C W+ R+TPD+AL+H W+
Sbjct: 456 LRRCLVWEPSLRMTPDQALKHAWI 479
|
|
| RGD|1306800 Dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1001 (357.4 bits), Expect = 8.7e-115, Sum P(2) = 8.7e-115
Identities = 172/264 (65%), Positives = 223/264 (84%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKR 160
NKKRFHHQAL+E++IL+ LR+KD D+++NV+HM ++FYFRNHLCI+FEL+ +NLYEL+K
Sbjct: 253 NKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYELMKN 312
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
N++QGFSL ++RRF S+++CL++L+ E IIHCDLKPEN++L RG ++KVIDFGSSCY
Sbjct: 313 NSFQGFSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKVIDFGSSCY 372
Query: 221 SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
HQ+VYTYIQSRFYRSPEVILG PY IDMWSLGCI+AELYTG PLFPGENEVEQLACI
Sbjct: 373 EHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGENEVEQLACI 432
Query: 281 MEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340
ME+LG PP +I TA+RR++FFDSKG P+ ITN++G KR P SKD+ V++ D +F+DF
Sbjct: 433 MEVLGLPPTHLIQTATRRQIFFDSKGLPKNITNNRGEKRYPNSKDLPMVVKTYDSSFLDF 492
Query: 341 VTQCFNWDSKKRLTPDEALRHEWL 364
+ +C W+ R+TPD+AL+H W+
Sbjct: 493 LRRCLVWEPSLRMTPDQALKHAWI 516
|
|
| UNIPROTKB|D4A0W8 Dyrk4 "Protein Dyrk4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1001 (357.4 bits), Expect = 8.7e-115, Sum P(2) = 8.7e-115
Identities = 172/264 (65%), Positives = 223/264 (84%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKR 160
NKKRFHHQAL+E++IL+ LR+KD D+++NV+HM ++FYFRNHLCI+FEL+ +NLYEL+K
Sbjct: 217 NKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYELMKN 276
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
N++QGFSL ++RRF S+++CL++L+ E IIHCDLKPEN++L RG ++KVIDFGSSCY
Sbjct: 277 NSFQGFSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKVIDFGSSCY 336
Query: 221 SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
HQ+VYTYIQSRFYRSPEVILG PY IDMWSLGCI+AELYTG PLFPGENEVEQLACI
Sbjct: 337 EHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGENEVEQLACI 396
Query: 281 MEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340
ME+LG PP +I TA+RR++FFDSKG P+ ITN++G KR P SKD+ V++ D +F+DF
Sbjct: 397 MEVLGLPPTHLIQTATRRQIFFDSKGLPKNITNNRGEKRYPNSKDLPMVVKTYDSSFLDF 456
Query: 341 VTQCFNWDSKKRLTPDEALRHEWL 364
+ +C W+ R+TPD+AL+H W+
Sbjct: 457 LRRCLVWEPSLRMTPDQALKHAWI 480
|
|
| MGI|MGI:1330292 Dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 987 (352.5 bits), Expect = 1.3e-113, Sum P(2) = 1.3e-113
Identities = 170/264 (64%), Positives = 220/264 (83%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKR 160
NKKRFHHQAL+E++IL+ LR+KD D+++NV+HM ++FYFRNHLCI+FEL+ +NLYEL+K
Sbjct: 252 NKKRFHHQALVELKILEALRRKDKDNNHNVVHMKDFFYFRNHLCITFELLGINLYELMKN 311
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
N++ GF+L ++RRF FS+++CL +L+ E IIHCDLKPEN++L QRG ++KVIDFGSSCY
Sbjct: 312 NSFHGFNLSIVRRFTFSILKCLHMLYVEKIIHCDLKPENIVLYQRGQVTVKVIDFGSSCY 371
Query: 221 SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
HQ+VYTYIQSRFYRSPEVILG PY IDMWSLGCI+AELYTG PLFPGENEVEQLACI
Sbjct: 372 EHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGENEVEQLACI 431
Query: 281 MEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340
ME+LG PP TASRR++FFDSKG P+ I N++G KR P SKD+ V++ D +F+DF
Sbjct: 432 MEVLGLPPAHFTQTASRRQVFFDSKGLPKNINNNRGGKRYPDSKDLTMVVKTYDSSFLDF 491
Query: 341 VTQCFNWDSKKRLTPDEALRHEWL 364
+ +C W+ R+TP++AL+H W+
Sbjct: 492 LRRCLVWEPSLRMTPEQALKHAWI 515
|
|
| ZFIN|ZDB-GENE-030131-2804 dyrk2 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 799 (286.3 bits), Expect = 5.0e-108, Sum P(3) = 5.0e-108
Identities = 153/247 (61%), Positives = 192/247 (77%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKR 160
N+KRFH QA E+RIL+HLRK+D DS+ NVIHMLE F FRNH+C++FEL+++NLYELIK+
Sbjct: 242 NEKRFHRQAAEEIRILEHLRKQDKDSTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK 301
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
N +QGFSL L+R+FA S++QCL LH+ IIHCDLKPEN+LLKQ+G S IKVIDFGSSCY
Sbjct: 302 NKFQGFSLPLVRKFAHSILQCLESLHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 361
Query: 221 SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
HQRVYTYIQSRFYR+PEVILG YG PIDMWSLGCILAEL TG PL PGE+E +QLAC+
Sbjct: 362 EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACV 421
Query: 281 MEILGCPPDEVINTASRRRLFFDSKGTPR-C-ITN--------SKGRKRK------PGSK 324
+E+LG P ++++ ++ R + F SKG PR C +T + GR R+ PGS+
Sbjct: 422 IEMLGMPSEKLLESSKRAKNFISSKGHPRYCTVTTLPDASVVLNGGRSRRGKLRGPPGSR 481
Query: 325 DMASVLR 331
D + L+
Sbjct: 482 DWVTALK 488
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9XTF3 | MBK2_CAEEL | 2, ., 7, ., 1, 2, ., 1 | 0.5230 | 0.7156 | 0.3757 | yes | N/A |
| Q9V3D5 | DYRK2_DROME | 2, ., 7, ., 1, 2, ., 1 | 0.6478 | 0.7226 | 0.4293 | yes | N/A |
| Q5ZIU3 | DYRK2_CHICK | 2, ., 7, ., 1, 2, ., 1 | 0.4715 | 0.8414 | 0.6863 | yes | N/A |
| Q9NR20 | DYRK4_HUMAN | 2, ., 7, ., 1, 2, ., 1 | 0.5552 | 0.7552 | 0.6230 | yes | N/A |
| Q8BI55 | DYRK4_MOUSE | 2, ., 7, ., 1, 2, ., 1 | 0.5665 | 0.7179 | 0.4873 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.12 | 0.766 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 429 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-69 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-58 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-57 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-57 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-56 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-56 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-52 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-47 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-46 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-46 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-45 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-43 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-43 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-42 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-39 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-38 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-38 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-37 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-37 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-35 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-35 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-34 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-34 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-34 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-33 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-33 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-33 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-32 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-31 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-31 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-31 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-31 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-31 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-31 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-30 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-30 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-29 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-28 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-28 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-27 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-27 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-27 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-27 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-27 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-27 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-27 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-26 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-26 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-26 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-26 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-25 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-24 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-24 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-22 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-22 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-10 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-06 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-05 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-04 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 0.002 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.002 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 9e-69
Identities = 90/346 (26%), Positives = 148/346 (42%), Gaps = 96/346 (27%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
YEILE +G+GSFG+V A D KT A+K ++ +I+K E
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIK-------VIKKKKIKKDRE----------- 42
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ L E++IL L+ N++ + + F +
Sbjct: 43 --------------------------RILREIKILKKLKHP------NIVRLYDVFEDED 70
Query: 142 HLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L + E +L++L+K+ S R + ++ L LH + I+H DLKPEN+
Sbjct: 71 KLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSKGIVHRDLKPENI 128
Query: 201 LLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
LL + G +K+ DFG + +++ T++ + Y +PEV+LG YG +D+WSLG IL
Sbjct: 129 LLDEDGH--VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVIL 186
Query: 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
EL TG P FPG++++ + + + +G P
Sbjct: 187 YELLTGKPPFPGDDQLLE---LFKKIGKPKPP---------------------------- 215
Query: 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
P + S D + + D +KRLT +EAL+H +
Sbjct: 216 -FPPPEWDIS------PEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 7e-58
Identities = 96/347 (27%), Positives = 141/347 (40%), Gaps = 92/347 (26%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
YE+L +G GSFG V +A T + A KI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTG-------------------KIV---------AVKI- 31
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
K + A E+RIL L N++ +++ F ++H
Sbjct: 32 -------------LKKRSEKSKKDQTARREIRILRRLSHP------NIVRLIDAFEDKDH 72
Query: 143 LCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + E +L++ + R S ++ A +++ L LH IIH DLKPEN+L
Sbjct: 73 LYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENIL 130
Query: 202 LKQRGSSSIKVIDFGSSC---YSHQRVYTYIQSRFYRSPEVIL-GLPYGPPIDMWSLGCI 257
L + G +K+ DFG + S + T++ + +Y +PEV+L G YGP +D+WSLG I
Sbjct: 131 LDENGV--VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
L EL TG P F GEN ++QL I ILG P + S G+
Sbjct: 189 LYELLTGKPPFSGENILDQLQLIRRILGPPLEFDE--------PKWSSGSEEAK------ 234
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
D + +C N D KR T +E L+H W
Sbjct: 235 ---------------------DLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 6e-57
Identities = 102/347 (29%), Positives = 157/347 (45%), Gaps = 69/347 (19%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y+ L IG+G++G V +A D T A+K ++ +E
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK----KIKLRFESEGIP-------------- 42
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
AL E+++L L N+I +L+ F +
Sbjct: 43 -------------------------KTALREIKLLKELNHP------NIIKLLDVFRHKG 71
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + FE M+ +LY+LIK G LI+ + + L+Q L H I+H DLKPEN+L
Sbjct: 72 DLYLVFEFMDTDLYKLIKDRQR-GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLL 130
Query: 202 LKQRGSSSIKVIDFGS--SCYSHQRVYT-YIQSRFYRSPEVILGLP-YGPPIDMWSLGCI 257
+ +K+ DFG S S R YT Y+ +R+YR+PE++LG Y P+D+WS+GCI
Sbjct: 131 INT--EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCI 188
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
AEL + PLFPG++E++QL I LG P EV K T
Sbjct: 189 FAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP-----------KFTSLARNYKFSF 237
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
+K G + + +D ++Q ++D KR+T ++AL H +
Sbjct: 238 PKKAGM-PLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 7e-57
Identities = 107/364 (29%), Positives = 168/364 (46%), Gaps = 89/364 (24%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RYE+L+ IG G++G V A+D +T A+K +++ I DA
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK----KISNVFDDLI-----------DA-- 43
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY-- 138
KR L E+++L HLR + N+I +L+
Sbjct: 44 ----------------------KR----ILREIKLLRHLRHE------NIIGLLDILRPP 71
Query: 139 ----FRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCD 194
F N + I ELM +L+++IK Q + I+ F + +++ L+ LH N+IH D
Sbjct: 72 SPEDF-NDVYIVTELMETDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRD 128
Query: 195 LKPENVLLKQRGSSSIKVIDFG-----SSCYSHQRVYT-YIQSRFYRSPEVILGLP-YGP 247
LKP N+L+ + +K+ DFG + T Y+ +R+YR+PE++L Y
Sbjct: 129 LKPSNILVNS--NCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTK 186
Query: 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT 307
ID+WS+GCI AEL T PLFPG + ++QL I+E+LG P +E +
Sbjct: 187 AIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK-------------- 232
Query: 308 PRCITNSKGRK-----RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHE 362
IT+ K R K K ++ + +D + + +D KKR+T DEAL H
Sbjct: 233 --FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290
Query: 363 WLKS 366
+L
Sbjct: 291 YLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 1e-56
Identities = 99/347 (28%), Positives = 163/347 (46%), Gaps = 70/347 (20%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
YE LE +G+G++G V +A D KT ALK KI
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK----------------------------KI 32
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ +E G AL E+ +L L+ N++ +L+ +
Sbjct: 33 RLDN---------EEEG------IPSTALREISLLKELKHP------NIVKLLDVIHTER 71
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + FE +++L + + S LI+ + L++ L H I+H DLKP+N+L
Sbjct: 72 KLYLVFEYCDMDLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNIL 130
Query: 202 LKQRGSSSIKVIDFG-SSCYSHQ-RVYTY-IQSRFYRSPEVILGLP-YGPPIDMWSLGCI 257
+ + G +K+ DFG + + R YT+ + + +YR+PE++LG Y +D+WS+GCI
Sbjct: 131 INRDGV--LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCI 188
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
AE+ TG PLFPG++E++QL I +ILG P +E + +L P
Sbjct: 189 FAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT--KLPDYKPTFP--------- 237
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
K P KD+ VL D +D +++ ++ KR++ EAL+H +
Sbjct: 238 KFPP--KDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 7e-56
Identities = 101/353 (28%), Positives = 156/353 (44%), Gaps = 81/353 (22%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
Y++++ +G G+FG V A + +T E I+K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETG--------------ELVAIKKM-------------- 32
Query: 83 GEESLSQNGGFDDENGSYNKKRFHH----QALIEVRILDHLRKKDADSSYNVIHMLEYFY 138
KK+F+ L EV+ L L + N++ + E F
Sbjct: 33 -------------------KKKFYSWEECMNLREVKSLRKLNEHP-----NIVKLKEVFR 68
Query: 139 FRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ L FE M NLY+L+K + FS +IR + ++Q L +H+ H DLKPE
Sbjct: 69 ENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPE 128
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQR-VYT-YIQSRFYRSPEVILGLP-YGPPIDMWSLG 255
N+L+ +K+ DFG + R YT Y+ +R+YR+PE++L Y P+D+W+LG
Sbjct: 129 NLLVSGPEV--VKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALG 186
Query: 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPP----DEVINTASRRRLFFDSKGTPRCI 311
CI+AELYT PLFPG +E++QL I +LG P E AS+ F P+
Sbjct: 187 CIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF-----PQFA 241
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
S + ++ +D + WD KKR T +AL+H +
Sbjct: 242 PTS-----------LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 3e-52
Identities = 99/350 (28%), Positives = 162/350 (46%), Gaps = 76/350 (21%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+YE+L V+G+G++G V++ + T E I+K+ E
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATG--------------EIVAIKKFKES---------- 37
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
DDE+ AL EV++L LR + N++++ E F +
Sbjct: 38 -----------EDDED-------VKKTALREVKVLRQLRHE------NIVNLKEAFRRKG 73
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + FE + L EL++ + G +R + + L+Q + H NIIH D+KPEN+L
Sbjct: 74 RLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENIL 132
Query: 202 LKQRGSSSIKVIDFG----SSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPIDMWSLGC 256
+ + S +K+ DFG + Y+ +R+YR+PE+++G YG P+D+W++GC
Sbjct: 133 VSE--SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGC 190
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
I+AEL G PLFPG+++++QL I + LG + F S +
Sbjct: 191 IMAELLDGEPLFPGDSDIDQLYLIQKCLG-------PLPPSHQELFSSNPRFAGV----- 238
Query: 317 RKRKPGSKDMASVLR-----CNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
P S+ R + A +DF+ C D K+RLT DE L+H
Sbjct: 239 --AFPEPSQPESLERRYPGKVSSPA-LDFLKACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-47
Identities = 102/357 (28%), Positives = 162/357 (45%), Gaps = 92/357 (25%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
Y+IL IG+G+F +V++A KT KYY A K
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTG----KYY------------------------AIK-- 30
Query: 83 GEESLSQNGGFDDENGSYNKKRFHH----QALIEVRILDHLRKKDADSSYNVIHMLEYFY 138
KK F L E++ L L N++ ++E +
Sbjct: 31 -----------------CMKKHFKSLEQVNNLREIQALRRL-----SPHPNILRLIEVLF 68
Query: 139 FRNHLCIS--FELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
R ++ FELM++NLYELIK + ++ + + L++ L +HR I H D+K
Sbjct: 69 DRKTGRLALVFELMDMNLYELIK-GRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIK 127
Query: 197 PENVLLKQRGSSSIKVIDFGSSC--YSHQRVYTYIQSRFYRSPEVIL--GLPYGPPIDMW 252
PEN+L+K +K+ DFGS YS YI +R+YR+PE +L G YGP +D+W
Sbjct: 128 PENILIKD---DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGY-YGPKMDIW 183
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVI---NTASRRRLFFDSK---G 306
++GC+ E+ + PLFPG NE++Q+A I ++LG P EV+ + F SK G
Sbjct: 184 AVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTG 243
Query: 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
+ + N + + +D + + +D +R+T +ALRH +
Sbjct: 244 LRKLLPN------------------ASAEG-LDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 99/361 (27%), Positives = 153/361 (42%), Gaps = 94/361 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RY+IL IG+G+ G V +A D +T T ALK K
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALK----------------------------K 32
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ GG +QAL E++ L + V+ +L+ F
Sbjct: 33 VALR---RLEGGIP------------NQALREIKALQACQ------HPYVVKLLDVFPHG 71
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + E M +L E++ R+ + ++ + L++ + +H I+H DLKP N+
Sbjct: 72 SGFVLVMEYMPSDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL 130
Query: 201 LLKQRGSSSIKVIDFG---------SSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPID 250
L+ G +K+ DFG YSHQ + +R+YR+PE++ G Y P +D
Sbjct: 131 LISADGV--LKIADFGLARLFSEEEPRLYSHQ-----VATRWYRAPELLYGARKYDPGVD 183
Query: 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL-------FFD 303
+W++GCI AEL G PLFPGEN++EQLA + LG P +E L F +
Sbjct: 184 LWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGL--TSLPDYNKITFPE 241
Query: 304 SKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
SK P + P + +D + +D KRL+ EALRH +
Sbjct: 242 SKPIPL-------EEIFPDA----------SPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
Query: 364 L 364
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 8e-46
Identities = 104/357 (29%), Positives = 168/357 (47%), Gaps = 75/357 (21%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGN---QLTEFERTEIEKYLEIWYLGLD 77
RY+ +E IG G++G V A+D ++ A+K + T +RT E+ L
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT----LRELKIL--- 58
Query: 78 ACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF 137
+ F H +I +R D LR AD
Sbjct: 59 -------------------------RHFKHDNIIAIR--DILRPPGAD------------ 79
Query: 138 YFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
F+ + + +LM +L+ +I + Q + IR F + L++ L+ +H N+IH DLKP
Sbjct: 80 -FK-DVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKP 135
Query: 198 ENVLLKQRGSSSIKVIDFG------SSCYSHQRVYT-YIQSRFYRSPEVILGLP-YGPPI 249
N+L+ + +++ DFG SS H+ T Y+ +R+YR+PE++L LP Y I
Sbjct: 136 SNLLVNEDCE--LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAI 193
Query: 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309
DMWS+GCI AE+ LFPG+N V QL I+ +LG P +EV+N R +
Sbjct: 194 DMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR-------VRK 246
Query: 310 CITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
I N ++ P SK + +D ++Q +D ++R+T ++AL+H +L
Sbjct: 247 YIQNLPRKQPVPWSK----IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 102/354 (28%), Positives = 160/354 (45%), Gaps = 81/354 (22%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
YE + IG+G++GQV +A + KT ALK KI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK----------------------------KI 32
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF--YF 139
E +++ G F A+ E+++L LR N++ + E
Sbjct: 33 RME---------NEKEG------FPITAIREIKLLQKLRHP------NIVRLKEIVTSKG 71
Query: 140 RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ + + FE M+ +L L+ + F+ I+ + L++ L+ LH I+H D+K N
Sbjct: 72 KGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSN 130
Query: 200 VLLKQRGSSSIKVIDFG---SSCYSHQRVYTY-IQSRFYRSPEVILGLP-YGPPIDMWSL 254
+L+ G +K+ DFG + YT + + +YR PE++LG YGP +DMWS+
Sbjct: 131 ILINNDGV--LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSV 188
Query: 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314
GCILAEL+ G P+F G E+EQL I E+ G P DE S+ F N
Sbjct: 189 GCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF----------ENL 238
Query: 315 KGRKRKPGSKDMASVLR-----CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
K +K LR D + +D + + D KKR++ D+AL+HE+
Sbjct: 239 KPKKPYK------RRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 102/365 (27%), Positives = 170/365 (46%), Gaps = 84/365 (23%)
Query: 17 DHICYRYEILEVIGKGSFGQVIRALDHKTN-THALK----YYGNQLTEFERTEIEKYLEI 71
HI +YEIL+ +GKG++G V +A+D +T ALK + N T+ +RT + EI
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRT----FREI 57
Query: 72 WYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNV 130
+L + I V++L+ ++ + D D
Sbjct: 58 MFL----------------------------QELGDHPNI-VKLLNVIKAENDKD----- 83
Query: 131 IHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRF-AFSLVQCLRLLHREN 189
I+++ FE M +L+ +I+ N + + +R+ + L++ L+ +H N
Sbjct: 84 IYLV------------FEYMETDLHAVIRANILED----VHKRYIMYQLLKALKYIHSGN 127
Query: 190 IIHCDLKPENVLLKQRGSSSIKVIDFG--SSCYSHQRVYT------YIQSRFYRSPEVIL 241
+IH DLKP N+LL +K+ DFG S + Y+ +R+YR+PE++L
Sbjct: 128 VIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL 185
Query: 242 GLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL 300
G Y +DMWS+GCIL E+ G PLFPG + + QL I+E++G P E I +
Sbjct: 186 GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES------ 239
Query: 301 FFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360
S + + R RKP + +L +D + + ++ KRLT +EAL
Sbjct: 240 -IKSPFAATMLDSLPSRPRKP----LDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294
Query: 361 HEWLK 365
H ++
Sbjct: 295 HPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 9e-43
Identities = 97/362 (26%), Positives = 161/362 (44%), Gaps = 91/362 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTE-FERTEIEKYLEIWYLGLDAC 79
RY+ L +G G++GQV A D KT A+K +L+ F+
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK----KLSRPFQSA---------------- 55
Query: 80 KIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF-- 137
IH KR E+R+L H+ + NVI +L+ F
Sbjct: 56 -IHA-------------------KR----TYRELRLLKHMDHE------NVIGLLDVFTP 85
Query: 138 ----------YFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHR 187
Y HL M +L ++K Q S I+ + +++ L+ +H
Sbjct: 86 ASSLEDFQDVYLVTHL------MGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS 136
Query: 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYG 246
IIH DLKP N+ + +K++DFG + ++ + Y+ +R+YR+PE++L + Y
Sbjct: 137 AGIIHRDLKPSNIAVN--EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYN 194
Query: 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVIN--TASRRRLFFDS 304
+D+WS+GCI+AEL TG LFPG + ++QL IM ++G P +E++ ++ R +
Sbjct: 195 QTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYI-- 252
Query: 305 KGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
+ P+ + KD V + +D + + D KR+T EAL H +L
Sbjct: 253 QSLPQ-------MPK----KDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
Query: 365 KS 366
Sbjct: 302 AE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 93/354 (26%), Positives = 159/354 (44%), Gaps = 76/354 (21%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RYE + +G+G++ V +A D +T A+K K
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK----------------------------K 32
Query: 81 IH-GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF 139
I GE +++G + AL E+++L L+ N+I +L+ F
Sbjct: 33 IKLGERKEAKDG-------------INFTALREIKLLQELKHP------NIIGLLDVFGH 73
Query: 140 RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
++++ + FE M +L ++IK + + I+ + ++ L LH I+H DLKP N
Sbjct: 74 KSNINLVFEFMETDLEKVIKDKSIV-LTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNN 132
Query: 200 VLLKQRGSSSIKVIDFGSSCY--SHQRVYTY-IQSRFYRSPEVILGLP-YGPPIDMWSLG 255
+L+ G +K+ DFG + S R T+ + +R+YR+PE++ G YG +DMWS+G
Sbjct: 133 LLIASDGV--LKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVG 190
Query: 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL---FFDSKGTPRCIT 312
CI AEL P PG+++++QL I E LG P +E + F TP
Sbjct: 191 CIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTP---- 246
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
++ P + D A +D + + + KR+T +AL H + +
Sbjct: 247 ---LKQIFPAASDDA----------LDLLQRLLTLNPNKRITARQALEHPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 87/360 (24%), Positives = 148/360 (41%), Gaps = 91/360 (25%)
Query: 23 YEILEVIGKGSFGQVIRALD-HKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
YE L IG+G++G V +A D + ALK K+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK----------------------------KV 32
Query: 82 H---GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY 138
EE + + L E+ +L L ++ N++ +L+ +
Sbjct: 33 RVPLSEEGIPLS------------------TLREIALLKQL---ESFEHPNIVRLLDVCH 71
Query: 139 F-RNHLCIS----FELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHC 193
R + FE ++ +L + + G I+ L++ + LH I+H
Sbjct: 72 GPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHR 131
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF--------YRSPEVILGLPY 245
DLKP+N+L+ G +K+ DFG + R+Y++ + YR+PEV+L Y
Sbjct: 132 DLKPQNILVTSDG--QVKIADFGLA-----RIYSF-EMALTSVVVTLWYRAPEVLLQSSY 183
Query: 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP-DEVINTASRRRLFFDS 304
P+DMWS+GCI AEL+ PLF G +E +QL I +++G P +E S R F S
Sbjct: 184 ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPS 243
Query: 305 KGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
+ S + + +D + + ++ KR++ EAL+H +
Sbjct: 244 Y----------------TPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 69/238 (28%), Positives = 94/238 (39%), Gaps = 56/238 (23%)
Query: 29 IGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88
+G+G FG V A D KT K A KI
Sbjct: 1 LGEGGFGTVYLARDKKTG----KKV------------------------AIKI------- 25
Query: 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFE 148
E+ S + L E+ IL L N++ + F NHL + E
Sbjct: 26 ----IKKEDSSSLLEEL----LREIEILKKLNHP------NIVKLYGVFEDENHLYLVME 71
Query: 149 LMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS 207
+L +L+K N S I R +++ L LH IIH DLKPEN+LL +
Sbjct: 72 YCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-N 129
Query: 208 SSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGCILAEL 261
+K+ DFG S + T + + Y +PEV+LG Y D+WSLG IL EL
Sbjct: 130 GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 79/256 (30%), Positives = 139/256 (54%), Gaps = 24/256 (9%)
Query: 112 EVRILDHLRKKDADSSYNV-IHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGL 170
E+++L HLR ++ S ++ I LE YF EL+ +L+ L+ +
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVT------ELLGTDLHRLLTSRPLEK---QF 109
Query: 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ 230
I+ F + +++ L+ +H ++H DLKP N+L+ + + +K+ DFG + ++ Y+
Sbjct: 110 IQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE--NCDLKICDFGLARIQDPQMTGYVS 167
Query: 231 SRFYRSPEVILGL-PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPD 289
+R+YR+PE++L Y +D+WS GCI AE+ G PLFPG++ V Q + I ++LG PPD
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227
Query: 290 EVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDS 349
+VINT S+ T R + + R+ P + + D + +D + + +D
Sbjct: 228 DVINTIC-------SENTLRFVQSLPKREPVP----FSEKFKNADPSAIDLLEKMLVFDP 276
Query: 350 KKRLTPDEALRHEWLK 365
+KR++ EAL H +L
Sbjct: 277 QKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 5e-38
Identities = 93/347 (26%), Positives = 165/347 (47%), Gaps = 68/347 (19%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+YE L ++G+GS+G V++ +T + I+K+LE
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETG--------------QIVAIKKFLE----------- 36
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
S + K A+ E+R+L LR + N+++++E F +
Sbjct: 37 -----------------SEDDKMVKKIAMREIRMLKQLRHE------NLVNLIEVFRRKK 73
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L + FE + + L +L K N G +R++ F +++ + H NIIH D+KPEN+
Sbjct: 74 RLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI 131
Query: 201 LLKQRGSSSIKVIDFG--SSCYSHQRVYT-YIQSRFYRSPEVILGLP-YGPPIDMWSLGC 256
L+ Q G +K+ DFG + + VYT Y+ +R+YR+PE+++G YG +D+W++GC
Sbjct: 132 LVSQSGV--VKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGC 189
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
++ E+ TG PLFPG+++++QL I++ LG N R + F + +
Sbjct: 190 LVTEMLTGEPLFPGDSDIDQLYHIIKCLG-------NLIPRHQEIFQKNPLFAGMRLPEV 242
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
++ +P K + +D QC D R + + L HE+
Sbjct: 243 KEIEPLEKRFPKL----SGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-37
Identities = 106/373 (28%), Positives = 165/373 (44%), Gaps = 84/373 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RY+I EVIGKGS+G V A+D T E+ I+K +++ DA +I
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTG--------------EKVAIKKINDVFEHVSDATRI 46
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
L E+++L LR D +++ F++
Sbjct: 47 ----------------------------LREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78
Query: 142 HLCISFELMNLNLYELIKRNN-----YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
+ + FELM +L+++IK N+ + F F + L++ L+ +H N+ H DLK
Sbjct: 79 -IYVVFELMESDLHQVIKANDDLTPEHHQF-------FLYQLLRALKYIHTANVFHRDLK 130
Query: 197 PENVLLKQRGSSSIKVIDFGSSCYSHQRVYT------YIQSRFYRSPEVILGL--PYGPP 248
P+N+L +K+ DFG + + T Y+ +R+YR+PE+ Y P
Sbjct: 131 PKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPA 188
Query: 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVI----NTASRRRLFFDS 304
ID+WS+GCI AE+ TG PLFPG+N V QL I ++LG P E I N +RR L
Sbjct: 189 IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYL---- 244
Query: 305 KGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
S RK++P + D + + + +D K R T +EAL +
Sbjct: 245 ---------SSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293
Query: 365 KSSSSSSSSSSHH 377
K + S
Sbjct: 294 KGLAKVEREPSAQ 306
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 102/363 (28%), Positives = 165/363 (45%), Gaps = 85/363 (23%)
Query: 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTE--IEKYLEIWYL 74
+ RY+ L IG+G++G V A T A+K +++ FE EI L
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK----KISPFEHQTFCQRTLREIKIL 57
Query: 75 GLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHML 134
+RF H+ +I ILD +R +S +N ++++
Sbjct: 58 ----------------------------RRFKHENIIG--ILDIIRPPSFES-FNDVYIV 86
Query: 135 EYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCD 194
+ ELM +LY+LIK Q S I+ F + +++ L+ +H N++H D
Sbjct: 87 Q------------ELMETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRD 131
Query: 195 LKPENVLLKQRGSSSIKVIDFG-----SSCYSHQRVYT-YIQSRFYRSPEVILGLP-YGP 247
LKP N+LL + +K+ DFG + H T Y+ +R+YR+PE++L Y
Sbjct: 132 LKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 189
Query: 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT 307
ID+WS+GCILAE+ + PLFPG++ + QL I+ +LG P E +N
Sbjct: 190 AIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN-------------- 235
Query: 308 PRCITNSKGRKR------KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
CI + + R KP + D +D + + ++ KR+T +EAL H
Sbjct: 236 --CIISLRARNYIKSLPFKPK-VPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292
Query: 362 EWL 364
+L
Sbjct: 293 PYL 295
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 98/350 (28%), Positives = 168/350 (48%), Gaps = 64/350 (18%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+Y ++ IG+G++G V A + +TN A+K N F+ +DA
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA---FDNR------------IDA-- 48
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
KR L E+++L HL ++ + +++ F
Sbjct: 49 ----------------------KR----TLREIKLLRHLDHENVIAIKDIMPPPHREAF- 81
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
N + I +ELM+ +L+++I+ + Q S + F + L++ L+ +H N++H DLKP N+
Sbjct: 82 NDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL 139
Query: 201 LLKQRGSSSIKVIDFG---SSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGC 256
LL + +K+ DFG ++ + Y+ +R+YR+PE++L Y ID+WS+GC
Sbjct: 140 LLN--ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGC 197
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
I AEL PLFPG++ V QL I E+LG P +E + F ++ R I +
Sbjct: 198 IFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG-------FIRNEKARRYIRSLPY 250
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
R+ ++ N A +D + + +D KR+T +EAL H +L S
Sbjct: 251 TPRQSFARLFPHA---NPLA-IDLLEKMLVFDPSKRITVEEALAHPYLAS 296
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 91/352 (25%), Positives = 162/352 (46%), Gaps = 66/352 (18%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RYE+++ +G+G++G V A + +T+ E E I+K +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETS------------EEETVAIKKITNV---------- 38
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR- 140
++KK +AL E+++L H R + + M F
Sbjct: 39 ------------------FSKKILAKRALRELKLLRHFRGHK--NITCLYDMDIVFPGNF 78
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
N L + ELM +L+++I+ Q + + F + ++ L+ +H N++H DLKP N+
Sbjct: 79 NELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNL 136
Query: 201 LLKQRGSSSIKVIDFGSSCYSH-------QRVYTYIQSRFYRSPEVILGL-PYGPPIDMW 252
L+ +K+ DFG + + Y+ +R+YR+PE++L Y ID+W
Sbjct: 137 LVNADCE--LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVW 194
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
S+GCILAEL P+F G++ V+QL I+++LG P +E + R+ G+P+
Sbjct: 195 SVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL-----SRI-----GSPKAQN 244
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
+ P + N A +D + + +D KR++ +EAL H +L
Sbjct: 245 YIRSLPNIPKKPFESIFPNANPLA-LDLLEKLLAFDPTKRISVEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 89/366 (24%), Positives = 159/366 (43%), Gaps = 90/366 (24%)
Query: 29 IGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESL 87
+G+G++G+V +A D T A+K + T+ + + C IH
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLV-------GMCGIH----- 64
Query: 88 SQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISF 147
L E++I++ ++ + N++ +++ + + + +
Sbjct: 65 -------------------FTTLRELKIMNEIKHE------NIMGLVDVYVEGDFINLVM 99
Query: 148 ELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL--------LHRENIIHCDLKPEN 199
++M +L +++ R R S V+C+ L LH+ +H DL P N
Sbjct: 100 DIMASDLKKVVDRKI----------RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPAN 149
Query: 200 VLLKQRGSSSIKVIDFG-SSCYSHQRVY------TYIQSR----------FYRSPEVILG 242
+ + +G K+ DFG + Y + +Q R +YR+PE+++G
Sbjct: 150 IFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207
Query: 243 LP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLF 301
Y +DMWS+GCI AEL TG PLFPGENE++QL I E+LG P ++ A + L+
Sbjct: 208 AEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLY 267
Query: 302 FDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
+ RKP KD+ ++ +D + + +R++ EAL+H
Sbjct: 268 TEFT------------PRKP--KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313
Query: 362 EWLKSS 367
E+ KS
Sbjct: 314 EYFKSD 319
|
Length = 335 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 84/267 (31%), Positives = 144/267 (53%), Gaps = 40/267 (14%)
Query: 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLN-LYELIKRNNYQGFS 167
AL E+R+L L+ N+++++E F + L + FE + L EL K N +G
Sbjct: 47 ALREIRMLKQLKHP------NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK--NPRGVP 98
Query: 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-- 225
LI++ + +Q + H+ N IH D+KPEN+L+ ++G IK+ DFG + R+
Sbjct: 99 EHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFA-----RILT 151
Query: 226 -----YT-YIQSRFYRSPEVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLA 278
YT Y+ +R+YR+PE+++G YGPP+D+W++GC+ AEL TG PL+PG+++V+QL
Sbjct: 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
Query: 279 CIMEILG--CPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336
I + LG P R + F + + ++ + R+P ++ + A
Sbjct: 212 LIRKTLGDLIP---------RHQQIFSTNQFFKGLSIPEPETREPLESKFPNI---SSPA 259
Query: 337 FVDFVTQCFNWDSKKRLTPDEALRHEW 363
+ F+ C D +RL+ +E L H +
Sbjct: 260 -LSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 7e-34
Identities = 81/356 (22%), Positives = 132/356 (37%), Gaps = 109/356 (30%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+ E++G+GSFG V ALD T A+K +L+ E+E
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV--ELSGDSEEELEALER---------- 48
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
E+RIL L+ N++ Y+
Sbjct: 49 -------------------------------EIRILSSLQHP------NIVR---YYGSE 68
Query: 141 -----NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCD 194
N L I E ++ +L L+K+ + +IR++ +++ L LH I+H D
Sbjct: 69 RDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRD 126
Query: 195 LKPENVLLKQRGSSSIKVIDFGSS------CYSHQRVYTYIQSRFYRSPEVILGLPYGPP 248
+K N+L+ G +K+ DFG + + + ++ +PEVI G YG
Sbjct: 127 IKGANILVDSDG--VVKLADFGCAKRLGDIETGEGT-GSVRGTPYWMAPEVIRGEEYGRA 183
Query: 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTP 308
D+WSLGC + E+ TG P P +A + +I S P
Sbjct: 184 ADIWSLGCTVIEMATGKP--PWSELGNPMAALYKIGS------------------SGEPP 223
Query: 309 RCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
+ ++ + DF+ +C D KKR T DE L+H +L
Sbjct: 224 ------------EIPEHLSEEAK-------DFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 9e-34
Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 55/273 (20%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
++E+L V+G+G++G V++ +T E I+K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETK--------------EIVAIKK-------------- 33
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
F D + K L E+++L L+++ N++ + E F R
Sbjct: 34 -----------FKDSEENEEVKE---TTLRELKMLRTLKQE------NIVELKEAFRRRG 73
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + FE + N+ EL++ G +R + + L++ + H+ +I+H D+KPEN+L
Sbjct: 74 KLYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLL 132
Query: 202 LKQRGSSSIKVIDFGS----SCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
+ + +K+ DFG S S+ Y+ +R+YRSPE++LG PYG +DMWS+GCI
Sbjct: 133 ISH--NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCI 190
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDE 290
L EL G PLFPGE+E++QL I ++LG P E
Sbjct: 191 LGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-33
Identities = 71/265 (26%), Positives = 130/265 (49%), Gaps = 36/265 (13%)
Query: 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQG-FS 167
A+ E+ ++ L+ ++ ++VIH N L + FE M+ +L + + + +G
Sbjct: 45 AIREISLMKELKHENIVRLHDVIHT------ENKLMLVFEYMDKDLKKYMDTHGVRGALD 98
Query: 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG--------SSC 219
++ F + L++ + H ++H DLKP+N+L+ +RG +K+ DFG +
Sbjct: 99 PNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNT 156
Query: 220 YSHQRVYTYIQSRFYRSPEVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLA 278
+S++ V + +YR+P+V+LG Y ID+WS+GCI+AE+ TG PLFPG N +QL
Sbjct: 157 FSNEVV-----TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211
Query: 279 CIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338
I I+G P + S+ P +D+ + D +
Sbjct: 212 KIFRIMGTPTESTWPGISQ---------LPEYKPTFPRYPP----QDLQQLFPHADPLGI 258
Query: 339 DFVTQCFNWDSKKRLTPDEALRHEW 363
D + + + + R++ +AL+H W
Sbjct: 259 DLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 102/364 (28%), Positives = 159/364 (43%), Gaps = 89/364 (24%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+YE L IG+G+FG+V +A KT ALK K
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALK----------------------------K 44
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLE----- 135
+ L +N K+ F AL E++IL L+ + NV++++E
Sbjct: 45 V-----LMEN----------EKEGFPITALREIKILQLLKHE------NVVNLIEICRTK 83
Query: 136 ---YFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIH 192
Y ++ + FE +L L+ N F+L I++ L+ L +HR I+H
Sbjct: 84 ATPYNRYKGSFYLVFEFCEHDLAGLLS-NKNVKFTLSEIKKVMKMLLNGLYYIHRNKILH 142
Query: 193 CDLKPENVLLKQRGSSSIKVIDFG------------SSCYSHQRVYTYIQSRFYRSPEVI 240
D+K N+L+ + G +K+ DFG + Y++ RV T +YR PE++
Sbjct: 143 RDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTN-RVVTL----WYRPPELL 195
Query: 241 LG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRR 299
LG YGPPIDMW GCI+AE++T P+ G E QL I ++ G EV +
Sbjct: 196 LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLE 255
Query: 300 LFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEAL 359
LF + + +G+KRK + V D +D + + D KR+ D AL
Sbjct: 256 LF-------KKMELPQGQKRKVKERLKPYV---KDPHALDLIDKLLVLDPAKRIDADTAL 305
Query: 360 RHEW 363
H++
Sbjct: 306 NHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-33
Identities = 98/348 (28%), Positives = 155/348 (44%), Gaps = 65/348 (18%)
Query: 21 YRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDAC 79
YE L I +G++G V RA D KT ALK + ++EK E G
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALK----------KLKMEKEKE----GFPIT 50
Query: 80 KIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF 139
+ L + H ++ V+ + + + D Y V +EY
Sbjct: 51 SLREINILLK---------------LQHPNIVTVK--EVVVGSNLDKIYMV---MEY--- 87
Query: 140 RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ +L L++ Q F ++ L+ + LH I+H DLK N
Sbjct: 88 ----------VEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSN 136
Query: 200 VLLKQRGSSSIKVIDFGSS--CYSHQRVYTYI-QSRFYRSPEVILGLP-YGPPIDMWSLG 255
+LL RG +K+ DFG + S + YT + + +YR+PE++LG Y IDMWS+G
Sbjct: 137 LLLNNRG--ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG 194
Query: 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315
CI AEL T PLFPG++E++QL I ++LG P ++ L K T ++
Sbjct: 195 CIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK--IWPGFSELPGAKKKTFTKYPYNQ 252
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
RK+ P L +D F D + + +D KR++ ++AL+H +
Sbjct: 253 LRKKFP-------ALSLSDNGF-DLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 94/353 (26%), Positives = 162/353 (45%), Gaps = 81/353 (22%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y+ +E IG+G++G V +A D T ALK KI
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALK----------------------------KI 32
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
E +DE A+ E+ +L L + +V+H N
Sbjct: 33 RLET--------EDEG-------VPSTAIREISLLKELNHPNIVRLLDVVHS------EN 71
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + FE ++L+L + + + G LI+ + + L+Q + H ++H DLKP+N+L
Sbjct: 72 KLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLL 131
Query: 202 LKQRGSSSIKVIDFGSS--------CYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMW 252
+ + G+ +K+ DFG + Y+H+ V + +YR+PE++LG Y P+D+W
Sbjct: 132 IDREGA--LKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEILLGSRQYSTPVDIW 184
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT-PRCI 311
S+GCI AE+ PLFPG++E++QL I LG P ++V + D K T P+
Sbjct: 185 SIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT---SLPDYKPTFPKW- 240
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
+D++ V+ D+ +D +++ +D KR++ AL+H +
Sbjct: 241 ----------ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 94/354 (26%), Positives = 161/354 (45%), Gaps = 75/354 (21%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RY L+ +G G++G V ALD +T + I+K
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGA--------------KVAIKKLYR----------- 50
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF---- 137
+ + F +A E+R+L H++ + NVI +L+ F
Sbjct: 51 -----------------PFQSELFAKRAYRELRLLKHMKHE------NVIGLLDVFTPDL 87
Query: 138 ----YFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHC 193
+ +L + F M +L +L+K ++ S I+ + +++ L+ +H IIH
Sbjct: 88 SLDRFHDFYLVMPF--MGTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHR 142
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPIDMW 252
DLKP N+ + + +K++DFG + + + Y+ +R+YR+PEVIL + Y +D+W
Sbjct: 143 DLKPGNLAVNE--DCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIW 200
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
S+GCI+AE+ TG PLF G + ++QL IM++ G P E + K PR
Sbjct: 201 SVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF-- 258
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
RK KD S+L + V+ + + D++ R+T EAL H + +
Sbjct: 259 ----RK-----KDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 78/264 (29%), Positives = 133/264 (50%), Gaps = 35/264 (13%)
Query: 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSL 168
A+ E+ +L L N++ +L+ + N L + FE ++ +L + + + G L
Sbjct: 46 AIREISLLKELNHP------NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPL 99
Query: 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS--------CY 220
LI+ + F L+Q L H ++H DLKP+N+L+ G+ IK+ DFG + Y
Sbjct: 100 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 157
Query: 221 SHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLAC 279
+H+ V + +YR+PE++LG Y +D+WSLGCI AE+ T LFPG++E++QL
Sbjct: 158 THEVV-----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212
Query: 280 IMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVD 339
I LG P + V + + + K K +D + V+ D+ D
Sbjct: 213 IFRTLGTPDEVVWPGVTS-------------LPDYKPSFPKWARQDFSKVVPPLDEDGRD 259
Query: 340 FVTQCFNWDSKKRLTPDEALRHEW 363
++Q ++D KR++ AL H +
Sbjct: 260 LLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 95/354 (26%), Positives = 169/354 (47%), Gaps = 78/354 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+YE +E IG+G++G V +A D TN T ALK K
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALK----------------------------K 34
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
I E+ +DE A+ E+ +L ++ + +V+H + Y
Sbjct: 35 IRLEQ--------EDEG-------VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY-- 77
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ FE ++L+L + + + + LI+ + + +++ + H ++H DLKP+N+
Sbjct: 78 ----LVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNL 133
Query: 201 LLKQRGSSSIKVIDFGSS--------CYSHQRVYTYIQSRFYRSPEVILG-LPYGPPIDM 251
L+ +R ++++K+ DFG + ++H+ V + +YR+PE++LG Y P+D+
Sbjct: 134 LIDRR-TNALKLADFGLARAFGIPVRTFTHEVV-----TLWYRAPEILLGSRHYSTPVDI 187
Query: 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311
WS+GCI AE+ PLFPG++E+++L I ILG P +E + +
Sbjct: 188 WSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT-------------SL 234
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
+ K K KD+A+V+ + A VD +++ D KR+T AL HE+ K
Sbjct: 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 83/281 (29%), Positives = 131/281 (46%), Gaps = 41/281 (14%)
Query: 108 QALIEVRILDHLRKKDADSSYNVIHML------------EYFYFRNHLCISFELMNLNLY 155
AL E++I+ R+ D D+ V +L + + I E M +L
Sbjct: 48 HALREIKII---RRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS-VYIVQEYMETDLA 103
Query: 156 ELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDF 215
++ S R F + L++ L+ +H N++H DLKP NV + +K+ DF
Sbjct: 104 NVL---EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE-DLVLKIGDF 159
Query: 216 G-----SSCYSHQRVYTY-IQSRFYRSPEVILGLP--YGPPIDMWSLGCILAELYTGCPL 267
G YSH+ + + +++YRSP ++L P Y IDMW+ GCI AE+ TG PL
Sbjct: 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPL 218
Query: 268 FPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327
F G +E+EQ+ I+E + V+ R L P + N G R+P +
Sbjct: 219 FAGAHELEQMQLILESV-----PVVREEDRNELL---NVIPSFVRNDGGEPRRPLRDLLP 270
Query: 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368
V N +A +DF+ Q ++ RLT +EAL H ++ S
Sbjct: 271 GV---NPEA-LDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 86/366 (23%), Positives = 148/366 (40%), Gaps = 88/366 (24%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
YEIL +G+G+FG+V +A KT ALK K L
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALK---------------KIL----------- 42
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY-- 138
+H E K F AL E++IL L+ NV+ +++
Sbjct: 43 MHNE-----------------KDGFPITALREIKILKKLKHP------NVVPLIDMAVER 79
Query: 139 ----FRNHLCIS--FELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIH 192
R + M+ +L L++ + + + I+ + L++ + LH +I+H
Sbjct: 80 PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-LTESQIKCYMLQLLEGINYLHENHILH 138
Query: 193 CDLKPENVLLKQRGSSSIKVIDFG-------------SSCYSHQRVYT-YIQSRFYRSPE 238
D+K N+L+ +G +K+ DFG R YT + +R+YR PE
Sbjct: 139 RDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE 196
Query: 239 VILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASR 297
++LG Y +D+W +GC+ AE++T P+ G+++++QL I ++ G P +E
Sbjct: 197 LLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRS 256
Query: 298 RRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDE 357
+ R K G + D +++ + D KRLT +
Sbjct: 257 LPGCEGVHSFTNYPRTLEERFGKLG-PEGL-----------DLLSKLLSLDPYKRLTASD 304
Query: 358 ALRHEW 363
AL H +
Sbjct: 305 ALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-31
Identities = 78/264 (29%), Positives = 139/264 (52%), Gaps = 32/264 (12%)
Query: 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNL---YELIKRNNYQG 165
A+ E+ +L L+ N++ + + + L + FE ++++L + + + Y
Sbjct: 46 AIREISLLKELQHP------NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY-- 97
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG--SSCYSHQ 223
L++ + + ++Q + H ++H DLKP+N+L+ +G IK+ DFG +
Sbjct: 98 MDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPV 155
Query: 224 RVYTY-IQSRFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM 281
RVYT+ + + +YR+PEV+LG P Y P+D+WS+G I AE+ T PLF G++E++QL I
Sbjct: 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIF 215
Query: 282 EILGCPPDEVINTASRRRLFFDSKGT-PRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340
ILG P ++V + D K T P K K GS + S ++ D+ +D
Sbjct: 216 RILGTPTEDVWPGVTSLP---DYKNTFP---------KWKKGS--LRSAVKNLDEDGLDL 261
Query: 341 VTQCFNWDSKKRLTPDEALRHEWL 364
+ + +D KR++ +AL H +
Sbjct: 262 LEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-30
Identities = 80/249 (32%), Positives = 134/249 (53%), Gaps = 37/249 (14%)
Query: 129 NVIHMLEYFY---FRNH-----LCISFELMNLNLYELIK---RNNYQGFSLGLIRRFAFS 177
N+I + +Y+Y F+ + L + E + +++ +K RNN L L++ +++
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNN-HALPLFLVKLYSYQ 178
Query: 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS--CYSHQRVYTYIQSRFYR 235
L + L +H + I H DLKP+N+L+ + ++K+ DFGS+ + QR +YI SRFYR
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLLIDPN-THTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237
Query: 236 SPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDE---V 291
+PE++LG Y ID+WSLGCI+AE+ G P+F G++ V+QL I+++LG P ++
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297
Query: 292 INTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL-RCNDKAFVDFVTQCFNWDSK 350
+N F D K KD+ V + ++F++Q ++
Sbjct: 298 MNPNYADIKFPDVK-----------------PKDLKKVFPKGTPDDAINFISQFLKYEPL 340
Query: 351 KRLTPDEAL 359
KRL P EAL
Sbjct: 341 KRLNPIEAL 349
|
Length = 440 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 76/263 (28%), Positives = 134/263 (50%), Gaps = 35/263 (13%)
Query: 112 EVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQG 165
E+R+L H++ + NVI +L+ F N + + LM +L ++K Q
Sbjct: 64 ELRLLKHMKHE------NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQK 114
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV 225
S ++ + L++ L+ +H IIH DLKP NV + + ++++DFG + + +
Sbjct: 115 LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DCELRILDFGLARQADDEM 172
Query: 226 YTYIQSRFYRSPEVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEIL 284
Y+ +R+YR+PE++L + Y +D+WS+GCI+AEL G LFPG + ++QL IME++
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232
Query: 285 GCPPDEV---INTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341
G P EV I++ R+ P+ +D+ + R + +D +
Sbjct: 233 GTPSPEVLKKISSEHARKYIQSLPHMPQ--------------QDLKKIFRGANPLAIDLL 278
Query: 342 TQCFNWDSKKRLTPDEALRHEWL 364
+ DS KR++ EAL H +
Sbjct: 279 EKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 99/355 (27%), Positives = 168/355 (47%), Gaps = 82/355 (23%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
YE LE IG+G++G+V +A D T +L ++T +E E G+ +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTG---------KLVALKKTRLEMDEE----GIPPTALR 49
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILD--HLRKKDADSSYNVIHMLEYFYFR 140
E SL Q +++ VR+LD H+ +K+ S
Sbjct: 50 -EISLLQ---------------MLSESIYIVRLLDVEHVEEKNGKPS------------- 80
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGL----IRRFAFSLVQCLRLLHRENIIHCDLK 196
L + FE ++ +L + + N +G L I+ F + L++ + H+ ++H DLK
Sbjct: 81 --LYLVFEYLDSDLKKFMDSN-GRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLK 137
Query: 197 PENVLL-KQRGSSSIKVIDFGSS--------CYSHQRVYTYIQSRFYRSPEVILGLP-YG 246
P+N+L+ KQ+G +K+ D G Y+H+ I + +YR+PEV+LG Y
Sbjct: 138 PQNLLVDKQKGL--LKIADLGLGRAFSIPVKSYTHE-----IVTLWYRAPEVLLGSTHYS 190
Query: 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306
P+D+WS+GCI AE+ PLFPG++E++QL I ++LG P ++V S+ R D
Sbjct: 191 TPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLR---DWHE 247
Query: 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
P + KP +D++ + +D + + +D KR++ AL H
Sbjct: 248 FP---------QWKP--QDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-29
Identities = 79/345 (22%), Positives = 125/345 (36%), Gaps = 97/345 (28%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+EILE IGKG FG+V +A +T A+K I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIK----------------------------VI 33
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
K + + E++IL + N++ + ++
Sbjct: 34 K-----------------LESKEKKEKIINEIQILKKCK------HPNIVKYYGSYLKKD 70
Query: 142 HLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L I E + +L +L+K + Q + I L++ L LH IIH D+K N+
Sbjct: 71 ELWIVMEFCSGGSLKDLLK-STNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANI 129
Query: 201 LLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
LL G +K+IDFG S + T + + ++ +PEVI G PY D+WSLG
Sbjct: 130 LLTSDGE--VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITA 187
Query: 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
EL G P + PP + + + G P K
Sbjct: 188 IELAEGKPPYS---------------ELPPMKALFKIAT-------NGPPGLRNPEK--- 222
Query: 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
F DF+ +C + +KR T ++ L+H +
Sbjct: 223 --------------WSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 7e-29
Identities = 52/146 (35%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 136 YFYF--RNHLCISFELMNLNLYELIKR-NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIH 192
++ F L + E EL + FS R +A +V L LH II+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGG--ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 193 CDLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPEVILGLPYGPPI 249
DLKPEN+LL G IK+ DFG + R T+ + Y +PEV+LG YG +
Sbjct: 117 RDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 250 DMWSLGCILAELYTGCPLFPGENEVE 275
D WSLG +L E+ TG P F E+ E
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 90/415 (21%), Positives = 135/415 (32%), Gaps = 93/415 (22%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
Y IL +G+GSFG+V A D K ALK +L
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL--VALKVLAKKLE------------------------ 35
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
+K + + L E++IL L N++ + ++F
Sbjct: 36 ------------------SKSKEVERFLREIQILASLNHPP-----NIVKLYDFFQDEGS 72
Query: 143 LCISFELM-NLNLYELIKRNNYQG-FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L + E + +L +L+K+ +G S ++ L LH + IIH D+KPEN+
Sbjct: 73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENI 132
Query: 201 LLKQRGSSSIKVIDFGSSCYSH---------QRVYTYIQSRFYRSPEVILGL---PYGPP 248
LL + G +K+IDFG + T + + Y +PEV+LGL
Sbjct: 133 LLDRDG-RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSS 191
Query: 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTP 308
D+WSLG L EL TG P F GE + T
Sbjct: 192 SDIWSLGITLYELLTGLPPFEGEKN---------------------------SSATSQTL 224
Query: 309 RCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368
+ I S KA D + + D K RL+ L H+ L
Sbjct: 225 KIILELPTPSLASPLSP--SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282
Query: 369 SSSSSSSHHATDLRKSPSAHTNMYRLYRGVPTKPSAPADIDLNDSGTFLPPILFN 423
S S +P + L + + S
Sbjct: 283 LKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELA 337
|
Length = 384 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 70/254 (27%), Positives = 131/254 (51%), Gaps = 17/254 (6%)
Query: 112 EVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLI 171
E+R+L H++ ++ +V N + + LM +L ++K Q + +
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHV 122
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQS 231
+ + +++ L+ +H +IIH DLKP N+ + + +K++DFG + ++ + Y+ +
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELKILDFGLARHTDDEMTGYVAT 180
Query: 232 RFYRSPEVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDE 290
R+YR+PE++L + Y +D+WS+GCI+AEL TG LFPG + ++QL I+ ++G P E
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240
Query: 291 VINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSK 350
++ S + R S + K + A+V + VD + + DS
Sbjct: 241 LLKKISSE--------SARNYIQSLTQMPK---MNFANVFIGANPLAVDLLEKMLVLDSD 289
Query: 351 KRLTPDEALRHEWL 364
KR+T +AL H +
Sbjct: 290 KRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 96/358 (26%), Positives = 149/358 (41%), Gaps = 80/358 (22%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
++I+ IG+G++GQV +A D T ALK R + EK
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKV--------RLDNEK-------------- 46
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKK----------DADSSYNVI 131
+ F A+ E++IL L + D + +
Sbjct: 47 ---------------------EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85
Query: 132 HMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENII 191
FY + FE M+ +L L++ + FS I+ F L++ L H++N +
Sbjct: 86 KDKGAFY------LVFEYMDHDLMGLLE-SGLVHFSEDHIKSFMKQLLEGLNYCHKKNFL 138
Query: 192 HCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYT-YIQSRFYRSPEVILGLP-YG 246
H D+K N+LL +G IK+ DFG + + R YT + + +YR PE++LG YG
Sbjct: 139 HRDIKCSNILLNNKGQ--IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYG 196
Query: 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306
P ID+WS GCIL EL+T P+F E+ QL I + G P V + F K
Sbjct: 197 PAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK- 255
Query: 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
K + R+ ++ + + +D + D KR T +EAL WL
Sbjct: 256 -------PKKQYRRRLREEFSFI----PTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 147 FELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG 206
FE ++ +L + + G I+ ++ L LH I+H DLKPEN+L+ G
Sbjct: 86 FEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG 145
Query: 207 SSSIKVIDFG-SSCYSHQRVYT-YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
+K+ DFG + YS Q T + + +YR+PEV+L Y P+DMWS+GCI AE++
Sbjct: 146 Q--VKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 203
Query: 265 CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324
PLF G +E +QL I +++G PP++ PR +T +G G +
Sbjct: 204 KPLFCGNSEADQLGKIFDLIGLPPED---------------DWPRDVTLPRGAFSPRGPR 248
Query: 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
+ SV+ +++ + + ++ KR++ AL+H +
Sbjct: 249 PVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 68/280 (24%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+YE LE IG+G++G V +A + +T+ ++ +R ++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETH---------EIVALKRVRLDD-------------- 37
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
DDE + AL E+ +L L+ K+ Y+V+H
Sbjct: 38 ------------DDEGVPSS-------ALREICLLKELKHKNIVRLYDVLHS------DK 72
Query: 142 HLCISFELMNLNLYELIKRNNYQG-FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L + FE + +L + ++ G +++ F F L++ L H N++H DLKP+N+
Sbjct: 73 KLTLVFEYCDQDLKKYF--DSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNL 130
Query: 201 LLKQRGSSSIKVIDFGSS--------CYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDM 251
L+ + G +K+ DFG + CYS + V + +YR P+V+ G Y IDM
Sbjct: 131 LINKNG--ELKLADFGLARAFGIPVRCYSAEVV-----TLWYRPPDVLFGAKLYSTSIDM 183
Query: 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDE 290
WS GCI AEL G PLFPG + +QL I +LG P +E
Sbjct: 184 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 91/355 (25%), Positives = 163/355 (45%), Gaps = 78/355 (21%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RY L+ +G G++G V A+D +T E+ I+K
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTG--------------EKVAIKK-------------- 47
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY--- 138
LS+ + + F +A E+ +L H++ + NVI +L+ F
Sbjct: 48 -----LSR---------PFQSEIFAKRAYRELTLLKHMQHE------NVIGLLDVFTSAV 87
Query: 139 -FRN----HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHC 193
+L + + M +L +++ S ++ + ++ L+ +H IIH
Sbjct: 88 SGDEFQDFYLVMPY--MQTDLQKIMGHP----LSEDKVQYLVYQMLCGLKYIHSAGIIHR 141
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPIDMW 252
DLKP N+ + + +K++DFG + ++ + Y+ +R+YR+PEVIL + Y +D+W
Sbjct: 142 DLKPGNLAVNE--DCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIW 199
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
S+GCI+AE+ TG LF G++ ++QL I+++ G P E + + K I
Sbjct: 200 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK-------LEDKAAKSYI- 251
Query: 313 NSKGRKRKPGSKDMASVL-RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
K + P KD +++ + + +A VD + + D KRLT EAL H + S
Sbjct: 252 --KSLPKYP-RKDFSTLFPKASPQA-VDLLEKMLELDVDKRLTATEALEHPYFDS 302
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 85/355 (23%), Positives = 131/355 (36%), Gaps = 103/355 (29%)
Query: 24 EILEVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
E ++V+G+GS G V + T +ALK KIH
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALK----------------------------KIH 35
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
DE F Q L E++ L + +S Y V+ FY
Sbjct: 36 V---------DGDEE-------FRKQLLRELKTL-----RSCESPY-VVKCYGAFYKEGE 73
Query: 143 LCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKPENV 200
+ I E M+ +L +L+K+ ++ A +++ L LH + +IIH D+KP N+
Sbjct: 74 ISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNL 131
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
L+ +G +K+ DFG S + T++ + Y SPE I G Y D+WSLG
Sbjct: 132 LINSKGE--VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189
Query: 258 LAELYTG-CPLFPGENEVEQLACIMEIL--GCPPDEVINTASRRRLFFDSKGTPRCITNS 314
L E G P P +M+ + G PP S
Sbjct: 190 LLECALGKFPFLP--PGQPSFFELMQAICDGPPPSLPAEEFS------------------ 229
Query: 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369
F DF++ C D KKR + E L+H ++K + +
Sbjct: 230 --------------------PEFRDFISACLQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-27
Identities = 75/263 (28%), Positives = 131/263 (49%), Gaps = 31/263 (11%)
Query: 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSL 168
A+ EV +L +L+ + + +++IH L + FE ++ +L + + N S+
Sbjct: 50 AIREVSLLKNLKHANIVTLHDIIHT------ERCLTLVFEYLDSDLKQYLD-NCGNLMSM 102
Query: 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTY 228
++ F F L++ L H+ I+H DLKP+N+L+ ++G +K+ DFG + TY
Sbjct: 103 HNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKTY 160
Query: 229 ---IQSRFYRSPEVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEIL 284
+ + +YR P+V+LG Y PIDMW +GCIL E+ TG P+FPG E+L I +L
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220
Query: 285 GCPPDEV---INTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341
G P +E I + R + + + + N R G +D +
Sbjct: 221 GTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDG---------------IDLL 265
Query: 342 TQCFNWDSKKRLTPDEALRHEWL 364
+ +++K R++ + ALRH +
Sbjct: 266 SSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 72/246 (29%), Positives = 128/246 (52%), Gaps = 34/246 (13%)
Query: 134 LEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCL---RLLHRENI 190
LE F + + ELM+ NL ++I+ + R ++ L Q L + LH I
Sbjct: 90 LEEF---QDVYLVMELMDANLCQVIQMDLDH-------ERMSYLLYQMLCGIKHLHSAGI 139
Query: 191 IHCDLKPENVLLKQRGSSSIKVIDFG--SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPP 248
IH DLKP N+++K ++K++DFG + + + Y+ +R+YR+PEVILG+ Y
Sbjct: 140 IHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 197
Query: 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINT-ASRRRLFFDSKGT 307
+D+WS+GCI+ E+ G LFPG + ++Q I+E LG P DE ++ R + +++
Sbjct: 198 VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENR-- 255
Query: 308 PRCITNSKGRKRK--------PGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEAL 359
P+ G + P + + L+ + D +++ D +KR++ D+AL
Sbjct: 256 PKY----AGYSFEELFPDVLFPPDSESHNKLKASQAR--DLLSKMLVIDPEKRISVDDAL 309
Query: 360 RHEWLK 365
+H ++
Sbjct: 310 QHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 96/368 (26%), Positives = 148/368 (40%), Gaps = 103/368 (27%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+E L IG+G++G V RA D + ALK R + E+ D I
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKV--------RMDNER---------DGIPI 51
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR- 140
L E+ +L +LR N++ + E +
Sbjct: 52 SS--------------------------LREITLLLNLRHP------NIVELKEVVVGKH 79
Query: 141 -NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ + + E +L L+ N FS ++ L++ L+ LH IIH DLK N
Sbjct: 80 LDSIFLVMEYCEQDLASLLD-NMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSN 138
Query: 200 VLLKQRGSSSIKVIDFG-SSCYSH-QRVYT-YIQSRFYRSPEVILG-LPYGPPIDMWSLG 255
+LL +G +K+ DFG + Y + T + + +YR+PE++LG Y IDMW++G
Sbjct: 139 LLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVG 196
Query: 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315
CILAEL PL PG++E+EQL I+++LG P + +
Sbjct: 197 CILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW----------------------- 233
Query: 316 GRKRKPGSKDMASVLRCN-DKAFVDFVTQCFNW---------------DSKKRLTPDEAL 359
PG D+ V + K + + F W D KKR T +EAL
Sbjct: 234 -----PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288
Query: 360 RHEWLKSS 367
+ K
Sbjct: 289 ESSYFKEK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 90/361 (24%), Positives = 152/361 (42%), Gaps = 67/361 (18%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
R++IL ++G+G+FG+V+ A D K + A KI
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYC----------------------------AVKI 161
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
N ++ A IE++ ++ +R+ D + ++ + YF
Sbjct: 162 -----------------VRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204
Query: 142 -HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKPEN 199
H+CI L + I ++ FS + + F L H E +++H DLKPEN
Sbjct: 205 GHMCIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPEN 262
Query: 200 VLLKQRGSS--------------SIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPY 245
+L++ + +++ D G C + +R YRSPEV+LGL +
Sbjct: 263 ILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGW 322
Query: 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDE--VINTASRRRLFFD 303
DMWS+GCI+ ELYTG L+ + +E L + + LG P E RL ++
Sbjct: 323 MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYN 382
Query: 304 SKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
S G R T+ K R ++ + V+R D D + ++D +KRL + H +
Sbjct: 383 SAGQLRPCTDPKHLARIARARPVREVIR--DDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440
Query: 364 L 364
+
Sbjct: 441 V 441
|
Length = 467 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-27
Identities = 58/186 (31%), Positives = 81/186 (43%), Gaps = 22/186 (11%)
Query: 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKR 160
+K Q L E IL + S Y V+ + F + +L + E + +L L++
Sbjct: 33 RKNQVDQVLTERDILSQAQ-----SPY-VVKLYYSFQGKKNLYLVMEYLPGGDLASLLE- 85
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
N + R + +V L LH IIH DLKP+N+L+ G +K+ DFG S
Sbjct: 86 -NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKV 142
Query: 221 SHQRVYTYIQSRF-----------YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFP 269
R + Y +PEVILG + +D WSLGCIL E G P F
Sbjct: 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202
Query: 270 GENEVE 275
GE E
Sbjct: 203 GETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 75/266 (28%), Positives = 127/266 (47%), Gaps = 34/266 (12%)
Query: 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSL 168
A+ E +L L+ + + +++IH + L + FE ++ +L + + G S+
Sbjct: 50 AIREASLLKDLKHANIVTLHDIIHT------KKTLTLVFEYLDTDLKQYMDDCG-GGLSM 102
Query: 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG--------SSCY 220
+R F F L++ L H+ ++H DLKP+N+L+ +RG +K+ DFG S Y
Sbjct: 103 HNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTY 160
Query: 221 SHQRVYTYIQSRFYRSPEVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEV-EQLA 278
S++ V + +YR P+V+LG Y +DMW +GCI E+ TG PLFPG +V +QL
Sbjct: 161 SNEVV-----TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH 215
Query: 279 CIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338
I +LG P +E S F P +P + R
Sbjct: 216 KIFRVLGTPTEETWPGVSSNPEFKPYSF-PFY-------PPRPLINHAPRLDRIPHG--E 265
Query: 339 DFVTQCFNWDSKKRLTPDEALRHEWL 364
+ + ++ KKR++ EA++H +
Sbjct: 266 ELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 77/271 (28%), Positives = 125/271 (46%), Gaps = 43/271 (15%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+YE + IG+G++G+V +A D K G + +R ++ E G+ I
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEE----GMPLSTI 49
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
L F+ N VR+ D D
Sbjct: 50 REVAVLRHLETFEHPN--------------VVRLFDVCTVSRTDR-------------ET 82
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + FE ++ +L + + G I+ F L++ L LH ++H DLKP+N+L
Sbjct: 83 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 142
Query: 202 LKQRGSSSIKVIDFG-SSCYSHQRVYT-YIQSRFYRSPEVILGLPYGPPIDMWSLGCILA 259
+ G IK+ DFG + YS Q T + + +YR+PEV+L Y P+D+WS+GCI A
Sbjct: 143 VTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 200
Query: 260 ELYTGCPLFPGENEVEQLACIMEILGCPPDE 290
E++ PLF G ++V+QL I++++G P +E
Sbjct: 201 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 73/265 (27%), Positives = 129/265 (48%), Gaps = 31/265 (11%)
Query: 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSL 168
A+ EV +L L+ + + +++IH L + FE ++ +L + + + ++
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIIHT------EKSLTLVFEYLDKDLKQYLD-DCGNSINM 103
Query: 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTY 228
++ F F L++ L HR ++H DLKP+N+L+ +RG +K+ DFG + TY
Sbjct: 104 HNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTY 161
Query: 229 ---IQSRFYRSPEVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEIL 284
+ + +YR P+++LG Y IDMW +GCI E+ TG PLFPG EQL I IL
Sbjct: 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221
Query: 285 GCPPDEV---INTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341
G P +E I + + + K C+ N R G + +
Sbjct: 222 GTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDG---------------AELL 266
Query: 342 TQCFNWDSKKRLTPDEALRHEWLKS 366
++ ++ +KR++ +EA++H +
Sbjct: 267 SKLLQFEGRKRISAEEAMKHPYFHC 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 66/269 (24%), Positives = 128/269 (47%), Gaps = 34/269 (12%)
Query: 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFS 167
+ E+++L + + S+ +++ F + + ELM +L+++I Q S
Sbjct: 45 RVFRELKMLCFFKHDNVLSALDILQPPHIDPFE-EIYVVTELMQSDLHKIIVSP--QPLS 101
Query: 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG--------SSC 219
++ F + +++ L+ LH I+H D+KP N+L+ + +K+ DFG S
Sbjct: 102 SDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS--NCVLKICDFGLARVEEPDESK 159
Query: 220 YSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLA 278
+ Q V T ++YR+PE+++G Y +D+WS+GCI AEL LF ++ ++QL
Sbjct: 160 HMTQEVVT----QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215
Query: 279 CIMEILGCPPDEVINTA---SRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335
I ++LG P E + +A +R + +G + P + ++
Sbjct: 216 LITDLLGTPSLEAMRSACEGARAHIL-------------RGPHKPPSLPVLYTLSSQATH 262
Query: 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
V + + +D KR++ +AL H +L
Sbjct: 263 EAVHLLCRMLVFDPDKRISAADALAHPYL 291
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 68/266 (25%), Positives = 114/266 (42%), Gaps = 44/266 (16%)
Query: 129 NVIHMLEYFYFRNHLCIS--FELMNLNLYELIK---RNNYQGFSLGLIRRFAFSLVQCLR 183
NV+ ++E F + F+ +L+++IK + +++ + ++ +
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 184 LLHRENIIHCDLKPENVLLKQRGSSS--IKVIDFG---------SSCYSHQRVYTYIQSR 232
LH ++H DLKP N+L+ G +K+ D G V I
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI--- 179
Query: 233 FYRSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENE---------VEQLACIME 282
+YR+PE++LG Y ID+W++GCI AEL T P+F G +QL I E
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239
Query: 283 ILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD-----MASVLRCNDKAF 337
+LG P ++ + D K P T K K K + M + + + F
Sbjct: 240 VLGTPTEKD---------WPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 338 VDFVTQCFNWDSKKRLTPDEALRHEW 363
D + + +D KR+T +EAL H +
Sbjct: 291 -DLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 72/265 (27%), Positives = 135/265 (50%), Gaps = 31/265 (11%)
Query: 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSL 168
A+ EV +L L+ + + ++++H L + FE ++ +L + + + S+
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIVHT------DKSLTLVFEYLDKDLKQYMD-DCGNIMSM 103
Query: 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTY 228
++ F + +++ L HR ++H DLKP+N+L+ +RG +K+ DFG + TY
Sbjct: 104 HNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKTY 161
Query: 229 ---IQSRFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEIL 284
+ + +YR P+V+LG Y IDMW +GCI E+ +G PLFPG ++L I +L
Sbjct: 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL 221
Query: 285 GCPPDEV---INTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341
G P +E I++ + + K P+ + N R G ++ +
Sbjct: 222 GTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEG---------------IELL 266
Query: 342 TQCFNWDSKKRLTPDEALRHEWLKS 366
T+ ++SKKR++ +EA++H + +S
Sbjct: 267 TKFLQYESKKRISAEEAMKHAYFRS 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 78/282 (27%), Positives = 115/282 (40%), Gaps = 71/282 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+YEI++ IGKGSFG+V LK ++ +E E+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLK----EIDLSNMSEKER------------- 43
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
E++L+ EV+IL L N+I E F +
Sbjct: 44 ---EDALN-----------------------EVKILKKLNHP------NIIKYYESFEEK 71
Query: 141 NHLCISFELMNL-NLYELIKRNNYQG--FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
LCI E + +L + IK+ +G F I + L L+ LH I+H D+KP
Sbjct: 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKP 131
Query: 198 ENVLLKQRGSSSIKVIDFGSSCYSHQRVY--------TYIQSRFYRSPEVILGLPYGPPI 249
+N+ L G +K+ DFG S +V T + + +Y SPE+ PY
Sbjct: 132 QNIFLTSNGL--VKLGDFGIS-----KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKS 184
Query: 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEV 291
D+WSLGC+L EL T F GEN L ++IL +
Sbjct: 185 DIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQYPPI 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 69/278 (24%), Positives = 111/278 (39%), Gaps = 80/278 (28%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
++ ++IG+GSF V+ A + +TN K Y A KI
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETN----KEY------------------------AIKIL 34
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
+ L K++ IE +L L + +I + Y+ F++
Sbjct: 35 DKRQL-------------IKEKKVKYVKIEKEVLTRL-----NGHPGIIKL--YYTFQDE 74
Query: 143 LCISFELMNL----NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ F ++ L + I++ Y R +A ++ L LH + IIH DLKPE
Sbjct: 75 ENLYF-VLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPE 131
Query: 199 NVLLKQRGSSSIKVIDFGSSC---------------YSHQRVYTYIQSRF--------YR 235
N+LL + IK+ DFG++ + + RF Y
Sbjct: 132 NILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV 189
Query: 236 SPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENE 273
SPE++ P G D+W+LGCI+ ++ TG P F G NE
Sbjct: 190 SPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 74/348 (21%), Positives = 132/348 (37%), Gaps = 99/348 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y++ ++IG+G+FG V + L+ +T A+K + +I
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIK-------QISLEKI--------------- 38
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
K+ + E+ +L +L+ N++ +
Sbjct: 39 ---------------------KEEALKSIMQEIDLLKNLKHP------NIVKYIGSIETS 71
Query: 141 NHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ L I E N +L ++IK+ + F L+ + + ++Q L LH + +IH D+K N
Sbjct: 72 DSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAAN 129
Query: 200 VLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
+L + G +K+ DFG + + + + + ++ +PEVI D+WSLGC
Sbjct: 130 ILTTKDG--VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGC 187
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
+ EL TG P + N + L I++ PP P I+
Sbjct: 188 TVIELLTGNPPYYDLNPMAALFRIVQ-DDHPP------------------LPEGIS---- 224
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
DF+ QCF D R T + L+H W+
Sbjct: 225 ------------------PELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 6e-24
Identities = 79/258 (30%), Positives = 125/258 (48%), Gaps = 42/258 (16%)
Query: 129 NVIHMLEYFYFRNHL------CISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCL 182
N+I +L F + L I ELM+ NL ++I+ R ++ L Q L
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-------ERMSYLLYQML 136
Query: 183 ---RLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG--SSCYSHQRVYTYIQSRFYRSP 237
+ LH IIH DLKP N+++K ++K++DFG + + + Y+ +R+YR+P
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 238 EVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASR 297
EVILG+ Y +D+WS+GCI+ E+ G LFPG + ++Q ++E LG P E
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE------- 247
Query: 298 RRLFFDSKGTPRCITNSKGRKRKPG---SKDMASVLRCNDKAF--------VDFVTQCFN 346
F K P T + R + G K VL D D +++
Sbjct: 248 ----FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 347 WDSKKRLTPDEALRHEWL 364
D+ KR++ DEAL+H ++
Sbjct: 304 IDASKRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 76/268 (28%), Positives = 123/268 (45%), Gaps = 62/268 (23%)
Query: 129 NVIHMLEYFYFRNHL------CISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCL 182
N+I +L F + L + ELM+ NL ++I R ++ L Q L
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDH-------ERMSYLLYQML 133
Query: 183 ---RLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG--SSCYSHQRVYTYIQSRFYRSP 237
+ LH IIH DLKP N+++K ++K++DFG + ++ + Y+ +R+YR+P
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191
Query: 238 EVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINT--- 294
EVILG+ Y +D+WS+GCI+ EL G +F G + ++Q ++E LG P E +N
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 295 --------------ASRRRLF----FDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336
S LF F S+ + S+ R
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQAR------------------- 292
Query: 337 FVDFVTQCFNWDSKKRLTPDEALRHEWL 364
D +++ D KR++ DEALRH ++
Sbjct: 293 --DLLSKMLVIDPDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 61/250 (24%), Positives = 109/250 (43%), Gaps = 50/250 (20%)
Query: 129 NVIHMLEYFYFRNHLCISFELMNLN-LYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHR 187
N++ + + + L + E M+ L ++I +N + + I ++Q L LH
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEYLHS 134
Query: 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFG-----SSCYSHQRVYTYIQSRFYRSPEVILG 242
+N+IH D+K +N+LL + GS +K+ DFG + + + + + ++ +PEVI
Sbjct: 135 QNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTK--EKSKRNSVVGTPYWMAPEVIKR 190
Query: 243 LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFF 302
YGP +D+WSLG + E+ G P + E + L I
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT--------------------- 229
Query: 303 DSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHE 362
+KG P + N + S + F DF+ +C D +KR + +E L+H
Sbjct: 230 -TKGIPP-LKNPEKW-----SPE-----------FKDFLNKCLVKDPEKRPSAEELLQHP 271
Query: 363 WLKSSSSSSS 372
+LK +
Sbjct: 272 FLKKACPKEE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 4e-22
Identities = 74/254 (29%), Positives = 123/254 (48%), Gaps = 34/254 (13%)
Query: 129 NVIHMLEYFYFRNHL------CISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCL 182
N+I +L F + L + ELM+ NL ++I+ R ++ L Q L
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDH-------ERMSYLLYQML 129
Query: 183 ---RLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG--SSCYSHQRVYTYIQSRFYRSP 237
+ LH IIH DLKP N+++K ++K++DFG + + + Y+ +R+YR+P
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 238 EVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDE------- 290
EVILG+ Y +D+WS+GCI+ E+ LFPG + ++Q ++E LG P E
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 291 VINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSK 350
+ R + P+ +S +K AS R D +++ D
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR-------DLLSKMLVIDPA 300
Query: 351 KRLTPDEALRHEWL 364
KR++ DEAL+H ++
Sbjct: 301 KRISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 4e-22
Identities = 59/188 (31%), Positives = 99/188 (52%), Gaps = 14/188 (7%)
Query: 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSL 168
A+ E +L L+ + +++IH E F FE M+ +L + + ++ G
Sbjct: 50 AIREASLLKGLKHANIVLLHDIIHTKETLTF------VFEYMHTDLAQYMIQHP-GGLHP 102
Query: 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRV 225
+R F F L++ L +H ++I+H DLKP+N+L+ G +K+ DFG + Q
Sbjct: 103 YNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQTY 160
Query: 226 YTYIQSRFYRSPEVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEV-EQLACIMEI 283
+ + + +YR P+V+LG Y +D+W GCI E+ G P FPG ++V EQL I +
Sbjct: 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220
Query: 284 LGCPPDEV 291
LG P ++
Sbjct: 221 LGVPTEDT 228
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 6e-22
Identities = 70/254 (27%), Positives = 104/254 (40%), Gaps = 54/254 (21%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+++L+ +GKGS+G V + K + Y A K
Sbjct: 1 DFKVLKKLGKGSYGSVYKV---KRLSDNQFY-------------------------ALKE 32
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
S+SQ K+R A+ E+RIL + + N+I E F N
Sbjct: 33 VDLGSMSQ------------KER--EDAVNEIRILASV------NHPNIISYKEAFLDGN 72
Query: 142 HLCISFELMNL-NLYELIKRNNYQG--FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
LCI E +L + I + + I R L++ L+ LH + I+H DLK
Sbjct: 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSA 132
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQRV-YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
N+LL +K+ D G S + + T I + Y +PEV G PY D+WSLGC+
Sbjct: 133 NILLVANDL--VKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCL 190
Query: 258 LAELYTGCPLFPGE 271
L E+ T P F
Sbjct: 191 LYEMATFAPPFEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 7e-21
Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 11/141 (7%)
Query: 135 EYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCD 194
+Y Y C+ EL + L + + Y R + +V LH II+ D
Sbjct: 66 KYIYMLMEYCLGGELWTI-LRDRGLFDEYTA------RFYIACVVLAFEYLHNRGIIYRD 118
Query: 195 LKPENVLLKQRGSSSIKVIDFGSS--CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252
LKPEN+LL G +K++DFG + S Q+ +T+ + Y +PE+IL Y +D W
Sbjct: 119 LKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 253 SLGCILAELYTGCPLFPGENE 273
SLG +L EL TG P F ++E
Sbjct: 177 SLGILLYELLTGRPPFGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 65/236 (27%), Positives = 95/236 (40%), Gaps = 49/236 (20%)
Query: 137 FYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDL 195
FY + I E M+ + I + ++ + A ++++ L LH + IIH D+
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDV 127
Query: 196 KPENVLLKQRGSSSIKVIDFGSSCYSHQRV-YTYIQSRFYRSPEVILGLPYGPPIDMWSL 254
KP N+L+ RG IK+ DFG S + T++ + Y +PE I G Y D+WSL
Sbjct: 128 KPSNILVNSRGQ--IKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSL 185
Query: 255 GCILAELYTGCPLFPGENE-----VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309
G L EL TG +P EN+ E L I+ PP
Sbjct: 186 GLSLIELATGRFPYPPENDPPDGIFELLQYIVN--EPPP--------------------- 222
Query: 310 CITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
R P K F DFV C D ++R + E L H ++K
Sbjct: 223 ---------RLPSGK--------FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 56/209 (26%), Positives = 83/209 (39%), Gaps = 58/209 (27%)
Query: 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS-------H 222
+IR + L++ L LH I+H D+KP N+ L G IK+ DFG +
Sbjct: 100 VIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG--VIKLGDFGCAVKLKNNTTTMG 157
Query: 223 QRVYTYIQSRFYRSPEVILGLP---YGPPIDMWSLGCILAELYTGCPLFPG-ENEVEQLA 278
+ V + + Y +PEVI G +G D+WSLGC++ E+ TG + +NE +
Sbjct: 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--- 214
Query: 279 CIMEILG---CPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335
IM +G PP S P
Sbjct: 215 -IMFHVGAGHKPPIPDSLQLS-----------PEGK------------------------ 238
Query: 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
DF+ +C D KKR T E L+H ++
Sbjct: 239 ---DFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 8e-19
Identities = 61/197 (30%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQS 231
+ A S+++ L LH IIH D+KP N+LL ++G +K+ DFG S + T+ +
Sbjct: 109 KIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNSLAGTFTGT 166
Query: 232 RFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEV 291
FY +PE I G PY D+WSLG L E+ FP E E +E+L
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR--FPFPPEGEPPLGPIELL-----SY 219
Query: 292 INTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKK 351
I L K +PG+ S + F DF+ QC D +
Sbjct: 220 IVNMPNPEL-----------------KDEPGNGIKWS------EEFKDFIKQCLEKDPTR 256
Query: 352 RLTPDEALRHEWLKSSS 368
R TP + L H W+K+
Sbjct: 257 RPTPWDMLEHPWIKAQM 273
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 53/181 (29%), Positives = 78/181 (43%), Gaps = 31/181 (17%)
Query: 126 SSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184
S V + F +++L + E +N + LIK G +++ +V +
Sbjct: 55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVED 112
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF-----YRSPEV 239
LH+ IIH D+KPEN+L+ Q G +K+ DFG S R +F Y +PE
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTG--HLKLTDFGLS-----RN-GLENKKFVGTPDYLAPET 164
Query: 240 ILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRR 299
ILG+ D WSLGC++ E G P F E PD V + RR
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET---------------PDAVFDNILSRR 209
Query: 300 L 300
+
Sbjct: 210 I 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 6e-18
Identities = 65/241 (26%), Positives = 114/241 (47%), Gaps = 18/241 (7%)
Query: 129 NVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE 188
N++ + + + + L + FE ++ +L + + ++ G ++ F F L++ L +H+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTY---IQSRFYRSPEVILG-LP 244
I+H DLKP+N+L+ G +K+ DFG + +TY + + +YR P+V+LG
Sbjct: 123 YILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVE-QLACIMEILGCPPDEVINTASRRRLFFD 303
Y +DMW +GCI E+ G FPG +++ QL I +LG P ++ F
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF-- 238
Query: 304 SKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
P T + + ++ V D A + QC K RL+ AL HE+
Sbjct: 239 ---KPERFTLYSPKNLRQAWNKLSYVNHAEDLA--SKLLQC---FPKNRLSAQAALSHEY 290
Query: 364 L 364
Sbjct: 291 F 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 51/229 (22%)
Query: 140 RNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
L I E M ++ + +K Y + + R++ +++ + LH I+H D+K
Sbjct: 76 DETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGA 133
Query: 199 NVLLKQRGSSSIKVIDFGSS------CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252
N+L G+ +K+ DFG+S C S + + + ++ SPEVI G YG D+W
Sbjct: 134 NILRDSAGN--VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVW 191
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
S+GC + E+ T P + E E +A I +I P + +
Sbjct: 192 SVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQL-------------------- 228
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
++ R +F+ + F ++KKR + +E LRH
Sbjct: 229 ----------PSHVSPDAR-------NFLRRTFVENAKKRPSAEELLRH 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 78/358 (21%), Positives = 137/358 (38%), Gaps = 98/358 (27%)
Query: 23 YEILEVIGKGSFGQVIRALDHKT-NTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y+ LE+IG+G++G V R T ALK + + ++I++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR-------------- 48
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
EV +L LR+ N+ +
Sbjct: 49 ------------------------------EVALLSQLRQSQPP---NITKYYGSYLKGP 75
Query: 142 HLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L I E ++ L+K + +I R ++ L+ +H+ +IH D+K N+
Sbjct: 76 RLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR---EVLVALKYIHKVGVIHRDIKAANI 132
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVIL-GLPYGPPIDMWSLGC 256
L+ G ++K+ DFG + +Q + T++ + ++ +PEVI G Y D+WSLG
Sbjct: 133 LVTNTG--NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGI 190
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
+ E+ TG P + V+ +M I P PR N
Sbjct: 191 TIYEMATGNPPYSD---VDAFRAMMLIPKSKP-------------------PRLEDNG-- 226
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSS 374
SK + +FV C + + K+RL+ +E L+ +W+K+ S + S
Sbjct: 227 -----YSKLLR-----------EFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSI 268
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 37/88 (42%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLP 244
LH IH DLKPEN L+ G IK+ DFG S + + S Y +PEV+ G
Sbjct: 117 LHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 245 YGPPIDMWSLGCILAELYTGCPLFPGEN 272
Y +D WSLGC+L E G P F G
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGST 202
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 40/103 (38%), Positives = 57/103 (55%), Gaps = 2/103 (1%)
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV 225
F + R +A +V L LH +I++ DLKPEN+LL G IK+ DFG + R
Sbjct: 98 FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGRT 155
Query: 226 YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLF 268
YT + Y +PE+IL YG +D W+LG ++ E+ G P F
Sbjct: 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 74/267 (27%), Positives = 111/267 (41%), Gaps = 58/267 (21%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y + V+GKG+FG+ T + RTE + L +W K
Sbjct: 1 HYIPIRVLGKGAFGEA--------------------TLYRRTE-DDSLVVW-------KE 32
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
LS+ D AL E+ IL L+ N+I +F N
Sbjct: 33 VNLTRLSEKERRD--------------ALNEIVILSLLQHP------NIIAYYNHFMDDN 72
Query: 142 HLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L I E N LY+ I R Q F ++ + F +V + +H+ I+H D+K N+
Sbjct: 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNI 132
Query: 201 LLKQRGSSSIKVIDFG-----SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255
L + G IK+ DFG S YS T + + +Y SPE+ G+ Y D+W+LG
Sbjct: 133 FLTKAGL--IKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQGVKYNFKSDIWALG 188
Query: 256 CILAELYTGCPLFPGENEVEQLACIME 282
C+L EL T F N + + I++
Sbjct: 189 CVLYELLTLKRTFDATNPLNLVVKIVQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 71/268 (26%), Positives = 105/268 (39%), Gaps = 67/268 (25%)
Query: 23 YEILEVIGKGSFGQ---VIRALDHKTNTHALK--YYGNQLTEFERTEIEKYLEIWYLGLD 77
YE+LE IGKGSFG V R D K K YGN +TE E+ ++ +
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGK--ILVWKEIDYGN-MTEKEKQQL----------VS 48
Query: 78 ACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF 137
I L + H + VR D + + + Y I M EY
Sbjct: 49 EVNI-----LRE---------------LKHPNI--VRYYDRIIDRSNQTLY--IVM-EY- 82
Query: 138 YFRNHLCISFELMNLNLYELIKR--NNYQGFSLGLIRRFAFSLVQCLRLLHR-----ENI 190
C +L LI++ + I R L+ L H +
Sbjct: 83 ------CEGGDLAQ-----LIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTV 131
Query: 191 IHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGP 247
+H DLKP N+ L ++K+ DFG + TY+ + +Y SPE + + Y
Sbjct: 132 LHRDLKPANIFLDANN--NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDE 189
Query: 248 PIDMWSLGCILAELYTGCPLFPGENEVE 275
D+WSLGC++ EL P F N+++
Sbjct: 190 KSDIWSLGCLIYELCALSPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 44/197 (22%)
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYR 235
+Q L LH +IH D+K +N+LL GS +K+ DFG + T + + ++
Sbjct: 125 LQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 236 SPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTA 295
+PEV+ YGP +D+WSLG + E+ G P + EN + L I
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------------- 228
Query: 296 SRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTP 355
+ GTP + ++++ R DF+ +C D +KR +
Sbjct: 229 --------TNGTPEL----------QNPEKLSAIFR-------DFLNRCLEMDVEKRGSA 263
Query: 356 DEALRHEWLKSSSSSSS 372
E L+H +LK + SS
Sbjct: 264 KELLQHPFLKIAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 44/197 (22%)
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYR 235
+Q L LH +IH D+K +NVLL GS +K+ DFG + T + + ++
Sbjct: 125 LQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 236 SPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTA 295
+PEV+ YGP +D+WSLG + E+ G P + EN + L I
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------------- 228
Query: 296 SRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTP 355
+ GTP K ++ + R DF+ +C D +KR +
Sbjct: 229 --------TNGTPELQNPEK----------LSPIFR-------DFLNRCLEMDVEKRGSA 263
Query: 356 DEALRHEWLKSSSSSSS 372
E L+H +LK + SS
Sbjct: 264 KELLQHPFLKLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 44/197 (22%)
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYR 235
+Q L LH +IH D+K +N+LL GS +K+ DFG + T + + ++
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 236 SPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTA 295
+PEV+ YGP +D+WSLG + E+ G P + EN + L I
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-------------- 229
Query: 296 SRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTP 355
+ GTP K ++++ R DF+ +C + D +KR +
Sbjct: 230 --------TNGTPELQNPEK----------LSAIFR-------DFLNRCLDMDVEKRGSA 264
Query: 356 DEALRHEWLKSSSSSSS 372
E L+H++LK + SS
Sbjct: 265 KELLQHQFLKIAKPLSS 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 70/266 (26%), Positives = 109/266 (40%), Gaps = 57/266 (21%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
+EIL IGKGSFG V + + K + L++ R E E
Sbjct: 2 FEILNKIGKGSFGVVFKVV-RKADKRVYAMKQIDLSKMNRRERE---------------- 44
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
+A+ E R+L L DSSY +I E F +
Sbjct: 45 -------------------------EAIDEARVLAKL-----DSSY-IIRYYESFLDKGK 73
Query: 143 LCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L I E N +L++L+K + + RF ++ L LH + I+H D+K N+
Sbjct: 74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLF 133
Query: 202 LKQRGSSSIKVIDFG-SSCYSHQRVY--TYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
L ++K+ D G + S + T + + +Y SPE+ PY D+W+LG +L
Sbjct: 134 LDA--YDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVL 191
Query: 259 AELYTGCPLFPGENEVEQLACIMEIL 284
E TG F N+ A I++I+
Sbjct: 192 YECCTGKHPFDANNQG---ALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 52/167 (31%), Positives = 75/167 (44%), Gaps = 10/167 (5%)
Query: 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFS 167
A E ++L L S N+I E F L I E L E I++
Sbjct: 46 AQNECQVLKLL------SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD 99
Query: 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS--CYSHQRV 225
I F ++ L +H + I+H DLK +N+LL + +K+ DFG S S +
Sbjct: 100 EDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH-KMVVKIGDFGISKILSSKSKA 158
Query: 226 YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGEN 272
YT + + Y SPE+ G PY D+W+LGC+L EL + F N
Sbjct: 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 79/350 (22%), Positives = 126/350 (36%), Gaps = 106/350 (30%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
++ILE +G+GS+G V +A+ +T A K+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVV----------------------------AIKV- 35
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALI-EVRILDHLRKKDADSSYNVIHMLEYF--YF 139
+ Q +I E+ IL K DS Y V +Y+ YF
Sbjct: 36 ----VPVEEDL--------------QEIIKEISIL-----KQCDSPYIV----KYYGSYF 68
Query: 140 RN-HLCISFELMNLN-LYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
+N L I E + +++K N + I + ++ L LH IH D+K
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKT-LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKA 127
Query: 198 ENVLLKQRGSSSIKVIDFGSSC---YSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254
N+LL + G K+ DFG S + + T I + F+ +PEVI + Y D+WSL
Sbjct: 128 GNILLNEEGQ--AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSL 185
Query: 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314
G E+ G P +++ + I I PP
Sbjct: 186 GITAIEMAEG---KPPYSDIHPMRAIFMIPNKPP-------------------------- 216
Query: 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
P D F DFV +C D ++R + + L+H ++
Sbjct: 217 ------PTLSDPEKW----SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 16/172 (9%)
Query: 101 NKKRFHHQ-----ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NL 154
+KKR + AL E +IL+ + SS ++ + F ++ LC+ LMN +L
Sbjct: 27 DKKRLKKRKGEQMALNEKKILEKV------SSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80
Query: 155 YELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVID 214
I GF +A ++ L LH+ I++ DLKPENVLL G ++++ D
Sbjct: 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG--NVRISD 138
Query: 215 FGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
G + +++ + Y +PEV+ G Y +D ++LGC L E+ G
Sbjct: 139 LGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 66/248 (26%), Positives = 104/248 (41%), Gaps = 48/248 (19%)
Query: 125 DSSYNVIHMLEYFYFRNHLCISFELMN---LNLYELIKRNNYQGFSLGLIRRFAFSLVQC 181
DS Y +I F+ N + I E M+ L++Y I + ++ R A ++V+
Sbjct: 57 DSPY-IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEH--------VLGRIAVAVVKG 107
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSRFYRSPEVI 240
L L I+H D+KP N+L+ RG +K+ DFG S+ + TY+ + Y +PE I
Sbjct: 108 LTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNSIAKTYVGTNAYMAPERI 165
Query: 241 LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL 300
G YG D+WSLG EL G +P + + +++L C DE
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE---------- 215
Query: 301 FFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360
D P + K FV F+TQC K+R P+ +
Sbjct: 216 --DPPVLPVGQFSEK---------------------FVHFITQCMRKQPKERPAPENLMD 252
Query: 361 HEWLKSSS 368
H ++ +
Sbjct: 253 HPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 44/197 (22%)
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYR 235
+Q L LH +IH D+K +N+LL GS +K+ DFG + T + + ++
Sbjct: 125 LQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 236 SPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTA 295
+PEV+ YGP +D+WSLG + E+ G P + EN + L I
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------------- 228
Query: 296 SRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTP 355
+ GTP + P + +++V R DF+ +C D +R +
Sbjct: 229 --------TNGTPEL--------QNP--ERLSAVFR-------DFLNRCLEMDVDRRGSA 263
Query: 356 DEALRHEWLKSSSSSSS 372
E L+H +LK + SS
Sbjct: 264 KELLQHPFLKLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 82/346 (23%), Positives = 129/346 (37%), Gaps = 90/346 (26%)
Query: 27 EVIGKGSFGQVIRALDHKT-NTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEE 85
E+IGKG++G+V AL+ T A+K E T + H
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQ-----VELPATIAGR--------------HDSR 47
Query: 86 SLSQNGGFDDENGSYNKKRFHHQALIE-VRILDHLRKKDADSSYNVIHMLEYFYFRNHLC 144
E IE ++ LDHL N++ L + +L
Sbjct: 48 QKDMVKALRSE--------------IETLKDLDHL---------NIVQYLGFETTEEYLS 84
Query: 145 ISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQ 204
I E + R Y F L+R F +++ L LH + I+H DLK +N+L+
Sbjct: 85 IFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA 143
Query: 205 RGSSSIKVIDFGSS-----CYSHQRVYTYIQSRFYRSPEVI--LGLPYGPPIDMWSLGCI 257
G K+ DFG S Y + + + S F+ +PEVI Y +D+WSLGC+
Sbjct: 144 DGIC--KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCV 201
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
+ E++ G P +E E +A + ++ R
Sbjct: 202 VLEMFAG--RRPWSDE-EAIAAMFKL------------------------------GNKR 228
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
P D++ L +DF+ CF + R T E L+H +
Sbjct: 229 SAPPIPPDVSMNL---SPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 50/157 (31%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 131 IHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN 189
+ F ++ L E +N +L I+R F R +A +V L+ LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERG 116
Query: 190 IIHCDLKPENVLLKQRGSSSIKVIDFGSS----CYSHQRVYTYIQSRFYRSPEVILGLPY 245
II+ DLK +NVLL G IK+ DFG T+ + Y +PE++ PY
Sbjct: 117 IIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQPY 173
Query: 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
GP +D W+LG +L E+ G F G++E E I+E
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 54/214 (25%)
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---- 216
NNY F L+R F +++ L LH IIH D+K N+L+ +G IK+ DFG
Sbjct: 98 NNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKK 155
Query: 217 ------SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPG 270
S+ + R + S F+ +PEV+ Y D+WSLGC++ E+ TG FP
Sbjct: 156 LEANSLSTKTNGARP-SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP- 213
Query: 271 ENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330
+ QL I +I G P S
Sbjct: 214 --DCTQLQAIFKI--------------------------------GENASPEIPSNISS- 238
Query: 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
+DF+ + F D KR T E L+H +L
Sbjct: 239 -----EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 65/268 (24%), Positives = 108/268 (40%), Gaps = 55/268 (20%)
Query: 110 LIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLG 169
++E+ IL + N++ + E +++ N L I E + + I +G +
Sbjct: 50 MVEIDILSECKHP------NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEP 103
Query: 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC---YSHQRVY 226
IR +++ L LH +IH DLK N+LL G +K+ DFG S + Q+
Sbjct: 104 QIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG--DVKLADFGVSAKNKSTLQKRD 161
Query: 227 TYIQSRFYRSPEVIL-----GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM 281
T+I + ++ +PEV+ PY D+WSLG L EL P P +E+ + ++
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLL 218
Query: 282 EILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341
+IL P + P ++S F DF+
Sbjct: 219 KILKSEPPTLDQ--------------PSKWSSS----------------------FNDFL 242
Query: 342 TQCFNWDSKKRLTPDEALRHEWLKSSSS 369
C D R T E L+H ++ S
Sbjct: 243 KSCLVKDPDDRPTAAELLKHPFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 42/113 (37%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH----QRVYTYI 229
+A + L LH + II+ DLK +NV+L G IK+ DFG C + + T+
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGM-CKENIFGGKTTRTFC 162
Query: 230 QSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
+ Y +PE+I PYG +D W+ G +L E+ G P F GE+E E IME
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 48/223 (21%)
Query: 143 LCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L I EL+ +L +L+K+ Y F +IR + ++ L LH N +H D+K N+L
Sbjct: 77 LYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANIL 134
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYT--YIQSRFYRSPEVILGL-PYGPPIDMWSLGCIL 258
+ G +K+ DFG + + + + S ++ +PEVI YG D+WSLGC +
Sbjct: 135 VDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTV 192
Query: 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
E+ TG P + +++E +A + +I SK P I + +
Sbjct: 193 LEMATGKPPW---SQLEGVAAVFKIG------------------RSKELPP-IPDHLSDE 230
Query: 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
K DF+ +C D R T E L H
Sbjct: 231 AK------------------DFILKCLQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 62/211 (29%), Positives = 83/211 (39%), Gaps = 51/211 (24%)
Query: 123 DADSSYNVIHMLEYFYFRNHLCISFE------LMNLNLYELIKRNNYQGFSLGLIRRFAF 176
DADS + ++ + F HL + E LMNL LI+ F R +
Sbjct: 57 DADSPW-IVKLYYSFQDEEHLYLVMEYMPGGDLMNL----LIR---KDVFPEETARFYIA 108
Query: 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC---YSHQRVYTYIQSRF 233
LV L +H+ IH D+KP+N+L+ G IK+ DFG + R Y S
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 234 -----------------------------YRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
Y +PEV+ G PYG D WSLG IL E+ G
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
Query: 265 CPLFPGENEVEQLACIM---EILGCPPDEVI 292
P F + E I+ E L PPD +
Sbjct: 227 FPPFYSDTLQETYNKIINWKESLRFPPDPPV 257
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 58/188 (30%), Positives = 84/188 (44%), Gaps = 29/188 (15%)
Query: 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQG 165
Q +E IL A++ + V+ M F + HLC+ E + + L+K N
Sbjct: 46 QQVFVERDILTF-----AENPF-VVSMFCSFETKRHLCMVMEYVEGGDCATLLK--NIGA 97
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV 225
+ + R + V L LH I+H DLKP+N+L+ G IK+ DFG S +
Sbjct: 98 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSL 155
Query: 226 YT-----YIQS---RF----------YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPL 267
T +I+ F Y +PEVIL YG P+D W++G IL E GC
Sbjct: 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
Query: 268 FPGENEVE 275
F G+ E
Sbjct: 216 FFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 41/104 (39%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTYIQSRFYRSPE 238
L LHR II+ DLK +NV+L G IK+ DFG T+ + Y +PE
Sbjct: 114 LFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPE 171
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
+I PYG +D W+ G +L E+ G P F GE+E E IME
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 51/194 (26%), Positives = 80/194 (41%), Gaps = 45/194 (23%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPE 238
L LH E IH D+K N+LL + G +K+ DFG S + + T++ + F+ +PE
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRR 298
VI Y D+WSLG EL G P P +++ + + I P +
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEP--P-LSDLHPMRVLFLIPKNNPPSL------- 218
Query: 299 RLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358
+ K F DFV+ C N D K+R + E
Sbjct: 219 --------EGNKFS----------------------KPFKDFVSLCLNKDPKERPSAKEL 248
Query: 359 LRHEWLKSSSSSSS 372
L+H+++K + +S
Sbjct: 249 LKHKFIKKAKKTSY 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 38/107 (35%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV 225
FS +A +V L LH + I++ DLKPEN+LL + G IK+ DFG + R
Sbjct: 98 FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRDRT 155
Query: 226 YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGEN 272
+T + Y +PEVI + +D W+LG ++ E+ G P F +N
Sbjct: 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 130 VIHMLEYFYFRNHLCISFELMNLNLY-ELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE 188
+I + F + C+ +LY L + N + I R S+++ ++ LH
Sbjct: 145 IIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIER---SVLRAIQYLHEN 201
Query: 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY----SHQRVYTYIQSRFYRSPEVILGLP 244
IIH D+K EN+ + G + + DFG++C+ + + Y + + +PE++ P
Sbjct: 202 RIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDP 259
Query: 245 YGPPIDMWSLGCILAELYTGC-PLFP-----GENEVE-QLACIMEILGCPPDEV-IN-TA 295
YGP +D+WS G +L E+ T LF G+ + + Q+ I+ G P+E I+ A
Sbjct: 260 YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319
Query: 296 SRRRLFFDSKGTPRCITNSKGRKRKPGSK 324
+ ++ I +K RKPGS+
Sbjct: 320 NLDEIY---------IGLAKKSSRKPGSR 339
|
Length = 391 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 61/261 (23%), Positives = 98/261 (37%), Gaps = 54/261 (20%)
Query: 116 LDHLRKKDADSSY----NVIHMLEYFYFRNHLCISFELMNL-NLYELIK-RNNYQGFSLG 169
+D LRK+ S NV+ F + L + ++ +L +++K G
Sbjct: 43 VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA 102
Query: 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS-------CYSH 222
+I +++ L LH IH D+K N+LL + G S+K+ DFG S +
Sbjct: 103 IIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDRTR 160
Query: 223 QRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM 281
+ T++ + + +PEV+ + Y D+WS G EL TG P
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA--PYSKY-------- 210
Query: 282 EILGCPPDEVI-NTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340
PP +V+ T L D K K+F
Sbjct: 211 -----PPMKVLMLT-----LQNDPPSLETGADYKK-----------------YSKSFRKM 243
Query: 341 VTQCFNWDSKKRLTPDEALRH 361
++ C D KR T +E L+H
Sbjct: 244 ISLCLQKDPSKRPTAEELLKH 264
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 40/118 (33%), Positives = 61/118 (51%), Gaps = 5/118 (4%)
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSH 222
F R +A ++ L+ LH++ II+ DLK +NVLL + G IK+ DFG +
Sbjct: 93 FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGE 150
Query: 223 QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
+ T+ + Y +PE++ G Y +D WS G +L E+ G F GE+E E I
Sbjct: 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 36/91 (39%), Positives = 51/91 (56%), Gaps = 2/91 (2%)
Query: 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSP 237
LV LH ++II+ DLKPEN+LL +G +KV DFG + R +T + Y +P
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPDRTFTLCGTPEYLAP 184
Query: 238 EVILGLPYGPPIDMWSLGCILAELYTGCPLF 268
EVI +G +D W++G +L E G P F
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 37/121 (30%), Positives = 67/121 (55%), Gaps = 7/121 (5%)
Query: 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYT 227
I ++++ L +LH + +IH D+K +++LL G +K+ DFG R +
Sbjct: 118 IAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKS 175
Query: 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCP 287
+ + ++ +PE+I LPYGP +D+WSLG ++ E+ G P + E ++ + I + L P
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--P 233
Query: 288 P 288
P
Sbjct: 234 P 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 5/113 (4%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTY 228
R +A + L LHR +I+ DLK +N+LL G K+ DFG + T+
Sbjct: 99 RFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTF 156
Query: 229 IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM 281
+ Y +PE++ L YGP +D W+LG ++ E+ G P F +NE + I+
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 163 YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---- 218
Y + + RR+ ++Q + LH I+H D+K N+L G+ +K+ DFG+S
Sbjct: 100 YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQ 157
Query: 219 --CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQ 276
C S + + + ++ SPEVI G YG D+WS+ C + E+ T P + E E
Sbjct: 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW---AEYEA 214
Query: 277 LACIMEILGCP-----PDEVINTASR--RRLFFDSKGTP 308
+A I +I P PD V + +++F + K P
Sbjct: 215 MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 8e-13
Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 163 YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---- 218
Y + + R++ +++ + LH I+H D+K N+L G+ +K+ DFG+S
Sbjct: 100 YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQ 157
Query: 219 --CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQ 276
C S + + + ++ SPEVI G YG D+WSLGC + E+ T P + E E
Sbjct: 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA---EYEA 214
Query: 277 LACIMEILGCPPDEVINTASR-------RRLFFDSKGTP 308
+A I +I P + + + +F +++ P
Sbjct: 215 MAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 9e-13
Identities = 60/209 (28%), Positives = 84/209 (40%), Gaps = 54/209 (25%)
Query: 169 GLIRRFAFSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY- 226
++RR +++V+ L+ L E NIIH D+KP NVL+ G +K+ DFG S +
Sbjct: 102 DVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVASLAK 159
Query: 227 TYIQSRFYRSPEVILG------LPYGPPIDMWSLGCILAELYTGCPLFPGE---NEVEQL 277
T I + Y +PE I Y D+WSLG + E+ G +P E N QL
Sbjct: 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL 219
Query: 278 ACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337
+ I++ G PP P G D A
Sbjct: 220 SAIVD--GDPP-----------------TLP------------SGYSDDAQ--------- 239
Query: 338 VDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
DFV +C N +R T + L H WL
Sbjct: 240 -DFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 44/139 (31%), Positives = 72/139 (51%), Gaps = 6/139 (4%)
Query: 129 NVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHR 187
N++ E F HL I E + +L + IK + F I ++ + ++ +H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSS-CYSHQRVY--TYIQSRFYRSPEVILGLP 244
+ ++H D+K +N+ L Q G +K+ DFGS+ + Y TY+ + +Y PE+ +P
Sbjct: 119 KRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176
Query: 245 YGPPIDMWSLGCILAELYT 263
Y D+WSLGCIL EL T
Sbjct: 177 YNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 9/171 (5%)
Query: 103 KRFHHQALIEVRILDHLRKKDADSSY----NVIHMLEYFYFRNHLCISFE-LMNLNLYEL 157
KRF +I+ + +DH+ + +Y +++ F ++L + E ++ +
Sbjct: 62 KRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTF 121
Query: 158 IKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGS 217
++RN +G +A +V L NI++ DLKPEN+LL + G IK+ DFG
Sbjct: 122 LRRNKRFPNDVGCF--YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGF 177
Query: 218 SCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLF 268
+ R YT + Y +PE++L + +G D W+LG + E+ GCP F
Sbjct: 178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 163 YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---- 218
Y + + R++ +++ + LH I+H D+K N+L G+ +K+ DFG+S
Sbjct: 100 YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQ 157
Query: 219 --CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQ 276
C S + + + ++ SPEVI G YG D+WS+GC + E+ T P + E E
Sbjct: 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA---EFEA 214
Query: 277 LACIMEILGCP-----PDEVINTASR--RRLFFDSKGTP 308
+A I +I P P V + +R+F ++K P
Sbjct: 215 MAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFVEAKLRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 30/183 (16%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH-----LCISFE------- 148
KK F A+ + + K + N +L+ NH L SF+
Sbjct: 24 TKKMF---AMKYMNKQKCVEKGSVRNVLNERRILQEL---NHPFLVNLWYSFQDEENMYL 77
Query: 149 LMNLNL-----YELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLK 203
+++L L Y L ++ FS ++ + +V L LH + IIH D+KP+N+LL
Sbjct: 78 VVDLLLGGDLRYHLSQKVK---FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD 134
Query: 204 QRGSSSIKVIDFGSSCYSHQRVYT--YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261
++G + + DF + T + Y +PEV+ Y +D WSLG E
Sbjct: 135 EQG--HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYEC 192
Query: 262 YTG 264
G
Sbjct: 193 LRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 79/303 (26%), Positives = 119/303 (39%), Gaps = 55/303 (18%)
Query: 98 GSYNKKRFHHQALIEVRILDHLRKKDA---------------DSSYNVIHMLEYFYFRNH 142
G K LI R L HL K A +S Y ++ FY
Sbjct: 15 GVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY-IVGFYGAFYSDGE 73
Query: 143 LCISFELMN-LNLYELIKR-----NNYQG-FSLGLIRRFAFSLVQCLRLLHRENIIHCDL 195
+ I E M+ +L +++K+ N G S+ ++R + LR H+ I+H D+
Sbjct: 74 ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY-----LREKHK--IMHRDV 126
Query: 196 KPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-TYIQSRFYRSPEVILGLPYGPPIDMWSL 254
KP N+L+ RG IK+ DFG S + +++ +R Y SPE + G Y D+WSL
Sbjct: 127 KPSNILVNSRGE--IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSL 184
Query: 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC---- 310
G L E+ G P + E A + G P E S R + +PR
Sbjct: 185 GLSLVEMAIGRYPIPPPDAKELEA----MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF 240
Query: 311 -----ITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
I N + P F DFV +C + K+R E +H ++K
Sbjct: 241 ELLDYIVNEPP-PKLPS--------GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
Query: 366 SSS 368
+
Sbjct: 292 RAE 294
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 34/91 (37%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTYIQSRFYRSPEVIL 241
LH++ II+ DLKPEN+LL +G +K+ DFG S + +T+ + Y +PE+++
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGEN 272
+G +D WSLG ++ ++ TG P F EN
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 29/180 (16%)
Query: 162 NYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS 221
Y F +I + L++ L LH IIH D+K N+L+ G +++ DFG++
Sbjct: 96 KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQR-LRIADFGAAA-- 152
Query: 222 HQRVYTYI------QSRF-----YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPG 270
R+ Q + + +PEV+ G YG D+WS+GC++ E+ T P +
Sbjct: 153 --RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210
Query: 271 ENEVEQLACIMEILGC--PPD--EVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326
E LA I +I P E ++ R RC+ + +P S+++
Sbjct: 211 EKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTL-------RCLELQ--PEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 48/140 (34%), Positives = 72/140 (51%), Gaps = 6/140 (4%)
Query: 137 FYFRNHLCISFELMNLNLYELIKRNNYQG-FSLGLIRRFAFSLVQCLRLLHRENIIHCDL 195
F F++ + L +N EL +G F L R + L+ L LH+ N+I+ DL
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119
Query: 196 KPENVLLKQRGSSSIKVIDFGS---SCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252
KPEN+LL +G I + DFG + + T+ + Y +PE++LG Y +D W
Sbjct: 120 KPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177
Query: 253 SLGCILAELYTGCPLFPGEN 272
+LG +L E+ TG P F EN
Sbjct: 178 TLGVLLYEMLTGLPPFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 52/207 (25%), Positives = 76/207 (36%), Gaps = 39/207 (18%)
Query: 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGF 166
+ L E IL L + Y Y C L+ L++R +
Sbjct: 46 KRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC-----PGGELFRLLQRQPGKCL 100
Query: 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS----H 222
S + R +A ++ L LH I++ DLKPEN+LL + G I + DF S S
Sbjct: 101 SEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG--HIMLSDFDLSKQSDVEPP 158
Query: 223 QRVYTYIQSR-----------------------F-----YRSPEVILGLPYGPPIDMWSL 254
+ F Y +PEVI G +G +D W+L
Sbjct: 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218
Query: 255 GCILAELYTGCPLFPGENEVEQLACIM 281
G +L E+ G F G N E + I+
Sbjct: 219 GILLYEMLYGTTPFKGSNRDETFSNIL 245
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 47/200 (23%)
Query: 179 VQCLR---LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSR 232
+ L+ LH + +IH D+K +++LL G +K+ DFG + V + + +
Sbjct: 122 LAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSLVGTP 179
Query: 233 FYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVI 292
++ +PEVI LPYG +D+WSLG ++ E+ G P P NE PP +
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP--PYFNE-------------PPLQ-- 222
Query: 293 NTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKR 352
A +R I ++ K K ++ LR F+ + D +R
Sbjct: 223 --AMKR------------IRDNLPPKLK-NLHKVSPRLR-------SFLDRMLVRDPAQR 260
Query: 353 LTPDEALRHEWLKSSSSSSS 372
T E L H +L + SS
Sbjct: 261 ATAAELLNHPFLAKAGPPSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 9/132 (6%)
Query: 164 QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS----C 219
+ F+ +R + +V L LH+ II+ D+K EN+LL G + + DFG S
Sbjct: 100 EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLA 157
Query: 220 YSHQRVYTYIQSRFYRSPEVILGLP--YGPPIDMWSLGCILAELYTGCPLFPGENEVEQL 277
+R Y++ + Y +PEVI G + +D WSLG + EL TG F + E
Sbjct: 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217
Query: 278 ACIME-ILGCPP 288
+ I IL P
Sbjct: 218 SEISRRILKSKP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 39/104 (37%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTYIQSRFYRSPE 238
L LH + II+ DLK +NV+L G IK+ DFG + + T+ + Y +PE
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTTKTFCGTPDYIAPE 171
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
+I PYG +D W+ G +L E+ G F GE+E E IME
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 43/138 (31%), Positives = 72/138 (52%), Gaps = 9/138 (6%)
Query: 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YT 227
I S+++ L LH + +IH D+K +++LL G IK+ DFG + V +
Sbjct: 120 IATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKS 177
Query: 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCP 287
+ + ++ +PEVI LPYG +D+WSLG ++ E+ G P + E ++ + I + L P
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL--P 235
Query: 288 P--DEVINTASRRRLFFD 303
P + +S R F D
Sbjct: 236 PRVKDSHKVSSVLRGFLD 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 132 HMLEYFYFRNHLCISFELMNLNLYELIKRNNYQG-FSLGLIRRFAFSLVQCLRLLHRENI 190
H+ F + HL E +N +L+ +G F L +A +V L+ LH + I
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGG--DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 191 IHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTYIQSRFYRSPEVILGLPYGP 247
I+ DLK +NV+L + G IK+ DFG + + R T+ + Y +PE++ GL Y
Sbjct: 118 IYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
+D WS G +L E+ G F G++E E I
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 130 VIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN 189
++ +L FY+ L I E + I +G + I+ +++ L+ LH
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 190 IIHCDLKPENVLLKQRGSSSIKVIDFGSSC---YSHQRVYTYIQSRFYRSPEVIL----- 241
IIH DLK NVLL G IK+ DFG S + QR ++I + ++ +PEV++
Sbjct: 131 IIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP 288
PY D+WSLG L E+ + P +E+ + +++I P
Sbjct: 189 DTPYDYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKSEP 232
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 50/213 (23%)
Query: 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS-- 218
N + + ++ ++ + LH ++H D+K NV+L G IK+IDFG +
Sbjct: 94 NRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARR 151
Query: 219 -CY-----SHQRVYTYIQ-SRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGE 271
+ +H + + + ++ +PEVI YG D+WS+GC + E+ TG P P
Sbjct: 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKP--PLA 209
Query: 272 NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331
+ +++LA + I R P D S
Sbjct: 210 S-MDRLAAMFYI------------------------------GAHRGLMPRLPDSFS--- 235
Query: 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
A +DFVT C D +R + + LRH++L
Sbjct: 236 ---AAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 8/139 (5%)
Query: 129 NVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQG--FSLGLIRRFAFSLVQCLRLL 185
NVI L F N L I EL + +L +IK Q I ++ L L +
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFG-SSCYSHQRV--YTYIQSRFYRSPEVILG 242
H + I+H D+KP NV + G +K+ D G +S + ++ + + +Y SPE I
Sbjct: 123 HSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 243 LPYGPPIDMWSLGCILAEL 261
Y D+WSLGC+L E+
Sbjct: 181 NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 40/124 (32%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTY 228
R +A + L LH + II+ DLK +NVLL G K+ DFG ++ + T+
Sbjct: 99 RFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHC--KLADFGMCKEGIFNGKTTSTF 156
Query: 229 IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP 288
+ Y +PE++ + YGP +D W++G +L E+ G F ENE + I+
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN------ 210
Query: 289 DEVI 292
DEV+
Sbjct: 211 DEVV 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 11/165 (6%)
Query: 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRN 161
K Q L E++I+ S Y ++ F N++C+ E M+ + I +
Sbjct: 43 KSSVRKQILRELQIMHE-----CRSPY-IVSFYGAFLNENNICMCMEFMDCGSLDRIYKK 96
Query: 162 NYQGFSLGLIRRFAFSLVQCLRLLHREN-IIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220
+ ++ + A ++V+ L L+ + I+H D+KP N+L+ RG IK+ DFG S
Sbjct: 97 -GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGE 153
Query: 221 SHQRVY-TYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
+ T++ + Y SPE I G Y D+WSLG + EL G
Sbjct: 154 LINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 14/96 (14%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-------TYIQSRFY 234
L+ LH I+H D+K +NVL+ S +K+ DFG+S +R+ T+ + Y
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTY-SGVVKISDFGTS----KRLAGINPCTETFTGTLQY 175
Query: 235 RSPEVILGLP--YGPPIDMWSLGCILAELYTGCPLF 268
+PEVI P YG P D+WSLGC + E+ TG P F
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 5/98 (5%)
Query: 178 LVQCLRLLHREN-IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY--TYIQSRFY 234
+V LR LH+E I+H DL P N++L + + + DFG + + + + Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGED--DKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 235 RSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGEN 272
PE++ PYG D+W+ GCIL ++ T P F N
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 41/140 (29%), Positives = 69/140 (49%), Gaps = 18/140 (12%)
Query: 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSS--IKVID------FGSSCY 220
G+++ + ++ + LH ++H DLKP N+L+ G +K+ D F S
Sbjct: 108 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 221 SHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENE------ 273
+ + + +YR+PE++LG Y ID+W++GCI AEL T P+F E
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 227
Query: 274 ---VEQLACIMEILGCPPDE 290
+QL I ++G P D+
Sbjct: 228 PYHHDQLDRIFNVMGFPADK 247
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 72/246 (29%), Positives = 104/246 (42%), Gaps = 59/246 (23%)
Query: 137 FY---FRNHLC-ISFELMNL---NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE- 188
FY FR C I ELM++ Y+ + ++ + A + V+ L L E
Sbjct: 68 FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQS-----RFYRSPEVIL-- 241
IIH D+KP N+LL + G +IK+ DFG S Q V + ++ R Y +PE I
Sbjct: 128 KIIHRDVKPSNILLDRNG--NIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPS 182
Query: 242 -GLPYGPPIDMWSLGCILAELYTGCPLFPGENEV-EQLACIMEILGCPPDEVINTASRRR 299
Y D+WSLG L E+ TG +P N V +QL +V+
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT-----------QVV------- 224
Query: 300 LFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEAL 359
KG P ++NS+ R+ P FV+F+ C D KR E L
Sbjct: 225 -----KGDPPILSNSEEREFSPS--------------FVNFINLCLIKDESKRPKYKELL 265
Query: 360 RHEWLK 365
H ++K
Sbjct: 266 EHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 129 NVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE 188
N++ +L+ FY+ N+L I E + + + + IR ++ L LH
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122
Query: 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVIL---- 241
IIH DLK N+L G IK+ DFG S + QR ++I + ++ +PEV++
Sbjct: 123 KIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 242 -GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP 288
PY D+WSLG L E+ + P +E+ + +++I P
Sbjct: 181 KDRPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKSEP 225
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 50/178 (28%), Positives = 78/178 (43%), Gaps = 17/178 (9%)
Query: 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY-FRNHLCISFELMN-----LNLY 155
K++ AL E +IL+ + +S + V L Y Y ++ LC+ LMN ++Y
Sbjct: 40 KRKGEAMALNEKQILEKV-----NSRFVV--SLAYAYETKDALCLVLTLMNGGDLKFHIY 92
Query: 156 ELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDF 215
+ GF +A + L LHRE I++ DLKPEN+LL G I +
Sbjct: 93 NMGN----PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL 148
Query: 216 GSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENE 273
+ + + + Y +PEV+ Y D W LGC++ E+ G F E
Sbjct: 149 AVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 46/198 (23%)
Query: 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFY 234
+++ L LH E IH D+K NVLL ++G +K+ DFG + + + T++ + F+
Sbjct: 110 ILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 235 RSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINT 294
+PEVI Y D+WSLG EL G P +
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS-----------------------DL 204
Query: 295 ASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT 354
R LF K +P + +G+ KP F +FV C N D + R T
Sbjct: 205 HPMRVLFLIPKNSPPTL---EGQYSKP---------------FKEFVEACLNKDPRFRPT 246
Query: 355 PDEALRHEWLKSSSSSSS 372
E L+H+++ + +S
Sbjct: 247 AKELLKHKFITRYTKKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 57/190 (30%), Positives = 88/190 (46%), Gaps = 25/190 (13%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTY 228
R +A + L LH NI++ DLKPEN+LL +G I + DFG + + T+
Sbjct: 99 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTF 156
Query: 229 IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM-EILGCP 287
+ Y +PEV+ PY +D W LG +L E+ G P F N E I+ + L
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 216
Query: 288 PDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNW 347
P+ I ++R L +G + K R ++ G+KD + + F + NW
Sbjct: 217 PN--ITNSARHLL----EGLLQ-----KDRTKRLGAKD--DFMEIKNHIFFSPI----NW 259
Query: 348 DS--KKRLTP 355
D K++TP
Sbjct: 260 DDLINKKITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 38/118 (32%), Positives = 59/118 (50%), Gaps = 5/118 (4%)
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSH 222
F L +A ++ L+ LH + I++ DLK +N+LL G IK+ DFG +
Sbjct: 93 FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGD 150
Query: 223 QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
+ T+ + Y +PE++LG Y +D WS G +L E+ G F G +E E I
Sbjct: 151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 65/257 (25%), Positives = 106/257 (41%), Gaps = 57/257 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RYEI++ IG+GSFG++ A + H + + + + ++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVI----KEIDLTKMPVK--------------- 41
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
E+ S+ EV +L ++ N++ F
Sbjct: 42 --EKEASKK---------------------EVILLAKMKHP------NIVTFFASFQENG 72
Query: 142 HLCISFELMNLNLYELIKRNNYQG---FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
L I E + +L+KR N Q FS I + + L+ +H I+H D+K +
Sbjct: 73 RLFIVMEYCDGG--DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQ 130
Query: 199 NVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255
N+ L + G + K+ DFG + S + YT + + +Y SPE+ PY D+WSLG
Sbjct: 131 NIFLSKNGMVA-KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLG 189
Query: 256 CILAELYTGCPLFPGEN 272
C+L EL T F G N
Sbjct: 190 CVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 39/107 (36%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVIL 241
LH II+ DLKPEN+LL + G IK+ DFG S S ++ Y++ + Y +PEV+
Sbjct: 114 LHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEI-LGCP 287
+ D WS G ++ E+ TG F G++ E + I++ LG P
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 7/179 (3%)
Query: 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NL 154
E K++ AL E +IL+ + +S V+++ + ++ LC+ +MN +L
Sbjct: 34 EKKRIKKRKGESMALNEKQILEKV------NSQFVVNLAYAYETKDALCLVLTIMNGGDL 87
Query: 155 YELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVID 214
I GF +A ++ L LHREN ++ DLKPEN+LL G I +
Sbjct: 88 KFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLG 147
Query: 215 FGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENE 273
+ + + + Y +PEV+ Y D W LGC++ E+ G F G E
Sbjct: 148 LAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 79/351 (22%), Positives = 130/351 (37%), Gaps = 99/351 (28%)
Query: 26 LEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGE 84
LE IGKGSFG+V + +D++T A+K + E E +I++ + +
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITV------------- 55
Query: 85 ESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLC 144
LSQ DS Y + Y
Sbjct: 56 --LSQ----------------------------------CDSPYVTKYYGSYLKGTKLWI 79
Query: 145 ISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQ 204
I L + +L++ + F + + + +++ L LH E IH D+K NVLL +
Sbjct: 80 IMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRDIKAANVLLSE 136
Query: 205 RGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261
+G +K+ DFG + + + T++ + F+ +PEVI Y D+WSLG EL
Sbjct: 137 QGD--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIEL 194
Query: 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321
G PP+ + R LF K P +T +
Sbjct: 195 AK---------------------GEPPNS--DMHPMRVLFLIPKNNPPTLTGEFSK---- 227
Query: 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSS 372
F +F+ C N D R T E L+H+++ ++ +S
Sbjct: 228 --------------PFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 43/131 (32%), Positives = 65/131 (49%), Gaps = 8/131 (6%)
Query: 164 QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS----C 219
FS +R ++ ++ L LH+ I++ D+K EN+LL G + + DFG S
Sbjct: 100 DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLS 157
Query: 220 YSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVE-QL 277
+R Y++ + Y +PE+I G +G +D WSLG ++ EL TG F E E Q
Sbjct: 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
Query: 278 ACIMEILGCPP 288
IL C P
Sbjct: 218 EVSRRILKCDP 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 11/172 (6%)
Query: 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NL 154
E K++ AL E +IL+ + +S V+ + + ++ LC+ LMN +L
Sbjct: 34 EKKRIKKRKGESMALNEKQILEKV------NSRFVVSLAYAYETKDALCLVLTLMNGGDL 87
Query: 155 YELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVID 214
I GF G +A + L LH+E I++ DLKPEN+LL G I++ D
Sbjct: 88 KFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG--HIRISD 145
Query: 215 FGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
G + + Q + + + Y +PEV+ Y D W+LGC+L E+ G
Sbjct: 146 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 15/168 (8%)
Query: 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-----LNLYE 156
K++ AL E RIL+ + +S V+ + + ++ LC+ +MN ++Y
Sbjct: 40 KRKGEAMALNEKRILEKV------NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN 93
Query: 157 LIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG 216
+ GF +A L L L RE I++ DLKPEN+LL RG I +
Sbjct: 94 M----GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA 149
Query: 217 SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
+ V + + Y +PEVI Y D W LGC++ E+ G
Sbjct: 150 VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 18/139 (12%)
Query: 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSS--IKVID------FGSSCYS 221
+++ + ++ + LH ++H DLKP N+L+ G +K+ D F S
Sbjct: 109 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 222 HQRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENE------- 273
+ + + +YR+PE++LG Y ID+W++GCI AEL T P+F E
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 228
Query: 274 --VEQLACIMEILGCPPDE 290
+QL I ++G P D+
Sbjct: 229 FHHDQLDRIFSVMGFPADK 247
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 63/242 (26%), Positives = 100/242 (41%), Gaps = 33/242 (13%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTY 228
R +A + + LH NII+ DLKPEN+LL +G + + DFG + T+
Sbjct: 99 RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEETTSTF 156
Query: 229 IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM-EILGCP 287
+ Y +PEV+ PY +D W LG +L E+ G P F + + I+ + L P
Sbjct: 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP 216
Query: 288 PDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNW 347
+ + K ++R+ G+K A L + F + NW
Sbjct: 217 GGKTVAACDLLVGLL-----------HKDQRRRLGAK--ADFLEIKNHVFFSPI----NW 259
Query: 348 DS--KKRLTP--------DEALRHEWLKSSSSSSSSSSHHATDLRKSPSAHTNMYRLYRG 397
D KR+TP LRH + + + SSS DL S S+ ++ + +
Sbjct: 260 DDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASSAFLGFSY 319
Query: 398 VP 399
P
Sbjct: 320 AP 321
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 41/168 (24%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-----LNLYE 156
KK AL+E IL+ + +S ++++ F + HLC+ LMN ++Y
Sbjct: 33 KKSGEKMALLEKEILEKV------NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN 86
Query: 157 LIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG 216
+ +R G + + ++ + + LH +I++ D+KPENVLL +G+ + +
Sbjct: 87 VGER----GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA 142
Query: 217 SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
+ + + Y +PE++ PY P+D +++GC + E+ G
Sbjct: 143 VELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 56/229 (24%)
Query: 145 ISFELMNLNLYELIKRNNYQGFSLG--LIRRFAFSLVQCLRLLH-RENIIHCDLKPENVL 201
I E+M+ +L + K+ +G ++ ++ + A S+V+ L LH + ++IH D+KP NVL
Sbjct: 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL 136
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQ--SRFYRSPEVILG----LPYGPPIDMWSLG 255
+ + G +K+ DFG S Y V I + Y +PE I Y D+WSLG
Sbjct: 137 INRNG--QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLG 194
Query: 256 CILAELYTGCPLFPGEN---EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
+ EL TG FP ++ +QL ++E P S
Sbjct: 195 ITMIELATG--RFPYDSWKTPFQQLKQVVE--EPSPQLPAEKFSPE-------------- 236
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
F DFV +C + K+R E L+H
Sbjct: 237 ------------------------FQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 41/118 (34%), Positives = 56/118 (47%), Gaps = 18/118 (15%)
Query: 154 LYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVI 213
L++L+K+ S +++ LV+ L LH+ NIIH D+K ENVL R I +
Sbjct: 96 LFDLLKKEGK--LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY-DRAKDRIYLC 152
Query: 214 DFG-------SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
D+G SCY Y F SPE I G Y D W++G + EL TG
Sbjct: 153 DYGLCKIIGTPSCYDGTLDY------F--SPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 60/282 (21%), Positives = 107/282 (37%), Gaps = 60/282 (21%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK-IH 82
+ + +G+G+FG+V + G K +E+ A K +
Sbjct: 2 TLGKKLGEGAFGEVYKG----------TLKG--------KGDGKEVEV------AVKTLK 37
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
+ S Q + F E RI+ L N++ +L
Sbjct: 38 EDASEQQ------------IEEFLR----EARIMRKLDHP------NIVKLLGVCTEEEP 75
Query: 143 LCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L I E M +L + +++N + SL + FA + + + L +N IH DL N L
Sbjct: 76 LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQSR----FYRSPEVILGLPYGPPIDMWSLGCI 257
+ + +K+ DFG S + Y ++ + +PE + + D+WS G +
Sbjct: 136 VGENL--VVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVL 193
Query: 258 LAELYTGC-PLFPGENEVEQLACIME--ILGCP---PDEVIN 293
L E++T +PG + E L + + L P P E+
Sbjct: 194 LWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYK 235
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 11/113 (9%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTYIQSRFYRSPE 238
L+ LH I++ DLK +N+LL G +K+ DFG R T+ + + +PE
Sbjct: 114 LQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEV 291
V+ Y +D W LG ++ E+ G FPG++E E I+ DEV
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN------DEV 218
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 33/104 (31%), Positives = 60/104 (57%), Gaps = 5/104 (4%)
Query: 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRF 233
S++Q L LH + +IH D+K +++LL G +K+ DFG + V + + + +
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVGTPY 182
Query: 234 YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQL 277
+ +PEVI PYG +D+WSLG ++ E+ G P + ++ V+ +
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 37/107 (34%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTY 228
R +A + L LH NII+ DLKPEN+LL +G + + DFG + T+
Sbjct: 99 RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTF 156
Query: 229 IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVE 275
+ Y +PEV+ PY +D W LG +L E+ G P F + E
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 14/167 (8%)
Query: 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIK 159
K+R ++ EV +L +++ N++ E F +L I + +LY+ I
Sbjct: 40 PKER--EESRKEVAVLSNMKHP------NIVQYQESFEENGNLYIVMDYCEGGDLYKKIN 91
Query: 160 RNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219
F I + + L+ +H I+H D+K +N+ L + G+ IK+ DFG +
Sbjct: 92 AQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIAR 149
Query: 220 YSHQRV---YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT 263
+ V T I + +Y SPE+ PY D+W+LGC+L E+ T
Sbjct: 150 VLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 48/193 (24%), Positives = 80/193 (41%), Gaps = 20/193 (10%)
Query: 112 EVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGL 170
E RI+ L NV+ +L L I E M +L +++N + SL
Sbjct: 51 EARIMRKLDHP------NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSD 103
Query: 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ 230
+ FA + + + L +N IH DL N L+ + +K+ DFG S + Y +
Sbjct: 104 LLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDYYRKR 161
Query: 231 SR----FYRSPEVILGLPYGPPIDMWSLGCILAELYTGC-PLFPGENEVEQLACIM--EI 283
+ +PE + + D+WS G +L E++T +PG + E L +
Sbjct: 162 GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR 221
Query: 284 LGCP---PDEVIN 293
L P P E+ +
Sbjct: 222 LPQPPNCPPELYD 234
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 40/138 (28%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 130 VIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE 188
++ M F+ + LC +LMN +L+ + ++ FS +R +A ++ L +H
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNR 116
Query: 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSC-YSHQRVYTYIQSRFYRSPEVIL-GLPYG 246
+++ DLKP N+LL + G +++ D G +C +S ++ + + + Y +PEV+ G Y
Sbjct: 117 FVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYD 174
Query: 247 PPIDMWSLGCILAELYTG 264
D +SLGC+L +L G
Sbjct: 175 SSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 36/100 (36%), Positives = 50/100 (50%), Gaps = 5/100 (5%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTY 228
R +A + L LH NI++ DLKPEN+LL +G + + DFG T+
Sbjct: 99 RFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTF 156
Query: 229 IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLF 268
+ Y +PEVI PY +D W LG +L E+ G P F
Sbjct: 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 73/273 (26%), Positives = 113/273 (41%), Gaps = 63/273 (23%)
Query: 114 RILDHLR--KKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLI 171
RIL L K D Y ++ YF + + I ELM+ L +L+KR ++
Sbjct: 59 RILMDLDVVLKSHDCPY-IVKCYGYFITDSDVFICMELMSTCLDKLLKRI-QGPIPEDIL 116
Query: 172 RRFAFSLVQCLRLL-HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ 230
+ ++V+ L L + +IH D+KP N+LL G ++K+ DFG S + V + +
Sbjct: 117 GKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFG---ISGRLVDSKAK 171
Query: 231 SR-----FYRSPEVILGLPYGPPIDM----WSLGCILAELYTGCPLFPGEN---EVEQLA 278
+R Y +PE I P D+ WSLG L EL TG FP +N E E L
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG--QFPYKNCKTEFEVLT 229
Query: 279 CIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338
I++ +E P + ++G S D F
Sbjct: 230 KILQ------EE-----------------PPSLPPNEGF-----SPD-----------FC 250
Query: 339 DFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
FV C D +KR E L+H +++ ++
Sbjct: 251 SFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 40/125 (32%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY-----S 221
L + A L+ + +H E IIH D+K ENVL+ G I + DFG++C+ S
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN--GPEDICLGDFGAACFARGSWS 315
Query: 222 HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAE--LYTGCPLFPGENEVEQLAC 279
Y + +PEV+ G PY P +D+WS G ++ E ++T LF E+
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA-SLFSASRGDERRPY 374
Query: 280 IMEIL 284
+IL
Sbjct: 375 DAQIL 379
|
Length = 461 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 15/163 (9%)
Query: 131 IHMLEY-FYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE 188
I L+Y F +++L + E +L L+ R Q F + + + LV + +H+
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQM 121
Query: 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY--SHQRVYTY--IQSRFYRSPEVILGL- 243
+H D+KPENVL+ + G IK+ DFGS+ +++ V + + + Y +PEV+ +
Sbjct: 122 GYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 244 -----PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM 281
YG D WSLG I E+ G F + IM
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 6/101 (5%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVIL 241
+H+ I+H DLK +N+ LK + +K+ DFG S S T+ + +Y SPE +
Sbjct: 122 MHQRRILHRDLKAKNIFLKN---NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
Y D+WSLGCIL E+ F G+N + + I+E
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 39/152 (25%), Positives = 56/152 (36%), Gaps = 46/152 (30%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---------------------- 222
+H+ IH D+KP+N+LL +G IK+ DFG
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 223 -----------------QRVYTY--IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT 263
+R Y + + Y +PEV L Y D WSLG I+ E+
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 264 GCPLFPGENEVEQLACIM---EILGCPPDEVI 292
G P F +N E I+ E L P + +
Sbjct: 235 GYPPFCSDNPQETYRKIINWKETLQFPDEVPL 266
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 11/155 (7%)
Query: 130 VIHMLEYFYFRNHLCISFELMN---LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186
++ M F+ + L +LMN L+ Y L + + FS +R +A ++ L +H
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLH-YHL---SQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC-YSHQRVYTYIQSRFYRSPEVIL-GLP 244
+++ DLKP N+LL + G +++ D G +C +S ++ + + + Y +PEV+ G+
Sbjct: 115 NRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVA 172
Query: 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLAC 279
Y D +SLGC+L +L G F ++
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 56/195 (28%), Positives = 86/195 (44%), Gaps = 45/195 (23%)
Query: 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFY 234
LV L LH+ +I++ DLKPEN+LL G I + DFG S ++ T+ + Y
Sbjct: 105 LVLALEHLHKYDIVYRDLKPENILLDATG--HIALCDFGLSKANLTDNKTTNTFCGTTEY 162
Query: 235 RSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVIN 293
+PEV+L Y +D WSLG ++ E+ G F E + +Q+
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-DTQQM---------------- 205
Query: 294 TASRRRLFFDSKGTPRCITNSKGRK-------RKP----GSKDMASVLRCNDKAFVDFVT 342
R + F P+ + + +GR+ R P G+ A L+ F D
Sbjct: 206 ---YRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELK-EHPFFAD--- 258
Query: 343 QCFNWD--SKKRLTP 355
+WD SKK++TP
Sbjct: 259 --IDWDLLSKKQITP 271
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 43/120 (35%), Positives = 58/120 (48%), Gaps = 18/120 (15%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF------YRSPE 238
+H+ +H D+KP+NVLL + G I++ DFGS C T +QS Y SPE
Sbjct: 118 VHQLGYVHRDIKPDNVLLDKNGH--IRLADFGS-CLRLLADGT-VQSNVAVGTPDYISPE 173
Query: 239 VILGLP-----YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM---EILGCPPDE 290
++ + YGP D WSLG + E+ G F E+ VE IM E PPD
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 35/99 (35%), Positives = 44/99 (44%), Gaps = 2/99 (2%)
Query: 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTY 228
++R+A +V L LHRE I+ DL P N+LL RG I++ F
Sbjct: 85 ECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG--HIQLTYFSRWSEVEDSCDGE 142
Query: 229 IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPL 267
Y +PEV D WSLG IL EL TG L
Sbjct: 143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 37/107 (34%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 184 LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSRFYRSPEVILG 242
L + I+H D+KP N+L+ RG IK+ DFG S +++ +R Y SPE + G
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG 176
Query: 243 LPYGPPIDMWSLGCILAELYTG-CPLFPGE-NEVEQLACIMEILGCP 287
Y D+WS+G L E+ G P+ P + E+E + GCP
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL------MFGCP 217
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 23/174 (13%)
Query: 101 NKKRF-----HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN---- 151
NKKR + A++E RIL + S ++ + F + LC+ +MN
Sbjct: 27 NKKRLKKRKGYEGAMVEKRILAKVH------SRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80
Query: 152 -LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSI 210
++Y + + N GF + ++ L LH+ II+ DLKPENVLL G ++
Sbjct: 81 RYHIYNVDEEN--PGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG--NV 136
Query: 211 KVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261
++ D G + + Y + + +PE++ G Y +D ++LG L E+
Sbjct: 137 RISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 51/195 (26%), Positives = 79/195 (40%), Gaps = 49/195 (25%)
Query: 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC---YSHQRVYTYIQSRFY 234
++ L LH +IH D+K +N+LL + +K++DFG S + R T+I + ++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179
Query: 235 RSPEVI-----LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPD 289
+PEVI Y D+WSLG EL G P C M P
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL----------CDM-----HPM 224
Query: 290 EVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDS 349
R LF PR N + P + K F DF+++C +
Sbjct: 225 --------RALFK----IPR---NPPPTLKSPENW---------SKKFNDFISECLIKNY 260
Query: 350 KKRLTPDEALRHEWL 364
++R +E L H ++
Sbjct: 261 EQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 41/123 (33%), Positives = 61/123 (49%), Gaps = 15/123 (12%)
Query: 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYI 229
+ R + +V + +H+ + +H D+KP+NVLL G I++ DFGS C + T +
Sbjct: 103 MARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGS-CLKMNQDGT-V 158
Query: 230 QSRF------YRSPEVILGL-----PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLA 278
QS Y SPE++ + YGP D WSLG + E+ G F E+ VE
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 279 CIM 281
IM
Sbjct: 219 KIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 17/172 (9%)
Query: 108 QALIEVRILDHLRKKDADSSYNVIHMLEY-FYFRNHLCISFELMNL-NLYELIKRNNYQG 165
L E R+L + R + + L+Y F ++ LC E +N L+ + R
Sbjct: 41 HTLTESRVLKNTR-------HPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERV-- 91
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSH 222
FS R + +V L LH I++ DLK EN++L + G IK+ DFG
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDA 149
Query: 223 QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG-CPLFPGENE 273
+ T+ + Y +PEV+ YG +D W LG ++ E+ G P + ++E
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 11/101 (10%)
Query: 186 HRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCY----------SHQRVYTYIQSRFY 234
H + I+H DLKP+N+++ Q G KV+DFG + R + + Y
Sbjct: 96 HNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTY 155
Query: 235 RSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVE 275
+PE + G P P D+++ G I E TG + G + E
Sbjct: 156 CAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 55/186 (29%), Positives = 82/186 (44%), Gaps = 30/186 (16%)
Query: 109 ALIEVRILDHLRKKDAD--SSYNVIHMLE----------YFYFRNH-----LCISFELMN 151
+L V+ILD + D + + YN++ L FY + L + EL N
Sbjct: 48 SLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCN 107
Query: 152 L-NLYELIKRNNYQGFSL--GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSS 208
++ EL+K G L +I + + L+ LH IIH D+K N+LL G
Sbjct: 108 GGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-- 165
Query: 209 SIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVI-----LGLPYGPPIDMWSLGCILAE 260
+K++DFG S + R T + + F+ +PEVI Y D+WSLG E
Sbjct: 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
Query: 261 LYTGCP 266
L G P
Sbjct: 226 LGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 10/99 (10%)
Query: 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG-SSCYSHQRV 225
S+ ++R A+ L + I+H D+KP N+L+ RG IK+ DFG S
Sbjct: 109 SIAVLRGLAY-------LREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDSMA 159
Query: 226 YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
+++ +R Y SPE + G Y D+WS+G L EL G
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 11/96 (11%)
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 238
+Q L LH IH D+K N+LL + G ++K+ DFGS+ +++ + ++ +PE
Sbjct: 125 LQGLAYLHSHERIHRDIKAGNILLTEPG--TVKLADFGSASLVSP-ANSFVGTPYWMAPE 181
Query: 239 VILGL---PYGPPIDMWSLG--CI-LAELYTGCPLF 268
VIL + Y +D+WSLG CI LAE PLF
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP--PLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 17/172 (9%)
Query: 108 QALIEVRILDHLRKKDADSSYNVIHMLEY-FYFRNHLCISFELMNL-NLYELIKRNNYQG 165
+ E R+L + R + + L+Y F + LC E N L+ + R
Sbjct: 41 HTVTESRVLQNTR-------HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-- 91
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSH 222
F+ R + +V L LH ++++ D+K EN++L + G IK+ DFG
Sbjct: 92 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDG 149
Query: 223 QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG-CPLFPGENE 273
+ T+ + Y +PEV+ YG +D W LG ++ E+ G P + ++E
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 52/198 (26%), Positives = 80/198 (40%), Gaps = 46/198 (23%)
Query: 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFY 234
+++ L LH E IH D+K NVLL + G +K+ DFG + + + T++ + F+
Sbjct: 110 ILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 235 RSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINT 294
+PEVI Y D+WSLG EL G P P E+
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEP--------------------PHSEL--- 204
Query: 295 ASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT 354
+ LF K P + +G KP +FV C N + R T
Sbjct: 205 HPMKVLFLIPKNNPPTL---EGNYSKP---------------LKEFVEACLNKEPSFRPT 246
Query: 355 PDEALRHEWLKSSSSSSS 372
E L+H+++ + +S
Sbjct: 247 AKELLKHKFIVRFAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 31/85 (36%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPE 238
L+ LH ++I+H DLK +NV L + ++ IKV D G + + T I + +Y SPE
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTR--TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 239 VILGLPYGPPIDMWSLGCILAELYT 263
+ PY D+W+LGC + E+ T
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 7/97 (7%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYT 227
R +A + L LH II+ DLK +NVLL G IK+ D+G C T
Sbjct: 99 RFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGM-CKEGLGPGDTTST 155
Query: 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
+ + Y +PE++ G YG +D W+LG ++ E+ G
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 50/199 (25%), Positives = 75/199 (37%), Gaps = 58/199 (29%)
Query: 162 NYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS 221
Y FS + R + V + +H+ IH D+KP+N+L+ + G IK+ DFG S
Sbjct: 94 KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGF 151
Query: 222 H---------------------------------------QRVYTYIQSRF--------- 233
H ++ T+ ++R
Sbjct: 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGT 211
Query: 234 --YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM---EILGCPP 288
Y +PE+ L YG D WSLG I+ E G P F EN E I+ E L P
Sbjct: 212 PDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD 271
Query: 289 DEVINTASR---RRLFFDS 304
D ++ + RRL ++
Sbjct: 272 DIHLSVEAEDLIRRLITNA 290
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 31/191 (16%)
Query: 129 NVIHMLEYFYFRNHLCISFELMNL-NLYELIK--RNNYQGFSLGLIRRFAFSLVQCLRLL 185
NVI L+ F N L I EL + +L ++IK + + + ++ L + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILG 242
H ++H D+KP NV + G +K+ D G + + ++ + + +Y SPE I
Sbjct: 123 HSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 243 LPYGPPIDMWSLGCILAE--------------LYTGC--------PLFPGENEVEQLACI 280
Y D+WSLGC+L E L++ C P P E+ E+L +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL 240
Query: 281 MEILGCP-PDE 290
+ + P PD+
Sbjct: 241 VSMCIYPDPDQ 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 32/86 (37%), Positives = 50/86 (58%), Gaps = 6/86 (6%)
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 238
+Q L LH N+IH D+K N+LL + G +K+ DFGS+ S +++ + ++ +PE
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASKSSP-ANSFVGTPYWMAPE 187
Query: 239 VILGL---PYGPPIDMWSLGCILAEL 261
VIL + Y +D+WSLG EL
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 8e-08
Identities = 31/86 (36%), Positives = 50/86 (58%), Gaps = 6/86 (6%)
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 238
+Q L LH N+IH D+K N+LL + G +K+ DFGS+ + +++ + ++ +PE
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASIASP-ANSFVGTPYWMAPE 191
Query: 239 VILGL---PYGPPIDMWSLGCILAEL 261
VIL + Y +D+WSLG EL
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 61/252 (24%), Positives = 103/252 (40%), Gaps = 53/252 (21%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
+E++EV+G G++GQV + KT A + +TE E EI+ LEI L
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIK--LEINML-------- 66
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
K++ H I ++K + ++E+
Sbjct: 67 --------------------KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF------ 100
Query: 143 LCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLL 202
C + + +L+K I +++ L LH +IH D+K +NVLL
Sbjct: 101 -CGAGSVT-----DLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL 154
Query: 203 KQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVIL-----GLPYGPPIDMWSL 254
+ ++ +K++DFG S + R T+I + ++ +PEVI Y D+WSL
Sbjct: 155 TE--NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSL 212
Query: 255 GCILAELYTGCP 266
G E+ G P
Sbjct: 213 GITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 8/123 (6%)
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--- 222
F ++ ++ +V L LH+ II+ D+K EN+LL G + + DFG S H
Sbjct: 102 FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHEDE 159
Query: 223 -QRVYTYIQSRFYRSPEVILGLPYG--PPIDMWSLGCILAELYTGCPLFPGENEVEQLAC 279
+R Y++ + Y +P+++ G G +D WS+G ++ EL TG F + E A
Sbjct: 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE 219
Query: 280 IME 282
I
Sbjct: 220 ISR 222
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 6/113 (5%)
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSH 222
FS R + +V L LH ++++ DLK EN++L + G IK+ DFG
Sbjct: 92 FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG--HIKITDFGLCKEGISDG 149
Query: 223 QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG-CPLFPGENEV 274
+ T+ + Y +PEV+ YG +D W LG ++ E+ G P + ++E
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 18/173 (10%)
Query: 108 QALIEVRILDHLRKKDADSSYNVIHMLEY-FYFRNHLCISFELMNL-NLYELIKRNNYQG 165
L E R+L +S + + L+Y F + LC E N L+ + R
Sbjct: 41 HTLTENRVLQ-------NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-- 91
Query: 166 FSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYS 221
FS R + +V L LH E N+++ DLK EN++L + G IK+ DFG
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKD 149
Query: 222 HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG-CPLFPGENE 273
+ T+ + Y +PEV+ YG +D W LG ++ E+ G P + ++E
Sbjct: 150 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 3e-07
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 10/97 (10%)
Query: 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFY 234
+++ L LH+ +IH D+K +NVLL + ++ +K++DFG S + R T+I + ++
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 177
Query: 235 RSPEVIL-----GLPYGPPIDMWSLGCILAELYTGCP 266
+PEVI Y D+WSLG E+ G P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 39/123 (31%), Positives = 60/123 (48%), Gaps = 15/123 (12%)
Query: 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYI 229
+ R + +V + +H+ + +H D+KP+N+L+ G I++ DFGS C T +
Sbjct: 103 MARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGS-CLKLMEDGT-V 158
Query: 230 QSRF------YRSPEVILGLP-----YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLA 278
QS Y SPE++ + YGP D WSLG + E+ G F E+ VE
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 279 CIM 281
IM
Sbjct: 219 KIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 50/191 (26%), Positives = 77/191 (40%), Gaps = 49/191 (25%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPE 238
L+ LH IH D+K N+LL G +K++DFG S + R T + + F+ +PE
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEG--GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194
Query: 239 VI-----LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVIN 293
VI L Y D+WSLG EL G P ++ + + +I PP +
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA---DLHPMRALFKIPRNPPPTL-- 249
Query: 294 TASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRL 353
+P L N+ F DF+ +C D +KR
Sbjct: 250 -------------------------HQPE-------LWSNE--FNDFIRKCLTKDYEKRP 275
Query: 354 TPDEALRHEWL 364
T + L+H ++
Sbjct: 276 TVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYT 227
R ++ + L LH II+ DLK +NVLL G IK+ D+G C R T
Sbjct: 99 RFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGM-CKEGIRPGDTTST 155
Query: 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
+ + Y +PE++ G YG +D W+LG ++ E+ G
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 31/86 (36%), Positives = 48/86 (55%), Gaps = 6/86 (6%)
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPE 238
+Q L LH N+IH D+K N+LL + G +K+ DFGS+ ++ + ++ +PE
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP-ANXFVGTPYWMAPE 181
Query: 239 VILGL---PYGPPIDMWSLGCILAEL 261
VIL + Y +D+WSLG EL
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 40/139 (28%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 129 NVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSL--GLIRRFAFSLVQCLRLL 185
NVI F N L I EL + +L +IK Q + + ++ L L +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILG 242
H ++H D+KP NV + G +K+ D G + + ++ + + +Y SPE I
Sbjct: 123 HSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 243 LPYGPPIDMWSLGCILAEL 261
Y D+WSLGC+L E+
Sbjct: 181 NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 41/129 (31%), Positives = 60/129 (46%), Gaps = 15/129 (11%)
Query: 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RVYTYIQSR 232
+V L +H IH D+KP+N+LL + G +K+ DFG +C R T + +
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFG-TCMKMDANGMVRCDTAVGTP 207
Query: 233 FYRSPEVILGL----PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME---ILG 285
Y SPEV+ YG D WS+G L E+ G F ++ V + IM+ L
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT 267
Query: 286 CPPDEVINT 294
P D I+
Sbjct: 268 FPDDIEISK 276
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 29/126 (23%), Positives = 48/126 (38%), Gaps = 6/126 (4%)
Query: 143 LCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLL 202
+ I E M R + + + + L IH DL N L+
Sbjct: 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV 133
Query: 203 KQRGSSSIKVIDFGSSCYSHQRVYTYIQ-SRF---YRSPEVILGLPYGPPIDMWSLGCIL 258
+ +KV DFG + Y YT Q ++F + PEV + D+WS G ++
Sbjct: 134 GEDNV--VKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLM 191
Query: 259 AELYTG 264
E+++
Sbjct: 192 WEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 7/93 (7%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFG-----SSCYSHQRVYTYIQSRFYRSPEV 239
+H +++IH D+K N+LL G +K+ DFG ++ S T+ + +Y +PE+
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216
Query: 240 ILGLPYGPPIDMWSLGCILAELYTGCPLFPGEN 272
PY DM+SLG +L EL T F GEN
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 40/118 (33%), Positives = 56/118 (47%), Gaps = 10/118 (8%)
Query: 163 YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222
+Q + +GL+ + +V L +H ++H DLK N+ L G IK+ DFG S
Sbjct: 166 FQEYEVGLL---FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYS 220
Query: 223 QRVYTYIQSRF-----YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVE 275
V + S F Y +PE+ Y DMWSLG IL EL T F G ++ E
Sbjct: 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE 278
|
Length = 478 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYT 227
R ++ + L LH II+ DLK +NVLL G IK+ D+G C R T
Sbjct: 99 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGM-CKEGLRPGDTTST 155
Query: 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
+ + Y +PE++ G YG +D W+LG ++ E+ G
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 34/121 (28%), Positives = 56/121 (46%), Gaps = 8/121 (6%)
Query: 156 ELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDF 215
L+ + +G + + F + + + + L +N +H DL NVLL Q +K+ DF
Sbjct: 224 NLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ--GKIVKICDF 281
Query: 216 G-SSCYSHQRVYTYIQSRF----YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFP 269
G + H Y S F + +PE I Y D+WS G +L E+++ G +P
Sbjct: 282 GLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341
Query: 270 G 270
G
Sbjct: 342 G 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 49/192 (25%), Positives = 72/192 (37%), Gaps = 51/192 (26%)
Query: 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC---YSHQRVYTYIQSRFYRS 236
+ L LH IH D+K N+LL + G +K+ DFG S + + ++I + ++ +
Sbjct: 112 KGLAYLHETGKIHRDIKGANILLTEDG--DVKLADFGVSAQLTATIAKRKSFIGTPYWMA 169
Query: 237 PEVI---LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVIN 293
PEV Y D+W+LG EL E PP + +
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIEL--------AE-------------LQPP--MFD 206
Query: 294 TASRRRLFFDSKGTPRCITNSKGRKRKPGS---KDMASVLRCNDKAFVDFVTQCFNWDSK 350
R LF SK P K+ S F DF+ +C D K
Sbjct: 207 LHPMRALFLISK-----------SNFPPPKLKDKEKWS------PVFHDFIKKCLTKDPK 249
Query: 351 KRLTPDEALRHE 362
KR T + L+H
Sbjct: 250 KRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 41/154 (26%), Positives = 63/154 (40%), Gaps = 43/154 (27%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---------------------SSCYSHQ 223
+H+ IH D+KP+N+LL +G +K+ DFG S +S Q
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 224 RV-----------------YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCP 266
+ Y+ + + Y +PEV + Y D WSLG I+ E+ G P
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 267 LFPGENEVEQLACIM---EILGCPPDEVINTASR 297
F E E +M E L PP+ I+ ++
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAK 268
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 110 LIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQG--- 165
L E++I+ L+ N+I +L + LC+ E M N +L + + R+ Q
Sbjct: 67 LKEIKIMSRLKDP------NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 166 ------FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219
S + A + ++ L N +H DL N L+ + +IK+ DFG S
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN--YTIKIADFGMSR 178
Query: 220 YSHQRVYTYIQSRF-----YRSPEVILGLPYGPPIDMWSLGCILAELYTGC 265
+ Y IQ R + S E IL + D+W+ G L E+ T C
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 36/117 (30%), Positives = 57/117 (48%), Gaps = 10/117 (8%)
Query: 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----RVYTYI 229
+ +V L +H +IH D+KP+N+LL + G +K+ DFG+ + R T +
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMVRCDTAV 204
Query: 230 QSRFYRSPEVILGLP----YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
+ Y SPEV+ YG D WS+G L E+ G F ++ V + IM+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 50/187 (26%), Positives = 78/187 (41%), Gaps = 21/187 (11%)
Query: 112 EVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGL 170
EV+ L LR K S + V + E Y I ELM +L + + +G L +
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVY------IITELMEKGSLLAFL--RSPEGQVLPV 103
Query: 171 --IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTY 228
+ A + + + L +N IH DL N+L+ + KV DFG + + VY
Sbjct: 104 ASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE--DLVCKVADFGLARLIKEDVYLS 161
Query: 229 IQSRF---YRSPEVILGLPYGPPIDMWSLGCILAELYT--GCPLFPGENEVEQLACIME- 282
+ + +PE + D+WS G +L E++T P +PG N E I
Sbjct: 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP-YPGMNNHEVYDQITAG 220
Query: 283 -ILGCPP 288
+ CP
Sbjct: 221 YRMPCPA 227
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 6e-06
Identities = 55/280 (19%), Positives = 106/280 (37%), Gaps = 60/280 (21%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHG 83
E+ + +G+G+FG+V + G E T++ A K
Sbjct: 2 ELGKKLGEGAFGEVYKG----------TLKG--DGEGTETKV------------AVKT-- 35
Query: 84 EESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHL 143
+ ++ F E I+ L N++ +L L
Sbjct: 36 ---------LKEGASEEEREEFLE----EASIMKKLSHP------NIVRLLGVCTQGEPL 76
Query: 144 CISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLL 202
I E M +L + ++++ + +L + + A + + + L +N +H DL N L+
Sbjct: 77 YIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLV 135
Query: 203 KQRGSSSIKVIDFGSSCYSHQRVYTYIQSR-----FYRSPEVILGLPYGPPIDMWSLGCI 257
+ +K+ DFG S ++ Y + + +PE + + D+WS G +
Sbjct: 136 TENLV--VKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVL 193
Query: 258 LAELYTGCPL-FPGENEVEQLACIME--ILGCP---PDEV 291
L E++T +PG + E L + + L P PDE+
Sbjct: 194 LWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL 233
|
Length = 258 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 37/118 (31%), Positives = 57/118 (48%), Gaps = 10/118 (8%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----RVYT 227
R + +V L +H IH D+KP+N+LL + G +K+ DFG+ ++ R T
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCDT 202
Query: 228 YIQSRFYRSPEVILGLP----YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM 281
+ + Y SPEV+ YG D WS+G L E+ G F ++ V + IM
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 37/207 (17%)
Query: 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMNLNLYELIK 159
K+R Q +IEV ++ L+ K N++ ++ F + L I E +
Sbjct: 52 KEREKSQLVIEVNVMRELKHK------NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI 105
Query: 160 RNNYQGFS-------LGLIRRFAFSLVQCLRLL---HRENIIHCDLKPENVLLKQ----- 204
+ Y+ F + + R+ +L C L + E ++H DLKP+N+ L
Sbjct: 106 QKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165
Query: 205 ----------RGSSSIKVIDFGSS--CYSHQRVYTYIQSRFYRSPEVIL--GLPYGPPID 250
G K+ DFG S ++ + + +Y SPE++L Y D
Sbjct: 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSD 225
Query: 251 MWSLGCILAELYTGCPLFPGENEVEQL 277
MW+LGCI+ EL +G F N QL
Sbjct: 226 MWALGCIIYELCSGKTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 37/155 (23%), Positives = 70/155 (45%), Gaps = 15/155 (9%)
Query: 112 EVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLI 171
E+ IL + S +I+++ + +++ +C+ +L+ + R+ L
Sbjct: 136 EIDILKTI------SHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS--GPLPLEQA 187
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT---- 227
L++ L LH IIH D+K EN+ L + ++ + DFG++C T
Sbjct: 188 ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCY 245
Query: 228 -YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261
+ + SPE++ PY D+WS G +L E+
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 40/154 (25%), Positives = 63/154 (40%), Gaps = 43/154 (27%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---------------------------S 217
+H+ IH D+KP+N+LL +G +K+ DFG
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 218 SCYSHQRVYTYIQSRF-----------YRSPEVILGLPYGPPIDMWSLGCILAELYTGCP 266
+ S ++ T+ ++R Y +PEV + Y D WSLG I+ E+ G P
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 267 LFPGENEVEQLACIM---EILGCPPDEVINTASR 297
F E E +M E L PP+ I+ ++
Sbjct: 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAK 268
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 49/220 (22%), Positives = 80/220 (36%), Gaps = 48/220 (21%)
Query: 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQS 231
A ++ + LHR +I+H D+KP N+L+ ++K+ DFG S Q + + + +
Sbjct: 174 ARQILSGIAYLHRRHIVHRDIKPSNLLINSA--KNVKIADFGVSRILAQTMDPCNSSVGT 231
Query: 232 RFYRSPEVI-----LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGC 286
Y SPE I G G D+WSLG + E Y G F + + + + I
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS 291
Query: 287 PPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFN 346
P E TASR F F++ C
Sbjct: 292 QPPEAPATASRE--------------------------------------FRHFISCCLQ 313
Query: 347 WDSKKRLTPDEALRHEWLKSSSSSSSSSSHHATDLRKSPS 386
+ KR + + L+H ++ + + L P
Sbjct: 314 REPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPPPR 353
|
Length = 353 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 34/128 (26%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 140 RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
R+ +C+ FE M R FS + + + + L N+IH DL N
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARN 130
Query: 200 VLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ-SRF---YRSPEVILGLPYGPPIDMWSLG 255
L+ + + +KV DFG + + YT ++F + SPEV Y D+WS G
Sbjct: 131 CLVGE--NQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFG 188
Query: 256 CILAELYT 263
++ E+++
Sbjct: 189 VLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 48/196 (24%), Positives = 75/196 (38%), Gaps = 67/196 (34%)
Query: 136 YFYFRNHLCISF--------ELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHR 187
Y+ F++ + F ++M+L LI+ F L R + L + +H+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSL----LIR---LGIFEEDLARFYIAELTCAIESVHK 119
Query: 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFG----------SSCY----------------- 220
IH D+KP+N+L+ + G IK+ DFG S Y
Sbjct: 120 MGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177
Query: 221 -----------------SHQRV--YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261
HQR ++ + + Y +PEV+L Y D WS+G IL E+
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237
Query: 262 YTGCPLF----PGENE 273
G P F P E +
Sbjct: 238 LVGQPPFLADTPAETQ 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 5e-05
Identities = 51/254 (20%), Positives = 87/254 (34%), Gaps = 65/254 (25%)
Query: 27 EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK-IHGEE 85
+ +G+G+FG+V + K G E A K + +
Sbjct: 1 KKLGEGAFGEVYKG----------KLKGKDGKTTEV---------------AVKTLKEDA 35
Query: 86 SLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCI 145
S + +K F E R++ L NV+ +L L +
Sbjct: 36 SEEE------------RKDFLK----EARVMKKLGHP------NVVRLLGVCTEEEPLYL 73
Query: 146 SFELM---NLNLYELIKRNNYQGF------SLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
E M +L Y L K SL + FA + + + L + +H DL
Sbjct: 74 VLEYMEGGDLLDY-LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLA 132
Query: 197 PENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYR-----SPEVILGLPYGPPIDM 251
N L+ + +K+ DFG S + Y ++ +PE + + D+
Sbjct: 133 ARNCLVGEDLV--VKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDV 190
Query: 252 WSLGCILAELYTGC 265
WS G +L E++T
Sbjct: 191 WSFGVLLWEIFTLG 204
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 22/161 (13%)
Query: 145 ISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLK 203
I E M NL + ++ N Q + ++ A + + L ++N IH DL N L+
Sbjct: 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138
Query: 204 QRGSSSIKVIDFGSSCYSHQRVYT-YIQSRF---YRSPEVILGLPYGPPIDMWSLGCILA 259
+ + +KV DFG S YT + ++F + +PE + + D+W+ G +L
Sbjct: 139 E--NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 196
Query: 260 ELYT-GCPLFPGENEVEQLACIMEIL----------GCPPD 289
E+ T G +PG + L+ + E+L GCPP
Sbjct: 197 EIATYGMSPYPGID----LSQVYELLEKGYRMERPEGCPPK 233
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 27/162 (16%)
Query: 110 LIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNN--YQGFS 167
LIE +L ++ + +VI M + C+ + +LY + + +
Sbjct: 105 LIEAMLLQNV------NHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158
Query: 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT 227
+I + +++ LR LH + IIH D+K EN+ + + + D G++ +
Sbjct: 159 ALIIEK---QILEGLRYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAA------QFP 207
Query: 228 YIQSRFY--------RSPEVILGLPYGPPIDMWSLGCILAEL 261
+ F +PEV+ Y D+WS G +L E+
Sbjct: 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 52/160 (32%)
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG--------- 216
F L R + L + +H+ IH D+KP+N+L+ + G IK+ DFG
Sbjct: 98 FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTH 155
Query: 217 -------------------------SSCY--------------SHQR--VYTYIQSRFYR 235
++C HQR ++ + + Y
Sbjct: 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYI 215
Query: 236 SPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVE 275
+PEV+L Y D WS+G IL E+ G P F + +E
Sbjct: 216 APEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC-YSHQRV---YT 227
R L+ + +H + +IH D+K EN+ L I + DFG++ + +R Y
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN--CDGKIVLGDFGTAMPFEKEREAFDYG 327
Query: 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG--CPL 267
++ + SPE++ G Y D+WS G IL ++ + CP+
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369
|
Length = 501 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 53/295 (17%), Positives = 105/295 (35%), Gaps = 34/295 (11%)
Query: 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL 152
+ ++ S + Q +I R L H N++ + F + L + LM
Sbjct: 33 INLDSCSKEDLKLLQQEIITSRQLQH---------PNILPYVTSFIVDSELYVVSPLMAY 83
Query: 153 -NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIK 211
+ +L+K + +G I ++ L +H + IH +K ++LL G +
Sbjct: 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLS 143
Query: 212 ----VIDFGSSCYSHQRVYTYIQSR----FYRSPEV----ILGLPYGPPIDMWSLGCILA 259
+ + V+ + +S + SPEV + G Y D++S+G
Sbjct: 144 GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG--YNEKSDIYSVGITAC 201
Query: 260 ELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
EL G F ++ ++E + G P +++ ++ + + R
Sbjct: 202 ELANGHVPF---KDMPATQMLLEKVRGTVP-CLLDKSTYPLYEDSMSQSRSSNEHPNNRD 257
Query: 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSS 373
R + F FV C D + R + + L H + K ++S
Sbjct: 258 SVD-----HPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 9/75 (12%)
Query: 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-YTY 228
+I+ ++ L LH I+H D+KP+N++ + GS S K+ID G++ + RV Y
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE-GSGSFKIIDLGAA--ADLRVGINY 312
Query: 229 IQSRF-----YRSPE 238
I F Y +PE
Sbjct: 313 IPKEFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 44/172 (25%), Positives = 71/172 (41%), Gaps = 24/172 (13%)
Query: 110 LIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM---NLNLY--------ELI 158
L E++I+ L+ N+I +L + LC+ E M +LN +
Sbjct: 65 LKEIKIMSRLKNP------NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT 118
Query: 159 KRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS 218
NN S+ + A + ++ L N +H DL N L+ +IK+ DFG S
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN--HYTIKIADFGMS 176
Query: 219 CYSHQRVYTYIQSRF-----YRSPEVILGLPYGPPIDMWSLGCILAELYTGC 265
+ Y IQ R + + E IL + D+W+ G L E++T C
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 29/172 (16%)
Query: 143 LCISFELMNL-NLYE-LIKRNNYQGFSLGLIRRFAFSLVQCLRLLH-------------R 187
C+ FE + +L+E L++ + + S + C LH
Sbjct: 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS 142
Query: 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSS--CYSHQRVYTYIQSRF-----YRSPEVI 240
+ +H DL N L+ + ++K+ DFG S YS Y +QS+ + PE I
Sbjct: 143 HHFVHRDLAARNCLVGEG--LTVKISDFGLSRDIYSAD--YYRVQSKSLLPVRWMPPEAI 198
Query: 241 LGLPYGPPIDMWSLGCILAELYT-GCPLFPG--ENEVEQLACIMEILGCPPD 289
L + D+WS G +L E+++ G + G EV ++ ++L CP D
Sbjct: 199 LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 24/96 (25%), Positives = 42/96 (43%), Gaps = 14/96 (14%)
Query: 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTYIQ 230
FA + + + L +N +H DL NVL+ + + KV DFG +
Sbjct: 107 FALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVA--KVSDFGLAKEASQGQD------S 158
Query: 231 SRF---YRSPEVILGLPYGPPIDMWSLGCILAELYT 263
+ + +PE + + D+WS G +L E+Y+
Sbjct: 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 30/108 (27%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 160 RNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219
R + + F + + + + L + IH DL N L+ +G +KV DFG S
Sbjct: 91 REHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSR 148
Query: 220 YSHQRVYTY-IQSRF---YRSPEVILGLPYGPPIDMWSLGCILAELYT 263
Y YT + S+F + PEV+L + D+W+ G ++ E+Y+
Sbjct: 149 YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 110 LIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSL 168
L E +I+ LR Y V+ + I E M+ +L + +K + L
Sbjct: 49 LEEAQIMKKLRHDKLVQLYAVVS-------EEPIYIVTEYMSKGSLLDFLKDGEGRALKL 101
Query: 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSI-KVIDFGSSCYSHQRVYT 227
+ A + + + R N IH DL+ N+L+ G + K+ DFG + YT
Sbjct: 102 PNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIEDNEYT 158
Query: 228 YIQ-SRF---YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQL 277
Q ++F + +PE L + D+WS G +L EL T G +PG N E L
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC-----YSHQRVYTYIQSRFYRS 236
LR LHR I+H D+KPEN+L+ G +K+IDFG++ + +Y + R+
Sbjct: 322 LRKLHRIGIVHRDIKPENLLVTVDG--QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379
Query: 237 PEVIL--GLPYGPPIDMWSLGCILAELYTGCPLF 268
E+++ P P M +L A LY LF
Sbjct: 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF 413
|
Length = 507 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 31/119 (26%), Positives = 54/119 (45%), Gaps = 9/119 (7%)
Query: 153 NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKV 212
+L E + RN + +L ++A + + + L +H DL NVL++ +K+
Sbjct: 94 SLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKI 150
Query: 213 IDFG--SSCYSHQRVYTYIQSR----FYRSPEVILGLPYGPPIDMWSLGCILAELYTGC 265
DFG + + + YT F+ +PE ++ + D+WS G L EL T C
Sbjct: 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 20/37 (54%), Positives = 24/37 (64%), Gaps = 2/37 (5%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS 218
L LHR IIH DLKP+N+L+ G IK+ DFG S
Sbjct: 117 LDYLHRHGIIHRDLKPDNMLISNEG--HIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYE 156
G+ + K F L E +I+ LR Y V + E Y I ELM +L E
Sbjct: 41 GTMDPKDF----LAEAQIMKKLRHPKLIQLYAVCTLEEPIY------IVTELMKYGSLLE 90
Query: 157 LIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG 216
++ + L + A + + L +N IH DL NVL+ + ++ KV DFG
Sbjct: 91 YLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE--NNICKVADFG 148
Query: 217 SSCYSHQRVYT-YIQSRF---YRSPEVILGLPYGPPIDMWSLGCILAELYT 263
+ + +Y ++F + +PE L + D+WS G +L E+ T
Sbjct: 149 LARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 10/157 (6%)
Query: 141 NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
N L I ELM+ NL ++ S+ + +F+ + + + L + ++H DL N
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARN 130
Query: 200 VLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILA 259
+L+ + G + KV DFG + V + +PE + + D+WS G +L
Sbjct: 131 ILVSEDGVA--KVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLW 188
Query: 260 ELYT-GCPLFPGENEVEQLACI-----MEIL-GCPPD 289
E+++ G +P + E C+ ME GCP D
Sbjct: 189 EVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPAD 225
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 16/31 (51%), Positives = 23/31 (74%), Gaps = 1/31 (3%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALK 51
+ +LE IGKGSFG+V +A+D +TN A+K
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIK 32
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 19/38 (50%), Positives = 25/38 (65%)
Query: 234 YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGE 271
Y +PE++LG P+GP +D W+LG L E TG P F E
Sbjct: 546 YLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDE 583
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 31/140 (22%), Positives = 59/140 (42%), Gaps = 13/140 (9%)
Query: 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG-SSCYSHQRV 225
+L + F+ + + + L + IH DL N+L++ +K+ DFG + +
Sbjct: 107 NLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVES--EDLVKISDFGLAKVLPEDKD 164
Query: 226 YTYIQSR-----FYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
Y Y++ F+ +PE + + D+WS G L EL+T + A
Sbjct: 165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYG-----DPSQSPPAEF 219
Query: 281 MEILGCPPDEVINTASRRRL 300
+ ++G ++I T L
Sbjct: 220 LRMIGIAQGQMIVTRLLELL 239
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 31/116 (26%), Positives = 48/116 (41%), Gaps = 15/116 (12%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ-SRF---YRSPEVI 240
L N IH DL N+L+ + + K+ DFG + YT + ++F + +PE
Sbjct: 119 LESRNYIHRDLAARNILVGE--NLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 241 LGLPYGPPIDMWSLGCILAELYT--GCPLFPGENEVEQLACIME------ILGCPP 288
+ D+WS G +L E+ T P +PG E L + CP
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP-YPGMTNREVLEQVERGYRMPRPPNCPE 231
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 42/162 (25%), Positives = 60/162 (37%), Gaps = 53/162 (32%)
Query: 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG------------- 216
L R + L + +H+ IH D+KP+N+L+ G IK+ DFG
Sbjct: 102 LARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKY 159
Query: 217 ---------------------SSCY--------------SHQR--VYTYIQSRFYRSPEV 239
S+C HQR ++ + + Y +PEV
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219
Query: 240 ILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVE-QLACI 280
+L Y D WS+G IL E+ G P F E QL I
Sbjct: 220 LLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 9e-04
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 17/188 (9%)
Query: 110 LIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSL 168
L E +++ LR + Y V+ E Y I E M+ +L + +K + L
Sbjct: 49 LQEAQVMKKLRHEKLVQLYAVVSE-EPIY------IVTEYMSKGSLLDFLKGEMGKYLRL 101
Query: 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTY 228
+ A + + + R N +H DL+ N+L+ + + KV DFG + YT
Sbjct: 102 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEYTA 159
Query: 229 IQ-SRF---YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIME- 282
Q ++F + +PE L + D+WS G +L EL T G +PG E L +
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 219
Query: 283 -ILGCPPD 289
+ CPP+
Sbjct: 220 YRMPCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 29/125 (23%), Positives = 52/125 (41%), Gaps = 11/125 (8%)
Query: 147 FELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQR 205
EL L +L + ++++ F + + +A + +R L + IH DL N+LL
Sbjct: 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD 133
Query: 206 GSSSIKVIDFGSSCYSHQRVYTYIQSRFYR-------SPEVILGLPYGPPIDMWSLGCIL 258
+K+ DFG Q Y+ + +PE + + D+W G L
Sbjct: 134 --DKVKIGDFGLMRALPQNEDHYV-MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTL 190
Query: 259 AELYT 263
E++T
Sbjct: 191 WEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 9e-04
Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 6/108 (5%)
Query: 160 RNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219
R S ++ + + + L R + IH DL N L+ G +KV DFG +
Sbjct: 91 RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTR 148
Query: 220 YSHQRVYTYIQ-SRF---YRSPEVILGLPYGPPIDMWSLGCILAELYT 263
Y YT ++F + PEV Y D+WS G ++ E++T
Sbjct: 149 YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 43/172 (25%), Positives = 68/172 (39%), Gaps = 29/172 (16%)
Query: 112 EVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGL 170
EV+IL L S N+ +L LC+ E M +L + +++ + + GL
Sbjct: 69 EVKILSRL------SDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK--HVAETSGL 120
Query: 171 IRRFAFSLVQCL-----------RLLHRENIIHCDLKPENVLLKQRGSS-SIKVIDFGSS 218
L R L N +H DL N L+ G + +IK+ DFG S
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGMS 177
Query: 219 CYSHQRVYTYIQSRF-----YRSPEVILGLPYGPPIDMWSLGCILAELYTGC 265
+ Y +Q R + + E +L + D+W+ G L E+ T C
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 29/112 (25%), Positives = 49/112 (43%), Gaps = 8/112 (7%)
Query: 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG--SSCYSHQRVYTYIQS 231
++F + + + L IH DL N+LL + + +K+ DFG Y +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSEN--NVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 232 RF---YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLAC 279
R + +PE I Y D+WS G +L E+++ G +PG E+
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 293
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 31/112 (27%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ-SR 232
F+ + + + + R+N IH DL+ NVL+ + S K+ DFG + YT + ++
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSE--SLMCKIADFGLARVIEDNEYTAREGAK 165
Query: 233 F---YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACI 280
F + +PE I + D+WS G +L E+ T G +PG + + ++ +
Sbjct: 166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 34/123 (27%), Positives = 57/123 (46%), Gaps = 7/123 (5%)
Query: 153 NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKV 212
+L + +K + + L + A + + + R N IH DL+ N+L+ + K+
Sbjct: 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD--NLVCKI 143
Query: 213 IDFGSSCYSHQRVYTYIQ-SRF---YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPL 267
DFG + YT Q ++F + +PE L + D+WS G +L EL T G
Sbjct: 144 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
Query: 268 FPG 270
+PG
Sbjct: 204 YPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 27/96 (28%), Positives = 42/96 (43%), Gaps = 10/96 (10%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF-----YRS 236
+ L +N IH DL N L+ + +K+ DFG S +YT + +
Sbjct: 106 MEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163
Query: 237 PEVILGLPYGPPIDMWSLGCILAELYTG--CPLFPG 270
PE + Y D+WS G +L E ++ P +PG
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTP-YPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 29/107 (27%), Positives = 52/107 (48%), Gaps = 16/107 (14%)
Query: 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT---YIQ 230
++F + + + L IH DL N+LL + ++ +K+ DFG + + +Y Y++
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLA----RDIYKDPDYVR 232
Query: 231 SRFYR------SPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPG 270
R +PE I Y D+WS G +L E+++ G +PG
Sbjct: 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 7/95 (7%)
Query: 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSR 232
F++ + + L +N +H DL NVL+ + +K+ DFG + Y S
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICE--GKLVKICDFGLARDIMRDSNYISKGST 301
Query: 233 F----YRSPEVILGLPYGPPIDMWSLGCILAELYT 263
F + +PE I Y D+WS G +L E++T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 8/110 (7%)
Query: 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS--CYSHQR 224
++G + FA+ + + ++ L ++H DL NVL+ + +K+ DFG S Y
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAE--GRKMKISDFGLSRDVYEEDS 182
Query: 225 VYTYIQSRF---YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPG 270
+ R + + E + Y D+WS G +L E+ T G +PG
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 429 | |||
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| KOG4236|consensus | 888 | 100.0 | ||
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0664|consensus | 449 | 100.0 | ||
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0984|consensus | 282 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1345|consensus | 378 | 99.97 | ||
| KOG2052|consensus | 513 | 99.97 | ||
| KOG0200|consensus | 609 | 99.97 | ||
| KOG0576|consensus | 829 | 99.97 | ||
| KOG3653|consensus | 534 | 99.97 | ||
| KOG1025|consensus | 1177 | 99.96 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1024|consensus | 563 | 99.95 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164|consensus | 322 | 99.93 | ||
| KOG0590|consensus | 601 | 99.93 | ||
| KOG1163|consensus | 341 | 99.91 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| KOG1240|consensus | 1431 | 99.89 | ||
| KOG4158|consensus | 598 | 99.89 | ||
| KOG0603|consensus | 612 | 99.88 | ||
| KOG1165|consensus | 449 | 99.88 | ||
| KOG0606|consensus | 1205 | 99.86 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG0195|consensus | 448 | 99.81 | ||
| KOG1166|consensus | 974 | 99.81 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1033|consensus | 516 | 99.78 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1023|consensus | 484 | 99.68 | ||
| KOG0590|consensus | 601 | 99.66 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG0601|consensus | 524 | 99.51 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| KOG0606|consensus | 1205 | 99.35 | ||
| KOG1266|consensus | 458 | 99.31 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG3087|consensus | 229 | 99.24 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| KOG1243|consensus | 690 | 99.16 | ||
| KOG0601|consensus | 524 | 99.14 | ||
| KOG2137|consensus | 700 | 99.01 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.95 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.94 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.92 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.86 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.8 | |
| KOG3741|consensus | 655 | 98.79 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.64 | |
| KOG1235|consensus | 538 | 98.55 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.42 | |
| KOG0576|consensus | 829 | 98.39 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.34 | |
| KOG1035|consensus | 1351 | 98.28 | ||
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.27 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.17 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.89 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.88 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.81 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.69 | |
| KOG2268|consensus | 465 | 97.48 | ||
| KOG1093|consensus | 725 | 97.41 | ||
| KOG2270|consensus | 520 | 97.39 | ||
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.37 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.35 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.25 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.23 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.98 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.96 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.67 | |
| KOG1826|consensus | 2724 | 96.57 | ||
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.48 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.41 | |
| KOG1236|consensus | 565 | 96.1 | ||
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.88 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.66 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.65 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.53 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.39 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.1 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.06 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.95 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.72 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.52 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.31 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.26 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.22 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.68 | |
| KOG2269|consensus | 531 | 91.6 | ||
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 89.63 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 89.04 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 88.89 |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-58 Score=452.60 Aligned_cols=312 Identities=59% Similarity=1.052 Sum_probs=276.3
Q ss_pred ehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 11 AFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 11 ~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
..-++++.|+.||+|.+.||+|+||+|-+|.|.+|++. |||+++
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiK----------------------------------- 220 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIK----------------------------------- 220 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeec-----------------------------------
Confidence 34567889999999999999999999999999999976 888763
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHH
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~ 169 (429)
+++.|..+...|+.+|++|+..+...-.|+|+++|+|...+|+|||+|.++.+|+++++.+...+++..
T Consensus 221 -----------N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~ 289 (586)
T KOG0667|consen 221 -----------NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLP 289 (586)
T ss_pred -----------cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHH
Confidence 356777888889999999996556666699999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCc
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
.++.++.||+.||..||..||||+||||+|||+...++..||++|||+++.......+.++++.|+|||++.|.+|+.+.
T Consensus 290 ~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~I 369 (586)
T KOG0667|consen 290 LVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAI 369 (586)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCcc
Confidence 99999999999999999999999999999999999888899999999999999888899999999999999999999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccC-CCCCcc-ccCCC------------
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDS-KGTPRC-ITNSK------------ 315 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~------------ 315 (429)
||||||||++||++|.++|+|.+..+++..|.+++|.|+..+++.......+|+. .+.+.. .+...
T Consensus 370 DmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~ 449 (586)
T KOG0667|consen 370 DMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKY 449 (586)
T ss_pred ceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhh
Confidence 9999999999999999999999999999999999999999999999988888888 666552 22220
Q ss_pred -----CCCCCC-CCchhhhhhc-cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 316 -----GRKRKP-GSKDMASVLR-CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 316 -----~~~~~~-~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....+ .......... .....|.|||.+||.+||.+|+|+.++|+||||+...
T Consensus 450 ~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 450 YRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred hhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence 111122 3444444444 6678999999999999999999999999999999543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-58 Score=432.81 Aligned_cols=289 Identities=32% Similarity=0.550 Sum_probs=247.5
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
-++-+||+++++||.|+||.||+|+.+.++.+ |||.+++..-..++
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--------------------------------- 52 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--------------------------------- 52 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH---------------------------------
Confidence 35678999999999999999999999999976 99987543322111
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcC-eEEEEEeecCcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRN-HLCISFELMNLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.--++|+.-|++|. |+ ||+++.+++.+.. ++|+|||||+.+|+++++.+ ...|++..++.
T Consensus 53 -----------~~nLREvksL~kln~hp------niikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irn 114 (538)
T KOG0661|consen 53 -----------CMNLREVKSLRKLNPHP------NIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDR-NRLFSESDIRN 114 (538)
T ss_pred -----------HHHHHHHHHHHhcCCCC------cchhhHHHhhccCceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHH
Confidence 12355999999988 65 9999999999888 99999999999999999988 46899999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCC-CCCCCcc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGL-PYGPPID 250 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~D 250 (429)
|+.||++||+|+|.+|++|||+||+|||+.... .|||+|||+|+.+. ......+.|++|+|||++... .|+.++|
T Consensus 115 im~QilqGL~hiHk~GfFHRDlKPENiLi~~~~--~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD 192 (538)
T KOG0661|consen 115 IMYQILQGLAHIHKHGFFHRDLKPENILISGND--VIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVD 192 (538)
T ss_pred HHHHHHHHHHHHHhcCcccccCChhheEecccc--eeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchH
Confidence 999999999999999999999999999999655 89999999998755 344558899999999998865 5899999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||+|||++|+.+-++.|+|.++.+++.+|+.++|.|.++.|......+-. .....++.....+..+.
T Consensus 193 ~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~------------mnf~~P~~~~~~l~~L~ 260 (538)
T KOG0661|consen 193 MWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA------------MNFRFPQVKPSPLKDLL 260 (538)
T ss_pred HHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH------------hccCCCcCCCCChHHhC
Confidence 999999999999999999999999999999999999998877664322211 11233455566778888
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
+..++++.++|.+||+|||++||||.|+|+||||+.....
T Consensus 261 p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 261 PNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred cccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 8889999999999999999999999999999999876544
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-56 Score=398.55 Aligned_cols=283 Identities=28% Similarity=0.588 Sum_probs=242.5
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|+.+.++|+|+||.||+++++.||+. |||++..+..+.
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~--------------------------------------- 42 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP--------------------------------------- 42 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH---------------------------------------
Confidence 5799999999999999999999999986 999985443221
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
...+-+++|+++|++|+|+ |+|.++++|.-...++||+|||+.++.+.+.... .++++..++.+++|++
T Consensus 43 ----~VkKIAlREIrmLKqLkH~------NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l 111 (396)
T KOG0593|consen 43 ----VVKKIALREIRMLKQLKHE------NLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLL 111 (396)
T ss_pred ----HHHHHHHHHHHHHHhcccc------hHHHHHHHHHhcceeEEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHH
Confidence 1223456799999999998 9999999999999999999999999999998887 5799999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhC-CCCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILG-LPYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG 255 (429)
.|+.|||+++++||||||+|||++.+| .+||||||+|+... ......+.|+||+|||.+.+ .+|+.++||||+|
T Consensus 112 ~ai~~cHk~n~IHRDIKPENILit~~g--vvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiG 189 (396)
T KOG0593|consen 112 KAIHFCHKNNCIHRDIKPENILITQNG--VVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIG 189 (396)
T ss_pred HHhhhhhhcCeecccCChhheEEecCC--cEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhh
Confidence 999999999999999999999999999 99999999998754 33445789999999999998 4799999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++.||++|.+.|+|.++.+++..|..++|...+.-..-+..... |..-. .+......+++...+..+.
T Consensus 190 Cv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~-F~Gv~----------lP~~~~~epLe~k~p~~s~ 258 (396)
T KOG0593|consen 190 CVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF-FHGVR----------LPEPEHPEPLERKYPKISN 258 (396)
T ss_pred HHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc-eeeee----------cCCCCCccchhhhcccchH
Confidence 999999999999999999999999999999988776554433222 11111 1223344556666777888
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.+.||+.+||..||.+|++.+|+|.|+||..
T Consensus 259 ~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 259 VLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred HHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 9999999999999999999999999999953
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-55 Score=386.21 Aligned_cols=283 Identities=31% Similarity=0.587 Sum_probs=242.6
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
.||..+++||+|+||.||+|+|.+||+. |||+++...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~------------------------------------------ 39 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN------------------------------------------ 39 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc------------------------------------------
Confidence 6899999999999999999999999976 999884331
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.+.+....+++|+..|+.+.|+ ||+.++|+|...+.+.||+|||+.+|..+|+... ..++...++.|+.+++
T Consensus 40 -~kdGi~~talREIK~Lqel~h~------nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~L 111 (318)
T KOG0659|consen 40 -AKDGINRTALREIKLLQELKHP------NIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTL 111 (318)
T ss_pred -cccCccHHHHHHHHHHHHccCc------chhhhhhhccCCCceEEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHH
Confidence 1345566788999999999988 9999999999999999999999999999998765 5699999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc---eeeecCccccchhhhhCC-CCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILGL-PYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG 255 (429)
.||+|||++.|+||||||+|+|++.+| .+||+|||+++...... ...+.|++|+|||++.|. .|+..+||||+|
T Consensus 112 kGl~y~H~~~IlHRDlKPnNLLis~~g--~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavG 189 (318)
T KOG0659|consen 112 KGLAYCHSKWILHRDLKPNNLLISSDG--QLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVG 189 (318)
T ss_pred HHHHHHHhhhhhcccCCccceEEcCCC--cEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHH
Confidence 999999999999999999999999999 99999999998755332 224789999999999987 599999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
||++||+.|.+.|+|.++-+|+..|++.+|.|.++.|...... ++..... ..+ ......+++..+.
T Consensus 190 CI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l---------pdY~~~~----~~P-~~~~~~lf~aas~ 255 (318)
T KOG0659|consen 190 CIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL---------PDYVKIQ----QFP-KPPLNNLFPAASS 255 (318)
T ss_pred HHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc---------ccHHHHh----cCC-CCccccccccccH
Confidence 9999999999999999999999999999999998887765432 2211111 011 1122226777788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
++.||+.+||.+||.+|+||.|+|+|+||++.+.
T Consensus 256 d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 256 DALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred HHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 9999999999999999999999999999987543
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=421.79 Aligned_cols=255 Identities=29% Similarity=0.400 Sum_probs=227.1
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
..||...+.||+|||+.||.+++..+|++ |+|++.+...
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l---------------------------------------- 56 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL---------------------------------------- 56 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh----------------------------------------
Confidence 36899999999999999999999888876 8888744321
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.+....+.+.+|++|.+.|+|+ |||+++++|++.+++|+|+|+|. ++|..+++++. .++|.+++.+++|
T Consensus 57 --~k~~~reKv~~EIeIHr~L~Hp------nIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk--~ltEpEary~l~Q 126 (592)
T KOG0575|consen 57 --KKPKQREKVLNEIEIHRSLKHP------NIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQ 126 (592)
T ss_pred --cCcchHHHHHHHHHHHHhcCCC------cEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHH
Confidence 1345566788899999999998 99999999999999999999995 79999988554 5999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
|+.||.|||+++|+|||||..|+|++.+- +|||+|||+|.... ++..+.||||.|.|||++....++..+||||+
T Consensus 127 Iv~GlkYLH~~~IiHRDLKLGNlfL~~~~--~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSl 204 (592)
T KOG0575|consen 127 IVEGLKYLHSLGIIHRDLKLGNLFLNENM--NVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSL 204 (592)
T ss_pred HHHHHHHHHhcCceecccchhheeecCcC--cEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhh
Confidence 99999999999999999999999999877 89999999998755 67888999999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|||||.||+|++||...+-.+.+.+|...-...|.. .+
T Consensus 205 GcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~------------------------------------------ls 242 (592)
T KOG0575|consen 205 GCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSH------------------------------------------LS 242 (592)
T ss_pred hhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccc------------------------------------------cC
Confidence 999999999999999999999999888644444432 27
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.++.+||.+||+.||.+|||+.++|.|+||++..
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 8889999999999999999999999999996544
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-55 Score=407.87 Aligned_cols=271 Identities=26% Similarity=0.389 Sum_probs=221.9
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
.-+.+.|.+.+.||+|+||.|-+|.++.|++. |||++.+........+
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~------------------------------- 216 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRA------------------------------- 216 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccccc-------------------------------
Confidence 44788999999999999999999999999975 9998865533222110
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
..-...+.+|+++|++|.|| ||++++++|+..+..|+||||+ +|+|.+.+-.+.. +.+...+.+
T Consensus 217 -------~~~~~~v~~EieILkkL~HP------~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~ 281 (475)
T KOG0615|consen 217 -------IAKTRDVQNEIEILKKLSHP------NIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY--LREDLGKLL 281 (475)
T ss_pred -------ccchhhhHHHHHHHHhcCCC------CEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc--cccchhHHH
Confidence 01112356799999999988 9999999999999999999999 5799999988765 889999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecC-CCcceEEeeeccccccc--CcceeeecCccccchhhhhCCC---CCCC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQR-GSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLP---YGPP 248 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~-~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~---~~~~ 248 (429)
++|++.|+.|||++||+||||||+|||+..+ ....+||+|||+|+..+ ....+.||||.|.|||++.+.. +..+
T Consensus 282 f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~k 361 (475)
T KOG0615|consen 282 FKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSK 361 (475)
T ss_pred HHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccch
Confidence 9999999999999999999999999999987 33478999999998774 4566799999999999998764 3448
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHH-HHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVE-QLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+||||+||++|.+++|.+||.+..... ..++|.......-+..|
T Consensus 362 VDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w----------------------------------- 406 (475)
T KOG0615|consen 362 VDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW----------------------------------- 406 (475)
T ss_pred heeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh-----------------------------------
Confidence 999999999999999999998765443 44445443332222222
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~~ 371 (429)
..++++..+||.+||..||+.|||+.|+|+||||+..+..+
T Consensus 407 ---~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 407 ---DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred ---hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 23478899999999999999999999999999999765443
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-53 Score=402.19 Aligned_cols=290 Identities=29% Similarity=0.515 Sum_probs=244.3
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.++.-.+.|+.+++||+|+||.||+|++..||+. |+|+++....
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~----------------------------------- 155 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE----------------------------------- 155 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-----------------------------------
Confidence 3445567799999999999999999999999975 9999854421
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecCcCHHHHHHhhCCCCCCHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMNLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~ 171 (429)
+.++-.-..+|+.||++|.|+ ||+++.+..... ..+|+|+|||+.+|..++.... -.|++.++
T Consensus 156 --------~~~~~~t~~REI~ILr~l~Hp------NIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qI 220 (560)
T KOG0600|consen 156 --------KEGFPITAIREIKILRRLDHP------NIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQI 220 (560)
T ss_pred --------CCcchHHHHHHHHHHHhcCCC------cccceeeEEEecCCceEEEEEecccchhhhhhcCCC-cccChHHH
Confidence 234445566799999999998 999999998776 6899999999999999988754 45999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC----cceeeecCccccchhhhhCC-CCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----RVYTYIQSRFYRSPEVILGL-PYG 246 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~ 246 (429)
+.|+.||+.||+|||++||+|||||.+|||++++| .+||+|||+|+.... .....+.|++|+|||++.|. .|+
T Consensus 221 Kc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G--~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg 298 (560)
T KOG0600|consen 221 KCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG--VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYG 298 (560)
T ss_pred HHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC--CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccc
Confidence 99999999999999999999999999999999999 999999999985332 24457889999999999987 599
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
.++|+||+||||.||++|++.|+|.+..+|+..|..+.|.|.++.|... .+|..... ....+....+
T Consensus 299 ~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~----------kLP~~~~~---kp~~~y~r~l 365 (560)
T KOG0600|consen 299 TAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS----------KLPHATIF---KPQQPYKRRL 365 (560)
T ss_pred cceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc----------cCCccccc---CCCCcccchH
Confidence 9999999999999999999999999999999999999999999987621 12211111 1222333445
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
.+.+...++...+|+..||..||.+|.||.++|+|+||+....
T Consensus 366 ~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~ 408 (560)
T KOG0600|consen 366 RETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPL 408 (560)
T ss_pred HHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCC
Confidence 5667788999999999999999999999999999999955443
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-53 Score=382.73 Aligned_cols=286 Identities=30% Similarity=0.518 Sum_probs=241.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|+.+.+|++|+||.||+|+|+.|+++ |+|+++-..
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek------------------------------------------ 113 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK------------------------------------------ 113 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc------------------------------------------
Confidence 4599999999999999999999999986 999874321
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.+.+|--..++|+.+|.+++|+ ||+.+.++.... +.+|+|||||+.+|..++..-. ++|...+++.++.|
T Consensus 114 -ek~GFPItsLREIniLl~~~H~------NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~Q 185 (419)
T KOG0663|consen 114 -EKEGFPITSLREINILLKARHP------NIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQ 185 (419)
T ss_pred -ccCCCcchhHHHHHHHHhcCCC------CeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHH
Confidence 1456777888999999999887 999999988755 4799999999999999998876 57999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWS 253 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwS 253 (429)
++.|++|||.++|+||||||+|+|++..| .+||+|||+|+..+.+ ....+.|.+|+|||++.+. .|+.++|+||
T Consensus 186 lL~glk~lH~~wilHRDLK~SNLLm~~~G--~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWS 263 (419)
T KOG0663|consen 186 LLRGLKHLHDNWILHRDLKTSNLLLSHKG--ILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWS 263 (419)
T ss_pred HHHHHHHHhhceeEecccchhheeeccCC--cEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhh
Confidence 99999999999999999999999999999 9999999999987765 4557889999999999987 5999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc-
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC- 332 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 332 (429)
+|||+.||+++++.|+|.+..+++.+|+..+|.|.+..|.........-..+ ..... ...+...+..
T Consensus 264 vGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~--------f~~~p----yn~lr~kF~~~ 331 (419)
T KOG0663|consen 264 VGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT--------FSEHP----YNNLRKKFGAL 331 (419)
T ss_pred HHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc--------cCCCC----chhhhhhcccc
Confidence 9999999999999999999999999999999999999987665432210000 00000 1111112222
Q ss_pred -CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 333 -NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 333 -~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
.++...+|+..+|.+||.+|.||.|+|+|.||...+..
T Consensus 332 ~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 332 SLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred ccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 35888899999999999999999999999999886443
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-53 Score=387.13 Aligned_cols=288 Identities=34% Similarity=0.602 Sum_probs=244.7
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|..++.||.|+||.|+.|.++.+++. |||++..+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~-------------------------------------- 60 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE-------------------------------------- 60 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh--------------------------------------
Confidence 3688899999999999999999999999965 9998743211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE-----cCeEEEEEeecCcCHHHHHHhhCCCCCCHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-----RNHLCISFELMNLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~ 171 (429)
..-..++.++|+.+|++++|+ ||+.+++++.. -..+|+|+|+|+.+|..+++.+.. +++..+
T Consensus 61 -----~~~~akRtlRElklLr~~~He------NIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~--L~d~H~ 127 (359)
T KOG0660|consen 61 -----NQIDAKRTLRELKLLRHLRHE------NIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQD--LTDDHA 127 (359)
T ss_pred -----chHHHHHHHHHHHHHHHhcCC------CcceEEeecccccccccceeEEehhHHhhHHHHHHHcCcc--ccHHHH
Confidence 233445778899999999998 99999999865 257999999999999999998764 999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc-----CcceeeecCccccchhhhhCC-CC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-----QRVYTYIQSRFYRSPEVILGL-PY 245 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-----~~~~~~~~t~~y~aPE~~~~~-~~ 245 (429)
+.+++|++.||.|+|+.+|+||||||.|++++.+. .+||||||+|+... ...+..+.|++|+|||++... .|
T Consensus 128 q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c--~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Y 205 (359)
T KOG0660|consen 128 QYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC--DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEY 205 (359)
T ss_pred HHHHHHHHHhcchhhcccccccccchhheeeccCC--CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccc
Confidence 99999999999999999999999999999999988 89999999998773 333557889999999998754 79
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++||||+|||++||++|++.|+|.+..+|+..|...+|.|+++.+......... ..+.. .++....+
T Consensus 206 t~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar-------~yi~s----lp~~p~~~ 274 (359)
T KOG0660|consen 206 TKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR-------PYIKS----LPQIPKQP 274 (359)
T ss_pred cchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH-------HHHHh----CCCCCCCC
Confidence 99999999999999999999999999999999999999999999988766521111 01111 12333455
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
....++..++.+.||+.+||.+||.+|+||+|+|.||||..-..
T Consensus 275 f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 275 FSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 77888888999999999999999999999999999999987543
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=385.05 Aligned_cols=254 Identities=29% Similarity=0.462 Sum_probs=217.7
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
....+.++.||+|..|+||+|.|+.|++. |+|++....
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~----------------------------------------- 116 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI----------------------------------------- 116 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC-----------------------------------------
Confidence 34788899999999999999999999987 999884332
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-eEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-HLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.....+++.+|+++++...++ +||.+|+.|..+. .++|+||||+ |+|.+++.... ++++.....++.
T Consensus 117 ---~~~~~~Qi~rEl~il~~~~sp------yIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~ 185 (364)
T KOG0581|consen 117 ---DPALQKQILRELEILRSCQSP------YIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIAR 185 (364)
T ss_pred ---CHHHHHHHHHHHHHHhhCCCC------CeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHH
Confidence 234456778899999999776 9999999999999 5999999995 69999988764 599999999999
Q ss_pred HHHHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeeccccc-ccCcceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 177 SLVQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY-SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 177 qil~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
+|+.||.|||. ++||||||||+|||++..| +|||||||.+.. .+...++++||..|||||.+.+..|+.++|||||
T Consensus 186 ~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG--eVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSL 263 (364)
T KOG0581|consen 186 AVLRGLSYLHEERKIIHRDIKPSNLLVNSKG--EVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSL 263 (364)
T ss_pred HHHHHHHHHhhccCeeeccCCHHHeeeccCC--CEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecc
Confidence 99999999995 8999999999999999999 999999999875 3455688999999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCC-----CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 255 GCILAELYTGCPLFPGE-----NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 255 G~il~~lltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|++++|+++|+.||... +..+.+..|+. .+++. +
T Consensus 264 GLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP~--------------------------------------l 302 (364)
T KOG0581|consen 264 GLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPPR--------------------------------------L 302 (364)
T ss_pred cHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCCC--------------------------------------C
Confidence 99999999999999875 44455555543 22211 1
Q ss_pred hc-cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LR-CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~-~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+. ..+++|++||..||++||.+|||+.|+++|||++...
T Consensus 303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 11 2489999999999999999999999999999998754
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=377.11 Aligned_cols=311 Identities=35% Similarity=0.676 Sum_probs=262.8
Q ss_pred ehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 11 AFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 11 ~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
+....++.+.+||.+++.+|+|+||.|-.+.|..++.+ |+|+++.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---------------------------------- 124 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---------------------------------- 124 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH----------------------------------
Confidence 44567889999999999999999999999999999765 8887631
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHH
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~ 169 (429)
...+.+.++-|+++|+++.+.+..+..-++.+.+||...++.|||+|.++.++.+++..+...+++..
T Consensus 125 ------------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~ 192 (415)
T KOG0671|consen 125 ------------VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPID 192 (415)
T ss_pred ------------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchH
Confidence 23455566679999999988876777789999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC------------------CcceEEeeecccccccCcceeeecC
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG------------------SSSIKVIDFGSSCYSHQRVYTYIQS 231 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~------------------~~~vkl~Dfg~~~~~~~~~~~~~~t 231 (429)
.++.|.+|++.++++||+.+++|.||||+|||+.+.. +..|+++|||.|....+.....+.|
T Consensus 193 ~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsT 272 (415)
T KOG0671|consen 193 HIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVST 272 (415)
T ss_pred HHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeec
Confidence 9999999999999999999999999999999996421 2358999999999999888899999
Q ss_pred ccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccc
Q psy17270 232 RFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311 (429)
Q Consensus 232 ~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (429)
+.|+|||++.+-.++.++||||+|||++|+.||...|.+.++.++++.+..++|+.|..++.... ...+|......+..
T Consensus 273 RHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~-~~Kyf~~~rldw~e 351 (415)
T KOG0671|consen 273 RHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR-KEKYFRRGRLDWPE 351 (415)
T ss_pred cccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh-hHhhhhcccccCcc
Confidence 99999999999999999999999999999999999999999999999999999999999888774 33334444444433
Q ss_pred cCCCC--CCCCCCCchhhhhhccC---ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 312 TNSKG--RKRKPGSKDMASVLRCN---DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 312 ~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....+ +.-.....++...+... ...+.|||++||.+||.+|+|+.|+|.||||+...
T Consensus 352 ~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 352 VSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred ccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 33333 22233334444444433 35788999999999999999999999999998753
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=387.77 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=224.8
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-..|.+++.||.|+|++|++|+++.++.. |||++.+...-.+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike------------------------------------- 114 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE------------------------------------- 114 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh-------------------------------------
Confidence 35799999999999999999999999965 9999855433211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.-...+..|-++|..|. .||.|++++-.|.++..+|+|+||+ +|+|.++|.+.+. |++..++.++.+
T Consensus 115 -----~KvkYV~~Ek~~l~~L~-----~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAe 182 (604)
T KOG0592|consen 115 -----KKVKYVTREKEALTQLS-----GHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAE 182 (604)
T ss_pred -----cccchhhHHHHHHHHhh-----CCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHH
Confidence 22234555999999995 3469999999999999999999999 6899999998764 999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC----------------cceeeecCccccchhhhh
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----------------RVYTYIQSRFYRSPEVIL 241 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~----------------~~~~~~~t~~y~aPE~~~ 241 (429)
|+.||+|||++|||||||||+|||++.++ +++|+|||.|..... ....++||-.|++||++.
T Consensus 183 IldAleylH~~GIIHRDlKPENILLd~dm--hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~ 260 (604)
T KOG0592|consen 183 ILDALEYLHSNGIIHRDLKPENILLDKDG--HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN 260 (604)
T ss_pred HHHHHHHHHhcCceeccCChhheeEcCCC--cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc
Confidence 99999999999999999999999999999 999999999864221 124589999999999999
Q ss_pred CCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 242 ~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
....+..+|||+||||+|.|+.|.+||.+.++.-.+++|+.+...+++.+
T Consensus 261 ~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~f------------------------------ 310 (604)
T KOG0592|consen 261 DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGF------------------------------ 310 (604)
T ss_pred CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCC------------------------------
Confidence 99999999999999999999999999999999999999998766666543
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
++.+.|||+++|..||++|+|+.++-+||||..+.
T Consensus 311 ------------p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 311 ------------PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred ------------CHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 68889999999999999999999999999999764
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=373.88 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=221.4
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-+.|+++++||.|+||+||.++.++|++. |+|++++......
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~------------------------------------- 66 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK------------------------------------- 66 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-------------------------------------
Confidence 57799999999999999999999999976 9998865533211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.-......|..||..++|+ .|+.++-.|++...+|+|+||+ +|.|...+.+... |++..++.|+..
T Consensus 67 -----~e~~~~~~Er~IL~~v~hP------Fiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaE 133 (357)
T KOG0598|consen 67 -----KEVRHTKAERNILSKIKHP------FIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAE 133 (357)
T ss_pred -----hhHHHHHHHHHHHHhCCCC------cEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHH
Confidence 1123455699999998877 9999999999999999999999 4699999987754 999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc---ccCcceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
|+.||.|||++|||||||||+|||++.+| +++|+|||+++. .+....++|||+.|||||++.+..|+.++|.|||
T Consensus 134 i~lAL~~LH~~gIiyRDlKPENILLd~~G--Hi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsL 211 (357)
T KOG0598|consen 134 IVLALGYLHSKGIIYRDLKPENILLDEQG--HIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSL 211 (357)
T ss_pred HHHHHHHHHhCCeeeccCCHHHeeecCCC--cEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhH
Confidence 99999999999999999999999999999 999999999974 3345667899999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|+++|+|++|.+||.+.+.......|...-...++ ...+
T Consensus 212 GillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p-----------------------------------------~~ls 250 (357)
T KOG0598|consen 212 GILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP-----------------------------------------GYLS 250 (357)
T ss_pred HHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-----------------------------------------ccCC
Confidence 99999999999999999988888777652211111 1137
Q ss_pred hHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRL----TPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rp----ta~ell~h~~~~~~~ 368 (429)
+++++|++++|..||++|. .+.++-+||||+...
T Consensus 251 ~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 251 EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 8899999999999999996 689999999999764
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=368.89 Aligned_cols=285 Identities=31% Similarity=0.581 Sum_probs=239.8
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
...|+.+++||+|+||+||+|+++.+|.. |+|+++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~---------------------------------------- 49 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE---------------------------------------- 49 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc----------------------------------------
Confidence 34588889999999999999999999964 9998854321
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCc-eeEEEEEEEEcC------eEEEEEeecCcCHHHHHHhhCC--CCCCHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYN-VIHMLEYFYFRN------HLCISFELMNLNLYELIKRNNY--QGFSLG 169 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~-i~~~~~~~~~~~------~~~lv~e~~~g~L~~~i~~~~~--~~~~~~ 169 (429)
.++.-+.+.+|+-+|+.|+|. | |+.+++++.... .+++|+||++.+|..++..... ++++..
T Consensus 50 ---~EG~P~taiREisllk~L~~~------~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~ 120 (323)
T KOG0594|consen 50 ---EEGVPSTAIREISLLKRLSHA------NHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPR 120 (323)
T ss_pred ---ccCCCchhhHHHHHHHHhCCC------cceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHH
Confidence 123455677899999999998 5 999999998877 8999999999999999998774 368889
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCC-CC
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGL-PY 245 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~-~~ 245 (429)
.++.+++||+.||+|||++||+||||||.|||++..| .+||+|||+|+... ......++|.+|+|||++.+. .|
T Consensus 121 ~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G--~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Y 198 (323)
T KOG0594|consen 121 LIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG--VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSY 198 (323)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC--cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcC
Confidence 9999999999999999999999999999999999988 99999999997544 224456899999999999988 68
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCC-CCCCCc
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK-RKPGSK 324 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 324 (429)
+..+||||+|||++||+++++.|++.++.+++..|.+.+|.|.++.|....... .. +... ......
T Consensus 199 s~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~---------~~----k~~f~~~~~~~ 265 (323)
T KOG0594|consen 199 STSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLP---------DY----KAPFPKWPGPK 265 (323)
T ss_pred CCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccc---------cc----cccCcCCCCcc
Confidence 999999999999999999999999999999999999999999988776543211 00 0011 112244
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
......+..+++..+++.+||+.||.+|.||..+|+||||....
T Consensus 266 ~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 266 DLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred chHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 45555566668999999999999999999999999999998754
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=368.46 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=219.3
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..++|.+.+.||+|+||+||+|++++++.+ |||.+.+...
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--------------------------------------- 48 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--------------------------------------- 48 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---------------------------------------
Confidence 356799999999999999999999999965 9998854321
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.+...+.+..|+.+|+.++|+ |||.++|+++.++.+|+|||||+ |+|.+++++.. ++++..++.++.
T Consensus 49 ----~~k~~e~L~~Ei~iLkel~H~------nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~ 116 (429)
T KOG0595|consen 49 ----NKKLVELLLSEIKILKELKHP------NIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQ 116 (429)
T ss_pred ----CHHHHHHHHHHHHHHHhcCCc------ceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHH
Confidence 112334566799999999988 99999999999999999999995 79999999886 499999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecC-CC---cceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCcc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQR-GS---SSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~-~~---~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
||+.||++||+++||||||||+|||++.. +. ..+||+|||+|+..... ..+.||++.|||||++....|+.++|
T Consensus 117 QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKAD 196 (429)
T KOG0595|consen 117 QLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKAD 196 (429)
T ss_pred HHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhh
Confidence 99999999999999999999999999985 32 47999999999876543 44689999999999999999999999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
+||+|+|+|+|++|++||...+..+.+..+...-...+ ...
T Consensus 197 LWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~---------------------------------------~~~ 237 (429)
T KOG0595|consen 197 LWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP---------------------------------------VLP 237 (429)
T ss_pred HHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC---------------------------------------chh
Confidence 99999999999999999999998888775543221111 111
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
...++...+++...|+.||.+|.+..+-+.|+++....
T Consensus 238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 238 AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 12256667999999999999999999999999987654
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=357.57 Aligned_cols=257 Identities=27% Similarity=0.422 Sum_probs=227.8
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-++|++++.||.|+||.|.+++++.++.+ |+|++.+...-
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV--------------------------------------- 83 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV--------------------------------------- 83 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH---------------------------------------
Confidence 46799999999999999999999999987 99998544221
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
+....+...+|.++|+.+.|+ .++++++.|.+.+++|+||||.+ |.|..++++.. +|+++.++.++.|
T Consensus 84 ---klKQveH~~nEk~vL~~v~~P------Flv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAe 152 (355)
T KOG0616|consen 84 ---KLKQVEHTHNEKRVLKAVSHP------FLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAE 152 (355)
T ss_pred ---HHHHHHHHhhHHHHHhhccCc------eeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHH
Confidence 112234567799999999887 99999999999999999999995 69999998875 4999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
|+.||+|||+++|++|||||+|||+|++| .+||+|||+|+.......+.||||.|+|||++....|+.++|-|||||+
T Consensus 153 ivlAleylH~~~iiYRDLKPENiLlD~~G--~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVL 230 (355)
T KOG0616|consen 153 IVLALEYLHSLDIIYRDLKPENLLLDQNG--HIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVL 230 (355)
T ss_pred HHHHHHHHHhcCeeeccCChHHeeeccCC--cEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHH
Confidence 99999999999999999999999999999 9999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|||+.|.+||...+.....++|+..--.+| +..++++
T Consensus 231 IYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP------------------------------------------~~fs~~~ 268 (355)
T KOG0616|consen 231 IYEMLAGYPPFYDDNPIQIYEKILEGKVKFP------------------------------------------SYFSSDA 268 (355)
T ss_pred HHHHHcCCCCCcCCChHHHHHHHHhCcccCC------------------------------------------cccCHHH
Confidence 9999999999999999999988886433333 2337899
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q psy17270 338 VDFVTQCFNWDSKKRL-----TPDEALRHEWLKSSSSS 370 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~~~~ 370 (429)
.+||+++|+.|-.+|. ...++..||||++..-.
T Consensus 269 kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 269 KDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred HHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 9999999999999994 47899999999976543
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=363.58 Aligned_cols=280 Identities=31% Similarity=0.545 Sum_probs=228.4
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
=+|.-.+++|+|+||.||.|....+++ +|||++.....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----------------------------------------- 62 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----------------------------------------- 62 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----------------------------------------
Confidence 369999999999999999999998865 49998743321
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-----eEEEEEeecCcCHHHHHHhh--CCCCCCHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-----HLCISFELMNLNLYELIKRN--NYQGFSLGLIR 172 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~g~L~~~i~~~--~~~~~~~~~~~ 172 (429)
+ -.+|+++|+.+.|+ ||+++.-+|.... ...+|||||+.+|.++++.. .+.+++.-.++
T Consensus 63 -----~---knrEl~im~~l~Hp------NIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iK 128 (364)
T KOG0658|consen 63 -----Y---KNRELQIMRKLDHP------NIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIK 128 (364)
T ss_pred -----c---CcHHHHHHHhcCCc------CeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeH
Confidence 1 12399999988887 9999998886532 46799999999999999853 22459999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccc--cCcceeeecCccccchhhhhCC-CCCCCc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS--HQRVYTYIQSRFYRSPEVILGL-PYGPPI 249 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~--~~~~~~~~~t~~y~aPE~~~~~-~~~~~~ 249 (429)
-+.+||++||+|||+.||+||||||.|+|+|.+. ..+||||||+|+.. ++.......|+.|+|||.+.+. .|+.+.
T Consensus 129 LYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~I 207 (364)
T KOG0658|consen 129 LYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSI 207 (364)
T ss_pred HHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCcee
Confidence 9999999999999999999999999999999862 28999999999753 3455667889999999999987 599999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh-h
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA-S 328 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 328 (429)
||||.||+++||+-|++.|+|.+..+|+..|..++|.|..+-...+......+. . +........ -
T Consensus 208 DiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~---~-----------p~ik~~~~~~~ 273 (364)
T KOG0658|consen 208 DIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFK---F-----------PQIKAHPWHKV 273 (364)
T ss_pred EEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccccc---C-----------cccccccceee
Confidence 999999999999999999999999999999999999999988765543221000 0 000111111 1
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
.....+++..+|+.++|.++|++|.++.|++.||||......
T Consensus 274 ~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 274 FFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 234568999999999999999999999999999999876544
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=370.55 Aligned_cols=319 Identities=33% Similarity=0.546 Sum_probs=276.7
Q ss_pred eeeeeehhhhccccc-CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhccccccccc
Q psy17270 6 RILSFAFQVLHDHIC-YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHG 83 (429)
Q Consensus 6 ~~~~~~~~~~~~~~~-~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~ 83 (429)
+++..-..-+|+.|. +||-+.++||.|.|++||+|.|.++..+ |+|+++..
T Consensus 62 ~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--------------------------- 114 (590)
T KOG1290|consen 62 RKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--------------------------- 114 (590)
T ss_pred hcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---------------------------
Confidence 444555667889998 9999999999999999999999999877 88887432
Q ss_pred ccccccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCC--CCCCCceeEEEEEEEEc----CeEEEEEeecCcCHHHH
Q psy17270 84 EESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKD--ADSSYNVIHMLEYFYFR----NHLCISFELMNLNLYEL 157 (429)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~--~~~~~~i~~~~~~~~~~----~~~~lv~e~~~g~L~~~ 157 (429)
+-+.+.++.|+++|+.++..+ ......||+++|.|... .|+|+|+|+++.+|..+
T Consensus 115 -------------------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLkl 175 (590)
T KOG1290|consen 115 -------------------QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKL 175 (590)
T ss_pred -------------------hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHH
Confidence 345566777999999998655 67788999999999864 59999999999999999
Q ss_pred HHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCCCcEEEe---------------------------------
Q psy17270 158 IKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKPENVLLK--------------------------------- 203 (429)
Q Consensus 158 i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~dlkp~Nili~--------------------------------- 203 (429)
|....+++++...++.|++|||.||.|||.. ||||.||||+|||+.
T Consensus 176 I~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d 255 (590)
T KOG1290|consen 176 IKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPD 255 (590)
T ss_pred HHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCccccccccc
Confidence 9999999999999999999999999999966 999999999999990
Q ss_pred --------------------------------------------------------------------------------
Q psy17270 204 -------------------------------------------------------------------------------- 203 (429)
Q Consensus 204 -------------------------------------------------------------------------------- 203 (429)
T Consensus 256 ~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~ 335 (590)
T KOG1290|consen 256 ALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLP 335 (590)
T ss_pred ccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCcccc
Confidence
Q ss_pred -cC---------------------------CC-----------------------cceEEeeecccccccCcceeeecCc
Q psy17270 204 -QR---------------------------GS-----------------------SSIKVIDFGSSCYSHQRVYTYIQSR 232 (429)
Q Consensus 204 -~~---------------------------~~-----------------------~~vkl~Dfg~~~~~~~~~~~~~~t~ 232 (429)
.. .+ ..|||+|||.|++.......-++|+
T Consensus 336 ~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTR 415 (590)
T KOG1290|consen 336 IKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTR 415 (590)
T ss_pred ccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhh
Confidence 00 00 1379999999999998888889999
Q ss_pred cccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCC------CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 233 FYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGE------NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 233 ~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
.|+||||+.+..|+..+||||++|++|||+||..+|... .++++++.|++++|..|..+.......+-+|+..+
T Consensus 416 QYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G 495 (590)
T KOG1290|consen 416 QYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRG 495 (590)
T ss_pred hccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhcccc
Confidence 999999999999999999999999999999999999543 37899999999999999999998888899999999
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
....+..++.+.......+.......+..+|.+||.-||+.+|++||||.++|+||||.....+
T Consensus 496 ~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 496 ELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred ceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 9988888887766555555555555567899999999999999999999999999999876543
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=371.26 Aligned_cols=259 Identities=29% Similarity=0.435 Sum_probs=218.6
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
-.+.|+++.+||+|+||.||+|+-+.||.+ |+|++++...-
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-------------------------------------- 180 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-------------------------------------- 180 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH--------------------------------------
Confidence 467899999999999999999999999987 99998655321
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
+++-...+..|-.+|.....+ .||++|-.|.+..++||||||+ +|++..++..... +++..++.|+.
T Consensus 181 ----~~~Qv~hV~aERdiL~~~ds~------~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYia 248 (550)
T KOG0605|consen 181 ----KKNQVEHVRAERDILAEVDSP------WVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIA 248 (550)
T ss_pred ----hhhhHHHHHHHHHHhhhcCCC------cEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCc--CchHHHHHHHH
Confidence 111223455688888885555 9999999999999999999999 5799999988764 99999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--------------------------C-------
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--------------------------Q------- 223 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--------------------------~------- 223 (429)
+++.|+.-+|+.|+|||||||+|+||+..| ++||+|||++.... .
T Consensus 249 E~vlAI~~iH~~gyIHRDIKPdNlLiD~~G--HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (550)
T KOG0605|consen 249 ETVLAIESIHQLGYIHRDIKPDNLLIDAKG--HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRS 326 (550)
T ss_pred HHHHHHHHHHHcCcccccCChhheeecCCC--CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccc
Confidence 999999999999999999999999999999 99999999972100 0
Q ss_pred -----------------cceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCC
Q psy17270 224 -----------------RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGC 286 (429)
Q Consensus 224 -----------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 286 (429)
.....+|||.|+|||++.+..|+..+|.||||||+||||.|.+||.+.++.+...+|+.....
T Consensus 327 ~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~ 406 (550)
T KOG0605|consen 327 TMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET 406 (550)
T ss_pred hhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh
Confidence 011247999999999999999999999999999999999999999999999999999864321
Q ss_pred --CcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCC---HHHHhcC
Q psy17270 287 --PPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT---PDEALRH 361 (429)
Q Consensus 287 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~ell~h 361 (429)
.|.+ ...++++.|||.+||. ||++|.. ++|+-+|
T Consensus 407 l~fP~~----------------------------------------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 407 LKFPEE----------------------------------------VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred ccCCCc----------------------------------------CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 1111 1125788999999999 9999996 9999999
Q ss_pred CCCCCCCCC
Q psy17270 362 EWLKSSSSS 370 (429)
Q Consensus 362 ~~~~~~~~~ 370 (429)
|||+.+.-.
T Consensus 446 PfF~~v~W~ 454 (550)
T KOG0605|consen 446 PFFKGVDWD 454 (550)
T ss_pred CccccCCcc
Confidence 999987643
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=372.83 Aligned_cols=257 Identities=29% Similarity=0.409 Sum_probs=217.7
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|.+.+.||+|+||+|++|.+..++.. |+|++.+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~------------------------------------ 57 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSS------------------------------------ 57 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccc------------------------------------
Confidence 4678999999999999999999999988754 888664321000
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.. ......+.+|+.+++.+. |+ ||+++++++.....+++|||||. |+|.+++... +++.+..++.+
T Consensus 58 ---~~-~~~~~~i~rEi~~~~~~~~Hp------nI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~ 125 (370)
T KOG0583|consen 58 ---KS-QKLDELIKREISILRRLRSHP------NIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKY 125 (370)
T ss_pred ---cc-cccchhhHHHHHHHHHhccCC------CEeEEEEEEecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHH
Confidence 00 022334557999999998 65 99999999999999999999995 6999999984 45999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecC-CCcceEEeeecccccc---cCcceeeecCccccchhhhhCCC-CC-CC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQR-GSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLP-YG-PP 248 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~-~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~-~~-~~ 248 (429)
++|++.|++|||++||+||||||+|||++.+ + .+||+|||++... .....+.+||+.|+|||++.+.. |+ .+
T Consensus 126 F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~--~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~ 203 (370)
T KOG0583|consen 126 FRQLISAVAYCHSRGIVHRDLKPENILLDGNEG--NLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKA 203 (370)
T ss_pred HHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC--CEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCch
Confidence 9999999999999999999999999999998 6 9999999999865 45677899999999999999987 85 79
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+||||+||++|.|++|+.||...+.......|....-..|
T Consensus 204 aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p---------------------------------------- 243 (370)
T KOG0583|consen 204 ADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP---------------------------------------- 243 (370)
T ss_pred hhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC----------------------------------------
Confidence 9999999999999999999999877777666543211111
Q ss_pred hhccC-ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 329 VLRCN-DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 329 ~~~~~-~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
... ++++.+|+++||..||.+|+|+.+++.||||+.
T Consensus 244 --~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 --SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 222 678899999999999999999999999999997
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=377.46 Aligned_cols=266 Identities=27% Similarity=0.391 Sum_probs=227.3
Q ss_pred hhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 14 ~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
+.+..-.+-|++++.||.|+.|.|-+|+|..||+. |||++.+.. +.
T Consensus 5 ~~~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~----------------------------~~----- 51 (786)
T KOG0588|consen 5 MSHKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS----------------------------EL----- 51 (786)
T ss_pred ccccccccceeccccccCCCCceehhhhcccccceeEEEeecccc----------------------------cc-----
Confidence 44555567799999999999999999999999987 666663321 00
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~ 171 (429)
.......+.+|+-||+.+.|+ ||+++||+|+...++|+|.||+ +|.|.+++-..+ ++++.++
T Consensus 52 ---------s~s~~~~IerEIviMkLi~Hp------nVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG--~l~e~ea 114 (786)
T KOG0588|consen 52 ---------SSSQPAGIEREIVIMKLIEHP------NVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG--PLPEREA 114 (786)
T ss_pred ---------ccccccchhhhhHHHHHhcCC------CeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC--CCCCHHH
Confidence 011233566799999999998 9999999999999999999999 579999998765 4999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc--ccCcceeeecCccccchhhhhCCCC-CCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPY-GPP 248 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~-~~~ 248 (429)
..+++||+.|+.|||..+|+|||+||+|+|++..+ +|||+|||.|.. .+....+.||+|.|.|||++.|.+| +.+
T Consensus 115 a~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~--nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~ 192 (786)
T KOG0588|consen 115 AHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN--NIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRP 192 (786)
T ss_pred HHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc--CEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCc
Confidence 99999999999999999999999999999999988 799999999965 3445667899999999999999998 669
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+||||-|||||.|+||+.||++.+....+.++.+.....|.
T Consensus 193 sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs--------------------------------------- 233 (786)
T KOG0588|consen 193 SDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS--------------------------------------- 233 (786)
T ss_pred cccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC---------------------------------------
Confidence 99999999999999999999998888888777764443443
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSS 373 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~~~~ 373 (429)
.+++++++||++||.+||.+|+|.+|+++|||+......+.+
T Consensus 234 ---~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 234 ---NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred ---cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 348999999999999999999999999999999876554433
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=342.43 Aligned_cols=265 Identities=27% Similarity=0.402 Sum_probs=233.3
Q ss_pred eehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 10 FAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 10 ~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
+-.+.....--++|++++.||.|.||.||+|+.++++-. |+|++.+.. +
T Consensus 11 ~~~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-------i----------------------- 60 (281)
T KOG0580|consen 11 FGSRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-------I----------------------- 60 (281)
T ss_pred cccccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-------H-----------------------
Confidence 333444444567899999999999999999999999865 999985432 1
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCC
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFS 167 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~ 167 (429)
.+....+++.+|++|..+|+|+ ||+++|++|.+...+||++||. .|++...+......+++
T Consensus 61 ------------~~~~v~~qlrREiEIqs~L~hp------nilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~ 122 (281)
T KOG0580|consen 61 ------------LKTQVEHQLRREIEIQSHLRHP------NILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFD 122 (281)
T ss_pred ------------HHhcchhhhhheeEeecccCCc------cHHhhhhheeccceeEEEEEecCCchHHHHHHhccccccc
Confidence 1345677889999999999988 9999999999999999999999 58999999987777899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccc-cCcceeeecCccccchhhhhCCCCC
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS-HQRVYTYIQSRFYRSPEVILGLPYG 246 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~ 246 (429)
+..+..+++|++.||.|||.++|+||||||+|+|++..+ .+||+|||.+... .....+.|||..|.+||+..+..++
T Consensus 123 e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~--~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd 200 (281)
T KOG0580|consen 123 EQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHD 200 (281)
T ss_pred ccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC--CeeccCCCceeecCCCCceeeecccccCCHhhcCCCCcc
Confidence 999999999999999999999999999999999999998 8999999998765 4556778999999999999999999
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
..+|+|++|++.||++.|.+||...+..+..++|...--..|..
T Consensus 201 ~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~------------------------------------ 244 (281)
T KOG0580|consen 201 KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPST------------------------------------ 244 (281)
T ss_pred chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcc------------------------------------
Confidence 99999999999999999999999999889998888754444422
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
++.++.|+|.+||..+|.+|.+..|++.|||...
T Consensus 245 ------is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 245 ------ISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ------cChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 3788899999999999999999999999999864
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=384.06 Aligned_cols=300 Identities=29% Similarity=0.549 Sum_probs=231.4
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..++|+++++||.|+||+||+|.+..++.. |+|++....
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------------------------------------- 166 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------------------------------------- 166 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----------------------------------------
Confidence 468999999999999999999999888865 888874211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.....+..|+++++.+.|.+...+.+++.++++|... .++|+|||+++++|.+++.... .+++..+..++.
T Consensus 167 ------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~~--~l~~~~~~~i~~ 238 (467)
T PTZ00284 167 ------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIF 238 (467)
T ss_pred ------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEeccCCCHHHHHHHcC--CCCHHHHHHHHH
Confidence 1122344599999999999888888999999999765 5899999999999999987654 499999999999
Q ss_pred HHHHHHHHHHH-CCceecccCCCcEEEecCCC--------------cceEEeeecccccccCcceeeecCccccchhhhh
Q psy17270 177 SLVQCLRLLHR-ENIIHCDLKPENVLLKQRGS--------------SSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVIL 241 (429)
Q Consensus 177 qil~~l~~lH~-~~ivH~dlkp~Nili~~~~~--------------~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~ 241 (429)
||+.||.|||+ .||+||||||+|||++.++. ..+||+|||.+..........+||+.|+|||++.
T Consensus 239 qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~ 318 (467)
T PTZ00284 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVL 318 (467)
T ss_pred HHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhh
Confidence 99999999998 59999999999999987652 1489999999876555555678999999999999
Q ss_pred CCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhh--hhhccCCCCCccccCCCCCCC
Q psy17270 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRR--RLFFDSKGTPRCITNSKGRKR 319 (429)
Q Consensus 242 ~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 319 (429)
+..|+.++|||||||++|||++|++||.+.+..+++..+...++.++.++....... ...+...+........+....
T Consensus 319 ~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (467)
T PTZ00284 319 GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLAR 398 (467)
T ss_pred cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHh
Confidence 999999999999999999999999999999999999999999999988876432110 001111000000000000000
Q ss_pred CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
......... ...++.+.|||.+||++||++||||.|+|+||||+...
T Consensus 399 ~~~~~~~~~--~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 399 IARARPVRE--VIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred hhcccchhh--hhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 000000000 11256788999999999999999999999999998643
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=359.55 Aligned_cols=279 Identities=28% Similarity=0.517 Sum_probs=225.2
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|+++++||.|+||+||+|.+..++.. |+|++......
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------------------------------------- 44 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---------------------------------------- 44 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC----------------------------------------
Confidence 5799999999999999999999988865 88876432110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.....+.+|+++++.++|+ ||+++++++......++||||++++|.+++.... ..+++..+..++.||+
T Consensus 45 ----~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~ 113 (288)
T cd07871 45 ----GAPCTAIREVSLLKNLKHA------NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLL 113 (288)
T ss_pred ----CcchhHHHHHHHHHhCCCC------CEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHH
Confidence 1123455699999999887 9999999999999999999999999999887654 3489999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhC-CCCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILG-LPYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG 255 (429)
.||+|||++||+||||||+|||++.++ .+||+|||++..... ......+++.|+|||++.+ ..++.++||||+|
T Consensus 114 ~aL~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 191 (288)
T cd07871 114 RGLSYCHKRKILHRDLKPQNLLINEKG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVG 191 (288)
T ss_pred HHHHHHHhCCcccCCCCHHHEEECCCC--CEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHH
Confidence 999999999999999999999999888 899999999865332 2233567899999999876 4688999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|+||+.||.+.+..+.+..+...++.++.+.+........+. .. ..+..............++
T Consensus 192 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----------~~~~~~~~~~~~~~~~~~~ 259 (288)
T cd07871 192 CILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR-SY-----------LFPQYRAQPLINHAPRLDT 259 (288)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh-cc-----------ccCccCCCchHHhCCCCCH
Confidence 99999999999999999999999999999998888776543211110 00 0000111112223345678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
++.+||++||++||.+|||+.|+++||||
T Consensus 260 ~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 260 DGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 89999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=372.05 Aligned_cols=252 Identities=31% Similarity=0.533 Sum_probs=219.3
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|-+.+.||+|+||.||+|+.+.+.++ |+|.+.+....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~---------------------------------------- 41 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN---------------------------------------- 41 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc----------------------------------------
Confidence 6899999999999999999999999987 88887544322
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
+.-.+.+.+|++|++.++|+ ||+.++++|+...++|+|+|||.|+|..++..... +++..++.++.|++
T Consensus 42 ---~k~l~~l~~ev~i~r~lkHp------niv~m~esfEt~~~~~vVte~a~g~L~~il~~d~~--lpEe~v~~~a~~LV 110 (808)
T KOG0597|consen 42 ---EKELKNLRQEVRILRSLKHP------NIVEMLESFETSAHLWVVTEYAVGDLFTILEQDGK--LPEEQVRAIAYDLV 110 (808)
T ss_pred ---hHHHHHHHHHHHHHHhcCCc------chhhHHHhhcccceEEEEehhhhhhHHHHHHhccC--CCHHHHHHHHHHHH
Confidence 11234567799999999998 99999999999999999999999999999998765 99999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc---eeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
.||.|||+.+|.|||+||.|||+..++ .+|+||||+++..+... ....|||.|||||++.+..|+..+|+|||||
T Consensus 111 saL~yLhs~rilhrd~kPqniLl~~~~--~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGc 188 (808)
T KOG0597|consen 111 SALYYLHSNRILHRDMKPQNILLEKGG--TLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGC 188 (808)
T ss_pred HHHHHHHhcCcccccCCcceeeecCCC--ceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHH
Confidence 999999999999999999999999998 99999999998765432 3357999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
|+||+.+|++||-..+..+....|..---.+|. ..+..
T Consensus 189 ilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~------------------------------------------~~S~~ 226 (808)
T KOG0597|consen 189 ILYELYVGQPPFYARSITQLVKSILKDPVKPPS------------------------------------------TASSS 226 (808)
T ss_pred HHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc------------------------------------------cccHH
Confidence 999999999999887776666665531111111 23789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
|..|+..+|..||.+|+|..+++.|||++..
T Consensus 227 f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 227 FVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 9999999999999999999999999999864
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=354.00 Aligned_cols=269 Identities=25% Similarity=0.357 Sum_probs=222.5
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
++.-.+.|++...||.|..++||+|+...++++ |||++....+..+-.
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld------------------------------- 69 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLD------------------------------- 69 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHH-------------------------------
Confidence 345567899999999999999999999999976 999987665554433
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.+.+|+..++.+.|+ ||++++..|..+..+|+||++| .|++.++++..-..+++|..+..
T Consensus 70 -------------~l~kE~~~msl~~HP------NIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~ 130 (516)
T KOG0582|consen 70 -------------ALRKEVQTMSLIDHP------NIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIAT 130 (516)
T ss_pred -------------HHHHHHHHhhhcCCC------CcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHH
Confidence 344599999999887 9999999999999999999999 57999999988778899999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---Cc----ceeeecCccccchhhhhCC--C
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QR----VYTYIQSRFYRSPEVILGL--P 244 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~----~~~~~~t~~y~aPE~~~~~--~ 244 (429)
|+++++.||.|||.+|.||||||+.|||++.+| .|+|+|||.+.... .+ .++++||+.|||||++.+. .
T Consensus 131 iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG--~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~G 208 (516)
T KOG0582|consen 131 ILREVLKALDYLHQNGHIHRDVKAGNILIDSDG--TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHG 208 (516)
T ss_pred HHHHHHHHHHHHHhcCceecccccccEEEcCCC--cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccC
Confidence 999999999999999999999999999999999 99999999874322 11 1456899999999997654 6
Q ss_pred CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
|+.++||||||++..||.+|..||....+...+..- +.+.||.-.....
T Consensus 209 YdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~pp~~~t~~~----------------------------- 257 (516)
T KOG0582|consen 209 YDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDPPTLLTSGL----------------------------- 257 (516)
T ss_pred ccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCCCCcccccC-----------------------------
Confidence 999999999999999999999999988776655333 3344442211110
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
..+.....+.+|..++..||+.||.+||||+++|+|+||+...
T Consensus 258 -~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 258 -DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred -ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 0111122367999999999999999999999999999999754
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=338.95 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=221.3
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.+.|++-+.||+|.|+.|+++.+..||+. |+|++......
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~------------------------------------- 50 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS------------------------------------- 50 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc-------------------------------------
Confidence 4678899999999999999999999999975 87776322111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
..-.+.+.+|++|-+.|+|+ ||+++.+.+......|+|+|+|+ ++|..-|-++.. +++..+..++
T Consensus 51 ------~~~~e~l~rEarIC~~LqHP------~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~--ySEa~aSH~~ 116 (355)
T KOG0033|consen 51 ------ARDFQKLEREARICRKLQHP------NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCI 116 (355)
T ss_pred ------cccHHHHHHHHHHHHhcCCC------cEeehhhhhcccceeEEEEecccchHHHHHHHHHHH--HHHHHHHHHH
Confidence 11234667799999999988 99999999999999999999996 478777766544 8999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
+||+++|.|||.+||||||+||+|+++.+.. ..-+||+|||++...+.. ...++|||.|||||++...+|+.++|||
T Consensus 117 rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW 196 (355)
T KOG0033|consen 117 QQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 196 (355)
T ss_pred HHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhh
Confidence 9999999999999999999999999997643 236999999999876632 2347899999999999999999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
+-||++|-|+.|++||.+.+.....++|...-...+... +..
T Consensus 197 ~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~--------------------------------------w~~ 238 (355)
T KOG0033|consen 197 ACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE--------------------------------------WDT 238 (355)
T ss_pred hhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc--------------------------------------cCc
Confidence 999999999999999999999888888886444333221 123
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+++++.+|+++||..||++|+||.|+|+|||+.+..
T Consensus 239 is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 239 VTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred CCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 488999999999999999999999999999998753
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=352.62 Aligned_cols=281 Identities=29% Similarity=0.540 Sum_probs=221.3
Q ss_pred CCeEEEeEeeccccceEEEEEecCC-Cc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKT-NT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~-~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
+||++++.||+|+||+||+|.+..+ +. +|+|++......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--------------------------------------- 41 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--------------------------------------- 41 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC---------------------------------------
Confidence 4899999999999999999999654 44 488876432211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE-----cCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-----RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
......+.+|+.+++.+... .||||+++++++.. ...+++|||+++++|.+++.......+++..+..
T Consensus 42 ----~~~~~~~~~e~~~l~~l~~~---~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~ 114 (290)
T cd07862 42 ----EGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 114 (290)
T ss_pred ----CCchHHHHHHHHHHHhhccc---CCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHH
Confidence 11122345577787777533 45699999999853 3569999999999999999876656699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
++.|++.||+|||++|++||||||+|||++.++ .++|+|||++..... ......||+.|+|||++.+..++.++||
T Consensus 115 i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 192 (290)
T cd07862 115 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDL 192 (290)
T ss_pred HHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC--CEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccch
Confidence 999999999999999999999999999999888 899999999865432 2334568999999999998889999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|++||.+.+..+.+..+.+..+.+.++.+....... . ...............+
T Consensus 193 wslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------~------~~~~~~~~~~~~~~~~ 257 (290)
T cd07862 193 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP---------R------QAFHSKSAQPIEKFVT 257 (290)
T ss_pred HHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhccc---------c------hhccCCCCCCHHHHcc
Confidence 999999999999999999999999999999888776655432211000 0 0000111223334445
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
..++.+.+|+.+||+.||++|||+.|+|+||||
T Consensus 258 ~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 258 DIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred CCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=355.39 Aligned_cols=256 Identities=30% Similarity=0.453 Sum_probs=206.3
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.-++...+.||+|+||+||++.+.+++.. |+|.+.......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-------------------------------------- 57 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-------------------------------------- 57 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--------------------------------------
Confidence 34588899999999999999999998876 888764331110
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC--eEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN--HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
...+.+|+.+|+.++|+ |||++++...... .+++.|||+ +|+|.+++..... ++++..++.+.
T Consensus 58 -------~~~l~~Ei~iL~~l~~p------~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~yt 123 (313)
T KOG0198|consen 58 -------SESLEREIRILSRLNHP------NIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYT 123 (313)
T ss_pred -------HHHHHHHHHHHHhCCCC------CEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHH
Confidence 23466799999999977 9999999754444 699999999 5799999998874 69999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEec-CCCcceEEeeecccccccC------cceeeecCccccchhhhhCC-CCCC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQ-RGSSSIKVIDFGSSCYSHQ------RVYTYIQSRFYRSPEVILGL-PYGP 247 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~-~~~~~vkl~Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~~-~~~~ 247 (429)
+||++||+|||++|+|||||||+|||++. ++ .+||+|||++..... ......||+.|||||++.+. ..+.
T Consensus 124 r~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~--~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~ 201 (313)
T KOG0198|consen 124 RQILEGLAYLHSKGIVHCDIKPANILLDPSNG--DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARR 201 (313)
T ss_pred HHHHHHHHHHHhCCEeccCcccceEEEeCCCC--eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCc
Confidence 99999999999999999999999999999 57 899999999875442 23347899999999999963 3345
Q ss_pred CccccchhhHHHHHhhCCCCCCCC-CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGE-NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
++|||||||++.||+||+.||... ...+.+..+.. .. ..
T Consensus 202 ~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~--~~--------------------------------------~~ 241 (313)
T KOG0198|consen 202 ESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR--ED--------------------------------------SL 241 (313)
T ss_pred cchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc--cC--------------------------------------CC
Confidence 999999999999999999999874 22222222211 00 01
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
+..+...++++.+||++||..||++||||.++|+|||.++...
T Consensus 242 P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 242 PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 1223345889999999999999999999999999999987654
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=372.79 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=218.8
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
--+.|+++++||+|+||+|++|..+.++++ |||++++...-
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il-------------------------------------- 407 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL-------------------------------------- 407 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee--------------------------------------
Confidence 346799999999999999999999999987 99988655321
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
...-.++.+.|.+|+.... .||.++.++..|.+..++|+||||+. |+ +......+.|++..++.|+.
T Consensus 408 ----~~d~Ve~~~~EkrI~~la~-----~HPFL~~L~~~fQT~~~l~fvmey~~Ggd---m~~~~~~~~F~e~rarfyaA 475 (694)
T KOG0694|consen 408 ----QRDEVESLMCEKRIFELAN-----RHPFLVNLFSCFQTKEHLFFVMEYVAGGD---LMHHIHTDVFSEPRARFYAA 475 (694)
T ss_pred ----ccccHHHHHHHHHHHHHhc-----cCCeEeecccccccCCeEEEEEEecCCCc---EEEEEecccccHHHHHHHHH
Confidence 1122345667999999887 45699999999999999999999995 46 33222324599999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc---ccCcceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
.|+.||.|||++|||+||||.+|||+|..| ++||+|||+++. .+....++||||.|+|||++.+..|+.++|-||
T Consensus 476 ev~l~L~fLH~~~IIYRDlKLdNiLLD~eG--h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~ 553 (694)
T KOG0694|consen 476 EVVLGLQFLHENGIIYRDLKLDNLLLDTEG--HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWG 553 (694)
T ss_pred HHHHHHHHHHhcCceeeecchhheEEcccC--cEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHH
Confidence 999999999999999999999999999999 999999999975 345677899999999999999999999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|||++|+.||++.+..+....|...-. ..+...
T Consensus 554 lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~------------------------------------------~yP~~l 591 (694)
T KOG0694|consen 554 LGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV------------------------------------------RYPRFL 591 (694)
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC------------------------------------------CCCCcc
Confidence 99999999999999999999999888875111 112234
Q ss_pred ChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSSS 368 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~ 368 (429)
+.++.++|+++|..||++|+. +.++..||||+...
T Consensus 592 s~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 592 SKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred cHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 788999999999999999996 57899999999865
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=357.34 Aligned_cols=284 Identities=26% Similarity=0.470 Sum_probs=219.6
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|++.+.||.|+||+||+|.+..++.. |+|++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------------------------------------- 44 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--------------------------------------- 44 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc---------------------------------------
Confidence 57899999999999999999999988764 88877432110
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+|+++++.+.|+ ||+++++++......++||||++++|.+++.... ..+++..++.++.|+
T Consensus 45 -----~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi 112 (303)
T cd07869 45 -----GTPFTAIREASLLKGLKHA------NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQL 112 (303)
T ss_pred -----ccchhHHHHHHHHhhCCCC------CcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHH
Confidence 1122455699999999887 9999999999999999999999999999887654 458999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCC-CCCCCccccch
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGL-PYGPPIDMWSL 254 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSl 254 (429)
+.||+|||++||+||||||+|||++.++ .+||+|||++..... ......+|+.|+|||++.+. .++.++|||||
T Consensus 113 ~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 190 (303)
T cd07869 113 LRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGV 190 (303)
T ss_pred HHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHH
Confidence 9999999999999999999999999888 899999999864332 22335678999999998764 57889999999
Q ss_pred hhHHHHHhhCCCCCCCCC-HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc--
Q psy17270 255 GCILAELYTGCPLFPGEN-EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR-- 331 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 331 (429)
||++|+|++|..||.+.. ..+.+..+...++.+....+........ +.+... ...........+.
T Consensus 191 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----------~~~~~~~~~~~~~~~ 258 (303)
T cd07869 191 GCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH-FKPERF-----------TLYSPKNLRQAWNKL 258 (303)
T ss_pred HHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc-cccccc-----------cccCCccHHHHhhcc
Confidence 999999999999998754 4566777777777766655433221100 000000 0000111111111
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
..++.+.+|+++||+.||++|||+.|+++||||++..
T Consensus 259 ~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 259 SYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred CCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 2357889999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=362.83 Aligned_cols=265 Identities=30% Similarity=0.470 Sum_probs=225.7
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
...+.++|++.+.||+|.||.||+|+++.||.. |+|++.+......
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~--------------------------------- 76 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK--------------------------------- 76 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc---------------------------------
Confidence 456788999999999999999999999998865 8888754322111
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|+.+|+++. |+ ||+.+++.|++...+++|||+|. |.|.+.+... .+++..+.
T Consensus 77 ---------~~~~~v~~Ev~il~~l~~hp------niv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~ 138 (382)
T KOG0032|consen 77 ---------EDREDVRREVAILQQLSGHP------NIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAA 138 (382)
T ss_pred ---------ccHHHHHHHHHHHHhccCCC------CEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHH
Confidence 12346677999999998 55 99999999999999999999995 7999999887 29999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCC--cceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS--SSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~--~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
.++.|++.+++|||+.|++||||||+|+|+..... ..++++|||++..... .....+||+.|+|||++.+..|+..
T Consensus 139 ~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~ 218 (382)
T KOG0032|consen 139 GIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDE 218 (382)
T ss_pred HHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcc
Confidence 99999999999999999999999999999987632 3799999999987665 5667899999999999999999999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+||||+||++|.|++|.+||.+.+.......|...-..+..+.|
T Consensus 219 ~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w------------------------------------ 262 (382)
T KOG0032|consen 219 VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW------------------------------------ 262 (382)
T ss_pred cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc------------------------------------
Confidence 99999999999999999999999988887766653332222222
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
...+..+.+||++||..||.+|+||.++|+|||++....
T Consensus 263 --~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 263 --DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred --cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 233788999999999999999999999999999987533
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=360.81 Aligned_cols=254 Identities=27% Similarity=0.381 Sum_probs=213.6
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-+.|++.+.||.|+||.||+|.++.+++. |+|++......
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------------------------------------- 57 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL--------------------------------------- 57 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh---------------------------------------
Confidence 46799999999999999999999988865 99987532110
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.......+.+|+.+++.+.|+ ||+++++++...+.+|+||||+. ++|.+.+.... .+++..+..++.|
T Consensus 58 ---~~~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~q 126 (329)
T PTZ00263 58 ---KMKQVQHVAQEKSILMELSHP------FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAE 126 (329)
T ss_pred ---hhhhHHHHHHHHHHHHhCCCC------CCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHH
Confidence 011123566799999999877 99999999999999999999995 69999988754 4899999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
|+.||+|||++||+||||||+|||++.++ .++|+|||++..........+||+.|+|||++.+..++.++|||||||+
T Consensus 127 i~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 204 (329)
T PTZ00263 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKG--HVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVL 204 (329)
T ss_pred HHHHHHHHHHCCeeecCCCHHHEEECCCC--CEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHH
Confidence 99999999999999999999999999988 8999999999877666666789999999999999889999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|..||.+.+..+....+...... .+...++.+
T Consensus 205 l~elltg~~pf~~~~~~~~~~~i~~~~~~------------------------------------------~p~~~~~~~ 242 (329)
T PTZ00263 205 LYEFIAGYPPFFDDTPFRIYEKILAGRLK------------------------------------------FPNWFDGRA 242 (329)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCCcC------------------------------------------CCCCCCHHH
Confidence 99999999999887776555544321000 011236788
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q psy17270 338 VDFVTQCFNWDSKKRLT-----PDEALRHEWLKSS 367 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~ 367 (429)
.+||++||+.||++|++ +.+++.||||+..
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999999999997 7999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=351.54 Aligned_cols=282 Identities=30% Similarity=0.590 Sum_probs=222.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||+|+||+||+|+++.++.. |+|++......
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---------------------------------------- 40 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN---------------------------------------- 40 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc----------------------------------------
Confidence 5899999999999999999999988865 88877432111
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+++++.++|+ ||+++++++.....+|+||||+.+++.+.+.... ..+++..++.++.|++
T Consensus 41 ---~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~ 110 (287)
T cd07848 41 ---EEVKETTLRELKMLRTLKQE------NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLI 110 (287)
T ss_pred ---ccchhhHHHHHHHHHhCCCc------cccchhhhEecCCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHH
Confidence 11233456699999999887 9999999999999999999999877666665443 4599999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC----cceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
.||.|||+.|++||||||+||+++.++ .++|+|||++..... ......||+.|+|||++.+..++.++||||||
T Consensus 111 ~~L~~lH~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 188 (287)
T cd07848 111 KAIHWCHKNDIVHRDIKPENLLISHND--VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVG 188 (287)
T ss_pred HHHHHHHHCCeecCCCCHHHEEEcCCC--cEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHH
Confidence 999999999999999999999999888 899999999876432 12235689999999999988899999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|++||.+.+..+.+..+....+..+.+.+....... .+.....+. ...............+.
T Consensus 189 vil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~~~~~~~s~ 258 (287)
T cd07848 189 CILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP-RFHGLRFPA---------VNHPQSLERRYLGILSG 258 (287)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc-hhcccccCc---------ccCcccHHHhhhcccCH
Confidence 99999999999999998888888888888877766554322110 000000000 00011111222334578
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
++.+||++||++||++|||+.|+|+||||
T Consensus 259 ~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 259 VLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=360.26 Aligned_cols=284 Identities=32% Similarity=0.581 Sum_probs=224.2
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||++.++||+|+||.||+|++..++.. |+|++......
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------------------- 39 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH----------------------------------------- 39 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-----------------------------------------
Confidence 799999999999999999999988765 88877422110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
......+.+|+++++.++|+ ||+++++++... ..+|+|||||+++|.+++.... .+++..+..++
T Consensus 40 --~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~ 109 (338)
T cd07859 40 --VSDATRILREIKLLRLLRHP------DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHHQFFL 109 (338)
T ss_pred --chhHHHHHHHHHHHHhCCCC------CEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcc--cCCHHHHHHHH
Confidence 01112456799999999887 999999988543 3589999999999999988664 39999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhhC--CCCCC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILG--LPYGP 247 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~ 247 (429)
.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... .....+|+.|+|||++.+ ..++.
T Consensus 110 ~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 187 (338)
T cd07859 110 YQLLRALKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 187 (338)
T ss_pred HHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCc
Confidence 9999999999999999999999999999988 8999999998653211 123568999999999876 57899
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
++|||||||++|+|++|++||.+.+...++..+....+.++.+........... ..... ..........
T Consensus 188 ~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-------~~~~~----~~~~~~~~~~ 256 (338)
T cd07859 188 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKAR-------RYLSS----MRKKQPVPFS 256 (338)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHH-------HHHHh----hcccCCCchH
Confidence 999999999999999999999999988888888888898887766543211000 00000 0001111223
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
+..+..++.+.++|.+||+.||++|||+.|+++||||+....
T Consensus 257 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 257 QKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 334456788999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=366.20 Aligned_cols=254 Identities=28% Similarity=0.486 Sum_probs=218.4
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
=..+|+...+||+|+.|.||.|....+++. |+|.+....
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---------------------------------------- 310 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---------------------------------------- 310 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc----------------------------------------
Confidence 367899999999999999999999988865 888874321
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
..-.+-+.+|+.+|+.+.|+ |||.+++.|...+.+|.|||||+ |+|.+++.... ++|.++..+++
T Consensus 311 -----Q~~keLilnEi~Vm~~~~H~------NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icr 376 (550)
T KOG0578|consen 311 -----QPKKELLLNEILVMRDLHHP------NIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICR 376 (550)
T ss_pred -----CCchhhhHHHHHHHHhccch------HHHHHHHHhcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHH
Confidence 12234567799999999998 99999999999999999999995 69999998766 99999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
.++.||+|||.+||+|||||.+|||+..+| .+||+|||++..... ...+.+|||+|||||++....|++++||||
T Consensus 377 e~l~aL~fLH~~gIiHrDIKSDnILL~~~g--~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWS 454 (550)
T KOG0578|consen 377 EILQGLKFLHARGIIHRDIKSDNILLTMDG--SVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWS 454 (550)
T ss_pred HHHHHHHHHHhcceeeeccccceeEeccCC--cEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchh
Confidence 999999999999999999999999999999 899999999976543 345679999999999999999999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
||++++||+-|++||-..+....+..|.. -|.+.-. -....
T Consensus 455 LGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk--------------------------------------~~~kl 495 (550)
T KOG0578|consen 455 LGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK--------------------------------------NPEKL 495 (550)
T ss_pred hhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC--------------------------------------Ccccc
Confidence 99999999999999988777766665553 1211111 11234
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
++.|.|||.+||+.|+.+|++|.|||+||||+..
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 8999999999999999999999999999999653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=356.49 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=213.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||.||+|.+..++.. |+|++.......
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR--------------------------------------- 41 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh---------------------------------------
Confidence 4799999999999999999999988865 999874321110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+.+|+++++.+.|+ ||+++++++.+...+|+||||+. ++|.+++.... .+++..+..++.|+
T Consensus 42 ---~~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi 110 (291)
T cd05612 42 ---LKQEQHVHNEKRVLKEVSHP------FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEI 110 (291)
T ss_pred ---hHHHHHHHHHHHHHHhCCCC------cHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHH
Confidence 01123456699999999887 99999999999999999999995 69999988754 49999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHH
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 258 (429)
+.||+|||++|++||||||+|||++.++ .++|+|||++..........+||+.|+|||++.+..++.++|||||||++
T Consensus 111 ~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 188 (291)
T cd05612 111 VCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILI 188 (291)
T ss_pred HHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 9999999999999999999999999888 89999999998766555567899999999999998899999999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 259 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
|+|++|+.||.+.+..+....+...... .+...++.+.
T Consensus 189 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~~ 226 (291)
T cd05612 189 YEMLVGYPPFFDDNPFGIYEKILAGKLE------------------------------------------FPRHLDLYAK 226 (291)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCcC------------------------------------------CCccCCHHHH
Confidence 9999999999988776666555431100 0112367889
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q psy17270 339 DFVTQCFNWDSKKRLT-----PDEALRHEWLKSSS 368 (429)
Q Consensus 339 ~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~ 368 (429)
+||++||+.||.+|++ +.|+++||||+...
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 9999999999999995 99999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=346.51 Aligned_cols=280 Identities=28% Similarity=0.519 Sum_probs=221.6
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||++++.||+|+||+||+|.++.++.. |+|.+......
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~----------------------------------------- 39 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE----------------------------------------- 39 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-----------------------------------------
Confidence 699999999999999999999988865 88876432111
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
......+.+|+++++.+.+. .|+||+++++++... ..++++||++.++|.+++.......+++..+..++
T Consensus 40 --~~~~~~~~~e~~~l~~l~~~---~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~ 114 (288)
T cd07863 40 --DGLPLSTVREVALLKRLEAF---DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLM 114 (288)
T ss_pred --CCCchHHHHHHHHHHHhhhc---CCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHH
Confidence 11122345588888887643 456999999988642 46899999999999999887655569999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
.|++.||.|||++|++||||||+||+++.++ .++|+|||++...... .....+|..|+|||++.+..++.++||||
T Consensus 115 ~qi~~al~~lH~~~ivH~dikp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 192 (288)
T cd07863 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGG--QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWS 192 (288)
T ss_pred HHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhh
Confidence 9999999999999999999999999999888 8999999998754422 22356788999999999888999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
+||++|+|++|.+||.+.+..+.+..+....+.+....+....... ................+..
T Consensus 193 lG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~ 257 (288)
T cd07863 193 VGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP---------------RGAFSPRGPRPVQSVVPEI 257 (288)
T ss_pred HHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc---------------ccccCCCCCCchHHhCcCc
Confidence 9999999999999999998888888888887776655433211000 0000011112233444556
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
++.+.++|.+||+.||++|||+.|++.||||
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 258 EESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 7889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=312.55 Aligned_cols=281 Identities=28% Similarity=0.534 Sum_probs=241.2
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|.-.++||+|+||+|++|++..+++. |+|.++....
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd------------------------------------------ 40 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD------------------------------------------ 40 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC------------------------------------------
Confidence 477788999999999999999999976 9998854322
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.++.-..+++|+-+|+.++|. ||++++++...+..+-+|+|+|+.+|..+..... +.++...++.++.|++.
T Consensus 41 -degvpssalreicllkelkhk------nivrl~dvlhsdkkltlvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllr 112 (292)
T KOG0662|consen 41 -DEGVPSSALREICLLKELKHK------NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLR 112 (292)
T ss_pred -CCCCcHHHHHHHHHHHHhhhc------ceeehhhhhccCceeEEeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHh
Confidence 134455788899999999998 9999999999999999999999999999988765 45999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc---eeeecCccccchhhhhCCC-CCCCccccchhh
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILGLP-YGPPIDMWSLGC 256 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~ 256 (429)
||.+||++++.|||+||.|++++.+| .+||+|||+++-.+.+. ...+.|.+|++|.++.+.+ |+.+.|+||.||
T Consensus 113 gl~fchshnvlhrdlkpqnllin~ng--elkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagc 190 (292)
T KOG0662|consen 113 GLGFCHSHNVLHRDLKPQNLLINRNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190 (292)
T ss_pred hhhhhhhhhhhhccCCcceEEeccCC--cEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcch
Confidence 99999999999999999999999999 99999999998766443 3357799999999999876 799999999999
Q ss_pred HHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 257 ILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 257 il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|+.|+.. |++.|++.+..+++.+|+..+|.+.++.|..+... .+-+..+..+......++.+....
T Consensus 191 ifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l-------------pdyk~yp~ypattswsqivp~lns 257 (292)
T KOG0662|consen 191 IFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL-------------PDYKPYPIYPATTSWSQIVPKLNS 257 (292)
T ss_pred HHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC-------------CCCcccCCccccchHHHHhhhhcc
Confidence 9999987 99999999999999999999999999887655321 112223334445556666677777
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.-.|++.++|..+|.+|++|+++++||||...
T Consensus 258 ~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 258 TGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred hhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 88899999999999999999999999999753
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=358.60 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=215.5
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCC--cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTN--THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.....++|++++.||.|+||.||+|.+..++ .+|+|++......
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~---------------------------------- 70 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII---------------------------------- 70 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh----------------------------------
Confidence 3445678999999999999999999987665 4588887433211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.......+.+|+++++.+.|+ ||+++++++.....+|+||||+ +|+|.+++.... .+++..++
T Consensus 71 --------~~~~~~~~~~E~~~l~~l~hp------~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~ 134 (340)
T PTZ00426 71 --------KQKQVDHVFSERKILNYINHP------FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGC 134 (340)
T ss_pred --------hhhhHHHHHHHHHHHHhCCCC------CCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 011123456799999999877 9999999999999999999999 569999998764 49999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.++.|++.||.|||++||+||||||+|||++.++ .++|+|||++..........+||+.|+|||++.+..++.++|||
T Consensus 135 ~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 212 (340)
T PTZ00426 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG--FIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWW 212 (340)
T ss_pred HHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCcccccc
Confidence 9999999999999999999999999999999888 89999999998766655667899999999999998899999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|..||.+.+.......+....... +..
T Consensus 213 SlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------------------------------------p~~ 250 (340)
T PTZ00426 213 TLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF------------------------------------------PKF 250 (340)
T ss_pred chhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC------------------------------------------CCC
Confidence 99999999999999999887766555544311111 112
Q ss_pred CChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
.++.+.++|++||+.||.+|+ ++.++++||||+...
T Consensus 251 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 251 LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 367888999999999999995 899999999998754
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=347.81 Aligned_cols=261 Identities=27% Similarity=0.360 Sum_probs=223.0
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-+.|++++.||.|.-|+||+|....++.. |+|++.+.....
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-------------------------------------- 117 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-------------------------------------- 117 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh--------------------------------------
Confidence 35789999999999999999999999876 999985543221
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
..-..++..|-+||..+.|+ .++.+|..|+.+...|++|||| +|+|..+++++..+.|++..++.|+..
T Consensus 118 ----rkKl~Ra~tE~eIL~~lDHP------FlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAE 187 (459)
T KOG0610|consen 118 ----RKKLKRAQTEREILSLLDHP------FLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAE 187 (459)
T ss_pred ----hhHHHHHHHHHHHHHhcCCC------ccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHH
Confidence 11234567799999999988 9999999999999999999999 579999999998888999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccc-----------------------------------c
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS-----------------------------------H 222 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~-----------------------------------~ 222 (429)
|+.||+|||-.|||+|||||+||||.++| +|.|+||.++... .
T Consensus 188 vl~ALEYLHmlGivYRDLKPENILvredG--HIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~ 265 (459)
T KOG0610|consen 188 VLLALEYLHMLGIVYRDLKPENILVREDG--HIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSS 265 (459)
T ss_pred HHHHHHHHHhhceeeccCCcceeEEecCC--cEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcc
Confidence 99999999999999999999999999999 9999999986210 0
Q ss_pred ------------------------CcceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHH
Q psy17270 223 ------------------------QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLA 278 (429)
Q Consensus 223 ------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 278 (429)
...+.++||-.|.|||++.|...+.++|.|+|||.+|||+.|..||.|.+..+.+.
T Consensus 266 ~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~ 345 (459)
T KOG0610|consen 266 SKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR 345 (459)
T ss_pred ccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH
Confidence 01223578889999999999999999999999999999999999999999999998
Q ss_pred HHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCC----
Q psy17270 279 CIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT---- 354 (429)
Q Consensus 279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---- 354 (429)
+|+..--.+|+. +.++..+.|||+++|.+||++|+.
T Consensus 346 NIv~~~l~Fp~~----------------------------------------~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 346 NIVGQPLKFPEE----------------------------------------PEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred HHhcCCCcCCCC----------------------------------------CcchhHHHHHHHHHhccChhhhhccccc
Confidence 887422222211 123678899999999999999999
Q ss_pred HHHHhcCCCCCCCCCC
Q psy17270 355 PDEALRHEWLKSSSSS 370 (429)
Q Consensus 355 a~ell~h~~~~~~~~~ 370 (429)
|+|+-+||||+.+.-.
T Consensus 386 A~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 386 AAEIKRHPFFEGVNWA 401 (459)
T ss_pred hHHhhcCccccCCChh
Confidence 9999999999987644
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=357.59 Aligned_cols=292 Identities=28% Similarity=0.483 Sum_probs=224.2
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++.+.||.|+||.||+|.+..++.. |+|++.......
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------------------------------ 61 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ------------------------------------ 61 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch------------------------------------
Confidence 4678999999999999999999999988865 999875432111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC------eEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN------HLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~------~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
.....+.+|+.+++.++|+ ||+++++++.... .+|+||||++++|.+.+.. .+++..
T Consensus 62 -------~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~ 124 (359)
T cd07876 62 -------THAKRAYRELVLLKCVNHK------NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM----ELDHER 124 (359)
T ss_pred -------hHHHHHHHHHHHHHhCCCC------CEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc----cCCHHH
Confidence 1123455699999999877 9999999986543 5799999999988887743 388999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++..... ......+|+.|+|||++.+..++.+
T Consensus 125 ~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 202 (359)
T cd07876 125 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKEN 202 (359)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcc
Confidence 999999999999999999999999999999999988 899999999875432 2234578999999999999899999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhc--cCCCCCccccCCCCCCCCCCCchh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFF--DSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
+|||||||++|+|++|+.||.+.+..+.+..+...++.++.++..........+ .....+....... .........
T Consensus 203 ~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 280 (359)
T cd07876 203 VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEEL--FPDWIFPSE 280 (359)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhh--ccccccccc
Confidence 999999999999999999999999999999999988888877765443211110 0001110000000 000000000
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.......++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 281 ~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 281 SERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred cccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 1111233678899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=365.43 Aligned_cols=282 Identities=31% Similarity=0.557 Sum_probs=221.1
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++++.||+|+||.||+|.+..++.. |+|++....
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------------------------------------- 103 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------------------------------------- 103 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------------------------------------
Confidence 3467899999999999999999999888754 888763211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--------CeEEEEEeecCcCHHHHHHhh--CCCCC
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--------NHLCISFELMNLNLYELIKRN--NYQGF 166 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~g~L~~~i~~~--~~~~~ 166 (429)
....+|+.+++.++|+ ||++++++|... ..+++||||++++|.+++... ....+
T Consensus 104 ----------~~~~~Ei~il~~l~h~------niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l 167 (440)
T PTZ00036 104 ----------QYKNRELLIMKNLNHI------NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHAL 167 (440)
T ss_pred ----------chHHHHHHHHHhcCCC------CCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCC
Confidence 1123499999999887 999998887542 257899999999998887642 23459
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCC-
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGL- 243 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~- 243 (429)
++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||++.... ......++|+.|+|||++.+.
T Consensus 168 ~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 246 (440)
T PTZ00036 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT 246 (440)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCC
Confidence 99999999999999999999999999999999999986541 69999999997543 233346789999999998765
Q ss_pred CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
.|+.++|||||||++|+|++|.+||.+.+..+++..+...++.+..+.+....... ..-. .+....
T Consensus 247 ~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~---~~~~-----------~~~~~~ 312 (440)
T PTZ00036 247 NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY---ADIK-----------FPDVKP 312 (440)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhh---hccc-----------CCccCc
Confidence 68999999999999999999999999999999999999999988877654321100 0000 000011
Q ss_pred chh-hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 324 KDM-ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 324 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
... ...+...++++.+||.+||++||.+|||+.|+|+||||.....
T Consensus 313 ~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 313 KDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 111 1222345789999999999999999999999999999986543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=349.62 Aligned_cols=283 Identities=28% Similarity=0.513 Sum_probs=227.4
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||.|+||+||+|+++.++.. |+|.+......
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------------------------------------- 45 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---------------------------------------- 45 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC----------------------------------------
Confidence 6799999999999999999999888764 88876432111
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.....+.+|+++++.++|+ ||+++++++..+...++||||++++|.+++.... ..+++..+..++.|++
T Consensus 46 ----~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~ 114 (309)
T cd07872 46 ----GAPCTAIREVSLLKDLKHA------NIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQIL 114 (309)
T ss_pred ----CcchhHHHHHHHHHhCCCC------CcceEEEEEeeCCeEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHH
Confidence 1122345699999999877 9999999999999999999999999999887654 3489999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG 255 (429)
.||+|||++||+||||||+||+++.++ .++|+|||++...... .....+|+.|+|||++.+. .++.++||||||
T Consensus 115 ~aL~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 192 (309)
T cd07872 115 RGLAYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVG 192 (309)
T ss_pred HHHHHHHHCCeecCCCCHHHEEECCCC--CEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHH
Confidence 999999999999999999999999888 8999999998653321 2234678899999998764 578899999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|+||+.||.+.+..+.+..+...++.+..+.+..........+.. . ...............++
T Consensus 193 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----------~~~~~~~~~~~~~~~~~ 260 (309)
T cd07872 193 CIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN-F-----------PKYKPQPLINHAPRLDT 260 (309)
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh-c-----------CccCCCchhhhccCCCH
Confidence 99999999999999999999999999999988888776543222111100 0 00011112223344578
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 261 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 261 EGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred HHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=356.17 Aligned_cols=292 Identities=27% Similarity=0.492 Sum_probs=223.2
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.+||++.+.||+|+||.||+|.+..++.. |+|++......
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------------------------- 63 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN------------------------------------- 63 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-------------------------------------
Confidence 3578999999999999999999999888865 88887543211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
......+.+|+.+++.+.|+ ||+.+++++... ..+|+||||++++|.+.+.. .+++..
T Consensus 64 ------~~~~~~~~~E~~~l~~l~h~------~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~ 127 (364)
T cd07875 64 ------QTHAKRAYRELVLMKCVNHK------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM----ELDHER 127 (364)
T ss_pred ------chhHHHHHHHHHHHHhcCCC------CccccceeecccccccccCeEEEEEeCCCCCHHHHHHh----cCCHHH
Confidence 11123455699999998887 899998887543 46899999999999888753 388999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++...... .....+|+.|+|||++.+..++.+
T Consensus 128 ~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 205 (364)
T cd07875 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205 (364)
T ss_pred HHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC--cEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCch
Confidence 999999999999999999999999999999999888 8999999999765432 234578999999999999899999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhh-hhccCCC-CCccccCCCCCCCCCCCchh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRR-LFFDSKG-TPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 326 (429)
+|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+....... ....... ....... + ..........
T Consensus 206 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~ 283 (364)
T cd07875 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFE-K-LFPDVLFPAD 283 (364)
T ss_pred hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChH-h-hCcccccccc
Confidence 999999999999999999999999999999999988888777655443211 1111100 0000000 0 0000000000
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.......+..+.+||.+||+.||++|||+.|+|+||||..
T Consensus 284 ~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 284 SEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred ccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 1111223568899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=337.21 Aligned_cols=243 Identities=26% Similarity=0.412 Sum_probs=202.2
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
..|+|.++||+|+||+||+|.+..++.. |.|.+.....+.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~--------------------------------------- 59 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDA--------------------------------------- 59 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccH---------------------------------------
Confidence 4599999999999999999999999976 888875322211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEE-EEEcC-eEEEEEeecC-cCHHHHHHhhC--CCCCCHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY-FYFRN-HLCISFELMN-LNLYELIKRNN--YQGFSLGLIRRF 174 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~-~~~~~-~~~lv~e~~~-g~L~~~i~~~~--~~~~~~~~~~~i 174 (429)
........|+.+|++|+|+ ||++++++ |-.+. -++||||+|+ |+|.++|+... .+.+++..++.+
T Consensus 60 ----k~rq~~v~Ei~lLkQL~Hp------NIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~ 129 (375)
T KOG0591|consen 60 ----KARQDCVKEISLLKQLNHP------NIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKY 129 (375)
T ss_pred ----HHHHHHHHHHHHHHhcCCc------hHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHH
Confidence 1123455699999999998 99999984 43344 4899999995 79999998543 345999999999
Q ss_pred HHHHHHHHHHHHH--CC--ceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCC
Q psy17270 175 AFSLVQCLRLLHR--EN--IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 175 ~~qil~~l~~lH~--~~--ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
+.|++.||..||+ .. |+||||||.||+++.+| .+||+|||+++..... ..+.+|||+||+||++.+.+|+.
T Consensus 130 f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g--vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~ 207 (375)
T KOG0591|consen 130 FVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG--VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNF 207 (375)
T ss_pred HHHHHHHHHHHhccccccceeeccCcchheEEcCCC--ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCc
Confidence 9999999999999 44 89999999999999999 9999999999875543 34579999999999999999999
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCC-CcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGC-PPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
++||||+||++|||+.-++||.+.+-.+.-.+|.++-.+ .|.+.
T Consensus 208 kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~----------------------------------- 252 (375)
T KOG0591|consen 208 KSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH----------------------------------- 252 (375)
T ss_pred chhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH-----------------------------------
Confidence 999999999999999999999999887777777764222 12222
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCH
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTP 355 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta 355 (429)
.+.++..+|.-|+.+||..||+.
T Consensus 253 ------YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 253 ------YSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ------hhhHHHHHHHHHccCCcccCCCc
Confidence 26788899999999999999984
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=353.59 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=203.8
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||.||+|.++.++.. |+|++........ ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~------------------------------------------~~ 38 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAK------------------------------------------DE 38 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh------------------------------------------HH
Confidence 4699999999999999988865 9998754321100 11
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+.+|+++++.+.|+ ||+++++++.....+|+||||+. ++|.+.+.... .+++..++.++.||+.||+|
T Consensus 39 ~~~~~~e~~~l~~l~hp------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~ 110 (323)
T cd05571 39 VAHTLTESRVLQNTRHP------FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGY 110 (323)
T ss_pred HHHHHHHHHHHHhCCCC------CCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 12455699999998877 99999999999999999999995 68988887654 49999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++||+||||||+|||++.++ .++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 111 lH~~~ivHrDlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 188 (323)
T cd05571 111 LHSCDVVYRDLKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188 (323)
T ss_pred HHhCCeEeCCCCHHHEEECCCC--CEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhh
Confidence 9999999999999999999888 89999999986432 223346799999999999998999999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
++|..||.+.+.......+...... .+...++++.+||
T Consensus 189 ltg~~Pf~~~~~~~~~~~~~~~~~~------------------------------------------~p~~~~~~~~~li 226 (323)
T cd05571 189 MCGRLPFYNQDHEKLFELILMEEIR------------------------------------------FPRTLSPEAKSLL 226 (323)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCCCCHHHHHHH
Confidence 9999999887765555443321000 0112378899999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 342 TQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 342 ~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
++||+.||++|| ++.++++||||++..
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 227 AGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred HHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999 899999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=347.72 Aligned_cols=258 Identities=26% Similarity=0.334 Sum_probs=207.4
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|++.+.||+|+||+||+|.+..++.. |+|.+.......
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~----------------------------------------- 40 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK----------------------------------------- 40 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-----------------------------------------
Confidence 88999999999999999999988865 888874332110
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
......+.+|+++++.+.|+ +|+.+++++...+.+++||||+. |+|.+.+.......+++..+..++.|++.
T Consensus 41 -~~~~~~~~~E~~il~~l~~~------~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~ 113 (285)
T cd05631 41 -RKGEAMALNEKRILEKVNSR------FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCC 113 (285)
T ss_pred -hhhHHHHHHHHHHHHhcCCC------cEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHH
Confidence 01122456699999999887 99999999999999999999995 68988887655456999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccccchhhHH
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 258 (429)
||+|||++|++||||||+|||++.++ .++|+|||++..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 114 ~l~~lH~~~iiH~dikp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil 191 (285)
T cd05631 114 GLEDLQRERIVYRDLKPENILLDDRG--HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLI 191 (285)
T ss_pred HHHHHHhCCEEeCCCCHHHEEECCCC--CEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHH
Confidence 99999999999999999999999887 899999999876432 22345789999999999998999999999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 259 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
|+|++|+.||.+.+.......+........ .......++.+.
T Consensus 192 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~s~~~~ 233 (285)
T cd05631 192 YEMIQGQSPFRKRKERVKREEVDRRVKEDQ--------------------------------------EEYSEKFSEDAK 233 (285)
T ss_pred HHHHhCCCCCCCCCcchhHHHHHHHhhccc--------------------------------------ccCCccCCHHHH
Confidence 999999999987654332222221111000 001122378899
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q psy17270 339 DFVTQCFNWDSKKRLT-----PDEALRHEWLKSSS 368 (429)
Q Consensus 339 ~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~ 368 (429)
+|+++||+.||++||+ ++++++||||....
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 9999999999999997 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=355.98 Aligned_cols=286 Identities=30% Similarity=0.582 Sum_probs=227.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.+||++++.||.|+||+||+|.+..++.. |+|++.......
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------------------------------ 55 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL------------------------------------ 55 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh------------------------------------
Confidence 4678999999999999999999999888764 888875432110
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
.....+.+|+++++.++|+ ||+++++++... ...|+++++++++|.+++... .+++..
T Consensus 56 -------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~---~l~~~~ 119 (343)
T cd07878 56 -------IHARRTYRELRLLKHMKHE------NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ---KLSDEH 119 (343)
T ss_pred -------HHHHHHHHHHHHHHhcCCC------chhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhcC---CCCHHH
Confidence 1122355699999999887 999999887533 468999999999998887643 499999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC-CCCCCCc
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPI 249 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~ 249 (429)
+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..........++|+.|+|||++.+ ..++.++
T Consensus 120 ~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 197 (343)
T cd07878 120 VQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTV 197 (343)
T ss_pred HHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC--CEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchh
Confidence 999999999999999999999999999999999888 8999999999876665566789999999999987 4688999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||.+.+..+.+..+....+.++.+........... ..... ............
T Consensus 198 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~----~~~~~~~~~~~~ 266 (343)
T cd07878 198 DIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR-------KYIQS----LPHMPQQDLKKI 266 (343)
T ss_pred hhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH-------HHhhc----cccccchhHHHh
Confidence 9999999999999999999999988889999888888777665443221100 00000 001111223333
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||.+||+.||++|||+.|+|+||||....
T Consensus 267 ~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 267 FRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 445678889999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=361.40 Aligned_cols=281 Identities=23% Similarity=0.406 Sum_probs=216.3
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+-.++|++++.||.|+||.||+|.+..++.. |+|....
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------------------------------------- 127 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------------------------------------- 127 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------------------------------------
Confidence 3457899999999999999999999998875 8775311
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
..+.+|++++++++|+ ||++++++|......++|+|++.++|..++.... .+++..+..++.
T Consensus 128 ----------~~~~~E~~il~~l~Hp------nIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~ 189 (391)
T PHA03212 128 ----------GGTATEAHILRAINHP------SIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKR--NIAICDILAIER 189 (391)
T ss_pred ----------hhhHHHHHHHHhCCCC------CCCCEeEEEEECCeeEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHH
Confidence 1244599999999887 9999999999999999999999999999887654 489999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc----CcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH----QRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
||+.||+|||++||+||||||+|||++.++ .++|+|||++.... ......+||+.|+|||++.+..++.++|||
T Consensus 190 qi~~aL~ylH~~~IvHrDiKP~NIll~~~~--~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 267 (391)
T PHA03212 190 SVLRAIQYLHENRIIHRDIKAENIFINHPG--DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIW 267 (391)
T ss_pred HHHHHHHHHHhCCcccCCCChHhEEEcCCC--CEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHH
Confidence 999999999999999999999999999888 89999999986432 223345799999999999998999999999
Q ss_pred chhhHHHHHhhCCCCCCCC-------CHHHHHHHHHHHhCCCcHHHHhhhh-h-hhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 253 SLGCILAELYTGCPLFPGE-------NEVEQLACIMEILGCPPDEVINTAS-R-RRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
||||++|+|++|..||-.. +...++..+....+.++.++..... . ...+... .......+..
T Consensus 268 SlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 338 (391)
T PHA03212 268 SAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGL---------AKKSSRKPGS 338 (391)
T ss_pred HHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHH---------HhccCCCCCC
Confidence 9999999999999776432 2345677777777776654321100 0 0000000 0000000111
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
..........+.++.+||.+||++||++||||.|+|+||||+...
T Consensus 339 ~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 339 RPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred CCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 111111223466889999999999999999999999999998743
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=352.37 Aligned_cols=294 Identities=26% Similarity=0.463 Sum_probs=223.0
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.+||++++.||+|+||.||+|.+..++.. |+|++.......
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------ 57 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ------------------------------------ 57 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh------------------------------------
Confidence 3568999999999999999999999888765 888875432111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
.....+.+|+.+++.++|+ ||+++++++... ..+|+||||+++++.+.+.. .+++..
T Consensus 58 -------~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~ 120 (355)
T cd07874 58 -------THAKRAYRELVLMKCVNHK------NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM----ELDHER 120 (355)
T ss_pred -------HHHHHHHHHHHHHHHhCCC------chhceeeeeeccccccccceeEEEhhhhcccHHHHHhh----cCCHHH
Confidence 1123455699999999887 999999988643 35799999999998887753 388999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
+..++.|++.||+|||++||+||||||+|||++.++ .++|+|||++...... .....+|+.|+|||++.+..++.+
T Consensus 121 ~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 198 (355)
T cd07874 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198 (355)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC--CEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCch
Confidence 999999999999999999999999999999999888 8999999999765432 234578999999999999889999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhh-hccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL-FFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+........ ........... ...............
T Consensus 199 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 277 (355)
T cd07874 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL-TFPKLFPDSLFPADS 277 (355)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccc-cchhhcccccccccc
Confidence 9999999999999999999999998888888888888877766544322111 11100000000 000000000000001
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
......+..+.+||.+||+.||++|||+.|+|+||||...
T Consensus 278 ~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 278 EHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred ccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 1112235678999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=354.45 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=206.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|.+..++.. |+|++.+.....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE--------------------------------------- 41 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---------------------------------------
Confidence 5799999999999999999999988865 999885432110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+.+|+.++..+.|+ +|+++++.+.+...+|+|||||. |+|.+++.... .+++..++.++.|+
T Consensus 42 ---~~~~~~~~~E~~il~~~~~~------~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi 110 (363)
T cd05628 42 ---KEQVGHIRAERDILVEADSL------WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAET 110 (363)
T ss_pred ---hhHHHHHHHHHHHHHhCCCC------CcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHH
Confidence 11123455689999988776 99999999999999999999995 69999988754 49999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----------------------------------
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---------------------------------- 224 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---------------------------------- 224 (429)
+.||+|||++||+||||||+|||++.++ .++|+|||++......
T Consensus 111 ~~aL~~lH~~givHrDlKp~NILi~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (363)
T cd05628 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188 (363)
T ss_pred HHHHHHHHhCCeEecCCCHHHeEECCCC--CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhc
Confidence 9999999999999999999999999888 8999999998643210
Q ss_pred ----ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhh
Q psy17270 225 ----VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL 300 (429)
Q Consensus 225 ----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 300 (429)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+........
T Consensus 189 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~------------ 256 (363)
T cd05628 189 RRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI------------ 256 (363)
T ss_pred cccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCccc------------
Confidence 1235799999999999998999999999999999999999999998887776665543111000
Q ss_pred hccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCC---CCCCHHHHhcCCCCCCCC
Q psy17270 301 FFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSK---KRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~---~Rpta~ell~h~~~~~~~ 368 (429)
.+. ....++++.+||.+|+. +|. .||++.|+++||||+...
T Consensus 257 -------------------~p~-------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 257 -------------------FPP-------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred -------------------CCC-------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 000 01236788999999875 454 458999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=344.83 Aligned_cols=254 Identities=29% Similarity=0.475 Sum_probs=220.6
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.-||++.+.||.|+||+|-+|++...|.. |||.+++.....+..
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD---------------------------------- 96 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD---------------------------------- 96 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH----------------------------------
Confidence 567999999999999999999999888765 999887654433322
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.-.+.+|++|+..|+|+ ||+.+|++|+..+.+.|||||. .|.|++++.++.. +++.+++.+++
T Consensus 97 --------lvhIRREIeIMSsLNHP------hII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~--LsErEaRhfFR 160 (668)
T KOG0611|consen 97 --------LVHIRREIEIMSSLNHP------HIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS--LSEREARHFFR 160 (668)
T ss_pred --------HHHHHHHHHHHhhcCCC------ceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHH
Confidence 22466799999999998 9999999999999999999999 5799999998865 99999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCCCC-CCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPY-GPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwS 253 (429)
||..|+.|||.++++|||||.+|||+++++ ++||+|||++.... ....++||++-|.+||++++.+| ++.+|.||
T Consensus 161 QIvSAVhYCHknrVvHRDLKLENILLD~N~--NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWs 238 (668)
T KOG0611|consen 161 QIVSAVHYCHKNRVVHRDLKLENILLDQNN--NIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWS 238 (668)
T ss_pred HHHHHHHHHhhccceecccchhheeecCCC--CeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhh
Confidence 999999999999999999999999999999 99999999997644 34567999999999999999988 78999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|.|+.|..||+|.+-...+.+|.+.-...|+ .
T Consensus 239 LGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-------------------------------------------~ 275 (668)
T KOG0611|consen 239 LGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-------------------------------------------T 275 (668)
T ss_pred HHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-------------------------------------------C
Confidence 999999999999999999988777777652221111 1
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
+.++.-||+.||.+||..|.|+.++..|-|.+=.
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence 4566799999999999999999999999998743
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=331.36 Aligned_cols=295 Identities=25% Similarity=0.508 Sum_probs=229.7
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCc-----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNT-----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..|+++..||+|+||.||+|+.++++. +|||++..+..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd------------------------------------- 66 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD------------------------------------- 66 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-------------------------------------
Confidence 459999999999999999998766552 48877643211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE-cCeEEEEEeecCcCHHHHHHhhCC---CCCCHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-RNHLCISFELMNLNLYELIKRNNY---QGFSLGLI 171 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~g~L~~~i~~~~~---~~~~~~~~ 171 (429)
..++...+-+|+.+++.++|+ |++.+..+|.. +..+++++||.+.+|..+|+.++. ..++...+
T Consensus 67 ------~tGiS~SAcREiaL~REl~h~------nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mv 134 (438)
T KOG0666|consen 67 ------GTGISMSACREIALLRELKHP------NVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMV 134 (438)
T ss_pred ------CCCcCHHHHHHHHHHHHhcCC------cchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHH
Confidence 124455677799999999998 99999999877 779999999999999999986542 34999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCC--cceEEeeecccccccCcc------eeeecCccccchhhhhCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS--SSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGL 243 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~--~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~ 243 (429)
+.+++||+.|+.|||++.|+||||||.|||+..++. ..|||+|||+++...... ...+.|.+|+|||.+.|.
T Consensus 135 KsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa 214 (438)
T KOG0666|consen 135 KSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA 214 (438)
T ss_pred HHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhccc
Confidence 999999999999999999999999999999998822 289999999998765432 235678999999999987
Q ss_pred C-CCCCccccchhhHHHHHhhCCCCCCCCC---------HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccC
Q psy17270 244 P-YGPPIDMWSLGCILAELYTGCPLFPGEN---------EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313 (429)
Q Consensus 244 ~-~~~~~DiwSlG~il~~lltg~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (429)
. |+.+.||||+|||+.||+|.++.|.+.. ..+++.+|+.++|.|.++.|......-.+ .....+
T Consensus 215 ~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~------q~~ls~ 288 (438)
T KOG0666|consen 215 RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEY------QTLLSD 288 (438)
T ss_pred ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcch------HHHHHH
Confidence 5 8999999999999999999999997643 45789999999999998887654321110 000111
Q ss_pred CCCCCCCC-CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 314 SKGRKRKP-GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 314 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
.+.....+ ...........-++...+|+.+||.+||-+|.|++++|+|+||+.....
T Consensus 289 f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 289 FRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred hHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 11111111 1112223333346668899999999999999999999999999986544
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.39 Aligned_cols=262 Identities=26% Similarity=0.340 Sum_probs=215.1
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||.|+||.||+|++..++.. |+|++.......
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------------------------------------- 41 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK--------------------------------------- 41 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---------------------------------------
Confidence 4799999999999999999999988765 999885432110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+.+|++++..++|+ ||+++++++.....+|+||||+. ++|.+++.... .+++..++.++.|+
T Consensus 42 ---~~~~~~~~~e~~~l~~~~h~------~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi 110 (333)
T cd05600 42 ---LNEVRHVLTERDILTTTKSE------WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEM 110 (333)
T ss_pred ---hhHHHHHHHHHHHHHhCCCC------CCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHH
Confidence 01123456699999998876 99999999999999999999995 69999997654 48999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHH
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 258 (429)
+.||.|||++|++||||||+||+++.++ .+||+|||++..........+||+.|+|||++.+..++.++|||||||++
T Consensus 111 ~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 188 (333)
T cd05600 111 FEAVDALHELGYIHRDLKPENFLIDASG--HIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCML 188 (333)
T ss_pred HHHHHHHHHCCccccCCCHHHEEECCCC--CEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHH
Confidence 9999999999999999999999999888 89999999998766555667899999999999998999999999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 259 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
|+|++|..||.+.+..+....+......... +.. .......++++.
T Consensus 189 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------------~~~---~~~~~~~s~~~~ 234 (333)
T cd05600 189 YEFLCGFPPFSGSTPNETWENLKYWKETLQR-------------------------------PVY---DDPRFNLSDEAW 234 (333)
T ss_pred hhhhhCCCCCCCCCHHHHHHHHHhccccccC-------------------------------CCC---CccccccCHHHH
Confidence 9999999999988877666554431110000 000 000022378899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 339 DFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 339 ~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+||.+||..+|.+||++.++++||||+...
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=355.77 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=208.3
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||.|+||+||+|.+..++.. |+|++.......
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------------------------- 41 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE--------------------------------------- 41 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---------------------------------------
Confidence 4799999999999999999999988865 999885331110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+.+|++++..+.|+ ||++++++|....++|+|||||. |+|.+++.... .+++..++.++.|+
T Consensus 42 ---~~~~~~~~~E~~il~~l~h~------~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi 110 (364)
T cd05599 42 ---KEQVAHVRAERDILAEADNP------WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAET 110 (364)
T ss_pred ---hhHHHHHHHHHHHHHhCCCC------CCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHH
Confidence 11123455699999998876 99999999999999999999994 69999987654 49999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----------------------------------
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---------------------------------- 224 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---------------------------------- 224 (429)
+.||+|||++||+||||||+|||++.++ .++|+|||++......
T Consensus 111 ~~aL~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (364)
T cd05599 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETW 188 (364)
T ss_pred HHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEeecccceeccccccccccccccccccccccccccccccccccccch
Confidence 9999999999999999999999999988 8999999998542210
Q ss_pred -------ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhh
Q psy17270 225 -------VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASR 297 (429)
Q Consensus 225 -------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 297 (429)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~--------- 259 (364)
T cd05599 189 KRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQ--------- 259 (364)
T ss_pred hhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccC---------
Confidence 1124689999999999988999999999999999999999999998887665554432100000
Q ss_pred hhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q psy17270 298 RRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT---PDEALRHEWLKSSS 368 (429)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~ell~h~~~~~~~ 368 (429)
.+. ....++.+.+||++||. ||.+|++ +.|++.||||+...
T Consensus 260 ----------------------~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 260 ----------------------FPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred ----------------------CCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 000 00236788999999997 9999998 99999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=347.50 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=205.1
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|++++.||+|+||.||+|.+..++.. |+|++........
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---------------------------------------- 40 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR---------------------------------------- 40 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------------------------------------
Confidence 78999999999999999999988865 9998754321100
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.....+.+|++++..++.. .||||+++++++....++|+||||+. ++|...+... .+++..+..++.||+.
T Consensus 41 --~~~~~l~~e~~~~~~~~~l---~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~ 112 (324)
T cd05589 41 --DEVESLMCEKRIFETANSE---RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVL 112 (324)
T ss_pred --hHHHHHHHHHHHHHhcccc---CCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHH
Confidence 0112344576666554432 45699999999999999999999995 5888777543 4999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
||+|||++|++||||||+||+++.++ .+||+|||++.... ......+|++.|+|||++.+..++.++|||||||+
T Consensus 113 al~~lH~~~ivHrdlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~i 190 (324)
T cd05589 113 GLQYLHENKIVYRDLKLDNLLLDTEG--FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVL 190 (324)
T ss_pred HHHHHHhCCeEecCCCHHHeEECCCC--cEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHH
Confidence 99999999999999999999999988 89999999986422 22334678999999999999889999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|+.||.+.+..+.+..+....... +...++.+
T Consensus 191 l~el~~G~~pf~~~~~~~~~~~i~~~~~~~------------------------------------------p~~~~~~~ 228 (324)
T cd05589 191 IYEMLVGESPFPGDDEEEVFDSIVNDEVRY------------------------------------------PRFLSREA 228 (324)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------------------------------------CCCCCHHH
Confidence 999999999999888776665544311100 11236788
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 338 VDFVTQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
.+||.+||+.||++|| ++.++++||||+...
T Consensus 229 ~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 9999999999999999 699999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.74 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=205.9
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||.|+||+||+|.+..++.. |+|++......
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---------------------------------------- 40 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF---------------------------------------- 40 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH----------------------------------------
Confidence 4799999999999999999999988865 99987432110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.......+.+|+++++.+.|+ ||++++++|....++|+||||+ +|+|.+++.... .+++..++.++.|+
T Consensus 41 --~~~~~~~~~~E~~il~~l~hp------~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql 110 (377)
T cd05629 41 --KKDQLAHVKAERDVLAESDSP------WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAEC 110 (377)
T ss_pred --HhHHHHHHHHHHHHHHhCCCC------CcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHH
Confidence 011123456699999998776 9999999999999999999999 569999987654 49999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----------------------------------
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---------------------------------- 224 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---------------------------------- 224 (429)
+.||+|||++||+||||||+|||++.++ .++|+|||++......
T Consensus 111 ~~aL~~LH~~givHrDlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (377)
T cd05629 111 VLAIEAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTM 188 (377)
T ss_pred HHHHHHHHhCCeeccCCCHHHEEECCCC--CEEEeecccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999888 8999999998521100
Q ss_pred ----------------ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCc
Q psy17270 225 ----------------VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP 288 (429)
Q Consensus 225 ----------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 288 (429)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 268 (377)
T cd05629 189 SSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY 268 (377)
T ss_pred cchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC
Confidence 0124689999999999998999999999999999999999999988877666555443100000
Q ss_pred HHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCCC
Q psy17270 289 DEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKR---LTPDEALRHEWLK 365 (429)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pta~ell~h~~~~ 365 (429)
.+. ....+..+.+||.+||. +|.+| +|+.|++.||||+
T Consensus 269 -------------------------------~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~ 309 (377)
T cd05629 269 -------------------------------FPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR 309 (377)
T ss_pred -------------------------------CCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence 000 01236788999999998 77775 5999999999998
Q ss_pred CCC
Q psy17270 366 SSS 368 (429)
Q Consensus 366 ~~~ 368 (429)
...
T Consensus 310 ~~~ 312 (377)
T cd05629 310 GVD 312 (377)
T ss_pred CCC
Confidence 653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=352.77 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=204.9
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++++.||+|+||+||+|.+..++.. |+|++.......
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---------------------------------------- 41 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN---------------------------------------- 41 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh----------------------------------------
Confidence 699999999999999999999988865 999875322110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+++++.+.|+ ||+++++++.+..++|+||||+ +|+|.+++.... .+++..++.++.||+
T Consensus 42 --~~~~~~~~~E~~il~~l~h~------~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~ 111 (381)
T cd05626 42 --RNQVAHVKAERDILAEADNE------WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELT 111 (381)
T ss_pred --hHHHHHHHHHHHHHHhcCCC------CeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHH
Confidence 11123456699999998877 9999999999999999999999 469999987754 499999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC------------------------------------
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ------------------------------------ 223 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~------------------------------------ 223 (429)
.||.|||++||+||||||+|||++.++ .++|+|||++.....
T Consensus 112 ~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (381)
T cd05626 112 LAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRL 189 (381)
T ss_pred HHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCcccccccccccccccccccccccCccccccccccccccccc
Confidence 999999999999999999999999888 899999998642100
Q ss_pred --------------cceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcH
Q psy17270 224 --------------RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPD 289 (429)
Q Consensus 224 --------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 289 (429)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~- 268 (381)
T cd05626 190 KTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH- 268 (381)
T ss_pred chhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC-
Confidence 01234799999999999988899999999999999999999999988776655444432110000
Q ss_pred HHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcc--cCCCCCCCHHHHhcCCCCCCC
Q psy17270 290 EVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFN--WDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~--~dP~~Rpta~ell~h~~~~~~ 367 (429)
.+ .....++++.+||.+|+. .++..|+++.|++.||||+..
T Consensus 269 ------------------------------~~-------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 269 ------------------------------IP-------PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred ------------------------------CC-------CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 00 001237889999999664 455569999999999999875
Q ss_pred C
Q psy17270 368 S 368 (429)
Q Consensus 368 ~ 368 (429)
.
T Consensus 312 ~ 312 (381)
T cd05626 312 D 312 (381)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=346.19 Aligned_cols=265 Identities=28% Similarity=0.472 Sum_probs=232.8
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
...-|++=|.+.+.||+|.|+.|-+|+|--||+. |+|++.+...+...
T Consensus 12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s------------------------------- 60 (864)
T KOG4717|consen 12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS------------------------------- 60 (864)
T ss_pred cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-------------------------------
Confidence 3455889999999999999999999999999965 88888655433221
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
...+..|++-|+.+.|+ ||+++|++......+|||+|+-+ |+|.++|.++. .++.+..++
T Consensus 61 ------------t~hlfqEVRCMKLVQHp------NiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~ 121 (864)
T KOG4717|consen 61 ------------TGHLFQEVRCMKLVQHP------NIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAK 121 (864)
T ss_pred ------------hhHHHHHHHHHHHhcCc------CeeeeeehhcccceEEEEEEecCCchHHHHHHhhh-ccccHHHHH
Confidence 23455699999988877 99999999999999999999995 69999999887 579999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecC-CCcceEEeeeccccc--ccCcceeeecCccccchhhhhCCCCCC-C
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQR-GSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGP-P 248 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~-~~~~vkl~Dfg~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~-~ 248 (429)
.|+.||+.|+.|||...+|||||||+|+.+... | -|||+|||++-. .+....+.||++.|.|||++.+..|+. +
T Consensus 122 kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlG--lVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPA 199 (864)
T KOG4717|consen 122 KYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLG--LVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPA 199 (864)
T ss_pred HHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecC--ceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcc
Confidence 999999999999999999999999999998764 5 899999999854 456678899999999999999999965 8
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+||||||||+|.|++|++||...++.+.+..|+++-...|...
T Consensus 200 VDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshv------------------------------------- 242 (864)
T KOG4717|consen 200 VDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHV------------------------------------- 242 (864)
T ss_pred hhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhh-------------------------------------
Confidence 9999999999999999999999999999999998766666554
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSS 373 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~~~~ 373 (429)
+.++.+||..||..||++|.+.+|+..|+|++........
T Consensus 243 -----S~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 243 -----SKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred -----hHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence 7888999999999999999999999999999988765543
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=329.34 Aligned_cols=267 Identities=26% Similarity=0.385 Sum_probs=220.4
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+.+.+.|...+.||+|..+.|-++.++.++.. |+|++.........+.
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~------------------------------- 61 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGET------------------------------- 61 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCcc-------------------------------
Confidence 45678899999999999999999999999965 8888744333222111
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
-+...+.-..|+.||+++. +||+|+.+.|+|+.+..+++|+|.| .|.|.|++...-. +++...+.+
T Consensus 62 ------~~~~~EaT~~Ev~ILRqv~-----GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt--lSEK~tR~i 128 (411)
T KOG0599|consen 62 ------PYEMREATRQEISILRQVM-----GHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT--LSEKETRRI 128 (411)
T ss_pred ------HHHHHHHHHHHHHHHHHhc-----CCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee--ecHHHHHHH
Confidence 2344555667999999986 5679999999999999999999999 4899999987654 999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhC------CCCC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILG------LPYG 246 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~------~~~~ 246 (429)
++|+++|++|||.++||||||||+|||++++- +++|+|||+++... ......||||.|.|||.+.- ..|+
T Consensus 129 MrqlfegVeylHa~~IVHRDLKpENILlddn~--~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs 206 (411)
T KOG0599|consen 129 MRQLFEGVEYLHARNIVHRDLKPENILLDDNM--NIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYS 206 (411)
T ss_pred HHHHHHHHHHHHHhhhhhcccChhheeecccc--ceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCcc
Confidence 99999999999999999999999999999877 99999999998643 55667899999999999863 3588
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
..+|+||.|||+|.|+.|++||-.....-.+..|...-..+...-| .+
T Consensus 207 ~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW---------------ad----------------- 254 (411)
T KOG0599|consen 207 KEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW---------------AD----------------- 254 (411)
T ss_pred chhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch---------------hh-----------------
Confidence 9999999999999999999999876666666666653333322222 11
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.+....|||++||++||.+|.|+.|+|.||||.+.
T Consensus 255 ------is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 255 ------ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred ------ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 26777899999999999999999999999999643
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=343.53 Aligned_cols=260 Identities=23% Similarity=0.320 Sum_probs=204.4
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|.+..++.. |+|++.+....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------------------------------------- 40 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML---------------------------------------- 40 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh----------------------------------------
Confidence 5799999999999999999999988865 99987532110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
+......+.+|+.++..+.|+ ||+.+++++..+.++|+||||+ +|+|.+++.... ..+++..++.++.||
T Consensus 41 --~~~~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi 111 (331)
T cd05597 41 --KRAETACFREERDVLVNGDRR------WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEM 111 (331)
T ss_pred --hhhhHHHHHHHHHHHHhCCCC------CCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHH
Confidence 011123455688888888776 9999999999999999999999 569999997643 359999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhC-----CCCCCCc
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILG-----LPYGPPI 249 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~-----~~~~~~~ 249 (429)
+.||+|||++||+||||||+|||++.++ .++|+|||++...... .....||+.|+|||++.+ ..++.++
T Consensus 112 ~~~l~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 189 (331)
T cd05597 112 VLAIDSVHQLGYVHRDIKPDNVLLDKNG--HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPEC 189 (331)
T ss_pred HHHHHHHHhCCeEECCCCHHHEEECCCC--CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcc
Confidence 9999999999999999999999999888 8999999998653321 122468999999999973 3478899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||+||++|+|++|+.||.+.+..+....+........ ....
T Consensus 190 DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------------~~~~ 232 (331)
T cd05597 190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ-------------------------------------FPPD 232 (331)
T ss_pred eeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc-------------------------------------CCCc
Confidence 999999999999999999988776665554432100000 0000
Q ss_pred hccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKK--RLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~--Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||++||..+++. |+++.++++||||....
T Consensus 233 ~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 233 VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 1124788999999999765444 78999999999998754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=354.59 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=206.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
.+|+++++||+|+||+||+|.+..++.. |+|++......
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~---------------------------------------- 40 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL---------------------------------------- 40 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh----------------------------------------
Confidence 4799999999999999999999988875 99987533211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.......+.+|+++++.+.|+ ||+++++.|....++|+|||||. |+|.+++.+.. .+++..++.++.||
T Consensus 41 --~~~~~~~~~~E~~il~~~~h~------~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi 110 (382)
T cd05625 41 --LRNQVAHVKAERDILAEADNE------WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAEL 110 (382)
T ss_pred --hHHHHHHHHHHHHHHHhCCCC------cCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHH
Confidence 011123456699999999877 99999999999999999999995 69999987654 48999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----------------------------------
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----------------------------------- 223 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~----------------------------------- 223 (429)
+.||+|||++||+||||||+|||++.++ .++|+|||++.....
T Consensus 111 ~~al~~lH~~~ivHrDlKp~NILl~~~g--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (382)
T cd05625 111 TCAVESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDR 188 (382)
T ss_pred HHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEeECCCCcccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999988 899999998642110
Q ss_pred ---------------cceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCc
Q psy17270 224 ---------------RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP 288 (429)
Q Consensus 224 ---------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 288 (429)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 268 (382)
T cd05625 189 LKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH 268 (382)
T ss_pred ccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC
Confidence 01124689999999999998999999999999999999999999998877655544432110000
Q ss_pred HHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCC
Q psy17270 289 DEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT---PDEALRHEWLK 365 (429)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~ell~h~~~~ 365 (429)
.+ .....++++.++|.+|+ .||.+|++ +.++++||||+
T Consensus 269 -------------------------------~p-------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~ 309 (382)
T cd05625 269 -------------------------------IP-------PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFK 309 (382)
T ss_pred -------------------------------CC-------CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcC
Confidence 00 00123688899999986 59999997 99999999998
Q ss_pred CCC
Q psy17270 366 SSS 368 (429)
Q Consensus 366 ~~~ 368 (429)
...
T Consensus 310 ~~~ 312 (382)
T cd05625 310 TID 312 (382)
T ss_pred CcC
Confidence 754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=346.14 Aligned_cols=254 Identities=28% Similarity=0.383 Sum_probs=208.4
Q ss_pred CeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++++.||+|+||.||+|.++.++. +|+|++.......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---------------------------------------- 40 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ---------------------------------------- 40 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh----------------------------------------
Confidence 48999999999999999999998886 4999885432110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+..|++++..+.|+ ++|+.+++++...+.+|+||||+. |+|.+++.... .+++..+..++.||+
T Consensus 41 --~~~~~~~~~e~~~l~~~~~~-----~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~ 111 (324)
T cd05587 41 --DDDVECTMVEKRVLALPGKP-----PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIA 111 (324)
T ss_pred --hhHHHHHHHHHHHHHhcCCC-----CceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHH
Confidence 01122455688888888765 378899999999999999999995 69999887654 389999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccc---cCcceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
.||+|||++||+||||||+|||++.++ .++|+|||++... .......+||+.|+|||++.+..++.++||||+||
T Consensus 112 ~al~~lH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv 189 (324)
T cd05587 112 IGLFFLHSKGIIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189 (324)
T ss_pred HHHHHHHHCCeEecCCCHHHeEEcCCC--CEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHH
Confidence 999999999999999999999999988 8999999998642 22233467899999999999988999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|+||+.||.+.+..+.+..+....... +...++.
T Consensus 190 il~elltG~~pf~~~~~~~~~~~i~~~~~~~------------------------------------------~~~~~~~ 227 (324)
T cd05587 190 LLYEMLAGQPPFDGEDEDELFQSIMEHNVSY------------------------------------------PKSLSKE 227 (324)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------------------------------------CCCCCHH
Confidence 9999999999999888766665554311100 1123678
Q ss_pred HHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTP-----DEALRHEWLKSSS 368 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta-----~ell~h~~~~~~~ 368 (429)
+.+++++||..||++|+++ .++++||||+...
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 228 AVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 8999999999999999986 8999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=349.98 Aligned_cols=258 Identities=28% Similarity=0.405 Sum_probs=211.4
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||.|+||+||+|.+..++.. |+|++......
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---------------------------------------- 40 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI---------------------------------------- 40 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh----------------------------------------
Confidence 5799999999999999999999988865 99987533211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.......+..|++++..+.|+ ||+++++++.+..++|+||||+ +++|.+++... ..+++..++.++.|+
T Consensus 41 --~~~~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi 110 (350)
T cd05573 41 --KRNQIAHVRAERDILADADSP------WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAEL 110 (350)
T ss_pred --hccHHHHHHHHHHHHHhcCCC------CccchhhheecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHH
Confidence 011123456699999998876 9999999999999999999999 46999999876 359999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--------------------------------ce
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--------------------------------VY 226 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--------------------------------~~ 226 (429)
+.||+|||++|++||||||+|||++.++ .++|+|||++...... ..
T Consensus 111 ~~aL~~LH~~giiH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (350)
T cd05573 111 VLALDSVHKLGFIHRDIKPDNILIDADG--HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN 188 (350)
T ss_pred HHHHHHHHHCCeeccCCCHHHeEECCCC--CEEeecCCCCccCcccCccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999988 8999999998654322 23
Q ss_pred eeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 227 TYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 227 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------ 250 (350)
T cd05573 189 STVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLR------------------ 250 (350)
T ss_pred ccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCccc------------------
Confidence 35689999999999999999999999999999999999999998887666555543111000
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCCC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT-PDEALRHEWLKSSSS 369 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-a~ell~h~~~~~~~~ 369 (429)
.+. ....++.+.+||.+||. ||.+|++ +.++++||||+....
T Consensus 251 -------------~p~-------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 251 -------------FPP-------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred -------------CCC-------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 000 00137889999999998 9999999 999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=352.58 Aligned_cols=283 Identities=25% Similarity=0.460 Sum_probs=222.3
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++++.||.|+||+||+|.+..++.. |+|++......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------------------- 39 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN----------------------------------------- 39 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-----------------------------------------
Confidence 378999999999999999999887764 88877432111
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-----eEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-----HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
......+.+|+++++.++|+ ||+++++++.... ++|+||||+.++|.+.+.... .+++..+..++
T Consensus 40 --~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--~l~~~~~~~~~ 109 (372)
T cd07853 40 --LVSCKRVFRELKMLCFFKHD------NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ--PLSSDHVKVFL 109 (372)
T ss_pred --hHHHHHHHHHHHHHHhCCCC------CcCCHhheecCCCccccceEEEEeeccccCHHHHHhcCC--CCCHHHHHHHH
Confidence 01123456799999999887 9999999998776 899999999999999887654 49999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCC-CCCCCcc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGL-PYGPPID 250 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~D 250 (429)
.||+.||.|||++|++||||||+|||++.++ .++|+|||++...... .....+|+.|+|||++.+. .++.++|
T Consensus 110 ~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 187 (372)
T cd07853 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVD 187 (372)
T ss_pred HHHHHHHHHHHhCCeeCCCCChHHEEECCCC--CEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHH
Confidence 9999999999999999999999999999988 8999999998754321 2234678899999999875 4788999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhh-hccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL-FFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||++|+|++|+.||.+.+..+++..+...++.++.+.+........ .+... ....+........
T Consensus 188 iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ 256 (372)
T cd07853 188 IWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG-----------PHKPPSLPVLYTL 256 (372)
T ss_pred HHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhC-----------CCCCCchHHhccc
Confidence 99999999999999999999999999999999999887665433221100 00000 0000111111122
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 257 ~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 257 SSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred CCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 234478899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=342.64 Aligned_cols=272 Identities=25% Similarity=0.342 Sum_probs=214.5
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
...-+.|++++.||+|.||.|-+|++..+++. |||++.+....... ++..
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~-----------------------------~~~~ 143 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQY-----------------------------GFPR 143 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhc-----------------------------cccc
Confidence 34467899999999999999999999999986 88887544322111 1111
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecC-cCHHHHHHhhCCCC-CCHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMN-LNLYELIKRNNYQG-FSLGLI 171 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~-g~L~~~i~~~~~~~-~~~~~~ 171 (429)
+ ...+..-.+...+|+.||+++.|+ |||+++++..+. +.+|||+|||. |.+.+. ..... +++.++
T Consensus 144 ~--~a~~~~~~ekv~~EIailKkl~H~------nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~A 212 (576)
T KOG0585|consen 144 Q--PAMKLMPIEKVRREIAILKKLHHP------NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQA 212 (576)
T ss_pred c--cccccCcHHHHHHHHHHHHhcCCc------CeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHH
Confidence 0 011222345778899999999987 999999999765 58999999995 544332 23334 899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--------CcceeeecCccccchhhhhCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--------QRVYTYIQSRFYRSPEVILGL 243 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--------~~~~~~~~t~~y~aPE~~~~~ 243 (429)
+.|+++++.||+|||.+||+||||||+|+|++.+| ++||+|||.+.... ......+|||.|+|||...+.
T Consensus 213 r~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g--~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~ 290 (576)
T KOG0585|consen 213 RKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG--TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGG 290 (576)
T ss_pred HHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC--cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCC
Confidence 99999999999999999999999999999999998 99999999986431 122336899999999999873
Q ss_pred C----CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCC
Q psy17270 244 P----YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319 (429)
Q Consensus 244 ~----~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (429)
. .+.+.||||+||++|.|+.|+.||-+....+...+|+..--.+|+.
T Consensus 291 ~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~----------------------------- 341 (576)
T KOG0585|consen 291 NSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPEN----------------------------- 341 (576)
T ss_pred CCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCc-----------------------------
Confidence 2 3679999999999999999999999998888888887522111111
Q ss_pred CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
+.+.+.+.|||.+||.+||++|.+..++..|||....-..
T Consensus 342 -----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 342 -----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred -----------ccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 1236788999999999999999999999999999865333
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=352.44 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=215.1
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
-...|+..+.||+|+||.||+|.+..++++ |+|++.......+-++++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediq------------------------------- 59 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQ------------------------------- 59 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHH-------------------------------
Confidence 356788899999999999999999999987 999997666555544443
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.|+.+|..++++ ||.++|+.|..+..++++||||+ |++.++++...- +.+..+..+++
T Consensus 60 -------------qei~~Ls~~~~~------~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~--~~E~~i~~ilr 118 (467)
T KOG0201|consen 60 -------------QEISVLSQCDSP------NITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNI--LDEFEIAVILR 118 (467)
T ss_pred -------------HHHHHHHhcCcc------hHHhhhhheeecccHHHHHHHhcCcchhhhhccCCC--CccceeeeehH
Confidence 399999999886 99999999999999999999995 699999887653 59999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
+++.||.|||.++.+|||||+.|||+..+| .+||+|||.+.... ....+++||+.|||||++.+..|+.++||||
T Consensus 119 e~l~~l~ylH~~~kiHrDIKaanil~s~~g--~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWS 196 (467)
T KOG0201|consen 119 EVLKGLDYLHSEKKIHRDIKAANILLSESG--DVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWS 196 (467)
T ss_pred HHHHHhhhhhhcceecccccccceeEeccC--cEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhh
Confidence 999999999999999999999999999998 89999999986533 3346799999999999999989999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
||++.+||++|.+|+....+...+..|- +..| +.+....
T Consensus 197 LGITaiEla~GePP~s~~hPmrvlflIp-----------------------k~~P------------------P~L~~~~ 235 (467)
T KOG0201|consen 197 LGITAIELAKGEPPHSKLHPMRVLFLIP-----------------------KSAP------------------PRLDGDF 235 (467)
T ss_pred hhHHHHHHhcCCCCCcccCcceEEEecc-----------------------CCCC------------------Ccccccc
Confidence 9999999999999998866532221111 1000 1111234
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
++.|++||..||..||+.||+|.++|+|+|++...
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 78999999999999999999999999999998743
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=351.89 Aligned_cols=257 Identities=24% Similarity=0.340 Sum_probs=206.2
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
..|++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~---------------------------------------- 40 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL---------------------------------------- 40 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH----------------------------------------
Confidence 3699999999999999999999988865 99987432110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.......+.+|+++++.+.|+ ||+++++.|..++.+|+|||||. |+|.+++.... .+++..++.++.||
T Consensus 41 --~~~~~~~~~~E~~il~~l~h~------~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi 110 (376)
T cd05598 41 --MRNQAAHVKAERDILAEADNE------WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAEL 110 (376)
T ss_pred --hhhhHHHHHHHHHHHHhCCCC------CcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHH
Confidence 011123456699999999877 99999999999999999999994 69999997754 48999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc------------------------------------
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH------------------------------------ 222 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~------------------------------------ 222 (429)
+.||+|||++||+||||||+|||++.++ .++|+|||++....
T Consensus 111 ~~al~~lH~~~ivHrDlkp~Nill~~~~--~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (376)
T cd05598 111 TCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPL 188 (376)
T ss_pred HHHHHHHHHCCeEeCCCCHHHEEECCCC--CEEEEeCCCCccccccccccccccccccccccccccccccccccccccch
Confidence 9999999999999999999999999888 89999999874210
Q ss_pred ----------CcceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHH
Q psy17270 223 ----------QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVI 292 (429)
Q Consensus 223 ----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 292 (429)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+........
T Consensus 189 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---- 264 (376)
T cd05598 189 ERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLH---- 264 (376)
T ss_pred hhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcccc----
Confidence 001124789999999999998999999999999999999999999998877655544332100000
Q ss_pred hhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCC
Q psy17270 293 NTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRL---TPDEALRHEWLKSSS 368 (429)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---ta~ell~h~~~~~~~ 368 (429)
.+ .....++.+.+||.+|+ .+|.+|+ |+.++++||||+...
T Consensus 265 ---------------------------~~-------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 265 ---------------------------IP-------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred ---------------------------CC-------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 00 00123678899999987 5999999 999999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=338.58 Aligned_cols=284 Identities=27% Similarity=0.505 Sum_probs=224.6
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-++|++.+.||.|+||.||+|.+..++.. |+|.+......
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--------------------------------------- 45 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--------------------------------------- 45 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---------------------------------------
Confidence 36799999999999999999999887764 88876422111
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+|+.+++.+.|+ ||+++++++.....+++||||++++|.+++.... ..+++..+..++.|+
T Consensus 46 -----~~~~~~~~E~~~l~~l~h~------nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi 113 (301)
T cd07873 46 -----GAPCTAIREVSLLKDLKHA------NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQL 113 (301)
T ss_pred -----CchhHHHHHHHHHHhcCCC------CcceEEEEEecCCeEEEEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHH
Confidence 1122445699999999877 9999999999999999999999999999887654 358999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccch
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSL 254 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSl 254 (429)
+.||+|||++|++|+||||+||+++.++ .++|+|||++...... .....+++.|+|||++.+. .++.++|||||
T Consensus 114 ~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 191 (301)
T cd07873 114 LRGLNYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGV 191 (301)
T ss_pred HHHHHHHHhCCeeCCCCCHHHEEECCCC--cEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHH
Confidence 9999999999999999999999999888 8999999998653321 2234568889999998764 47889999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||++|+|+||++||.+.+..+++..+...++.+....+........+ .... .+..............+
T Consensus 192 G~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~~~~~ 259 (301)
T cd07873 192 GCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF-KSYN-----------YPKYRADCLHNHAPRLD 259 (301)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc-cccc-----------cCccccccHHhhcCCCC
Confidence 99999999999999999998899888888888877665443211100 0000 00011111122233457
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 260 ~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 260 SDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 8899999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=342.62 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=199.9
Q ss_pred CeEEEeEeeccccceEEEEEec---CCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 22 RYEILEVIGKGSFGQVIRALDH---KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~---~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
.|++++.||+|+||+||+|++. .++. +|+|++.+.....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~------------------------------------- 43 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ------------------------------------- 43 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh-------------------------------------
Confidence 4899999999999999999874 3444 4888875332110
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.......+..|+++++.+++ |++|+++++++.....+++||||+. |+|.+++.... .+++..+..++.
T Consensus 44 ----~~~~~~~~~~e~~~l~~l~~-----~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~ 112 (332)
T cd05614 44 ----KAKTVEHTRTERNVLEHVRQ-----SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSG 112 (332)
T ss_pred ----hhhHHHHHHHHHHHHHhccC-----CCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHH
Confidence 01112345569999998863 3499999999999999999999995 69999987654 499999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc----CcceeeecCccccchhhhhCC-CCCCCccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH----QRVYTYIQSRFYRSPEVILGL-PYGPPIDM 251 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~----~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di 251 (429)
||+.||.|||++||+||||||+|||++.++ .++|+|||++.... ......+||+.|+|||++.+. .++.++||
T Consensus 113 qi~~~l~~lH~~~ivHrDlkp~Nili~~~~--~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 190 (332)
T cd05614 113 EIILALEHLHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDW 190 (332)
T ss_pred HHHHHHHHHHHCCcEecCCCHHHeEECCCC--CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCcccc
Confidence 999999999999999999999999999988 89999999986532 122345789999999999875 47889999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|+||..||...+.......+....... + ...+.
T Consensus 191 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---------------~-----------------------~~~~~ 232 (332)
T cd05614 191 WSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC---------------D-----------------------PPFPS 232 (332)
T ss_pred ccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC---------------C-----------------------CCCCC
Confidence 999999999999999997543211111111100000 0 00112
Q ss_pred cCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
..++.+.+||.+||+.||++|| ++.++++||||+...
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 2377889999999999999999 788999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.80 Aligned_cols=254 Identities=28% Similarity=0.390 Sum_probs=207.3
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++++.||+|+||+||+|.+..++.. |+|++.+......
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--------------------------------------- 41 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD--------------------------------------- 41 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---------------------------------------
Confidence 489999999999999999999988854 9998754321110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
........|.+++..+.| |++|+.+++++...+.+|+||||+. |+|.+.+.... .+++..+..++.|++
T Consensus 42 ---~~~~~~~~e~~~l~~~~~-----~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~ 111 (323)
T cd05616 42 ---DDVECTMVEKRVLALSGK-----PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIA 111 (323)
T ss_pred ---hHHHHHHHHHHHHHhccC-----CCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHH
Confidence 111234457777777654 3589999999999999999999995 69998887654 499999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
.||+|||++||+||||||+|||++.++ .++|+|||++.... ......+||+.|+|||++.+..++.++|||||||
T Consensus 112 ~aL~~LH~~~ivHrDlkp~Nill~~~~--~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 189 (323)
T cd05616 112 IGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189 (323)
T ss_pred HHHHHHHHCCEEecCCCHHHeEECCCC--cEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhH
Confidence 999999999999999999999999988 89999999986432 2233467899999999999989999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|+||+.||.+.+..+....+.......+ ...+++
T Consensus 190 il~elltg~~Pf~~~~~~~~~~~i~~~~~~~p------------------------------------------~~~s~~ 227 (323)
T cd05616 190 LLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP------------------------------------------KSMSKE 227 (323)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------------------------------------CcCCHH
Confidence 99999999999998887766665543111111 123678
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSSS 368 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~ 368 (429)
+.+++.+||+.||++|++ ..++++|+||+...
T Consensus 228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 228 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred HHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 899999999999999998 48999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=323.04 Aligned_cols=269 Identities=25% Similarity=0.359 Sum_probs=219.8
Q ss_pred cccccCCeEEEe-EeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 16 HDHICYRYEILE-VIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 16 ~~~~~~rY~i~~-~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.-.+.+.|.+-. +||-|-.|+|-.+.++.|++. |+|++...
T Consensus 56 ~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------------------------------------- 98 (400)
T KOG0604|consen 56 EYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------------------------------------- 98 (400)
T ss_pred cccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------------------------------------
Confidence 344788898876 899999999999999999976 98887321
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc----CeEEEEEeecC-cCHHHHHHhhCCCCCCH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR----NHLCISFELMN-LNLYELIKRNNYQGFSL 168 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~-g~L~~~i~~~~~~~~~~ 168 (429)
..+.+|+++....+ +|+|||.++|+|+.. ..+.+|||.|+ |.|...|..+..+.|++
T Consensus 99 -------------~KARrEVeLHw~~s-----~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTE 160 (400)
T KOG0604|consen 99 -------------PKARREVELHWMAS-----GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTE 160 (400)
T ss_pred -------------HHHHhHhhhhhhhc-----CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchH
Confidence 23445777765554 567999999998643 46889999995 69999999998889999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeeccccccc--CcceeeecCccccchhhhhCCCC
Q psy17270 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 169 ~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~ 245 (429)
.++..|++||..|+.|||+.+|.||||||+|+|+...+ +..+||+|||+|+... ....+.|-||+|+|||++...+|
T Consensus 161 rea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKy 240 (400)
T KOG0604|consen 161 REASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKY 240 (400)
T ss_pred HHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhc
Confidence 99999999999999999999999999999999998653 2468999999998755 45667899999999999999999
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCH----HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENE----VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
+..+|+||+||++|-|++|.+||.+... ...-.+|......+|++-|+
T Consensus 241 dkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs---------------------------- 292 (400)
T KOG0604|consen 241 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS---------------------------- 292 (400)
T ss_pred CCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh----------------------------
Confidence 9999999999999999999999977543 23334444444444444333
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSSHH 377 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~~~~~~~~ 377 (429)
+++++..|+|+++|+.+|.+|.|+.+++.|||+.+...-+......
T Consensus 293 ----------~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t 338 (400)
T KOG0604|consen 293 ----------CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLST 338 (400)
T ss_pred ----------HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchh
Confidence 3378889999999999999999999999999998866554444333
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.76 Aligned_cols=245 Identities=29% Similarity=0.425 Sum_probs=201.1
Q ss_pred eeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhh
Q psy17270 29 IGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHH 107 (429)
Q Consensus 29 lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (429)
||+|+||+||+|.+..++.. |+|++....... .....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~------------------------------------------~~~~~ 38 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS------------------------------------------RSEVT 38 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh------------------------------------------hhHHH
Confidence 79999999999999988865 999875322110 01122
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
.+.+|++++..+.|+ ||+++++++.....+|+||||+. |+|.+++.... .+++..+..++.|++.||.|||
T Consensus 39 ~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH 110 (312)
T cd05585 39 HTLAERTVLAQVNCP------FIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG--RFDLSRARFYTAELLCALENLH 110 (312)
T ss_pred HHHHHHHHHHhCCCC------cEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 455699999998876 99999999999999999999995 69999987654 4999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh
Q psy17270 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT 263 (429)
Q Consensus 187 ~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 263 (429)
++||+||||||+||+++.++ .++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 111 ~~~i~HrDlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~t 188 (312)
T cd05585 111 KFNVIYRDLKPENILLDYQG--HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188 (312)
T ss_pred hCCeEeCCCCHHHeEECCCC--cEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHh
Confidence 99999999999999999888 89999999986432 22334578999999999999899999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHH
Q psy17270 264 GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQ 343 (429)
Q Consensus 264 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 343 (429)
|..||.+.+..+....+..... ..+...++.+.+||.+
T Consensus 189 g~~pf~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~li~~ 226 (312)
T cd05585 189 GLPPFYDENVNEMYRKILQEPL------------------------------------------RFPDGFDRDAKDLLIG 226 (312)
T ss_pred CCCCcCCCCHHHHHHHHHcCCC------------------------------------------CCCCcCCHHHHHHHHH
Confidence 9999998776655544432100 0012236788999999
Q ss_pred hcccCCCCCC---CHHHHhcCCCCCCC
Q psy17270 344 CFNWDSKKRL---TPDEALRHEWLKSS 367 (429)
Q Consensus 344 ~L~~dP~~Rp---ta~ell~h~~~~~~ 367 (429)
||..||++|| ++.|++.||||+..
T Consensus 227 ~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 227 LLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 9999999997 58999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.08 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=207.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|++++.||+|+||+||+|.++.++.. |+|++......
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------------------------------------- 40 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML---------------------------------------- 40 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh----------------------------------------
Confidence 4699999999999999999999988865 99987532111
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.......+.+|+.++..+.|+ +|+++++.+....++|+|||||. |+|.+++.+.. .+++..++.++.|+
T Consensus 41 --~~~~~~~~~~e~~~l~~l~~~------~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi 110 (360)
T cd05627 41 --EKEQVAHIRAERDILVEADGA------WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAET 110 (360)
T ss_pred --hhhhHHHHHHHHHHHHhCCCC------CEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHH
Confidence 011123455689999888776 99999999999999999999995 69999987654 49999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----------------------------------
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---------------------------------- 224 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---------------------------------- 224 (429)
+.||+|||++||+||||||+|||++.++ .++|+|||++......
T Consensus 111 ~~~L~~lH~~givHrDLkp~NIli~~~~--~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (360)
T cd05627 111 VLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188 (360)
T ss_pred HHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEeeccCCcccccccccccccccccCCccccccccccccccccccccc
Confidence 9999999999999999999999999888 8999999987532110
Q ss_pred ----ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhh
Q psy17270 225 ----VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL 300 (429)
Q Consensus 225 ----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 300 (429)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 189 ~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~------------- 255 (360)
T cd05627 189 RRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETL------------- 255 (360)
T ss_pred ccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCce-------------
Confidence 123478999999999999999999999999999999999999999888776655554210000
Q ss_pred hccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q psy17270 301 FFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT---PDEALRHEWLKSSS 368 (429)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~ell~h~~~~~~~ 368 (429)
..+. ....++.+.+||.+|+. ||.+|++ +.|+++||||+...
T Consensus 256 ------------------~~p~-------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 256 ------------------VFPP-------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred ------------------ecCC-------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCC
Confidence 0000 01136788999999874 9999994 89999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=346.01 Aligned_cols=259 Identities=23% Similarity=0.319 Sum_probs=207.7
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++.+.||+|+||.||+|.+..++.. |+|++.+.....
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~------------------------------------ 83 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK------------------------------------ 83 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh------------------------------------
Confidence 3468899999999999999999999988865 888874321100
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
......+.+|+.+++.+.|+ ||+++++++..+..+|+|||||. |+|.+++.... +++..+..++
T Consensus 84 ------~~~~~~~~~e~~i~~~~~hp------~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~---~~~~~~~~~~ 148 (370)
T cd05621 84 ------RSDSAFFWEERDIMAFANSP------WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYT 148 (370)
T ss_pred ------hhhHHHHHHHHHHHHhCCCC------CEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHH
Confidence 01122355689999988877 99999999999999999999995 69999987543 8999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCCC----CCC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGLP----YGP 247 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~----~~~ 247 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ....+||+.|+|||++.+.. ++.
T Consensus 149 ~qil~aL~~LH~~~IvHrDLKp~NILl~~~~--~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~ 226 (370)
T cd05621 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226 (370)
T ss_pred HHHHHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCc
Confidence 9999999999999999999999999999888 8999999998764322 23467999999999997643 788
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
++|+||+||++|+|++|+.||.+.+.......+........ .+.
T Consensus 227 ~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------~p~----- 270 (370)
T cd05621 227 ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN-------------------------------FPE----- 270 (370)
T ss_pred ccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC-------------------------------CCC-----
Confidence 99999999999999999999998887766665543111000 000
Q ss_pred hhhccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKK--RLTPDEALRHEWLKSS 367 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~--Rpta~ell~h~~~~~~ 367 (429)
....+..+.+++.+||..++.. |+|+.|+++||||+..
T Consensus 271 --~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 271 --DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred --cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 0123678899999999865543 8899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=344.73 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=202.0
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||.||+|.+..++.. |+|++....... ...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~------------------------------------------~~~ 38 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA------------------------------------------KDE 38 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh------------------------------------------hhH
Confidence 4699999999999999988865 999875432110 111
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+.+|+++++.+.|+ ||+++++++.....+|+||||+. |+|.+.+.... .+++..+..++.||+.||+|
T Consensus 39 ~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~ 110 (328)
T cd05593 39 VAHTLTESRVLKNTRHP------FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDY 110 (328)
T ss_pred HHHHHHHHHHHHhCCCC------CCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHH
Confidence 23456699999998877 99999999999999999999995 68988887654 49999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 111 LH~~~ivHrDikp~NIll~~~~--~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el 188 (328)
T cd05593 111 LHSGKIVYRDLKLENLMLDKDG--HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188 (328)
T ss_pred HHhCCeEecccCHHHeEECCCC--cEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHH
Confidence 9999999999999999999888 89999999986532 222345789999999999988899999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
++|+.||.+.+..+....+...-. ..+...++++.+||
T Consensus 189 ltG~~Pf~~~~~~~~~~~~~~~~~------------------------------------------~~p~~~~~~~~~li 226 (328)
T cd05593 189 MCGRLPFYNQDHEKLFELILMEDI------------------------------------------KFPRTLSADAKSLL 226 (328)
T ss_pred hhCCCCCCCCCHHHHHHHhccCCc------------------------------------------cCCCCCCHHHHHHH
Confidence 999999988776554443321000 01122378889999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCCCCCC
Q psy17270 342 TQCFNWDSKKRL-----TPDEALRHEWLKSS 367 (429)
Q Consensus 342 ~~~L~~dP~~Rp-----ta~ell~h~~~~~~ 367 (429)
++||+.||++|+ ++.|+++|+||...
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 227 SGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.17 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=203.1
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||.||+|.+..++.. |+|++........ ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------------------------------------------~~ 38 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK------------------------------------------DE 38 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh------------------------------------------HH
Confidence 4699999999999999888865 9998854321100 11
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+.+|+++++.+.|+ ||+++++.|.....+|+||||++ |+|.+++.... .+++..++.++.||+.||+|
T Consensus 39 ~~~~~~E~~~l~~l~hp------~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~ 110 (323)
T cd05595 39 VAHTVTESRVLQNTRHP------FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEY 110 (323)
T ss_pred HHHHHHHHHHHHhCCCC------CCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 22445699999998877 99999999999999999999995 68988887654 49999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++||+||||||+|||++.++ .++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 111 LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 188 (323)
T cd05595 111 LHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188 (323)
T ss_pred HHHCCeEecCCCHHHEEEcCCC--CEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHH
Confidence 9999999999999999999988 899999999864221 22335789999999999988899999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
++|+.||.+.+.......+...... .+...++.+.+||
T Consensus 189 l~g~~Pf~~~~~~~~~~~~~~~~~~------------------------------------------~p~~~~~~~~~li 226 (323)
T cd05595 189 MCGRLPFYNQDHERLFELILMEEIR------------------------------------------FPRTLSPEAKSLL 226 (323)
T ss_pred HhCCCCCCCCCHHHHHHHHhcCCCC------------------------------------------CCCCCCHHHHHHH
Confidence 9999999887766555444321000 0122378899999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 342 TQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 342 ~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
.+||+.||++|+ ++.++++|+||.+..
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 227 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999998 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=342.11 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=202.0
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||+||+|.++.++.. |+|++.+...... ..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------------------------------------------~~ 38 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD------------------------------------------DD 38 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhc------------------------------------------cH
Confidence 4799999999999999988865 9998754321100 11
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+..|.+++..+. .||||+++++++.....+|+||||+. |+|.+++.... .+++..+..++.|++.||+|
T Consensus 39 ~~~~~~e~~~l~~~~-----~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~ 111 (320)
T cd05590 39 VECTMTEKRILSLAR-----NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMF 111 (320)
T ss_pred HHHHHHHHHHHHhcc-----CCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 123445777777653 24599999999999999999999995 69988887654 49999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++|++||||||+|||++.++ .++|+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 112 lH~~~ivH~dlkp~NIli~~~~--~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 189 (320)
T cd05590 112 LHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEM 189 (320)
T ss_pred HHHCCeEeCCCCHHHeEECCCC--cEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHH
Confidence 9999999999999999999988 89999999986432 223346789999999999988899999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
++|+.||.+.+..+.+..+....... +...++++.+||
T Consensus 190 ~~g~~Pf~~~~~~~~~~~i~~~~~~~------------------------------------------~~~~~~~~~~li 227 (320)
T cd05590 190 LCGHAPFEAENEDDLFEAILNDEVVY------------------------------------------PTWLSQDAVDIL 227 (320)
T ss_pred hhCCCCCCCCCHHHHHHHHhcCCCCC------------------------------------------CCCCCHHHHHHH
Confidence 99999999888776665554211000 112367889999
Q ss_pred HHhcccCCCCCCCH------HHHhcCCCCCCCC
Q psy17270 342 TQCFNWDSKKRLTP------DEALRHEWLKSSS 368 (429)
Q Consensus 342 ~~~L~~dP~~Rpta------~ell~h~~~~~~~ 368 (429)
++||+.||++|+++ .+++.||||+...
T Consensus 228 ~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 228 KAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred HHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 99999999999998 8999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=342.66 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=207.7
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||+|+||+||+|.+..++.. |+|++.......
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA--------------------------------------- 41 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh---------------------------------------
Confidence 4799999999999999999999988865 999885432110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+.+|+.+++.+.|+ ||+++++++.....+|+||||+ +++|.+++.... ..+++..+..++.|+
T Consensus 42 ---~~~~~~~~~e~~i~~~~~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi 111 (330)
T cd05601 42 ---QETVSFFEEERDILSISNSP------WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAEL 111 (330)
T ss_pred ---hhHHHHHHHHHHHHHhCCCC------CCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHH
Confidence 01122455688888888776 9999999999999999999999 569999998763 359999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhh------CCCCCCC
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVIL------GLPYGPP 248 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~------~~~~~~~ 248 (429)
+.||.|||++||+||||||+|||++.++ .++|+|||++...... .....||+.|+|||++. +..++.+
T Consensus 112 ~~aL~~lH~~~i~H~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 189 (330)
T cd05601 112 VLAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVE 189 (330)
T ss_pred HHHHHHHHHCCeEcccCchHheEECCCC--CEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCc
Confidence 9999999999999999999999999988 8999999998754322 12246899999999987 3457889
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++|..||...+....+..+....... ..+
T Consensus 190 ~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------~~~------- 231 (330)
T cd05601 190 CDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL-------------------------------KFP------- 231 (330)
T ss_pred ceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc-------------------------------CCC-------
Confidence 999999999999999999998877766655544310000 000
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....++.+.+||.+||+ ||++|||+.+++.||||+...
T Consensus 232 ~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 232 EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 001237889999999998 999999999999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=341.59 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=201.3
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||+||+|.+..++.. |+|++........ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~------------------------------------------~~ 38 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK------------------------------------------DE 38 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh------------------------------------------hH
Confidence 4699999999999999988865 9998754321100 11
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+.+|++++..+.|+ ||+++++++.....+|+||||+. |+|.+++.... .+++..+..++.||+.||+|
T Consensus 39 ~~~~~~e~~~l~~~~hp------~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~ 110 (325)
T cd05594 39 VAHTLTENRVLQNSRHP------FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDY 110 (325)
T ss_pred HHHHHHHHHHHHhCCCC------CCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHH
Confidence 12345588888888776 99999999999999999999995 68888877654 49999999999999999999
Q ss_pred HHH-CCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhHHHH
Q psy17270 185 LHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAE 260 (429)
Q Consensus 185 lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~ 260 (429)
||+ +||+||||||+|||++.++ .++|+|||++.... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 111 lH~~~~ivHrDikp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 188 (325)
T cd05594 111 LHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 188 (325)
T ss_pred HHhcCCEEecCCCCCeEEECCCC--CEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeee
Confidence 997 7999999999999999988 89999999986422 22234579999999999999899999999999999999
Q ss_pred HhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHH
Q psy17270 261 LYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340 (429)
Q Consensus 261 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 340 (429)
|++|..||.+.+.......+...... .+...++++.+|
T Consensus 189 l~tG~~Pf~~~~~~~~~~~i~~~~~~------------------------------------------~p~~~~~~~~~l 226 (325)
T cd05594 189 MMCGRLPFYNQDHEKLFELILMEEIR------------------------------------------FPRTLSPEAKSL 226 (325)
T ss_pred eccCCCCCCCCCHHHHHHHHhcCCCC------------------------------------------CCCCCCHHHHHH
Confidence 99999999887765544433210000 012237889999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 341 VTQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 341 i~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
|++||+.||++|+ ++.++++|+||....
T Consensus 227 i~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 227 LSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred HHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.36 Aligned_cols=290 Identities=23% Similarity=0.354 Sum_probs=211.4
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..++|++++.||+|+||.||+|.+..++.. |+|++.....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--------------------------------------- 43 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--------------------------------------- 43 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC---------------------------------------
Confidence 468999999999999999999999988875 8887643221
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
......+.+|+++++.++|+ ||+++++++.....+++||||+. ++|.+++.... .+++..+..++.
T Consensus 44 -----~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ 110 (331)
T cd06649 44 -----PAIRNQIIRELQVLHECNSP------YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSI 110 (331)
T ss_pred -----HHHHHHHHHHHHHHHHCCCC------CCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHH
Confidence 11233566799999999887 99999999999999999999995 59999998754 389999999999
Q ss_pred HHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccC-cceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 177 SLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 177 qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
|++.||.|||++ +|+||||||+||+++.++ .++|+|||++..... ......||+.|+|||++.+..++.++|||||
T Consensus 111 ~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 188 (331)
T cd06649 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (331)
T ss_pred HHHHHHHHHhhcCCEEcCCCChhhEEEcCCC--cEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHH
Confidence 999999999986 699999999999999988 899999999865432 2334578999999999998889999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc----------
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK---------- 324 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 324 (429)
||++|+|++|+.||...+..+....+.................... ....+. ........+...
T Consensus 189 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T cd06649 189 GLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR---PPGRPV---SGHGMDSRPAMAIFELLDYIVN 262 (331)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc---cccccc---cccccccccchhHHHHHHHHHh
Confidence 9999999999999987766443222111000000000000000000 000000 000000000000
Q ss_pred --hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 325 --DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 325 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.........++++.+||.+||++||++|||+.|+++||||+...
T Consensus 263 ~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 263 EPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred CCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 00000112467899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=334.48 Aligned_cols=258 Identities=25% Similarity=0.343 Sum_probs=207.8
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++.+.||.|+||+||+|.+..++.. |+|++.......
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------------------------------------- 40 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---------------------------------------- 40 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh----------------------------------------
Confidence 489999999999999999999888765 888874322110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+++++.++|+ ||+.+++.+....++|+||||+. ++|.+.+.......+++..+..++.|++
T Consensus 41 --~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~ 112 (285)
T cd05605 41 --RKGEAMALNEKQILEKVNSR------FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEIT 112 (285)
T ss_pred --hhhHHHHHHHHHHHHhcCCC------CEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHH
Confidence 01123456699999999877 99999999999999999999995 6898888765445699999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
.||.|||+.|++|+||||+||+++.++ .++|+|||++..... .....+|++.|+|||++.+..++.++||||+||+
T Consensus 113 ~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~ 190 (285)
T cd05605 113 CGLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCL 190 (285)
T ss_pred HHHHHHHHCCcEecCCCHHHEEECCCC--CEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHH
Confidence 999999999999999999999999887 899999999875432 2233578899999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|..||.+.+.......+........ .......+..+
T Consensus 191 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~ 232 (285)
T cd05605 191 IYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--------------------------------------EEYSEKFSEAA 232 (285)
T ss_pred HHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--------------------------------------cccCcccCHHH
Confidence 9999999999988665443333322111000 00112236788
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q psy17270 338 VDFVTQCFNWDSKKRL-----TPDEALRHEWLKSS 367 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~ 367 (429)
.+|+.+||+.||++|| ++.++++|+||...
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 9999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=339.56 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=198.3
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||+||+|.+..++.. |+|++......... .
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------------------------~ 38 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK------------------------------------------E 38 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhh------------------------------------------H
Confidence 4799999999999999988865 99987543211110 1
Q ss_pred hhhHHHHHH-HHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVR-ILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 106 ~~~~~~E~~-il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~ 183 (429)
...+..|.. +++.++|+ ||+++++++.....+|+||||+. |+|.+++.... .+++..+..++.||+.||.
T Consensus 39 ~~~~~~e~~~~~~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~ 110 (323)
T cd05575 39 QKHIMAERNVLLKNVKHP------FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALG 110 (323)
T ss_pred HHHHHHHHHHHHhhCCCC------CCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHH
Confidence 112333443 44556665 99999999999999999999995 69988887654 4999999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhHHHH
Q psy17270 184 LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAE 260 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~ 260 (429)
|||++||+||||||+|||++.++ .++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 111 ~lH~~givH~dikp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e 188 (323)
T cd05575 111 YLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYE 188 (323)
T ss_pred HHHHCCeEeCCCCHHHeEECCCC--cEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhh
Confidence 99999999999999999999988 89999999986432 22334578999999999999899999999999999999
Q ss_pred HhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHH
Q psy17270 261 LYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340 (429)
Q Consensus 261 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 340 (429)
|++|..||.+.+..+....+..... ......++.+.++
T Consensus 189 ll~g~~pf~~~~~~~~~~~i~~~~~------------------------------------------~~~~~~~~~~~~l 226 (323)
T cd05575 189 MLYGLPPFYSRDTAEMYDNILNKPL------------------------------------------RLKPNISVSARHL 226 (323)
T ss_pred hhcCCCCCCCCCHHHHHHHHHcCCC------------------------------------------CCCCCCCHHHHHH
Confidence 9999999998877665554432000 0011236788999
Q ss_pred HHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q psy17270 341 VTQCFNWDSKKRLTP----DEALRHEWLKSSS 368 (429)
Q Consensus 341 i~~~L~~dP~~Rpta----~ell~h~~~~~~~ 368 (429)
|++||+.||++||++ .++++||||....
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 227 LEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred HHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999998 6999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=347.30 Aligned_cols=258 Identities=25% Similarity=0.343 Sum_probs=208.4
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|++++.||.|+||.||+|.+..++.. |+|++......
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--------------------------------------- 82 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--------------------------------------- 82 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---------------------------------------
Confidence 56899999999999999999999988865 99987432110
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.......+.+|+++++.+.|+ ||+++++++.+...+|+||||+ +|+|.+++.... +++..+..++.|
T Consensus 83 ---~~~~~~~~~~e~~il~~~~h~------~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~---l~~~~~~~~~~q 150 (370)
T cd05596 83 ---KRSDSAFFWEERDIMAHANSE------WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWARFYTAE 150 (370)
T ss_pred ---hhhhHHHHHHHHHHHHhCCCC------CcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHH
Confidence 001112345689999998876 9999999999999999999999 469999887643 899999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC----cceeeecCccccchhhhhCC----CCCCCc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----RVYTYIQSRFYRSPEVILGL----PYGPPI 249 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~----~~~~~~ 249 (429)
|+.||+|||++||+||||||+|||++.++ .++|+|||++..... .....+||+.|+|||++.+. .++.++
T Consensus 151 i~~aL~~LH~~~ivHrDLkp~NILl~~~~--~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 228 (370)
T cd05596 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228 (370)
T ss_pred HHHHHHHHHHCCeeccCCCHHHEEEcCCC--CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCce
Confidence 99999999999999999999999999988 899999999875432 22345799999999998754 378899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|..||.+.+.......+........ .+ .
T Consensus 229 DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------~~-------~ 270 (370)
T cd05596 229 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT-------------------------------FP-------D 270 (370)
T ss_pred eeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC-------------------------------CC-------C
Confidence 999999999999999999998887666655543110000 00 0
Q ss_pred hccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKK--RLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~--Rpta~ell~h~~~~~~~ 368 (429)
....+..+.+||.+||+.+|++ |+|+.|+++||||+...
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 0123788999999999999987 99999999999998743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=338.70 Aligned_cols=249 Identities=29% Similarity=0.409 Sum_probs=199.5
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||.||+|.++.++.. |+|++......... .
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~------------------------------------------~ 38 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDD------------------------------------------D 38 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcc------------------------------------------h
Confidence 4799999999999999988865 99988543221000 0
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
......|.+++..+. .|++|+++++++...+++|+||||+. |+|.+++.... .+++..+..++.|++.||+|
T Consensus 39 ~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~ 111 (316)
T cd05620 39 VECTMVEKRVLALAW-----ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQF 111 (316)
T ss_pred HHHHHHHHHHHHhcc-----CCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 122344777766542 23599999999999999999999995 69998887654 48999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccc---cCcceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++||+||||||+||+++.++ .++|+|||++... .......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 112 lH~~~ivHrDlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el 189 (316)
T cd05620 112 LHSKGIIYRDLKLDNVMLDRDG--HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEM 189 (316)
T ss_pred HHHCCeEecCCCHHHeEECCCC--CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHH
Confidence 9999999999999999999988 8999999998642 2233456789999999999998999999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
++|..||.+.+..+....+....... +...+.++.+||
T Consensus 190 ~~g~~Pf~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~li 227 (316)
T cd05620 190 LIGQSPFHGDDEDELFESIRVDTPHY------------------------------------------PRWITKESKDIL 227 (316)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCC------------------------------------------CCCCCHHHHHHH
Confidence 99999999877765554443210000 112367889999
Q ss_pred HHhcccCCCCCCCH-HHHhcCCCCCCCC
Q psy17270 342 TQCFNWDSKKRLTP-DEALRHEWLKSSS 368 (429)
Q Consensus 342 ~~~L~~dP~~Rpta-~ell~h~~~~~~~ 368 (429)
++||+.||++|+++ .++++||||+...
T Consensus 228 ~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 228 EKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred HHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 99999999999997 5899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=339.26 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=201.6
Q ss_pred EeEeeccccceEEEEEecC---CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 26 LEVIGKGSFGQVIRALDHK---TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~---~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
++.||+|+||.||+|.+.. ++. +|+|++.........
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~--------------------------------------- 41 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQ--------------------------------------- 41 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhh---------------------------------------
Confidence 3689999999999999742 443 488887543211111
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.....+.+|+++++.+.|+ ||++++++|..+..+|+||||+. ++|.+++.... .+++..++.++.|++.
T Consensus 42 --~~~~~~~~E~~il~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~ 111 (323)
T cd05584 42 --KDTAHTKAERNILEAVKHP------FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISL 111 (323)
T ss_pred --hhHHHHHHHHHHHHhCCCC------chhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHH
Confidence 1122345699999999877 99999999999999999999995 59999887654 4899999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
||.|||++||+||||||+|||++.++ .++|+|||++.... .......||+.|+|||++.+..++.++|||||||+
T Consensus 112 ~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 189 (323)
T cd05584 112 ALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGAL 189 (323)
T ss_pred HHHHHHHCCeecCCCCHHHeEECCCC--CEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHH
Confidence 99999999999999999999999888 89999999986422 22234578999999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|+.||.+.+....+..+..... ..+...++.+
T Consensus 190 l~ell~G~~pf~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~ 227 (323)
T cd05584 190 MYDMLTGAPPFTAENRKKTIDKILKGKL------------------------------------------NLPPYLTPEA 227 (323)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------------------------------CCCCCCCHHH
Confidence 9999999999998877665555442110 0112236788
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q psy17270 338 VDFVTQCFNWDSKKRL-----TPDEALRHEWLKSS 367 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~ 367 (429)
.+||++||+.||++|| ++.++++||||+..
T Consensus 228 ~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 228 RDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=335.92 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=199.0
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||.||+|.+..++.. |+|++........ ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------------------------------------------~~ 38 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED------------------------------------------DD 38 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh------------------------------------------hh
Confidence 4799999999999999988864 9998854321110 01
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
......|.+++..+. .||||+++++++.....+|+||||++ |+|.+++.... .+++..+..++.|++.||+|
T Consensus 39 ~~~~~~e~~~l~~~~-----~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~ 111 (316)
T cd05592 39 VECTMVERRVLALAW-----EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQF 111 (316)
T ss_pred HHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 112333666665432 34599999999999999999999994 69998887654 49999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++||+||||||+||+++.++ .++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 112 LH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 189 (316)
T cd05592 112 LHKKGIIYRDLKLDNVLLDKDG--HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEM 189 (316)
T ss_pred HHHCCEEeCCCCHHHeEECCCC--CEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHH
Confidence 9999999999999999999888 89999999986432 223346789999999999998899999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
++|..||.+.+..+.+..+...... .+...+.++.+||
T Consensus 190 l~G~~Pf~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~~~ll 227 (316)
T cd05592 190 LIGQSPFHGEDEDELFDSILNDRPH------------------------------------------FPRWISKEAKDCL 227 (316)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCCCCHHHHHHH
Confidence 9999999988876655544321000 0112367889999
Q ss_pred HHhcccCCCCCCCH-HHHhcCCCCCCCC
Q psy17270 342 TQCFNWDSKKRLTP-DEALRHEWLKSSS 368 (429)
Q Consensus 342 ~~~L~~dP~~Rpta-~ell~h~~~~~~~ 368 (429)
.+||+.||++||++ .++++|+||+...
T Consensus 228 ~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 228 SKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred HHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 99999999999986 5899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=337.18 Aligned_cols=282 Identities=24% Similarity=0.430 Sum_probs=204.9
Q ss_pred EeEeeccccceEEEEEecC--CC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 26 LEVIGKGSFGQVIRALDHK--TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~--~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
.++||+|+||+||+|.++. ++ .+|+|.+....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--------------------------------------------- 40 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--------------------------------------------- 40 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---------------------------------------------
Confidence 4689999999999999764 33 34877763221
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--cCeEEEEEeecCcCHHHHHHhhC-------CCCCCHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--RNHLCISFELMNLNLYELIKRNN-------YQGFSLGLIRR 173 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~g~L~~~i~~~~-------~~~~~~~~~~~ 173 (429)
....+.+|++++++++|+ ||+++++++.. ...+|++|||++++|.+++.... ...+++..++.
T Consensus 41 --~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~ 112 (317)
T cd07868 41 --ISMSACREIALLRELKHP------NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 112 (317)
T ss_pred --CcHHHHHHHHHHHhcCCC------CCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHH
Confidence 122345699999999887 99999999864 45789999999999999886432 12489999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecC--CCcceEEeeecccccccCc------ceeeecCccccchhhhhCC-C
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQR--GSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILGL-P 244 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~--~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~-~ 244 (429)
++.||+.||.|||++||+||||||+|||++.+ ....+||+|||++...... .....+|+.|+|||++.+. .
T Consensus 113 i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 192 (317)
T cd07868 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH 192 (317)
T ss_pred HHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCC
Confidence 99999999999999999999999999999532 1227999999999754321 2235789999999999874 5
Q ss_pred CCCCccccchhhHHHHHhhCCCCCCCCCH---------HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCC
Q psy17270 245 YGPPIDMWSLGCILAELYTGCPLFPGENE---------VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (429)
++.++||||+||++|+|++|++||.+... .+++..+...++.+....+......... ...........
T Consensus 193 ~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~- 269 (317)
T cd07868 193 YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEH--STLMKDFRRNT- 269 (317)
T ss_pred cCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccch--hhhhhhhhccc-
Confidence 88999999999999999999999975442 4667788888888877766543221000 00000000000
Q ss_pred CCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.................+..+.+||++||++||++|||++|+|+||||
T Consensus 270 -~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 270 -YTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred -cCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000000011111112335678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=334.91 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=204.4
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|+++++||+|+||.||++.++.++.. |+|++.+....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---------------------------------------- 40 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML---------------------------------------- 40 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH----------------------------------------
Confidence 4799999999999999999999988865 88887432110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
+......+..|+.++..+.|+ +|+.+++.+....++|+||||+ +|+|.+++.+.. ..+++..++.++.|+
T Consensus 41 --~~~~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi 111 (332)
T cd05623 41 --KRAETACFREERDVLVNGDNQ------WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEM 111 (332)
T ss_pred --HhhHHHHHHHHHHHHhhCCCC------CEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHH
Confidence 001112345588888887766 9999999999999999999999 579999998743 358999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhC-----CCCCCCc
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILG-----LPYGPPI 249 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~-----~~~~~~~ 249 (429)
+.||.|||++||+||||||+|||++.++ .++|+|||++...... ....+||+.|+|||++.+ ..++.++
T Consensus 112 ~~al~~lH~~~iiHrDlkp~Nili~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 189 (332)
T cd05623 112 VIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPEC 189 (332)
T ss_pred HHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcC
Confidence 9999999999999999999999999888 8999999998643211 123578999999999873 3578899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||.+.+..+....+....... . ....
T Consensus 190 DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------~------~p~~ 232 (332)
T cd05623 190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF-------------------------------Q------FPAQ 232 (332)
T ss_pred CEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc-------------------------------c------CCCc
Confidence 99999999999999999999887766665554210000 0 0001
Q ss_pred hccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKK--RLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~--Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||++||..+++. |+++.|+++||||+...
T Consensus 233 ~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 233 VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 1234788999999999765544 78999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=339.52 Aligned_cols=248 Identities=28% Similarity=0.383 Sum_probs=202.0
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||.||+|++..++.. |+|++........ ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~------------------------------------------~~ 38 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD------------------------------------------DD 38 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh------------------------------------------hH
Confidence 4699999999999999988764 9998754321110 11
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+..|.+++..+. .||||+++++++.....+|+||||++ ++|.+.+.... .+++..+..++.||+.||.|
T Consensus 39 ~~~~~~e~~il~~~~-----~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~ 111 (321)
T cd05591 39 VDCTMTEKRILALAA-----KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMF 111 (321)
T ss_pred HHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 123445888887653 24599999999999999999999995 69988887654 49999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++||+||||||+||+++.++ .++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 112 LH~~~ivHrDikp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 189 (321)
T cd05591 112 LHRHGVIYRDLKLDNILLDAEG--HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEM 189 (321)
T ss_pred HHHCCeeccCCCHHHeEECCCC--CEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHH
Confidence 9999999999999999999988 89999999986422 223345789999999999998999999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
++|+.||.+.+..+.+..+....... +...++++.++|
T Consensus 190 ~tg~~Pf~~~~~~~~~~~i~~~~~~~------------------------------------------p~~~~~~~~~ll 227 (321)
T cd05591 190 MAGQPPFEADNEDDLFESILHDDVLY------------------------------------------PVWLSKEAVSIL 227 (321)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCC------------------------------------------CCCCCHHHHHHH
Confidence 99999999988777666554311000 011367889999
Q ss_pred HHhcccCCCCCC-------CHHHHhcCCCCCCC
Q psy17270 342 TQCFNWDSKKRL-------TPDEALRHEWLKSS 367 (429)
Q Consensus 342 ~~~L~~dP~~Rp-------ta~ell~h~~~~~~ 367 (429)
.+||+.||++|+ ++.++++||||...
T Consensus 228 ~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 228 KAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=331.25 Aligned_cols=278 Identities=29% Similarity=0.522 Sum_probs=219.6
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||++.+.||.|+||.||+|.+..++.. |+|.+.....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~------------------------------------------ 38 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------------------------------------------ 38 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc------------------------------------------
Confidence 799999999999999999999988865 8887632211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.......+.+|+++++.+.|+ ||+++++++.+...+++++||++++|.+++.... ..+++..+..++.||+.
T Consensus 39 -~~~~~~~~~~ei~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~ 110 (284)
T cd07839 39 -DEGVPSSALREICLLKELKHK------NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLK 110 (284)
T ss_pred -cccCccchhHHHHHHHhcCCC------CeeeHHHHhccCCceEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHH
Confidence 011223455699999999877 9999999999999999999999999999887643 45999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCC-CCCCccccchhh
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGC 256 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~ 256 (429)
||.|||++|++|+||||+||+++.++ .++|+|||++...... .....++..|+|||++.+.. ++.++|||||||
T Consensus 111 al~~LH~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 188 (284)
T cd07839 111 GLAFCHSHNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 188 (284)
T ss_pred HHHHHHHCCEecCCCCHHHEEEcCCC--cEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHH
Confidence 99999999999999999999999888 8999999998754322 12345688899999987754 688999999999
Q ss_pred HHHHHhhCCCC-CCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 257 ILAELYTGCPL-FPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 257 il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
++|+|+||..| |.+.+..+.+..+....+.+....+......... .............+..+..++
T Consensus 189 il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~ 255 (284)
T cd07839 189 IFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY-------------KPYPMYPATTSLVNVVPKLNS 255 (284)
T ss_pred HHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc-------------cccCCCCCcchhhhhcccCCH
Confidence 99999998776 5777777888888888887776665443221100 000011111112333445688
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
++.+||.+||+.||.+|||+.+++.||||
T Consensus 256 ~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 256 TGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 99999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=343.49 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=223.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|.+++++|+|+||.+++++++..+. +|+|.+......
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t---------------------------------------- 43 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT---------------------------------------- 43 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC----------------------------------------
Confidence 579999999999999999999988775 488887533211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCe-EEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH-LCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
......+.+|+.+++++.|+ ||+.+++.|..++. +||||+||+ |++.+.|.+....-|++..+..|+.|
T Consensus 44 ---~~~r~~A~~E~~lis~~~hP------~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q 114 (426)
T KOG0589|consen 44 ---EPERRSAIQEMDLLSKLLHP------NIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQ 114 (426)
T ss_pred ---chhhHHHHHHHHHHHhccCC------CeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHH
Confidence 11223566799999999887 99999999998887 999999995 69999999887667999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
++.|+.|||+++|+|||||+.|||++.++ .|+|+|||+|+..+.. ..+.+||+.|++||++.+.+|+.++|||||
T Consensus 115 ~~~av~ylH~~~iLHRDlK~~Nifltk~~--~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsL 192 (426)
T KOG0589|consen 115 ILLAVNYLHENRVLHRDLKCANIFLTKDK--KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSL 192 (426)
T ss_pred HHHHHHHHHhhhhhcccchhhhhhccccC--ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhh
Confidence 99999999999999999999999999998 8899999999876543 456899999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||++|||++-+++|.+.+....+.+|.+....|.+. ..+
T Consensus 193 GC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~-----------------------------------------~ys 231 (426)
T KOG0589|consen 193 GCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS-----------------------------------------MYS 231 (426)
T ss_pred cchHHHHHhcccccCccchHHHHHHHhhccCCCCCc-----------------------------------------ccc
Confidence 999999999999999999999999998866444332 237
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.++..+|+.||+.+|..||+|.++|.+|.++.
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 88999999999999999999999999988873
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=338.01 Aligned_cols=249 Identities=29% Similarity=0.400 Sum_probs=201.8
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||.|+||+||+|.+..++.. |+|++.+...... ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------------------------------------------~~ 38 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD------------------------------------------DD 38 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh------------------------------------------hH
Confidence 4799999999999999988754 9998854321111 01
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+..|.+++..+. .||||+++++++....++|+||||+. ++|.+.+.... .+++..+..++.|++.||+|
T Consensus 39 ~~~~~~e~~il~~~~-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~ 111 (318)
T cd05570 39 VECTMTEKRVLALAG-----KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQF 111 (318)
T ss_pred HHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 123445888888774 34599999999999999999999995 69988887654 49999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccc---cCcceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++|++||||||+||+++.++ .++|+|||++... .......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 112 LH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l 189 (318)
T cd05570 112 LHERGIIYRDLKLDNVLLDSEG--HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189 (318)
T ss_pred HHhCCeEccCCCHHHeEECCCC--cEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHH
Confidence 9999999999999999999988 8999999998642 2223345789999999999998999999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
++|+.||.+.+..+....+...... .+...++.+.+||
T Consensus 190 ~~G~~pf~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~~~li 227 (318)
T cd05570 190 LAGQSPFEGDDEDELFQSILEDEVR------------------------------------------YPRWLSKEAKSIL 227 (318)
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCcCCHHHHHHH
Confidence 9999999987766555444320000 0112367889999
Q ss_pred HHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q psy17270 342 TQCFNWDSKKRLTP-----DEALRHEWLKSSS 368 (429)
Q Consensus 342 ~~~L~~dP~~Rpta-----~ell~h~~~~~~~ 368 (429)
++||+.||++|||+ .++++||||+...
T Consensus 228 ~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 228 KSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred HHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999999999999 9999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.17 Aligned_cols=254 Identities=28% Similarity=0.390 Sum_probs=207.0
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++.+.||.|+||+||+|.++.++.. |+|++........
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------------------------------------- 41 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD--------------------------------------- 41 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---------------------------------------
Confidence 488999999999999999999988864 9998754321100
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
...+.+..|++++..+.|+ ++|+++++++.....+|+||||+. |+|.+++.... .+++..+..++.|++
T Consensus 42 ---~~~~~~~~e~~~l~~~~~~-----~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~ 111 (323)
T cd05615 42 ---DDVECTMVEKRVLALQDKP-----PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEIS 111 (323)
T ss_pred ---hHHHHHHHHHHHHHhccCC-----CchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHH
Confidence 1112345588888877654 488889999999999999999995 69999887654 499999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
.||+|||++|++||||||+|||++.++ .++|+|||++.... .......||+.|+|||++.+..++.++||||+||
T Consensus 112 ~al~~lH~~~ivHrDikp~Nill~~~~--~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv 189 (323)
T cd05615 112 VGLFFLHRRGIIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGV 189 (323)
T ss_pred HHHHHHHHCCeeccCCCHHHeEECCCC--CEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHH
Confidence 999999999999999999999999988 89999999986432 1223456899999999999888999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|..||.+.+.......+....... +...+..
T Consensus 190 il~elltG~~pf~~~~~~~~~~~i~~~~~~~------------------------------------------p~~~~~~ 227 (323)
T cd05615 190 LLYEMLAGQPPFDGEDEDELFQSIMEHNVSY------------------------------------------PKSLSKE 227 (323)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------------------------------------CccCCHH
Confidence 9999999999999887766665554311111 1123678
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSSS 368 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~ 368 (429)
+.+++.+||+.||.+|++ ..++++||||+...
T Consensus 228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 228 AVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 899999999999999997 57899999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=334.48 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=205.2
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|.+..++.. |+|++.+.....
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK--------------------------------------- 41 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHh---------------------------------------
Confidence 5799999999999999999999988865 988874321100
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+.+|..++..+.|+ +|+.+++++...+..|+||||+ +|+|.+++.... ..+++..+..++.|+
T Consensus 42 ---~~~~~~~~~e~~~l~~~~~~------~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi 111 (331)
T cd05624 42 ---RAETACFREERNVLVNGDCQ------WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEM 111 (331)
T ss_pred ---hHHHHHHHHHHHHHHhCCCC------CEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHH
Confidence 01122345588888887776 9999999999999999999999 579999998743 358999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhC-----CCCCCCc
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILG-----LPYGPPI 249 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~-----~~~~~~~ 249 (429)
+.||+|||++||+||||||+|||++.++ .++|+|||++...... ....+||+.|+|||++.+ ..++.++
T Consensus 112 ~~~L~~lH~~~iiHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 189 (331)
T cd05624 112 VLAIHSIHQLHYVHRDIKPDNVLLDMNG--HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189 (331)
T ss_pred HHHHHHHHHCCeeeccCchHHEEEcCCC--CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcc
Confidence 9999999999999999999999999888 8999999998654322 123568999999999976 4578899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||...+..+.+..+.......+ ....
T Consensus 190 DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------------~p~~ 232 (331)
T cd05624 190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ-------------------------------------FPSH 232 (331)
T ss_pred cEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc-------------------------------------CCCc
Confidence 999999999999999999988777665554432100000 0001
Q ss_pred hccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKK--RLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~--Rpta~ell~h~~~~~~~ 368 (429)
....++.+.++|.+||..++++ |++++++++|+||+...
T Consensus 233 ~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 233 ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 1223788999999999976654 56899999999998753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=327.82 Aligned_cols=279 Identities=28% Similarity=0.513 Sum_probs=219.1
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++++.||.|++|.||+|++..++.. |+|++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------------------------------------------ 38 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE------------------------------------------ 38 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc------------------------------------------
Confidence 489999999999999999999888765 8887643211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCC-CCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNY-QGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~-~~~~~~~~~~i~~qil 179 (429)
.......+.+|+.+++.+.|+ ||+++++++..+..+|+||||+.++|.+++..... ..+++..++.++.|++
T Consensus 39 -~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~ 111 (285)
T cd07861 39 -EEGVPSTAIREISLLKELQHP------NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL 111 (285)
T ss_pred -cCCchHHHHHHHHHHHhcCCC------CEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 111223456699999999876 99999999999999999999999999998876443 4589999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG 255 (429)
.||+|||++|++|+||+|+||+++.++ .++|+|||++...... .....+++.|+|||++.+. .++.++|+||||
T Consensus 112 ~~L~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 189 (285)
T cd07861 112 QGILFCHSRRVLHRDLKPQNLLIDNKG--VIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIG 189 (285)
T ss_pred HHHHHHHhCCeeecCCCHHHEEEcCCC--cEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHH
Confidence 999999999999999999999999988 8999999998654322 1223567889999998764 478899999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|+||++||.+.+..+.+..+...++.+.+..+........+.. .................++
T Consensus 190 ~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~ 256 (285)
T cd07861 190 TIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN-------------TFPKWKKGSLRSAVKNLDE 256 (285)
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh-------------hccccCcchhHHhcCCCCH
Confidence 999999999999999888888888877777766665543221111000 0000001111222334688
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
++.+||++||..||++|||+.++++||||
T Consensus 257 ~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 257 DGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 99999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.29 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=196.2
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||.||+|.+..++.. |+|++........ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~------------------------------------------~~ 38 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD------------------------------------------ED 38 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh------------------------------------------hH
Confidence 4799999999999999988865 9998854321111 11
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+.+|..++..+. .||||++++++|.....+|+|||||. |+|.+++.... .+++..+..++.|++.||.|
T Consensus 39 ~~~~~~e~~il~~~~-----~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~ 111 (329)
T cd05588 39 IDWVQTEKHVFETAS-----NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNF 111 (329)
T ss_pred HHHHHHHHHHHHhcc-----CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 123455888888874 23499999999999999999999995 69988887653 49999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccc---cCcceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++|++||||||+||+++.++ .++|+|||++... .......+||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 112 lH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el 189 (329)
T cd05588 112 LHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189 (329)
T ss_pred HHHCCeEecCCCHHHeEECCCC--CEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHH
Confidence 9999999999999999999888 8999999998642 2333456799999999999998999999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHH-hhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVI-NTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 340 (429)
++|+.||......+.. .....+.. ...... ....+...+..+.++
T Consensus 190 ~~g~~Pf~~~~~~~~~-------~~~~~~~~~~~~~~~---------------------------~~~~p~~~~~~~~~l 235 (329)
T cd05588 190 MAGRSPFDIVGMSDNP-------DQNTEDYLFQVILEK---------------------------QIRIPRSLSVKASSV 235 (329)
T ss_pred HHCCCCcccccccccc-------cccchHHHHHHHHcC---------------------------CCCCCCCCCHHHHHH
Confidence 9999999642211000 00000000 000000 000112346788999
Q ss_pred HHHhcccCCCCCCC------HHHHhcCCCCCCC
Q psy17270 341 VTQCFNWDSKKRLT------PDEALRHEWLKSS 367 (429)
Q Consensus 341 i~~~L~~dP~~Rpt------a~ell~h~~~~~~ 367 (429)
|++||+.||.+|+| +.++++||||...
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999997 7899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=337.83 Aligned_cols=246 Identities=22% Similarity=0.318 Sum_probs=211.2
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
.+-+++++.||+|.||.||+|.+..+..+|+|.+..-
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~------------------------------------------- 241 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG------------------------------------------- 241 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-------------------------------------------
Confidence 3446678899999999999999998888888876321
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
....+.|.+|+++|++|+|+ +|+++++++..+..+||||||| .|+|.++++......+...+...++.||
T Consensus 242 ---~m~~~~f~~Ea~iMk~L~H~------~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qI 312 (468)
T KOG0197|consen 242 ---SMSPEAFLREAQIMKKLRHE------KLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQI 312 (468)
T ss_pred ---ccChhHHHHHHHHHHhCccc------CeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHH
Confidence 12235677899999999998 9999999999888999999999 5899999998665679999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee-eec---CccccchhhhhCCCCCCCccccch
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT-YIQ---SRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~-~~~---t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
++|++||+++++|||||...||||+.+. .+||+|||+++...+..++ ..+ +..|.|||.+....++.++|||||
T Consensus 313 aeGM~YLes~~~IHRDLAARNiLV~~~~--~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSF 390 (468)
T KOG0197|consen 313 AEGMAYLESKNYIHRDLAARNILVDEDL--VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSF 390 (468)
T ss_pred HHHHHHHHhCCccchhhhhhheeeccCc--eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeeh
Confidence 9999999999999999999999999988 9999999999965554443 222 234999999999999999999999
Q ss_pred hhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 255 GCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 255 G~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
||+||||+| |+.||++.+..+.+..+.+....+.+ ..+
T Consensus 391 GVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P-----------------------------------------~~C 429 (468)
T KOG0197|consen 391 GVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP-----------------------------------------EGC 429 (468)
T ss_pred hhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC-----------------------------------------CCC
Confidence 999999999 99999999999999888764443332 345
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
++++.+++..||+.+|++|||.+.+..
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 889999999999999999999886643
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=336.87 Aligned_cols=247 Identities=25% Similarity=0.390 Sum_probs=201.2
Q ss_pred EeEeeccccceEEEEEec---CCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 26 LEVIGKGSFGQVIRALDH---KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~---~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
++.||+|+||+||++.+. .++. +|+|++.......
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----------------------------------------- 39 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV----------------------------------------- 39 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-----------------------------------------
Confidence 367999999999999874 3454 4888875432110
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.....+.+|++++++++|+ ||+++++++.....+|+||||+. ++|.+++.... .+++..+..++.||+.
T Consensus 40 --~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~ 109 (318)
T cd05582 40 --RDRVRTKMERDILAEVNHP------FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELAL 109 (318)
T ss_pred --hhHHHHHHHHHHHHhCCCC------CcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHH
Confidence 0112345699999999877 99999999999999999999995 69999887654 4999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
||+|||++||+||||||+||+++.++ .++|+|||++...... .....||+.|+|||++.+..++.++|||||||+
T Consensus 110 ~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~i 187 (318)
T cd05582 110 ALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVL 187 (318)
T ss_pred HHHHHHHCCEecCCCCHHHeEECCCC--cEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceE
Confidence 99999999999999999999999888 8999999998654322 334578999999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|+.||.+.+..+....+...... .+...++.+
T Consensus 188 l~el~tg~~p~~~~~~~~~~~~i~~~~~~------------------------------------------~p~~~~~~~ 225 (318)
T cd05582 188 MFEMLTGSLPFQGKDRKETMTMILKAKLG------------------------------------------MPQFLSPEA 225 (318)
T ss_pred eeeeccCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------CCCCCCHHH
Confidence 99999999999988776665544321110 011236788
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q psy17270 338 VDFVTQCFNWDSKKRLT-----PDEALRHEWLKSS 367 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~ 367 (429)
.+||++||+.||++||+ +.+++.|+||+..
T Consensus 226 ~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 226 QSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999999999999999 6779999999875
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=346.11 Aligned_cols=256 Identities=27% Similarity=0.489 Sum_probs=212.2
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.+-++|+..||.|+||+||+|.++.++.. |.|++....
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks----------------------------------------- 69 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS----------------------------------------- 69 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-----------------------------------------
Confidence 35578999999999999999999988876 666652211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
..-.+.++.|++||..+.|+ +|+.+++.|+.++.+++..|||+| -+..++-... ..+++.++..+++|
T Consensus 70 ----eEELEDylVEIeILa~CdHP------~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q 138 (1187)
T KOG0579|consen 70 ----EEELEDYLVEIEILAECDHP------VIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQ 138 (1187)
T ss_pred ----hhHHhhhhhhhhhhhcCCCh------HHHHHHHHHhccCceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHH
Confidence 11123566799999999887 999999999999999999999965 6666666655 57999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhh-----CCCCCCCc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVIL-----GLPYGPPI 249 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~-----~~~~~~~~ 249 (429)
++.||.|||+++|||||||..|||++.+| .|+|+|||.+.... ....+++|||+|||||++. ..+|++++
T Consensus 139 ~ldALn~LHs~~iIHRDLKAGNiL~TldG--dirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDyka 216 (1187)
T KOG0579|consen 139 VLDALNWLHSQNIIHRDLKAGNILLTLDG--DIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKA 216 (1187)
T ss_pred HHHHHHHHhhcchhhhhccccceEEEecC--cEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhh
Confidence 99999999999999999999999999999 99999999985432 3445689999999999875 45799999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||+++.+|..+.+|....++...+.+|.. ..||. ++ .
T Consensus 217 DiWSlGITLIEMAqiEPPHhelnpMRVllKiaK--SePPT-Ll------------------------------------q 257 (1187)
T KOG0579|consen 217 DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--SEPPT-LL------------------------------------Q 257 (1187)
T ss_pred hHHhhhhHHHHHhccCCCccccchHHHHHHHhh--cCCCc-cc------------------------------------C
Confidence 999999999999999999999999888777664 11111 10 0
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+...+..|.||+.+||..||..||+++++|+|||+++..
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 112267889999999999999999999999999999643
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.06 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=207.3
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+......+.+.||+|+||+||+|.+..+..+|+|++.........
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~----------------------------------- 82 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES----------------------------------- 82 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-----------------------------------
Confidence 334556667779999999999999988777888887543222111
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-eEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
...+.+|+.+|..++|+ ||+.+++++.... .+++||||+ +|+|.+++.......++...+..++
T Consensus 83 --------~~~f~~E~~il~~l~Hp------NIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~a 148 (362)
T KOG0192|consen 83 --------RKAFRREASLLSRLRHP------NIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIA 148 (362)
T ss_pred --------HHHHHHHHHHHHhCCCC------CeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHH
Confidence 34677799999999988 9999999998887 799999999 5799999988544569999999999
Q ss_pred HHHHHHHHHHHHCC-ceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhh--CCCCCCCc
Q psy17270 176 FSLVQCLRLLHREN-IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVIL--GLPYGPPI 249 (429)
Q Consensus 176 ~qil~~l~~lH~~~-ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~--~~~~~~~~ 249 (429)
.||+.||.|||+++ ||||||||+|||++.+. .++||+|||+++.... ......||+.|||||++. ...|+.++
T Consensus 149 ldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~ 227 (362)
T KOG0192|consen 149 LDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKS 227 (362)
T ss_pred HHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccc
Confidence 99999999999999 99999999999999874 3899999999976553 333368999999999999 55899999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||+++|||+||+.||.+....+....+...... ...
T Consensus 228 DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R----------------------------------------p~~ 267 (362)
T KOG0192|consen 228 DVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR----------------------------------------PPI 267 (362)
T ss_pred hhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC----------------------------------------CCC
Confidence 9999999999999999999998885555444421110 011
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+..+++.+..++.+||..||++||+..+++.
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 1224788999999999999999999998865
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=334.02 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=199.7
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||+||+|.+..++.. |+|++......... .
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~------------------------------------------~ 38 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDD------------------------------------------D 38 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcc------------------------------------------h
Confidence 4799999999999999988864 99988543211000 1
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
......|..++.... .||||+++++++.+...+++||||+. |+|.+++.... .+++..+..++.|++.||.|
T Consensus 39 ~~~~~~e~~~l~~~~-----~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~ 111 (316)
T cd05619 39 VECTMVEKRVLSLAW-----EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQF 111 (316)
T ss_pred HHHHHHHHHHHHhcc-----CCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 122344677776541 34599999999999999999999995 69999987653 48999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccc---cCcceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++|++||||||+|||++.++ .++|+|||++... ........||+.|+|||++.+..++.++||||+||++|+|
T Consensus 112 LH~~~ivHrdikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 189 (316)
T cd05619 112 LHSKGIVYRDLKLDNILLDTDG--HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEM 189 (316)
T ss_pred HHhCCeEeCCCCHHHEEECCCC--CEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHH
Confidence 9999999999999999999988 8999999998642 2233456789999999999998899999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
++|..||.+.+..+....+....... +...+..+.+||
T Consensus 190 ~~G~~pf~~~~~~~~~~~i~~~~~~~------------------------------------------~~~~~~~~~~li 227 (316)
T cd05619 190 LIGQSPFHGHDEEELFQSIRMDNPCY------------------------------------------PRWLTREAKDIL 227 (316)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCC------------------------------------------CccCCHHHHHHH
Confidence 99999999887765554443210000 011367889999
Q ss_pred HHhcccCCCCCCCHH-HHhcCCCCCCCC
Q psy17270 342 TQCFNWDSKKRLTPD-EALRHEWLKSSS 368 (429)
Q Consensus 342 ~~~L~~dP~~Rpta~-ell~h~~~~~~~ 368 (429)
.+||+.||++|+++. ++++||||+...
T Consensus 228 ~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 228 VKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred HHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 999999999999996 899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.31 Aligned_cols=288 Identities=22% Similarity=0.359 Sum_probs=210.1
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+..++|++.++||.|+||.||+|.+..++.. |+|.+......
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~------------------------------------- 44 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP------------------------------------- 44 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-------------------------------------
Confidence 4568999999999999999999999988876 77766432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+++++.+.|+ ||++++++|....++++||||+. ++|.+++.... .+++..+..++
T Consensus 45 -------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~ 109 (333)
T cd06650 45 -------AIRNQIIRELQVLHECNSP------YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVS 109 (333)
T ss_pred -------HHHHHHHHHHHHHHHCCCC------cccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHH
Confidence 1223456699999999877 99999999999999999999995 69999998754 48999999999
Q ss_pred HHHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccC-cceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 176 FSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 176 ~qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
.|++.||.|||++ +++|+||||+|||++.++ .++|+|||++..... ......++..|+|||++.+..++.++|+||
T Consensus 110 ~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 187 (333)
T cd06650 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187 (333)
T ss_pred HHHHHHHHHHHhcCCEEecCCChhhEEEcCCC--CEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHH
Confidence 9999999999975 799999999999999888 899999999865432 223456899999999999888999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHH-hCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc--------
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEI-LGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK-------- 324 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 324 (429)
|||++|+|++|+.||...+..+....+... .+.+........ ... ...... .... ...+...
T Consensus 188 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~---~~~~--~~~~~~~~~~~~~~~ 258 (333)
T cd06650 188 MGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR-PRP---PGRPLS---SYGP--DSRPPMAIFELLDYI 258 (333)
T ss_pred HHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc-cCC---ccchhh---hhcc--cccccccHHHHHHHH
Confidence 999999999999999876654332211100 011110000000 000 000000 0000 0000000
Q ss_pred ---hhhhh-hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 325 ---DMASV-LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 325 ---~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
..... ....+.++.+||.+||+.||++|||+.|++.|+||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 259 VNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000 012467899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=333.65 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=196.6
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||.|+||+||+|++..++.. |+|++.+....... .
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~------------------------------------------~ 38 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK------------------------------------------E 38 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhh------------------------------------------H
Confidence 4799999999999999988865 99987543221111 1
Q ss_pred hhhHHHHHH-HHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVR-ILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 106 ~~~~~~E~~-il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~ 183 (429)
...+..|.. +++.++|+ ||+++++++.....+|+||||++ ++|...+.... .+++..+..++.||+.||.
T Consensus 39 ~~~~~~e~~~~l~~~~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~ 110 (321)
T cd05603 39 QNHIMAERNVLLKNLKHP------FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIG 110 (321)
T ss_pred HHHHHHHHHHHHHhCCCC------CccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHH
Confidence 112233443 56666665 99999999999999999999995 58888876543 4899999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhHHHH
Q psy17270 184 LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAE 260 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~ 260 (429)
|||++||+||||||+||+++.++ .+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 111 ~lH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 188 (321)
T cd05603 111 YLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYE 188 (321)
T ss_pred HHHHCCeEeccCCHHHeEECCCC--CEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhh
Confidence 99999999999999999999988 89999999986432 22234578999999999998889999999999999999
Q ss_pred HhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHH
Q psy17270 261 LYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340 (429)
Q Consensus 261 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 340 (429)
|++|..||.+.+.......+... + ...+...+..+.++
T Consensus 189 l~~g~~pf~~~~~~~~~~~i~~~---~---------------------------------------~~~~~~~~~~~~~l 226 (321)
T cd05603 189 MLYGLPPFYSRDVSQMYDNILHK---P---------------------------------------LQLPGGKTVAACDL 226 (321)
T ss_pred hhcCCCCCCCCCHHHHHHHHhcC---C---------------------------------------CCCCCCCCHHHHHH
Confidence 99999999987765554443320 0 00112236788999
Q ss_pred HHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q psy17270 341 VTQCFNWDSKKRLTP----DEALRHEWLKSSS 368 (429)
Q Consensus 341 i~~~L~~dP~~Rpta----~ell~h~~~~~~~ 368 (429)
|.+||+.||.+|+++ .++++|+||....
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 227 LVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred HHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 999999999999976 4999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=328.85 Aligned_cols=258 Identities=25% Similarity=0.344 Sum_probs=204.9
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++.+.||.|+||+||+|.+..++.. |+|.+.......
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~---------------------------------------- 40 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---------------------------------------- 40 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc----------------------------------------
Confidence 488999999999999999999998865 888774322110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+.+++.++|+ +|+.+++.+.....+|+||||+. ++|.+++.......+++..+..++.|++
T Consensus 41 --~~~~~~~~~E~~il~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~ 112 (285)
T cd05630 41 --RKGESMALNEKQILEKVNSR------FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEIC 112 (285)
T ss_pred --hHHHHHHHHHHHHHHhCCCC------CeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHH
Confidence 11123455699999999877 99999999999999999999995 6899988765555699999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
.||.|||+.|++|+||||+||+++.++ .++|+|||++...... .....|+..|+|||++.+..++.++|+||+||+
T Consensus 113 ~~l~~lH~~~iiH~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~ 190 (285)
T cd05630 113 CGLEDLHQERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCL 190 (285)
T ss_pred HHHHHHHhCCEEeCCCCHHHEEECCCC--CEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHH
Confidence 999999999999999999999999887 8999999998654322 223468999999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|+.||.................... .......++++
T Consensus 191 l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~ 232 (285)
T cd05630 191 LYEMIAGQSPFQQRKKKIKREEVERLVKEVQ--------------------------------------EEYSEKFSPDA 232 (285)
T ss_pred HHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------------------------------hhcCccCCHHH
Confidence 9999999999987543211111111000000 00112236788
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q psy17270 338 VDFVTQCFNWDSKKRLT-----PDEALRHEWLKSS 367 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~ 367 (429)
.+|+++||+.||++||| +.|+++||||++.
T Consensus 233 ~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 233 RSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999999999999 9999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=334.81 Aligned_cols=294 Identities=28% Similarity=0.494 Sum_probs=223.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++++.||+|+||.||+|.+..++.. |+|.+.......
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------ 56 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV------------------------------------ 56 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh------------------------------------
Confidence 4678999999999999999999999988865 888774332111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
.....+.+|+.+++.++|+ ||++++++|... .++|+||||+.++|.+.+... +++..
T Consensus 57 -------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~----l~~~~ 119 (353)
T cd07850 57 -------THAKRAYRELVLMKLVNHK------NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHER 119 (353)
T ss_pred -------hHHHHHHHHHHHHHhcCCC------CCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc----CCHHH
Confidence 1112345699999999887 999999988643 367999999999999887643 88999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc--eeeecCccccchhhhhCCCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV--YTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++....... ....++..|+|||++.+..++.+
T Consensus 120 ~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (353)
T cd07850 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 197 (353)
T ss_pred HHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCc
Confidence 999999999999999999999999999999999988 89999999997654322 23467889999999999899999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhcc-CCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFD-SKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|||||||++|+|++|+.||.+.+..+.+..+...++.++.++..........+. ...........+............
T Consensus 198 ~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
T cd07850 198 VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSE 277 (353)
T ss_pred hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccc
Confidence 9999999999999999999999998899999999999998887665432211111 000000000000000000000000
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
......++.+.+||.+||+.||++|||+.|+|.||||+.
T Consensus 278 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 278 SHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred cccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 001233567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=334.29 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=197.5
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||+||+|.+..++.. |+|++..........
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~------------------------------------------ 38 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE------------------------------------------ 38 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhH------------------------------------------
Confidence 4799999999999999988864 999885432111110
Q ss_pred hhhHHHHH-HHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEV-RILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 106 ~~~~~~E~-~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~ 183 (429)
...+..|. .+++.+.|+ ||+++++++...+.+|+||||+. ++|.+++.... .+++..++.++.||+.||.
T Consensus 39 ~~~~~~e~~~~l~~~~h~------~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~ 110 (325)
T cd05602 39 EKHIMSERNVLLKNVKHP------FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALG 110 (325)
T ss_pred HHHHHHHHHHHHHhCCCC------CCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHH
Confidence 11222233 345566665 99999999999999999999995 58999887654 4899999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhHHHH
Q psy17270 184 LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAE 260 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~ 260 (429)
|||++||+||||||+|||++.++ .++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 111 ~lH~~giiHrDlkp~Nili~~~~--~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 188 (325)
T cd05602 111 YLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 188 (325)
T ss_pred HHHHCCeEecCCCHHHeEECCCC--CEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHH
Confidence 99999999999999999999888 89999999986422 22334679999999999999899999999999999999
Q ss_pred HhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHH
Q psy17270 261 LYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340 (429)
Q Consensus 261 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 340 (429)
|++|..||.+.+..+.+..+..... ...+..++.+.++
T Consensus 189 l~~g~~pf~~~~~~~~~~~i~~~~~------------------------------------------~~~~~~~~~~~~l 226 (325)
T cd05602 189 MLYGLPPFYSRNTAEMYDNILNKPL------------------------------------------QLKPNITNSARHL 226 (325)
T ss_pred HhcCCCCCCCCCHHHHHHHHHhCCc------------------------------------------CCCCCCCHHHHHH
Confidence 9999999998877666555432100 0012236788999
Q ss_pred HHHhcccCCCCCCCHH----HHhcCCCCCCC
Q psy17270 341 VTQCFNWDSKKRLTPD----EALRHEWLKSS 367 (429)
Q Consensus 341 i~~~L~~dP~~Rpta~----ell~h~~~~~~ 367 (429)
|.+||+.||.+|+++. ++++|+||...
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 227 LEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 9999999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=337.97 Aligned_cols=260 Identities=25% Similarity=0.328 Sum_probs=207.0
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.-.++|++.+.||+|+||.||+|.++.++.. |+|++.......
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~------------------------------------ 83 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK------------------------------------ 83 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh------------------------------------
Confidence 3458999999999999999999999998875 888874321110
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
......+.+|+.+++.++|+ ||+++++.+.....+|+||||++ |+|.+++.... +++..+..++
T Consensus 84 ------~~~~~~~~~e~~i~~~~~hp------~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~---~~~~~~~~~~ 148 (371)
T cd05622 84 ------RSDSAFFWEERDIMAFANSP------WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYT 148 (371)
T ss_pred ------hHHHHHHHHHHHHHHhCCCC------CCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHH
Confidence 01112345688888888776 99999999999999999999995 69999887643 8999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC----cceeeecCccccchhhhhCCC----CCC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----RVYTYIQSRFYRSPEVILGLP----YGP 247 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~~----~~~ 247 (429)
.||+.||.|||++||+||||||+|||++.++ .++|+|||++..... .....+||+.|+|||++.+.. ++.
T Consensus 149 ~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~--~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~ 226 (371)
T cd05622 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226 (371)
T ss_pred HHHHHHHHHHHHCCEEeCCCCHHHEEECCCC--CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCC
Confidence 9999999999999999999999999999888 899999999875432 223467999999999997643 788
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
++|||||||++|+|++|..||.+.+.......+........ .+
T Consensus 227 ~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------~~------ 269 (371)
T cd05622 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-------------------------------FP------ 269 (371)
T ss_pred ccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc-------------------------------CC------
Confidence 99999999999999999999998887666655543111000 00
Q ss_pred hhhccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKK--RLTPDEALRHEWLKSSS 368 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~--Rpta~ell~h~~~~~~~ 368 (429)
.....++.+.++|.+||..++.+ |+++.|+++|+||+...
T Consensus 270 -~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 270 -DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred -CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 01123788899999999844433 78999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=341.65 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=197.0
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.+.|+++++||.|+||+||+|.+..+++. |+|++......
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------- 113 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--------------------------------------- 113 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH---------------------------------------
Confidence 45689999999999999999999888764 88887433211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.....+.+|+++++.++|+ ||+++++++.....+++||||+. ++|.+. ...++..+..++.|
T Consensus 114 -----~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~q 176 (353)
T PLN00034 114 -----TVRRQICREIEILRDVNHP------NVVKCHDMFDHNGEIQVLLEFMDGGSLEGT------HIADEQFLADVARQ 176 (353)
T ss_pred -----HHHHHHHHHHHHHHhCCCC------CcceeeeEeccCCeEEEEEecCCCCccccc------ccCCHHHHHHHHHH
Confidence 1223556699999999887 99999999999999999999996 466432 23678888999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-----CCCCCc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-----PYGPPI 249 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-----~~~~~~ 249 (429)
|+.||+|||++||+||||||+|||++.++ .+||+|||++...... .....||..|+|||++... ..+.++
T Consensus 177 i~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 254 (353)
T PLN00034 177 ILSGIAYLHRRHIVHRDIKPSNLLINSAK--NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAG 254 (353)
T ss_pred HHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEcccccceecccccccccccccCccccCccccccccccCcCCCcch
Confidence 99999999999999999999999999888 8999999998754322 2345789999999998532 245689
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||......+....+........ ...
T Consensus 255 DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~ 296 (353)
T PLN00034 255 DIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--------------------------------------PEA 296 (353)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC--------------------------------------CCC
Confidence 999999999999999999974332221111111000000 001
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
....+.++.+||.+||+.||++|||+.|+++||||.....
T Consensus 297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 297 PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 1233688999999999999999999999999999987543
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=334.15 Aligned_cols=256 Identities=22% Similarity=0.334 Sum_probs=194.7
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||+||+|.+..++.. |+|++.+...... ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------------------------------------------~~ 38 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD------------------------------------------ED 38 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch------------------------------------------hH
Confidence 4799999999999999988865 9898754321110 11
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+.+|+.++..+. .||||+++++++.....+|+||||+. ++|...+.... .+++..++.++.|++.||+|
T Consensus 39 ~~~~~~E~~~l~~~~-----~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~ 111 (329)
T cd05618 39 IDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNY 111 (329)
T ss_pred HHHHHHHHHHHHhcC-----CCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 123455888877663 23499999999999999999999995 68988876654 49999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccc---cCcceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++||+||||||+||+++.++ .++|+|||++... .......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 112 lH~~~ivH~Dikp~Nili~~~~--~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 189 (329)
T cd05618 112 LHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189 (329)
T ss_pred HHHCCeeeCCCCHHHEEECCCC--CEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHH
Confidence 9999999999999999999988 8999999998642 2223446789999999999998999999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHH-hhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVI-NTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 340 (429)
++|..||......... ........ ...... ....+...+..+.+|
T Consensus 190 ~~g~~Pf~~~~~~~~~-------~~~~~~~~~~~i~~~---------------------------~~~~p~~~~~~~~~l 235 (329)
T cd05618 190 MAGRSPFDIVGSSDNP-------DQNTEDYLFQVILEK---------------------------QIRIPRSLSVKAASV 235 (329)
T ss_pred hhCCCCCccCCCcCCc-------ccccHHHHHHHHhcC---------------------------CCCCCCCCCHHHHHH
Confidence 9999999532110000 00000000 000000 001122346788999
Q ss_pred HHHhcccCCCCCCC------HHHHhcCCCCCCC
Q psy17270 341 VTQCFNWDSKKRLT------PDEALRHEWLKSS 367 (429)
Q Consensus 341 i~~~L~~dP~~Rpt------a~ell~h~~~~~~ 367 (429)
|++||+.||++|+| +.++++||||+..
T Consensus 236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999998 4799999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=343.15 Aligned_cols=280 Identities=21% Similarity=0.340 Sum_probs=211.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCC---cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTN---THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.++..+|++++.||.|+||.||+|...... .+|+|.+...
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------------------------------------- 130 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------------------------------------- 130 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------------------------------
Confidence 456778999999999999999999875432 2366654211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
....+|+++++.++|+ ||+++++++.....+|++||++.++|.+++... ..+++..+..
T Consensus 131 -------------~~~~~E~~il~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~--~~l~~~~~~~ 189 (392)
T PHA03207 131 -------------KTPGREIDILKTISHR------AIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS--GPLPLEQAIT 189 (392)
T ss_pred -------------ccHHHHHHHHHhcCCC------CccceeeeEeeCCEEEEEehhcCCCHHHHHHhc--CCCCHHHHHH
Confidence 1234599999999887 999999999999999999999999999998544 3599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
++.||+.||.|||++||+||||||+|||++.++ .++|+|||++...... .....||+.|+|||++.+..++.+
T Consensus 190 i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~--~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 267 (392)
T PHA03207 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE--NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK 267 (392)
T ss_pred HHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCch
Confidence 999999999999999999999999999999888 8999999998654322 223578999999999999899999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCC---HHHHHHHHHHHhCCCcHHHHhhhhhh-hhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGEN---EVEQLACIMEILGCPPDEVINTASRR-RLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
+|||||||++|+|++|+.||.+.. ....+..+...++..+.+........ ...+.... ...+....
T Consensus 268 ~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~--- 337 (392)
T PHA03207 268 TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYA-------IVLRPPYT--- 337 (392)
T ss_pred hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhc-------ccccCCcc---
Confidence 999999999999999999996643 45666677776665443321110000 00000000 00000000
Q ss_pred hhhhhh--ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 325 DMASVL--RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 325 ~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
..... ...+.++.+||++||..||++|||+.|+|.||||+..
T Consensus 338 -~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 338 -IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred -ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00011 1235788899999999999999999999999999764
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=339.38 Aligned_cols=277 Identities=20% Similarity=0.297 Sum_probs=205.8
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
..+|++++.||.|+||.||+|.+..++.. |+|+....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------------------------------------ 102 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------------------------------------ 102 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------------------------------------
Confidence 45799999999999999999999888754 77753111
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
....|+.+++.++|+ ||+++++++......++|||++.++|.+++.... ..+++..+..++.||
T Consensus 103 ---------~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi 166 (357)
T PHA03209 103 ---------TTLIEAMLLQNVNHP------SVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQI 166 (357)
T ss_pred ---------ccHHHHHHHHhCCCC------CCcChhheEEeCCeeEEEEEccCCcHHHHHHhcc-CCCCHHHHHHHHHHH
Confidence 123489999998877 9999999999999999999999999999987654 459999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
+.||.|||++||+||||||+|||++.++ .++|+|||++..... ......||+.|+|||++.+..++.++|||||||
T Consensus 167 ~~aL~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 244 (357)
T PHA03209 167 LEGLRYLHAQRIIHRDVKTENIFINDVD--QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGI 244 (357)
T ss_pred HHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHH
Confidence 9999999999999999999999999888 899999999875332 233457899999999999989999999999999
Q ss_pred HHHHHhhC-CCCCCCCC---------HHHHHHHHHHHhCCCcHHHHhhhhh--hhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 257 ILAELYTG-CPLFPGEN---------EVEQLACIMEILGCPPDEVINTASR--RRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 257 il~~lltg-~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
++|+|+++ .++|.... ...++..+...++..++++...... ...++..... ...+...
T Consensus 245 vl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~ 314 (357)
T PHA03209 245 VLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASL----------ERQPYTR 314 (357)
T ss_pred HHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhccc----------CCCcccc
Confidence 99999985 45554322 1233444455555444332210000 0000000000 0000000
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
...-.....+.++.+||.+||+.||++||||.|+|+||||++
T Consensus 315 ~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 315 YPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000011134667789999999999999999999999999975
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=326.65 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=197.3
Q ss_pred eeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhh
Q psy17270 29 IGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHH 107 (429)
Q Consensus 29 lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (429)
||+|+||+||+|.++.++.. |+|++........ ....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~------------------------------------------~~~~ 38 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR------------------------------------------KGYE 38 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhh------------------------------------------HHHH
Confidence 79999999999999988864 8888754321110 1112
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRN--NYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~--~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
.+..|+++++.+.|+ ||+++.+++....++|+||||+. |+|.+.+... ....+++..+..++.||+.||.|
T Consensus 39 ~~~~E~~il~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~ 112 (280)
T cd05608 39 GAMVEKRILAKVHSR------FIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEH 112 (280)
T ss_pred HHHHHHHHHHhCCCC------cEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHH
Confidence 455699999999876 99999999999999999999995 6898877542 22359999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++||+||||||+||+++.++ .++|+|||++...... .....||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 113 lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el 190 (280)
T cd05608 113 LHQRRIIYRDLKPENVLLDNDG--NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEM 190 (280)
T ss_pred HHHCCcccCCCCHHHEEECCCC--CEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHH
Confidence 9999999999999999999887 8999999998653322 2235689999999999999999999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
++|+.||...+.......+.......+ ...+...++.+.+++
T Consensus 191 ~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~li 232 (280)
T cd05608 191 IAARGPFRARGEKVENKELKQRILNDS--------------------------------------VTYPDKFSPASKSFC 232 (280)
T ss_pred HhCCCCCCCCCcchhHHHHHHhhcccC--------------------------------------CCCcccCCHHHHHHH
Confidence 999999987543222111111000000 001123478899999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCCCCCC
Q psy17270 342 TQCFNWDSKKRL-----TPDEALRHEWLKSS 367 (429)
Q Consensus 342 ~~~L~~dP~~Rp-----ta~ell~h~~~~~~ 367 (429)
.+||+.||++|| |++++++||||++.
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=333.63 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=197.0
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||.|+||+||+|.+..++.. |+|++......... .
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------------------------------------------~ 38 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK------------------------------------------E 38 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh------------------------------------------H
Confidence 4699999999999999988865 99987543211110 1
Q ss_pred hhhHHHHHH-HHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVR-ILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 106 ~~~~~~E~~-il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~ 183 (429)
...+..|.. +++.+.|+ ||+++++++...+.+|+||||+. |+|...+.... .+++..+..++.||+.||+
T Consensus 39 ~~~~~~e~~~~l~~~~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~ 110 (325)
T cd05604 39 QKHIMAERNVLLKNVKHP------FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALG 110 (325)
T ss_pred HHHHHHHHHHHHHhCCCC------CCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHH
Confidence 112233443 45556665 99999999999999999999995 68988887654 4999999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchhhHHHH
Q psy17270 184 LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAE 260 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~ 260 (429)
|||++||+||||||+|||++.++ .++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 111 ~lH~~givH~Dlkp~NIll~~~~--~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e 188 (325)
T cd05604 111 YLHSINIVYRDLKPENILLDSQG--HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYE 188 (325)
T ss_pred HHHHCCeeecCCCHHHeEECCCC--CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehh
Confidence 99999999999999999999988 89999999986422 22334678999999999999899999999999999999
Q ss_pred HhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHH
Q psy17270 261 LYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340 (429)
Q Consensus 261 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 340 (429)
|++|..||.+.+..+....+..... ...+..+..+.++
T Consensus 189 l~~G~~pf~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~l 226 (325)
T cd05604 189 MLYGLPPFYCRDVAEMYDNILHKPL------------------------------------------VLRPGASLTAWSI 226 (325)
T ss_pred hhcCCCCCCCCCHHHHHHHHHcCCc------------------------------------------cCCCCCCHHHHHH
Confidence 9999999998776665544432000 0011236788899
Q ss_pred HHHhcccCCCCCCCH----HHHhcCCCCCCC
Q psy17270 341 VTQCFNWDSKKRLTP----DEALRHEWLKSS 367 (429)
Q Consensus 341 i~~~L~~dP~~Rpta----~ell~h~~~~~~ 367 (429)
|++||+.||.+||++ .++++||||+..
T Consensus 227 l~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 227 LEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 999999999999987 589999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=319.62 Aligned_cols=254 Identities=32% Similarity=0.555 Sum_probs=207.4
Q ss_pred eEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|++++.||+|+||+||+|.+..+++ +|+|++..........
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~-------------------------------------- 42 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEER-------------------------------------- 42 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHH--------------------------------------
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccccc--------------------------------------
Confidence 8999999999999999999999985 5999986654432221
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
....+|+.++++++|+ ||+++++++......+++||++.+ +|.+++.... .+++..+..++.|++.
T Consensus 43 -----~~~~~e~~~~~~l~~~------~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~ 109 (260)
T PF00069_consen 43 -----EENIREIKILRRLRHP------NIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILE 109 (260)
T ss_dssp -----HHHHHHHHHHHHHTBT------TBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHH
T ss_pred -----chhhhhhhcccccccc------ccccccccccccccccccccccccccccccccccc--cccccccccccccccc
Confidence 1223399999999877 999999999999999999999976 9999998544 3999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc---ccCcceeeecCccccchhhhh-CCCCCCCccccchhh
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVIL-GLPYGPPIDMWSLGC 256 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~---~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~ 256 (429)
||++||++|++|+||||+||+++.++ .++|+|||.+.. .........++..|+|||++. +..++.++|+||||+
T Consensus 110 ~L~~Lh~~~i~H~dikp~NIl~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 187 (260)
T PF00069_consen 110 ALAYLHSKGIVHRDIKPENILLDENG--EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGI 187 (260)
T ss_dssp HHHHHHHTTEEESSBSGGGEEESTTS--EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHH
T ss_pred cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999887 899999999864 223334467889999999998 778899999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|..||......+....+.............. .....+.
T Consensus 188 il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------------~~~~~~~ 232 (260)
T PF00069_consen 188 ILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ-----------------------------------SREKSEE 232 (260)
T ss_dssp HHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS-----------------------------------HTTSHHH
T ss_pred ccccccccccccccccchhhhhhhhhcccccccccccc-----------------------------------cchhHHH
Confidence 99999999999998855555444443322211111000 0001278
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.++|.+||+.||++|||+.++++||||
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 8999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.93 Aligned_cols=285 Identities=30% Similarity=0.493 Sum_probs=223.1
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|++.+.||.|+||.||+|.+..++.. |+|++.....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---------------------------------------- 45 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE---------------------------------------- 45 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC----------------------------------------
Confidence 46799999999999999999999988865 8887642211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.......+.+|+.+++.++|+ ||+++++++... ..+++||||++++|.+++.... ..+++.++..++.
T Consensus 46 ---~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~ 115 (309)
T cd07845 46 ---RDGIPISSLREITLLLNLRHP------NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLML 115 (309)
T ss_pred ---CCCCcchhhHHHHHHHhCCCC------CCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHH
Confidence 011122345699999999887 999999998765 4689999999999999987654 4599999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~Diw 252 (429)
|++.||+|||+.|++|+||||+||+++.++ .++|+|||.+...... .....+++.|+|||++.+. .++.++|+|
T Consensus 116 qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw 193 (309)
T cd07845 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKG--CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMW 193 (309)
T ss_pred HHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHH
Confidence 999999999999999999999999999888 8999999998764432 2223457789999998764 578999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|++||.+.+..+.+..+...++.+...++......... ... ................
T Consensus 194 slG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~------~~~~~~~~~~~~~~~~ 261 (309)
T cd07845 194 AVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV------GKF------TLPKQPYNNLKHKFPW 261 (309)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc------ccc------cccCCCCCchHHhccc
Confidence 9999999999999999999999999999998888877765433221100 000 0000000112222333
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.++.+.+||.+||++||++|||+.|++.||||++..
T Consensus 262 ~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 262 LSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 478899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=333.27 Aligned_cols=250 Identities=27% Similarity=0.348 Sum_probs=195.7
Q ss_pred eeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhh
Q psy17270 29 IGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHH 107 (429)
Q Consensus 29 lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (429)
||+|+||+||+|.+..++.. |+|++......... ...
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~------------------------------------------~~~ 38 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------------------------------------------EVA 38 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhh------------------------------------------HHH
Confidence 79999999999999988865 99987532211110 011
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
....|..++..+.. ..||+|+.+++++....++|+||||+. |+|.+.+.... .+++..+..++.||+.||+|||
T Consensus 39 ~~~~e~~~l~~~~~---~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH 113 (330)
T cd05586 39 HTIGERNILVRTLL---DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLH 113 (330)
T ss_pred HHHHHHHHHHHhcc---CCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 22336666655431 245699999999999999999999995 68988887654 4999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCC-CCCCCccccchhhHHHHHh
Q psy17270 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCILAELY 262 (429)
Q Consensus 187 ~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~~ll 262 (429)
++||+||||||+|||++.++ .++|+|||++.... ......+||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 114 ~~~ivHrDlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell 191 (330)
T cd05586 114 KYDIVYRDLKPENILLDATG--HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC 191 (330)
T ss_pred HCCeEeccCCHHHeEECCCC--CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEec
Confidence 99999999999999999988 89999999986422 223346799999999999765 4789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHH
Q psy17270 263 TGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVT 342 (429)
Q Consensus 263 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 342 (429)
+|..||.+.+..+....+.......+. ...++++.+||+
T Consensus 192 tG~~Pf~~~~~~~~~~~i~~~~~~~~~-----------------------------------------~~~~~~~~~li~ 230 (330)
T cd05586 192 CGWSPFYAEDTQQMYRNIAFGKVRFPK-----------------------------------------NVLSDEGRQFVK 230 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCC-----------------------------------------ccCCHHHHHHHH
Confidence 999999887766554443321000000 012678899999
Q ss_pred HhcccCCCCCC----CHHHHhcCCCCCCCC
Q psy17270 343 QCFNWDSKKRL----TPDEALRHEWLKSSS 368 (429)
Q Consensus 343 ~~L~~dP~~Rp----ta~ell~h~~~~~~~ 368 (429)
+||+.||++|| ++.++++||||+...
T Consensus 231 ~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 231 GLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred HHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 99999999998 799999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=321.62 Aligned_cols=280 Identities=31% Similarity=0.564 Sum_probs=223.6
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|++.+.||.|+||.||+|.+..++.. |+|++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~----------------------------------------- 39 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE----------------------------------------- 39 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-----------------------------------------
Confidence 699999999999999999999887754 88877433211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
......+.+|+.+++.++|+ ||+++++++.....+++||||++++|.+++.... ..+++..+..++.|++.
T Consensus 40 --~~~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~ 110 (286)
T cd07832 40 --GGIPNQALREIKALQACQHP------YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLK 110 (286)
T ss_pred --chhhHHHHHHHHHHHhCCCC------CCcceeeEEecCCeeEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHH
Confidence 11223566799999999876 9999999999999999999999889999987654 46999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCC-CCCCCccccchh
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLG 255 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG 255 (429)
||+|||++|++|+||||+||+++.++ .++|+|||.+...... .....++..|+|||++.+. .++.++||||+|
T Consensus 111 ~l~~lH~~~i~H~dl~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 188 (286)
T cd07832 111 GVAYMHANGIMHRDLKPANLLISADG--VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVG 188 (286)
T ss_pred HHHHHHHCCeecCCcCHHHEEEcCCC--cEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHH
Confidence 99999999999999999999999887 8999999998764432 2345688899999998765 468899999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|.+||.+.+....+..+....+.+....+........+ . ...................+.
T Consensus 189 ~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----------~~~~~~~~~~~~~~~~~~~~~ 256 (286)
T cd07832 189 CIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY-N-----------KITFPESKPIPLEEIFPDASP 256 (286)
T ss_pred HHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh-h-----------cccCCCCCcchHHHhCCCccH
Confidence 9999999999999999988888888888887766555432211000 0 000011111123344455678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
.+.+||.+||+.||++|||+++++.||||.
T Consensus 257 ~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 257 EALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=339.84 Aligned_cols=256 Identities=27% Similarity=0.386 Sum_probs=217.3
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
.+|.=++.||.|+||.||-|+|..+.++ |||++..+....... |
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EK----W------------------------------- 70 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK----W------------------------------- 70 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHH----H-------------------------------
Confidence 4577788999999999999999998876 999987655432222 1
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
..++.|+++|++++|+ |++.+.++|.-+...|||||||-|+-.|++.-+. +++.+-++..|..+.+
T Consensus 71 -------qDIlKEVrFL~~l~HP------ntieYkgCyLre~TaWLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL 136 (948)
T KOG0577|consen 71 -------QDILKEVRFLRQLRHP------NTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGAL 136 (948)
T ss_pred -------HHHHHHHHHHHhccCC------CcccccceeeccchHHHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHH
Confidence 2456699999999998 9999999999999999999999888888887665 5799999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC---CCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG---LPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~ 256 (429)
.||+|||+++.||||||..|||++..| .|||+|||.+... .+.++++|||+|||||++.. +.|+-++||||||+
T Consensus 137 ~gLaYLHS~~~IHRDiKAGNILLse~g--~VKLaDFGSAsi~-~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGI 213 (948)
T KOG0577|consen 137 QGLAYLHSHNRIHRDIKAGNILLSEPG--LVKLADFGSASIM-APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213 (948)
T ss_pred HHHHHHHHhhHHhhhccccceEecCCC--eeeeccccchhhc-CchhcccCCccccchhHheeccccccCCccceeeccc
Confidence 999999999999999999999999999 9999999998543 45678999999999999874 46999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++.||...++|+-..+....+..|...- +|.- + -...+..
T Consensus 214 TCIELAERkPPlFnMNAMSALYHIAQNe--sPtL-----------------q---------------------s~eWS~~ 253 (948)
T KOG0577|consen 214 TCIELAERKPPLFNMNAMSALYHIAQNE--SPTL-----------------Q---------------------SNEWSDY 253 (948)
T ss_pred hhhhhhhcCCCccCchHHHHHHHHHhcC--CCCC-----------------C---------------------CchhHHH
Confidence 9999999999998888888887776521 1100 0 0112688
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
|..|+..||+.-|.+|||++++|.|+|.....
T Consensus 254 F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 254 FRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 99999999999999999999999999987643
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=342.66 Aligned_cols=279 Identities=22% Similarity=0.318 Sum_probs=204.8
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
...+|.+.+.||.|+||.||+|.+..++.. |+|...
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------------------------------------------- 203 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------------------------------------------- 203 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------------------------------------------
Confidence 466899999999999999999999988764 777421
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
...+.+|+++++++.|+ ||+++++++......++|||++.++|.+++.... ..+++..+..++.|
T Consensus 204 --------~~~~~~E~~iL~~L~Hp------nIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~q 268 (461)
T PHA03211 204 --------YASSVHEARLLRRLSHP------AVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARL-RPLGLAQVTAVARQ 268 (461)
T ss_pred --------ccCHHHHHHHHHHCCCC------CCCcEEEEEEECCEEEEEEEccCCCHHHHHHhcC-CCCCHHHHHHHHHH
Confidence 11234599999999887 9999999999999999999999999999987654 35999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
++.||.|||++||+||||||+|||++.++ .++|+|||+++..... .....||+.|+|||++.+..++.++|||
T Consensus 269 i~~aL~yLH~~gIvHrDLKP~NILl~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvw 346 (461)
T PHA03211 269 LLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIW 346 (461)
T ss_pred HHHHHHHHHHCCEEECcCCHHHEEECCCC--CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHH
Confidence 99999999999999999999999999887 8999999998754321 1235689999999999998999999999
Q ss_pred chhhHHHHHhhCCCCC-CCCC------HHHHHHHHHHHhCCCcHHHHhhhh--hhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 253 SLGCILAELYTGCPLF-PGEN------EVEQLACIMEILGCPPDEVINTAS--RRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 253 SlG~il~~lltg~~pf-~~~~------~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
||||++|||++|..++ .... ...++.++....+....++..... ........ ......... .
T Consensus 347 SlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~--------~~~~~~~~~-~ 417 (461)
T PHA03211 347 SAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHR--------AARNRRPAY-T 417 (461)
T ss_pred HHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhh--------hhcccCCcc-C
Confidence 9999999999987554 3221 123444444433322111100000 00000000 000000000 0
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
..........+..+.+||.+||+.||++|||+.|+|+||||++
T Consensus 418 ~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 418 RPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0001111234568899999999999999999999999999975
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=321.45 Aligned_cols=280 Identities=28% Similarity=0.497 Sum_probs=217.7
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-++|++.+.||.|++|.||+|.++.++.. |+|.+......
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--------------------------------------- 44 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--------------------------------------- 44 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---------------------------------------
Confidence 37899999999999999999999877754 88876432110
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+|+++++.++|+ ||+++++++....+.++||||+.++|.+++.... ..+++..++.++.|+
T Consensus 45 -----~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql 112 (291)
T cd07844 45 -----GAPFTAIREASLLKDLKHA------NIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQL 112 (291)
T ss_pred -----CCchhHHHHHHHHhhCCCc------ceeeEEEEEecCCeEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHH
Confidence 1112345699999999887 9999999999999999999999999999887654 358999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccch
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSL 254 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSl 254 (429)
+.||.|||++|++|+||||+||+++.++ .++|+|||++...... .....++..|+|||++.+. .++.++||||+
T Consensus 113 ~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl 190 (291)
T cd07844 113 LRGLAYCHQRRVLHRDLKPQNLLISERG--ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV 190 (291)
T ss_pred HHHHHHHHhCCeecccCCHHHEEEcCCC--CEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHH
Confidence 9999999999999999999999999988 8999999998653321 1223467889999998764 57889999999
Q ss_pred hhHHHHHhhCCCCCCCCC-HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 255 GCILAELYTGCPLFPGEN-EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
||++|+|++|+.||.+.. ..+++..+.+.++.+.++.+............ .................
T Consensus 191 G~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~ 258 (291)
T cd07844 191 GCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY------------SFPFYPPRPLINHAPRL 258 (291)
T ss_pred HHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc------------cccccCChhHHHhCcCC
Confidence 999999999999998766 56777777777777776665443321110000 00001111122222233
Q ss_pred C--hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 334 D--KAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 334 ~--~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+ ..+.+++.+||+.||++|||+.|+++||||
T Consensus 259 ~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 259 DRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 4 788899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=317.72 Aligned_cols=281 Identities=30% Similarity=0.576 Sum_probs=214.5
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||.|+||.||+|.++.++.. |+|++......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------------------------------------- 40 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---------------------------------------- 40 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC----------------------------------------
Confidence 5899999999999999999999987764 88876322110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+.+++.+.|+ |++++++++.....+++||||+++.+.+.+.... ..+++..+..++.|++
T Consensus 41 ---~~~~~~~~~e~~~l~~~~h~------~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~ 110 (286)
T cd07847 41 ---PVIKKIALREIRMLKQLKHP------NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTL 110 (286)
T ss_pred ---ccccHHHHHHHHHHHhCCCC------CEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHH
Confidence 11123456799999999877 9999999999999999999999765444443332 3499999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc---eeeecCccccchhhhhCC-CCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILGL-PYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG 255 (429)
.||+|||+.|++|+||||+||+++.++ .++|+|||++....... ....++..|+|||++.+. .++.++|+||||
T Consensus 111 ~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG 188 (286)
T cd07847 111 QAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIG 188 (286)
T ss_pred HHHHHHHHCCceecCCChhhEEEcCCC--cEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHH
Confidence 999999999999999999999999888 89999999987644322 234578889999998764 578899999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|..||.+.+..+.+..+....+...+........ ..... ....................+.
T Consensus 189 ~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 257 (286)
T cd07847 189 CVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST-------NQFFK----GLSIPEPETREPLESKFPNISS 257 (286)
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc-------ccccc----cccCCCcccccCHHHHhccCCH
Confidence 999999999999999888777777776665544432211100 00000 0000011111223334455688
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.+.+|+.+||+.||++|||+.|++.||||
T Consensus 258 ~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 258 PALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 99999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=323.08 Aligned_cols=279 Identities=30% Similarity=0.548 Sum_probs=221.6
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++++.||.|++|.||+|.++.++.. |+|++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------------------------------------- 39 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET----------------------------------------- 39 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-----------------------------------------
Confidence 489999999999999999999888765 88876422110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
......+.+|++++++++|+ ||+++++++......++||||+.++|.+++.......+++..+..++.|++.
T Consensus 40 --~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~ 111 (284)
T cd07860 40 --EGVPSTAIREISLLKELNHP------NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111 (284)
T ss_pred --cccchHHHHHHHHHHhcCCC------CCcchhhhcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHH
Confidence 11223566799999999887 9999999999999999999999889999988765566999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCC-CCCCccccchhh
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGC 256 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~ 256 (429)
||+|||++|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||++.+.. ++.++|+|||||
T Consensus 112 ~l~~lh~~~i~H~~l~p~nill~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 189 (284)
T cd07860 112 GLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 189 (284)
T ss_pred HHHHHHHCCeecCCCCHHHEEECCCC--CEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHH
Confidence 99999999999999999999999988 8999999998654322 12235678899999887654 588999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|+||+.||.+.+..+.+.++.+..+.+....+......... .. ..............+..++.
T Consensus 190 il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~----~~~~~~~~~~~~~~~~~~~~ 256 (284)
T cd07860 190 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY---------KP----SFPKWARQDFSKVVPPLDED 256 (284)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH---------Hh----hcccccccCHHHHcccCCHH
Confidence 999999999999999888888888888888776655432211000 00 00001111223333456788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.++|.+||+.||++|||+.++++||||
T Consensus 257 ~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 257 GRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=328.86 Aligned_cols=285 Identities=32% Similarity=0.562 Sum_probs=222.0
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
++++|++.+.||.|+||.||+|.+..++.. |+|++.....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--------------------------------------- 43 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--------------------------------------- 43 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc---------------------------------------
Confidence 568999999999999999999999988865 8887642110
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELMNLNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~ 172 (429)
......+.+|+.+++.++|+ ||+++++++... .++|+++|+++++|.+.+... .+++..+.
T Consensus 44 -----~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~ 109 (336)
T cd07849 44 -----QTFCQRTLREIKILRRFKHE------NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQ 109 (336)
T ss_pred -----chhHHHHHHHHHHHHhCCCC------CcCchhheeecccccccceEEEEehhcccCHHHHHhcC---CCCHHHHH
Confidence 11223455699999999877 899998876543 368999999999998887654 39999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhhC-CCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILG-LPY 245 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~-~~~ 245 (429)
.++.|++.||+|||++|++||||||+||+++.++ .++|+|||++...... .....+|+.|+|||++.+ ..+
T Consensus 110 ~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 187 (336)
T cd07849 110 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC--DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGY 187 (336)
T ss_pred HHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC--CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCC
Confidence 9999999999999999999999999999999888 8999999998653321 122467889999998765 468
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++||||+||++|+|++|+.||.+.+....+..+...++.++.+.+............. .........
T Consensus 188 ~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~ 256 (336)
T cd07849 188 TKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIK-----------SLPFKPKVP 256 (336)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHh-----------hcCcCCccc
Confidence 889999999999999999999999998888888888888887766554332111000000 000111112
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
.....+..++.+.+||.+||+.||++|||+.|+++||||+....
T Consensus 257 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 257 WNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 23334455788999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=322.56 Aligned_cols=285 Identities=28% Similarity=0.526 Sum_probs=224.5
Q ss_pred CeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||++.+.||.|+||.||+|.+..++. +|+|.+........
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~--------------------------------------- 41 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA--------------------------------------- 41 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc---------------------------------------
Confidence 69999999999999999999988775 48888754322110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.......+..|+++++.++|+ ||+++++++......++||||++++|.+++.... ..+++..+..++.||+.
T Consensus 42 -~~~~~~~~~~e~~~l~~~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~ 113 (298)
T cd07841 42 -KDGINFTALREIKLLQELKHP------NIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLR 113 (298)
T ss_pred -cchhhHHHHHHHHHHhhcCCC------CChhhhheeecCCEEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHH
Confidence 112233456699999999877 9999999999999999999999889999997654 35999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccchhh
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGC 256 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~ 256 (429)
||.|||++|++|+||+|+||+++.++ .++|+|||++...... .....+++.|+|||.+.+. .++.++|+|||||
T Consensus 114 al~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 191 (298)
T cd07841 114 GLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGC 191 (298)
T ss_pred HHHHHHhCCeeecCCChhhEEEcCCC--CEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHH
Confidence 99999999999999999999999988 8999999998764432 2223567789999998653 5788999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|.+||.+.+..+.+..+....+.+....+.......... .................+..
T Consensus 192 il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~ 257 (298)
T cd07841 192 IFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV--------------EFKPFPPTPLKQIFPAASDD 257 (298)
T ss_pred HHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc--------------cccccCCcchhhhcccccHH
Confidence 9999999999999988888888888777777666554332211000 00011111223334455788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
+.+||.+||++||++|||+.|+++|+||++...
T Consensus 258 ~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 258 ALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=327.02 Aligned_cols=281 Identities=24% Similarity=0.437 Sum_probs=202.2
Q ss_pred EeEeeccccceEEEEEecCCC---cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 26 LEVIGKGSFGQVIRALDHKTN---THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
..+||.|+||+||+|.+..+. .+|+|.+....
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--------------------------------------------- 40 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--------------------------------------------- 40 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---------------------------------------------
Confidence 368999999999999976533 34777653211
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--cCeEEEEEeecCcCHHHHHHhhC-------CCCCCHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--RNHLCISFELMNLNLYELIKRNN-------YQGFSLGLIRR 173 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~g~L~~~i~~~~-------~~~~~~~~~~~ 173 (429)
....+.+|+++++.+.|+ ||+++++++.. +..+++||||++++|.+++.... ...+++..+..
T Consensus 41 --~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~ 112 (317)
T cd07867 41 --ISMSACREIALLRELKHP------NVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKS 112 (317)
T ss_pred --CcHHHHHHHHHHHhCCCC------CeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHH
Confidence 112355699999999887 99999999854 45789999999999998886431 12488999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCC--CcceEEeeecccccccCc------ceeeecCccccchhhhhCC-C
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG--SSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILGL-P 244 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~--~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~-~ 244 (429)
++.|++.||.|||++|++||||||+||++..++ ...++|+|||+++..... .....+|+.|+|||++.+. .
T Consensus 113 i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 192 (317)
T cd07867 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH 192 (317)
T ss_pred HHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCc
Confidence 999999999999999999999999999994321 127999999999754322 2235678999999999874 5
Q ss_pred CCCCccccchhhHHHHHhhCCCCCCCCCH---------HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCC
Q psy17270 245 YGPPIDMWSLGCILAELYTGCPLFPGENE---------VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (429)
++.++|||||||++|+|+||.+||..... ..++..+...++.+..+.+........+....... ..
T Consensus 193 ~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 267 (317)
T cd07867 193 YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDF-----RR 267 (317)
T ss_pred cCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhh-----cc
Confidence 78999999999999999999999975432 35566777777777666654432211100000000 00
Q ss_pred CCCCCCC-CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 316 GRKRKPG-SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 316 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
....... ...........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 268 TTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000000 000111112335678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=321.85 Aligned_cols=258 Identities=25% Similarity=0.356 Sum_probs=207.7
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|+..+.||.|+||+||+|.+..+++. |+|.+.......
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---------------------------------------- 40 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK---------------------------------------- 40 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh----------------------------------------
Confidence 488999999999999999999988865 888874332110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+++++.++|+ +|+.+++.+..++..|++|||+. ++|.+.+......++++..+..++.|++
T Consensus 41 --~~~~~~~~~E~~il~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~ 112 (285)
T cd05632 41 --RKGESMALNEKQILEKVNSQ------FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEIL 112 (285)
T ss_pred --hhHHHHHHHHHHHHHHcCCc------CceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 11122455699999999887 99999999999999999999995 5898888765545699999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
.||.|||++||+||||||+||+++.++ .++|+|||++..... ......|+..|+|||++.+..++.++|+|||||+
T Consensus 113 ~~l~~lH~~~iiH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~ 190 (285)
T cd05632 113 CGLEDLHRENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCL 190 (285)
T ss_pred HHHHHHHhCCeeecCCCHHHEEECCCC--CEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHH
Confidence 999999999999999999999999887 899999999865332 2233568999999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|..||.+.........+.......... .....++.+
T Consensus 191 l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~ 232 (285)
T cd05632 191 IYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV--------------------------------------YSAKFSEEA 232 (285)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc--------------------------------------cCccCCHHH
Confidence 999999999998876554433332211110000 011236778
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q psy17270 338 VDFVTQCFNWDSKKRLT-----PDEALRHEWLKSS 367 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~ 367 (429)
.+|+.+||+.||++||| +.+++.|+||+..
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 89999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=328.48 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=203.4
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-+..|+++++||+||-+.||++...+.+.+|+|++.....+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D--------------------------------------- 399 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD--------------------------------------- 399 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC---------------------------------------
Confidence 35669999999999999999999988888887776322111
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+.+|+..|.+|+.. .+|++++||-..++.+|+|||+-+.+|..++++... -.+...++.|+.|+
T Consensus 400 ----~qtl~gy~nEI~lL~KLkg~-----~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~-~~~~~~lk~ywkqM 469 (677)
T KOG0596|consen 400 ----NQTLDGYRNEIALLNKLKGH-----DKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKS-IDPDWFLKFYWKQM 469 (677)
T ss_pred ----HHHHHHHHHHHHHHHHhcCC-----ceEEEEeeeeccCceEEEEeecccccHHHHHHhccC-CCchHHHHHHHHHH
Confidence 12334677899999999844 499999999999999999999999999999998763 34546999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCC---------
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLP--------- 244 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~--------- 244 (429)
|.++.++|.+||||.||||.|+|+... .+||+|||.|..+... ....+||..||+||.+....
T Consensus 470 L~aV~~IH~~gIVHSDLKPANFLlVkG---~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k 546 (677)
T KOG0596|consen 470 LLAVKTIHQHGIVHSDLKPANFLLVKG---RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSK 546 (677)
T ss_pred HHHHHHHHHhceeecCCCcccEEEEee---eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcc
Confidence 999999999999999999999999864 8999999999754433 23478999999999987432
Q ss_pred --CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 245 --YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 245 --~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
.+.++||||||||+|+|+.|++||...- ..++++..... |..++ +++.
T Consensus 547 ~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~-P~~~I---------------------------efp~ 596 (677)
T KOG0596|consen 547 IKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITD-PNHEI---------------------------EFPD 596 (677)
T ss_pred eeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcC-CCccc---------------------------cccC
Confidence 4678999999999999999999997632 12333333221 11110 0000
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
. . ...+++++++.||.+||++|||..|+|+|||++-
T Consensus 597 ~------~--~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 597 I------P--ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred C------C--CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 0 0 0223899999999999999999999999999975
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=326.94 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=197.1
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|+||+||+|.+..++.. |+|++........ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------------------------------------------~~ 38 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD------------------------------------------ED 38 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh------------------------------------------hH
Confidence 4799999999999999988865 9998854322111 11
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+.+|+.++..+.+ |++|+.+++++.....+|+||||+. ++|...+.... .+++..++.++.||+.||+|
T Consensus 39 ~~~~~~e~~~~~~~~~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~ 111 (327)
T cd05617 39 IDWVQTEKHVFEQASS-----NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNF 111 (327)
T ss_pred HHHHHHHHHHHHhhcC-----CCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 1234558888888753 3499999999999999999999995 68988887654 49999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccc---cCcceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
||++|++||||||+|||++.++ .++|+|||++... .......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 112 lH~~~ivHrDlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el 189 (327)
T cd05617 112 LHERGIIYRDLKLDNVLLDADG--HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189 (327)
T ss_pred HHHCCeeccCCCHHHEEEeCCC--CEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHH
Confidence 9999999999999999999988 8999999998642 2233456799999999999998999999999999999999
Q ss_pred hhCCCCCCCCCH------HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 262 YTGCPLFPGENE------VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 262 ltg~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
++|..||..... .+.+..... ..+ ...+...+.
T Consensus 190 l~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~---------------------------------------~~~p~~~~~ 228 (327)
T cd05617 190 MAGRSPFDIITDNPDMNTEDYLFQVIL--EKP---------------------------------------IRIPRFLSV 228 (327)
T ss_pred HhCCCCCCccCCCcccccHHHHHHHHH--hCC---------------------------------------CCCCCCCCH
Confidence 999999964321 111111110 000 001122367
Q ss_pred HHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLT------PDEALRHEWLKSSS 368 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpt------a~ell~h~~~~~~~ 368 (429)
.+.++|.+||+.||++|++ ..++++||||+...
T Consensus 229 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 8899999999999999998 46999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=324.21 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=212.2
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.+-|.++.+||+|+||.||+|.|+.+|.+ |||.+....
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----------------------------------------- 70 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----------------------------------------- 70 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----------------------------------------
Confidence 34588999999999999999999999987 998874321
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
-.+.+..|+.|++++..+ +++++|+.|.-...+|+|||||+ |++.++++.+. +++++.++..+++.
T Consensus 71 ------DLQEIIKEISIMQQC~S~------yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~ 137 (502)
T KOG0574|consen 71 ------DLQEIIKEISIMQQCKSK------YVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRD 137 (502)
T ss_pred ------hHHHHHHHHHHHHHcCCc------hhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHH
Confidence 123455699999999877 99999999999999999999996 79999998776 57999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
.+.||+|||...-+|||||..|||++.+| ..||+|||.+.... ...++.+|||.|||||++..-.|+..+|||||
T Consensus 138 TLKGL~YLH~~~KIHRDIKAGNILLNT~G--~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSL 215 (502)
T KOG0574|consen 138 TLKGLQYLHDLKKIHRDIKAGNILLNTDG--IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSL 215 (502)
T ss_pred HHhHHHHHHHHHHHHhhcccccEEEcccc--hhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhh
Confidence 99999999999999999999999999999 99999999986544 34567899999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|++..||..|++||..-.+...+-.|- ..||+. ...+...+
T Consensus 216 GITaIEMAEG~PPYsDIHPMRAIFMIP---T~PPPT------------------------------------F~KPE~WS 256 (502)
T KOG0574|consen 216 GITAIEMAEGRPPYSDIHPMRAIFMIP---TKPPPT------------------------------------FKKPEEWS 256 (502)
T ss_pred cchhhhhhcCCCCcccccccceeEecc---CCCCCC------------------------------------CCChHhhh
Confidence 999999999999998755533221110 011110 01111227
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.+|.||+++||..+|++|.||.++++|+|.++..
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 8899999999999999999999999999998754
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=319.28 Aligned_cols=281 Identities=29% Similarity=0.545 Sum_probs=218.2
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|+||.||+|.+..++.. |+|++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~----------------------------------------- 39 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD----------------------------------------- 39 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-----------------------------------------
Confidence 5799999999999999999999988865 8887632211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCe-----EEEEEeecCcCHHHHHHhhCC---CCCCHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH-----LCISFELMNLNLYELIKRNNY---QGFSLGLI 171 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~-----~~lv~e~~~g~L~~~i~~~~~---~~~~~~~~ 171 (429)
.......+.+|+.+++.+.|+ +||+++++++..... .|+||||++++|.+++..... ..+++..+
T Consensus 40 --~~~~~~~~~~E~~~l~~l~~~-----~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~ 112 (295)
T cd07837 40 --EEGIPPTALREISLLQMLSES-----IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTI 112 (295)
T ss_pred --ccCCchHHHHHHHHHHHccCC-----CCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHH
Confidence 111234566799999999652 499999999887665 899999999999998875432 35899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEec-CCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQ-RGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYG 246 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~-~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~ 246 (429)
..++.||+.||.|||++|++||||+|+||+++. ++ .++|+|||.+...... .....+++.|+|||++.+. .++
T Consensus 113 ~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 190 (295)
T cd07837 113 KSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG--LLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYS 190 (295)
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC--eEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCC
Confidence 999999999999999999999999999999998 66 8999999998653322 1223567889999998764 578
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
.++|+|||||++|+|++|..||.+.+..+.+..+...++.+....+........... .........
T Consensus 191 ~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~ 256 (295)
T cd07837 191 TPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHE--------------FPQWKPQDL 256 (295)
T ss_pred chHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhh--------------cCcccchhH
Confidence 899999999999999999999999988888888887777766655432221111000 000011122
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
....+..++.+.+||.+||..||++|||+.|++.||||+
T Consensus 257 ~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 257 SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 233345688999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=320.33 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=196.8
Q ss_pred eeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhh
Q psy17270 29 IGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHH 107 (429)
Q Consensus 29 lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (429)
||.|+||+||+|.++.++.. |+|++....... .....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------------------------------------------~~~~~ 38 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK------------------------------------------KSGEK 38 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc------------------------------------------chhhH
Confidence 79999999999999988865 888874321110 01112
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
.+..|+++++.++|+ ||+++++++....++|+||||+. ++|.+++.......+++..+..++.|++.||+|||
T Consensus 39 ~~~~E~~il~~l~hp------~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 112 (277)
T cd05607 39 MALLEKEILEKVNSP------FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112 (277)
T ss_pred HHHHHHHHHHhcCCC------cEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 334599999999877 99999999999999999999995 69988887665556899999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhC
Q psy17270 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264 (429)
Q Consensus 187 ~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 264 (429)
++|++||||||+||+++.++ .++|+|||++...... .....++..|+|||++.+..++.++|+||+||++|+|++|
T Consensus 113 ~~~ivH~dikp~Nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g 190 (277)
T cd05607 113 SMDIVYRDMKPENVLLDDQG--NCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190 (277)
T ss_pred HCCEEEccCChHhEEEcCCC--CEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC
Confidence 99999999999999999887 8999999998654432 2235688999999999988899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHh
Q psy17270 265 CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQC 344 (429)
Q Consensus 265 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 344 (429)
..||...........+..... ... ........++++.+|+++|
T Consensus 191 ~~p~~~~~~~~~~~~~~~~~~-----------~~~--------------------------~~~~~~~~~~~~~~li~~~ 233 (277)
T cd05607 191 RTPFKDHKEKVAKEELKRRTL-----------EDE--------------------------VKFEHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCCCcchhhHHHHHHHhh-----------ccc--------------------------cccccccCCHHHHHHHHHH
Confidence 999976543211111111000 000 0000012367889999999
Q ss_pred cccCCCCCCCH----HHHhcCCCCCCC
Q psy17270 345 FNWDSKKRLTP----DEALRHEWLKSS 367 (429)
Q Consensus 345 L~~dP~~Rpta----~ell~h~~~~~~ 367 (429)
|+.||++||++ .+++.|+||+..
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCC
Confidence 99999999999 678899999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=321.25 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=211.1
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|+||.||+|.+..+++. |+|++......
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---------------------------------------- 40 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV---------------------------------------- 40 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh----------------------------------------
Confidence 4799999999999999999999887765 88887432111
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.......+.+|+++++.+.|+ ||+++++++.....+++||||+ +++|.+++.... .+++..+..++.|+
T Consensus 41 --~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi 110 (290)
T cd05580 41 --KLKQVEHVLNEKRILQSIRHP------FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQV 110 (290)
T ss_pred --hhhHHHHHHHHHHHHHhCCCC------CccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHH
Confidence 011223456699999999876 9999999999999999999999 679999988764 49999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHH
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 258 (429)
+.||.|||++|++|+||+|+||+++.++ .++|+|||++...........+++.|+|||.+.+..++.++|+||||+++
T Consensus 111 l~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 188 (290)
T cd05580 111 VLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188 (290)
T ss_pred HHHHHHHHHCCEecCCCCHHHEEECCCC--CEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHH
Confidence 9999999999999999999999999988 89999999997765555556788999999999888888999999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 259 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
|+|++|..||...+.......+...... .+...++.+.
T Consensus 189 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~l~ 226 (290)
T cd05580 189 YEMLAGYPPFFDDNPIQIYEKILEGKVR------------------------------------------FPSFFSPDAK 226 (290)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhcCCcc------------------------------------------CCccCCHHHH
Confidence 9999999999887755444443321000 0112267889
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 339 DFVTQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 339 ~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
++|.+||..||.+|+ ++.|+++||||+...
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 999999999999999 899999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=315.85 Aligned_cols=276 Identities=33% Similarity=0.638 Sum_probs=216.0
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|++++.||.|+||.||+|.+..++.. |+|++........
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~---------------------------------------- 40 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE---------------------------------------- 40 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch----------------------------------------
Confidence 78999999999999999999887765 8887643221100
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.....+|+.++.++. .|+|++++++++.+. +.+++||||++++|.+.+.... ..+++..+..++.|++
T Consensus 41 ----~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~ 110 (282)
T cd07831 41 ----QVNNLREIQALRRLS-----PHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLL 110 (282)
T ss_pred ----hhhHHHHHHHHhhcC-----CCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHH
Confidence 012234777887775 234999999999987 8999999999999999887643 3589999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCC-CCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~ 256 (429)
.||+|||+.|++|+||+|+||+++. + .++|+|||++...... .....++..|+|||++.+. .++.++|||||||
T Consensus 111 ~~L~~LH~~~i~H~dl~p~ni~l~~-~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv 187 (282)
T cd07831 111 KSLDHMHRNGIFHRDIKPENILIKD-D--ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGC 187 (282)
T ss_pred HHHHHHHHCCceecccCHHHEEEcC-C--CeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHH
Confidence 9999999999999999999999998 6 8999999998754322 2234578899999987654 5688999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|.+||.+.+..+.+..+...++.+++.+......... .. ..................+..
T Consensus 188 ~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~------~~~~~~~~~~~~~~~~~~~~~ 254 (282)
T cd07831 188 VFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH-------MN------YNFPSKKGTGLRKLLPNASAE 254 (282)
T ss_pred HHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc-------cc------ccCcccccccHHHHcccccHH
Confidence 99999999999999999888899988888888877432211100 00 000111111223333455899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.+||.+||+.||++|||+.++++||||
T Consensus 255 ~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 255 GLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 9999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=331.71 Aligned_cols=310 Identities=34% Similarity=0.613 Sum_probs=248.5
Q ss_pred eehhhhcccccCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 10 FAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 10 ~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
.--..+++.+..||.+....|.|-||+|.+|.|...|. +|||+++..
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-------------------------------- 468 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-------------------------------- 468 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--------------------------------
Confidence 33456788999999999999999999999999988775 487777432
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhC-CCCCC
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNN-YQGFS 167 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~-~~~~~ 167 (429)
+.+.+.-+.|++||++|...+...-.++++++-.|...+|+|||+|.+..+|.++++..+ ..++.
T Consensus 469 --------------E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ 534 (752)
T KOG0670|consen 469 --------------EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLH 534 (752)
T ss_pred --------------hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCccccee
Confidence 223344456999999999887777789999999999999999999999999999998764 34588
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee-eecCccccchhhhhCCCCC
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT-YIQSRFYRSPEVILGLPYG 246 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~-~~~t~~y~aPE~~~~~~~~ 246 (429)
...++.|++|++.||..|-..||+|.||||+|||++.... .+||||||.|...+....+ +..+..|+|||++.|-+|+
T Consensus 535 ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd 613 (752)
T KOG0670|consen 535 IKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYD 613 (752)
T ss_pred ehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccccccccHHHHHHhccCcceeecCccc
Confidence 9999999999999999999999999999999999987643 7999999999877655443 4567889999999999999
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCC-----CCCCCC
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK-----GRKRKP 321 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 321 (429)
...|+||+||++|||.||+..|+|.+..+.+...+.+-|.+|..++....-..--|+..-.-...+..+ .+....
T Consensus 614 ~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~ 693 (752)
T KOG0670|consen 614 YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMV 693 (752)
T ss_pred CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEec
Confidence 999999999999999999999999999999999999999999998866554444444333221111111 011111
Q ss_pred CC---chhhhhhcc----------CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 322 GS---KDMASVLRC----------NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 322 ~~---~~~~~~~~~----------~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.. .++.+.... .-..|.+||.+||..||++|.|..++|.||||+.
T Consensus 694 ~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 694 NVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred ccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 11 112221111 1248899999999999999999999999999974
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=318.82 Aligned_cols=285 Identities=30% Similarity=0.534 Sum_probs=223.3
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|++|+||+|.+..+++. |+|.+......
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------------------------------------- 41 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---------------------------------------- 41 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc----------------------------------------
Confidence 5799999999999999999999888754 88876432110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+++++.++|+ ||+++++++....+.++||||++++|.+.+.......+++..+..++.||+
T Consensus 42 ---~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~ 112 (294)
T PLN00009 42 ---EGVPSTAIREISLLKEMQHG------NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112 (294)
T ss_pred ---ccchHHHHHHHHHHHhccCC------CEeeEEEEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHH
Confidence 01123455699999999887 999999999999999999999999999988766544578899999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG 255 (429)
.||+|||++|++|+||+|+||+++..+. .++|+|||++...... .....+++.|+|||++.+. .++.++||||+|
T Consensus 113 ~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG 191 (294)
T PLN00009 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVG 191 (294)
T ss_pred HHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHH
Confidence 9999999999999999999999986432 6899999998654322 1234567889999998764 578899999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|+||++||...+..+.+.++....+.+.+..+........+.. ..............+..++
T Consensus 192 ~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~ 258 (294)
T PLN00009 192 CIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS-------------AFPKWPPKDLATVVPTLEP 258 (294)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh-------------hcccCCCCCHHHhCcCCCh
Confidence 999999999999999888888888888888887777653321111000 0000011112222344578
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.+.+++.+||+.||++||++.++++||||....
T Consensus 259 ~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 259 AGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 899999999999999999999999999998653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=343.23 Aligned_cols=253 Identities=22% Similarity=0.259 Sum_probs=206.5
Q ss_pred cCCeEEEeEeeccccceEEEEEecCC-Cc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKT-NT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~-~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
...|.+.+.||+|+||.||+|.+..+ +. +|+|.+.....
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--------------------------------------- 106 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--------------------------------------- 106 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---------------------------------------
Confidence 44599999999999999999999877 43 47776532211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhh--CCCCCCHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRN--NYQGFSLGLIRRF 174 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~--~~~~~~~~~~~~i 174 (429)
.....+.+|+++++.+.|+ ||+++++++...+++|+||||+ +|+|.+.+... ....+++..+..+
T Consensus 107 ------~~~~~~~~E~~~l~~l~Hp------niv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i 174 (478)
T PTZ00267 107 ------RQAAYARSELHCLAACDHF------GIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174 (478)
T ss_pred ------HHHHHHHHHHHHHHhCCCC------CEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHH
Confidence 1112345699999999887 9999999999999999999999 56999888643 2235899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCCc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
+.|++.||.|||++||+||||||+|||++.++ .+||+|||++...... ....+||+.|+|||++.+..++.++
T Consensus 175 ~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~--~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 252 (478)
T PTZ00267 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTG--IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKA 252 (478)
T ss_pred HHHHHHHHHHHHhCCEEECCcCHHhEEECCCC--cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHH
Confidence 99999999999999999999999999999888 8999999999764332 2345699999999999998899999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||.+.+..+.+..+......+ .
T Consensus 253 Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-----------------------------------------~ 291 (478)
T PTZ00267 253 DMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-----------------------------------------F 291 (478)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------------------------------------C
Confidence 99999999999999999999877766555544211000 0
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
+...+..+.+||.+||..||++||++.+++.|+|++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 1123678899999999999999999999999999863
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=344.68 Aligned_cols=304 Identities=18% Similarity=0.257 Sum_probs=211.2
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc--hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH--ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~--aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
+.+.++|++++.||+|+||+||+|..+..... +.|.+......... ..+. ..|..
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---------~~k~~------------ 200 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPK--CERL---------IAKRV------------ 200 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchh--hhhh---------HhHHh------------
Confidence 45678999999999999999999987655432 33322111100000 0000 00000
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCC---CCCCHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNY---QGFSLGLI 171 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~---~~~~~~~~ 171 (429)
.........+.+|++++++++|+ ||+++++++...+..|++++++.++|.+++..... .......+
T Consensus 201 -----~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ 269 (501)
T PHA03210 201 -----KAGSRAAIQLENEILALGRLNHE------NILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQT 269 (501)
T ss_pred -----hcchHHHHHHHHHHHHHHhCCCC------CcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHH
Confidence 00123445678899999999887 99999999999999999999999999888764321 22456778
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCCCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
+.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ....+||..|+|||++.+..++.
T Consensus 270 ~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~--~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 347 (501)
T PHA03210 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG--KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCE 347 (501)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCc
Confidence 89999999999999999999999999999999888 8999999999754322 22357899999999999989999
Q ss_pred CccccchhhHHHHHhhCCC-CCCC--CCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 248 PIDMWSLGCILAELYTGCP-LFPG--ENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~-pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
++|||||||++|+|++|.. ||.. .+...++..+...++...+++........-++...... ....
T Consensus 348 ~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~------------~~~~ 415 (501)
T PHA03210 348 ITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEID------------HAGH 415 (501)
T ss_pred HHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcc------------cCcc
Confidence 9999999999999999875 4433 23445566666555544333211100000000000000 0000
Q ss_pred hhhhhh--ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 325 DMASVL--RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 325 ~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
...... ...+.++.++|.+||++||++||||.|+|.||||....
T Consensus 416 ~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 416 SVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred chhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 111111 12467889999999999999999999999999997754
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=309.26 Aligned_cols=288 Identities=31% Similarity=0.565 Sum_probs=231.2
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..+.|+-..+||+|.||.||+|+.+++++. |+|++.-.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme----------------------------------------- 53 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME----------------------------------------- 53 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-----------------------------------------
Confidence 456788899999999999999999999975 66654110
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--------cCeEEEEEeecCcCHHHHHHhhCCCCCCHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--------RNHLCISFELMNLNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--------~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~ 169 (429)
-.+++|....++|+++|..|+|+ |++.+++.+.. ...+|+||.+|+.+|..++.... .+++..
T Consensus 54 --neKeGfpitalreikiL~~lkHe------nv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls 124 (376)
T KOG0669|consen 54 --NEKEGFPITALREIKILQLLKHE------NVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLS 124 (376)
T ss_pred --ccccCCcHHHHHHHHHHHHhcch------hHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCcc-ccccHH
Confidence 11567888899999999999999 66666665532 24699999999999999998664 569999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-------cceeeecCccccchhhhhC
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-------RVYTYIQSRFYRSPEVILG 242 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-------~~~~~~~t~~y~aPE~~~~ 242 (429)
++..++.+++.||.|+|+..|+|||+||.|+||+.+| .+||+|||+++.... .....+.|.+|++||.+.+
T Consensus 125 ~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg--ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG 202 (376)
T KOG0669|consen 125 EIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG--ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG 202 (376)
T ss_pred HHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc--eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhc
Confidence 9999999999999999999999999999999999999 999999999964332 2334567999999999998
Q ss_pred C-CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccC--CCCCccccCCCCCCC
Q psy17270 243 L-PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDS--KGTPRCITNSKGRKR 319 (429)
Q Consensus 243 ~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 319 (429)
. .|+++.|||..|||+.+|+|+.+.+.+.+...++..|..+.|....+.|.......++-.- ...+. .+.
T Consensus 203 ~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~----~~~--- 275 (376)
T KOG0669|consen 203 DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPK----GQK--- 275 (376)
T ss_pred ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCc----chh---
Confidence 6 6999999999999999999999999999999999999999999998888766543332111 10110 000
Q ss_pred CCCCchhhhhhc--cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 320 KPGSKDMASVLR--CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 320 ~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
.-.....+ .-+++..||+.+||..||.+|+++.++|.|.||.....
T Consensus 276 ----rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 276 ----RKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred ----hhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 00111111 12568889999999999999999999999999986543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=328.28 Aligned_cols=286 Identities=31% Similarity=0.573 Sum_probs=228.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++.+.||.|++|.||+|.+..++.. |+|++......
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~------------------------------------- 54 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS------------------------------------- 54 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-------------------------------------
Confidence 3688999999999999999999999888765 88877433211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCe------EEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH------LCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~------~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
......+.+|+.+++.+.|+ |++++++++..... +++|+|+++++|.+++... ++++..
T Consensus 55 ------~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~ 119 (343)
T cd07851 55 ------AIHAKRTYRELRLLKHMDHE------NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDH 119 (343)
T ss_pred ------hhHHHHHHHHHHHHHhccCC------CHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhcC---CCCHHH
Confidence 11123455699999999887 99998887765543 9999999999999998763 499999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCC-CCCCCc
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGL-PYGPPI 249 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~ 249 (429)
+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++...........++..|+|||++.+. .++.++
T Consensus 120 ~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 197 (343)
T cd07851 120 IQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 197 (343)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEccccccccccccccCCcccccccCHHHHhCCCCCCchH
Confidence 999999999999999999999999999999999988 89999999998765555556788899999998764 578899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||.+.+..+.+..+....+.++++++......... ... ..............
T Consensus 198 DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-------~~~----~~~~~~~~~~~~~~ 266 (343)
T cd07851 198 DIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR-------NYI----QSLPQMPKKDFKEV 266 (343)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH-------HHH----HhccccCCCCHHHH
Confidence 9999999999999999999999888888888888888887776544211100 000 00011112233444
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||++||+.||++|||+.|+++||||++..
T Consensus 267 ~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 267 FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred hccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 455688999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=326.88 Aligned_cols=286 Identities=32% Similarity=0.571 Sum_probs=222.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.++|.+.+.||.|+||+||+|.+..++.. |+|.+.......
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~------------------------------------- 45 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR------------------------------------- 45 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-------------------------------------
Confidence 577999999999999999999999888765 888764321110
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELMNLNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|+.+++.+.|+ ||+++++++... ..+|+++||++++|.+++.... .+++..+.
T Consensus 46 ------~~~~~~~~E~~~l~~l~h~------ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~ 111 (337)
T cd07858 46 ------IDAKRTLREIKLLRHLDHE------NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQ--TLSDDHCQ 111 (337)
T ss_pred ------chhHHHHHHHHHHHhcCCC------CccchHHheecccccccCcEEEEEeCCCCCHHHHHhcCC--CCCHHHHH
Confidence 0112345699999999887 999999887644 3589999999999999987654 49999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhC-CCCCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILG-LPYGPP 248 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~ 248 (429)
.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...... .....++..|+|||.+.+ ..++.+
T Consensus 112 ~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 189 (337)
T cd07858 112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTA 189 (337)
T ss_pred HHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCc
Confidence 9999999999999999999999999999999887 8999999998764332 233467889999999875 458899
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|+|||||++|+|++|+.||.+.+....+..+....+.++.+.+........ .... + ............
T Consensus 190 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~---~-~~~~~~~~~~~~ 258 (337)
T cd07858 190 IDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA-------RRYI---R-SLPYTPRQSFAR 258 (337)
T ss_pred ccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh-------hHHH---H-hcCcccccCHHH
Confidence 9999999999999999999999988888888888888877665532211100 0000 0 000001111223
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
..+..++.+.+||++||+.||++|||+.|+++||||....
T Consensus 259 ~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 259 LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 3345688999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=327.99 Aligned_cols=288 Identities=29% Similarity=0.554 Sum_probs=227.3
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.++|++.+.||.|+||.||+|.+..++.. |+|++......
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-------------------------------------- 44 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-------------------------------------- 44 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc--------------------------------------
Confidence 458899999999999999999999988865 88876432110
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE----cCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF----RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
......+.+|+.+++.++|+ ||+++++++.. ...+++||||++++|.+++.... .+++..+..
T Consensus 45 -----~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~ 111 (334)
T cd07855 45 -----PTLAKRTLRELKILRHFKHD------NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ--PLTEEHIRY 111 (334)
T ss_pred -----ccchHHHHHHHHHHHhcCCC------CccCHHHhccccCCCCceEEEEEehhhhhHHHHhccCC--CCCHHHHHH
Confidence 11223455699999999877 99998888753 35789999999999999887654 399999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-------ceeeecCccccchhhhhC-CCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-------VYTYIQSRFYRSPEVILG-LPY 245 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~-~~~ 245 (429)
++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+...... .....++..|+|||++.+ ..+
T Consensus 112 i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 189 (334)
T cd07855 112 FLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC--ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEY 189 (334)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEecccccceeecccCcCCCcccccccccccccChHHhcCCccc
Confidence 999999999999999999999999999999988 8999999998653321 123467889999999876 457
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|||||||++|+|++|+.||.+.+...++..+....+.++.+.+.........-.... ........
T Consensus 190 ~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~ 258 (334)
T cd07855 190 TTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN-----------LPRKQPVP 258 (334)
T ss_pred ccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhh-----------cccCCCCC
Confidence 8999999999999999999999999999999999999999988887654432221100000 00111112
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
.....+..++++.+||.+||+.||++|||+.+++.||||.+....
T Consensus 259 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 259 WSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 233445568999999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=321.02 Aligned_cols=283 Identities=32% Similarity=0.547 Sum_probs=216.1
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
.-++|++.+.||.|+||.||+|.+..++.. |+|.+.....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--------------------------------------- 50 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--------------------------------------- 50 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC---------------------------------------
Confidence 346799999999999999999999888865 8887632211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC--------eEEEEEeecCcCHHHHHHhhCCCCCCHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN--------HLCISFELMNLNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~--------~~~lv~e~~~g~L~~~i~~~~~~~~~~~ 169 (429)
...+...+.+|+++++++.|+ ||+++++++.... ..++||||++++|.+++.... ..+++.
T Consensus 51 ----~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~ 119 (310)
T cd07865 51 ----KEGFPITALREIKILQLLKHE------NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLS 119 (310)
T ss_pred ----cCCchhHHHHHHHHHHhCCCC------CccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHH
Confidence 112223445699999999887 9999999886543 469999999999998887653 358999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-------eeeecCccccchhhhhC
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-------YTYIQSRFYRSPEVILG 242 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-------~~~~~t~~y~aPE~~~~ 242 (429)
++..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... ....++..|+|||++.+
T Consensus 120 ~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 197 (310)
T cd07865 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG--ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG 197 (310)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC--cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcC
Confidence 9999999999999999999999999999999999888 89999999986543211 22456788999999876
Q ss_pred C-CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 243 L-PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 243 ~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
. .++.++||||||+++|+|++|..||.+.+....+..+....+..+.+++........+ .....+... .
T Consensus 198 ~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---------~ 267 (310)
T cd07865 198 ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELF-KKMELPQGQ---------K 267 (310)
T ss_pred CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhh-hhccCCCcc---------c
Confidence 5 3688999999999999999999999999888888888888887777665433221110 000000000 0
Q ss_pred CCchhhhh-hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 322 GSKDMASV-LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 322 ~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
......+ ....+..+.+||.+||..||.+|||+.|+++||||
T Consensus 268 -~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 268 -RKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred -hhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0000000 01236778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.22 Aligned_cols=278 Identities=27% Similarity=0.543 Sum_probs=222.1
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|+++++||.|++|.||+|++..++.. |+|++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----------------------------------------- 39 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----------------------------------------- 39 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-----------------------------------------
Confidence 599999999999999999999888865 88877432211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhC-CCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNN-YQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~-~~~~~~~~~~~i~~qil 179 (429)
.....+.+|+++++.+.|+ ||+++++++...+..++||||+.++|.+++.... ...+++..+..++.|++
T Consensus 40 ---~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~ 110 (284)
T cd07836 40 ---GTPSTAIREISLMKELKHE------NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110 (284)
T ss_pred ---cchHHHHHHHHHHHhhcCC------CEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHH
Confidence 1112445699999999877 9999999999999999999999999999887654 23489999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG 255 (429)
.||.|||++|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||++.+. .++.++|+||||
T Consensus 111 ~~l~~lH~~~i~h~dl~p~ni~~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG 188 (284)
T cd07836 111 KGIAFCHENRVLHRDLKPQNLLINKRG--ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG 188 (284)
T ss_pred HHHHHHHHCCeeeCCCCHHHEEECCCC--cEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHH
Confidence 999999999999999999999999888 8999999998654322 2234568889999998764 468899999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|+.||.+.+..+....+.+....+.+..+.......... ...+...........+..++
T Consensus 189 ~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~ 255 (284)
T cd07836 189 CIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK-------------PTFPRYPPQDLQQLFPHADP 255 (284)
T ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc-------------ccccCCChHHHHHHhhhcCc
Confidence 99999999999999998888888888888777776665443211100 00011111222333445678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.+.++|.+||+.||.+||++.++++||||
T Consensus 256 ~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 256 LGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 89999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=326.14 Aligned_cols=297 Identities=27% Similarity=0.511 Sum_probs=227.4
Q ss_pred ccccCCeEEE-eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 17 DHICYRYEIL-EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 17 ~~~~~rY~i~-~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
..+.+||..+ +.||.|+||+||+|.+..++.. |+|++.............+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~--------------------------- 56 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQ--------------------------- 56 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchh---------------------------
Confidence 3578899865 6799999999999999877754 8888754322211110000
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
..........+.+|+++++.+.|+ ||+++++++......++|||++.++|.+++.... .+++..+..+
T Consensus 57 ----~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~ 124 (335)
T PTZ00024 57 ----LVGMCGIHFTTLRELKIMNEIKHE------NIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCI 124 (335)
T ss_pred ----hhcccccchhHHHHHHHHHhCCCc------ceeeeeEEEecCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHH
Confidence 000112234567799999999887 9999999999999999999999999999987654 4999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----------------cceeeecCccccch
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----------------RVYTYIQSRFYRSP 237 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----------------~~~~~~~t~~y~aP 237 (429)
+.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+..... ......++..|+||
T Consensus 125 ~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 202 (335)
T PTZ00024 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKG--ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAP 202 (335)
T ss_pred HHHHHHHHHHHHhCCeecccccHHHeEECCCC--CEEECCccceeecccccccccccccccccccccccccccccCCCCC
Confidence 99999999999999999999999999999888 899999999865431 11123457789999
Q ss_pred hhhhCC-CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCC
Q psy17270 238 EVILGL-PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316 (429)
Q Consensus 238 E~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (429)
|.+.+. .++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.+....+.......... .
T Consensus 203 E~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~------------~- 269 (335)
T PTZ00024 203 ELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYT------------E- 269 (335)
T ss_pred hhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhccccc------------c-
Confidence 998765 46889999999999999999999999999999998888888877765443221111000 0
Q ss_pred CCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
................+..+.+||.+||+.||++|||+.|+|.||||+...
T Consensus 270 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 270 -FTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred -cCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 001111222333445578899999999999999999999999999998653
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=343.59 Aligned_cols=257 Identities=24% Similarity=0.264 Sum_probs=206.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...+||++.+.||+|+||+||+|.+..++.. |+|++.......
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~------------------------------------ 72 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE------------------------------------ 72 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH------------------------------------
Confidence 3568999999999999999999999888865 999875432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC--------eEEEEEeecC-cCHHHHHHhhC--CCC
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN--------HLCISFELMN-LNLYELIKRNN--YQG 165 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~--------~~~lv~e~~~-g~L~~~i~~~~--~~~ 165 (429)
.....+.+|+.++..+.|+ ||+++++.+.... .+++||||+. |+|.+++.... ...
T Consensus 73 -------~~~~~~~~Ei~~l~~~~h~------~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~ 139 (496)
T PTZ00283 73 -------ADKNRAQAEVCCLLNCDFF------SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRT 139 (496)
T ss_pred -------HHHHHHHHHHHHHhcCCCC------cEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCC
Confidence 1112345588888887776 9999887775432 4789999995 79999987542 235
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----cceeeecCccccchhhh
Q psy17270 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RVYTYIQSRFYRSPEVI 240 (429)
Q Consensus 166 ~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~ 240 (429)
+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.... .....+||+.|+|||++
T Consensus 140 l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~--~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 217 (496)
T PTZ00283 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG--LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217 (496)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC--CEEEEecccCeeccccccccccccccCCcceeCHHHh
Confidence 89999999999999999999999999999999999999988 899999999865332 22346789999999999
Q ss_pred hCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCC
Q psy17270 241 LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRK 320 (429)
Q Consensus 241 ~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (429)
.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 218 ~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~---------------------------------- 263 (496)
T PTZ00283 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD---------------------------------- 263 (496)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC----------------------------------
Confidence 9989999999999999999999999999987766555444321000
Q ss_pred CCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 321 PGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
..+...++.+.+++.+||+.||.+||++.+++.|||++.
T Consensus 264 -------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 264 -------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred -------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 011234788999999999999999999999999999875
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=318.48 Aligned_cols=280 Identities=31% Similarity=0.500 Sum_probs=222.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|++.+.||.|+||.||+|.+..++.. |+|.+......
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------------------------------------- 44 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---------------------------------------- 44 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc----------------------------------------
Confidence 5799999999999999999999888765 88876422110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
..+...+.+|+.+++.++|+ ||+++++++... ...|+||||++++|.+++.... ..+++..+..++.|
T Consensus 45 ---~~~~~~~~~e~~~l~~l~h~------ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~q 114 (293)
T cd07843 45 ---EGFPITSLREINILLKLQHP------NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQ 114 (293)
T ss_pred ---ccchhhHHHHHHHHHhcCCC------CEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHH
Confidence 12233456699999999877 999999999877 8999999999999999987654 35899999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCC-CCCCccccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLP-YGPPIDMWS 253 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~DiwS 253 (429)
++.||+|||++|++|+||||+||+++.++ .++|+|||++...... .....+++.|+|||.+.+.. ++.++|+||
T Consensus 115 i~~aL~~LH~~~i~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 192 (293)
T cd07843 115 LLSGVAHLHDNWILHRDLKTSNLLLNNRG--ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWS 192 (293)
T ss_pred HHHHHHHHHHCCeeeccCCHHHEEECCCC--cEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHH
Confidence 99999999999999999999999999988 8999999998754432 22345788899999987654 688999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc-
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC- 332 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 332 (429)
|||++|+|++|.+||...+..+.+..+....+.+....+........... .... ...........+.
T Consensus 193 lG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~~ 260 (293)
T cd07843 193 VGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK-KTFT-----------KYPYNQLRKKFPAL 260 (293)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc-cccc-----------cccchhhhcccccc
Confidence 99999999999999999999999999998888887777654432111100 0000 0001111111222
Q ss_pred -CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 333 -NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 333 -~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.++.+.++|++||+.||++|||+.|+++|+||
T Consensus 261 ~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 261 SLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred CCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 37889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=325.77 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=191.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecC-----CC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHK-----TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
+-.+||++.++||.|+||.||+|.+.. ++ .+|+|++......
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------------------- 51 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA-------------------------------- 51 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--------------------------------
Confidence 346799999999999999999998632 22 3588876432211
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEc-CeEEEEEeecC-cCHHHHHHhhC------
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFR-NHLCISFELMN-LNLYELIKRNN------ 162 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~-g~L~~~i~~~~------ 162 (429)
.....+.+|++++..+ .|+ ||+++++++... ..++++|||+. |+|.+++....
T Consensus 52 ------------~~~~~~~~E~~~l~~l~~h~------niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~ 113 (338)
T cd05102 52 ------------SEHKALMSELKILIHIGNHL------NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPY 113 (338)
T ss_pred ------------HHHHHHHHHHHHHHHhccCc------ceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccc
Confidence 1123466699999999 555 999999988764 46899999994 79999987532
Q ss_pred ------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17270 163 ------------------------------------------------------YQGFSLGLIRRFAFSLVQCLRLLHRE 188 (429)
Q Consensus 163 ------------------------------------------------------~~~~~~~~~~~i~~qil~~l~~lH~~ 188 (429)
...+++..+..++.||+.||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 193 (338)
T cd05102 114 REKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193 (338)
T ss_pred cccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 12477889999999999999999999
Q ss_pred CceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT 263 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 263 (429)
||+||||||+|||++.++ .++|+|||+++..... .....++..|+|||++.+..++.++|||||||++|+|++
T Consensus 194 ~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~ 271 (338)
T cd05102 194 KCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271 (338)
T ss_pred CEECCCCccceEEEcCCC--cEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHh
Confidence 999999999999999887 8999999998753221 112334578999999998889999999999999999997
Q ss_pred -CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHH
Q psy17270 264 -GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVT 342 (429)
Q Consensus 264 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 342 (429)
|..||.+....+.+...... +.. ...+...++.+.+++.
T Consensus 272 ~g~~pf~~~~~~~~~~~~~~~-~~~---------------------------------------~~~~~~~~~~l~~li~ 311 (338)
T cd05102 272 LGASPYPGVQINEEFCQRLKD-GTR---------------------------------------MRAPENATPEIYRIML 311 (338)
T ss_pred CCCCCCCCCCccHHHHHHHhc-CCC---------------------------------------CCCCCCCCHHHHHHHH
Confidence 99999886543332221110 000 0001223678999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q psy17270 343 QCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 343 ~~L~~dP~~Rpta~ell~ 360 (429)
+||+.||++|||+.|+++
T Consensus 312 ~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 312 ACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHccCChhhCcCHHHHHH
Confidence 999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=322.44 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=210.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|+||+||+|.+..++.. |+|.+.......
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK--------------------------------------- 41 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch---------------------------------------
Confidence 4799999999999999999999887754 888875432211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+..|+++++.+.|+ ||+++++.+......|+||||+. ++|.+++.......+++..+..++.|+
T Consensus 42 ---~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi 112 (316)
T cd05574 42 ---RNKVKRVLTEQEILATLDHP------FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112 (316)
T ss_pred ---HHHHHHHHHHHHHHHhCCCC------CchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHH
Confidence 11223566699999999876 99999999999999999999995 599999887655569999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--------------------------------ce
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--------------------------------VY 226 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--------------------------------~~ 226 (429)
+.||+|||+.|++|+||||+||+++.++ .++|+|||++...... ..
T Consensus 113 ~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (316)
T cd05574 113 LLALEYLHLLGIVYRDLKPENILLHESG--HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSN 190 (316)
T ss_pred HHHHHHHHHCCeeccCCChHHeEEcCCC--CEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCC
Confidence 9999999999999999999999999888 8999999987542211 11
Q ss_pred eeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 227 TYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 227 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
...||..|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+.......+.
T Consensus 191 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------- 253 (316)
T cd05574 191 SFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPG----------------- 253 (316)
T ss_pred CCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCC-----------------
Confidence 236788899999999888999999999999999999999999988776555444320000000
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCC----HHHHhcCCCCCCCC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT----PDEALRHEWLKSSS 368 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~ell~h~~~~~~~ 368 (429)
....++.+.++|.+||..||++||| ++|++.||||++..
T Consensus 254 -----------------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 254 -----------------------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred -----------------------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 0013688999999999999999999 99999999998654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.18 Aligned_cols=280 Identities=26% Similarity=0.470 Sum_probs=214.0
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|++++.||.|+||.||+|.+..++.. |+|++.....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------------------------------------- 43 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---------------------------------------- 43 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc----------------------------------------
Confidence 46899999999999999999999877754 8887632211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+.+|+++++.++|+ ||+++++++......|+||||+.+++.+.+.... ..+++..+..++.|+
T Consensus 44 ----~~~~~~~~~e~~~l~~l~h~------ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi 112 (291)
T cd07870 44 ----EGVPFTAIREASLLKGLKHA------NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQL 112 (291)
T ss_pred ----CCCcHHHHHHHHHHHhcCCC------CEeEEEEEEecCCeEEEEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHH
Confidence 01122445699999999887 9999999999999999999999999888876543 358889999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCC-CCCCCccccch
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGL-PYGPPIDMWSL 254 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSl 254 (429)
+.||+|||++|++|+||||+||+++.++ .++|+|||++..... ......++..|+|||++.+. .++.++|+|||
T Consensus 113 ~~~L~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 190 (291)
T cd07870 113 LRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGA 190 (291)
T ss_pred HHHHHHHHhCCcccCCCChHHEEEcCCC--cEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHH
Confidence 9999999999999999999999999888 899999999865322 12334578889999998764 47889999999
Q ss_pred hhHHHHHhhCCCCCCCCC-HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc--
Q psy17270 255 GCILAELYTGCPLFPGEN-EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR-- 331 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 331 (429)
||++|+|++|..||.+.+ ..+.+..+....+.+.+..+........+. ...... ...........
T Consensus 191 G~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----------~~~~~~~~~~~~~ 258 (291)
T cd07870 191 GCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK-PEWFLP-----------CKPQQLRVVWKRL 258 (291)
T ss_pred HHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc-chhccc-----------cCCcchhhhcccc
Confidence 999999999999997654 446677777777777766554332211000 000000 00000111111
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
..+..+.+++.+||..||++|||+.|++.||||
T Consensus 259 ~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 259 SRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred CCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 125788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.36 Aligned_cols=286 Identities=30% Similarity=0.561 Sum_probs=226.1
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.+||++++.||.|+||.||+|.+..++.. |+|++......
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------------------------- 54 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS------------------------------------- 54 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-------------------------------------
Confidence 3688999999999999999999999888864 88876432111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC------eEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN------HLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~------~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
......+.+|+++++.+.|+ ||+++++++.... .+++|||+++++|.+++... .+++..
T Consensus 55 ------~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~ 119 (343)
T cd07880 55 ------ELFAKRAYRELRLLKHMKHE------NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE---KLSEDR 119 (343)
T ss_pred ------hHHHHHHHHHHHHHHhcCCC------CccceeeeecCCccccccceEEEEEecCCCCHHHHHhcC---CCCHHH
Confidence 11223456799999999887 9999999987543 46999999988998888653 499999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCC-CCCCCc
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGL-PYGPPI 249 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~ 249 (429)
+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||.+...........+++.|+|||++.+. .++.++
T Consensus 120 ~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 197 (343)
T cd07880 120 IQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTV 197 (343)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHH
Confidence 999999999999999999999999999999999887 89999999997665544455678899999998763 578899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|+|||||++|+|++|..||.+.+....+..+....+.++.++.......... ..... ............
T Consensus 198 Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~----~~~~~~~~~~~~ 266 (343)
T cd07880 198 DIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK-------NYVKK----LPRFRKKDFRSL 266 (343)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH-------HHHHh----ccccCcchHHHh
Confidence 9999999999999999999998888888888887777776655433211100 00000 001111223344
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.++|.+||+.||++|||+.+++.||||+...
T Consensus 267 ~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 267 LPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred ccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 456688899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=321.97 Aligned_cols=286 Identities=29% Similarity=0.564 Sum_probs=223.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.+||++.+.||+|+||.||+|.+..++.. |+|++........
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------- 58 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----------------------------------- 58 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH-----------------------------------
Confidence 4679999999999999999999999888865 8888754321111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
....+.+|++++++++|+ ||+++++++... ...|+++++++++|.+++... .+++..
T Consensus 59 --------~~~~~~~Ei~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~ 121 (345)
T cd07877 59 --------HAKRTYRELRLLKHMKHE------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDH 121 (345)
T ss_pred --------HHHHHHHHHHHHHHcCCC------cccceeeeeeecccccccccEEEEehhcccCHHHHHhcC---CCCHHH
Confidence 122455699999999887 999999887543 358899999999998887654 389999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC-CCCCCCc
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPI 249 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~ 249 (429)
+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...........++..|+|||++.+ ..++.++
T Consensus 122 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 199 (345)
T cd07877 122 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 199 (345)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC--CEEEecccccccccccccccccCCCccCHHHHhCccCCCchh
Confidence 999999999999999999999999999999999988 8999999999876555455678899999999876 4678899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||...+....+..+....+.++..+........... ...... ..........
T Consensus 200 DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~----~~~~~~~~~~ 268 (345)
T cd07877 200 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN-------YIQSLT----QMPKMNFANV 268 (345)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH-------HHHHhc----ccCCcchhhh
Confidence 99999999999999999999988888888888888887777654332110000 000000 0000011112
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||.+||+.||.+|||+.+++.||||++..
T Consensus 269 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 269 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 223477899999999999999999999999999998744
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.61 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=204.3
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|++.+.||.|++|.||+|.+..++.. |+|.+..........
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~------------------------------------ 45 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETK------------------------------------ 45 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhH------------------------------------
Confidence 4699999999999999999999887765 888875432211110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+|+++++++.|+ ||+++++++.....+++++|++. ++|.+++.... .+++..+..++.|+
T Consensus 46 ----~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l 113 (263)
T cd06625 46 ----KEVNALECEIQLLKNLQHE------RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQI 113 (263)
T ss_pred ----HHHHHHHHHHHHHHhCCCC------CeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHH
Confidence 1122456699999999877 99999999999999999999995 68999988764 38999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhCCCCCCCcccc
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
+.||+|||+.|++|+||+|+||+++.++ .++|+|||++....... ....++..|+|||++.+..++.++|||
T Consensus 114 ~~~l~~lH~~~i~H~dl~p~nilv~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 191 (263)
T cd06625 114 LEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVW 191 (263)
T ss_pred HHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhH
Confidence 9999999999999999999999999887 89999999986433211 224567889999999998899999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|+.||...+.......+..... ....+..
T Consensus 192 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~ 231 (263)
T cd06625 192 SVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT----------------------------------------NPQLPSH 231 (263)
T ss_pred HHHHHHHHHHhCCCCccccchHHHHHHHhccCC----------------------------------------CCCCCcc
Confidence 999999999999999987655444333221000 0011123
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.+..+.++|++||..||++|||+.++++|+||
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 232 VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 46788999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=324.47 Aligned_cols=286 Identities=29% Similarity=0.549 Sum_probs=224.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|.+.+.||.|+||.||+|++..++.. |+|++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------------------------------------- 53 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-------------------------------------- 53 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--------------------------------------
Confidence 3578999999999999999999999887764 8887643211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
.......+.+|+.+++.+.|+ ||+++++++... ..+++|+||+..+|..++. ..+++..
T Consensus 54 -----~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~ 118 (342)
T cd07879 54 -----SEIFAKRAYRELTLLKHMQHE------NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG----HPLSEDK 118 (342)
T ss_pred -----cccchhHHHHHHHHHHhcCCC------CccchhheecccccCCCCceEEEEecccccCHHHHHc----CCCCHHH
Confidence 111233566799999999887 999999988654 3579999999888776642 2489999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC-CCCCCCc
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPI 249 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~ 249 (429)
+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++...........++..|+|||++.+ ..++.++
T Consensus 119 ~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 196 (342)
T cd07879 119 VQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTV 196 (342)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchH
Confidence 999999999999999999999999999999999988 8999999999765554445577889999999876 4588899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|+|||||++|+|++|+.||.+.+....+..+....+.+..++................ ...........
T Consensus 197 Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~ 265 (342)
T cd07879 197 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSL-----------PKYPRKDFSTL 265 (342)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhc-----------CCcccchHHHH
Confidence 9999999999999999999998888888888888887777765544221110000000 01111222333
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
.+..++.+.+||++||+.||++||++.+++.||||+....
T Consensus 266 ~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 266 FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 3455788999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=319.28 Aligned_cols=286 Identities=27% Similarity=0.514 Sum_probs=214.9
Q ss_pred CeEEEeEeeccccceEEEEEecC--CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHK--TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~--~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
+|++.+.||+|+||.||+|.+.. ++. +|+|.+......
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~--------------------------------------- 41 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ--------------------------------------- 41 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc---------------------------------------
Confidence 69999999999999999999987 554 488887432110
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecCcCHHHHHHhhCC---CCCCHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMNLNLYELIKRNNY---QGFSLGLIRR 173 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g~L~~~i~~~~~---~~~~~~~~~~ 173 (429)
.......+.+|+.+++.++|+ ||+++++++... ..+++||||++++|.+++..... ..+++..+..
T Consensus 42 ---~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 112 (316)
T cd07842 42 ---YTGISQSACREIALLRELKHE------NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS 112 (316)
T ss_pred ---ccCccHHHHHHHHHHHhcCCC------CccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHH
Confidence 112334556799999999887 999999999988 78999999999999888764432 2589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEec----CCCcceEEeeecccccccCc------ceeeecCccccchhhhhCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQ----RGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILGL 243 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~----~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~ 243 (429)
++.|++.||+|||++|++||||||+||+++. ++ .++|+|||++...... .....++..|+|||++.+.
T Consensus 113 i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 190 (316)
T cd07842 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG--VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA 190 (316)
T ss_pred HHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc--eEEECCCccccccCCCcccccccCCccccccccCHHHHhCC
Confidence 9999999999999999999999999999998 66 8999999998754322 1234678889999998764
Q ss_pred -CCCCCccccchhhHHHHHhhCCCCCCCCCHH---------HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccC
Q psy17270 244 -PYGPPIDMWSLGCILAELYTGCPLFPGENEV---------EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313 (429)
Q Consensus 244 -~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (429)
.++.++|||||||++|+|++|++||.+.... ..+..++..++.+....+........+... . .
T Consensus 191 ~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~------~-~ 263 (316)
T cd07842 191 RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTL------M-K 263 (316)
T ss_pred CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhh------h-h
Confidence 5788999999999999999999999765532 356667777776666555332221110000 0 0
Q ss_pred CCCCCCCCCC--chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 314 SKGRKRKPGS--KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 314 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.......+.. ....+.....+..+.+++.+||+.||++|||+.|+++||||
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 264 DFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000111111 11111112567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=324.58 Aligned_cols=287 Identities=21% Similarity=0.236 Sum_probs=203.8
Q ss_pred EEeEeecc--ccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 25 ILEVIGKG--SFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 25 i~~~lG~G--~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
++++||+| +||+||++.+..+++. |+|.+........
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~---------------------------------------- 41 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE---------------------------------------- 41 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH----------------------------------------
Confidence 57889999 7899999999999876 8998754322111
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
....+.+|+++++.++|+ ||+++++++..++..++||||+. ++|.+++..+....+++..++.++.|++.
T Consensus 42 ---~~~~~~~e~~~l~~l~hp------niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~ 112 (327)
T cd08227 42 ---MVTFLQGELHVSKLFNHP------NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLK 112 (327)
T ss_pred ---HHHHHHHHHHHHHhcCCC------CeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHH
Confidence 122345599999999887 99999999999999999999995 69999998765456999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC----------cceeeecCccccchhhhhCC--CCCCC
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----------RVYTYIQSRFYRSPEVILGL--PYGPP 248 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~----------~~~~~~~t~~y~aPE~~~~~--~~~~~ 248 (429)
||+|||++|++||||||+||+++.++ .++++||+....... ......++..|+|||++.+. .++.+
T Consensus 113 ~L~~LH~~~iiH~dlkp~Nil~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 190 (327)
T cd08227 113 ALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 190 (327)
T ss_pred HHHHHHHCCEecCCCChhhEEEecCC--cEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCch
Confidence 99999999999999999999999888 899999986533211 11123456779999999863 58899
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCc----------HHHHhhhhhhhhhccCCCCCccccCCCCCC
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP----------DEVINTASRRRLFFDSKGTPRCITNSKGRK 318 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (429)
+|||||||++|+|++|..||.............. +..+ ++........ ..+....... .... ..
T Consensus 191 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~-~~ 264 (327)
T cd08227 191 SDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPAEELTMKPSRS--GANSGLGEST-TVST-PR 264 (327)
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchhhhhcccCCccc--CCcCCCCccc-ccCC-cC
Confidence 9999999999999999999987655443322221 1111 1100000000 0000000000 0000 00
Q ss_pred CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
...............++.+.+||++||+.||++|||+.|+++||||++..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 265 PSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred ccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00000111112234578899999999999999999999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=321.13 Aligned_cols=286 Identities=30% Similarity=0.596 Sum_probs=227.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.++|++++.||.|+||.||+|.+..++.. |+|++......
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------------------------------------- 49 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-------------------------------------- 49 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc--------------------------------------
Confidence 688999999999999999999999988865 88876432111
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE-cCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
......+.+|+++++.++|+ ||++++++|.. ...+++++||++++|.+++... ++++..+..++.
T Consensus 50 -----~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ 115 (328)
T cd07856 50 -----PVLAKRTYRELKLLKHLRHE------NIISLSDIFISPLEDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLY 115 (328)
T ss_pred -----cchhHHHHHHHHHHHhcCCC------CeeeEeeeEecCCCcEEEEeehhccCHHHHHhcC---CCCHHHHHHHHH
Confidence 11123455699999999887 99999999876 4579999999999998888753 388999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC-CCCCCCccccchh
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPIDMWSLG 255 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG 255 (429)
|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+...........++..|+|||++.+ ..++.++|+||||
T Consensus 116 ql~~aL~~LH~~~iiH~dl~p~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 193 (328)
T cd07856 116 QILRGLKYVHSAGVVHRDLKPSNILINENC--DLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAG 193 (328)
T ss_pred HHHHHHHHHHhCCcccCCCCHHHEeECCCC--CEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHH
Confidence 999999999999999999999999999887 8999999999766554445567889999998766 4688999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|+.||.+.+.......+.+.++.+++++......... ....... ......+..+.....++
T Consensus 194 ~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~----~~~~~~~~~~~~~~~~~ 262 (328)
T cd07856 194 CIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT-------LRFVQSL----PKREPVPFSEKFKNADP 262 (328)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh-------HHHHhhc----cccCCCcHHHHcCCCCH
Confidence 999999999999999988888888889999998888654322110 0000000 00111122333445678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
.+.++|++||+.||++|||+.+++.|+||.....
T Consensus 263 ~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 263 SAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 9999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=313.80 Aligned_cols=281 Identities=33% Similarity=0.631 Sum_probs=218.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||+|+||.||+|.+..+++. |+|++.....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~----------------------------------------- 39 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED----------------------------------------- 39 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-----------------------------------------
Confidence 5899999999999999999999988754 8887643211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.......+.+|+++++.+.|+ ||+++++++...+..+++|||+++++.+.+.... ..+++..+..++.||+
T Consensus 40 --~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~ 110 (288)
T cd07833 40 --DEDVKKTALREVKVLRQLRHE------NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLL 110 (288)
T ss_pred --cccchhHHHHHHHHHHhcCCC------CeeehhheEEECCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHH
Confidence 112334667799999999877 9999999999999999999999876666554443 3489999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCC-CCCCCccccch
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGL-PYGPPIDMWSL 254 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSl 254 (429)
.||.|||.+|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||++.+. .++.++|+|||
T Consensus 111 ~~l~~LH~~~i~H~dl~~~ni~~~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~sl 188 (288)
T cd07833 111 QAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAI 188 (288)
T ss_pred HHHHHHHHCCeecCCCCHHHeEECCCC--CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHH
Confidence 999999999999999999999999887 8999999998764432 2235678889999999888 78899999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh-hhccC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS-VLRCN 333 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 333 (429)
|+++|+|++|++||.+.+..+.+..+...++..+.............. .... ........... .....
T Consensus 189 G~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~~~~~ 257 (288)
T cd07833 189 GCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA-GVAF----------PEPSQPESLERRYPGKV 257 (288)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc-cccc----------CCCCCcHHHHHhcCCcc
Confidence 999999999999999988888888887777776665433221110000 0000 00000111111 12234
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
++.+.+||++||..||++|||+.++++|+||
T Consensus 258 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 258 SSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred chHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 7889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=330.84 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=201.4
Q ss_pred EeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhh
Q psy17270 28 VIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFH 106 (429)
Q Consensus 28 ~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (429)
+||.|+||+||.|+|..|... |||.+... ..++.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---------------------------------------------dsr~~ 616 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---------------------------------------------DSREV 616 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---------------------------------------------cchhh
Confidence 799999999999999999865 88877322 12334
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCC--CHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGF--SLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~--~~~~~~~i~~qil~~l~ 183 (429)
+.+..|+.+.++|+|. ||+++++.+..++++-|.||-. +|+|..+++..= +++ .+.++..|.+||++||.
T Consensus 617 QPLhEEIaLH~~LrHk------NIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLk 689 (1226)
T KOG4279|consen 617 QPLHEEIALHSTLRHK------NIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLK 689 (1226)
T ss_pred ccHHHHHHHHHHHhhH------hHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhh
Confidence 5667799999999998 9999999999999999999999 579999987643 345 78999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCCcceEEeeeccccc---ccCcceeeecCccccchhhhhCC--CCCCCccccchhhHH
Q psy17270 184 LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGL--PYGPPIDMWSLGCIL 258 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~---~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il 258 (429)
|||.+.|||||||-+|+|++... ..+||.|||-++. .+....++.||..|||||++.+. .|+.++|||||||++
T Consensus 690 YLHen~IVHRDIKGDNVLvNTyS-GvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~ 768 (1226)
T KOG4279|consen 690 YLHENKIVHRDIKGDNVLVNTYS-GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTM 768 (1226)
T ss_pred hhhhcceeeccccCCcEEEeecc-ceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhcccee
Confidence 99999999999999999998752 2899999999875 33445678999999999999865 599999999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 259 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
.||.||++||......... ++.. |. .....+ ++...+.+++
T Consensus 769 vEMATGrPPF~ElgspqAA--MFkV-Gm---------------------------------yKvHP~---iPeelsaeak 809 (1226)
T KOG4279|consen 769 VEMATGRPPFVELGSPQAA--MFKV-GM---------------------------------YKVHPP---IPEELSAEAK 809 (1226)
T ss_pred EeeccCCCCeeecCChhHh--hhhh-cc---------------------------------eecCCC---CcHHHHHHHH
Confidence 9999999999765432221 1110 10 000111 1112267889
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 339 DFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 339 ~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.||.+|+.+||.+||+|.++|++||++...
T Consensus 810 ~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 810 NFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 999999999999999999999999998763
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.58 Aligned_cols=264 Identities=26% Similarity=0.416 Sum_probs=207.1
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
++.+.++|++++.||.|+||+||+|.+..++.. |+|++......
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~----------------------------------- 52 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK----------------------------------- 52 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-----------------------------------
Confidence 456778999999999999999999999988865 78876433211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecC-cCHHHHHHhhC--CCCCCHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMN-LNLYELIKRNN--YQGFSLG 169 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~-g~L~~~i~~~~--~~~~~~~ 169 (429)
......+..|+.+++.|.|+ ||++++++|... ..+|+||||+. ++|.+++.... ...+++.
T Consensus 53 --------e~~~~~~~~EI~IL~~L~HP------NIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~ 118 (1021)
T PTZ00266 53 --------EREKSQLVIEVNVMRELKHK------NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118 (1021)
T ss_pred --------HHHHHHHHHHHHHHHHcCCC------CcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHH
Confidence 11223566699999999887 999999998654 57999999995 69999987532 2359999
Q ss_pred HHHHHHHHHHHHHHHHHHC-------CceecccCCCcEEEecC---------------CCcceEEeeecccccccCc--c
Q psy17270 170 LIRRFAFSLVQCLRLLHRE-------NIIHCDLKPENVLLKQR---------------GSSSIKVIDFGSSCYSHQR--V 225 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~-------~ivH~dlkp~Nili~~~---------------~~~~vkl~Dfg~~~~~~~~--~ 225 (429)
.++.|+.||+.||.|||+. +||||||||+|||++.. +...++|+|||++...... .
T Consensus 119 ~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~ 198 (1021)
T PTZ00266 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA 198 (1021)
T ss_pred HHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccc
Confidence 9999999999999999985 49999999999999642 2235899999998754322 2
Q ss_pred eeeecCccccchhhhhCC--CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhcc
Q psy17270 226 YTYIQSRFYRSPEVILGL--PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFD 303 (429)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 303 (429)
...+||+.|+|||++.+. .++.++||||||||+|+|+||..||...+....+..........+
T Consensus 199 ~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp--------------- 263 (1021)
T PTZ00266 199 HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP--------------- 263 (1021)
T ss_pred cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC---------------
Confidence 345789999999999753 478899999999999999999999987665544332221000000
Q ss_pred CCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 304 SKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
....+.++.+||..||..||.+||++.|+|.|+|++....
T Consensus 264 --------------------------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 264 --------------------------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred --------------------------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 0123678999999999999999999999999999986543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=306.95 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=206.1
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|.+.+.||+|++|.||+|.+..++.. ++|.+......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----------------------------------------- 39 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN----------------------------------------- 39 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-----------------------------------------
Confidence 388999999999999999999888764 88876432111
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+++++.++|+ ||+++++++......++||||+. ++|.+++.......+++..+..++.|++
T Consensus 40 --~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~ 111 (256)
T cd08529 40 --RREREEAIDEARVLAKLDSS------YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL 111 (256)
T ss_pred --HHHHHHHHHHHHHHHhcCCC------CeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 11123456699999999887 99999999999999999999995 6999999876545699999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... .....+++.|+|||++.+..++.++|+|||||
T Consensus 112 ~al~~lH~~~i~h~dl~~~nili~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 189 (256)
T cd08529 112 LGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGV 189 (256)
T ss_pred HHHHHHHHCCcccCCCCcceEEEeCCC--CEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHH
Confidence 999999999999999999999999887 8999999998754332 22346788999999999888999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++++|++|+.||...+..+....+....... .....+++
T Consensus 190 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~ 228 (256)
T cd08529 190 VLYECCTGKHPFDANNQGALILKIIRGVFPP-----------------------------------------VSQMYSQQ 228 (256)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------------------CccccCHH
Confidence 9999999999998877655444433210000 00123678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.+++.+||+.+|++||++.++++|||+
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 8999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=307.29 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=202.5
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|++.+.||.|++|.||+|.++.++.. |+|++.......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---------------------------------------- 40 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR---------------------------------------- 40 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH----------------------------------------
Confidence 599999999999999999999887764 888874321110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE-cCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-RNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+|+++++.++|+ |++++++.+.. +..+|++|||+. ++|.+++.......+++.++..++.|+
T Consensus 41 ---~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l 111 (257)
T cd08223 41 ---RERKAAEQEAQLLSQLKHP------NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI 111 (257)
T ss_pred ---HHHHHHHHHHHHHHhCCCC------CeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 1122345689999999887 99999988764 446899999995 689999987655569999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
+.||++||++|++|+||+|+||+++.++ .++|+|||++..... ......+++.|+|||++.+..++.++|+||||
T Consensus 112 ~~~l~~lH~~~i~H~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 189 (257)
T cd08223 112 AMALQYLHEKHILHRDLKTQNVFLTRTN--IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALG 189 (257)
T ss_pred HHHHHHHHhCCeeccCCCchhEEEecCC--cEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHH
Confidence 9999999999999999999999999887 899999999865432 22335678899999999988899999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++++|++|+.||...+.......+.... .+ ......++
T Consensus 190 ~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~~---------------------------------------~~~~~~~~ 228 (257)
T cd08223 190 CCVYEMATLKHAFNAKDMNSLVYRIIEGK--LP---------------------------------------PMPKDYSP 228 (257)
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHhcC--CC---------------------------------------CCccccCH
Confidence 99999999999998776655443332210 00 00112367
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.+.+|+.+||+.||++|||+.++++||||
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 89999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=323.80 Aligned_cols=285 Identities=33% Similarity=0.604 Sum_probs=227.4
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||++.+.||.|++|.||+|.+..++.. |+|++......
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----------------------------------------- 39 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD----------------------------------------- 39 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-----------------------------------------
Confidence 799999999999999999999887755 88877432110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-----eEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-----HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
......+.+|+++++.++|+ ||+++++++.... .+|++|||++++|.+++.... .+++..+..++
T Consensus 40 --~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~ 109 (330)
T cd07834 40 --LIDAKRILREIKLLRHLRHE------NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFL 109 (330)
T ss_pred --chhhhhHHHHHHHHHhcCCc------chhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHH
Confidence 11223566699999999877 9999999987765 899999999989999887654 59999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhhCC-CCCCC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILGL-PYGPP 248 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~ 248 (429)
.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+...... .....++..|+|||++.+. .++.+
T Consensus 110 ~~l~~~l~~LH~~gi~H~dlkp~nili~~~~--~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 187 (330)
T cd07834 110 YQILRGLKYLHSANVIHRDLKPSNILVNSNC--DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKA 187 (330)
T ss_pred HHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcc
Confidence 9999999999999999999999999999987 8999999998764432 2234678899999999887 78999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|+|||||++|+|++|.+||.+.+..+.+..+....+.++++.+....... ....... ...........
T Consensus 188 sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-------~~~~~~~----~~~~~~~~~~~ 256 (330)
T cd07834 188 IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK-------ARNYLKS----LPKKPKKPLSK 256 (330)
T ss_pred hhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc-------hhhHHhh----cccCCcchhHH
Confidence 999999999999999999999999999999999988888877654221110 0000000 01111122333
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
..+..+..+.+||.+||++||++|||+.+++.||||++....
T Consensus 257 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 257 LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 445568899999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=315.05 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=219.6
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.+.-.+-|+..++||+||||.||.+.-+.||+. |.|++.+...
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi------------------------------------ 223 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI------------------------------------ 223 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH------------------------------------
Confidence 455567799999999999999999999999975 8887632211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.++.-..-+++|..||.++..+ .||.+--.|++.+.+|+||..|+ |+|.--|.+....+|++..++.
T Consensus 224 ------Kkr~ge~maLnEk~iL~kV~s~------FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~F 291 (591)
T KOG0986|consen 224 ------KKRKGETMALNEKQILEKVSSP------FIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARF 291 (591)
T ss_pred ------HHhhhhHHhhHHHHHHHHhccC------cEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHH
Confidence 1223334577899999999876 89999888999999999999995 6998888887767799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCCCCCCCccc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
|+.+|+.||++||+.+||.||+||+|||+|++| +|+|.|+|+|.... ......+||..|||||++.+..|+.++|-
T Consensus 292 YAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G--hvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dw 369 (591)
T KOG0986|consen 292 YAAEIICGLEHLHRRRIVYRDLKPENILLDDHG--HVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDW 369 (591)
T ss_pred HHHHHHhhHHHHHhcceeeccCChhheeeccCC--CeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccH
Confidence 999999999999999999999999999999999 99999999997654 34445689999999999999999999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|+.|+.||...........+-+..-..+++ +..
T Consensus 370 f~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e--------------------------------------y~~ 411 (591)
T KOG0986|consen 370 FSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE--------------------------------------YSD 411 (591)
T ss_pred HHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh--------------------------------------ccc
Confidence 999999999999999997755443333333222222221 223
Q ss_pred cCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSSSSS 370 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~~~ 370 (429)
..++++.++.+.+|..||++|+. ++++-+||||+...-.
T Consensus 412 kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 412 KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 34889999999999999999985 7899999999986533
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=318.03 Aligned_cols=288 Identities=25% Similarity=0.391 Sum_probs=206.1
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|+||.||+|.+..++.. |+|.+.....
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~----------------------------------------- 39 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK----------------------------------------- 39 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-----------------------------------------
Confidence 4699999999999999999999988865 7776532211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....++.+|++++++++|+ ||+++++.+..+.++++||||+. ++|.+++.... .+++..+..++.|+
T Consensus 40 ---~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i 108 (308)
T cd06615 40 ---PAIRNQIIRELKVLHECNSP------YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPENILGKISIAV 108 (308)
T ss_pred ---HHHHHHHHHHHHHHHhCCCC------CCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHH
Confidence 11233566799999999887 99999999999999999999995 59999998664 48999999999999
Q ss_pred HHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeecccccccC-cceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 179 VQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 179 l~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
+.||.|||+ .+++|+||||+||+++.++ .++|+|||++..... ......+++.|+|||++.+..++.++|+|||||
T Consensus 109 ~~~l~~lH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ 186 (308)
T cd06615 109 LRGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGL 186 (308)
T ss_pred HHHHHHHHhhCCEEECCCChHHEEEecCC--cEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHH
Confidence 999999997 5999999999999999888 899999999865432 223457889999999998888999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh-hccCCh
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV-LRCNDK 335 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 335 (429)
++|+|++|..||...+...... +. .......................+.......-...... ...... ....+.
T Consensus 187 ~l~~l~~g~~p~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 261 (308)
T cd06615 187 SLVEMAIGRYPIPPPDAKELEA-MF---GRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVN-EPPPKLPSGAFSD 261 (308)
T ss_pred HHHHHHhCCCCCCCcchhhHHH-hh---cCccccccccCCcccccCCCCCccchhhHHHHHHHHhc-CCCccCcCcccCH
Confidence 9999999999998765433221 11 11111000000000000000000000000000000000 000000 012467
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
++.+|+.+||..||++|||+.++++||||...
T Consensus 262 ~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 262 EFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 89999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=313.63 Aligned_cols=278 Identities=30% Similarity=0.575 Sum_probs=220.0
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|++.+.||.|++|+||+|.+..++.. |+|++.....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~------------------------------------------- 37 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE------------------------------------------- 37 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-------------------------------------------
Confidence 78899999999999999999887765 8887642211
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQC 181 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~ 181 (429)
.......+.+|+++++.++|+ |++++++++......+++|||++++|.+++.......+++..+..++.|++.|
T Consensus 38 ~~~~~~~~~~E~~~l~~l~~~------~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~ 111 (283)
T cd07835 38 DEGVPSTAIREISLLKELNHP------NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111 (283)
T ss_pred cccchhHHHHHHHHHHhcCCC------CccCHhheeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHH
Confidence 011223456699999999877 99999999999999999999999999999987664459999999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc---eeeecCccccchhhhhCC-CCCCCccccchhhH
Q psy17270 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCI 257 (429)
Q Consensus 182 l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~i 257 (429)
|+|||+++++|+||+|+||+++.++ .++|+|||.+....... ....++..|+|||++.+. .++.++|+|||||+
T Consensus 112 L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 189 (283)
T cd07835 112 IAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI 189 (283)
T ss_pred HHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHH
Confidence 9999999999999999999999987 89999999986543221 223567889999988765 46889999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|+.||...+....+..+.+..+.+.+..+.......... . .................+..+
T Consensus 190 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~----~~~~~~~~~~~~~~~~~~~~~ 256 (283)
T cd07835 190 FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK---------P----TFPKWARQDLSKVVPNLDEDG 256 (283)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh---------h----hcccccccchhhhcCCCCHHH
Confidence 999999999999998888888888888877776654332111000 0 000000111222334557899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.++|.+||+.||.+|||+.|++.|+||
T Consensus 257 ~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 257 LDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=309.54 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=203.2
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
+|++.+.||.|+||+||+|.+.....+|+|.+.........
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~--------------------------------------- 41 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLA--------------------------------------- 41 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhh---------------------------------------
Confidence 58999999999999999999864445688877543221111
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.......+.+|+++++.++|+ ||+++++++.+...+++++||+. ++|.+++.+.. .+++..+..++.|++.
T Consensus 42 ~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~ 113 (265)
T cd06631 42 AEKEYEKLQEEVDLLKSLKHV------NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILD 113 (265)
T ss_pred HHHHHHHHHHHHHHHHhcCCC------CEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHH
Confidence 111223566799999999887 99999999999999999999995 59999987654 4899999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---------cceeeecCccccchhhhhCCCCCCCccc
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---------RVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
||+|||+.|++|+||+|+||+++.++ .++|+|||.+..... ......++..|+|||++.+..++.++|+
T Consensus 114 ~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv 191 (265)
T cd06631 114 GVAYLHNNCVVHRDIKGNNVMLMPNG--IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDI 191 (265)
T ss_pred HHHHHHhCCcccCCcCHHhEEECCCC--eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhH
Confidence 99999999999999999999999887 899999998864321 1123457888999999998888999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|..||...+.......+....+.. .....
T Consensus 192 ~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~ 232 (265)
T cd06631 192 WSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM---------------------------------------PRLPD 232 (265)
T ss_pred HHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC---------------------------------------CCCCC
Confidence 999999999999999998765544333222211100 01112
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
..+..+.+||++||..||++||++.++++||||
T Consensus 233 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 347888999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=311.56 Aligned_cols=252 Identities=25% Similarity=0.419 Sum_probs=199.4
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
-.++|++.+.||.|+||.||+|.+..++.. |+|++.....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--------------------------------------- 44 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--------------------------------------- 44 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---------------------------------------
Confidence 467899999999999999999999888865 8887643211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEc------CeEEEEEeecC-cCHHHHHHhhCCCCCCHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFR------NHLCISFELMN-LNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~ 169 (429)
-...+..|+.+++.+. |+ ||+++++++... ..++++|||+. ++|.+++.......+++.
T Consensus 45 -------~~~~~~~e~~~l~~~~~h~------~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~ 111 (272)
T cd06637 45 -------EEEEIKQEINMLKKYSHHR------NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111 (272)
T ss_pred -------cHHHHHHHHHHHHHhcCCC------CeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHH
Confidence 1123455888888884 54 999999998753 46899999995 699999887655569999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhC----
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILG---- 242 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~---- 242 (429)
.+..++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||++..... ......|+..|+|||++.+
T Consensus 112 ~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 189 (272)
T cd06637 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 189 (272)
T ss_pred HHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC--CEEEccCCCceecccccccCCcccccccccCHhHhccccCc
Confidence 9999999999999999999999999999999999888 899999999875432 2234568889999999863
Q ss_pred -CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 243 -LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 243 -~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
..++.++|+||+||++|+|++|..||...........+.. ....
T Consensus 190 ~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~-------------------------------- 234 (272)
T cd06637 190 DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPAP-------------------------------- 234 (272)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CCCC--------------------------------
Confidence 3578899999999999999999999976554333221110 0000
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.......+..+.+|+.+||..||.+|||+.++++||||
T Consensus 235 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 -----RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -----CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00011236788999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.18 Aligned_cols=259 Identities=27% Similarity=0.358 Sum_probs=215.8
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
-.+.|+|+++||+|+||.|.+++++.|+++ |+|++++-.. +
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM------l-------------------------------- 114 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM------L-------------------------------- 114 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH------h--------------------------------
Confidence 367899999999999999999999999986 9888743110 0
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
+..-...|..|-.+|..-... =|+.+.-.|.++.++|+||||| +|+|..++.... ++++..+++|+.
T Consensus 115 ----Kr~~tA~F~EERDimv~~ns~------Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~a 182 (1317)
T KOG0612|consen 115 ----KRAETACFREERDIMVFGNSE------WIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTA 182 (1317)
T ss_pred ----hchhHHHHHHHhHHHHcCCcH------HHHHHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHH
Confidence 112223455577777765544 7888888999999999999999 679999999876 599999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc----CcceeeecCccccchhhhhC-----CCCCC
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH----QRVYTYIQSRFYRSPEVILG-----LPYGP 247 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~----~~~~~~~~t~~y~aPE~~~~-----~~~~~ 247 (429)
.|..||..+|+.|+|||||||+|||++..| +|||+|||.+.... -.....+|||.|.+||++.. +.|+.
T Consensus 183 EiVlAldslH~mgyVHRDiKPDNvLld~~G--HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ 260 (1317)
T KOG0612|consen 183 EIVLALDSLHSMGYVHRDIKPDNVLLDKSG--HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGR 260 (1317)
T ss_pred HHHHHHHHHHhccceeccCCcceeEecccC--cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCC
Confidence 999999999999999999999999999999 99999999986654 23456799999999999972 46899
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHh--CCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEIL--GCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
.+|.||+||++|||+.|..||...+-.+.+.+|++.- -.+|++
T Consensus 261 ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~----------------------------------- 305 (1317)
T KOG0612|consen 261 ECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE----------------------------------- 305 (1317)
T ss_pred ccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc-----------------------------------
Confidence 9999999999999999999999999999998888641 112211
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLT---PDEALRHEWLKSSSSS 370 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~ell~h~~~~~~~~~ 370 (429)
..+++.+.+||++++. +|..|.. ++++-.||||.+..-.
T Consensus 306 -----~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 306 -----TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred -----cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence 1248899999999875 6778888 9999999999987653
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=312.07 Aligned_cols=252 Identities=31% Similarity=0.454 Sum_probs=206.5
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+||++.+.||.|++|.||+|.+..++.. |+|++........
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------------------------------------- 42 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-------------------------------------- 42 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchH--------------------------------------
Confidence 5899999999999999999999887755 8888743321111
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
...+.+|+++++.+.|+ ||+++++.+.....+++|+||+. ++|.+++... .+++..+..++.|+
T Consensus 43 ------~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql 107 (274)
T cd06609 43 ------IEDIQQEIQFLSQCRSP------YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREV 107 (274)
T ss_pred ------HHHHHHHHHHHHHcCCC------CeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHH
Confidence 12345699999999877 99999999999999999999995 5899998865 48999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
+.||.|||+++++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||++.+..++.++|+||||
T Consensus 108 ~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG 185 (274)
T cd06609 108 LLGLEYLHEEGKIHRDIKAANILLSEEG--DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLG 185 (274)
T ss_pred HHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHH
Confidence 9999999999999999999999999988 8999999998765432 2345678889999999988899999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc-cCC
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR-CND 334 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 334 (429)
|++|+|+||..||...+.......+..... + .... ..+
T Consensus 186 ~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~---------------------------------------~~~~~~~~ 224 (274)
T cd06609 186 ITAIELAKGEPPLSDLHPMRVLFLIPKNNP--P---------------------------------------SLEGNKFS 224 (274)
T ss_pred HHHHHHHhCCCCcccCchHHHHHHhhhcCC--C---------------------------------------CCcccccC
Confidence 999999999999987665443332221100 0 0000 136
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+++.+++.+||..||++|||++++++|+||+...
T Consensus 225 ~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 225 KPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 7889999999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=313.05 Aligned_cols=255 Identities=27% Similarity=0.479 Sum_probs=205.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
....+|++++.||.|+||.||+|.+..++.. ++|.+......
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~------------------------------------- 59 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP------------------------------------- 59 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-------------------------------------
Confidence 4568999999999999999999999877754 88876432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+.+++.+.|+ ||+++++.+....+.|+||||+. ++|.+++... .+++.++..++
T Consensus 60 --------~~~~~~~e~~~l~~~~h~------~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~ 122 (296)
T cd06654 60 --------KKELIINEILVMRENKNP------NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVC 122 (296)
T ss_pred --------hHHHHHHHHHHHHhCCCC------CEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHH
Confidence 112455699999988877 99999999999999999999995 6999988654 38999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... .....+++.|+|||.+.+..++.++|+|
T Consensus 123 ~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 200 (296)
T cd06654 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200 (296)
T ss_pred HHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHH
Confidence 9999999999999999999999999999887 8999999988653321 2234688899999999988889999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|+.||...+....+..+.. .+.+. ......
T Consensus 201 s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~--------------------------------------~~~~~~ 241 (296)
T cd06654 201 SLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE--------------------------------------LQNPEK 241 (296)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCC--------------------------------------CCCccc
Confidence 999999999999999987765443322211 00000 000112
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.+..+.+++.+||..||++|||+.++++|+||...
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 36778999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=314.87 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=198.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|+++++||+|+||.||+|.+..++.. |+|++......
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---------------------------------------- 40 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV---------------------------------------- 40 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh----------------------------------------
Confidence 4689999999999999999999888865 88877433211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+|++++.++.|+ ||+++++.+......++||||+++ +|..+ ..+++..+..++.|+
T Consensus 41 ----~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi 104 (279)
T cd06619 41 ----ELQKQIMSELEILYKCDSP------YIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAV 104 (279)
T ss_pred ----HHHHHHHHHHHHHHhCCCC------CeeeEEEEEEECCEEEEEEecCCCCChHHh------hcCCHHHHHHHHHHH
Confidence 1123456699999998877 999999999999999999999965 65433 237899999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-cceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
+.||.|||+.|++|+||||+||+++.++ .++|+|||++..... ......+|..|+|||++.+..++.++|+|||||+
T Consensus 105 ~~~l~~lH~~~i~H~dlkp~Nill~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~ 182 (279)
T cd06619 105 VKGLTYLWSLKILHRDVKPSNMLVNTRG--QVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGIS 182 (279)
T ss_pred HHHHHHHHHCCEeeCCCCHHHEEECCCC--CEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHH
Confidence 9999999999999999999999999988 899999999875433 2334578999999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|..||......+... .+.......... ..... .....++++
T Consensus 183 l~~l~~g~~pf~~~~~~~~~~--------~~~~~~~~~~~~----~~~~~---------------------~~~~~~~~~ 229 (279)
T cd06619 183 FMELALGRFPYPQIQKNQGSL--------MPLQLLQCIVDE----DPPVL---------------------PVGQFSEKF 229 (279)
T ss_pred HHHHHhCCCCchhhccccccc--------chHHHHHHHhcc----CCCCC---------------------CCCcCCHHH
Confidence 999999999997633211000 000000000000 00000 001236788
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.+|+.+||+.||++||++.|+++||||+...
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 9999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=313.03 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=207.1
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
...+|++++.||.|++|.||+|.+..++.. ++|.+.....
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--------------------------------------- 57 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--------------------------------------- 57 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---------------------------------------
Confidence 456899999999999999999999888765 8887632211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.....+.+|+.+++.++|+ ||+.+++.+.....+++|+||+. ++|.+++... .+++.++..++.
T Consensus 58 ------~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~ 122 (296)
T cd06655 58 ------PKKELIINEILVMKELKNP------NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCR 122 (296)
T ss_pred ------chHHHHHHHHHHHHhcCCC------ceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHH
Confidence 1123456699999998877 99999999999999999999995 6888888654 389999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
|++.||+|||++|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.+..++.++|+||
T Consensus 123 ~l~~al~~LH~~~i~H~dL~p~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 200 (296)
T cd06655 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200 (296)
T ss_pred HHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHH
Confidence 999999999999999999999999999888 8999999988653322 22346788999999999888999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|+|++|..||.+.+.......+... ..+. .......
T Consensus 201 lGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~--------------------------------------~~~~~~~ 241 (296)
T cd06655 201 LGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------------------------------------LQNPEKL 241 (296)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc--------------------------------------cCCcccC
Confidence 999999999999999887765544333210 0000 0001123
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
++.+.+||++||..||++|||+.+++.||||+...
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 67889999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=319.36 Aligned_cols=282 Identities=29% Similarity=0.484 Sum_probs=211.5
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+..||++.+.||.|+||.||+|.+..++.. |+|++.....
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------------------------------------- 43 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------------------------------------- 43 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---------------------------------------
Confidence 578999999999999999999999988864 8887633211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--------------CeEEEEEeecCcCHHHHHHhhCC
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--------------NHLCISFELMNLNLYELIKRNNY 163 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--------------~~~~lv~e~~~g~L~~~i~~~~~ 163 (429)
.....+.+|+++++.++|+ ||+++++.+... ..+|+||||++++|.+++...
T Consensus 44 ------~~~~~~~~Ei~~l~~l~h~------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-- 109 (342)
T cd07854 44 ------QSVKHALREIKIIRRLDHD------NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG-- 109 (342)
T ss_pred ------chHHHHHHHHHHHHhcCCC------cchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHcC--
Confidence 1123456699999999887 899988776543 358999999999998888653
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccch
Q psy17270 164 QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSP 237 (429)
Q Consensus 164 ~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aP 237 (429)
.+++..++.++.|++.||.|||++|++||||||+||+++..+. .++|+|||.+...... .....++..|+||
T Consensus 110 -~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 187 (342)
T cd07854 110 -PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187 (342)
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcccceecCCccccccccccccccccccCH
Confidence 3899999999999999999999999999999999999985432 6899999998654321 1123568889999
Q ss_pred hhhhC-CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCC
Q psy17270 238 EVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316 (429)
Q Consensus 238 E~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (429)
|++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.........+........ .+.....
T Consensus 188 E~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~--- 256 (342)
T cd07854 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNV--------IPSFVRN--- 256 (342)
T ss_pred HHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhh--------hhhhhhh---
Confidence 98765 45788999999999999999999999988887777666655444333222211100 0000000
Q ss_pred CCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
................+.++.+||.+||+.||.+|||+.|++.||||+..
T Consensus 257 -~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 257 -DGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred -cccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00011111223334567889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=305.68 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=206.2
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||++.+.||.|+||+||++.+..++.. |+|.+.......
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~---------------------------------------- 40 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP---------------------------------------- 40 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh----------------------------------------
Confidence 699999999999999999999888765 888774321110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.....+.+|+++++.+.|+ ||+++++++....+.++||||+. ++|.+.+.......+++..+..++.|++
T Consensus 41 ---~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~ 111 (256)
T cd08218 41 ---KEREESRKEVAVLSNMKHP------NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQIC 111 (256)
T ss_pred ---HHHHHHHHHHHHHHhCCCC------CeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHH
Confidence 1112456699999999877 99999999999999999999995 6999998775545589999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
.||.|||++|++|+||+|+||+++.++ .++|+|||.+...... .....+++.|+|||++.+..++.++|+|||||
T Consensus 112 ~~l~~lh~~~i~h~~l~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~ 189 (256)
T cd08218 112 LALKHVHDRKILHRDIKSQNIFLTKDG--TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGC 189 (256)
T ss_pred HHHHHHHhCCEecCCCCHHHEEEcCCC--CEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHH
Confidence 999999999999999999999999887 8999999998654332 12345788899999998888899999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++++|++|..||...+..+....+.. +..+. .....+.+
T Consensus 190 i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~---------------------------------------~~~~~~~~ 228 (256)
T cd08218 190 VLYEMCTLKHAFEAGNMKNLVLKIIR--GSYPP---------------------------------------VSSHYSYD 228 (256)
T ss_pred HHHHHHcCCCCccCCCHHHHHHHHhc--CCCCC---------------------------------------CcccCCHH
Confidence 99999999999987776655544432 11100 01123678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.++|.+||+.+|++||++.++++||||
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 8999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=307.22 Aligned_cols=279 Identities=29% Similarity=0.508 Sum_probs=215.1
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|++.+.||.|+||.||+|.++.++.. |+|++.......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~----------------------------------------- 39 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE----------------------------------------- 39 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-----------------------------------------
Confidence 78999999999999999999886654 888875332210
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCe-----EEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH-----LCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~-----~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.....+.+|+.+++++... .|+|++++++++..... ++++||++.++|.+++.......+++..+..++.
T Consensus 40 --~~~~~~~~e~~~l~~l~~~---~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~ 114 (287)
T cd07838 40 --GIPLSTLREIALLKQLESF---EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR 114 (287)
T ss_pred --hhhhhHHHHHHHHHHhhcc---CCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHH
Confidence 1112344588888777532 35599999999988776 9999999999999988776544699999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||++.+..++.++|+|||
T Consensus 115 ~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~ 192 (287)
T cd07838 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSV 192 (287)
T ss_pred HHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhH
Confidence 999999999999999999999999999987 8999999998664322 223457888999999998889999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||++|+|++|.+||.+.+..+.+..+....+.+....+...... ....................+
T Consensus 193 G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~ 257 (287)
T cd07838 193 GCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL---------------PRSSFPSYTPRSFKSFVPEIC 257 (287)
T ss_pred HHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc---------------chhhcccccccchhhhhhhhh
Confidence 99999999999999999988888888776655433222111000 000000001111122333446
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.+.+||.+||+.||++||++.|++.||||
T Consensus 258 ~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 258 EEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=308.45 Aligned_cols=256 Identities=28% Similarity=0.438 Sum_probs=204.6
Q ss_pred CeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||.+...||.|++|.||+|.+..++. +|+|.+.......... .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~------------------------------------~ 44 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSK------------------------------------D 44 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchh------------------------------------H
Confidence 68899999999999999999987765 4888775443221110 0
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
........+.+|+.+++.+.|+ ||+++++++......+++|||+. ++|.+++.... .+++..+..++.|++
T Consensus 45 ~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~ 116 (267)
T cd06628 45 RKRSMLDALAREIALLKELQHE------NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQIL 116 (267)
T ss_pred HHHHHHHHHHHHHHHHHhcCCC------CeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHH
Confidence 0122334567799999999887 99999999999999999999995 59999998754 489999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---------ceeeecCccccchhhhhCCCCCCCcc
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---------VYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
.||+|||++|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+..++.++|
T Consensus 117 ~~l~~lH~~~ivH~di~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~D 194 (267)
T cd06628 117 KGLNYLHNRGIIHRDIKGANILVDNKG--GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKAD 194 (267)
T ss_pred HHHHHHHhcCcccccCCHHHEEEcCCC--CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhh
Confidence 999999999999999999999999887 8999999998654311 11235778899999999888899999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
+|||||++|+|++|+.||...+....+..+.... . ...+
T Consensus 195 v~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~--------------------------------------~~~~ 233 (267)
T cd06628 195 IWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---S--------------------------------------PEIP 233 (267)
T ss_pred hHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---C--------------------------------------CcCC
Confidence 9999999999999999998765544333222100 0 0011
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
...+..+.++|++||+.||++||++.|+++|+||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 2236788999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=313.26 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=203.7
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
.+++|+++++||.|+||.||+|.+..++.. ++|.+.....
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~--------------------------------------- 50 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--------------------------------------- 50 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH---------------------------------------
Confidence 467899999999999999999999988765 8887643211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.....+.+|+.+++.++|+ ||+++++.+..+..+++||||+. ++|..++.+.. ..+++..+..++.
T Consensus 51 ------~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ 117 (292)
T cd06644 51 ------EELEDYMVEIEILATCNHP------YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICR 117 (292)
T ss_pred ------HHHHHHHHHHHHHHhCCCC------cEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHH
Confidence 1123455689999998887 99999999999999999999996 47777765543 4589999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhh-----CCCCCCC
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVIL-----GLPYGPP 248 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~-----~~~~~~~ 248 (429)
|++.+|.|||++|++|+||||+||+++.++ .++|+|||.+..... ......+++.|+|||++. ...++.+
T Consensus 118 ql~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 195 (292)
T cd06644 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK 195 (292)
T ss_pred HHHHHHHHHhcCCeeecCCCcceEEEcCCC--CEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCch
Confidence 999999999999999999999999999887 899999998864322 223456788999999985 3346889
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|+|||||++|+|++|..||...+.......+.. ..... ..
T Consensus 196 ~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~------------------------------------~~ 236 (292)
T cd06644 196 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPT------------------------------------LS 236 (292)
T ss_pred hhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCcc------------------------------------CC
Confidence 9999999999999999999987665443333221 00000 00
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....+.++.++|.+||..||++||++.++++||||....
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0112357889999999999999999999999999997654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=308.20 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=216.8
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+--+.|+.+++||.|+||+|.+++.+.++++ |+|++++...-...+
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdE--------------------------------- 211 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDE--------------------------------- 211 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHH---------------------------------
Confidence 3457799999999999999999999999987 999886654322111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.. .-+.|-++|+..+|+ .+..+.-.|...+++|+||||.+ |.|.--+.+.. .|++..++.+-
T Consensus 212 --------VA-HTlTE~RVL~~~~HP------FLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYG 274 (516)
T KOG0690|consen 212 --------VA-HTLTENRVLQNCRHP------FLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYG 274 (516)
T ss_pred --------hh-hhhhHHHHHHhccCc------HHHHhhhhhccCceEEEEEEEccCceEeeehhhhh--cccchhhhhhh
Confidence 11 234488999998887 88888778899999999999995 67877776654 49999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc---ccCcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
..|+.||.|||+++||.||||.+|+|++.+| ++||+|||+++. .+....++||||.|.|||++....|+.++|-|
T Consensus 275 aEIvsAL~YLHs~~ivYRDlKLENLlLDkDG--HIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWW 352 (516)
T KOG0690|consen 275 AEIVSALGYLHSRNIVYRDLKLENLLLDKDG--HIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWW 352 (516)
T ss_pred HHHHHHhhhhhhCCeeeeechhhhheeccCC--ceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehh
Confidence 9999999999999999999999999999999 999999999975 33456679999999999999999999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
.+||++|||++|+.||...+....+..|...--.+| +.
T Consensus 353 G~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP------------------------------------------r~ 390 (516)
T KOG0690|consen 353 GVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP------------------------------------------RT 390 (516)
T ss_pred hhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC------------------------------------------cc
Confidence 999999999999999999888777666653211122 22
Q ss_pred CChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~ 368 (429)
.++++..|+..+|..||++|+. |.|+.+|+||.+..
T Consensus 391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 3789999999999999999995 89999999999765
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=310.87 Aligned_cols=280 Identities=30% Similarity=0.586 Sum_probs=214.5
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|+||.||+|.+..++.. |+|++......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---------------------------------------- 40 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---------------------------------------- 40 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc----------------------------------------
Confidence 5799999999999999999999877754 88876332111
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+.+|+++++.++|+ ||+++++++......++||||+.+ .|.++.... ..+++..+..++.|+
T Consensus 41 ---~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i 109 (286)
T cd07846 41 ---KMVKKIAMREIRMLKQLRHE------NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQI 109 (286)
T ss_pred ---chhhHHHHHHHHHHHhcCCc------chhhHHHhcccCCeEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHH
Confidence 11223456699999999887 999999999999999999999976 455544433 348999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccch
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSL 254 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSl 254 (429)
+.||+|||+.|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||++.+. .++.++|||||
T Consensus 110 ~~~l~~LH~~~i~h~~l~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 187 (286)
T cd07846 110 LRGIEFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAV 187 (286)
T ss_pred HHHHHHHHHCCccccCCCHHHEEECCCC--cEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHH
Confidence 9999999999999999999999999888 8999999998653321 2234578889999998764 46789999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||++|+|++|++||.+.+..+....+....+...+............ ..... .............+..+
T Consensus 188 G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~~~ 256 (286)
T cd07846 188 GCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF-AGMRL----------PEVKEIEPLEKRFPKLS 256 (286)
T ss_pred HHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh-hcccc----------ccccCcchHHHhCCCcC
Confidence 99999999999999988888888887777666544332211111000 00000 01111222333445668
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
..+.+|+.+||..||++||++.++++|+||
T Consensus 257 ~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 257 GLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=311.47 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=199.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
-.++|++.+.||.|+||.||+|.+..++.. |+|++.....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--------------------------------------- 54 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--------------------------------------- 54 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH---------------------------------------
Confidence 357899999999999999999999888865 8887643211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE------cCeEEEEEeecC-cCHHHHHHhhCCCCCCHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF------RNHLCISFELMN-LNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~------~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~ 170 (429)
....+..|+.+++.+. .|+||+++++++.. ...+|++|||++ ++|.+++.......+++..
T Consensus 55 -------~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~ 122 (282)
T cd06636 55 -------EEEEIKLEINMLKKYS-----HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122 (282)
T ss_pred -------HHHHHHHHHHHHHHhc-----CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHH
Confidence 1123445888888884 23499999999853 457899999996 5999999876655689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhh-----C
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVIL-----G 242 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~-----~ 242 (429)
+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++..... ......+++.|+|||++. +
T Consensus 123 ~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~ 200 (282)
T cd06636 123 IAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200 (282)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcC
Confidence 999999999999999999999999999999999888 899999999865432 233456888999999986 3
Q ss_pred CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
..++.++|+|||||++|+|++|..||........+..+.. ..+.
T Consensus 201 ~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~--------------------------------- 244 (282)
T cd06636 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPP--------------------------------- 244 (282)
T ss_pred cCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---CCCC---------------------------------
Confidence 4578899999999999999999999977655433322111 0000
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.......+..+.+||++||..||.+|||+.|+++||||
T Consensus 245 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 ----KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ----CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00011236789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=303.62 Aligned_cols=251 Identities=29% Similarity=0.440 Sum_probs=207.6
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||++++.||.|+||.||.+.+..++.. ++|.+.......
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------------------------------------- 40 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---------------------------------------- 40 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch----------------------------------------
Confidence 799999999999999999999988865 888764322111
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.....+.+|+++++++.|+ ||+++++++.....++++|||+. ++|.+++.......+++..+..++.|++
T Consensus 41 ---~~~~~~~~e~~~l~~~~h~------~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~ 111 (256)
T cd08221 41 ---KERRDALNEIVILSLLQHP------NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111 (256)
T ss_pred ---hHHHHHHHHHHHHHhCCCC------CeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHH
Confidence 1123456699999999876 99999999999999999999995 6999999876445699999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
.||+|||+.|++|+||+|+||+++.++ .++|+|||++...... .....+++.|+|||++.+..++.++|+|||||
T Consensus 112 ~~l~~lh~~~i~h~dl~p~ni~~~~~~--~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~ 189 (256)
T cd08221 112 SAVSYIHKAGILHRDIKTLNIFLTKAG--LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGC 189 (256)
T ss_pred HHHHHHHhCCccccCCChHhEEEeCCC--CEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHH
Confidence 999999999999999999999999888 8999999998654332 23456889999999998888899999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|..||...+..+....+.. +..+. .....+..
T Consensus 190 i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~---------------------------------------~~~~~~~~ 228 (256)
T cd08221 190 VLYELLTLKRTFDATNPLNLVVKIVQ--GNYTP---------------------------------------VVSVYSSE 228 (256)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHc--CCCCC---------------------------------------CccccCHH
Confidence 99999999999988776665554432 10000 00223678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.+++.+||..||.+||++.++++|+|+
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 8999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=313.43 Aligned_cols=282 Identities=27% Similarity=0.477 Sum_probs=216.3
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..++|++.++||.|+||.||+|.+..++.. |+|++.....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------------------------------------- 46 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--------------------------------------- 46 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC---------------------------------------
Confidence 358999999999999999999999888754 8887633211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--------CeEEEEEeecCcCHHHHHHhhCCCCCCHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--------NHLCISFELMNLNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~ 169 (429)
+......+.+|+++++.++|+ ||+++++++... ..+++||||+++++.+.+.... ..+++.
T Consensus 47 ----~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~ 115 (311)
T cd07866 47 ----KDGFPITALREIKILKKLKHP------NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTES 115 (311)
T ss_pred ----CCCcchhHHHHHHHHHhcCCC------CccchhhheecccccccccCceEEEEEecCCcCHHHHHhccc-cCCCHH
Confidence 011122445699999999887 999998887543 3579999999998888877543 359999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc--------------eeeecCcccc
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV--------------YTYIQSRFYR 235 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~--------------~~~~~t~~y~ 235 (429)
.+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... ....+++.|+
T Consensus 116 ~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 193 (311)
T cd07866 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG--ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR 193 (311)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECcCccchhccCCCcccccCCcccccccccceeccCcC
Confidence 9999999999999999999999999999999999988 89999999986433211 1235678899
Q ss_pred chhhhhCC-CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCC
Q psy17270 236 SPEVILGL-PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314 (429)
Q Consensus 236 aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (429)
|||++.+. .++.++|||||||++|+|++|++||.+.+.......+....+.+.+..+......... ..
T Consensus 194 aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~----- 262 (311)
T cd07866 194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGC------EG----- 262 (311)
T ss_pred ChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccc------cc-----
Confidence 99998764 5788999999999999999999999999998888888887777665544322111100 00
Q ss_pred CCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
...................+.+.+||.+||+.||.+|||+.|++.||||
T Consensus 263 -~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 263 -VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred -cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0000111111222334456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=314.85 Aligned_cols=258 Identities=27% Similarity=0.469 Sum_probs=206.5
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
.....+|++++.||.|+||.||+|.+..++.. |+|.+......
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------------------------------------ 58 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP------------------------------------ 58 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc------------------------------------
Confidence 34679999999999999999999999877754 88877432111
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
....+.+|+.+++.++|+ ||+++++++....++++||||+. ++|.+++.... +++..+..+
T Consensus 59 ---------~~~~~~~e~~~l~~~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~ 120 (297)
T cd06656 59 ---------KKELIINEILVMRENKNP------NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAV 120 (297)
T ss_pred ---------hHHHHHHHHHHHHhCCCC------CEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCC---CCHHHHHHH
Confidence 112355689999988877 99999999999999999999995 69999886543 899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
+.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++...... .....+++.|+|||.+.+..++.++|+
T Consensus 121 ~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 198 (297)
T cd06656 121 CRECLQALDFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198 (297)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHH
Confidence 99999999999999999999999999999888 8999999998654322 223467889999999998888999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|..||.+.+....+..+.. .+.+. ...+.
T Consensus 199 ~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~--------------------------------------~~~~~ 239 (297)
T cd06656 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------------------------------LQNPE 239 (297)
T ss_pred HHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC--------------------------------------CCCcc
Confidence 9999999999999999977654332211110 00000 00012
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
..+..+.+|+.+||..||++||++.++++||||+....
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 23677889999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=294.23 Aligned_cols=286 Identities=24% Similarity=0.438 Sum_probs=223.3
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
-.+.|++++++|+|.++.|+.|.+..+++. +||+++.-
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----------------------------------------- 74 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----------------------------------------- 74 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----------------------------------------
Confidence 457899999999999999999999777654 77776321
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i 174 (429)
-.+.+.+|+.||+.|. ++|||++++|+..+. ....||+|+.+. +...+.. .++...++.+
T Consensus 75 -------kkkKIkREikIL~nL~-----gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY 137 (338)
T KOG0668|consen 75 -------KKKKIKREIKILQNLR-----GGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYY 137 (338)
T ss_pred -------HHHHHHHHHHHHHhcc-----CCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh-----hhchhhHHHH
Confidence 1234556999999987 456999999998765 478999999965 4444322 3888999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCC-CCCCCccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGL-PYGPPIDM 251 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di 251 (429)
+.+++.||.|||++||+|||+||.|++++.... .++|+|+|+|...+ ...+-.+.++.|-.||.+..- .|+.+-|+
T Consensus 138 ~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~ 216 (338)
T KOG0668|consen 138 IYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDM 216 (338)
T ss_pred HHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHH
Confidence 999999999999999999999999999997643 89999999997644 334557788999999999865 58999999
Q ss_pred cchhhHHHHHhhCCCC-CCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYTGCPL-FPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||+++.|+..+.| |.|.+..+|+.+|...+|. +++........+.++++.........+..+.....++...+
T Consensus 217 WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt--~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl- 293 (338)
T KOG0668|consen 217 WSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT--DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHL- 293 (338)
T ss_pred HHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh--HHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccccc-
Confidence 9999999999997666 5899999999999999984 44444444555555544433333333333333333332222
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.++++.||+.++|..|..+|+||.|++.||||....
T Consensus 294 --~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 294 --VSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred --CChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 268899999999999999999999999999998654
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=311.03 Aligned_cols=255 Identities=28% Similarity=0.469 Sum_probs=204.7
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|++.+.||.|+||+||+|.+..++.. |+|.+.....
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------------------------------------- 43 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE---------------------------------------- 43 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH----------------------------------------
Confidence 46799999999999999999999877755 8887643211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.....+.+|+++++.++|+ ||+++++.+......|+||||++ ++|.+++.... ..+++..++.++.|
T Consensus 44 -----~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~q 111 (280)
T cd06611 44 -----EELEDFMVEIDILSECKHP------NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQ 111 (280)
T ss_pred -----HHHHHHHHHHHHHHhCCCC------ceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHH
Confidence 1123455699999999877 99999999999999999999996 58988887654 35999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhC-----CCCCCCc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILG-----LPYGPPI 249 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~-----~~~~~~~ 249 (429)
++.||.|||++|++|+||+|+||+++.++ .++|+|||.+..... ......++..|+|||++.. ..++.++
T Consensus 112 l~~~l~~lh~~~i~h~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~s 189 (280)
T cd06611 112 MLEALNFLHSHKVIHRDLKAGNILLTLDG--DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA 189 (280)
T ss_pred HHHHHHHHHHCCcccCCCChhhEEECCCC--CEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccc
Confidence 99999999999999999999999999888 899999998764332 2234568899999999853 3467799
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|+|||||++|+|++|..||...+....+..+.. +..+ . ...
T Consensus 190 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~-~------------------------------------~~~ 230 (280)
T cd06611 190 DIWSLGITLIELAQMEPPHHELNPMRVLLKILK--SEPP-T------------------------------------LDQ 230 (280)
T ss_pred cHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--CCCC-C------------------------------------cCC
Confidence 999999999999999999988766544433321 0000 0 000
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
....+..+.+||.+||+.||.+||++.++++|+||...
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 11236788999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=311.88 Aligned_cols=256 Identities=20% Similarity=0.258 Sum_probs=195.2
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCc-----------------chheeccccchhhHHHHHHHHHHHHHhccccccc
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNT-----------------HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-----------------~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~ 81 (429)
..+||++.++||+|+||.||+|.+..+.. +|+|.+.....
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------- 59 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN----------------------- 59 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-----------------------
Confidence 46799999999999999999998754432 35554432211
Q ss_pred ccccccccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHh
Q psy17270 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKR 160 (429)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~ 160 (429)
......+.+|++++..++|+ ||+++++++......++||||+. ++|.+++..
T Consensus 60 ---------------------~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 112 (304)
T cd05096 60 ---------------------KNARNDFLKEVKILSRLKDP------NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSS 112 (304)
T ss_pred ---------------------HHHHHHHHHHHHHHhhcCCC------CeeEEEEEEecCCceEEEEecCCCCcHHHHHHh
Confidence 12234567799999999876 99999999999999999999994 699999865
Q ss_pred hCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC
Q psy17270 161 NNY-----------------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ 223 (429)
Q Consensus 161 ~~~-----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~ 223 (429)
... ..++...+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++.....
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kl~DfG~~~~~~~ 190 (304)
T cd05096 113 HHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENL--TIKIADFGMSRNLYA 190 (304)
T ss_pred ccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCc--cEEECCCccceeccc
Confidence 321 1367788999999999999999999999999999999999887 899999999875432
Q ss_pred cc-----eeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh--CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhh
Q psy17270 224 RV-----YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT--GCPLFPGENEVEQLACIMEILGCPPDEVINTAS 296 (429)
Q Consensus 224 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 296 (429)
.. ....++..|+|||++.+..++.++|||||||++|+|++ +..||.+.+..+.+..+...........
T Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 265 (304)
T cd05096 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV----- 265 (304)
T ss_pred CceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc-----
Confidence 21 12234678999999998889999999999999999986 5678887776655544332111000000
Q ss_pred hhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 297 RRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
....++.+++.+.+|+.+||+.||++|||+.++..
T Consensus 266 -----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 266 -----------------------------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred -----------------------------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 00001233678999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=309.35 Aligned_cols=278 Identities=33% Similarity=0.603 Sum_probs=219.3
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|++.+.||.|++|+||+|.+..++.. ++|.+.........
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~--------------------------------------- 41 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE--------------------------------------- 41 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhH---------------------------------------
Confidence 78999999999999999999887764 88877433221110
Q ss_pred hhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
....+|+..++.+. |+ |++++++++..+...++||||++++|.+.+.......+++..+..++.|++.
T Consensus 42 -----~~~~~e~~~l~~~~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~ 110 (283)
T cd07830 42 -----CMNLREVKSLRKLNEHP------NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110 (283)
T ss_pred -----HHHHHHHHHHHhccCCC------CchhHHHHhhcCCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHH
Confidence 12234777887776 55 9999999999999999999999999999988765445899999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhC-CCCCCCccccchhhH
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILG-LPYGPPIDMWSLGCI 257 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~i 257 (429)
+|.|||++|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||++.+ ..++.++|+||||++
T Consensus 111 ~l~~Lh~~~i~H~dl~~~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~ 188 (283)
T cd07830 111 GLAHIHKHGFFHRDLKPENLLVSGPE--VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCI 188 (283)
T ss_pred HHHHHHHCCcccCCCChhhEEEcCCC--CEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHH
Confidence 99999999999999999999999988 8999999998765432 233567888999998864 357889999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+++|++|++||...+..+.+..+...++.+..+.+..........+ ..................+..+
T Consensus 189 l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~ 256 (283)
T cd07830 189 MAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG------------FRFPQFAPTSLHQLIPNASPEA 256 (283)
T ss_pred HHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc------------ccccccccccHHHHcccCCHHH
Confidence 9999999999999999999999998888877765543322111000 0001111112233334447889
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.+||++||+.||++|||+.|++.||||
T Consensus 257 ~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 257 IDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.41 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=203.9
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|+||+||+|.+..++.. ++|++.......
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------------------------------------- 41 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--------------------------------------- 41 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch---------------------------------------
Confidence 4799999999999999999999877754 888774332211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC-CCCCHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY-QGFSLGLIRRFAFS 177 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~-~~~~~~~~~~i~~q 177 (429)
....+.+|+++++.+.|+ ||+++++.+......+++||++. ++|.+++..... ..+++..+..++.|
T Consensus 42 -----~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~q 110 (267)
T cd06610 42 -----SVDELRKEVQAMSQCNHP------NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKE 110 (267)
T ss_pred -----HHHHHHHHHHHHHhcCCC------CEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHH
Confidence 122455699999998877 99999999999999999999995 699999876532 45899999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-------ceeeecCccccchhhhhCC-CCCCCc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-------VYTYIQSRFYRSPEVILGL-PYGPPI 249 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~ 249 (429)
++.||+|||++|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||++... .++.++
T Consensus 111 l~~al~~lh~~~i~h~~l~p~ni~~~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~ 188 (267)
T cd06610 111 VLKGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKA 188 (267)
T ss_pred HHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCccc
Confidence 99999999999999999999999999887 8999999998643321 1234688899999998876 678899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|+|||||++|+|++|+.||...+....+..+... .+... +. ...
T Consensus 189 Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~----------------~~-----------------~~~ 232 (267)
T cd06610 189 DIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSL----------------ET-----------------GAD 232 (267)
T ss_pred chHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCc----------------CC-----------------ccc
Confidence 9999999999999999999876655443333221 00000 00 000
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
....++.+.+|+.+||..||++|||+.++++||||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 12336788999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=314.02 Aligned_cols=282 Identities=30% Similarity=0.552 Sum_probs=219.6
Q ss_pred CeEEEeEeeccccceEEEEEecCC--Cc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKT--NT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~--~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
+|++.+.||.|+||.||+|.+..+ +. +|+|++.....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~---------------------------------------- 40 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---------------------------------------- 40 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc----------------------------------------
Confidence 699999999999999999999877 54 48887642211
Q ss_pred CcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEc----CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFR----NHLCISFELMNLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.......+.+|+++++.+. |+ ||+++++.+... ..+++++|+++++|.+++.... .+++..++.
T Consensus 41 ---~~~~~~~~~~E~~~l~~l~~h~------~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~--~~~~~~~~~ 109 (332)
T cd07857 41 ---KKILAKRALRELKLLRHFRGHK------NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ--PLTDAHFQS 109 (332)
T ss_pred ---cchhHHHHHHHHHHHHHhcCCC------ChheeeeeeeeccccCCcEEEEEecccCCHHHHHhcCC--CCCHHHHHH
Confidence 1112334566999999985 54 999998875432 4689999999999999987654 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-------ceeeecCccccchhhhhC-CCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-------VYTYIQSRFYRSPEVILG-LPY 245 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~-~~~ 245 (429)
++.||+.||.|||++|++||||||+||+++.++ .++|+|||.+...... .....||..|+|||++.+ ..+
T Consensus 110 ~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 187 (332)
T cd07857 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADC--ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY 187 (332)
T ss_pred HHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC--CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCC
Confidence 999999999999999999999999999999988 8999999998653321 123468889999998876 468
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|+||+||++|+|++|.+||.+.+..+.+..+...++.++++.+............... .......
T Consensus 188 ~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~ 256 (332)
T cd07857 188 TKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSL-----------PNIPKKP 256 (332)
T ss_pred CcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhc-----------cccCCcc
Confidence 89999999999999999999999999999999999999998888776544321110000000 0001112
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
........+..+.+|+.+||+.||++|||+.+++.||||+.-
T Consensus 257 ~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 257 FESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 223334457889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=335.49 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=199.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCC-CcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKT-NTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
.+=.-+++|.+.|.+|||+.||+|.+... .++|+|++-.. .+
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de------------------------------------ 75 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DE------------------------------------ 75 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CH------------------------------------
Confidence 34466899999999999999999999988 56799988544 11
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEE-Ec------CeEEEEEeecC-cCHHHHHHhhCCCCCC
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY-FR------NHLCISFELMN-LNLYELIKRNNYQGFS 167 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~-~~------~~~~lv~e~~~-g~L~~~i~~~~~~~~~ 167 (429)
.....+.+|+++|+.|+ +|+|||.++|... .. -.++|.||||. |.|.+++..+...+|+
T Consensus 76 --------~~L~~v~~EI~~MK~L~-----gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lt 142 (738)
T KOG1989|consen 76 --------EALNAVKREIDIMKLLS-----GHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLT 142 (738)
T ss_pred --------HHHHHHHHHHHHHHHhc-----CCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCC
Confidence 11234456999999998 3349999999322 11 26899999997 7999999988778899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCC--ceecccCCCcEEEecCCCcceEEeeecccccccCcc------------eeeecCcc
Q psy17270 168 LGLIRRFAFSLVQCLRLLHREN--IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------------YTYIQSRF 233 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~--ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------------~~~~~t~~ 233 (429)
+.++..|+.|+++|+++||... |||||||-+|||++.++ ++||||||.+....... ....-|+.
T Consensus 143 e~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g--~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~ 220 (738)
T KOG1989|consen 143 EDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG--NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQ 220 (738)
T ss_pred hHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC--CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCcc
Confidence 9999999999999999999997 99999999999999999 99999999986533221 11345899
Q ss_pred ccchhhhh---CCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcc
Q psy17270 234 YRSPEVIL---GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC 310 (429)
Q Consensus 234 y~aPE~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (429)
|+|||++. +...+.|+|||||||+||-|+....||+......++. .-...|+
T Consensus 221 YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln----g~Y~~P~--------------------- 275 (738)
T KOG1989|consen 221 YRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN----GNYSFPP--------------------- 275 (738)
T ss_pred ccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe----ccccCCC---------------------
Confidence 99999975 5678999999999999999999999998865433221 0011110
Q ss_pred ccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy17270 311 ITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363 (429)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~ 363 (429)
.+..+..+.+||+.||+.||++||++.+++.+-+
T Consensus 276 -------------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 276 -------------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred -------------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 0223678999999999999999999999987633
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.33 Aligned_cols=278 Identities=34% Similarity=0.619 Sum_probs=219.8
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|++.+.||.|+||.||+|.+..++.. |+|++.....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~------------------------------------------- 37 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE------------------------------------------- 37 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc-------------------------------------------
Confidence 78999999999999999999987765 8888754320
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.......+.+|+++++.+.|+ |++++++++... ...++||||++++|.+++.... ..+++..+..++.|++
T Consensus 38 ~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~ 110 (287)
T cd07840 38 KEGFPITAIREIKLLQKLRHP------NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLL 110 (287)
T ss_pred cccchHHHHHHHHHHHhccCC------CeeeheeeEecCCCCcEEEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHH
Confidence 112223456699999999877 999999999888 8999999999999999887653 3599999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCC-CCCCCccccch
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGL-PYGPPIDMWSL 254 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSl 254 (429)
.||+|||++|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+. .++.++|||||
T Consensus 111 ~al~~LH~~~~~h~dl~p~nil~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 188 (287)
T cd07840 111 EGLQYLHSNGILHRDIKGSNILINNDG--VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSV 188 (287)
T ss_pred HHHHHHHHCCceeccCcHHHeEEcCCC--CEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHH
Confidence 999999999999999999999999988 8999999998765433 2234567789999987754 57889999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc-C
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC-N 333 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 333 (429)
|+++|+|++|+.||...+....+..+....+.+....+......... ................... +
T Consensus 189 G~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T cd07840 189 GCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF------------ENLKPKKPYKRRLREFFKHLI 256 (287)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh------------hhccccccchhHHHHHhcccC
Confidence 99999999999999999888888888887777766554332211000 0000111111222233333 3
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
++.+.+++++||..||.+||++.++++|+||
T Consensus 257 ~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 257 DPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.94 Aligned_cols=253 Identities=27% Similarity=0.443 Sum_probs=202.2
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|++.+.||.|+||.||+|.+..++.. ++|.+.....
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------------------------------------------- 43 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE------------------------------------------- 43 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-------------------------------------------
Confidence 78999999999999999999988865 7777632211
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.....+.+|+++++.+.|+ ||+++++.+......++|+||+. ++|..++.... ..+++..+..++.|++.
T Consensus 44 --~~~~~~~~e~~~l~~l~h~------~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~ 114 (282)
T cd06643 44 --EELEDYMVEIDILASCDHP------NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLE 114 (282)
T ss_pred --HHHHHHHHHHHHHHHCCCC------CeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHH
Confidence 1122455699999998877 99999999999999999999995 57777766533 45899999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhh-----CCCCCCCcccc
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVIL-----GLPYGPPIDMW 252 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~-----~~~~~~~~Diw 252 (429)
||.|||+.|++|+||||+||+++.++ .++|+|||++..... ......++..|+|||++. +..++.++|+|
T Consensus 115 ~L~~LH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 192 (282)
T cd06643 115 ALNYLHENKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 192 (282)
T ss_pred HHHHHHHCCeeecCCCcccEEEccCC--CEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhh
Confidence 99999999999999999999999888 899999999865432 223356888999999984 33577899999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|+||++|+|++|.+||...+..+....+........ ..+..
T Consensus 193 slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~ 233 (282)
T cd06643 193 SLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL---------------------------------------AQPSR 233 (282)
T ss_pred hHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC---------------------------------------CCccc
Confidence 999999999999999988776655444432111000 00112
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.+..+.+||.+||+.||.+|||+.++++||||+...
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 234 WSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 367889999999999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=301.94 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=201.7
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|++.+.||.|+||.||++.+..++.. |+|.+.......
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---------------------------------------- 40 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS---------------------------------------- 40 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH----------------------------------------
Confidence 599999999999999999999888765 888774332111
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
..+.+.+|+.+++.++|+ ||+++++.+.....+|++|||+. ++|.+++.......+++..+..++.|++
T Consensus 41 ----~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~ 110 (255)
T cd08219 41 ----AVEDSRKEAVLLAKMKHP------NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110 (255)
T ss_pred ----HHHHHHHHHHHHHhCCCC------CcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHH
Confidence 122445589999998877 99999999999999999999995 6999988765555689999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
.||.|||++|++|+||||+||+++.++ .++|+|||.+...... .....+++.|+|||++.+..++.++|+||||+
T Consensus 111 ~al~~lH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 188 (255)
T cd08219 111 LGVQHIHEKRVLHRDIKSKNIFLTQNG--KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGC 188 (255)
T ss_pred HHHHHHhhCCcccCCCCcceEEECCCC--cEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhch
Confidence 999999999999999999999999888 8999999998654322 22356888899999999888999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|..||...+.......+......+ .+...+..
T Consensus 189 i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~ 227 (255)
T cd08219 189 ILYELCTLKHPFQANSWKNLILKVCQGSYKP-----------------------------------------LPSHYSYE 227 (255)
T ss_pred hheehhhccCCCCCCCHHHHHHHHhcCCCCC-----------------------------------------CCcccCHH
Confidence 9999999999998876654443332210000 01123667
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHE 362 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~ 362 (429)
+.+||.+||+.||++|||+.+++.-.
T Consensus 228 ~~~li~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 228 LRSLIKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHHHHHHhCCcccCCCHHHHhhcc
Confidence 88999999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=303.07 Aligned_cols=252 Identities=26% Similarity=0.357 Sum_probs=205.6
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|++.+.||.|+||.||+|.+..++.. |+|.+......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------------------------------------- 39 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT----------------------------------------- 39 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-----------------------------------------
Confidence 699999999999999999999887765 88877433211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+++++.++|+ |++++++.+.....+++||||+. ++|.+++.......+++..+..++.|++
T Consensus 40 --~~~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~ 111 (256)
T cd08220 40 --KDERLAAQNECQVLKLLSHP------NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111 (256)
T ss_pred --cHHHHHHHHHHHHHhhCCCC------chhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHH
Confidence 01123566799999999877 99999999999999999999995 5999999876545589999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
.+|+|||++|++|+||+|+||+++.++. .++|+|||.+...... .....++..|+|||.+.+..++.++|+||||++
T Consensus 112 ~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 190 (256)
T cd08220 112 LALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCV 190 (256)
T ss_pred HHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHH
Confidence 9999999999999999999999986542 6899999998765432 223567889999999998888999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|..||.+.+.......+...... ......++.+
T Consensus 191 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~l 229 (256)
T cd08220 191 LYELASLKRAFEAANLPALVLKIMSGTFA-----------------------------------------PISDRYSPDL 229 (256)
T ss_pred HHHHHhCCCCcccCchHHHHHHHHhcCCC-----------------------------------------CCCCCcCHHH
Confidence 99999999999887765554443321000 0011236788
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.+++.+||..||++|||+.|++.||||
T Consensus 230 ~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 230 RQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=309.92 Aligned_cols=256 Identities=16% Similarity=0.154 Sum_probs=201.7
Q ss_pred hhhhcccccCCeEEE--eEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 12 FQVLHDHICYRYEIL--EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 12 ~~~~~~~~~~rY~i~--~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
+..+..+-.+.++.. ..||.|++|.||+|.+. ...+|+|++......
T Consensus 9 ~~~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~------------------------------ 57 (283)
T PHA02988 9 INDIKCIESDDIDKYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKG------------------------------ 57 (283)
T ss_pred cCcceecCHHHcCCCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccc------------------------------
Confidence 333344444455555 67999999999999983 335688887543211
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE----cCeEEEEEeecC-cCHHHHHHhhCCC
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF----RNHLCISFELMN-LNLYELIKRNNYQ 164 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~-g~L~~~i~~~~~~ 164 (429)
.+.....+.+|++++++++|+ ||+++++++.+ ...+++||||+. |+|.+++....
T Consensus 58 ------------~~~~~~~~~~E~~~l~~l~h~------nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-- 117 (283)
T PHA02988 58 ------------HKVLIDITENEIKNLRRIDSN------NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-- 117 (283)
T ss_pred ------------cHHHHHHHHHHHHHHHhcCCC------CEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC--
Confidence 112234566799999999887 99999999876 357899999995 68999998754
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC-
Q psy17270 165 GFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG- 242 (429)
Q Consensus 165 ~~~~~~~~~i~~qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~- 242 (429)
.+++.....++.|++.||.|||+. +++||||||+||+++.++ .+||+|||++...........++..|+|||++.+
T Consensus 118 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~ 195 (283)
T PHA02988 118 DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY--KLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDI 195 (283)
T ss_pred CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC--cEEEcccchHhhhccccccccCcccccCHHHhhhc
Confidence 489999999999999999999985 999999999999999988 8999999998765554455678899999999976
Q ss_pred -CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 243 -LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 243 -~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
..++.++|||||||++|+|++|+.||.+.+..+....+......++
T Consensus 196 ~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------------- 242 (283)
T PHA02988 196 FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK--------------------------------- 242 (283)
T ss_pred cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------------
Confidence 5789999999999999999999999998877665554432110000
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+...++.+.+|+.+||+.||++|||+.|+++
T Consensus 243 -------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 -------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01123678999999999999999999999986
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=307.50 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=197.7
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|++++.||.|+||.||+|.+..++.. |+|.+........
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-------------------------------------- 42 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-------------------------------------- 42 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--------------------------------------
Confidence 4699999999999999999999988865 9998754322111
Q ss_pred cchhhhhhhHHHHHHH-HHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhh--CCCCCCHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRI-LDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRN--NYQGFSLGLIRRFAF 176 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~i-l~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~--~~~~~~~~~~~~i~~ 176 (429)
...+..|+.+ ++.+.| +||+++++++..+..+|++|||++++|.+++... ....+++..+..++.
T Consensus 43 ------~~~~~~e~~~~~~~~~~------~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 110 (283)
T cd06617 43 ------QKRLLMDLDISMRSVDC------PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV 110 (283)
T ss_pred ------HHHHHHHHHHHHHHcCC------CCeeeeeEEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHH
Confidence 1123335554 333444 4999999999999999999999999998888653 224589999999999
Q ss_pred HHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhC----CCCCCCc
Q psy17270 177 SLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILG----LPYGPPI 249 (429)
Q Consensus 177 qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~ 249 (429)
|++.||+|||++ +++||||||+||+++.++ .++|+|||.+...... .....++..|+|||++.+ ..++.++
T Consensus 111 qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 188 (283)
T cd06617 111 SIVKALEYLHSKLSVIHRDVKPSNVLINRNG--QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKS 188 (283)
T ss_pred HHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecccccccccccccccccCCccccChhhcCCcccccccCccc
Confidence 999999999997 999999999999999888 8999999998754322 122467888999999865 3468899
Q ss_pred cccchhhHHHHHhhCCCCCCCC-CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGE-NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
|+|||||++|+|++|+.||... ...+.+..+.. +..+ .. +
T Consensus 189 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~-~~-----------------------------~------- 229 (283)
T cd06617 189 DVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSP-QL-----------------------------P------- 229 (283)
T ss_pred cchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cCCC-CC-----------------------------C-------
Confidence 9999999999999999999653 22222222211 0000 00 0
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++++.+||.+||..||++|||+.++++||||+...
T Consensus 230 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 230 -AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred -ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 011367899999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=311.55 Aligned_cols=258 Identities=29% Similarity=0.455 Sum_probs=203.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||.|+||.||+|.+..++.. |+|.+.......
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~--------------------------------------- 41 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES--------------------------------------- 41 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH---------------------------------------
Confidence 4799999999999999999999877765 888774332111
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC-CCCCCHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN-YQGFSLGLIRRFAFS 177 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~-~~~~~~~~~~~i~~q 177 (429)
....+.+|+++++.+.|+ ||+++++.+.....+++||||+. ++|..++.... ...+++..+..++.|
T Consensus 42 -----~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 110 (286)
T cd06622 42 -----KFNQIIMELDILHKAVSP------YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA 110 (286)
T ss_pred -----HHHHHHHHHHHHHhcCCC------cHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHH
Confidence 112456699999998877 99999999999999999999996 58888887642 235999999999999
Q ss_pred HHHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeecccccccC-cceeeecCccccchhhhhCC------CCCCCc
Q psy17270 178 LVQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGL------PYGPPI 249 (429)
Q Consensus 178 il~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~------~~~~~~ 249 (429)
++.||.|||+ .|++|+||||+||+++.++ .++|+|||.+..... ......+++.|+|||.+.+. .++.++
T Consensus 111 i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 188 (286)
T cd06622 111 VVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQS 188 (286)
T ss_pred HHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCccc
Confidence 9999999997 5999999999999999977 899999999865432 23335678889999998654 357899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|+|||||++|+|++|+.||...+.......+.......+. ..
T Consensus 189 DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~ 230 (286)
T cd06622 189 DVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP--------------------------------------TL 230 (286)
T ss_pred chHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC--------------------------------------CC
Confidence 9999999999999999999776544433333221111110 01
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+...++++.+||.+||+.||++||++.+++.||||....
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 122378889999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.62 Aligned_cols=285 Identities=31% Similarity=0.535 Sum_probs=219.1
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
+....++|++.+.||.|+||+||+|.++.+++. |+|++.....
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------------------------------------ 45 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE------------------------------------ 45 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc------------------------------------
Confidence 345678899999999999999999999887765 7887643211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC----------eEEEEEeecCcCHHHHHHhhCCC
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN----------HLCISFELMNLNLYELIKRNNYQ 164 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~----------~~~lv~e~~~g~L~~~i~~~~~~ 164 (429)
.......+.+|+++++.++|+ ||+++++++.... .+++|+||+++++.+.+.... .
T Consensus 46 -------~~~~~~~~~~e~~~~~~l~h~------~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~ 111 (302)
T cd07864 46 -------KEGFPITAIREIKILRQLNHR------NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-V 111 (302)
T ss_pred -------ccCchHHHHHHHHHHHhCCCC------CeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCC-C
Confidence 011223455699999999887 9999999887654 899999999998888877653 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhh
Q psy17270 165 GFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVI 240 (429)
Q Consensus 165 ~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~ 240 (429)
.+++..+..++.|++.||+|||+.||+|+||+|+||++++++ .++|+|||++....... ....++..|+|||.+
T Consensus 112 ~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 189 (302)
T cd07864 112 HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG--QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELL 189 (302)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--cEEeCcccccccccCCcccccccceeccCccChHHh
Confidence 599999999999999999999999999999999999999888 89999999987543221 123457789999988
Q ss_pred hCC-CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCC
Q psy17270 241 LGL-PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319 (429)
Q Consensus 241 ~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (429)
.+. .++.++|||||||++++|++|++||...+..+.+..+....+.+....+........+.... ..
T Consensus 190 ~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~ 257 (302)
T cd07864 190 LGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK------------PK 257 (302)
T ss_pred cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccc------------cc
Confidence 754 46889999999999999999999999988888888888877776665543322111100000 00
Q ss_pred CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
..............+..+.+++.+||+.||++|||+.+++.||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 258 KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 000011112223347889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.63 Aligned_cols=278 Identities=34% Similarity=0.629 Sum_probs=222.8
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|++.+.||.|++|.||+|.+..+++. ++|.+......
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------------------------------------------ 38 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES------------------------------------------ 38 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc------------------------------------------
Confidence 78899999999999999999877765 88876433211
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQC 181 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~ 181 (429)
......+.+|+++++.++|+ ||+++++++.....+++|+||++++|.+++.... ..+++..+..++.|++.|
T Consensus 39 -~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~ 110 (283)
T cd05118 39 -EGIPKTALREIKLLKELNHP------NIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQG 110 (283)
T ss_pred -chhHHHHHHHHHHHHHhcCC------CcchHHHhhccCCCEEEEEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHH
Confidence 11223556699999999877 9999999999999999999999999999887754 459999999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc---eeeecCccccchhhhhCC-CCCCCccccchhhH
Q psy17270 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCI 257 (429)
Q Consensus 182 l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~i 257 (429)
|.|||++|++|+||+|+||+++.++ .++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||++
T Consensus 111 l~~LH~~~i~H~dl~p~nili~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~ 188 (283)
T cd05118 111 LAFCHSHGILHRDLKPENLLINTEG--VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCI 188 (283)
T ss_pred HHHHHHCCeeecCcCHHHEEECCCC--cEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHH
Confidence 9999999999999999999999887 89999999986554322 224577889999999876 68899999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|+||+.||.+.+..+.+..+...++.+..+.+.......... . ...............+..+..+
T Consensus 189 l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~----~~~~~~~~~~~~~~~~~~~~~~ 256 (283)
T cd05118 189 FAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY--------K----FSFPKKAGMPLPKLFPNASPQA 256 (283)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh--------h----hhhccccccCHHHhhhhhCHHH
Confidence 999999999999999888888888888877766655433210000 0 0001111122233445568999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.+||.+||+.||.+||++.+++.||||
T Consensus 257 ~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 257 LDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=323.05 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=203.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.+.|++...+|.|+||.|-.+.+..+++. ++|++.+...+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------------------------------------- 361 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------------------------------------- 361 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccccc-------------------------------------
Confidence 5788999999999999999999999999976 88887544111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
..+|+.++.... .|+||+++.+++.+..+.|+|||.+.| -+.+.+.... .....+..|+
T Consensus 362 ------------~~~e~~~~~~~~-----~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~ 421 (612)
T KOG0603|consen 362 ------------NQDEIPISLLVR-----DHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWA 421 (612)
T ss_pred ------------cccccchhhhhc-----CCCcceeecceecCCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHH
Confidence 112666666554 346999999999999999999999965 5556555544 3337888899
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEe-cCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLK-QRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~-~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
.+|+.++.|||++|+|||||||+|||++ +.+ +++|+|||.+........+.+-|..|+|||++....|+.++|+|||
T Consensus 422 ~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g--~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSL 499 (612)
T KOG0603|consen 422 AELVSAVDYLHEQGVVHRDLKPGNILLDGSAG--HLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSL 499 (612)
T ss_pred HHHHHHHHHHHhcCeeecCCChhheeecCCCC--cEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHH
Confidence 9999999999999999999999999995 666 8999999999887777777788999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|+++|+|++|+.||....... .|...++.++.. ..+|
T Consensus 500 GvlLy~ML~G~tp~~~~P~~~---ei~~~i~~~~~s----------------------------------------~~vS 536 (612)
T KOG0603|consen 500 GVLLYEMLTGRTLFAAHPAGI---EIHTRIQMPKFS----------------------------------------ECVS 536 (612)
T ss_pred HHHHHHHHhCCCccccCCchH---HHHHhhcCCccc----------------------------------------cccC
Confidence 999999999999998766552 222222222211 2348
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
..+.+||++||++||.+|+++.+++.|+||.+
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence 89999999999999999999999999999943
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=319.57 Aligned_cols=251 Identities=26% Similarity=0.409 Sum_probs=212.0
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||+|.||+||-|.++++|+. |+|++.+-..... -
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-------------------------------------------q 606 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-------------------------------------------Q 606 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCc-------------------------------------------h
Confidence 5899999999999999999975 8887744322211 1
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
..++.+|+.||+.+.|+ .|+.+.-.|+..+.++.|||.+.|++.+.|-....+++++...+.++.||+.||.||
T Consensus 607 esqlR~EVaILq~l~HP------GiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~L 680 (888)
T KOG4236|consen 607 ESQLRNEVAILQNLHHP------GIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYL 680 (888)
T ss_pred HHHHHHHHHHHHhcCCC------CeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHh
Confidence 24667799999999887 999999999999999999999999999999988888899999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCC-cceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHh
Q psy17270 186 HRENIIHCDLKPENVLLKQRGS-SSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELY 262 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~-~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~ll 262 (429)
|-++|||+||||+|||+.+... +++||||||+|+.+++. ....+|||.|.|||++..+.|+.+-|+||+|||+|.-+
T Consensus 681 H~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsL 760 (888)
T KOG4236|consen 681 HFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSL 760 (888)
T ss_pred hhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEe
Confidence 9999999999999999987543 57999999999987754 34578999999999999999999999999999999999
Q ss_pred hCCCCCCCCC-HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 263 TGCPLFPGEN-EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 263 tg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
.|..||.... ..+++++- --..|.+- ++.+++.++|||
T Consensus 761 SGTFPFNEdEdIndQIQNA---aFMyPp~P--------------------------------------W~eis~~AidlI 799 (888)
T KOG4236|consen 761 SGTFPFNEDEDINDQIQNA---AFMYPPNP--------------------------------------WSEISPEAIDLI 799 (888)
T ss_pred cccccCCCccchhHHhhcc---ccccCCCc--------------------------------------hhhcCHHHHHHH
Confidence 9999996543 33443321 11222211 233478899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 342 TQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 342 ~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
..+|++.=.+|.|....|.|||++.-
T Consensus 800 n~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999999863
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.98 Aligned_cols=287 Identities=31% Similarity=0.546 Sum_probs=223.2
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.++|++.+.||.|+||.||+|.+..++.. |+|++.......
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~----------------------------------- 47 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA----------------------------------- 47 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-----------------------------------
Confidence 45788999999999999999999999887754 888763221100
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEc--CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFR--NHLCISFELMNLNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|+.+++.+ .|+ ||+++++++... ..+++||||+.++|.+++... .+++..+.
T Consensus 48 --------~~~~~~~~E~~~l~~l~~h~------ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~ 110 (337)
T cd07852 48 --------TDAQRTFREIMFLQELGDHP------NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN---ILEDVHKR 110 (337)
T ss_pred --------hhhhhhhHHHHHHHHhcCCC------CccceeeeeccCCCceEEEEecccccCHHHHHhcC---CCCHHHHH
Confidence 0112344599999999 776 999999998654 368999999999999988765 48899999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--------ceeeecCccccchhhhhCC-
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--------VYTYIQSRFYRSPEVILGL- 243 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--------~~~~~~t~~y~aPE~~~~~- 243 (429)
.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+...... .....++..|+|||++.+.
T Consensus 111 ~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 188 (337)
T cd07852 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC--RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGST 188 (337)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEEeeccchhccccccccccCcchhcccccccccCceeeeccc
Confidence 9999999999999999999999999999999988 8999999998643321 2234678899999987654
Q ss_pred CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
.++.++|+|||||++|+|++|+.||.+.+..+....+....+.++.+.+......... ... . .......
T Consensus 189 ~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----~----~~~~~~~ 257 (337)
T cd07852 189 RYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAA---TML----D----SLPSRPR 257 (337)
T ss_pred cccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHH---Hhh----h----hcccccc
Confidence 5788999999999999999999999999988888888888887776655433211000 000 0 0001111
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.......+..+.++.+||.+||+.||++|||+.++++|+||++..
T Consensus 258 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 258 KPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred cchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 122334444688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=306.12 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=202.9
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|++.+.||.|+||.||+|.+..++.. |+|++......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------------------------------------- 39 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV----------------------------------------- 39 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-----------------------------------------
Confidence 599999999999999999999887765 88887532211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.......+.+|++++++++|+ ||+++++.+.....+++|+||+. ++|.+.+... ..+++..+..++.|++
T Consensus 40 -~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~ 110 (258)
T cd05578 40 -EKGSVRNVLNERRILQELNHP------FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIV 110 (258)
T ss_pred -chhHHHHHHHHHHHHHhCCCC------ChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHH
Confidence 011234566799999999877 99999999999999999999995 5999998876 3499999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
.||.|||++|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||++.+..++.++|+||||++
T Consensus 111 ~~l~~lh~~~i~h~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~ 188 (258)
T cd05578 111 LALEYLHSKGIIHRDIKPDNILLDEQG--HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVT 188 (258)
T ss_pred HHHHHHHhCCeeccCCCHHHeEEcCCC--CEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHH
Confidence 999999999999999999999999988 8999999998754432 233567888999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCCHH--HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 258 LAELYTGCPLFPGENEV--EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
+|+|++|..||...+.. +.+..... .. ....+...+.
T Consensus 189 l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~--------------------------------------~~~~~~~~~~ 227 (258)
T cd05578 189 AYECLRGKRPYRGHSRTIRDQIRAKQE---TA--------------------------------------DVLYPATWST 227 (258)
T ss_pred HHHHHhCCCCCCCCCccHHHHHHHHhc---cc--------------------------------------cccCcccCcH
Confidence 99999999999876642 21111110 00 0001112367
Q ss_pred HHHHHHHHhcccCCCCCCCH--HHHhcCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTP--DEALRHEWL 364 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta--~ell~h~~~ 364 (429)
.+.++|.+||..||.+||++ .|++.||||
T Consensus 228 ~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 228 EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 88999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=304.32 Aligned_cols=253 Identities=28% Similarity=0.414 Sum_probs=200.0
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
-.+||++.+.||.|++|.||+|.++.++. +++|++.....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------------------------------------- 44 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--------------------------------------- 44 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---------------------------------------
Confidence 46899999999999999999999987775 48887643321
Q ss_pred CCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcC------eEEEEEeecC-cCHHHHHHhhC--CCCCC
Q psy17270 98 GSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRN------HLCISFELMN-LNLYELIKRNN--YQGFS 167 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~------~~~lv~e~~~-g~L~~~i~~~~--~~~~~ 167 (429)
....+.+|+++++.+ .|+ ||+++++++.... .+++||||++ ++|.+++.... ...++
T Consensus 45 -------~~~~~~~e~~~l~~~~~h~------~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 111 (275)
T cd06608 45 -------EEEEIKEEYNILRKYSNHP------NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111 (275)
T ss_pred -------hHHHHHHHHHHHHHhcCCC------ChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCC
Confidence 112455699999998 455 9999999997644 5899999996 58999887543 35699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCC-
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGL- 243 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~- 243 (429)
+..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+..... ......++..|+|||++...
T Consensus 112 ~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (275)
T cd06608 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDE 189 (275)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC--eEEECCCccceecccchhhhcCccccccccCHhHhcccc
Confidence 999999999999999999999999999999999999887 899999999865332 22345688899999998642
Q ss_pred ----CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCC
Q psy17270 244 ----PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319 (429)
Q Consensus 244 ----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (429)
.++.++|||||||++|+|++|..||...+....+..+.. .....+
T Consensus 190 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~---------------------------- 238 (275)
T cd06608 190 QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPTL---------------------------- 238 (275)
T ss_pred cccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCCC----------------------------
Confidence 467899999999999999999999987655444433321 000000
Q ss_pred CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
......++.+.+||.+||..||++|||+.++++|||+
T Consensus 239 --------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 --------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred --------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0001136788999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=305.87 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=199.4
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
....++|++++.||+|+||.||+|++..++.. |+|++......
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~------------------------------------ 48 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD------------------------------------ 48 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc------------------------------------
Confidence 34567899999999999999999999888765 88876432110
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
....+.+|+.+++.++|+ ||+++++++.....+++||||++ ++|.+++.... .+++..+..+
T Consensus 49 ---------~~~~~~~e~~~l~~~~h~------~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~ 111 (267)
T cd06646 49 ---------DFSLIQQEIFMVKECKHC------NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYV 111 (267)
T ss_pred ---------hHHHHHHHHHHHHhcCCC------CeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence 012345699999998887 99999999999999999999996 58999887654 4899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhC---CCCCCC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILG---LPYGPP 248 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~ 248 (429)
+.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.. ..++.+
T Consensus 112 ~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~ 189 (267)
T cd06646 112 CRETLQGLAYLHSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189 (267)
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEECCCC--CEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcch
Confidence 99999999999999999999999999999887 8999999998754322 233567889999999853 347789
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|+||+||++|+|++|..||...+..+....+...... .+.. .
T Consensus 190 ~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------------~~~~----~ 232 (267)
T cd06646 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ---------------------------------PPKL----K 232 (267)
T ss_pred hhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC---------------------------------CCCC----c
Confidence 99999999999999999999654433221111100000 0000 0
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~ 363 (429)
.....+..+.+||++||..||++|||++++++|+|
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 01123678999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.21 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=198.7
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|++.+.||+|+||.||+|.+..++.. |+|++......
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------------------------------------- 48 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--------------------------------------- 48 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---------------------------------------
Confidence 46899999999999999999999888765 88876432111
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
....+.+|+.+++.++|+ ||+++++.+.....+++||||++ ++|.+++.... .+++.++..++.|
T Consensus 49 ------~~~~~~~e~~~~~~l~h~------~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~ 114 (267)
T cd06645 49 ------DFAVVQQEIIMMKDCKHS------NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRE 114 (267)
T ss_pred ------HHHHHHHHHHHHHhCCCC------CeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHH
Confidence 011344588899998877 99999999999999999999996 59999987654 4999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhh---CCCCCCCccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVIL---GLPYGPPIDM 251 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~---~~~~~~~~Di 251 (429)
++.||.|||++|++|+||||+||+++.++ .++|+|||++...... .....|+..|+|||++. ...++.++|+
T Consensus 115 i~~~l~~lH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv 192 (267)
T cd06645 115 TLQGLYYLHSKGKMHRDIKGANILLTDNG--HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDI 192 (267)
T ss_pred HHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhh
Confidence 99999999999999999999999999887 8999999998654322 23356889999999985 3457889999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|..||........+..+... ...+.. .. ...
T Consensus 193 wSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--------------------------------~~----~~~ 235 (267)
T cd06645 193 WAVGITAIELAELQPPMFDLHPMRALFLMTKS-NFQPPK--------------------------------LK----DKM 235 (267)
T ss_pred HHHHHHHHHHhcCCCCcccccchhhHHhhhcc-CCCCCc--------------------------------cc----ccC
Confidence 99999999999999999765543332221110 000000 00 001
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~ 363 (429)
..+..+.+|+.+||+.||++|||+.++++|||
T Consensus 236 ~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 23577899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.22 Aligned_cols=259 Identities=24% Similarity=0.414 Sum_probs=202.9
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|+..+.||.|++|.||+|.+..++.. |+|++.........
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~-------------------------------------- 42 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSE-------------------------------------- 42 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchh--------------------------------------
Confidence 488999999999999999999888765 88887533211100
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.......+.+|+.+++.++|+ ||+++++++....++++|+||+. ++|.+++.... .+++..+..++.|++
T Consensus 43 -~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~ 113 (268)
T cd06630 43 -QEEVVEALRKEIRLMARLNHP------HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLL 113 (268)
T ss_pred -HHHHHHHHHHHHHHHHHcCCC------ceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHH
Confidence 112234667799999999887 99999999999999999999995 59999987654 489999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-------ceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-------VYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.||+|||++|++|+||+|+||+++.++. .++|+|||.+...... .....++..|+|||++.+..++.++|+|
T Consensus 114 ~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~ 192 (268)
T cd06630 114 RGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVW 192 (268)
T ss_pred HHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchH
Confidence 9999999999999999999999987652 5999999998654321 1224578889999999888889999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|+||++|+|++|..||...+.......+....... ........
T Consensus 193 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~ 235 (268)
T cd06630 193 SVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-------------------------------------TAPSIPEH 235 (268)
T ss_pred HHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC-------------------------------------CCCCCchh
Confidence 99999999999999997654332222221110000 00011122
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
.++.+.+++.+||..||++|||+.++++||||+
T Consensus 236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 368899999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=292.76 Aligned_cols=252 Identities=23% Similarity=0.261 Sum_probs=193.8
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
=++||+|.+.||.|||+-||++.+..++. ||+|++..+..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~--------------------------------------- 59 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ--------------------------------------- 59 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---------------------------------------
Confidence 37899999999999999999999988885 59999854431
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeec-CcCHHHHHHhhCCC--CCCHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELM-NLNLYELIKRNNYQ--GFSLG 169 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~-~g~L~~~i~~~~~~--~~~~~ 169 (429)
.-.+.+++|++..++++|+ |+++++++...+ ...||+++|. .|+|.+.+.....+ .+++.
T Consensus 60 ------~~~e~~~rEid~~rkf~s~------~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~ 127 (302)
T KOG2345|consen 60 ------EDIEEALREIDNHRKFNSP------NVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEA 127 (302)
T ss_pred ------HHHHHHHHHHHHHHhhCCc------chHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHH
Confidence 1233566799999999987 999998876433 3599999999 68999999865433 39999
Q ss_pred HHHHHHHHHHHHHHHHHHCC--ceecccCCCcEEEecCCCcceEEeeecccccccCcce------------eeecCcccc
Q psy17270 170 LIRRFAFSLVQCLRLLHREN--IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY------------TYIQSRFYR 235 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~--ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~------------~~~~t~~y~ 235 (429)
++..|+.+|++||.+||... ++||||||.|||++..+ ..+|+|||.+........ ..-.|..|+
T Consensus 128 ~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~--~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyR 205 (302)
T KOG2345|consen 128 QILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG--LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYR 205 (302)
T ss_pred HHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC--ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCccc
Confidence 99999999999999999998 99999999999999877 899999999865332111 123478899
Q ss_pred chhhhhCC---CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 236 SPEVILGL---PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 236 aPE~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
|||.+.-+ ..+.++|||||||++|.|+.|..||...-.. -+... .++.-..-..|+
T Consensus 206 APELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------GgSla---------LAv~n~q~s~P~--- 264 (302)
T KOG2345|consen 206 APELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------GGSLA---------LAVQNAQISIPN--- 264 (302)
T ss_pred CchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------CCeEE---------EeeeccccccCC---
Confidence 99999743 5688999999999999999999999542110 00000 000000000111
Q ss_pred CCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
. ...++.+.+||+.||++||.+||++.+++.+
T Consensus 265 ----------~-------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 265 ----------S-------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ----------C-------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 1137899999999999999999999999864
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=296.85 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=206.7
Q ss_pred CeEEE-eEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 22 RYEIL-EVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 22 rY~i~-~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
-|++. +.||+|+|+.|--++...++. ||+|++.+...
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g----------------------------------------- 116 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG----------------------------------------- 116 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc-----------------------------------------
Confidence 35554 489999999999999999996 49888754311
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
-.+.++.+|++++.+.. +|+||++++++|+++..+|||||.| +|+|...|.++.. |++.++..++++|
T Consensus 117 ----HsR~RvfREVe~f~~Cq-----gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdi 185 (463)
T KOG0607|consen 117 ----HSRSRVFREVETFYQCQ-----GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDI 185 (463)
T ss_pred ----hHHHHHHHHHHHHHHhc-----CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHH
Confidence 12345677999999886 5569999999999999999999999 6799999888765 9999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCC-cceEEeeeccccccc----------CcceeeecCccccchhhhh---CC-
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGS-SSIKVIDFGSSCYSH----------QRVYTYIQSRFYRSPEVIL---GL- 243 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~-~~vkl~Dfg~~~~~~----------~~~~~~~~t~~y~aPE~~~---~~- 243 (429)
+.||.+||.+||.||||||+|||-...+. .-||||||.+..... ....+.+|+-.|||||+.. +.
T Consensus 186 a~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA 265 (463)
T KOG0607|consen 186 ASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQA 265 (463)
T ss_pred HHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcccc
Confidence 99999999999999999999999876542 348999999864311 1233467888899999864 22
Q ss_pred -CCCCCccccchhhHHHHHhhCCCCCCCCC---------------HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCC
Q psy17270 244 -PYGPPIDMWSLGCILAELYTGCPLFPGEN---------------EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT 307 (429)
Q Consensus 244 -~~~~~~DiwSlG~il~~lltg~~pf~~~~---------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (429)
.|+.++|.||||||+|-|+.|.+||.|.- ....+..|.+.-..+|++-|..
T Consensus 266 ~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWah------------- 332 (463)
T KOG0607|consen 266 TFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAH------------- 332 (463)
T ss_pred ccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHH-------------
Confidence 58999999999999999999999997642 2334445554444455544433
Q ss_pred CccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 308 PRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
++.+..|+++.+|..|+..|.+|.+++.|||++....
T Consensus 333 -------------------------IS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 333 -------------------------ISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred -------------------------hhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 3678889999999999999999999999999987543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=320.20 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=193.3
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCC------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTN------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.++|++.+.||+|+||.||+|++..++ .+|+|++.......
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------------- 83 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--------------------------------- 83 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH---------------------------------
Confidence 567999999999999999999975543 35777764332211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhC---------
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNN--------- 162 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~--------- 162 (429)
....+.+|+++++.+ .|+ ||+++++++.....+++||||| .|+|.+++....
T Consensus 84 -----------~~~~~~~E~~il~~l~~h~------nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~ 146 (374)
T cd05106 84 -----------EREALMSELKILSHLGQHK------NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMA 146 (374)
T ss_pred -----------HHHHHHHHHHHHHhhccCC------ceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhcccccc
Confidence 123456699999998 566 9999999999999999999999 479999886432
Q ss_pred -----------------------------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q psy17270 163 -----------------------------------------------------------YQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 163 -----------------------------------------------------------~~~~~~~~~~~i~~qil~~l~ 183 (429)
..++++..+..++.||+.||.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 226 (374)
T cd05106 147 LPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMD 226 (374)
T ss_pred ccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHH
Confidence 124788899999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-----eeecCccccchhhhhCCCCCCCccccchhhHH
Q psy17270 184 LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-----TYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 258 (429)
|||++||+||||||+|||++.++ .++|+|||++........ ...++..|+|||++.+..++.++|||||||++
T Consensus 227 yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil 304 (374)
T cd05106 227 FLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304 (374)
T ss_pred HHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHH
Confidence 99999999999999999999877 899999999865432211 12234579999999988899999999999999
Q ss_pred HHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 259 AELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 259 ~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
|+|++ |+.||........+..+......+. .....++++
T Consensus 305 ~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~l 344 (374)
T cd05106 305 WEIFSLGKSPYPGILVNSKFYKMVKRGYQMS----------------------------------------RPDFAPPEI 344 (374)
T ss_pred HHHHhCCCCCCccccccHHHHHHHHcccCcc----------------------------------------CCCCCCHHH
Confidence 99997 9999987654333322221100000 001136789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+++.+||+.||++|||+.++++
T Consensus 345 ~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 345 YSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=301.81 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=202.6
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|+||.||+|.+..++. +++|.+.....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------------------------------------- 41 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----------------------------------------- 41 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----------------------------------------
Confidence 679999999999999999999988665 48887643211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
...+.+|+++++.++|+ ||+++++.+.....+|+++|++. ++|.+++.... ..+++..+..++.|+
T Consensus 42 ------~~~~~~e~~~~~~l~~~------~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l 108 (256)
T cd06612 42 ------LQEIIKEISILKQCDSP------YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQT 108 (256)
T ss_pred ------HHHHHHHHHHHHhCCCC------cEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHH
Confidence 23455699999999776 99999999999999999999996 58999887544 458999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
+.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||++.+..++.++||||||
T Consensus 109 ~~~l~~lh~~~i~H~dl~~~ni~~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G 186 (256)
T cd06612 109 LKGLEYLHSNKKIHRDIKAGNILLNEEG--QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLG 186 (256)
T ss_pred HHHHHHHHHCCcccCCCCcceEEECCCC--cEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHH
Confidence 9999999999999999999999999988 8999999998754432 2234578889999999988899999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|+.||...+.......+.. ..... .......+.
T Consensus 187 ~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~------------------------------------~~~~~~~~~ 227 (256)
T cd06612 187 ITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPT------------------------------------LSDPEKWSP 227 (256)
T ss_pred HHHHHHHhCCCCCCCcchhhhhhhhcc---CCCCC------------------------------------CCchhhcCH
Confidence 999999999999987655433221110 00000 000112357
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.+.+|+.+||+.||++|||+.|+++||||
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 88999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=299.70 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=203.6
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|++.+.||.|+||.||+|.+..++.. ++|++......
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------------------------------------- 42 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--------------------------------------- 42 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---------------------------------------
Confidence 36899999999999999999999887754 88877433211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
....+.+|+++++.++|+ ||+++++.+.....+|++|||++ ++|.+++.... ..+++..+..++.|
T Consensus 43 ------~~~~~~~e~~~l~~~~h~------~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~q 109 (262)
T cd06613 43 ------DFEIIQQEISMLKECRHP------NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRE 109 (262)
T ss_pred ------hHHHHHHHHHHHHhCCCC------ChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHH
Confidence 123455699999999887 99999999999999999999996 58988887652 34999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCC---CCCCCccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGL---PYGPPIDM 251 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~---~~~~~~Di 251 (429)
++.||+|||++|++|+||+|+||+++.++ .++|+|||.+..... ......++..|+|||++.+. .++.++|+
T Consensus 110 l~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di 187 (262)
T cd06613 110 TLKGLAYLHETGKIHRDIKGANILLTEDG--DVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI 187 (262)
T ss_pred HHHHHHHHHhCCceecCCChhhEEECCCC--CEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhh
Confidence 99999999999999999999999999888 899999999865432 22335678889999999876 78889999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|..||...+.......+..... .+... ....
T Consensus 188 ~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~------------------------------------~~~~ 230 (262)
T cd06613 188 WALGITAIELAELQPPMFDLHPMRALFLISKSNF-PPPKL------------------------------------KDKE 230 (262)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCccc------------------------------------cchh
Confidence 9999999999999999988776554433322100 00000 0001
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~ 363 (429)
..+.++.+|+++||..||.+|||+.+++.|+|
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 12567899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=307.98 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=205.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|++++.||.|+||.||+|.+..++. +++|.+.......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--------------------------------------- 41 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL--------------------------------------- 41 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh---------------------------------------
Confidence 369999999999999999999998875 4888764332110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+.+|+++++.++|+ ||+++++.+..+.++++||||+. ++|.+++.... .+++..+..++.|+
T Consensus 42 ---~~~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i 110 (305)
T cd05609 42 ---RNQIQQVFVERDILTFAENP------FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAET 110 (305)
T ss_pred ---HHHHHHHHHHHHHHHhCCCC------CeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHH
Confidence 11123455699999988876 99999999999999999999995 59999997654 48999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC------------------cceeeecCccccchhhh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ------------------RVYTYIQSRFYRSPEVI 240 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~------------------~~~~~~~t~~y~aPE~~ 240 (429)
+.||+|||++|++|+||||+||+++.++ .++|+|||.+..... ......++..|+|||.+
T Consensus 111 ~~~l~~lH~~~i~H~dl~p~NIll~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 188 (305)
T cd05609 111 VLALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188 (305)
T ss_pred HHHHHHHHHCCccccCCchHHEEECCCC--CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhc
Confidence 9999999999999999999999999888 899999998753110 00123467789999999
Q ss_pred hCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCC
Q psy17270 241 LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRK 320 (429)
Q Consensus 241 ~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (429)
.+..++.++|+|||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 189 ~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------------------- 237 (305)
T cd05609 189 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE------------------------------- 237 (305)
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-------------------------------
Confidence 8888999999999999999999999999887766555444321100000
Q ss_pred CCCchhhhhhccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q psy17270 321 PGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT---PDEALRHEWLKSSS 368 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~ell~h~~~~~~~ 368 (429)
.....+..+.++|.+||+.||++||+ +.++++||||....
T Consensus 238 --------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 238 --------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred --------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 00123678899999999999999998 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=303.63 Aligned_cols=249 Identities=15% Similarity=0.228 Sum_probs=196.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCC----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTN----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
+-.++|++.+.||+|+||.||+|.++..+ .+|+|.+......
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~---------------------------------- 47 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD---------------------------------- 47 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH----------------------------------
Confidence 34578999999999999999999875322 2377776433221
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|+.+++.++|+ ||+++++++....+.++||||++ |+|.+++.... ..+++..+.
T Consensus 48 ----------~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~ 110 (266)
T cd05064 48 ----------KQRRGFLAEALTLGQFDHS------NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLM 110 (266)
T ss_pred ----------HHHHHHHHHHHHHhcCCCC------CcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHH
Confidence 1123456699999888776 99999999999999999999995 58888887653 358999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhhhCCCCCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
.++.|++.||+|||++|++||||||+||+++.++ .++++|||.+....... ....++..|+|||++.+..++.+
T Consensus 111 ~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 188 (266)
T cd05064 111 GMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188 (266)
T ss_pred HHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC--cEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccch
Confidence 9999999999999999999999999999999887 89999999875432111 11234567999999998899999
Q ss_pred ccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|||||||++|++++ |..||.+.+..+.+..+.+....+
T Consensus 189 ~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------------------- 228 (266)
T cd05064 189 SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---------------------------------------- 228 (266)
T ss_pred hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC----------------------------------------
Confidence 999999999999775 999998887766555443211000
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+...+..+.+++.+||+.||.+|||+.++++
T Consensus 229 -~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 -APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 01223678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=304.58 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=192.2
Q ss_pred EeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhh
Q psy17270 28 VIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFH 106 (429)
Q Consensus 28 ~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (429)
.||+|+||.||+|.+..++.. |+|.+.......... .
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~------------------------------------------~ 38 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG------------------------------------------E 38 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH------------------------------------------H
Confidence 489999999999999888765 888875432211110 1
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
..+.+|..+++.+.+. .|++|+.+++++...+..++||||+. ++|.+++.... .+++..+..++.|++.||.||
T Consensus 39 ~~~~~~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~l 113 (279)
T cd05633 39 TLALNERIMLSLVSTG---DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHM 113 (279)
T ss_pred HHHHHHHHHHHHHhhC---CCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Confidence 1223355555555433 45699999999999999999999995 68988887654 499999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCCcceEEeeecccccccC-cceeeecCccccchhhhhC-CCCCCCccccchhhHHHHHhh
Q psy17270 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILG-LPYGPPIDMWSLGCILAELYT 263 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~~llt 263 (429)
|++|++|+||||+||+++.++ .++|+|||++..... ......|+..|+|||.+.+ ..++.++|+||+||++|+|++
T Consensus 114 H~~~ivH~dikp~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 191 (279)
T cd05633 114 HNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191 (279)
T ss_pred HHCCcCCCCCCHHHEEECCCC--CEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHh
Confidence 999999999999999999888 899999999865432 2223468999999999874 467899999999999999999
Q ss_pred CCCCCCCCCHHH--HHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 264 GCPLFPGENEVE--QLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 264 g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
|..||....... .+..... . . ...++...+..+.++|
T Consensus 192 g~~pf~~~~~~~~~~~~~~~~--~-~--------------------------------------~~~~~~~~~~~~~~li 230 (279)
T cd05633 192 GHSPFRQHKTKDKHEIDRMTL--T-V--------------------------------------NVELPDSFSPELKSLL 230 (279)
T ss_pred CCCCcCCCCCcCHHHHHHHhh--c-C--------------------------------------CcCCccccCHHHHHHH
Confidence 999997643211 1111100 0 0 0011123478899999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 342 TQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 342 ~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
++||+.||++|+ |+.|+++||||+...
T Consensus 231 ~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 231 EGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 999999999999 699999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.29 Aligned_cols=258 Identities=21% Similarity=0.361 Sum_probs=207.2
Q ss_pred ccCCeEE-EeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEI-LEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i-~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
=.+||-- -..||+|+|-+||+|.|..+|..+. +....+.+.
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~~giEVA---------Wnqvk~~d~----------------------------- 78 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVA---------WNQVKIRDV----------------------------- 78 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccccchhhH---------HHHHhHHHh-----------------------------
Confidence 3566654 4599999999999999999986421 111111100
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC--eEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN--HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
-....-.+++..|+.+|+.|+|+ ||+++|+.|.+.. .+-+|+|.| .|+|..++++.+. ++...++.|
T Consensus 79 --~q~~~~leR~~~Ev~lLKsL~H~------NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W 148 (632)
T KOG0584|consen 79 --TQSPEELERLYSEVHLLKSLKHP------NIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSW 148 (632)
T ss_pred --hcChHHHHHHHHHHHHHccCCCC------ceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHH
Confidence 00223346788899999999988 9999999998765 488999999 6899999999875 999999999
Q ss_pred HHHHHHHHHHHHHC--CceecccCCCcEEEecCCCcceEEeeecccccccCcc-eeeecCccccchhhhhCCCCCCCccc
Q psy17270 175 AFSLVQCLRLLHRE--NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-YTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 175 ~~qil~~l~~lH~~--~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
++||+.||.|||++ -|+|||||.+||||+.+- ..|||+|+|+|....... ...+|||.|||||++. ..|+..+||
T Consensus 149 ~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~-G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDV 226 (632)
T KOG0584|consen 149 CRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL-GEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDV 226 (632)
T ss_pred HHHHHHHhhhhhcCCCCccccccccceEEEcCCc-CceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhh
Confidence 99999999999999 599999999999998752 389999999998765443 3469999999999997 589999999
Q ss_pred cchhhHHHHHhhCCCCCC-CCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYTGCPLFP-GENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||+.+.||+|+..||. +.+...++.++.. |..|..+.
T Consensus 227 YaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~sl~-------------------------------------- 266 (632)
T KOG0584|consen 227 YAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAALS-------------------------------------- 266 (632)
T ss_pred hhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHHhh--------------------------------------
Confidence 999999999999999995 4555555555543 33343321
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
+-.++++++||.+||.. .++|+||.|+|.|+||...
T Consensus 267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 11278999999999999 9999999999999999874
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.47 Aligned_cols=259 Identities=31% Similarity=0.450 Sum_probs=201.0
Q ss_pred hhhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 13 QVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 13 ~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
..+++ ..++|++.+.||.|+||.||+|.+..+++. |+|++....
T Consensus 15 ~~~~~-~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------------------------------- 59 (291)
T cd06639 15 ESLGD-PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------------------------------- 59 (291)
T ss_pred ccCCC-CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----------------------------------
Confidence 34444 578999999999999999999999888865 888763221
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecC-cCHHHHHHhh--C
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFR-----NHLCISFELMN-LNLYELIKRN--N 162 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~-g~L~~~i~~~--~ 162 (429)
.....+.+|+.+++.+ +|+ |++++++++... ..+++||||+. ++|.+++... .
T Consensus 60 ------------~~~~~~~~e~~~l~~l~~h~------ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~ 121 (291)
T cd06639 60 ------------DVDEEIEAEYNILQSLPNHP------NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121 (291)
T ss_pred ------------cHHHHHHHHHHHHHHhcCCC------CeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhc
Confidence 1122345588888888 454 999999998754 36899999995 5999988642 2
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhh
Q psy17270 163 YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEV 239 (429)
Q Consensus 163 ~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~ 239 (429)
...+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... ......++..|+|||+
T Consensus 122 ~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 199 (291)
T cd06639 122 GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG--GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199 (291)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC--CEEEeecccchhcccccccccCccCCccccChhh
Confidence 24589999999999999999999999999999999999999887 899999999865332 2233567888999999
Q ss_pred hhCC-----CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCC
Q psy17270 240 ILGL-----PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314 (429)
Q Consensus 240 ~~~~-----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (429)
+... .++.++|||||||++|+|++|+.||...+....+..+.. ..+...
T Consensus 200 ~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~----------------------- 253 (291)
T cd06639 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPTL----------------------- 253 (291)
T ss_pred hcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCCC-----------------------
Confidence 8643 267899999999999999999999987665444433321 000000
Q ss_pred CCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
.........+.+||.+||+.||++||++.|+++||||+
T Consensus 254 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 -------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00011256789999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=311.79 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=205.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...+.|.....||.|+||.||+|.+..++.. |+|++.....
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------------------------------------- 60 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-------------------------------------- 60 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--------------------------------------
Confidence 4567788888999999999999999877754 8887632211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+.+++.++|+ ||+++++.+......++||||+. ++|.+++... .+++..+..++
T Consensus 61 -------~~~~~~~~e~~~l~~l~h~------~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~ 124 (292)
T cd06658 61 -------QRRELLFNEVVIMRDYHHE------NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVC 124 (292)
T ss_pred -------HHHHHHHHHHHHHHhCCCC------cHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHH
Confidence 1122455699999998877 99999999999999999999995 5888877543 38999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.||+.||+|||++|++||||||+||+++.++ .++|+|||++..... ......++..|+|||++.+..++.++|+|
T Consensus 125 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 202 (292)
T cd06658 125 LSVLRALSYLHNQGVIHRDIKSDSILLTSDG--RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202 (292)
T ss_pred HHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHH
Confidence 9999999999999999999999999999887 899999999864321 22345688899999999888899999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||+++|+|++|+.||...+....+..+......... ....
T Consensus 203 slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~ 243 (292)
T cd06658 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK---------------------------------------DSHK 243 (292)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc---------------------------------------cccc
Confidence 9999999999999999887765554433321110000 0012
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.++.+.+|+.+||..||++|||+.|+++|+||+...
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 367888999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=305.97 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=204.3
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.+.|+.+++||.|+||.||+|.+..++.. |+|++.......
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-------------------------------------- 44 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-------------------------------------- 44 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH--------------------------------------
Confidence 46799999999999999999999887754 888775332211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
....+.+|+.+++++.|+ ||+++++.+......++||||++ ++|.+++... .+++..+..++.|
T Consensus 45 ------~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~ 109 (277)
T cd06640 45 ------EIEDIQQEITVLSQCDSP------YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKE 109 (277)
T ss_pred ------HHHHHHHHHHHHHhCCCC------CEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHH
Confidence 123455699999998877 99999999999999999999995 5999988753 4899999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
++.||+|||+.+++|+||+|+||+++.++ .++|+|||++..... ......++..|+|||++.+..++.++|+|||
T Consensus 110 l~~~l~~lh~~~ivH~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~sl 187 (277)
T cd06640 110 ILKGLDYLHSEKKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSL 187 (277)
T ss_pred HHHHHHHHHhCCccCcCCChhhEEEcCCC--CEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHH
Confidence 99999999999999999999999999887 899999999865432 1223457888999999988888999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||++|+|++|..||...+.......+.. +.+ .......+
T Consensus 188 G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~---------------------------------------~~~~~~~~ 226 (277)
T cd06640 188 GITAIELAKGEPPNSDMHPMRVLFLIPK--NNP---------------------------------------PTLTGEFS 226 (277)
T ss_pred HHHHHHHHHCCCCCCCcChHhHhhhhhc--CCC---------------------------------------CCCchhhh
Confidence 9999999999999987665433322110 000 00111235
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
..+.+++.+||+.||++||++.+++.|+||....
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 7788999999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=308.71 Aligned_cols=260 Identities=26% Similarity=0.374 Sum_probs=207.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
.....+|++.+.||.|+||+||+|.+..++.. |+|++........
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~---------------------------------- 56 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---------------------------------- 56 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH----------------------------------
Confidence 34568899999999999999999999877754 8887643211100
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+++++.+.|+ ||+++++++......++||||+.|++.+++.... ..+++..+..++
T Consensus 57 --------~~~~~~~~Ei~~l~~l~h~------niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~ 121 (307)
T cd06607 57 --------EKWQDIIKEVRFLQQLRHP------NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAIC 121 (307)
T ss_pred --------HHHHHHHHHHHHHHhCCCC------CEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHH
Confidence 1122456699999999887 9999999999999999999999999988887544 359999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhh---CCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVIL---GLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Diw 252 (429)
.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... ....++..|+|||++. ...++.++|||
T Consensus 122 ~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~--~~kL~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~ 198 (307)
T cd06607 122 HGALQGLAYLHSHERIHRDIKAGNILLTEPG--TVKLADFGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVW 198 (307)
T ss_pred HHHHHHHHHHHHCCceecCCCcccEEECCCC--CEEEeecCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchH
Confidence 9999999999999999999999999999988 8999999998654332 3456788999999885 34578899999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||+++|+|++|..||.+.+.......+.. ..++. . ....
T Consensus 199 s~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~---------------------------------~-----~~~~ 238 (307)
T cd06607 199 SLGITCIELAERKPPLFNMNAMSALYHIAQ--NDSPT---------------------------------L-----SSND 238 (307)
T ss_pred HHHHHHHHHHcCCCCCCCccHHHHHHHHhc--CCCCC---------------------------------C-----Cchh
Confidence 999999999999999988766544333221 00000 0 0011
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.+..+.++|.+||..||++||++.+++.|+||....
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 267889999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=303.52 Aligned_cols=277 Identities=32% Similarity=0.586 Sum_probs=222.5
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|++.+.||+|++|.||+|.+..+++. |+|++.....
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------------------------------------------- 37 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE------------------------------------------- 37 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-------------------------------------------
Confidence 77889999999999999999987765 8887743321
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQC 181 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~ 181 (429)
.......+..|+.+++.+.|+ |++++++++......++|||+++++|.+++.+.. ..+++..+..++.|++.|
T Consensus 38 ~~~~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~ 110 (282)
T cd07829 38 EEGIPSTALREISLLKELKHP------NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRG 110 (282)
T ss_pred cccccHHHHHHHHHHHhcCCC------CHHHHHhhhhcCCceEEEecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHH
Confidence 112233455699999998876 9999999999999999999999999999998764 349999999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccchhhH
Q psy17270 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCI 257 (429)
Q Consensus 182 l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~i 257 (429)
|+|||++|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+. .++.++|+|||||+
T Consensus 111 l~~LH~~~i~H~~l~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~ 188 (282)
T cd07829 111 LAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCI 188 (282)
T ss_pred HHHHHHCCcccCCCChheEEEcCCC--CEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHH
Confidence 9999999999999999999999987 8999999998754332 2233457789999999876 78899999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+++|++|..||.+.+..+.+..+...++.+.+..+....... .++. ..............+..+..+
T Consensus 189 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~------------~~~~~~~~~~~~~~~~~~~~~ 255 (282)
T cd07829 189 FAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKP------------TFPKFPPKDLEKVLPRLDPEG 255 (282)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-cccc------------cccccCccchHHhcccccHHH
Confidence 999999999999999989999999888888877765443321 0000 000111111122233447889
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.++|++||..||++||++.+++.||||
T Consensus 256 ~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 256 IDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=300.98 Aligned_cols=247 Identities=20% Similarity=0.298 Sum_probs=200.8
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-.++|+++++||+|+||.||+|.+..+..+|+|.+.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---------------------------------------- 43 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------------------------------------- 43 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----------------------------------------
Confidence 4578999999999999999999987666678887643211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
....+.+|+.+++.++|+ ||+++++.+......+++|||+ +++|.+++.......++...+..++.|
T Consensus 44 ------~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 111 (261)
T cd05072 44 ------SVQAFLEEANLMKTLQHD------KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ 111 (261)
T ss_pred ------hHHHHHHHHHHHHhCCCC------CeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 012455699999999877 9999999999889999999999 469999998765556899999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCccccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
++.||+|||+.|++|+||||+||+++.++ .++|+|||++........ ...++..|+|||.+.+..++.++||||
T Consensus 112 l~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 189 (261)
T cd05072 112 IAEGMAYIERKNYIHRDLRAANVLVSESL--MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189 (261)
T ss_pred HHHHHHHHHHCCeeccccchhhEEecCCC--cEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhh
Confidence 99999999999999999999999999888 899999999976543221 123456799999998888999999999
Q ss_pred hhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 254 LGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 254 lG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||++|+|++ |..||...+..+....+......+ ....
T Consensus 190 lG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~ 228 (261)
T cd05072 190 FGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP-----------------------------------------RMEN 228 (261)
T ss_pred hHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------------------CCCC
Confidence 9999999998 999998877665554443211000 0112
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+.++.+++.+||..||++|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 229 CPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 3678899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=291.87 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=205.1
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
.+++..||.|+.|+||+++.+.+|.. |+|.+.+.....+.
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~--------------------------------------- 134 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEEN--------------------------------------- 134 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHH---------------------------------------
Confidence 35678899999999999999999987 99988665443222
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQC 181 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~ 181 (429)
+++++.++++.... .+|+|++++++|-.+..+++.||.|...+..++++-. ++++|..+-.+...++.|
T Consensus 135 -----kRILmDldvv~~s~-----dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik-~piPE~ilGk~tva~v~A 203 (391)
T KOG0983|consen 135 -----KRILMDLDVVLKSH-----DCPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIK-GPIPERILGKMTVAIVKA 203 (391)
T ss_pred -----HHHHHhhhHHhhcc-----CCCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhc-CCchHHhhhhhHHHHHHH
Confidence 23444555554432 4579999999999999999999999877777766654 679999999999999999
Q ss_pred HHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCC---CCCCCccccchh
Q psy17270 182 LRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGL---PYGPPIDMWSLG 255 (429)
Q Consensus 182 l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG 255 (429)
|.||..+ ||+|||+||+|||++..| ++||||||.+....+ ......|.+.|||||.+.-. +|+..+||||||
T Consensus 204 L~YLKeKH~viHRDvKPSNILlDe~G--niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlG 281 (391)
T KOG0983|consen 204 LYYLKEKHGVIHRDVKPSNILLDERG--NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLG 281 (391)
T ss_pred HHHHHHhcceeecccCccceEEccCC--CEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhc
Confidence 9999955 899999999999999999 999999999865433 23346788999999998744 689999999999
Q ss_pred hHHHHHhhCCCCCCCC-CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYTGCPLFPGE-NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
++++||+||+.||.+- .+.+.+..+.+. .|| .+ ....+.+
T Consensus 282 ITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP-~L------------------------------------~~~~gFS 322 (391)
T KOG0983|consen 282 ITLVELATGQYPYKGCKTDFEVLTKVLNE--EPP-LL------------------------------------PGHMGFS 322 (391)
T ss_pred cchhhhhcccCCCCCCCccHHHHHHHHhc--CCC-CC------------------------------------CcccCcC
Confidence 9999999999999874 566677666641 111 10 0011248
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+.|++|+..||+.|+.+||.-.++|+|||++.-.
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 9999999999999999999999999999997643
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=301.74 Aligned_cols=261 Identities=29% Similarity=0.430 Sum_probs=200.6
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|++|.||+|.+..++.. |+|.+......
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---------------------------------------- 40 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP---------------------------------------- 40 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch----------------------------------------
Confidence 5799999999999999999999887765 88876433221
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecC-cCHHHHHHhh--CCCCCCHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMN-LNLYELIKRN--NYQGFSLGLIRRF 174 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~-g~L~~~i~~~--~~~~~~~~~~~~i 174 (429)
.....+.+|+++++.++|+ ||++++++|... ..+++||||++ ++|.+++... ....+++..+..+
T Consensus 41 ----~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i 110 (287)
T cd06621 41 ----DLQKQILRELEINKSCKSP------YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKI 110 (287)
T ss_pred ----HHHHHHHHHHHHHHhCCCC------CeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHH
Confidence 1223566699999999887 999999988654 47899999995 5898887542 2244899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-ceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-VYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
+.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.+..++.++|+||
T Consensus 111 ~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~s 188 (287)
T cd06621 111 AESVLKGLSYLHSRKIIHRDIKPSNILLTRKG--QVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWS 188 (287)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEEecCC--eEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHH
Confidence 99999999999999999999999999999887 8999999998654322 22345778899999999888999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCH-----HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 254 LGCILAELYTGCPLFPGENE-----VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
|||++|+|++|..||..... .+....+. ........ . ...
T Consensus 189 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~----------------~----------------~~~ 233 (287)
T cd06621 189 LGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV---NMPNPELK----------------D----------------EPG 233 (287)
T ss_pred HHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh---cCCchhhc----------------c----------------CCC
Confidence 99999999999999986522 11111111 00000000 0 000
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....++.+.+||.+||..||++|||+.|+++|+||++..
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 0001246789999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=302.77 Aligned_cols=254 Identities=29% Similarity=0.458 Sum_probs=197.7
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++.+.||+|+||.||+|.+..++.. |+|++....
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--------------------------------------- 55 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--------------------------------------- 55 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---------------------------------------
Confidence 4788999999999999999999999888865 888753211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEE-----EcCeEEEEEeecC-cCHHHHHHhh--CCCCCC
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFY-----FRNHLCISFELMN-LNLYELIKRN--NYQGFS 167 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~-g~L~~~i~~~--~~~~~~ 167 (429)
.....+.+|+.+++.+. |+ ||+++++++. ....+++||||++ ++|.+++... ....++
T Consensus 56 -------~~~~~~~~e~~~l~~l~~h~------~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 122 (286)
T cd06638 56 -------DIDEEIEAEYNILKALSDHP------NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122 (286)
T ss_pred -------chHHHHHHHHHHHHHHhcCC------CeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCcccc
Confidence 11123456889999984 65 9999999874 3457999999995 6999887643 223588
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhC--
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILG-- 242 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~-- 242 (429)
+..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||++..... ......|++.|+|||++..
T Consensus 123 ~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (286)
T cd06638 123 EPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG--GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 200 (286)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC--CEEEccCCceeecccCCCccccccCCCcccChhhhchhh
Confidence 999999999999999999999999999999999999988 799999999865432 2233568899999999853
Q ss_pred ---CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCC
Q psy17270 243 ---LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319 (429)
Q Consensus 243 ---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (429)
..++.++||||+||++|+|++|+.||...+....+..+.. +..+.
T Consensus 201 ~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~--~~~~~------------------------------ 248 (286)
T cd06638 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR--NPPPT------------------------------ 248 (286)
T ss_pred hccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc--cCCCc------------------------------
Confidence 3478899999999999999999999987654333221110 00000
Q ss_pred CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.......+..+.+||.+||+.||++|||+.|+++|+||
T Consensus 249 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 -------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00001125678999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=299.55 Aligned_cols=244 Identities=21% Similarity=0.305 Sum_probs=197.6
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+.|++.+.||+|+||.||+|.++....+|+|.+.....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~------------------------------------------ 41 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM------------------------------------------ 41 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc------------------------------------------
Confidence 46999999999999999999987766678887532210
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
....+.+|+++++.+.|+ ||+++++++.....+++||||+. |+|.+++.... ..+++..+..++.|++
T Consensus 42 ----~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~ 110 (256)
T cd05114 42 ----SEEDFIEEAKVMMKLSHP------KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVC 110 (256)
T ss_pred ----cHHHHHHHHHHHHHCCCC------CceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHH
Confidence 123456699999999877 99999999999999999999995 79999887643 3489999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
.||+|||++|++|+||+|+||+++.++ .++|+|||.+........ ...++..|+|||++.+..++.++|+||||
T Consensus 111 ~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G 188 (256)
T cd05114 111 EGMEYLERNSFIHRDLAARNCLVSSTG--VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFG 188 (256)
T ss_pred HHHHHHHHCCccccccCcceEEEcCCC--eEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHH
Confidence 999999999999999999999999887 899999999875432211 12234579999999888899999999999
Q ss_pred hHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
+++|+|++ |+.||...+..+.+..+........ +...+
T Consensus 189 ~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~-----------------------------------------~~~~~ 227 (256)
T cd05114 189 VLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR-----------------------------------------PKLAS 227 (256)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC-----------------------------------------CCCCC
Confidence 99999999 9999988777666555543110000 01125
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 228 MTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 67899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=301.16 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=199.3
Q ss_pred eeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhh
Q psy17270 29 IGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHH 107 (429)
Q Consensus 29 lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (429)
||.|++|.||+|++..++.. |+|++....... .....
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------------------------------------------~~~~~ 38 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE------------------------------------------TGQQE 38 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh------------------------------------------hhHHH
Confidence 79999999999999887754 888875432111 11223
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
.+.+|+.+++.+.|+ ||+++++.+..+..++++|||+. ++|.+++.... .+++..+..++.|++.||+|||
T Consensus 39 ~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH 110 (262)
T cd05572 39 HIFSEKEILEECNHP------FIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLH 110 (262)
T ss_pred HHHHHHHHHHhCCCC------CEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh
Confidence 566799999999877 99999999999999999999995 69999998754 3899999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhC
Q psy17270 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264 (429)
Q Consensus 187 ~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 264 (429)
++|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 111 ~~~~~h~dl~~~nilv~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g 188 (262)
T cd05572 111 NRGIIYRDLKPENLLLDSNG--YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188 (262)
T ss_pred hCCcccCCCCHHHEEEcCCC--CEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC
Confidence 99999999999999999988 8999999998765432 3345688899999999888899999999999999999999
Q ss_pred CCCCCCCC--HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHH
Q psy17270 265 CPLFPGEN--EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVT 342 (429)
Q Consensus 265 ~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 342 (429)
..||...+ ..+....+...... ...+...++.+.++|.
T Consensus 189 ~~p~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~i~ 228 (262)
T cd05572 189 RPPFGEDDEDPMEIYNDILKGNGK----------------------------------------LEFPNYIDKAAKDLIK 228 (262)
T ss_pred CCCcCCCCCCHHHHHHHHhccCCC----------------------------------------CCCCcccCHHHHHHHH
Confidence 99998766 33333322210000 0001112678899999
Q ss_pred HhcccCCCCCCC-----HHHHhcCCCCCCC
Q psy17270 343 QCFNWDSKKRLT-----PDEALRHEWLKSS 367 (429)
Q Consensus 343 ~~L~~dP~~Rpt-----a~ell~h~~~~~~ 367 (429)
+||+.||++||+ +.|+++||||++-
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 229 QLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred HHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=298.09 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=202.5
Q ss_pred CeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||+..+.||+|+||+||+|.+..++. +++|.+........
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~--------------------------------------- 41 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT--------------------------------------- 41 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc---------------------------------------
Confidence 68899999999999999999986665 48887643321111
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.+.....+.+|+.+++.++|+ ||+++++++.....+++++||+. ++|.+++.... .+++..+..++.|++
T Consensus 42 -~~~~~~~~~~e~~~l~~~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~ 112 (258)
T cd06632 42 -GQEAVKQLEQEIALLSKLQHP------NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQIL 112 (258)
T ss_pred -chHHHHHHHHHHHHHHhcCCC------CchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHH
Confidence 011223566799999999877 99999999999999999999995 59999987654 489999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCC-CCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~ 256 (429)
.||+|||+.|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.... ++.++|+|||||
T Consensus 113 ~~l~~lH~~~i~H~dl~~~ni~~~~~~--~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~ 190 (258)
T cd06632 113 LGLEYLHDRNTVHRDIKGANILVDTNG--VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC 190 (258)
T ss_pred HHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHH
Confidence 999999999999999999999999887 8999999998654322 23456788899999998766 889999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|..||......+....+..... ........++.
T Consensus 191 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~ 230 (258)
T cd06632 191 TVLEMATGKPPWSQLEGVAAVFKIGRSKE----------------------------------------LPPIPDHLSDE 230 (258)
T ss_pred HHHHHHhCCCCcccCcHHHHHHHHHhccc----------------------------------------CCCcCCCcCHH
Confidence 99999999999987664433332221000 00111223688
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.+|+++||..||++||++.+++.|||+
T Consensus 231 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 231 AKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 8999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=299.63 Aligned_cols=253 Identities=24% Similarity=0.407 Sum_probs=197.7
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++.+.||.|+||.||+|.+..++.. ++|++.........
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~-------------------------------------- 44 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET-------------------------------------- 44 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh--------------------------------------
Confidence 589999999999999999999887754 88876433211110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
......+.+|+.+++.++|+ ||+++++.+... ..+++++||+. ++|.+++.... .+++..+..++.|
T Consensus 45 --~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~q 114 (266)
T cd06651 45 --SKEVSALECEIQLLKNLQHE------RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQ 114 (266)
T ss_pred --HHHHHHHHHHHHHHHHcCCC------CeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHH
Confidence 11123456699999999887 999999988763 57899999995 58999987654 3899999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhhCCCCCCCccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
++.||+|||+++++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.+..++.++|+
T Consensus 115 i~~~l~~LH~~~i~H~~l~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 192 (266)
T cd06651 115 ILEGMSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADV 192 (266)
T ss_pred HHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhh
Confidence 99999999999999999999999999887 8999999998643221 122457888999999998889999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
||+||++|+|++|+.||...+.......+.. ... ......
T Consensus 193 ~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~-------------------------------------~~~~~~ 232 (266)
T cd06651 193 WSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT-------------------------------------NPQLPS 232 (266)
T ss_pred HHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCC-------------------------------------CCCCch
Confidence 9999999999999999987654443322211 000 000111
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
..++.+.+++ +||..||++||++.|+++||||+
T Consensus 233 ~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 233 HISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 2367778888 68889999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.71 Aligned_cols=262 Identities=27% Similarity=0.429 Sum_probs=202.8
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|.+.+.||.|+||.||+|.+..++.. |+|.+........... .
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~-----------------------------------~ 46 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHD-----------------------------------S 46 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccc-----------------------------------h
Confidence 699999999999999999999888764 8887743322111100 0
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+.+|+.+++.+.|+ |++++++++......++||||+ +++|.+++.... .+++..+..++.|++
T Consensus 47 ~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~ 118 (272)
T cd06629 47 RQKDMVKALRSEIETLKDLDHL------NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVL 118 (272)
T ss_pred HHHHHHHHHHHHHHHHHhcCCC------CcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHH
Confidence 0112234566799999999877 9999999999999999999999 469999987763 499999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCC--CCCCcccc
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLP--YGPPIDMW 252 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~--~~~~~Diw 252 (429)
.||.|||++|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||++.... ++.++|+|
T Consensus 119 ~~l~~lH~~~i~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~ 196 (272)
T cd06629 119 EGLAYLHSKGILHRDLKADNLLVDADG--ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIW 196 (272)
T ss_pred HHHHHHhhCCeeecCCChhhEEEcCCC--eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhH
Confidence 999999999999999999999999887 8999999998654321 22345788899999988654 78899999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||+++|+|++|..||...+....+..+....... .........
T Consensus 197 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~ 240 (272)
T cd06629 197 SLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP------------------------------------PIPPDVSMN 240 (272)
T ss_pred HHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC------------------------------------cCCcccccc
Confidence 99999999999999997655443322211100000 000011123
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.+..+.+||.+||..||++|||+.++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 241 LSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 47889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=303.82 Aligned_cols=255 Identities=30% Similarity=0.466 Sum_probs=203.3
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|++|.||+|.++.++.. |+|.+......
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------------------------------------- 40 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE---------------------------------------- 40 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh----------------------------------------
Confidence 4689999999999999999999987765 88877543222
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+|+++++.+.|+ ||+++++.+.....+++++|++. ++|.+++.... ..+++..+..++.|+
T Consensus 41 ----~~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l 109 (265)
T cd06605 41 ----AIQKQILRELDILHKCNSP------YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAV 109 (265)
T ss_pred ----HHHHHHHHHHHHHHHCCCC------chhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHH
Confidence 1123455699999988876 99999999999999999999997 69999998764 459999999999999
Q ss_pred HHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeecccccccCc-ceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 179 VQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 179 l~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
+.||+|||+ .|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+..++.++|+|||||
T Consensus 110 ~~~l~~lH~~~~i~H~dl~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ 187 (265)
T cd06605 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGL 187 (265)
T ss_pred HHHHHHHcCCCCeecCCCCHHHEEECCCC--CEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHH
Confidence 999999999 9999999999999999988 8999999998654321 11256788899999999888999999999999
Q ss_pred HHHHHhhCCCCCCCCCH--HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc-C
Q psy17270 257 ILAELYTGCPLFPGENE--VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC-N 333 (429)
Q Consensus 257 il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 333 (429)
++|+|++|..||...+. ......+.......... .... .
T Consensus 188 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~ 229 (265)
T cd06605 188 SLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR--------------------------------------LPSGKF 229 (265)
T ss_pred HHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC--------------------------------------CChhhc
Confidence 99999999999976421 11111111111100000 0000 3
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
++.+.+||.+||..||++|||+.+++.||||+.
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 678999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=304.82 Aligned_cols=248 Identities=20% Similarity=0.300 Sum_probs=198.7
Q ss_pred CCeEEEeEeeccccceEEEEEecCCC------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTN------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
++|++.+.||.|+||.||+|.+...+ .+|+|.+......
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~----------------------------------- 49 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP----------------------------------- 49 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-----------------------------------
Confidence 57999999999999999999986654 2466765432211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC----------
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY---------- 163 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~---------- 163 (429)
.....+.+|++++..+.|+ ||+++++++......+++|||+. ++|.+++.....
T Consensus 50 ---------~~~~~~~~ei~~l~~l~h~------~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 114 (283)
T cd05048 50 ---------KVQQEFRQEAELMSDLQHP------NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114 (283)
T ss_pred ---------HHHHHHHHHHHHHHhcCCc------ccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCccccccccc
Confidence 1223466799999999877 99999999998889999999995 699999976421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccc
Q psy17270 164 ----QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFY 234 (429)
Q Consensus 164 ----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y 234 (429)
..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... .....+++.|
T Consensus 115 ~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~--~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y 192 (283)
T cd05048 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL--TVKISDFGLSRDIYSADYYRVQSKSLLPVRW 192 (283)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC--cEEECCCcceeeccccccccccCCCcccccc
Confidence 3488899999999999999999999999999999999999887 8999999998654321 1223557789
Q ss_pred cchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccC
Q psy17270 235 RSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313 (429)
Q Consensus 235 ~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (429)
+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 193 ~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~---------------------------- 244 (283)
T cd05048 193 MPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL---------------------------- 244 (283)
T ss_pred cCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc----------------------------
Confidence 99999988889999999999999999998 9999988777655444332000
Q ss_pred CCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
...+...++++.+|+.+||+.||++||++.|++++
T Consensus 245 -------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 245 -------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred -------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00112347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=299.04 Aligned_cols=248 Identities=19% Similarity=0.298 Sum_probs=200.0
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
++..++|+++++||+|+||.||+|.++.+..+|+|.+......
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~------------------------------------- 44 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS------------------------------------- 44 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc-------------------------------------
Confidence 4567899999999999999999999877666788876432111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
...+.+|+.+++.+.|+ ||+++++++. ...++++||++ +++|.+++.......++..++..++
T Consensus 45 ---------~~~~~~E~~~l~~l~h~------~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~ 108 (260)
T cd05067 45 ---------PEAFLAEANLMKQLQHP------RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA 108 (260)
T ss_pred ---------HHHHHHHHHHHHhcCCc------CeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHH
Confidence 12456699999999877 9999998864 56789999999 4699999877655568999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.|++.||+|||+.|++|+||||+||+++.++ .++|+|||.+........ ...++..|+|||++.+..++.++||
T Consensus 109 ~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di 186 (260)
T cd05067 109 AQIAEGMAFIERKNYIHRDLRAANILVSETL--CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186 (260)
T ss_pred HHHHHHHHHHhcCCeecccccHHhEEEcCCC--CEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccch
Confidence 9999999999999999999999999999988 899999999865442111 1234567999999998889999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||+++|+|++ |+.||.+.+..+....+......+ ..
T Consensus 187 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~ 225 (260)
T cd05067 187 WSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP-----------------------------------------RP 225 (260)
T ss_pred HHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-----------------------------------------CC
Confidence 999999999999 999998877665544433211100 01
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...+.++.+++.+||+.||++|||++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 123678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=306.41 Aligned_cols=259 Identities=27% Similarity=0.382 Sum_probs=220.8
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+-...|.++.+||.|+||+|.+|..+.+.+. |||++++.+.-....
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD--------------------------------- 392 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD--------------------------------- 392 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc---------------------------------
Confidence 3467899999999999999999999988875 999887654322211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
-+.-+.|.++|.....+ |.++++...|..-+.+|+||||+ +|+|-.-|++-.. |.++.+..++
T Consensus 393 ---------vectm~EKrvLAL~~kp-----pFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYA 456 (683)
T KOG0696|consen 393 ---------VECTMVEKRVLALPGKP-----PFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYA 456 (683)
T ss_pred ---------ccceehhhhheecCCCC-----chHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhh
Confidence 12334478888777655 58899999999999999999999 5688888887754 9999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc---ccCcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
..|+-||-+||++||+.||||.+|||++.+| ++||+|||.+.. .+....++||||.|+|||++...+|+.++|.|
T Consensus 457 aEiaigLFFLh~kgIiYRDLKLDNvmLd~eG--HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWW 534 (683)
T KOG0696|consen 457 AEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 534 (683)
T ss_pred HHHHHHhhhhhcCCeeeeeccccceEeccCC--ceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHH
Confidence 9999999999999999999999999999999 999999999964 33445679999999999999999999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|+||++|||+.|++||.+.+..+.++.|.+.--..|..
T Consensus 535 a~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs------------------------------------------ 572 (683)
T KOG0696|consen 535 AFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS------------------------------------------ 572 (683)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc------------------------------------------
Confidence 99999999999999999999999999988744433433
Q ss_pred CChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTP-----DEALRHEWLKSSSS 369 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta-----~ell~h~~~~~~~~ 369 (429)
.+.++.++++.+|...|.+|+.+ .++-.||||+...-
T Consensus 573 lSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 573 LSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred ccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 37888999999999999999964 68999999998653
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.12 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=199.4
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
..|++.+.||.|+||.||+|.+..++.. |+|.+........
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~-------------------------------------- 43 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPE-------------------------------------- 43 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcc--------------------------------------
Confidence 4699999999999999999999988865 8887643211100
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.......+.+|+++++.+.|+ ||+++++++.+. ..++++|||+. ++|.+++.... .+++..+..++.
T Consensus 44 --~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ 113 (265)
T cd06652 44 --TSKEVNALECEIQLLKNLLHE------RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTR 113 (265)
T ss_pred --cHHHHHHHHHHHHHHHhcCCC------CeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHH
Confidence 011123556699999999877 999999988764 46889999995 69999987654 389999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC------cceeeecCccccchhhhhCCCCCCCcc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ------RVYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+..... ......++..|+|||++.+..++.++|
T Consensus 114 ~l~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 191 (265)
T cd06652 114 QILEGVSYLHSNMIVHRDIKGANILRDSVG--NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKAD 191 (265)
T ss_pred HHHHHHHHHHhCCEecCCCCHHHEEecCCC--CEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchh
Confidence 999999999999999999999999999888 899999998864321 122345788899999998888899999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
+|||||++|+|++|+.||...+....+..+. ..+.. ...+
T Consensus 192 v~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~-------------------------------------~~~~ 231 (265)
T cd06652 192 IWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTN-------------------------------------PVLP 231 (265)
T ss_pred HHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCC-------------------------------------CCCc
Confidence 9999999999999999998765544333222 11100 0011
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
...+..+.++|++||. +|++||++.|+++|||++
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 2236778899999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=295.93 Aligned_cols=291 Identities=27% Similarity=0.494 Sum_probs=230.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+.-.||.-++.+|.|+- .|..|.|..++.. |+|++..+...
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n------------------------------------- 55 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN------------------------------------- 55 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-------------------------------------
Confidence 45679999999999999 8999999888765 88876544111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
..-..++.+|..++..+.|. ||+.++++|.-. ..+|+|||+|..+|.+.+... ++-..
T Consensus 56 ------~~~akra~rel~l~~~v~~~------nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~e----lDH~t 119 (369)
T KOG0665|consen 56 ------QTHAKRAYRELKLMKCVNHK------NIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILME----LDHET 119 (369)
T ss_pred ------Cccchhhhhhhhhhhhhccc------ceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHHh----cchHH
Confidence 11224567799999999998 999999998533 479999999999999999832 78899
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
+..++.|+++|+.|||+.||+||||||+||++..+. .+|+.|||+++..... ....+.|+.|+|||++.+..|...
T Consensus 120 is~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~--~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~ 197 (369)
T KOG0665|consen 120 ISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC--TLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKEN 197 (369)
T ss_pred HHHHHHHHHHHHHHHHhcceeecccCcccceecchh--heeeccchhhcccCcccccCchhheeeccCchheeccCCccc
Confidence 999999999999999999999999999999999988 8999999999875543 344788999999999999999999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc-CCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT-NSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 327 (429)
+||||+||++.||++|+..|+|.+.-+++.++.+.+|.+.++...+.....--+.. ..+...- ......+........
T Consensus 198 vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~-~~~~y~~~~f~~~fpD~~f~~~~ 276 (369)
T KOG0665|consen 198 VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE-NRPQYQAISFSELFPDSLFPVVL 276 (369)
T ss_pred chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh-cChHhhccchhhhCCcccccccc
Confidence 99999999999999999999999999999999999999999998876543221111 2221110 000000001111111
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
+-.+.....+.+++.+||..||++|.+++++|.|||++
T Consensus 277 e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 277 EGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred cCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 11123456788999999999999999999999999998
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=302.88 Aligned_cols=251 Identities=26% Similarity=0.348 Sum_probs=197.9
Q ss_pred eeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhh
Q psy17270 29 IGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHH 107 (429)
Q Consensus 29 lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (429)
||.|+||+||+|.+..++.. |+|.+....... .....
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~------------------------------------------~~~~~ 38 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK------------------------------------------RKGEQ 38 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh------------------------------------------hhhhH
Confidence 69999999999999888865 888774321110 01122
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
.+.+|+++++.++|+ ||+++++.+...+.+|+||||++ ++|.+++.......+++..+..++.|++.||.|||
T Consensus 39 ~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH 112 (277)
T cd05577 39 MALNEKKILEKVSSR------FIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112 (277)
T ss_pred HHHHHHHHHHhCCCC------CEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 445699999999876 99999999999999999999996 69999988766456999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhC
Q psy17270 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264 (429)
Q Consensus 187 ~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 264 (429)
+.|++|+||+|+||+++.++ .++|+|||.+..... ......++..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 113 ~~~i~H~di~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g 190 (277)
T cd05577 113 QRRIVYRDLKPENVLLDDHG--NVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190 (277)
T ss_pred hCCcccCCCCHHHEEECCCC--CEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC
Confidence 99999999999999999888 899999998865432 22234567889999999888899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHh
Q psy17270 265 CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQC 344 (429)
Q Consensus 265 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 344 (429)
+.||...........+...... .....+...++.+.++|++|
T Consensus 191 ~~p~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 191 RSPFRQRKEKVEKEELKRRTLE--------------------------------------MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred CCCCCCCcccccHHHHHhcccc--------------------------------------ccccCCccCCHHHHHHHHHH
Confidence 9999775542111111110000 00011123378899999999
Q ss_pred cccCCCCCC-----CHHHHhcCCCCCCC
Q psy17270 345 FNWDSKKRL-----TPDEALRHEWLKSS 367 (429)
Q Consensus 345 L~~dP~~Rp-----ta~ell~h~~~~~~ 367 (429)
|+.||++|| ++.+++.||||+..
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcC
Confidence 999999999 89999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.84 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=192.7
Q ss_pred EeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhh
Q psy17270 28 VIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFH 106 (429)
Q Consensus 28 ~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (429)
.||.|+||.||+|.+..+++ +|+|.+......... ..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~------------------------------------------~~ 38 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ------------------------------------------GE 38 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch------------------------------------------hH
Confidence 48999999999999988875 499887543211100 01
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
..+..|..+++.+.+. .|++|+.+++++.....+++||||+. ++|.+++.... .+++..++.++.|++.||+||
T Consensus 39 ~~~~~~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~l 113 (278)
T cd05606 39 TLALNERIMLSLVSTG---DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHM 113 (278)
T ss_pred HHHHHHHHHHHHHHhC---CCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Confidence 1223355555555442 45699999999999999999999995 68988887543 499999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCCcceEEeeecccccccC-cceeeecCccccchhhhhCC-CCCCCccccchhhHHHHHhh
Q psy17270 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCILAELYT 263 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~~llt 263 (429)
|+.+++|+||||+||+++.++ .++|+|||++..... ......|+..|+|||++.+. .++.++||||+||++|+|++
T Consensus 114 H~~~i~H~di~p~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~ 191 (278)
T cd05606 114 HNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191 (278)
T ss_pred HHCCEEcCCCCHHHEEECCCC--CEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHh
Confidence 999999999999999999888 899999999864332 22345789999999999754 68899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHH
Q psy17270 264 GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQ 343 (429)
Q Consensus 264 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 343 (429)
|+.||.................. ....+...++.+.+++.+
T Consensus 192 g~~p~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 192 GHSPFRQHKTKDKHEIDRMTLTM---------------------------------------AVELPDSFSPELRSLLEG 232 (278)
T ss_pred CCCCCCCCCccchHHHHHHhhcc---------------------------------------CCCCCCcCCHHHHHHHHH
Confidence 99999875322111100000000 000112236889999999
Q ss_pred hcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 344 CFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 344 ~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
||..||.+|+ ++.++++||||+...
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 9999999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=305.35 Aligned_cols=259 Identities=27% Similarity=0.391 Sum_probs=198.9
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|+..+.||.|+||.||++.+..++.. |+|.+......
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~---------------------------------------- 43 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE---------------------------------------- 43 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh----------------------------------------
Confidence 3577788999999999999999988865 88887533221
Q ss_pred cchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHH---hhCCCCCCHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIK---RNNYQGFSLGLIRRFA 175 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~---~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+.++.++. |+ ||+++++++..+...+++||++++++.++.. ......+++..+..++
T Consensus 44 ----~~~~~~~~e~~~l~~~~~~~------~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~ 113 (288)
T cd06616 44 ----KEQKRLLMDLDVVMRSSDCP------YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIA 113 (288)
T ss_pred ----HHHHHHHHHHHHHHHhcCCC------CEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHH
Confidence 11224556888888886 55 9999999999999999999999877666543 2233459999999999
Q ss_pred HHHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCC---CCCCCc
Q psy17270 176 FSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGL---PYGPPI 249 (429)
Q Consensus 176 ~qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~---~~~~~~ 249 (429)
.|++.||+|||+. +++||||||+||+++.++ .++|+|||++...... .....++..|+|||++.+. .++.++
T Consensus 114 ~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 191 (288)
T cd06616 114 VATVKALNYLKEELKIIHRDVKPSNILLDRNG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRS 191 (288)
T ss_pred HHHHHHHHHHhhcCCeeccCCCHHHEEEccCC--cEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchh
Confidence 9999999999975 999999999999999887 8999999998653322 2234678899999999876 588999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||+||++|+|++|+.||...+. ....+.......+... ....
T Consensus 192 Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~----------------------------------~~~~ 235 (288)
T cd06616 192 DVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL----------------------------------SNSE 235 (288)
T ss_pred hhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC----------------------------------CCcC
Confidence 999999999999999999976542 2222221111100000 0000
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
....+.++.+||++||+.||++|||+.+++.||||+..
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 11247789999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=315.76 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=192.4
Q ss_pred cCCeEEEeEeeccccceEEEEEec-----CCC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDH-----KTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~-----~~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.++|++.+.||.|+||.||+|++. .++ .+|+|++......
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~---------------------------------- 79 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL---------------------------------- 79 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc----------------------------------
Confidence 568999999999999999999752 233 3488876432211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCC--------
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNY-------- 163 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~-------- 163 (429)
.....+.+|++++..+ .|+ ||+++++++......++||||| +|+|.+++.....
T Consensus 80 ----------~~~~~~~~Ei~il~~l~~Hp------nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~ 143 (375)
T cd05104 80 ----------TEREALMSELKVLSYLGNHI------NIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHE 143 (375)
T ss_pred ----------HHHHHHHHHHHHHHHhcCCc------ceeeeeeeeccCCcceeeehhccCCcHHHHHHhccccccccccc
Confidence 1123456799999999 555 9999999999999999999999 4799999865321
Q ss_pred -----------------------------------------------------------------CCCCHHHHHHHHHHH
Q psy17270 164 -----------------------------------------------------------------QGFSLGLIRRFAFSL 178 (429)
Q Consensus 164 -----------------------------------------------------------------~~~~~~~~~~i~~qi 178 (429)
..+++..+..++.||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 223 (375)
T cd05104 144 DHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQV 223 (375)
T ss_pred chhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHH
Confidence 137788899999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-----eeecCccccchhhhhCCCCCCCccccc
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-----TYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
+.||+|||++|++||||||+|||++.++ .++|+|||++........ ...++..|+|||++.+..++.++||||
T Consensus 224 ~~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~s 301 (375)
T cd05104 224 AKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 301 (375)
T ss_pred HHHHHHHHHCCeeccCCchhhEEEECCC--cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHH
Confidence 9999999999999999999999999877 899999999875432211 122345699999999989999999999
Q ss_pred hhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 254 LGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 254 lG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||++|+|++ |..||.+......+........ ... .+..
T Consensus 302 lG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------------------------~~~---------~~~~ 341 (375)
T cd05104 302 YGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-------------------------------RML---------SPEC 341 (375)
T ss_pred HHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-------------------------------cCC---------CCCC
Confidence 9999999998 8999987654333322221000 000 0012
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+.++.+|+.+||+.||++|||+.|+++.
T Consensus 342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 342 APSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 25788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=313.53 Aligned_cols=257 Identities=23% Similarity=0.394 Sum_probs=221.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
...+++..||.||||.|=++....... .|+|++++.+.-...
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtk------------------------------------- 462 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTK------------------------------------- 462 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchh-------------------------------------
Confidence 457888999999999999998876654 588887655433222
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
-.+.+..|-+||..+..+ .|+++|-.|.++..+|++||.| +|.|+..++.+.. |++.+++.++..+
T Consensus 463 -----QqeHv~sEr~Im~~~~s~------fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv 529 (732)
T KOG0614|consen 463 -----QQEHVFSERNIMMECRSD------FIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS--FDDYTARFYVACV 529 (732)
T ss_pred -----HHHHHHhHHHHHHhcCch------HHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHH
Confidence 223466699999988765 9999999999999999999999 7899999998765 9999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
++|++|||++|||+|||||+|++++.+| .+||.|||+|+... ....++||||.|.|||++.+...+.++|.||||+
T Consensus 530 ~EAfeYLH~k~iIYRDLKPENllLd~~G--y~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGI 607 (732)
T KOG0614|consen 530 LEAFEYLHRKGIIYRDLKPENLLLDNRG--YLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGI 607 (732)
T ss_pred HHHHHHHHhcCceeccCChhheeeccCC--ceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHH
Confidence 9999999999999999999999999999 99999999998754 5567899999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|||++|.+||.+.++......|...+. ....++.++..
T Consensus 608 li~ELL~G~pPFs~~dpmktYn~ILkGid----------------------------------------~i~~Pr~I~k~ 647 (732)
T KOG0614|consen 608 LIYELLTGSPPFSGVDPMKTYNLILKGID----------------------------------------KIEFPRRITKT 647 (732)
T ss_pred HHHHHHcCCCCCCCCchHHHHHHHHhhhh----------------------------------------hhhcccccchh
Confidence 99999999999999999988888876432 12223344678
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSSSS 369 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~~ 369 (429)
..+||+++.+.+|.+|+. ..++-+|.||.+-.-
T Consensus 648 a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 648 ATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred HHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 889999999999999997 899999999987543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.23 Aligned_cols=254 Identities=27% Similarity=0.466 Sum_probs=201.9
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++.+.||.|+||.||+|.+..++.. |+|.+........
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~--------------------------------------- 42 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD--------------------------------------- 42 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh---------------------------------------
Confidence 488899999999999999999887765 8887754322111
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
...+.+|+.+++.+.+. .|+|++++++++......|+||||+. ++|.+++... .+++..+..++.|++
T Consensus 43 -----~~~~~~e~~~l~~l~~~---~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~ 111 (277)
T cd06917 43 -----VSDIQREVALLSQLRQS---QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVL 111 (277)
T ss_pred -----HHHHHHHHHHHHHhccC---CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHH
Confidence 12455689999999752 46699999999999999999999995 5899888654 489999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG 255 (429)
.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... .....|+..|+|||.+.+. .++.++|+||||
T Consensus 112 ~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 189 (277)
T cd06917 112 VALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLG 189 (277)
T ss_pred HHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHH
Confidence 999999999999999999999999987 8999999998654322 2334688899999998754 468899999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh-ccCC
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL-RCND 334 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 334 (429)
|++|+|++|..||.+.+.......+.. ..+. ... ...+
T Consensus 190 ~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~--------------------------------------~~~~~~~~ 228 (277)
T cd06917 190 ITIYEMATGNPPYSDVDAFRAMMLIPK---SKPP--------------------------------------RLEDNGYS 228 (277)
T ss_pred HHHHHHHhCCCCCCCCChhhhhhcccc---CCCC--------------------------------------CCCcccCC
Confidence 999999999999987654332211100 0000 000 0136
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.++.+|+.+||+.||++||++.+++.|+||+...
T Consensus 229 ~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 229 KLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 7889999999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=318.93 Aligned_cols=253 Identities=24% Similarity=0.294 Sum_probs=203.2
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
-++..+...+...||+|.||+||+|.+. |.+|||++.......+.
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~q--------------------------------- 431 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQ--------------------------------- 431 (678)
T ss_pred cccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHH---------------------------------
Confidence 3567788899999999999999999994 67899998655544332
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.+.|.+|+.+|++-+|. ||+-+++++..+.. .||+.||+| +|+..++... ..|.....+.|
T Consensus 432 ----------lqaFKnEVa~lkkTRH~------NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idI 493 (678)
T KOG0193|consen 432 ----------LQAFKNEVAVLKKTRHE------NILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDI 493 (678)
T ss_pred ----------HHHHHHHHHHHhhcchh------hheeeehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHH
Confidence 23566799999999999 99999999987777 999999987 8999998665 46999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc-----CcceeeecCccccchhhhhCC---CCC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-----QRVYTYIQSRFYRSPEVILGL---PYG 246 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-----~~~~~~~~t~~y~aPE~~~~~---~~~ 246 (429)
++||+.|+.|||.++|||||||..|||+.+++ .|||+|||++.... .......|...|||||+++.. +|+
T Consensus 494 AqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~--kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS 571 (678)
T KOG0193|consen 494 AQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL--KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFS 571 (678)
T ss_pred HHHHHHhhhhhhhhhhhhhhccccceEEccCC--cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCC
Confidence 99999999999999999999999999999988 99999999985322 222334566779999999843 689
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
..+|||||||++|||+||..||........+-.+-+... ..+.
T Consensus 572 ~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l-------------------------------------~pd~ 614 (678)
T KOG0193|consen 572 FQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL-------------------------------------MPDL 614 (678)
T ss_pred cccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc-------------------------------------Cccc
Confidence 999999999999999999999995444333322211111 1112
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......+++++.+|+..||.+++++||...++|.
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 2222344679999999999999999999999887
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=298.09 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=201.2
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+..++|++.+.||.|++|.||+|.+..+..+|+|.+.....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--------------------------------------- 43 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--------------------------------------- 43 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---------------------------------------
Confidence 45678999999999999999999987766678887643211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
....+.+|+++++.+.|+ ||+++++++.....++++||++ +++|.+++.......++...+..++.
T Consensus 44 -------~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 110 (261)
T cd05068 44 -------DPKDFLAEAQIMKKLRHP------KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110 (261)
T ss_pred -------cHHHHHHHHHHHHHCCCC------CccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHH
Confidence 112456699999999877 9999999999999999999999 67999999876544589999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-eeec---CccccchhhhhCCCCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-TYIQ---SRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-~~~~---t~~y~aPE~~~~~~~~~~~Diw 252 (429)
|++.||.|||++|++|+||||+||+++.++ .++|+|||++........ ...+ +..|+|||++.+..++.++|+|
T Consensus 111 ~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 188 (261)
T cd05068 111 QVASGMAYLEAQNYIHRDLAARNVLVGENN--ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188 (261)
T ss_pred HHHHHHHHHHhCCeeeccCCcceEEEcCCC--CEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHH
Confidence 999999999999999999999999999988 899999999875442211 1122 3469999999888899999999
Q ss_pred chhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 253 SLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 253 SlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
||||++|+|++ |+.||.+.+....+..+......+ ...
T Consensus 189 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~ 227 (261)
T cd05068 189 SFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP-----------------------------------------CPP 227 (261)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------------------CCC
Confidence 99999999999 999998877665554443211000 011
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+..+.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 23678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=303.60 Aligned_cols=248 Identities=19% Similarity=0.278 Sum_probs=198.0
Q ss_pred cCCeEEEeEeeccccceEEEEEecCC------CcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKT------NTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.++|.+.+.||+|+||.||+|.+... ..+|+|.+......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------------------------------- 49 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN---------------------------------- 49 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH----------------------------------
Confidence 45799999999999999999998544 23477776433211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC----------
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN---------- 162 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~---------- 162 (429)
.....+.+|+++++.+.|+ ||+++++++......+++|||+. ++|.+++....
T Consensus 50 ----------~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 113 (280)
T cd05049 50 ----------DARKDFEREAELLTNFQHE------NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPD 113 (280)
T ss_pred ----------HHHHHHHHHHHHHHhcCCC------CchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccc
Confidence 1224566799999999877 99999999999999999999995 69999997643
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCcccc
Q psy17270 163 --YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYR 235 (429)
Q Consensus 163 --~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~ 235 (429)
...+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...... .....++..|+
T Consensus 114 ~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~ 191 (280)
T cd05049 114 SPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL--VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM 191 (280)
T ss_pred cccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC--eEEECCcccceecccCcceecCCCCcccceec
Confidence 13478899999999999999999999999999999999999988 8999999998653221 11234567899
Q ss_pred chhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCC
Q psy17270 236 SPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314 (429)
Q Consensus 236 aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (429)
|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.......
T Consensus 192 aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------- 244 (280)
T cd05049 192 PPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ--------------------------- 244 (280)
T ss_pred ChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC---------------------------
Confidence 9999998899999999999999999998 999998877665544433100000
Q ss_pred CCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.....+..+.+++++||+.||++|||+.|+++
T Consensus 245 --------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 245 --------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred --------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 01123678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=300.62 Aligned_cols=251 Identities=19% Similarity=0.248 Sum_probs=196.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCC-----C-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKT-----N-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~-----~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
+..++|++.+.||+|+||.||+|.+... + .+|+|++......
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-------------------------------- 50 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-------------------------------- 50 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--------------------------------
Confidence 4678999999999999999999987532 1 3477765322111
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC-------
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY------- 163 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~------- 163 (429)
.....+.+|+.+++.++|+ ||+++++++......++||||+. ++|.+++.....
T Consensus 51 ------------~~~~~~~~e~~~l~~l~~~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 112 (277)
T cd05062 51 ------------RERIEFLNEASVMKEFNCH------HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 112 (277)
T ss_pred ------------HHHHHHHHHHHHHHhCCCC------CeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCcccccccc
Confidence 1122456699999988876 99999999998899999999995 699999876431
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-----eeecCccccch
Q psy17270 164 -QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-----TYIQSRFYRSP 237 (429)
Q Consensus 164 -~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-----~~~~t~~y~aP 237 (429)
..++...+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++........ ...++..|+||
T Consensus 113 ~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05062 113 QAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190 (277)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC--CEEECCCCCccccCCcceeecCCCCccCHhhcCh
Confidence 2357788999999999999999999999999999999999887 899999999865432211 12346679999
Q ss_pred hhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCC
Q psy17270 238 EVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316 (429)
Q Consensus 238 E~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (429)
|++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+..... +
T Consensus 191 E~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~--~---------------------------- 240 (277)
T cd05062 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL--L---------------------------- 240 (277)
T ss_pred hHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--C----------------------------
Confidence 99998889999999999999999999 7899988776555443322000 0
Q ss_pred CCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......+..+.+++.+||+.||++|||+.|++++
T Consensus 241 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 -----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0011236788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=303.86 Aligned_cols=250 Identities=29% Similarity=0.453 Sum_probs=204.9
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|.+.+.||+|+||.||+|.+..++.. |+|++........
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-------------------------------------- 42 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-------------------------------------- 42 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch--------------------------------------
Confidence 4799999999999999999999888765 8888754221110
Q ss_pred cchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.....+.+|+++++.+. |+ ||+++++++......+++||++ +++|.+++.... .+++..+..++.|
T Consensus 43 ----~~~~~~~~e~~~~~~l~~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~q 110 (280)
T cd05581 43 ----KKVKYVKIEKEVLTRLNGHP------GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAE 110 (280)
T ss_pred ----HHHHHHHHHHHHHHhcccCC------CchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHH
Confidence 11234556888988887 55 9999999999999999999999 679999998764 4999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----------------------eeeecCccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----------------------YTYIQSRFY 234 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----------------------~~~~~t~~y 234 (429)
++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....... ....++..|
T Consensus 111 l~~~l~~Lh~~~~~H~dl~~~ni~i~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (280)
T cd05581 111 ILLALEYLHSKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY 188 (280)
T ss_pred HHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccc
Confidence 99999999999999999999999999888 89999999986533221 224567889
Q ss_pred cchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCC
Q psy17270 235 RSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314 (429)
Q Consensus 235 ~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (429)
+|||++.+..++.++|+||||++++++++|..||...+....+..+.......+
T Consensus 189 ~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------- 242 (280)
T cd05581 189 VSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFP-------------------------- 242 (280)
T ss_pred cCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCC--------------------------
Confidence 999999888889999999999999999999999998876555444432111111
Q ss_pred CCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCC
Q psy17270 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTP----DEALRHEWL 364 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~ell~h~~~ 364 (429)
...++.+.+||.+||+.||++|||+ .++++||||
T Consensus 243 ----------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 243 ----------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred ----------------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 1226788999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=298.24 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=198.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+..++|+++++||.|+||.||+|.+..+..+|+|.+.....
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--------------------------------------- 43 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--------------------------------------- 43 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---------------------------------------
Confidence 45678999999999999999999987666778887643211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
..+.+.+|+.+++.++|+ +++++++++. ....+++|||+. ++|.+++.......+++..+..++.
T Consensus 44 -------~~~~~~~E~~~l~~l~~~------~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (260)
T cd05070 44 -------SPESFLEEAQIMKKLRHD------KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA 109 (260)
T ss_pred -------CHHHHHHHHHHHHhcCCC------ceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHH
Confidence 112456699999999887 9999999874 456899999995 6999999876545589999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
|++.||+|||++|++|+||||+||+++.++ .++|+|||++........ ...++..|+|||++.+..++.++|+|
T Consensus 110 ~l~~al~~lH~~~i~H~di~p~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 187 (260)
T cd05070 110 QVAAGMAYIERMNYIHRDLRSANILVGDGL--VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187 (260)
T ss_pred HHHHHHHHHHHCCcccCCCccceEEEeCCc--eEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhH
Confidence 999999999999999999999999999887 899999999875433221 12244579999999888899999999
Q ss_pred chhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 253 SLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 253 SlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||+++|+|++ |..||.+.+..+....+...... ..+.
T Consensus 188 slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~ 226 (260)
T cd05070 188 SFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-----------------------------------------PCPQ 226 (260)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------------------------------------CCCC
Confidence 99999999999 89999887766555444321000 0011
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+..+.+|+.+||..||++|||+.++++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 23678899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.88 Aligned_cols=247 Identities=22% Similarity=0.280 Sum_probs=198.0
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+..++|++.++||.|+||.||+|.+..+..+|+|++.....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--------------------------------------- 43 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--------------------------------------- 43 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---------------------------------------
Confidence 44688999999999999999999998777778888743211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
....+.+|+++++.+.|+ ||+++++.+. ....++||||+. ++|.+++.......+++..+..++.
T Consensus 44 -------~~~~~~~E~~~l~~l~~~------~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (262)
T cd05071 44 -------SPEAFLQEAQVMKKLRHE------KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 109 (262)
T ss_pred -------CHHHHHHHHHHHHhCCCC------CcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHH
Confidence 112456699999998876 9999998874 456899999995 6999999875444589999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
|++.||+|||+.|++|+||||+||+++.++ .++|+|||.+........ ...++..|+|||+..+..++.++|+|
T Consensus 110 ~l~~aL~~lH~~~i~H~dl~p~Nill~~~~--~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvw 187 (262)
T cd05071 110 QIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187 (262)
T ss_pred HHHHHHHHHHHCCccccccCcccEEEcCCC--cEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHH
Confidence 999999999999999999999999999887 899999999865433221 22345679999999888899999999
Q ss_pred chhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 253 SLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 253 SlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
||||++|+|+| |..||.+....+....+......+ ...
T Consensus 188 slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~ 226 (262)
T cd05071 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-----------------------------------------CPP 226 (262)
T ss_pred HHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC-----------------------------------------Ccc
Confidence 99999999999 899998876655544332210000 011
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+..+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 23678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.59 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=203.8
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||.+.+.||.|+||.||+|.++.++.. |+|.+.......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---------------------------------------- 40 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV---------------------------------------- 40 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc----------------------------------------
Confidence 699999999999999999999988765 888764321110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.....+.+|+++++.++|+ ||+++++.+......++|+||+. ++|.+++.......+++..+..++.|++
T Consensus 41 ---~~~~~~~~E~~~l~~~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~ 111 (257)
T cd08225 41 ---KEKEASKKEVILLAKMKHP------NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQIS 111 (257)
T ss_pred ---hhhHHHHHHHHHHHhCCCC------ChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHH
Confidence 0112455699999999887 99999999999999999999995 6999998876545589999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
.||.|||+.+++|+||+|+||+++.++. .++|+|||.+...... .....+++.|+|||++.+..++.++|+|||||
T Consensus 112 ~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~ 190 (257)
T cd08225 112 LGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGC 190 (257)
T ss_pred HHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHH
Confidence 9999999999999999999999987752 5799999998654432 22345788899999998888999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++++|++|..||...+..+....+... .. .......+.+
T Consensus 191 il~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------------------------------------~~~~~~~~~~ 229 (257)
T cd08225 191 VLYELCTLKHPFEGNNLHQLVLKICQG--YF---------------------------------------APISPNFSRD 229 (257)
T ss_pred HHHHHHhCCCCCCCccHHHHHHHHhcc--cC---------------------------------------CCCCCCCCHH
Confidence 999999999999877655444332210 00 0001223678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.++|.+||..+|++|||+.|++.||||
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 230 LRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 8999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=296.43 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=201.7
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|++.+.||.|+||.||+|.+..++.. |+|.+......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----------------------------------------- 39 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT----------------------------------------- 39 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-----------------------------------------
Confidence 599999999999999999999888865 88876432211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--cCeEEEEEeecC-cCHHHHHHhhC--CCCCCHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--RNHLCISFELMN-LNLYELIKRNN--YQGFSLGLIRRFA 175 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~-g~L~~~i~~~~--~~~~~~~~~~~i~ 175 (429)
......+..|+++++.+.|+ ||+++++++.. ...++++|||+. ++|.+++.... ...+++..+..++
T Consensus 40 --~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~ 111 (265)
T cd08217 40 --EKEKQQLVSEVNILRELKHP------NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111 (265)
T ss_pred --HHHHHHHHHHHHHHHhcCCC------ccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHH
Confidence 11123455699999999887 99999998764 356899999995 69999987642 2458999999999
Q ss_pred HHHHHHHHHHH-----HCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCC
Q psy17270 176 FSLVQCLRLLH-----RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 176 ~qil~~l~~lH-----~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
.|++.||+||| +.+++|+||+|+||+++.++ .++|+|||++...... .....+++.|+|||++.+..++.
T Consensus 112 ~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~ 189 (265)
T cd08217 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDE 189 (265)
T ss_pred HHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--CEEEecccccccccCCcccccccccCCCccChhhhcCCCCCc
Confidence 99999999999 88999999999999999887 8999999998765432 22356888999999999888899
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
++|+||||+++++|++|+.||...+.......+.... . .
T Consensus 190 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------------------------------------~ 228 (265)
T cd08217 190 KSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--F---------------------------------------R 228 (265)
T ss_pred hhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--C---------------------------------------C
Confidence 9999999999999999999998877544333322100 0 0
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
......+..+.+++.+||+.||++|||+.++++|||+
T Consensus 229 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0111236788999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=297.64 Aligned_cols=248 Identities=20% Similarity=0.301 Sum_probs=200.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+....|++.+.||.|+||.||+|.+..++.. |+|.+.....
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-------------------------------------- 44 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-------------------------------------- 44 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch--------------------------------------
Confidence 3455699999999999999999999887765 8887642211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+++++.+.|+ ||+++++++.....++++|||+. ++|.+++.......+++..+..++
T Consensus 45 --------~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~ 110 (263)
T cd05052 45 --------EVEEFLKEAAVMKEIKHP------NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 110 (263)
T ss_pred --------HHHHHHHHHHHHHhCCCC------ChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHH
Confidence 112456699999999877 99999999999999999999994 699999987655568999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee----eecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT----YIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~----~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.|++.||+|||++|++|+||||+||+++.++ .++|+|||++......... ..++..|+|||.+.+..++.++||
T Consensus 111 ~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 188 (263)
T cd05052 111 TQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188 (263)
T ss_pred HHHHHHHHHHHhCCEeecccCcceEEEcCCC--cEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHH
Confidence 9999999999999999999999999999887 8999999998764432221 123457999999998889999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||++|+|++ |..||++.+..+....+..... + ...
T Consensus 189 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~---------------------------------------~~~ 227 (263)
T cd05052 189 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR--M---------------------------------------ERP 227 (263)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC--C---------------------------------------CCC
Confidence 999999999998 9999988776554443321000 0 001
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...++.+.+++.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 223688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=300.17 Aligned_cols=257 Identities=19% Similarity=0.240 Sum_probs=199.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecC--CC----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHK--TN----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~--~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
+-.+||++.+.||+|+||.||+|.++. ++ .+|+|.+......
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------------------- 50 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-------------------------------- 50 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--------------------------------
Confidence 456899999999999999999998653 22 2477765322111
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCC-------
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNY------- 163 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~------- 163 (429)
.....+.+|+.+++.+.|+ ||+++++++......++||||+ +|+|.+++.....
T Consensus 51 ------------~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 112 (288)
T cd05061 51 ------------RERIEFLNEASVMKGFTCH------HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112 (288)
T ss_pred ------------HHHHHHHHHHHHHHhCCCC------CeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCC
Confidence 1122455688899988876 9999999999889999999999 4799999976421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCccccch
Q psy17270 164 -QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRFYRSP 237 (429)
Q Consensus 164 -~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~y~aP 237 (429)
..++...+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++...... ....++..|+||
T Consensus 113 ~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~--~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p 190 (288)
T cd05061 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF--TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC--cEEECcCCccccccccccccccCCCcccccccCH
Confidence 2246678899999999999999999999999999999999887 89999999987533211 112345679999
Q ss_pred hhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCC
Q psy17270 238 EVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316 (429)
Q Consensus 238 E~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (429)
|.+.+..++.++|+|||||++|+|++ |..||.+.+..+....+... ...
T Consensus 191 E~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--~~~---------------------------- 240 (288)
T cd05061 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG--GYL---------------------------- 240 (288)
T ss_pred HHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CCC----------------------------
Confidence 99998889999999999999999998 79999887765544433210 000
Q ss_pred CCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCCC
Q psy17270 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR------HEWLKSS 367 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~------h~~~~~~ 367 (429)
......++.+.+++.+||+.||++|||+.++++ ||||+..
T Consensus 241 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 241 -----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 001123678999999999999999999999987 8999764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=297.14 Aligned_cols=245 Identities=20% Similarity=0.306 Sum_probs=197.2
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
++|++.+.||.|+||+||+|.+.....+|+|.+.....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~------------------------------------------ 41 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------------------------------------------ 41 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc------------------------------------------
Confidence 56999999999999999999887665678887642211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
....+.+|+.+++.+.|+ ||+++++++.....++++|||+. ++|.+++.... ..+++..+..++.|++
T Consensus 42 ----~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~ 110 (256)
T cd05113 42 ----SEDEFIEEAKVMMKLSHE------KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVC 110 (256)
T ss_pred ----cHHHHHHHHHHHhcCCCC------CeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHH
Confidence 012455699999998776 99999999998889999999995 68999987654 2589999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-e---eecCccccchhhhhCCCCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-T---YIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-~---~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
.||+|||+.|++|+||||+||+++.++ .++|+|||.+........ . ..++..|+|||.+.+..++.++||||||
T Consensus 111 ~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG 188 (256)
T cd05113 111 EGMAYLESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFG 188 (256)
T ss_pred HHHHHHHhCCeeccccCcceEEEcCCC--CEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHH
Confidence 999999999999999999999999887 899999999875433221 1 2234569999999888899999999999
Q ss_pred hHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|++|+|++ |..||...+..+....+......+. ....+
T Consensus 189 ~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~ 227 (256)
T cd05113 189 VLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR-----------------------------------------PHLAS 227 (256)
T ss_pred HHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC-----------------------------------------CCCCC
Confidence 99999998 9999987776554444432111000 01126
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
+.+.+++.+||+.||.+|||+.+++.+
T Consensus 228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 228 EKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.28 Aligned_cols=251 Identities=28% Similarity=0.381 Sum_probs=193.8
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||.|+||.||+|.+..++.. |+|++..........
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~------------------------------------------ 39 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ------------------------------------------ 39 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHH------------------------------------------
Confidence 5799999999999999888765 888875332111000
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+..|..++... ..|+|++++++++.....+|+|+||+. ++|.+++.... .+++..+..++.|++.||.|
T Consensus 40 ~~~~~~e~~~~~~~-----~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~ 112 (260)
T cd05611 40 VTNVKAERAIMMIQ-----GESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVED 112 (260)
T ss_pred HHHHHHHHHHHhhc-----CCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHH
Confidence 01112243333222 134599999999999999999999995 69999987654 48999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhC
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg 264 (429)
||+.|++|+||+|+||+++.++ .++|+|||++..... .....++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 113 lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g 189 (260)
T cd05611 113 LHQRGIIHRDIKPENLLIDQTG--HLKLTDFGLSRNGLE-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189 (260)
T ss_pred HHHCCeecCCCCHHHeEECCCC--cEEEeecccceeccc-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHC
Confidence 9999999999999999999887 899999999865433 2334678899999999888889999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHh
Q psy17270 265 CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQC 344 (429)
Q Consensus 265 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 344 (429)
..||...+.......+.......+. ......++.+.+++.+|
T Consensus 190 ~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 190 YPPFHAETPDAVFDNILSRRINWPE--------------------------------------EVKEFCSPEAVDLINRL 231 (260)
T ss_pred CCCCCCCCHHHHHHHHHhcccCCCC--------------------------------------cccccCCHHHHHHHHHH
Confidence 9999887766554443321100000 01113478889999999
Q ss_pred cccCCCCCCCH---HHHhcCCCCCCC
Q psy17270 345 FNWDSKKRLTP---DEALRHEWLKSS 367 (429)
Q Consensus 345 L~~dP~~Rpta---~ell~h~~~~~~ 367 (429)
|+.||++||++ .|++.||||+..
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcC
Confidence 99999999955 799999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.48 Aligned_cols=265 Identities=27% Similarity=0.382 Sum_probs=203.2
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|++++.||+|+||+||+|.+..++.. |+|++....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----------------------------------------- 42 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----------------------------------------- 42 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-----------------------------------------
Confidence 46799999999999999999999988865 777653221
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.......+.+|+++++.++|+ ||+++++.+.....+++||||+. ++|.+++.... .+++..+..++.+
T Consensus 43 ---~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~ 111 (284)
T cd06620 43 ---KSSVRKQILRELQIMHECRSP------YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVA 111 (284)
T ss_pred ---cchHHHHHHHHHHHHHHcCCC------CcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHH
Confidence 112234567799999999877 99999999999999999999995 58988887653 4899999999999
Q ss_pred HHHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeeccccccc-CcceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 178 LVQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 178 il~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
++.||.|||+ +|++|+||+|+||+++.++ .++|+|||++.... .......++..|+|||++.+..++.++|+||||
T Consensus 112 i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 189 (284)
T cd06620 112 VVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLG 189 (284)
T ss_pred HHHHHHHHHHhcCeeccCCCHHHEEECCCC--cEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHH
Confidence 9999999997 6999999999999999887 89999999886432 222345688999999999888889999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|..||......+.... .+......... ..... .+ ..+ ....+.
T Consensus 190 ~~l~~l~tg~~p~~~~~~~~~~~~-------~~~~~~~~~~~--~~~~~--~~----------~~~--------~~~~~~ 240 (284)
T cd06620 190 ISIIELALGKFPFAFSNIDDDGQD-------DPMGILDLLQQ--IVQEP--PP----------RLP--------SSDFPE 240 (284)
T ss_pred HHHHHHHhCCCCCcccchhhhhhh-------hhhHHHHHHHH--Hhhcc--CC----------CCC--------chhcCH
Confidence 999999999999987554211000 00000000000 00000 00 000 001356
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.+.+|+.+||+.||++|||+.|+++|+||.+.
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 78999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.33 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=202.5
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+=|++.+.||.|+||.||+|.+..++.. |+|.+......
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~---------------------------------------- 43 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---------------------------------------- 43 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch----------------------------------------
Confidence 3488999999999999999999877754 88876432211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+|+++++.+.|+ ||+++++.+..+...++||||++ ++|.+++... .+++..+..++.|+
T Consensus 44 ----~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l 110 (277)
T cd06641 44 ----DEIEDIQQEITVLSQCDSP------YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREI 110 (277)
T ss_pred ----HHHHHHHHHHHHHHhcCCC------CEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHH
Confidence 1123456699999998876 99999999999999999999995 5888888653 38999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
+.++.|||++|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.+..++.++|+||||
T Consensus 111 ~~~l~~lh~~~i~h~dl~p~Ni~i~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG 188 (277)
T cd06641 111 LKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 188 (277)
T ss_pred HHHHHHHccCCeecCCCCHHhEEECCCC--CEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHH
Confidence 9999999999999999999999999887 8999999998654322 2234578889999999888888999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|..||...+.......+.. +.. .......+.
T Consensus 189 ~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~---------------------------------------~~~~~~~~~ 227 (277)
T cd06641 189 ITAIELAKGEPPHSELHPMKVLFLIPK--NNP---------------------------------------PTLEGNYSK 227 (277)
T ss_pred HHHHHHHcCCCCCCccchHHHHHHHhc--CCC---------------------------------------CCCCcccCH
Confidence 999999999999987655443332211 000 001122367
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
++.+++.+||..||.+||++.++++||||...
T Consensus 228 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 228 PLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 88999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.30 Aligned_cols=232 Identities=25% Similarity=0.371 Sum_probs=193.7
Q ss_pred eEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFH 106 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (429)
+-||+|+.|.||+|+.+ +.++|||+++.
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~e--------------------------------------------------- 157 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVRE--------------------------------------------------- 157 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhh---------------------------------------------------
Confidence 45899999999999975 45678887621
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
.-..+++=|++|+|+ ||+.|.++|.-.-.+||||||| .|.|.++++.... ++......|..+|+.|+.||
T Consensus 158 -lkETdIKHLRkLkH~------NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YL 228 (904)
T KOG4721|consen 158 -LKETDIKHLRKLKHP------NIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYL 228 (904)
T ss_pred -hhhhhHHHHHhccCc------ceeeEeeeecCCceeEEeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHH
Confidence 111267778888877 9999999998888999999999 5899999998764 99999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh
Q psy17270 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT 263 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 263 (429)
|.+.|||||||.-||||+.++ .|||+|||-++..... ...++||..|||||++...+++.++|||||||+||||+|
T Consensus 229 H~hKIIHRDLKSPNiLIs~~d--~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT 306 (904)
T KOG4721|consen 229 HLHKIIHRDLKSPNILISYDD--VVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT 306 (904)
T ss_pred HHhhHhhhccCCCceEeeccc--eEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh
Confidence 999999999999999999988 9999999998765543 345899999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHH
Q psy17270 264 GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQ 343 (429)
Q Consensus 264 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 343 (429)
|..||...+...++-- ... ...-..++..+++.|.=||++
T Consensus 307 ~EiPYkdVdssAIIwG------------------------VGs----------------NsL~LpvPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 307 GEIPYKDVDSSAIIWG------------------------VGS----------------NSLHLPVPSTCPDGFKLLLKQ 346 (904)
T ss_pred cCCCccccchheeEEe------------------------ccC----------------CcccccCcccCchHHHHHHHH
Confidence 9999988765443211 000 000112234457889999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q psy17270 344 CFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 344 ~L~~dP~~Rpta~ell~h 361 (429)
||+-.|..||+..++|.|
T Consensus 347 cw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 347 CWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHhcCCCCCccHHHHHHH
Confidence 999999999999999998
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=298.47 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=193.9
Q ss_pred ccCCeEEEeEe--eccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 19 ICYRYEILEVI--GKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 19 ~~~rY~i~~~l--G~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+.+.|++.+.+ |.|+||.||++.++.++.. |+|.+......
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------------------------------------ 55 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN------------------------------------ 55 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc------------------------------------
Confidence 34678888877 9999999999999988865 77776322100
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
..|+.....+. .|+||+++++.|...+.+|+||||+. ++|.+++.... .+++.++..+
T Consensus 56 --------------~~e~~~~~~~~-----~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~ 114 (267)
T PHA03390 56 --------------AIEPMVHQLMK-----DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKI 114 (267)
T ss_pred --------------hhhHHHHHHhh-----cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence 00222222222 35699999999999999999999994 69999998764 5999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
+.|++.||.|||+.|++|+||+|+||+++.++. .++|+|||.+...... ....++..|+|||++.+..++.++|+||+
T Consensus 115 ~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 192 (267)
T PHA03390 115 IRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192 (267)
T ss_pred HHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHH
Confidence 999999999999999999999999999987652 6999999998765433 23468889999999998889999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHH-HHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQ-LACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
||++|+|++|..||........ ...+..... . .....+..
T Consensus 193 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~--------------------------------------~~~~~~~~ 233 (267)
T PHA03390 193 GVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-K--------------------------------------KLPFIKNV 233 (267)
T ss_pred HHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-c--------------------------------------cCCccccc
Confidence 9999999999999986543321 111111000 0 00111234
Q ss_pred ChHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLT-PDEALRHEWLKS 366 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpt-a~ell~h~~~~~ 366 (429)
++.+.+||.+||+.||.+|++ .+++|+||||+.
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 789999999999999999996 599999999963
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=296.17 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=198.2
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+..++|++.+.||.|++|.||+|.+..+..+|+|.+....
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---------------------------------------- 42 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---------------------------------------- 42 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC----------------------------------------
Confidence 3457899999999999999999999877777888763221
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.....+.+|+++++.++|+ |++++++++. ....+++|||+. ++|.+++.......++...+..++.
T Consensus 43 ------~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (260)
T cd05069 43 ------MMPEAFLQEAQIMKKLRHD------KLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109 (260)
T ss_pred ------ccHHHHHHHHHHHHhCCCC------CeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Confidence 1123456699999999887 9999998875 456889999996 5999999875544589999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
|++.||+|||+.|++|+||||+||+++.++ .++|+|||.+........ ...++..|+|||...+..++.++|||
T Consensus 110 ~l~~al~~lH~~~i~H~dl~~~Nill~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~ 187 (260)
T cd05069 110 QIADGMAYIERMNYIHRDLRAANILVGDNL--VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187 (260)
T ss_pred HHHHHHHHHHhCCEeecccCcceEEEcCCC--eEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHH
Confidence 999999999999999999999999999887 899999999875432221 12345679999999888899999999
Q ss_pred chhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 253 SLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 253 SlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
||||++|+|++ |..||.+....+....+......+ ...
T Consensus 188 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~ 226 (260)
T cd05069 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP-----------------------------------------CPQ 226 (260)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------------------CCc
Confidence 99999999999 999998877665554433210000 011
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+..+.+++++||+.||++||++.++++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 23678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=307.47 Aligned_cols=252 Identities=28% Similarity=0.417 Sum_probs=202.1
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.+.|++.+.||.|+||.||+|.+..++.. |+|.+.......
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-------------------------------------- 44 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-------------------------------------- 44 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH--------------------------------------
Confidence 45688889999999999999999887754 888764332211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
....+.+|+++++.+.|+ ||+++++.+......++||||++ ++|.+++... .+++..+..++.|
T Consensus 45 ------~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ 109 (277)
T cd06642 45 ------EIEDIQQEITVLSQCDSP------YITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILRE 109 (277)
T ss_pred ------HHHHHHHHHHHHHcCCCC------ccHhhhcccccCCceEEEEEccCCCcHHHHhhcC---CCCHHHHHHHHHH
Confidence 123456699999998877 99999999999999999999996 5888887653 4899999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
++.|+.|||++|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.+..++.++|+|||
T Consensus 110 i~~~l~~lH~~~ivH~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 187 (277)
T cd06642 110 ILKGLDYLHSERKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187 (277)
T ss_pred HHHHHHHHhcCCeeccCCChheEEEeCCC--CEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHH
Confidence 99999999999999999999999999887 8999999998654322 223457888999999998888999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||++|+|++|..||...........+.. +.+ .......+
T Consensus 188 G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~---------------------------------------~~~~~~~~ 226 (277)
T cd06642 188 GITAIELAKGEPPNSDLHPMRVLFLIPK--NSP---------------------------------------PTLEGQYS 226 (277)
T ss_pred HHHHHHHHhCCCCCcccchhhHHhhhhc--CCC---------------------------------------CCCCcccC
Confidence 9999999999999976554332221110 000 00111236
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.++.+++.+||+.+|++|||+.++++|+||...
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 788999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=298.86 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=197.8
Q ss_pred ccCCeEEEeEeeccccceEEEEEecC-----CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHK-----TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
-.++|.+.+.||+|+||.||+|.+.. ++. +++|.+......
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--------------------------------- 50 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--------------------------------- 50 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH---------------------------------
Confidence 35679999999999999999999976 443 377765332211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCC-----CCC
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNY-----QGF 166 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~-----~~~ 166 (429)
.....+.+|+.+++.++|+ ||+++++++......++||||+ +++|.+++..... ..+
T Consensus 51 -----------~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~ 113 (277)
T cd05036 51 -----------QDESDFLMEALIMSKFNHQ------NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSL 113 (277)
T ss_pred -----------HHHHHHHHHHHHHHhCCCC------CEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCC
Confidence 1123466699999999877 9999999999888999999999 5699999976542 248
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccCcce-----eeecCccccchhhh
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQRVY-----TYIQSRFYRSPEVI 240 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~~~~-----~~~~t~~y~aPE~~ 240 (429)
++..+..++.||+.||+|||+++++|+||||+||+++.++ ...++|+|||++........ ....+..|+|||++
T Consensus 114 ~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05036 114 TMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF 193 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHH
Confidence 8999999999999999999999999999999999998754 23589999999876532211 12234579999999
Q ss_pred hCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCC
Q psy17270 241 LGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319 (429)
Q Consensus 241 ~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (429)
.+..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 194 ~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---------------------------------- 239 (277)
T cd05036 194 LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR---------------------------------- 239 (277)
T ss_pred hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc----------------------------------
Confidence 98889999999999999999997 9999998776554433221000
Q ss_pred CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
...+...+..+.+++.+||+.||++|||+.++++|
T Consensus 240 -------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 -------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00012236788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=309.77 Aligned_cols=292 Identities=19% Similarity=0.220 Sum_probs=199.7
Q ss_pred eEeecc--ccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchh
Q psy17270 27 EVIGKG--SFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKK 103 (429)
Q Consensus 27 ~~lG~G--~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~ 103 (429)
..||.| +||+||+|.+..++.. |+|++........
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~------------------------------------------ 41 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE------------------------------------------ 41 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHH------------------------------------------
Confidence 356666 9999999999888865 8888754322111
Q ss_pred hhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH
Q psy17270 104 RFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCL 182 (429)
Q Consensus 104 ~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l 182 (429)
....+.+|+.+++.++|+ ||++++++|......++||||+. ++|.+++.+.....+++..+..++.|++.||
T Consensus 42 -~~~~~~~e~~~~~~l~h~------niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL 114 (328)
T cd08226 42 -HLKALQNEVVLSHFFRHP------NIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGL 114 (328)
T ss_pred -HHHHHHHHHHHHHhCCCC------CcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence 113455688888888877 99999999999999999999995 6999998876555699999999999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---c-------ceeeecCccccchhhhhCC--CCCCCcc
Q psy17270 183 RLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---R-------VYTYIQSRFYRSPEVILGL--PYGPPID 250 (429)
Q Consensus 183 ~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~-------~~~~~~t~~y~aPE~~~~~--~~~~~~D 250 (429)
+|||++|++||||||+||+++.++ .++++||+.+..... . .....++..|+|||++.+. .++.++|
T Consensus 115 ~~lH~~~ivHrDlkp~Nill~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 192 (328)
T cd08226 115 NYLHQNGYIHRNIKASHILISGDG--LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD 192 (328)
T ss_pred HHHHhCCeecCCCCHHHEEEeCCC--cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhh
Confidence 999999999999999999999887 899999986532111 0 0112245569999999764 4788999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcc-----ccCCCCCCCCCCCch
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC-----ITNSKGRKRKPGSKD 325 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 325 (429)
|||+||++|+|++|..||........+..........+..............+....... ...............
T Consensus 193 iwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (328)
T cd08226 193 IYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL 272 (328)
T ss_pred HHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccc
Confidence 999999999999999999887655444333321111111000000000000000000000 000000000000000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
........++.+.+|+++||+.||++|||+.|+|+|+||+....
T Consensus 273 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 273 RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 01112234678999999999999999999999999999987544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=309.75 Aligned_cols=250 Identities=22% Similarity=0.347 Sum_probs=191.5
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCC------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTN------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.+||++.+.||.|+||.||+|.+..++ .+|+|++.......
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~--------------------------------- 52 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS--------------------------------- 52 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH---------------------------------
Confidence 579999999999999999999865432 35888764332111
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEc-CeEEEEEeecC-cCHHHHHHhhCC-------
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFR-NHLCISFELMN-LNLYELIKRNNY------- 163 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~-g~L~~~i~~~~~------- 163 (429)
....+.+|+.++.++ .|+ ||+++++++... ..++++|||+. ++|.+++.....
T Consensus 53 -----------~~~~~~~E~~~~~~l~~h~------niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~ 115 (337)
T cd05054 53 -----------EYKALMTELKILIHIGHHL------NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRN 115 (337)
T ss_pred -----------HHHHHHHHHHHHHhhccCc------chhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccc
Confidence 112345699999998 454 999999988654 57899999995 699998865321
Q ss_pred ----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy17270 164 ----------------------------------------------------QGFSLGLIRRFAFSLVQCLRLLHRENII 191 (429)
Q Consensus 164 ----------------------------------------------------~~~~~~~~~~i~~qil~~l~~lH~~~iv 191 (429)
.+++...+..++.||+.||+|||++||+
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iv 195 (337)
T cd05054 116 KSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCI 195 (337)
T ss_pred ccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 2578999999999999999999999999
Q ss_pred ecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CC
Q psy17270 192 HCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GC 265 (429)
Q Consensus 192 H~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~ 265 (429)
||||||+||+++.++ .++|+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 196 HrDikp~Nill~~~~--~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~ 273 (337)
T cd05054 196 HRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 273 (337)
T ss_pred cCCCCcceEEEeCCC--cEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCC
Confidence 999999999999887 8999999999754321 112334567999999999999999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhc
Q psy17270 266 PLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCF 345 (429)
Q Consensus 266 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 345 (429)
.||.+....+.+...... +.. .......++++.+++.+||
T Consensus 274 ~p~~~~~~~~~~~~~~~~-~~~---------------------------------------~~~~~~~~~~~~~l~~~cl 313 (337)
T cd05054 274 SPYPGVQIDEEFCRRLKE-GTR---------------------------------------MRAPEYATPEIYSIMLDCW 313 (337)
T ss_pred CCCCCCCccHHHHHHHhc-cCC---------------------------------------CCCCccCCHHHHHHHHHHc
Confidence 999875433322221110 000 0001123678899999999
Q ss_pred ccCCCCCCCHHHHhcC
Q psy17270 346 NWDSKKRLTPDEALRH 361 (429)
Q Consensus 346 ~~dP~~Rpta~ell~h 361 (429)
+.+|++||++.|+++|
T Consensus 314 ~~~p~~RPs~~ell~~ 329 (337)
T cd05054 314 HNNPEDRPTFSELVEI 329 (337)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=299.01 Aligned_cols=256 Identities=24% Similarity=0.427 Sum_probs=205.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
....+|.-.+.||.|++|.||+|.+..++.. ++|++.....
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------------------------------------- 57 (285)
T cd06648 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-------------------------------------- 57 (285)
T ss_pred cchHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--------------------------------------
Confidence 3445788889999999999999999877764 8887632111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+.+++.+.|+ ||+++++++....+.++++||+. ++|.+++... ++++..+..++
T Consensus 58 -------~~~~~~~~e~~~l~~~~h~------~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~ 121 (285)
T cd06648 58 -------QRRELLFNEVVIMRDYQHP------NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVC 121 (285)
T ss_pred -------hHHHHHHHHHHHHHHcCCC------ChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC---CCCHHHHHHHH
Confidence 0112355689999998876 99999999999999999999995 6999988773 48999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.|++.||+|||++|++||||+|+||+++.++ .++|+|||.+...... .....++..|+|||++.+..++.++|+|
T Consensus 122 ~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 199 (285)
T cd06648 122 LAVLKALSFLHAQGVIHRDIKSDSILLTSDG--RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIW 199 (285)
T ss_pred HHHHHHHHHHHhCCeecCCCChhhEEEcCCC--cEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHH
Confidence 9999999999999999999999999999888 8999999987543321 2234688899999999888899999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|..||...+.......+... .+... .....
T Consensus 200 slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~~~~~------------------------------------~~~~~ 240 (285)
T cd06648 200 SLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---LPPKL------------------------------------KNLHK 240 (285)
T ss_pred HHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---CCCCC------------------------------------ccccc
Confidence 9999999999999999877665554443321 00000 00011
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.+..+.+|+.+||+.||++|||+.++++|+||+...
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 367889999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=303.28 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=204.2
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..++|++.+.||+|+||.||+|.+..++. +++|.+......
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------------------------------------- 58 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-------------------------------------- 58 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch--------------------------------------
Confidence 46899999999999999999999987765 488876322111
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
....+.+|+.+++.++|+ ||+++++.+......|+|+||+. ++|.+++.+.. +++..+..++.
T Consensus 59 -------~~~~~~~e~~~l~~l~hp------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---l~~~~~~~i~~ 122 (293)
T cd06647 59 -------KKELIINEILVMRENKHP------NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCR 122 (293)
T ss_pred -------HHHHHHHHHHHHhhcCCC------CeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcC---CCHHHHHHHHH
Confidence 123456688899888777 99999999999999999999995 69999887643 88999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
|++.||.|||++|++|+||+|+||+++.++ .++|+|||++...... .....+++.|+|||.+.+..++.++|+||
T Consensus 123 ~l~~al~~LH~~gi~H~dL~p~Nili~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s 200 (293)
T cd06647 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200 (293)
T ss_pred HHHHHHHHHHhCCEeeccCCHHHEEEcCCC--CEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHH
Confidence 999999999999999999999999999887 8999999987643321 22346788899999998888899999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|++++|+.||...+..+.+..+.. +.. + ........
T Consensus 201 lG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~~---------------------------------~----~~~~~~~~ 241 (293)
T cd06647 201 LGIMAIEMVEGEPPYLNENPLRALYLIAT--NGT---------------------------------P----ELQNPEKL 241 (293)
T ss_pred HHHHHHHHHhCCCCCCCCChhhheeehhc--CCC---------------------------------C----CCCCcccc
Confidence 99999999999999987665433221110 000 0 00011123
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+..+.+++++||..||++||++.+++.|+||+...
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 67789999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=303.06 Aligned_cols=248 Identities=23% Similarity=0.286 Sum_probs=194.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCc-c--hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNT-H--ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~--aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.|++.+.||.|+||.||+|.+..++. + ++|.+.....
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~--------------------------------------- 47 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--------------------------------------- 47 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC---------------------------------------
Confidence 469999999999999999999987764 2 6555432111
Q ss_pred CCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC------------
Q psy17270 98 GSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY------------ 163 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~------------ 163 (429)
......+.+|++++.++ .|+ ||+++++++.....+++||||+. ++|.+++.....
T Consensus 48 -----~~~~~~~~~Ei~~l~~l~~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 116 (303)
T cd05088 48 -----KDDHRDFAGELEVLCKLGHHP------NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 116 (303)
T ss_pred -----HHHHHHHHHHHHHHHHhcCCC------CcceEEEEECCCCCceEEEEeCCCCcHHHHHHhccccccccccccccc
Confidence 11223556699999998 555 99999999999999999999995 699999875431
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee--eecCccccchhh
Q psy17270 164 --QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT--YIQSRFYRSPEV 239 (429)
Q Consensus 164 --~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~--~~~t~~y~aPE~ 239 (429)
..+++..+..++.|++.||+|||++|++||||||+|||++.++ .++|+|||++......... ...+..|+|||+
T Consensus 117 ~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~ 194 (303)
T cd05088 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 194 (303)
T ss_pred ccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC--cEEeCccccCcccchhhhcccCCCcccccCHHH
Confidence 2478999999999999999999999999999999999999887 8999999998643221111 223567999999
Q ss_pred hhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCC
Q psy17270 240 ILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318 (429)
Q Consensus 240 ~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (429)
+.+..++.++|||||||++|+|+| |..||.+.+..+....+... ...
T Consensus 195 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--~~~------------------------------ 242 (303)
T cd05088 195 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--YRL------------------------------ 242 (303)
T ss_pred HhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC--CcC------------------------------
Confidence 988888999999999999999998 99999876655443322110 000
Q ss_pred CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+...++++.+|+.+||+.||++||++.+++.+
T Consensus 243 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 243 ---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0001236788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=332.25 Aligned_cols=252 Identities=22% Similarity=0.363 Sum_probs=196.6
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+||+++++||+|+||.||+|++..++.. |+|++......
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~---------------------------------------- 41 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE---------------------------------------- 41 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc----------------------------------------
Confidence 6899999999999999999999988865 99987543211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC---------CCCCCHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN---------YQGFSLG 169 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~---------~~~~~~~ 169 (429)
.......+.+|+++++.+.|+ ||+++++++...+..+++|||++ ++|.+++.... ....+..
T Consensus 42 --~e~~~~rflrEi~ILs~L~HP------NIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~ 113 (932)
T PRK13184 42 --NPLLKKRFLREAKIAADLIHP------GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVG 113 (932)
T ss_pred --CHHHHHHHHHHHHHHHhCCCc------CcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHH
Confidence 112334577799999999887 99999999999999999999995 69999886421 1235667
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---------------------cceee
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---------------------RVYTY 228 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---------------------~~~~~ 228 (429)
.+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++..... .....
T Consensus 114 ~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg--~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~ 191 (932)
T PRK13184 114 AFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG--EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKI 191 (932)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC--CEEEEecCcceecccccccccccccccccccccccccCCCC
Confidence 8889999999999999999999999999999999988 899999999865410 01124
Q ss_pred ecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCC
Q psy17270 229 IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTP 308 (429)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (429)
+||+.|+|||++.+..++.++|||||||++|+|+||..||...+....... .... .+...
T Consensus 192 vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~-~P~~~----------------- 251 (932)
T PRK13184 192 VGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVIL-SPIEV----------------- 251 (932)
T ss_pred CCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhcc-Chhhc-----------------
Confidence 689999999999998999999999999999999999999987544322111 0000 00000
Q ss_pred ccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 309 RCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......++.+.+++.+||+.||++|++..+.+.+
T Consensus 252 -------------------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 252 -------------------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred -------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012346788999999999999999886665543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=303.30 Aligned_cols=260 Identities=27% Similarity=0.378 Sum_probs=207.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
....+.|...+.||.|+||+||+|++..++.. ++|++......
T Consensus 17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~------------------------------------ 60 (313)
T cd06633 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ------------------------------------ 60 (313)
T ss_pred CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC------------------------------------
Confidence 34566799999999999999999999888765 88876432211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.......+.+|+++++.++|+ |++.+++++......|+||||+.+++.+++.... ..+++..+..++
T Consensus 61 ------~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~ 127 (313)
T cd06633 61 ------TNEKWQDIIKEVKFLQQLKHP------NTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAIT 127 (313)
T ss_pred ------chHHHHHHHHHHHHHHhCCCC------CCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHH
Confidence 011123456699999998877 9999999999999999999999999988887654 458999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhh---CCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVIL---GLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Diw 252 (429)
.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++..... .....++..|+|||++. ...++.++|+|
T Consensus 128 ~qi~~al~~LH~~gi~H~dl~p~nili~~~~--~~kL~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~ 204 (313)
T cd06633 128 HGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 204 (313)
T ss_pred HHHHHHHHHHHHCCeecCCCChhhEEECCCC--CEEEeecCCCcccCC-CCCccccccccChhhccccCCCCCCchhhHH
Confidence 9999999999999999999999999999887 899999999864332 23456888999999985 34578899999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|..||...+.......+... ..+.. ....
T Consensus 205 slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~--------------------------------------~~~~ 244 (313)
T cd06633 205 SLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTL--------------------------------------QSNE 244 (313)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCC--------------------------------------Cccc
Confidence 9999999999999999887665554433220 00000 0011
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.+..+.+|+.+||+.+|.+||++.+++.||||+...
T Consensus 245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 256788999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=293.99 Aligned_cols=252 Identities=29% Similarity=0.439 Sum_probs=200.1
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||++.+.||+|+||.||+|.+..++.. ++|.+......
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------------------------------------- 39 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----------------------------------------- 39 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-----------------------------------------
Confidence 799999999999999999999877754 88887543221
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+++++.++|+ ||+++++.+.....+++|+||+. ++|.+++.... .+++..+..++.|++
T Consensus 40 --~~~~~~~~~e~~~~~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~ 109 (264)
T cd06626 40 --PKTIKEIADEMKVLELLKHP------NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLL 109 (264)
T ss_pred --hHHHHHHHHHHHHHHhCCCC------ChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHH
Confidence 11234566799999999887 99999999998999999999995 69999987654 388999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-------eeecCccccchhhhhCCC---CCCCc
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-------TYIQSRFYRSPEVILGLP---YGPPI 249 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~---~~~~~ 249 (429)
.||.|||+.|++|+||+|+||+++.++ .++|+|||++........ ...++..|+|||++.+.. ++.++
T Consensus 110 ~~l~~lh~~~i~H~dl~~~nil~~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~ 187 (264)
T cd06626 110 EGLAYLHSHGIVHRDIKPANIFLDHNG--VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAA 187 (264)
T ss_pred HHHHHHHHCCcccCCCCHHHEEECCCC--CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCccc
Confidence 999999999999999999999999987 899999999865432211 245678899999998766 78899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||+++|+|++|+.||...+........... +..+. .+ .
T Consensus 188 Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~------------------------------~~-------~ 229 (264)
T cd06626 188 DIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP------------------------------IP-------D 229 (264)
T ss_pred chHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC------------------------------CC-------c
Confidence 9999999999999999999765432222111110 10000 00 0
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
....++.+.+||.+||+.||.+|||+.|++.|||+
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01226778899999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=294.92 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=202.3
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
++..++|++.+.||.|+||.||+|.+..+..+|+|.+.....
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-------------------------------------- 43 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-------------------------------------- 43 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--------------------------------------
Confidence 356789999999999999999999987665668887643211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+.+++.+.|+ ||+++++++......+++||++. ++|.+++.......++...+..++
T Consensus 44 --------~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~ 109 (261)
T cd05034 44 --------SPEAFLQEAQIMKKLRHD------KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109 (261)
T ss_pred --------CHHHHHHHHHHHhhCCCC------CEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHH
Confidence 113456699999998876 99999999998889999999995 699999987654569999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.|++.||.|||++|++|+||||+||+++.++ .++|+|||.+........ ....+..|+|||.+.+..++.++|+
T Consensus 110 ~~i~~al~~lh~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di 187 (261)
T cd05034 110 AQIAEGMAYLESRNYIHRDLAARNILVGENL--VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187 (261)
T ss_pred HHHHHHHHHHHhCCcccCCcchheEEEcCCC--CEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHH
Confidence 9999999999999999999999999999988 899999999875442211 1223457999999998889999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||+||++|+|++ |+.||.+.+....+..+......+. .
T Consensus 188 ~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~ 226 (261)
T cd05034 188 WSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR-----------------------------------------P 226 (261)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----------------------------------------C
Confidence 999999999998 9999988777666655432111000 0
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...+..+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 112578899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=292.12 Aligned_cols=251 Identities=31% Similarity=0.459 Sum_probs=205.4
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|++.+.||.|+||.||+|.+..++.. ++|++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------------------------------------- 39 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS----------------------------------------- 39 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-----------------------------------------
Confidence 699999999999999999999877755 88887433221
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC--CCCCCHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN--YQGFSLGLIRRFAFS 177 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~--~~~~~~~~~~~i~~q 177 (429)
......+.+|+++++.++|+ |++++.+.+......++++|+++ ++|.+.+.... ...+++..+..++.|
T Consensus 40 --~~~~~~~~~e~~~l~~l~~~------~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 111 (258)
T cd08215 40 --EKEREDALNEVKILKKLNHP------NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111 (258)
T ss_pred --hHHHHHHHHHHHHHHhcCCC------ChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHH
Confidence 11223455699999999877 99999999999999999999996 59999988753 345999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
++.||.|||++|++|+||+|+||+++.++ .++|+|||.+...... .....+++.|+|||.+.+..++.++|+||+
T Consensus 112 i~~~l~~lh~~~~~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 189 (258)
T cd08215 112 LCLALKYLHSRKILHRDIKPQNIFLTSNG--LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSL 189 (258)
T ss_pred HHHHHHHHHhCCEecccCChHHeEEcCCC--cEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHH
Confidence 99999999999999999999999999877 8999999998654332 233567888999999988889999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|+++++|++|..||...+..+....+..... ...+...+
T Consensus 190 G~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~ 228 (258)
T cd08215 190 GCVLYELCTLKHPFEGENLLELALKILKGQY-----------------------------------------PPIPSQYS 228 (258)
T ss_pred HHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC-----------------------------------------CCCCCCCC
Confidence 9999999999999988765544433321000 00111336
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
..+.+++.+||..||++|||+.++|+||||
T Consensus 229 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 229 SELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=294.84 Aligned_cols=252 Identities=31% Similarity=0.473 Sum_probs=205.6
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|++.+.||.|++|.||+|.+..++.. ++|++......
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---------------------------------------- 40 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---------------------------------------- 40 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----------------------------------------
Confidence 3689999999999999999999987755 88877543221
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+|++++..++|+ |++++++.+.....+++||||+. ++|.+++.... .+++..+..++.|+
T Consensus 41 ----~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l 108 (264)
T cd06623 41 ----EFRKQLLRELKTLRSCESP------YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQI 108 (264)
T ss_pred ----HHHHHHHHHHHHHHhcCCC------CeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHH
Confidence 1223566699999999877 99999999999999999999996 79999998763 49999999999999
Q ss_pred HHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeecccccccCcc---eeeecCccccchhhhhCCCCCCCccccch
Q psy17270 179 VQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 179 l~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
+.||+|||+ .|++|+||+|+||+++.++ .++|+|||.+....... ....++..|+|||.+.+..++.++|+|||
T Consensus 109 ~~~l~~lh~~~~~~H~~l~~~ni~~~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 186 (264)
T cd06623 109 LKGLDYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSL 186 (264)
T ss_pred HHHHHHHhccCCCccCCCCHHHEEECCCC--CEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHH
Confidence 999999999 9999999999999999988 89999999987644222 23567888999999998888999999999
Q ss_pred hhHHHHHhhCCCCCCCCCH---HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 255 GCILAELYTGCPLFPGENE---VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|+++|+|++|..||...+. .+....+.. ... .....
T Consensus 187 G~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~--------------------------------------~~~~~ 225 (264)
T cd06623 187 GLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP--------------------------------------PSLPA 225 (264)
T ss_pred HHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC--------------------------------------CCCCc
Confidence 9999999999999987642 222222211 000 00011
Q ss_pred c-CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 332 C-NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 332 ~-~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
. .+..+.++|.+||..+|++|||+.++++|||++..
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 1 36789999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=311.66 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=192.8
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCC------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTN------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.++|+++++||.|+||.||+|++...+ .+|+|++......
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---------------------------------- 81 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS---------------------------------- 81 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh----------------------------------
Confidence 678889999999999999999975433 2477776433211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhC---------
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNN--------- 162 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~--------- 162 (429)
.....+.+|++++.++. |+ ||+++++++.....+|+||||| +|+|.+++....
T Consensus 82 ----------~~~~~~~~Ei~~l~~l~~Hp------nIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~ 145 (400)
T cd05105 82 ----------SEKQALMSELKIMTHLGPHL------NIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPE 145 (400)
T ss_pred ----------HHHHHHHHHHHHHHhcCCCC------CeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccc
Confidence 11235677999999996 65 9999999999999999999999 479998886532
Q ss_pred --------------------------------------------------------------------------------
Q psy17270 163 -------------------------------------------------------------------------------- 162 (429)
Q Consensus 163 -------------------------------------------------------------------------------- 162 (429)
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 225 (400)
T cd05105 146 KPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNL 225 (400)
T ss_pred cccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHH
Confidence
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCc
Q psy17270 163 -----YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSR 232 (429)
Q Consensus 163 -----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~ 232 (429)
...+++..+..++.|++.||+|||+++++|+||||+|||++.++ .++|+|||++...... .....++.
T Consensus 226 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 303 (400)
T cd05105 226 LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK--IVKICDFGLARDIMHDSNYVSKGSTFLPV 303 (400)
T ss_pred HHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC--EEEEEeCCcceeccccccccccCCcCCCc
Confidence 12377888899999999999999999999999999999999887 8999999998754321 11234567
Q ss_pred cccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccc
Q psy17270 233 FYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311 (429)
Q Consensus 233 ~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (429)
.|+|||++.+..++.++|||||||++|+|++ |..||........+.........+
T Consensus 304 ~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~------------------------ 359 (400)
T cd05105 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM------------------------ 359 (400)
T ss_pred ceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC------------------------
Confidence 8999999998889999999999999999997 999998754333222211100000
Q ss_pred cCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......+..+.+++.+||+.||++|||+.++.+
T Consensus 360 ----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 360 ----------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred ----------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 001123678899999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=302.69 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=209.9
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.+....+.|+..+.||.|+||.||+|.+..++.. |+|++.......
T Consensus 19 ~~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~--------------------------------- 65 (317)
T cd06635 19 FKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS--------------------------------- 65 (317)
T ss_pred cCCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc---------------------------------
Confidence 4455667799999999999999999999887755 888764321110
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
......+.+|+++++.+.|+ |++++++++......++||||+.|+|.+.+.... ..+++..+..
T Consensus 66 ---------~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~ 129 (317)
T cd06635 66 ---------NEKWQDIIKEVKFLQRIKHP------NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAA 129 (317)
T ss_pred ---------hHHHHHHHHHHHHHHhCCCC------CEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhc-CCCCHHHHHH
Confidence 11223566799999998887 9999999999999999999999999988876543 4589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhh---CCCCCCCcc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVIL---GLPYGPPID 250 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~D 250 (429)
++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++..... .....++..|+|||++. +..++.++|
T Consensus 130 i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~--~~kl~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~D 206 (317)
T cd06635 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVD 206 (317)
T ss_pred HHHHHHHHHHHHHHCCcccCCCCcccEEECCCC--CEEEecCCCccccCC-cccccCCccccChhhhhcCCCCCCCcccc
Confidence 999999999999999999999999999999887 899999998865432 23456888999999984 345788999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
+|||||++|+|++|..||...+....+..+........ ..
T Consensus 207 v~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~ 246 (317)
T cd06635 207 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL----------------------------------------QS 246 (317)
T ss_pred HHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC----------------------------------------CC
Confidence 99999999999999999987665555444432111000 00
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
...++.+.+|+.+||+.+|.+||++.++++|+|+.....
T Consensus 247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 112567899999999999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=303.91 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=203.4
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
...-|.....||.|+||.||+|.+..++. +|+|++.....
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------------------------------------- 59 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--------------------------------------- 59 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---------------------------------------
Confidence 34446667789999999999999987775 48887632211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.....+.+|+.+++.+.|+ ||+++++.+......+++|||+. ++|.+++... .+++..+..++.
T Consensus 60 ------~~~~~~~~e~~~l~~l~hp------~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ 124 (297)
T cd06659 60 ------QRRELLFNEVVIMRDYQHQ------NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCE 124 (297)
T ss_pred ------chHHHHHHHHHHHHhCCCC------chhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc---CCCHHHHHHHHH
Confidence 1123455688899988877 99999999999999999999995 5888877653 389999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
|++.||+|||++|++|+||+|+||+++.++ .++|+|||++..... ......++..|+|||++.+..++.++|+||
T Consensus 125 qi~~~L~~LH~~~ivH~dl~p~Nill~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 202 (297)
T cd06659 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202 (297)
T ss_pred HHHHHHHHHHhCCeecCCCCHHHeEEccCC--cEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHH
Confidence 999999999999999999999999999888 899999999864332 123356889999999999888999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|+|++|+.||...+..+.+..+.. ..... .......
T Consensus 203 lG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~------------------------------------~~~~~~~ 243 (297)
T cd06659 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPPPK------------------------------------LKNAHKI 243 (297)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCCCC------------------------------------ccccCCC
Confidence 99999999999999987766555443321 00000 0001123
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
++.+.++|++||+.||++||++.++++|+||....
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 67889999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=304.27 Aligned_cols=247 Identities=20% Similarity=0.269 Sum_probs=193.3
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCc-----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNT-----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
..+|++.+.||+|+||+||+|.+..++. +|+|++.....
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~------------------------------------ 49 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS------------------------------------ 49 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC------------------------------------
Confidence 4679999999999999999999876665 36666532211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
......+.+|+.+++.+.|+ ||+++++++... ..++++|++ .|+|.+++.... ..++...+..
T Consensus 50 --------~~~~~~~~~e~~~l~~l~h~------niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~ 113 (316)
T cd05108 50 --------PKANKEILDEAYVMASVDNP------HVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLN 113 (316)
T ss_pred --------HHHHHHHHHHHHHHHhCCCC------CCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHH
Confidence 11233566699999999887 999999988754 577999998 579999988754 3488999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce--e---eecCccccchhhhhCCCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY--T---YIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~--~---~~~t~~y~aPE~~~~~~~~~~ 248 (429)
++.||+.||+|||++|++||||||+||+++.++ .++|+|||++........ . ..++..|+|||++.+..++.+
T Consensus 114 ~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~ 191 (316)
T cd05108 114 WCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191 (316)
T ss_pred HHHHHHHHHHHHHhcCeeccccchhheEecCCC--cEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCch
Confidence 999999999999999999999999999999887 899999999975432211 1 223567999999998889999
Q ss_pred ccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|||||||++|+|++ |..||.+....+... +......++
T Consensus 192 ~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~--------------------------------------- 231 (316)
T cd05108 192 SDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP--------------------------------------- 231 (316)
T ss_pred hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCC---------------------------------------
Confidence 999999999999997 999998866544322 221000000
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+...+.++.+++.+||..||++|||+.+++.+
T Consensus 232 -~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 232 -QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011235678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=300.07 Aligned_cols=248 Identities=24% Similarity=0.289 Sum_probs=194.6
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCc---chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNT---HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~---~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
++|++.+.||.|+||.||+|.+..++. +++|.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~--------------------------------------- 42 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS--------------------------------------- 42 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC---------------------------------------
Confidence 579999999999999999999987764 26665532111
Q ss_pred CCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC-------------
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN------------- 162 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~------------- 162 (429)
......+.+|++++.++. |+ ||+++++++.....++++|||+. ++|.+++....
T Consensus 43 -----~~~~~~~~~E~~~l~~l~~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 111 (297)
T cd05089 43 -----ENDHRDFAGELEVLCKLGHHP------NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111 (297)
T ss_pred -----HHHHHHHHHHHHHHHhhcCCC------chhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccC
Confidence 111234667999999984 54 99999999999899999999995 69999997542
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee--eecCccccchhh
Q psy17270 163 -YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT--YIQSRFYRSPEV 239 (429)
Q Consensus 163 -~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~--~~~t~~y~aPE~ 239 (429)
...+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++......... ...+..|+|||+
T Consensus 112 ~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~ 189 (297)
T cd05089 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL--ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIES 189 (297)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC--eEEECCcCCCccccceeccCCCCcCccccCchh
Confidence 12488999999999999999999999999999999999999887 8999999998643322111 122456999999
Q ss_pred hhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCC
Q psy17270 240 ILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318 (429)
Q Consensus 240 ~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (429)
+.+..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 190 ~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~-------------------------------- 237 (297)
T cd05089 190 LNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM-------------------------------- 237 (297)
T ss_pred hccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC--------------------------------
Confidence 988889999999999999999997 99999887765554433211000
Q ss_pred CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 238 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 238 ---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0011236788999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=298.42 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=197.1
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCC------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTN------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
+-.++|++.+.||+|+||.||+|.+.... .+|+|.+.......
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~------------------------------- 57 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK------------------------------- 57 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-------------------------------
Confidence 44678999999999999999999986543 23777764322111
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhh--------
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRN-------- 161 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~-------- 161 (429)
....+.+|+++++.+ +|+ ||+++++++.....++++|||+ +|+|.+++...
T Consensus 58 -------------~~~~~~~E~~~l~~l~~h~------~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~ 118 (293)
T cd05053 58 -------------DLSDLVSEMEMMKMIGKHK------NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYAS 118 (293)
T ss_pred -------------HHHHHHHHHHHHHhhcCCC------CeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccc
Confidence 112455699999988 565 9999999999999999999999 56999998753
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-----eeec
Q psy17270 162 ------NYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-----TYIQ 230 (429)
Q Consensus 162 ------~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-----~~~~ 230 (429)
....+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........ ...+
T Consensus 119 ~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 196 (293)
T cd05053 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH--VMKIADFGLARDIHHIDYYRKTTNGRL 196 (293)
T ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC--eEEeCccccccccccccceeccCCCCC
Confidence 224588999999999999999999999999999999999999888 899999999875433211 1223
Q ss_pred CccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCc
Q psy17270 231 SRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309 (429)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (429)
+..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..... +
T Consensus 197 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~--------------------- 253 (293)
T cd05053 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--M--------------------- 253 (293)
T ss_pred CccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--C---------------------
Confidence 457999999988889999999999999999997 9999988766554433321000 0
Q ss_pred cccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 310 CITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......+..+.+|+.+||..||++|||+.|++++
T Consensus 254 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 254 ------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0011236788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=295.40 Aligned_cols=245 Identities=17% Similarity=0.254 Sum_probs=197.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.+|++.+.||.|+||.||+|.++.++.+|+|++.....
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------------------------------------------ 41 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------------------------------------------ 41 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC------------------------------------------
Confidence 45899999999999999999987655678887642211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
....+.+|+++++.+.|+ ||+++++++......++||||+. ++|.+++.... ..+++..+..++.|++
T Consensus 42 ----~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~ 110 (256)
T cd05059 42 ----SEDDFIEEAKVMMKLSHP------NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVC 110 (256)
T ss_pred ----CHHHHHHHHHHHHhCCCC------CEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHH
Confidence 112455699999998876 99999999999999999999995 68999987654 3589999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-ee---ecCccccchhhhhCCCCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-TY---IQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-~~---~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
.||+|||++|++|+||||+||+++.++ .++|+|||.+........ .. .++..|+|||.+.+..++.++|+||||
T Consensus 111 ~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG 188 (256)
T cd05059 111 EAMEYLESNGFIHRDLAARNCLVGEDN--VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFG 188 (256)
T ss_pred HHHHHHHHCCcccccccHhhEEECCCC--cEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHH
Confidence 999999999999999999999999888 899999999875433211 11 223469999999988899999999999
Q ss_pred hHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|++|+|++ |..||...+..+....+...... ..+...+
T Consensus 189 ~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~ 227 (256)
T cd05059 189 VLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-----------------------------------------YRPKLAP 227 (256)
T ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-----------------------------------------CCCCCCC
Confidence 99999999 89999887766554433221000 0011237
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+.+++.+||..+|++|||+.|+++.
T Consensus 228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=294.39 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=196.9
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|+||.||+|++..++.. |+|.+......
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------------------------------------- 41 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM---------------------------------------- 41 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC----------------------------------------
Confidence 5799999999999999999999888765 88876432110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC--CCCCCHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN--YQGFSLGLIRRFAF 176 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~--~~~~~~~~~~~i~~ 176 (429)
.......+.+|+++++.++|+ ||+++++++...+..++++||+. ++|.+++.... ...+++..+..++.
T Consensus 42 --~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 113 (267)
T cd08228 42 --DAKARQDCVKEIDLLKQLNHP------NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV 113 (267)
T ss_pred --CHHHHHHHHHHHHHHHhCCCc------ceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHH
Confidence 111223456699999999887 99999999999999999999996 59998886432 23489999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc---eeeecCccccchhhhhCCCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
|++.||+|||++|++|+||+|+||+++.++ .++|+|||++....... ....++..|+|||.+.+..++.++|+||
T Consensus 114 ~i~~~l~~LH~~~i~H~dl~~~nil~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 191 (267)
T cd08228 114 QLCSAVEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191 (267)
T ss_pred HHHHHHHHHhhCCeeCCCCCHHHEEEcCCC--CEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHH
Confidence 999999999999999999999999999887 89999999987544322 2346788899999999888899999999
Q ss_pred hhhHHHHHhhCCCCCCCCCH--HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 254 LGCILAELYTGCPLFPGENE--VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
+|+++|+|++|..||..... .+....+.. .+.++. ...
T Consensus 192 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~---------------------------------------~~~ 231 (267)
T cd08228 192 LGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CDYPPL---------------------------------------PTE 231 (267)
T ss_pred HHHHHHHHhcCCCCCccccccHHHHHHHHhc-CCCCCC---------------------------------------Chh
Confidence 99999999999999965432 222221111 111110 001
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+..+.+++.+||..||++||++.++++
T Consensus 232 ~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 232 HYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred hcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 23678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=296.03 Aligned_cols=251 Identities=19% Similarity=0.273 Sum_probs=198.1
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCC------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTN------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
++..++|++.+.||.|+||.||+|.+.... .+|+|.+......
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~------------------------------- 50 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM------------------------------- 50 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-------------------------------
Confidence 345678999999999999999999987543 3477765322111
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC------
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY------ 163 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~------ 163 (429)
.....+.+|+.+++.+.|+ ||+++++++......++||||+. ++|.+++.....
T Consensus 51 -------------~~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~ 111 (277)
T cd05032 51 -------------RERIEFLNEASVMKEFNCH------HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNP 111 (277)
T ss_pred -------------HHHHHHHHHHHHHHhCCCC------ceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhcc
Confidence 1122455689999988877 99999999999999999999995 799999875321
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccc
Q psy17270 164 --QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRS 236 (429)
Q Consensus 164 --~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~a 236 (429)
..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||+++..... .....++..|+|
T Consensus 112 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 189 (277)
T cd05032 112 GLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL--TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189 (277)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC--CEEECCcccchhhccCcccccCCCCCccccccC
Confidence 2367889999999999999999999999999999999999988 8999999998654322 122345678999
Q ss_pred hhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCC
Q psy17270 237 PEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315 (429)
Q Consensus 237 PE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (429)
||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.. +..+
T Consensus 190 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~~~--------------------------- 240 (277)
T cd05032 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GGHL--------------------------- 240 (277)
T ss_pred HHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc--CCCC---------------------------
Confidence 999988889999999999999999998 9999988776554443321 0000
Q ss_pred CCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+...+..+.+++.+||+.||++|||+.++++
T Consensus 241 ------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 ------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001122678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=296.36 Aligned_cols=247 Identities=22% Similarity=0.299 Sum_probs=201.0
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
...|++.++||.|+||.||+|.+.....+++|++......
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~---------------------------------------- 44 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL---------------------------------------- 44 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh----------------------------------------
Confidence 3569999999999999999999988556688887433211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
....+.+|+.+++.++|+ ||+++++++.....+++||||+. ++|.+++.......++...+..++.|+
T Consensus 45 -----~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i 113 (261)
T cd05148 45 -----KQQDFQKEVQALKRLRHK------HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV 113 (261)
T ss_pred -----hHHHHHHHHHHHhcCCCc------chhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 122455699999998876 99999999999999999999995 699999987655568999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce---eeecCccccchhhhhCCCCCCCccccchh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY---TYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
+.||.|||++|++|+||+|+||+++.++ .++|+|||.+........ ...++..|+|||++.+..++.++||||||
T Consensus 114 ~~al~~lH~~~i~h~dl~~~nilv~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG 191 (261)
T cd05148 114 AEGMAYLEEQNSIHRDLAARNILVGEDL--VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFG 191 (261)
T ss_pred HHHHHHHHHCCeeccccCcceEEEcCCc--eEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHH
Confidence 9999999999999999999999999888 899999999865432211 22345679999999888899999999999
Q ss_pred hHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
+++|+|++ |+.||.+.+..+.+..+...... ..+...+
T Consensus 192 ~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~ 230 (261)
T cd05148 192 ILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-----------------------------------------PCPAKCP 230 (261)
T ss_pred HHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-----------------------------------------CCCCCCC
Confidence 99999998 89999887766655544321100 0012336
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+.+.+++.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 88999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=312.55 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=212.1
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
-.+-|.+.+.||.|.|+.|.+|++..++. +|||.+.+...+..
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~------------------------------------ 97 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS------------------------------------ 97 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH------------------------------------
Confidence 35679999999999999999999999985 49998855432211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
....+.+|+++++.++|+ ||++++.+.+....+|+||||+ +|.+.+++.++.. ..+..++.++.
T Consensus 98 -------~~~k~~rev~imk~l~HP------nIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~ 162 (596)
T KOG0586|consen 98 -------KRQKLGREVDIMKSLNHP------NIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFR 162 (596)
T ss_pred -------HHHHHHHHHHHHHhcCCc------ceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhH
Confidence 112356799999999988 9999999999999999999999 6799999998864 88899999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCCCC-CCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPY-GPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwS 253 (429)
|+..|++|||+++|||||||++|||++.+- ++||+|||++.... ....+.||++.|.|||++.+.+| ++.+|+||
T Consensus 163 q~vsaveYcH~k~ivHrdLk~eNilL~~~m--nikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Ws 240 (596)
T KOG0586|consen 163 QIVSAVEYCHSKNIVHRDLKAENILLDENM--NIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWS 240 (596)
T ss_pred HHHHHHHHHhhcceeccccchhhccccccc--ceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhh
Confidence 999999999999999999999999999876 79999999997644 44567899999999999999987 67999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
+|+++|.|+.|..||.+.+-.+.-.+.... . ..++-..
T Consensus 241 lgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--------------------k----------------------~rIp~~m 278 (596)
T KOG0586|consen 241 LGVVLYALVEGSLPFDGQNLKELRPRVLRG--------------------K----------------------YRIPFYM 278 (596)
T ss_pred hhhhheeeeecccccCCcccccccchheee--------------------e----------------------eccccee
Confidence 999999999999999997654433222210 0 0011112
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
+.++.++|+++|..+|.+|++.+++.+|.|....
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 5677899999999999999999999999998753
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.00 Aligned_cols=248 Identities=19% Similarity=0.265 Sum_probs=198.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
++..++|++.++||+|+||.||+|.+.....+|+|.+....
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--------------------------------------- 42 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--------------------------------------- 42 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---------------------------------------
Confidence 35688999999999999999999998766667888764321
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+++++.+.|+ ||+++++.+.. ...+++|||+. ++|.+++.......++...+..++
T Consensus 43 -------~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 108 (260)
T cd05073 43 -------MSVEAFLAEANVMKTLQHD------KLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 108 (260)
T ss_pred -------hHHHHHHHHHHHHHhcCCC------CcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHH
Confidence 1123456699999999887 99999999877 78899999995 699999987654558899999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+........ ...++..|+|||++.+..++.++|+
T Consensus 109 ~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di 186 (260)
T cd05073 109 AQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186 (260)
T ss_pred HHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccc
Confidence 9999999999999999999999999999887 899999999865432211 1234456999999988888999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||++|++++ |..||.+.+..+....+...... ...
T Consensus 187 ~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~ 225 (260)
T cd05073 187 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-----------------------------------------PRP 225 (260)
T ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-----------------------------------------CCc
Confidence 999999999999 99999887765554433221000 001
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...+.++.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 123678999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=301.06 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=195.6
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCC--------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTN--------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~--------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
++..++|.+.+.||+|+||.||+|.+...+ .+|+|.+......
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~----------------------------- 64 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE----------------------------- 64 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh-----------------------------
Confidence 445689999999999999999999875322 2466665432111
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC---
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY--- 163 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~--- 163 (429)
.....+..|+++++.+ +|+ ||+++++++......|+||||+. ++|.+++.....
T Consensus 65 ---------------~~~~~~~~e~~~l~~l~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~ 123 (307)
T cd05098 65 ---------------KDLSDLISEMEMMKMIGKHK------NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 123 (307)
T ss_pred ---------------HHHHHHHHHHHHHHHhcCCC------CEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCccc
Confidence 1123456699999988 455 99999999999999999999995 699999986531
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----ee
Q psy17270 164 -----------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YT 227 (429)
Q Consensus 164 -----------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~ 227 (429)
..++..++..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+....... ..
T Consensus 124 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~--~~kL~dfg~a~~~~~~~~~~~~~~ 201 (307)
T cd05098 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN--VMKIADFGLARDIHHIDYYKKTTN 201 (307)
T ss_pred ccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC--cEEECCCcccccccccchhhcccc
Confidence 2478899999999999999999999999999999999999887 89999999986543211 11
Q ss_pred eecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
..++..|+|||++.+..++.++|+|||||++|+|++ |..||.+....+....+.... .
T Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~------------------- 260 (307)
T cd05098 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH--R------------------- 260 (307)
T ss_pred CCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC--C-------------------
Confidence 123457999999998889999999999999999998 899998766544333322100 0
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
...+...+.++.+|+.+||..+|++|||+.+++++
T Consensus 261 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 261 --------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred --------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 00011236788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=292.87 Aligned_cols=240 Identities=21% Similarity=0.352 Sum_probs=188.9
Q ss_pred eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.||.|+||.||+|++..++.. |+|.+...... ..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~--------------------------------------------~~ 36 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP--------------------------------------------DL 36 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH--------------------------------------------HH
Confidence 4699999999999999877764 88876432211 12
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
...+.+|+++++.+.|+ ||+++++++.....+++||||+. ++|.+++.... ..+++..+..++.|++.||+|
T Consensus 37 ~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~ 109 (252)
T cd05084 37 KAKFLQEARILKQYSHP------NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEY 109 (252)
T ss_pred HHHHHHHHHHHHhCCCC------CcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHH
Confidence 23566699999998876 99999999999999999999995 69999987543 348999999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee-----eecCccccchhhhhCCCCCCCccccchhhHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT-----YIQSRFYRSPEVILGLPYGPPIDMWSLGCILA 259 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~-----~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 259 (429)
||++|++|+||||+||+++.++ .++|+|||.+......... ...+..|+|||.+.+..++.++|+|||||++|
T Consensus 110 lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 187 (252)
T cd05084 110 LESKHCIHRDLAARNCLVTEKN--VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLW 187 (252)
T ss_pred HHhCCccccccchheEEEcCCC--cEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHH
Confidence 9999999999999999999887 8999999998653322111 11234699999998888999999999999999
Q ss_pred HHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 260 ELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 260 ~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
+|++ |..||...+.......+...... ......+..+.
T Consensus 188 e~~~~~~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 226 (252)
T cd05084 188 EAFSLGAVPYANLSNQQTREAIEQGVRL-----------------------------------------PCPELCPDAVY 226 (252)
T ss_pred HHHhCCCCCccccCHHHHHHHHHcCCCC-----------------------------------------CCcccCCHHHH
Confidence 9998 89999776554433322210000 00112367889
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy17270 339 DFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 339 ~li~~~L~~dP~~Rpta~ell~ 360 (429)
+|+.+||+.||++|||+.++++
T Consensus 227 ~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 227 RLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=293.40 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=197.5
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCC----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTN----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
.++|++.+.||+|+||+||+|.+..++ .+|+|.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~------------------------------------ 46 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD------------------------------------ 46 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh------------------------------------
Confidence 467999999999999999999987552 2377776433211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.....+.+|+.+++.++|+ ||+++++.+......+++||++. ++|.+++.... ..+++..+..+
T Consensus 47 --------~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~ 111 (266)
T cd05033 47 --------KQRLDFLTEASIMGQFDHP------NIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGM 111 (266)
T ss_pred --------HHHHHHHHHHHHHHhCCCC------CcceEeEEEecCCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHH
Confidence 1123456699999999877 99999999999999999999995 69999987654 35899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--c-ee--eecCccccchhhhhCCCCCCCc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--V-YT--YIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~-~~--~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
+.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... . .. ..++..|+|||.+.+..++.++
T Consensus 112 ~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~ 189 (266)
T cd05033 112 LRGIASGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSAS 189 (266)
T ss_pred HHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCcccc
Confidence 99999999999999999999999999999887 8999999998765311 1 11 2235679999999988899999
Q ss_pred cccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 250 DMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 250 DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
||||||+++|+|++ |..||......+....+......+.
T Consensus 190 Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------------------- 229 (266)
T cd05033 190 DVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---------------------------------------- 229 (266)
T ss_pred chHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------------------
Confidence 99999999999998 9999977666554443332100000
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
....++.+.+++.+||+.||++||++.|++++
T Consensus 230 -~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 230 -PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11236788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=297.59 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=196.1
Q ss_pred cCCeEEEeEeeccccceEEEEEecC-----CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHK-----TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
...|.+.+.||.|+||+||++.+.. ++. +|+|.+....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~------------------------------------ 47 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS------------------------------------ 47 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC------------------------------------
Confidence 3569999999999999999998633 222 3677653221
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC---------
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY--------- 163 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~--------- 163 (429)
......+.+|+++++.+.|+ ||+++++++.....+++||||+. ++|.+++.....
T Consensus 48 ---------~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 112 (288)
T cd05093 48 ---------DNARKDFHREAELLTNLQHE------HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 112 (288)
T ss_pred ---------HHHHHHHHHHHHHHHhCCCC------CcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccC
Confidence 11233566799999999887 99999999999999999999995 699999875431
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-----eeecCccccc
Q psy17270 164 --QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-----TYIQSRFYRS 236 (429)
Q Consensus 164 --~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-----~~~~t~~y~a 236 (429)
..+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++........ ...++..|+|
T Consensus 113 ~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 190 (288)
T cd05093 113 RPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190 (288)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cEEeccCCccccccCCceeecCCCCCccccccC
Confidence 2489999999999999999999999999999999999999888 899999999875432211 2234667999
Q ss_pred hhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCC
Q psy17270 237 PEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315 (429)
Q Consensus 237 PE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (429)
||++.+..++.++|+|||||++|+|++ |..||...+..+.+..+.... ..
T Consensus 191 PE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~--~~--------------------------- 241 (288)
T cd05093 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR--VL--------------------------- 241 (288)
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--cC---------------------------
Confidence 999998889999999999999999998 999998877665554443210 00
Q ss_pred CCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......+.++.+|+.+||+.||.+|||+.+++.
T Consensus 242 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 ------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred ------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 001123678999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=297.58 Aligned_cols=272 Identities=19% Similarity=0.237 Sum_probs=198.7
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
.++|++++.||+|+||.||+|.+..++....|.......... -...|+|......
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~------------~~~va~K~~~~~~------------- 58 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADA------------PVLVAVKVLRPDA------------- 58 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCC------------ceeEEEEEecCcc-------------
Confidence 468999999999999999999987765432111000000000 0011233222100
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC---------CCCCCHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN---------YQGFSLG 169 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~---------~~~~~~~ 169 (429)
.......+.+|+++++.++|+ ||+++++++..+..++++||++. ++|.+++.... ...+++.
T Consensus 59 --~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 130 (296)
T cd05051 59 --SDNAREDFLKEVKILSRLSDP------NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130 (296)
T ss_pred --CHHHHHHHHHHHHHHHhcCCC------CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHH
Confidence 112334567799999999887 99999999999999999999995 69999987654 1248999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCC
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~ 244 (429)
.+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... .....++..|+|||++.+..
T Consensus 131 ~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (296)
T cd05051 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY--TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK 208 (296)
T ss_pred HHHHHHHHHHHHHHHHHHcCccccccchhceeecCCC--ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC
Confidence 9999999999999999999999999999999999987 8999999998653322 11234567899999998888
Q ss_pred CCCCccccchhhHHHHHhh--CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 245 YGPPIDMWSLGCILAELYT--GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~llt--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
++.++|||||||++|+|++ |..||...+..+.+..+.......... .
T Consensus 209 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~---- 257 (296)
T cd05051 209 FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ---------------------------I---- 257 (296)
T ss_pred CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccccc---------------------------c----
Confidence 9999999999999999998 788888776665554443211100000 0
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
........++++.+++.+||+.||++|||+.|+++
T Consensus 258 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 258 ---YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ---cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 00001223678999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=295.26 Aligned_cols=247 Identities=19% Similarity=0.237 Sum_probs=192.7
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCc-----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNT-----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
-..+|+++++||.|+||+||+|.+..++. +|+|++......
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~---------------------------------- 50 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP---------------------------------- 50 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH----------------------------------
Confidence 35789999999999999999999877775 366665432211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|+.+++.+.|+ ||+.+++++.. ...++++|++. |+|.+++.... ..+++..+.
T Consensus 51 ----------~~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~ 112 (279)
T cd05109 51 ----------KANKEILDEAYVMAGVGSP------YVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLL 112 (279)
T ss_pred ----------HHHHHHHHHHHHHHhcCCC------CCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHH
Confidence 1223455688888888776 99999998864 45789999994 79999987653 358999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-----eeecCccccchhhhhCCCCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-----TYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~ 247 (429)
.++.|++.||+|||++|++||||||+||++++++ .++|+|||++........ ...++..|+|||.+.+..++.
T Consensus 113 ~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~--~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (279)
T cd05109 113 NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN--HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH 190 (279)
T ss_pred HHHHHHHHHHHHHHHCCeeccccccceEEEcCCC--cEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCc
Confidence 9999999999999999999999999999998877 899999999875432211 112356799999998888999
Q ss_pred CccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 248 PIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 248 ~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
++|||||||++|||++ |..||...........+... ..++
T Consensus 191 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~-------------------------------------- 231 (279)
T cd05109 191 QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERLP-------------------------------------- 231 (279)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCC--------------------------------------
Confidence 9999999999999998 99999876654433222210 0000
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+...+..+.+++.+||+.||++||++.++++
T Consensus 232 --~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 --QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01123678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=292.60 Aligned_cols=246 Identities=27% Similarity=0.416 Sum_probs=191.0
Q ss_pred EeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhh
Q psy17270 26 LEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKR 104 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~ 104 (429)
...||+|+||.||+|.+..++. +++|.+......
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--------------------------------------------- 47 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--------------------------------------------- 47 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH---------------------------------------------
Confidence 4589999999999999988775 488876432211
Q ss_pred hhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCC--CHHHHHHHHHHHHHH
Q psy17270 105 FHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGF--SLGLIRRFAFSLVQC 181 (429)
Q Consensus 105 ~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~--~~~~~~~i~~qil~~ 181 (429)
..+.+.+|+++++.++|+ ||+++++++......++++||+. ++|.+++.... ..+ ++..+..++.|++.|
T Consensus 48 ~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~a 120 (268)
T cd06624 48 YVQPLHEEIALHSYLKHR------NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEG 120 (268)
T ss_pred HHHHHHHHHHHHHhcCCC------CeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHH
Confidence 123456699999999877 99999999999999999999995 69999987653 234 888999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEec-CCCcceEEeeecccccccC---cceeeecCccccchhhhhCCC--CCCCccccchh
Q psy17270 182 LRLLHRENIIHCDLKPENVLLKQ-RGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLP--YGPPIDMWSLG 255 (429)
Q Consensus 182 l~~lH~~~ivH~dlkp~Nili~~-~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG 255 (429)
|+|||++||+|+||||+||+++. ++ .++|+|||.+..... ......++..|+|||++.+.. ++.++|+||+|
T Consensus 121 l~~lH~~~i~h~dl~p~nil~~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG 198 (268)
T cd06624 121 LKYLHDNQIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLG 198 (268)
T ss_pred HHHHHHCCEeecCCCHHHEEEcCCCC--eEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHH
Confidence 99999999999999999999976 44 799999999865322 122345788999999987643 78899999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
+++|+|++|..||.................. ....+...++
T Consensus 199 vvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~ 239 (268)
T cd06624 199 CTIVEMATGKPPFIELGEPQAAMFKVGMFKI---------------------------------------HPEIPESLSA 239 (268)
T ss_pred HHHHHHHhCCCCCccccChhhhHhhhhhhcc---------------------------------------CCCCCcccCH
Confidence 9999999999999764322111000000000 0011123467
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.+.+|+++||+.+|++|||+.|++.||||
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 88999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=301.28 Aligned_cols=259 Identities=26% Similarity=0.354 Sum_probs=205.3
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+.-..+|+..+.||.|+||.||+|.+..++.. |+|.+.......
T Consensus 11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~----------------------------------- 55 (308)
T cd06634 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS----------------------------------- 55 (308)
T ss_pred CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC-----------------------------------
Confidence 33566799999999999999999999887764 888764321110
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
......+.+|+++++.+.|+ |++++++++......++||||+.|++.+++.... ..+++..+..++
T Consensus 56 -------~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~ 121 (308)
T cd06634 56 -------NEKWQDIIKEVRFLQKLRHP------NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVT 121 (308)
T ss_pred -------hHHHHHHHHHHHHHHhCCCC------CcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHH
Confidence 01122455699999999877 9999999999999999999999999888876544 458999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC---CCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG---LPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Diw 252 (429)
.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++...... ....++..|+|||.+.+ ..++.++|||
T Consensus 122 ~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~ 198 (308)
T cd06634 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVW 198 (308)
T ss_pred HHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeecCc-ccccCCccccCHHHHhhcccCCCCcccchH
Confidence 9999999999999999999999999999887 8999999998654432 34567889999999853 4578899999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|..||...+..+....+..... +. .....
T Consensus 199 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~--------------------------------------~~~~~ 238 (308)
T cd06634 199 SLGITCIELAERKPPLFNMNAMSALYHIAQNES--PA--------------------------------------LQSGH 238 (308)
T ss_pred HHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CC--------------------------------------cCccc
Confidence 999999999999999977655444333221000 00 00112
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.+..+.+||++||+.+|++||++.++++|+|+...
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 36788999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=291.64 Aligned_cols=243 Identities=22% Similarity=0.331 Sum_probs=194.7
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.+|++.+.||+|+||.||+|... ...+|+|.+....
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~------------------------------------------- 41 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------------------------------------------- 41 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-------------------------------------------
Confidence 47999999999999999999875 3345777653211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEE-EcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY-FRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
....+.+|+.+++.+.|+ |++++++++. .....+++|||+. ++|.+++.......+++..+..++.|+
T Consensus 42 ----~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i 111 (256)
T cd05082 42 ----TAQAFLAEASVMTQLRHS------NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111 (256)
T ss_pred ----hHHHHHHHHHHHHhCCCC------CeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHH
Confidence 122456699999999877 9999998764 4567999999995 699999987655558999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHH
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 258 (429)
+.||+|||++|++|+||||+||+++.++ .++|+|||++...........++..|+|||++.+..++.++|||||||++
T Consensus 112 ~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~ 189 (256)
T cd05082 112 CEAMEYLEANNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 189 (256)
T ss_pred HHHHHHHHhCCEeccccchheEEEcCCC--cEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHH
Confidence 9999999999999999999999999888 89999999987654433344456679999999888899999999999999
Q ss_pred HHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 259 AELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 259 ~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
|+|++ |+.||...+..+....+..... .......++.+
T Consensus 190 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 228 (256)
T cd05082 190 WEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------------------------------------MDAPDGCPPVV 228 (256)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcCCC-----------------------------------------CCCCCCCCHHH
Confidence 99997 9999987665544433321000 00112347888
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+++.+||+.||++|||+.++++
T Consensus 229 ~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 229 YDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=295.75 Aligned_cols=248 Identities=17% Similarity=0.265 Sum_probs=194.3
Q ss_pred CCeEEEeEeeccccceEEEEEecCCC-----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTN-----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..|++.+.||+|+||+||+|.+..++ .+++|.+......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~------------------------------------ 48 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP------------------------------------ 48 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH------------------------------------
Confidence 46899999999999999999964333 2377765422111
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC------------
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN------------ 162 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~------------ 162 (429)
.....+.+|+++++.+.|+ ||+++++++......|++|||+. ++|.+++....
T Consensus 49 --------~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 114 (283)
T cd05090 49 --------QQWGEFQQEASLMAELHHP------NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114 (283)
T ss_pred --------HHHHHHHHHHHHHhhCCCC------CeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccc
Confidence 1123456699999999877 99999999999999999999995 69999986432
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccc
Q psy17270 163 ---YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFY 234 (429)
Q Consensus 163 ---~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y 234 (429)
...+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... .....++..|
T Consensus 115 ~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 192 (283)
T cd05090 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL--HVKISDLGLSREIYSADYYRVQPKSLLPIRW 192 (283)
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC--cEEeccccccccccCCcceecccCCCcccee
Confidence 12378899999999999999999999999999999999999887 8999999998754321 1223345679
Q ss_pred cchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccC
Q psy17270 235 RSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313 (429)
Q Consensus 235 ~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (429)
+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+....+..... +
T Consensus 193 ~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~-------------------------- 245 (283)
T cd05090 193 MPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL-L-------------------------- 245 (283)
T ss_pred cChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-C--------------------------
Confidence 99999988889999999999999999998 9999988776554443322000 0
Q ss_pred CCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......++.+.+++.+||+.||++||++.+++++
T Consensus 246 --------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 246 --------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred --------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0111236788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.45 Aligned_cols=269 Identities=17% Similarity=0.174 Sum_probs=187.1
Q ss_pred hhcccccCCeEEEeEeeccccceEEEEEecCC---Ccc-hheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKT---NTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 14 ~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~---~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
++.++..++|++.+.||+|+||+||+|.+..+ +.. |+|+..........+ ....
T Consensus 5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e-~~~~--------------------- 62 (294)
T PHA02882 5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVME-TLVY--------------------- 62 (294)
T ss_pred eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhH-HHHH---------------------
Confidence 34567889999999999999999999998877 333 555432111110000 0000
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC----eEEEEEeecCcCHHHHHHhhCCCC
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN----HLCISFELMNLNLYELIKRNNYQG 165 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~g~L~~~i~~~~~~~ 165 (429)
+.. .-..++..+..+. ...|++++++++...... ..+++++++..++.+.+.... .
T Consensus 63 ------------~~~---~~~~~~~~~~~~~---~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 122 (294)
T PHA02882 63 ------------NNI---YDIDKIALWKNIH---NIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK--C 122 (294)
T ss_pred ------------Hhh---hhHHHHHHHHHhc---cCCCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc--c
Confidence 000 0011222222222 235669999998765543 457888988778888776643 2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC----------cceeeecCcccc
Q psy17270 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----------RVYTYIQSRFYR 235 (429)
Q Consensus 166 ~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~----------~~~~~~~t~~y~ 235 (429)
.++..+..++.|++.||+|||+++++||||||+|||++.++ .++|+|||+++.... ......||+.|+
T Consensus 123 ~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ 200 (294)
T PHA02882 123 KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYA 200 (294)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEEEEEcCCceeeccCCcccccccccccccCCCcccc
Confidence 68889999999999999999999999999999999999877 899999999865321 112246899999
Q ss_pred chhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCC
Q psy17270 236 SPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315 (429)
Q Consensus 236 aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (429)
|||++.+..++.++|||||||++|+|++|..||.+.+.......... .++........
T Consensus 201 ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~------~~~~~~~~~~~---------------- 258 (294)
T PHA02882 201 GLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK------CDFIKRLHEGK---------------- 258 (294)
T ss_pred CHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH------HHHHHHhhhhh----------------
Confidence 99999999999999999999999999999999988743322211111 00000000000
Q ss_pred CCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......++.+.++++.|+..+|++||+..++++
T Consensus 259 ------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 259 ------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 001122678899999999999999999999875
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=285.65 Aligned_cols=249 Identities=31% Similarity=0.504 Sum_probs=203.8
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|++.+.||.|++|.||+|.+..++.. ++|++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------------------------------------------ 38 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK------------------------------------------ 38 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch------------------------------------------
Confidence 389999999999999999999877764 8888744322
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.....+.+|+++++.+.|+ +++++++.+......++++||++ ++|.+++.... ..+++..+..++.|++
T Consensus 39 ---~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~ 108 (253)
T cd05122 39 ---EKKEKIINEIQILKKCKHP------NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELL 108 (253)
T ss_pred ---hHHHHHHHHHHHHHhCCCC------CEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHH
Confidence 1123556699999998876 99999999999999999999997 69999988763 3599999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc--eeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV--YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
.||.+||++|++|+||+|+||+++.++ .++|+|||.+....... ....++..|+|||.+.+..++.++|+||||++
T Consensus 109 ~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~i 186 (253)
T cd05122 109 KGLEYLHSNGIIHRDIKAANILLTSDG--EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGIT 186 (253)
T ss_pred HHHHHhhcCCEecCCCCHHHEEEccCC--eEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHH
Confidence 999999999999999999999999887 89999999987655432 45678889999999998888999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|..||...+.......+.. ...+.. + .....+..+
T Consensus 187 l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~-----------------~--------------------~~~~~~~~~ 227 (253)
T cd05122 187 AIELAEGKPPYSELPPMKALFKIAT--NGPPGL-----------------R--------------------NPEKWSDEF 227 (253)
T ss_pred HHHHHhCCCCCCCCchHHHHHHHHh--cCCCCc-----------------C--------------------cccccCHHH
Confidence 9999999999988765444333221 000000 0 000025788
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCC
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALRHEW 363 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~h~~ 363 (429)
.++|.+||+.||++|||+.|+++|||
T Consensus 228 ~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 228 KDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHccCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.23 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=197.0
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecC-----CC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHK-----TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
+...++|.+.+.||.|+||.||+|.+.. ++ .+|+|.+......
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------------- 79 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS------------------------------- 79 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh-------------------------------
Confidence 4556789999999999999999998632 22 2477765432211
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCH
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSL 168 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~ 168 (429)
.....+.+|+++++++ .|+ ||+++++++.....++++|||+. ++|.+++.......+++
T Consensus 80 -------------~~~~~~~~E~~~l~~l~~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~ 140 (302)
T cd05055 80 -------------SEREALMSELKIMSHLGNHE------NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140 (302)
T ss_pred -------------HHHHHHHHHHHHHHhccCCC------CcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCH
Confidence 1123456699999999 566 99999999999999999999995 79999998655444899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-----eeecCccccchhhhhCC
Q psy17270 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-----TYIQSRFYRSPEVILGL 243 (429)
Q Consensus 169 ~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-----~~~~t~~y~aPE~~~~~ 243 (429)
.++..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........ ...++..|+|||.+.+.
T Consensus 141 ~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 218 (302)
T cd05055 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218 (302)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC
Confidence 99999999999999999999999999999999999877 899999999875432211 12346779999999988
Q ss_pred CCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
.++.++||||+||++|+|++ |..||.+....+.+........ .+
T Consensus 219 ~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~---------------------------------- 263 (302)
T cd05055 219 VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY-RM---------------------------------- 263 (302)
T ss_pred CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC-cC----------------------------------
Confidence 89999999999999999998 9999987665444333221000 00
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......++.+.+|+.+||..||++|||+.|+++
T Consensus 264 -----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 -----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 001123678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=298.07 Aligned_cols=255 Identities=20% Similarity=0.287 Sum_probs=195.0
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCc---------------chheeccccchhhHHHHHHHHHHHHHhcccccccccc
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNT---------------HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGE 84 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~---------------~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~ 84 (429)
.+||++.+.||+|+||.||+|++..++. +|+|.+......
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------- 58 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK------------------------- 58 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH-------------------------
Confidence 4689999999999999999999865432 355555322111
Q ss_pred cccccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC
Q psy17270 85 ESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY 163 (429)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~ 163 (429)
.....+.+|+++++.++|+ |++++++++......++||||+. ++|.+++.....
T Consensus 59 -------------------~~~~~~~~ei~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 113 (295)
T cd05097 59 -------------------TARNDFLKEIKIMSRLKNP------NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREI 113 (295)
T ss_pred -------------------HHHHHHHHHHHHHHhCCCC------CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccc
Confidence 1223566799999999887 99999999999999999999995 699999865421
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eee
Q psy17270 164 ----------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTY 228 (429)
Q Consensus 164 ----------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~ 228 (429)
..++...+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... ...
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~ 191 (295)
T cd05097 114 ESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY--TIKIADFGMSRNLYSGDYYRIQGRA 191 (295)
T ss_pred cccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCC--cEEecccccccccccCcceeccCcC
Confidence 1267889999999999999999999999999999999999877 89999999986533211 112
Q ss_pred ecCccccchhhhhCCCCCCCccccchhhHHHHHhh--CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 229 IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT--GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
.++..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+.+..+...........
T Consensus 192 ~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------- 256 (295)
T cd05097 192 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQI--------------- 256 (295)
T ss_pred cCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccc---------------
Confidence 34567999999998889999999999999999988 6788888776655544332111000000
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
........++.+.+|+.+||+.||++|||+.++++
T Consensus 257 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 257 -------------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred -------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00001123678999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=293.95 Aligned_cols=247 Identities=30% Similarity=0.432 Sum_probs=199.8
Q ss_pred eeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhh
Q psy17270 29 IGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHH 107 (429)
Q Consensus 29 lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (429)
||.|+||.||+|++..++.. ++|++....... .....
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~------------------------------------------~~~~~ 38 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR------------------------------------------KNQVD 38 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh------------------------------------------hhHHH
Confidence 68999999999999987765 888874432211 12234
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
.+.+|+++++.++|+ ||+++++.+......|++|||+. ++|.+++.... .+++..+..++.||+.||+|||
T Consensus 39 ~~~~e~~~l~~~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH 110 (265)
T cd05579 39 QVLTERDILSQAQSP------YVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLH 110 (265)
T ss_pred HHHHHHHHHHhCCCc------chhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 566699999999877 99999999999999999999995 59999998755 4999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----------ceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----------VYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 187 ~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
+.|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.+..++.++|+||||
T Consensus 111 ~~~i~H~di~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG 188 (265)
T cd05579 111 SNGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLG 188 (265)
T ss_pred HcCeecCCCCHHHeEEcCCC--CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHH
Confidence 99999999999999999988 8999999998643221 1234577889999999888889999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
+++|+|++|..||...+..+....+.......+.. ...+.
T Consensus 189 ~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~ 228 (265)
T cd05579 189 CILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED----------------------------------------VEVSD 228 (265)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc----------------------------------------ccCCH
Confidence 99999999999998877665554433200000000 00267
Q ss_pred HHHHHHHHhcccCCCCCCCH---HHHhcCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTP---DEALRHEWLKSS 367 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta---~ell~h~~~~~~ 367 (429)
.+.+|+.+||+.||++|||+ .++|+||||+..
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 88999999999999999999 999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=339.15 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=210.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.-|++-..+||.|.||.||-|.+..+|+. |+|.+......
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-------------------------------------- 1274 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-------------------------------------- 1274 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--------------------------------------
Confidence 455788889999999999999999999987 88877544332
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
........+|+.++..++|+ |++++|++-.+.+.++|.|||| +|+|.+++..... .++...+.+..
T Consensus 1275 -----~k~~~~i~eEm~vlE~lnHp------NlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri--~dE~vt~vyt~ 1341 (1509)
T KOG4645|consen 1275 -----HKTFKLIAEEMKVLEGLNHP------NLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRI--EDEMVTRVYTK 1341 (1509)
T ss_pred -----cccCcchHHHHHHHHhccCc------cccccCceeecHHHHHHHHHHhccCcHHHHHHhcch--hhhhHHHHHHH
Confidence 11122344599999999998 9999999999999999999999 5799999887654 88899999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-------eeeecCccccchhhhhCCC---CC
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-------YTYIQSRFYRSPEVILGLP---YG 246 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~---~~ 246 (429)
|++.|++|||++|||||||||.||+++.+| .+|++|||.|..+.... ....||+.|||||++.+.. -.
T Consensus 1342 qll~gla~LH~~gIVHRDIK~aNI~Ld~~g--~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~ 1419 (1509)
T KOG4645|consen 1342 QLLEGLAYLHEHGIVHRDIKPANILLDFNG--LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHG 1419 (1509)
T ss_pred HHHHHHHHHHhcCceecCCCccceeeecCC--cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCC
Confidence 999999999999999999999999999999 99999999997655432 3467999999999998753 45
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
-++|||||||++.||+||+-||...+..=++..-+.. | ..
T Consensus 1420 ~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-g---------------------------------------h~ 1459 (1509)
T KOG4645|consen 1420 GAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-G---------------------------------------HK 1459 (1509)
T ss_pred cchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-c---------------------------------------CC
Confidence 6999999999999999999999887655443332221 1 11
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
++.+...+++..|||.+||..||+.|.++.|+|+|.|=+...
T Consensus 1460 Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1460 PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 122222478889999999999999999999999999987643
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=294.21 Aligned_cols=258 Identities=29% Similarity=0.471 Sum_probs=210.0
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+...+.|++...||.|++|.||+|.+..++. +++|++.....
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------------------------------------- 57 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------------------------------------- 57 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------------------------------------
Confidence 3478889999999999999999999986665 48888743321
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
....+.+|+++++.+.|+ |++++++.+......++++||++ ++|.+++.... ..++...+..+
T Consensus 58 ---------~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i 121 (286)
T cd06614 58 ---------NKELIINEILIMKDCKHP------NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYV 121 (286)
T ss_pred ---------hHHHHHHHHHHHHHCCCC------CeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHH
Confidence 123455699999999877 99999999999999999999997 69999998875 35999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
+.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||++.+..++.++|+
T Consensus 122 ~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv 199 (286)
T cd06614 122 CREVLQGLEYLHSQNVIHRDIKSDNILLSKDG--SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDI 199 (286)
T ss_pred HHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC--CEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCcccc
Confidence 99999999999999999999999999999888 8999999987643321 223457788999999988889999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|..||...+.......+... +.+. .....
T Consensus 200 ~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~--------------------------------------~~~~~ 240 (286)
T cd06614 200 WSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--------------------------------------LKNPE 240 (286)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC--------------------------------------Ccchh
Confidence 99999999999999999887665444333210 0000 00001
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
..+..+.+||.+||+.||.+|||+.++++|+||+...
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 1367889999999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=298.68 Aligned_cols=253 Identities=24% Similarity=0.425 Sum_probs=202.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
..|+-..+||.|+||.||+|.+..++.. |+|++.....
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----------------------------------------- 58 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ----------------------------------------- 58 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-----------------------------------------
Confidence 3445557899999999999999888764 8887632110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+|+.+++.++|+ ||+++++.+....+.+++|||+. ++|.+++... .+++..+..++.|+
T Consensus 59 ----~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql 125 (292)
T cd06657 59 ----QRRELLFNEVVIMRDYQHE------NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAV 125 (292)
T ss_pred ----hHHHHHHHHHHHHHhcCCc------chhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHH
Confidence 1123466699999998877 99999999999999999999995 5888876543 38999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
+.||+|||++|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+..++.++|+||+|
T Consensus 126 ~~~l~~lH~~givH~dl~p~Nilv~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG 203 (292)
T cd06657 126 LKALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203 (292)
T ss_pred HHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHH
Confidence 9999999999999999999999999887 8999999987644321 2234678899999999888889999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
+++|+|++|..||.+.+.......+......... .....++
T Consensus 204 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~ 244 (292)
T cd06657 204 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLK---------------------------------------NLHKVSP 244 (292)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccC---------------------------------------CcccCCH
Confidence 9999999999999887665554433321110000 0012367
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.+.+++.+||..||.+||++.++++|+||....
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 888999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=298.09 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=195.5
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCC--------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTN--------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~--------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
+.-.+||.+.+.||.|+||.||+|.+.... .+|+|.+.......
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~---------------------------- 59 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK---------------------------- 59 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChH----------------------------
Confidence 344679999999999999999999874321 24777664322111
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC----
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN---- 162 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~---- 162 (429)
....+.+|+++++.+. |+ ||+++++++.....++++|||+. |+|.+++....
T Consensus 60 ----------------~~~~~~~E~~~l~~l~~h~------~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~ 117 (314)
T cd05099 60 ----------------DLADLISEMELMKLIGKHK------NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGP 117 (314)
T ss_pred ----------------HHHHHHHHHHHHHhccCCC------CeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcc
Confidence 1123556889998884 55 99999999998899999999995 69999997642
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----ee
Q psy17270 163 ----------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YT 227 (429)
Q Consensus 163 ----------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~ 227 (429)
...++..++..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||.++...... ..
T Consensus 118 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~ 195 (314)
T cd05099 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN--VMKIADFGLARGVHDIDYYKKTSN 195 (314)
T ss_pred cccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC--cEEEcccccccccccccccccccc
Confidence 13488899999999999999999999999999999999999887 89999999997543221 11
Q ss_pred eecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
..++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 196 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------------- 254 (314)
T cd05099 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--------------------- 254 (314)
T ss_pred CCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence 123457999999998889999999999999999999 8999988776655544332000
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...+...+.++.+++.+||..||++|||+.|+++
T Consensus 255 --------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 255 --------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0001223678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=286.60 Aligned_cols=249 Identities=27% Similarity=0.487 Sum_probs=203.8
Q ss_pred CeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|++.+.||.|++|.||+|.+..++. +++|.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------------------------------------- 39 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK----------------------------------------- 39 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-----------------------------------------
Confidence 69999999999999999999987775 488887543211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+++++++.|+ |++++++++......+++||+++ ++|.+++.... .+++..+..++.|++
T Consensus 40 --~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~ 109 (254)
T cd06627 40 --EEALKSIMQEIDLLKNLKHP------NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVL 109 (254)
T ss_pred --HHHHHHHHHHHHHHHhCCCC------CccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHH
Confidence 11223566799999999877 99999999999999999999996 59999988763 499999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc---eeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---YTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
.||.|||+.|++|+||+|+||+++.++ .++|+|||.+....... ....++..|+|||.+.+..++.++|+||+|+
T Consensus 110 ~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~ 187 (254)
T cd06627 110 QGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGC 187 (254)
T ss_pred HHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHH
Confidence 999999999999999999999999877 89999999987654332 2356788899999998878889999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|..||...+.......+.. .. ........++.
T Consensus 188 ~l~~l~~g~~p~~~~~~~~~~~~~~~--~~---------------------------------------~~~~~~~~~~~ 226 (254)
T cd06627 188 TVIELLTGNPPYYDLNPMAALFRIVQ--DD---------------------------------------HPPLPEGISPE 226 (254)
T ss_pred HHHHHHhCCCCCCCccHHHHHHHHhc--cC---------------------------------------CCCCCCCCCHH
Confidence 99999999999987665433322211 00 00011223678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.+++.+||..||++|||+.+++.|+||
T Consensus 227 ~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 227 LKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 8999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=291.30 Aligned_cols=247 Identities=21% Similarity=0.263 Sum_probs=196.6
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
.++|++.+.||.|+||.||+|.+..++. +|+|.+.......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~----------------------------------- 47 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK----------------------------------- 47 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH-----------------------------------
Confidence 4689999999999999999999875543 4777764332211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
....+.+|+.+++.++|+ ||+++++++.....+++||||+. ++|.+++.... ..++..++..+
T Consensus 48 ---------~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i 111 (267)
T cd05066 48 ---------QRRDFLSEASIMGQFDHP------NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGM 111 (267)
T ss_pred ---------HHHHHHHHHHHHHhCCCC------CcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHH
Confidence 123456699999998877 99999999999999999999995 69999987654 35899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce---e---eecCccccchhhhhCCCCCCC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY---T---YIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~---~---~~~t~~y~aPE~~~~~~~~~~ 248 (429)
+.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+........ . ..++..|+|||.+.+..++.+
T Consensus 112 ~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~ 189 (267)
T cd05066 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 189 (267)
T ss_pred HHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCch
Confidence 99999999999999999999999999999887 899999999875433211 1 122457999999998889999
Q ss_pred ccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|+|||||++|++++ |..||...+..+....+......+
T Consensus 190 ~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------------------- 229 (267)
T cd05066 190 SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP---------------------------------------- 229 (267)
T ss_pred hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC----------------------------------------
Confidence 999999999999886 999998876655544443211000
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.....++.+.+++.+||+.+|.+||++.++++
T Consensus 230 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 -APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 01123678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.92 Aligned_cols=147 Identities=26% Similarity=0.389 Sum_probs=126.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|+++++||.|+||+||+|.+..++.. |+|++......
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~---------------------------------------- 43 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI---------------------------------------- 43 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc----------------------------------------
Confidence 6899999999999999999999987764 88887432111
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+..|+.++..++|+ ||+++++++....++|+||||+ +++|.+++.... .+++..++.++.||
T Consensus 44 --~~~~~~~~~~E~~~l~~l~hp------~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qi 113 (669)
T cd05610 44 --NKNMVHQVQAERDALALSKSP------FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEV 113 (669)
T ss_pred --CHHHHHHHHHHHHHHHhcCCC------CcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHH
Confidence 112234566799999988877 9999999999999999999999 569999997654 48999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
+.||.|||.+||+||||||+|||++.++ .++|+|||+++
T Consensus 114 l~aL~yLH~~gIiHrDLKP~NILl~~~g--~vkL~DFGls~ 152 (669)
T cd05610 114 ALALDYLHRHGIIHRDLKPDNMLISNEG--HIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHhCCEEeCCccHHHEEEcCCC--CEEEEeCCCCc
Confidence 9999999999999999999999999888 89999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=288.42 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=199.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
..|++.+.||.|+||.||+|.+..++.. |+|.+........
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-------------------------------------- 43 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE-------------------------------------- 43 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccch--------------------------------------
Confidence 5799999999999999999999888765 8887632211100
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.......+.+|+++++.++|+ ||+++++.+... ..+++++||+. ++|.+++.... .+++..+..++.
T Consensus 44 --~~~~~~~~~~ei~~l~~l~h~------~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~ 113 (264)
T cd06653 44 --TSKEVNALECEIQLLKNLRHD------RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTR 113 (264)
T ss_pred --hhHHHHHHHHHHHHHHHcCCC------CcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHH
Confidence 011223566799999999887 999999998764 46899999995 58999987654 389999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC------cceeeecCccccchhhhhCCCCCCCcc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ------RVYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
|++.||.|||++|++|+||+|+||+++.++ .++|+|||++..... ......++..|+|||++.+..++.++|
T Consensus 114 ~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 191 (264)
T cd06653 114 QILQGVSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKAD 191 (264)
T ss_pred HHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCcccc
Confidence 999999999999999999999999999887 899999999865322 112345788899999999888899999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
+|||||++|+|++|+.||...........+. ..+.. ...+
T Consensus 192 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~-------------------------------------~~~p 231 (264)
T cd06653 192 VWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTK-------------------------------------PMLP 231 (264)
T ss_pred HHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCC-------------------------------------CCCC
Confidence 9999999999999999998765544433322 11110 0112
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
...++.+.++|++||. +|..||++.+++.|||.
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 2346789999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=290.78 Aligned_cols=248 Identities=21% Similarity=0.245 Sum_probs=196.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
-..+|+..+.||+|+||.||+|.+..++. +|+|.+.......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~---------------------------------- 48 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK---------------------------------- 48 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH----------------------------------
Confidence 45689999999999999999999976653 4777764332111
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
....+.+|+++++.++|+ ||+++.+++......++||||++ ++|.+++.... ..+++..+..
T Consensus 49 ----------~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~ 111 (268)
T cd05063 49 ----------QRQDFLSEASIMGQFSHH------NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVG 111 (268)
T ss_pred ----------HHHHHHHHHHHHhcCCCC------CeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHH
Confidence 123455699999988876 99999999999999999999995 58999887643 4589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee------eecCccccchhhhhCCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT------YIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~------~~~t~~y~aPE~~~~~~~~~ 247 (429)
++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++......... ...+..|+|||++.+..++.
T Consensus 112 ~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 189 (268)
T cd05063 112 MLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189 (268)
T ss_pred HHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcCh
Confidence 999999999999999999999999999999877 8999999998654322111 11234699999999888999
Q ss_pred CccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 248 PIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 248 ~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
++|+|||||++|+|++ |..||...+..+....+......+.
T Consensus 190 ~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------------------------------- 231 (268)
T cd05063 190 ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-------------------------------------- 231 (268)
T ss_pred HhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC--------------------------------------
Confidence 9999999999999997 9999988776665554432111000
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
....+..+.+++.+||+.||++||++.++++
T Consensus 232 ---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 ---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0122678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=289.11 Aligned_cols=242 Identities=22% Similarity=0.340 Sum_probs=196.5
Q ss_pred eEeeccccceEEEEEecCC---C-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 27 EVIGKGSFGQVIRALDHKT---N-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~---~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
+.||.|+||.||+|.+... + .+++|.+.......
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~------------------------------------------ 38 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE------------------------------------------ 38 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh------------------------------------------
Confidence 4799999999999999864 3 45888775443221
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhC-------CCCCCHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNN-------YQGFSLGLIRRF 174 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~-------~~~~~~~~~~~i 174 (429)
....+.+|+++++.++|+ ||+++++++.....++++|||+ +++|.+++.... ...+++..+..+
T Consensus 39 --~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 110 (262)
T cd00192 39 --ERKDFLKEARVMKKLGHP------NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110 (262)
T ss_pred --HHHHHHHHHHHHhhcCCC------ChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHH
Confidence 123456699999999876 9999999999999999999999 679999998752 245999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCCc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
+.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+..++.++
T Consensus 111 ~~~l~~al~~lH~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 188 (262)
T cd00192 111 AIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS 188 (262)
T ss_pred HHHHHHHHHHHHcCCcccCccCcceEEECCCC--cEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhh
Confidence 99999999999999999999999999999988 8999999999765432 2234567889999999988899999
Q ss_pred cccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 250 DMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 250 DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
|||||||++|+|++ |..||...+..+....+..... ..
T Consensus 189 Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~ 227 (262)
T cd00192 189 DVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR-----------------------------------------LP 227 (262)
T ss_pred ccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------------------------------CC
Confidence 99999999999999 6999998876655544432000 00
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.....++++.+++.+||..||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 011236889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=293.63 Aligned_cols=244 Identities=28% Similarity=0.396 Sum_probs=190.3
Q ss_pred EEEeEeeccccceEEEEEecC--C--C-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 24 EILEVIGKGSFGQVIRALDHK--T--N-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 24 ~i~~~lG~G~~g~Vy~a~~~~--~--~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.+.+.||.|+||.||+|.... . + .+++|.+.......
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~-------------------------------------- 43 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE-------------------------------------- 43 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH--------------------------------------
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccc--------------------------------------
Confidence 578999999999999999982 1 1 24777774322211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
....+.+|++.++.++|+ ||+++++++.....+++|+|||. |+|.+++.......+++..+..|+.|
T Consensus 44 ------~~~~~~~e~~~l~~l~h~------ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~ 111 (259)
T PF07714_consen 44 ------EEEEFLNEIQILRKLRHP------NIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQ 111 (259)
T ss_dssp ------HHHHHHHHHHHHHTHSBT------TBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHH
T ss_pred ------cceeeeeccccccccccc------cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 134566699999999887 99999999998888999999995 79999999884456999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCccccchhhhhCCCCCCCcccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
++.||+|||+++++|++|+++||+++.++ .+||+|||++....... ........|+|||.+.+..++.++|||
T Consensus 112 i~~~l~~Lh~~~iiH~~l~~~nill~~~~--~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVy 189 (259)
T PF07714_consen 112 IAEALSYLHSNNIIHGNLSPSNILLDSNG--QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVY 189 (259)
T ss_dssp HHHHHHHHHHTTEEEST-SGGGEEEETTT--EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHH
T ss_pred ccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999988 99999999987652211 113456679999999988899999999
Q ss_pred chhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 253 SLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 253 SlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||+++|||++ |+.||...+..+....+......+ ...
T Consensus 190 sfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~ 228 (259)
T PF07714_consen 190 SFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP-----------------------------------------IPD 228 (259)
T ss_dssp HHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT-----------------------------------------SBT
T ss_pred ccccccccccccccccccccccccccccccccccce-----------------------------------------ecc
Confidence 99999999999 789999887776665553211100 011
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+..+.++|.+||..||++|||+.++++
T Consensus 229 ~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 229 NCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp TSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred chhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 23678899999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=285.69 Aligned_cols=251 Identities=30% Similarity=0.457 Sum_probs=203.3
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|.+.+.||+|++|.||+|.+..++.. ++|++......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------------------------------------- 39 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS----------------------------------------- 39 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-----------------------------------------
Confidence 589999999999999999999977754 88877543321
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
......+.+|+.+++++.|+ ||+++++.+... ..+++++|++ +++|.+++.... .+++..+..++.|
T Consensus 40 --~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~ 109 (260)
T cd06606 40 --EEELEALEREIRILSSLQHP------NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQ 109 (260)
T ss_pred --hHHHHHHHHHHHHHHHcCCC------CEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHH
Confidence 11123556699999999877 999999999988 8999999999 579999988765 5999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+..++.++|+|
T Consensus 110 l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~ 187 (260)
T cd06606 110 ILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIW 187 (260)
T ss_pred HHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHH
Confidence 99999999999999999999999999987 8999999998765433 2345678889999999888889999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||+++++|++|..||...+.. ...+..... .......+..
T Consensus 188 slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-------------------------------------~~~~~~~~~~ 228 (260)
T cd06606 188 SLGCTVIEMATGKPPWSELGNP--MAALYKIGS-------------------------------------SGEPPEIPEH 228 (260)
T ss_pred HHHHHHHHHHhCCCCCCCCCch--HHHHHhccc-------------------------------------cCCCcCCCcc
Confidence 9999999999999999876621 111111000 0000111122
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.+..+.+|+.+||..||++||++.+++.||||
T Consensus 229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 229 LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred cCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 36889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=287.14 Aligned_cols=251 Identities=28% Similarity=0.391 Sum_probs=202.7
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|++.++||.|+||.||+|.+..++.. |+|.+........
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------------------------------------- 41 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK--------------------------------------- 41 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH---------------------------------------
Confidence 699999999999999999999888754 8888754322110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC--CCCCCHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN--YQGFSLGLIRRFAFS 177 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~--~~~~~~~~~~~i~~q 177 (429)
-...+.+|+++++.+.|+ ||+++++++......++||||+. ++|.+++.... ...+++..+..++.|
T Consensus 42 ----~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (256)
T cd08530 42 ----EREDAVNEIRILASVNHP------NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111 (256)
T ss_pred ----HHHHHHHHHHHHHhCCCC------CchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHH
Confidence 112445589999998876 99999999999999999999995 58999887632 234899999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-ceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
++.||+|||+.|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.+..++.++|+||||+
T Consensus 112 l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~ 189 (256)
T cd08530 112 LLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGC 189 (256)
T ss_pred HHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHH
Confidence 99999999999999999999999999877 8999999998754432 22345788899999999888999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|+.||...+.......+... ..+ ......+.+
T Consensus 190 ~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---------------------------------------~~~~~~~~~ 228 (256)
T cd08530 190 LLYEMATFAPPFEARSMQDLRYKVQRG--KYP---------------------------------------PIPPIYSQD 228 (256)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHhcC--CCC---------------------------------------CCchhhCHH
Confidence 999999999999887765443332210 000 001123678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.+++.+||..+|++|||+.++++||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=287.82 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=199.5
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
.+.|++.+.||.|+||.||+|.+. ...+|+|.+.....
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----------------------------------------- 42 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----------------------------------------- 42 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-----------------------------------------
Confidence 467999999999999999999986 34568888743321
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
....+.+|+.+++.+.|+ ||+++++++......++|||++. ++|.+++.......+++..+..++.|+
T Consensus 43 -----~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi 111 (256)
T cd05039 43 -----AAQAFLAEASVMTTLRHP------NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111 (256)
T ss_pred -----HHHHHHHHHHHHHhcCCc------ceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHH
Confidence 123456699999999887 99999999998899999999996 699999987764569999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHH
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 258 (429)
+.||.|||++|++|+||||+||+++.++ .++|+|||.+............+..|+|||.+.+..++.++|+||||+++
T Consensus 112 ~~~l~~lh~~~i~H~di~p~Nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il 189 (256)
T cd05039 112 CEGMEYLEEKNFVHRDLAARNVLVSEDL--VAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILL 189 (256)
T ss_pred HHHHHHHHhCCccchhcccceEEEeCCC--CEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHH
Confidence 9999999999999999999999999888 89999999997664433333445679999999888889999999999999
Q ss_pred HHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 259 AELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 259 ~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
|+|++ |..||...+..+....+..... .......++.+
T Consensus 190 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 228 (256)
T cd05039 190 WEIYSFGRVPYPRIPLKDVVPHVEKGYR-----------------------------------------MEAPEGCPPEV 228 (256)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHhcCCC-----------------------------------------CCCccCCCHHH
Confidence 99997 9999987765544333221000 00011236788
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.++|++||..+|++|||+.|++.
T Consensus 229 ~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 229 YKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=293.93 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=194.7
Q ss_pred cCCeEEEeEeeccccceEEEEEecCC-----Cc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKT-----NT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~-----~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.++|.+.+.||.|+||.||+|.+... +. +++|.+.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~----------------------------------- 48 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL----------------------------------- 48 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-----------------------------------
Confidence 45799999999999999999986432 22 36665532211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCC---------
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNY--------- 163 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~--------- 163 (429)
.....+.+|+++++.+.|+ ||+++++++......++||||+ +++|.+++.....
T Consensus 49 ----------~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 112 (291)
T cd05094 49 ----------AARKDFQREAELLTNLQHE------HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112 (291)
T ss_pred ----------HHHHHHHHHHHHHhcCCCC------CcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccc
Confidence 1123456699999998877 9999999999999999999999 5799999976431
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCcc
Q psy17270 164 -----QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRF 233 (429)
Q Consensus 164 -----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~ 233 (429)
..+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++....... ....++..
T Consensus 113 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~ 190 (291)
T cd05094 113 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL--LVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190 (291)
T ss_pred cccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cEEECCCCcccccCCCceeecCCCCCccee
Confidence 2388999999999999999999999999999999999999887 89999999986543221 12345678
Q ss_pred ccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 234 YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 234 y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
|+|||++.+..++.++|||||||++|+|+| |..||...+..+.+..+... ..+
T Consensus 191 y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~~------------------------ 244 (291)
T cd05094 191 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG--RVL------------------------ 244 (291)
T ss_pred ecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC--CCC------------------------
Confidence 999999998889999999999999999999 99999887765544332210 000
Q ss_pred CCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......+..+.+++.+||+.||++|||+.++++
T Consensus 245 ---------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 245 ---------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred ---------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 001123678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=295.94 Aligned_cols=248 Identities=17% Similarity=0.225 Sum_probs=195.7
Q ss_pred CCeEEEeEeeccccceEEEEEecCC------CcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKT------NTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.+|++.+.||.|+||.||+|.+..+ ..+|+|++......
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------------------------- 49 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG----------------------------------- 49 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-----------------------------------
Confidence 4588999999999999999998654 23488876432211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC-----------
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN----------- 162 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~----------- 162 (429)
.....+.+|+.++..+.|+ ||+++++++......++++||+. ++|.+++....
T Consensus 50 ---------~~~~~~~~e~~~~~~l~h~------~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~ 114 (283)
T cd05091 50 ---------PLREEFKHEAMMRSRLQHP------NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114 (283)
T ss_pred ---------HHHHHHHHHHHHHhcCCCC------CcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccc
Confidence 1223456688999988877 99999999999999999999995 68998885321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCccc
Q psy17270 163 ---YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRFY 234 (429)
Q Consensus 163 ---~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~y 234 (429)
...+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++...... ....+++.|
T Consensus 115 ~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y 192 (283)
T cd05091 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL--NVKISDLGLFREVYAADYYKLMGNSLLPIRW 192 (283)
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC--ceEecccccccccccchheeeccCccCCccc
Confidence 13478889999999999999999999999999999999999887 89999999986543221 123346789
Q ss_pred cchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccC
Q psy17270 235 RSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313 (429)
Q Consensus 235 ~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (429)
+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 193 ~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--------------------------- 245 (283)
T cd05091 193 MSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL--------------------------- 245 (283)
T ss_pred cCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC---------------------------
Confidence 99999988889999999999999999998 88999887776655544421100
Q ss_pred CCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......+..+.+|+.+||+.||++||++.+++..
T Consensus 246 --------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 246 --------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred --------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 0112346788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=287.14 Aligned_cols=250 Identities=28% Similarity=0.385 Sum_probs=197.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|+||.||+|.+..++.. |+|.+.......
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------------------------------------- 42 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--------------------------------------- 42 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc---------------------------------------
Confidence 6899999999999999999999977765 888764321110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC--CCCCCHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN--YQGFSLGLIRRFAF 176 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~--~~~~~~~~~~~i~~ 176 (429)
......+.+|+++++.+.|+ +++++++.+......++||||+. ++|.+++.... ...+++..+..++.
T Consensus 43 ---~~~~~~~~~ei~~l~~~~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 113 (267)
T cd08224 43 ---AKARQDCLKEIDLLKQLDHP------NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV 113 (267)
T ss_pred ---hhhHHHHHHHHHHHHhCCCC------CeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHH
Confidence 11123566799999999887 99999999999999999999995 69999987532 23489999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+..++.++|+||
T Consensus 114 ~l~~~l~~lh~~~i~h~dl~p~nil~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s 191 (267)
T cd08224 114 QLCSALEHMHSKRIMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191 (267)
T ss_pred HHHHHHHHHHhCCEecCCcChhhEEECCCC--cEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHH
Confidence 999999999999999999999999999888 8999999998654322 23356888899999999888999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCH--HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 254 LGCILAELYTGCPLFPGENE--VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||++|+|++|+.||..... .+....+.. +..+ ..+ ..
T Consensus 192 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~------------------------------~~~--------~~ 231 (267)
T cd08224 192 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--CDYP------------------------------PLP--------AD 231 (267)
T ss_pred HHHHHHHHHHCCCCcccCCccHHHHHhhhhc--CCCC------------------------------CCC--------hh
Confidence 99999999999999965432 111111110 0000 000 01
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+..+.++|.+||..+|++|||+.++++
T Consensus 232 ~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 232 HYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred hcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 23678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=284.96 Aligned_cols=286 Identities=28% Similarity=0.505 Sum_probs=222.2
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
....+.-+.||.|+||.||.++|..+|.. |+|++..-..
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq---------------------------------------- 91 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ---------------------------------------- 91 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH----------------------------------------
Confidence 33456678999999999999999988865 8887732110
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELMNLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
...-.+++.+|+.+|..++|. |++..+|...-. ..+|.++|.|..+|..+|-.-. .++...++-
T Consensus 92 ---~L~s~krvFre~kmLcfFkHd------NVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSPQ--~Ls~DHvKV 160 (449)
T KOG0664|consen 92 ---NLASCKRVFREIKMLSSFRHD------NVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSPQ--ALTPDHVKV 160 (449)
T ss_pred ---HHHHHHHHHHHHHHHHhhccc------cHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccCC--CCCcchhhh
Confidence 111234567799999999998 777777765432 4688999999999999887654 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCC-CCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGL-PYGPP 248 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~ 248 (429)
+++||+.||.|||+.+|.||||||.|+|++++- .+||||||+++..... ....+.|.+|+|||++.|. .|+.+
T Consensus 161 FlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC--vLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~A 238 (449)
T KOG0664|consen 161 FVYQILRGLKYLHTANILHRDIKPGNLLVNSNC--ILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGA 238 (449)
T ss_pred hHHHHHhhhHHHhhcchhhccCCCccEEeccCc--eEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCc
Confidence 999999999999999999999999999999987 8999999999875532 2235678899999999987 48999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+||||+|||+.||+..+..|...++.++++.|.+++|.|..|-+........--..++-.+ .+...-+..
T Consensus 239 vDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k----------~Ps~~vLYt 308 (449)
T KOG0664|consen 239 VDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLR----------APDTQRLYK 308 (449)
T ss_pred cceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCC----------CCCccceee
Confidence 9999999999999999999999999999999999999999887765543322111111111 011111111
Q ss_pred hhc--cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLR--CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~--~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+-. .-..+..+++.++|.+||++|.+.++++.|+|+....
T Consensus 309 lsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 309 IASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred ecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 111 1134667999999999999999999999999997643
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=295.35 Aligned_cols=252 Identities=20% Similarity=0.288 Sum_probs=196.5
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecC----C---C-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHK----T---N-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~----~---~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
+...++|++.+.||.|+||.||+|.+.. + + .+|+|.+.......
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~---------------------------- 62 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK---------------------------- 62 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchH----------------------------
Confidence 3557789999999999999999998532 1 1 24777664321111
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC---
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY--- 163 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~--- 163 (429)
....+.+|+.+++.+ .|+ ||+++++.+.....++++|||+. ++|.+++.....
T Consensus 63 ----------------~~~~~~~E~~~l~~l~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 120 (304)
T cd05101 63 ----------------DLSDLVSEMEMMKMIGKHK------NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120 (304)
T ss_pred ----------------HHHHHHHHHHHHHhhccCC------CchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCccc
Confidence 112455699999988 565 99999999999999999999995 699999976421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----ee
Q psy17270 164 -----------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YT 227 (429)
Q Consensus 164 -----------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~ 227 (429)
..++...+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||.+....... ..
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~--~~kl~D~g~~~~~~~~~~~~~~~~ 198 (304)
T cd05101 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLARDVNNIDYYKKTTN 198 (304)
T ss_pred ccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC--cEEECCCccceecccccccccccC
Confidence 2478889999999999999999999999999999999999887 89999999987543211 11
Q ss_pred eecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
..+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..... .
T Consensus 199 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~------------------ 258 (304)
T cd05101 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--M------------------ 258 (304)
T ss_pred CCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--C------------------
Confidence 234567999999988889999999999999999998 8899988776655443321000 0
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......+..+.+|+.+||+.+|++|||+.|+++.
T Consensus 259 ---------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 259 ---------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 0011236789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=287.67 Aligned_cols=245 Identities=20% Similarity=0.337 Sum_probs=195.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.+|++.+.||.|+||.||+|.+.....+|+|.+.....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~------------------------------------------ 41 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM------------------------------------------ 41 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC------------------------------------------
Confidence 47999999999999999999987655668887642211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
....+.+|+++++.+.|+ +++++++++......+++|||+. ++|.+++.... ..+++..+..++.|++
T Consensus 42 ----~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~ 110 (256)
T cd05112 42 ----SEEDFIEEAQVMMKLSHP------KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVC 110 (256)
T ss_pred ----CHHHHHHHHHHHHhCCCC------CeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHH
Confidence 112456699999999876 99999999999999999999995 58988887543 3489999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
.||+|||+.|++|+||||+||+++.++ .++|+|||.+........ ...++..|+|||.+.+..++.++|+||||
T Consensus 111 ~~l~~lH~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG 188 (256)
T cd05112 111 EGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFG 188 (256)
T ss_pred HHHHHHHHCCccccccccceEEEcCCC--eEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHH
Confidence 999999999999999999999999877 899999999865432211 12345679999999988899999999999
Q ss_pred hHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|++|+|++ |..||...+..+.+..+....... . ....+
T Consensus 189 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------------~---------~~~~~ 227 (256)
T cd05112 189 VLMWEVFSEGKTPYENRSNSEVVETINAGFRLY--------------------------------K---------PRLAS 227 (256)
T ss_pred HHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC--------------------------------C---------CCCCC
Confidence 99999998 999998776655544432110000 0 01126
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+.+|+.+||+.||++|||+.+++++
T Consensus 228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 228 QSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=289.00 Aligned_cols=247 Identities=22% Similarity=0.312 Sum_probs=195.9
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
...|++.+.||+|+||.||+|.++.++. +|+|.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~------------------------------------ 46 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE------------------------------------ 46 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH------------------------------------
Confidence 3569999999999999999999987764 588876433211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.....+..|+.+++.+.|+ ||+++++++......++||||++ ++|.+++.... ..+++..+..+
T Consensus 47 --------~~~~~~~~e~~~l~~l~h~------ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 111 (269)
T cd05065 47 --------KQRRDFLSEASIMGQFDHP------NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGM 111 (269)
T ss_pred --------HHHHHHHHHHHHHHhCCCc------CcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHH
Confidence 1123456699999999877 99999999998899999999995 58999887654 35899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-----eee---cCccccchhhhhCCCCC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-----TYI---QSRFYRSPEVILGLPYG 246 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-----~~~---~t~~y~aPE~~~~~~~~ 246 (429)
+.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........ ... .+..|+|||.+.+..++
T Consensus 112 ~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 189 (269)
T cd05065 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT 189 (269)
T ss_pred HHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCccc
Confidence 99999999999999999999999999999877 899999999865332111 111 13469999999988899
Q ss_pred CCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 247 PPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 247 ~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
.++|||||||++|||++ |..||...+..+....+......+.
T Consensus 190 ~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------------------------------------- 232 (269)
T cd05065 190 SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP------------------------------------- 232 (269)
T ss_pred chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC-------------------------------------
Confidence 99999999999999886 9999988766555444422110000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+...+..+.+++.+||..||++||++.+++.
T Consensus 233 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 233 ----PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ----cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0123678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=292.12 Aligned_cols=246 Identities=17% Similarity=0.231 Sum_probs=188.5
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-----hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-----ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-----aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.+.|++++.||.|+||+||+|.+..++.. ++|.+....
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~------------------------------------- 48 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS------------------------------------- 48 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-------------------------------------
Confidence 35799999999999999999999877753 444432110
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.......+..|+.++..+.|+ ||+++++++. ....++++|++ .|+|.+++.... ..+++..+..
T Consensus 49 -------~~~~~~~~~~~~~~l~~l~h~------~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~ 113 (279)
T cd05111 49 -------GRQTFQEITDHMLAMGSLDHA------YIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLN 113 (279)
T ss_pred -------chHHHHHHHHHHHHHhcCCCC------CcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHH
Confidence 011223455577777777666 9999999875 45678899998 579999997654 3589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+...... .....++..|+|||.+.+..++.+
T Consensus 114 i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~ 191 (279)
T cd05111 114 WCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ 191 (279)
T ss_pred HHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCch
Confidence 999999999999999999999999999999887 8999999998754321 112345667999999998889999
Q ss_pred ccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|||||||++|+|++ |..||.+.........+.. +..+
T Consensus 192 ~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~~~--------------------------------------- 230 (279)
T cd05111 192 SDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK--GERL--------------------------------------- 230 (279)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--CCcC---------------------------------------
Confidence 999999999999998 9999988765443222211 0000
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......+.++.+++.+||..||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000112567789999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=299.49 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=196.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCC--------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTN--------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~--------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
+....||++++.||.|+||.||+|.+...+ .+|+|.+......
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------------------- 58 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD----------------------------- 58 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-----------------------------
Confidence 455678999999999999999999875322 2467765422111
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC----
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN---- 162 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~---- 162 (429)
.....+.+|+++++++ +|+ ||+++++++.....++++|||+. |+|.+++....
T Consensus 59 ---------------~~~~~~~~E~~~l~~l~~h~------~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 117 (334)
T cd05100 59 ---------------KDLSDLVSEMEMMKMIGKHK------NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117 (334)
T ss_pred ---------------HHHHHHHHHHHHHHhhcCCC------CeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCccc
Confidence 1123456699999998 566 99999999998899999999995 69999987642
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----ee
Q psy17270 163 ----------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YT 227 (429)
Q Consensus 163 ----------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~ 227 (429)
...++...+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||+++...... ..
T Consensus 118 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~ 195 (334)
T cd05100 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN--VMKIADFGLARDVHNIDYYKKTTN 195 (334)
T ss_pred ccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC--cEEECCcccceecccccccccccC
Confidence 12377888999999999999999999999999999999999887 89999999987543221 11
Q ss_pred eecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
..++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..... .
T Consensus 196 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~------------------ 255 (334)
T cd05100 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--M------------------ 255 (334)
T ss_pred CCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--C------------------
Confidence 223456999999998889999999999999999998 8999988776555443321000 0
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......+..+.+++.+||+.+|++|||+.|++++
T Consensus 256 ---------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 256 ---------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 0011236788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=292.52 Aligned_cols=272 Identities=21% Similarity=0.270 Sum_probs=194.6
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
.+||++.++||.|+||+||+|.+......+.|.+........ ....|+|+.....
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~a~K~~~~~~------------- 58 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQ------------PVLVAVKMLREDA------------- 58 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCc------------eeEEEEEeccccC-------------
Confidence 568999999999999999999876544322221110000000 0012333322110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC---------CCCCHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY---------QGFSLG 169 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~---------~~~~~~ 169 (429)
.......+.+|+.+++.++|+ ||+++++++.....++++|||+. ++|.+++..... ..+++.
T Consensus 59 --~~~~~~~~~~E~~~l~~l~~~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 130 (296)
T cd05095 59 --NKNARNDFLKEIKIMSRLKDP------NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130 (296)
T ss_pred --CHHHHHHHHHHHHHHHhCCCC------CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHH
Confidence 112234677799999999887 99999999999999999999995 699999876431 236778
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCccccchhhhhCCC
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~ 244 (429)
.+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... ....++..|+|||+..+..
T Consensus 131 ~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 208 (296)
T cd05095 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK 208 (296)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCC--CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC
Confidence 9999999999999999999999999999999999877 89999999987543221 1123356799999988888
Q ss_pred CCCCccccchhhHHHHHhh--CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 245 YGPPIDMWSLGCILAELYT--GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~llt--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
++.++|+|||||++|+|++ |..||...+..+.+........ . ..... ..
T Consensus 209 ~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~--------~----------~~~~~---------~~-- 259 (296)
T cd05095 209 FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR--------D----------QGRQV---------YL-- 259 (296)
T ss_pred ccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHh--------h----------ccccc---------cC--
Confidence 9999999999999999998 7789987666554432211000 0 00000 00
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.....+++.+.+|+.+||+.||++||++.++++
T Consensus 260 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 260 -----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 001223678899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.82 Aligned_cols=253 Identities=27% Similarity=0.406 Sum_probs=196.7
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
||.+.+.||.|+||+||+|.+..++.. ++|++........
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------- 41 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL--------------------------------------- 41 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccccc---------------------------------------
Confidence 799999999999999999999877643 5554321110000
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhh--CCCCCCHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRN--NYQGFSLGLIRRFAFS 177 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~--~~~~~~~~~~~~i~~q 177 (429)
.......+..|+.+++.++|+ ||+++++++......++||||+. ++|.+++... ....+++..+..++.|
T Consensus 42 -~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (260)
T cd08222 42 -NPNETVQANQEAQLLSKLDHP------AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114 (260)
T ss_pred -CcchHHHHHHHHHHHHhCCCC------cHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHH
Confidence 011122455688888888876 99999999998899999999995 5898888642 2245999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
++.||.|||++|++|+||+|+||+++. + .++|+|||.+...... .....++..|+|||.+.+..++.++|+||+
T Consensus 115 l~~~l~~lH~~~i~h~~l~~~nili~~-~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl 191 (260)
T cd08222 115 LLLGVHYMHQRRILHRDLKAKNIFLKN-N--LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSL 191 (260)
T ss_pred HHHHHHHHHHcCccccCCChhheEeec-C--CEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHH
Confidence 999999999999999999999999975 3 6999999988654321 223457888999999988888899999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|+++|+|++|..||...+.......+.. +..+ ......+
T Consensus 192 G~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~---------------------------------------~~~~~~~ 230 (260)
T cd08222 192 GCILYEMCCLAHAFEGQNFLSVVLRIVE--GPTP---------------------------------------SLPETYS 230 (260)
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCC---------------------------------------CCcchhc
Confidence 9999999999999987665444433321 1000 0112336
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
.++.++|.+||..||++||++.|+++||||
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 231 RQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=296.95 Aligned_cols=240 Identities=20% Similarity=0.253 Sum_probs=175.8
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
.+.+|+++++.++|+ ||+++++++......+++|||+. ++|.+++.......+++..+..++.|++.||+|||
T Consensus 45 ~~~~Ei~~l~~l~h~------~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH 118 (314)
T cd08216 45 LLQQEIITSRQLQHP------NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH 118 (314)
T ss_pred HHHHHHHHHHhcCCc------chhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 456699999999877 99999999999999999999996 68999998765556999999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCCcceEEeeecccccccC----------cceeeecCccccchhhhhCC--CCCCCccccch
Q psy17270 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----------RVYTYIQSRFYRSPEVILGL--PYGPPIDMWSL 254 (429)
Q Consensus 187 ~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~----------~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSl 254 (429)
++||+|+||||+||+++.++ .++|+|||.+..... ......++..|+|||++.+. .++.++|+||+
T Consensus 119 ~~~ivH~dlk~~Nili~~~~--~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~ 196 (314)
T cd08216 119 SKGFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196 (314)
T ss_pred HCCeecCCCCcceEEEecCC--ceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHH
Confidence 99999999999999999888 899999998754321 11223467789999999764 58889999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCC-----CCCCCCCCchhhhh
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK-----GRKRKPGSKDMASV 329 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 329 (429)
||++|+|++|..||........+... ..+..+..+ +....+....... ..............
T Consensus 197 G~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (314)
T cd08216 197 GITACELANGHVPFKDMPATQMLLEK--VRGTVPCLL-----------DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPY 263 (314)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCcccc-----------ccCchhhhcCCcCcccccccccchhhhhhcch
Confidence 99999999999999876554332211 112111100 0000000000000 00000000111111
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....+.++.+|+++||.+||++|||+.++|+||||+...
T Consensus 264 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 264 TRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 223357889999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=292.22 Aligned_cols=248 Identities=20% Similarity=0.270 Sum_probs=195.2
Q ss_pred ccCCeEEEeEeeccccceEEEEEecC-----CC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHK-----TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
...+|++.++||+|+||.||+|.... ++ .+++|.+....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----------------------------------- 47 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----------------------------------- 47 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-----------------------------------
Confidence 45789999999999999999997532 22 23666543211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC--------
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY-------- 163 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~-------- 163 (429)
......+.+|+++++.+.|+ ||+++++++......+++|||+. ++|.+++.....
T Consensus 48 ----------~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~ 111 (280)
T cd05092 48 ----------ESARQDFQREAELLTVLQHQ------HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111 (280)
T ss_pred ----------HHHHHHHHHHHHHHhcCCCC------CCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhccc
Confidence 12234566799999999877 99999999999999999999995 699999876532
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCcc
Q psy17270 164 -----QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRF 233 (429)
Q Consensus 164 -----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~ 233 (429)
..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... ....+++.
T Consensus 112 ~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~ 189 (280)
T cd05092 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL--VVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189 (280)
T ss_pred ccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--CEEECCCCceeEcCCCceeecCCCcccccc
Confidence 2488999999999999999999999999999999999999877 89999999986543221 12234577
Q ss_pred ccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 234 YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 234 y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
|+|||++.+..++.++|||||||++|+|++ |.+||......+....+..... .
T Consensus 190 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~------------------------ 243 (280)
T cd05092 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE--L------------------------ 243 (280)
T ss_pred ccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc--C------------------------
Confidence 999999998889999999999999999998 9999987766655444332100 0
Q ss_pred CCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......++.+.+|+.+||+.||++||++.|+++
T Consensus 244 ---------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 244 ---------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 001123678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=291.10 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=195.6
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++.+.||.|+||.||+|.+..++.. |+|.+.......
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~--------------------------------------- 42 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--------------------------------------- 42 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh---------------------------------------
Confidence 4799999999999999999999877754 888764321110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC--CCCCCHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN--YQGFSLGLIRRFAF 176 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~--~~~~~~~~~~~i~~ 176 (429)
......+.+|+++++.+.|+ ||+++++++...+..+++||++. ++|.+++.... ...+++..+..++.
T Consensus 43 ---~~~~~~~~~e~~~l~~~~h~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 113 (267)
T cd08229 43 ---AKARADCIKEIDLLKQLNHP------NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113 (267)
T ss_pred ---HHHHHHHHHHHHHHHHccCC------chhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHH
Confidence 11123566799999999887 99999999999999999999996 59999887432 23489999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+..++.++|+||
T Consensus 114 ~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~s 191 (267)
T cd08229 114 QLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191 (267)
T ss_pred HHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHH
Confidence 999999999999999999999999999887 8999999988654322 12346888999999998888999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHH--HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 254 LGCILAELYTGCPLFPGENEV--EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
||+++|+|++|..||.+.... .....+... ..++ . ...
T Consensus 192 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~-------------------------------~--------~~~ 231 (267)
T cd08229 192 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPP-------------------------------L--------PSD 231 (267)
T ss_pred HHHHHHHHHhCCCCcccccchHHHHhhhhhcC-CCCC-------------------------------C--------Ccc
Confidence 999999999999999764322 111111100 0000 0 001
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..++.+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 232 HYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred cccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 23678999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=294.95 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=198.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.-.+.|++.+.||.|+||.||+|.+..++.. |+|.+........
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----------------------------------- 56 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE----------------------------------- 56 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-----------------------------------
Confidence 3457799999999999999999999987754 8888754322111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
...+..|+.++.... .|+||+++++++......|++|||+++++.+++.... ..+++..+..++.
T Consensus 57 ---------~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~ 121 (296)
T cd06618 57 ---------NKRILMDLDVVLKSH-----DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQ-GPIPEDILGKMTV 121 (296)
T ss_pred ---------HHHHHHHHHHHHhcc-----CCCchHhhheeeecCCeEEEEeeccCcCHHHHHHHhc-CCCCHHHHHHHHH
Confidence 123334665554443 3459999999999999999999999988888877644 3689999999999
Q ss_pred HHHHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCC----CCCCc
Q psy17270 177 SLVQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLP----YGPPI 249 (429)
Q Consensus 177 qil~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~----~~~~~ 249 (429)
|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+.. ++.++
T Consensus 122 ~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 199 (296)
T cd06618 122 AIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRA 199 (296)
T ss_pred HHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccch
Confidence 99999999997 5999999999999999887 8999999998654321 12234677899999987653 78899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCH-HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENE-VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
|+||||+++|+|++|+.||..... .+.+..+.. ..... .+
T Consensus 200 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~----------------~~-------------------- 240 (296)
T cd06618 200 DVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEPPS----------------LP-------------------- 240 (296)
T ss_pred hHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---CCCCC----------------CC--------------------
Confidence 999999999999999999976432 222222211 00000 00
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.....+.++.+|+.+||..||++|||+.++++|+||+..
T Consensus 241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 001236788999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=293.16 Aligned_cols=246 Identities=20% Similarity=0.308 Sum_probs=191.8
Q ss_pred CeEEEeEeeccccceEEEEEecCCC------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTN------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+|++.+.||.|+||.||+|++.... .+++|.+......
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~------------------------------------ 44 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS------------------------------------ 44 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH------------------------------------
Confidence 4889999999999999999975322 2366655332211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC------------
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN------------ 162 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~------------ 162 (429)
.....+.+|+.+++.+.|+ ||+++++.+......++++||+. ++|.+++....
T Consensus 45 --------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (290)
T cd05045 45 --------SELRDLLSEFNLLKQVNHP------HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110 (290)
T ss_pred --------HHHHHHHHHHHHHhhCCCC------CEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccc
Confidence 1123466699999999876 99999999999999999999995 79999887532
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----cee
Q psy17270 163 ----------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYT 227 (429)
Q Consensus 163 ----------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~ 227 (429)
...+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...... ...
T Consensus 111 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~ 188 (290)
T cd05045 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR--KMKISDFGLSRDVYEEDSYVKRSK 188 (290)
T ss_pred cccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCC--cEEeccccccccccCccchhcccC
Confidence 12478899999999999999999999999999999999999887 8999999998653221 112
Q ss_pred eecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
..++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+......
T Consensus 189 ~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------------- 248 (290)
T cd05045 189 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM-------------------- 248 (290)
T ss_pred CCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--------------------
Confidence 234567999999988889999999999999999998 99999887655443322210000
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......+.++.+|+.+||+.||++||++.++++
T Consensus 249 ---------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 249 ---------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 001223678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=290.20 Aligned_cols=260 Identities=20% Similarity=0.234 Sum_probs=189.5
Q ss_pred ccCCe-EEEeEeeccccceEEEEEec----CCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 19 ICYRY-EILEVIGKGSFGQVIRALDH----KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 19 ~~~rY-~i~~~lG~G~~g~Vy~a~~~----~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
+.+|| ++++.||.|+||+||++... .++. +|+|.+.......
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------- 48 (283)
T cd05080 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-------------------------------- 48 (283)
T ss_pred CChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH--------------------------------
Confidence 35677 99999999999999887642 3333 4888764332111
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecC-cCHHHHHHhhCCCCCCHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMN-LNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~ 169 (429)
....+.+|+++++.+.|+ ||+++++++... ..++++|||+. ++|.+++.... +++.
T Consensus 49 ------------~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---l~~~ 107 (283)
T cd05080 49 ------------NTSGWKKEINILKTLYHE------NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLA 107 (283)
T ss_pred ------------HHHHHHHHHHHHHhCCCC------CEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcC---CCHH
Confidence 123455699999999887 999999988654 46899999995 68999987643 9999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce------eeecCccccchhhhhCC
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY------TYIQSRFYRSPEVILGL 243 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~------~~~~t~~y~aPE~~~~~ 243 (429)
.+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++........ ...++..|+|||.+.+.
T Consensus 108 ~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 185 (283)
T cd05080 108 QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC--cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhccc
Confidence 9999999999999999999999999999999999887 899999999875432211 12345669999999888
Q ss_pred CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHh-CCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEIL-GCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
.++.++|||||||++|+|+||..||...... +..+.... +......+.... ..
T Consensus 186 ~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~------------------~~------ 239 (283)
T cd05080 186 KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIELL------------------ER------ 239 (283)
T ss_pred CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhhh------------------hc------
Confidence 8999999999999999999999998664321 11111000 000000000000 00
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..........+..+.+++.+||+.||++|||+.++++
T Consensus 240 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 240 -GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000012234688999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=287.62 Aligned_cols=242 Identities=30% Similarity=0.437 Sum_probs=197.9
Q ss_pred eeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhh
Q psy17270 29 IGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHH 107 (429)
Q Consensus 29 lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (429)
||.|+||.||+|.+..+++. |+|.+........ ....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~------------------------------------------~~~~ 38 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR------------------------------------------KEVE 38 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch------------------------------------------HHHH
Confidence 69999999999999876654 8888754322111 1223
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
.+..|+++++.+.|+ ||+++++.+.....++++||++ +++|.+++.... .+++..+..++.|++.||.|||
T Consensus 39 ~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh 110 (250)
T cd05123 39 HTLTERNILSRINHP------FIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLH 110 (250)
T ss_pred HHHHHHHHHHHcCCC------cHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 456699999999877 9999999999999999999999 679999998764 3899999999999999999999
Q ss_pred HCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh
Q psy17270 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT 263 (429)
Q Consensus 187 ~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 263 (429)
+.+++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 111 ~~~~~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~ 188 (250)
T cd05123 111 SLGIIYRDLKPENILLDADG--HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT 188 (250)
T ss_pred HCCceecCCCcceEEEcCCC--cEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999988 8999999998764432 334567888999999988888899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHH
Q psy17270 264 GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQ 343 (429)
Q Consensus 264 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 343 (429)
|..||...+.......+.. +.. ......+..+.+++++
T Consensus 189 g~~p~~~~~~~~~~~~~~~--~~~----------------------------------------~~~~~~~~~l~~~i~~ 226 (250)
T cd05123 189 GKPPFYAEDRKEIYEKILK--DPL----------------------------------------RFPEFLSPEARDLISG 226 (250)
T ss_pred CCCCCCCCCHHHHHHHHhc--CCC----------------------------------------CCCCCCCHHHHHHHHH
Confidence 9999988766444333322 000 0111126788999999
Q ss_pred hcccCCCCCCCH---HHHhcCCCC
Q psy17270 344 CFNWDSKKRLTP---DEALRHEWL 364 (429)
Q Consensus 344 ~L~~dP~~Rpta---~ell~h~~~ 364 (429)
||..||++|||+ .++++||||
T Consensus 227 ~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 227 LLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhcCCHhhCCCcccHHHHHhCCCC
Confidence 999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=285.70 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=196.7
Q ss_pred eEEEeEeeccccceEEEEEecCCC----c-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTN----T-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~----~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+++.+.||.|+||.||+|.+..++ . +|+|++.......
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------- 43 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ------------------------------------- 43 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-------------------------------------
Confidence 467899999999999999998755 3 3888764332211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
....+..|+++++.+.|+ ||+++++++.+.+..+++||++. ++|.+++.......+++..+..++.
T Consensus 44 -------~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 110 (258)
T smart00219 44 -------QIEEFLREARIMRKLDHP------NIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFAL 110 (258)
T ss_pred -------HHHHHHHHHHHHHhcCCC------chheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHH
Confidence 123556699999998776 99999999999999999999995 6999998876533389999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+........ ...++..|+|||.+.+..++.++|+|
T Consensus 111 ql~~~l~~lh~~~~~h~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~ 188 (258)
T smart00219 111 QIARGMEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVW 188 (258)
T ss_pred HHHHHHHHHhcCCeeecccccceEEEccCC--eEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHH
Confidence 999999999999999999999999999988 899999999875443211 12256789999999887889999999
Q ss_pred chhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 253 SLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 253 SlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|+||++|+|++ |.+||...+.......+...... ....
T Consensus 189 slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~ 227 (258)
T smart00219 189 SFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL-----------------------------------------PKPE 227 (258)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-----------------------------------------CCCC
Confidence 99999999998 89999887665555444321000 0011
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+.++.+++.+||..||++|||+.|+++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 228 NCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred cCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 13778999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=288.12 Aligned_cols=247 Identities=19% Similarity=0.260 Sum_probs=191.9
Q ss_pred eEEEeEeeccccceEEEEEecCCC----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTN----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
|++.+.||+|+||.||+|.+..++ .+|+|.+......
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------- 41 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--------------------------------------- 41 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC---------------------------------------
Confidence 678999999999999999986543 2488876432111
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCe------EEEEEeecC-cCHHHHHHhhC----CCCCC
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH------LCISFELMN-LNLYELIKRNN----YQGFS 167 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~------~~lv~e~~~-g~L~~~i~~~~----~~~~~ 167 (429)
......+.+|+++++.+.|+ ||+++++++..... .+++|||+. ++|..++.... ...++
T Consensus 42 ----~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~ 111 (273)
T cd05035 42 ----YSEIEEFLSEAACMKDFDHP------NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP 111 (273)
T ss_pred ----HHHHHHHHHHHHHHHhCCCC------CeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCC
Confidence 11123466699999998877 99999998765443 899999995 69998885432 13489
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-----eeecCccccchhhhhC
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-----TYIQSRFYRSPEVILG 242 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-----~~~~t~~y~aPE~~~~ 242 (429)
+..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||+++....... ...++..|+|||++.+
T Consensus 112 ~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05035 112 LQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 189 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC--eEEECCccceeeccccccccccccccCCccccCHhhccc
Confidence 999999999999999999999999999999999999887 899999999875432211 1234567999999988
Q ss_pred CCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
..++.++|||||||++|+|++ |..||.+.+..+.+..+.... .
T Consensus 190 ~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~---------------------------------- 233 (273)
T cd05035 190 RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--R---------------------------------- 233 (273)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--C----------------------------------
Confidence 889999999999999999999 999998877655444332200 0
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
...+...++.+.+++.+||+.||++|||+.|++++
T Consensus 234 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 -----LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -----CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=286.46 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=192.4
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
++|++.+.||.|+||.||++... ...+|+|.+....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~iK~~~~~~------------------------------------------- 41 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV------------------------------------------- 41 (254)
T ss_pred HHceeeeeeccCCCCceEecccC-CCceEEEeecCcc-------------------------------------------
Confidence 56999999999999999998752 2345888763221
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
....+.+|+.+++.++|+ |++++++++.. ...+++|||+. ++|.+++.......+++..+..++.|++
T Consensus 42 ----~~~~~~~e~~~l~~~~~~------~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~ 110 (254)
T cd05083 42 ----TAQAFLEETAVMTKLHHK------NLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVA 110 (254)
T ss_pred ----hHHHHHHHHHHHHhCCCC------CcCeEEEEEcC-CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHH
Confidence 112455699999998877 99999998865 45799999995 6999999876555689999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHHH
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILA 259 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 259 (429)
.||.|||+.|++||||||+||+++.++ .++|+|||++............+..|+|||.+.+..++.++|+|||||++|
T Consensus 111 ~al~~lH~~~~~H~dl~p~nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ 188 (254)
T cd05083 111 EGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLW 188 (254)
T ss_pred HHHHHHHhCCeeccccCcceEEEcCCC--cEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHH
Confidence 999999999999999999999999888 899999999875443322333456799999998888999999999999999
Q ss_pred HHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 260 ELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 260 ~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
+|++ |+.||...+..+....+...... ......++.+.
T Consensus 189 el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 227 (254)
T cd05083 189 EVFSYGRAPYPKMSLKEVKECVEKGYRM-----------------------------------------EPPEGCPADVY 227 (254)
T ss_pred HHHhCCCCCCccCCHHHHHHHHhCCCCC-----------------------------------------CCCCcCCHHHH
Confidence 9997 99999887765543333210000 00122367889
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy17270 339 DFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 339 ~li~~~L~~dP~~Rpta~ell~ 360 (429)
+++++||+.+|++||++.++++
T Consensus 228 ~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 228 VLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.27 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=206.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCC------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTN------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
+-...-++.+.||+|+||+||+|.-.... -+|||.++.......
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~------------------------------ 532 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQA------------------------------ 532 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHH------------------------------
Confidence 34556788899999999999999975443 247777654433333
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCC-------
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNY------- 163 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~------- 163 (429)
..+|.+|++++..|.|+ |||++++++..++-+|+|+||| .|||.++++.+..
T Consensus 533 --------------~~dF~REaeLla~l~H~------nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~ 592 (774)
T KOG1026|consen 533 --------------RQDFRREAELLAELQHP------NIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLAS 592 (774)
T ss_pred --------------HHHHHHHHHHHHhccCC------CeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccC
Confidence 34667799999999998 9999999999999999999999 5899999986532
Q ss_pred -C----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeec-----Ccc
Q psy17270 164 -Q----GFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ-----SRF 233 (429)
Q Consensus 164 -~----~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~-----t~~ 233 (429)
. +++..+...|+.||+.|+.||-++.+|||||-..|+||..+- .|||+|||+++..-...+...+ ...
T Consensus 593 g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l--~VKIsDfGLsRdiYssDYYk~~~~t~lPIR 670 (774)
T KOG1026|consen 593 GQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL--VVKISDFGLSRDIYSSDYYKVRGNTLLPIR 670 (774)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce--EEEecccccchhhhhhhhhcccCCceeeee
Confidence 1 278899999999999999999999999999999999999876 9999999999865443333222 446
Q ss_pred ccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 234 YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 234 y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
|||||.+...+|+.++||||+||++||+++ |.-||.+.+..+.++.|.+.
T Consensus 671 WMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g----------------------------- 721 (774)
T KOG1026|consen 671 WMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG----------------------------- 721 (774)
T ss_pred cCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC-----------------------------
Confidence 999999999999999999999999999998 99999999999999887641
Q ss_pred CCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHH
Q psy17270 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el 358 (429)
..-+.+..++.++.+||..||+.+|++||+..|+
T Consensus 722 ------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 722 ------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred ------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 1122234568899999999999999999999987
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=284.99 Aligned_cols=238 Identities=19% Similarity=0.267 Sum_probs=187.6
Q ss_pred eEeeccccceEEEEEecCCC----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 27 EVIGKGSFGQVIRALDHKTN----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
++||+|+||.||+|.+..++ .+|+|.+......
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~------------------------------------------- 37 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA------------------------------------------- 37 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------------------------------------------
Confidence 47999999999999876554 3488876543221
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQC 181 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~ 181 (429)
.....+.+|+.+++.+.|+ ||+++++++. ...+++||||+. ++|.+++.... .+++..+..++.|++.|
T Consensus 38 -~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~ 107 (257)
T cd05060 38 -AGKKEFLREASVMAQLDHP------CIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMG 107 (257)
T ss_pred -HHHHHHHHHHHHHHhcCCC------CeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHH
Confidence 1223456699999998876 9999999875 457899999995 69999998765 48999999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee------eecCccccchhhhhCCCCCCCccccchh
Q psy17270 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT------YIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 182 l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
|+|||..|++|+||||+||+++.++ .++|+|||.+......... ..++..|+|||.+.+..++.++||||||
T Consensus 108 l~~lh~~~i~H~di~p~nili~~~~--~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 185 (257)
T cd05060 108 MAYLESKHFVHRDLAARNVLLVNRH--QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYG 185 (257)
T ss_pred HHHHhhcCeeccCcccceEEEcCCC--cEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHH
Confidence 9999999999999999999999888 8999999998754322211 1123569999999888899999999999
Q ss_pred hHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|++|+|++ |..||...+..+....+..... ...+...+
T Consensus 186 ~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~ 224 (257)
T cd05060 186 VTLWEAFSYGAKPYGEMKGAEVIAMLESGER-----------------------------------------LPRPEECP 224 (257)
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-----------------------------------------CCCCCCCC
Confidence 99999998 9999988766554433321100 00012236
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+.+.+++.+||..||++||++.++++
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 78899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=290.39 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=198.5
Q ss_pred CeEEEeEeeccccceEEEEEec---CCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 22 RYEILEVIGKGSFGQVIRALDH---KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~---~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
.|++.+.||.|+||.||+|.+. .++. +|+|++.......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~------------------------------------- 43 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ------------------------------------- 43 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh-------------------------------------
Confidence 4899999999999999999985 2444 4888874321100
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.......+.+|+++++.+.+ |+||+.+++.+..+..+|+||||+. ++|.+++.... .+++..+..++.
T Consensus 44 ----~~~~~~~~~~e~~~l~~l~~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~ 112 (290)
T cd05613 44 ----KAKTTEHTRTERQVLEHIRQ-----SPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSG 112 (290)
T ss_pred ----cchHHHHHHHHHHHHHhccc-----CCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHH
Confidence 11223455669999999863 2499999999999999999999995 69999988654 489999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCC--CCCCCcc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGL--PYGPPID 250 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~D 250 (429)
|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.+. .++.++|
T Consensus 113 qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 190 (290)
T cd05613 113 EIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVD 190 (290)
T ss_pred HHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCcccc
Confidence 999999999999999999999999999887 8999999998654321 2235688899999998753 4678999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||+++|+|++|..||...........+........ ....
T Consensus 191 v~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~ 232 (290)
T cd05613 191 WWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--------------------------------------PPYP 232 (290)
T ss_pred HHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--------------------------------------CCCC
Confidence 99999999999999999975433222222211100000 0001
Q ss_pred ccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKSS 367 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~ 367 (429)
...++.+.+++++||+.||++|+ ++.+++.||||+..
T Consensus 233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 12367889999999999999997 89999999999775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=288.22 Aligned_cols=250 Identities=18% Similarity=0.245 Sum_probs=195.2
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCC-----CcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKT-----NTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
+-.++|++.+.||+|+||.||+|.+..+ ..+++|.+......
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~--------------------------------- 49 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE--------------------------------- 49 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH---------------------------------
Confidence 3468999999999999999999999872 23477765422111
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE-cCeEEEEEeecC-cCHHHHHHhhCC------C
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-RNHLCISFELMN-LNLYELIKRNNY------Q 164 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~-g~L~~~i~~~~~------~ 164 (429)
.....+.+|+.+++.+.|+ ||+++++++.. ....++++|++. ++|.+++..... .
T Consensus 50 -----------~~~~~~~~e~~~l~~l~h~------ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~ 112 (280)
T cd05043 50 -----------IQVTLLLQESCLLYGLSHQ------NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112 (280)
T ss_pred -----------HHHHHHHHHHHHHHhCCCC------CCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhcccccccccc
Confidence 1123456699999999877 99999998765 467899999995 799999876532 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce-----eeecCccccchhh
Q psy17270 165 GFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-----TYIQSRFYRSPEV 239 (429)
Q Consensus 165 ~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-----~~~~t~~y~aPE~ 239 (429)
.+++..+..++.|++.||+|||+++++|+||||+||+++.++ .++|+|||+++....... ...++..|+|||+
T Consensus 113 ~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~ 190 (280)
T cd05043 113 ALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALES 190 (280)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECCCCCcccccCCceEEeCCCCCcchhccCHHH
Confidence 489999999999999999999999999999999999999887 899999999875432211 1234567999999
Q ss_pred hhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCC
Q psy17270 240 ILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318 (429)
Q Consensus 240 ~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (429)
+.+..++.++|||||||++|++++ |+.||...+..+....+..... .
T Consensus 191 ~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~------------------------------ 238 (280)
T cd05043 191 LVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR--L------------------------------ 238 (280)
T ss_pred HhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC--C------------------------------
Confidence 998889999999999999999999 9999988766544332221000 0
Q ss_pred CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......++++.+++.+||..||++|||+.++++
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 ---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000112578899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=288.23 Aligned_cols=247 Identities=17% Similarity=0.231 Sum_probs=190.1
Q ss_pred eEEEeEeeccccceEEEEEecCCCc---chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNT---HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~---~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
|.+.+.||.|+||.||+|.+..++. +|+|.+......
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~---------------------------------------- 40 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT---------------------------------------- 40 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC----------------------------------------
Confidence 4578899999999999999987774 477776433211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecC-cCHHHHHHhhC----CCCCCH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMN-LNLYELIKRNN----YQGFSL 168 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~-g~L~~~i~~~~----~~~~~~ 168 (429)
......+.+|+++++.++|+ ||+++++++... ...+++|||+. |+|.+++.... ...+++
T Consensus 41 ---~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 111 (272)
T cd05075 41 ---RSEMEDFLSEAVCMKEFDHP------NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT 111 (272)
T ss_pred ---HHHHHHHHHHHHHHHhCCCC------CcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCH
Confidence 11123456699999999877 999999876432 25789999995 69988875321 234889
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCccccchhhhhCC
Q psy17270 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRFYRSPEVILGL 243 (429)
Q Consensus 169 ~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~ 243 (429)
..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++....... ....+++.|+|||.+.+.
T Consensus 112 ~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 189 (272)
T cd05075 112 QMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM--NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR 189 (272)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC--CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCC
Confidence 99999999999999999999999999999999999887 89999999987643221 122356679999999988
Q ss_pred CCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
.++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 190 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------ 233 (272)
T cd05075 190 VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL------------------------------------ 233 (272)
T ss_pred CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC------------------------------------
Confidence 89999999999999999999 89999887665444333210000
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......+..+.+++.+||+.||++|||+.+++++
T Consensus 234 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 -----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0011235778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=282.90 Aligned_cols=241 Identities=22% Similarity=0.381 Sum_probs=190.3
Q ss_pred eEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFH 106 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (429)
++||.|+||.||+|.+.....+|+|.+...... ...
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~--------------------------------------------~~~ 36 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ--------------------------------------------ELK 36 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH--------------------------------------------HHH
Confidence 478999999999999776556688887543221 112
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
..+.+|+++++.+.|+ ||+++++++......++||||+. ++|.+++.... ..+++..+..++.|++.+|.||
T Consensus 37 ~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l 109 (250)
T cd05085 37 IKFLSEARILKQYDHP------NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYL 109 (250)
T ss_pred HHHHHHHHHHHhCCCC------CcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH
Confidence 2455699999998776 99999999999999999999995 69999887544 3489999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
|++|++|+||+|+||+++.++ .++|+|||++........ ...++..|+|||++.+..++.++||||||+++|+|
T Consensus 110 H~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~ 187 (250)
T cd05085 110 ESKNCIHRDLAARNCLVGENN--VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWET 187 (250)
T ss_pred HhCCeeecccChheEEEcCCC--eEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 999999999999999999887 899999999865332211 12334569999999888889999999999999999
Q ss_pred hh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHH
Q psy17270 262 YT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340 (429)
Q Consensus 262 lt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 340 (429)
++ |..||.+.........+..... .......+..+.++
T Consensus 188 ~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~l 226 (250)
T cd05085 188 FSLGVCPYPGMTNQQAREQVEKGYR-----------------------------------------MSCPQKCPDDVYKV 226 (250)
T ss_pred hcCCCCCCCCCCHHHHHHHHHcCCC-----------------------------------------CCCCCCCCHHHHHH
Confidence 98 9999988765544333321000 00011236789999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q psy17270 341 VTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 341 i~~~L~~dP~~Rpta~ell~h 361 (429)
+.+||+.||++||++.|+++.
T Consensus 227 i~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 227 MQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHcccCcccCCCHHHHHHH
Confidence 999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=290.69 Aligned_cols=248 Identities=19% Similarity=0.260 Sum_probs=194.4
Q ss_pred cCCeEEEeEeeccccceEEEEEecC-----CC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHK-----TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.++|++++.||.|+||.||+|.+.. ++ .+|+|.+......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~---------------------------------- 49 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---------------------------------- 49 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH----------------------------------
Confidence 5689999999999999999999753 22 3477776433221
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC---------
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY--------- 163 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~--------- 163 (429)
.....+.+|+.+++++.|+ ||+++++++......+++|||+. ++|.+++.....
T Consensus 50 ----------~~~~~~~~ei~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 113 (288)
T cd05050 50 ----------DMQADFQREAALMAEFDHP------NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113 (288)
T ss_pred ----------HHHHHHHHHHHHHHhcCCC------chheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCcccccccccc
Confidence 1123456699999999877 99999999999899999999995 699999875321
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----ee
Q psy17270 164 -----------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YT 227 (429)
Q Consensus 164 -----------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~ 227 (429)
..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... ..
T Consensus 114 ~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~ 191 (288)
T cd05050 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKASEN 191 (288)
T ss_pred ccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCC--ceEECccccceecccCccccccCC
Confidence 2378889999999999999999999999999999999999888 89999999986533221 12
Q ss_pred eecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
...+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~--------------------- 250 (288)
T cd05050 192 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV--------------------- 250 (288)
T ss_pred CccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------------------
Confidence 234567999999998889999999999999999997 8889987766554443321000
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 251 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 251 --------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0001123678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=295.00 Aligned_cols=272 Identities=24% Similarity=0.380 Sum_probs=210.7
Q ss_pred hhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 14 ~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
.-++.+++||.++..||+|||+.||+|.|..-..| |+|+-...
T Consensus 456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlN------------------------------------ 499 (775)
T KOG1151|consen 456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLN------------------------------------ 499 (775)
T ss_pred ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhc------------------------------------
Confidence 34678999999999999999999999999876666 66543111
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-CeEEEEEeecCc-CHHHHHHhhCCCCCCHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-NHLCISFELMNL-NLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~ 170 (429)
+.|..-.+..+.+.+.+|.+|-+.|.|+ .||++||+|..+ +.+|-|+|||+| +|.-+++++.- +++.+
T Consensus 500 --K~WrdEKKeNYhKHAcREyrIHKeLDHp------RIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl--mSEKE 569 (775)
T KOG1151|consen 500 --KNWRDEKKENYHKHACREYRIHKELDHP------RIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL--MSEKE 569 (775)
T ss_pred --cchhhHhhhhHHHHHHHHHhhhhccCcc------eeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhh--hhHHH
Confidence 1122223667888899999999999988 999999999865 579999999977 77777887764 99999
Q ss_pred HHHHHHHHHHHHHHHHHC--CceecccCCCcEEEecCC-CcceEEeeecccccccCc----------ceeeecCccccch
Q psy17270 171 IRRFAFSLVQCLRLLHRE--NIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQR----------VYTYIQSRFYRSP 237 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~--~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~~----------~~~~~~t~~y~aP 237 (429)
++.|+.||+.||.||... -|+|-||||.|||+.+.. ...+||+|||+++.+... .....||.+|++|
T Consensus 570 ARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPP 649 (775)
T KOG1151|consen 570 ARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPP 649 (775)
T ss_pred HHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCc
Confidence 999999999999999977 599999999999997531 137999999999754422 2336789999999
Q ss_pred hhhhCC----CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccC
Q psy17270 238 EVILGL----PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313 (429)
Q Consensus 238 E~~~~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (429)
|.+.-. +.+.++||||+|||+|..+.|+.||...-....+..-...+..- + ..
T Consensus 650 EcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAt--E---------Vq------------ 706 (775)
T KOG1151|consen 650 ECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKAT--E---------VQ------------ 706 (775)
T ss_pred ceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcce--e---------cc------------
Confidence 988643 46889999999999999999999997753332221111111100 0 00
Q ss_pred CCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
++ ..+.++.++.+||++||++.-++|....++..||||...
T Consensus 707 ------FP-------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 707 ------FP-------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred ------CC-------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 00 012347889999999999999999999999999999764
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.94 Aligned_cols=241 Identities=24% Similarity=0.294 Sum_probs=187.2
Q ss_pred eEeeccccceEEEEEecCCCc---chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNT---HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKK 103 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~---~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~ 103 (429)
+.||.|+||.||+|.+..++. +++|.+......
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-------------------------------------------- 36 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-------------------------------------------- 36 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH--------------------------------------------
Confidence 368999999999999988774 266665322111
Q ss_pred hhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC--------------CCCCC
Q psy17270 104 RFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN--------------YQGFS 167 (429)
Q Consensus 104 ~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~--------------~~~~~ 167 (429)
.....+.+|++++.++ .|+ ||+++++++.....++++|||+. ++|.+++.... ...++
T Consensus 37 ~~~~~~~~E~~~l~~l~~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~ 110 (270)
T cd05047 37 DDHRDFAGELEVLCKLGHHP------NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 110 (270)
T ss_pred HHHHHHHHHHHHHHhhccCC------CeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCC
Confidence 1123455699999998 455 99999999999999999999994 79999987643 12478
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce--eeecCccccchhhhhCCCC
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY--TYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~ 245 (429)
+..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........ ....+..|+|||++.+..+
T Consensus 111 ~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 188 (270)
T cd05047 111 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY 188 (270)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC--eEEECCCCCccccchhhhccCCCCccccCChHHHccCCC
Confidence 999999999999999999999999999999999999888 899999999853322111 1223456999999988889
Q ss_pred CCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 246 GPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 246 ~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
+.++|+|||||++|+|++ |..||.+.+..+....+.....
T Consensus 189 ~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--------------------------------------- 229 (270)
T cd05047 189 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--------------------------------------- 229 (270)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC---------------------------------------
Confidence 999999999999999997 9999987665544433221000
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.......+.++.+++.+||+.||.+|||+.+++.
T Consensus 230 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 230 --LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred --CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0001123678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=287.14 Aligned_cols=247 Identities=19% Similarity=0.265 Sum_probs=195.2
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCc-----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNT-----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
..++|++.+.||.|+||.||+|.++.++. +|+|.......
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~----------------------------------- 49 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS----------------------------------- 49 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-----------------------------------
Confidence 45789999999999999999999877664 36665533221
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~ 172 (429)
......+.+|+++++.++|+ ||+++++++.. ...++||||+ +|+|.+++.... ..+++..+.
T Consensus 50 ---------~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~ 112 (279)
T cd05057 50 ---------PKANKEILDEAYVMASVDHP------HVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLL 112 (279)
T ss_pred ---------HHHHHHHHHHHHHHHhCCCC------CcceEEEEEec-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHH
Confidence 11223566699999999876 99999999876 7899999999 469999988754 348999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee-----eecCccccchhhhhCCCCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT-----YIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~-----~~~t~~y~aPE~~~~~~~~~ 247 (429)
.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+......... ..++..|+|||.+....++.
T Consensus 113 ~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (279)
T cd05057 113 NWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190 (279)
T ss_pred HHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC--eEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCc
Confidence 9999999999999999999999999999999887 8999999998754422211 11245799999998888899
Q ss_pred CccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 248 PIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 248 ~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
++|+|||||++|++++ |..||.+....+....+......
T Consensus 191 ~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------------------- 230 (279)
T cd05057 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL---------------------------------------- 230 (279)
T ss_pred hhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC----------------------------------------
Confidence 9999999999999998 99999887665544333220000
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+...+..+.+++.+||..||++|||+.++++
T Consensus 231 -~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 -PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001113567889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=287.01 Aligned_cols=204 Identities=17% Similarity=0.240 Sum_probs=161.9
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
..+.+|+.+++.+.|+ ||+++++++......++||||+. |+|.+++.... ..+++..+..++.||+.||+||
T Consensus 44 ~~~~~e~~~l~~~~h~------~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~l 116 (258)
T cd05078 44 ESFFEAASMMSQLSHK------HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFL 116 (258)
T ss_pred HHHHHHHHHHHhCCCC------ChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHH
Confidence 3566688898888776 99999999999999999999995 68999987654 2589999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCCc------ceEEeeecccccccCcceeeecCccccchhhhhCC-CCCCCccccchhhHH
Q psy17270 186 HRENIIHCDLKPENVLLKQRGSS------SIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCIL 258 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~~------~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il 258 (429)
|++|++||||||+||+++.++.. .++++|||.+...... ....++..|+|||++.+. .++.++|||||||++
T Consensus 117 H~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 195 (258)
T cd05078 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-EILLERIPWVPPECIENPQNLSLAADKWSFGTTL 195 (258)
T ss_pred HHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc-hhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence 99999999999999999876531 3799999998654332 234678889999999874 578899999999999
Q ss_pred HHHhhC-CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 259 AELYTG-CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 259 ~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
|+|++| ..||...+.......... .. ..+...+.++
T Consensus 196 ~~l~~g~~~~~~~~~~~~~~~~~~~-~~------------------------------------------~~~~~~~~~~ 232 (258)
T cd05078 196 WEIFSGGDKPLSALDSQKKLQFYED-RH------------------------------------------QLPAPKWTEL 232 (258)
T ss_pred HHHHcCCCCChhhccHHHHHHHHHc-cc------------------------------------------cCCCCCcHHH
Confidence 999998 567666554332211110 00 0011225678
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+++.+||+.||++|||++++++.
T Consensus 233 ~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 233 ANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHhccChhhCCCHHHHHHh
Confidence 899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=282.36 Aligned_cols=241 Identities=21% Similarity=0.284 Sum_probs=192.7
Q ss_pred eEeeccccceEEEEEecC-CCc---chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 27 EVIGKGSFGQVIRALDHK-TNT---HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~-~~~---~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
++||.|++|.||+|.+.. ++. +|+|.+......
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~------------------------------------------- 37 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS------------------------------------------- 37 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------------------------------------------
Confidence 468999999999999865 333 488877543322
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQC 181 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~ 181 (429)
.....+.+|+++++++.|+ ||+++++.+.. ..++++|||+. ++|.+++.......+++..+..++.|++.|
T Consensus 38 -~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~ 109 (257)
T cd05040 38 -DIMDDFLKEAAIMHSLDHE------NLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG 109 (257)
T ss_pred -HHHHHHHHHHHHHhhcCCC------CccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHH
Confidence 1233566699999999887 99999999988 89999999994 799999987653458999999999999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 182 l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
|+|||++|++|+||+|+||+++.++ .++|+|||++....... ....++..|+|||.+.+..++.++||||||
T Consensus 110 L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG 187 (257)
T cd05040 110 MRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFG 187 (257)
T ss_pred HHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHH
Confidence 9999999999999999999999987 89999999987543311 123456789999999988899999999999
Q ss_pred hHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|++|+|++ |..||...+..+....+....... ......+
T Consensus 188 ~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~ 227 (257)
T cd05040 188 VTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL----------------------------------------ERPEACP 227 (257)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC----------------------------------------CCCccCC
Confidence 99999998 999998877766554443200000 0001236
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 78899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=288.77 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=196.2
Q ss_pred CeEEEeEeeccccceEEEEEecC---CC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHK---TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~---~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
.|++.+.||.|++|.||+|.+.. ++ .+|+|++.......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~------------------------------------- 43 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ------------------------------------- 43 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHh-------------------------------------
Confidence 48999999999999999998643 33 35888774321110
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.......+.+|+.++..+.+ |+||+++++.+......++||||+. ++|.+.+.... .+++..++.++.
T Consensus 44 ----~~~~~~~~~~E~~~l~~~~~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ 112 (288)
T cd05583 44 ----KAKTAEHTRTERQVLEAVRR-----CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIA 112 (288)
T ss_pred ----hhhHHHHHHHHHHHHHhccC-----CcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHH
Confidence 11122355669999999863 2499999999999999999999995 69998887653 489999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCCC--CCCCcc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGLP--YGPPID 250 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~--~~~~~D 250 (429)
|++.+|.|||+.|++|+||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.+.. .+.++|
T Consensus 113 ql~~~l~~lH~~~~~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 190 (288)
T cd05583 113 EIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVD 190 (288)
T ss_pred HHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhh
Confidence 999999999999999999999999999887 8999999998653322 12345788999999987765 678999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHH-hCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEI-LGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
+||||+++|+|++|..||...+.......+... .... ...
T Consensus 191 v~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~ 231 (288)
T cd05583 191 WWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK---------------------------------------PPF 231 (288)
T ss_pred hHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC---------------------------------------CCC
Confidence 999999999999999999654322111111110 0000 000
Q ss_pred hccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLT---PDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpt---a~ell~h~~~~~~~ 368 (429)
....+..+.++|.+||+.||++||| +.++|+||||++..
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 1123678899999999999999998 56789999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=285.36 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=194.6
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCC-C---cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKT-N---THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~-~---~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
-.++|++.+.||.|+||.||+|.+..+ + .+++|........
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~----------------------------------- 48 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP----------------------------------- 48 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-----------------------------------
Confidence 356799999999999999999998655 2 2477765433211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
...+.+.+|+++++.+.|+ ||+++++++.. ...++||||+. ++|.+++.... ..+++..+..
T Consensus 49 ---------~~~~~~~~e~~~l~~~~h~------~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 111 (270)
T cd05056 49 ---------SVREKFLQEAYIMRQFDHP------HIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLIL 111 (270)
T ss_pred ---------HHHHHHHHHHHHHHhCCCC------chhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHH
Confidence 1223566699999999877 99999998865 56789999995 69999997654 3589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++........ ...++..|+|||.+....++.++
T Consensus 112 ~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 189 (270)
T cd05056 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSAS 189 (270)
T ss_pred HHHHHHHHHHHHHhCCeeccccChheEEEecCC--CeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchh
Confidence 999999999999999999999999999999887 899999999865432211 11234579999999888899999
Q ss_pred cccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 250 DMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 250 DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
|||||||++|+|++ |..||.+.+..+....+...... .
T Consensus 190 Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-----------------------------------------~ 228 (270)
T cd05056 190 DVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-----------------------------------------P 228 (270)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-----------------------------------------C
Confidence 99999999999986 99999887766555443221000 0
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+...+..+.+++.+||..+|++|||+.+++..
T Consensus 229 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112336789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=284.84 Aligned_cols=238 Identities=19% Similarity=0.281 Sum_probs=186.4
Q ss_pred EeeccccceEEEEEec--CCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhh
Q psy17270 28 VIGKGSFGQVIRALDH--KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKR 104 (429)
Q Consensus 28 ~lG~G~~g~Vy~a~~~--~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~ 104 (429)
.||+|+||.||+|.+. .++. +|+|++..... ...
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-------------------------------------------~~~ 38 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-------------------------------------------DPA 38 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-------------------------------------------cHH
Confidence 6899999999999764 3333 48887643211 112
Q ss_pred hhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy17270 105 FHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 105 ~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~ 183 (429)
....+.+|+.+++.+.|+ ||+++++++. ....++||||+. ++|.+++.... .+++..+..++.|++.||+
T Consensus 39 ~~~~~~~e~~~l~~l~h~------~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~ 109 (257)
T cd05116 39 LKDELLREANVMQQLDNP------YIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMK 109 (257)
T ss_pred HHHHHHHHHHHHHhCCCC------CcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHH
Confidence 334566799999998877 9999999875 457789999996 68999987654 4999999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce------eeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 184 LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY------TYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
|||++|++|+||||.||+++.++ .++|+|||.+........ ...++..|+|||.+....++.++|+|||||+
T Consensus 110 ~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 187 (257)
T cd05116 110 YLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVL 187 (257)
T ss_pred HHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHH
Confidence 99999999999999999999877 899999999875432211 1123467999999988888999999999999
Q ss_pred HHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 258 LAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 258 l~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
+|+|++ |..||...+..+....+..... ...+...+++
T Consensus 188 l~el~t~g~~p~~~~~~~~~~~~i~~~~~-----------------------------------------~~~~~~~~~~ 226 (257)
T cd05116 188 MWEAFSYGQKPYKGMKGNEVTQMIESGER-----------------------------------------MECPQRCPPE 226 (257)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHCCCC-----------------------------------------CCCCCCCCHH
Confidence 999998 9999988776655444432100 0011234788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+.++|.+||+.||++||++.++.+
T Consensus 227 l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 227 MYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHHhccCchhCcCHHHHHH
Confidence 999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=298.22 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=188.8
Q ss_pred cCCeEEEeEeeccccceEEEEEecC-----CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHK-----TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.+||++++.||.|+||.||+|.+.. ++. +|+|++......
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------------------- 51 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---------------------------------- 51 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh----------------------------------
Confidence 5799999999999999999998642 333 488876432211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-CeEEEEEeecC-cCHHHHHHhhCC--------
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-NHLCISFELMN-LNLYELIKRNNY-------- 163 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~-g~L~~~i~~~~~-------- 163 (429)
.....+.+|+.++.++.| |+||+++++++... ..++++||||+ |+|.+++.....
T Consensus 52 ----------~~~~~~~~E~~~l~~l~~-----h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~ 116 (343)
T cd05103 52 ----------SEHRALMSELKILIHIGH-----HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTK 116 (343)
T ss_pred ----------HHHHHHHHHHHHHHhccC-----CccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCcccccccc
Confidence 112245669999999953 24999999987654 46899999995 699999875321
Q ss_pred ---------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 164 ---------------------------------------------------------QGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 164 ---------------------------------------------------------~~~~~~~~~~i~~qil~~l~~lH 186 (429)
..++...+..++.|++.||+|||
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 196 (343)
T cd05103 117 DARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA 196 (343)
T ss_pred ccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH
Confidence 23677888999999999999999
Q ss_pred HCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 187 ~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
++|++||||||+||+++.++ .++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|
T Consensus 197 ~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 274 (343)
T cd05103 197 SRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274 (343)
T ss_pred hCCeecCCCccCeEEEcCCC--cEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999887 89999999986532211 112345679999999888899999999999999999
Q ss_pred hh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHH
Q psy17270 262 YT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDF 340 (429)
Q Consensus 262 lt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 340 (429)
++ |..||.+......+...... +.. ...+...++.+.++
T Consensus 275 ~~~g~~p~~~~~~~~~~~~~~~~-~~~---------------------------------------~~~~~~~~~~~~~~ 314 (343)
T cd05103 275 FSLGASPYPGVKIDEEFCRRLKE-GTR---------------------------------------MRAPDYTTPEMYQT 314 (343)
T ss_pred HHCCCCCCCCccccHHHHHHHhc-cCC---------------------------------------CCCCCCCCHHHHHH
Confidence 97 99999875433222211110 000 00001125788999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q psy17270 341 VTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 341 i~~~L~~dP~~Rpta~ell~h 361 (429)
+.+||+.||++|||+.|+++|
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=280.72 Aligned_cols=240 Identities=23% Similarity=0.382 Sum_probs=190.3
Q ss_pred eEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFH 106 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (429)
++||.|+||.||+|.+.....+|+|.+...... ...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--------------------------------------------~~~ 36 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--------------------------------------------DLK 36 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--------------------------------------------HHH
Confidence 479999999999999987445588877543322 112
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
..+.+|+++++.+.|+ ||+++++++......++|||++. ++|.+++.... ..++...+..++.+++.||+||
T Consensus 37 ~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~l 109 (251)
T cd05041 37 RKFLQEAEILKQYDHP------NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYL 109 (251)
T ss_pred HHHHHHHHHHHhCCCC------CeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH
Confidence 3456699999999877 99999999999999999999995 68999987643 3589999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee-----eecCccccchhhhhCCCCCCCccccchhhHHHH
Q psy17270 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT-----YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAE 260 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~-----~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~ 260 (429)
|++|++|+||+|+||+++.++ .++|+|||.+......... ...+..|+|||.+.+..++.++|+|||||++|+
T Consensus 110 H~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~ 187 (251)
T cd05041 110 ESKNCIHRDLAARNCLVGENN--VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWE 187 (251)
T ss_pred HhCCEehhhcCcceEEEcCCC--cEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHH
Confidence 999999999999999999888 8999999998754321111 122456999999988889999999999999999
Q ss_pred Hhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHH
Q psy17270 261 LYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVD 339 (429)
Q Consensus 261 llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (429)
|+| |..||...+.......+......+ .....+..+.+
T Consensus 188 l~t~~~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 226 (251)
T cd05041 188 TFSLGDTPYPGMSNQQTRERIESGYRMP-----------------------------------------APQLCPEEIYR 226 (251)
T ss_pred HHhccCCCCccCCHHHHHHHHhcCCCCC-----------------------------------------CCccCCHHHHH
Confidence 999 899998876544433322100000 01123678899
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q psy17270 340 FVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 340 li~~~L~~dP~~Rpta~ell~ 360 (429)
++.+||+.+|++|||+.|+++
T Consensus 227 li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 227 LMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=300.54 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=203.3
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCc-----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNT-----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.++-.+.++||+|+||.||+|+.+..+. +|+|......
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~------------------------------------- 198 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS------------------------------------- 198 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-------------------------------------
Confidence 5556677899999999999999876543 4666553211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
...+.....+++|+++++.++|+ ||+++|++.....-+++|||+| +|+|.++++.... .++..+...
T Consensus 199 -----~~~~~~~~e~m~EArvMr~l~H~------NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~ 266 (474)
T KOG0194|consen 199 -----ELTKEQIKEFMKEARVMRQLNHP------NVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLR 266 (474)
T ss_pred -----cccHHHHHHHHHHHHHHHhCCCC------CEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHH
Confidence 01223345678899999999998 9999999999999999999999 5699999998873 599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee--e-ecCccccchhhhhCCCCCCCcc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT--Y-IQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~--~-~~t~~y~aPE~~~~~~~~~~~D 250 (429)
++.+.+.||+|||+++++||||-.+|+|++.++ .+||+|||+++........ . .-...|+|||.+....|+.++|
T Consensus 267 ~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~--~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTD 344 (474)
T KOG0194|consen 267 FCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG--VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTD 344 (474)
T ss_pred HHHHHHhHHHHHHHCCCcchhHhHHHheecCCC--eEEeCccccccCCcceeeccccccCcceecChhhhccCccccccc
Confidence 999999999999999999999999999999887 7899999998765421111 1 2345699999999989999999
Q ss_pred ccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHH-HhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 251 MWSLGCILAELYT-GCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 251 iwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
||||||++||+++ |..||++....+....|.. ....+.+
T Consensus 345 V~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--------------------------------------- 385 (474)
T KOG0194|consen 345 VWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--------------------------------------- 385 (474)
T ss_pred hhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC---------------------------------------
Confidence 9999999999998 8899999999888877743 1111111
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...+..+..++.+|+..||++|||+.++.+
T Consensus 386 --~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 386 --SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 122677889999999999999999998865
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=281.70 Aligned_cols=238 Identities=18% Similarity=0.252 Sum_probs=185.6
Q ss_pred EeeccccceEEEEEecC--CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhh
Q psy17270 28 VIGKGSFGQVIRALDHK--TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKR 104 (429)
Q Consensus 28 ~lG~G~~g~Vy~a~~~~--~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~ 104 (429)
.||.|+||.||+|.+.. ++. +|+|++..... ..
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--------------------------------------------~~ 37 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--------------------------------------------KS 37 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--------------------------------------------hH
Confidence 48999999999998753 332 47777643211 12
Q ss_pred hhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy17270 105 FHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 105 ~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~ 183 (429)
....+.+|+.+++++.|+ ||+++++++. ....++||||++ ++|.+++.... ..+++..+..++.|++.||+
T Consensus 38 ~~~~~~~E~~~l~~l~h~------~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~ 109 (257)
T cd05115 38 VRDEMMREAEIMHQLDNP------YIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMK 109 (257)
T ss_pred HHHHHHHHHHHHHhcCCC------CeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHH
Confidence 234566799999999877 9999999875 457899999995 69999887543 45999999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce------eeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 184 LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY------TYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
|||++|++|+||||+||+++.++ .++|+|||++........ ...++..|+|||++.+..++.++|||||||+
T Consensus 110 ~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 187 (257)
T cd05115 110 YLEGKNFVHRDLAARNVLLVNQH--YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGIT 187 (257)
T ss_pred HHHhcCeeecccchheEEEcCCC--cEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHH
Confidence 99999999999999999999887 899999999864332211 1122467999999988889999999999999
Q ss_pred HHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 258 LAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 258 l~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
+|+|++ |..||.+....+....+..... .......+++
T Consensus 188 l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~ 226 (257)
T cd05115 188 MWEAFSYGQKPYKKMKGPEVMSFIEQGKR-----------------------------------------LDCPAECPPE 226 (257)
T ss_pred HHHHhcCCCCCcCcCCHHHHHHHHHCCCC-----------------------------------------CCCCCCCCHH
Confidence 999996 9999988776554433322100 0011234788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+.+++.+||..||++||++.++.+
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.36 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=196.2
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecC-----CC-cchheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHK-----TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
..+-.++|.+.++||.|+||.||+|++.. ++ .+|+|++......
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~------------------------------ 81 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS------------------------------ 81 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh------------------------------
Confidence 34456779999999999999999999743 22 3588877433211
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC----
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY---- 163 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~---- 163 (429)
...+.+.+|++++..+. |+ ||+++++++.....+++|||||. |+|.+++.....
T Consensus 82 --------------~~~~~~~~E~~~l~~l~~H~------niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~ 141 (401)
T cd05107 82 --------------SEKQALMSELKIMSHLGPHL------NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQ 141 (401)
T ss_pred --------------hHHHHHHHHHHHHHhcCCCC------CeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchh
Confidence 11224566999999986 65 99999999999999999999995 799999875421
Q ss_pred --------------------------------------------------------------------------------
Q psy17270 164 -------------------------------------------------------------------------------- 163 (429)
Q Consensus 164 -------------------------------------------------------------------------------- 163 (429)
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (401)
T cd05107 142 YYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAP 221 (401)
T ss_pred hhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccC
Confidence
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ce
Q psy17270 164 ------------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VY 226 (429)
Q Consensus 164 ------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~ 226 (429)
..++...+..++.|++.||+|||+.+++||||||+|||++.++ .++|+|||++...... ..
T Consensus 222 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~--~~kL~DfGla~~~~~~~~~~~~~ 299 (401)
T cd05107 222 ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK--LVKICDFGLARDIMRDSNYISKG 299 (401)
T ss_pred CCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC--EEEEEecCcceecccccccccCC
Confidence 1366778899999999999999999999999999999999877 8999999998653211 12
Q ss_pred eeecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCC
Q psy17270 227 TYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSK 305 (429)
Q Consensus 227 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (429)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.+...... +..+
T Consensus 300 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~-~~~~----------------- 361 (401)
T cd05107 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR-GYRM----------------- 361 (401)
T ss_pred CcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc-CCCC-----------------
Confidence 2356778999999998889999999999999999998 89999876554443322210 0000
Q ss_pred CCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 306 GTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+...+..+.+|+.+||..||.+||++.|+++.
T Consensus 362 ----------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 362 ----------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0011236789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=283.86 Aligned_cols=204 Identities=19% Similarity=0.261 Sum_probs=159.7
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
..+.+|+.+++.++|+ ||+++++++..+...+++|||++ ++|..++.... ..+++..+..++.||+.||+||
T Consensus 49 ~~~~~~~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~l 121 (262)
T cd05077 49 LAFFETASMMRQVSHK------HIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYL 121 (262)
T ss_pred HHHHHHHHHHHhCCCC------CEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHh
Confidence 3456688899988877 99999999998889999999996 57777766543 4589999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCC-----cceEEeeecccccccCcceeeecCccccchhhhh-CCCCCCCccccchhhHHH
Q psy17270 186 HRENIIHCDLKPENVLLKQRGS-----SSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVIL-GLPYGPPIDMWSLGCILA 259 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~-----~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ 259 (429)
|++|++||||||+|||++.++. ..++++|||++...... ....++..|+|||++. +..++.++|||||||++|
T Consensus 122 H~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 200 (262)
T cd05077 122 EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLW 200 (262)
T ss_pred hhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHH
Confidence 9999999999999999986542 13899999998654322 2346788899999987 456889999999999999
Q ss_pred HHh-hCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 260 ELY-TGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 260 ~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
+|+ +|..||......+... +.. + .. .......+++.
T Consensus 201 el~~~~~~p~~~~~~~~~~~-~~~--~-~~---------------------------------------~~~~~~~~~~~ 237 (262)
T cd05077 201 EICYNGEIPLKDKTLAEKER-FYE--G-QC---------------------------------------MLVTPSCKELA 237 (262)
T ss_pred HHHhCCCCCCCCcchhHHHH-HHh--c-Cc---------------------------------------cCCCCChHHHH
Confidence 997 5889987754432211 100 0 00 00011146788
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q psy17270 339 DFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 339 ~li~~~L~~dP~~Rpta~ell~h 361 (429)
+||.+||+.||++||++.+++++
T Consensus 238 ~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 238 DLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHcCCChhhCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.36 Aligned_cols=271 Identities=16% Similarity=0.234 Sum_probs=177.6
Q ss_pred cCCeEEEeEeeccccceEEEEEecCC----Cc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKT----NT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~----~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.++|++.++||+|+||.||+|++..+ +. +|+|++......
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----------------------------------- 175 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----------------------------------- 175 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----------------------------------
Confidence 57899999999999999999999887 54 588876422110
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEE------EEEcCeEEEEEeecC-cCHHHHHHhhCCC---
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY------FYFRNHLCISFELMN-LNLYELIKRNNYQ--- 164 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~------~~~~~~~~lv~e~~~-g~L~~~i~~~~~~--- 164 (429)
|..+...+.+.. +.++..+... ......+++|+||++ ++|.+++......
T Consensus 176 -----------------e~~~~e~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v 235 (566)
T PLN03225 176 -----------------EIWMNERVRRAC---PNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNV 235 (566)
T ss_pred -----------------HHHHHHHHHhhc---hhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhH
Confidence 111111111110 0011111111 234568999999995 6899988754310
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEec-CCCcceEEeeeccccccc----Cc
Q psy17270 165 ---------------GFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQ-RGSSSIKVIDFGSSCYSH----QR 224 (429)
Q Consensus 165 ---------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~-~~~~~vkl~Dfg~~~~~~----~~ 224 (429)
......+..++.|++.||+|||++||+||||||+|||++. ++ .+||+|||++.... ..
T Consensus 236 ~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~--~~KL~DFGlA~~l~~~~~~~ 313 (566)
T PLN03225 236 EPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG--SFKIIDLGAAADLRVGINYI 313 (566)
T ss_pred HHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCC--cEEEEeCCCccccccccccC
Confidence 0123456789999999999999999999999999999986 35 79999999997532 22
Q ss_pred ceeeecCccccchhhhhCCC----------------------CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHH
Q psy17270 225 VYTYIQSRFYRSPEVILGLP----------------------YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282 (429)
Q Consensus 225 ~~~~~~t~~y~aPE~~~~~~----------------------~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 282 (429)
....++|+.|+|||.+.... ++.++||||+||++|+|+++..+ ..+....+..+..
T Consensus 314 ~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~--~~~~~~~~~~~l~ 391 (566)
T PLN03225 314 PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLR--SDSNLIQFNRQLK 391 (566)
T ss_pred CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCC--CchHHHHHHHHHH
Confidence 34567899999999765322 34466999999999999986554 3344444444444
Q ss_pred HhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy17270 283 ILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHE 362 (429)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~ 362 (429)
..+.....|...... . ....................+||.+||+.||++|||+.|+|+||
T Consensus 392 ~~~~~~~~~~~~~~~-------~-------------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hp 451 (566)
T PLN03225 392 RNDYDLVAWRKLVEP-------R-------------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHP 451 (566)
T ss_pred hcCCcHHHHHHhhcc-------c-------------cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCc
Confidence 333333332211100 0 00000011122223355677999999999999999999999999
Q ss_pred CCCCCCC
Q psy17270 363 WLKSSSS 369 (429)
Q Consensus 363 ~~~~~~~ 369 (429)
||+....
T Consensus 452 ff~~~~~ 458 (566)
T PLN03225 452 YFDREGL 458 (566)
T ss_pred CcCCCCc
Confidence 9987544
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=286.47 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=188.6
Q ss_pred eEEEeEeeccccceEEEEEec----CCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 23 YEILEVIGKGSFGQVIRALDH----KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~----~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
|++++.||+|+||.||+|... .++. +|+|.+......
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-------------------------------------- 47 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-------------------------------------- 47 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH--------------------------------------
Confidence 699999999999999999853 3343 488876433211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.....+.+|+++++.+.|+ ||+++++++... ..+++||||+ +++|.+++.+.. ..+++..+..+
T Consensus 48 ------~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i 114 (284)
T cd05079 48 ------NHIADLKKEIEILRNLYHE------NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKY 114 (284)
T ss_pred ------HHHHHHHHHHHHHHhCCCC------CeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHH
Confidence 1123456699999999877 999999998775 5789999999 569999987654 34899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhCCCCCCC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
+.|++.||+|||++|++||||||+||+++.++ .++|+|||++....... ....++..|+|||++.+..++.+
T Consensus 115 ~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~ 192 (284)
T cd05079 115 AVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA 192 (284)
T ss_pred HHHHHHHHHHHHHCCeeecccchheEEEcCCC--CEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCcc
Confidence 99999999999999999999999999999887 89999999987543221 12345667999999988889999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++++.|+..... .. ....+....+........... . + .+ ..
T Consensus 193 ~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~-~--~---------~~---------~~ 246 (284)
T cd05079 193 SDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQMTVTRLVRVLE-E--G---------KR---------LP 246 (284)
T ss_pred ccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccccHHHHHHHHH-c--C---------cc---------CC
Confidence 9999999999999998776533211 11 111111111100000000000 0 0 00 00
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+...++.+.+|+.+||+.||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 247 RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 112347889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=285.55 Aligned_cols=204 Identities=18% Similarity=0.234 Sum_probs=160.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
..+.+|+.+++.+.|+ ||+++++++......++||||++ ++|..++.... ..+++..+..++.|++.||+||
T Consensus 61 ~~~~~~~~~~~~l~h~------niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~l 133 (274)
T cd05076 61 LAFFETASLMSQVSHI------HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYL 133 (274)
T ss_pred HHHHHHHHHHhcCCCC------CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH
Confidence 4566688888888876 99999999999999999999995 58888876543 4589999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCC-----CcceEEeeecccccccCcceeeecCccccchhhhhC-CCCCCCccccchhhHHH
Q psy17270 186 HRENIIHCDLKPENVLLKQRG-----SSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPIDMWSLGCILA 259 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~-----~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ 259 (429)
|++||+||||||+||+++..+ ...++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|
T Consensus 134 H~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~ 212 (274)
T cd05076 134 EDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212 (274)
T ss_pred HcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHH
Confidence 999999999999999998643 124899999987543322 23357788999998876 46889999999999999
Q ss_pred HHh-hCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 260 ELY-TGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 260 ~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
+|+ +|..||.+.+..+....+... ... +....+.+.
T Consensus 213 el~~~g~~p~~~~~~~~~~~~~~~~-~~~------------------------------------------~~~~~~~~~ 249 (274)
T cd05076 213 EICFDGEVPLKERTPSEKERFYEKK-HRL------------------------------------------PEPSCKELA 249 (274)
T ss_pred HHHhCCCCCccccChHHHHHHHHhc-cCC------------------------------------------CCCCChHHH
Confidence 995 699999876554332211100 000 001145788
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q psy17270 339 DFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 339 ~li~~~L~~dP~~Rpta~ell~h 361 (429)
++|.+||+.||++|||+.+++++
T Consensus 250 ~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 250 TLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHcccChhhCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=283.29 Aligned_cols=249 Identities=18% Similarity=0.245 Sum_probs=195.4
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCc------chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNT------HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
++|++++.||.|+||+||+|.++.+.. +++|.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~------------------------------------- 47 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK------------------------------------- 47 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-------------------------------------
Confidence 689999999999999999999865432 3555442211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCC-------CC
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQ-------GF 166 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~-------~~ 166 (429)
.......+.+|+++++.+.|+ ||+++++++......++||||+. ++|.+++...... .+
T Consensus 48 -------~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l 114 (275)
T cd05046 48 -------DENLQSEFRRELDMFRKLSHK------NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114 (275)
T ss_pred -------chHHHHHHHHHHHHHHhcCCc------ceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCC
Confidence 111334567799999999887 99999999988889999999996 6999999765411 48
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhC
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILG 242 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~ 242 (429)
++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++++|||++...... .....++..|+|||.+.+
T Consensus 115 ~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 192 (275)
T cd05046 115 STKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR--EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE 192 (275)
T ss_pred CHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC--cEEEcccccccccCcccccccCCceeEEeecChhhhcc
Confidence 9999999999999999999999999999999999999887 8999999998643221 122345667999999988
Q ss_pred CCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
..++.++||||||+++|+|++ |..||........+..+..... . .
T Consensus 193 ~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~-----------------------------~--- 238 (275)
T cd05046 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL--E-----------------------------L--- 238 (275)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc--C-----------------------------C---
Confidence 888899999999999999998 8899977665544433321000 0 0
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......+..+.+++.+||+.||++|||+.|++..
T Consensus 239 ------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 ------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0011236789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=281.50 Aligned_cols=227 Identities=22% Similarity=0.284 Sum_probs=180.3
Q ss_pred cccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhhhHH
Q psy17270 32 GSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQAL 110 (429)
Q Consensus 32 G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 110 (429)
|.+|+||+|.+..+++. |+|.+..... ..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------------------------------------------------~~ 33 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------------------------------------------------YS 33 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------------------------------------------------hh
Confidence 89999999999999865 8888743210 11
Q ss_pred HHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy17270 111 IEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN 189 (429)
Q Consensus 111 ~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ 189 (429)
.|...+.... ||||+++++++.....++++|||+. ++|.+++.... .+++..+..++.|++.||+|||++|
T Consensus 34 ~~~~~~~~~~------~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~ 105 (237)
T cd05576 34 RERLTIIPHC------VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--NIPEECVKRWAAEMVVALDALHREG 105 (237)
T ss_pred hHHHHHHhcC------CCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 1333333323 4599999999999999999999995 69999987664 3999999999999999999999999
Q ss_pred ceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCC
Q psy17270 190 IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFP 269 (429)
Q Consensus 190 ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~ 269 (429)
++|+||||+||+++.++ .++++|||.+...........++..|+|||.+.+..++.++|+||+||++|+|++|..|+.
T Consensus 106 i~H~dlkp~Nil~~~~~--~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 106 IVCRDLNPNNILLDDRG--HIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred eeccCCCHHHEEEcCCC--CEEEecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 99999999999999988 8999999988665554444556778999999988888999999999999999999998875
Q ss_pred CCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCC
Q psy17270 270 GENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDS 349 (429)
Q Consensus 270 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 349 (429)
...... .. .. ....+...++.+.++|.+||+.||
T Consensus 184 ~~~~~~-----~~--------------------------------~~---------~~~~~~~~~~~~~~li~~~l~~dp 217 (237)
T cd05576 184 CHPSGI-----NT--------------------------------HT---------TLNIPEWVSEEARSLLQQLLQFNP 217 (237)
T ss_pred cCchhc-----cc--------------------------------cc---------ccCCcccCCHHHHHHHHHHccCCH
Confidence 421100 00 00 000112236788999999999999
Q ss_pred CCCCCH-----HHHhcCCCC
Q psy17270 350 KKRLTP-----DEALRHEWL 364 (429)
Q Consensus 350 ~~Rpta-----~ell~h~~~ 364 (429)
++|+|+ .+++.||||
T Consensus 218 ~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 218 TERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHhcCCCccchHHHHcCCCC
Confidence 999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=282.39 Aligned_cols=208 Identities=20% Similarity=0.237 Sum_probs=161.4
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY---QGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~---~~~~~~~~~~i~~qil~~l~ 183 (429)
.+.+|+++++.++|+ ||+++++.+.....+++||||+. |+|.+++..... ...++..+..++.||+.||+
T Consensus 41 ~~~~e~~~~~~l~h~------nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 114 (269)
T cd05042 41 LFLQEVQPYRELNHP------NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL 114 (269)
T ss_pred HHHHHHHHHHhCCCC------CcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHH
Confidence 456689998888776 99999999998999999999995 699999976542 22567888999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhC-------CCCCCCccc
Q psy17270 184 LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILG-------LPYGPPIDM 251 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~-------~~~~~~~Di 251 (429)
|||++||+||||||+||+++.++ .++|+|||++...... .....++..|+|||++.. ..++.++||
T Consensus 115 ~lH~~~ivH~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Di 192 (269)
T cd05042 115 WLHQADFIHSDLALRNCQLTADL--SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNI 192 (269)
T ss_pred HHHhcCEecccccHhheEecCCC--cEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHH
Confidence 99999999999999999999988 8999999998643211 112234567999999753 346789999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||++|+|++ |..||......+.+..+......... .....
T Consensus 193 wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~ 236 (269)
T cd05042 193 WSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP------------------------------------KPQLD 236 (269)
T ss_pred HHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC------------------------------------CCccc
Confidence 999999999999 88999887766655444321110000 00111
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...++.+.+++..|+ .||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 223677889999998 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.46 Aligned_cols=249 Identities=21% Similarity=0.337 Sum_probs=205.7
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCC-c-----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTN-T-----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~-~-----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
=...-++.+.||+|+||.||.|+..... . +|+|.+.+.....+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~------------------------------- 738 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQE------------------------------- 738 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHH-------------------------------
Confidence 3567889999999999999999975433 2 47777754433322
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCC-----CCC
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNY-----QGF 166 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~-----~~~ 166 (429)
...|++|+.+++.+.|+ ||+++++++.+....+|++||| +|+|..++++.+. ..+
T Consensus 739 -------------~~~Fl~Ea~~m~~f~Hp------Niv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L 799 (1025)
T KOG1095|consen 739 -------------VSDFLKEALLMSKFDHP------NIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNL 799 (1025)
T ss_pred -------------HHHHHHHHHHHhcCCCc------ceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCC
Confidence 23577799999999998 9999999999999999999999 5799999997721 348
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeec-----Cccccchhhhh
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ-----SRFYRSPEVIL 241 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~-----t~~y~aPE~~~ 241 (429)
+..+...++.||+.|+.||+++++|||||..+|+|++... .+||+|||+|+......+...+ ...|||||.+.
T Consensus 800 ~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r--~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~ 877 (1025)
T KOG1095|consen 800 SMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR--VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK 877 (1025)
T ss_pred CHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC--cEEEcccchhHhhhhchheeccCccccceecCCHHHHh
Confidence 8999999999999999999999999999999999999886 9999999999854433322221 23599999999
Q ss_pred CCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCC
Q psy17270 242 GLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRK 320 (429)
Q Consensus 242 ~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (429)
...++.++|||||||++||++| |..||++.+..+.+....+.-
T Consensus 878 d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg------------------------------------ 921 (1025)
T KOG1095|consen 878 DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG------------------------------------ 921 (1025)
T ss_pred hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC------------------------------------
Confidence 9899999999999999999999 999999999888776554311
Q ss_pred CCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 321 PGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
....+..+++.+.++|..||+.+|++||+...+++
T Consensus 922 -----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11123456888899999999999999999999988
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=281.65 Aligned_cols=243 Identities=21% Similarity=0.314 Sum_probs=188.2
Q ss_pred eEeeccccceEEEEEecCCC-------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 27 EVIGKGSFGQVIRALDHKTN-------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~-------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.||.|+||.||+|.+.... .+|+|.+......
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~---------------------------------------- 40 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD---------------------------------------- 40 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch----------------------------------------
Confidence 46899999999999986543 2477765322111
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC-----CCCCHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY-----QGFSLGLIRR 173 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~-----~~~~~~~~~~ 173 (429)
.....+.+|+.+++.+.|+ ||+++++++......++||||+. ++|.+++..... ..+++..+..
T Consensus 41 ----~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 110 (269)
T cd05044 41 ----QEKKEFLKEAHLMSNFNHP------NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLD 110 (269)
T ss_pred ----hhHHHHHHHHHHHHhcCCC------CeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHH
Confidence 1123466699999999877 99999999998899999999995 699999875422 2378899999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCC---CcceEEeeecccccccCcc-----eeeecCccccchhhhhCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG---SSSIKVIDFGSSCYSHQRV-----YTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~---~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~ 245 (429)
++.|++.||+|||+++++|+||+|+||+++.++ ...++|+|||++....... ....++..|+|||++.+..+
T Consensus 111 ~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 190 (269)
T cd05044 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF 190 (269)
T ss_pred HHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCc
Confidence 999999999999999999999999999998754 2368999999986533211 12234677999999998889
Q ss_pred CCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 246 GPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 246 ~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
+.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 191 ~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------------------------------- 231 (269)
T cd05044 191 TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR--------------------------------------- 231 (269)
T ss_pred ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc---------------------------------------
Confidence 999999999999999998 9999987766554443321000
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.......++.+.+++.+||+.+|++||++.++++
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 --LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred --cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0001123678899999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=280.58 Aligned_cols=245 Identities=18% Similarity=0.212 Sum_probs=182.5
Q ss_pred eEeeccccceEEEEEecCCC---cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchh
Q psy17270 27 EVIGKGSFGQVIRALDHKTN---THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKK 103 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~ 103 (429)
+.||+|+||.||+|.+.... .+|+|.+.......
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~------------------------------------------- 37 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ------------------------------------------- 37 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChH-------------------------------------------
Confidence 46899999999999875432 34777664332211
Q ss_pred hhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC---CCCCHHHHHHHHHHHH
Q psy17270 104 RFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY---QGFSLGLIRRFAFSLV 179 (429)
Q Consensus 104 ~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~---~~~~~~~~~~i~~qil 179 (429)
....+.+|+.+++.++|+ ||+++++++.....+++||||+. |+|.+++..... ...+...+..++.|++
T Consensus 38 -~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~ 110 (269)
T cd05087 38 -EQMKFLEEAQPYRSLQHS------NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIA 110 (269)
T ss_pred -HHHHHHHHHHHHHhCCCC------CEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHH
Confidence 112456699999999877 99999999998889999999995 799999875431 2366778889999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCccccchhhhhCC-------CCCC
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRFYRSPEVILGL-------PYGP 247 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~-------~~~~ 247 (429)
.||+|||+.|++|+||||+||+++.++ .++|+|||.+....... ....++..|+|||++.+. .++.
T Consensus 111 ~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 188 (269)
T cd05087 111 LGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTK 188 (269)
T ss_pred HHHHHHHHCCEeccccCcceEEEcCCC--cEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCc
Confidence 999999999999999999999999877 89999999986433211 123456789999998642 3578
Q ss_pred CccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 248 PIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 248 ~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
++|+|||||++|+|++ |..||...+..+............. . .
T Consensus 189 ~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~------~ 232 (269)
T cd05087 189 ESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL------------------------------P------K 232 (269)
T ss_pred cchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC------------------------------C------C
Confidence 9999999999999996 9999987766544332221000000 0 0
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.......++.+.+++.+|+ .||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0011123677889999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=278.67 Aligned_cols=262 Identities=26% Similarity=0.354 Sum_probs=205.1
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.+..+-+..||.|+||+|++..|+.+|+. |+|.++......+.
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq------------------------------------ 106 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQ------------------------------------ 106 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHH------------------------------------
Confidence 34445567899999999999999999988 99999766553222
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHH---hhCCCCCCHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIK---RNNYQGFSLGLIRRFA 175 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~---~~~~~~~~~~~~~~i~ 175 (429)
.++++|.++..+-+ ..|||+++|+....++..|+.||+|+-+|..+.+ .-.+..++|.-+..|.
T Consensus 107 --------~rll~e~d~~mks~-----~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~It 173 (361)
T KOG1006|consen 107 --------KRLLMEHDTVMKSS-----NCPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHIT 173 (361)
T ss_pred --------HHHHHHHHHHHhhc-----CCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhhee
Confidence 24555777666554 4579999999999999999999999877665543 2333459999999999
Q ss_pred HHHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCC--CCCCCcc
Q psy17270 176 FSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGL--PYGPPID 250 (429)
Q Consensus 176 ~qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~--~~~~~~D 250 (429)
...+.||.||-.. .|+|||+||+|||++..| .|||||||.+...... ...-.|.+.|||||.+... .|+.++|
T Consensus 174 vatV~AL~yLK~~lkiIHRDvKPSNILldr~G--~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSD 251 (361)
T KOG1006|consen 174 VATVDALDYLKEELKIIHRDVKPSNILLDRHG--DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSD 251 (361)
T ss_pred eeehhHHHHHHHHhhhhhccCChhheEEecCC--CEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhh
Confidence 9999999999965 899999999999999999 9999999998654332 2234688899999999754 4899999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCH-HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENE-VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
+||||+++||+.||..||.+.+. .+++..++. |.||.-. ....
T Consensus 252 vWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~-~~~~--------------------------------- 295 (361)
T KOG1006|consen 252 VWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILL-FDKE--------------------------------- 295 (361)
T ss_pred hhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeec-Cccc---------------------------------
Confidence 99999999999999999988654 355544443 4333211 0000
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....+..+..||.-||..|-++||...++++++|++.-.
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 011378899999999999999999999999999998643
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=302.78 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=212.4
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.+-|+|++.||.|.+|.||+++++.+++. |+|+........++.+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE---------------------------------- 63 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIE---------------------------------- 63 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHH----------------------------------
Confidence 56799999999999999999999999986 8888765555444333
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE-----cCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-----RNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.|.+||+.+.+ |||++.+|++|.. ++.+|||||||+ |+.-|+++.....++.+..+.
T Consensus 64 ------------~eynil~~~~~-----hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~Ia 126 (953)
T KOG0587|consen 64 ------------LEYNMLKKYSH-----HPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIA 126 (953)
T ss_pred ------------HHHHHHHhccC-----CCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHH
Confidence 38888888764 4699999999864 358999999995 799999998877789999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCC-----C
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGL-----P 244 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~-----~ 244 (429)
.|++.++.|+.+||.+.++|||||-.|||++.++ .|||+|||.+.... ...++.+|||.|||||++... .
T Consensus 127 YI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~--~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~t 204 (953)
T KOG0587|consen 127 YILREILRGLAHLHNNKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDAT 204 (953)
T ss_pred HHHHHHHHHHHHHhhcceeeecccCceEEEeccC--cEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCC
Confidence 9999999999999999999999999999999999 99999999986533 456778999999999999743 4
Q ss_pred CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
|+..+|+||||++..||.-|.+|+-..-+...+-.|- ..||+....
T Consensus 205 yd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RNPPPkLkr------------------------------- 250 (953)
T KOG0587|consen 205 YDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPPKLKR------------------------------- 250 (953)
T ss_pred cccccchhhccceeehhcCCCCCccCcchhhhhccCC---CCCCccccc-------------------------------
Confidence 7889999999999999999999998766654433222 222222110
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
+...++.|.+||..||..|-.+||+..++|+|||++..
T Consensus 251 -----p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 251 -----PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred -----hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 11226899999999999999999999999999999843
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=287.17 Aligned_cols=247 Identities=18% Similarity=0.237 Sum_probs=190.7
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-----hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-----ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-----aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.++|++.+.||+|+||.||+|.+..++.. |+|.+.....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~------------------------------------ 49 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG------------------------------------ 49 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC------------------------------------
Confidence 46789999999999999999999877752 5555432211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
......+.+|+.+++.+.|+ ||+++++++.. ...++++|++. |+|.+++.... ..+++..+..
T Consensus 50 --------~~~~~~~~~e~~~~~~l~h~------niv~~~~~~~~-~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~ 113 (303)
T cd05110 50 --------PKANVEFMDEALIMASMDHP------HLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLN 113 (303)
T ss_pred --------HHHHHHHHHHHHHHHhCCCC------CcccEEEEEcC-CCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHH
Confidence 11122456699999998877 99999998864 45678999995 79999987654 3489999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCccccchhhhhCCCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++....... ....++..|+|||++.+..++.+
T Consensus 114 ~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 191 (303)
T cd05110 114 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN--HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191 (303)
T ss_pred HHHHHHHHHHHHhhcCeeccccccceeeecCCC--ceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChH
Confidence 999999999999999999999999999998877 89999999997543211 12234667999999988889999
Q ss_pred ccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|||||||++|+|++ |..||.+....+....+.. ...++
T Consensus 192 ~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~--------------------------------------- 231 (303)
T cd05110 192 SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-GERLP--------------------------------------- 231 (303)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCC---------------------------------------
Confidence 999999999999997 9999987654433221110 00000
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+...+..+.+++.+||..||++||++.++++.
T Consensus 232 -~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 -QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011235678899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=294.47 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=201.9
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
.-|..++.||-|+||.|.++.-.+|... |+|.+++... ...
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-------l~r------------------------------- 670 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-------LMR------------------------------- 670 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-------Hhh-------------------------------
Confidence 4588999999999999999998888754 8887743311 000
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.-...+..|-.||..-..+ =||++|-.|.+.+.+|+||+|+ +|++-.++-+..- |.|..++.|+..+
T Consensus 671 ----nQvaHVKAERDILAEADn~------WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEl 738 (1034)
T KOG0608|consen 671 ----NQVAHVKAERDILAEADNE------WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAEL 738 (1034)
T ss_pred ----hhhhhhhhhhhhHhhcCCc------ceEEEEEEeccCCceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHH
Confidence 0011233477888887666 8999999999999999999999 5798888877654 9999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc---ccC--------------------------------
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQ-------------------------------- 223 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~---~~~-------------------------------- 223 (429)
.+|+++.|..|+|||||||+|||||.+| +|||+|||++.- .+.
T Consensus 739 tcAiesVHkmGFIHRDiKPDNILIDrdG--HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~ 816 (1034)
T KOG0608|consen 739 TCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLE 816 (1034)
T ss_pred HHHHHHHHhccceecccCccceEEccCC--ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHH
Confidence 9999999999999999999999999999 999999999831 100
Q ss_pred ----------cceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHh
Q psy17270 224 ----------RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVIN 293 (429)
Q Consensus 224 ----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 293 (429)
.....+||+.|+|||++....|+..+|.||.|||||||+.|++||-..+..+.-.++..... .+.
T Consensus 817 ~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-----~l~ 891 (1034)
T KOG0608|consen 817 RRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN-----FLH 891 (1034)
T ss_pred HHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh-----ccc
Confidence 00124789999999999999999999999999999999999999988776554444332111 000
Q ss_pred hhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCCC
Q psy17270 294 TASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT---PDEALRHEWLKSSSSS 370 (429)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~ell~h~~~~~~~~~ 370 (429)
. + .-...++++.++|.++ ..++++|+. ++|+-.||||+.....
T Consensus 892 ~--------------------------~-------~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 892 I--------------------------P-------YQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGIDFS 937 (1034)
T ss_pred c--------------------------c-------cccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccchH
Confidence 0 0 0012378888999885 457888885 7889999999987644
Q ss_pred C
Q psy17270 371 S 371 (429)
Q Consensus 371 ~ 371 (429)
.
T Consensus 938 s 938 (1034)
T KOG0608|consen 938 S 938 (1034)
T ss_pred h
Confidence 3
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=278.92 Aligned_cols=241 Identities=20% Similarity=0.274 Sum_probs=182.1
Q ss_pred eEeeccccceEEEEEecCCC----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 27 EVIGKGSFGQVIRALDHKTN----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
+.||+|+||.||+|.+...+ .+|+|.+......
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~------------------------------------------- 37 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL------------------------------------------- 37 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH-------------------------------------------
Confidence 46899999999999975433 2477765321111
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEE-EcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY-FRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.....+.+|+.+++.++|+ ||+++++++. .+...+++|||+. ++|.+++.... ...+...+..++.|++.
T Consensus 38 -~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~ 109 (262)
T cd05058 38 -EEVEQFLKEGIIMKDFSHP------NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAK 109 (262)
T ss_pred -HHHHHHHHHHHHHccCCCC------CcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHH
Confidence 1123455688888888776 9999999765 4556899999995 79999987654 23678888999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-------eeeecCccccchhhhhCCCCCCCccccc
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-------YTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
||+|||+.+++|+||||+||+++.++ .++|+|||++....... ....++..|+|||.+.+..++.++||||
T Consensus 110 ~l~~lH~~~i~H~dlk~~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 187 (262)
T cd05058 110 GMEYLASKKFVHRDLAARNCMLDESF--TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWS 187 (262)
T ss_pred HHHHHHhCCccccccCcceEEEcCCC--cEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHH
Confidence 99999999999999999999999887 89999999986543211 1223466799999998888999999999
Q ss_pred hhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 254 LGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 254 lG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||++|+|++ |.+||...+..+....+... ..+ .....
T Consensus 188 lG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~~---------------------------------------~~~~~ 226 (262)
T cd05058 188 FGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RRL---------------------------------------LQPEY 226 (262)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CCC---------------------------------------CCCCc
Confidence 9999999999 57778776654433322210 000 00012
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.++.+.+++.+||..||++||++.|+++.
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 35788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=278.56 Aligned_cols=202 Identities=19% Similarity=0.243 Sum_probs=160.2
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
..+.+|+.+++.++|+ ||+++++++.. ...++||||+. ++|.+++.... ..++...+..++.||+.||+||
T Consensus 46 ~~~~~e~~~l~~l~h~------~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~L 117 (259)
T cd05037 46 LAFFETASLMSQLSHK------HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYL 117 (259)
T ss_pred HHHHHHHHHHHcCCCc------chhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHH
Confidence 4566789999988877 99999999887 77899999995 68999988765 2589999999999999999999
Q ss_pred HHCCceecccCCCcEEEecCCCc-----ceEEeeecccccccCcceeeecCccccchhhhhCC--CCCCCccccchhhHH
Q psy17270 186 HRENIIHCDLKPENVLLKQRGSS-----SIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGL--PYGPPIDMWSLGCIL 258 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~~-----~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il 258 (429)
|++|++|+||||+||+++.++.. .++|+|||++..... .....++..|+|||++.+. .++.++|||||||++
T Consensus 118 H~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~ 196 (259)
T cd05037 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTL 196 (259)
T ss_pred hhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHH
Confidence 99999999999999999876532 599999999876544 2234567789999999876 688999999999999
Q ss_pred HHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 259 AELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 259 ~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
|+|++ |..||...+..+....... .. .. .......+
T Consensus 197 ~~l~~~~~~p~~~~~~~~~~~~~~~-~~-------------------------------~~-----------~~~~~~~~ 233 (259)
T cd05037 197 LEICSNGEEPLSTLSSSEKERFYQD-QH-------------------------------RL-----------PMPDCAEL 233 (259)
T ss_pred HHHHhCCCCCcccCCchhHHHHHhc-CC-------------------------------CC-----------CCCCchHH
Confidence 99999 5888876543222111100 00 00 00012678
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+++.+||..||.+|||+.++++
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 234 ANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHhccChhhCCCHHHHHH
Confidence 89999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=279.87 Aligned_cols=260 Identities=19% Similarity=0.292 Sum_probs=187.7
Q ss_pred cCCeEEEeEeeccccceEEEEEe----cCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALD----HKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~----~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
..+|++++.||+|+||+||+|.. ..++. +|+|++.....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~------------------------------------ 46 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA------------------------------------ 46 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH------------------------------------
Confidence 45899999999999999999984 33444 48887643211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeec-CcCHHHHHHhhCCCCCCHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELM-NLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~ 171 (429)
.....+.+|+++++.+.|+ ||+++++++... ..+++||||+ +++|.+++.... ..+++..+
T Consensus 47 ---------~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~ 110 (284)
T cd05081 47 ---------EHLRDFEREIEILKSLQHD------NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKL 110 (284)
T ss_pred ---------HHHHHHHHHHHHHHhCCCC------CeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHH
Confidence 1123456699999999877 999999987543 4689999999 479999987653 34899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce------eeecCccccchhhhhCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY------TYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~ 245 (429)
..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........ ...++..|+|||++.+..+
T Consensus 111 ~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 188 (284)
T cd05081 111 LLYASQICKGMEYLGSKRYVHRDLATRNILVESEN--RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188 (284)
T ss_pred HHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC--eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCc
Confidence 99999999999999999999999999999999888 899999999875432211 1122345999999988889
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcH--HHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPD--EVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
+.++|||||||++|+|++|..++...... .... .+.... ........ .. .. ...
T Consensus 189 ~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~--~~-~~----------~~~------ 244 (284)
T cd05081 189 SVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRM----MGNDKQGQMIVYHLIE--LL-KN----------NGR------ 244 (284)
T ss_pred ChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhh----cccccccccchHHHHH--HH-hc----------CCc------
Confidence 99999999999999999988776543221 1110 011000 00000000 00 00 000
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.......+..+.+|+.+||..||++|||+.|++.
T Consensus 245 ---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 245 ---LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0011234678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=290.35 Aligned_cols=211 Identities=26% Similarity=0.357 Sum_probs=177.1
Q ss_pred eeeeehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccc
Q psy17270 7 ILSFAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEES 86 (429)
Q Consensus 7 ~~~~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~ 86 (429)
...|.+..+.. -.+.|.-...||+|+||.||+|.-..+..+|||++......
T Consensus 62 ~~~fs~~el~~-AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~--------------------------- 113 (361)
T KOG1187|consen 62 LRSFSYDELRK-ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ--------------------------- 113 (361)
T ss_pred cceeeHHHHHH-HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc---------------------------
Confidence 44566666664 45788889999999999999999987766799876332111
Q ss_pred cccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-eEEEEEeec-CcCHHHHHHhhCCC
Q psy17270 87 LSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-HLCISFELM-NLNLYELIKRNNYQ 164 (429)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~-~g~L~~~i~~~~~~ 164 (429)
. ..+|.+|++++.+++|+ |++++++||.+.. +.+||+||| +|+|.+.+......
T Consensus 114 -----------------~-~~eF~~Ei~~ls~l~H~------Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~ 169 (361)
T KOG1187|consen 114 -----------------G-EREFLNEVEILSRLRHP------NLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE 169 (361)
T ss_pred -----------------c-hhHHHHHHHHHhcCCCc------CcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC
Confidence 0 23578899999999988 9999999999888 599999999 58999999876532
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCCCcEEEecCCCcceEEeeecccccccC-cce--ee-ecCccccch
Q psy17270 165 GFSLGLIRRFAFSLVQCLRLLHREN---IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVY--TY-IQSRFYRSP 237 (429)
Q Consensus 165 ~~~~~~~~~i~~qil~~l~~lH~~~---ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~--~~-~~t~~y~aP 237 (429)
.+++..+..|+.+++.||+|||... |+|||||++|||+|.+. ..||+|||+|+.... ... +. .||..|+||
T Consensus 170 ~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~--~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~P 247 (361)
T KOG1187|consen 170 PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF--NAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAP 247 (361)
T ss_pred CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC--CEEccCccCcccCCccccceeeecCCCCccCCh
Confidence 6899999999999999999999863 99999999999999887 899999999976543 222 22 799999999
Q ss_pred hhhhCCCCCCCccccchhhHHHHHhhCCCCCCCC
Q psy17270 238 EVILGLPYGPPIDMWSLGCILAELYTGCPLFPGE 271 (429)
Q Consensus 238 E~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 271 (429)
|++.....+.++|||||||++.||+||+.+.+..
T Consensus 248 Ey~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 248 EYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred hhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999888999999999999999999999888754
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=275.94 Aligned_cols=245 Identities=19% Similarity=0.268 Sum_probs=182.3
Q ss_pred eEeeccccceEEEEEecCCCcc---hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTH---ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKK 103 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~---aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~ 103 (429)
+.||+|+||+||+|.....+.+ ++|.+..... .
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--------------------------------------------~ 36 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--------------------------------------------S 36 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--------------------------------------------h
Confidence 3699999999999987555433 4444322111 1
Q ss_pred hhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC--CCCCHHHHHHHHHHHHH
Q psy17270 104 RFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY--QGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 104 ~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~--~~~~~~~~~~i~~qil~ 180 (429)
.....+.+|+.+++.++|+ ||+++++.+......|+||||+. |+|.+++.+... ..+++..+..++.||+.
T Consensus 37 ~~~~~~~~e~~~~~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~ 110 (268)
T cd05086 37 KEQNEFLQQGDPYRILQHP------NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110 (268)
T ss_pred HHHHHHHHHHHHHhccCCc------chhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHH
Confidence 1234566788888888877 99999999998899999999996 699999876432 23677888999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----cceeeecCccccchhhhhC-------CCCCCC
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RVYTYIQSRFYRSPEVILG-------LPYGPP 248 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~-------~~~~~~ 248 (429)
||+|||+++++|+||||+|||++.++ .++|+|||++..... ......++..|+|||++.. ..++.+
T Consensus 111 al~~lH~~~i~H~dikp~nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 188 (268)
T cd05086 111 GVTHMHKHNFLHSDLALRNCFLTSDL--TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP 188 (268)
T ss_pred HHHHHHHCCeeccCCccceEEEcCCc--cEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCc
Confidence 99999999999999999999999887 899999999753211 1123467788999999853 235779
Q ss_pred ccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|||||||++|+|++ |..||...+..+.+..+....... . . ..
T Consensus 189 ~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~----------------~-----------------~~ 232 (268)
T cd05086 189 SNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---L----------------F-----------------KP 232 (268)
T ss_pred chhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc---c----------------C-----------------CC
Confidence 999999999999997 678998777665555443210000 0 0 00
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......++.+.+++..|| .||++||++.++++
T Consensus 233 ~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 011123677889999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=277.74 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=195.0
Q ss_pred CeEEEeEeeccccceEEEEEecC-CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHK-TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~-~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
.|++.+.||.|+||.||+|.+.. ++. +|+|.+.......... .
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~-----------------------------------~ 45 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKD-----------------------------------K 45 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccc-----------------------------------c
Confidence 38899999999999999999987 343 4888764332211000 0
Q ss_pred cchhhhhhhHHHHHHHHHH-HhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhh--CCCCCCHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDH-LRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRN--NYQGFSLGLIRRFA 175 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~-l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~--~~~~~~~~~~~~i~ 175 (429)
.........+..|+.++.. +.|+ ||+++++++......+++|||+. ++|.+++... ....+++..++.++
T Consensus 46 ~~~~~~~~~~~~e~~~l~~~~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~ 119 (269)
T cd08528 46 RERDKSIGDIVSEVTIIKEQLRHP------NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119 (269)
T ss_pred ccchHHHHHHHHHHHHHhhcCCCC------CeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHH
Confidence 0011122344557777765 4554 99999999999999999999995 5898887542 22458999999999
Q ss_pred HHHHHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+...... .....++..|+|||.+.+..++.++|+|
T Consensus 120 ~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~ 197 (269)
T cd08528 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD--KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVW 197 (269)
T ss_pred HHHHHHHHHhccCCceeecCCCHHHEEECCCC--cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHH
Confidence 999999999996 6899999999999999888 8999999998754432 2235678889999999988899999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||+++|+|++|+.||...+.......+......+.. ...
T Consensus 198 slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~ 237 (269)
T cd08528 198 AFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP----------------------------------------EGM 237 (269)
T ss_pred HHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC----------------------------------------ccc
Confidence 9999999999999999876655444433321111000 012
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.++.+.+++.+||+.||++||++.|+..+
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 36788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.48 Aligned_cols=180 Identities=28% Similarity=0.442 Sum_probs=136.2
Q ss_pred eEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 142 HLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 142 ~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.+||-||||+. .+.++++++... -....++.++++|++||+|+|++|||||||||.|||++.++ .|||+|||++..
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~--~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRN--SVKIGDFGLATD 746 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCC--Ceeecccccchh
Confidence 47899999976 566666665521 14789999999999999999999999999999999999887 999999999865
Q ss_pred cc---------------------CcceeeecCccccchhhhhCCC---CCCCccccchhhHHHHHhhCCCCCCCCCHHHH
Q psy17270 221 SH---------------------QRVYTYIQSRFYRSPEVILGLP---YGPPIDMWSLGCILAELYTGCPLFPGENEVEQ 276 (429)
Q Consensus 221 ~~---------------------~~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 276 (429)
.. ...+..+||-.|+|||++.+.. |+.++||||||+|++||+. ||.. ..+.
T Consensus 747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMER 821 (1351)
T KOG1035|consen 747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMER 821 (1351)
T ss_pred hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc--hHHH
Confidence 10 1233468999999999998654 9999999999999999973 4644 3333
Q ss_pred HHHHHHHh-CCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCH
Q psy17270 277 LACIMEIL-GCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTP 355 (429)
Q Consensus 277 ~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 355 (429)
...+..+. +..|.. +..+...-+.-..+|+.||+.||++||||
T Consensus 822 a~iL~~LR~g~iP~~------------------------------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 822 ASILTNLRKGSIPEP------------------------------------ADFFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred HHHHHhcccCCCCCC------------------------------------cccccccchHHHHHHHHHhcCCCccCCCH
Confidence 33333221 111111 01111123455699999999999999999
Q ss_pred HHHhcCCCCC
Q psy17270 356 DEALRHEWLK 365 (429)
Q Consensus 356 ~ell~h~~~~ 365 (429)
.|+|.+.||.
T Consensus 866 ~eLL~s~llp 875 (1351)
T KOG1035|consen 866 TELLNSELLP 875 (1351)
T ss_pred HHHhhccCCC
Confidence 9999999997
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=278.05 Aligned_cols=260 Identities=18% Similarity=0.260 Sum_probs=191.2
Q ss_pred CCeEEEeEeeccccceEEEEEecCC----C-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKT----N-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~----~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+.|++.+.||.|+||.||+|....+ + .+|+|++......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~------------------------------------ 47 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE------------------------------------ 47 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch------------------------------------
Confidence 5689999999999999999996533 3 3488877543221
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--cCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--RNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|+++++.+.|+ ||+++++++.. ....+++|||+. ++|.+++.... ..++...+.
T Consensus 48 --------~~~~~~~~ei~~l~~l~~~------~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~ 112 (284)
T cd05038 48 --------QHRSDFEREIEILRTLDHE------NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLL 112 (284)
T ss_pred --------HHHHHHHHHHHHHHhCCCC------ChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHH
Confidence 1223566699999998877 99999999877 558999999995 69999997654 248999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce------eeecCccccchhhhhCCCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY------TYIQSRFYRSPEVILGLPYG 246 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~ 246 (429)
.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+........ ...++..|+|||.+.+..++
T Consensus 113 ~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~ 190 (284)
T cd05038 113 LFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFS 190 (284)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCC
Confidence 9999999999999999999999999999999887 899999999876542211 12334569999999888899
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcH-HHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPD-EVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
.++|+|||||++|+|++|..|+........ . ..+.... ........ .+ .. ... .
T Consensus 191 ~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~---~~~~~~~~~~~~~~~~-~~--~~----------~~~--~----- 245 (284)
T cd05038 191 SASDVWSFGVTLYELFTYGDPSQSPPAEFL--R---MIGIAQGQMIVTRLLE-LL--KE----------GER--L----- 245 (284)
T ss_pred cccchHHHhhhhheeeccCCCcccccchhc--c---ccccccccccHHHHHH-HH--Hc----------CCc--C-----
Confidence 999999999999999999999865432110 0 0000000 00000000 00 00 000 0
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 246 --~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 246 --PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 001123578999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=273.93 Aligned_cols=247 Identities=19% Similarity=0.227 Sum_probs=187.7
Q ss_pred eEEEeEeeccccceEEEEEecC---CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 23 YEILEVIGKGSFGQVIRALDHK---TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~---~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
|++.+.||+|+||.||+|.+.. ++. +|+|++.......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-------------------------------------- 42 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-------------------------------------- 42 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh--------------------------------------
Confidence 6788999999999999999754 333 4888774332111
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC------eEEEEEeecC-cCHHHHHHhhC----CCCCC
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN------HLCISFELMN-LNLYELIKRNN----YQGFS 167 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~------~~~lv~e~~~-g~L~~~i~~~~----~~~~~ 167 (429)
.....+.+|+++++.+.|+ ||+++++++.... ..++++||+. |+|.+++.... ...++
T Consensus 43 -----~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 111 (273)
T cd05074 43 -----SDIEEFLREAACMKEFDHP------NVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLP 111 (273)
T ss_pred -----HHHHHHHHHHHHHhcCCCC------CcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCC
Confidence 1123456699999999877 9999999886532 2478899984 78888775322 12378
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCccccchhhhhC
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRFYRSPEVILG 242 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~ 242 (429)
...+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... ....++..|++||.+.+
T Consensus 112 ~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05074 112 LQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM--TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD 189 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC--CEEECcccccccccCCcceecCCCccCchhhcCHhHHhc
Confidence 999999999999999999999999999999999998877 89999999987543211 12234567999999998
Q ss_pred CCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
..++.++|||||||++|+|++ |.+||.+.+..+....+..... .
T Consensus 190 ~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------------- 234 (273)
T cd05074 190 NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-L---------------------------------- 234 (273)
T ss_pred CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-C----------------------------------
Confidence 888999999999999999999 8999987766544333221000 0
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......+..+.+++.+||+.+|++|||+.+++.+
T Consensus 235 ------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 ------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0001236788999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=292.99 Aligned_cols=258 Identities=18% Similarity=0.256 Sum_probs=209.4
Q ss_pred hhcccccCCeEEEeEeeccccceEEEEEecCCC-c---chheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTN-T---HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 14 ~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~-~---~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
..+=|=.+..++.++||+|+||.||+|.++..+ + +|+|+++......
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~----------------------------- 153 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA----------------------------- 153 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-----------------------------
Confidence 333333567788899999999999999997654 2 3777764332211
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCH
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSL 168 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~ 168 (429)
....|++|+.+|..|.|+ |++++|++..+ .-..+|||++. |+|.+.++......|..
T Consensus 154 ---------------~mddflrEas~M~~L~H~------hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv 211 (1039)
T KOG0199|consen 154 ---------------IMDDFLREASHMLKLQHP------HLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLV 211 (1039)
T ss_pred ---------------hHHHHHHHHHHHHhccCc------ceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeH
Confidence 234678899999999998 99999999987 77889999995 79999999866667999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeec------CccccchhhhhC
Q psy17270 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ------SRFYRSPEVILG 242 (429)
Q Consensus 169 ~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~------t~~y~aPE~~~~ 242 (429)
...+.|+.||+.||.||.++++|||||...|+|+.... .|||+|||+.+........++. ...|||||.++.
T Consensus 212 ~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh 289 (1039)
T KOG0199|consen 212 SRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH 289 (1039)
T ss_pred HHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc--eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc
Confidence 99999999999999999999999999999999999865 8999999999875543322222 234999999999
Q ss_pred CCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
.+++.++|+|++||++|||+| |+.||.|-....++..|-+.-
T Consensus 290 ~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e------------------------------------- 332 (1039)
T KOG0199|consen 290 RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE------------------------------------- 332 (1039)
T ss_pred ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-------------------------------------
Confidence 999999999999999999999 899999999888777664211
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
.-.-++.+++++.+++..||..+|.+|||...+.+.-++.
T Consensus 333 ----rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 333 ----RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred ----cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 1111345689999999999999999999999886554443
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=265.61 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=201.5
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|+++++||+|+|++|.++++++|.+. |+|++++.....+.. ..
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded--id-------------------------------- 295 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED--ID-------------------------------- 295 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc--ch--------------------------------
Confidence 5699999999999999999999999875 999886654332211 11
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
-+..|..+...-+ .+|.++-+..+|..+..+++|.||.+ |+|---++++++ +++..++.+...|
T Consensus 296 --------wvqtek~vfe~as-----n~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei 360 (593)
T KOG0695|consen 296 --------WVQTEKHVFEQAS-----NNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEI 360 (593)
T ss_pred --------hHHhhHHHHHhcc-----CCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHH
Confidence 1222555555543 34699999999999999999999995 577655555543 9999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc---ccCcceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
+.||.|||++||+.||||.+|+|++..| ++||+|+|.++. .+....++||||.|.|||++.+..|+.++|.|+||
T Consensus 361 ~lal~flh~rgiiyrdlkldnvlldaeg--hikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalg 438 (593)
T KOG0695|consen 361 CLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALG 438 (593)
T ss_pred HHHHHHHhhcCeeeeeccccceEEccCC--ceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHH
Confidence 9999999999999999999999999999 999999999864 34556789999999999999999999999999999
Q ss_pred hHHHHHhhCCCCCCCC-------CHHHHHHHHH-HHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 256 CILAELYTGCPLFPGE-------NEVEQLACIM-EILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 256 ~il~~lltg~~pf~~~-------~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
|+++||+.|+.||.-. +.++.+-++. +..- +
T Consensus 439 vlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-------------------------------r---------- 477 (593)
T KOG0695|consen 439 VLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-------------------------------R---------- 477 (593)
T ss_pred HHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-------------------------------c----------
Confidence 9999999999999532 2222222221 1000 0
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLT------PDEALRHEWLKSSSS 369 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpt------a~ell~h~~~~~~~~ 369 (429)
.++..+-.+..+++..|+.||.+|.. .+++-.|+||+...-
T Consensus 478 -iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 478 -IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred -ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 11122444568899999999999985 689999999997653
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=288.95 Aligned_cols=206 Identities=26% Similarity=0.378 Sum_probs=170.9
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..-+.-+..-+.||.||||.||+++++.+|.. |||.++.......
T Consensus 9 ~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~---------------------------------- 54 (732)
T KOG4250|consen 9 SGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP---------------------------------- 54 (732)
T ss_pred cCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccch----------------------------------
Confidence 33445567778999999999999999999975 9998765432211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeec-CcCHHHHHHhhCC-CCCC
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELM-NLNLYELIKRNNY-QGFS 167 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~-~g~L~~~i~~~~~-~~~~ 167 (429)
.+.-.+|+++|++|+|+ |||++.++-++. ....+||||| +|+|+.++.+-.. .+++
T Consensus 55 ----------~e~~~~EieilkKLnh~------NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLp 118 (732)
T KOG4250|consen 55 ----------RERWCREIEILKKLNHP------NIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLP 118 (732)
T ss_pred ----------HHHHHHHHHHHHHcCch------hhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCC
Confidence 22334499999999988 999998876543 3678999999 5799999986533 4599
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecC--CCcceEEeeecccccccC--cceeeecCccccchhhhh-C
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQR--GSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVIL-G 242 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~--~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~-~ 242 (429)
+.++..++.++..||.|||.+||+||||||.||++... |+...||+|||.|+...+ .....+||+.|.+||++. +
T Consensus 119 E~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q 198 (732)
T KOG4250|consen 119 ESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQ 198 (732)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhc
Confidence 99999999999999999999999999999999998753 455679999999987553 456689999999999998 4
Q ss_pred CCCCCCccccchhhHHHHHhhCCCCCCCCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYTGCPLFPGEN 272 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 272 (429)
..|+..+|.|||||++|+.+||..||....
T Consensus 199 ~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 199 KKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 789999999999999999999999996543
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=282.76 Aligned_cols=244 Identities=21% Similarity=0.320 Sum_probs=205.5
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.....+.++||.|.||.||.|++++-. .+|+|.++....
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---------------------------------------- 305 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------------------------------------- 305 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----------------------------------------
Confidence 344667789999999999999998876 458887643321
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
-.++|+.|+.+|+.++|+ |+++++++|..+--+|||+||| .|+|.+++++.....++.-....++.|
T Consensus 306 ------eveEFLkEAAvMKeikHp------NLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQ 373 (1157)
T KOG4278|consen 306 ------EVEEFLKEAAVMKEIKHP------NLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQ 373 (1157)
T ss_pred ------hHHHHHHHHHHHHhhcCc------cHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHH
Confidence 135678899999999998 9999999999999999999999 689999999988777888999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee-eec---CccccchhhhhCCCCCCCccccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT-YIQ---SRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~-~~~---t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
|..|++||..+++|||||...|.|+..+. .||++|||+++.+....++ ..| ..-|.|||-+..+.++.++|||+
T Consensus 374 IsSaMeYLEkknFIHRDLAARNCLVgEnh--iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWA 451 (1157)
T KOG4278|consen 374 ISSAMEYLEKKNFIHRDLAARNCLVGENH--IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWA 451 (1157)
T ss_pred HHHHHHHHHHhhhhhhhhhhhhccccccc--eEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHH
Confidence 99999999999999999999999999887 8999999999987766554 233 34599999999999999999999
Q ss_pred hhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 254 LGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 254 lG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||++||+.| |-.||++-+.......+.... .+.-+.+
T Consensus 452 FGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-----------------------------------------RM~~PeG 490 (1157)
T KOG4278|consen 452 FGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-----------------------------------------RMDGPEG 490 (1157)
T ss_pred HHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-----------------------------------------cccCCCC
Confidence 9999999999 999999987665544333211 1122346
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHH
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEA 358 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~el 358 (429)
+++...+|++.||+|+|.+||+.+|+
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHH
Confidence 68899999999999999999998887
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=285.20 Aligned_cols=244 Identities=20% Similarity=0.352 Sum_probs=197.6
Q ss_pred cCCeEEEeEeeccccceEEEEEecCC--Cc---chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKT--NT---HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~--~~---~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
+++.++.+.||.|.||.||.|+.... |+ +|||.-+..-..
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~----------------------------------- 432 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP----------------------------------- 432 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-----------------------------------
Confidence 45566778999999999999997544 22 255543322211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.-.+.|+.|+.+++.+.|+ ||+++++++. +.-.|||||.+. |.|..+++.+. ..++......
T Consensus 433 ---------d~tekflqEa~iMrnfdHp------hIikLIGv~~-e~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~l 495 (974)
T KOG4257|consen 433 ---------DDTEKFLQEASIMRNFDHP------HIIKLIGVCV-EQPMWIVMELAPLGELREYLQQNK-DSLPLRTLTL 495 (974)
T ss_pred ---------hhHHHHHHHHHHHHhCCCc------chhheeeeee-ccceeEEEecccchhHHHHHHhcc-ccchHHHHHH
Confidence 1245677799999999988 9999999986 467899999995 89999999876 4699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceee--ec--CccccchhhhhCCCCCCCc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTY--IQ--SRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~--~~--t~~y~aPE~~~~~~~~~~~ 249 (429)
+++||+.||+|||+..+|||||...|||+.+.. -|||+|||+++......+.. .| ..-|||||-++-..++.++
T Consensus 496 y~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~--CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtAS 573 (974)
T KOG4257|consen 496 YCYQICTALAYLESKRFVHRDIAARNILVSSPQ--CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTAS 573 (974)
T ss_pred HHHHHHHHHHHHHhhchhhhhhhhhheeecCcc--eeeecccchhhhccccchhhccccccceeecCccccchhcccchh
Confidence 999999999999999999999999999999887 89999999999877554321 12 2349999999999999999
Q ss_pred cccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 250 DMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 250 DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
|||.|||.+||++. |..||.+....+.+..|.+ ++...
T Consensus 574 DVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn-----------------------------------------GeRlP 612 (974)
T KOG4257|consen 574 DVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN-----------------------------------------GERLP 612 (974)
T ss_pred hHHHHHHHHHHHHHhcCCccccccccceEEEecC-----------------------------------------CCCCC
Confidence 99999999999987 9999999877666544432 11222
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHH
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~el 358 (429)
.++.+++.+..++.+||++||.+||+..++
T Consensus 613 ~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 613 CPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred CCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 345568999999999999999999997665
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=273.62 Aligned_cols=290 Identities=25% Similarity=0.404 Sum_probs=208.9
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecC---CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHK---TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~---~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
+.+.+-|.++++||.|+|++||+|++.. .+. +|+|.+.....
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---------------------------------- 77 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---------------------------------- 77 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----------------------------------
Confidence 5678889999999999999999999876 333 38776632211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~ 171 (429)
-..+.+|+++|..+.-. .||+.+.+.+..++.+++||||++. +..++... ++...+
T Consensus 78 -------------p~ri~~El~~L~~~gG~-----~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i 134 (418)
T KOG1167|consen 78 -------------PSRILNELEMLYRLGGS-----DNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEI 134 (418)
T ss_pred -------------chHHHHHHHHHHHhccc-----hhhhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHH
Confidence 12467799999999744 4999999999999999999999975 66666554 778999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc-----------c------cC-----------
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY-----------S------HQ----------- 223 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~-----------~------~~----------- 223 (429)
+.+++.++.||+++|.+|||||||||.|+|++.... .-.|+|||++.. . ..
T Consensus 135 ~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~ 213 (418)
T KOG1167|consen 135 RWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSV 213 (418)
T ss_pred HHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccccccc
Confidence 999999999999999999999999999999987533 678999999841 0 00
Q ss_pred -----c--------------ceeeecCccccchhhhhCC-CCCCCccccchhhHHHHHhhCCCCC-CCCCHHHHHHHHHH
Q psy17270 224 -----R--------------VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCILAELYTGCPLF-PGENEVEQLACIME 282 (429)
Q Consensus 224 -----~--------------~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf-~~~~~~~~~~~i~~ 282 (429)
. .....||++|+|||++... ..+.++||||.|||+..++++..|| ...++.+.+.+|+.
T Consensus 214 ~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~t 293 (418)
T KOG1167|consen 214 ATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIAT 293 (418)
T ss_pred ccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHH
Confidence 0 0114689999999999865 4688999999999999999999886 56677788888888
Q ss_pred HhCCCcHHHHhhhhhhhhhccCCCCCcc------------ccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCC
Q psy17270 283 ILGCPPDEVINTASRRRLFFDSKGTPRC------------ITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSK 350 (429)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 350 (429)
..|...-.-.-....+...+...+.+.. ....+..+. ...........+..+.||+.+||..||.
T Consensus 294 ifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~---n~~~~~~~d~~~~~~~dlLdk~le~np~ 370 (418)
T KOG1167|consen 294 IFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP---NTEREIGSDVFPALLLDLLDKCLELNPQ 370 (418)
T ss_pred HhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc---ceeeccccccccHHHHHHHHHHccCChh
Confidence 7775332221111111000110110000 000000000 0011111122345889999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q psy17270 351 KRLTPDEALRHEWLKSS 367 (429)
Q Consensus 351 ~Rpta~ell~h~~~~~~ 367 (429)
+|.||+++|+||||...
T Consensus 371 kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 371 KRITAEDALKHPFFDEA 387 (418)
T ss_pred hcccHHHHhcCcCCcch
Confidence 99999999999999843
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=284.11 Aligned_cols=285 Identities=19% Similarity=0.265 Sum_probs=186.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCC-----------------cchheeccccchhhHHHHHHHHHHHHHhccccccc
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTN-----------------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~-----------------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~ 81 (429)
-.++|++.++||+|+||+||+|.+..++ .+|+|++........ .++.+...
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~-~~fl~e~~----------- 210 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVR-QDFLKTGT----------- 210 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhH-HHHHhhhh-----------
Confidence 3678999999999999999999864332 246666543221111 11110000
Q ss_pred ccccccccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--------cCeEEEEEeecC-c
Q psy17270 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--------RNHLCISFELMN-L 152 (429)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--------~~~~~lv~e~~~-g 152 (429)
......+....|+.++..+.|.+ ..+.++++++++|.. ....++||||+. +
T Consensus 211 -------------------~~~~~~e~~~vE~~~l~~l~~~~-l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~g 270 (507)
T PLN03224 211 -------------------LAKGSAETGMVEAYMCAKIKRNP-IAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDA 270 (507)
T ss_pred -------------------hhhcccchhHHHHHHHHHhhccc-chhhhhhhhhhhcccccccccccCCceEEEEEcCCCC
Confidence 01123345666888888888763 223455677777643 356899999995 6
Q ss_pred CHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcce
Q psy17270 153 NLYELIKRNN----------------------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSI 210 (429)
Q Consensus 153 ~L~~~i~~~~----------------------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~v 210 (429)
+|.+++.... ...++...++.++.|++.+|.|||+++|+||||||+||+++.++ .+
T Consensus 271 sL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~--~~ 348 (507)
T PLN03224 271 TLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG--QV 348 (507)
T ss_pred cHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC--cE
Confidence 9998886421 01245678899999999999999999999999999999999887 89
Q ss_pred EEeeecccccccCc--ce--eeecCccccchhhhhCCC--------------------CC--CCccccchhhHHHHHhhC
Q psy17270 211 KVIDFGSSCYSHQR--VY--TYIQSRFYRSPEVILGLP--------------------YG--PPIDMWSLGCILAELYTG 264 (429)
Q Consensus 211 kl~Dfg~~~~~~~~--~~--~~~~t~~y~aPE~~~~~~--------------------~~--~~~DiwSlG~il~~lltg 264 (429)
+|+|||++...... .. ...+|+.|+|||++.... |+ ...|+||+||++++|++|
T Consensus 349 kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~ 428 (507)
T PLN03224 349 KIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVP 428 (507)
T ss_pred EEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhC
Confidence 99999998653221 11 123478899999986432 12 247999999999999998
Q ss_pred CC-CCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHH
Q psy17270 265 CP-LFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQ 343 (429)
Q Consensus 265 ~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 343 (429)
.. ||........ .+.. ....... |...... ..........++...||+.+
T Consensus 429 ~l~p~~~~~~f~~--~~~~-~~~~~~~-~r~~~~~-------------------------~~~~~~~d~~s~~~~dLi~~ 479 (507)
T PLN03224 429 ELRPVANIRLFNT--ELRQ-YDNDLNR-WRMYKGQ-------------------------KYDFSLLDRNKEAGWDLACK 479 (507)
T ss_pred CCCCccchhhhhh--HHhh-ccchHHH-HHhhccc-------------------------CCCcccccccChHHHHHHHH
Confidence 75 6654321111 0000 0000000 0000000 00011233347889999999
Q ss_pred hcccCC---CCCCCHHHHhcCCCCCC
Q psy17270 344 CFNWDS---KKRLTPDEALRHEWLKS 366 (429)
Q Consensus 344 ~L~~dP---~~Rpta~ell~h~~~~~ 366 (429)
||..+| .+|+|+.|+|+||||..
T Consensus 480 LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 480 LITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HhccCCCCcccCCCHHHHhCCCCcCC
Confidence 999876 68999999999999964
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=290.28 Aligned_cols=256 Identities=21% Similarity=0.277 Sum_probs=218.6
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
++-...-.|.++||.|.||.||+|+.+..++ +|||.++.-.++
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte--------------------------------- 671 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE--------------------------------- 671 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH---------------------------------
Confidence 4456677899999999999999999988774 388887544433
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~ 171 (429)
+....|+.|+.||.++.|+ ||+++.++.....-+.||+||| +|+|..+++.+. +.|+.-+.
T Consensus 672 -----------kqrrdFL~EAsIMGQFdHP------NIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQL 733 (996)
T KOG0196|consen 672 -----------KQRRDFLSEASIMGQFDHP------NIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQL 733 (996)
T ss_pred -----------HHHhhhhhhhhhcccCCCC------cEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehH
Confidence 3344677799999999988 9999999999889999999999 589999999887 45999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeec------CccccchhhhhCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ------SRFYRSPEVILGLPY 245 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~------t~~y~aPE~~~~~~~ 245 (429)
..+++-|+.|+.||-++++|||||...|||++.+- .+|++|||+++...+....... ...|.|||.+...++
T Consensus 734 VgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL--vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKF 811 (996)
T KOG0196|consen 734 VGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKF 811 (996)
T ss_pred HHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce--EEEeccccceeecccCCCccccccCCccceeecChhHhhhccc
Confidence 99999999999999999999999999999999987 8999999999876443322222 245999999999999
Q ss_pred CCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 246 GPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 246 ~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
+.++||||+|+++||.++ |.-||-..+..+.+..|.+....|++
T Consensus 812 TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP----------------------------------- 856 (996)
T KOG0196|consen 812 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP----------------------------------- 856 (996)
T ss_pred CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-----------------------------------
Confidence 999999999999999887 99999999999999999886665553
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC--CCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH--EWLKS 366 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h--~~~~~ 366 (429)
.+++..+.+|+..||++|-+.||+..+++.+ ..+++
T Consensus 857 ------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 857 ------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 2458899999999999999999999999774 44443
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=278.12 Aligned_cols=259 Identities=20% Similarity=0.272 Sum_probs=208.8
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
+.+.=..+..++++||+|.||.|.++.-...-.+|+|.++...+...
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~--------------------------------- 578 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA--------------------------------- 578 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH---------------------------------
Confidence 34455778899999999999999999987655678888866544433
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
+..|.+|+++|.+|+|+ ||++++++|..++.+|+|+||| .|+|.+++.++.--.........
T Consensus 579 -----------r~~F~kEIkiLsqLkhP------NIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vs 641 (807)
T KOG1094|consen 579 -----------RNDFLKEIKILSRLKHP------NIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVS 641 (807)
T ss_pred -----------HHHHHHHHHHHhccCCC------CeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHH
Confidence 34566799999999887 9999999999999999999999 58999999988432244556667
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-cee----eecCccccchhhhhCCCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-VYT----YIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-~~~----~~~t~~y~aPE~~~~~~~~~~ 248 (429)
|+.||+.|++||.+.++||||+.+.|+|++.+. ++||+|||.++..-.. .+. .+-...|||+|.+.-.+++.+
T Consensus 642 i~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~--~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFtta 719 (807)
T KOG1094|consen 642 ICTQIASGMAYLESLNFVHRDLATRNCLVDGEF--TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTA 719 (807)
T ss_pred HHHHHHHHHHHHHhhchhhccccccceeecCcc--cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccch
Confidence 999999999999999999999999999999888 9999999999843222 222 334567999999999999999
Q ss_pred ccccchhhHHHHHhh--CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 249 IDMWSLGCILAELYT--GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 249 ~DiwSlG~il~~llt--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
+|+|+||+++||+++ ..-||...++.+...+....+...+... .
T Consensus 720 SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~----------------------------------~ 765 (807)
T KOG1094|consen 720 SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV----------------------------------V 765 (807)
T ss_pred hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce----------------------------------e
Confidence 999999999999865 7899999888877766555444333221 1
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHh
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEAL 359 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell 359 (429)
...+.-++..+.++|.+||+.|-.+||+.+++-
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 112334577888999999999999999999984
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=289.32 Aligned_cols=245 Identities=26% Similarity=0.306 Sum_probs=188.2
Q ss_pred eEeeccccce-EEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQ-VIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~-Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
+.+|.|+-|+ ||+|..... .+|+|.+-. .+
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~R-~VAVKrll~------------------------------------------------e~ 545 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEGR-EVAVKRLLE------------------------------------------------EF 545 (903)
T ss_pred HHcccCCCCcEEEEEeeCCc-eehHHHHhh------------------------------------------------Hh
Confidence 4688998876 599998654 678887622 23
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRN--NYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~--~~~~~~~~~~~~i~~qil~~l~ 183 (429)
..-+.+|+..|+.-. .||||++++..-.+.++.||..|.|..+|.+++... .......-..+.++.|++.||+
T Consensus 546 ~~~A~rEi~lL~eSD-----~H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~Gla 620 (903)
T KOG1027|consen 546 FDFAQREIQLLQESD-----EHPNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLA 620 (903)
T ss_pred HHHHHHHHHHHHhcc-----CCCceEEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHH
Confidence 334566988888865 457999999999999999999999999999999874 1111222456788999999999
Q ss_pred HHHHCCceecccCCCcEEEec---CCCcceEEeeecccccccC------cceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 184 LLHRENIIHCDLKPENVLLKQ---RGSSSIKVIDFGSSCYSHQ------RVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~---~~~~~vkl~Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
+||+.+||||||||.||||+. ++...++|.|||+++.... +.....||-+|+|||++....-+.++||+||
T Consensus 621 HLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFsl 700 (903)
T KOG1027|consen 621 HLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSL 700 (903)
T ss_pred HHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhc
Confidence 999999999999999999987 4556799999999976442 2344678999999999998888889999999
Q ss_pred hhHHHHHhhC-CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 255 GCILAELYTG-CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 255 G~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
||++|+.++| ..||+..-.. -.+|.. + ...+..+....
T Consensus 701 GCvfyYvltgG~HpFGd~~~R--~~NIl~--~-------------------------------------~~~L~~L~~~~ 739 (903)
T KOG1027|consen 701 GCVFYYVLTGGSHPFGDSLER--QANILT--G-------------------------------------NYTLVHLEPLP 739 (903)
T ss_pred CceEEEEecCCccCCCchHHh--hhhhhc--C-------------------------------------ccceeeeccCc
Confidence 9999999995 9999874322 122221 0 00000111111
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
...+.|||.+||++||..||+|.++|.||+|=.
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 227789999999999999999999999999954
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=277.52 Aligned_cols=205 Identities=26% Similarity=0.469 Sum_probs=175.0
Q ss_pred CeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|..++++|.|+||.||+|.|+.+.. ++||.+.+... +.+-|+.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRI---------L~DtWvr-------------------------- 606 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERI---------LVDTWVR-------------------------- 606 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhh---------hhhhhhc--------------------------
Confidence 49999999999999999999998864 48888755422 1112222
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-c-CHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-L-NLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g-~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.+-...+..|+.||..++.+ +|+||++++++|++++++||+||..+ | +|.++|...+. ++|.++..|++||
T Consensus 607 --DrkLGtVp~EIqIla~l~~~---sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV 679 (772)
T KOG1152|consen 607 --DRKLGTVPSEIQILATLNKH---SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQV 679 (772)
T ss_pred --ccccCccchhHHHHHHhhhc---CccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHH
Confidence 22223345599999999855 67799999999999999999999994 4 99999998875 9999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc-CcceeeecCccccchhhhhCCCC-CCCccccchhh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-QRVYTYIQSRFYRSPEVILGLPY-GPPIDMWSLGC 256 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~ 256 (429)
+.|+++||+.||||||||-+|+.++.+| -+||+|||.+.... .+...++||..|.|||++.|.+| +.+-|||+||+
T Consensus 680 ~agi~hlh~~~ivhrdikdenvivd~~g--~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgi 757 (772)
T KOG1152|consen 680 VAGIKHLHDQGIVHRDIKDENVIVDSNG--FVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGI 757 (772)
T ss_pred HhccccccccCceecccccccEEEecCC--eEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhh
Confidence 9999999999999999999999999999 99999999987654 44556899999999999999987 78999999999
Q ss_pred HHHHHhhCCCCCCC
Q psy17270 257 ILAELYTGCPLFPG 270 (429)
Q Consensus 257 il~~lltg~~pf~~ 270 (429)
++|.++....||..
T Consensus 758 llytivykenpyyn 771 (772)
T KOG1152|consen 758 LLYTIVYKENPYYN 771 (772)
T ss_pred eeeEEEeccCCCcC
Confidence 99999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=256.33 Aligned_cols=239 Identities=33% Similarity=0.530 Sum_probs=191.5
Q ss_pred ccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhhhHHH
Q psy17270 33 SFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALI 111 (429)
Q Consensus 33 ~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (429)
+||.||+|.+..++.. |+|++........ ...+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------------------------------------------~~~~~~ 36 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--------------------------------------------RERILR 36 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--------------------------------------------HHHHHH
Confidence 5899999999887754 8888743322100 235666
Q ss_pred HHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy17270 112 EVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENI 190 (429)
Q Consensus 112 E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~i 190 (429)
|++.++.++|+ |++++++.+......++++|++++ +|.+++..... ++...+..++.+++.++.+||+.++
T Consensus 37 e~~~~~~l~~~------~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i 108 (244)
T smart00220 37 EISILKKLKHP------NIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSNGI 108 (244)
T ss_pred HHHHHHhCCCC------cHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCe
Confidence 99999999776 999999999988999999999976 99999887553 8999999999999999999999999
Q ss_pred eecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCC
Q psy17270 191 IHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLF 268 (429)
Q Consensus 191 vH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf 268 (429)
+|+||+|.||+++.++ .++|+|||.+..... ......++..|++||.+.+..++.++|+||+|+++++|++|..||
T Consensus 109 ~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~ 186 (244)
T smart00220 109 IHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPF 186 (244)
T ss_pred ecCCcCHHHeEECCCC--cEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999987 899999999876554 234456788899999999888899999999999999999999999
Q ss_pred CCCCHHHHHHHHHH-HhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhccc
Q psy17270 269 PGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNW 347 (429)
Q Consensus 269 ~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 347 (429)
........+..... ........ ....+..+.+++.+||..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~i~~~l~~ 227 (244)
T smart00220 187 PGDDQLLELFKKIGKPKPPFPPP---------------------------------------EWKISPEAKDLIRKLLVK 227 (244)
T ss_pred CCCCcHHHHHHHHhccCCCCccc---------------------------------------cccCCHHHHHHHHHHccC
Confidence 87433333222221 00000000 000367889999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q psy17270 348 DSKKRLTPDEALRHEWL 364 (429)
Q Consensus 348 dP~~Rpta~ell~h~~~ 364 (429)
||++||++.++++||||
T Consensus 228 ~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 228 DPEKRLTAEEALQHPFF 244 (244)
T ss_pred CchhccCHHHHhhCCCC
Confidence 99999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=241.51 Aligned_cols=213 Identities=24% Similarity=0.378 Sum_probs=174.6
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
-.+....+..||+|++|.|=+.++..+|+. |+|.+.......+.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q----------------------------------- 88 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQ----------------------------------- 88 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHH-----------------------------------
Confidence 344566678899999999999999999998 99998766553222
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhC--CCCCCHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNN--YQGFSLGLIRRFA 175 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~--~~~~~~~~~~~i~ 175 (429)
++.++|+.+..+. ..+|.++++|+.+..+..+++.||.|..+|..+-++.- .+.++|..+-+|+
T Consensus 89 ---------~r~L~dldi~~r~-----~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa 154 (282)
T KOG0984|consen 89 ---------KRLLMDLDIIMRT-----VDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIA 154 (282)
T ss_pred ---------HHHHHhhhhhccC-----CCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhH
Confidence 2344466655443 36789999999999999999999999988887766432 2459999999999
Q ss_pred HHHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccCcce-e-eecCccccchhhhhC----CCCCCC
Q psy17270 176 FSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY-T-YIQSRFYRSPEVILG----LPYGPP 248 (429)
Q Consensus 176 ~qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~-~-~~~t~~y~aPE~~~~----~~~~~~ 248 (429)
..+..||.|||++ .++|||+||+|||++.+| +||+||||.+....+... + ..|...|||||.+.. ..|+.+
T Consensus 155 ~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G--qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vk 232 (282)
T KOG0984|consen 155 VSVVHALEFLHSKLSVIHRDVKPSNILINYDG--QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVK 232 (282)
T ss_pred HHHHHHHHHHHHHhhhhhccCCcceEEEccCC--cEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceee
Confidence 9999999999987 899999999999999999 999999999876443322 2 467788999999864 368999
Q ss_pred ccccchhhHHHHHhhCCCCCCC-CCHHHHHHHHHH
Q psy17270 249 IDMWSLGCILAELYTGCPLFPG-ENEVEQLACIME 282 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~-~~~~~~~~~i~~ 282 (429)
+||||||+++.||.+++.||+. .++.+++.++++
T Consensus 233 sDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 233 SDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 9999999999999999999976 467788877775
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=295.94 Aligned_cols=252 Identities=17% Similarity=0.229 Sum_probs=179.6
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.+.|...+.||+|+||.||+|.+..++.. |+|++.....
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------------------------------------- 728 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------------------------------------- 728 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----------------------------------------
Confidence 35677888999999999999999877754 8887632110
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
....|++++++++|+ ||+++++++......++||||+. |+|.++++. +++..+..++.|
T Consensus 729 ---------~~~~~~~~l~~l~Hp------nIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ 788 (968)
T PLN00113 729 ---------IPSSEIADMGKLQHP------NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIG 788 (968)
T ss_pred ---------ccHHHHHHHhhCCCC------CcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHH
Confidence 111267778887766 99999999999999999999995 799999853 788999999999
Q ss_pred HHHHHHHHH---HCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLH---RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH---~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
++.||+||| +.+++||||||+||+++.++ ..++. ||....... .....+|+.|+|||++.+..++.++|||||
T Consensus 789 ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~--~~~~~-~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~ 864 (968)
T PLN00113 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD--EPHLR-LSLPGLLCT-DTKCFISSAYVAPETRETKDITEKSDIYGF 864 (968)
T ss_pred HHHHHHHhccCCCCCeecCCCCHHhEEECCCC--ceEEE-ecccccccc-CCCccccccccCcccccCCCCCcccchhhH
Confidence 999999999 66999999999999999877 44443 554432211 122367899999999999899999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHH-HHHHHHHHHh-CCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 255 GCILAELYTGCPLFPGENEV-EQLACIMEIL-GCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||++|||+||+.||...... ..+....... ..... ..+.++ ...........
T Consensus 865 Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~-----------------~~~~~~~~~~~ 918 (968)
T PLN00113 865 GLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL---------DMWIDP-----------------SIRGDVSVNQN 918 (968)
T ss_pred HHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccch---------hheeCc-----------------cccCCCCccHH
Confidence 99999999999998542110 0111111000 00000 000000 00000000011
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
+..++.+++.+||+.||++|||+.|+++.
T Consensus 919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 919 EIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 13467799999999999999999999885
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-33 Score=244.63 Aligned_cols=262 Identities=19% Similarity=0.253 Sum_probs=196.0
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.+.|+|.+.||+|.||.+-+|+|+.+.+. |+|-+..+.....
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~----------------------------------- 65 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQA----------------------------------- 65 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHH-----------------------------------
Confidence 4788899999999999999999999999876 8888765543311
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEE-EEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY-FYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~-~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.|.+|..---.|+ .|.||+.-|++ |+..+.+++++||+. |+|..-+... ++.+...+.+
T Consensus 66 -----------dF~rEfhY~~~Ls-----~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v 126 (378)
T KOG1345|consen 66 -----------DFVREFHYSFFLS-----PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKV 126 (378)
T ss_pred -----------HHHHHhccceeec-----cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc---cccHHHHHHH
Confidence 2222332222233 34488877665 567778999999996 7888777664 4999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCC-----CCCCCc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGL-----PYGPPI 249 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~ 249 (429)
+.|+++|+.|||++++||||||.+||||...+-..|||||||..+..+......-.+..|.|||+.... ..++.+
T Consensus 127 ~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~ 206 (378)
T KOG1345|consen 127 FAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPST 206 (378)
T ss_pred HHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccc
Confidence 999999999999999999999999999987655589999999998777655555567789999987643 247899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|+|.||+++|..+||++||......+. +.-++. .. ........+..
T Consensus 207 D~WqfGIi~f~cltG~~PWQka~~~d~----------~Y~~~~-~w-----------------------~~rk~~~~P~~ 252 (378)
T KOG1345|consen 207 DIWQFGIIFFYCLTGKFPWQKASIMDK----------PYWEWE-QW-----------------------LKRKNPALPKK 252 (378)
T ss_pred cchheeeeeeeeecCCCcchhhhccCc----------hHHHHH-HH-----------------------hcccCccCchh
Confidence 999999999999999999975433221 111111 00 01111123344
Q ss_pred hccCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKR---LTPDEALRHEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~R---pta~ell~h~~~~~~ 367 (429)
+...++.+..++++-|..++++| .++.......|....
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 55568889999999999999999 677777777776543
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=254.98 Aligned_cols=204 Identities=24% Similarity=0.323 Sum_probs=163.9
Q ss_pred eeeehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhccccccccccccc
Q psy17270 8 LSFAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESL 87 (429)
Q Consensus 8 ~~~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~ 87 (429)
++.+.-.++..++.+.++.+.||+|.||.||+|.++ .+.+|+|++....
T Consensus 198 GSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd------------------------------ 246 (513)
T KOG2052|consen 198 GSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD------------------------------ 246 (513)
T ss_pred CCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc------------------------------
Confidence 355666778889999999999999999999999996 3456999884321
Q ss_pred ccCCCCCCCCCCcchhhhhhhHHHHHHHHHH--HhcCCCCCCCceeEEEEEEEEc----CeEEEEEeecC-cCHHHHHHh
Q psy17270 88 SQNGGFDDENGSYNKKRFHHQALIEVRILDH--LRKKDADSSYNVIHMLEYFYFR----NHLCISFELMN-LNLYELIKR 160 (429)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~h~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~-g~L~~~i~~ 160 (429)
+....+|.+|+++ |+|+ ||+.+++.--.+ ..++||++|.+ |+|.|++.+
T Consensus 247 ------------------E~SWfrEtEIYqTvmLRHE------NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r 302 (513)
T KOG2052|consen 247 ------------------ERSWFRETEIYQTVMLRHE------NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR 302 (513)
T ss_pred ------------------hhhhhhHHHHHHHHHhccc------hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh
Confidence 1123346666665 6777 999988765333 37999999995 899999998
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecccCCCcEEEecCCCcceEEeeecccccc-------cCcc
Q psy17270 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRE--------NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS-------HQRV 225 (429)
Q Consensus 161 ~~~~~~~~~~~~~i~~qil~~l~~lH~~--------~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~-------~~~~ 225 (429)
.. ++......++..++.||++||.. .|.|||||..|||+.+++ .+.|+|+|+|..- ....
T Consensus 303 ~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~--~C~IADLGLAv~h~~~t~~idi~~ 377 (513)
T KOG2052|consen 303 NT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSDTDTIDIPP 377 (513)
T ss_pred cc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC--cEEEeeceeeEEecccCCcccCCC
Confidence 55 99999999999999999999964 499999999999999999 9999999998542 2345
Q ss_pred eeeecCccccchhhhhCCC----C--CCCccccchhhHHHHHhhC----------CCCCCCC
Q psy17270 226 YTYIQSRFYRSPEVILGLP----Y--GPPIDMWSLGCILAELYTG----------CPLFPGE 271 (429)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~~----~--~~~~DiwSlG~il~~lltg----------~~pf~~~ 271 (429)
+..+||..|||||++...- + -..+||||||.++||++.. ++||.+.
T Consensus 378 N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 378 NPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred CCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 6789999999999997531 1 2378999999999999752 5777553
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=269.98 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=195.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecC--------CCcchheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHK--------TNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~--------~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
+-.++..+.+.||+|+||+||+|.-.. .-.+|+|.........+.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~--------------------------- 345 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEK--------------------------- 345 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHH---------------------------
Confidence 344555777899999999999998531 112377776555444222
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhC------
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNN------ 162 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~------ 162 (429)
..+..|+++++.+.+ |+||+.+++++.....+++|+||+ .|+|.++++..+
T Consensus 346 -----------------~~~~~El~~m~~~g~-----H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~ 403 (609)
T KOG0200|consen 346 -----------------KDLMSELNVLKELGK-----HPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESID 403 (609)
T ss_pred -----------------HHHHHHHHHHHHhcC-----CcchhhheeeeccCCceEEEEEeccCCcHHHHHHhcccccccc
Confidence 345559999999973 359999999999888999999999 589999998776
Q ss_pred ------C--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-eeee---c
Q psy17270 163 ------Y--QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-YTYI---Q 230 (429)
Q Consensus 163 ------~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-~~~~---~ 230 (429)
. ..++..+...+++||+.|++||+++.+|||||-..|||+..+. .+||+|||+++...... +... +
T Consensus 404 ~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~--~~kIaDFGlar~~~~~~~y~~~~~~~ 481 (609)
T KOG0200|consen 404 GSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK--VIKIADFGLARDHYNKDYYRTKSSAG 481 (609)
T ss_pred ccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC--EEEEccccceeccCCCCceEecCCCC
Confidence 0 1288999999999999999999999999999999999999987 89999999998544322 2212 2
Q ss_pred --CccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCC-HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 231 --SRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGEN-EVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 231 --t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
...|||||.+....|+.++||||+|+++||++| |..||++.. ..+.+..+....
T Consensus 482 ~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~---------------------- 539 (609)
T KOG0200|consen 482 TLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN---------------------- 539 (609)
T ss_pred ccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC----------------------
Confidence 223999999999999999999999999999999 899999854 333333222210
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
....+..+++++.++++.||+.+|++||+..++.+
T Consensus 540 -------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 540 -------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred -------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 11122344788899999999999999999888765
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=267.18 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=203.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.=.++|+++.++|+|++|.||+|+|+.+++- |+|+++.....+ ++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd------------------~~---------------- 57 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD------------------FS---------------- 57 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc------------------cc----------------
Confidence 3467899999999999999999999999986 888774433221 11
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.+..|+-+++..+|+ ||+.+++.+.-...+++.||||+ |+|.+.-.-. +.+++.++..+.
T Consensus 58 -----------~iqqei~~~~dc~h~------nivay~gsylr~dklwicMEycgggslQdiy~~T--gplselqiayvc 118 (829)
T KOG0576|consen 58 -----------GIQQEIGMLRDCRHP------NIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVC 118 (829)
T ss_pred -----------ccccceeeeecCCCc------ChHHHHhhhhhhcCcEEEEEecCCCcccceeeec--ccchhHHHHHHH
Confidence 122378888888777 99999999999999999999996 5777764433 469999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhh---CCCCCCCc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVIL---GLPYGPPI 249 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~---~~~~~~~~ 249 (429)
+..+.||+|||++|-+|||||-.||+++..| .+|++|||.+...+ .....++||++|||||+-. ...|...+
T Consensus 119 Retl~gl~ylhs~gk~hRdiKGanilltd~g--DvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlc 196 (829)
T KOG0576|consen 119 RETLQGLKYLHSQGKIHRDIKGANILLTDEG--DVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 196 (829)
T ss_pred hhhhccchhhhcCCcccccccccceeecccC--ceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccc
Confidence 9999999999999999999999999999999 89999999986544 2344579999999999865 34689999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||++|++..|+.-.++|.-..-+...+..+..-...++ ...+.
T Consensus 197 diwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp-~lkDk----------------------------------- 240 (829)
T KOG0576|consen 197 DIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP-TLKDK----------------------------------- 240 (829)
T ss_pred cccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC-cccCC-----------------------------------
Confidence 999999999999888887655544444433332211121 11000
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
...++.|.+|++.+|..+|++|||++.+|.|||..+.
T Consensus 241 -~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 241 -TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred -ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 0116889999999999999999999999999998753
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=247.24 Aligned_cols=258 Identities=26% Similarity=0.345 Sum_probs=182.3
Q ss_pred eEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
.++.+.||+|.||.||+|.... ..+|||++....
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~--------------------------------------------- 245 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQE--------------------------------------------- 245 (534)
T ss_pred hhhHHHhhcCccceeehhhccC-ceeEEEecCHHH---------------------------------------------
Confidence 5678899999999999998764 456999884221
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC----eEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN----HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
...+.+|-+|++... ..|+||++++..-.... .++||++|. .|+|.++++.+- +++...++++..
T Consensus 246 ---kqs~~~Ek~Iy~lp~----m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~S 315 (534)
T KOG3653|consen 246 ---KQSFQNEKNIYSLPG----MKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAES 315 (534)
T ss_pred ---HHHHHhHHHHHhccC----ccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHH
Confidence 234556777777742 24569999998876544 899999999 589999999876 999999999999
Q ss_pred HHHHHHHHHHC---------CceecccCCCcEEEecCCCcceEEeeeccccccc-----CcceeeecCccccchhhhhCC
Q psy17270 178 LVQCLRLLHRE---------NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-----QRVYTYIQSRFYRSPEVILGL 243 (429)
Q Consensus 178 il~~l~~lH~~---------~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-----~~~~~~~~t~~y~aPE~~~~~ 243 (429)
++.||+|||.- .|+|||||..|||+.++. ++.|+|||+|.... ......+||..|||||++.+.
T Consensus 316 marGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl--TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 316 MARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL--TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred HHHHHHHhcccCCcCCCCCCccccccccccceEEccCC--cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 99999999973 599999999999999999 99999999996533 122237899999999999875
Q ss_pred C-CC-----CCccccchhhHHHHHhhCCCCCC-CCCHHHHHHHHHHHhCCCc-HHHHhhhhhhhhhccCCCCCccccCCC
Q psy17270 244 P-YG-----PPIDMWSLGCILAELYTGCPLFP-GENEVEQLACIMEILGCPP-DEVINTASRRRLFFDSKGTPRCITNSK 315 (429)
Q Consensus 244 ~-~~-----~~~DiwSlG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (429)
- +. ...||||+|.++|||++....+. +..+.-++---..+-..|. +++.....+ .+..|.
T Consensus 394 inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~------kK~RP~------ 461 (534)
T KOG3653|consen 394 INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVR------KKQRPK------ 461 (534)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHh------hccCCC------
Confidence 2 22 36899999999999998765542 2211111100001111121 222221111 111111
Q ss_pred CCCCCCCCchhhhhhc--cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 316 GRKRKPGSKDMASVLR--CNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+.+.+. .....+.+.+..||..||+.|+||.-+.+
T Consensus 462 ----------~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 462 ----------IPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred ----------ChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 111111 12467889999999999999999876644
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=256.97 Aligned_cols=243 Identities=20% Similarity=0.254 Sum_probs=191.8
Q ss_pred eEEEeEeeccccceEEEEEecCCCc-----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNT-----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
.+..++||+|+||+||+|.+...++ +|||++......
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-------------------------------------- 739 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-------------------------------------- 739 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--------------------------------------
Confidence 3456799999999999999965553 366665332222
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.....++.|+.+|..+.|+ |++++++++.... +-||++|+. |+|.++++.++ ..+.......|..
T Consensus 740 ------~~s~e~LdeAl~masldHp------nl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~ 805 (1177)
T KOG1025|consen 740 ------KASIELLDEALRMASLDHP------NLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCY 805 (1177)
T ss_pred ------hhhHHHHHHHHHHhcCCCc------hHHHHhhhcccch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHH
Confidence 1234567799999999887 9999999987655 889999995 79999999876 5699999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee-----eecCccccchhhhhCCCCCCCccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT-----YIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~-----~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
||++||.|||.+++|||||-..|+|+...+ .+|++|||+++........ ....+.|||-|.+....|+.++||
T Consensus 806 QIAkgM~YLe~qrlVHrdLaaRNVLVksP~--hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDV 883 (1177)
T KOG1025|consen 806 QIAKGMKYLEEQRLVHRDLAARNVLVKSPN--HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDV 883 (1177)
T ss_pred HHHHHHHHHHhcchhhhhhhhhheeecCCC--eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhh
Confidence 999999999999999999999999999877 9999999999764432211 112345999999999999999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||+||++||++| |..|+.+....++-..+... +.-..+
T Consensus 884 WsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g-----------------------------------------eRLsqP 922 (1177)
T KOG1025|consen 884 WSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG-----------------------------------------ERLSQP 922 (1177)
T ss_pred hhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-----------------------------------------ccCCCC
Confidence 999999999998 99999987665443222110 001112
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+-++-++..++.+||..|++.||+++++..
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 334678889999999999999999988743
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=279.20 Aligned_cols=195 Identities=15% Similarity=0.194 Sum_probs=146.8
Q ss_pred ceeEEEEEE-------EEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEE
Q psy17270 129 NVIHMLEYF-------YFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201 (429)
Q Consensus 129 ~i~~~~~~~-------~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nil 201 (429)
||..++++| .....+++++|+++++|.+++.... ..+++..+..+++||+.||+|||++||+||||||+|||
T Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL 112 (793)
T PLN00181 34 YVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV 112 (793)
T ss_pred HHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence 788888877 2234678899999999999997543 45999999999999999999999999999999999999
Q ss_pred EecCC-----------------CcceEEeeecccccccCc-------------------ceeeecCccccchhhhhCCCC
Q psy17270 202 LKQRG-----------------SSSIKVIDFGSSCYSHQR-------------------VYTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 202 i~~~~-----------------~~~vkl~Dfg~~~~~~~~-------------------~~~~~~t~~y~aPE~~~~~~~ 245 (429)
++..+ ...+|++|||+++..... ....+||+.|+|||++.+..|
T Consensus 113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 192 (793)
T PLN00181 113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSS 192 (793)
T ss_pred EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCC
Confidence 96432 125677777776532110 011357889999999999999
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|||||||++|||++|.+|+.... ..+..+... ..+...
T Consensus 193 ~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~--~~~~~~---------------------------------- 234 (793)
T PLN00181 193 NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR--VLPPQI---------------------------------- 234 (793)
T ss_pred CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh--hcChhh----------------------------------
Confidence 999999999999999999988875421 111111110 001000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
....+...+++.+||+.||.+||++.|+++||||...
T Consensus 235 -----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 235 -----LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred -----hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 0013455689999999999999999999999999763
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=216.72 Aligned_cols=208 Identities=35% Similarity=0.545 Sum_probs=176.3
Q ss_pred eeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhh
Q psy17270 29 IGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHH 107 (429)
Q Consensus 29 lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (429)
||.|++|.||++.+..++.. ++|++....... ...
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--------------------------------------------~~~ 36 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--------------------------------------------LLE 36 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--------------------------------------------HHH
Confidence 68999999999999876654 888875432211 123
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
.+.+|++.++.+.|. +++++++++......++++|++. ++|.+++.... ..++...+..++.+++.++++||
T Consensus 37 ~~~~e~~~~~~l~~~------~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh 109 (215)
T cd00180 37 ELLREIEILKKLNHP------NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLH 109 (215)
T ss_pred HHHHHHHHHHhcCCC------CeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 566699999999885 99999999999899999999997 79999988763 24899999999999999999999
Q ss_pred HCCceecccCCCcEEEec-CCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccchhhHHHHH
Q psy17270 187 RENIIHCDLKPENVLLKQ-RGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 187 ~~~ivH~dlkp~Nili~~-~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l 261 (429)
++|++|+||+|.||+++. ++ .++|+|||.+...... .....+...|++||.+... .++.+.|+|++|+++++|
T Consensus 110 ~~~~~H~dl~~~ni~~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 110 SNGIIHRDLKPENILLDSDNG--KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hCCeeccCCCHhhEEEeCCCC--cEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 999999999999999998 66 8999999998765543 3345577889999999887 778899999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHH
Q psy17270 262 YTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFV 341 (429)
Q Consensus 262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 341 (429)
..+.+++
T Consensus 188 -------------------------------------------------------------------------~~~~~~l 194 (215)
T cd00180 188 -------------------------------------------------------------------------PELKDLI 194 (215)
T ss_pred -------------------------------------------------------------------------HHHHHHH
Confidence 0235999
Q ss_pred HHhcccCCCCCCCHHHHhcCC
Q psy17270 342 TQCFNWDSKKRLTPDEALRHE 362 (429)
Q Consensus 342 ~~~L~~dP~~Rpta~ell~h~ 362 (429)
.+||+.||++||++.++++|+
T Consensus 195 ~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 195 RKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHhhCCcccCcCHHHHhhCC
Confidence 999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=216.12 Aligned_cols=199 Identities=34% Similarity=0.547 Sum_probs=167.5
Q ss_pred eEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|.+.+.||.|++|+||+|.+..++. +++|.+......
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------------------------------------------ 38 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE------------------------------------------ 38 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch------------------------------------------
Confidence 6789999999999999999988665 488887543322
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.....+.+|++.++.++|+ |++++++.+......++++|++.+ +|.+++..... .+++..+..++.+++.
T Consensus 39 --~~~~~~~~e~~~~~~~~~~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~ 109 (225)
T smart00221 39 --KQREEFLREIRILKKLKHP------NIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILE 109 (225)
T ss_pred --HHHHHHHHHHHHHHhCCCC------ChhhheeeeecCCceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHH
Confidence 0123556699999998766 999999999888999999999976 99999887542 2789999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhh-hCCCCCCCccccchh
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVI-LGLPYGPPIDMWSLG 255 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG 255 (429)
++.+||+++++|+|++|.||+++.++ .++|+|||.+....... ....++..|++||.+ ....++.++|+|+||
T Consensus 110 ~l~~lh~~~i~h~di~~~ni~v~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG 187 (225)
T smart00221 110 ALEYLHSLGIVHRDLKPENILLGMDG--LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLG 187 (225)
T ss_pred HHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHH
Confidence 99999999999999999999999887 89999999987655432 445678889999999 566778899999999
Q ss_pred hHHHHHhhCCCCCCC-CCHH
Q psy17270 256 CILAELYTGCPLFPG-ENEV 274 (429)
Q Consensus 256 ~il~~lltg~~pf~~-~~~~ 274 (429)
+++++|++|+.||.. .++.
T Consensus 188 ~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 188 VILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred HHHHHHHHCCCCccccchhH
Confidence 999999999999977 4444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=221.80 Aligned_cols=249 Identities=17% Similarity=0.215 Sum_probs=190.8
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCC------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTN------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
-.+|+++...+-+|+||.||+|.+..-. ++.+|.++...++.+-
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv------------------------------ 331 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQV------------------------------ 331 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHH------------------------------
Confidence 4788999999999999999999765332 2244444322222111
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-CeEEEEEeecC-cCHHHHHHhhC------CC
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-NHLCISFELMN-LNLYELIKRNN------YQ 164 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~-g~L~~~i~~~~------~~ 164 (429)
..++.|.-.+..+.| ||+..+.++..++ ...+.++++++ |+|..++...+ .+
T Consensus 332 --------------~~~L~es~lly~~sH------~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aq 391 (563)
T KOG1024|consen 332 --------------NLLLQESMLLYGASH------PNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQ 391 (563)
T ss_pred --------------HHHHHHHHHHhcCcC------CCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCcccc
Confidence 123335555555555 4999998887544 57788899986 79999998432 13
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeec-----Cccccchhh
Q psy17270 165 GFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ-----SRFYRSPEV 239 (429)
Q Consensus 165 ~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~-----t~~y~aPE~ 239 (429)
.++..+...++.|++.|++|||++|+||.||...|.+|++.- ++||+|=.+++..-...+...| +..||+||.
T Consensus 392 tvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEa 469 (563)
T KOG1024|consen 392 TVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEA 469 (563)
T ss_pred chhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccchhccccCcccccccCCCCCCcccccCHHH
Confidence 377888899999999999999999999999999999999876 8999999999865544444433 345999999
Q ss_pred hhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCC
Q psy17270 240 ILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318 (429)
Q Consensus 240 ~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (429)
+..+.|+.++|+|||||++|||+| |+.||..-++.+....+.+.. +.
T Consensus 470 l~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy--------------------------------Rl 517 (563)
T KOG1024|consen 470 LQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY--------------------------------RL 517 (563)
T ss_pred HhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc--------------------------------ee
Confidence 999999999999999999999998 999999999888766665421 11
Q ss_pred CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+| -.+++++..++.-||+.+|++||+.+|+..
T Consensus 518 aQP---------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQP---------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCC---------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 111 234788899999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=211.20 Aligned_cols=166 Identities=23% Similarity=0.355 Sum_probs=127.7
Q ss_pred cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecC
Q psy17270 152 LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQS 231 (429)
Q Consensus 152 g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t 231 (429)
|+|.+++.... .++++..++.++.|++.||.|||+++ ||+||+++.++ .+++ ||.+....... ..||
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~--~~~~--fG~~~~~~~~~--~~g~ 67 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG--LLKL--DGSVAFKTPEQ--SRVD 67 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc--ceee--ccceEeecccc--CCCc
Confidence 68999998654 45999999999999999999999998 99999999888 7888 99987654322 2688
Q ss_pred ccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHH-HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcc
Q psy17270 232 RFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEV-EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC 310 (429)
Q Consensus 232 ~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (429)
+.|+|||++.+..++.++|||||||++|+|+||+.||...... ..+..+..........
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------- 127 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR-------------------- 127 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc--------------------
Confidence 9999999999999999999999999999999999999765432 2222222111100000
Q ss_pred ccCCCCCCCCCCCchhhhhhccCC--hHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 311 ITNSKGRKRKPGSKDMASVLRCND--KAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
.. ......+ ..+.+|+.+||..||++|||+.|+++|+|+.
T Consensus 128 ------------~~---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 128 ------------DR---SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ------------cc---ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00 0000112 2688999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=213.64 Aligned_cols=256 Identities=23% Similarity=0.255 Sum_probs=193.3
Q ss_pred CeEEEeEeeccccceEEEEEecCCC--cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTN--THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+|.+.++||.|+||.||+|.+..++ .+|+|........
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~---------------------------------------- 58 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS---------------------------------------- 58 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC----------------------------------------
Confidence 9999999999999999999998876 3477765322110
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEE-EEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF-YFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
....+..|..++..+.. .....++..+++.. .....-++||+.++.+|.++......+.++..++..++.|+
T Consensus 59 -----~~~~l~~E~~vl~~l~~--~~~~~~~~~~~~~G~~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~ 131 (322)
T KOG1164|consen 59 -----KPSVLKIEIQVLKKLEK--KNGPSHFPKLLDHGRSTEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQN 131 (322)
T ss_pred -----CCccchhHHHHHHHHhh--hcCCCCCCEEEEeccCCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHH
Confidence 01134558999999885 22334888888888 47778999999999999999977766679999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCC-C--cceEEeeecccc--cc----c-----Cc--ceeeecCccccchhhhhC
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRG-S--SSIKVIDFGSSC--YS----H-----QR--VYTYIQSRFYRSPEVILG 242 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~-~--~~vkl~Dfg~~~--~~----~-----~~--~~~~~~t~~y~aPE~~~~ 242 (429)
+.+|.+||+.|++||||||+|+++...+ . ..+.|+|||+++ .. + .. .....||..|+++.+..+
T Consensus 132 l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~ 211 (322)
T KOG1164|consen 132 LNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG 211 (322)
T ss_pred HHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC
Confidence 9999999999999999999999998753 1 369999999998 31 1 11 122459999999999999
Q ss_pred CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
...+...|+||++.++.+++.|..||.+.........+..........
T Consensus 212 ~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~-------------------------------- 259 (322)
T KOG1164|consen 212 IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD-------------------------------- 259 (322)
T ss_pred CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc--------------------------------
Confidence 999999999999999999999999997766443333332211000000
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......+..+.++...+-..+..++|....+...
T Consensus 260 -----~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 260 -----RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred -----cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 0111224677777777777899999987766543
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-27 Score=240.59 Aligned_cols=271 Identities=23% Similarity=0.330 Sum_probs=196.1
Q ss_pred ccCCe-EEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 19 ICYRY-EILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 19 ~~~rY-~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+.+.| ...+.+|.|++|.|+.+......+. +.|.++.... ..+.
T Consensus 315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~---~~~s------------------------------- 360 (601)
T KOG0590|consen 315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVK---PTES------------------------------- 360 (601)
T ss_pred cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccC---Cccc-------------------------------
Confidence 34556 5677999999998888887665543 5444321100 0000
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
...+...+..|.-+-..|.|+ |++..++.+.......-.||||.++|..++..... +...++..++.
T Consensus 361 -----~~~~~~~i~sE~~i~~~l~h~------~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~~~--~~~~e~~c~fK 427 (601)
T KOG0590|consen 361 -----ERKYNYNITSEFCIGSSLSHP------NIIETLDIVQEIDGILQSMEYCPYDLFSLVMSNGK--LTPLEADCFFK 427 (601)
T ss_pred -----HHHHhhhhhhheeecccccCC------chhhhHHHHhhcccchhhhhcccHHHHHHHhcccc--cchhhhhHHHH
Confidence 011111244466666667766 77666555554444444499998899999988733 89999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-------cceeeecCccccchhhhhCCCCCC-C
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-------RVYTYIQSRFYRSPEVILGLPYGP-P 248 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~-~ 248 (429)
|++.|++|||+.||.|||+|++|+++..++ .+||+|||.+..... .....+|+..|+|||++.+..|++ .
T Consensus 428 qL~~Gv~y~h~~GiahrdlK~enll~~~~g--~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~ 505 (601)
T KOG0590|consen 428 QLLRGVKYLHSMGLAHRDLKLENLLVTENG--ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRA 505 (601)
T ss_pred HHHHHHHHHHhcCceeccCccccEEEecCC--ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcch
Confidence 999999999999999999999999999999 999999999854221 123478899999999999999977 8
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+||||.|+++..|.+|+.||.-....+.... ................
T Consensus 506 vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---------------------------------~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 506 VDVWSCGIIYICMILGRFPWKVAKKSDNSFK---------------------------------TNNYSDQRNIFEGPNR 552 (601)
T ss_pred hhhhhccceEEEEecCCCccccccccccchh---------------------------------hhccccccccccChHH
Confidence 9999999999999999999977654332110 0000011222233344
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~~ 371 (429)
+....+...+.+|.+||++||.+|.|+.++++.+||+....+.
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH 595 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence 4445577888999999999999999999999999999876543
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=184.76 Aligned_cols=207 Identities=22% Similarity=0.330 Sum_probs=168.3
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+..+.|.++++||+|+||.+|+|.+..+|+. |||+-+..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---------------------------------------- 51 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---------------------------------------- 51 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc----------------------------------------
Confidence 5688999999999999999999999988865 88875322
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.-.-++..|.++++.|.+. ..|.++.-+..+..+-.+||+..+.+|.++..-.. ..|+..++.-++-
T Consensus 52 -------a~hpqL~yEskvY~iL~~g-----~GiP~i~~y~~e~~ynvlVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaD 118 (341)
T KOG1163|consen 52 -------AKHPQLLYESKVYRILQGG-----VGIPHIRHYGTEKDYNVLVMDLLGPSLEDLFNFCS-RRFTMKTVLMLAD 118 (341)
T ss_pred -------CCCcchhHHHHHHHHhccC-----CCCchhhhhccccccceeeeeccCccHHHHHHHHh-hhhhHHhHHHHHH
Confidence 1122456699999999865 36666667777778889999999999999998765 4699999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccC----------cceeeecCccccchhhhhCCCC
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQ----------RVYTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~ 245 (429)
|++.-++|+|.++++||||||+|+|..-+- ...+.|+|||+++..-+ ......||..|.+--...+...
T Consensus 119 Qml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq 198 (341)
T KOG1163|consen 119 QMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ 198 (341)
T ss_pred HHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhh
Confidence 999999999999999999999999986431 12689999999965321 1223578888998877777777
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHH
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQL 277 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 277 (429)
+...|+=|+|.++.++.-|..||.+.......
T Consensus 199 SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 199 SRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred hhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 88999999999999999999999986554433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-22 Score=193.01 Aligned_cols=262 Identities=32% Similarity=0.470 Sum_probs=198.2
Q ss_pred eEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
|.+.+.||.|+||.||++.+. ..+++|.+........
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~----------------------------------------- 38 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS----------------------------------------- 38 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-----------------------------------------
Confidence 889999999999999999998 4457776643322211
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC-CCCCHHHHHHHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY-QGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~-~~~~~~~~~~i~~qil~ 180 (429)
.....+.+|+.++..+.|+. +++.+++.+......+++++++. +++.+++..... ..++...+..++.|++.
T Consensus 39 -~~~~~~~~e~~~~~~~~~~~-----~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 112 (384)
T COG0515 39 -KEVERFLREIQILASLNHPP-----NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112 (384)
T ss_pred -hHHHHHHHHHHHHHHccCCc-----ceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHH
Confidence 13446677999999998763 79999999977778899999996 578766665532 14999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---------cceeeecCccccchhhhhC---CCCCCC
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---------RVYTYIQSRFYRSPEVILG---LPYGPP 248 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---------~~~~~~~t~~y~aPE~~~~---~~~~~~ 248 (429)
++.|+|+.|++|||+||+||+++..+. .++++|||.+..... ......+|..|+|||.+.+ ..++..
T Consensus 113 ~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~ 191 (384)
T COG0515 113 ALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSS 191 (384)
T ss_pred HHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCch
Confidence 999999999999999999999998752 489999999864332 2355789999999999988 567889
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCH---HHHHHHHHHHhCCC--cHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENE---VEQLACIMEILGCP--PDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
.|+||+|++++++++|..||..... .............+ .... ....
T Consensus 192 ~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~ 243 (384)
T COG0515 192 SDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL----------------------------SPSN 243 (384)
T ss_pred HhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccccc----------------------------Cccc
Confidence 9999999999999999999887764 22222222211111 0000 0000
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
. ......+.+++.+++..+|..|.+..+...++|.....
T Consensus 244 ~------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 244 P------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred c------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 0 11135778999999999999999999999887766544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=203.32 Aligned_cols=184 Identities=22% Similarity=0.250 Sum_probs=131.2
Q ss_pred hhcccccCCeEEEeEeeccccceEEEEEecC-CCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHK-TNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 14 ~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
..-+.+.++|++.+.||+|+||+||+|.++. ++.+ |+|++......
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~-------------------------------- 58 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW-------------------------------- 58 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc--------------------------------
Confidence 3446788999999999999999999999876 5665 88875321100
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCcee-EEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHH
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVI-HMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLG 169 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~-~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~ 169 (429)
.......+.+.+|+++|+.++|+ |++ .++++ ...|+|||||.| +|.. +. . ..
T Consensus 59 --------~~~~~~~~~~~~E~~iL~~L~h~------~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~--~---~~-- 112 (365)
T PRK09188 59 --------WSKPLARHLAAREIRALKTVRGI------GVVPQLLAT----GKDGLVRGWTEGVPLHL-AR--P---HG-- 112 (365)
T ss_pred --------cccHHHHHHHHHHHHHHHhccCC------CCCcEEEEc----CCcEEEEEccCCCCHHH-hC--c---cc--
Confidence 00111234577799999999987 666 44442 468999999965 6652 21 1 11
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccc-CCCcEEEecCCCcceEEeeecccccccCcc-----------eeeecCccccch
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDL-KPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----------YTYIQSRFYRSP 237 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dl-kp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----------~~~~~t~~y~aP 237 (429)
...++.|++.+|.|||++||+|||| ||+|||++.++ .++|+|||+++...... ....+++.|.||
T Consensus 113 -~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~p 189 (365)
T PRK09188 113 -DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAP 189 (365)
T ss_pred -hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCc
Confidence 1467899999999999999999999 99999998777 89999999997533221 234567789999
Q ss_pred hhhhCCC------CCCCcccc-chhhHH
Q psy17270 238 EVILGLP------YGPPIDMW-SLGCIL 258 (429)
Q Consensus 238 E~~~~~~------~~~~~Diw-SlG~il 258 (429)
|++.... .+..+|-| .-|=+.
T Consensus 190 e~~~~~~~~~~~~~~~~~dgW~~TGDlg 217 (365)
T PRK09188 190 DALTPRERKILARKSLPSRIWLATGKKV 217 (365)
T ss_pred ccCChhhhccccccccccCcEEeCCCEE
Confidence 9986432 23456777 444433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=187.99 Aligned_cols=186 Identities=15% Similarity=0.209 Sum_probs=137.4
Q ss_pred hhhhcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 12 FQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 12 ~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
..++.+++++||++++.||.|+||.||++.+ ..+.+|+|++.......+... ..
T Consensus 22 ~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~-~~------------------------ 75 (232)
T PRK10359 22 KEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFL-KS------------------------ 75 (232)
T ss_pred HHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHH-Hh------------------------
Confidence 4677889999999999999999999999766 456779999865544322210 00
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--------CeEEEEEeecCc-CHHHHHHhhC
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--------NHLCISFELMNL-NLYELIKRNN 162 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~g-~L~~~i~~~~ 162 (429)
-.....+.+|++.+.++.|+ +|..+.+++... ...+++|||++| +|.++..
T Consensus 76 -----------f~~g~~~e~Ea~~l~rL~~~------GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--- 135 (232)
T PRK10359 76 -----------FVKGDYYENLIVQTDRVRSE------GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--- 135 (232)
T ss_pred -----------hhhhHHHHHHHHHHHHHHHC------CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh---
Confidence 00123466799999999998 777777765533 468999999987 7877621
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC
Q psy17270 163 YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG 242 (429)
Q Consensus 163 ~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~ 242 (429)
+++ ....+++.+|..||+.|++|||++|+||+++.++ ++|+|||........... ..++..
T Consensus 136 ---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~~e~~a~---------d~~vle 196 (232)
T PRK10359 136 ---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCTAQRKAK---------DRIDLE 196 (232)
T ss_pred ---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccccchhhH---------HHHHHH
Confidence 333 2456999999999999999999999999998765 999999987544221110 114445
Q ss_pred CCCCCCccccchhhHHHHHh
Q psy17270 243 LPYGPPIDMWSLGCILAELY 262 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~ll 262 (429)
..|+.++|+||||+++..+.
T Consensus 197 r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 197 RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hHhcccccccceeEeehHHH
Confidence 56778999999999987664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=193.45 Aligned_cols=251 Identities=20% Similarity=0.245 Sum_probs=152.5
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.+...+.||.|+++.||.++|..|++. |+|++.... .....+.+++.+.........++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~------------------- 72 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGV------------------- 72 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--------------------
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccC-------------------
Confidence 356778999999999999999999977 999987665 33344444444432211000000
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEE---EEEEEc--------CeEEEEEeecCcCHHHHHHh---hCCCC-
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHML---EYFYFR--------NHLCISFELMNLNLYELIKR---NNYQG- 165 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~---~~~~~~--------~~~~lv~e~~~g~L~~~i~~---~~~~~- 165 (429)
.-.+.+....+++.-+ .++++- .++... -..+++|+-+.++|.+++.. .....
T Consensus 73 ---~~p~~a~~~~r~l~P~---------d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~ 140 (288)
T PF14531_consen 73 ---KNPKEAYRHLRFLVPL---------DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHS 140 (288)
T ss_dssp ----SHHHHHHHH-B---S---------EEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSH
T ss_pred ---CCHHHHHHhceEEeee---------EEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccc
Confidence 0001111122221111 222221 111111 14578999999988888653 22211
Q ss_pred -CCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCC-
Q psy17270 166 -FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGL- 243 (429)
Q Consensus 166 -~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~- 243 (429)
+.......+..|++..+++||+.|+||+||+|+|++++.+| .+.|+||+.....+........+..|.+||.....
T Consensus 141 ~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G--~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~ 218 (288)
T PF14531_consen 141 PLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDG--GVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAG 218 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHT
T ss_pred hhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCC--CEEEcChHHHeecCceeeccCCCcccCChhhhhhhc
Confidence 22334455668999999999999999999999999999999 99999999887766554433455779999987542
Q ss_pred -------CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCC
Q psy17270 244 -------PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316 (429)
Q Consensus 244 -------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (429)
.++.+.|.|+||+++|.|++|..||........ ...
T Consensus 219 ~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~----------~~~--------------------------- 261 (288)
T PF14531_consen 219 QFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD----------PEW--------------------------- 261 (288)
T ss_dssp SCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST----------SGG---------------------------
T ss_pred ccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc----------ccc---------------------------
Confidence 468899999999999999999999987543210 000
Q ss_pred CCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCC
Q psy17270 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKR 352 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 352 (429)
.+.... ..++.+++||+.+|++||.+|
T Consensus 262 --------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 --------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp --------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred --------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 011111 337899999999999999988
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-24 Score=219.14 Aligned_cols=249 Identities=22% Similarity=0.394 Sum_probs=183.1
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
+...|...+.||++.|=+|.+|.|.+ |.+++|++-++.....-.++.+
T Consensus 21 ~~~e~~~~~~LGstRFlKv~r~k~~e-G~vVvKVFvk~~p~~sL~~~~q------------------------------- 68 (1431)
T KOG1240|consen 21 LSVECHYVENLGSTRFLKVARAKDRE-GLVVVKVFVKQDPTISLRPFKQ------------------------------- 68 (1431)
T ss_pred CccceeeecccCchhhhhhhhccCCC-ceEEEEEEeccCCCCCchHHHH-------------------------------
Confidence 34478999999999999999999975 4589999865543322222221
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
-+.|++ ...++++ |++.+.-+...+...|+|-+|...+|+|.+..+++ +..-+.+-|+.|+
T Consensus 69 ----------rL~~ik-~~l~~~p------n~lPfqk~~~t~kAAylvRqyvkhnLyDRlSTRPF--L~~iEKkWiaFQL 129 (1431)
T KOG1240|consen 69 ----------RLEEIK-FALMKAP------NCLPFQKVLVTDKAAYLVRQYVKHNLYDRLSTRPF--LVLIEKKWIAFQL 129 (1431)
T ss_pred ----------HHHHHH-HHhhcCC------cccchHHHHHhhHHHHHHHHHHhhhhhhhhccchH--HHHHHHHHHHHHH
Confidence 122444 4444444 88888888778889999999999999999998876 8888999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc---ccCcc---eeeecCc----cccchhhhhCC-----
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY---SHQRV---YTYIQSR----FYRSPEVILGL----- 243 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~---~~~~~---~~~~~t~----~y~aPE~~~~~----- 243 (429)
+.||..||..||+|||||.+|||+++=+ -+.|+||..-+. ..+.+ .-+..|. .|.|||.+...
T Consensus 130 L~al~qcH~~gVcHGDIKsENILiTSWN--W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~ 207 (1431)
T KOG1240|consen 130 LKALSQCHKLGVCHGDIKSENILITSWN--WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTS 207 (1431)
T ss_pred HHHHHHHHHcCccccccccceEEEeeec--hhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccc
Confidence 9999999999999999999999999876 789999987642 11111 1123332 49999998641
Q ss_pred -----C-CCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCC
Q psy17270 244 -----P-YGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316 (429)
Q Consensus 244 -----~-~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (429)
. .+++.||||+||+++||++ |++||.- .++-.....-...++..+.
T Consensus 208 ~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~e~~Le----------------------- 260 (1431)
T KOG1240|consen 208 VGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDPEQLLE----------------------- 260 (1431)
T ss_pred cCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCHHHHHH-----------------------
Confidence 1 4678999999999999988 8999953 1221111111111111111
Q ss_pred CCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.-++..++.+|..|++.||++|.+|++.|+-
T Consensus 261 --------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 261 --------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred --------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1125678899999999999999999999886
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=192.49 Aligned_cols=194 Identities=18% Similarity=0.243 Sum_probs=147.6
Q ss_pred CCCCCceeEEEEEEEE---------------------------cCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 124 ADSSYNVIHMLEYFYF---------------------------RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 124 ~~~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
...||||+++...|.+ +..+|+||.....+|.+++..+. .+.....-++.
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~la 348 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILA 348 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHH
Confidence 4689999998877643 24799999999999999998766 78899999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEe--cCCCcceEEeeeccccccc---------CcceeeecCccccchhhhhCCC-
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLK--QRGSSSIKVIDFGSSCYSH---------QRVYTYIQSRFYRSPEVILGLP- 244 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~--~~~~~~vkl~Dfg~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~- 244 (429)
|+++|+.|||.+||.|||+|.+|||+. +++-+.++++|||.+---. ......-|.-.-||||+....+
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999999999999999999985 3444678999999863211 1122234555689999987432
Q ss_pred ----CC-CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCC
Q psy17270 245 ----YG-PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319 (429)
Q Consensus 245 ----~~-~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (429)
.+ .++|.|+.|.+.||+++...||.+......-.+
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r---------------------------------------- 468 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR---------------------------------------- 468 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechh----------------------------------------
Confidence 22 389999999999999999999988443211000
Q ss_pred CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCC---HHHHhc
Q psy17270 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT---PDEALR 360 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~ell~ 360 (429)
...+++++.++..+++.+++++..+|+.||++|++ |+.+|+
T Consensus 469 ~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 469 TYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 01123344455566899999999999999999999 455555
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-23 Score=207.36 Aligned_cols=201 Identities=26% Similarity=0.345 Sum_probs=167.1
Q ss_pred HHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy17270 112 EVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENI 190 (429)
Q Consensus 112 E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~i 190 (429)
|..++.... .+|.++++.-.|+.+...++++++.. |+|...+....+ +.+...+.+...++-++.++|+.|+
T Consensus 46 er~il~~~~-----~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~i 118 (612)
T KOG0603|consen 46 ERIILAFVH-----NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLGI 118 (612)
T ss_pred HHHHHhhcc-----CCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhHH
Confidence 677777765 23599999999999999999999994 577776665544 8999999999999999999999999
Q ss_pred eecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCC
Q psy17270 191 IHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPG 270 (429)
Q Consensus 191 vH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~ 270 (429)
+|||+|++||+++.+| ++++.|||+++..-..... |||..|||||+++ ....++|.||+|+++++|+||..||.+
T Consensus 119 iyrd~k~enilld~~G--hi~~tdfglske~v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 119 AYRDYKLENVLLLLEG--HIKLTDFGLSKEAVKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred HHhcccccceeecccC--ccccCCchhhhHhHhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 9999999999999999 9999999999764433333 8999999999998 457799999999999999999999988
Q ss_pred CCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCC
Q psy17270 271 ENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSK 350 (429)
Q Consensus 271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 350 (429)
+...+|...--..|.++ +..+.+++..++..+|.
T Consensus 194 ----~~~~~Il~~~~~~p~~l------------------------------------------~~~a~~~~~~l~~r~p~ 227 (612)
T KOG0603|consen 194 ----DTMKRILKAELEMPREL------------------------------------------SAEARSLFRQLFKRNPE 227 (612)
T ss_pred ----HHHHHHhhhccCCchhh------------------------------------------hHHHHHHHHHHHhhCHH
Confidence 45555554333333333 56778999999999999
Q ss_pred CCCC-----HHHHhcCCCCCCCCCC
Q psy17270 351 KRLT-----PDEALRHEWLKSSSSS 370 (429)
Q Consensus 351 ~Rpt-----a~ell~h~~~~~~~~~ 370 (429)
.|.. +.|+++|+||.+....
T Consensus 228 nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 228 NRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHhccCcchhHHHhccchheeeeHh
Confidence 9996 4799999999876543
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=178.18 Aligned_cols=200 Identities=21% Similarity=0.279 Sum_probs=165.1
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
.+=.|+|+++||+|+||..+.|++.-+++. |||.-...
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----------------------------------------- 64 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----------------------------------------- 64 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc-----------------------------------------
Confidence 344599999999999999999999888876 88764211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.-.-++..|.+.++.|... ++|...|-+-....+-.||+|+++.+|.|+...+. .+|+..++..++.|
T Consensus 65 ------S~APQLrdEYr~YKlL~g~-----~GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~Cg-R~FSvKTV~miA~Q 132 (449)
T KOG1165|consen 65 ------SEAPQLRDEYRTYKLLGGT-----EGIPQVYYFGQEGKYNILVIDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQ 132 (449)
T ss_pred ------CCcchHHHHHHHHHHHcCC-----CCCCceeeeccccchhhhhhhhhCcCHHHHHHHhc-CcccHHhHHHHHHH
Confidence 0112455599999999854 47776665556667888999999999999999887 56999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCC---cceEEeeecccccccCcc----------eeeecCccccchhhhhCCC
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGS---SSIKVIDFGSSCYSHQRV----------YTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~---~~vkl~Dfg~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~ 244 (429)
++.-++|+|++.+|.|||||+|+||...++ ..|.++|||+|+...++. ....||-.||+=....+.+
T Consensus 133 mi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE 212 (449)
T KOG1165|consen 133 MITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE 212 (449)
T ss_pred HHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccch
Confidence 999999999999999999999999986543 258999999997533221 2356899999999999999
Q ss_pred CCCCccccchhhHHHHHhhCCCCCCCC
Q psy17270 245 YGPPIDMWSLGCILAELYTGCPLFPGE 271 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg~~pf~~~ 271 (429)
.+..-|+=|||=++.+.+-|..||.|.
T Consensus 213 QSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 213 QSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhhhhhHHHhhhhhhhhccCCCccccc
Confidence 999999999999999999999999874
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-22 Score=205.18 Aligned_cols=149 Identities=31% Similarity=0.448 Sum_probs=125.2
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC------------------cceeeecCccccchhhh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ------------------RVYTYIQSRFYRSPEVI 240 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~------------------~~~~~~~t~~y~aPE~~ 240 (429)
+.+++|+|+-||+|||+||+|++|+.-| ++|++|||+++.... .....+||+.|+|||++
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mG--hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecc--cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 6789999999999999999999999999 999999999854211 12235899999999999
Q ss_pred hCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCC
Q psy17270 241 LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRK 320 (429)
Q Consensus 241 ~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (429)
....|+.++|.|++|+|+|+.+.|+.||.+.+.++.+..++......+++.
T Consensus 231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d----------------------------- 281 (1205)
T KOG0606|consen 231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED----------------------------- 281 (1205)
T ss_pred hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC-----------------------------
Confidence 999999999999999999999999999999999988877775433333221
Q ss_pred CCCchhhhhhccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q psy17270 321 PGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT---PDEALRHEWLKSSS 368 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~ell~h~~~~~~~ 368 (429)
....+++++++.++|+.+|..|.- +.++.+|+||+...
T Consensus 282 ----------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 282 ----------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred ----------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 122678999999999999999984 78899999998654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=166.40 Aligned_cols=163 Identities=20% Similarity=0.260 Sum_probs=106.6
Q ss_pred EeEeeccccceEEEEEecCCC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC-CCCCcchh
Q psy17270 26 LEVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD-ENGSYNKK 103 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~-~~~~~~~~ 103 (429)
...||+|+||.||+|.+. +| .+|+|+++.......... .. +.. ...|.. .......+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~--~~-----~~~-------------~~~~~~~~~~~~~~~ 60 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRD--RY-----VSG-------------EFRFRHGYCKSNPRK 60 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHH--Hh-----hcC-------------CchhhccccCCCHHH
Confidence 468999999999999997 56 459999875432211100 00 000 000000 00000011
Q ss_pred hhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHH
Q psy17270 104 RFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCL 182 (429)
Q Consensus 104 ~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l 182 (429)
........|++.+..+.+... ..|++.. . ...++||||++| ++....... .+++...+..++.|++.+|
T Consensus 61 ~~~~~~~~E~~~l~~l~~~~v-~~p~~~~------~-~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L 130 (190)
T cd05147 61 MVRTWAEKEMRNLKRLVTAGI-PCPEPIL------L-KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIM 130 (190)
T ss_pred HHHHHHHHHHHHHHHHHHCCC-CCCcEEE------e-cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHH
Confidence 223344569999999987633 2344321 1 223799999976 443332222 3589999999999999999
Q ss_pred HHH-HHCCceecccCCCcEEEecCCCcceEEeeeccccccc
Q psy17270 183 RLL-HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222 (429)
Q Consensus 183 ~~l-H~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~ 222 (429)
.++ |+.||+||||||+||+++. + .++|+|||++....
T Consensus 131 ~~l~H~~giiHrDlkP~NIli~~-~--~v~LiDFG~a~~~~ 168 (190)
T cd05147 131 RILYQDCRLVHADLSEYNLLYHD-G--KLYIIDVSQSVEHD 168 (190)
T ss_pred HHHHHhCCcccCCCCHHHEEEEC-C--cEEEEEccccccCC
Confidence 999 6999999999999999984 5 79999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=162.90 Aligned_cols=140 Identities=14% Similarity=0.126 Sum_probs=107.2
Q ss_pred EeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 26 LEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
.+.||+|+||.||. |..++..+||++..... ..
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~---------------------------------------------~~ 39 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD---------------------------------------------GG 39 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEecccc---------------------------------------------ch
Confidence 46899999999995 77666667777633211 11
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC---e-EEEEEeecC---cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN---H-LCISFELMN---LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~---~-~~lv~e~~~---g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
...+.+|+.+++.+.|. ...||||++++++++++. . +.+|+||++ ++|.+++.+.. +++. ..++.|+
T Consensus 40 ~~~~~rEi~~l~~L~~~-~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~ 113 (210)
T PRK10345 40 DKEIRRELKYYAHLSRR-LIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR---YEED--VAQLRQL 113 (210)
T ss_pred HHHHHHHHHHHHHhhcc-CCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc---ccHh--HHHHHHH
Confidence 23567799999999874 356889999999999874 4 347899954 69999997642 6666 3567888
Q ss_pred HHHH-HHHHHCCceecccCCCcEEEecC--CCcceEEeeeccc
Q psy17270 179 VQCL-RLLHRENIIHCDLKPENVLLKQR--GSSSIKVIDFGSS 218 (429)
Q Consensus 179 l~~l-~~lH~~~ivH~dlkp~Nili~~~--~~~~vkl~Dfg~~ 218 (429)
+.++ +|||+++|+||||||+|||++.. +...++|+||+.+
T Consensus 114 L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 114 LKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8777 99999999999999999999853 3347999995544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-19 Score=159.72 Aligned_cols=163 Identities=20% Similarity=0.196 Sum_probs=106.5
Q ss_pred EEeEeeccccceEEEEEecCCC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC-Ccch
Q psy17270 25 ILEVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG-SYNK 102 (429)
Q Consensus 25 i~~~lG~G~~g~Vy~a~~~~~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~-~~~~ 102 (429)
+.+.||+|++|+||+|.+. +| .+|+|+++......... .. ++.. ...+..... ....
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~--~~-----~~~~-------------~~~~~~~~~~~~~~ 59 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDR--DK-----YIEG-------------DPRFRSRYSKSNPR 59 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeH--HH-----HhcC-------------CcccccccccCCHH
Confidence 3578999999999999988 55 45999987653221110 00 0000 000000000 0001
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcC-HHH-HHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLN-LYE-LIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~-L~~-~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.........|.+.+.++.+. ++.....+... ..++||||++|. +.. .+.. .+++...+..++.|++.
T Consensus 60 ~~~~~~~~~E~~~l~~l~~~------~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~ 128 (190)
T cd05145 60 KLVFAWAEKEFRNLKRLYEA------GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVE 128 (190)
T ss_pred HHHHHHHHHHHHHHHHHHhC------CCCCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHH
Confidence 11122345799999999987 43222222222 248999999763 333 2332 34888999999999999
Q ss_pred HHHHHHH-CCceecccCCCcEEEecCCCcceEEeeeccccccc
Q psy17270 181 CLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222 (429)
Q Consensus 181 ~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~ 222 (429)
++.++|+ +||+||||||+||+++ ++ .++|+|||++....
T Consensus 129 ~l~~lH~~~givHrDlkP~NIll~-~~--~~~liDFG~a~~~~ 168 (190)
T cd05145 129 QMRRLYQEAGLVHGDLSEYNILYH-DG--KPYIIDVSQAVELD 168 (190)
T ss_pred HHHHHHHhCCEecCCCChhhEEEE-CC--CEEEEEcccceecC
Confidence 9999999 9999999999999998 56 89999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=167.88 Aligned_cols=245 Identities=19% Similarity=0.184 Sum_probs=184.4
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
-....++-+|.....|..|+|++..+..+ .|++.....
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgndiv-akil~vr~~----------------------------------------- 226 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGNDIV-AKILNVREV----------------------------------------- 226 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCcchh-hhhhhhhhc-----------------------------------------
Confidence 34456777899999999999999776544 344311100
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
..+....|..|.-.|+-+.|+ ||+.+++.+....++.++..||. |+|++++.....--.+..++.+++.++
T Consensus 227 --t~risrdfneefp~lrifshp------nilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldi 298 (448)
T KOG0195|consen 227 --TARISRDFNEEFPALRIFSHP------NILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDI 298 (448)
T ss_pred --chhhcchhhhhCcceeeecCC------chhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHH
Confidence 112233455566667777666 99999999999999999999995 899999998765558889999999999
Q ss_pred HHHHHHHHHCC--ceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCC---CCccccc
Q psy17270 179 VQCLRLLHREN--IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYG---PPIDMWS 253 (429)
Q Consensus 179 l~~l~~lH~~~--ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~---~~~DiwS 253 (429)
+.|++|||+.. |.---|....++++.+-...+..+|-.++.... .....|.|++||.+...+.+ .++|+||
T Consensus 299 argmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~----gr~y~pawmspealqrkped~n~raadmws 374 (448)
T KOG0195|consen 299 ARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV----GRAYSPAWMSPEALQRKPEDLNIRAADMWS 374 (448)
T ss_pred HhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeecc----ccccCcccCCHHHHhcCchhcchhhhhHHH
Confidence 99999999873 334467888999998765566677765553322 22346789999999876543 3899999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|++++|||.|...||...++.+--.+|.- .+.....+++.
T Consensus 375 faillwel~trevpfadlspmecgmkial----------------------------------------eglrv~ippgi 414 (448)
T KOG0195|consen 375 FAILLWELNTREVPFADLSPMECGMKIAL----------------------------------------EGLRVHIPPGI 414 (448)
T ss_pred HHHHHHHhhccccccccCCchhhhhhhhh----------------------------------------ccccccCCCCc
Confidence 99999999999999998877654433321 12234456677
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHH
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEA 358 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~el 358 (429)
+..+..|+.-|++.||.+||....+
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCccee
Confidence 8999999999999999999997654
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-20 Score=194.21 Aligned_cols=200 Identities=24% Similarity=0.346 Sum_probs=157.5
Q ss_pred hhhcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 13 QVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 13 ~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
....+.-++.|.|-+.||.|+||+||+|.+.+...+|+|+-+.+..
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---------------------------------- 735 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---------------------------------- 735 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc----------------------------------
Confidence 3344555789999999999999999999998844558887643321
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
| .|+-..+++.+|+ + .-.+.|.++...+...+..++|+||.+ |+|.+++... +.+++..+
T Consensus 736 -------W-------EfYI~~q~~~RLk-~--~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv 796 (974)
T KOG1166|consen 736 -------W-------EFYICLQVMERLK-P--QMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTN--KVMDEYLV 796 (974)
T ss_pred -------e-------eeeehHHHHHhhc-h--hhhcchHHHHHHHccCCcceeeeeccccccHHHhhccC--CCCCchhh
Confidence 1 1122344455554 1 122356666677777888999999995 8999999944 45999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEec-----CCCcceEEeeeccccccc-----CcceeeecCccccchhhhh
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQ-----RGSSSIKVIDFGSSCYSH-----QRVYTYIQSRFYRSPEVIL 241 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~-----~~~~~vkl~Dfg~~~~~~-----~~~~~~~~t~~y~aPE~~~ 241 (429)
..+..|++..+..||..+|||+||||+|+|+.. .+...++|+|||.+..+. ......++|-.+-++|+..
T Consensus 797 ~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~ 876 (974)
T KOG1166|consen 797 MFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE 876 (974)
T ss_pred hHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhc
Confidence 999999999999999999999999999999964 234579999999986432 2334467888999999999
Q ss_pred CCCCCCCccccchhhHHHHHhhCC
Q psy17270 242 GLPYGPPIDMWSLGCILAELYTGC 265 (429)
Q Consensus 242 ~~~~~~~~DiwSlG~il~~lltg~ 265 (429)
|.+|+..+|.|.|+.+++.||.|+
T Consensus 877 grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 877 GRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred CCCCchhhhhHHHHHHHHHHHHHH
Confidence 999999999999999999999985
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.7e-19 Score=155.19 Aligned_cols=144 Identities=20% Similarity=0.138 Sum_probs=106.6
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
.+.+|+++|++|.|. +++++++++ ...+++|||+.| +|..... .. ...++.|++.+|.++|
T Consensus 47 l~~rE~~iL~~L~~~-----~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~--------~~-~~~~~~qi~~~L~~lH 108 (218)
T PRK12274 47 LARREALALRQLDGL-----PRTPRLLHW----DGRHLDRSYLAGAAMYQRPP--------RG-DLAYFRAARRLLQQLH 108 (218)
T ss_pred HHHHHHHHHHhcCCC-----CCCCEEEEE----cCEEEEEeeecCccHHhhhh--------hh-hHHHHHHHHHHHHHHH
Confidence 467799999999764 377777775 456899999976 5643321 11 1357889999999999
Q ss_pred HCCceeccc-CCCcEEEecCCCcceEEeeecccccccCcce----------------eeecCccccchhhhhCC-CCC-C
Q psy17270 187 RENIIHCDL-KPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----------------TYIQSRFYRSPEVILGL-PYG-P 247 (429)
Q Consensus 187 ~~~ivH~dl-kp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----------------~~~~t~~y~aPE~~~~~-~~~-~ 247 (429)
++||+|||| ||+|||++.++ .++|+|||++........ ....++.|+.|+--.-- ..+ .
T Consensus 109 ~~GIvHrDL~kp~NILv~~~g--~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~ 186 (218)
T PRK12274 109 RCGVAHNDLAKEANWLVQEDG--SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWI 186 (218)
T ss_pred HCcCccCCCCCcceEEEcCCC--CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhH
Confidence 999999999 79999999887 899999999975443221 01246667777754322 223 3
Q ss_pred CccccchhhHHHHHhhCCCCCCCC
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGE 271 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~ 271 (429)
..+-++.|+.+|.++|+..++-+.
T Consensus 187 ~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 187 RELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHhcchHHHHHhccCCcccc
Confidence 567889999999999999887554
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=175.93 Aligned_cols=174 Identities=26% Similarity=0.393 Sum_probs=133.6
Q ss_pred eEEEEEeecC-cCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 142 HLCISFELMN-LNLYELIKRNN-YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 142 ~~~lv~e~~~-g~L~~~i~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
++||.|++|. .+|.+++.... ....+......++.|+..|+.| +|.+|+|+||.||++..++ .+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--QLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--hhhhhhhhhee
Confidence 6899999995 79999997443 2347788999999999999999 9999999999999999888 89999999986
Q ss_pred cccCc---------ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcH
Q psy17270 220 YSHQR---------VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPD 289 (429)
Q Consensus 220 ~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 289 (429)
..... ....+||+.||+||.+.+..|+.++||||||++++|++. -...|.. ...+..+.. |..|+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~--g~ip~ 479 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRD--GIIPP 479 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhc--CCCCh
Confidence 54322 234689999999999999999999999999999999987 2222211 111111111 22332
Q ss_pred HHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 290 EVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
+.+.. .+.-.+|+.+||...|.+||++.+.--|.|.
T Consensus 480 ~~~~d---------------------------------------~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 480 EFLQD---------------------------------------YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHhhc---------------------------------------CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 22211 2344599999999999999998888888775
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.7e-18 Score=155.20 Aligned_cols=167 Identities=20% Similarity=0.186 Sum_probs=108.5
Q ss_pred eEEEeEeeccccceEEEEE-ecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 23 YEILEVIGKGSFGQVIRAL-DHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~-~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
|.+.+.||.|+||.||+|+ +..+|. +|+|++...........-. ... ...+......
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~-----------~~~---------~~~~~~~~~~- 88 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRY-----------VDG---------DFRFKYRKIN- 88 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhh-----------ccc---------chhhccCCCC-
Confidence 8899999999999999999 555664 5999886543221100000 000 0000000000
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
........+..|++++..+.+. .. .+..++++ ...++||||++| +|....... ..+....+..++.|++
T Consensus 89 ~~~~~~~~~~~E~~~L~~L~~~-~i---~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~ 158 (237)
T smart00090 89 PRKLVRLWAEKEFRNLQRLYEA-GV---PVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDIL 158 (237)
T ss_pred HHHHHHHHHHHHHHHHHHHHhc-CC---CCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHH
Confidence 0011123456799999999863 11 23333332 234799999977 554443222 2366777889999999
Q ss_pred HHHHHHHHCC-ceecccCCCcEEEecCCCcceEEeeecccccccC
Q psy17270 180 QCLRLLHREN-IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ 223 (429)
Q Consensus 180 ~~l~~lH~~~-ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~ 223 (429)
.++.+||++| ++|+||||+||+++ ++ .++|+|||.+.....
T Consensus 159 ~~l~~LH~~g~iiH~Dikp~NIli~-~~--~i~LiDFg~a~~~~~ 200 (237)
T smart00090 159 EEMRKLYKEGELVHGDLSEYNILVH-DG--KVVIIDVSQSVELDH 200 (237)
T ss_pred HHHHHHHhcCCEEeCCCChhhEEEE-CC--CEEEEEChhhhccCC
Confidence 9999999999 99999999999998 55 899999999864433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.9e-17 Score=147.91 Aligned_cols=142 Identities=23% Similarity=0.289 Sum_probs=106.6
Q ss_pred eEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFH 106 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (429)
+.||+|++|.||+|.+ ....+++|+............ .....
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~-------------------------------------~~~~~ 43 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELD-------------------------------------ERIRR 43 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHH-------------------------------------HHHHH
Confidence 6799999999999988 333557776543221111000 01112
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
..+.+|++++..+.+. ++.....++......+++|||++| +|.+++.... . ....++.+++.+|.++
T Consensus 44 ~~~~~E~~~l~~l~~~------~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~l 111 (211)
T PRK14879 44 ERTRREARIMSRARKA------GVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKL 111 (211)
T ss_pred HHHHHHHHHHHHHHHC------CCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHH
Confidence 3466799999999887 565555566667788999999965 8988876532 2 8889999999999999
Q ss_pred HHCCceecccCCCcEEEecCCCcceEEeeecccccc
Q psy17270 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS 221 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~ 221 (429)
|+.|++|+|++|.||+++ ++ .++|+|||.+...
T Consensus 112 H~~~i~H~Dl~p~Nil~~-~~--~~~liDf~~a~~~ 144 (211)
T PRK14879 112 HSAGIIHGDLTTSNMILS-GG--KIYLIDFGLAEFS 144 (211)
T ss_pred HhCCcccCCCCcccEEEE-CC--CEEEEECCcccCC
Confidence 999999999999999998 55 7999999998653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.8e-16 Score=161.94 Aligned_cols=145 Identities=19% Similarity=0.236 Sum_probs=106.7
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
..+|...+.||+|+||+||+|.+.... +++|+.......... ..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~--~~--------------------------------- 375 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPE--LD--------------------------------- 375 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchh--HH---------------------------------
Confidence 455677899999999999999876544 334432111100000 00
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.......+.+|+++++.+.|+ +++....++......++||||++ ++|.+++. ....++.++
T Consensus 376 --~~~~~~~~~~E~~~l~~l~~~------~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i 437 (535)
T PRK09605 376 --ERLRTERTRAEARLLSEARRA------GVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKV 437 (535)
T ss_pred --HHHHHHHHHHHHHHHHhhccc------CCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHH
Confidence 011223566799999999887 77766666666677899999995 58888775 346789999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccc
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS 221 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~ 221 (429)
+.+|.+||+.|++|||+||+||++ .++ .++|+|||+++..
T Consensus 438 ~~~L~~lH~~giiHrDlkp~NILl-~~~--~~~liDFGla~~~ 477 (535)
T PRK09605 438 GEIVAKLHKAGIVHGDLTTSNFIV-RDD--RLYLIDFGLGKYS 477 (535)
T ss_pred HHHHHHHHhCCCccCCCChHHEEE-ECC--cEEEEeCcccccC
Confidence 999999999999999999999999 445 7999999998653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.6e-16 Score=140.32 Aligned_cols=137 Identities=20% Similarity=0.247 Sum_probs=97.6
Q ss_pred EeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhhh
Q psy17270 28 VIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHH 107 (429)
Q Consensus 28 ~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (429)
.||+|+||.||+|... ...+++|+...........+ ......
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~-------------------------------------~~~~~~ 42 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELD-------------------------------------ERIRRE 42 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHH-------------------------------------HHHHHH
Confidence 4899999999999953 23557777532211100000 001123
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
.+.+|++++..+.+. ++.....++......+++|||++ ++|.+++.... . .++.+++.+|.+||
T Consensus 43 ~~~~E~~~l~~l~~~------~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH 107 (199)
T TIGR03724 43 RTRNEARLLSRARKA------GVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLH 107 (199)
T ss_pred HHHHHHHHHHHHHHC------CCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHH
Confidence 456799999999876 33333333445667789999996 48888765432 1 78999999999999
Q ss_pred HCCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 187 ~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
+.|++|+|++|.||+++ ++ .++++|||++..
T Consensus 108 ~~gi~H~Dl~~~Nil~~-~~--~~~liDfg~a~~ 138 (199)
T TIGR03724 108 KAGIVHGDLTTSNIIVR-DD--KLYLIDFGLGKY 138 (199)
T ss_pred HCCeecCCCCcceEEEE-CC--cEEEEECCCCcC
Confidence 99999999999999998 55 899999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=156.15 Aligned_cols=196 Identities=18% Similarity=0.237 Sum_probs=146.2
Q ss_pred CCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecccCCCcEEEec
Q psy17270 127 SYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENI-IHCDLKPENVLLKQ 204 (429)
Q Consensus 127 ~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~i-vH~dlkp~Nili~~ 204 (429)
|.|+.++++.+.+....+.|.+||. |+|.+.+.... ..++..-...++++++.||+|+|...| +|+.++..|.+++.
T Consensus 6 h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~ 84 (484)
T KOG1023|consen 6 HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDS 84 (484)
T ss_pred hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeee
Confidence 4499999999999999999999995 89999998854 458889999999999999999998755 99999999999998
Q ss_pred CCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCC-------CCCCccccchhhHHHHHhhCCCCCCCCC
Q psy17270 205 RGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLP-------YGPPIDMWSLGCILAELYTGCPLFPGEN 272 (429)
Q Consensus 205 ~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-------~~~~~DiwSlG~il~~lltg~~pf~~~~ 272 (429)
.- .+||+|||+....... .....-..-|.|||++.+.. .+.+.||||+|++++|+++...||+...
T Consensus 85 ~w--~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~ 162 (484)
T KOG1023|consen 85 RW--VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRN 162 (484)
T ss_pred eE--EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccccc
Confidence 77 8999999997654321 01111223499999998742 3667999999999999999999997632
Q ss_pred H----HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccC
Q psy17270 273 E----VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWD 348 (429)
Q Consensus 273 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 348 (429)
. .+.+..+.. .+. .+......... ...+.+..++.+||..+
T Consensus 163 ~~~~~~eii~~~~~-~~~---------------------------------~~~rP~i~~~~-e~~~~l~~l~~~cw~e~ 207 (484)
T KOG1023|consen 163 LVEDPDEIILRVKK-GGS---------------------------------NPFRPSIELLN-ELPPELLLLVARCWEEI 207 (484)
T ss_pred ccCChHHHHHHHHh-cCC---------------------------------CCcCcchhhhh-hcchHHHHHHHHhcccC
Confidence 2 223333222 000 00000011000 22457889999999999
Q ss_pred CCCCCCHHHHhc
Q psy17270 349 SKKRLTPDEALR 360 (429)
Q Consensus 349 P~~Rpta~ell~ 360 (429)
|.+||++.++-.
T Consensus 208 P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 208 PEKRPSIEQIRS 219 (484)
T ss_pred hhhCccHHHHHh
Confidence 999999988744
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.3e-18 Score=174.56 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=192.3
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc--hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH--ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~--aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
...|.+.+.||.|+|+.|-++......+. |.|.+.....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~--------------------------------------- 59 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPK--------------------------------------- 59 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCC---------------------------------------
Confidence 45699999999999999998887555543 5444432220
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
...+......|..+.+.+.. |.|++++++........++++++.. +++.+.+........+...+..++.
T Consensus 60 ----~~~~~~~i~~e~~~~~~~s~-----h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ 130 (601)
T KOG0590|consen 60 ----SEDSSEHIDTETDIQKKLSK-----HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLP 130 (601)
T ss_pred ----ccchhhhcCccccccccccc-----cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhh
Confidence 01112222235666566551 3499999999999999999999985 5777777322222588899999999
Q ss_pred HHHHHHHHHH-HCCceecccCCCcEEEecCCCcceEEeeecccccccC------cceeeec-CccccchhhhhCCCC-CC
Q psy17270 177 SLVQCLRLLH-RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ------RVYTYIQ-SRFYRSPEVILGLPY-GP 247 (429)
Q Consensus 177 qil~~l~~lH-~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~------~~~~~~~-t~~y~aPE~~~~~~~-~~ 247 (429)
|+..++.|+| ..++.|+|+||+|.+++..+. .+++.|||+|..... .....+| ++.|+|||...+..| .+
T Consensus 131 ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~ 209 (601)
T KOG0590|consen 131 QLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGP 209 (601)
T ss_pred hhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCC
Confidence 9999999999 999999999999999998765 789999999965333 2334678 999999999998654 67
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
..|+||.|+++..+++|..|+......+... ..+. ..+ .....
T Consensus 210 ~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~----------~~~~----------~~~-----------------~~~~~ 252 (601)
T KOG0590|consen 210 SVDVWSLGIVLSAMLTGELPWDFPSRKDGRY----------SSWK----------SNK-----------------GRFTQ 252 (601)
T ss_pred CcccccccccccccccCCCCccccccccccc----------eeec----------ccc-----------------ccccc
Confidence 9999999999999999999998765533100 0000 000 00001
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
..+...+....+++.+++..+|..|.+..++-.++|+..
T Consensus 253 ~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 253 LPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 112334667789999999999999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=137.10 Aligned_cols=159 Identities=23% Similarity=0.230 Sum_probs=106.3
Q ss_pred eEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
|.+.+.||.|+||.||+|.+.....+|+|++.............. .++.. +.. . ...
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~----~~~~~---~~~--~--------------~~~ 73 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKR----DYLGD---RKH--A--------------SWL 73 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchH----HHHhc---ccc--c--------------hhH
Confidence 889999999999999999986444569998765432211110000 00000 000 0 000
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQC 181 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~ 181 (429)
......+..|..++..+.+.+. .+...++ ....++||||+.| +|..+.. ......++.+++.+
T Consensus 74 ~~~~~~~~~E~~~l~~l~~~~i----~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~ 137 (198)
T cd05144 74 YLSRLAAQKEFAALKALYEEGF----PVPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEE 137 (198)
T ss_pred HHhHHHHHHHHHHHHHHHHcCC----CCCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHH
Confidence 1122345679999999977531 2333333 2455899999975 6654422 13456788999999
Q ss_pred HHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc
Q psy17270 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222 (429)
Q Consensus 182 l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~ 222 (429)
+.++|..|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 138 l~~lh~~gi~H~Dl~p~Nill~~~~--~~~liDfg~~~~~~ 176 (198)
T cd05144 138 IVKAYKHGIIHGDLSEFNILVDDDE--KIYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHHCCCCcCCCCcccEEEcCCC--cEEEEECCccccCC
Confidence 9999999999999999999999877 89999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.7e-15 Score=131.64 Aligned_cols=161 Identities=20% Similarity=0.211 Sum_probs=99.1
Q ss_pred EeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 26 LEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
.+.||+|+||+||+|.+.....+|+|++................+ .. ......++ ....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~--------------~~~~ 60 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGD--YR-----FGRKKSNW--------------RYLS 60 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHH--HH-----hccCCcch--------------hhhh
Confidence 568999999999999988444569998865433221111000000 00 00000000 0011
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHH-HHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLY-ELIKRNNYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~-~~i~~~~~~~~~~~~~~~i~~qil~~l~ 183 (429)
......|.+.+..+.+.. ..+..++.. ...++||||+++ ++. ..+.... .. ..+..++.+++.++.
T Consensus 61 ~~~~~~e~~~l~~l~~~~----~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~ 128 (187)
T cd05119 61 RLWAEKEFRNLKRLYEAG----VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMR 128 (187)
T ss_pred hHHHHHHHHHHHHHHHcC----CCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHH
Confidence 112245777777776541 123444432 346899999976 221 1122111 11 677899999999999
Q ss_pred HHHH-CCceecccCCCcEEEecCCCcceEEeeeccccccc
Q psy17270 184 LLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222 (429)
Q Consensus 184 ~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~ 222 (429)
++|. .|++|+||||+||+++ ++ .++|+|||.+....
T Consensus 129 ~lh~~~~ivH~Dl~p~Nili~-~~--~~~liDfg~a~~~~ 165 (187)
T cd05119 129 KLYREAGLVHGDLSEYNILVD-DG--KVYIIDVPQAVEID 165 (187)
T ss_pred HHhhccCcCcCCCChhhEEEE-CC--cEEEEECccccccc
Confidence 9999 9999999999999999 66 89999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-14 Score=133.31 Aligned_cols=148 Identities=20% Similarity=0.207 Sum_probs=101.5
Q ss_pred eEee-ccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIG-KGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG-~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
..|| .|+.|+||.+... .+.+++|.+..... +.|+....- . .....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~-------------------i~kv~~~~~------------~-~~~~~ 83 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGL-------------------IGKLSKDRY------------L-FTGLE 83 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcch-------------------HHhhhhhcc------------c-ccchh
Confidence 4677 8888889888774 55678888743211 111111000 0 00112
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC----eEEEEEeecCc--CHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN----HLCISFELMNL--NLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~g--~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
...+.+|++++..|.+.++ .++..+++..... ..++|||+++| +|.+++... .+++.. +.|++
T Consensus 84 ~~r~~rE~~ll~~L~~~gi----~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~ 152 (239)
T PRK01723 84 RTRAFAEFRLLAQLYEAGL----PVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIG 152 (239)
T ss_pred hhHHHHHHHHHHHHHhCCC----CCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHH
Confidence 3456779999999998732 2455555543322 23599999974 888887653 255543 56899
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.+|.+||++||+|+||||.|||++.++ .++|+|||.+..
T Consensus 153 ~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg~~~~ 191 (239)
T PRK01723 153 QLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECCCccc
Confidence 999999999999999999999999877 899999998854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.6e-14 Score=122.70 Aligned_cols=133 Identities=23% Similarity=0.210 Sum_probs=104.9
Q ss_pred EEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhh
Q psy17270 25 ILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKR 104 (429)
Q Consensus 25 i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~ 104 (429)
+++.||.|.++.||++.+.. ..+++|.......
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---------------------------------------------- 34 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---------------------------------------------- 34 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----------------------------------------------
Confidence 46889999999999999865 5568887643211
Q ss_pred hhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy17270 105 FHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 105 ~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~ 183 (429)
...+..|+.+++.+.+. ...+++++.++...+..+++|||+.| .+..+ +......++.+++.+++
T Consensus 35 -~~~~~~e~~~~~~l~~~----~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~ 100 (155)
T cd05120 35 -GADREREVAILQLLARK----GLPVPKVLASGESDGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLA 100 (155)
T ss_pred -hhHHHHHHHHHHHHHHc----CCCCCeEEEEcCCCCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHH
Confidence 22455699999999875 23677777777777889999999976 33322 45667788999999999
Q ss_pred HHHHC---CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 184 LLHRE---NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 184 ~lH~~---~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
++|.. +++|+|++|+||+++..+ .++++|||.+..
T Consensus 101 ~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~~ 138 (155)
T cd05120 101 KLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAGY 138 (155)
T ss_pred HHhCCCceEEEecCCCcceEEEECCc--EEEEEecccccC
Confidence 99985 799999999999999866 899999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.4e-14 Score=143.19 Aligned_cols=257 Identities=23% Similarity=0.209 Sum_probs=187.7
Q ss_pred ccccCCeEEEeEeec--cccceEEEEEe--cCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 17 DHICYRYEILEVIGK--GSFGQVIRALD--HKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~--G~~g~Vy~a~~--~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
..+..++.+...+|. |.+|.||.+.. ..++.. |+|.-....... +..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p-----------------------~~~----- 161 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP-----------------------LDS----- 161 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc-----------------------ccc-----
Confidence 456778999999999 99999999998 555543 666532211100 000
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHH
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~ 171 (429)
..-++|+ ..|.....|.+.++.+..++..+..++-+|+|+.+|..+..... .-++...+
T Consensus 162 ---------------~~k~~~~-----~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l 220 (524)
T KOG0601|consen 162 ---------------KRKLREF-----LSHHKIDSHENPVRDSPAWEGSGILFIQTELCGESLQSYCHTPC-NFLPDNLL 220 (524)
T ss_pred ---------------ccccchh-----hcccccCccccccccCcccccCCcceeeeccccchhHHhhhccc-ccCCchhh
Confidence 0001122 24556667889999999999999999999999988888876543 34889999
Q ss_pred HHHHHHHHH----HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce--------eeecCccccchhh
Q psy17270 172 RRFAFSLVQ----CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY--------TYIQSRFYRSPEV 239 (429)
Q Consensus 172 ~~i~~qil~----~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~--------~~~~t~~y~aPE~ 239 (429)
+..+.+... ||.++|+.+++|-|+||.||+...+. ..++++|||+....+.... ...+...|++||.
T Consensus 221 ~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~ 299 (524)
T KOG0601|consen 221 WNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL 299 (524)
T ss_pred hhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhh
Confidence 999999999 99999999999999999999999883 2899999999876553321 1145566999999
Q ss_pred hhCCCCCCCccccchhhHHHHHhhCCCCCCCC--CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCC
Q psy17270 240 ILGLPYGPPIDMWSLGCILAELYTGCPLFPGE--NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317 (429)
Q Consensus 240 ~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (429)
..+ -++...|++++|.++.+..++..++... +...++.... .+.+
T Consensus 300 ~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----ip~e--------------------------- 346 (524)
T KOG0601|consen 300 LNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----IPLE--------------------------- 346 (524)
T ss_pred hcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----Cchh---------------------------
Confidence 877 5788999999999999999886665443 3322221110 1111
Q ss_pred CCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
...+.+.++...+..|++.+|..|++++.++.|.+..+.
T Consensus 347 -----------~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 347 -----------FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred -----------hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 111224555679999999999999999999999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.7e-13 Score=134.59 Aligned_cols=177 Identities=18% Similarity=0.178 Sum_probs=105.8
Q ss_pred eEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHH-HhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIW-YLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
++||+|++|+||+|+.+....+|||+.+......-..++.-...+. .+.... .....-+. ....+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~-~~~~~~~~-----------~~~~~e~ 190 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLS-PDSRRLRP-----------TEVVKEF 190 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhC-ccccccCH-----------HHHHHHH
Confidence 5799999999999998766667999987665444433333222111 000000 00000000 0000111
Q ss_pred h------hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 106 H------HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 106 ~------~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
. -.+.+|++.+.++.+. ...++++.-..-+.......++||||++| +|.++..... .+.+ ...++.++
T Consensus 191 ~~~l~~Eldf~~Ea~n~~~~~~~-~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~ 265 (437)
T TIGR01982 191 EKTLRRELDLRREAANASELGEN-FKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENL 265 (437)
T ss_pred HHHHHHHHCHHHHHHHHHHHHHh-cCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHH
Confidence 1 1366677777777642 11223332222223334567999999965 7777665332 1232 23455555
Q ss_pred HH-HHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc
Q psy17270 179 VQ-CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222 (429)
Q Consensus 179 l~-~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~ 222 (429)
+. .+..+|..|++|+|++|.||+++.++ .++++|||++....
T Consensus 266 ~~~~l~ql~~~g~~H~D~hPgNilv~~~g--~i~liDfG~~~~l~ 308 (437)
T TIGR01982 266 ARSFLNQVLRDGFFHADLHPGNIFVLKDG--KIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHhCCceeCCCCcccEEECCCC--cEEEEeCCCeeECC
Confidence 55 47889999999999999999999888 89999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.2e-13 Score=137.89 Aligned_cols=181 Identities=13% Similarity=0.142 Sum_probs=103.6
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
..|+. +.||+|++|+||+|+.+.+|+ +|+|+.++.....-..++.....+.-.-.........-++ .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~-----------~ 187 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKP-----------R 187 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCH-----------H
Confidence 35776 799999999999999998665 5999998776555444443332221110000000000000 0
Q ss_pred cchhhhhhh------HHHHHHHHHHHhcCCCCCCCceeEEEEEE-EEcCeEEEEEeecCc-CHHHHH--HhhCC--CCCC
Q psy17270 100 YNKKRFHHQ------ALIEVRILDHLRKKDADSSYNVIHMLEYF-YFRNHLCISFELMNL-NLYELI--KRNNY--QGFS 167 (429)
Q Consensus 100 ~~~~~~~~~------~~~E~~il~~l~h~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~~g-~L~~~i--~~~~~--~~~~ 167 (429)
.....+... +.+|+.-+.++.+. .... +.+.+-.++ ......++||||+.| ++.++. ..... ..+.
T Consensus 188 ~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~-f~~~-~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la 265 (537)
T PRK04750 188 EVVAEFEKTLHDELDLMREAANASQLRRN-FEDS-DMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLA 265 (537)
T ss_pred HHHHHHHHHHHHhhCHHHHHHHHHHHHHH-ccCC-CCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHH
Confidence 001122333 44455555555432 1111 223333333 336678899999965 776643 22210 0133
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC--CcceEEeeeccccccc
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG--SSSIKVIDFGSSCYSH 222 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~--~~~vkl~Dfg~~~~~~ 222 (429)
+..+..++.|++ ..|++|+|++|.||+++.++ ...++++|||.+...+
T Consensus 266 ~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 266 ERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 444555555554 58999999999999998764 2379999999986544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.6e-12 Score=109.95 Aligned_cols=163 Identities=18% Similarity=0.261 Sum_probs=106.4
Q ss_pred EeEeeccccceEEEEEecCC-------CcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC-
Q psy17270 26 LEVIGKGSFGQVIRALDHKT-------NTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN- 97 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~- 97 (429)
...||.|.-+.||.|..... ..+|+|+++.....+.... .+. .+. +-|....
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~--~y~------------~~~------~rf~~~~~ 61 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRD--KYI------------KDD------YRFKDRFS 61 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChh--hhc------------cCC------cccccCcC
Confidence 35799999999999987642 3559999975544433211 100 000 0010000
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcC-HH-HHHHhhCCCCCCHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLN-LY-ELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~-L~-~~i~~~~~~~~~~~~~~~i~ 175 (429)
....++....-+.+|.+.|+++.... . +++.++++ ..-++||||++++ +. ..++.. .+++..+..+.
T Consensus 62 k~~~~~~~~~wa~kE~r~L~rl~~~G-v---~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~ 130 (197)
T cd05146 62 KLNPRKIIRMWAEKEMHNLKRMQKAG-I---PCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAY 130 (197)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHcC-C---CCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHH
Confidence 00112333444568999999998763 2 34555543 5667999999763 21 122221 25666778889
Q ss_pred HHHHHHHHHH-HHCCceecccCCCcEEEecCCCcceEEeeeccccccc
Q psy17270 176 FSLVQCLRLL-HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222 (429)
Q Consensus 176 ~qil~~l~~l-H~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~ 222 (429)
.+++.+|..| |..|+||+||++.||++.. + .+.|+|||.+....
T Consensus 131 ~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~--~v~iIDF~qav~~~ 175 (197)
T cd05146 131 YQVLSMMKQLYKECNLVHADLSEYNMLWHD-G--KVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEEC-C--cEEEEECCCceeCC
Confidence 9999999999 8999999999999999974 4 79999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.1e-13 Score=137.49 Aligned_cols=200 Identities=24% Similarity=0.291 Sum_probs=152.7
Q ss_pred CceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC
Q psy17270 128 YNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG 206 (429)
Q Consensus 128 ~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~ 206 (429)
|-++...--+.-....+|+++|.+ ++|...++... ..+..-++.++..+..+++|||+..+.|+|++|.|++...++
T Consensus 864 P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g 941 (1205)
T KOG0606|consen 864 PAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG 941 (1205)
T ss_pred CceecccCCCCCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccC
Confidence 344433333333467899999995 57777776654 377778888889999999999999999999999999999988
Q ss_pred CcceEEeeeccccccc----------------------------------CcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 207 SSSIKVIDFGSSCYSH----------------------------------QRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 207 ~~~vkl~Dfg~~~~~~----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
+.++.|||.....+ .......+|+.|.+||...+...+..+|.|
T Consensus 942 --h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~ 1019 (1205)
T KOG0606|consen 942 --HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWW 1019 (1205)
T ss_pred --CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhh
Confidence 88999998321100 001224678999999999999999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
++|+++++.++|.+||........+..|...-. .| ......
T Consensus 1020 ~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~--------------------~~-------------------p~g~~~ 1060 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQIFENILNRDI--------------------PW-------------------PEGPEE 1060 (1205)
T ss_pred hhhhhhhhhhcCCCCCCCcchhhhhhccccCCC--------------------CC-------------------CCCccc
Confidence 999999999999999999888766654432100 01 111122
Q ss_pred CChHHHHHHHHhcccCCCCCCCHH---HHhcCCCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPD---EALRHEWLKSSSSS 370 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~---ell~h~~~~~~~~~ 370 (429)
.+..+++++.++|..+|.+|..+. ++-.|+||+.....
T Consensus 1061 ~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1061 GSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred cChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence 367889999999999999999987 99999999986544
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.6e-12 Score=119.38 Aligned_cols=190 Identities=17% Similarity=0.212 Sum_probs=131.6
Q ss_pred ceeEEEEEEEEc-----CeEEEEEeec-CcCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC--CceecccCCC
Q psy17270 129 NVIHMLEYFYFR-----NHLCISFELM-NLNLYELIKRNNY--QGFSLGLIRRFAFSLVQCLRLLHRE--NIIHCDLKPE 198 (429)
Q Consensus 129 ~i~~~~~~~~~~-----~~~~lv~e~~-~g~L~~~i~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~--~ivH~dlkp~ 198 (429)
||++++.|+.+. ....++.||| .|++..++++..+ ..+......+|+.||+.||.|||+. -++|+++..+
T Consensus 128 nlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~ 207 (458)
T KOG1266|consen 128 NLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCD 207 (458)
T ss_pred HHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchh
Confidence 899998887554 3689999999 5899999986543 3488899999999999999999988 5999999999
Q ss_pred cEEEecCCCcceEEeeecccccccCc--------ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCC-C
Q psy17270 199 NVLLKQRGSSSIKVIDFGSSCYSHQR--------VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLF-P 269 (429)
Q Consensus 199 Nili~~~~~~~vkl~Dfg~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf-~ 269 (429)
.|++..++ -+|+.--.-. ..+.. .....+-++|.+||.-.....+.++|||++|....+|..+..-- .
T Consensus 208 tifiq~ng--LIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tn 284 (458)
T KOG1266|consen 208 TIFIQHNG--LIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTN 284 (458)
T ss_pred heeecCCc--eEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCC
Confidence 99999776 5554321111 11100 01123457799999766556677999999999999998775432 2
Q ss_pred CCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCC
Q psy17270 270 GENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDS 349 (429)
Q Consensus 270 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 349 (429)
+.+....-..+.+.+.. ...+--.+++.+||+-.|
T Consensus 285 seS~~~~ee~ia~~i~~---------------------------------------------len~lqr~~i~kcl~~eP 319 (458)
T KOG1266|consen 285 SESKVEVEENIANVIIG---------------------------------------------LENGLQRGSITKCLEGEP 319 (458)
T ss_pred Ccceeehhhhhhhheee---------------------------------------------ccCccccCcCcccccCCC
Confidence 22211111111110000 001112488999999999
Q ss_pred CCCCCHHHHhcCCCCCC
Q psy17270 350 KKRLTPDEALRHEWLKS 366 (429)
Q Consensus 350 ~~Rpta~ell~h~~~~~ 366 (429)
+.||+|.+++.||-+-.
T Consensus 320 ~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 320 NGRPDARLLLFHPLLFE 336 (458)
T ss_pred CCCcchhhhhcCceeee
Confidence 99999999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.4e-11 Score=104.90 Aligned_cols=127 Identities=16% Similarity=0.106 Sum_probs=89.6
Q ss_pred EeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 26 LEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
++.|+.|.++.||++... .+.+++|....... .
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~----------------------------------------------~ 35 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE----------------------------------------------L 35 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc----------------------------------------------c
Confidence 578999999999999875 45568887532210 0
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
.....+|+++++.+.+.. .+.+++... ....++||||++| ++.+. . .....++.+++.+|+.
T Consensus 36 ~~~~~~E~~~l~~l~~~~-----~~P~~~~~~--~~~~~lv~e~i~G~~l~~~----~------~~~~~~~~~l~~~l~~ 98 (170)
T cd05151 36 LINRENEAENSKLAAEAG-----IGPKLYYFD--PETGVLITEFIEGSELLTE----D------FSDPENLEKIAKLLKK 98 (170)
T ss_pred ccCHHHHHHHHHHHHHhC-----CCCceEEEe--CCCCeEEEEecCCCccccc----c------ccCHHHHHHHHHHHHH
Confidence 113345999999997652 233444433 3345799999976 44322 0 1123456799999999
Q ss_pred HHHCCc-----eecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 185 LHRENI-----IHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 185 lH~~~i-----vH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
||..++ +|+|++|.||+++ ++ .++++|||.+.
T Consensus 99 LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~ 135 (170)
T cd05151 99 LHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG 135 (170)
T ss_pred HhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence 999985 9999999999998 45 79999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.9e-10 Score=98.12 Aligned_cols=108 Identities=23% Similarity=0.252 Sum_probs=85.6
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc--CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL--NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g--~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
++-.+|++.|.++... .|.-..-+|.+...-.|+|||++| ++.+++...-...........++++|-+.+.-
T Consensus 55 ~Rt~~Ear~l~k~~~~------GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igk 128 (229)
T KOG3087|consen 55 KRTKQEARLLAKCRAL------GIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGK 128 (229)
T ss_pred HHHHHHHHHHHHHHHh------CCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHH
Confidence 4556699999999876 444444456666777899999988 89999987765444445557899999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCc-ceEEeeeccccc
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSS-SIKVIDFGSSCY 220 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~-~vkl~Dfg~~~~ 220 (429)
||..+++|+||..+||++..++.. .+.++|||++..
T Consensus 129 lH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 129 LHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred hhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999999999999999999887642 348999999843
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.6e-10 Score=96.85 Aligned_cols=96 Identities=24% Similarity=0.301 Sum_probs=74.4
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
++-.+|++++..+... .|...+=++.+.....|+|||++| .|.+.+.... ..++..+-.-+.-|
T Consensus 44 ~Rt~~Earil~~a~~~------GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~~---------~~~~r~vG~~vg~l 108 (204)
T COG3642 44 ERTRREARILAKAREA------GVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEAR---------PDLLREVGRLVGKL 108 (204)
T ss_pred HHHHHHHHHHHHHHHc------CCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhcc---------hHHHHHHHHHHHHH
Confidence 3456799999999876 333333344557788899999988 5666777651 45666777778889
Q ss_pred HHCCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
|..||+|+||.++||++..+ .+.++|||++..
T Consensus 109 H~~givHGDLTtsNiIl~~~---~i~~IDfGLg~~ 140 (204)
T COG3642 109 HKAGIVHGDLTTSNIILSGG---RIYFIDFGLGEF 140 (204)
T ss_pred HhcCeecCCCccceEEEeCC---cEEEEECCcccc
Confidence 99999999999999999875 499999999853
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.5e-10 Score=114.55 Aligned_cols=143 Identities=22% Similarity=0.311 Sum_probs=110.6
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
...+.+.+..|+.++|+ ||+++++.++..++.|+|+|.+. .|..++++ +....+..-++||+.||.+|
T Consensus 53 ~~~~~~A~k~lKtlRHP------~Il~yL~t~e~~~~~ylvTErV~-Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL 120 (690)
T KOG1243|consen 53 TELAKRAVKRLKTLRHP------NILSYLDTTEEEGTLYLVTERVR-PLETVLKE-----LGKEEVCLGLFQILAALSFL 120 (690)
T ss_pred hHHHHHHHHHhhhccCc------hhhhhhhhhcccCceEEEeeccc-cHHHHHHH-----hHHHHHHHHHHHHHHHHHHH
Confidence 34566678888888877 99999999999999999999884 23445554 33677888899999999999
Q ss_pred H-HCCceecccCCCcEEEecCCCcceEEeeecccccccCcce--e-eecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 186 H-RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY--T-YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 186 H-~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~--~-~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
| +.+++|++|.-..|+++..| ..||++|.++........ . ...-..|..|+.+.... -..|.|-|||+++++
T Consensus 121 ~~d~~lvHgNv~~~SVfVn~~G--eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el 196 (690)
T KOG1243|consen 121 NDDCNLVHGNVCKDSVFVNESG--EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEEL 196 (690)
T ss_pred hccCCeeeccEeeeeEEEcCCC--cEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHH
Confidence 8 56899999999999999999 899999999865433221 1 11112366666554333 357999999999999
Q ss_pred hhC
Q psy17270 262 YTG 264 (429)
Q Consensus 262 ltg 264 (429)
+.|
T Consensus 197 ~ng 199 (690)
T KOG1243|consen 197 FNG 199 (690)
T ss_pred hCc
Confidence 998
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.8e-11 Score=120.01 Aligned_cols=253 Identities=21% Similarity=0.195 Sum_probs=171.1
Q ss_pred cccCCeEEEeEeeccccceEEEEEec-CCC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDH-KTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~-~~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
....+|..+..||.|.|+.|+.+.-. .++ .|++|............
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-------------------------------- 309 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-------------------------------- 309 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh--------------------------------
Confidence 45678999999999999999998744 222 44777654333221111
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
...+.|+.+...+.- |.+++..+..|....+.|+=.|||. +++...+.-. ..+++...+.+
T Consensus 310 -----------i~sl~ev~l~~~l~~-----~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~ 371 (524)
T KOG0601|consen 310 -----------IFSLGEVILEAILGS-----HLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRL 371 (524)
T ss_pred -----------hcchhhhhHhhHhhc-----ccccCCCCCCccccccccCchhhhcCcchhhhhHHH--HhcCcchhhhh
Confidence 112235555555542 2377777777777777789999995 4544444222 23889999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecC-ccc-cchhhhhCCCCCCCcccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQS-RFY-RSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t-~~y-~aPE~~~~~~~~~~~Diw 252 (429)
..|++.++.++|++.++|+|++|+||++..++ ...++.|||......-......+. ..| .+++......+..++|++
T Consensus 372 ~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~ 450 (524)
T KOG0601|consen 372 TAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIF 450 (524)
T ss_pred HHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccccceecccccccccccccchhhccccccccccccc
Confidence 99999999999999999999999999999864 378999999886433222222233 334 244445555678899999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||..+.+.+++.+.-...+.... |.. + .. ...++
T Consensus 451 sl~~~~~e~~~~~~ls~~~~~~~~---i~~--~--------------------~~--------------------p~~~~ 485 (524)
T KOG0601|consen 451 SLGLSVDEAITGSPLSESGVQSLT---IRS--G--------------------DT--------------------PNLPG 485 (524)
T ss_pred cccccccccccCcccCccccccee---eec--c--------------------cc--------------------cCCCc
Confidence 999999999998655443322111 100 0 00 00112
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
....++.+.+.++..|+..|+.+.++..|.=|..
T Consensus 486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 486 LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 2356778999999999999999999988876643
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.6e-10 Score=116.36 Aligned_cols=154 Identities=19% Similarity=0.297 Sum_probs=111.9
Q ss_pred HHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccCcce------e------eecCccccchhhhhCC
Q psy17270 177 SLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY------T------YIQSRFYRSPEVILGL 243 (429)
Q Consensus 177 qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~------~------~~~t~~y~aPE~~~~~ 243 (429)
++..|+.|+|.. ++||++|.|++|.++.++ ..||+.|+++........ . ......|.|||++.+.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~--~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG--DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCc--ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 344899999966 899999999999999998 899999998754333111 0 1224469999999998
Q ss_pred CCCCCccccchhhHHHHHh-hCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELY-TGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
..+.++|++|+||++|.+. .|+..+...+...... .........
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~---------------------------------- 229 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAG---------------------------------- 229 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccccc----------------------------------
Confidence 8889999999999999998 5777776654322111 110000000
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
........++++.+=|.++|..|+..||++.+++..+||......
T Consensus 230 ---~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~ 274 (700)
T KOG2137|consen 230 ---AFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLK 274 (700)
T ss_pred ---cccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchhh
Confidence 000013347888999999999999999999999999999876543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.5e-09 Score=96.24 Aligned_cols=144 Identities=18% Similarity=0.138 Sum_probs=96.0
Q ss_pred EeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 26 LEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
++.||.|..+.||++.......+++|........ ..
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--------------------------------------------~~ 38 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--------------------------------------------PS 38 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC--------------------------------------------cc
Confidence 3678999999999998865345677775322110 01
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc---CeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR---NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQC 181 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~---~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~ 181 (429)
...+..|+++++.+.+.. . .+.+++.+.... +..++|||+++| ++.+.+.. ..+++.....++.+++.+
T Consensus 39 ~~~~~~E~~~~~~l~~~~-~---~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~ 111 (223)
T cd05154 39 AHDVAREYRVLRALAGTG-V---PVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADT 111 (223)
T ss_pred cccHHHHHHHHHHhhCCC-C---CCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHH
Confidence 234566999999998751 1 345555555443 367899999976 45443321 125666666677777777
Q ss_pred HHHHHH--------------------------------------------------------CCceecccCCCcEEEecC
Q psy17270 182 LRLLHR--------------------------------------------------------ENIIHCDLKPENVLLKQR 205 (429)
Q Consensus 182 l~~lH~--------------------------------------------------------~~ivH~dlkp~Nili~~~ 205 (429)
|..||+ ..++|+|+.|.||+++.+
T Consensus 112 l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~ 191 (223)
T cd05154 112 LAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD 191 (223)
T ss_pred HHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC
Confidence 777763 246999999999999883
Q ss_pred CCcceEEeeeccccc
Q psy17270 206 GSSSIKVIDFGSSCY 220 (429)
Q Consensus 206 ~~~~vkl~Dfg~~~~ 220 (429)
+...+.|+||+.+..
T Consensus 192 ~~~~~~iID~e~~~~ 206 (223)
T cd05154 192 EPRVVAVLDWELATL 206 (223)
T ss_pred CCcEEEEEecccccc
Confidence 112689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.3e-09 Score=95.94 Aligned_cols=153 Identities=24% Similarity=0.287 Sum_probs=87.4
Q ss_pred eEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC-CCCcchhhhhhhHHHHHH
Q psy17270 36 QVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE-NGSYNKKRFHHQALIEVR 114 (429)
Q Consensus 36 ~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~E~~ 114 (429)
.||.|...+...+|+|+.+.....+.... +. +. .... +... ..............+|.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~--~y-----~~-------~~~r------~~~~~~~~~~~~~~~~~~~~E~~ 60 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRK--KY-----RD-------YDYR------FKKYRHKSSWRYLIREWAKKEFR 60 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHH--HH-----TT-------TSTT------STTC--G--CHHHHHHHHHHHHH
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEee--ee-----ec-------ccch------hcccccccCHHHHHHHHHHHHHH
Confidence 48999997777789999987665554421 11 00 0000 0000 000112334456778999
Q ss_pred HHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC--cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHHCCce
Q psy17270 115 ILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN--LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL-LHRENII 191 (429)
Q Consensus 115 il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~--g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~-lH~~~iv 191 (429)
.|..+..... ++++++++. .-++||||++ |.....+.... ++......++.+++..+.. +|..|++
T Consensus 61 ~L~~l~~~Gv----~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~giv 129 (188)
T PF01163_consen 61 NLKRLYEAGV----PVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIV 129 (188)
T ss_dssp HHHHCCCTT-----SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEE
T ss_pred HHHHHHHCCc----cCCcEEEEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCce
Confidence 9999986521 355555442 3469999997 63222233222 2245567778888886555 5799999
Q ss_pred ecccCCCcEEEecCCCcceEEeeeccccccc
Q psy17270 192 HCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222 (429)
Q Consensus 192 H~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~ 222 (429)
|+|+++.||+++.+ .+.++|||.+....
T Consensus 130 HGDLs~~NIlv~~~---~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 130 HGDLSEYNILVDDG---KVYIIDFGQAVDSS 157 (188)
T ss_dssp ESS-STTSEEEETT---CEEE--GTTEEETT
T ss_pred ecCCChhhEEeecc---eEEEEecCcceecC
Confidence 99999999999875 69999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.3e-08 Score=95.04 Aligned_cols=108 Identities=19% Similarity=0.093 Sum_probs=83.2
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE-----cCeEEEEEeecCc--CHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYF-----RNHLCISFELMNL--NLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~g--~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.+.+|.+.+..|....+. ++.++.+.+. ....++|||++++ +|.+++........+......++.+++.
T Consensus 74 ~a~rE~~~l~~L~~~GIp----tP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~ 149 (268)
T PRK15123 74 GADREWRAIHRLHEVGVD----TMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVAT 149 (268)
T ss_pred HHHHHHHHHHHHHHcCCC----CCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHH
Confidence 467799999999876332 2233344432 2357899999976 7999886543344677888899999999
Q ss_pred HHHHHHHCCceecccCCCcEEEec-----CCCcceEEeeecccc
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQ-----RGSSSIKVIDFGSSC 219 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~-----~~~~~vkl~Dfg~~~ 219 (429)
.+.-||..||+|+|+++.|||++. ++...+.|+||+.+.
T Consensus 150 ~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 150 MVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999999999999999999999985 233479999999874
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.9e-08 Score=87.32 Aligned_cols=112 Identities=13% Similarity=0.141 Sum_probs=87.0
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecC--cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMN--LNLYELIKRNNYQGFSLGLIRRFAFSLVQCL 182 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~--g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l 182 (429)
-.+.+|...+..|...+++ .|.++ +.+.-... -..+||+|-++ -+|.+++......+.+......++.+++..+
T Consensus 64 ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~i 141 (216)
T PRK09902 64 PTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAF 141 (216)
T ss_pred hHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHH
Confidence 3577899999999987544 44444 22211111 25789999987 4899988775544578888899999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 183 RLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 183 ~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
+-||+.|+.|+|+.+.||+++.++...+.++||.-++.
T Consensus 142 a~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 142 KKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99999999999999999999877755699999987753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.8e-08 Score=101.74 Aligned_cols=184 Identities=18% Similarity=0.215 Sum_probs=116.4
Q ss_pred eEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc-hhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN-KKRF 105 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~-~~~~ 105 (429)
..|+.++-|+||+|+.+....+|||+.+......-..++........+.....+-...-++... .. +.. .-..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~v---v~---e~~~~l~~ 204 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEV---VD---EFEKRLRE 204 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHH---HH---HHHHHHHH
Confidence 6899999999999999987778999999888877777766655543322222221000000000 00 000 1122
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
+-.+.+|+.-+.++++. ....+++.-..=+++....-.|+|||++| .+.+...-.. .+++...+.....++. +..
T Consensus 205 ElDy~~EA~n~~~~~~n-f~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 205 ELDYRREAANAERFREN-FKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQ 280 (517)
T ss_pred HhCHHHHHHHHHHHHHH-cCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHH
Confidence 23356677777777753 33455555444555667888899999987 5666643222 3466444433333222 333
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeeccccccc
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~ 222 (429)
+-..|++|.|..|.||+++.++ .+.+.|||......
T Consensus 281 ~~~dgffHaDpHpGNi~v~~~g--~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLRDGFFHADPHPGNILVRSDG--RIVLLDFGIVGRLD 316 (517)
T ss_pred HHhcCccccCCCccceEEecCC--cEEEEcCcceecCC
Confidence 4457999999999999999998 99999999986544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.1e-08 Score=87.33 Aligned_cols=108 Identities=22% Similarity=0.264 Sum_probs=85.5
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc----CeEEEEEeecCc--CHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR----NHLCISFELMNL--NLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~g--~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
..+.+|.+.+..|....+. ++..+.+.+.. ...++|+|++++ +|.+++..... .+......++.+++.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~----tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIP----TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALAR 129 (206)
T ss_pred hHHHHHHHHHHHHHHcCCC----CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHH
Confidence 3577799999999876432 34444444432 356899999975 79998887543 677888999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCC-CcceEEeeeccccc
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCY 220 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~ 220 (429)
.++-||..||+|+|+++.|||++.++ ...+.++||+.+..
T Consensus 130 ~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999999999874 45799999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-07 Score=93.01 Aligned_cols=134 Identities=19% Similarity=0.225 Sum_probs=102.5
Q ss_pred HHHHHHHHhcCCCCCCCceeEEEEEEEE----cCeEEEEEeecC--cCHHHHHHhhC-------------CCCCCHHHHH
Q psy17270 112 EVRILDHLRKKDADSSYNVIHMLEYFYF----RNHLCISFELMN--LNLYELIKRNN-------------YQGFSLGLIR 172 (429)
Q Consensus 112 E~~il~~l~h~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~--g~L~~~i~~~~-------------~~~~~~~~~~ 172 (429)
-+++++++-|. |++++.++|.. +..+++|++|.. ++|.++.-... ....++..++
T Consensus 323 lve~wkkl~h~------NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW 396 (655)
T KOG3741|consen 323 LVEAWKKLCHT------NVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLW 396 (655)
T ss_pred HHHHHHHhccC------ceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHH
Confidence 67788888887 99999998863 357999999995 57888753221 1237789999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.|+.|+..||.++|+.|+.-+-|.|.+|+++.+. +++|...|.......... |.+.+ -.+-|.=
T Consensus 397 ~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~~-----------~~le~---~Qq~D~~ 460 (655)
T KOG3741|consen 397 SYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDPT-----------EPLES---QQQNDLR 460 (655)
T ss_pred HHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCCCC-----------cchhH---HhhhhHH
Confidence 9999999999999999999999999999999765 788888877644333221 11111 2356888
Q ss_pred chhhHHHHHhhCCCC
Q psy17270 253 SLGCILAELYTGCPL 267 (429)
Q Consensus 253 SlG~il~~lltg~~p 267 (429)
.||.+++.|.||..-
T Consensus 461 ~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 461 DLGLLLLALATGTEN 475 (655)
T ss_pred HHHHHHHHHhhcccc
Confidence 999999999998543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.2e-07 Score=89.01 Aligned_cols=127 Identities=14% Similarity=0.199 Sum_probs=96.8
Q ss_pred EEEEEeecCc--CHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeec
Q psy17270 143 LCISFELMNL--NLYELIKRN----NYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG 216 (429)
Q Consensus 143 ~~lv~e~~~g--~L~~~i~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg 216 (429)
..+.|+.+.| .+..+.+.. ..-...+.-+.+..+.++.+.+.||..|.+-+|+.++|+|+++++ .|.|+|-.
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~--~V~LVdsD 162 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS--KVVLVDSD 162 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc--eEEEEccc
Confidence 6788888854 455554321 212266788999999999999999999999999999999999988 88888744
Q ss_pred ccc--cccCcceeeecCccccchhhhh-----CCCCCCCccccchhhHHHHHhhC-CCCCCCC
Q psy17270 217 SSC--YSHQRVYTYIQSRFYRSPEVIL-----GLPYGPPIDMWSLGCILAELYTG-CPLFPGE 271 (429)
Q Consensus 217 ~~~--~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~~lltg-~~pf~~~ 271 (429)
.-. ..+......+|...|.+||... +-.-+...|.|.||+++|+++.| +.||.|-
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 321 1222333467889999999876 22346789999999999999986 9999873
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.4e-07 Score=85.84 Aligned_cols=158 Identities=25% Similarity=0.271 Sum_probs=105.3
Q ss_pred eEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
+.+..+||.|.-|.||.|.+.+..++|+|.=+.-.+.+....-.+. ..|- .+..+| -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~-------y~~~---------------~~h~sW-l 149 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRD-------YLAD---------------KEHGSW-L 149 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhh-------hhcc---------------ccCcch-h
Confidence 4577899999999999999998888888865433332222110000 0000 001111 0
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcC-HHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLN-LYELIKRNNYQGFSLGLIRRFAFSLVQC 181 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~-L~~~i~~~~~~~~~~~~~~~i~~qil~~ 181 (429)
......+.+|.++|..|.... -.+...+++ +..++|||+++|. |... +++......++..|++-
T Consensus 150 ~~sRl~A~rEf~~L~~L~~~G----~~VP~P~~~----nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~ 214 (304)
T COG0478 150 YVSRLAAEREFEALQRLYPEG----VKVPKPIAW----NRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEE 214 (304)
T ss_pred hhHHHHHHHHHHHHHHhhhcC----CCCCCcccc----ccceeeeehcccceeecc-------cCcccCHHHHHHHHHHH
Confidence 122345677999999997541 145555553 5667999999873 3222 13456666777888888
Q ss_pred HHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 182 l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
+.-+-..|+||+|+++=||+++.+| .+.++||--+..
T Consensus 215 ~~~~~~~GiVHGDlSefNIlV~~dg--~~~vIDwPQ~v~ 251 (304)
T COG0478 215 VRKAYRRGIVHGDLSEFNILVTEDG--DIVVIDWPQAVP 251 (304)
T ss_pred HHHHHHcCccccCCchheEEEecCC--CEEEEeCccccc
Confidence 8877799999999999999999998 899999977644
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.64 E-value=8.7e-07 Score=79.11 Aligned_cols=156 Identities=17% Similarity=0.199 Sum_probs=99.5
Q ss_pred hhhhcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 12 FQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 12 ~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
.....+++.+.|.+.+.+-......|.+..-. ++.+++|..+......++.-. ...
T Consensus 22 ~~l~~~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~-sf~---------------------- 77 (229)
T PF06176_consen 22 LELGEKILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFK-SFF---------------------- 77 (229)
T ss_pred HHHHHHHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHH-HHh----------------------
Confidence 34566788999999999999988888777653 456788877554433222110 000
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEE-----EEEEcCeEEEEEeecCc-CHHHHHHhhCCCC
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLE-----YFYFRNHLCISFELMNL-NLYELIKRNNYQG 165 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~-----~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~ 165 (429)
+ ...+.+++..+..+..... .....++- .+......+++|||++| .|.+...
T Consensus 78 ----------k---g~~~~~l~~~~~~i~~~g~---~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------ 135 (229)
T PF06176_consen 78 ----------K---GSEYSRLINNTDKIRNEGF---TEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------ 135 (229)
T ss_pred ----------c---cHHHHHHHHHHHHHHHcCc---cccccceeeeeeeeccceeEEEEEEEEecCeecccchh------
Confidence 0 1223445555555544311 12222222 22233567799999987 5544422
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 166 ~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
+++ .+...+.+++.-+|..|++|+|..|.|++++.+ .++++||+..+.
T Consensus 136 i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~---~i~iID~~~k~~ 183 (229)
T PF06176_consen 136 IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN---GIRIIDTQGKRM 183 (229)
T ss_pred cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC---cEEEEECccccc
Confidence 333 244567788999999999999999999999865 599999987643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.1e-07 Score=91.76 Aligned_cols=187 Identities=16% Similarity=0.150 Sum_probs=104.1
Q ss_pred eEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFH 106 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (429)
+.||..+.|+|++|+-+....+|+|+-+......-..++.-. .++....-|..+..++.++..-..+ .....-.|.
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~---~~~~~~l~k~~p~~~~~~lvdE~~~-~L~~ELDF~ 242 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNL---RLLAKVLQKFFPDFDLVWLVDEIAK-SLPQELDFT 242 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHH---HHHHHHHHHhCcCCchhhHHHHHHh-hhHhhcchH
Confidence 589999999999999998556799998777665544443322 2222222222222222211000000 000112333
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHH--HHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLY--ELIKRNNYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~--~~i~~~~~~~~~~~~~~~i~~qil~~l~ 183 (429)
.++.+--++.+.++|.+....-.|.++| +.....-.|+||||+| .+. +.+.+.. ++...+..-+.+... .
T Consensus 243 ~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~--~ 315 (538)
T KOG1235|consen 243 KEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYL--E 315 (538)
T ss_pred HHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHH--H
Confidence 3333333444555555311111133322 2335678899999976 333 3444443 777755544444332 3
Q ss_pred HHHHCCceecccCCCcEEEecC--CCcceEEeeecccccccCc
Q psy17270 184 LLHRENIIHCDLKPENVLLKQR--GSSSIKVIDFGSSCYSHQR 224 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~~--~~~~vkl~Dfg~~~~~~~~ 224 (429)
.+-..|++|+|-.|.||++..+ +...+.+.|||+.......
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 3445689999999999999953 3448999999998665443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.5e-06 Score=75.45 Aligned_cols=170 Identities=21% Similarity=0.224 Sum_probs=104.1
Q ss_pred cCCeEEEe---EeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 20 CYRYEILE---VIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 20 ~~rY~i~~---~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
..|..+.. .|.+|.-+.||+|.......+|+|++......+....- +.+ +.+.+.. .
T Consensus 44 ~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~--Yi~------------gd~Rf~~------~ 103 (268)
T COG1718 44 LSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRR--YIQ------------GDPRFRN------S 103 (268)
T ss_pred hcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHH--HHh------------cChhhhc------C
Confidence 44455444 55578888999998865566799999877666555221 111 0000000 0
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.. ..++....=..+|..-|+++..-. + .+.+.+.+. +-.||||+++.. ..-.-.....++...++..+..
T Consensus 104 ~~-~rr~lv~~W~~kEf~NL~R~~eAG-V---rvP~Pi~~~----~nVLvMEfIg~~-g~pAP~LkDv~~e~~e~~~~~~ 173 (268)
T COG1718 104 RS-NRRKLVFAWARKEFRNLKRAYEAG-V---RVPEPIAFR----NNVLVMEFIGDD-GLPAPRLKDVPLELEEAEGLYE 173 (268)
T ss_pred CC-CHHHHHHHHHHHHHHHHHHHHHcC-C---CCCCceeec----CCeEEEEeccCC-CCCCCCcccCCcCchhHHHHHH
Confidence 00 111122222456888888887642 1 334444432 345999999643 1000011111234447888999
Q ss_pred HHHHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeeccccccc
Q psy17270 177 SLVQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222 (429)
Q Consensus 177 qil~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~ 222 (429)
++++.+.-|-. .|+||+||+.=|||+. ++ .+.++|||-+....
T Consensus 174 ~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~--~p~iID~~QaV~~~ 217 (268)
T COG1718 174 DVVEYMRRLYKEAGLVHGDLSEYNILVH-DG--EPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHHHHhcCcccccchhhheEEE-CC--eEEEEECccccccC
Confidence 99999999887 8999999999999999 45 78999999886544
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.39 E-value=8.3e-08 Score=96.18 Aligned_cols=245 Identities=17% Similarity=0.144 Sum_probs=165.1
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
..-|...+-.++|+++++++.+...+.....+.+..+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~------------------------------------------- 277 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------------------------------------------- 277 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------------------------------------------
Confidence 3445666678899999999998876654444443222
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCc-eeEEEEEEEEcCeEEEEEeecCcC--HHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYN-VIHMLEYFYFRNHLCISFELMNLN--LYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~-i~~~~~~~~~~~~~~lv~e~~~g~--L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
....-++++|.+++|+ | .++.++-+..+...++.++++++. ....+.... ..+.+.+...+.+
T Consensus 278 -------l~~rl~~eLLdK~n~P------~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r 343 (829)
T KOG0576|consen 278 -------LSRRLAIELLDKVNNP------NPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSE-IALEQYQFAYPLR 343 (829)
T ss_pred -------hhhHHHHHHHHHccCC------CCcccccccCCcccccchhhhhhcCCccccccCChhh-Hhhhhhhhhhhhh
Confidence 1222388999999988 5 666666666778899999999542 222221111 1255556666777
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
.-..+++++|+.-=+|+| ||+..+. ..++.||+........ .++..+|+.++|||+...+.++...|.|++
T Consensus 344 ~et~~l~~l~~~~~~~~d----~~l~s~~---~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~ 416 (829)
T KOG0576|consen 344 KETRPLAELHSSYKVHRD----NILGSEE---EVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSL 416 (829)
T ss_pred hhcccccccccccccCcc----ccccccc---ccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCC
Confidence 778899999988778988 8888764 6899999988765544 566789999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|+-..+|.-|.+|-...- ..+.. .+..+ +.+..... ...+
T Consensus 417 ~~~~~~~ap~~pPr~~P~--~~~~~----~g~~p-----------------~s~~L~~~-----------------~aw~ 456 (829)
T KOG0576|consen 417 AVSAIQMAPGLPPRSSPP--AVLPM----IGNGP-----------------NSPMLTDK-----------------SAWS 456 (829)
T ss_pred CcchhhcCCCCCCCCCCc--cccCC----CCCCC-----------------Cccccchh-----------------hhcC
Confidence 998778877776654411 00000 00000 00000000 0001
Q ss_pred hHHH-HHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 335 KAFV-DFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~-~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+.+. ++...|+..-|..|+.+..++.|.+|..-.
T Consensus 457 ~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 457 PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred cccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 1222 588999999999999999999999998654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.5e-05 Score=72.67 Aligned_cols=79 Identities=18% Similarity=0.230 Sum_probs=53.9
Q ss_pred EeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 26 LEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
++.|+.|..+.||++.... +.+++|..... ..
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-----------------------------------------------~~ 33 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-----------------------------------------------DA 33 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-----------------------------------------------HH
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-----------------------------------------------CC
Confidence 5789999999999999987 78888886433 01
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEE---EEcCeEEEEEeecCc-CHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYF---YFRNHLCISFELMNL-NLYE 156 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~---~~~~~~~lv~e~~~g-~L~~ 156 (429)
...+..|..+++.+..... . +.+++... ......+++|++++| .+..
T Consensus 34 ~~~~~~e~~~~~~l~~~~~-p---vP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 34 AERLRREAAVLRQLAEHGI-P---VPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp HHHHHHHHHHHHHHHHTTS-B---S--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred HHHHHHHHHHHHHHHhcCC-C---CceEEeecccccccccceEEEEEeccccccc
Confidence 1234459999999987643 3 44444433 233467999999976 4555
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.28 E-value=5e-06 Score=88.91 Aligned_cols=258 Identities=20% Similarity=0.244 Sum_probs=154.5
Q ss_pred HHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEE----EEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy17270 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLC----ISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 109 ~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~----lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~ 183 (429)
..-|++.+..+.|. |+..++.|-....... +..++|.. ++...+..-. .++...++.+..++++||.
T Consensus 229 ~E~e~~~l~k~~~~------n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~ 300 (1351)
T KOG1035|consen 229 TEIELESLSKIAHD------NLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLA 300 (1351)
T ss_pred HHHHHHHHHhhccc------cccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHH
Confidence 34466777777777 8888877765443322 33456643 6666666554 3899999999999999999
Q ss_pred HHHHCCceecccCCC---cEEEecCCCcceEEe--eecccccccCccee--eecCccccchhhhhCCCCCCC--ccccch
Q psy17270 184 LLHRENIIHCDLKPE---NVLLKQRGSSSIKVI--DFGSSCYSHQRVYT--YIQSRFYRSPEVILGLPYGPP--IDMWSL 254 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~---Nili~~~~~~~vkl~--Dfg~~~~~~~~~~~--~~~t~~y~aPE~~~~~~~~~~--~DiwSl 254 (429)
|+|+..+.|.-+... +...+..+ .+.+. ||+.+......... ...+..+.++|....+.++.+ .|+|.+
T Consensus 301 ~~h~~~l~~v~L~~s~~~~~~~~~e~--~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 301 YLHSLSLEHVVLSASSSKESTVDGEG--VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred HHHHhccceeEEecccccccccCccc--eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHH
Confidence 999996666555544 33333333 44444 88877655443332 234556888888877666554 699999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|.....+..|..+-.-... . ...+... ..
T Consensus 379 gll~~~~~~~~~i~~~~~~---~-----------~~~l~~~-------------------------------------~~ 407 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAV---P-----------VSLLDVL-------------------------------------ST 407 (1351)
T ss_pred HHHHhhhhhcCcccccccc---h-----------hhhhccc-------------------------------------cc
Confidence 9999999876543221110 0 0000000 01
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC--CcCCCCCCc-cccccccccCCCCCCCCCCcCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSSHHA--TDLRKSPSA-HTNMYRLYRGVPTKPSAPADIDLN 411 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~ 411 (429)
....+++.+|+.-++++|+++.+++.|+|.+.......+.-... ...+..... ...+.-..++.+.--.-...+.+-
T Consensus 408 ~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~~r~~SRY~~DFEEL~lL 487 (1351)
T KOG1035|consen 408 SELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNESSEFAPNDETSVPQFRLRFSGAMSPLQRQFSRYLNDFEELELL 487 (1351)
T ss_pred hhhhhhhhhhcchhhhhccchhhhhhchhcccccccccccccCccccccCccCCCCccccCccccchhhHhhhhHHHHHh
Confidence 14569999999999999999999999999986543332111100 000000000 000000000001111223445677
Q ss_pred CCCCCCCCEEEeeccC
Q psy17270 412 DSGTFLPPILFNIKLD 427 (429)
Q Consensus 412 ~~~~~~~~~~~~~~~~ 427 (429)
+.|.+...+.+.+|+|
T Consensus 488 GkGGFG~VvkVRNKlD 503 (1351)
T KOG1035|consen 488 GKGGFGSVVKVRNKLD 503 (1351)
T ss_pred cCCCCceEEEEeeccc
Confidence 8889999999888887
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.9e-05 Score=69.10 Aligned_cols=150 Identities=19% Similarity=0.268 Sum_probs=100.5
Q ss_pred eEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhhh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFH 106 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (429)
..||+|+.-.||.-- .+....||+..... .........+... .......
T Consensus 7 ~~i~~G~~R~cy~HP--~dp~~cIKV~~~~~-~~~~~~~~~~~k~----------------------------~~~~~~~ 55 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP--DDPNLCIKVMRPDR-GERRRPFKRWLKR----------------------------LRPKSRY 55 (199)
T ss_pred cccccCCCceEEECC--CCCCeEEEEEcccc-ccccccchhHHHh----------------------------hcccchh
Confidence 578999999998643 34455788776554 1111111110000 0012234
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec---C----cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 107 HQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM---N----LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 107 ~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~---~----g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.+..+|+.-+..+.-.....+..|.+++++.+++....+|+|.+ + .+|.+++.... +++ .... .+-
T Consensus 56 ~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~---~L~ 128 (199)
T PF10707_consen 56 RQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQ---ALD 128 (199)
T ss_pred HHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHH---HHH
Confidence 56777888888887334456668999999999999999999987 2 37888886543 666 3333 444
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCc--ceEEee
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSS--SIKVID 214 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~--~vkl~D 214 (429)
+-..||-..+|+.+|++|.||++...+.. .+.|+|
T Consensus 129 ~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 129 EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 45568888999999999999999876532 477787
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.9e-05 Score=66.69 Aligned_cols=147 Identities=22% Similarity=0.323 Sum_probs=96.4
Q ss_pred cCCeEEEeEeecccc-ceEEEEEecCCCcchheeccc---cchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 20 CYRYEILEVIGKGSF-GQVIRALDHKTNTHALKYYGN---QLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~-g~Vy~a~~~~~~~~aiK~~~~---~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
...++.++.||.|.- |.||++..... .+|+|++.. .........+ .. .
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~-~YALKlf~~~~~~~~~~~~~~~----------------------~~-----~ 87 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGR-IYALKLFRFWDYTEPDYTRERF----------------------AG-----H 87 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCe-EEEEEEeeccccCCCccccccc----------------------cc-----c
Confidence 378999999999999 99999997543 679998321 1111000000 00 0
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCce--eEEEEEEEEc------------------CeEEEEEeecCcCHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNV--IHMLEYFYFR------------------NHLCISFELMNLNLY 155 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i--~~~~~~~~~~------------------~~~~lv~e~~~g~L~ 155 (429)
+.+......+...|..|-+.+.+|++.+ .-++ +++++|+... ....||.||....-
T Consensus 88 ~~~~~~~~~y~~PF~~ECRAfgRLke~~---~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~- 163 (207)
T PF13095_consen 88 ETSLSTPAHYADPFNCECRAFGRLKEAG---REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP- 163 (207)
T ss_pred ccccchhhhhcChHHHHHHhhHHHHhcc---ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-
Confidence 0000011234557889999999998762 2244 8999998543 13467888775431
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccc
Q psy17270 156 ELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS 218 (429)
Q Consensus 156 ~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~ 218 (429)
.+.... +.++++-+..+|..||+-+|+++.|.. +| +|+|||.+
T Consensus 164 ---------~~~~~~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~G----~lvDfs~~ 206 (207)
T PF13095_consen 164 ---------PLQIRD----IPQMLRDLKILHKLGIVPRDVKPRNYR---GG----KLVDFSSS 206 (207)
T ss_pred ---------ccchhH----HHHHHHHHHHHHHCCeeeccCcccccc---CC----EEEecccC
Confidence 133333 446777788899999999999999987 34 89999965
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.8e-05 Score=68.10 Aligned_cols=40 Identities=13% Similarity=-0.017 Sum_probs=29.2
Q ss_pred HHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc
Q psy17270 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL 152 (429)
Q Consensus 109 ~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 152 (429)
..+|.++++.+.... . .+.+.+++........+|||+++|
T Consensus 39 i~~E~~~l~~l~~~g-l---pvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 39 IKREFDASRKVFSLG-I---PTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred HHHHHHHHHHHHHcC-C---CCCceEEEEecCCeeeeeeeecCC
Confidence 455999999987542 1 245566676667778899999987
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00017 Score=66.62 Aligned_cols=29 Identities=21% Similarity=0.224 Sum_probs=25.2
Q ss_pred CceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
.++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~--~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGK--FSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCc--EEEEEEccccc
Confidence 489999999999999865 67899999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=9e-05 Score=63.57 Aligned_cols=130 Identities=21% Similarity=0.176 Sum_probs=85.0
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
.-++.+.||.|++|.||++.+... .+|+|+-+.+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d--------------------------------------------- 56 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGG-EVALKVRRRD--------------------------------------------- 56 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCc-eEEEEEecCC---------------------------------------------
Confidence 345677899999999999998643 4466654322
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.....+..|+++|..+.-.. --.++|.|-+ -.+.|||+.| .|.+..... + +.-+..+++
T Consensus 57 --s~r~~l~kEakiLeil~g~~-----~~p~vy~yg~----~~i~me~i~G~~L~~~~~~~-----~----rk~l~~vlE 116 (201)
T COG2112 57 --SPRRNLEKEAKILEILAGEG-----VTPEVYFYGE----DFIRMEYIDGRPLGKLEIGG-----D----RKHLLRVLE 116 (201)
T ss_pred --cchhhHHHHHHHHHHhhhcC-----CCceEEEech----hhhhhhhhcCcchhhhhhcc-----c----HHHHHHHHH
Confidence 23345666999999988652 2334444422 2344999987 666654321 2 223345566
Q ss_pred HHHHHHHCCceecccC-CCcEEEecCCCcceEEeeecccc
Q psy17270 181 CLRLLHRENIIHCDLK-PENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlk-p~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
..--|-..||-|+.|+ |...++..++ .+.|+||..|.
T Consensus 117 ~a~~LD~~GI~H~El~~~~k~vlv~~~--~~~iIDFd~At 154 (201)
T COG2112 117 KAYKLDRLGIEHGELSRPWKNVLVNDR--DVYIIDFDSAT 154 (201)
T ss_pred HHHHHHHhccchhhhcCCceeEEecCC--cEEEEEccchh
Confidence 6445667799999987 5555555555 78999999986
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00024 Score=77.26 Aligned_cols=32 Identities=22% Similarity=0.470 Sum_probs=25.1
Q ss_pred CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.+||+|+++.|++++.++...+-++||+.+..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 49999999999999864322457899998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00022 Score=65.63 Aligned_cols=29 Identities=38% Similarity=0.522 Sum_probs=24.2
Q ss_pred CceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
+++|+|+.+.||+++.++ ..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~--i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGR--LSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCC--EEEEEeCcccC
Confidence 589999999999998653 45699999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00031 Score=66.03 Aligned_cols=157 Identities=21% Similarity=0.227 Sum_probs=97.8
Q ss_pred eEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
|-+++.||-|.-+.||.+.+......++|.=+.-.+.+-. +|--+ +... -..+..|.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~----------------Vk~kR--DY~r----~r~~~sWl- 150 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRN----------------VKNKR--DYLR----KRKSGSWL- 150 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHH----------------hhhhh--hhHh----cCCccchh-
Confidence 6788999999999999999987777788754322221111 11000 0000 00000010
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQC 181 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~ 181 (429)
..-+-.+.+|...|+.|..... -+.+.+| .+..|+|||++.| +|...-.- .+ +..+...+..-
T Consensus 151 yLSRlaa~kEfafmkaL~e~gf----pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~ 214 (465)
T KOG2268|consen 151 YLSRLAATKEFAFMKALYERGF----PVPKPID----HNRHCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGL 214 (465)
T ss_pred hhHHHHHHHHHHHHHHHHHcCC----CCCCccc----ccceeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHH
Confidence 1112235678889999876422 2444444 3567899999976 55444211 12 23344556666
Q ss_pred HHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 182 l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
+.-|..+|+||+|..-=||++..++ .++++||--...
T Consensus 215 Iv~la~~GlIHgDFNEFNimv~dd~--~i~vIDFPQmvS 251 (465)
T KOG2268|consen 215 IVRLANHGLIHGDFNEFNIMVKDDD--KIVVIDFPQMVS 251 (465)
T ss_pred HHHHHHcCceecccchheeEEecCC--CEEEeechHhhc
Confidence 6778899999999999999999877 899999987644
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00096 Score=66.32 Aligned_cols=171 Identities=21% Similarity=0.323 Sum_probs=107.6
Q ss_pred HHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17270 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHR 187 (429)
Q Consensus 109 ~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~ 187 (429)
.+-...+++.+.|. |...++++-... ....+|||+++.+|.+....+... .... + .
T Consensus 29 ilgr~~~lktl~~~------~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l~---~~s~-------~-------~ 85 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHD------NLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNLK---DESL-------L-------A 85 (725)
T ss_pred HhhhhHHHHhhcCc------cceeeEeeecCccceEEEEehhhccchHHHHHhcccc---hhhh-------c-------c
Confidence 33466777777776 888888876543 358899999999999998865411 0100 0 2
Q ss_pred CCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCC
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPL 267 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~p 267 (429)
+|+.|- |+ +..+| .++... .. ..++++||||+|.++.++..|...
T Consensus 86 ~~~~~~-----~~---------~~~td-~~~t~~----~~----------------~~~pKsdVwsl~~i~~el~L~~~l 130 (725)
T KOG1093|consen 86 HGVLHL-----NI---------IYITD-HFLTKY----PS----------------PIGPKSDVWSLGFIILELYLGISL 130 (725)
T ss_pred ccccee-----hh---------hhccc-cccccC----CC----------------CCCcchhhhhHHHHHHHHHHhhHH
Confidence 222221 22 23333 000000 00 122499999999999999999998
Q ss_pred CCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhccc
Q psy17270 268 FPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNW 347 (429)
Q Consensus 268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 347 (429)
+......+++..+......+-+........ ..-...+.-+..+..+|+-.
T Consensus 131 ~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~------------------------------~~~~~~d~~~~~~~~~c~~~ 180 (725)
T KOG1093|consen 131 EAELTESEYLEILLKYYTDDQELLSTAMEH------------------------------LIQLLADKKRLPLLKKCLWL 180 (725)
T ss_pred HHHHHHHHHHHHHHHhccCchhHHHHHHHH------------------------------HHHHhhhHhHHHHhccCCcc
Confidence 888877777776665433332222211110 00112356778999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q psy17270 348 DSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 348 dP~~Rpta~ell~h~~~~~~ 367 (429)
.|..||...++.+++-|..+
T Consensus 181 ~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 181 EPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred ccccccchhHHhcCccHHHH
Confidence 99999999999999887643
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.001 Score=63.62 Aligned_cols=163 Identities=21% Similarity=0.266 Sum_probs=104.2
Q ss_pred EEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhh
Q psy17270 25 ILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKR 104 (429)
Q Consensus 25 i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~ 104 (429)
|-.-|..|.-+.||.|+......+|||+++.+...+...+- + +-+.+-+. .--+..+ .++.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdR--Y----V~GEfRFR---hgyck~N----------PRKM 208 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDR--Y----VSGEFRFR---HGYCKHN----------PRKM 208 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhh--h----ccceeeee---cccccCC----------cHHH
Confidence 44567789999999999987777899999766543322110 0 00000000 0000000 1334
Q ss_pred hhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHH--HHHHhhCCCCCCHHHHHHHHHHHHHHH
Q psy17270 105 FHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLY--ELIKRNNYQGFSLGLIRRFAFSLVQCL 182 (429)
Q Consensus 105 ~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~--~~i~~~~~~~~~~~~~~~i~~qil~~l 182 (429)
..-=+..|++-|.+|..-. .++|--+-+.. ..|||++++.+-+ -.++. ..++...+..+-.|++.-+
T Consensus 209 Vk~WAEKE~RNLkRl~~aG-IP~PePIlLk~-------hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~M 277 (520)
T KOG2270|consen 209 VKTWAEKEMRNLKRLNNAG-IPCPEPILLKN-------HVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIM 277 (520)
T ss_pred HHHHHHHHHHHHHHHHhcC-CCCCCceeeec-------ceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHH
Confidence 4444677999999998764 44444443333 3499999964311 11222 2377888888888888888
Q ss_pred HHHHH-CCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 183 RLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 183 ~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.-|-. .++||.||+==|+|+.. | .+.++|.+-+..
T Consensus 278 R~lY~~c~LVHADLSEfN~Lyhd-G--~lyiIDVSQSVE 313 (520)
T KOG2270|consen 278 RRLYQKCRLVHADLSEFNLLYHD-G--KLYIIDVSQSVE 313 (520)
T ss_pred HHHHHHhceeccchhhhhheEEC-C--EEEEEEcccccc
Confidence 88764 48999999999999975 4 799999987743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0029 Score=57.93 Aligned_cols=29 Identities=28% Similarity=0.486 Sum_probs=25.5
Q ss_pred CceecccCCCcEEEec-CCCcceEEeeecccc
Q psy17270 189 NIIHCDLKPENVLLKQ-RGSSSIKVIDFGSSC 219 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~-~~~~~vkl~Dfg~~~ 219 (429)
+++|+|+.+.||+++. ++ .+.++||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~--~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKN--SVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCC--CEEEEEcccCC
Confidence 5999999999999997 34 79999998874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0013 Score=63.08 Aligned_cols=30 Identities=43% Similarity=0.707 Sum_probs=26.3
Q ss_pred CCceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
.+++|+|+.+.||+++.++ .+.++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDS--VKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence 5899999999999998875 56899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0057 Score=58.91 Aligned_cols=31 Identities=35% Similarity=0.527 Sum_probs=25.6
Q ss_pred CCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.|++|+|+.|.||+++.+. ..-++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~--~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR--LSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCc--eEEEEecccccC
Confidence 3899999999999998553 457999998753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0022 Score=61.00 Aligned_cols=31 Identities=39% Similarity=0.551 Sum_probs=26.2
Q ss_pred CCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.+++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~--~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDE--LSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCc--eEEEeehhhhcC
Confidence 3799999999999999765 568999998743
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.015 Score=57.43 Aligned_cols=28 Identities=25% Similarity=0.426 Sum_probs=24.5
Q ss_pred CceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
.++|||+.+.||++..+ .++++||..+.
T Consensus 224 ~l~HgDl~~gni~~~~~---~~~viD~E~a~ 251 (401)
T PRK09550 224 ALLHGDLHTGSIFVTEE---ETKVIDPEFAF 251 (401)
T ss_pred ceeeccCCcccEEeeCC---CcEEEeccccc
Confidence 68999999999999765 58999998774
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0032 Score=55.64 Aligned_cols=97 Identities=20% Similarity=0.301 Sum_probs=75.6
Q ss_pred HHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHH---HHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy17270 112 EVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYEL---IKRNNYQGFSLGLIRRFAFSLVQCLRLLHR 187 (429)
Q Consensus 112 E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~---i~~~~~~~~~~~~~~~i~~qil~~l~~lH~ 187 (429)
|.-+++.+.+.. +++++++.+ ++ .++.|+.+ +++.+. +.+. -..++..+..++.++++.+.+++.
T Consensus 9 E~lll~~l~~~~-----~~pk~lG~C---G~-~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 9 EPLLLQLLQGSE-----PFPKLLGSC---GR-FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred HHHHHHHcCCCC-----CCCCeeeEC---CC-EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhc
Confidence 888899988753 889999987 33 56889986 444321 1111 126889999999999999999998
Q ss_pred C---CceecccCCCcEEEecCCCcceEEeeecccccc
Q psy17270 188 E---NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS 221 (429)
Q Consensus 188 ~---~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~ 221 (429)
. .+.-.|++|+|+-++.++ .+|++|...+...
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~--~lk~iDld~v~~~ 112 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDG--RLKLIDLDDVFVE 112 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCC--cEEEEechhcchh
Confidence 3 577899999999999888 8999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.011 Score=56.33 Aligned_cols=29 Identities=31% Similarity=0.455 Sum_probs=25.6
Q ss_pred CceecccCCCcEEEecC----CCcceEEeeecccc
Q psy17270 189 NIIHCDLKPENVLLKQR----GSSSIKVIDFGSSC 219 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~----~~~~vkl~Dfg~~~ 219 (429)
+++|+|+.+.||+++.+ + .+.++||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~--~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETK--KLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCC--cEEEEeeCCCC
Confidence 58999999999999874 5 79999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.57 E-value=9e-05 Score=81.54 Aligned_cols=150 Identities=11% Similarity=-0.078 Sum_probs=106.9
Q ss_pred HHHHHHHHhcCCCCCCCceeEEEEEEEE--cCeEEEEEeec-CcCHHHHHHhhCCCC--CCHHHHHHHHHHHHHHHHHHH
Q psy17270 112 EVRILDHLRKKDADSSYNVIHMLEYFYF--RNHLCISFELM-NLNLYELIKRNNYQG--FSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 112 E~~il~~l~h~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~-~g~L~~~i~~~~~~~--~~~~~~~~i~~qil~~l~~lH 186 (429)
|...+++..|. ++...+.-... ....+.+++++ .|.+.+.|.+..... +...-+.....+...+..-+|
T Consensus 1279 e~de~~~~~h~------~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1279 ERDELREAKHY------LTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhce------eeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 33344445554 66555444432 34678999999 578999887654322 334444444444477777777
Q ss_pred HC-----CceecccCCCcEEEecCCCcceEEeeecccc-cccC--cceeeecCccccchhhhhCCCCCCCccccchhhHH
Q psy17270 187 RE-----NIIHCDLKPENVLLKQRGSSSIKVIDFGSSC-YSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258 (429)
Q Consensus 187 ~~-----~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~-~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 258 (429)
+. -.+|+++|+-|.++..+- .+++.++|+.+ .... ......+++.|+.|++.+.-.++.++|+|..|+.+
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny--~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNY--NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCC--cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 65 278999999999999876 89999999997 3221 22335678889999999988898889999999999
Q ss_pred HHHhhCCCCCC
Q psy17270 259 AELYTGCPLFP 269 (429)
Q Consensus 259 ~~lltg~~pf~ 269 (429)
|...-|..+|-
T Consensus 1431 y~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI 1441 (2724)
T ss_pred HHHhcccHHHH
Confidence 99988877664
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.066 Score=51.19 Aligned_cols=29 Identities=34% Similarity=0.500 Sum_probs=25.2
Q ss_pred CCceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
.+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C--cEEEEECcccc
Confidence 47899999999999987 4 68999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.064 Score=49.81 Aligned_cols=29 Identities=24% Similarity=0.492 Sum_probs=25.0
Q ss_pred CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.++|+|+.|.||+++.++ +.++||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~---~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG---LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC---CEEEeccccCc
Confidence 589999999999998764 68999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.023 Score=55.31 Aligned_cols=63 Identities=22% Similarity=0.309 Sum_probs=43.5
Q ss_pred CeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecccCCCcEEEecCC
Q psy17270 141 NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL-HRENIIHCDLKPENVLLKQRG 206 (429)
Q Consensus 141 ~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l-H~~~ivH~dlkp~Nili~~~~ 206 (429)
....++-+|..| ++..+++... .++.....++.--..|+--| --.+++|.|+.|.||++..+.
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ccceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 344556666655 7777777655 56666666666666665444 355899999999999996544
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.079 Score=50.80 Aligned_cols=30 Identities=17% Similarity=0.326 Sum_probs=26.9
Q ss_pred CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
+++|+|+.+.|++++.++ .+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~--~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR--GGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCC--CEEEEEhhhccc
Confidence 799999999999998877 789999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.071 Score=50.80 Aligned_cols=109 Identities=11% Similarity=0.038 Sum_probs=70.3
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
.-.-.+.||.|..+.||+..+.+ +.+++|..+. .
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~-~~~~~k~~~~-~-------------------------------------------- 48 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQ-GNPMPLMARS-F-------------------------------------------- 48 (297)
T ss_pred hhheeeecCCccceeEEEEEcCC-CCEEEEEecc-c--------------------------------------------
Confidence 44556789999999999997543 3455565321 0
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE---cCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF---RNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~---~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.....+..|++.|+.|.....+ .+.++++++.+ .+..++|||+++| ++.+. . .+......+..+
T Consensus 49 --~~~~~~~~Ea~~L~~L~~~~~v---pVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~----~---~~~~~~~~l~~~ 116 (297)
T PRK10593 49 --STPGVAQQEAWKLSMLARSGTV---RMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP----A---RTPERWEQLKDQ 116 (297)
T ss_pred --ccchHHHHHHHHHHHHccCCCC---CcCcEEEEeccCCcCCCeEEEEeccCCEecCCC----C---CCHHHHHHHHHH
Confidence 0112455699999999765333 35555555543 3668999999976 44331 1 234445566778
Q ss_pred HHHHHHHHHHC
Q psy17270 178 LVQCLRLLHRE 188 (429)
Q Consensus 178 il~~l~~lH~~ 188 (429)
++.+|+-||+.
T Consensus 117 l~~~La~LH~~ 127 (297)
T PRK10593 117 IVEGLLAWHRI 127 (297)
T ss_pred HHHHHHHHhCC
Confidence 88888889874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.075 Score=51.60 Aligned_cols=28 Identities=25% Similarity=0.442 Sum_probs=24.0
Q ss_pred CceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
.++|+|+.+.||+++.+ .++++|+..+.
T Consensus 193 ~llHGDl~~gNi~~~~~---~~~~iD~e~~~ 220 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEH---ETKVIDPEFAF 220 (370)
T ss_pred eeeeccCCcccEEEcCC---CCEEEcCcccc
Confidence 68999999999999765 47899998764
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.083 Score=47.43 Aligned_cols=84 Identities=15% Similarity=0.246 Sum_probs=58.3
Q ss_pred HHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy17270 109 ALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE 188 (429)
Q Consensus 109 ~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~ 188 (429)
+.++.+++.++. .|+++..- ..-.+.++.|.|-..- .. ...++..=+.+|.-.|+.
T Consensus 105 y~nky~v~Armh--------GilrL~ND--n~~~yGvIlE~Cy~~~-------------i~-~~N~i~agi~~L~~fH~~ 160 (308)
T PF07387_consen 105 YFNKYRVFARMH--------GILRLKND--NNYKYGVILERCYKIK-------------IN-FSNFITAGIKDLMDFHSE 160 (308)
T ss_pred hhhhhhHHHHhh--------heeEeecC--CCceeEEEEeeccCcc-------------cc-hhHHHHHhHHHHHHhhcc
Confidence 345788888875 78888742 3346789999984210 00 011222224567788843
Q ss_pred --CceecccCCCcEEEecCCCcceEEeeeccc
Q psy17270 189 --NIIHCDLKPENVLLKQRGSSSIKVIDFGSS 218 (429)
Q Consensus 189 --~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~ 218 (429)
+.+|+|..|+||+-+..| .+||.|-+..
T Consensus 161 ~~~~lHGD~np~NiM~D~~G--~lKlVDP~~L 190 (308)
T PF07387_consen 161 NQHCLHGDCNPDNIMCDKFG--YLKLVDPVCL 190 (308)
T ss_pred CCCeecCCCChhheeecCCC--CEEecChhhh
Confidence 799999999999999999 9999998864
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.14 Score=48.32 Aligned_cols=31 Identities=23% Similarity=0.483 Sum_probs=24.9
Q ss_pred CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.++|+|+.|.||+++.++. ..-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhccc
Confidence 4899999999999987441 356999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.43 Score=47.27 Aligned_cols=28 Identities=29% Similarity=0.415 Sum_probs=23.5
Q ss_pred CceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
.++|+|+.+.||+++.+ ..+++|...+.
T Consensus 231 ~L~HGDl~~g~i~~~~~---~~~~id~ef~~ 258 (418)
T PLN02756 231 ALVHGDLHTGSVMVTPD---STQVIDPEFAF 258 (418)
T ss_pred ceeecCCCCCcEEEcCC---CceEecchhhc
Confidence 59999999999999876 47888877653
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.088 Score=50.74 Aligned_cols=71 Identities=23% Similarity=0.305 Sum_probs=56.9
Q ss_pred CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 141 ~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
...|++|++.++++.-. + .....++..++++.+..+.-+..+ ..=|||+.-.||+++ +| +|.|+||.+++
T Consensus 299 ~y~yl~~kdhgt~is~i-k-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G--nvtLIDfklsR 369 (488)
T COG5072 299 LYLYLHFKDHGTPISII-K-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG--NVTLIDFKLSR 369 (488)
T ss_pred eEEEEEEecCCceeeee-e-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC--ceEEEEeeeee
Confidence 36788888887765322 1 145678888999999888888866 688999999999999 67 89999999997
Q ss_pred c
Q psy17270 220 Y 220 (429)
Q Consensus 220 ~ 220 (429)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 4
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.11 Score=51.08 Aligned_cols=29 Identities=41% Similarity=0.557 Sum_probs=25.0
Q ss_pred CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.++|||+.|.|||++.+ .+|++|..++..
T Consensus 228 aLlHGDlHtGSI~v~~~---~~kvIDpEFAfy 256 (409)
T PRK12396 228 ALIHGDLHTGSVFVKND---STKVIDPEFAFY 256 (409)
T ss_pred hhccCcCCCCCEEecCC---ceEEEccccccc
Confidence 59999999999999976 589999888743
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.6 Score=52.25 Aligned_cols=33 Identities=30% Similarity=0.531 Sum_probs=26.3
Q ss_pred CCceecccCCCcEEEecCCCcce-EEeeeccccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSI-KVIDFGSSCY 220 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~v-kl~Dfg~~~~ 220 (429)
.++||+|+.+.||+++.++...+ -|+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 47999999999999997642244 4999998754
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.23 Score=48.05 Aligned_cols=29 Identities=34% Similarity=0.621 Sum_probs=24.9
Q ss_pred ceecccCCCcEEEecC-CCcceEEeeeccccc
Q psy17270 190 IIHCDLKPENVLLKQR-GSSSIKVIDFGSSCY 220 (429)
Q Consensus 190 ivH~dlkp~Nili~~~-~~~~vkl~Dfg~~~~ 220 (429)
++|.|+.+.||+++.+ + .++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~--~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEG--KLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCC--cEEEEcccccCC
Confidence 7899999999999754 4 799999998843
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.31 E-value=0.33 Score=47.97 Aligned_cols=29 Identities=31% Similarity=0.243 Sum_probs=24.3
Q ss_pred CCceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
..++|.|+-+.||+.+.+ .+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~---~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ---GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC---CEEEEEecccc
Confidence 467899999999997644 69999999874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.13 Score=48.57 Aligned_cols=77 Identities=12% Similarity=0.122 Sum_probs=46.1
Q ss_pred eEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
-+-.+.+|.|....+|+.. ...+.+.+|+-..
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~----------------------------------------------- 50 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE----------------------------------------------- 50 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG-----------------------------------------------
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh-----------------------------------------------
Confidence 3445688999999999988 4444567776431
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN 151 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 151 (429)
....-+..|++-|+.|..... -.+++.+.+....+..+|||||++
T Consensus 51 -~~~~~f~~Ea~gL~~L~~~~~---~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 51 -SGRDMFEGEAEGLKALAEANP---IRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -GGCCHHHHHHHHHHHHCHTTT---SBS--EEEEEE-SSCCEEEEE---
T ss_pred -hhHHHHHHHHHHHHHHHhcCC---CCCCeEEEEEeecCCceEEEEeec
Confidence 112235559999999965432 257777788777777899999984
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.22 E-value=1.4 Score=42.48 Aligned_cols=28 Identities=21% Similarity=0.354 Sum_probs=23.4
Q ss_pred CCceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
.+++|+|+.+.||+++ + .+.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d---~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D---GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C---CcEEEeCCCCC
Confidence 3789999999999994 3 46799999874
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.68 E-value=0.2 Score=46.95 Aligned_cols=53 Identities=26% Similarity=0.379 Sum_probs=42.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC--CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 166 FSLGLIRRFAFSLVQCLRLLHRE--NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 166 ~~~~~~~~i~~qil~~l~~lH~~--~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.+.......+..+-.++.-.+.. -++|+|+.|+|++.+..+ .+.|+||..|..
T Consensus 129 ~~~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~--~l~LIDWEyAg~ 183 (269)
T COG0510 129 RDNHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG--GLFLIDWEYAGL 183 (269)
T ss_pred hhhHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC--cEEEEecccCCC
Confidence 44556666777777777777765 588999999999999867 899999998854
|
|
| >KOG2269|consensus | Back alignment and domain information |
|---|
Probab=91.60 E-value=0.83 Score=43.56 Aligned_cols=161 Identities=20% Similarity=0.210 Sum_probs=96.9
Q ss_pred EEeEeeccccceEEEEEe------cCC-----CcchheeccccchhhHHHHHHHHHHHHHhccccccc--ccccccccCC
Q psy17270 25 ILEVIGKGSFGQVIRALD------HKT-----NTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI--HGEESLSQNG 91 (429)
Q Consensus 25 i~~~lG~G~~g~Vy~a~~------~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~--~~~~~~~~~~ 91 (429)
|-..|..|.-+.|..|+- ++. .++|||+++....++....-. +|. ..++.
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~Y------------iKDDfRFKDR----- 318 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEY------------IKDDFRFKDR----- 318 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhh------------hccchhhhhh-----
Confidence 445678899999988843 111 135999998777655432110 000 00111
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcC-H-HHHHHhhCCCCCCHH
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLN-L-YELIKRNNYQGFSLG 169 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~-L-~~~i~~~~~~~~~~~ 169 (429)
|++.|.....+.+ +.+|+--|.++... ..++|.++.+... .|||.+++.+ + .--++. ..++..
T Consensus 319 -FSK~NpR~i~~mW---AEkEmhNL~RMq~~-GlpcP~vV~lkkh-------vLVMsFiGd~~~aAPkLK~---v~l~d~ 383 (531)
T KOG2269|consen 319 -FSKQNPRGILKMW---AEKEMHNLSRMQKH-GLPCPQVVKLKKH-------VLVMSFIGDQGLAAPKLKN---VELTDD 383 (531)
T ss_pred -hcccCcHHHHHHH---HHHHHHHHHHHHhc-CCCCCceeeeecc-------eEEEEeecCCCCCCccccc---cccChH
Confidence 1111111111111 33465566666554 3456777776544 3899998532 1 111111 238888
Q ss_pred HHHHHHHHHHHHHHHHH-HCCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 170 LIRRFAFSLVQCLRLLH-RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH-~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
+.+..-.|+...+.-|. ..-+||.|++--|+|...+ .|.++|..-+..
T Consensus 384 E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~g---Kvw~IDVsQsve 432 (531)
T KOG2269|consen 384 ERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTPG---KVWVIDVSQSVE 432 (531)
T ss_pred HHHHHHHHHHHHHHHHHHhhheeecchhhhhheecCC---ceEEEechhccC
Confidence 88888889999888775 4579999999999999864 799999887643
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=89.63 E-value=0.76 Score=40.79 Aligned_cols=33 Identities=30% Similarity=0.494 Sum_probs=26.1
Q ss_pred CCceecccCCCcEEEecCCC---cceEEeeeccccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGS---SSIKVIDFGSSCY 220 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~---~~vkl~Dfg~~~~ 220 (429)
..++|||+.+.|+++..++. ..+.++||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 46899999999999986532 2589999998743
|
subfamily of choline kinases |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.04 E-value=0.37 Score=42.37 Aligned_cols=29 Identities=17% Similarity=0.351 Sum_probs=24.6
Q ss_pred CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
..+|+|+.|.|++++.+ .++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~---~~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSAS---GLRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECC---CEEEEeCCcccC
Confidence 36899999999999765 488999999854
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=88.89 E-value=0.32 Score=39.45 Aligned_cols=33 Identities=27% Similarity=0.214 Sum_probs=27.2
Q ss_pred eEeeccccceEEEEEecCCCcchheeccccchh
Q psy17270 27 EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTE 59 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~ 59 (429)
..||+|+.|+||+|+.+...++|||+.+.....
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~ 49 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRPGIEE 49 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcchHHHH
Confidence 589999999999999988667799987655443
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 429 | ||||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-106 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-106 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-105 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-67 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-67 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-67 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-46 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-45 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-44 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-42 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-42 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-42 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-31 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-31 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-30 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-30 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-29 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-29 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-29 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-29 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-29 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-29 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-28 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-28 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-28 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-28 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-28 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-28 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-28 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-28 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-28 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-28 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-28 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-28 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-28 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-28 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-28 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-28 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-28 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-28 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-28 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-28 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-28 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-28 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-28 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-28 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-28 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-28 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-28 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-28 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-28 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-28 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-27 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-27 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-27 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-27 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-27 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-27 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-27 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-26 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-26 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-26 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-26 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-26 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-26 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-26 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-26 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-26 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-26 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-26 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-26 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-26 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-26 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-26 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-26 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-26 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-26 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-26 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-26 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-26 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-26 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-26 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-26 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-26 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-26 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-26 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-26 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-26 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-26 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-26 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-26 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-26 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-26 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-26 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-26 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-26 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-26 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-26 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-26 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-26 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-26 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-26 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-26 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-26 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-26 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-26 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-26 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-26 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-26 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-25 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-25 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-25 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-25 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-25 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-25 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-25 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-25 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-25 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-25 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-25 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-25 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-25 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-25 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-25 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-25 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-25 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 5e-25 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-25 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-25 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-25 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-25 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-24 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-24 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-24 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-24 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-24 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-24 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-24 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-24 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-24 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-24 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-24 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-24 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-24 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-23 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-23 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-23 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-23 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-23 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-23 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-23 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-23 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-23 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-23 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-23 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-23 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-23 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-23 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-23 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-23 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-23 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-23 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-23 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-23 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-23 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-23 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-23 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-23 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-23 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-23 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-23 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-23 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-23 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-23 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-23 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-23 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-22 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-22 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-22 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-22 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-22 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-22 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-22 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-22 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-22 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-22 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-22 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-22 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-22 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-22 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-21 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-21 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-21 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-21 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-21 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-21 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-21 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-21 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-21 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-21 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-21 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-21 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-21 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-21 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-21 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-21 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-21 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-21 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-21 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-21 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-21 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-21 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-21 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-21 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-20 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-20 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-20 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-20 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-20 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-20 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-20 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-20 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-20 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-20 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-20 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-19 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-18 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-16 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-16 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-16 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-16 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-16 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-16 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-16 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-16 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-16 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-16 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-16 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-16 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-16 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-16 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-15 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-15 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-15 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-15 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-15 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-15 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-15 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-15 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-15 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-15 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-15 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-15 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 9e-04 |
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 468 bits (1205), Expect = e-164
Identities = 193/370 (52%), Positives = 247/370 (66%), Gaps = 64/370 (17%)
Query: 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIW 72
V HDH+ YRYE+L+VIGKGSFGQV++A DHK + H ALK + +
Sbjct: 90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALK-------------MVR----- 131
Query: 73 YLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIH 132
N+KRFH QA E+RIL+HLRK+D D++ NVIH
Sbjct: 132 ----------------------------NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 133 MLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIH 192
MLE F FRNH+C++FEL+++NLYELIK+N +QGFSL L+R+FA S++QCL LH+ IIH
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIH 223
Query: 193 CDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252
CDLKPEN+LLKQ+G S IKVIDFGSSCY HQRVYTYIQSRFYR+PEVILG YG PIDMW
Sbjct: 224 CDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMW 283
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC-- 310
SLGCILAEL TG PL PGE+E +QLAC++E+LG P ++++ + R + F SKG PR
Sbjct: 284 SLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCT 343
Query: 311 --------ITNSKGRKRK------PGSKDMASVLR-CNDKAFVDFVTQCFNWDSKKRLTP 355
+ + GR R+ P S++ + L+ C+D F+DF+ QC WD R+TP
Sbjct: 344 VTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403
Query: 356 DEALRHEWLK 365
+ALRH WL+
Sbjct: 404 GQALRHPWLR 413
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 446 bits (1149), Expect = e-157
Identities = 112/374 (29%), Positives = 171/374 (45%), Gaps = 69/374 (18%)
Query: 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH--ALKYYGNQLTEFERTEIEKYLEI 71
D + RYEI++ +G+G+FG+V+ +DHK A+K I K
Sbjct: 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVK-------------IVK---- 49
Query: 72 WYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVI 131
N R+ A E+++L+HL D +S++ +
Sbjct: 50 -----------------------------NVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 132 HMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENII 191
MLE+F H+CI FEL+ L+ Y+ IK N + F L IR+ A+ + + + LH +
Sbjct: 81 QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLT 140
Query: 192 HCDLKPENVLLKQRG-----------------SSSIKVIDFGSSCYSHQRVYTYIQSRFY 234
H DLKPEN+L Q + IKV+DFGS+ Y + T + +R Y
Sbjct: 141 HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHY 200
Query: 235 RSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINT 294
R+PEVIL L + P D+WS+GCIL E Y G +FP + E LA + ILG P +I
Sbjct: 201 RAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQK 260
Query: 295 ASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND---KAFVDFVTQCFNWDSKK 351
+R+ F + +S GR K + + D + D + + +D K
Sbjct: 261 TRKRKYFHHDRL-DWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319
Query: 352 RLTPDEALRHEWLK 365
R+T EAL+H +
Sbjct: 320 RITLREALKHPFFD 333
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 444 bits (1144), Expect = e-156
Identities = 111/391 (28%), Positives = 175/391 (44%), Gaps = 69/391 (17%)
Query: 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH--ALKYYGNQLTEFERTEIEKYLEI 71
+ D + RYEI+ +G+G+FG+V+ LDH ALK I +
Sbjct: 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALK-------------IIR---- 54
Query: 72 WYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVI 131
N ++ A +E+ +L +++KD ++ + +
Sbjct: 55 -----------------------------NVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 132 HMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENII 191
M ++F F H+CI+FEL+ N +E +K NN+Q + L +R A+ L LR LH +
Sbjct: 86 LMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLT 145
Query: 192 HCDLKPENVLL-----------------KQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFY 234
H DLKPEN+L K ++SI+V DFGS+ + H+ T + +R Y
Sbjct: 146 HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHY 205
Query: 235 RSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINT 294
R PEVIL L + P D+WS+GCIL E Y G LF E L + +ILG P +I+
Sbjct: 206 RPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHR 265
Query: 295 ASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN---DKAFVDFVTQCFNWDSKK 351
+++ F+ G +S GR K K + S + + D + + +D +
Sbjct: 266 TRKQKYFYK-GGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324
Query: 352 RLTPDEALRHEWLKSSSSSSSSSSHHATDLR 382
R+T EAL H + + S R
Sbjct: 325 RITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 435 bits (1121), Expect = e-152
Identities = 143/380 (37%), Positives = 204/380 (53%), Gaps = 71/380 (18%)
Query: 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIW 72
+ RYEI +IGKGSFGQV++A D A+K I K
Sbjct: 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-------------IIK----- 88
Query: 73 YLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIH 132
NKK F +QA IEVR+L+ + K D + Y ++H
Sbjct: 89 ----------------------------NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 133 MLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE--NI 190
+ +F FRNHLC+ FE+++ NLY+L++ N++G SL L R+FA + L L +I
Sbjct: 121 LKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSI 180
Query: 191 IHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPID 250
IHCDLKPEN+LL S+IK++DFGSSC QR+Y YIQSRFYRSPEV+LG+PY ID
Sbjct: 181 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAID 240
Query: 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFF----DSKG 306
MWSLGCIL E++TG PLF G NEV+Q+ I+E+LG PP +++ A + R FF D
Sbjct: 241 MWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTW 300
Query: 307 TPRCITNSKGRKRKPGSKDMASVLR------------------CNDKAFVDFVTQCFNWD 348
+ + K + PG++ + ++L + F D + + ++D
Sbjct: 301 NLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360
Query: 349 SKKRLTPDEALRHEWLKSSS 368
K R+ P AL+H + K ++
Sbjct: 361 PKTRIQPYYALQHSFFKKTA 380
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 432 bits (1113), Expect = e-151
Identities = 95/380 (25%), Positives = 160/380 (42%), Gaps = 75/380 (19%)
Query: 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIW 72
+ + ++ +G G+FG+V+ + A+K + +
Sbjct: 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-------------VVR----- 69
Query: 73 YLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIH 132
N K++ A IE IL ++ D ++ N++
Sbjct: 70 ----------------------------NIKKYTRSAKIEADILKKIQNDDINN-NNIVK 100
Query: 133 MLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIH 192
F + +H+C+ FE + +LYE+I RNNY GF + I+ + +++ L L + ++ H
Sbjct: 101 YHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTH 160
Query: 193 CDLKPENVLLK-----------------------QRGSSSIKVIDFGSSCYSHQRVYTYI 229
DLKPEN+LL + S+ IK+IDFG + + + I
Sbjct: 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSII 220
Query: 230 QSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPD 289
+R YR+PEVIL L + DMWS GC+LAELYTG LF +E LA + I+ P
Sbjct: 221 NTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPK 280
Query: 290 EVINTASRRR-LFFDSKGTPRCIT---NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCF 345
++ A++ + +K + S K K + + F DF+
Sbjct: 281 NMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340
Query: 346 NWDSKKRLTPDEALRHEWLK 365
D R +P E L+H++L+
Sbjct: 341 QIDPTLRPSPAELLKHKFLE 360
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-140
Identities = 97/371 (26%), Positives = 161/371 (43%), Gaps = 67/371 (18%)
Query: 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYL 74
+ RY ++ +G G F V A D NTH A+K I +
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-------------IVR------- 53
Query: 75 GLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADS-----SYN 129
K + A E+++L + D + +
Sbjct: 54 --------------------------GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87
Query: 130 VIHMLEYFYFRN----HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185
++ +L++F + H+ + FE++ NL LIK+ ++G L +++ + L+ L +
Sbjct: 88 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM 147
Query: 186 HRE-NIIHCDLKPENVLLK----QRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVI 240
HR IIH D+KPENVL++ IK+ D G++C+ + IQ+R YRSPEV+
Sbjct: 148 HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVL 207
Query: 241 LGLPYGPPIDMWSLGCILAELYTGCPLFPGE------NEVEQLACIMEILGCPPDEVINT 294
LG P+G D+WS C++ EL TG LF + + + +A I+E+LG P ++
Sbjct: 208 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRN 267
Query: 295 ASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT 354
R FF+S+G R I+ K + + + K DF++ D +KR
Sbjct: 268 GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327
Query: 355 PDEALRHEWLK 365
+ H WLK
Sbjct: 328 AGGLVNHPWLK 338
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 4e-67
Identities = 100/413 (24%), Positives = 160/413 (38%), Gaps = 107/413 (25%)
Query: 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWY 73
+ D RY ++ +G G F V + D + A+K + K
Sbjct: 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-------------VVK------ 71
Query: 74 LGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDAD--SSYNVI 131
+ + + AL E+R+L +R D + + V+
Sbjct: 72 ---------------------------SAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 132 HMLEYFYFR----NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHR 187
+L+ F H+C+ FE++ +L + I ++NYQG L +++ ++Q L LH
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT 164
Query: 188 E-NIIHCDLKPENVLL-------------------------------------------- 202
+ IIH D+KPEN+LL
Sbjct: 165 KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNP 224
Query: 203 ---KQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILA 259
K +K+ D G++C+ H+ IQ+R YRS EV++G Y P D+WS C+
Sbjct: 225 LEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAF 284
Query: 260 ELYTGCPLFPGEN------EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
EL TG LF + + + +A I+E+LG P ++I + FF KG + IT
Sbjct: 285 ELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344
Query: 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
K + + F DF+ +KR T E LRH WL S
Sbjct: 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 6e-64
Identities = 91/366 (24%), Positives = 154/366 (42%), Gaps = 78/366 (21%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+YE + IG+GS+G V + + T A+K K
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----------------------------K 35
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
E DD AL E+R+L L+ N++++LE F +
Sbjct: 36 FLESE--------DDPV-------IKKIALREIRMLKQLKHP------NLVNLLEVFRRK 74
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L + FE + + + R +G L++ + +Q + H+ N IH D+KPEN+
Sbjct: 75 RRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133
Query: 201 LLKQRGSSSIKVIDFG--------SSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDM 251
L+ + IK+ DFG S Y + V T R+YRSPE+++G YGPP+D+
Sbjct: 134 LITKHSV--IKLCDFGFARLLTGPSDYYDDE-VAT----RWYRSPELLVGDTQYGPPVDV 186
Query: 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311
W++GC+ AEL +G PL+PG+++V+QL I + LG S + F
Sbjct: 187 WAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF---------- 236
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
+ K + + + + + C + D +RLT ++ L H + ++
Sbjct: 237 SGVKIPDPED-MEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295
Query: 372 SSSSHH 377
+ H
Sbjct: 296 DLAKEH 301
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-61
Identities = 82/350 (23%), Positives = 156/350 (44%), Gaps = 68/350 (19%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+YE L ++G+GS+G V++ + T A+K K
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----------------------------K 57
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ DD+ A+ E+++L LR + N++++LE +
Sbjct: 58 FLESD--------DDKM-------VKKIAMREIKLLKQLRHE------NLVNLLEVCKKK 96
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ FE ++ + + ++ G +++++ F ++ + H NIIH D+KPEN+
Sbjct: 97 KRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENI 155
Query: 201 LLKQRGSSSIKVIDFG-SSCYSHQ-RVYT-YIQSRFYRSPEVILGLP-YGPPIDMWSLGC 256
L+ Q G +K+ DFG + + VY + +R+YR+PE+++G YG +D+W++GC
Sbjct: 156 LVSQSGV--VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGC 213
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
++ E++ G PLFPG+++++QL IM LG ++ F P
Sbjct: 214 LVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP-VFAGVRLPEIKEREPL 272
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+R P ++ +D +C + D KR E L H++ +
Sbjct: 273 ERRYPKLSEVV----------IDLAKKCLHIDPDKRPFCAELLHHDFFQM 312
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 5e-59
Identities = 92/359 (25%), Positives = 149/359 (41%), Gaps = 86/359 (23%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y +VIG GSFG V +A +++ A+K K+
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIK----------------------------KV 72
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ KRF E++I+ ++ NV+ + +FY
Sbjct: 73 LQD------------------KRF---KNRELQIMRIVKHP------NVVDLKAFFYSNG 105
Query: 142 H------LCISFELMNLNLYELIK--RNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHC 193
L + E + +Y + Q + LI+ + + L++ L +H I H
Sbjct: 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSS-CYSHQRVYT-YIQSRFYRSPEVILGLP-YGPPID 250
D+KP+N+LL S +K+IDFGS+ YI SR+YR+PE+I G Y ID
Sbjct: 166 DIKPQNLLL-DPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNID 224
Query: 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC 310
+WS GC++AEL G PLFPGE+ ++QL I+++LG P E I +
Sbjct: 225 IWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI----------------KT 268
Query: 311 ITNSKGRKRKPGSK--DMASVLRCN-DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + + P + + V R +D +++ + RLT EAL H +
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-59
Identities = 89/360 (24%), Positives = 143/360 (39%), Gaps = 87/360 (24%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y +VIG GSFG V +A + A+K K
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----------------------------K 86
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ D KRF E++I+ L N++ + +FY
Sbjct: 87 V-----------LQD-------KRF---KNRELQIMRKLDHC------NIVRLRYFFYSS 119
Query: 141 N------HLCISFELMNLNLYELIK--RNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIH 192
+L + + + +Y + + Q + ++ + + L + L +H I H
Sbjct: 120 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 179
Query: 193 CDLKPENVLLKQRGSSSIKVIDFGSS-CYSHQRVYT-YIQSRFYRSPEVILGLP-YGPPI 249
D+KP+N+LL ++ +K+ DFGS+ YI SR+YR+PE+I G Y I
Sbjct: 180 RDIKPQNLLLDPD-TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI 238
Query: 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309
D+WS GC+LAEL G P+FPG++ V+QL I+++LG P E I R
Sbjct: 239 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----------------R 282
Query: 310 CITNSKGRKRKPGSK--DMASVLRCN-DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + + P K V R + ++ + RLTP EA H +
Sbjct: 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 9e-58
Identities = 90/369 (24%), Positives = 143/369 (38%), Gaps = 90/369 (24%)
Query: 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGL 76
R+++ + G+G+FG V + T A+K
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK------------------------- 54
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
K+ D RF ++ L ++ L L N++ + Y
Sbjct: 55 ---KV-----------IQD-------PRFRNRELQIMQDLAVLHHP------NIVQLQSY 87
Query: 137 FYFRNH-------LCISFELMNLNLYELIK--RNNYQGFSLGLIRRFAFSLVQCLRLLHR 187
FY L + E + L+ + LI+ F F L++ + LH
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147
Query: 188 E--NIIHCDLKPENVLLKQRGSSSIKVIDFGSS-CYSHQRVYT-YIQSRFYRSPEVILGL 243
N+ H D+KP NVL+ ++K+ DFGS+ S YI SR+YR+PE+I G
Sbjct: 148 PSVNVCHRDIKPHNVLV-NEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGN 206
Query: 244 P-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFF 302
Y +D+WS+GCI AE+ G P+F G+N QL I+ +LGCP EV+
Sbjct: 207 QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL---------- 256
Query: 303 DSKGTPRCITNSKGR------KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPD 356
R + S K P S + + K D ++ + ++R+ P
Sbjct: 257 ------RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310
Query: 357 EALRHEWLK 365
EAL H +
Sbjct: 311 EALCHPYFD 319
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-57
Identities = 79/353 (22%), Positives = 145/353 (41%), Gaps = 53/353 (15%)
Query: 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLD 77
+ Y + I GS+G V +D + A+K
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIK-------------------------- 52
Query: 78 ACKIHGEESLSQNGG-FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
++ S + D KR L E+R+L+H + ++ E
Sbjct: 53 --RVFNTVSDGRTVNILSDSFLC---KR----VLREIRLLNHFHHPNILGLRDIFVHFEE 103
Query: 137 FYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
+ L + ELM +L ++I S I+ F + ++ L +LH ++H DL
Sbjct: 104 PAM-HKLYLVTELMRTDLAQVIHDQRIV-ISPQHIQYFMYHILLGLHVLHEAGVVHRDLH 161
Query: 197 PENVLLKQRGSSSIKVIDFG-SSCYSHQRVYT-YIQSRFYRSPEVILGLP-YGPPIDMWS 253
P N+LL ++ I + DF + + T Y+ R+YR+PE+++ + +DMWS
Sbjct: 162 PGNILLAD--NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWS 219
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
GC++AE++ LF G QL I+E++G P E + F S + N
Sbjct: 220 AGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV-------MFSSPSARDYLRN 272
Query: 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
S + +V+ D +D + + ++ ++R++ ++ALRH + +S
Sbjct: 273 SLSNVPA---RAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 7e-56
Identities = 85/360 (23%), Positives = 147/360 (40%), Gaps = 55/360 (15%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+Y + + +G GSFG V D ++ ALK ++ + R K E+ + +
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK----KVLQDPRY---KNRELDIMKV---- 56
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
D N F+ E + + N +
Sbjct: 57 ------------LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVI 104
Query: 141 ------NHLCISFELMNLNLYELIK--RNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIH 192
+L + E + L++++K + + + LI + + L + + +H I H
Sbjct: 105 VNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICH 164
Query: 193 CDLKPENVLLKQRGSSSIKVIDFGSS-CYSHQRVYT-YIQSRFYRSPEVILGLP-YGPPI 249
D+KP+N+L+ + +++K+ DFGS+ YI SRFYR+PE++LG Y P I
Sbjct: 165 RDIKPQNLLVNSK-DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI 223
Query: 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309
D+WS+GC+ EL G PLF GE ++QL I++I+G P E +
Sbjct: 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM----------------I 267
Query: 310 CITNSKGRKRKPGSK--DMASVLR-CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ R P K D +L +D + Q ++ R+ P EA+ H +
Sbjct: 268 RMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 7e-56
Identities = 86/353 (24%), Positives = 150/353 (42%), Gaps = 68/353 (19%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RYE + IG G++G V +A D + ALK
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALK----------------------------S 41
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ G + EV +L L + NV+ +++
Sbjct: 42 VRVPN---------GGGG---GGGLPISTVREVALLRRLEAFEHP---NVVRLMDVCATS 86
Query: 141 NH-----LCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDL 195
+ + FE ++ +L + + G I+ ++ L LH I+H DL
Sbjct: 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDL 146
Query: 196 KPENVLLKQRGSSSIKVIDFG-SSCYSHQRVYTY-IQSRFYRSPEVILGLPYGPPIDMWS 253
KPEN+L+ G+ +K+ DFG + YS+Q T + + +YR+PEV+L Y P+DMWS
Sbjct: 147 KPENILVTSGGT--VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWS 204
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
+GCI AE++ PLF G +E +QL I +++G PP++ PR ++
Sbjct: 205 VGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW---------------PRDVSL 249
Query: 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+G G + + SV+ +++ + + ++ KR++ AL+H +L
Sbjct: 250 PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-54
Identities = 84/360 (23%), Positives = 144/360 (40%), Gaps = 67/360 (18%)
Query: 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALK--YYGNQLTEFERTEIEKYLEIWYL 74
+ RY L+ +G G G V A+D+ + A+K + + EI +
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHA----LREIKII 62
Query: 75 GLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHML 134
+R H +++V + + + L
Sbjct: 63 ----------------------------RRLDHDNIVKVF---EILGPSGSQLTDDVGSL 91
Query: 135 EYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCD 194
N + I E M +L ++++ R F + L++ L+ +H N++H D
Sbjct: 92 TEL---NSVYIVQEYMETDLANVLEQGP---LLEEHARLFMYQLLRGLKYIHSANVLHRD 145
Query: 195 LKPENVLLKQRGSSSIKVIDFG-----SSCYSHQRVYT-YIQSRFYRSPEVILGLP-YGP 247
LKP N+ + +K+ DFG YSH+ + + +++YRSP ++L Y
Sbjct: 146 LKPANLFINTE-DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTK 204
Query: 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINT-ASRRRLFFDSKG 306
IDMW+ GCI AE+ TG LF G +E+EQ+ I+E + +E S ++
Sbjct: 205 AIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVY----- 259
Query: 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
I N KP + +L + VDF+ Q + RLT +EAL H ++
Sbjct: 260 ----IRNDMTEPHKP----LTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-54
Identities = 86/356 (24%), Positives = 150/356 (42%), Gaps = 79/356 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+Y LE IG+G++G V +A ++ T ALK KI
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALK----------------------------KI 34
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
E ++ G + E+ IL L+ N++ + + + +
Sbjct: 35 RLE---------KEDEG------IPSTTIREISILKELKHS------NIVKLYDVIHTKK 73
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + FE ++ +L +L+ G + F L+ + H ++H DLKP+N+L
Sbjct: 74 RLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL 132
Query: 202 LKQRGSSSIKVIDFG--------SSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMW 252
+ + G +K+ DFG Y+H+ + T +YR+P+V++G Y ID+W
Sbjct: 133 INREGE--LKIADFGLARAFGIPVRKYTHE-IVT----LWYRAPDVLMGSKKYSTTIDIW 185
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
S+GCI AE+ G PLFPG +E +QL I ILG P + + +
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY----------- 234
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368
S L+ D++ +D +++ D +R+T +AL H + K ++
Sbjct: 235 --DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 7e-54
Identities = 90/356 (25%), Positives = 153/356 (42%), Gaps = 81/356 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+YE LE IG+G++G V +A + +T+ ALK +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK----------------------------R 34
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ + DD+ G AL E+ +L L+ K N++ + + +
Sbjct: 35 VRLD---------DDDEG------VPSSALREICLLKELKHK------NIVRLHDVLHSD 73
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L + FE + +L + N +++ F F L++ L H N++H DLKP+N+
Sbjct: 74 KKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132
Query: 201 LLKQRGSSSIKVIDFG--------SSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDM 251
L+ + G +K+ +FG CYS + V T +YR P+V+ G Y IDM
Sbjct: 133 LINRNGE--LKLANFGLARAFGIPVRCYSAE-VVT----LWYRPPDVLFGAKLYSTSIDM 185
Query: 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC 310
WS GCI AEL G PLFPG + +QL I +LG P +E + ++ +
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY--------- 236
Query: 311 ITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
K P + + +V+ + D + + +R++ +EAL+H +
Sbjct: 237 ----KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 8e-54
Identities = 93/355 (26%), Positives = 152/355 (42%), Gaps = 78/355 (21%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RYE L+ +G+G F V +A D TN A+K K
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIK----------------------------K 42
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
I G + AL E+++L L N+I +L+ F +
Sbjct: 43 IKLGHRSEAKDGIN------------RTALREIKLLQELSHP------NIIGLLDAFGHK 84
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+++ + F+ M +L +IK N+ + I+ + +Q L LH+ I+H DLKP N+
Sbjct: 85 SNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143
Query: 201 LLKQRGSSSIKVIDFG--------SSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDM 251
LL + G +K+ DFG + Y+HQ V T R+YR+PE++ G YG +DM
Sbjct: 144 LLDENGV--LKLADFGLAKSFGSPNRAYTHQ-VVT----RWYRAPELLFGARMYGVGVDM 196
Query: 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311
W++GCILAEL P PG+++++QL I E LG P +E + K P
Sbjct: 197 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG-- 254
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + +D + F ++ R+T +AL+ ++ +
Sbjct: 255 ------------IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-53
Identities = 81/356 (22%), Positives = 146/356 (41%), Gaps = 68/356 (19%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RY+ L+ IG G+ G V A D + + A+K K
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK----------------------------K 94
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ F ++ + KR A E+ ++ + K+ S NV +
Sbjct: 95 LSRP--------FQNQTHA---KR----AYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + ELM+ NL ++I+ + + ++ ++ LH IIH DLKP N+
Sbjct: 140 QDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
Query: 201 LLKQRGSSSIKVIDFG-SSCYSHQRVYT-YIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
++K ++K++DFG + + T Y+ +R+YR+PEVILG+ Y +D+WS+GCI+
Sbjct: 196 VVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
Query: 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
E+ LFPG + ++Q ++E LG P E + + N
Sbjct: 254 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT--------VRNYVENRPKYA 305
Query: 319 RKP--------GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + D +++ D KR++ D+AL+H ++
Sbjct: 306 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-53
Identities = 77/351 (21%), Positives = 143/351 (40%), Gaps = 62/351 (17%)
Query: 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGL 76
+ Y +G G++G V A+D ++ A+K K + +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK---------------KLSRPFQSEI 65
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
A KR A E+ +L H++ ++ +V
Sbjct: 66 FA------------------------KR----AYRELLLLKHMQHENVIGLLDVFTPASS 97
Query: 137 FYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
+ M +L +++ FS I+ + +++ L+ +H ++H DLK
Sbjct: 98 LRNFYDFYLVMPFMQTDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK 153
Query: 197 PENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLG 255
P N+ + + +K++DFG + ++ + Y+ +R+YR+PEVIL Y +D+WS+G
Sbjct: 154 PGNLAVNE--DCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315
CI+AE+ TG LF G++ ++QL I+++ G P E + + K I +
Sbjct: 212 CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ-------KLNDKAAKSYIQSLP 264
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
RK + D + + D KRLT +AL H + +
Sbjct: 265 QTPRKD----FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 87/354 (24%), Positives = 152/354 (42%), Gaps = 72/354 (20%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH--ALKYYGNQLTEFERTEIEKYLEIWYLGLDAC 79
+YE + IG+G++G+V +A D K ALK
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALK---------------------------- 43
Query: 80 KIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF 139
++ + E G + EV +L HL + NV+ + +
Sbjct: 44 RVRVQT---------GEEG------MPLSTIREVAVLRHLETFEHP---NVVRLFDVCTV 85
Query: 140 R-----NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCD 194
L + FE ++ +L + + G I+ F L++ L LH ++H D
Sbjct: 86 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD 145
Query: 195 LKPENVLLKQRGSSSIKVIDFG-SSCYSHQRVYTY-IQSRFYRSPEVILGLPYGPPIDMW 252
LKP+N+L+ G IK+ DFG + YS Q T + + +YR+PEV+L Y P+D+W
Sbjct: 146 LKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLW 203
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
S+GCI AE++ PLF G ++V+QL I++++G P +E PR +
Sbjct: 204 SVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---------------PRDVA 248
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ ++ + + D+ D + +C ++ KR++ AL H + +
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 4e-53
Identities = 84/354 (23%), Positives = 153/354 (43%), Gaps = 78/354 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+Y+ LE +G+G++G V +A D + ALK +I
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALK----------------------------RI 53
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ ++ G A+ E+ +L L N++ +++ +
Sbjct: 54 RLDA---------EDEG------IPSTAIREISLLKELHHP------NIVSLIDVIHSER 92
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + FE M +L +++ N G I+ + + L++ + H+ I+H DLKP+N+L
Sbjct: 93 CLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLL 151
Query: 202 LKQRGSSSIKVIDFG--------SSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMW 252
+ G+ +K+ DFG Y+H+ V T +YR+P+V++G Y +D+W
Sbjct: 152 INSDGA--LKLADFGLARAFGIPVRSYTHE-VVT----LWYRAPDVLMGSKKYSTSVDIW 204
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
S+GCI AE+ TG PLFPG + +QL I ILG P L+
Sbjct: 205 SIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW----------- 253
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + K +S++ + +D ++ +D KR++ +A+ H + K
Sbjct: 254 -KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-53
Identities = 89/353 (25%), Positives = 155/353 (43%), Gaps = 69/353 (19%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RY L IG+G++G V A D+ A+K +++ FE
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----KISPFEHQ------------TYC-- 69
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+R L E++IL R ++ ++I
Sbjct: 70 ----------------------QR----TLREIKILLRFRHENIIGINDIIRAPTIEQM- 102
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ I +LM +LY+L+K Q S I F + +++ L+ +H N++H DLKP N+
Sbjct: 103 KDVYIVQDLMETDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159
Query: 201 LLKQRGSSSIKVIDFG-----SSCYSHQRVYT-YIQSRFYRSPEVILGLP-YGPPIDMWS 253
LL + +K+ DFG + H T Y+ +R+YR+PE++L Y ID+WS
Sbjct: 160 LLNT--TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 217
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
+GCILAE+ + P+FPG++ ++QL I+ ILG P E +N + + +
Sbjct: 218 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN-------CIINLKARNYLLS 270
Query: 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + P + D +D + + ++ KR+ ++AL H +L+
Sbjct: 271 LPHKNKVP----WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-53
Identities = 91/365 (24%), Positives = 156/365 (42%), Gaps = 77/365 (21%)
Query: 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGL 76
+I +++ ++G+G++G V A T A+K ++ F++ L
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK----KIEPFDKP------------L 51
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
A R L E++IL H + ++ + +N+ +
Sbjct: 52 FA------------------------LR----TLREIKILKHFKHENIITIFNIQRPDSF 83
Query: 137 FYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
F N + I ELM +L+ +I Q S I+ F + ++ +++LH N+IH DLK
Sbjct: 84 ENF-NEVYIIQELMQTDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLK 139
Query: 197 PENVLLKQRGSSSIKVIDFG------------SSCYSHQRVYT-YIQSRFYRSPEVILGL 243
P N+L+ + +KV DFG S Q ++ +R+YR+PEV+L
Sbjct: 140 PSNLLINS--NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS 197
Query: 244 P-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCP-PDEVINTASRRRLF 301
Y +D+WS GCILAEL+ P+FPG + QL I I+G P D +
Sbjct: 198 AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR-------C 250
Query: 302 FDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
+S I + P + + + +D + + +D KR+T EAL H
Sbjct: 251 IESPRAREYIKSLPMYPAAP----LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 362 EWLKS 366
+L++
Sbjct: 307 PYLQT 311
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-53
Identities = 89/347 (25%), Positives = 153/347 (44%), Gaps = 61/347 (17%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y L+ +G G++G V A+D +T A+K K
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK----------------------------K 57
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
++ F E + KR A E+R+L H+R ++ +V E
Sbjct: 58 LYRP--------FQSELFA---KR----AYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ M +L +L+K + I+ + +++ LR +H IIH DLKP N+
Sbjct: 103 TDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL 159
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGCILA 259
+ + +K++DFG + + + Y+ +R+YR+PEVIL Y +D+WS+GCI+A
Sbjct: 160 AVNE--DCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 217
Query: 260 ELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319
E+ TG LF G + ++QL IM++ G PP E + S + ++
Sbjct: 218 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ-------RLQSDEAKNYMKGLPELEK 270
Query: 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
K AS+L V+ + + D+++R+T EAL H + +S
Sbjct: 271 KD----FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-52
Identities = 84/355 (23%), Positives = 147/355 (41%), Gaps = 80/355 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y L+ +G+G++ V + T+ ALK +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALK----------------------------E 34
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
I + E G A+ EV +L L+ N++ + + +
Sbjct: 35 IR----------LEHEEG------APCTAIREVSLLKDLKHA------NIVTLHDIIHTE 72
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L + FE ++ +L + + ++ ++ F F L++ L HR+ ++H DLKP+N+
Sbjct: 73 KSLTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 131
Query: 201 LLKQRGSSSIKVIDFG--------SSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDM 251
L+ +RG +K+ DFG + Y ++ V T +YR P+++LG Y IDM
Sbjct: 132 LINERGE--LKLADFGLARAKSIPTKTYDNE-VVT----LWYRPPDILLGSTDYSTQIDM 184
Query: 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311
W +GCI E+ TG PLFPG EQL I ILG P +E F
Sbjct: 185 WGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF---------- 234
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
K ++ + S D D +T+ ++ + R++ ++A++H + S
Sbjct: 235 --KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-52
Identities = 91/364 (25%), Positives = 160/364 (43%), Gaps = 89/364 (24%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+++ LE +G G++ V + L+ T + ALK +
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALK----------------------------E 37
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ D E G A+ E+ ++ L+ + N++ + + +
Sbjct: 38 VK----------LDSEEG------TPSTAIREISLMKELKHE------NIVRLYDVIHTE 75
Query: 141 NHLCISFELMNLNLYELIKRNNY----QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
N L + FE M+ +L + + +G L L++ F + L+Q L H I+H DLK
Sbjct: 76 NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLK 135
Query: 197 PENVLLKQRGSSSIKVIDFG--------SSCYSHQRVYTYIQSRFYRSPEVILGLP-YGP 247
P+N+L+ +RG +K+ DFG + +S + V T +YR+P+V++G Y
Sbjct: 136 PQNLLINKRGQ--LKLGDFGLARAFGIPVNTFSSE-VVT----LWYRAPDVLMGSRTYST 188
Query: 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT 307
ID+WS GCILAE+ TG PLFPG N+ EQL I +I+G P + + + ++ +
Sbjct: 189 SIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY------ 242
Query: 308 PRCITNSKGRKRKPGSKDMASVLRCN-----DKAFVDFVTQCFNWDSKKRLTPDEALRHE 362
++ +D+ VL+ + D +DF+ + RL+ +AL H
Sbjct: 243 -------NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 363 WLKS 366
W
Sbjct: 296 WFAE 299
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-52
Identities = 85/347 (24%), Positives = 152/347 (43%), Gaps = 61/347 (17%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RY+ L +G G++G V A D KT A+K F+ + A
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSI------------IHA-- 72
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
KR E+R+L H++ ++ +V
Sbjct: 73 ----------------------KR----TYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
N + + LM +L ++K Q + ++ + +++ L+ +H +IIH DLKP N+
Sbjct: 107 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 163
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGCILA 259
+ + +K++DFG + ++ + Y+ +R+YR+PE++L Y +D+WS+GCI+A
Sbjct: 164 AVNE--DCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 260 ELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319
EL TG LFPG + ++QL I+ ++G P E++ S+ I + +
Sbjct: 222 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK-------KISSESARNYIQSLTQMPK 274
Query: 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
A+V + VD + + DS KR+T +AL H +
Sbjct: 275 MN----FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-52
Identities = 83/356 (23%), Positives = 146/356 (41%), Gaps = 68/356 (19%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RY+ L+ IG G+ G V A D + A+K K
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK----------------------------K 57
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ F ++ + KR A E+ ++ + K+ NV +
Sbjct: 58 LSRP--------FQNQTHA---KR----AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ I ELM+ NL ++I+ + + ++ ++ LH IIH DLKP N+
Sbjct: 103 QDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158
Query: 201 LLKQRGSSSIKVIDFG-SSCYSHQRVYT-YIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
++K ++K++DFG + + T Y+ +R+YR+PEVILG+ Y +D+WS+GCI+
Sbjct: 159 VVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 216
Query: 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
E+ G LFPG + ++Q ++E LG P E + + N
Sbjct: 217 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT--------VRTYVENRPKYA 268
Query: 319 RKP--------GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + D +++ D+ KR++ DEAL+H ++
Sbjct: 269 GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-51
Identities = 85/384 (22%), Positives = 161/384 (41%), Gaps = 90/384 (23%)
Query: 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGL 76
H+ +YE+++ +GKG++G V +++D +T A+K K + +
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---------------KIFDAFQNST 50
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
DA +R E+ IL L + N++++L
Sbjct: 51 DA------------------------QR----TFREIMILTELSGHE-----NIVNLLNV 77
Query: 137 FY---FRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHC 193
+ + F+ M +L+ +I+ + + L++ ++ LH ++H
Sbjct: 78 LRADND-RDVYLVFDYMETDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHR 133
Query: 194 DLKPENVLLKQRGSSSIKVIDFG-----------------------SSCYSHQRVYT-YI 229
D+KP N+LL +KV DFG + Q + T Y+
Sbjct: 134 DMKPSNILLNA--ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYV 191
Query: 230 QSRFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP 288
+R+YR+PE++LG Y IDMWSLGCIL E+ G P+FPG + + QL I+ ++ P
Sbjct: 192 ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPS 251
Query: 289 DEVIN--TASRRRLFFDS----KGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVT 342
+E + + + +S + K K + CN++A +D +
Sbjct: 252 NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA-LDLLD 310
Query: 343 QCFNWDSKKRLTPDEALRHEWLKS 366
+ ++ KR++ ++AL+H ++
Sbjct: 311 KLLQFNPNKRISANDALKHPFVSI 334
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 6e-51
Identities = 88/358 (24%), Positives = 149/358 (41%), Gaps = 81/358 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RY + +G+G++G+V +A+D TN A+K +
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIK----------------------------R 66
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
I E +E G A+ EV +L L+ + N+I + +
Sbjct: 67 IRLEH---------EEEG------VPGTAIREVSLLKELQHR------NIIELKSVIHHN 105
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ L + FE +L + + +N S+ +I+ F + L+ + H +H DLKP+N+
Sbjct: 106 HRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163
Query: 201 LLKQRGSSS---IKVIDFG--------SSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPP 248
LL +S +K+ DFG ++H+ + T +YR PE++LG Y
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE-IIT----LWYRPPEILLGSRHYSTS 218
Query: 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTP 308
+D+WS+ CI AE+ PLFPG++E++QL I E+LG P D + + S P
Sbjct: 219 VDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSF--P 276
Query: 309 RCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + R D +D +T D KR++ AL H +
Sbjct: 277 KFRGKTLKRVLGALLDDEG----------LDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-49
Identities = 93/412 (22%), Positives = 147/412 (35%), Gaps = 122/412 (29%)
Query: 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGL 76
I RYEI +IG GS+G V A D A+K
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK------------------------- 84
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
KI F+D KR L E+ IL+ L +++ +
Sbjct: 85 ---KILRV--------FEDLIDC---KR----ILREIAILNRLNHDHVVKVLDIVIPKDV 126
Query: 137 FYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
F + L + E+ + + +L + + I+ ++L+ ++ +H I+H DLK
Sbjct: 127 EKF-DELYVVLEIADSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLK 183
Query: 197 PENVLLKQRGSSSIKVIDFG-----------------------------SSCYSHQRVYT 227
P N L+ Q S +KV DFG + +R T
Sbjct: 184 PANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241
Query: 228 -YIQSRFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGC-----------PLFPGEN-- 272
++ +R+YR+PE+IL Y ID+WS+GCI AEL PLFPG +
Sbjct: 242 GHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCF 301
Query: 273 ------------------EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314
+QL I ILG P +E I + + R I
Sbjct: 302 PLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIE-------ALEKEDAKRYIRIF 354
Query: 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
R+ +A + + + + ++ KR+T +E L H + K
Sbjct: 355 PKREGTD----LAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-48
Identities = 74/355 (20%), Positives = 143/355 (40%), Gaps = 76/355 (21%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y+++ +G+G + +V A++ N +K L ++ +I
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVK----ILKPVKKKKI--------------- 77
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
KR E++IL++LR N+I + +
Sbjct: 78 ----------------------KR-------EIKILENLRGGP-----NIITLADIVKDP 103
Query: 141 NHLCISF---ELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
+ + N + +L YQ + IR + + +++ L H I+H D+KP
Sbjct: 104 VSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKP 158
Query: 198 ENVLLKQRGSSSIKVIDFG-SSCYSHQRVYT-YIQSRFYRSPEVILGLP-YGPPIDMWSL 254
NV++ +++ID+G + Y + Y + SR+++ PE+++ Y +DMWSL
Sbjct: 159 HNVMIDHE-HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL 217
Query: 255 GCILAELYTG-CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
GC+LA + P F G + +QL I ++LG ++ + PR
Sbjct: 218 GCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID------KYNIELDPRFNDI 271
Query: 314 SKGRKRKPGSK--DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
RK + + + +A +DF+ + +D + RLT EA+ H + +
Sbjct: 272 LGRHSRKRWERFVHSENQHLVSPEA-LDFLDKLLRYDHQSRLTAREAMEHPYFYT 325
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-47
Identities = 70/377 (18%), Positives = 132/377 (35%), Gaps = 109/377 (28%)
Query: 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y IL+ IG G +V + L+ K +A+KY L E + ++ Y
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRN---------- 75
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
E+ L+ L+ S +I + +Y
Sbjct: 76 -------------------------------EIAYLNKLQ----QHSDKIIRLYDYEITD 100
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
++ + E N++L +K+ + + + ++++ + +H+ I+H DLKP N
Sbjct: 101 QYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 158
Query: 201 LLKQRGSSSIKVIDFGSSCY-----SHQRVYTYIQSRFYRSPEVILGLP----------- 244
L+ +K+IDFG + + + + + Y PE I +
Sbjct: 159 LIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 215
Query: 245 YGPPIDMWSLGCILAELYTGCPLFPG-ENEVEQLACIMEILGCPPDEVINTASRRRLFFD 303
P D+WSLGCIL + G F N++ +L I++ P+ I
Sbjct: 216 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----PNHEIE---------- 260
Query: 304 SKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
P +K D + C D K+R++ E L H +
Sbjct: 261 ---FPDIP----------------------EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295
Query: 364 LKSSSSSSSSSSHHATD 380
++ + + + T+
Sbjct: 296 VQIQTHPVNQMAKGTTE 312
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-47
Identities = 98/370 (26%), Positives = 154/370 (41%), Gaps = 93/370 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+YE L IG+G+FG+V +A KT ALK K
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALK----------------------------K 49
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ ++E K+ F AL E++IL L+ + NV++++E +
Sbjct: 50 VL----------MENE-----KEGFPITALREIKILQLLKHE------NVVNLIEICRTK 88
Query: 141 NHLCIS--------FELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIH 192
F+ +L L+ N F+L I+R L+ L +HR I+H
Sbjct: 89 ASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH 147
Query: 193 CDLKPENVLLKQRGSSSIKVIDFG------------SSCYSHQRVYTYIQSRFYRSPEVI 240
D+K NVL+ + G +K+ DFG + Y++ RV T +YR PE++
Sbjct: 148 RDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTN-RVVT----LWYRPPELL 200
Query: 241 LGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRR 299
LG YGPPID+W GCI+AE++T P+ G E QLA I ++ G EV
Sbjct: 201 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 260
Query: 300 LFFDSKGTPRCITNSKGRKRKPGSKDMASVLR--CNDKAFVDFVTQCFNWDSKKRLTPDE 357
L+ K K + + L+ D +D + + D +R+ D+
Sbjct: 261 LY------------EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308
Query: 358 ALRHEWLKSS 367
AL H++ S
Sbjct: 309 ALNHDFFWSD 318
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 96/405 (23%), Positives = 152/405 (37%), Gaps = 116/405 (28%)
Query: 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGL 76
H+ Y I +IG+GS+G V A D T + A+K
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK------------------------- 57
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
K++ F+D KR L E+ IL+ L+ Y++I +
Sbjct: 58 ---KVNRM--------FEDLIDC---KR----ILREITILNRLKSDYIIRLYDLIIPDDL 99
Query: 137 FYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
F + L I E+ + +L +L K + I+ ++L+ +H IIH DLK
Sbjct: 100 LKF-DELYIVLEIADSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLK 156
Query: 197 PENVLLKQRGSSSIKVIDFG------------------------SSCYSHQRVYT-YIQS 231
P N LL Q S+KV DFG + ++ T ++ +
Sbjct: 157 PANCLLNQ--DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214
Query: 232 RFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGC-----------PLFPG--------- 270
R+YR+PE+IL Y ID+WS GCI AEL PLFPG
Sbjct: 215 RWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPD 274
Query: 271 --------ENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322
++ +QL I I+G P ++ + + + I RK
Sbjct: 275 RNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK-------NINKPEVIKYIKLFPHRKPIN- 326
Query: 323 SKDMASVL-RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ +D ++ + ++ KR+T D+AL H +LK
Sbjct: 327 ---LKQKYPSISDDG-INLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 7e-46
Identities = 72/381 (18%), Positives = 132/381 (34%), Gaps = 109/381 (28%)
Query: 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y IL+ IG G +V + L+ K +A+KY L E + ++ Y
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRN---------- 56
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
E+ L+ L+ S +I + +Y
Sbjct: 57 -------------------------------EIAYLNKLQ----QHSDKIIRLYDYEITD 81
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
++ + E N++L +K+ + + + ++++ + +H+ I+H DLKP N
Sbjct: 82 QYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 139
Query: 201 LLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSR----FYRSPEVILGLP----------- 244
L+ +K+IDFG ++ S+ Y PE I +
Sbjct: 140 LIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 196
Query: 245 YGPPIDMWSLGCILAELYTGCPLFPG-ENEVEQLACIMEILGCPPDEVINTASRRRLFFD 303
P D+WSLGCIL + G F N++ +L I++ P+ I
Sbjct: 197 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----PNHEIE---------- 241
Query: 304 SKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
P +K D + C D K+R++ E L H +
Sbjct: 242 ---FPDIP----------------------EKDLQDVLKCCLKRDPKQRISIPELLAHPY 276
Query: 364 LKSSSSSSSSSSHHATDLRKS 384
++ + + + T+ K
Sbjct: 277 VQIQTHPVNQMAKGTTEEMKY 297
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 71/381 (18%), Positives = 129/381 (33%), Gaps = 109/381 (28%)
Query: 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y IL+ IG G +V + L+ K +A+KY L E + ++ Y
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRN---------- 103
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
E+ L+ L+ S +I + +Y
Sbjct: 104 -------------------------------EIAYLNKLQ----QHSDKIIRLYDYEITD 128
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
++ + E N++L +K+ + + + ++++ + +H+ I+H DLKP N
Sbjct: 129 QYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186
Query: 201 LLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSR----FYRSPEVILGLP----------- 244
L+ +K+IDFG ++ S+ Y PE I +
Sbjct: 187 LIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 245 YGPPIDMWSLGCILAELYTGCPLFPG-ENEVEQLACIMEILGCPPDEVINTASRRRLFFD 303
P D+WSLGCIL + G F N++ +L
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-------------------------- 277
Query: 304 SKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
I + P D+ K D + C D K+R++ E L H +
Sbjct: 278 -----HAIIDPNHEIEFP---DIPE------KDLQDVLKCCLKRDPKQRISIPELLAHPY 323
Query: 364 LKSSSSSSSSSSHHATDLRKS 384
++ + + + T+ K
Sbjct: 324 VQIQTHPVNQMAKGTTEEMKY 344
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-41
Identities = 74/376 (19%), Positives = 127/376 (33%), Gaps = 88/376 (23%)
Query: 22 RYEIL-EVIGKGSFGQVIRALDHKTNTH---ALKYYGNQLTEFERTEIEKYLEIWYLGLD 77
+E +G+G++G V +A ALK
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK-------------------------- 54
Query: 78 ACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF 137
+I G G A E+ +L L+ NVI + + F
Sbjct: 55 --QIEGT-------GISMS------------ACREIALLRELKHP------NVISLQKVF 87
Query: 138 YFRNHLCIS--FELMNLNLYELIK-------RNNYQGFSLGLIRRFAFSLVQCLRLLHRE 188
+ F+ +L+ +IK G+++ + ++ + LH
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 189 NIIHCDLKPENVLLKQRGSSS--IKVIDFG--SSCYSHQRVYTYIQSR----FYRSPEVI 240
++H DLKP N+L+ G +K+ D G S + + +YR+PE++
Sbjct: 148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 207
Query: 241 LGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEV---------EQLACIMEILGCPPDE 290
LG Y ID+W++GCI AEL T P+F E +QL I ++G P D+
Sbjct: 208 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK 267
Query: 291 VINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSK 350
+ R K M D + + D
Sbjct: 268 DWEDIKKMPEHSTLMKDFR----RNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323
Query: 351 KRLTPDEALRHEWLKS 366
KR+T ++A++ +
Sbjct: 324 KRITSEQAMQDPYFLE 339
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 71/357 (19%), Positives = 134/357 (37%), Gaps = 82/357 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y + +G G++G+V+ + + + A K+
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGH-------------------SEK---------AIKV 68
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
SQ + + N ++FH + E+ +L L N+I + + F +
Sbjct: 69 ---IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL------DHPNIIKLFDVFEDKK 119
Query: 142 HLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + E L+E I + F ++ + LH+ NI+H D+KPEN+
Sbjct: 120 YFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177
Query: 201 LLKQRGS-SSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
LL+ + S +IK++DFG S + ++ + + +Y +PEV+ Y D+WS G I
Sbjct: 178 LLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVI 236
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
+ L G P F G+N+ + + ++ FD +K
Sbjct: 237 MYILLCGYPPFGGQNDQDIIK---KVEKGKYY------------FDFNDWKNISDEAK-- 279
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSS 374
+ + +D KR T +EAL W+K +++ + S
Sbjct: 280 ---------------------ELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 9e-40
Identities = 43/361 (11%), Positives = 98/361 (27%), Gaps = 65/361 (18%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+ +++E + G V D + ALK F + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALK-------VFTMGAENS-------RSELER 108
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+H + + + +++R + V + + + Y
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDA-VAVQSQPPFAQLSPGQDDYAVANYLLL- 166
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGL-----IRRFAFSLVQCLRLLHRENIIHCDL 195
+++L L ++ G + L++ L + ++H
Sbjct: 167 ------MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220
Query: 196 KPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG--LPYGPPIDMWS 253
P+N+ + G + + D + R Y E + + ++ W
Sbjct: 221 TPDNLFIMPDG--RLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQ 278
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
LG + ++ F + + L P L F
Sbjct: 279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG--------TDSLAF----------- 319
Query: 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSS 373
+ ++ + + N+D ++RL P EA+ + SS
Sbjct: 320 -------GSCTPLPDFVK-------TLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISS 365
Query: 374 S 374
S
Sbjct: 366 S 366
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 87/368 (23%), Positives = 138/368 (37%), Gaps = 97/368 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
YE+ EVIGKG F V R ++ +T +++ A KI
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETG-------------------QQF---------AVKI 56
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + G E+ KR E I L+ +++ +LE +
Sbjct: 57 VDVAKFTSSPGLSTED----LKR-------EASICHMLKHP------HIVELLETYSSDG 99
Query: 142 HLCISFELMN---LNLYELIKR-NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
L + FE M+ L +E++KR + +S + + +++ LR H NIIH D+KP
Sbjct: 100 MLYMVFEFMDGADL-CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKP 158
Query: 198 ENVLLKQRG-SSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253
VLL + S+ +K+ FG + S + + + +PEV+ PYG P+D+W
Sbjct: 159 HCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWG 218
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
G IL L +GC F G E + E I+ + + I+
Sbjct: 219 CGVILFILLSGCLPFYGTKER-----LFEGIIKGKYK------------MNPRQWSH-IS 260
Query: 313 NS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
S K D V + D +R+T EAL H WLK +
Sbjct: 261 ESAK-----------------------DLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
Query: 372 SSSSHHAT 379
T
Sbjct: 298 YKIHLPET 305
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 64/392 (16%), Positives = 122/392 (31%), Gaps = 97/392 (24%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+Y L+ IG+GSFG+ I + +K EI +
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIK------------------EINISRMS--- 63
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ ++ EV +L +++ N++ E F
Sbjct: 64 ----------------------SKEREESRREVAVLANMK------HPNIVQYRESFEEN 95
Query: 141 NHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
L I + +L++ I F I + + L+ +H I+H D+K +N
Sbjct: 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQN 155
Query: 200 VLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
+ L + G+ +++ DFG + + + I + +Y SPE+ PY D+W+LGC
Sbjct: 156 IFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGC 213
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
+L EL T F + +++I+ V S
Sbjct: 214 VLYELCTLKHAFEAGS---MKNLVLKIISGSFPPVSLHYS-------------------- 250
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSSH 376
V+Q F + + R + + L ++ S
Sbjct: 251 ------------------YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
Query: 377 HATDLRKSPSAHTNMYRLYRGVPTKPSAPADI 408
A + + + P +
Sbjct: 293 IAEEFCLKTFSKFGSQPIPAKRPASGQNSISV 324
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 76/362 (20%), Positives = 137/362 (37%), Gaps = 93/362 (25%)
Query: 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGL 76
H+ Y+ ++ +G G++G+V+ D T+ +
Sbjct: 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTH-------------------VER-------- 65
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
A KI + S+S + EV +L L N++ + ++
Sbjct: 66 -AIKIIRKTSVSTSSNSKLLE--------------EVAVLKLL------DHPNIMKLYDF 104
Query: 137 FYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDL 195
F + + + E L++ I F+ ++ + LH+ NI+H DL
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRDL 162
Query: 196 KPENVLLKQRGS-SSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252
KPEN+LL+ + + IK++DFG S + +++ + + +Y +PEV+ Y D+W
Sbjct: 163 KPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVW 221
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
S+G IL L G P F G+ + E L ++ FDS
Sbjct: 222 SIGVILFILLAGYPPFGGQTDQEILR---KVEKGKYT------------FDSPEWKNVSE 266
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSS 372
+K D + Q +DS++R++ +AL H W+K S
Sbjct: 267 GAK-----------------------DLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKE 303
Query: 373 SS 374
S
Sbjct: 304 SG 305
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 74/402 (18%), Positives = 125/402 (31%), Gaps = 131/402 (32%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+Y + IG+GS+G V A++++T A KI
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTR-------------------AIR---------AIKI 58
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + Q D E EVR++ L N+ + E +
Sbjct: 59 MNKNKIRQINPKDVER-----------IKTEVRLMKKLHHP------NIARLYEVYEDEQ 101
Query: 142 HLCISFELMNL-NLYELIKRNNYQG----------------------------------- 165
++C+ EL + +L + +
Sbjct: 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161
Query: 166 ---FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222
LI + L LH + I H D+KPEN L S IK++DFG S +
Sbjct: 162 DFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY 221
Query: 223 -------QRVYTYIQSRFYRSPEVILGL--PYGPPIDMWSLGCILAELYTGCPLFPGENE 273
+ T + ++ +PEV+ YGP D WS G +L L G FPG N+
Sbjct: 222 KLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND 281
Query: 274 VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333
+ ++ ++L F++ ++
Sbjct: 282 ADTIS---QVLNKKLC------------FENPNYNVLSPLAR------------------ 308
Query: 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSS 375
D ++ N + +R AL+H W+ S S
Sbjct: 309 -----DLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKMS 345
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-37
Identities = 44/272 (16%), Positives = 88/272 (32%), Gaps = 63/272 (23%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+ ++G+G+F QV A N + +K+ K+
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLN--------------DAKNKQKF---------VLKV 102
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
K + I ++++ L+ + + F+N
Sbjct: 103 -------------------QKPANPWEFYIGTQLMERLKP---SMQHMFMKFYSAHLFQN 140
Query: 142 HLCISFELMN----LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
+ EL + LN L K + GL+ FA ++ + +H IIH D+KP
Sbjct: 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKP 200
Query: 198 ENVLLKQRG---------SSSIKVIDFGSSCYSH-----QRVYTYIQSRFYRSPEVILGL 243
+N +L S+ + +ID G S ++ ++ E++
Sbjct: 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK 260
Query: 244 PYGPPIDMWSLGCILAELYTGCPLFPGENEVE 275
P+ ID + + + + G + E
Sbjct: 261 PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 80/359 (22%), Positives = 142/359 (39%), Gaps = 94/359 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RY+ V+GKGSFG+VI D T ++ A K+
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITG-------------------QEC---------AVKV 58
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + Q K L EV++L L N++ + E+F +
Sbjct: 59 ISKRQVKQ-------------KTDKESLLREVQLLKQL------DHPNIMKLYEFFEDKG 99
Query: 142 HLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + E+ L++ I FS R ++ + +H+ I+H DLKPEN+
Sbjct: 100 YFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL 157
Query: 201 LLKQRGS-SSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
LL+ + ++I++IDFG S + + +++ I + +Y +PEV+ G Y D+WS G I
Sbjct: 158 LLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVI 216
Query: 258 LAELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
L L +GCP F G NE + I++ + F+ + ++K
Sbjct: 217 LYILLSGCPPFNGANEYD----ILKKVEKGKYT------------FELPQWKKVSESAK- 259
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSS 375
D + + + R++ +AL HEW+++ + S
Sbjct: 260 ----------------------DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVD 296
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 77/360 (21%), Positives = 129/360 (35%), Gaps = 97/360 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+Y I E +G+G FG V R ++ + + Y K
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSK-------------------KTY---------MAKF 37
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALI-EVRILDHLRKKDADSSYNVIHMLEYFYFR 140
K + E+ IL+ R + N++H+ E F
Sbjct: 38 ------------------VKVKGTDQVLVKKEISILNIARHR------NILHLHESFESM 73
Query: 141 NHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
L + FE ++ L+++E I + ++ + I + + + L+ LH NI H D++PEN
Sbjct: 74 EELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 200 VLLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
++ + R SS+IK+I+FG + + Y +PEV DMWSLG +
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS-KG 316
+ L +G F E + + I+ FD + I+
Sbjct: 193 VYVLLSGINPFLAETNQQIIE---NIMNAEYT------------FDEEAFKE-ISIEAM- 235
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSSH 376
DFV + + K R+T EAL+H WLK S+
Sbjct: 236 ----------------------DFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 82/363 (22%), Positives = 132/363 (36%), Gaps = 93/363 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RY I+ ++GKGSFG+V++ D T ++Y A K+
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQ-------------------QEY---------AVKV 54
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ S EV +L L N++ + E +
Sbjct: 55 INKASAKNKDTSTILR--------------EVELLKKLDHP------NIMKLFEILEDSS 94
Query: 142 HLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
I EL L++ I + FS R + + +H+ NI+H DLKPEN+
Sbjct: 95 SFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 201 LLKQRGS-SSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
LL+ + IK+IDFG S ++ I + +Y +PEV+ G Y D+WS G I
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVI 211
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
L L +G P F G+NE + L + FD ++K
Sbjct: 212 LYILLSGTPPFYGKNEYDILK---RVETGKYA------------FDLPQWRTISDDAK-- 254
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSSHH 377
D + + + R+T + L H W++ SS + + S
Sbjct: 255 ---------------------DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDL 293
Query: 378 ATD 380
+
Sbjct: 294 PSL 296
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 78/376 (20%), Positives = 135/376 (35%), Gaps = 96/376 (25%)
Query: 13 QVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIW 72
++ HDH+ Y+I E +G G+FG V R + T +
Sbjct: 149 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG-------------------NNF---- 185
Query: 73 YLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALI--EVRILDHLRKKDADSSYNV 130
A K + + E++ + LR +
Sbjct: 186 -----AAKF------------------VMTPHESDKETVRKEIQTMSVLRHP------TL 216
Query: 131 IHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN 189
+++ + F N + + +E M+ L+E + + + S + + + L +H N
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN 275
Query: 190 IIHCDLKPENVLLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGP 247
+H DLKPEN++ + S+ +K+IDFG + + Q V + + +PEV G P G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT 307
DMWS+G + L +G F GEN+ E L + C + D
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLR---NVKSCDWN------------MDDSAF 380
Query: 308 PRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367
I+ K DF+ + D R+T +AL H WL
Sbjct: 381 SG-ISED--------GK--------------DFIRKLLLADPNTRMTIHQALEHPWLTPG 417
Query: 368 SSSSSSSSHHATDLRK 383
++ S ++ K
Sbjct: 418 NAPGRDSQIPSSRYTK 433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 75/360 (20%), Positives = 125/360 (34%), Gaps = 91/360 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
YE+ E +G G F V + T ++Y A K
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTG-------------------KEY---------AAKF 37
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ LS + EV IL +R N+I + + F +
Sbjct: 38 IKKRRLSSSRRGVSREEIER----------EVNILREIRHP------NIITLHDIFENKT 81
Query: 142 HLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + EL++ L++ + + +F ++ + LH + I H DLKPEN+
Sbjct: 82 DVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139
Query: 201 LL--KQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
+L K + IK+IDFG + + + + +PE++ P G DMWS+G
Sbjct: 140 MLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS-K 315
I L +G F GE + E L I D FD + + K
Sbjct: 200 ITYILLSGASPFLGETKQETLT---NISAVNYD------------FDEEYFSN-TSELAK 243
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSS 375
DF+ + D K+R+T ++L H W+K+ +
Sbjct: 244 -----------------------DFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-37
Identities = 76/368 (20%), Positives = 123/368 (33%), Gaps = 91/368 (24%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y+I E +G G F V + + T +Y A K
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTG-------------------LEY---------AAKF 44
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + EV IL + NVI + + + R
Sbjct: 45 IKKRQSRASRRGVSREEIER----------EVSILRQVLHH------NVITLHDVYENRT 88
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + EL+ L++ + + S F ++ + LH + I H DLKPEN+
Sbjct: 89 DVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 201 LL--KQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
+L K IK+IDFG + + + +PE++ P G DMWS+G
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS-K 315
I L +G F G+ + E LA I D FD + + K
Sbjct: 207 ITYILLSGASPFLGDTKQETLA---NITSVSYD------------FDEEFFSH-TSELAK 250
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSS 375
DF+ + +++KRLT EALRH W+ + +
Sbjct: 251 -----------------------DFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVR 287
Query: 376 HHATDLRK 383
+ +
Sbjct: 288 RESVVNLE 295
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 73/365 (20%), Positives = 127/365 (34%), Gaps = 98/365 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y++ E +GKG+F V R + T ++ A KI
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTG-------------------LEF---------AAKI 61
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ LS E E RI L+ N++ + + +
Sbjct: 62 INTKKLSARDFQKLER--------------EARICRKLQHP------NIVRLHDSIQEES 101
Query: 142 HLCISFELMN---LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ F+L+ L +++ R Y S +++ + H I+H +LKPE
Sbjct: 102 FHYLVFDLVTGGEL-FEDIVAREFY---SEADASHCIQQILESIAYCHSNGIVHRNLKPE 157
Query: 199 NVLLKQRG-SSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255
N+LL + +++K+ DFG + + + + + Y SPEV+ PY P+D+W+ G
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 217
Query: 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS- 314
IL L G P F E++ A I + S +T
Sbjct: 218 VILYILLVGYPPFWDEDQHRLYAQIK---------------AGAYDYPSPEWDT-VTPEA 261
Query: 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSS 374
K + + KKR+T D+AL+ W+ + +S+
Sbjct: 262 K-----------------------SLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 298
Query: 375 SHHAT 379
T
Sbjct: 299 HRQDT 303
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 74/360 (20%), Positives = 124/360 (34%), Gaps = 93/360 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK- 80
Y+ E +G G F V + + T +Y A K
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTG-------------------LQY---------AAKF 43
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
I + S G E+ EV IL ++ NVI + E + +
Sbjct: 44 IKKRRTKSSRRGVSRED-----------IEREVSILKEIQHP------NVITLHEVYENK 86
Query: 141 NHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ + EL+ L++ + + F ++ + LH I H DLKPEN
Sbjct: 87 TDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 144
Query: 200 VLL--KQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255
++L + IK+IDFG + + + +PE++ P G DMWS+G
Sbjct: 145 IMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG 204
Query: 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS- 314
I L +G F G+ + E LA + + F+ + +
Sbjct: 205 VITYILLSGASPFLGDTKQETLA---NVSAVNYE------------FEDEYFSN-TSALA 248
Query: 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSS 374
K DF+ + D KKR+T ++L+H W+K + + S
Sbjct: 249 K-----------------------DFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS 285
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 74/370 (20%), Positives = 129/370 (34%), Gaps = 108/370 (29%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y++ E +GKG+F V R + T ++ A KI
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTG-------------------LEF---------AAKI 38
Query: 82 HGEESLSQNGGFDDENGSYNKKRFH---HQALI-EVRILDHLRKKDADSSYNVIHMLEYF 137
N K+ Q L E RI L+ N++ + +
Sbjct: 39 ------------------INTKKLSARDFQKLEREARICRKLQHP------NIVRLHDSI 74
Query: 138 YFRNHLCISFELMN---LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCD 194
+ + F+L+ L +++ R Y S +++ + H I+H +
Sbjct: 75 QEESFHYLVFDLVTGGEL-FEDIVAREFY---SEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 195 LKPENVLLKQRG-SSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDM 251
LKPEN+LL + +++K+ DFG + + + + + Y SPEV+ PY P+D+
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDI 190
Query: 252 WSLGCILAELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRC 310
W+ G IL L G P F E++ + I D + S
Sbjct: 191 WACGVILYILLVGYPPFWDEDQHR----LYAQIKAGAYD------------YPSPEWDT- 233
Query: 311 ITNS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369
+T K + + KKR+T D+AL+ W+ +
Sbjct: 234 VTPEAK-----------------------SLIDSMLTVNPKKRITADQALKVPWICNRER 270
Query: 370 SSSSSSHHAT 379
+S+ T
Sbjct: 271 VASAIHRQDT 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 79/371 (21%), Positives = 131/371 (35%), Gaps = 109/371 (29%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y++ E +GKG+F V R + + Y A I
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAG----QEY------------------------AAMI 43
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALI-EVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ LS HQ L E RI L+ N++ + +
Sbjct: 44 INTKKLS---------------ARDHQKLEREARICRLLKHP------NIVRLHDSISEE 82
Query: 141 NHLCISFELMN---LNLYELIKRNNYQGFS----LGLIRRFAFSLVQCLRLLHRENIIHC 193
H + F+L+ L +++ R Y S I+ +++ + H+ ++H
Sbjct: 83 GHHYLIFDLVTGGEL-FEDIVAREYY---SEADASHCIQ----QILEAVLHCHQMGVVHR 134
Query: 194 DLKPENVLLKQRG-SSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPI 249
+LKPEN+LL + +++K+ DFG + Q + + + Y SPEV+ PYG P+
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPV 194
Query: 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309
D+W+ G IL L G P F E++ I F S
Sbjct: 195 DLWACGVILYILLVGYPPFWDEDQHRLYQQIK---------------AGAYDFPSPEWDT 239
Query: 310 CITNS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368
+T K D + + + KR+T EAL+H W+ S
Sbjct: 240 -VTPEAK-----------------------DLINKMLTINPSKRITAAEALKHPWISHRS 275
Query: 369 SSSSSSSHHAT 379
+ +S T
Sbjct: 276 TVASCMHRQET 286
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 4e-36
Identities = 74/358 (20%), Positives = 135/358 (37%), Gaps = 96/358 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y+ILE +G G+FG V R ++ T + K
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATG-------------------RVF---------VAKF 83
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALI--EVRILDHLRKKDADSSYNVIHMLEYFYF 139
N + + E+ I++ L +I++ + F
Sbjct: 84 ------------------INTPYPLDKYTVKNEISIMNQLHHP------KLINLHDAFED 119
Query: 140 RNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ + + E ++ L++ I +Y+ S + + + L+ +H +I+H D+KPE
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE 178
Query: 199 NVLLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
N++ + + +SS+K+IDFG + + V + + +PE++ P G DMW++G
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
+ L +G F GE+++E L + C + FD S
Sbjct: 239 LGYVLLSGLSPFAGEDDLETLQ---NVKRCDWE------------FDEDAFSSV---SPE 280
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSS 374
K DF+ + +KRLT +AL H WLK S+ +S
Sbjct: 281 AK--------------------DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-36
Identities = 67/357 (18%), Positives = 119/357 (33%), Gaps = 99/357 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+ +EV+G G+F +V T + + A K
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTG-------------------KLF---------ALKC 41
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALI--EVRILDHLRKKDADSSYNVIHMLEYFYF 139
K + + E+ +L ++ + N++ + + +
Sbjct: 42 ------------------IKKSPAFRDSSLENEIAVLKKIKHE------NIVTLEDIYES 77
Query: 140 RNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
H + +L++ L++ I ++ ++ ++ LH I+H DLKPE
Sbjct: 78 TTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPE 135
Query: 199 NVLLKQRGS-SSIKVIDFG-SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
N+L S I + DFG S + + T + Y +PEV+ PY +D WS+G
Sbjct: 136 NLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS-K 315
I L G P F E E + I F+S I+ S K
Sbjct: 196 ITYILLCGYPPFYEETESKLFEKIK---------------EGYYEFESPFWDD-ISESAK 239
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSS 372
DF+ D +R T ++AL H W+ +++
Sbjct: 240 -----------------------DFICHLLEKDPNERYTCEKALSHPWIDGNTALHR 273
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 75/364 (20%), Positives = 123/364 (33%), Gaps = 91/364 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y+I E +G G F V + + T +Y A K
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTG-------------------LEY---------AAKF 44
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + EV IL + N+I + + + R
Sbjct: 45 IKKRQSRASRRGVCREEIER----------EVSILRQVLHP------NIITLHDVYENRT 88
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + EL+ L++ + + S F ++ + LH + I H DLKPEN+
Sbjct: 89 DVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 201 LL--KQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
+L K IK+IDFG + + + +PE++ P G DMWS+G
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS-K 315
I L +G F G+ + E LA I D FD + + + K
Sbjct: 207 ITYILLSGASPFLGDTKQETLA---NITAVSYD------------FDEEFFSQ-TSELAK 250
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSS 375
DF+ + +++KRLT EALRH W+ + +
Sbjct: 251 -----------------------DFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVR 287
Query: 376 HHAT 379
+
Sbjct: 288 RESV 291
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 56/365 (15%), Positives = 97/365 (26%), Gaps = 106/365 (29%)
Query: 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+ +V+G G+ G ++ N A K
Sbjct: 24 ISFCPKDVLGHGAEGTIVYR-GMFDN-------------------RDV---------AVK 54
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
A EV++L D NVI R
Sbjct: 55 RI-------------------LPECFSFADREVQLLRES-----DEHPNVIRYFCTEKDR 90
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
I+ EL L E +++ ++ L LH NI+H DLKP N+
Sbjct: 91 QFQYIAIELCAATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 201 LLKQRGSSS---IKVIDFGSSC------YSHQRVYTYIQSRFYRSPEVILGLP---YGPP 248
L+ + + DFG +S R + + +PE++
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209
Query: 249 IDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT 307
+D++S GC+ + + G F + R+
Sbjct: 210 VDIFSAGCVFYYVISEGSHPFGKSLQ------------------------RQANI----- 240
Query: 308 PRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367
S D + D + + + D +KR + L+H + S
Sbjct: 241 ----------LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290
Query: 368 SSSSS 372
Sbjct: 291 EKQLQ 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 82/353 (23%), Positives = 130/353 (36%), Gaps = 95/353 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RY I+ ++GKGSFG+V++ D T ++Y A K+
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQ-------------------QEY---------AVKV 54
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ S EV +L L N++ + E +
Sbjct: 55 INKASAKNKDTSTILR--------------EVELLKKLDHP------NIMKLFEILEDSS 94
Query: 142 HLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
I EL L++ I + FS R + + +H+ NI+H DLKPEN+
Sbjct: 95 SFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 201 LLKQRG-SSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
LL+ + IK+IDFG S + ++ I + +Y +PEV+ G Y D+WS G I
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVI 211
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS-KG 316
L L +G P F G+NE + L + FD I++ K
Sbjct: 212 LYILLSGTPPFYGKNEYDILK---RVETGKYA------------FDLPQWRT-ISDDAK- 254
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369
D + + + R+T + L H W++ SS
Sbjct: 255 ----------------------DLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 77/355 (21%), Positives = 119/355 (33%), Gaps = 97/355 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y + IG+GS+G+V A+ T A K I KY
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK------------IPKY-----------F 46
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ + Q E+ I+ L N+I + E F
Sbjct: 47 VEDVDRFKQ----------------------EIEIMKSLDHP------NIIRLYETFEDN 78
Query: 141 NHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ + EL L+E + F R ++ + H+ N+ H DLKPEN
Sbjct: 79 TDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPEN 136
Query: 200 VLLKQRGS-SSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
L S +K+IDFG + + + T + + +Y SP+V+ G YGP D WS G
Sbjct: 137 FLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGV 195
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
++ L G P F + E + +I F K S
Sbjct: 196 MMYVLLCGYPPFSAPTDSEVML---KIREGTFT------------FPEKDWLNV---SPQ 237
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
+ + + K+R+T +AL HEW + SSS
Sbjct: 238 AE--------------------SLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 72/365 (19%), Positives = 111/365 (30%), Gaps = 99/365 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALK--YYGNQLTEFERTEIEKYLEIWYLGLDA 78
+ I + IG+G F +V RA ALK + + R + K
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK----------- 81
Query: 79 CKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY 138
E+ +L L NVI F
Sbjct: 82 ---------------------------------EIDLLKQLN------HPNVIKYYASFI 102
Query: 139 FRNHLCISFELM-NLNLYELIKRNNYQG--FSLGLIRRFAFSLVQCLRLLHRENIIHCDL 195
N L I EL +L +IK Q + ++ L L +H ++H D+
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDI 162
Query: 196 KPENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252
KP NV + G +K+ D G + ++ + + +Y SPE I Y D+W
Sbjct: 163 KPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
SLGC+L E+ F G+ + +I C +
Sbjct: 221 SLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPPL--------------------- 258
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSS 372
D S + V C N D +KR + ++SS
Sbjct: 259 ----------PSDHYS------EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302
Query: 373 SSSHH 377
HH
Sbjct: 303 LEHHH 307
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 66/355 (18%), Positives = 112/355 (31%), Gaps = 101/355 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+ +G G+FG V + + +K I K +
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKT------------INKD-----------R 59
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ E+ +L L N+I + E F
Sbjct: 60 SQVPMEQIEA---------------------EIEVLKSLDHP------NIIKIFEVFEDY 92
Query: 141 NHLCISFELMN---LNLYELIKRNNYQG-FSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
+++ I E L L ++ S G + ++ L H ++++H DLK
Sbjct: 93 HNMYIVMETCEGGEL-LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLK 151
Query: 197 PENVLLKQRG-SSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253
PEN+L + S IK+IDFG + S + + Y +PEV D+WS
Sbjct: 152 PENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWS 210
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
G ++ L TGC F G + E + P+ + + R +T
Sbjct: 211 AGVVMYFLLTGCLPFTGTSLEEVQQ---KATYKEPN------------YAVE--CRPLTP 253
Query: 314 S-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367
D + Q D ++R + + L HEW K +
Sbjct: 254 QAV-----------------------DLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 76/360 (21%), Positives = 124/360 (34%), Gaps = 93/360 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
YE E++G+G V R + T ++Y A KI
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTC-------------------KEY---------AVKI 49
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + + EV IL + N+I + + +
Sbjct: 50 IDVTGGGSFSAEEVQELREATLK-------EVDILRKVSGHP-----NIIQLKDTYETNT 97
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ F+LM L++ + S R+ +L++ + LH+ NI+H DLKPEN+
Sbjct: 98 FFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENI 155
Query: 201 LLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGL------PYGPPIDMW 252
LL +IK+ DFG SC +++ + Y +PE+I YG +DMW
Sbjct: 156 LLD--DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 213
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
S G I+ L G P F ++ L IM F S +
Sbjct: 214 STGVIMYTLLAGSPPFWHRKQMLMLRMIM---------------SGNYQFGSPEWDD-YS 257
Query: 313 NS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
++ K D V++ +KR T +EAL H + +
Sbjct: 258 DTVK-----------------------DLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 76/360 (21%), Positives = 132/360 (36%), Gaps = 96/360 (26%)
Query: 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y E++G G FGQV + + T LK A K
Sbjct: 89 YTVSKTEILGGGRFGQVHKCEETATG---LKL-------------------------AAK 120
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALI--EVRILDHLRKKDADSSYNVIHMLEYFY 138
I + + + E+ +++ L N+I + + F
Sbjct: 121 I------------------IKTRGMKDKEEVKNEISVMNQLDHA------NLIQLYDAFE 156
Query: 139 FRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
+N + + E ++ L++ I +Y + F + + +R +H+ I+H DLKP
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMHQMYILHLDLKP 215
Query: 198 ENVLLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255
EN+L R + IK+IDFG + +++ + + +PEV+ P DMWS+G
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVG 275
Query: 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315
I L +G F G+N+ E L IL C D + + S+
Sbjct: 276 VIAYMLLSGLSPFLGDNDAETLN---NILACRWD------------LEDEEFQDI---SE 317
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSS 375
K +F+++ + R++ EAL+H WL S S+
Sbjct: 318 EAK--------------------EFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSA 357
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-34
Identities = 59/346 (17%), Positives = 105/346 (30%), Gaps = 96/346 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
++ L +G GS+G+V + + + Y A K
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDG----RLY------------------------AVK- 88
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
S+S G D + L EV + + + + + + +
Sbjct: 89 ---RSMSPFRGPKDRA----------RKLAEVGSHEKVGQ-----HPCCVRLEQAWEEGG 130
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + EL +L + + + + + L LH + ++H D+KP N+
Sbjct: 131 ILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 202 LKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILA 259
L RG K+ DFG + Y +PE++ G YG D++SLG +
Sbjct: 190 LGPRG--RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTIL 246
Query: 260 ELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319
E+ L G +QL R+ + + T
Sbjct: 247 EVACNMELPHGGEGWQQL--------------------RQGYLPPEFTAGL--------- 277
Query: 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
S + + D K R T + L L+
Sbjct: 278 ---SSE-----------LRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-34
Identities = 66/372 (17%), Positives = 120/372 (32%), Gaps = 100/372 (26%)
Query: 22 RYEIL-EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y + + +G+G F V + + T ++Y A K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTG-------------------QEY---------AAK 60
Query: 81 IHGEESLSQNGGFDDENGSYNKKRF----HHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
K+R + L E+ +L+ S VI++ E
Sbjct: 61 F------------------LKKRRRGQDCRAEILHEIAVLELA-----KSCPRVINLHEV 97
Query: 137 FYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDL 195
+ + + + E ++ L + S + R +++ + LH+ NI+H DL
Sbjct: 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDL 157
Query: 196 KPENVLLKQRGS-SSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252
KP+N+LL IK++DFG S + + + Y +PE++ P DMW
Sbjct: 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMW 217
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
++G I L T F GE+ E I D + + ++
Sbjct: 218 NIGIIAYMLLTHTSPFVGEDNQETYL---NISQVNVD------------YSEETFSS-VS 261
Query: 313 NS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
DF+ + +KR T + L H WL+ +
Sbjct: 262 QLAT-----------------------DFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298
Query: 372 SSSSHHATDLRK 383
+ +
Sbjct: 299 LFHPEETSSSSQ 310
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-34
Identities = 78/376 (20%), Positives = 126/376 (33%), Gaps = 105/376 (27%)
Query: 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGL 76
D + +E+ +G+G+ V R T K Y
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQ----KPY----------------------- 81
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
A K K E+ +L L N+I + E
Sbjct: 82 -ALK------------------VLKKTVDKKIVRTEIGVLLRLSHP------NIIKLKEI 116
Query: 137 FYFRNHLCISFELMN-LNLYELIKRNNYQGFS----LGLIRRFAFSLVQCLRLLHRENII 191
F + + EL+ L++ I Y +S ++ +++ + LH I+
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVK----QILEAVAYLHENGIV 170
Query: 192 HCDLKPENVLLKQRGS-SSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYGPP 248
H DLKPEN+L + +K+ DFG S + T + Y +PE++ G YGP
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTP 308
+DMWS+G I L G F E + + IL C F S
Sbjct: 231 VDMWSVGIITYILLCGFEPFYDERGDQFM--FRRILNCEYY------------FISPWWD 276
Query: 309 RCITNS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367
++ + K D V + D KKRLT +AL+H W+
Sbjct: 277 E-VSLNAK-----------------------DLVRKLIVLDPKKRLTTFQALQHPWVTGK 312
Query: 368 SSSSSSSSHHATDLRK 383
+++ L++
Sbjct: 313 AANFVHMDTAQKKLQE 328
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-34
Identities = 68/376 (18%), Positives = 119/376 (31%), Gaps = 100/376 (26%)
Query: 22 RYEIL-EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y++ +V+G G G+V+ +T +K A K
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTG-------------------QKC---------ALK 60
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF--- 137
+ D S ++ EV +++ +L+ +
Sbjct: 61 L-----------LYD---SPKARQ-------EVDHHWQASGGP-----HIVCILDVYENM 94
Query: 138 -YFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDL 195
+ + L I E M L+ I+ Q F+ + ++ LH NI H D+
Sbjct: 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDV 154
Query: 196 KPENVLLK-QRGSSSIKVIDFG-SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253
KPEN+L + + +K+ DFG + + + T + +Y +PEV+ Y DMWS
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWS 214
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
LG I+ L G P F + I F + ++
Sbjct: 215 LGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG------------FPNPEWSE-VS 261
Query: 313 NS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
K + D +RLT + + H W+ S
Sbjct: 262 EDAK-----------------------QLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
Query: 372 SSSSHHATDLRKSPSA 387
+ H A L++
Sbjct: 299 QTPLHTARVLQEDKDH 314
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 77/384 (20%), Positives = 130/384 (33%), Gaps = 113/384 (29%)
Query: 22 RYEIL---EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDA 78
Y++ + +G+GSF + + K+N + + A
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSN-------------------QAF---------A 40
Query: 79 CKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY 138
KI KR E+ L N++ + E F+
Sbjct: 41 VKII-------------------SKRMEANTQKEITALKLCEGHP-----NIVKLHEVFH 76
Query: 139 FRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFS----------LVQCLRLLHRE 188
+ H + EL+N EL +R + ++ FS LV + +H
Sbjct: 77 DQLHTFLVMELLNGG--ELFER---------IKKKKHFSETEASYIMRKLVSAVSHMHDV 125
Query: 189 NIIHCDLKPENVLLK-QRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLP 244
++H DLKPEN+L + + IK+IDFG + +Q + T + Y +PE++
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185
Query: 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDS 304
Y D+WSLG IL + +G F + +EI+ + I F+
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG---DFSFEG 237
Query: 305 KGTPRCITNS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
+ ++ K D + D KRL +EW
Sbjct: 238 EAWKN-VSQEAK-----------------------DLIQGLLTVDPNKRLKMSGLRYNEW 273
Query: 364 LKSSSSSSSSSSHHATDLRKSPSA 387
L+ S SS+ L S +A
Sbjct: 274 LQDGSQLSSNPLMTPDILGSSGAA 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 56/370 (15%), Positives = 104/370 (28%), Gaps = 94/370 (25%)
Query: 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLD 77
+ + + +++G+G+ V R KT A+K F + +++
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIK-------VFNNISFLRPVDVQ----- 54
Query: 78 ACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF 137
R E +L L K N++ +
Sbjct: 55 -------------------------MR-------EFEVLKKLNHK------NIVKLFAIE 76
Query: 138 YFRNH--------LCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN 189
C L L + +N G +V + L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYT----VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 190 IIHCDLKPENVLL--KQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGL-- 243
I+H ++KP N++ + G S K+ DFG++ ++ + + Y P++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 244 ------PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME--ILGCPPDEVINTA 295
YG +D+WS+G TG F + +M I G P +
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 296 SRRRLFFD-SKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT 354
D S P + S+G + + D +K
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVL----------------LTPVLANILEADQEKCWG 296
Query: 355 PDEALRHEWL 364
D+
Sbjct: 297 FDQFFAETSD 306
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 65/358 (18%), Positives = 113/358 (31%), Gaps = 106/358 (29%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
YE+L IG GS+G+ + K E+ Y +
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWK------------------ELDYGSMTE-- 46
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
++ + EV +L L+ N++ + R
Sbjct: 47 ---------------------AEK--QMLVSEVNLLRELK------HPNIVRYYDRIIDR 77
Query: 141 --NHLCISFELMNL-NLYELIKRNNYQG--FSLGLIRRFAFSLVQCLRLLHREN-----I 190
L I E +L +I + + + R L L+ HR + +
Sbjct: 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 137
Query: 191 IHCDLKPENVLLKQRGSSSIKVIDFGSS-CYSHQRVY--TYIQSRFYRSPEVILGLPYGP 247
+H DLKP NV L + + +K+ DFG + +H + T++ + +Y SPE + + Y
Sbjct: 138 LHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNE 195
Query: 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT 307
D+WSLGC+L EL P F + Q +I + S
Sbjct: 196 KSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREGKFRRIPYRYS----------- 241
Query: 308 PRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
+ +T+ N R + +E L + +
Sbjct: 242 ---------------------------DELNEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 68/355 (19%), Positives = 124/355 (34%), Gaps = 60/355 (16%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+E + +G G+ G V + + A K I
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARK----------------------------LI 66
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
H E K +Q + E+++L + +S Y ++ FY
Sbjct: 67 HLEI----------------KPAIRNQIIRELQVL-----HECNSPY-IVGFYGAFYSDG 104
Query: 142 HLCISFELMNLN-LYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKPEN 199
+ I E M+ L +++K+ ++ + + ++++ L L + I+H D+KP N
Sbjct: 105 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 162
Query: 200 VLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
+L+ RG IK+ DFG S +++ +R Y SPE + G Y D+WS+G L
Sbjct: 163 ILVNSRGE--IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 220
Query: 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
E+ G P + E + E + G +
Sbjct: 221 VEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL 280
Query: 319 RKPGSKDMASVLRCND--KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
+ L F DFV +C + +R + + H ++K S +
Sbjct: 281 LDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 55/369 (14%), Positives = 112/369 (30%), Gaps = 70/369 (18%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIW-------YL 74
+E ++ +G+G FG V A + + + A+K E R ++ + ++ +
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 75 GLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHML 134
+ Q + + +R+ D S+ N + L
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 135 EYFYFRNHLCISFELM-NLNLYELIKRNNYQGF-SLGLIRRFAFSLVQCLRLLHRENIIH 192
+ + +L I +L NL + + R G+ + + + LH + ++H
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187
Query: 193 CDLKPENVLLKQRGSSSIKVIDFG---------------SSCYSHQRVYTYIQSRFYRSP 237
DLKP N+ +KV DFG + ++ + ++ Y SP
Sbjct: 188 RDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 238 EVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASR 297
E I G Y +D++SLG IL EL V + + +
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELL--YSFSTQMERVRIITDVRNL-------------- 289
Query: 298 RRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDE 357
+ V + +R +
Sbjct: 290 ---------------------------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322
Query: 358 ALRHEWLKS 366
+ + ++
Sbjct: 323 IIENAIFEN 331
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 72/363 (19%), Positives = 122/363 (33%), Gaps = 102/363 (28%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+E + V+G+G+FGQV++A + + + A+K + TE + + I E+ L
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILS--EVMLL------- 56
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+HQ + VR ++ N + + ++
Sbjct: 57 ---------------------ASLNHQYV--VRYYAAWLERR-----NFVKPMTAVKKKS 88
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L I E N LY+LI N R +++ L +H + IIH DLKP N+
Sbjct: 89 TLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNI 147
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRVY-----------------TYIQSRFYRSPEVILGL 243
+ + ++K+ DFG + H+ + + I + Y + EV+ G
Sbjct: 148 FIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205
Query: 244 P-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFF 302
Y IDM+SLG I E+ P G V L + + P + +
Sbjct: 206 GHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKM------ 257
Query: 303 DSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHE 362
K + + D KR L
Sbjct: 258 --------------------------------KVEKKIIRLLIDHDPNKRPGARTLLNSG 285
Query: 363 WLK 365
WL
Sbjct: 286 WLP 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 57/352 (16%), Positives = 102/352 (28%), Gaps = 91/352 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
++ +E+IG G FGQV +A +K ++ + E+ E+ K
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIK-----RVKYNNEKAER--EV--------K 56
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ H + V D
Sbjct: 57 AL--------------------AKLDHVNI--VHYNGCW--DGFDYDPETSSKNSSRSKT 92
Query: 141 NHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
L I E L + I++ + L + + + +H + +I+ DLKP N
Sbjct: 93 KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSN 152
Query: 200 VLLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
+ L +K+ DFG + + + Y SPE I YG +D+++LG I
Sbjct: 153 IFLVDTKQ--VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
LAEL C ++ ++ ++
Sbjct: 211 LAELLHVCDTAFETSKF-----FTDLRDGIISDIF------------------------- 240
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369
DK + + + + R E LR + S
Sbjct: 241 ----------------DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 72/370 (19%), Positives = 117/370 (31%), Gaps = 70/370 (18%)
Query: 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLD 77
C +E+ E +G G FG V+R + T A+K +L+ R EI +
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL--EIQIM--- 66
Query: 78 ACKIHGEESLSQNGGFDDENGSYNKKRFHHQ---ALIEVRILDHLRKKDADSSYNVIHML 134
K+ +H + EV + D +
Sbjct: 67 -------------------------KKLNHPNVVSAREV-PDGLQKLAPNDLPLLA---M 97
Query: 135 EYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCD 194
EY C +L L + N G G IR + LR LH IIH D
Sbjct: 98 EY-------CEGGDLRKY----LNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRD 146
Query: 195 LKPENVLLKQRGSSS-IKVIDFGSSCYSHQRVY--TYIQSRFYRSPEVILGLPYGPPIDM 251
LKPEN++L+ K+ID G + Q ++ + Y +PE++ Y +D
Sbjct: 147 LKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDY 206
Query: 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311
WS G + E TG F + Q + R +
Sbjct: 207 WSFGTLAFECITGFRPFLPNWQPVQWHGKV---------------REKSNEHIVVYDDLT 251
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
K P ++ +L ++ W ++R T + ++ S
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGK---LERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308
Query: 372 SSSSHHATDL 381
S ++
Sbjct: 309 SLKLLSVMNM 318
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 40/375 (10%), Positives = 89/375 (23%), Gaps = 91/375 (24%)
Query: 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDAC 79
V+G+ + A D +T +
Sbjct: 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHV-----------------------PYFT 109
Query: 80 KIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF-- 137
+ ++ Q + QA + +R + +I +
Sbjct: 110 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 169
Query: 138 YFRNHLCISFELMNLNLYELI-----KRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIH 192
+ + M NL + ++ + +++ L LH ++H
Sbjct: 170 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229
Query: 193 CDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVIL----------- 241
L+P +++L QRG + + F SR + PE+
Sbjct: 230 TYLRPVDIVLDQRG--GVFLTGFEHLV-RDGARVVSSVSRGFEPPELEARRATISYHRDR 286
Query: 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLF 301
D W+LG ++ ++ + + I P V
Sbjct: 287 RTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPV---------- 336
Query: 302 FDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
+ + + RL P +A+
Sbjct: 337 ------------------------------------RALLEGFLRYPKEDRLLPLQAMET 360
Query: 362 EWLKSSSSSSSSSSH 376
+ + S++
Sbjct: 361 PEYEQLRTELSAALP 375
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 70/387 (18%), Positives = 137/387 (35%), Gaps = 109/387 (28%)
Query: 22 RYEIL-EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y++ +V+G G G+V++ + +T EK+ A K
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQ-------------------EKF---------ALK 93
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF--- 137
+ D +R EV + + +++ +++ +
Sbjct: 94 M-----------LQD---CPKARR-------EVELHWRASQCP-----HIVRIVDVYENL 127
Query: 138 -YFRNHLCISFELMN-LNLYELIKRNNYQGFS----LGLIRRFAFSLVQCLRLLHRENII 191
R L I E ++ L+ I+ Q F+ +++ S+ + ++ LH NI
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK----SIGEAIQYLHSINIA 183
Query: 192 HCDLKPENVLLK-QRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPP 248
H D+KPEN+L +R ++ +K+ DFG + SH + T + +Y +PEV+ Y
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 243
Query: 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGT 307
DMWSLG I+ L G P F + + + I + F +
Sbjct: 244 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE------------FPNPEW 291
Query: 308 PRCITNS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
++ K + + +R+T E + H W+
Sbjct: 292 SE-VSEEVK-----------------------MLIRNLLKTEPTQRMTITEFMNHPWIMQ 327
Query: 367 SSSSSSSSSHHATDLRKSPSAHTNMYR 393
S+ + H + L++ ++
Sbjct: 328 STKVPQTPLHTSRVLKEDKERWEDVKE 354
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 71/357 (19%), Positives = 130/357 (36%), Gaps = 100/357 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+Y+ +VIG+G V R + T ++ A KI
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATG-------------------HEF---------AVKI 126
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + E +R E IL + ++I +++ + +
Sbjct: 127 MEVTAERLSPE-QLEEVREATRR-------ETHILRQVAGHP-----HIITLIDSYESSS 173
Query: 142 HLCISFELMN---LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ + F+LM L L ++ S R SL++ + LH NI+H DLKPE
Sbjct: 174 FMFLVFDLMRKGEL-FDYLTEKVAL---SEKETRSIMRSLLEAVSFLHANNIVHRDLKPE 229
Query: 199 NVLLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGL------PYGPPID 250
N+LL + I++ DFG SC+ +++ + Y +PE++ YG +D
Sbjct: 230 NILLD--DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 251 MWSLGCILAELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPR 309
+W+ G IL L G P F ++ ++ I+ F S
Sbjct: 288 LWACGVILFTLLAGSPPFWHRRQIL----MLRMIMEGQYQ------------FSSPEWDD 331
Query: 310 CITNS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
+++ K D +++ D + RLT ++AL+H + +
Sbjct: 332 -RSSTVK-----------------------DLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-31
Identities = 74/391 (18%), Positives = 127/391 (32%), Gaps = 122/391 (31%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
YE+ E IG GS+ R + TN ++ A KI
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATN-------------------MEF---------AVKI 54
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+K + E+ IL + N+I + + +
Sbjct: 55 ------------------IDKSK--RDPTEEIEILLRYGQHP-----NIITLKDVYDDGK 89
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFS----------LVQCLRLLHRENII 191
++ + ELM EL+ + ++R+ FS + + + LH + ++
Sbjct: 90 YVYVVTELMKGG--ELLDK---------ILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 192 HCDLKPENVLL--KQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPYG 246
H DLKP N+L + SI++ DFG + + + T + + +PEV+ Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD 198
Query: 247 PPIDMWSLGCILAELYTGCPLF---PGENEVEQLACIMEILGCPPDEVINTASRRRLFFD 303
D+WSLG +L + TG F P + E LA I G +
Sbjct: 199 AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS--G-------------KFSLS 243
Query: 304 SKGTPRCITNS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHE 362
++++ K D V++ + D +RLT LRH
Sbjct: 244 GGYWNS-VSDTAK-----------------------DLVSKMLHVDPHQRLTAALVLRHP 279
Query: 363 WLKSSSSSSSSSSHHATDLRKSPSAHTNMYR 393
W+ + A Y
Sbjct: 280 WIVHWDQLPQYQLNRQDAPHLVKGAMAATYS 310
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 59/362 (16%), Positives = 100/362 (27%), Gaps = 106/362 (29%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+G+GSFG+V R D +T G Q A K
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQT--------GFQC--------------------AVKK 90
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
E E+ L S ++ +
Sbjct: 91 VRLEVFRVE---------------------ELVACAGLS------SPRIVPLYGAVREGP 123
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ I EL+ +L +LIK+ + ++ L LH I+H D+K +NV
Sbjct: 124 WVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 201 LLKQRGSSSIKVIDFGSS--------CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252
LL GS + DFG + S + + +PEV++G P +D+W
Sbjct: 182 LLSSDGSR-AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
S C++ + GC + + + ++I PP
Sbjct: 241 SSCCMMLHMLNGCHPWT---QYFRGPLCLKIASEPPP----------------------- 274
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSS 372
+ + + + R + E R
Sbjct: 275 -------IREIPPSCA------PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
Query: 373 SS 374
S
Sbjct: 322 KS 323
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-31
Identities = 56/369 (15%), Positives = 103/369 (27%), Gaps = 94/369 (25%)
Query: 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLD 77
+ + + +++G+G+ V R KT A+K F + +++
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIK-------VFNNISFLRPVDVQ----- 54
Query: 78 ACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF 137
R E +L L K N++ +
Sbjct: 55 -------------------------MR-------EFEVLKKLNHK------NIVKLFAIE 76
Query: 138 YFRNH--------LCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN 189
C L L + +N G +V + L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYT----VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 190 IIHCDLKPENVLLKQR--GSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGL-- 243
I+H ++KP N++ G S K+ DFG++ ++ + + Y P++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 244 ------PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME--ILGCPPDEVINTA 295
YG +D+WS+G TG F + +M I G P +
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 296 SRRRLFFD-SKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT 354
D S P + S+G + + D +K
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVL----------------LTPVLANILEADQEKCWG 296
Query: 355 PDEALRHEW 363
D+
Sbjct: 297 FDQFFAETS 305
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 76/358 (21%), Positives = 120/358 (33%), Gaps = 99/358 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+EI +GKG FG V A + ++ ALK L +
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKV-----------------------LFKAQ 46
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ K HQ EV I HLR N++ + YF+
Sbjct: 47 LE-------------------KAGVEHQLRREVEIQSHLRHP------NILRLYGYFHDA 81
Query: 141 NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ + E L +Y +++ F + L L H + +IH D+KPEN
Sbjct: 82 TRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 139
Query: 200 VLLKQRGSSSIKVIDFGSSCYS-HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
+LL G +K+ DFG S ++ R + Y PE+I G + +D+WSLG +
Sbjct: 140 LLLGSAGE--LKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197
Query: 259 AELYTGCPLFPGENEVEQLACIMEI-LGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
E G P F E I + P F
Sbjct: 198 YEFLVGKPPFEANTYQETYKRISRVEFTFPD------------FVT-------------- 231
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSS 375
G++ D +++ + +R E L H W+ ++SS S+
Sbjct: 232 ---EGAR--------------DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQ 272
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 76/358 (21%), Positives = 119/358 (33%), Gaps = 89/358 (24%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y + + +G G+ G+V A + KT +K A +I
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTC-------------------KKV---------AIRI 167
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + + + E+ IL L +I + F+
Sbjct: 168 ISKRKFAIGSAREADP--------ALNVETEIEILKKLNHP------CIIKIKN-FFDAE 212
Query: 142 HLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
I ELM L++ + N + + + ++ ++ LH IIH DLKPENV
Sbjct: 213 DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV 270
Query: 201 LLKQRGS-SSIKVIDFGSS--CYSHQRVYTYIQSRFYRSPEVILGL---PYGPPIDMWSL 254
LL + IK+ DFG S + T + Y +PEV++ + Y +D WSL
Sbjct: 271 LLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314
G IL +G P F L +I + F + S
Sbjct: 331 GVILFICLSGYPPFSEHRTQVSLK--DQIT------------SGKYNFIPEVWAEV---S 373
Query: 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSS 372
+ D V + D K R T +EALRH WL+
Sbjct: 374 EKAL--------------------DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 411
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 77/370 (20%), Positives = 124/370 (33%), Gaps = 89/370 (24%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y + + +G G+ G+V A + KT +K A KI
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTC-------------------KKV---------AIKI 42
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + + + E+ IL L +I + +F +
Sbjct: 43 ISKRKFAIGSAREADP--------ALNVETEIEILKKLNHP------CIIKIKNFFDAED 88
Query: 142 HLCISFELMNLN-LYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ I ELM L++ + N + + + ++ ++ LH IIH DLKPENV
Sbjct: 89 Y-YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV 145
Query: 201 LLKQRGS-SSIKVIDFGSS--CYSHQRVYTYIQSRFYRSPEVILGL---PYGPPIDMWSL 254
LL + IK+ DFG S + T + Y +PEV++ + Y +D WSL
Sbjct: 146 LLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 205
Query: 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314
G IL +G P F L +I + F + S
Sbjct: 206 GVILFICLSGYPPFSEHRTQVSLK--DQITSG------------KYNFIPEVWAEV---S 248
Query: 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSS 374
+ D V + D K R T +EALRH WL+
Sbjct: 249 EKAL--------------------DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288
Query: 375 SHHATDLRKS 384
+ + +
Sbjct: 289 DLLSEENEST 298
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 69/372 (18%), Positives = 122/372 (32%), Gaps = 103/372 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+Y++ ++G G FG V + N A+K+ E+ I + E+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH-------VEKDRISDWGELPNGT----R 92
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ EV +L + + VI +L++F
Sbjct: 93 V---------------------PM-------EVVLLKKVSSGFS----GVIRLLDWFERP 120
Query: 141 NHLCISFELMNLN--LYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ + E L++ I L R F + +++ +R H ++H D+K E
Sbjct: 121 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 178
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQRVY-TYIQSRFYRSPEVILGLPY-GPPIDMWSLGC 256
N+L+ +K+IDFGS VY + +R Y PE I Y G +WSLG
Sbjct: 179 NILIDLN-RGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
+L ++ G F + E+ +G
Sbjct: 238 LLYDMVCGDIPFEHDEEI---------------------------------------IRG 258
Query: 317 RKRKPG--SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSS 374
+ S + ++R C R T +E H W++ ++
Sbjct: 259 QVFFRQRVSSECQHLIR-----------WCLALRPSDRPTFEEIQNHPWMQDVLLPQETA 307
Query: 375 SHHATDLRKSPS 386
H L PS
Sbjct: 308 EIHLHSLSPGPS 319
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 71/373 (19%), Positives = 115/373 (30%), Gaps = 102/373 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RY +GKG F + D T E + A KI
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTK-------------------EVF---------AGKI 47
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ L K + +E+ I L + +V+ +F +
Sbjct: 48 VPKSLLL-------------KPHQREKMSMEISIHRSLAHQ------HVVGFHGFFEDND 88
Query: 142 HLCISFEL-MNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + EL +L EL KR + + R + +V + LHR +IH DLK N+
Sbjct: 89 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146
Query: 201 LLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
L + +K+ DFG + +R + Y +PEV+ + +D+WS+GCI
Sbjct: 147 FLNEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCI 204
Query: 258 LAELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
+ L G P F E I + P IN +
Sbjct: 205 MYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAA------------------- 243
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS---SSSSSS 373
+ + D R T +E L E+ S + +
Sbjct: 244 ----------------------SLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPIT 281
Query: 374 SSHHATDLRKSPS 386
+PS
Sbjct: 282 CLTIPPRFSIAPS 294
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 76/348 (21%), Positives = 119/348 (34%), Gaps = 99/348 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
++I +GKG FG V A + + ALK L +
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKV-----------------------LFKSQ 51
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ K+ HQ E+ I HLR N++ M YF+ R
Sbjct: 52 L-------------------EKEGVEHQLRREIEIQSHLRHP------NILRMYNYFHDR 86
Query: 141 NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ + E LY+ ++++ F F L L H +IH D+KPEN
Sbjct: 87 KRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERKVIHRDIKPEN 144
Query: 200 VLLKQRGSSSIKVIDFGSSCYS-HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
+L+ +G +K+ DFG S ++ R T + Y PE+I G + +D+W G +
Sbjct: 145 LLMGYKGE--LKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202
Query: 259 AELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
E G P F + E I+ L PP F
Sbjct: 203 YEFLVGMPPFDSPSHTETHRRIVNVDLKFPP------------FLS-------------- 236
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
GSK D +++ + +RL + H W+K
Sbjct: 237 ---DGSK--------------DLISKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 67/378 (17%), Positives = 106/378 (28%), Gaps = 121/378 (32%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+++G GS G V+ A K
Sbjct: 16 LVVSEKILGYGSSGTVVFQ-GSFQG-------------------RPV---------AVKR 46
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
F AL+E+++L D NVI
Sbjct: 47 M-------------------LIDFCDIALMEIKLLTES-----DDHPNVIRYYCSETTDR 82
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGL-----IRRFAFSLVQCLRLLHRENIIHCDLK 196
L I+ EL NLNL +L++ N +L L + + LH IIH DLK
Sbjct: 83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 197 PENVLLKQRGSSS-----------IKVIDFGSS-------CYSHQRVYTYIQSRFYRSPE 238
P+N+L+ + I + DFG + + +R+PE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
Query: 239 VILGL-------PYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDE 290
++ ID++S+GC+ + + G F + E I+
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-----NII------ 251
Query: 291 VINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSK 350
R D + D ++Q + D
Sbjct: 252 ------RGIFSLDEMKCLHDRSLIAEAT--------------------DLISQMIDHDPL 285
Query: 351 KRLTPDEALRHEWLKSSS 368
KR T + LRH S
Sbjct: 286 KRPTAMKVLRHPLFWPKS 303
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 69/350 (19%), Positives = 110/350 (31%), Gaps = 99/350 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RY +GKG F + D T E + A KI
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTK-------------------EVF---------AGKI 73
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ L K + +E+ I L + +V+ +F +
Sbjct: 74 VPKSLLL-------------KPHQREKMSMEISIHRSLAHQ------HVVGFHGFFEDND 114
Query: 142 HLCISFEL-MNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + EL +L EL KR + + R + +V + LHR +IH DLK N+
Sbjct: 115 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172
Query: 201 LLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
L + +K+ DFG + +R + Y +PEV+ + +D+WS+GCI
Sbjct: 173 FLNEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCI 230
Query: 258 LAELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
+ L G P F E I + P IN +
Sbjct: 231 MYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAA------------------- 269
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + D R T +E L E+ S
Sbjct: 270 ----------------------SLIQKMLQTDPTARPTINELLNDEFFTS 297
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 72/381 (18%), Positives = 133/381 (34%), Gaps = 116/381 (30%)
Query: 22 RYEIL-EVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y++ +V+G+G+ +V ++ T+ ++Y A K
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITS-------------------QEY---------AVK 44
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALI--EVRILDHLRKKDADSSYNVIHMLEYFY 138
I K+ H ++ + EV +L + NV+ ++E+F
Sbjct: 45 I------------------IEKQPGHIRSRVFREVEMLYQCQGHR-----NVLELIEFFE 81
Query: 139 FRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFS----------LVQCLRLLHRE 188
+ + FE M ++ + +R F+ + L LH +
Sbjct: 82 EEDRFYLVFEKMRGG--SILSH---------IHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 189 NIIHCDLKPENVLLKQRGS-SSIKVIDFG-SSCYSHQRVYTYIQSR---------FYRSP 237
I H DLKPEN+L + S +K+ DF S + I + Y +P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 238 EVILGL-----PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVI 292
EV+ Y D+WSLG IL L +G P F G + E + +
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 293 NTASRRRLFFDSKGTPRCITNS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKK 351
+ + F K I+ + K D +++ D+K+
Sbjct: 251 ESIQEGKYEFPDKDWAH-ISCAAK-----------------------DLISKLLVRDAKQ 286
Query: 352 RLTPDEALRHEWLKSSSSSSS 372
RL+ + L+H W++ + ++
Sbjct: 287 RLSAAQVLQHPWVQGCAPENT 307
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 49/417 (11%), Positives = 109/417 (26%), Gaps = 104/417 (24%)
Query: 22 RYEIL---EVIGKGSFGQVIRALDHKTNTH-ALK--YYGNQLTEFERTEIEKYLEIWYLG 75
R L V+G+ + A D +T + Y+ + ++++ +
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL--- 132
Query: 76 LDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRIL---DHLRKKDADSSYNVIH 132
+ QA + +R + D ++ V
Sbjct: 133 ----------------------RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL 170
Query: 133 MLEYFYFRNHLCISFELMNLNLYELIK---RNNYQGFSLGLIRRFAFS--LVQCLRLLHR 187
+ + + M NL + ++ SL R + +++ L LH
Sbjct: 171 DERDMWVLS-RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229
Query: 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF----YRSPEVILGL 243
++H L+P +++L QRG + + F + I F + ++
Sbjct: 230 YGLVHTYLRPVDIVLDQRG--GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFG 287
Query: 244 P-----YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRR 298
D W+LG + ++ + + I P V
Sbjct: 288 QHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPV------- 340
Query: 299 RLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358
+ + + RL P +A
Sbjct: 341 ---------------------------------------RALLEGFLRYPKEDRLLPLQA 361
Query: 359 LRHEWLKSSSSSSSSSSHHATDLRKSPSAHTNMYRLYRGVPTKPSAPADIDLNDSGT 415
+ + + S++ + R P+ S P + ++ T
Sbjct: 362 METPEYEQLRTELSAALPLYQTDGEPT-------REGGAPPSGTSQPDEAGAAEAVT 411
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-29
Identities = 57/368 (15%), Positives = 103/368 (27%), Gaps = 113/368 (30%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+ LE IG G FG V + + Y A K
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDG-------------------CIY---------AIK- 42
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
S G DE AL EV L + +V+ + +
Sbjct: 43 ---RSKKPLAGSVDEQ----------NALREVYAHAVLGQ-----HSHVVRYFSAWAEDD 84
Query: 142 HLCISFELMNL-NLYELIKRNNYQG--FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
H+ I E N +L + I N F ++ + + LR +H +++H D+KP
Sbjct: 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPS 144
Query: 199 NVLLKQRGSSSI-----------------KVIDFGSSCYSHQRVYTYIQSRFYRSPEVIL 241
N+ + + + K+ D G + + EV+
Sbjct: 145 NIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-RISSPQVEEGDSRFLANEVLQ 203
Query: 242 G-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL 300
+ P D+++L + PL ++ EI + S
Sbjct: 204 ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW------HEIRQGRLPRIPQVLS---- 253
Query: 301 FFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360
+ F + + + D ++R + ++
Sbjct: 254 ----------------------------------QEFTELLKVMIHPDPERRPSAMALVK 279
Query: 361 HEWLKSSS 368
H L S+S
Sbjct: 280 HSVLLSAS 287
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 54/380 (14%), Positives = 100/380 (26%), Gaps = 117/380 (30%)
Query: 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDAC 79
Y ++ +G+G F V ALK I
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALK------------------RI-------- 62
Query: 80 KIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF 139
H ++ +A E + N++ ++ Y
Sbjct: 63 LCHEQQDR-------------------EEAQREADMHRLFNHP------NILRLVAYCLR 97
Query: 140 R----NHLCISFELM-NLNLYELIKRNNYQG--FSLGLIRRFAFSLVQCLRLLHRENIIH 192
+ + L+ I+R +G + I + + L +H + H
Sbjct: 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAH 157
Query: 193 CDLKPENVLLKQRGSSSIKVIDFGSSCYSH------------QRVYTYIQSRFYRSPEVI 240
DLKP N+LL G ++D GS + Q + YR+PE+
Sbjct: 158 RDLKPTNILLGDEG--QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF 215
Query: 241 LGLPY---GPPIDMWSLGCILAELYTGCPLFPGENE-VEQLACIMEILGCPPDEVINTAS 296
+ D+WSLGC+L + G + + + +A +
Sbjct: 216 SVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV--------------- 260
Query: 297 RRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPD 356
+ + P S +S L + D +R
Sbjct: 261 ------------------QNQLSIPQSPRHSSALW-------QLLNSMMTVDPHQRPHIP 295
Query: 357 EALRHEWLKSSSSSSSSSSH 376
L + ++
Sbjct: 296 LLLSQLEALQPPAPGQHTTQ 315
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 64/384 (16%), Positives = 124/384 (32%), Gaps = 125/384 (32%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
+V+G G G+V++ + +T EK+ A K+
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQ-------------------EKF---------ALKM- 50
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF----Y 138
D +R EV + + +++ +++ +
Sbjct: 51 ----------LQDCP---KARR-------EVELHWRASQCP-----HIVRIVDVYENLYA 85
Query: 139 FRNHLCISFELMN-LNLYELIKRNNYQGFS----LGLIRRFAFSLVQCLRLLHRENIIHC 193
R L I E ++ L+ I+ Q F+ +++ S+ + ++ LH NI H
Sbjct: 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK----SIGEAIQYLHSINIAHR 141
Query: 194 DLKPENVLLK-QRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252
D+KPEN+L +R ++ +K+ DFG + E G Y DMW
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFG------------------FAKET-TGEKYDKSCDMW 182
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRCI 311
SLG I+ L G P F + + + I + F + +
Sbjct: 183 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE------------FPNPEWSE-V 229
Query: 312 TNS-KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370
+ K + + +R+T E + H W+ S+
Sbjct: 230 SEEVK-----------------------MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266
Query: 371 SSSSSHHATDLRKSPSAHTNMYRL 394
+ H + L++ ++
Sbjct: 267 PQTPLHTSRVLKEDKERWEDVKEE 290
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 58/355 (16%), Positives = 121/355 (34%), Gaps = 70/355 (19%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y I+ + +G F ++I + +ALK ++E++ +EK + D I
Sbjct: 32 DYRIIRTLNQGKFNKIILC-EKDNKFYALK-------KYEKSLLEKKRDFTKSNNDKISI 83
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ E++I+ ++ + + +
Sbjct: 84 KSKY---------------------DDFKNELQIITDIKNE------YCLTCEGIITNYD 116
Query: 142 HLCISFELMNL-NLYELIKRNNY------QGFSLGLIRRFAFSLVQCLRLLHRE-NIIHC 193
+ I +E M ++ + + + +I+ S++ +H E NI H
Sbjct: 117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176
Query: 194 DLKPENVLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSRFYRSPEVILGLP--YGPPID 250
D+KP N+L+ + G +K+ DFG S +++ + + PE G +D
Sbjct: 177 DVKPSNILMDKNGR--VKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVD 234
Query: 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC 310
+WSLG L ++ F + + +L +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVEL-------------------FNNI---RTKNIEY 272
Query: 311 ITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
+ +K +DF+ + +R+T ++AL+HEWL
Sbjct: 273 PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 56/375 (14%), Positives = 102/375 (27%), Gaps = 125/375 (33%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+E ++ +G+G FG V A + + + A+K I
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIK------------RIRLP------------ 41
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
N++ + + EV+ L L ++ + +
Sbjct: 42 --------------------NRELAREKVMREVKALAKLEHP------GIVRYFNAWLEK 75
Query: 141 N------------HLCISFELM-NLNLYELIKRNNYQGFS-LGLIRRFAFSLVQCLRLLH 186
N +L I +L NL + + + + + + LH
Sbjct: 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH 135
Query: 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC---------------YSHQRVYTYIQS 231
+ ++H DLKP N+ +KV DFG ++ R + +
Sbjct: 136 SKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193
Query: 232 RFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEV 291
+ Y SPE I G Y +D++SLG IL EL P V L + P
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDVRN--LKFPP-- 247
Query: 292 INTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKK 351
+ V + +
Sbjct: 248 -------------------------------------LFTQKYPCEYVMVQDMLSPSPME 270
Query: 352 RLTPDEALRHEWLKS 366
R + + +
Sbjct: 271 RPEAINIIENAVFED 285
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 73/361 (20%), Positives = 126/361 (34%), Gaps = 104/361 (28%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
E + +G+G++G V + + A+K +I
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVK----------------------------RI 40
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ E + L+++ I + D + + +
Sbjct: 41 RATVN-------SQEQ---------KRLLMDLDIS----MRTVDCPF-TVTFYGALFREG 79
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLG--LIRRFAFSLVQCLRLLHRE-NIIHCDLKPE 198
+ I ELM+ +L + K+ +G ++ ++ + A S+V+ L LH + ++IH D+KP
Sbjct: 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 139
Query: 199 NVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILG----LPYGPPIDM 251
NVL+ G +K+ DFG S Y + + Y +PE I Y D+
Sbjct: 140 NVLINALG--QVKMCDFGISGYLVDDVAK-DIDAGCKPYMAPERINPELNQKGYSVKSDI 196
Query: 252 WSLGCILAELYTGC-PLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC 310
WSLG + EL P +QL ++E P +L
Sbjct: 197 WSLGITMIELAILRFPYDSWGTPFQQLKQVVE--EPSP----------QL---------- 234
Query: 311 ITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370
D S FVDF +QC +SK+R T E ++H + S
Sbjct: 235 ------------PADKFS------AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK 276
Query: 371 S 371
Sbjct: 277 G 277
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 75/360 (20%), Positives = 120/360 (33%), Gaps = 103/360 (28%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
E L +G G+ GQV + KT A+K ++
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVK----------------------------QM 58
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ +EN + L+++ ++ K D Y ++ F
Sbjct: 59 RRSGN-------KEEN---------KRILMDLDVV----LKSHDCPY-IVQCFGTFITNT 97
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKPENV 200
+ I+ ELM +L KR ++ + ++V+ L L + +IH D+KP N+
Sbjct: 98 DVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156
Query: 201 LLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVI-----LGLPYGPPIDMW 252
LL +RG IK+ DFG S + Y +PE I Y D+W
Sbjct: 157 LLDERG--QIKLCDFGISGRLVDDKAK-DRSAGCAAYMAPERIDPPDPTKPDYDIRADVW 213
Query: 253 SLGCILAELYTGC-PLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311
SLG L EL TG P + + E L +++ PP
Sbjct: 214 SLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEPP----------------------- 248
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
S F FV C D +KR ++ L H ++K +
Sbjct: 249 --------LLPGHMGFS------GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 69/358 (19%), Positives = 123/358 (34%), Gaps = 98/358 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+++ ++GKGSF V RA T A K+
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEV----------------------------AIKM 43
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
++++ K + EV+I L+ +++ + YF N
Sbjct: 44 IDKKAMY-------------KAGMVQRVQNEVKIHCQLKHP------SILELYNYFEDSN 84
Query: 142 HLCISFEL-MNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
++ + E+ N + +K + FS R F ++ + LH I+H DL N+
Sbjct: 85 YVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNL 143
Query: 201 LLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
LL + + IK+ DFG + H++ YT + Y SPE+ +G D+WSLGC+
Sbjct: 144 LLTRNMN--IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCM 201
Query: 258 LAELYTGCPLFPGENEVEQLACIME-ILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
L G P F + L ++ P ++ ++
Sbjct: 202 FYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF--LSIEAK------------------- 240
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSS 374
D + Q + RL+ L H ++ +SS+ S
Sbjct: 241 ----------------------DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKD 276
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 76/358 (21%), Positives = 126/358 (35%), Gaps = 101/358 (28%)
Query: 27 EVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEE 85
V+GKG++G V D A+K ++ E + + +H E
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIK----EIPERDSRYSQP-------------LHEEI 70
Query: 86 SLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCI 145
+L K H+ N++ L F + I
Sbjct: 71 ALH--------------KHLKHK--------------------NIVQYLGSFSENGFIKI 96
Query: 146 SFELM-NLNLYELIKRNNYQGFSLG--LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLL 202
E + +L L++ + + I + +++ L+ LH I+H D+K +NVL+
Sbjct: 97 FMEQVPGGSLSALLR-SKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 155
Query: 203 KQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPEVILGLP--YGPPIDMWSLGCI 257
S +K+ DFG+S + T+ + Y +PE+I P YG D+WSLGC
Sbjct: 156 NTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCT 214
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
+ E+ TG P P E A + ++ G
Sbjct: 215 IIEMATGKP--PFYELGEPQAAMFKV----------------------GM---------F 241
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSS 375
K P + S F+ +CF D KR ++ L E+LK SS +
Sbjct: 242 KVHPEIPESMS------AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 73/362 (20%), Positives = 123/362 (33%), Gaps = 102/362 (28%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+ L IG+G++G V + + + A+K +I
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVK----------------------------RI 55
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ E Q L+++ ++ + +D Y ++ +
Sbjct: 56 RSTVD-------EKEQ---------KQLLMDLDVV----MRSSDCPY-IVQFYGALFREG 94
Query: 142 HLCISFELMN---LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKP 197
I ELM+ Y+ + ++ + + V+ L L IIH D+KP
Sbjct: 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKP 154
Query: 198 ENVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVI----LGLPYGPPID 250
N+LL + G +IK+ DFG S S + R Y +PE I Y D
Sbjct: 155 SNILLDRSG--NIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSASRQGYDVRSD 211
Query: 251 MWSLGCILAELYTGC-PLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309
+WSLG L EL TG P + +QL +++ G PP +L
Sbjct: 212 VWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPP----------QL--------- 250
Query: 310 CITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369
+ S +F++FV C D KR E L+H ++
Sbjct: 251 ----------SNSEEREFS------PSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294
Query: 370 SS 371
+
Sbjct: 295 RA 296
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 55/258 (21%), Positives = 88/258 (34%), Gaps = 49/258 (18%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y + ++GKG FG V A+K R + + +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKV-------IPRNRVLGWSPLSDSV----T 80
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
EV +L + VI +L++F +
Sbjct: 81 C---------------------PL-------EVALLWKVGA--GGGHPGVIRLLDWFETQ 110
Query: 141 NHLCISFELMNLN--LYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ E L++ I G R F +V ++ H ++H D+K E
Sbjct: 111 EGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDE 168
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQRVY-TYIQSRFYRSPEVILGLPY-GPPIDMWSLGC 256
N+L+ R K+IDFGS H Y + +R Y PE I Y P +WSLG
Sbjct: 169 NILIDLR-RGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGI 227
Query: 257 ILAELYTGCPLFPGENEV 274
+L ++ G F + E+
Sbjct: 228 LLYDMVCGDIPFERDQEI 245
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 65/259 (25%), Positives = 109/259 (42%), Gaps = 53/259 (20%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+Y + +G G+FG V A+D + N +K+ I+K
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF------------IKK------------- 59
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
E + ++ +D + +E+ IL + N+I +L+ F +
Sbjct: 60 ----EKVLEDCWIEDPK--------LGKVTLEIAILSRVEHA------NIIKVLDIFENQ 101
Query: 141 NHLCISFELMN--LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ E L+L+ I R+ L LV + L ++IIH D+K E
Sbjct: 102 GFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDE 159
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPY-GPPIDMWSLG 255
N+++ + +IK+IDFGS+ Y + YT+ + Y +PEV++G PY GP ++MWSLG
Sbjct: 160 NIVIAEDF--TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLG 217
Query: 256 CILAELYTGCPLFPGENEV 274
L L F E
Sbjct: 218 VTLYTLVFEENPFCELEET 236
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 59/282 (20%), Positives = 92/282 (32%), Gaps = 82/282 (29%)
Query: 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDAC 79
R + V+ +G F V A D + ALK +
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALK------------RLLS------------ 63
Query: 80 KIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF 139
+ EE + EV + L N++
Sbjct: 64 --NEEEKNRA-------------------IIQEVCFMKKLSGHP-----NIVQFCSAASI 97
Query: 140 RNH--------LCISFELMNLNLYELIKRNNYQG-FSLGLIRRFAFSLVQCLRLLHREN- 189
+ EL L E +K+ +G S + + + + ++ +HR+
Sbjct: 98 GKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP 157
Query: 190 -IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---------------QRVYTYIQSRF 233
IIH DLK EN+LL +G+ IK+ DFGS+ + T +
Sbjct: 158 PIIHRDLKVENLLLSNQGT--IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPM 215
Query: 234 YRSPEVI---LGLPYGPPIDMWSLGCILAELYTGCPLFPGEN 272
YR+PE+I P G D+W+LGCIL L F
Sbjct: 216 YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 58/356 (16%), Positives = 114/356 (32%), Gaps = 96/356 (26%)
Query: 20 CYRYE-ILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEK-YLEIWYLGL 76
R+ IG+GSF V + LD +T A Q + ++E ++ E L
Sbjct: 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQRFKEEAEML-- 79
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
K H + VR D
Sbjct: 80 --------------------------KGLQHPNI--VRFYDSWESTVKG----------- 100
Query: 137 FYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN--IIHC 193
+ + + ELM + L +KR ++ + ++R + +++ L+ LH IIH
Sbjct: 101 ---KKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 155
Query: 194 DLKPENVLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252
DLK +N+ + + S+K+ D G ++ I + + +PE+ Y +D++
Sbjct: 156 DLKCDNIFI-TGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVY 213
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
+ G + E+ T + Q+ +
Sbjct: 214 AFGMCMLEMATSEYPYSECQNAAQIYRRV------------------------------- 242
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368
KP S D + + + C + +R + + L H + + +
Sbjct: 243 ---TSGVKPASFD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 61/375 (16%), Positives = 110/375 (29%), Gaps = 77/375 (20%)
Query: 23 YEILEVIGKG--SFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYL-EIWYLGLDA 78
YE+L VIGKG V A T + ++ L + E+
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVS---- 80
Query: 79 CKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY 138
K F+H N++ F
Sbjct: 81 ------------------------KLFNHP--------------------NIVPYRATFI 96
Query: 139 FRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
N L + M + +LI + G + I +++ L +H +H +K
Sbjct: 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKA 156
Query: 198 ENVLLKQRGSSSIKVIDFGSSC----------YSHQRVYTYIQSRFYRSPEVI--LGLPY 245
++L+ G + + S+ H ++ + SPEV+ Y
Sbjct: 157 SHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY 214
Query: 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP---DEVINTASRRRLFF 302
D++S+G EL G P ++ + ++ G P D A +
Sbjct: 215 DAKSDIYSVGITACELANGHV--PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSP 272
Query: 303 DSKGTPRCITNSKGRKRKPGSKDMASVLRCND---KAFVDFVTQCFNWDSKKRLTPDEAL 359
+++S S + + F FV QC + R + L
Sbjct: 273 SRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332
Query: 360 RHEWLKSSSSSSSSS 374
H + K +S +
Sbjct: 333 NHSFFKQIKRRASEA 347
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-24
Identities = 77/357 (21%), Positives = 136/357 (38%), Gaps = 102/357 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+Y E IG+G+ G V A+D T A++ + +++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIR----------QMNLQQ------------- 57
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
++ L N E+ ++ + + N+++ L+ +
Sbjct: 58 -QPKKELIIN---------------------EILVMRENK------NPNIVNYLDSYLVG 89
Query: 141 NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ L + E + +L +++ G I +Q L LH +IH D+K +N
Sbjct: 90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 200 VLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
+LL GS +K+ DFG + T + + ++ +PEV+ YGP +D+WSLG
Sbjct: 147 ILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFF-DSKGTPRCITNSK 315
+ E+ G P P NE P R L+ + GTP
Sbjct: 205 MAIEMIEGEP--PYLNE-------------NP--------LRALYLIATNGTPEL----- 236
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSS 372
+ + S F DF+ +C D +KR + E L+H++LK + SS
Sbjct: 237 -QNPEKLSAI-----------FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 64/360 (17%), Positives = 121/360 (33%), Gaps = 108/360 (30%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+ IG+GS G V A + + A+K + + + +
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVK-----MMDLRKQQ---------------- 84
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
L N EV I+ +D NV+ M + +
Sbjct: 85 ---RRELLFN---------------------EVVIM-----RDYQHF-NVVEMYKSYLVG 114
Query: 141 NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
L + E + L +++ + + I +++Q L LH + +IH D+K ++
Sbjct: 115 EELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS 171
Query: 200 VLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
+LL G +K+ DFG + + + + ++ +PEVI Y +D+WSLG
Sbjct: 172 ILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFF-DSKGTPRCITNSK 315
++ E+ G P P ++ P + + P+
Sbjct: 230 MVIEMVDGEP--PYFSD-------------SP--------VQAMKRLRDSPPPK------ 260
Query: 316 GRKRKPGSKDMASVLRCNDK---AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSS 372
L+ + K DF+ + D ++R T E L H +L +
Sbjct: 261 --------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPEC 306
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-23
Identities = 79/357 (22%), Positives = 126/357 (35%), Gaps = 101/357 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+ LE IGKGSFG+V + +D++T A+K + E E +I++
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ------------- 69
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
E+ +L S V +
Sbjct: 70 -------------------------------EITVLSQCD------SPYVTKYYGSYLKD 92
Query: 141 NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
L I E + + +L++ + I R +++ L LH E IH D+K N
Sbjct: 93 TKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHSEKKIHRDIKAAN 149
Query: 200 VLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
VLL + G +K+ DFG + + + T++ + F+ +PEVI Y D+WSLG
Sbjct: 150 VLLSEHGE--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 207
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
EL G P P P + LF K P
Sbjct: 208 TAIELARGEP--PHSEL-------------HP--------MKVLFLIPKNNP-------- 236
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSS 373
P + S K +FV C N + R T E L+H+++ ++ +S
Sbjct: 237 ----PTLEGNYS------KPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 73/354 (20%), Positives = 128/354 (36%), Gaps = 80/354 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+Y + + IGKGS+G V A + NT+ A+K + ++ +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMK-------VLSKKKLIRQAGFPRRPPPR-- 64
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF- 139
+ G + E+ IL L NV+ ++E
Sbjct: 65 ---GTRPAPGGCIQPRGPIEQVYQ-------EIAILKKLDHP------NVVKLVEVLDDP 108
Query: 140 -RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+HL + FEL+N +++ + S R + L++ + LH + IIH D+KP
Sbjct: 109 NEDHLYMVFELVNQG--PVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 199 NVLLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGL--PY-GPPIDMW 252
N+L+ + G IK+ DFG S S + + + + +PE + + G +D+W
Sbjct: 167 NLLVGEDG--HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVW 224
Query: 253 SLGCILAELYTG-CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311
++G L G CP F E IM + I
Sbjct: 225 AMGVTLYCFVFGQCP-FMDER-------IMCLH-----SKI-----------KSQALEF- 259
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
P D+A L+ D +T+ + + + R+ E H W+
Sbjct: 260 ---------PDQPDIAEDLK-------DLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 57/252 (22%), Positives = 93/252 (36%), Gaps = 62/252 (24%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHG 83
E+ EV+G+G+FG V +A + A+K +I
Sbjct: 11 EVEEVVGRGAFGVVCKA-KWRAKDVAIK----------------------------QIES 41
Query: 84 EESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHL 143
E +K F E+R L + N++ + Y N +
Sbjct: 42 ES---------------ERKAFIV----ELRQLSRVN------HPNIVKL--YGACLNPV 74
Query: 144 CISFELM-NLNLYELI-KRNNYQGFSLGLIRRFAFSLVQCLRLLHREN---IIHCDLKPE 198
C+ E +LY ++ ++ + Q + LH +IH DLKP
Sbjct: 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
N+LL G+ +K+ DFG++C + S + +PEV G Y D++S G IL
Sbjct: 135 NLLLVAGGTV-LKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193
Query: 259 AELYTGCPLFPG 270
E+ T F
Sbjct: 194 WEVITRRKPFDE 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 74/363 (20%), Positives = 124/363 (34%), Gaps = 112/363 (30%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKY--YGNQLTEFERTEIEKYLEIWYLGLDA 78
+ L IG GSFG V A D + + A+K Y + + + +I K
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK----------- 103
Query: 79 CKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY 138
EVR L LR N I +
Sbjct: 104 ---------------------------------EVRFLQKLR------HPNTIQYRGCYL 124
Query: 139 FRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ + E + +L++ + + I +Q L LH N+IH D+K
Sbjct: 125 REHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 183
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGL---PYGPPIDMWSLG 255
N+LL + G +K+ DFGS+ +++ + ++ +PEVIL + Y +D+WSLG
Sbjct: 184 NILLSEPGL--VKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 240
Query: 256 --CI-LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSK-GTPRCI 311
CI LAE PP + N + L+ ++ +P
Sbjct: 241 ITCIELAE------------------------RKPP--LFNMNAMSALYHIAQNESPA-- 272
Query: 312 TNSKGRKRKPGSKDMASVLRCND--KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369
L+ + F +FV C + R T + L+H ++
Sbjct: 273 ------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314
Query: 370 SSS 372
+
Sbjct: 315 PTV 317
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 64/254 (25%), Positives = 99/254 (38%), Gaps = 52/254 (20%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
+ V+GKG FG+V T K Y ACK
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATG----KMY------------------------ACKKL 217
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
++ + + G AL E +IL + +S + V+ + + ++
Sbjct: 218 EKKRIKKRKGEA-------------MALNEKQIL-----EKVNSRF-VVSLAYAYETKDA 258
Query: 143 LCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
LC+ LMN +L I GF +A + L LHRE I++ DLKPEN+L
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318
Query: 202 LKQRGSSSIKVIDFGSSC--YSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILA 259
L G I++ D G + Q + + + Y +PEV+ Y D W+LGC+L
Sbjct: 319 LDDHGH--IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLY 376
Query: 260 ELYTGCPLFPGENE 273
E+ G F +
Sbjct: 377 EMIAGQSPFQQRKK 390
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 75/367 (20%), Positives = 128/367 (34%), Gaps = 115/367 (31%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+EI+ +G G+FG+V +A + +T A A K+
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALA----------------------------AAKV 51
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+S ++E Y E+ IL ++ +L +Y
Sbjct: 52 IETKS-------EEELEDYIV---------EIEILATCD------HPYIVKLLGAYYHDG 89
Query: 142 HLCISFELMN----LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
L I E + + R G + I+ +++ L LH + IIH DLK
Sbjct: 90 KLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKA 145
Query: 198 ENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPEVIL-----GLPYGPPI 249
NVL+ G I++ DFG S + Q+ ++I + ++ +PEV++ PY
Sbjct: 146 GNVLMTLEGD--IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSK-GTP 308
D+WSLG L E+ PP +N R L +K P
Sbjct: 204 DIWSLGITLIEM---------------------AQIEPPHHELNPM--RVLLKIAKSDPP 240
Query: 309 RCITNSKGRKRKPGSKDMASVLRCNDK---AFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
L K F DF+ + + + R + + L H ++
Sbjct: 241 T--------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280
Query: 366 SSSSSSS 372
S +S+ +
Sbjct: 281 SITSNKA 287
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 71/370 (19%), Positives = 122/370 (32%), Gaps = 105/370 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
YE+ EVIG G+ V A A+K E+ +
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIK-----RINLEKCQTSM------------- 57
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ L + E++ + N++ F +
Sbjct: 58 ----DELLK----------------------EIQAMSQCH------HPNIVSYYTSFVVK 85
Query: 141 NHLCISFELMNL-NLYELIKRNNYQGFSLGLI---RRFAFSLVQCLR---LLHRENIIHC 193
+ L + +L++ ++ ++IK +G + A L + L LH+ IH
Sbjct: 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR 145
Query: 194 DLKPENVLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSR-------FYRSPEVIL-GLP 244
D+K N+LL + G S+++ DFG S+ + T + R + +PEV+
Sbjct: 146 DVKAGNILLGEDG--SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG 203
Query: 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDS 304
Y D+WS G EL TG P PP +V L
Sbjct: 204 YDFKADIWSFGITAIELATGAA--PYHKY-------------PPMKV--------LMLTL 240
Query: 305 KGTPRCITNSKGRKRKPG--SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHE 362
+ P + K K+F ++ C D +KR T E LRH+
Sbjct: 241 QNDPPSLETGVQDKEMLKKYG-----------KSFRKMISLCLQKDPEKRPTAAELLRHK 289
Query: 363 WLKSSSSSSS 372
+ + + +
Sbjct: 290 FFQKAKNKEF 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 49/258 (18%), Positives = 81/258 (31%), Gaps = 60/258 (23%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLD-ACKIH 82
E + IGKG FG V + + + A K
Sbjct: 22 EYEKQIGKGGFGLVHKG----------RLVKD-------------------KSVVAIKS- 51
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY--FR 140
L + + F EV I+ +L N++ Y
Sbjct: 52 ----LILGDSEGETEMIEKFQEFQR----EVFIMSNLNHP------NIVK----LYGLMH 93
Query: 141 NHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN--IIHCDLKP 197
N + E + +LY + + + R + + + +N I+H DL+
Sbjct: 94 NPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRS 152
Query: 198 ENVLLKQRGSSS---IKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG--LPYGPPIDMW 252
N+ L+ ++ KV DFG S S V + + + +PE I Y D +
Sbjct: 153 PNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 253 SLGCILAELYTGCPLFPG 270
S IL + TG F
Sbjct: 213 SFAMILYTILTGEGPFDE 230
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 59/267 (22%), Positives = 104/267 (38%), Gaps = 60/267 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYG-NQLTEFERTEIEKYLEIWYLGLDAC 79
Y +L+ IGKG+F +V A T A+K QL ++ + E+ +
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR--EVRIM----- 68
Query: 80 KIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF 139
K +H N++ + E
Sbjct: 69 -----------------------KILNHP--------------------NIVKLFEVIET 85
Query: 140 RNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
L + E + +++ + + R +V ++ H++ I+H DLK E
Sbjct: 86 EKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAE 143
Query: 199 NVLLKQRGSSSIKVIDFG-SSCYSH-QRVYTYIQSRFYRSPEVILGLPY-GPPIDMWSLG 255
N+LL +IK+ DFG S+ ++ ++ + + Y +PE+ G Y GP +D+WSLG
Sbjct: 144 NLLLDADM--NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 256 CILAELYTGCPLFPGENEVEQLACIME 282
IL L +G F G+N E ++
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLR 228
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 5e-21
Identities = 63/259 (24%), Positives = 100/259 (38%), Gaps = 61/259 (23%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHG 83
V+G+G FG+V T K Y ACK
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATG----KLY------------------------ACKKLN 219
Query: 84 EESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY-FYFRNH 142
++ L + G+ A++E +IL S + V L Y F +
Sbjct: 220 KKRLKKRKGYQ-------------GAMVEKKIL-----AKVHSRFIV--SLAYAFETKTD 259
Query: 143 LCISFELMN-----LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
LC+ +MN ++Y + + N GF + +V L LH+ NII+ DLKP
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP 317
Query: 198 ENVLLKQRGSSSIKVIDFGSSC---YSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254
ENVLL G+ +++ D G + + Y + + +PE++LG Y +D ++L
Sbjct: 318 ENVLLDDDGN--VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 255 GCILAELYTGCPLFPGENE 273
G L E+ F E
Sbjct: 376 GVTLYEMIAARGPFRARGE 394
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 58/255 (22%), Positives = 91/255 (35%), Gaps = 61/255 (23%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLD-ACKIH 82
I E IG GSFG V RA + G D A KI
Sbjct: 40 NIKEKIGAGSFGTVHRA-------------------------------EWHGSDVAVKIL 68
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
E+ F EV I+ LR N++ + +
Sbjct: 69 MEQDFHAE----------RVNEFLR----EVAIMKRLRHP------NIVLFMGAVTQPPN 108
Query: 143 LCISFELM-NLNLYELIKRNNYQG-FSLGLIRRFAFSLVQCLRLLHREN--IIHCDLKPE 198
L I E + +LY L+ ++ + A+ + + + LH N I+H +LK
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSR---FYRSPEVILGLPYGPPIDMWSLG 255
N+L+ ++ + +KV DFG S + + + +PEV+ P D++S G
Sbjct: 169 NLLVDKKYT--VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226
Query: 256 CILAELYTGCPLFPG 270
IL EL T +
Sbjct: 227 VILWELATLQQPWGN 241
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-21
Identities = 76/361 (21%), Positives = 126/361 (34%), Gaps = 110/361 (30%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQL-TEFERTEIEKYLEIWYLGLDAC 79
+++LE +G+GS+G V +A+ +T A+K Q+ E + EI K
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIK----QVPVESDLQEIIK------------ 73
Query: 80 KIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF 139
E+ I+ S +V+ ++
Sbjct: 74 --------------------------------EISIMQQCD------SPHVVKYYGSYFK 95
Query: 140 RNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
L I E ++ ++I+ N + + I S ++ L LH IH D+K
Sbjct: 96 NTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAG 154
Query: 199 NVLLKQRGSSSIKVIDFGSSC---YSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255
N+LL G K+ DFG + + + T I + F+ +PEVI + Y D+WSLG
Sbjct: 155 NILLNTEGH--AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSK-GTPRCITNS 314
E+ G P P + P R +F P
Sbjct: 213 ITAIEMAEGKP--PYADI-------------HP--------MRAIFMIPTNPPPT----- 244
Query: 315 KGRKRKPGSKDMASVLRCNDK---AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
R + F DFV QC ++R T + L+H +++S+ S
Sbjct: 245 ---------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289
Query: 372 S 372
Sbjct: 290 I 290
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-21
Identities = 60/289 (20%), Positives = 101/289 (34%), Gaps = 79/289 (27%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLD-ACKIH 82
+ E+IG G FG+V RA ++G + A K
Sbjct: 10 TLEEIIGIGGFGKVYRAF-------------------------------WIGDEVAVKAA 38
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
+ DE+ S + E ++ L+ N+I + +
Sbjct: 39 RHD--------PDEDISQTIENVRQ----EAKLFAMLKHP------NIIALRGVCLKEPN 80
Query: 143 LCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN---IIHCDLKPE 198
LC+ E L ++ ++ +A + + + LH E IIH DLK
Sbjct: 81 LCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137
Query: 199 NVLLKQRGSSS------IKVIDFGSSCYSHQRVY-----TYIQSRFYRSPEVILGLPYGP 247
N+L+ Q+ + +K+ DFG + H+ Y + +PEVI +
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAY----AWMAPEVIRASMFSK 193
Query: 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACI------MEI-LGCPPD 289
D+WS G +L EL TG F G + + + + I CP
Sbjct: 194 GSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 63/259 (24%), Positives = 84/259 (32%), Gaps = 65/259 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEK---YLEIWYLGLD 77
RY+ ++ IG G+FG D T A+KY ER EI
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKY-------IERGAAIDENVQREIINH--- 70
Query: 78 ACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF 137
+ H N++ E
Sbjct: 71 -------------------------RSLRHP--------------------NIVRFKEVI 85
Query: 138 YFRNHLCISFEL-MNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
HL I E LYE I FS R F L+ + H I H DLK
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK 143
Query: 197 PENVLLKQRGSSSIKVIDFGSSCYS--HQRVYTYIQSRFYRSPEVILGLPY-GPPIDMWS 253
EN LL + +K+ DFG S S H + + + + Y +PEV+L Y G D+WS
Sbjct: 144 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWS 203
Query: 254 LGCILAELYTGCPLFPGEN 272
G L + G F
Sbjct: 204 CGVTLYVMLVGAYPFEDPE 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 39/289 (13%), Positives = 75/289 (25%), Gaps = 87/289 (30%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHG 83
L + + G++ + ++ G +I K+
Sbjct: 13 NFLTKLNENHSGELWKG----------RWQG--------NDI------------VVKVLK 42
Query: 84 EESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY----- 138
S + F+ E L NV+
Sbjct: 43 VRDWSTR----------KSRDFNE----ECPRLRIFSHP------NVLP----VLGACQS 78
Query: 139 -FRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN--IIHCD 194
H + M +LY ++ +FA + + + LH I
Sbjct: 79 PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA 138
Query: 195 LKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPP---I 249
L +V++ + + ++ R+Y + +PE + P
Sbjct: 139 LNSRSVMIDEDM--TARISMADVKFSFQSPGRMYAPA----WVAPEALQKKPEDTNRRSA 192
Query: 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEIL----------GCPP 288
DMWS +L EL T F + + M++ G P
Sbjct: 193 DMWSFAVLLWELVTREVPFAD---LSNMEIGMKVALEGLRPTIPPGISP 238
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 72/369 (19%), Positives = 126/369 (34%), Gaps = 113/369 (30%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+E++E++G G++GQV + KT A+K +T E EI++
Sbjct: 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQ------------- 69
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
E+ +L K N+ F +
Sbjct: 70 -------------------------------EINML-----KKYSHHRNIATYYGAFIKK 93
Query: 141 NHLCISFEL---MNL----NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHC 193
N + +L M ++ +LIK I +++ L LH+ +IH
Sbjct: 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR 153
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPEVIL-----GLPY 245
D+K +NVLL + +K++DFG S + R T+I + ++ +PEVI Y
Sbjct: 154 DIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY 211
Query: 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSK 305
D+WSLG E+ G P P + P LF
Sbjct: 212 DFKSDLWSLGITAIEMAEGAP--PLCDM-------------HPMRA--------LFL--- 245
Query: 306 GTPRCITNSKGRKRKPG--SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363
I + + K SK F F+ C + +R ++ ++H +
Sbjct: 246 -----IPRNPAPRLKSKKWSKK-----------FQSFIESCLVKNHSQRPATEQLMKHPF 289
Query: 364 LKSSSSSSS 372
++ +
Sbjct: 290 IRDQPNERQ 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-20
Identities = 56/294 (19%), Positives = 88/294 (29%), Gaps = 83/294 (28%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTH--ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
EV+GKG FGQ I+ H+ +K E
Sbjct: 13 IHGEVLGKGCFGQAIKV-THRETGEVMVMKELIRFDEE---------------------- 49
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
++ F EV+++ L NV+ + Y
Sbjct: 50 -------------------TQRTFLK----EVKVMRCLEHP------NVLKFIGVLYKDK 80
Query: 142 HLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L E + L +IK + Q + FA + + LH NIIH DL N
Sbjct: 81 RLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNC 139
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYR-----------------SPEVILGL 243
L+++ ++ V DFG + R + +PE+I G
Sbjct: 140 LVRENK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197
Query: 244 PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI-------MEI-LGCPPD 289
Y +D++S G +L E+ P + CPP
Sbjct: 198 SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPS 251
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 62/260 (23%), Positives = 107/260 (41%), Gaps = 57/260 (21%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+Y + +++G+GS+G+V LD +T A KI
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRR----------------------------AVKI 37
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-- 139
++ L + NG N K+ E+++L LR K NVI +++ Y
Sbjct: 38 LKKKKLRRIP-----NGEANVKK-------EIQLLRRLRHK------NVIQLVDVLYNEE 79
Query: 140 RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ + + E + E++ + F + + L+ L LH + I+H D+KP N
Sbjct: 80 KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGN 139
Query: 200 VLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRFYRSPEVILGL-PY-GPPIDMW 252
+LL G ++K+ G + H T S ++ PE+ GL + G +D+W
Sbjct: 140 LLLTTGG--TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIW 197
Query: 253 SLGCILAELYTGCPLFPGEN 272
S G L + TG F G+N
Sbjct: 198 SAGVTLYNITTGLYPFEGDN 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 63/264 (23%), Positives = 98/264 (37%), Gaps = 54/264 (20%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y I E +G+GSFG+V A +KT A K
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKV----------------------------ALKF 41
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ L + +R E+ L LR ++I + +
Sbjct: 42 ISRQLL------KKSDMHMRVER-------EISYLKLLRHP------HIIKLYDVITTPT 82
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ + E L++ I + + RRF ++ + HR I+H DLKPEN+L
Sbjct: 83 DIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL 140
Query: 202 LKQRGSSSIKVIDFG-SSCYSH-QRVYTYIQSRFYRSPEVILGLPY-GPPIDMWSLGCIL 258
L ++K+ DFG S+ + + T S Y +PEVI G Y GP +D+WS G +L
Sbjct: 141 LDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198
Query: 259 AELYTGCPLFPGENEVEQLACIME 282
+ G F E +
Sbjct: 199 YVMLVGRLPFDDEFIPNLFKKVNS 222
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 54/265 (20%), Positives = 94/265 (35%), Gaps = 70/265 (26%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHG 83
+ + IG GSFG V Y G + G A K+
Sbjct: 27 TVGQRIGSGSFGTV--------------YKG-----------------KWHGDVAVKMLN 55
Query: 84 EESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY---FR 140
+ + + F + EV +L R N++ F
Sbjct: 56 VTAPTPQ----------QLQAFKN----EVGVLRKTRHV------NILL----FMGYSTA 91
Query: 141 NHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
L I + +LY + + + F + + A + + LH ++IIH DLK N
Sbjct: 92 PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN 150
Query: 200 VLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF-----YRSPEVILG---LPYGPPIDM 251
+ L + ++K+ DFG + + ++ + + +PEVI PY D+
Sbjct: 151 IFLHEDN--TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDV 208
Query: 252 WSLGCILAELYTGCPLFPGENEVEQ 276
++ G +L EL TG + N +Q
Sbjct: 209 YAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 56/267 (20%), Positives = 94/267 (35%), Gaps = 73/267 (27%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHG 83
EI E+IGKG FGQV +++G E+ A ++
Sbjct: 36 EIGELIGKGRFGQVYHG----------RWHG---------------EV------AIRLID 64
Query: 84 EESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHL 143
E +++ K F EV R + NV+ + HL
Sbjct: 65 IERDNED----------QLKAFKR----EVMAYRQTRHE------NVVLFMGACMSPPHL 104
Query: 144 CISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLL 202
I L LY +++ + R+ A +V+ + LH + I+H DLK +NV
Sbjct: 105 AIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY 163
Query: 203 KQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF--------YRSPEVI---------LGLPY 245
+ + + DFG S + + + +PE+I LP+
Sbjct: 164 ---DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF 220
Query: 246 GPPIDMWSLGCILAELYTGCPLFPGEN 272
D+++LG I EL+ F +
Sbjct: 221 SKHSDVFALGTIWYELHAREWPFKTQP 247
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 8e-19
Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 53/254 (20%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHG 83
+ +IG+G FG+V T K Y A K
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTG----KMY------------------------AMKCLD 223
Query: 84 EESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY-FYFRNH 142
++ + K+ AL E +L + D I + Y F+ +
Sbjct: 224 KKRIKM------------KQGETL-ALNERIMLSLVSTGD----CPFIVCMSYAFHTPDK 266
Query: 143 LCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L +LMN +L+ + ++ FS +R +A ++ L +H +++ DLKP N+L
Sbjct: 267 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324
Query: 202 LKQRGSSSIKVIDFGSSCY-SHQRVYTYIQSRFYRSPEVIL-GLPYGPPIDMWSLGCILA 259
L + G +++ D G +C S ++ + + + Y +PEV+ G+ Y D +SLGC+L
Sbjct: 325 LDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 260 ELYTGCPLFPGENE 273
+L G F
Sbjct: 383 KLLRGHSPFRQHKT 396
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS-----CYSHQRVYTYIQSRFYRSPEV 239
LH + IIH DLKPEN+LL + I++ DFG++ R +++ + Y SPE+
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 240 ILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVE 275
+ D+W+LGCI+ +L G P F NE
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 58/260 (22%), Positives = 93/260 (35%), Gaps = 65/260 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y + + +G G+FG+V T A KI
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKV----------------------------AVKI 43
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALI-----EVRILDHLRKKDADSSYNVIHMLEY 136
N+++ ++ E++ L R ++I + +
Sbjct: 44 ------------------LNRQKIRSLDVVGKIKREIQNLKLFRHP------HIIKLYQV 79
Query: 137 FYFRNHLCISFELMNLN-LYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDL 195
+ E ++ L++ I ++ RR ++ + HR ++H DL
Sbjct: 80 ISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137
Query: 196 KPENVLLKQRGSSSIKVIDFGSSCYSHQRVY--TYIQSRFYRSPEVILGLPY-GPPIDMW 252
KPENVLL + K+ DFG S + T S Y +PEVI G Y GP +D+W
Sbjct: 138 KPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 195
Query: 253 SLGCILAELYTGCPLFPGEN 272
S G IL L G F E+
Sbjct: 196 SCGVILYALLCGTLPFDDEH 215
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 33/116 (28%), Positives = 54/116 (46%), Gaps = 13/116 (11%)
Query: 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS----CYSHQRVYTYIQSRF 233
+V + +HR +H D+KP+N+LL + G I++ DFGS R + +
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 234 YRSPEVILGL-------PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
Y SPE++ + YGP D W+LG E++ G F ++ E I+
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPE 238
L+ LH + I++ DLK +N+LL + G IK+ DFG + T+ + Y +PE
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
++LG Y +D WS G +L E+ G F G++E E I
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 36/104 (34%), Positives = 57/104 (54%), Gaps = 3/104 (2%)
Query: 173 RF-AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQS 231
RF A +V LH ++I+ DLKPEN+L+ Q+G I+V DFG + R +T +
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGRTWTLCGT 201
Query: 232 RFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVE 275
+PE+IL Y +D W+LG ++ E+ G P F + ++
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 54/289 (18%), Positives = 108/289 (37%), Gaps = 68/289 (23%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+++++ +G+G++G+V A++ T A+K + E
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-------VDMKRAVDCPE---------N 51
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
I K+ E+ I L + NV+ +
Sbjct: 52 I---------------------KK-------EICINKMLNHE------NVVKFYGHRREG 77
Query: 141 NHLCISFELMNLN-LYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
N + E + L++ I+ + G +RF L+ + LH I H D+KPEN
Sbjct: 78 NIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 135
Query: 200 VLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQ----SRFYRSPEVILGLPY-GPPIDMWS 253
+LL +R ++K+ DFG ++ + + + + Y +PE++ + P+D+WS
Sbjct: 136 LLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILG----CPPDEVINTASRR 298
G +L + G P + + + P + I++A
Sbjct: 194 CGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 39/109 (35%), Positives = 53/109 (48%), Gaps = 15/109 (13%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTYIQSRF----- 233
L L + II+ DLK +NV+L G IK+ DFG + + T F
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVTTKT-----FCGTPD 186
Query: 234 YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
Y +PE+I PYG +D W+ G +L E+ G F GE+E E IME
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 24/94 (25%), Positives = 43/94 (45%), Gaps = 13/94 (13%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT----YIQSRFYRSP 237
L LH +++ DLKPEN++L + +K+ID G+ + +++P
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQ---LKLIDLGAV-----SRINSFGYLYGTPGFQAP 246
Query: 238 EVILGLPYGPPIDMWSLGCILAELYTGCPLFPGE 271
E++ P D++++G LA L P G
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR 279
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 54/289 (18%), Positives = 108/289 (37%), Gaps = 68/289 (23%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+++++ +G+G++G+V A++ T A+K + E
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-------VDMKRAVDCPE---------N 51
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
I K+ E+ I L + NV+ +
Sbjct: 52 I---------------------KK-------EICINKMLNHE------NVVKFYGHRREG 77
Query: 141 NHLCISFELMNLN-LYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
N + E + L++ I+ + G +RF L+ + LH I H D+KPEN
Sbjct: 78 NIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 135
Query: 200 VLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQ----SRFYRSPEVILGLPY-GPPIDMWS 253
+LL +R ++K+ DFG ++ + + + + Y +PE++ + P+D+WS
Sbjct: 136 LLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILG----CPPDEVINTASRR 298
G +L + G P + + + P + I++A
Sbjct: 194 CGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 15/109 (13%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRF----- 233
L LH + II+ DLK +NVLL G K+ DFG + T F
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNGVTTAT-----FCGTPD 189
Query: 234 YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
Y +PE++ + YGP +D W++G +L E+ G F ENE + I+
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 40/104 (38%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG-SSCYSH-QRVYTYI 229
RR ++ + HR ++H DLKPENVLL + K+ DFG S+ S + + T
Sbjct: 119 RRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSC 176
Query: 230 QSRFYRSPEVILGLPY-GPPIDMWSLGCILAELYTGCPLFPGEN 272
S Y +PEVI G Y GP +D+WS G IL L G F ++
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 48/277 (17%), Positives = 92/277 (33%), Gaps = 86/277 (31%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLD-ACKIH 82
+ E IGKG FG+V R + G + A KI
Sbjct: 45 VLQESIGKGRFGEVWRGK-------------------------------WRGEEVAVKI- 72
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHML----EYFY 138
F ++ + +A E+ LR + N++ + +
Sbjct: 73 ----------FSSRE----ERSWFREA--EIYQTVMLRHE------NILGFIAADNKDNG 110
Query: 139 FRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE--------N 189
L + + + +L++ + R ++ + + A S L LH E
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167
Query: 190 IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQS-------RFYRSPEVILG 242
I H DLK +N+L+K+ G + + D G + T + + Y +PEV+
Sbjct: 168 IAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 243 ------LPYGPPIDMWSLGCILAELYTGCPLFPGENE 273
D++++G + E+ C + +
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 15/106 (14%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRF-----YRS 236
LH++ II+ DLKPEN++L +G +K+ DFG + +T F Y +
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKESIHDGTVTHT-----FCGTIEYMA 189
Query: 237 PEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
PE+++ + +D WSLG ++ ++ TG P F GEN + + I++
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 2e-16
Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 12/96 (12%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF-----YRSPEV 239
LH ++II+ DLKPEN+LL + G IK+ DFG + Y YT Y +PEV
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPDVTYT-----LCGTPDYIAPEV 174
Query: 240 ILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVE 275
+ PY ID WS G ++ E+ G F N ++
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 15/109 (13%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRF----- 233
L LH ++++ D+K EN++L + G IK+ DFG + T F
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKT-----FCGTPE 170
Query: 234 YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
Y +PEV+ YG +D W LG ++ E+ G F ++ I+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 37/126 (29%), Positives = 55/126 (43%), Gaps = 10/126 (7%)
Query: 164 QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS----C 219
R + +V L +H IH D+KP+N+LL + G +K+ DFG+
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNK 220
Query: 220 YSHQRVYTYIQSRFYRSPEVILG----LPYGPPIDMWSLGCILAELYTGCPLFPGENEVE 275
R T + + Y SPEV+ YG D WS+G L E+ G F ++ V
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280
Query: 276 QLACIM 281
+ IM
Sbjct: 281 TYSKIM 286
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG---SSCYSHQRVYTYIQSRFYRSPE 238
L L + II+ DLK +NV+L G IK+ DFG + + T+ + Y +PE
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512
Query: 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
+I PYG +D W+ G +L E+ G F GE+E E IME
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 11/113 (9%)
Query: 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS----CYSHQRVYTYIQSRF 233
+V + +H+ + +H D+KP+N+L+ G I++ DFGS + + +
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 234 YRSPEVILGLP-----YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM 281
Y SPE++ + YGP D WSLG + E+ G F E+ VE IM
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 5/101 (4%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPEVIL 241
LH II+ DLKPEN+LL + G IK+ DFG S ++ Y++ + Y +PEV+
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
+ D WS G ++ E+ TG F G++ E + I++
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 55/288 (19%), Positives = 91/288 (31%), Gaps = 102/288 (35%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLD-ACKIH 82
++++ IGKG +G+V + G A K+
Sbjct: 40 QMVKQIGKGRYGEVWMGK-------------------------------WRGEKVAVKVF 68
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY---- 138
F E S+ ++ E+ +R + N++ F
Sbjct: 69 ----------FTTEEASWFRET-------EIYQTVLMRHE------NILG----FIAADI 101
Query: 139 ----FRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN---- 189
L + + N +LY+ +K + + A+S V L LH E
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 190 ----IIHCDLKPENVLLKQRGSSSIKVIDFGSSC-----------YSHQRVYTYIQSRFY 234
I H DLK +N+L+K+ G + + D G + + RV T Y
Sbjct: 159 GKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVKFISDTNEVDIPPNTRVGTK----RY 212
Query: 235 RSPEVILG------LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQ 276
PEV+ DM+S G IL E+ C E +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-16
Identities = 32/171 (18%), Positives = 55/171 (32%), Gaps = 35/171 (20%)
Query: 143 LCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE--------NIIHC 193
L + +LY+ ++ R S+ L LH E I H
Sbjct: 81 LWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQS-------RFYRSPEVILGLPYG 246
DLK +N+L+K+ G + D G + Q + Y +PEV+
Sbjct: 138 DLKSKNILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 247 PP------IDMWSLGCILAELYTGCPLF--------PGENEVEQLACIMEI 283
+D+W+ G +L E+ P + V ++
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 38/109 (34%), Positives = 50/109 (45%), Gaps = 15/109 (13%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRF----- 233
L LH NI++ DLKPEN+LL +G I + DFG + T F
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNSTTST-----FCGTPE 204
Query: 234 YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME 282
Y +PEV+ PY +D W LG +L E+ G P F N E I+
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 36/121 (29%), Positives = 58/121 (47%), Gaps = 6/121 (4%)
Query: 166 FSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSS---CYS 221
FS R + +V L LH E N+++ DLK EN++L + G IK+ DFG
Sbjct: 245 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKD 302
Query: 222 HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIM 281
+ T+ + Y +PEV+ YG +D W LG ++ E+ G F ++ + I+
Sbjct: 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362
Query: 282 E 282
Sbjct: 363 M 363
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFG------SSCYSHQRVYTYIQSRFYRSPEV 239
H+ IIH D+KP N+++ ++KV+DFG S S + I + Y SPE
Sbjct: 133 HQNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 240 ILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEV 274
G D++SLGC+L E+ TG P F G++ V
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFG----SSCYSHQRVYTYIQSRFYRSPEVIL 241
H I+H D+KP+N+L+ ++K+ DFG S S + + + Y SPE
Sbjct: 128 HDMRIVHRDIKPQNILIDSNK--TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEV 274
G D++S+G +L E+ G P F GE V
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 23/91 (25%), Positives = 42/91 (46%), Gaps = 6/91 (6%)
Query: 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFG----SSCYSHQRVYTYIQSRFYRSPEVIL 241
H H D+KPEN+L+ ++DFG ++ ++ + + +Y +PE
Sbjct: 151 HAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGEN 272
D+++L C+L E TG P + G+
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 9/111 (8%)
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS----CYSHQRVYTYIQSRFYRSPEVI 240
LH+ II+ D+K EN+LL G + + DFG S +R Y + + Y +P+++
Sbjct: 175 LHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 241 LGLPYG--PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIME-ILGCPP 288
G G +D WSLG ++ EL TG F + E A I IL P
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 35/118 (29%), Positives = 48/118 (40%), Gaps = 24/118 (20%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRF----- 233
L LH II+ DLK +NVLL G IK+ D+G T F
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTST-----FCGTPN 175
Query: 234 YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFP---------GENEVEQLACIME 282
Y +PE++ G YG +D W+LG ++ E+ G F E I+E
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 35/118 (29%), Positives = 48/118 (40%), Gaps = 24/118 (20%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRF----- 233
L LH II+ DLK +NVLL G IK+ D+G T F
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTST-----FCGTPN 218
Query: 234 YRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFP---------GENEVEQLACIME 282
Y +PE++ G YG +D W+LG ++ E+ G F E I+E
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 32/128 (25%), Positives = 52/128 (40%), Gaps = 7/128 (5%)
Query: 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG--SSCYSHQ 223
F ++ F LV L L + IIH D+KP+N+LL + G + + DF +
Sbjct: 112 FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPRET 169
Query: 224 RVYTYIQSRFYRSPEVIL---GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACI 280
++ T ++ Y +PE+ G Y +D WSLG EL G + + +
Sbjct: 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
Query: 281 MEILGCPP 288
Sbjct: 230 HTFETTVV 237
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 45/260 (17%), Positives = 87/260 (33%), Gaps = 67/260 (25%)
Query: 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLD 77
+ Y++ IG+GSFG + + N A+K+ E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--------EPRRSD----------- 48
Query: 78 ACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF 137
Q E R L + ++ +
Sbjct: 49 ----------------------------APQLRDEYRTYKLLAGCT-----GIPNVYYFG 75
Query: 138 YFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
H + +L+ +L +L+ + FS+ + A ++ ++ +H +++++ D+KP
Sbjct: 76 QEGLHNVLVIDLLGPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKP 134
Query: 198 ENVLLKQRGSSS---IKVIDFG-SSCYSHQRVYTYIQSR---------FYRSPEVILGLP 244
+N L+ + S + I V+DFG Y +I R Y S LG
Sbjct: 135 DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 194
Query: 245 YGPPIDMWSLGCILAELYTG 264
D+ +LG + G
Sbjct: 195 QSRRDDLEALGHVFMYFLRG 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 47/258 (18%), Positives = 94/258 (36%), Gaps = 65/258 (25%)
Query: 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLD 77
+ ++ + IG GSFG++ + +TN A+K E + +
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTK----------- 45
Query: 78 ACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF 137
H Q L E +I L+ + ++ +
Sbjct: 46 ----------------------------HPQLLYESKIYRILQ-----GGTGIPNVRWFG 72
Query: 138 YFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
++ + +L+ +L +L + + SL + A ++ + +H ++ +H D+KP
Sbjct: 73 VEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
Query: 198 ENVLLKQRGSSS-IKVIDFGSSC-YSHQRVYTYIQSR---------FYRSPEVILGLPYG 246
+N L+ ++ + +IDFG + Y + +I R Y S LG+
Sbjct: 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS 191
Query: 247 PPIDMWSLGCILAELYTG 264
D+ SLG +L G
Sbjct: 192 RRDDLESLGYVLMYFLRG 209
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 53/258 (20%), Positives = 90/258 (34%), Gaps = 65/258 (25%)
Query: 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLD 77
+ RY + IG GSFG + D A+K E +T+
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTK------------- 47
Query: 78 ACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF 137
H Q IE +I ++ + +
Sbjct: 48 ----------------------------HPQLHIESKIYKMMQG-----GVGIPTIRWCG 74
Query: 138 YFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
++ + EL+ +L +L + + FSL + A ++ + +H +N IH D+KP
Sbjct: 75 AEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHSKNFIHRDVKP 133
Query: 198 ENVLLKQRG-SSSIKVIDFG-SSCYSHQRVYTYIQSR---------FYRSPEVILGLPYG 246
+N L+ + + +IDFG + Y R + +I R Y S LG+
Sbjct: 134 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 193
Query: 247 PPIDMWSLGCILAELYTG 264
D+ SLG +L G
Sbjct: 194 RRDDLESLGYVLMYFNLG 211
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 49/260 (18%), Positives = 88/260 (33%), Gaps = 67/260 (25%)
Query: 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLD 77
+ + + + IG G+FG++ + TN + A+K E +
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK--------LEPMKSR----------- 47
Query: 78 ACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYF 137
Q +E R L S + + +
Sbjct: 48 ----------------------------APQLHLEYRFYKQLG-----SGDGIPQVYYFG 74
Query: 138 YFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKP 197
+ + EL+ +L +L + FSL + A L+ + +H +N+I+ D+KP
Sbjct: 75 PCGKYNAMVLELLGPSLEDLFDLCDRT-FSLKTVLMIAIQLISRMEYVHSKNLIYRDVKP 133
Query: 198 ENVLLKQRGSSS---IKVIDFG-SSCYSHQRVYTYIQSR---------FYRSPEVILGLP 244
EN L+ + G+ + I +IDF + Y +I R Y S LG
Sbjct: 134 ENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE 193
Query: 245 YGPPIDMWSLGCILAELYTG 264
D+ +LG + G
Sbjct: 194 QSRRDDLEALGHMFMYFLRG 213
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 78/393 (19%), Positives = 126/393 (32%), Gaps = 113/393 (28%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHG 83
++LE+IG+G +G V + + A K+
Sbjct: 16 KLLELIGRGRYGAVYKG----------SLDE--------RPV------------AVKVFS 45
Query: 84 EESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHL 143
+ F +E Y H + R + + AD R
Sbjct: 46 FANRQN---FINEKNIYRVPLMEHDNI--ARFIVGDERVTADG-------------RMEY 87
Query: 144 CISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE---------NIIHC 193
+ E N +L + + + R A S+ + L LH E I H
Sbjct: 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR 144
Query: 194 DLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF-----------YRSPEVILG 242
DL NVL+K G + + DFG S Y +PEV+ G
Sbjct: 145 DLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202
Query: 243 L-------PYGPPIDMWSLGCILAELYTGC-PLFPGENEVE-QLACIMEILGCPPDEVIN 293
+DM++LG I E++ C LFPGE+ E Q+A E+ P E +
Sbjct: 203 AVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQ 262
Query: 294 TA---SRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSK 350
++R F NS ++ + + C++ D++
Sbjct: 263 VLVSREKQRPKFP----EAWKENSLAV-----------------RSLKETIEDCWDQDAE 301
Query: 351 KRLTPD------EALRHEWLKSSSSSSSSSSHH 377
RLT L W ++ S S ++ HH
Sbjct: 302 ARLTAQXAEERMAELMMIWERNKSVSPTAHHHH 334
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 23/208 (11%), Positives = 62/208 (29%), Gaps = 39/208 (18%)
Query: 13 QVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIW 72
VL D ++++ + + G + Y + + +
Sbjct: 34 TVLTDKSGRQWKLKSFQTRDNQGIL--------------YEAAPTSTLTCDSGPQKQKF- 78
Query: 73 YLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIH 132
+ K+ ++ ++G +E + + Q + L +
Sbjct: 79 -----SLKL---DA--KDGRLFNEQNFFQRAAKPLQVNKWKK----LYSTPL------LA 118
Query: 133 MLEYFYF----RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE 188
+ F + + + +L + + S + + A L+ L LH
Sbjct: 119 IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN 178
Query: 189 NIIHCDLKPENVLLKQRGSSSIKVIDFG 216
+H ++ EN+ + S + + +G
Sbjct: 179 EYVHGNVTAENIFVDPEDQSQVTLAGYG 206
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 40/161 (24%), Positives = 64/161 (39%), Gaps = 34/161 (21%)
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE----------NI 190
L + +L + +K N S + A ++ + L LH + I
Sbjct: 96 DLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152
Query: 191 IHCDLKPENVLLKQRGSSSIKVIDFG---------SSCYSHQRVYTYIQSRFYRSPEVI- 240
H D+K +NVLLK + + DFG S+ +H +V T R Y +PEV+
Sbjct: 153 SHRDIKSKNVLLKNNL--TACIADFGLALKFEAGKSAGDTHGQVGTR---R-YMAPEVLE 206
Query: 241 ----LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQL 277
IDM+++G +L EL + C G + L
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 35/275 (12%), Positives = 87/275 (31%), Gaps = 67/275 (24%)
Query: 13 QVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIW 72
+++ D +++ IG+G FG + Y + +
Sbjct: 27 EIITDMAAAAWKVGLPIGQGGFGCI--------------YLADMNSSESVGSDAPC---- 68
Query: 73 YLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIH 132
K+ + E++ K + +
Sbjct: 69 -----VVKVE--------------------PSDNGPLFTELKFYQRAAKPEQIQKWIRTR 103
Query: 133 ML------EYFYF-------RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179
L +Y+ +++ + + +L ++ + N + FS + + + ++
Sbjct: 104 KLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR-FSRKTVLQLSLRIL 162
Query: 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSR------ 232
L +H +H D+K N+LL + + ++D+G + Y + V+ +
Sbjct: 163 DILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD 222
Query: 233 ---FYRSPEVILGLPYGPPIDMWSLGCILAELYTG 264
+ S + G+ D+ LG + + TG
Sbjct: 223 GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG 257
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 14/107 (13%), Positives = 20/107 (18%), Gaps = 26/107 (24%)
Query: 182 LRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVIL 241
HR + P V + G + +
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA-----------------TMPDA--- 179
Query: 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP 288
P D+ +G L L P LA P
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 31/219 (14%), Positives = 71/219 (32%), Gaps = 60/219 (27%)
Query: 13 QVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIW 72
+VL D ++ + + IG G FG + A ++
Sbjct: 29 KVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-------------------- 68
Query: 73 YLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIH 132
K+ + + + E++ + KKD +
Sbjct: 69 -----VVKV--------------------EYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 133 MLE------YFYF-------RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179
L+ ++ R++ + E + ++L ++ +N F + + ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRML 161
Query: 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSS 218
L +H +H D+K N+LL + + + D+G S
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 1e-10
Identities = 43/258 (16%), Positives = 80/258 (31%), Gaps = 30/258 (11%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALK-----YYGNQLTEFERTEIEKYLEIWYLGL 76
+ + E IG+G FG+V + + T A+K ++T E EI
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTFEEILPEIIISK- 78
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
+ E ++ GF N + + + L++ +S+ +
Sbjct: 79 -ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKA-------WDHYNSTKGSANDRPD 130
Query: 137 FYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDL 195
F+ + L I E +++ + SL + L L + H DL
Sbjct: 131 FFKDDQLFIVLEFEFGG--IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDL 188
Query: 196 KPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255
NVLLK+ + G S S + + Y
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKS------------STIPSCGLQVSIIDYTLSRLERDGI 236
Query: 256 CILAELYTGCPLFPGENE 273
+ ++ LF G+ +
Sbjct: 237 VVFCDVSMDEDLFTGDGD 254
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 42/173 (24%), Positives = 70/173 (40%), Gaps = 14/173 (8%)
Query: 129 NVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHR 187
N++ +L I E M NL + ++ N Q S ++ A + + L +
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSR----FYRSPEVILGL 243
+N IH +L N L+ + +KV DFG S YT + +PE +
Sbjct: 337 KNFIHRNLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 244 PYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACI-----MEI-LGCPPD 289
+ D+W+ G +L E+ T G +PG + + + ME GCP
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 447
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 41/162 (25%), Positives = 63/162 (38%), Gaps = 14/162 (8%)
Query: 140 RNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ I E M +L + +K + L + A + + + R N +H DL+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 309
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSR----FYRSPEVILGLPYGPPIDMWSL 254
N+L+ + KV DFG + YT Q + +PE L + D+WS
Sbjct: 310 NILVGENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367
Query: 255 GCILAELYT-GCPLFPGENEVEQLACI-----MEI-LGCPPD 289
G +L EL T G +PG E L + M CP
Sbjct: 368 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 41/162 (25%), Positives = 63/162 (38%), Gaps = 14/162 (8%)
Query: 140 RNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ I E M +L + +K + L + A + + + R N +H DL+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 392
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSR----FYRSPEVILGLPYGPPIDMWSL 254
N+L+ + KV DFG + YT Q + +PE L + D+WS
Sbjct: 393 NILVGENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 450
Query: 255 GCILAELYT-GCPLFPGENEVEQLACI-----MEI-LGCPPD 289
G +L EL T G +PG E L + M CP
Sbjct: 451 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 492
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 31/129 (24%), Positives = 58/129 (44%), Gaps = 7/129 (5%)
Query: 140 RNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ + I E M +L + +K + L + F+ + + + + + N IH DL+
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 313
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ-SRF---YRSPEVILGLPYGPPIDMWSL 254
N+L+ K+ DFG + YT + ++F + +PE I + D+WS
Sbjct: 314 NILVSASL--VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 371
Query: 255 GCILAELYT 263
G +L E+ T
Sbjct: 372 GILLMEIVT 380
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 36/160 (22%), Positives = 67/160 (41%), Gaps = 20/160 (12%)
Query: 143 LCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L I E M +L + ++ + +F+ + + + L N +H DL NVL
Sbjct: 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 321
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQS--RF-YR--SPEVILGLPYGPPIDMWSLGC 256
+ + + KV DFG + + + Q + + +PE + + D+WS G
Sbjct: 322 VSE--DNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 374
Query: 257 ILAELYT-GCPLFPGENEVEQLACI-----MEI-LGCPPD 289
+L E+Y+ G +P + + + M+ GCPP
Sbjct: 375 LLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 414
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 34/158 (21%), Positives = 64/158 (40%), Gaps = 15/158 (9%)
Query: 143 LCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ I E M +L +++++ Q F++ + + ++ L +H DL N+L
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNIL 179
Query: 202 LKQRGSSSI-KVIDFGSSCYSHQRVYTYIQSRFYR------SPEVILGLPYGPPIDMWSL 254
+ S+ + KV DFG +R + SPE I + D+WS
Sbjct: 180 I---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSY 236
Query: 255 GCILAELYT-GCPLFPGENEVEQLACIME--ILGCPPD 289
G +L E+ + G + + + + + E L P D
Sbjct: 237 GIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 32/157 (20%), Positives = 57/157 (36%), Gaps = 13/157 (8%)
Query: 143 LCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
I E M +L ++ ++ Q F++ + + +R L +H DL NVL
Sbjct: 125 AMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVL 183
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYR------SPEVILGLPYGPPIDMWSLG 255
+ KV DFG S + + +PE I + D+WS G
Sbjct: 184 VDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFG 241
Query: 256 CILAELYT-GCPLFPGENEVEQLACIME--ILGCPPD 289
++ E+ G + + ++ + E L P
Sbjct: 242 VVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG 278
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 10/155 (6%)
Query: 143 LCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
I E M NL + ++ N Q S ++ A + + L ++N IH DL N L
Sbjct: 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYT-YIQSRF---YRSPEVILGLPYGPPIDMWSLGCI 257
+ + +KV DFG S YT + ++F + +PE + + D+W+ G +
Sbjct: 144 VGENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 258 LAELYT-GCPLFPGENEVEQLACIME--ILGCPPD 289
L E+ T G +PG + + + + + P
Sbjct: 202 LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 60/474 (12%), Positives = 129/474 (27%), Gaps = 136/474 (28%)
Query: 28 VIGKGSFG------QVIRALDHKTNTHALKYY---GNQLTEFERTEIEKYLEIWYLGLDA 78
+ G G V + + ++ N + E+ + L +D
Sbjct: 155 IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL---LYQID- 210
Query: 79 CKIHGEESLSQNGGFDDENGSYNKKRF-----HHQALIEVRILDHLRKKDADSSYNVIHM 133
S N + +R + L+ +L +++ A
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL---VLLNVQNAKA--------- 258
Query: 134 LEYFYFRNHLC----------ISFELMNLNLYELIKRNNYQGF----SLGLIRRFAFSLV 179
F C ++ L + ++ L+ ++
Sbjct: 259 WNAFNLS---CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 180 QCLR--------LLH-------RENIIHCD--LKPENVLLKQRGSSSIKVIDFGSSCYSH 222
Q L R+ + D L SS+ V++ +
Sbjct: 316 QDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP----AEY 371
Query: 223 QRVYTYIQSRFYRS---PEVILGLPYGPPIDMWS------LGCILAELYTGCPLFPGENE 273
++++ + S F S P ++L L +W + ++ +L+ + +
Sbjct: 372 RKMFDRL-SVFPPSAHIPTILLSL-------IWFDVIKSDVMVVVNKLHKYSLVE--KQP 421
Query: 274 VEQLACIMEI---LGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK------------ 318
E I I L + N + R D P+ +
Sbjct: 422 KESTISIPSIYLELKVKLE---NEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG 478
Query: 319 ---RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSS 375
+ + ++ R F+DF + +K +RH+ ++ ++S S
Sbjct: 479 HHLKNIEHPERMTLFR---MVFLDF-----RFLEQK-------IRHD--STAWNASGSIL 521
Query: 376 HHATDLRKSPSAHTNMYRLYRGVPTKPSAPADIDLNDSGTFLPPILFNIKLDKY 429
+ L+ Y+ + +N FLP I N+ KY
Sbjct: 522 NTLQQLKF-----------YKPYICDNDPKYERLVNAILDFLPKIEENLICSKY 564
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 2e-04
Identities = 31/183 (16%), Positives = 65/183 (35%), Gaps = 40/183 (21%)
Query: 15 LHDHICYRYEILEVIGKGSFGQVIRA-LDHKTNTHALKYYGNQLTEF-ERTEI-EKYLEI 71
+ D + ++ + + +I + L+ K + ++L+ F I L +
Sbjct: 337 IRDGLA-TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF-DRLSVFPPSAHIPTILLSL 394
Query: 72 -WY------LGLDACKIHG---------EESLSQNGGFDDENGSYNKKRFHHQALIEVRI 115
W+ + + K+H E ++S + + + H+ I
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR-----SI 449
Query: 116 LDHLRKKDADSSYNVI--HMLEYFYFRNHLCISFELMNLNLYELIK--RNNYQGFSLGLI 171
+DH S ++I ++ +YFY +H I L N+ E + R + F
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFY--SH--IGHHLKNIEHPERMTLFRMVFLDF----- 500
Query: 172 RRF 174
RF
Sbjct: 501 -RF 502
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 35/138 (25%), Positives = 63/138 (45%), Gaps = 10/138 (7%)
Query: 140 RNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198
+ + I E M N +L + +K + ++ + A + + + + N IH DL+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138
Query: 199 NVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ-SRF-YR--SPEVILGLPYGPPIDMWSL 254
N+L+ S K+ DFG + YT + ++F + +PE I + D+WS
Sbjct: 139 NILVSDTL--SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196
Query: 255 GCILAELYT--GCPLFPG 270
G +L E+ T P +PG
Sbjct: 197 GILLTEIVTHGRIP-YPG 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 52/277 (18%), Positives = 101/277 (36%), Gaps = 48/277 (17%)
Query: 24 EILEVIGKGSFGQVIRAL------DHKTNTHALKYYGNQLTEFERTEIEKYLEI------ 71
++ + +G+G+FGQVI A T A+K T E + L+I
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 72 -----------------WYLGLDACKIHGE--ESLSQNGGFDDENGSYNKKRFHHQALIE 112
+ ++ CK G L + + + +
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCK-FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 113 VRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIR 172
+D R+ D+ +S + ++ + E +LY+ +L +
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK-------DFLTLEHLI 196
Query: 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSR 232
++F + + + L IH DL N+LL + + +K+ DFG + ++ Y++
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYKDPD-YVRKG 253
Query: 233 FYR------SPEVILGLPYGPPIDMWSLGCILAELYT 263
R +PE I Y D+WS G +L E+++
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 34/157 (21%), Positives = 63/157 (40%), Gaps = 15/157 (9%)
Query: 143 LCISFELM---NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ I E + L Y L R++ +G + + + + + L IH DL N
Sbjct: 78 IYIVTEYISNGCLLNY-L--RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN 134
Query: 200 VLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ-SRF---YRSPEVILGLPYGPPIDMWSLG 255
L+ + +KV DFG + Y Y ++F + +PEV Y D+W+ G
Sbjct: 135 CLVDRDLC--VKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFG 192
Query: 256 CILAELYT-GCPLFPGENEVEQLACIME--ILGCPPD 289
++ E+++ G + E + + + L P
Sbjct: 193 ILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL 229
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 34/162 (20%), Positives = 61/162 (37%), Gaps = 19/162 (11%)
Query: 110 LIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM---NLNLYELIKRNNYQGF 166
L E RIL N++ ++ + + I EL+ + + L R
Sbjct: 160 LQEARILKQYSHP------NIVRLIGVCTQKQPIYIVMELVQGGDFLTF-L--RTEGARL 210
Query: 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY 226
+ + + + L + IH DL N L+ ++ +K+ DFG S VY
Sbjct: 211 RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLKISDFGMSREEADGVY 268
Query: 227 TYIQS--RF-YR--SPEVILGLPYGPPIDMWSLGCILAELYT 263
+ + +PE + Y D+WS G +L E ++
Sbjct: 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 34/157 (21%), Positives = 60/157 (38%), Gaps = 13/157 (8%)
Query: 143 LCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ I E M L + ++ + + FS+ + + ++ L N +H DL N+L
Sbjct: 121 MMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 179
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYR------SPEVILGLPYGPPIDMWSLG 255
+ KV DFG S + + +PE I + D+WS G
Sbjct: 180 VNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFG 237
Query: 256 CILAELYT-GCPLFPGENEVEQLACIME--ILGCPPD 289
++ E+ T G + + E + I + L P D
Sbjct: 238 IVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 274
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 429 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.24 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.81 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.36 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.25 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.18 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.18 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.09 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.0 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.84 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.26 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.85 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.84 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.33 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.4 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-61 Score=463.04 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=214.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+||++++.||+|+||+||+|+++.+++. |+|++.......
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--------------------------------------- 64 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS--------------------------------------- 64 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH---------------------------------------
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH---------------------------------------
Confidence 6899999999999999999999998865 999885443211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+|+++++.|+|+ ||++++++|.+++.+|||||||+ |+|.+++.......+++..++.|+.||
T Consensus 65 ----~~~~~~~~E~~il~~l~Hp------nIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi 134 (350)
T 4b9d_A 65 ----KEREESRREVAVLANMKHP------NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134 (350)
T ss_dssp ----HHHHHHHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHHHHHHCCCC------CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHH
Confidence 1123566799999999887 99999999999999999999995 699999987765668999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... ..+.+||+.|||||++.+..|+.++||||||
T Consensus 135 ~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlG 212 (350)
T 4b9d_A 135 CLALKHVHDRKILHRDIKSQNIFLTKDG--TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALG 212 (350)
T ss_dssp HHHHHHHHHTTCEETTCCGGGEEECTTC--CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred HHHHHHHHHCCeeeccCCHHHEEECCCC--CEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHH
Confidence 9999999999999999999999999988 8999999999865432 3456899999999999999999999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|+||+.||.+.+..+.+.+|.... .+. .....++
T Consensus 213 vilyemltG~~PF~~~~~~~~~~~i~~~~--~~~---------------------------------------~~~~~s~ 251 (350)
T 4b9d_A 213 CVLYELCTLKHAFEAGSMKNLVLKIISGS--FPP---------------------------------------VSLHYSY 251 (350)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCC---------------------------------------CCTTSCH
T ss_pred HHHHHHHHCCCCCCCcCHHHHHHHHHcCC--CCC---------------------------------------CCccCCH
Confidence 99999999999999999888887776521 110 0122478
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 252 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 252 DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 99999999999999999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-60 Score=445.02 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=204.7
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|+++.+++. |+|++.+....
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---------------------------------------- 52 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA---------------------------------------- 52 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------------------------------------------
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC----------------------------------------
Confidence 6899999999999999999999998865 99988543221
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.......+.+|+++++.++|+ ||++++++|.+++.+|+|||||+|+|.+++.+.. ++++..++.++.||+
T Consensus 53 --~~~~~~~~~~Ei~il~~l~Hp------nIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~~~--~l~e~~~~~~~~qi~ 122 (275)
T 3hyh_A 53 --KSDMQGRIEREISYLRLLRHP------HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD--KMSEQEARRFFQQII 122 (275)
T ss_dssp -----CHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEEECCCEEHHHHHHHSC--SCCHHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHHHHHHHCCCC------CCCeEEEEEEECCEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHH
Confidence 112234677899999999887 9999999999999999999999999999998764 499999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCC-CCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPY-GPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~ 256 (429)
.||+|||++||+||||||+|||++.++ .+||+|||+|+.... ...+.+||+.|+|||++.+..| +.++|||||||
T Consensus 123 ~al~ylH~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGv 200 (275)
T 3hyh_A 123 SAVEYCHRHKIVHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 200 (275)
T ss_dssp HHHHHHHHTTCCCCCCCTTTEEECTTC--CEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHH
T ss_pred HHHHHHHHCCcccccCChHHeEECCCC--CEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHH
Confidence 999999999999999999999999988 899999999976443 3445789999999999998876 57999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|+||+.||.+.+..+.+..+.......+ ...+++
T Consensus 201 ily~lltg~~PF~~~~~~~~~~~i~~~~~~~p------------------------------------------~~~s~~ 238 (275)
T 3hyh_A 201 ILYVMLCRRLPFDDESIPVLFKNISNGVYTLP------------------------------------------KFLSPG 238 (275)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------------------------------------------TTSCHH
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC------------------------------------------CCCCHH
Confidence 99999999999999888777766654211111 123788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
+.+||++||+.||++|||+.|+++||||+.
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 999999999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-60 Score=453.88 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=218.3
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|+++++||+|+||+||+|+++.+++. |||++....
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~----------------------------------------- 111 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----------------------------------------- 111 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-----------------------------------------
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-----------------------------------------
Confidence 57899999999999999999999999975 888874221
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
....+.+.+|+++|+.++|+ ||++++++|.+++.+|||||||+ |+|.+++... ++++..++.|+.|
T Consensus 112 ----~~~~~~~~~Ei~il~~l~Hp------nIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~q 178 (346)
T 4fih_A 112 ----QQRRELLFNEVVIMRDYQHE------NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLA 178 (346)
T ss_dssp ----CSSGGGGHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHH
T ss_pred ----hhHHHHHHHHHHHHHhCCCC------CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHH
Confidence 11124567899999999887 99999999999999999999995 6999998764 3999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
|+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... ...+.+||+.|||||++.+..|+.++|||||
T Consensus 179 i~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 256 (346)
T 4fih_A 179 VLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL 256 (346)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCcccccCCHHHEEECCCC--CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence 99999999999999999999999999988 899999999976542 3456799999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||++|||++|++||.+.+..+.+..|......... .+...+
T Consensus 257 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~---------------------------------------~~~~~s 297 (346)
T 4fih_A 257 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK---------------------------------------NLHKVS 297 (346)
T ss_dssp HHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCS---------------------------------------CGGGSC
T ss_pred HHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC---------------------------------------ccccCC
Confidence 99999999999999999888887776542111100 112348
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
+++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 298 ~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 298 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 899999999999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-60 Score=450.42 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=219.3
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|+++.+++. |+|++.+....
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~---------------------------------------- 71 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII---------------------------------------- 71 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH----------------------------------------
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC----------------------------------------
Confidence 5699999999999999999999999975 99988543211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.......+.+|+++|+.++|+ ||++++++|++++++|+|||||. |+|.+++.+.. .+++..++.++.||
T Consensus 72 --~~~~~~~~~~E~~il~~l~Hp------nIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi 141 (311)
T 4aw0_A 72 --KENKVPYVTRERDVMSRLDHP------FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEI 141 (311)
T ss_dssp --HTTCHHHHHHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHHHHHHhCCCC------CCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHH
Confidence 112234677899999999877 99999999999999999999995 69999998765 49999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc-----CcceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-----QRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
+.||+|||++||+||||||+|||++.++ .+||+|||+|+... ....+.+||+.|||||++.+..|+.++||||
T Consensus 142 ~~al~ylH~~~IiHRDlKPeNILl~~~g--~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWS 219 (311)
T 4aw0_A 142 VSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 219 (311)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHH
T ss_pred HHHHHHHHHCCCccCCCCHHHeEEcCCC--CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHH
Confidence 9999999999999999999999999988 89999999997643 2345679999999999999999999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|+|+||++||.+.+..+.+.+|...-...+ ...
T Consensus 220 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p------------------------------------------~~~ 257 (311)
T 4aw0_A 220 LGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP------------------------------------------EKF 257 (311)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------------------------------------------TTC
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------------------------------------------ccc
Confidence 99999999999999999998888877765221111 123
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDE------ALRHEWLKSSS 368 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~e------ll~h~~~~~~~ 368 (429)
++++.+||++||+.||++|||+.| +++||||++..
T Consensus 258 s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 258 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp CHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 788999999999999999999988 58999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=455.43 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=217.9
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|+++++||+|+||+||+|+++.+|+. |||++....
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~----------------------------------------- 188 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----------------------------------------- 188 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-----------------------------------------
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-----------------------------------------
Confidence 57899999999999999999999999975 888874221
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
....+.+.+|+++|+.++|+ ||++++++|.+.+.+|||||||+ |+|.+++... ++++..++.|+.|
T Consensus 189 ----~~~~~~~~~Ei~il~~l~Hp------nIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~q 255 (423)
T 4fie_A 189 ----QQRRELLFNEVVIMRDYQHE------NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLA 255 (423)
T ss_dssp ----CSSGGGHHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHH
T ss_pred ----hhHHHHHHHHHHHHHhCCCC------CCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHH
Confidence 11234577899999999887 99999999999999999999995 6999999764 3999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
|+.||+|||++|||||||||+|||++.++ .+||+|||+|+... ....+.+||+.|||||++.+..|+.++|||||
T Consensus 256 il~aL~ylH~~~IiHRDiKp~NILl~~~g--~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 333 (423)
T 4fie_A 256 VLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL 333 (423)
T ss_dssp HHHHHHHHHHTTEECCCCSTTTEEECTTC--CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence 99999999999999999999999999998 89999999997643 23456799999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||++|||++|++||.+.+..+.+..|........ ..+...+
T Consensus 334 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~---------------------------------------~~~~~~s 374 (423)
T 4fie_A 334 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL---------------------------------------KNLHKVS 374 (423)
T ss_dssp HHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---------------------------------------SCTTSSC
T ss_pred HHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---------------------------------------cccccCC
Confidence 9999999999999999988888777654211100 0012347
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
+++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 375 ~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 375 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 899999999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=455.18 Aligned_cols=286 Identities=29% Similarity=0.530 Sum_probs=234.1
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+++||++++.||+|+||+||+|+++.+|+. |||++......
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-------------------------------------- 93 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-------------------------------------- 93 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS--------------------------------------
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc--------------------------------------
Confidence 578999999999999999999999999975 99988543221
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~ 171 (429)
......+.+|+++|+.++|+ ||+++++++... +++|+|||||+|+|.+++.... ++++..+
T Consensus 94 -----~~~~~~~~~Ei~il~~l~Hp------nIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~--~l~~~~~ 160 (398)
T 4b99_A 94 -----VTNAKRTLRELKILKHFKHD------NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQ--PLTLEHV 160 (398)
T ss_dssp -----HHHHHHHHHHHHHHHHCCCT------TBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSS--CCCHHHH
T ss_pred -----hHHHHHHHHHHHHHHhcCCC------CcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhcC--CCCHHHH
Confidence 11223566799999999887 999999998643 5799999999999999997654 5999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc-------CcceeeecCccccchhhhhCC-
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-------QRVYTYIQSRFYRSPEVILGL- 243 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-------~~~~~~~~t~~y~aPE~~~~~- 243 (429)
+.+++||+.||+|||++|||||||||+|||++.++ .+||+|||+++... ....+.+||+.|+|||++.+.
T Consensus 161 ~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~--~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~ 238 (398)
T 4b99_A 161 RYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC--ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 238 (398)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC--CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCS
T ss_pred HHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC--CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCC
Confidence 99999999999999999999999999999999988 89999999997532 223457899999999999876
Q ss_pred CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
.|+.++||||+||++|+|++|++||.+.+..+++..|....+.++.+.+............ .. ......
T Consensus 239 ~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~-------~~----~~~~~~ 307 (398)
T 4b99_A 239 EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYI-------QS----LPPRQP 307 (398)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHH-------HS----SCCCCC
T ss_pred CCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhh-------hc----CCCcCC
Confidence 4699999999999999999999999999999999999999999887765433221111000 00 011122
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.......+..++++.|||++||++||++||||.|+|+||||+...
T Consensus 308 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 308 VPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 334556667789999999999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=428.13 Aligned_cols=259 Identities=20% Similarity=0.327 Sum_probs=210.1
Q ss_pred hcccccCCe-EEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 15 LHDHICYRY-EILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 15 ~~~~~~~rY-~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
.+....+|| ++.++||+|+||+||+|.+..++.. |+|++.......
T Consensus 19 ~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-------------------------------- 66 (290)
T 3fpq_A 19 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-------------------------------- 66 (290)
T ss_dssp EEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--------------------------------
T ss_pred cCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH--------------------------------
Confidence 444556777 7888999999999999999998864 888875432211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE----cCeEEEEEeecC-cCHHHHHHhhCCCCCC
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF----RNHLCISFELMN-LNLYELIKRNNYQGFS 167 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~-g~L~~~i~~~~~~~~~ 167 (429)
.....+.+|+++++.++|+ ||++++++|.. +..+|+|||||+ |+|.+++.+.. .++
T Consensus 67 -----------~~~~~~~~E~~il~~l~Hp------nIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~ 127 (290)
T 3fpq_A 67 -----------SERQRFKEEAEMLKGLQHP------NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMK 127 (290)
T ss_dssp -----------HHHHHHHHHHHHHHTCCCT------TBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS--SCC
T ss_pred -----------HHHHHHHHHHHHHHhCCCC------CCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCC
Confidence 1123567799999999887 99999999976 346899999995 69999998765 499
Q ss_pred HHHHHHHHHHHHHHHHHHHHCC--ceecccCCCcEEEec-CCCcceEEeeeccccccc-CcceeeecCccccchhhhhCC
Q psy17270 168 LGLIRRFAFSLVQCLRLLHREN--IIHCDLKPENVLLKQ-RGSSSIKVIDFGSSCYSH-QRVYTYIQSRFYRSPEVILGL 243 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~--ivH~dlkp~Nili~~-~~~~~vkl~Dfg~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 243 (429)
+..++.|+.||+.||+|||++| |+||||||+|||++. ++ .+||+|||+|+... ....+.+||+.|||||++.+
T Consensus 128 ~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g--~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~- 204 (290)
T 3fpq_A 128 IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE- 204 (290)
T ss_dssp HHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS--CEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC--CEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-
Confidence 9999999999999999999998 999999999999985 56 89999999997544 33456789999999999876
Q ss_pred CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
.|+.++|||||||++|+|+||+.||.+.+....+...... +..+.
T Consensus 205 ~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~---------------------------------- 249 (290)
T 3fpq_A 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA---------------------------------- 249 (290)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG----------------------------------
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCC----------------------------------
Confidence 6999999999999999999999999876655444332210 11111
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
......++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 250 ----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 112234788999999999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=437.68 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=209.2
Q ss_pred cCCeEEEeEeeccccceEEEEEecC---CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHK---TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~---~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
-++|++++.||+|+||+||+|++.. +++ +|+|++.+....
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~------------------------------------ 66 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK------------------------------------ 66 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE------------------------------------
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC------------------------------------
Confidence 3689999999999999999999853 443 488877433211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
......+.+|+++++.++|+ ||++++++|.+++.+|+|||||+ |+|.+++.+.. .+++.+++.+
T Consensus 67 -------~~~~~~~~~E~~il~~l~Hp------nIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~ 131 (304)
T 3ubd_A 67 -------VRDRVRTKMERDILVEVNHP------FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFY 131 (304)
T ss_dssp -------EEECC------CCCCCCCCT------TEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHH
T ss_pred -------hHHHHHHHHHHHHHHHCCCC------CCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHH
Confidence 01112455688888888776 99999999999999999999995 69999998765 4999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
+.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+... ....+.+||+.|||||++.+..|+.++||
T Consensus 132 ~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Di 209 (304)
T 3ubd_A 132 LAELALALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 209 (304)
T ss_dssp HHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS--CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHH
T ss_pred HHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC--CEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcc
Confidence 99999999999999999999999999999988 89999999997532 33456789999999999999999999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|+||+.||.+.+..+.+..|.......| .
T Consensus 210 wSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p------------------------------------------~ 247 (304)
T 3ubd_A 210 WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP------------------------------------------Q 247 (304)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------------------------------------T
T ss_pred cchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC------------------------------------------C
Confidence 9999999999999999999998888877765211111 1
Q ss_pred cCChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTP-----DEALRHEWLKSS 367 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta-----~ell~h~~~~~~ 367 (429)
..++++.+||++||+.||++|||| +|+++||||+..
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 248 FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 247899999999999999999994 799999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-57 Score=432.70 Aligned_cols=250 Identities=22% Similarity=0.295 Sum_probs=209.2
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|++.++||+|+||+||+|+++.++.. |+|++....
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~------------------------------------------ 95 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------------------------------------------ 95 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT------------------------------------------
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH------------------------------------------
Confidence 5699999999999999999999999865 888874221
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
...+|+++++.++|+ ||++++++|.++..+|||||||+ |+|.+++.+.. .+++..++.|+.||
T Consensus 96 --------~~~~E~~il~~l~Hp------nIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi 159 (336)
T 4g3f_A 96 --------FRVEELVACAGLSSP------RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQA 159 (336)
T ss_dssp --------CCTHHHHTTTTCCCT------TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHH
T ss_pred --------hHHHHHHHHHhCCCC------CCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHH
Confidence 112499999888776 99999999999999999999995 69999998765 49999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--------ceeeecCccccchhhhhCCCCCCCcc
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--------VYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
+.||+|||++|||||||||+|||++.++. .+||+|||+|+..... ....+||+.|||||++.+..|+.++|
T Consensus 160 ~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~D 238 (336)
T 4g3f_A 160 LEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 238 (336)
T ss_dssp HHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHH
T ss_pred HHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHH
Confidence 99999999999999999999999998762 5999999999754321 12357999999999999999999999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||||++|+|+||++||.+.+..+.+..|.. +.++ ....+
T Consensus 239 iwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~-------------------------------------~~~~~ 279 (336)
T 4g3f_A 239 IWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS--EPPP-------------------------------------IREIP 279 (336)
T ss_dssp HHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH--SCCG-------------------------------------GGGSC
T ss_pred HHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc--CCCC-------------------------------------chhcC
Confidence 99999999999999999998776665555543 1111 11223
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEA-------------LRHEWLKSSS 368 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~el-------------l~h~~~~~~~ 368 (429)
+..++.+.+||.+||+.||++|||+.|+ |+|||+....
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 3458899999999999999999999997 5799997654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=430.72 Aligned_cols=291 Identities=22% Similarity=0.353 Sum_probs=216.9
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecC---CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHK---TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~---~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
+.+.++|+++++||+|+||+||+|+++. +++ +|+|++....
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----------------------------------- 61 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----------------------------------- 61 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----------------------------------
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----------------------------------
Confidence 4588999999999999999999999852 343 4888763321
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
....+.+|+++|+.+. .||||++++++|.+.+++|+|||||+ |+|.+++. .+++.++
T Consensus 62 ------------~~~~~~~E~~~l~~~~-----~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~ 119 (361)
T 4f9c_A 62 ------------HPIRIAAELQCLTVAG-----GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEV 119 (361)
T ss_dssp ------------CHHHHHHHHHHHHHTC-----SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHH
T ss_pred ------------CHHHHHHHHHHHHHhc-----CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHH
Confidence 1224566999999884 23499999999999999999999995 69999884 3999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecC-CCcceEEeeecccccccC---------------------------
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQR-GSSSIKVIDFGSSCYSHQ--------------------------- 223 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~-~~~~vkl~Dfg~~~~~~~--------------------------- 223 (429)
+.++.||+.||+|||++||+||||||+|||++.+ + .+||+|||+|+....
T Consensus 120 ~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (361)
T 4f9c_A 120 REYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK--KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197 (361)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEECTTCSCGGGGGC------------------
T ss_pred HHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCC--eEEECcCCCCcccCCccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999876 5 899999999964321
Q ss_pred ----cceeeecCccccchhhhhCC-CCCCCccccchhhHHHHHhhCCCCC-CCCCHHHHHHHHHHHhCCCcHHHHhhhhh
Q psy17270 224 ----RVYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCILAELYTGCPLF-PGENEVEQLACIMEILGCPPDEVINTASR 297 (429)
Q Consensus 224 ----~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 297 (429)
...+.+||+.|+|||++.+. .|+.++||||+||++|+|+||+.|| .+.++.+++..|...+|.+..........
T Consensus 198 ~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~ 277 (361)
T 4f9c_A 198 SRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFG 277 (361)
T ss_dssp --------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred cccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcc
Confidence 12235799999999999876 4899999999999999999999998 56678899999999988655443322211
Q ss_pred hhhhccCCCCCcc--------ccCCCC-----CCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 298 RRLFFDSKGTPRC--------ITNSKG-----RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 298 ~~~~~~~~~~~~~--------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
........ .+.. ...... .............+...++++.|||++||++||++|+||+|+|+||||
T Consensus 278 ~~~~~~~~-~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 278 KSILCSKE-VPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp EEEEESSC-CCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred cccccccc-CcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 11111000 0000 000000 000000111122334568899999999999999999999999999999
Q ss_pred CCC
Q psy17270 365 KSS 367 (429)
Q Consensus 365 ~~~ 367 (429)
++.
T Consensus 357 ~~i 359 (361)
T 4f9c_A 357 KDM 359 (361)
T ss_dssp TTC
T ss_pred CCC
Confidence 874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=408.39 Aligned_cols=253 Identities=21% Similarity=0.329 Sum_probs=194.5
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|++++.||+|+||+||+|+++.++.. |+|++......
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---------------------------------------- 44 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE---------------------------------------- 44 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH----------------------------------------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH----------------------------------------
Confidence 3499999999999999999999998865 99988544322
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC------------eEEEEEeecC-cCHHHHHHhhCC-CC
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN------------HLCISFELMN-LNLYELIKRNNY-QG 165 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~------------~~~lv~e~~~-g~L~~~i~~~~~-~~ 165 (429)
...+.+.+|+++|+.++|+ ||++++++|...+ ++|+|||||. |+|.+++..... ..
T Consensus 45 ----~~~~~~~~E~~il~~l~Hp------nIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~ 114 (299)
T 4g31_A 45 ----LAREKVMREVKALAKLEHP------GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114 (299)
T ss_dssp ----HHHHHHHHHHHHHTTCCCT------TBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGG
T ss_pred ----HHHHHHHHHHHHHHhCCCC------CCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCCh
Confidence 1223566799999999877 9999999997654 4799999995 699999986542 12
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---------------ceeeec
Q psy17270 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---------------VYTYIQ 230 (429)
Q Consensus 166 ~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---------------~~~~~~ 230 (429)
.+...++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... ..+.+|
T Consensus 115 ~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~--~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~G 192 (299)
T 4g31_A 115 RERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVG 192 (299)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCCCC--------------------------C
T ss_pred hHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC--cEEEccCccceecCCCccccccccccccccccCCccc
Confidence 55677899999999999999999999999999999999988 8999999999754321 223579
Q ss_pred CccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcc
Q psy17270 231 SRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC 310 (429)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (429)
|+.|||||++.+..|+.++|||||||++|||++ ||.+. .+....+........+..
T Consensus 193 T~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~~~~~~p~~------------------- 248 (299)
T 4g31_A 193 TKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDVRNLKFPPL------------------- 248 (299)
T ss_dssp CCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHTTCCCHH-------------------
T ss_pred CccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHHhcCCCCCC-------------------
Confidence 999999999999999999999999999999996 77543 333333333222111111
Q ss_pred ccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 311 ITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+...++.+.+||++||+.||++|||+.|+|+||||+...
T Consensus 249 -------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 249 -------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp -------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred -------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 112256778999999999999999999999999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=419.68 Aligned_cols=311 Identities=61% Similarity=1.103 Sum_probs=260.0
Q ss_pred hhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 14 ~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
+.++.+.+||++++.||+|+||+||+|.+..++.. |+|++....
T Consensus 90 ~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----------------------------------- 134 (429)
T 3kvw_A 90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----------------------------------- 134 (429)
T ss_dssp CTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-----------------------------------
T ss_pred cCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-----------------------------------
Confidence 44567899999999999999999999999998865 999875321
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|+++++.++|.+...|+||+++++++....++|+|||+++++|.+++......++++..++
T Consensus 135 -----------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~ 203 (429)
T 3kvw_A 135 -----------RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR 203 (429)
T ss_dssp -----------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHH
T ss_pred -----------chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHH
Confidence 223355669999999999998999999999999999999999999999999999998876779999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.++.||+.||+|||++||+||||||+|||++.++...+||+|||++..........+||+.|+|||++.+..++.++|||
T Consensus 204 ~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 283 (429)
T 3kvw_A 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMW 283 (429)
T ss_dssp HHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHH
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHH
Confidence 99999999999999999999999999999999874449999999998877777778899999999999999999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCC----------------CC
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS----------------KG 316 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~ 316 (429)
||||++|+|++|.+||.+.+..+++..+...++.++.+++........+++..+.+...... ..
T Consensus 284 SlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (429)
T 3kvw_A 284 SLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGK 363 (429)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCC
T ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhh
Confidence 99999999999999999999999999999999999999988777666666666554321100 00
Q ss_pred CCCCCCCchhhh-hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 317 RKRKPGSKDMAS-VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 317 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
....+....... +....++.+.+||++||++||++|||+.|+|+||||++....
T Consensus 364 ~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 364 LRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418 (429)
T ss_dssp EECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-----
T ss_pred ccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCC
Confidence 001111222222 233558899999999999999999999999999999875433
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=439.45 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=223.4
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+.+-++|++++.||+|+||+||+|.++.+|+. |+|++......
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~------------------------------------ 196 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------------------------------------ 196 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------------------------------------
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh------------------------------------
Confidence 44567999999999999999999999999975 99987543211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
....+.+|+++|+.++|+ ||++++++|.+..++|+|||||+ |+|.+++.... ..+++.+++.+
T Consensus 197 ---------~~~~~~~Ei~il~~l~hp------nIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~ 260 (573)
T 3uto_A 197 ---------DKETVRKEIQTMSVLRHP------TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEY 260 (573)
T ss_dssp ---------HHHHHHHHHHHHHHTCCT------TBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHH
T ss_pred ---------hHHHHHHHHHHHHhCCCC------CCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHH
Confidence 122455699999999887 99999999999999999999995 69999986543 35999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
+.||+.||.|||++||+||||||+|||++.+....+||+|||+++.... .....+||+.|+|||++.+..|+.++|||
T Consensus 261 ~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiW 340 (573)
T 3uto_A 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340 (573)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHH
T ss_pred HHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHH
Confidence 9999999999999999999999999999875333899999999986543 34567899999999999999999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|.+||.+.+..+.+..|......++.. .+..
T Consensus 341 SlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------------------~~~~ 382 (573)
T 3uto_A 341 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS--------------------------------------AFSG 382 (573)
T ss_dssp HHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG--------------------------------------GGTT
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc--------------------------------------cccC
Confidence 99999999999999999999988887776533222221 1233
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
.++++.+||++||+.||++|||+.|+|+||||+....
T Consensus 383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 4789999999999999999999999999999987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=434.57 Aligned_cols=259 Identities=22% Similarity=0.354 Sum_probs=210.1
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
--++|++++.||+|+||+||+|+++.+++. |+|++.+.....
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~------------------------------------- 229 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM------------------------------------- 229 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-------------------------------------
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcch-------------------------------------
Confidence 346799999999999999999999999975 999985432210
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
......+.+|..++..+.+. .||||++++++|.+..++|+|||||. |+|.+++.+.. .+++..++.|+.
T Consensus 230 -----~~~~~~~~~E~~~l~ll~~~---~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~ 299 (689)
T 3v5w_A 230 -----KQGETLALNERIMLSLVSTG---DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAA 299 (689)
T ss_dssp -----TTCHHHHHHHHHHHHHHSSS---CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHH
T ss_pred -----hhhHHHHHHHHHHHHHHhhC---CCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHH
Confidence 11122344465666655543 46699999999999999999999995 69999998765 499999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc-CcceeeecCccccchhhhhC-CCCCCCccccch
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-QRVYTYIQSRFYRSPEVILG-LPYGPPIDMWSL 254 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSl 254 (429)
||+.||+|||++|||||||||+|||++.+| ++||+|||+|+... ....+.+||+.|||||++.+ ..|+.++|+|||
T Consensus 300 qIl~aL~yLH~~gIiHRDLKPeNILld~~G--~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSL 377 (689)
T 3v5w_A 300 EIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 377 (689)
T ss_dssp HHHHHHHHHHTTTEECCCCSGGGEEECTTS--CEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHH
T ss_pred HHHHHHHHHHHCCccccCCchHHeEEeCCC--CEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHH
Confidence 999999999999999999999999999999 99999999997654 44556899999999999974 579999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHH---HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 255 GCILAELYTGCPLFPGENEV---EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
||++|+|++|.+||.+.+.. +....+...-. ..+.
T Consensus 378 GvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~------------------------------------------~~p~ 415 (689)
T 3v5w_A 378 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------------------------------------------ELPD 415 (689)
T ss_dssp HHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC------------------------------------------CCCT
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC------------------------------------------CCCc
Confidence 99999999999999764322 22222221000 0112
Q ss_pred cCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSSS 368 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~ 368 (429)
..++++.+||.+||+.||++|++ |.|+++||||+...
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 34789999999999999999998 79999999999754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-53 Score=399.08 Aligned_cols=254 Identities=19% Similarity=0.252 Sum_probs=207.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecC-----CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHK-----TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
.+-.++|.+.+.||+|+||+||+|++.. ++. +|||++.....
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-------------------------------- 56 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-------------------------------- 56 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH--------------------------------
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh--------------------------------
Confidence 3446789999999999999999999753 343 48888753211
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhC-------
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNN------- 162 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~------- 162 (429)
...+.+.+|+++|++++|+ ||+++++++.+.+.+|+||||| +|+|.+++....
T Consensus 57 -------------~~~~~f~~E~~il~~l~Hp------nIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~ 117 (299)
T 4asz_A 57 -------------NARKDFHREAELLTNLQHE------HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA 117 (299)
T ss_dssp -------------HHHHHHHHHHHHHTTCCCT------TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC-
T ss_pred -------------HHHHHHHHHHHHHHhCCCC------CCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCccccccc
Confidence 1223567799999999887 9999999999999999999999 479999997642
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCcc
Q psy17270 163 ----YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRF 233 (429)
Q Consensus 163 ----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~ 233 (429)
...+++.++..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+...... ....||+.
T Consensus 118 ~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~--~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ 195 (299)
T 4asz_A 118 EGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--LVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195 (299)
T ss_dssp ---CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCSCHHHHTGGGCEEETTTEEECGG
T ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC--cEEECCcccceecCCCCceeecCceecChh
Confidence 24599999999999999999999999999999999999999988 89999999997543221 22468999
Q ss_pred ccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 234 YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 234 y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.+..+......+
T Consensus 196 ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~------------------------- 250 (299)
T 4asz_A 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ------------------------- 250 (299)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC-------------------------
T ss_pred hcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-------------------------
Confidence 999999999999999999999999999998 899999998887777665421100
Q ss_pred CCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.+..+++++.+|+.+||+.||++|||+.|++ +||++
T Consensus 251 ----------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 251 ----------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp ----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred ----------------CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence 0123478899999999999999999999994 46654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=396.78 Aligned_cols=253 Identities=25% Similarity=0.325 Sum_probs=200.2
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+-.++|++.++||+|+||+||+|++.. .+|||+++.....
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~-------------------------------------- 72 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPT-------------------------------------- 72 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCC--------------------------------------
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCC--------------------------------------
Confidence 446789999999999999999998754 4788877432211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
......+.+|++++++++|+ ||+++++++. ++.+|||||||+ |+|.+++.... ..+++.++..|+.
T Consensus 73 -----~~~~~~f~~E~~il~~l~Hp------NIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~ 139 (307)
T 3omv_A 73 -----PEQFQAFRNEVAVLRKTRHV------NILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIAR 139 (307)
T ss_dssp -----HHHHHHHHHHHHHHTTCCCT------TBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHH
T ss_pred -----HHHHHHHHHHHHHHHhCCCC------CEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHH
Confidence 11224577799999999887 9999999874 567899999995 79999997654 4599999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----cceeeecCccccchhhhhCC---CCCCC
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RVYTYIQSRFYRSPEVILGL---PYGPP 248 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~---~~~~~ 248 (429)
||+.||+|||+++||||||||+|||++.++ .+||+|||+|+.... .....+||+.|||||++.+. .|+.+
T Consensus 140 qia~gL~yLH~~~IiHRDlKp~NILl~~~~--~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k 217 (307)
T 3omv_A 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGL--TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217 (307)
T ss_dssp HHHHHHHHHHHTTCBCSCCCSSSEEEETTE--EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHH
T ss_pred HHHHHHHHHHHCCccCCccCHHHEEECCCC--cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcH
Confidence 999999999999999999999999999988 899999999975432 23346899999999999753 58899
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|||+||+.||.+.+....+..+.......| ....
T Consensus 218 sDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p------------------------------------~~~~ 261 (307)
T 3omv_A 218 SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP------------------------------------DLSK 261 (307)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC------------------------------------CSTT
T ss_pred HHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC------------------------------------Cccc
Confidence 9999999999999999999998776665554443111110 0111
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
....+++.+.+|+.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 223457899999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=398.92 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=203.3
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecC-----CCc-chheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHK-----TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
..+-.+.|.+.++||+|+||+||+|++.. ++. +|||++....
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-------------------------------- 83 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-------------------------------- 83 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--------------------------------
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--------------------------------
Confidence 33446789999999999999999998753 343 4888875321
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC------
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN------ 162 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~------ 162 (429)
....+.+.+|+++|++++|+ ||+++++++.+...+|||||||+ |+|.+++....
T Consensus 84 -------------~~~~~~f~~E~~il~~l~Hp------nIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~ 144 (329)
T 4aoj_A 84 -------------ESARQDFQREAELLTMLQHQ------HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 144 (329)
T ss_dssp -------------HHHHHHHHHHHHHHTTCCCT------TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC----
T ss_pred -------------HHHHHHHHHHHHHHHhCCCC------CCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccc
Confidence 11223567799999999887 99999999999999999999995 79999997643
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeec
Q psy17270 163 -------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQ 230 (429)
Q Consensus 163 -------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~ 230 (429)
..++++.++..|+.||+.||+|||+++||||||||+|||++.++ .+||+|||+++..... ....+|
T Consensus 145 ~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~--~~Ki~DFGla~~~~~~~~~~~~~~~~g 222 (329)
T 4aoj_A 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL--VVKIGDFGMSRDIYSTDYYRVGGRTML 222 (329)
T ss_dssp -------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC----------------CCC
T ss_pred cccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC--cEEEcccccceeccCCCcceecCcccc
Confidence 23589999999999999999999999999999999999999988 9999999999754321 234578
Q ss_pred CccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCc
Q psy17270 231 SRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309 (429)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (429)
|+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.+..+......+
T Consensus 223 t~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~---------------------- 280 (329)
T 4aoj_A 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE---------------------- 280 (329)
T ss_dssp CGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCC----------------------
T ss_pred cccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC----------------------
Confidence 999999999999999999999999999999999 899999998887776665421100
Q ss_pred cccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 310 CITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+..+++++.+|+.+||+.||++|||+.|++++
T Consensus 281 -------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 281 -------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp -------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred -------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 112347899999999999999999999999774
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=395.35 Aligned_cols=253 Identities=17% Similarity=0.223 Sum_probs=207.3
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecC-----CC-cchheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHK-----TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
.++-...++++++||+|+||+||+|.... ++ .+|||++.....
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~------------------------------- 69 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE------------------------------- 69 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-------------------------------
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-------------------------------
Confidence 34556789999999999999999999642 33 348887743211
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhC------
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNN------ 162 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~------ 162 (429)
....+.+.+|+.++++++|+ ||+++++++..+..+++||||| +|+|.+++....
T Consensus 70 -------------~~~~~~f~~E~~il~~l~Hp------NIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~ 130 (308)
T 4gt4_A 70 -------------GPLREEFRHEAMLRARLQHP------NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 130 (308)
T ss_dssp -------------C-CHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC
T ss_pred -------------hHHHHHHHHHHHHHHhCCCC------CCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCcccccc
Confidence 12234677899999999887 9999999999999999999999 579999997542
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeee
Q psy17270 163 --------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYI 229 (429)
Q Consensus 163 --------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~ 229 (429)
...+++..+..++.||+.||+|||+++||||||||+|||++.++ .+||+|||+++..... ....+
T Consensus 131 ~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~--~~Ki~DFGlar~~~~~~~~~~~~~~~ 208 (308)
T 4gt4_A 131 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL--NVKISDLGLFREVYAADYYKLLGNSL 208 (308)
T ss_dssp -----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCSCCBCGGGGGGCBCSSSSSC
T ss_pred ccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC--CEEECCcccceeccCCCceeEecccc
Confidence 13489999999999999999999999999999999999999988 8999999999754321 23457
Q ss_pred cCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCC
Q psy17270 230 QSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTP 308 (429)
Q Consensus 230 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (429)
||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..+.+..+......+
T Consensus 209 gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------- 267 (308)
T 4gt4_A 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP--------------------- 267 (308)
T ss_dssp BCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCC---------------------
T ss_pred cCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence 8999999999999999999999999999999998 899999998877766554311000
Q ss_pred ccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 309 RCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+..+++.+.+|+.+||+.||++|||+.|++++
T Consensus 268 --------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 268 --------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 112347889999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=388.88 Aligned_cols=290 Identities=27% Similarity=0.510 Sum_probs=235.2
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
-.+.+.+||++++.||+|+||+||+|.+.....+|+|++......
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------------------- 59 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED----------------------------------- 59 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC----------------------------------------
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-----------------------------------
Confidence 346789999999999999999999999976555699987533211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
......+.+|+++++.++|+ ||+++++++.....+++||||++++|.+++.... ..+++..+..+
T Consensus 60 --------~~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~ 124 (311)
T 3niz_A 60 --------EGIPSTAIREISLLKELHHP------NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIY 124 (311)
T ss_dssp ---------CHHHHHHHHHHHHHHCCCT------TBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHH
T ss_pred --------chhhHHHHHHHHHHHHcCCC------CEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHH
Confidence 12234566799999999876 9999999999999999999999999999988654 45999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhC-CCCCCCcc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILG-LPYGPPID 250 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~D 250 (429)
+.|++.||+|||++||+||||||+|||++.++ .+||+|||++..... ......+|+.|+|||++.+ ..++.++|
T Consensus 125 ~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 202 (311)
T 3niz_A 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVD 202 (311)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHH
T ss_pred HHHHHHHHHHHHHCCcccCCCchHhEEECCCC--CEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHH
Confidence 99999999999999999999999999999988 899999999976542 2334578999999999987 45899999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||||++|+|++|+.||.+.+..+.+..+...++.+....+........+... ..............
T Consensus 203 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~ 270 (311)
T 3niz_A 203 IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR------------TFQVFEKKPWSSII 270 (311)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC------------CCCCCCCCCHHHHS
T ss_pred hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc------------ccccccCCcHHHhC
Confidence 999999999999999999999999999999998888776655443322211110 01112223345555
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+..++++.+||++||++||++|||+.|+|+||||++..
T Consensus 271 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 271 PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 66789999999999999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=384.88 Aligned_cols=295 Identities=27% Similarity=0.479 Sum_probs=231.7
Q ss_pred hhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 14 ~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
.+++.+.+||++++.||+|+||+||+|.+..+++. |+|++.......
T Consensus 2 p~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------------- 49 (308)
T 3g33_A 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-------------------------------- 49 (308)
T ss_dssp --------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCT--------------------------------
T ss_pred CCCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccc--------------------------------
Confidence 35678899999999999999999999999888865 888874322110
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-----eEEEEEeecCcCHHHHHHhhCCCCCC
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-----HLCISFELMNLNLYELIKRNNYQGFS 167 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~g~L~~~i~~~~~~~~~ 167 (429)
........+.+|+++++.+... .||||+++++++.... .+++|||+++++|.+++.......++
T Consensus 50 --------~~~~~~~~~~~e~~~l~~l~~~---~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~ 118 (308)
T 3g33_A 50 --------GGGGLPISTVREVALLRRLEAF---EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLP 118 (308)
T ss_dssp --------TSSCCCHHHHHHHHHHHHHHHH---CCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSC
T ss_pred --------cccccchhHHHHHHHHHHHhhc---CCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCC
Confidence 0112233556688888888732 2449999999998765 58999999999999999987766699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCC
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~ 245 (429)
+..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..... .....+||+.|+|||++.+..+
T Consensus 119 ~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 196 (308)
T 3g33_A 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTY 196 (308)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS--CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEEeeCccccccCCCcccCCccccccccCchHHcCCCC
Confidence 999999999999999999999999999999999999888 899999999975442 2334678999999999999999
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...+..... .............
T Consensus 197 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~ 261 (308)
T 3g33_A 197 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS---------------LPRGAFPPRGPRP 261 (308)
T ss_dssp CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCS---------------SCGGGSCCCCCCC
T ss_pred CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhh---------------ccccccCCCCCCc
Confidence 9999999999999999999999999999999999999988887664432111 0011112223344
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....+..++.+.+||.+||++||++|||+.|+|+||||++..
T Consensus 262 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 262 VQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp HHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred HHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 5556667789999999999999999999999999999998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=397.83 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=202.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCc------chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNT------HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
+-.++|++++.||+|+||+||+|.+..++. +|+|++......
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~-------------------------------- 108 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------------------------------- 108 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--------------------------------
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--------------------------------
Confidence 446899999999999999999999876653 355555332211
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-CeEEEEEeecC-cCHHHHHHhhC-------
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-NHLCISFELMN-LNLYELIKRNN------- 162 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~-g~L~~~i~~~~------- 162 (429)
.....+.+|+++|.++.|+ |||++++++|... ..+|+|||||+ |+|.++++...
T Consensus 109 ------------~~~~~~~~E~~il~~l~hh-----pnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~ 171 (353)
T 4ase_A 109 ------------SEHRALMSELKILIHIGHH-----LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 171 (353)
T ss_dssp ------------HHHHHHHHHHHHHHHHCCC-----TTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-
T ss_pred ------------HHHHHHHHHHHHHHHcCCC-----CcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhccccccccc
Confidence 1123567799999999874 4999999998664 57999999995 79999997642
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeec
Q psy17270 163 -------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQ 230 (429)
Q Consensus 163 -------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~ 230 (429)
...+++..+..++.||+.||+|||+++||||||||+|||++.++ .+||+|||+|+..... ....+|
T Consensus 172 ~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~--~vKi~DFGlar~~~~~~~~~~~~~~~g 249 (353)
T 4ase_A 172 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARL 249 (353)
T ss_dssp ------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTTTCTTSEEETTEEE
T ss_pred ccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC--CEEECcchhhhhcccCCCceeeccccc
Confidence 23489999999999999999999999999999999999999988 8999999999764321 223578
Q ss_pred CccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCc
Q psy17270 231 SRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309 (429)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (429)
|+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.+..+...-..+
T Consensus 250 t~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~---------------------- 307 (353)
T 4ase_A 250 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------------- 307 (353)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------
T ss_pred cccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCC----------------------
Confidence 999999999999999999999999999999998 999999876544443332210000
Q ss_pred cccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 310 CITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+...++++.+||.+||+.||++|||+.|+++|
T Consensus 308 ------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 308 ------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 0112347889999999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=391.13 Aligned_cols=307 Identities=45% Similarity=0.822 Sum_probs=244.4
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.++.+.++|++++.||+|+||+||+|.+..++.. |+|++....
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------------ 91 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK------------------------------------ 91 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH------------------------------------
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH------------------------------------
Confidence 4567789999999999999999999999988864 999875321
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.....+.+|+++++.+.+.+...+++|+++++++....++|+|||+++++|.+++......++++..+..
T Consensus 92 ----------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~ 161 (382)
T 2vx3_A 92 ----------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK 161 (382)
T ss_dssp ----------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHH
T ss_pred ----------HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHH
Confidence 1223455699999999877666777899999999999999999999999999999987666799999999
Q ss_pred HHHHHHHHHHHHH--HCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccc
Q psy17270 174 FAFSLVQCLRLLH--RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 174 i~~qil~~l~~lH--~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
++.|++.||.||| ..||+||||||+|||++.++...+||+|||++..........+||+.|+|||++.+..++.++||
T Consensus 162 i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 241 (382)
T 2vx3_A 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDM 241 (382)
T ss_dssp HHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHH
T ss_pred HHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHH
Confidence 9999999999999 46999999999999996544338999999999887766667789999999999999999999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccc-c---CCCCCCCCCCCchhh
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI-T---NSKGRKRKPGSKDMA 327 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~ 327 (429)
|||||++|+|+||+.||.+.+..+.+..+....+.++..++.........+..-....+. . ........+....+.
T Consensus 242 wSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 321 (382)
T 2vx3_A 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLH 321 (382)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHH
Confidence 999999999999999999999999999999999999988876544333333221111000 0 000000111111111
Q ss_pred hhhc------------------cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 328 SVLR------------------CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 328 ~~~~------------------~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.... .+.+.+.+||++||++||++|||+.|+|+||||++.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 322 NILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 1111 012478999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=387.83 Aligned_cols=297 Identities=30% Similarity=0.558 Sum_probs=238.3
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
+..+.++|+++++||+|+||+||+|.+..++.. |+|++....
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------------------------- 72 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK------------------------------------- 72 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-------------------------------------
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-------------------------------------
Confidence 457899999999999999999999999888865 999875321
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.....+..|+++++.+.+. ...|+||+++++++....++|+|||+++++|.+++......++++..+..+
T Consensus 73 ---------~~~~~~~~e~~~l~~l~~~-~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i 142 (360)
T 3llt_A 73 ---------KYTRSAKIEADILKKIQND-DINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLY 142 (360)
T ss_dssp ---------HHHHHHHHHHHHHHHTCCC-STTGGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHH
T ss_pred ---------hhhhhhHHHHHHHHHhccc-CCCCCCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHH
Confidence 1122345599999999752 345779999999999999999999999999999999877667999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecC-----------------------CCcceEEeeecccccccCcceeeecC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQR-----------------------GSSSIKVIDFGSSCYSHQRVYTYIQS 231 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~-----------------------~~~~vkl~Dfg~~~~~~~~~~~~~~t 231 (429)
+.||+.||+|||++||+||||||+|||++.. ....+||+|||++...........||
T Consensus 143 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt 222 (360)
T 3llt_A 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINT 222 (360)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSC
T ss_pred HHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCc
Confidence 9999999999999999999999999999751 12389999999998777666677899
Q ss_pred ccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhh--hccCCCCCc
Q psy17270 232 RFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL--FFDSKGTPR 309 (429)
Q Consensus 232 ~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 309 (429)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....+..+..+......... .++......
T Consensus 223 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 302 (360)
T 3llt_A 223 RQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL 302 (360)
T ss_dssp GGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEE
T ss_pred ccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCccccee
Confidence 999999999999999999999999999999999999999999999999999999988887654432111 111110000
Q ss_pred cccCCCCCCCCCCC-c-------hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 310 CITNSKGRKRKPGS-K-------DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 310 ~~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
. ....... . .........++.+.+||.+||+.||++|||+.|+|+||||+
T Consensus 303 ~------~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 303 A------WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp C------TTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred c------CcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 0 0000000 0 00111223457889999999999999999999999999996
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=396.82 Aligned_cols=311 Identities=32% Similarity=0.532 Sum_probs=243.7
Q ss_pred eeeeehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhccccccccccc
Q psy17270 7 ILSFAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEE 85 (429)
Q Consensus 7 ~~~~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~ 85 (429)
...+.....++.+.+||++++.||+|+||+||+|.+..++.. |+|++....
T Consensus 23 ~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------------- 74 (397)
T 1wak_A 23 KGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---------------------------- 74 (397)
T ss_dssp C--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----------------------------
T ss_pred CCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----------------------------
Confidence 344555677889999999999999999999999999988865 999875321
Q ss_pred ccccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCC--CCCCCceeEEEEEEE----EcCeEEEEEeecCcCHHHHHH
Q psy17270 86 SLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKD--ADSSYNVIHMLEYFY----FRNHLCISFELMNLNLYELIK 159 (429)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~--~~~~~~i~~~~~~~~----~~~~~~lv~e~~~g~L~~~i~ 159 (429)
.....+.+|+++++.+.|.+ ...|+||++++++|. ...++|+||||++++|.+.+.
T Consensus 75 ------------------~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 136 (397)
T 1wak_A 75 ------------------HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII 136 (397)
T ss_dssp ------------------HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHH
T ss_pred ------------------cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHH
Confidence 12234566999999998753 234789999999998 445899999999999999888
Q ss_pred hhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCCCcEEEecCCC-------------------------------
Q psy17270 160 RNNYQGFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGS------------------------------- 207 (429)
Q Consensus 160 ~~~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~------------------------------- 207 (429)
......+++..++.++.||+.||+|||++ ||+||||||+|||++.++.
T Consensus 137 ~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (397)
T 1wak_A 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216 (397)
T ss_dssp HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------
T ss_pred hcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcc
Confidence 77656799999999999999999999998 9999999999999986531
Q ss_pred ----------------cceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCC
Q psy17270 208 ----------------SSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGE 271 (429)
Q Consensus 208 ----------------~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 271 (429)
..++|+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2699999999987766666678999999999999999999999999999999999999999876
Q ss_pred C------HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh---hhhhccCChHHHHHHH
Q psy17270 272 N------EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM---ASVLRCNDKAFVDFVT 342 (429)
Q Consensus 272 ~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~ 342 (429)
+ ..+.+..+...++.++..++........++...+.......... ....... .......++.+.+||.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~ 373 (397)
T 1wak_A 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP---WGLFEVLVEKYEWSQEEAAGFTDFLL 373 (397)
T ss_dssp CCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC---CCHHHHHHHTSCCCHHHHHHHHHHHG
T ss_pred cccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC---cchhHhhhhhcccchhhHHHHHHHHH
Confidence 5 66788899999999998887655444333333222111111000 0000000 0011223568899999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 343 QCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 343 ~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
+||+.||++|||+.|+|+||||++
T Consensus 374 ~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 374 PMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp GGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred HHhccChhhcCCHHHHhhCccccC
Confidence 999999999999999999999963
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=377.21 Aligned_cols=282 Identities=28% Similarity=0.512 Sum_probs=229.4
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+||++++.||+|+||+||+|.+..+++. |+|++......
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------------------------- 41 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---------------------------------------- 41 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS----------------------------------------
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc----------------------------------------
Confidence 5899999999999999999999988865 88887533211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
......+.+|+++++.++|+ ||+++++++.....+++||||+++++.+.+.... ..+++..++.++.|++
T Consensus 42 ---~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~ 111 (292)
T 3o0g_A 42 ---EGVPSSALREICLLKELKHK------NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLL 111 (292)
T ss_dssp ---TTHHHHHHHHHHHHTTCCCT------TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHH
T ss_pred ---CCcchHHHHHHHHHhcCCCC------CEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHH
Confidence 12234566799999998776 9999999999999999999999999888887654 4599999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCC-CCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG 255 (429)
.||+|||++||+||||||+||+++.++ .+||+|||++..... ......+|+.|+|||++.+.. ++.++||||||
T Consensus 112 ~~l~~lH~~~ivH~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 189 (292)
T 3o0g_A 112 KGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189 (292)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred HHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHH
Confidence 999999999999999999999999988 899999999976442 233457899999999998765 79999999999
Q ss_pred hHHHHHhhCCCC-CCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYTGCPL-FPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|++|+|++|..| |.+.+..+.+..+....+.+..+.+......... ......+.........+..+
T Consensus 190 ~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~ 256 (292)
T 3o0g_A 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY-------------KPYPMYPATTSLVNVVPKLN 256 (292)
T ss_dssp HHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC-------------CCCCCCCTTCCCTTTSTTCC
T ss_pred HHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc-------------cccccccCCcchhhcccccC
Confidence 999999987655 7888888999999999998887765543321110 00111112222333445568
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
+.+.+||++||+.||++|||+.|+|+||||++.
T Consensus 257 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 257 ATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 899999999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=393.62 Aligned_cols=299 Identities=25% Similarity=0.499 Sum_probs=220.2
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
++..+.+||++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---------------------------------- 48 (388)
T 3oz6_A 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN---------------------------------- 48 (388)
T ss_dssp -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC----------------------------------
T ss_pred ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC----------------------------------
Confidence 3456789999999999999999999999998865 99987543211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcC--eEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRN--HLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
......+.+|+.+++.+. |+ ||+++++++...+ .+|+|||||+++|.+++... .+++..
T Consensus 49 ---------~~~~~~~~~E~~~l~~l~~h~------niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~ 110 (388)
T 3oz6_A 49 ---------STDAQRTFREIMILTELSGHE------NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN---ILEPVH 110 (388)
T ss_dssp ---------HHHHHHHHHHHHHHHHTTTCT------TBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHHT---CCCHHH
T ss_pred ---------hHHHHHHHHHHHHHHhccCCC------CCCeeeeEEecCCCCEEEEEecccCcCHHHHHHcC---CCCHHH
Confidence 111234556999999987 65 9999999998654 79999999999999999874 399999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC------------------------cce
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ------------------------RVY 226 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~------------------------~~~ 226 (429)
+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 111 ~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (388)
T 3oz6_A 111 KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188 (388)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEESSSCCCCCCCGGGCCC--------------
T ss_pred HHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC--CEEecCCccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999999988 899999999965321 123
Q ss_pred eeecCccccchhhhhC-CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCC
Q psy17270 227 TYIQSRFYRSPEVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSK 305 (429)
Q Consensus 227 ~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (429)
..+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..+...++.++.+.+.............
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~ 268 (388)
T 3oz6_A 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIE 268 (388)
T ss_dssp -CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHH
T ss_pred CCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH
Confidence 3579999999999987 568999999999999999999999999999999999999999999887654321100000000
Q ss_pred CCCccccCCCCCCCCCCCchhh------hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 306 GTPRCITNSKGRKRKPGSKDMA------SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
..+....... ........... ......++.+.+||++||++||++|||+.|+|+||||+...
T Consensus 269 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 269 SLKEKVEIRQ-SNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHCC------CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred hCcccccccC-CCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 0000000000 00000000000 00124578999999999999999999999999999997643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=388.85 Aligned_cols=287 Identities=31% Similarity=0.567 Sum_probs=230.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++++.||+|+||.||+|.+..++.. |+|++......
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------------------------------------- 64 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS------------------------------------- 64 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-------------------------------------
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-------------------------------------
Confidence 4688999999999999999999999988865 99987443211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
......+.+|+++++.++|+ ||+++++++... ..+|+||||++++|.+++... .+++..
T Consensus 65 ------~~~~~~~~~E~~~l~~l~hp------nIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~ 129 (367)
T 1cm8_A 65 ------ELFAKRAYRELRLLKHMRHE------NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDR 129 (367)
T ss_dssp ------HHHHHHHHHHHHHHHHCCBT------TBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHH
T ss_pred ------HHHHHHHHHHHHHHHhCCCc------CCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhcC---CCCHHH
Confidence 12234566799999999877 999999999765 356999999988999999874 399999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC-CCCCCCc
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPI 249 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~ 249 (429)
+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++.........++|+.|+|||++.+ ..++.++
T Consensus 130 ~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 207 (367)
T 1cm8_A 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTV 207 (367)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTH
T ss_pred HHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC--CEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhh
Confidence 999999999999999999999999999999999988 8999999999877666666789999999999987 5789999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||.+.+..+++..+....+.++.+.+............... +..........
T Consensus 208 DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~ 276 (367)
T 1cm8_A 208 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL-----------PELEKKDFASI 276 (367)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHS-----------CCCCCCCGGGT
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhC-----------CCCCCCCHHHH
Confidence 9999999999999999999999999999999999999998887544221100000000 01111223444
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
....++.+.+||.+||..||++|||+.|+|+||||+....
T Consensus 277 ~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 277 LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred CCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 5566899999999999999999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=379.86 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=217.5
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.....++|++++.||+|+||.||+|.+..++.. |+|++.......
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---------------------------------- 55 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP---------------------------------- 55 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH----------------------------------
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH----------------------------------
Confidence 345678999999999999999999999888865 999885432211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.....+.+|+++++.++|+ ||+++++++.....+|+||||+ +++|.+++.... .+++..++.
T Consensus 56 ---------~~~~~~~~E~~~l~~l~hp------nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~ 118 (328)
T 3fe3_A 56 ---------TSLQKLFREVRIMKILNHP------NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARS 118 (328)
T ss_dssp ---------HHHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHH
T ss_pred ---------HHHHHHHHHHHHHHhCCCC------CEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 1123456699999999877 9999999999999999999999 569999998765 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCCCCC-CCcc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYG-PPID 250 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~-~~~D 250 (429)
++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..++ .++|
T Consensus 119 ~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 196 (328)
T 3fe3_A 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVD 196 (328)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHH
T ss_pred HHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC--CEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhh
Confidence 999999999999999999999999999999988 89999999997543 334456899999999999988875 7899
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||||++|+|++|+.||.+.+..+....+.......+
T Consensus 197 iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p------------------------------------------ 234 (328)
T 3fe3_A 197 VWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP------------------------------------------ 234 (328)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------------------------------------
T ss_pred hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------------------------------------
Confidence 99999999999999999999888777766654211111
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
...++++.+||++||+.||++|||+.|+++||||+...
T Consensus 235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 12378899999999999999999999999999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=403.69 Aligned_cols=282 Identities=28% Similarity=0.525 Sum_probs=223.7
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.+||++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~------------------------------------- 101 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN------------------------------------- 101 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGS-------------------------------------
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccC-------------------------------------
Confidence 4578999999999999999999999998865 99988544221
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
......+.+|+.+++.++|+ ||+++++++... .++|+||||++++|.+.+.. .+++..
T Consensus 102 ------~~~~~~~~~E~~~l~~l~hp------nIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~ 165 (464)
T 3ttj_A 102 ------QTHAKRAYRELVLMKCVNHK------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHER 165 (464)
T ss_dssp ------HHHHHHHHHHHHHHHHCCCT------TBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHH
T ss_pred ------hHHHHHHHHHHHHHHhCCCC------CCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh----cCCHHH
Confidence 11223556799999999877 999999999654 46899999999988888753 389999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ....+||+.|+|||++.+..|+.+
T Consensus 166 ~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 243 (464)
T 3ttj_A 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 243 (464)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTT
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC--CEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHH
Confidence 999999999999999999999999999999999988 8999999999765432 345689999999999999999999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++|+.||.+.+..+++..|...++.+..+.+.........+... .+ .........
T Consensus 244 ~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~-~~-----------~~~~~~~~~ 311 (464)
T 3ttj_A 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN-RP-----------KYAGLTFPK 311 (464)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTT-SC-----------CCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhc-cc-----------ccCCCChHH
Confidence 999999999999999999999999999999999999999888776543221111000 00 000001111
Q ss_pred hh------------ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 329 VL------------RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 329 ~~------------~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.. ...++.+.+||++||++||++|||+.|+|+||||+.
T Consensus 312 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 312 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 11 112567899999999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=379.25 Aligned_cols=309 Identities=35% Similarity=0.660 Sum_probs=244.8
Q ss_pred hhhhcccccCCeEEEeEeeccccceEEEEEe-cCCCc-chheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 12 FQVLHDHICYRYEILEVIGKGSFGQVIRALD-HKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 12 ~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~-~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
....++.+.+||++++.||+|+||+||+|.+ ..++. +|+|++....
T Consensus 5 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------------------------------- 52 (339)
T 1z57_A 5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-------------------------------- 52 (339)
T ss_dssp TCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--------------------------------
T ss_pred eeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--------------------------------
Confidence 4456788999999999999999999999998 44554 4888874321
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHH
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~ 169 (429)
.....+.+|+++++.+.|.+...+++++++++++....++++||||++++|.+++.......+++.
T Consensus 53 --------------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~ 118 (339)
T 1z57_A 53 --------------RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD 118 (339)
T ss_dssp --------------HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHH
T ss_pred --------------chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHH
Confidence 122345569999999999988889999999999999999999999999999999988765679999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-----------------CcceEEeeecccccccCcceeeecCc
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-----------------SSSIKVIDFGSSCYSHQRVYTYIQSR 232 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-----------------~~~vkl~Dfg~~~~~~~~~~~~~~t~ 232 (429)
.+..++.|++.||+|||++||+||||||+|||++..+ ...++|+|||++...........||+
T Consensus 119 ~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~ 198 (339)
T 1z57_A 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTR 198 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCG
T ss_pred HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccccccccCCc
Confidence 9999999999999999999999999999999998732 22799999999987766666778999
Q ss_pred cccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 233 FYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 233 ~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+....+..+..++............ ...+...
T Consensus 199 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 277 (339)
T 1z57_A 199 HYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHD-RLDWDEH 277 (339)
T ss_dssp GGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETT-EECCCTT
T ss_pred cccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhc-ccccccc
Confidence 999999999989999999999999999999999999999999999999999999998887654332221110 0000000
Q ss_pred CCCCC---CCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 313 NSKGR---KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 313 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
..... ................++.+.+||.+||+.||++|||+.|+++||||+..
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp SHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred ccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 00000 00000000000011225788999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=400.60 Aligned_cols=288 Identities=30% Similarity=0.491 Sum_probs=218.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.+||++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~------------------------------------- 92 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED------------------------------------- 92 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-------------------------------------
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-------------------------------------
Confidence 4678999999999999999999999988865 99987543211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecCcCHHHHHHhhCCCCCCHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELMNLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~ 171 (429)
......+.+|+++|+.++|+ ||+++++++... ..+|+|||+++++|.+++.... .+++..+
T Consensus 93 ------~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~ 158 (458)
T 3rp9_A 93 ------LIDCKRILREIAILNRLNHD------HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV--YLTELHI 158 (458)
T ss_dssp ------HHHHHHHHHHHHHHHHCCCT------TBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSSC--CCCHHHH
T ss_pred ------HHHHHHHHHHHHHHHhCCCC------CCCceEEEEecCCcccCceEEEEEeccccchhhhcccCC--CCCHHHH
Confidence 11223566799999999877 999999998543 5799999999999999998654 4999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC----------------------------
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---------------------------- 223 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---------------------------- 223 (429)
+.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 159 ~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (458)
T 3rp9_A 159 KTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC--SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236 (458)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC--CEEECCCTTCBCTTSCTTCCCCCC-------------------
T ss_pred HHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC--CEeecccccchhccCccccccccccCccccccccccccccccc
Confidence 99999999999999999999999999999999988 899999999975431
Q ss_pred --cceeeecCccccchhhhh-CCCCCCCccccchhhHHHHHhh-----------CCCCCCCCC-----------------
Q psy17270 224 --RVYTYIQSRFYRSPEVIL-GLPYGPPIDMWSLGCILAELYT-----------GCPLFPGEN----------------- 272 (429)
Q Consensus 224 --~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~~llt-----------g~~pf~~~~----------------- 272 (429)
.....+||+.|+|||++. +..|+.++|||||||++|||++ |+++|++.+
T Consensus 237 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~ 316 (458)
T 3rp9_A 237 KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFH 316 (458)
T ss_dssp --------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------
T ss_pred cccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccccccccc
Confidence 123457899999999875 5569999999999999999998 788887765
Q ss_pred ---HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCC
Q psy17270 273 ---EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDS 349 (429)
Q Consensus 273 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 349 (429)
..+++..|...+|.++.+.+.............. .............+..++++.+||++||++||
T Consensus 317 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 385 (458)
T 3rp9_A 317 TRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI-----------FPKREGTDLAERFPASSADAIHLLKRMLVFNP 385 (458)
T ss_dssp CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTT-----------SCCCCCCCGGGGSTTSCHHHHHHHHHHSCSST
T ss_pred ccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHh-----------cCCCCCCCHHHHCCCCCHHHHHHHHHHhccCc
Confidence 3678899999999999887765432211100000 01112233445556678999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCC
Q psy17270 350 KKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 350 ~~Rpta~ell~h~~~~~~~~ 369 (429)
++|||+.|+|+||||+....
T Consensus 386 ~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 386 NKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp TTSCCHHHHHHSGGGTTTCC
T ss_pred cccCCHHHHhcCHhhhhcCC
Confidence 99999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=373.22 Aligned_cols=281 Identities=29% Similarity=0.538 Sum_probs=224.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+||++++.||+|+||+||+|.+..+..+|+|++.....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~------------------------------------------ 39 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE------------------------------------------ 39 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG------------------------------------------
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc------------------------------------------
Confidence 68999999999999999999995444569888743321
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.......+.+|+++++.++|+ ||+++++++.....+++|||+++++|.+++.... ..+++..+..++.|++.
T Consensus 40 -~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~ 111 (288)
T 1ob3_A 40 -DEGIPSTTIREISILKELKHS------NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLN 111 (288)
T ss_dssp -GGCCCHHHHHHHHGGGGCCCT------TBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHH
T ss_pred -ccccchhHHHHHHHHHhcCCC------CEeeeeeEEccCCeEEEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHH
Confidence 112234566799999998776 9999999999999999999999999999988654 45999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCC-CCCCCccccchhh
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGC 256 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~ 256 (429)
||+|||++||+||||||+||+++.++ .+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||
T Consensus 112 ~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 189 (288)
T 1ob3_A 112 GIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189 (288)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred HHHHHHHCCeecCCCCHHHEEEcCCC--CEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHH
Confidence 99999999999999999999999988 899999999875432 22345789999999999765 5899999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|..||.+.+..+.+..+...++.+....+......... +. . .......+........++.
T Consensus 190 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--------~----~~~~~~~~~~~~~~~~~~~ 256 (288)
T 1ob3_A 190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY-DP--------N----FTVYEPLPWESFLKGLDES 256 (288)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC-CT--------T----CCCCCCCCGGGTCCSCCHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc-cc--------c----cccccCccHHHHhhhcCHH
Confidence 999999999999999999999999988887765544332211100 00 0 0011112233344566899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
+.+||++||+.||++|||+.|+|+||||++
T Consensus 257 ~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 257 GIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 999999999999999999999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=384.93 Aligned_cols=267 Identities=26% Similarity=0.426 Sum_probs=222.9
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
...+.++|++++.||+|+||+||+|.++.++.. |+|++........
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~--------------------------------- 53 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRAS--------------------------------- 53 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTC---------------------------------
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccc---------------------------------
Confidence 356889999999999999999999999998865 8888744321100
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
........+.+|+.+++.+.|+ ||++++++|.....+|+||||+ +|+|.+++.... .+++..+..
T Consensus 54 ------~~~~~~~~~~~E~~il~~l~hp------nIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~ 119 (361)
T 2yab_A 54 ------RRGVCREEIEREVSILRQVLHP------NIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATS 119 (361)
T ss_dssp ------SSSBCHHHHHHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHH
T ss_pred ------cchhHHHHHHHHHHHHHhCCCc------CCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 0011234577799999998876 9999999999999999999999 579999997654 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCC--cceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS--SSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~--~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++..... .....+||+.|+|||++.+..++.++
T Consensus 120 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 199 (361)
T 2yab_A 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA 199 (361)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHH
T ss_pred HHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccc
Confidence 9999999999999999999999999999987652 2699999999976443 23456899999999999998999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|..||.+.+..+.+..+......++.+.
T Consensus 200 DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------------------- 241 (361)
T 2yab_A 200 DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF-------------------------------------- 241 (361)
T ss_dssp HHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH--------------------------------------
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh--------------------------------------
Confidence 999999999999999999999988888777765433333332
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
+...++.+.+||++||..||++|||+.|+++||||+..
T Consensus 242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 23347889999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=391.58 Aligned_cols=293 Identities=29% Similarity=0.492 Sum_probs=233.4
Q ss_pred hhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 14 ~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
+..-.+.++|++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 19 ~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~--------------------------------- 65 (432)
T 3n9x_A 19 IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--------------------------------- 65 (432)
T ss_dssp GGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS---------------------------------
T ss_pred CCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC---------------------------------
Confidence 34445789999999999999999999999998865 99988543211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecCcCHHHHHHhhCCCCCC
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELMNLNLYELIKRNNYQGFS 167 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~L~~~i~~~~~~~~~ 167 (429)
......+.+|+++++.++|+ ||+++++++... ..+|+|||+++++|.+++.... .++
T Consensus 66 ----------~~~~~~~~~E~~~l~~l~h~------nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~ 127 (432)
T 3n9x_A 66 ----------LIDCKRILREITILNRLKSD------YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI--FLT 127 (432)
T ss_dssp ----------HHHHHHHHHHHHHHHHCCCT------TBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSSC--CCC
T ss_pred ----------hHHHHHHHHHHHHHHHcCCC------CcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhccC--CCC
Confidence 11223566799999999877 999999999766 5799999999999999998654 499
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----------------------
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----------------------- 224 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----------------------- 224 (429)
+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 128 ~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (432)
T 3n9x_A 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205 (432)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEEC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC--CEEEccCCCcccccccccccccccccccccccccccchh
Confidence 999999999999999999999999999999999999988 8999999999764321
Q ss_pred --ceeeecCccccchhhhh-CCCCCCCccccchhhHHHHHhh-----------CCCCCCCCC-----------------H
Q psy17270 225 --VYTYIQSRFYRSPEVIL-GLPYGPPIDMWSLGCILAELYT-----------GCPLFPGEN-----------------E 273 (429)
Q Consensus 225 --~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~~llt-----------g~~pf~~~~-----------------~ 273 (429)
....+||+.|+|||++. +..|+.++|||||||++|+|++ |.++|.+.+ .
T Consensus 206 ~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~ 285 (432)
T 3n9x_A 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSN 285 (432)
T ss_dssp -----CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHH
T ss_pred ccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccch
Confidence 24568899999999974 5569999999999999999997 566666654 4
Q ss_pred HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCC
Q psy17270 274 VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRL 353 (429)
Q Consensus 274 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 353 (429)
.+++..|...+|.++.+.+.........- .... .............+..++.+.+||++||++||++||
T Consensus 286 ~~ql~~i~~~~g~p~~~~~~~~~~~~~~~-------~~~~----~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 354 (432)
T 3n9x_A 286 RDQLNIIFNIIGTPTEDDLKNINKPEVIK-------YIKL----FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI 354 (432)
T ss_dssp HHHHHHHHHHHCSCCHHHHHTCCCHHHHH-------HHHT----SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHH-------HHHh----CCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCC
Confidence 78899999999999988765543221110 0000 011122334555566799999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCC
Q psy17270 354 TPDEALRHEWLKSSSSS 370 (429)
Q Consensus 354 ta~ell~h~~~~~~~~~ 370 (429)
|+.|+|+||||++....
T Consensus 355 ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 355 TIDQALDHPYLKDVRKK 371 (432)
T ss_dssp CHHHHHTCGGGTTTCCT
T ss_pred CHHHHhcChhhhhccCc
Confidence 99999999999986543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=379.29 Aligned_cols=310 Identities=33% Similarity=0.622 Sum_probs=245.2
Q ss_pred ehhhhcccccCCeEEEeEeeccccceEEEEEecCCC-c-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 11 AFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTN-T-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 11 ~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~-~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
.....++.+.+||++++.||+|+||+||+|.+..++ . +|+|++....
T Consensus 9 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~------------------------------- 57 (355)
T 2eu9_A 9 LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG------------------------------- 57 (355)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-------------------------------
T ss_pred cccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-------------------------------
Confidence 345568889999999999999999999999998777 3 5888875321
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCH
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSL 168 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~ 168 (429)
.....+.+|+++++.+.|.+...+.+++.+++++....++++||||+++++.+.+.......+++
T Consensus 58 ---------------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~ 122 (355)
T 2eu9_A 58 ---------------KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 122 (355)
T ss_dssp ---------------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCH
T ss_pred ---------------cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCH
Confidence 11234556999999999988777888999999999999999999999999999988776567999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEE-------------------ecCCCcceEEeeecccccccCcceeee
Q psy17270 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLL-------------------KQRGSSSIKVIDFGSSCYSHQRVYTYI 229 (429)
Q Consensus 169 ~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili-------------------~~~~~~~vkl~Dfg~~~~~~~~~~~~~ 229 (429)
..+..++.||+.||+|||++||+||||||+|||+ +.++ .++|+|||++...........
T Consensus 123 ~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~--~~kl~Dfg~~~~~~~~~~~~~ 200 (355)
T 2eu9_A 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT--SIRVADFGSATFDHEHHTTIV 200 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCC--CEEECCCTTCEETTSCCCSSC
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCC--cEEEeecCccccccccccCCc
Confidence 9999999999999999999999999999999999 3444 899999999987666666778
Q ss_pred cCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCC-C
Q psy17270 230 QSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT-P 308 (429)
Q Consensus 230 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 308 (429)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+....+..+..++.........+..... +
T Consensus 201 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 280 (355)
T 2eu9_A 201 ATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 280 (355)
T ss_dssp SCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCC
T ss_pred CCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccc
Confidence 999999999999989999999999999999999999999999999999999999999998887655433322211100 0
Q ss_pred ccccCCCCCC-CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 309 RCITNSKGRK-RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 309 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.......... ...............+..+.+||.+||+.||++|||+.|+|+||||++..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 281 ENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp TTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred cccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 0000000000 00000000000011245889999999999999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=384.37 Aligned_cols=258 Identities=27% Similarity=0.390 Sum_probs=212.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.--++|++++.||+|+||+||+|+++.+++. |+|++.+.....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~------------------------------------ 63 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ------------------------------------ 63 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcc------------------------------------
Confidence 3457899999999999999999999988865 999885432110
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
......+.+|.++++.+. .||||++++++|.+...+|+|||||. |+|.+++..... +++..++.++
T Consensus 64 ------~~~~~~~~~E~~il~~~~-----~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~ 130 (353)
T 3txo_A 64 ------DDDVECTMTEKRILSLAR-----NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYA 130 (353)
T ss_dssp ------HTTHHHHHHHHHHHHHTT-----TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHH
T ss_pred ------hhHHHHHHHHHHHHHhcc-----CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHH
Confidence 112234566999998874 23499999999999999999999995 699999987653 9999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..|+.++|||
T Consensus 131 ~qi~~aL~~LH~~givHrDlkp~NILl~~~g--~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 208 (353)
T 3txo_A 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWW 208 (353)
T ss_dssp HHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHH
T ss_pred HHHHHHHHHHHHCCCcccCCCHHHEEECCCC--CEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCC
Confidence 9999999999999999999999999999988 89999999987532 234457899999999999988899999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|+.||.+.+..+.+..|.......+ ..
T Consensus 209 slG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p------------------------------------------~~ 246 (353)
T 3txo_A 209 AMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP------------------------------------------TW 246 (353)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------------------------------------TT
T ss_pred cchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------------------------------------------CC
Confidence 999999999999999999998888877765211111 11
Q ss_pred CChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTP------DEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta------~ell~h~~~~~~~ 368 (429)
.++.+.+||++||+.||++||++ .|+++||||+...
T Consensus 247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 37889999999999999999998 8999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=379.16 Aligned_cols=284 Identities=28% Similarity=0.496 Sum_probs=226.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------------------------- 41 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE---------------------------------------- 41 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------------------------------------------
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc----------------------------------------
Confidence 6899999999999999999999988865 88887432211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.....+.+|+++++.++|+ ||+++++++.....+++||||++++|.+++.... ..+++..++.++.||+
T Consensus 42 ----~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~ 110 (324)
T 3mtl_A 42 ----GAPCTAIREVSLLKDLKHA------NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLL 110 (324)
T ss_dssp ------CCCCCCCHHHHSCCCCT------TBCCEEEEEECSSCEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHH
T ss_pred ----ccchhHHHHHHHHHhcCCC------CCCeeeeEEeeCCEEEEEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHH
Confidence 0011223488999888776 9999999999999999999999999999998764 4599999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhC-CCCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILG-LPYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG 255 (429)
.||.|||++||+||||||+||+++.++ .++|+|||++...... .....+|+.|+|||++.+ ..++.++||||||
T Consensus 111 ~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 188 (324)
T 3mtl_A 111 RGLAYCHRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 188 (324)
T ss_dssp HHHHHHHHTTEEESSCCGGGEEECTTC--CEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred HHHHHHHHCCccCCCcCHHHEEECCCC--CEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHH
Confidence 999999999999999999999999988 8999999998754322 233578999999999987 4689999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|+.||.+.+..+++..+...++.++.+.+........... ..................++
T Consensus 189 ~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~ 256 (324)
T 3mtl_A 189 CIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT------------YNYPKYRAEALLSHAPRLDS 256 (324)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH------------TCCCCCCCCCHHHHCTTSCH
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc------------cccccccchhhhhhcCCCCH
Confidence 999999999999999999999999999999888776544322111100 00111122233444556789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
++.+||.+||++||++|||+.|+|+||||.+...
T Consensus 257 ~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 257 DGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred HHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 9999999999999999999999999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=377.33 Aligned_cols=289 Identities=28% Similarity=0.491 Sum_probs=224.2
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
....+||++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------------------------ 73 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE------------------------------------ 73 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------------------------------
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc------------------------------------
Confidence 34678999999999999999999999988865 88887543211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
......+.+|+++++.++|+ ||+++++++.....+++||||++++|.+++..... +++..++.++
T Consensus 74 -------~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~--~~~~~~~~i~ 138 (329)
T 3gbz_A 74 -------EGVPGTAIREVSLLKELQHR------NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPD--VSMRVIKSFL 138 (329)
T ss_dssp -------------CHHHHHHGGGCCCT------TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHCTT--CCHHHHHHHH
T ss_pred -------cccchhHHHHHHHHHHcCCC------CcceEEEEEecCCEEEEEEecCCCCHHHHHhhcCC--CCHHHHHHHH
Confidence 11223455699999998876 99999999999999999999999999999987653 9999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCC---CcceEEeeeccccccc---CcceeeecCccccchhhhhCC-CCCCC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRG---SSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGL-PYGPP 248 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~---~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~ 248 (429)
.||+.||.|||++||+||||||+|||++.++ ...+||+|||++.... ......++|+.|+|||++.+. .++.+
T Consensus 139 ~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 218 (329)
T 3gbz_A 139 YQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTS 218 (329)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTH
T ss_pred HHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcH
Confidence 9999999999999999999999999996433 1259999999997544 223345789999999999875 48999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++|..||.+.+..+.+..+...++.++...+........+ . ..............
T Consensus 219 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~------~~~~~~~~~~~~~~ 286 (329)
T 3gbz_A 219 VDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW------K------QSFPKFRGKTLKRV 286 (329)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC------C------TTCCCCCCCCHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh------h------hhhhhhccccHhhh
Confidence 99999999999999999999999999999999998888876654433211110 0 00011111122222
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 287 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 3344689999999999999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=385.66 Aligned_cols=287 Identities=29% Similarity=0.551 Sum_probs=217.4
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
-.+.+||++++.||+|+||.||+|.+..++.. |+|++......
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------------------------------------ 68 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS------------------------------------ 68 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS------------------------------------
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC------------------------------------
Confidence 34679999999999999999999999988865 99987543211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~ 169 (429)
......+.+|+++++.++|+ ||+++++++... ..+|+|||+++++|.+++... .+++.
T Consensus 69 -------~~~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~ 132 (367)
T 2fst_X 69 -------IIHAKRTYRELRLLKHMKHE------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDD 132 (367)
T ss_dssp -------HHHHHHHHHHHHHHHHCCCT------TBCCCSEEECSCSSGGGCCCCEEEEECCCEECC-----C---CCCHH
T ss_pred -------HHHHHHHHHHHHHHHhCCCC------CCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhcC---CCCHH
Confidence 11223556799999999877 999999998654 568999999999999988763 49999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC-CCCCCC
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPP 248 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~ 248 (429)
.+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.........++|+.|+|||++.+ ..++.+
T Consensus 133 ~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 210 (367)
T 2fst_X 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQT 210 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECC---------------CCCTTCCHHHHTTCCSCCTT
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC--CEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCch
Confidence 9999999999999999999999999999999999988 8999999999876666666789999999999987 578999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++|+.||.+.+..+++..+...++.++.+.+.......... ..... ..........
T Consensus 211 ~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~-------~~~~~----~~~~~~~~~~ 279 (367)
T 2fst_X 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN-------YIQSL----TQMPKMNFAN 279 (367)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH-------HHHTS----CCCCCCCHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH-------HHhcc----CCCCCCCHHH
Confidence 999999999999999999999999999999999999999988775543211100 00000 0111223445
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....++.+.+||++||+.||++|||+.|+|+||||+...
T Consensus 280 ~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 280 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 5566789999999999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=375.83 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=218.6
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-++|++++.||+|+||+||+|.++.++.. |+|++.+....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------------------------------------- 45 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV--------------------------------------- 45 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---------------------------------------
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---------------------------------------
Confidence 46799999999999999999999988865 99988543211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.......+.+|+.+++.+.|+ ||+++++++.+...+|+||||+. |+|.+++.... .+++..++.++.|
T Consensus 46 ---~~~~~~~~~~E~~~l~~l~hp------~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~q 114 (318)
T 1fot_A 46 ---RLKQVEHTNDERLMLSIVTHP------FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAE 114 (318)
T ss_dssp ---HTTCHHHHHHHHHHHHSCCBT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHH
T ss_pred ---hhhHHHHHHHHHHHHhhCCCC------CCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHH
Confidence 011123455699999888776 99999999999999999999995 69999998764 4999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
|+.||.|||++||+||||||+|||++.++ .+||+|||++..........+||+.|+|||++.+..++.++|+|||||+
T Consensus 115 i~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 192 (318)
T 1fot_A 115 VCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGIL 192 (318)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHH
T ss_pred HHHHHHHHHHCCccccCCChheEEEcCCC--CEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHH
Confidence 99999999999999999999999999988 8999999999887776677889999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|..||.+.+..+....+.......+ ...++++
T Consensus 193 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~p------------------------------------------~~~~~~~ 230 (318)
T 1fot_A 193 IYEMLAGYTPFYDSNTMKTYEKILNAELRFP------------------------------------------PFFNEDV 230 (318)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC------------------------------------------TTSCHHH
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------------------------------------CCCCHHH
Confidence 9999999999999888777766654111111 1237889
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 338 VDFVTQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
.+||++||+.||++|| ++.|+++||||+...
T Consensus 231 ~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 9999999999999999 899999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=376.70 Aligned_cols=288 Identities=29% Similarity=0.560 Sum_probs=215.7
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|++++.||+|+||+||+|.+..++.. |+|++.....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------------------- 43 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---------------------------------------- 43 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST----------------------------------------
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc----------------------------------------
Confidence 46899999999999999999999988865 8887743211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCC----CCCCHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNY----QGFSLGLIRRF 174 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~----~~~~~~~~~~i 174 (429)
......+.+|+++++.++|+ ||+++++++...+.+++||||++++|.+++..... ..+++..+..+
T Consensus 44 ----~~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 113 (317)
T 2pmi_A 44 ----EGTPSTAIREISLMKELKHE------NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113 (317)
T ss_dssp ----TCSCHHHHHHHHHHTTCCBT------TBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHH
T ss_pred ----cccHHHHHHHHHHHHhcCCC------CcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHH
Confidence 11223566799999998876 99999999999999999999999999999876531 34899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCC-CCCCCcc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGL-PYGPPID 250 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~D 250 (429)
+.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... ......+|+.|+|||++.+. .++.++|
T Consensus 114 ~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 191 (317)
T 2pmi_A 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSID 191 (317)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHH
T ss_pred HHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC--CEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHH
Confidence 99999999999999999999999999999988 899999999976442 22345789999999999874 5899999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch-hhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD-MASV 329 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 329 (429)
||||||++|+|++|+.||.+.+..+.+..+....+.+++..+........+ . .............. ....
T Consensus 192 iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~~~~~ 262 (317)
T 2pmi_A 192 IWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY-N--------PNIQQRPPRDLRQVLQPHT 262 (317)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC-C--------TTCCCCCCCCSHHHHGGGC
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc-c--------cccccccchhHHHhhcccc
Confidence 999999999999999999999999999999999998887766543321110 0 00000000000000 0111
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus 263 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 124578999999999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=375.71 Aligned_cols=260 Identities=28% Similarity=0.448 Sum_probs=220.2
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++++.||+|+||+||+|.+..++.. |+|++.....
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-------------------------------------- 43 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-------------------------------------- 43 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--------------------------------------
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc--------------------------------------
Confidence 4678999999999999999999999998865 8888743321
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+++++.++|+ ||+++++++.+...+++|||||. ++|.+++.... ..+++..+..++
T Consensus 44 --------~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~ 108 (321)
T 1tki_A 44 --------DQVLVKKEISILNIARHR------NILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYV 108 (321)
T ss_dssp --------HHHHHHHHHHHHHHSCCT------TBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHH
T ss_pred --------cHHHHHHHHHHHHhCCCC------CCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHH
Confidence 112345699999999876 99999999999999999999996 59999987653 359999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
.|++.||.|||++||+||||||+|||++.++...+||+|||++..... ......||+.|+|||++.+..++.++||||
T Consensus 109 ~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 188 (321)
T 1tki_A 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWS 188 (321)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHH
Confidence 999999999999999999999999999973333899999999976532 334567999999999999888899999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|+|++|..||.+.+..+.+..+......++.+. +...
T Consensus 189 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------------------------------------~~~~ 230 (321)
T 1tki_A 189 LGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA--------------------------------------FKEI 230 (321)
T ss_dssp HHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH--------------------------------------HTTS
T ss_pred HHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh--------------------------------------hccC
Confidence 99999999999999999988888777766443333332 2234
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
++++.+||.+||..||++|||+.|+|+||||++..
T Consensus 231 s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 78899999999999999999999999999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=376.29 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=214.9
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-++|++++.||+|+||+||+|.++.++.. |+|++.+....
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------- 44 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII--------------------------------------- 44 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---------------------------------------
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh---------------------------------------
Confidence 46899999999999999999999988865 99988543211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.......+.+|+++++.++|+ ||+++++++.....+|+||||+. |+|.+++.... .+++..++.++.|
T Consensus 45 ---~~~~~~~~~~E~~~l~~l~hp------~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~q 113 (337)
T 1o6l_A 45 ---AKDEVAHTVTESRVLQNTRHP------FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAE 113 (337)
T ss_dssp ---HTTCHHHHHHHHHHHHSCCCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHH
T ss_pred ---hhhHHHHHHHHHHHHHhCCCC------cCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHH
Confidence 011123456699999888766 99999999999999999999995 69999998765 4999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
|+.||+|||++||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..++.++|+|||
T Consensus 114 i~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 191 (337)
T 1o6l_A 114 IVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191 (337)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred HHHHHHHHHHCCeecCcCCHHHEEECCCC--CEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccc
Confidence 99999999999999999999999999988 89999999997532 23445789999999999999899999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||++|+|++|..||.+.+.......+....... +...+
T Consensus 192 G~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------------------------------------p~~~s 229 (337)
T 1o6l_A 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------------------------------------------PRTLS 229 (337)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------------------------------------CTTSC
T ss_pred hhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------------------------------------------CCCCC
Confidence 999999999999999988776666554311100 11237
Q ss_pred hHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
+++.+||.+||+.||++|| ++.|+++||||+...
T Consensus 230 ~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 8899999999999999999 899999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=369.29 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=215.3
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------------------------- 59 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP------------------------------------- 59 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-------------------------------------
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-------------------------------------
Confidence 4678999999999999999999999888865 88887432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+.+++.++|+ ||+++++++.....+|+||||+ +++|.+++.... +++..+..++
T Consensus 60 --------~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~ 122 (297)
T 3fxz_A 60 --------KKELIINEILVMRENKNP------NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVC 122 (297)
T ss_dssp --------CHHHHHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC---CCHHHHHHHH
T ss_pred --------HHHHHHHHHHHHhcCCCC------CCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcC---CCHHHHHHHH
Confidence 123456699999998876 9999999999999999999999 579999998753 9999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.|++.||+|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++.+..++.++|||
T Consensus 123 ~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 200 (297)
T 3fxz_A 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200 (297)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHH
T ss_pred HHHHHHHHHHHhCCceeCCCCHHHEEECCCC--CEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHH
Confidence 9999999999999999999999999999988 899999999875442 23346799999999999999999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|..||.+.+....+..+........ .....
T Consensus 201 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~ 241 (297)
T 3fxz_A 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL---------------------------------------QNPEK 241 (297)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------------------------------------SCGGG
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------------------------------CCccc
Confidence 999999999999999999887766655543211100 00123
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.++.+.+||.+||+.||++|||+.|+++||||+..
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 47889999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=378.51 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=220.2
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
..-++|++++.||+|+||+||+|.++.++.. |+|++......
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------------------------------------- 80 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV------------------------------------- 80 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-------------------------------------
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-------------------------------------
Confidence 3457899999999999999999999988865 99987533211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.......+.+|+++++.+.|+ ||+++++++.+...+|+||||+ +|+|.+++.... .+++..++.++
T Consensus 81 -----~~~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~ 147 (350)
T 1rdq_E 81 -----KLKQIEHTLNEKRILQAVNFP------FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYA 147 (350)
T ss_dssp -----HTTCHHHHHHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHH
T ss_pred -----cHHHHHHHHHHHHHHHhCCCC------CCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHH
Confidence 011223566799999888766 9999999999999999999999 569999998765 39999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||++..........+||+.|+|||++.+..++.++||||||
T Consensus 148 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 225 (350)
T 1rdq_E 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALG 225 (350)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHH
T ss_pred HHHHHHHHHHHHCCcccccCccceEEECCCC--CEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEeccc
Confidence 9999999999999999999999999999988 89999999998877766778999999999999999999999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|..||.+.+..+....+.......+ ...++
T Consensus 226 ~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------------------------------------~~~~~ 263 (350)
T 1rdq_E 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP------------------------------------------SHFSS 263 (350)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------------------------------------TTCCH
T ss_pred HhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC------------------------------------------CCCCH
Confidence 999999999999999888777766654211111 12378
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSSS 368 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~ 368 (429)
.+.+||.+||+.||++||+ +.|+++||||+...
T Consensus 264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 8999999999999999998 99999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=376.30 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=215.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.-.++|++++.||+|+||+||+|+++.+++. |+|++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~------------------------------------- 56 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL------------------------------------- 56 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-------------------------------------
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh-------------------------------------
Confidence 3468899999999999999999999988865 99988543211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.......+..|.+++..+ .|+ ||+++++++.+...+|+||||+ +|+|.+++.... .+++..++.+
T Consensus 57 -----~~~~~~~~~~E~~il~~~~~hp------~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~ 123 (345)
T 1xjd_A 57 -----MDDDVECTMVEKRVLSLAWEHP------FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFY 123 (345)
T ss_dssp -----HTTCHHHHHHHHHHHHHHTTCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHH
T ss_pred -----hhhhHHHHHHHHHHHHhcCCCC------CCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence 011123455688898887 555 9999999999999999999999 469999998765 3999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
+.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..++.++|+
T Consensus 124 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 201 (345)
T 1xjd_A 124 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201 (345)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCeEeCCCChhhEEECCCC--CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhh
Confidence 99999999999999999999999999999988 89999999997532 33456789999999999999999999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|..||.+.+..+.+..+.......+ .
T Consensus 202 wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------------------------------------~ 239 (345)
T 1xjd_A 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP------------------------------------------R 239 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------------------------------------T
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC------------------------------------------c
Confidence 9999999999999999999888777766653111111 1
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPD-EALRHEWLKSSS 368 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~-ell~h~~~~~~~ 368 (429)
..++.+.+||.+||+.||++||++. ++++||||+...
T Consensus 240 ~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 240 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 2378899999999999999999998 999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=378.88 Aligned_cols=285 Identities=31% Similarity=0.524 Sum_probs=229.3
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.++....+|++++.||+|+||+||+|.+..++.+|+|++.....
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------------------------------------ 77 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------------------------------------ 77 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------------------------------------
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------------------------------------
Confidence 44567889999999999999999999999888888887632110
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCe------EEEEEeecCcCHHHHHHhh--CCCCC
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH------LCISFELMNLNLYELIKRN--NYQGF 166 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~------~~lv~e~~~g~L~~~i~~~--~~~~~ 166 (429)
...+|+++++.++|+ ||++++++|..... +++||||+++++...+... ....+
T Consensus 78 -------------~~~~E~~il~~l~h~------niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~ 138 (394)
T 4e7w_A 78 -------------FKNRELQIMRIVKHP------NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTM 138 (394)
T ss_dssp -------------SCCHHHHHHHTCCCT------TBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCC
T ss_pred -------------hHHHHHHHHHhCCCC------CcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCC
Confidence 111499999999876 99999999976543 8999999998877766532 23459
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEe-cCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCC
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLK-QRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGL 243 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~-~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 243 (429)
++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||+|||++.... ......++|+.|+|||++.+.
T Consensus 139 ~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~ 216 (394)
T 4e7w_A 139 PMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGA 216 (394)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCC
Confidence 9999999999999999999999999999999999998 566 89999999997542 333456789999999999875
Q ss_pred -CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 244 -PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 244 -~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
.++.++|||||||++|+|++|+.||.+.+..+++..+...++.+..+.+......... .. .+...
T Consensus 217 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~---~~-----------~~~~~ 282 (394)
T 4e7w_A 217 TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME---HK-----------FPQIR 282 (394)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS---SC-----------CCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh---hc-----------ccccc
Confidence 5899999999999999999999999999999999999999999988876544321110 00 01111
Q ss_pred Cchhhhhh-ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 323 SKDMASVL-RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 323 ~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
........ ...++++.+||.+||+.||++|||+.|+++||||+.....
T Consensus 283 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 283 PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred CCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 12222222 3468899999999999999999999999999999976543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=378.56 Aligned_cols=314 Identities=30% Similarity=0.516 Sum_probs=239.6
Q ss_pred eeehhhhcccc-cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccc
Q psy17270 9 SFAFQVLHDHI-CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEES 86 (429)
Q Consensus 9 ~~~~~~~~~~~-~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~ 86 (429)
.+.....++.+ .++|++++.||+|+||+||+|.+..++.. |+|++.....
T Consensus 6 ~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------- 57 (373)
T 1q8y_A 6 GYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---------------------------- 57 (373)
T ss_dssp -CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----------------------------
T ss_pred CceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----------------------------
Confidence 34444444444 67999999999999999999999888865 9998753211
Q ss_pred cccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCC-----CCCCceeEEEEEEEEcC----eEEEEEeecCcCHHHH
Q psy17270 87 LSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDA-----DSSYNVIHMLEYFYFRN----HLCISFELMNLNLYEL 157 (429)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~-----~~~~~i~~~~~~~~~~~----~~~lv~e~~~g~L~~~ 157 (429)
....+.+|+++++.+.|.+. ..|+||+++++++.... .+++|||+++++|.++
T Consensus 58 ------------------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~ 119 (373)
T 1q8y_A 58 ------------------YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 119 (373)
T ss_dssp ------------------HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHH
T ss_pred ------------------chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHH
Confidence 12345569999999886531 22669999999998754 8999999999999999
Q ss_pred HHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCCCcEEEecCC----CcceEEeeecccccccCcceeeecCc
Q psy17270 158 IKRNNYQGFSLGLIRRFAFSLVQCLRLLHRE-NIIHCDLKPENVLLKQRG----SSSIKVIDFGSSCYSHQRVYTYIQSR 232 (429)
Q Consensus 158 i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~dlkp~Nili~~~~----~~~vkl~Dfg~~~~~~~~~~~~~~t~ 232 (429)
+.......+++..+..++.||+.||+|||++ ||+||||||+|||++.++ ...++|+|||++...........||+
T Consensus 120 ~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~ 199 (373)
T 1q8y_A 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199 (373)
T ss_dssp HHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCG
T ss_pred HHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCc
Confidence 9987666799999999999999999999998 999999999999996432 12699999999987766666678999
Q ss_pred cccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCC------HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 233 FYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGEN------EVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 233 ~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+ ..+.+..+...++.++..++........+++..+
T Consensus 200 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 279 (373)
T 1q8y_A 200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 279 (373)
T ss_dssp GGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--
T ss_pred cccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcc
Confidence 9999999999999999999999999999999999998754 5677888999999999888776655555555444
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
...........................++.+.+||++||+.||++|||+.|+|+||||++..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 280 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 33322211111000000000011123467899999999999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=376.37 Aligned_cols=284 Identities=29% Similarity=0.540 Sum_probs=231.8
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.+||++++.||+|+||.||+|.+..++.. |+|++......
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------------------------- 66 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-------------------------------------- 66 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH--------------------------------------
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc--------------------------------------
Confidence 358999999999999999999999988864 99987532211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecCcCHHHHHHhhCCCCCCHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELMNLNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|+++++.++|+ ||+++++++... ..+|+|||+++++|.+++.... +++..+.
T Consensus 67 ------~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~---~~~~~~~ 131 (364)
T 3qyz_A 67 ------TYCQRTLREIKILLRFRHE------NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHIC 131 (364)
T ss_dssp ------HHHHHHHHHHHHHHHCCCT------TBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHHCC---CCHHHHH
T ss_pred ------HHHHHHHHHHHHHHhcCCC------CCccceeEEecCCccccceEEEEEcccCcCHHHHHHhCC---CCHHHHH
Confidence 1223566799999999877 999999999765 3799999999999999997643 9999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhhCC-CC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILGL-PY 245 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~-~~ 245 (429)
.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++...... ....+||+.|+|||++.+. .+
T Consensus 132 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 209 (364)
T 3qyz_A 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209 (364)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSC
T ss_pred HHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC--CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCC
Confidence 9999999999999999999999999999999988 8999999999754422 2345799999999987654 58
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|||||||++|+|++|+.||.+.+..+.+..+...++.++.+.+............ . .........
T Consensus 210 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-------~----~~~~~~~~~ 278 (364)
T 3qyz_A 210 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL-------L----SLPHKNKVP 278 (364)
T ss_dssp STHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHH-------H----TSCCCCCCC
T ss_pred CcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHH-------H----hcCCccCCC
Confidence 99999999999999999999999999999999999999999988876543221110000 0 001112223
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....+..++.+.+||.+||++||++|||+.|+|+||||++..
T Consensus 279 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 279 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 4455566789999999999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=372.05 Aligned_cols=266 Identities=26% Similarity=0.419 Sum_probs=220.7
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+.+.++|++.+.||+|+||+||+|.+..++.. |+|++........
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---------------------------------- 52 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS---------------------------------- 52 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTC----------------------------------
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccc----------------------------------
Confidence 45778999999999999999999999988865 8887743321100
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
........+.+|+.+++.+.|+ ||+++++++.....+++||||+. ++|.+++.... .+++..+..+
T Consensus 53 -----~~~~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 119 (326)
T 2y0a_A 53 -----RRGVSREDIEREVSILKEIQHP------NVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEF 119 (326)
T ss_dssp -----SSSBCHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHH
T ss_pred -----cchhhHHHHHHHHHHHHhCCCC------CCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHH
Confidence 0011234577899999999876 99999999999999999999995 69999997654 4999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCC--CcceEEeeeccccccc--CcceeeecCccccchhhhhCCCCCCCcc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRG--SSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~--~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
+.||+.||.|||++||+||||||+||+++.++ ...+||+|||++.... ......+||+.|+|||++.+..++.++|
T Consensus 120 ~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 199 (326)
T 2y0a_A 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEAD 199 (326)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHH
T ss_pred HHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHH
Confidence 99999999999999999999999999998765 2369999999997653 2334567999999999999889999999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||||++|+|++|..||.+.+..+.+..+.......+... .
T Consensus 200 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~ 241 (326)
T 2y0a_A 200 MWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY--------------------------------------F 241 (326)
T ss_dssp HHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH--------------------------------------H
T ss_pred HHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc--------------------------------------c
Confidence 99999999999999999999888877776665333333222 2
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
...++.+.+||++||+.||++|||+.|+|+||||+..
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 3347889999999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=385.93 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=217.2
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
...+.++|++++.||+|+||+||+|.+..++.. |+|++.......
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~---------------------------------- 51 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA---------------------------------- 51 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH----------------------------------
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH----------------------------------
Confidence 456788999999999999999999999998865 888875433211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.....+.+|+++++.++|+ ||+++++++.+....|+|||||. |+|.+.+.... .+++..+..
T Consensus 52 ---------~~~~~~~~E~~il~~l~hp------nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~ 114 (444)
T 3soa_A 52 ---------RDHQKLEREARICRLLKHP------NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASH 114 (444)
T ss_dssp ---------HHHHHHHHHHHHHHHCCBT------TBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHH
T ss_pred ---------HHHHHHHHHHHHHHhCCCc------CCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHH
Confidence 1123456699999999877 99999999999999999999994 69999998765 399999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
++.||+.||.|||++||+||||||+|||++.+. ...+||+|||++...... ....+||+.|+|||++.+..|+.++
T Consensus 115 i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~ 194 (444)
T 3soa_A 115 CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPV 194 (444)
T ss_dssp HHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHH
T ss_pred HHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCcc
Confidence 999999999999999999999999999998531 237999999999765432 2346899999999999998999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|.+||.+.+..+.+..+.......+...
T Consensus 195 DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------------------- 236 (444)
T 3soa_A 195 DLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE-------------------------------------- 236 (444)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT--------------------------------------
T ss_pred ccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc--------------------------------------
Confidence 999999999999999999999888887777765322222111
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
+...++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 1234788999999999999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=362.15 Aligned_cols=286 Identities=29% Similarity=0.542 Sum_probs=225.2
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+-+||++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------------------------- 42 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-------------------------------------- 42 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC---------------------------------------
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc--------------------------------------
Confidence 357899999999999999999999988865 89987543221
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
......+.+|+++++.++|+ ||+++++++......++||||+++ +|.+++.... .+++..+..++.
T Consensus 43 -----~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~ 109 (311)
T 4agu_A 43 -----PVIKKIALREIRMLKQLKHP------NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITW 109 (311)
T ss_dssp -----HHHHHHHHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHH
T ss_pred -----hHHHHHHHHHHHHHHhCCCC------CccchhheeecCCeEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHH
Confidence 11223456699999999876 999999999999999999999976 5666655443 499999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhC-CCCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILG-LPYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~Diw 252 (429)
|++.||+|||++|++||||||+||+++.++ .++|+|||++...... ....++|+.|+|||++.+ ..++.++|||
T Consensus 110 ~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 187 (311)
T 4agu_A 110 QTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVW 187 (311)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHH
T ss_pred HHHHHHHHHHHCCCcCCCCChhhEEEcCCC--CEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhH
Confidence 999999999999999999999999999888 8999999999764422 234578999999999987 5689999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|..||.+.+..+.+..+...++...+............ ..... .............+.
T Consensus 188 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~ 256 (311)
T 4agu_A 188 AIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF-SGVKI----------PDPEDMEPLELKFPN 256 (311)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG-TTCCC----------CCCSSCCCHHHHCTT
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc-ccCcC----------CCccccchhhhhccc
Confidence 9999999999999999999999999999998888777655443322111 11111 111122233444456
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.++.+.+||++||+.||++|||+.|+++||||++..
T Consensus 257 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 257 ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 789999999999999999999999999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=378.98 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=208.6
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
--++|++++.||+|+||+||+|+++.++.. |+|++.+....
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-------------------------------------- 91 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-------------------------------------- 91 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC--------------------------------------
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc--------------------------------------
Confidence 357899999999999999999999998865 88887543221
Q ss_pred CCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.......+.+|..++..+ +|+ ||++++++|.+...+|+||||+. |+|.+++.... .+++..++.++
T Consensus 92 ----~~~~~~~~~~E~~il~~~~~hp------~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~ 159 (396)
T 4dc2_A 92 ----DDEDIDWVQTEKHVFEQASNHP------FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYS 159 (396)
T ss_dssp --------CCHHHHHHHHHHHHTTCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred ----CHHHHHHHHHHHHHHHhcCCCC------CcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHH
Confidence 111223466799999887 455 99999999999999999999995 69999998765 49999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccc---cCcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.. .......+||+.|+|||++.+..|+.++|+|
T Consensus 160 ~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~Diw 237 (396)
T 4dc2_A 160 AEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 237 (396)
T ss_dssp HHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHH
T ss_pred HHHHHHHHHHHHCCEEeccCCHHHEEECCCC--CEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHH
Confidence 9999999999999999999999999999988 8999999999752 2345567899999999999999999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHH---------HHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 253 SLGCILAELYTGCPLFPGENEVE---------QLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~---------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
||||++|+|++|+.||.+....+ ....+.....
T Consensus 238 slGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------------------------------------- 279 (396)
T 4dc2_A 238 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------------------------------------- 279 (396)
T ss_dssp HHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--------------------------------------
T ss_pred HHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--------------------------------------
Confidence 99999999999999997543211 1111111000
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTP------DEALRHEWLKSSS 368 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta------~ell~h~~~~~~~ 368 (429)
..+...++.+.+||++||+.||++||++ .|+++||||+...
T Consensus 280 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 280 ----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred ----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 0112347889999999999999999995 7999999998753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=371.14 Aligned_cols=287 Identities=32% Similarity=0.531 Sum_probs=227.6
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
.-++|++++.||+|+||+||+|.+..++.. |+|++.....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------------------- 55 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--------------------------------------- 55 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC---------------------------------------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc---------------------------------------
Confidence 357999999999999999999999888865 8887633211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--------cCeEEEEEeecCcCHHHHHHhhCCCCCCHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--------RNHLCISFELMNLNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--------~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~ 169 (429)
.......+.+|+++++.++|+ ||+++++++.. .+.+|+||||++++|.+.+.... ..+++.
T Consensus 56 ----~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~ 124 (351)
T 3mi9_A 56 ----KEGFPITALREIKILQLLKHE------NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLS 124 (351)
T ss_dssp ----SSSSCHHHHHHHHHHHHCCCT------TBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTT-SCCCHH
T ss_pred ----cccchHHHHHHHHHHHhccCC------CcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhcc-CCCCHH
Confidence 112334567799999999877 99999999987 34789999999999999887654 359999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc-------CcceeeecCccccchhhhhC
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-------QRVYTYIQSRFYRSPEVILG 242 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-------~~~~~~~~t~~y~aPE~~~~ 242 (429)
.+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... .......||+.|+|||++.+
T Consensus 125 ~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--CEEEccchhcccccccccccccccCCcccccCccCchhhcC
Confidence 9999999999999999999999999999999999888 89999999986533 12234578999999999986
Q ss_pred C-CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 243 L-PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 243 ~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
. .++.++|||||||++|+|++|..||.+.+..+.+..+....+.++.+.+............. ......
T Consensus 203 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~ 272 (351)
T 3mi9_A 203 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE----------LVKGQK 272 (351)
T ss_dssp CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSC----------CCSSCC
T ss_pred CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccc----------cccccc
Confidence 4 58999999999999999999999999999999999999999988877665443322111000 000000
Q ss_pred CCchhhhhh-ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 322 GSKDMASVL-RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 322 ~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
........ ...++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 273 -~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 273 -RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp -CCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred -cCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 00111111 12478899999999999999999999999999997643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=382.66 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=211.4
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
....-++|++.+.||+|+||+||+|.+..++.. |+|++......
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----------------------------------- 48 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK----------------------------------- 48 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----------------------------------
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-----------------------------------
Confidence 345678999999999999999999999888865 99987532111
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.......+.+|+++++.++|+ ||+++++++.....+++||||++|+|.+++.... .+++..++.+
T Consensus 49 -------~~~~~~~~~~E~~~l~~l~hp------nIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~~~--~l~~~~~~~i 113 (336)
T 3h4j_B 49 -------KSDMHMRVEREISYLKLLRHP------HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRF 113 (336)
T ss_dssp -------HTTCSHHHHHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHH
T ss_pred -------chhHHHHHHHHHHHHHhCCCC------CCCeEEEEEEeCCEEEEEEECCCCcHHHHHHHcC--CCCHHHHHHH
Confidence 112234567799999998876 9999999999999999999999999999998765 4999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCC-CCCccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPY-GPPIDM 251 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~-~~~~Di 251 (429)
+.|++.||.|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++.+..+ +.++||
T Consensus 114 ~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 191 (336)
T 3h4j_B 114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDV 191 (336)
T ss_dssp HHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC--CEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHH
T ss_pred HHHHHHHHHHHHHCCeEecCCchhhEEEcCCC--CEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccch
Confidence 99999999999999999999999999999988 899999999975432 2345689999999999988776 679999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|+.||.+.........+ . ......+.
T Consensus 192 wslG~il~~ll~g~~Pf~~~~~~~~~~~i----------------------------------~--------~~~~~~p~ 229 (336)
T 3h4j_B 192 WSCGIVLYVMLVGRLPFDDEFIPNLFKKV----------------------------------N--------SCVYVMPD 229 (336)
T ss_dssp HHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------------------------------C--------SSCCCCCT
T ss_pred hHHHHHHHHHHhCCCCCCCccHHHHHHHH----------------------------------H--------cCCCCCcc
Confidence 99999999999999999764321110000 0 00001122
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
..++.+.+||++||+.||.+|||+.|+++||||+..
T Consensus 230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 230 FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 347899999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=373.31 Aligned_cols=288 Identities=30% Similarity=0.546 Sum_probs=226.8
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..++|++++.||+|+||+||+|.+..++.. |+|++........
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------------------------ 51 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA------------------------------------ 51 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------------------------------
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh------------------------------------
Confidence 568999999999999999999999988865 9998754321110
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.......+.+|+++++.++|+ ||+++++++......++||||++++|.+++.... ..+++..+..++.|
T Consensus 52 ----~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~q 120 (346)
T 1ua2_A 52 ----KDGINRTALREIKLLQELSHP------NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLM 120 (346)
T ss_dssp --------CTHHHHHHHHHHHCCCT------TBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHH
T ss_pred ----hhhhhHHHHHHHHHHhhCCCC------CCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHH
Confidence 112234567799999999876 9999999999999999999999999999887654 45899999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCC-CCCCCccccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGL-PYGPPIDMWS 253 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwS 253 (429)
++.||+|||++||+||||||+||+++.++ .+||+|||++..... .....++|+.|+|||++.+. .++.++||||
T Consensus 121 i~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 198 (346)
T 1ua2_A 121 TLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 198 (346)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred HHHHHHHHHHCCEECCCCCHHHEEEcCCC--CEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHh
Confidence 99999999999999999999999999988 899999999976432 23346789999999999765 4788999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|+|++|.+||.+.+..+.+..+....+.+..+.+...... +.... .......+........
T Consensus 199 lG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~---------~~~~~-----~~~~~~~~~~~~~~~~ 264 (346)
T 1ua2_A 199 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL---------PDYVT-----FKSFPGIPLHHIFSAA 264 (346)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS---------TTCCC-----CCCCCCCCHHHHCTTC
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC---------ccccc-----ccccCCCChHHhhccC
Confidence 999999999999999999999999999998888776654332111 00000 0011112234455667
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
++++.+||++||+.||++|||+.|+|+||||+....
T Consensus 265 ~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 265 GDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 899999999999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=374.53 Aligned_cols=258 Identities=26% Similarity=0.364 Sum_probs=214.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.--++|++++.||+|+||+||+|.++.++.. |+|++.+....
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~------------------------------------- 59 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI------------------------------------- 59 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-------------------------------------
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-------------------------------------
Confidence 3457899999999999999999999988865 99988543211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.......+..|.+++..+. .||+|+++++++.....+|+||||+. |+|.+++.... .+++..++.++
T Consensus 60 -----~~~~~~~~~~E~~~l~~~~-----~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~ 127 (353)
T 2i0e_A 60 -----QDDDVECTMVEKRVLALPG-----KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYA 127 (353)
T ss_dssp -----HTTCHHHHHHHHHHHTCTT-----CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred -----cchHHHHHHHHHHHHHhcC-----CCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHH
Confidence 0111234556888887663 34599999999999999999999995 69999998765 39999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccc---cCcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.||+.||.|||++||+||||||+|||++.++ .+||+|||++... .......+||+.|+|||++.+..++.++|+|
T Consensus 128 ~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 205 (353)
T 2i0e_A 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 205 (353)
T ss_dssp HHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHH
T ss_pred HHHHHHHHHHHHCCEEeccCCHHHEEEcCCC--cEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCccccc
Confidence 9999999999999999999999999999988 8999999999753 2334557899999999999999999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|+.||.+.+..+.+..|.......+ ..
T Consensus 206 slG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p------------------------------------------~~ 243 (353)
T 2i0e_A 206 AFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP------------------------------------------KS 243 (353)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------------------------------------TT
T ss_pred chHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC------------------------------------------CC
Confidence 999999999999999999888877776664111111 12
Q ss_pred CChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~ 368 (429)
.++++.+||++||+.||++||+ +.++++||||+...
T Consensus 244 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 3788999999999999999994 69999999998653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=376.27 Aligned_cols=279 Identities=30% Similarity=0.547 Sum_probs=222.8
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++++.||+|+||+||+|.+..+++. |+|++.....
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------------------------------------- 45 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------------------------------------- 45 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------------------------------------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------------------------------------
Confidence 4678999999999999999999999988865 8887632210
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------------------------------------
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------------------------------------ 140 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------------------------------------ 140 (429)
...+|+++++.++|+ ||++++++|...
T Consensus 46 -----------~~~~E~~il~~l~hp------nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (383)
T 3eb0_A 46 -----------YKNRELDIMKVLDHV------NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108 (383)
T ss_dssp -----------SCCHHHHHHTTCCCT------TBCCEEEEEEEC------------------------------------
T ss_pred -----------hHHHHHHHHHHcCCC------CccchhheeeecCcccccccccccccccccccccccccccccccccCC
Confidence 112499999998776 999999998543
Q ss_pred --CeEEEEEeecCcCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEe-cCCCcceEEeee
Q psy17270 141 --NHLCISFELMNLNLYELIKR--NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLK-QRGSSSIKVIDF 215 (429)
Q Consensus 141 --~~~~lv~e~~~g~L~~~i~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~-~~~~~~vkl~Df 215 (429)
..+++||||++++|.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||+||
T Consensus 109 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~--~~kl~Df 186 (383)
T 3eb0_A 109 QNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCDF 186 (383)
T ss_dssp -CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTT--EEEECCC
T ss_pred CceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCC--cEEEEEC
Confidence 34899999999998888874 2334599999999999999999999999999999999999998 456 8999999
Q ss_pred ccccccc--CcceeeecCccccchhhhhCCC-CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHH
Q psy17270 216 GSSCYSH--QRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVI 292 (429)
Q Consensus 216 g~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 292 (429)
|++.... .......+|+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+..+++..+...++.++.+.+
T Consensus 187 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 266 (383)
T 3eb0_A 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266 (383)
T ss_dssp TTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 9997543 3344567899999999998754 899999999999999999999999999999999999999999988876
Q ss_pred hhhhhhhhhccCCCCCccccCCCCCCCCCCCchh-hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 293 NTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM-ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
........ .. ..+....... .......++.+.+||++||+.||++|||+.|+|+||||+..
T Consensus 267 ~~~~~~~~---~~-----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 267 IRMNPHYT---EV-----------RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp HHHCTTC-----C-----------CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred HHhCcccc---cc-----------cCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 54432110 00 0001111111 22233468899999999999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=362.78 Aligned_cols=289 Identities=28% Similarity=0.521 Sum_probs=230.8
Q ss_pred cccCCeEEEeEeeccccceEEEEEec-CCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDH-KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~-~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
...++|++++.||+|+||+||+|.+. .++. +|+|++......
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~------------------------------------ 51 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE------------------------------------ 51 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT------------------------------------
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc------------------------------------
Confidence 35689999999999999999999995 5555 488877432110
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEE-----EcCeEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY-----FRNHLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
......+.+|+.+++.+... .||||+++++++. ....+++||||++|+|.+++.......+++..
T Consensus 52 -------~~~~~~~~~e~~~l~~l~~~---~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~ 121 (326)
T 1blx_A 52 -------EGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121 (326)
T ss_dssp -------TSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHH
T ss_pred -------ccCCchhhHHHHHHHhhhcc---CCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHH
Confidence 11123456688888888532 3459999999987 45689999999999999999887656699999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..... ......+|+.|+|||++.+..++.+
T Consensus 122 ~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 199 (326)
T 1blx_A 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 199 (326)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC--CEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcc
Confidence 999999999999999999999999999999999988 899999999975442 2334678999999999999899999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++|+.||.+.+..+.+..+...++.+....+...... +... ...........
T Consensus 200 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~---------~~~~------~~~~~~~~~~~ 264 (326)
T 1blx_A 200 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL---------PRQA------FHSKSAQPIEK 264 (326)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS---------CGGG------SCCCCCCCGGG
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc---------chhh------hcccCcchhhh
Confidence 99999999999999999999999999999999988887766544321110 0000 00111122334
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
.....++.+.+||.+||+.||++|||+.|+++||||+....
T Consensus 265 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 265 FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 44566899999999999999999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=376.97 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=218.6
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
....+.++|++.+.||+|+||.||+|.++.++.. |+|++.......
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--------------------------------- 69 (362)
T 2bdw_A 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--------------------------------- 69 (362)
T ss_dssp -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH---------------------------------
T ss_pred CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH---------------------------------
Confidence 3456788999999999999999999999988865 999875432211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|+++++.+.|+ ||+++++++.+....|+||||+. |+|.+.+.... .+++..+.
T Consensus 70 ----------~~~~~~~~E~~il~~l~hp------nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~ 131 (362)
T 2bdw_A 70 ----------RDFQKLEREARICRKLQHP------NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADAS 131 (362)
T ss_dssp ----------HHHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHH
T ss_pred ----------HHHHHHHHHHHHHHhCCCC------CCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHH
Confidence 1123456799999999876 99999999999999999999995 59999987654 49999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCC-cceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS-SSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~-~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++...... ....+||+.|+|||++.+..++.++
T Consensus 132 ~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 211 (362)
T 2bdw_A 132 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPV 211 (362)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHH
T ss_pred HHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchh
Confidence 99999999999999999999999999999987542 36999999999765432 2346799999999999998999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|..||.+.+..+....+.......+...
T Consensus 212 DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------------------- 253 (362)
T 2bdw_A 212 DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE-------------------------------------- 253 (362)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG--------------------------------------
T ss_pred hHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc--------------------------------------
Confidence 999999999999999999999888777766654322222111
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
+...++.+.+||.+||+.||++|||+.|+|+||||..
T Consensus 254 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 254 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 1234788999999999999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=370.64 Aligned_cols=195 Identities=23% Similarity=0.319 Sum_probs=155.5
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
|+++|.+.++||+|+||+||+|++. ...+|||++...... .
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~----~---------------------------------- 41 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER----S---------------------------------- 41 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH----H----------------------------------
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh----h----------------------------------
Confidence 4678999999999999999999984 334699988543211 0
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC----eEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN----HLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.....|+..+..++|+ ||+++++++..++ .+|||||||+ |+|.++++... +++..+..
T Consensus 42 --------~~~e~Ei~~~~~l~Hp------NIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---l~~~~~~~ 104 (303)
T 3hmm_A 42 --------WFREAEIYQTVMLRHE------NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIK 104 (303)
T ss_dssp --------HHHHHHHHTSTTCCCT------TBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHH
T ss_pred --------HHHHHHHHHHhcCCCC------CCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC---CCHHHHHH
Confidence 0111255555556555 9999999998664 6899999995 79999998754 99999999
Q ss_pred HHHHHHHHHHHHHHC--------CceecccCCCcEEEecCCCcceEEeeecccccccCc-------ceeeecCccccchh
Q psy17270 174 FAFSLVQCLRLLHRE--------NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-------VYTYIQSRFYRSPE 238 (429)
Q Consensus 174 i~~qil~~l~~lH~~--------~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE 238 (429)
++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++..... ....+||+.|||||
T Consensus 105 i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~--~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE 182 (303)
T 3hmm_A 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182 (303)
T ss_dssp HHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHH
T ss_pred HHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC--CEEEEeCCCCccccCCCCceeeecccccccccccCHH
Confidence 999999999999987 999999999999999988 8999999999754322 22357999999999
Q ss_pred hhhCC------CCCCCccccchhhHHHHHhhCCCCCCCC
Q psy17270 239 VILGL------PYGPPIDMWSLGCILAELYTGCPLFPGE 271 (429)
Q Consensus 239 ~~~~~------~~~~~~DiwSlG~il~~lltg~~pf~~~ 271 (429)
++.+. .|+.++|||||||++|||+||.+||...
T Consensus 183 ~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp HHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred HhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 99764 3567899999999999999998877543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=375.43 Aligned_cols=285 Identities=27% Similarity=0.535 Sum_probs=230.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++.+.||+|+||+||+|.+..++.. |+|++......
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------------------------------------- 81 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS------------------------------------- 81 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-------------------------------------
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-------------------------------------
Confidence 3689999999999999999999999998865 99987543221
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeE------EEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHL------CISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~------~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
......+.+|+.+++.++|+ ||+++++++...... |+||||++++|.+++. ..+++..
T Consensus 82 ------~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~ 145 (371)
T 4exu_A 82 ------EIFAKRAYRELLLLKHMQHE------NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG----MEFSEEK 145 (371)
T ss_dssp ------HHHHHHHHHHHHHHHHCCCT------TBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT----SCCCHHH
T ss_pred ------hhHHHHHHHHHHHHHhcCCC------CchhhhhheeccCCcccceeEEEEEccccccHHHHhh----cCCCHHH
Confidence 12234566799999999877 999999999876654 9999999999888763 2499999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC-CCCCCCc
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPI 249 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~ 249 (429)
+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++..........++|+.|+|||++.+ ..++.++
T Consensus 146 ~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (371)
T 4exu_A 146 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTV 223 (371)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTH
T ss_pred HHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC--CEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHH
Confidence 999999999999999999999999999999999988 8999999999877766666789999999999987 6789999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||.+.+..+.+..+....+.++.+++........... .. .............
T Consensus 224 DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-------~~----~~~~~~~~~~~~~ 292 (371)
T 4exu_A 224 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY-------IQ----SLPQTPRKDFTQL 292 (371)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHH-------HH----HSCCCCCCCHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhh-------hh----ccCCCcchhHHHh
Confidence 999999999999999999999999999999999999998887654322111000 00 0011222334555
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||++||+.||++|||+.|+|+||||+...
T Consensus 293 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 293 FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp STTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred ccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 566789999999999999999999999999999998643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=370.01 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=209.2
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.--++|++++.||+|+||+||+|+++.++.. |+|++.+.....
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~------------------------------------ 49 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND------------------------------------ 49 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS------------------------------------
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc------------------------------------
Confidence 3457899999999999999999999988865 999886443211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
......+.+|+.++..+ +|+ ||++++++|.+...+|+||||+. |+|.+++.... .+++..++.+
T Consensus 50 ------~~~~~~~~~E~~~l~~~~~hp------~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~ 115 (345)
T 3a8x_A 50 ------DEDIDWVQTEKHVFEQASNHP------FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFY 115 (345)
T ss_dssp ------HHHHHHHHHHHHHHHHTTTCT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHH
T ss_pred ------hHHHHHHHHHHHHHHhcCCCC------ccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence 11123455699999887 555 99999999999999999999995 69999998765 4999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccc---cCcceeeecCccccchhhhhCCCCCCCccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
+.||+.||+|||++||+||||||+|||++.++ .+||+|||++... .......+||+.|+|||++.+..++.++|+
T Consensus 116 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 193 (345)
T 3a8x_A 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193 (345)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhH
Confidence 99999999999999999999999999999988 8999999999752 233455789999999999999999999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCH---------HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 252 WSLGCILAELYTGCPLFPGENE---------VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
|||||++|+|++|+.||..... ......+.....
T Consensus 194 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------------------------------------- 236 (345)
T 3a8x_A 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------------------------------------- 236 (345)
T ss_dssp HHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-------------------------------------
T ss_pred HHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-------------------------------------
Confidence 9999999999999999975321 111111111000
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTP------DEALRHEWLKSSS 368 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta------~ell~h~~~~~~~ 368 (429)
..+...++.+.+||++||+.||++||++ .|+++||||+...
T Consensus 237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 237 -----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred -----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 0012347889999999999999999996 8999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=376.21 Aligned_cols=263 Identities=25% Similarity=0.429 Sum_probs=217.7
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.++|++++.||+|+||+||+|.+..++.. |+|++.......
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~----------------------------------- 91 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD----------------------------------- 91 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH-----------------------------------
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh-----------------------------------
Confidence 34678999999999999999999999988875 888875432110
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
...+.+|+++++.+.|+ ||+++++++.....+++||||+. ++|.+++.... ..+++..+..+
T Consensus 92 ----------~~~~~~E~~il~~l~hp------nIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i 154 (387)
T 1kob_A 92 ----------KYTVKNEISIMNQLHHP------KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINY 154 (387)
T ss_dssp ----------HHHHHHHHHHHTTCCST------TBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHH
T ss_pred ----------HHHHHHHHHHHHhCCCc------CCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHH
Confidence 12355699999988776 99999999999999999999995 69999887653 35999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
+.||+.||+|||++||+||||||+|||++.++...+||+|||++..... .....+||+.|+|||++.+..++.++|||
T Consensus 155 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 234 (387)
T 1kob_A 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234 (387)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHH
T ss_pred HHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEe
Confidence 9999999999999999999999999999865434799999999976543 23446799999999999998899999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|..||.+.+..+.+..+.......+. ..+..
T Consensus 235 SlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------------------~~~~~ 276 (387)
T 1kob_A 235 AIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--------------------------------------DAFSS 276 (387)
T ss_dssp HHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS--------------------------------------STTTT
T ss_pred eHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------------------------------------ccccc
Confidence 9999999999999999998887777666542111110 01123
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
.++.+.+||++||+.||++|||+.|+|+||||+....
T Consensus 277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 4789999999999999999999999999999987543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=379.97 Aligned_cols=291 Identities=27% Similarity=0.491 Sum_probs=217.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++++.||+|+||+||+|.+..++.. |+|++.......
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------------------------------ 65 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ------------------------------------ 65 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSH------------------------------------
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCCh------------------------------------
Confidence 4678999999999999999999999988865 999875432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC------eEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN------HLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~------~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
.....+.+|+.+++.+.|+ ||+++++++.... .+|+||||++++|.+.+.. .+++..
T Consensus 66 -------~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~ 128 (371)
T 2xrw_A 66 -------THAKRAYRELVLMKCVNHK------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM----ELDHER 128 (371)
T ss_dssp -------HHHHHHHHHHHHHHHCCCT------TBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS----CCCHHH
T ss_pred -------HHHHHHHHHHHHHHhcCCC------CccceEEeeccccccccccceEEEEEcCCCCHHHHHhh----ccCHHH
Confidence 1123456699999999876 9999999997654 7899999999999998862 389999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ....+||+.|+|||++.+..++.+
T Consensus 129 ~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 206 (371)
T 2xrw_A 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206 (371)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCC----------------CTTCCHHHHTTCCCCTT
T ss_pred HHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCch
Confidence 999999999999999999999999999999999988 8999999999765432 334678999999999999899999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhc-cC-CCCCccc-cCCCCCCCCCCCch
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFF-DS-KGTPRCI-TNSKGRKRKPGSKD 325 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~-~~~~~~~~~~~~~~ 325 (429)
+|||||||++|+|++|..||.+.+..+++..+...++.+..+.+.........+ .. ....... .........+.
T Consensus 207 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 283 (371)
T 2xrw_A 207 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA--- 283 (371)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCC---
T ss_pred HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcc---
Confidence 999999999999999999999999999999999988888877765432211100 00 0000000 00000000000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
........++.+.+||++||+.||++|||+.|+|+||||+.
T Consensus 284 ~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 284 DSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp SSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00111122568899999999999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=379.63 Aligned_cols=258 Identities=26% Similarity=0.343 Sum_probs=216.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++++.||+|+||+||+|.++.++.. |+|++.+....
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~------------------------------------- 108 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI------------------------------------- 108 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-------------------------------------
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh-------------------------------------
Confidence 4468999999999999999999999998875 99987532110
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.......+.+|+++++.+.|+ ||++++++|.+..++|+||||| +|+|.+++... .+++..++.++
T Consensus 109 -----~~~~~~~~~~E~~il~~l~hp------~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~ 174 (410)
T 3v8s_A 109 -----KRSDSAFFWEERDIMAFANSP------WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYT 174 (410)
T ss_dssp -----HTCCCSTHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHH
T ss_pred -----hhHHHHHHHHHHHHHHhCCCC------CCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHH
Confidence 111223466799999998876 9999999999999999999999 56999998764 39999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCCC----CCC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGLP----YGP 247 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~----~~~ 247 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ....+||+.|+|||++.+.. |+.
T Consensus 175 ~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~ 252 (410)
T 3v8s_A 175 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 252 (410)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEET
T ss_pred HHHHHHHHHHHHCCeEeccCCHHHeeECCCC--CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCC
Confidence 9999999999999999999999999999988 8999999999765432 23568999999999998765 788
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhC--CCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILG--CPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
++|||||||++|+|++|+.||.+.+..+....|..... ..+.
T Consensus 253 ~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------------------ 296 (410)
T 3v8s_A 253 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD------------------------------------ 296 (410)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT------------------------------------
T ss_pred cceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC------------------------------------
Confidence 99999999999999999999999998888777764211 0000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKK--RLTPDEALRHEWLKSSS 368 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||++||..+|.+ |+++.|+++||||+...
T Consensus 297 ----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 297 ----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp ----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred ----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 0123788999999999999988 99999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=372.37 Aligned_cols=266 Identities=27% Similarity=0.390 Sum_probs=213.7
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.++|++.+.||+|+||+||+|.++.++.. |+|++........
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------------------------------- 65 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS---------------------------------- 65 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTS----------------------------------
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccc----------------------------------
Confidence 45678999999999999999999999988865 9998743211000
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC--CCCCCHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN--YQGFSLGLIR 172 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~--~~~~~~~~~~ 172 (429)
.......+.+|+++++.++|+ ||+++++++.....+|+|||||. ++|.+.+.... ...+++..+.
T Consensus 66 ------~~~~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~ 133 (351)
T 3c0i_A 66 ------PGLSTEDLKREASICHMLKHP------HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133 (351)
T ss_dssp ------SSCCHHHHHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHH
T ss_pred ------ccchHHHHHHHHHHHHhCCCC------CCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHH
Confidence 001134567799999999876 99999999999999999999996 69988876542 2348999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCC-cceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS-SSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~-~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||++...... ....+||+.|+|||++.+..++.+
T Consensus 134 ~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 213 (351)
T 3c0i_A 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKP 213 (351)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCch
Confidence 99999999999999999999999999999987652 24999999999765432 234679999999999999899999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++|..||.+.. .+....+.......+..
T Consensus 214 ~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~-------------------------------------- 254 (351)
T 3c0i_A 214 VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR-------------------------------------- 254 (351)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH--------------------------------------
T ss_pred HhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc--------------------------------------
Confidence 999999999999999999998753 33444443321111111
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.+...++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 255 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 123347899999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=380.28 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=217.0
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|+++++||+|+||+||+|+++.+++. |+|++.+....
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~------------------------------------- 113 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML------------------------------------- 113 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-------------------------------------
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh-------------------------------------
Confidence 4568999999999999999999999998865 99987532110
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.......+.+|..++..+.|+ ||++++++|.+...+|+||||| +|+|.+++.... ..+++..++.++
T Consensus 114 -----~~~~~~~~~~E~~il~~~~hp------~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~ 181 (437)
T 4aw2_A 114 -----KRAETACFREERDVLVNGDSK------WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYL 181 (437)
T ss_dssp -----HTTTTCCHHHHHHHHHHSCTT------TBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHH
T ss_pred -----hHHHHHHHHHHHHHHHhCCCC------CEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHH
Confidence 111123466799999998776 9999999999999999999999 579999998743 359999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhh-----CCCCC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVIL-----GLPYG 246 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~-----~~~~~ 246 (429)
.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ....+||+.|+|||++. ...|+
T Consensus 182 ~qi~~aL~~LH~~giiHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~ 259 (437)
T 4aw2_A 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYG 259 (437)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEEC
T ss_pred HHHHHHHHHHHhCCeEecccCHHHeeEcCCC--CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCC
Confidence 9999999999999999999999999999988 8999999999654322 22368999999999997 45689
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhC--CCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILG--CPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
.++|||||||++|+|++|+.||.+.+..+....|..... ..+.
T Consensus 260 ~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~----------------------------------- 304 (437)
T 4aw2_A 260 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT----------------------------------- 304 (437)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-----------------------------------
T ss_pred CcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-----------------------------------
Confidence 999999999999999999999999998888777764211 0000
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKK--RLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~ell~h~~~~~~~~ 369 (429)
.....++++.+||++||..+|++ |++++|+++||||+...-
T Consensus 305 ----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 305 ----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp ----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred ----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 01224789999999999999988 999999999999997643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=368.42 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=207.7
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++++.||+|+||+||+|.+..+++. |+|++......
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------------------------- 46 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV------------------------------------- 46 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------------------------------------
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-------------------------------------
Confidence 4678999999999999999999999988865 88887432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+.+++.++|+ ||+++++++......|+|||||. ++|.+++.... .+++..+..++
T Consensus 47 -------~~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~ 111 (323)
T 3tki_A 47 -------DCPENIKKEICINKMLNHE------NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFF 111 (323)
T ss_dssp -----------CHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHH
T ss_pred -------chHHHHHHHHHHHHhCCCC------CCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHH
Confidence 1123456799999999877 99999999999999999999995 59998887553 49999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc-----CcceeeecCccccchhhhhCCCC-CCCc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-----QRVYTYIQSRFYRSPEVILGLPY-GPPI 249 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~-~~~~ 249 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..+ +.++
T Consensus 112 ~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 189 (323)
T 3tki_A 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189 (323)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHH
T ss_pred HHHHHHHHHHHHCCccccccchHHEEEeCCC--CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcc
Confidence 9999999999999999999999999999988 89999999996532 12234679999999999988775 6789
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||.+.+............... ...
T Consensus 190 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------------------~~~ 230 (323)
T 3tki_A 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------------------------------LNP 230 (323)
T ss_dssp HHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT---------------------------------------STT
T ss_pred cHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc---------------------------------------CCc
Confidence 99999999999999999998765432221111100000 001
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 123478899999999999999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=363.04 Aligned_cols=261 Identities=20% Similarity=0.266 Sum_probs=206.6
Q ss_pred eehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 10 FAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 10 ~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
+.....++.+.++|+++++||+|+||+||+|.+..++.. |+|++.........
T Consensus 46 ~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-------------------------- 99 (311)
T 3p1a_A 46 YDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-------------------------- 99 (311)
T ss_dssp CCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH--------------------------
T ss_pred CCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH--------------------------
Confidence 334445566778999999999999999999999988865 99987543222111
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCC
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFS 167 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~ 167 (429)
......|+..+..+ .| +||+++++++.....+|+|||+++++|.+++.... ..++
T Consensus 100 -----------------~~~~~~e~~~~~~~~~h------~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~ 155 (311)
T 3p1a_A 100 -----------------RARKLAEVGSHEKVGQH------PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLP 155 (311)
T ss_dssp -----------------HHHHHHHHHHHHHHCCC------TTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHC-SCCC
T ss_pred -----------------HHHHHHHHHHHHHhcCC------CcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcC-CCCC
Confidence 11223355555554 44 49999999999999999999999999999988765 4699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCC
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~ 245 (429)
+..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++...... .....||+.|+|||++.+ .+
T Consensus 156 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~ 232 (311)
T 3p1a_A 156 EAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG--RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SY 232 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG--CEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC--CEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CC
Confidence 999999999999999999999999999999999999988 8999999998765432 233568999999999887 78
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|||||||++|+|++|..||.+.+.... +.. +..+
T Consensus 233 ~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~------------------------------------- 270 (311)
T 3p1a_A 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLP------------------------------------- 270 (311)
T ss_dssp STHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCC-------------------------------------
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCC-------------------------------------
Confidence 9999999999999999999777655332221 111 1111
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.......++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus 271 -~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 -PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1223345889999999999999999999999999999976
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=359.43 Aligned_cols=260 Identities=28% Similarity=0.408 Sum_probs=215.0
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
..-++|++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------------------------- 48 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE------------------------------------- 48 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-------------------------------------
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-------------------------------------
Confidence 3457899999999999999999999988864 99987432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.......+.+|+++++.++|+ ||+++++++......++||||++ ++|.+++..... +++..+..++
T Consensus 49 -----~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~ 115 (279)
T 3fdn_A 49 -----KAGVEHQLRREVEIQSHLRHP------NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 115 (279)
T ss_dssp -----HHTCHHHHHHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHH
T ss_pred -----hhhHHHHHHHHHHHHHcCCCC------CCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHH
Confidence 112234566799999988776 99999999999999999999996 699999987653 9999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-cceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... ......||+.|+|||++.+..++.++|||||
T Consensus 116 ~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (279)
T 3fdn_A 116 TELANALSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193 (279)
T ss_dssp HHHHHHHHHHHTTTCEECCCCGGGEEECTTS--CEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred HHHHHHHHHHHhCCEecccCChHhEEEcCCC--CEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhH
Confidence 9999999999999999999999999999888 899999999865433 2344678999999999999889999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|+++|+|++|..||.+.+..+....+.......+ ...+
T Consensus 194 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~ 231 (279)
T 3fdn_A 194 GVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------------------------------------DFVT 231 (279)
T ss_dssp HHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC------------------------------------------TTSC
T ss_pred HHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC------------------------------------------CcCC
Confidence 9999999999999999887777666554221111 1236
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~~ 371 (429)
+.+.+||.+||+.||++|||+.|+++||||+.....+
T Consensus 232 ~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 232 EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred HHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence 8889999999999999999999999999998754433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=371.95 Aligned_cols=259 Identities=22% Similarity=0.371 Sum_probs=212.1
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
+++..++|++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~----------------------------------- 54 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV----------------------------------- 54 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-----------------------------------
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-----------------------------------
Confidence 455678999999999999999999999998875 99987533211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.......+.+|+++++.+.|+ ||++++++|.+...+|+||||+ +|+|.+++.... .+++..++.
T Consensus 55 -------~~~~~~~~~~E~~il~~l~hp------~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~ 119 (384)
T 4fr4_A 55 -------ERNEVRNVFKELQIMQGLEHP------FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKL 119 (384)
T ss_dssp -------HTTCHHHHHHHHHHHHTCCCT------TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHH
T ss_pred -------cHHHHHHHHHHHHHHHhCCCC------CCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 111234566799999998776 9999999999999999999999 569999998754 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhC---CCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILG---LPYGPP 248 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~---~~~~~~ 248 (429)
++.||+.||.|||++||+||||||+|||++.++ .++|+|||++.... ......+||+.|+|||++.+ ..|+.+
T Consensus 120 ~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~ 197 (384)
T 4fr4_A 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA 197 (384)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTT
T ss_pred HHHHHHHHHHHHHHCCceeccCcHHHeEECCCC--CEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCcc
Confidence 999999999999999999999999999999988 89999999997643 33455789999999999974 358999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCH---HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENE---VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+|||||||++|+|++|+.||.+.+. .+....+.......
T Consensus 198 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------------------------------- 239 (384)
T 4fr4_A 198 VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY-------------------------------------- 239 (384)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC--------------------------------------
T ss_pred ceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC--------------------------------------
Confidence 9999999999999999999975432 22222222110100
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLT-PDEALRHEWLKSSS 368 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-a~ell~h~~~~~~~ 368 (429)
+...++.+.+||.+||+.||++||+ +.++++||||+...
T Consensus 240 ----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 240 ----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred ----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 1223788999999999999999998 89999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=364.28 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=208.5
Q ss_pred cccccCCeEEEeEeeccccceEEEEEec---CCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDH---KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~---~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
..+..++|++++.||+|+||+||+|++. .++. +|+|++.........
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----------------------------- 62 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA----------------------------- 62 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-----------------------------------
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhh-----------------------------
Confidence 3456789999999999999999999985 4554 488887544221110
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHH
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~ 170 (429)
.....+.+|+++++.++|+ ||+++++++.....+|+||||+. ++|.+++.... .+++..
T Consensus 63 ------------~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 122 (327)
T 3a62_A 63 ------------KDTAHTKAERNILEEVKHP------FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDT 122 (327)
T ss_dssp --------------------HHHHHHHCCCT------TBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHH
T ss_pred ------------hHHHHHHHHHHHHHhCCCC------CccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHH
Confidence 1122345699999999876 99999999999999999999995 69999998765 399999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..++.
T Consensus 123 ~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 200 (327)
T 3a62_A 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200 (327)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS--CEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCT
T ss_pred HHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC--cEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCC
Confidence 999999999999999999999999999999999888 89999999986532 2233467999999999999988999
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 201 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p--------------------------------------- 241 (327)
T 3a62_A 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--------------------------------------- 241 (327)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---------------------------------------
T ss_pred cccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC---------------------------------------
Confidence 99999999999999999999999888777766654211111
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKSS 367 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~ 367 (429)
...++.+.+||.+||+.||++|| ++.|+++||||+..
T Consensus 242 ---~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 242 ---PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp ---TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred ---CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 12378899999999999999999 89999999999865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=374.89 Aligned_cols=280 Identities=29% Similarity=0.490 Sum_probs=222.5
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
...+|++++.||+|+||+||+|.+..++.. |+|++....
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------------------------------------- 91 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------------------------------------- 91 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----------------------------------------
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----------------------------------------
Confidence 345899999999999999999999988764 888763211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHh--hCCCCCCHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKR--NNYQGFSLG 169 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~--~~~~~~~~~ 169 (429)
....+|+++++.++|+ ||++++++|... ..+++||||++++|.+++.. .....+++.
T Consensus 92 ---------~~~~~E~~il~~l~hp------niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~ 156 (420)
T 1j1b_A 92 ---------RFKNRELQIMRKLDHC------NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156 (420)
T ss_dssp ---------TSCCHHHHHHHTCCCT------TBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHH
T ss_pred ---------hhHHHHHHHHHHcCCC------CccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHH
Confidence 0112499999999876 999999998653 24789999999988887764 233469999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCC-CCC
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGL-PYG 246 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~ 246 (429)
.++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++... ......++|+.|+|||++.+. .|+
T Consensus 157 ~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 235 (420)
T 1j1b_A 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYT 235 (420)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCC
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCC
Confidence 99999999999999999999999999999999996531 68999999997543 233446789999999999875 689
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
.++|||||||++|+|++|+.||.+.+..+++..+...++.+..+.+.........+ ..+.......
T Consensus 236 ~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~--------------~~p~~~~~~~ 301 (420)
T 1j1b_A 236 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--------------KFPQIKAHPW 301 (420)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCC--------------CCCCCCCCCH
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh--------------ccCccCCCCH
Confidence 99999999999999999999999999999999999999999887765432110000 0001111112
Q ss_pred hhh-hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 327 ASV-LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 327 ~~~-~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
... ....++++.+||++||+.||++|||+.|+++||||+...
T Consensus 302 ~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 302 TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 222 234578999999999999999999999999999997654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.99 Aligned_cols=296 Identities=20% Similarity=0.232 Sum_probs=212.5
Q ss_pred ccCCeEEEeEeecc--ccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 19 ICYRYEILEVIGKG--SFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 19 ~~~rY~i~~~lG~G--~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
-.+||++++.||+| +||+||+|.+..++.. |+|++.......
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------- 67 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN----------------------------------- 67 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-----------------------------------
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-----------------------------------
Confidence 46789999999999 9999999999988865 999885443221
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.....+.+|+++++.++|+ ||+++++++.....+|+|||||. ++|.+++.......+++..+..+
T Consensus 68 --------~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 133 (389)
T 3gni_B 68 --------EMVTFLQGELHVSKLFNHP------NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133 (389)
T ss_dssp --------HHHHHHHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHH
T ss_pred --------HHHHHHHHHHHHHHhCCCC------CCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHH
Confidence 1223456699999999877 99999999999999999999995 69999998875566999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc----------CcceeeecCccccchhhhhC--
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH----------QRVYTYIQSRFYRSPEVILG-- 242 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~----------~~~~~~~~t~~y~aPE~~~~-- 242 (429)
+.||+.||+|||++||+||||||+|||++.++ .++|+|||.+.... ......+||+.|+|||++.+
T Consensus 134 ~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 211 (389)
T 3gni_B 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211 (389)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTS
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccccceeeccccccccccccccccccccccccCHHHHhccC
Confidence 99999999999999999999999999999888 89999999875321 11222478899999999987
Q ss_pred CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhC--------CCcHHHHhhhhhhhhhccCCCCCccccCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILG--------CPPDEVINTASRRRLFFDSKGTPRCITNS 314 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (429)
..++.++|||||||++|+|++|+.||.+.+..+.+..+..... .+.++....... .............
T Consensus 212 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~- 287 (389)
T 3gni_B 212 QGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSR---SVANSGLSDSLTT- 287 (389)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------------------------------------
T ss_pred CCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccc---ccccccccccccc-
Confidence 5789999999999999999999999988776555544332110 000000000000 0000000000000
Q ss_pred CCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
...................++.+.+||++||+.||++|||+.|+|+||||++...
T Consensus 288 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 288 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp ------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred CccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 0000001111122234456889999999999999999999999999999987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=366.62 Aligned_cols=272 Identities=24% Similarity=0.374 Sum_probs=220.6
Q ss_pred eehhhhcccccCCeEEE-eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhccccccccccccc
Q psy17270 10 FAFQVLHDHICYRYEIL-EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESL 87 (429)
Q Consensus 10 ~~~~~~~~~~~~rY~i~-~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~ 87 (429)
..|... +.+.++|.+. +.||+|+||+||+|.+..++.. |+|++......
T Consensus 18 ~~~~~~-~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------------- 68 (327)
T 3lm5_A 18 LYFQSM-ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG---------------------------- 68 (327)
T ss_dssp CCSBCH-HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT----------------------------
T ss_pred hHHHHH-HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc----------------------------
Confidence 344444 4689999999 8999999999999999988865 88887543211
Q ss_pred ccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCC
Q psy17270 88 SQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGF 166 (429)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~ 166 (429)
......+.+|+.+++.+.+ ||||+++++++.....+++||||+. ++|.+++.......+
T Consensus 69 ---------------~~~~~~~~~e~~~l~~l~~-----~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 128 (327)
T 3lm5_A 69 ---------------QDCRAEILHEIAVLELAKS-----CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV 128 (327)
T ss_dssp ---------------EECHHHHHHHHHHHHHTTT-----CTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCC
T ss_pred ---------------hHHHHHHHHHHHHHHhccC-----CCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCC
Confidence 1223456679999999864 3599999999999999999999995 599998866544569
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEec---CCCcceEEeeecccccccCc--ceeeecCccccchhhhh
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQ---RGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVIL 241 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~---~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~ 241 (429)
++..+..++.|++.||+|||++||+||||||+||+++. ++ .++|+|||++...... .....||+.|+|||++.
T Consensus 129 ~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 206 (327)
T 3lm5_A 129 SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG--DIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206 (327)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC--CEEECCGGGCEEC---------CCCGGGCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC--cEEEeeCccccccCCccccccccCCcCccCCeeec
Confidence 99999999999999999999999999999999999987 55 8999999999765432 23467999999999999
Q ss_pred CCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 242 ~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
+..++.++|||||||++|+|++|..||.+.+..+....+.......+...
T Consensus 207 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------------ 256 (327)
T 3lm5_A 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET------------------------------ 256 (327)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT------------------------------
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh------------------------------
Confidence 98999999999999999999999999999888877766655332222111
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
....++.+.+||.+||+.||++|||+.|+|+||||++....
T Consensus 257 --------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 257 --------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp --------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred --------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 12347889999999999999999999999999999876543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=370.73 Aligned_cols=299 Identities=24% Similarity=0.443 Sum_probs=228.4
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
..+.++|++++.||+|+||.||+|.+.....+|+|++..........
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~--------------------------------- 64 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV--------------------------------- 64 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCE---------------------------------
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchh---------------------------------
Confidence 45789999999999999999999999875567999875432210000
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecCcCHHHHHHhhCCCCCCHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELMNLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~ 171 (429)
...........+.+|+++++.++|+ ||+++++++... ..+|+||||++|+|.+.+.... ..+++..+
T Consensus 65 -~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~ 136 (362)
T 3pg1_A 65 -NILSDSFLCKRVLREIRLLNHFHHP------NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHI 136 (362)
T ss_dssp -EGGGSHHHHHHHHHHHHHHHHCCCT------TBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHH
T ss_pred -hhhhhhhHHHHHHHHHHHHHhCCCc------CccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHH
Confidence 0001122345678899999999877 999999998653 3689999999999999988654 45999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhC-CCCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILG-LPYGPP 248 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~ 248 (429)
..++.||+.||.|||++||+||||||+||+++.++ .++|+|||++..... ......+|+.|+|||++.+ ..++.+
T Consensus 137 ~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 214 (362)
T 3pg1_A 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN--DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKL 214 (362)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCTTC---------------CGGGCCHHHHTTCTTCCTH
T ss_pred HHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC--CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcH
Confidence 99999999999999999999999999999999888 899999999975332 2334678999999999987 578999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++|+.||.+.+..+.+..+....+.+..+...........- ................
T Consensus 215 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~ 284 (362)
T 3pg1_A 215 VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARD----------YLRNSLSNVPARAWTA 284 (362)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHH----------HTTTCCCCCCCCCHHH
T ss_pred hHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhH----------HHHhhcccCChhhHHh
Confidence 999999999999999999999999999999999999988776554322111000 0000011111223344
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
..+..++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus 285 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 285 VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 5566789999999999999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=372.52 Aligned_cols=259 Identities=27% Similarity=0.357 Sum_probs=199.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...+||++++.||+|+||+||+|.+..+++. |+|++....
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------------------------- 57 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--------------------------------------- 57 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---------------------------------------
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---------------------------------------
Confidence 3578999999999999999999999988865 888874321
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+.+++.++|+ ||+++++++.....+++||||+ +|+|.+++.... ++++..++.++
T Consensus 58 -------~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~ 122 (361)
T 3uc3_A 58 -------AIDENVQREIINHRSLRHP------NIVRFKEVILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFF 122 (361)
T ss_dssp -------TSCHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred -------cccHHHHHHHHHHHhCCCC------CCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHH
Confidence 1123456799999999876 9999999999999999999999 569999998765 49999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccc--cCcceeeecCccccchhhhhCCCCCCC-cccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS--HQRVYTYIQSRFYRSPEVILGLPYGPP-IDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Diw 252 (429)
.|++.||+|||++||+||||||+|||++.++...+||+|||++... .......+||+.|+|||++.+..++.+ +|||
T Consensus 123 ~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 202 (361)
T 3uc3_A 123 QQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVW 202 (361)
T ss_dssp HHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHH
T ss_pred HHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeee
Confidence 9999999999999999999999999998877446999999998742 233345679999999999998887654 8999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHH-hCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEI-LGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
||||++|+|++|+.||.+.+.......+... ..... ..+ ...
T Consensus 203 slG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-----------------~~~--------------------~~~ 245 (361)
T 3uc3_A 203 SCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-----------------SIP--------------------DDI 245 (361)
T ss_dssp HHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-----------------CCC--------------------TTS
T ss_pred hhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-----------------CCC--------------------CcC
Confidence 9999999999999999875543222222211 00000 000 001
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
..++.+.+||++||+.||++|||+.|+++||||...
T Consensus 246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 246 RISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 237889999999999999999999999999999654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=361.82 Aligned_cols=289 Identities=28% Similarity=0.489 Sum_probs=226.6
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
...+.++|++.+.||+|+||+||+|.+..++.. |+|++......
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------------- 50 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP----------------------------------- 50 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH-----------------------------------
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc-----------------------------------
Confidence 345789999999999999999999999988865 99987432211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecCcCHHHHHHhhCCCCCCHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELMNLNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~L~~~i~~~~~~~~~~~ 169 (429)
.....+.+|+++++.++|+ ||+++++++... ...++|||+++++|.+++... .+++.
T Consensus 51 ---------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~ 112 (353)
T 2b9h_A 51 ---------LFALRTLREIKILKHFKHE------NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ---MLSDD 112 (353)
T ss_dssp ---------HHHHHHHHHHHHHHHCCCT------TBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHHC---CCCHH
T ss_pred ---------hHHHHHHHHHHHHHhCcCC------CcCCeeeeecccccCccceEEEEEeccCccHHHHHhhc---CCCHH
Confidence 1223455699999999876 999999988654 679999999999999998874 39999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-------------ceeeecCccccc
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-------------VYTYIQSRFYRS 236 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-------------~~~~~~t~~y~a 236 (429)
.+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++...... ....+||+.|+|
T Consensus 113 ~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 190 (353)
T 2b9h_A 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECC----------------CCCCCCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC--cEEEEecccccccccccccccCccccccchhhccccccccC
Confidence 9999999999999999999999999999999999888 8999999998754321 122468999999
Q ss_pred hhhhhC-CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCC
Q psy17270 237 PEVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315 (429)
Q Consensus 237 PE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (429)
||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.+............. .......
T Consensus 191 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~-- 262 (353)
T 2b9h_A 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR------AREYIKS-- 262 (353)
T ss_dssp HHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHH------HHHHHHT--
T ss_pred CeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccch------hhHHhhc--
Confidence 999875 5688999999999999999999999999999999988888887765321110000000 0000000
Q ss_pred CCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
................++.+.+||.+||+.||++|||+.|+++||||+....
T Consensus 263 --~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 263 --LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp --SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred --ccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 0011122344455667899999999999999999999999999999987543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=377.85 Aligned_cols=295 Identities=24% Similarity=0.427 Sum_probs=210.7
Q ss_pred hcccccCCeEEE-eEeeccccceEEEEEecC--CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 15 LHDHICYRYEIL-EVIGKGSFGQVIRALDHK--TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 15 ~~~~~~~rY~i~-~~lG~G~~g~Vy~a~~~~--~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
....+.++|++. ++||+|+||+||+|.++. ++. +|+|++...
T Consensus 14 ~~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---------------------------------- 59 (405)
T 3rgf_A 14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---------------------------------- 59 (405)
T ss_dssp HCCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS----------------------------------
T ss_pred hhhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC----------------------------------
Confidence 345677889984 589999999999999763 443 488876322
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--cCeEEEEEeecCcCHHHHHHhhC------
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--RNHLCISFELMNLNLYELIKRNN------ 162 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~g~L~~~i~~~~------ 162 (429)
.....+.+|+++++.++|+ ||+++++++.. ...+|+||||++++|.+++....
T Consensus 60 -------------~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~ 120 (405)
T 3rgf_A 60 -------------GISMSACREIALLRELKHP------NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK 120 (405)
T ss_dssp -------------SCCHHHHHHHHHHHHCCCT------TBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC---
T ss_pred -------------CCCHHHHHHHHHHHhcCCC------CeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccc
Confidence 1223566799999999877 99999999965 56899999999999999886432
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEE----ecCCCcceEEeeecccccccC------cceeeecC
Q psy17270 163 -YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLL----KQRGSSSIKVIDFGSSCYSHQ------RVYTYIQS 231 (429)
Q Consensus 163 -~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili----~~~~~~~vkl~Dfg~~~~~~~------~~~~~~~t 231 (429)
...+++..++.++.||+.||+|||++||+||||||+|||+ +.++ .+||+|||++..... .....+||
T Consensus 121 ~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt 198 (405)
T 3rgf_A 121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG--RVKIADMGFARLFNSPLKPLADLDPVVVT 198 (405)
T ss_dssp ----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT--CEEECCTTCCC----------------CC
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC--cEEEEECCCceecCCCCcccccCCCceec
Confidence 1239999999999999999999999999999999999999 4445 899999999976442 22346789
Q ss_pred ccccchhhhhCC-CCCCCccccchhhHHHHHhhCCCCCCCCCH---------HHHHHHHHHHhCCCcHHHHhhhhhhhhh
Q psy17270 232 RFYRSPEVILGL-PYGPPIDMWSLGCILAELYTGCPLFPGENE---------VEQLACIMEILGCPPDEVINTASRRRLF 301 (429)
Q Consensus 232 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 301 (429)
+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+. .+++..+...++.++...|.........
T Consensus 199 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 278 (405)
T 3rgf_A 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEH 278 (405)
T ss_dssp CTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTH
T ss_pred CcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcch
Confidence 999999999875 489999999999999999999999987654 4788999999998887665443211000
Q ss_pred ccCCCCCccccCCCCCCC-CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 302 FDSKGTPRCITNSKGRKR-KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
... .......... ..............++.+.+||++||++||++|||+.|+|+||||+....
T Consensus 279 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 279 STL-----MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp HHH-----HHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred hhh-----hhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 000 0000000000 00000001111123678899999999999999999999999999987543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=352.94 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=217.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++.+.||+|+||.||+|.+..++.. |+|++.......
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------------------------------ 46 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA------------------------------------ 46 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH------------------------------------
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH------------------------------------
Confidence 4789999999999999999999999988865 888875432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+++++.++|+ ||+++++++......++||||+. ++|.+.+..... +++..+..++
T Consensus 47 -------~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~ 111 (284)
T 3kk8_A 47 -------RDFQKLEREARICRKLQHP------NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCI 111 (284)
T ss_dssp -------HHHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHH
T ss_pred -------HHHHHHHHHHHHHHHcCCC------CcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHH
Confidence 1123455699999999876 99999999999999999999995 599898887653 9999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCC-cceEEeeecccccccCcc--eeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGS-SSIKVIDFGSSCYSHQRV--YTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~-~~vkl~Dfg~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.|++.||.|||++|++||||||+||+++.++. ..++|+|||.+....... ....||+.|+|||++.+..++.++|||
T Consensus 112 ~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 191 (284)
T 3kk8_A 112 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 191 (284)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHH
T ss_pred HHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchH
Confidence 99999999999999999999999999987652 249999999997654332 345789999999999998999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|..||.+.+.......+.......+.. ....
T Consensus 192 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~ 233 (284)
T 3kk8_A 192 ACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP--------------------------------------EWDT 233 (284)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--------------------------------------TTTT
T ss_pred HHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch--------------------------------------hhcc
Confidence 99999999999999999988877766665422211111 0123
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 478899999999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=373.81 Aligned_cols=256 Identities=27% Similarity=0.370 Sum_probs=206.5
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.++|++++.||+|+||+||+|.++.++.. |+|++....
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------------------------------------- 59 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------------------------------------- 59 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT--------------------------------------
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc--------------------------------------
Confidence 35788999999999999999999999998865 888874321
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
....+|++++.++ .|+ ||+++++++.+...+|+|||||. |+|.+.+.... .+++..+..
T Consensus 60 -----------~~~~~E~~~l~~~~~hp------~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~ 120 (342)
T 2qr7_A 60 -----------RDPTEEIEILLRYGQHP------NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASA 120 (342)
T ss_dssp -----------CCCHHHHHHHHHHTTST------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHH
T ss_pred -----------CChHHHHHHHHHhcCCC------CcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 1223488888888 454 99999999999999999999995 69999988654 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCC--cceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS--SSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~--~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
++.||+.||+|||++||+||||||+|||+...+. ..+||+|||++..... .....+||+.|+|||++.+..|+.+
T Consensus 121 ~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 200 (342)
T 2qr7_A 121 VLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAA 200 (342)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCc
Confidence 9999999999999999999999999999865321 2599999999975432 2345688999999999998788999
Q ss_pred ccccchhhHHHHHhhCCCCCCCC---CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGE---NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+|||||||++|+|++|..||.+. +..+.+..+.......+
T Consensus 201 ~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~------------------------------------- 243 (342)
T 2qr7_A 201 CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS------------------------------------- 243 (342)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-------------------------------------
T ss_pred cCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-------------------------------------
Confidence 99999999999999999999863 33344443332110000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
...+...++.+.+||++||..||++|||+.|+++||||...
T Consensus 244 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 244 -GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp -STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred -ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 00122347899999999999999999999999999999653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=361.68 Aligned_cols=267 Identities=27% Similarity=0.422 Sum_probs=220.4
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.++|++.+.||+|+||.||+|.+..++.. |+|++.......
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------- 52 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA----------------------------------- 52 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSS-----------------------------------
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccc-----------------------------------
Confidence 45778999999999999999999999988865 888774332110
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.........+.+|+.+++.+.|+ ||+++++++.....+++||||+. ++|.+++.... .+++..+..+
T Consensus 53 ----~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 120 (321)
T 2a2a_A 53 ----SRRGVSREEIEREVSILRQVLHH------NVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSF 120 (321)
T ss_dssp ----CSSSBCHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHH
T ss_pred ----cccchhHHHHHHHHHHHHhCCCC------CcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence 00111234577899999999877 99999999999999999999995 69999998654 4999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCC--cceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCcc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS--SSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~--~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
+.|++.||+|||++|++||||||+||+++.++. ..++|+|||++...... .....||+.|+|||++.+..++.++|
T Consensus 121 ~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 200 (321)
T 2a2a_A 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEAD 200 (321)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred HHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccc
Confidence 999999999999999999999999999987652 25999999999764432 23457899999999999989999999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||||++|+|++|..||.+.+..+.+..+.......+.+. .
T Consensus 201 i~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------------------------------------~ 242 (321)
T 2a2a_A 201 MWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF--------------------------------------F 242 (321)
T ss_dssp HHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH--------------------------------------H
T ss_pred cHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh--------------------------------------h
Confidence 99999999999999999999888777766654333222222 2
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
...++.+.+||++||+.||++|||+.|+++||||+...
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 33478899999999999999999999999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=355.03 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=215.7
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.++|++.+.||+|+||+||+|.+..++.. |+|++......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------------------------------------ 48 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE------------------------------------ 48 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS------------------------------------
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc------------------------------------
Confidence 35788999999999999999999999988864 88877432211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
....+.+|+++++.++|+ ||+++++++......++||||+. ++|.+++..... +++..+..+
T Consensus 49 ---------~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i 111 (277)
T 3f3z_A 49 ---------DVDRFKQEIEIMKSLDHP------NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARI 111 (277)
T ss_dssp ---------CHHHHHHHHHHHHTCCCT------TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHH
T ss_pred ---------hHHHHHHHHHHHHhCCCC------CEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCC--CCHHHHHHH
Confidence 123456699999999776 99999999999999999999995 599999887653 999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEE---ecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCCCCCCCc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLL---KQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili---~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
+.|++.||.|||++|++|+||||+||++ +.++ .++|+|||++.... .......+|+.|+|||++.+. ++.++
T Consensus 112 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 188 (277)
T 3f3z_A 112 MKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS--PLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPEC 188 (277)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC--CEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTH
T ss_pred HHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC--cEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchh
Confidence 9999999999999999999999999999 5555 89999999997543 223446799999999998764 89999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|..||.+.+..+....+.......+...+
T Consensus 189 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------- 231 (277)
T 3f3z_A 189 DEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW------------------------------------- 231 (277)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH-------------------------------------
T ss_pred hehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh-------------------------------------
Confidence 9999999999999999999998888877777654333333321
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
...++.+.+||.+||+.||++|||+.|+|+||||++.
T Consensus 232 -~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 232 -LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred -hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 2237889999999999999999999999999999764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=360.18 Aligned_cols=284 Identities=27% Similarity=0.538 Sum_probs=225.3
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
.-++|++++.||+|+||.||+|.+..++.. |+|++......
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------------------------- 64 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-------------------------------------- 64 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC--------------------------------------
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc--------------------------------------
Confidence 456899999999999999999999988865 88887433221
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcC-HHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLN-LYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~-L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
......+.+|+++++.++|+ ||+++++++.....+++||||+++. |.+++... ..+++..+..++.
T Consensus 65 -----~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ 131 (331)
T 4aaa_A 65 -----KMVKKIAMREIKLLKQLRHE------NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLF 131 (331)
T ss_dssp -----HHHHHHHHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHH
T ss_pred -----hHHHHHHHHHHHHHhhCCCC------CEeeEEEEeecCCEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHH
Confidence 12233456699999999876 9999999999999999999999865 54444433 3599999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCC-CCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGL-PYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~Diw 252 (429)
|++.||.|||++|++||||||+||+++.++ .++|+|||++..... ......+|+.|+|||++.+. .++.++|||
T Consensus 132 qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~ 209 (331)
T 4aaa_A 132 QIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVW 209 (331)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHH
T ss_pred HHHHHHHHHHHCCEEccCcChheEEEcCCC--cEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHH
Confidence 999999999999999999999999999888 899999999975432 23345789999999999876 689999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|+.||.+.+..+.+..+....+...+............ ..... .............+.
T Consensus 210 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~ 278 (331)
T 4aaa_A 210 AIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF-AGVRL----------PEIKEREPLERRYPK 278 (331)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG-TTCCC----------CCCSSCCCHHHHSTT
T ss_pred HHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc-ccccC----------ccccccchhhhcccc
Confidence 9999999999999999999999999999998888777655443322111 11111 111222334445556
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 279 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 279 LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 7899999999999999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=365.32 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=190.2
Q ss_pred cccCCeEEE---eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 18 HICYRYEIL---EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 18 ~~~~rY~i~---~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.+.++|++. +.||+|+||+||+|.+..++.. |+|++....
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------------------------ 48 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------------------------------------ 48 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------------------------------------
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------------------------------------
Confidence 356789987 7899999999999999988865 999874321
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
...+.+|+.+++.+. .||||+++++++.+..+.|+||||+. ++|.+++.... .+++..+.
T Consensus 49 ------------~~~~~~e~~~l~~l~-----~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 109 (325)
T 3kn6_A 49 ------------EANTQKEITALKLCE-----GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK--HFSETEAS 109 (325)
T ss_dssp ------------HHHHHHHHHHHHHTT-----TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS--CCCHHHHH
T ss_pred ------------hhhHHHHHHHHHHhc-----CCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC--CCCHHHHH
Confidence 223445999999987 23499999999999999999999995 59999998764 49999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
.++.|++.||+|||++||+||||||+|||++.++ ...++|+|||++..... .....++|+.|+|||++.+..++.+
T Consensus 110 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 189 (325)
T 3kn6_A 110 YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES 189 (325)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHH
T ss_pred HHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCc
Confidence 9999999999999999999999999999998653 23699999999975432 2344678999999999999899999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHH-------HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEV-------EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
+|||||||++|+|++|..||.+.+.. +.+..+.......+
T Consensus 190 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~--------------------------------- 236 (325)
T 3kn6_A 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE--------------------------------- 236 (325)
T ss_dssp HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC---------------------------------
T ss_pred cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC---------------------------------
Confidence 99999999999999999999875432 22222211100011
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
...+...++++.+||.+||+.||++|||+.|+++||||+....
T Consensus 237 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 237 -----GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp -----SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred -----cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 1122345889999999999999999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=371.53 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=215.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++++.||+|+||+||+|+++.+++. |+|++.+....
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~------------------------------------- 100 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML------------------------------------- 100 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-------------------------------------
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-------------------------------------
Confidence 4568999999999999999999999988865 99988542111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.......+.+|..++..+.|+ ||++++++|.+..++|+||||+ +|+|.+++.+.. ..+++..++.++
T Consensus 101 -----~~~~~~~~~~E~~il~~~~hp------~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~ 168 (412)
T 2vd5_A 101 -----KRGEVSCFREERDVLVNGDRR------WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYL 168 (412)
T ss_dssp -----HHGGGCCHHHHHHHHHHSCTT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHH
T ss_pred -----hHHHHHHHHHHHHHHHhcCCC------CeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHH
Confidence 011123466799999988776 9999999999999999999999 579999998764 359999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhh-------CCC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVIL-------GLP 244 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~-------~~~ 244 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ....+||+.|+|||++. +..
T Consensus 169 ~qi~~aL~~LH~~giiHrDLKp~NILld~~g--~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~ 246 (412)
T 2vd5_A 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246 (412)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSE
T ss_pred HHHHHHHHHHHHCCeeecccCHHHeeecCCC--CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCC
Confidence 9999999999999999999999999999988 8999999999765432 22358999999999998 346
Q ss_pred CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhC--CCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILG--CPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
|+.++|+|||||++|+|++|+.||.+.+..+....|..... ..+
T Consensus 247 ~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p---------------------------------- 292 (412)
T 2vd5_A 247 YGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP---------------------------------- 292 (412)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----------------------------------
T ss_pred CChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC----------------------------------
Confidence 89999999999999999999999999988887777764210 000
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCCCC
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKR---LTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pta~ell~h~~~~~~~~~ 370 (429)
......++++.+||++||. ||.+| ++++|+++||||+...-.
T Consensus 293 -----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 293 -----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp ---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred -----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 0112347899999999999 99998 589999999999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=367.98 Aligned_cols=258 Identities=26% Similarity=0.345 Sum_probs=207.3
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++++.||+|+||+||+|+++.++.. |+|++.+.......
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~---------------------------------- 80 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK---------------------------------- 80 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------------------------------
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH----------------------------------
Confidence 3457899999999999999999999998875 99988544321110
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|..++ .....||||++++++|.+...+|+||||+. |+|.+++.... .+++..++.++
T Consensus 81 --------~~~~~~~e~~~l-----l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~ 145 (373)
T 2r5t_A 81 --------EEKHIMSERNVL-----LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYA 145 (373)
T ss_dssp ------------------CC-----BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred --------HHHHHHHHHHHH-----HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHH
Confidence 011222243331 122356699999999999999999999995 59999998765 39999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..++.++|+|
T Consensus 146 ~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 223 (373)
T 2r5t_A 146 AEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 223 (373)
T ss_dssp HHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHH
T ss_pred HHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhH
Confidence 9999999999999999999999999999988 89999999997532 234457899999999999999999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|..||.+.+..+....|...... ....
T Consensus 224 slG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------------------------------------~~~~ 261 (373)
T 2r5t_A 224 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ------------------------------------------LKPN 261 (373)
T ss_dssp HHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC------------------------------------------CCSS
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC------------------------------------------CCCC
Confidence 9999999999999999998887777766541100 0122
Q ss_pred CChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTP----DEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta----~ell~h~~~~~~~ 368 (429)
.++.+.+||++||+.||.+||++ .++++||||+...
T Consensus 262 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 262 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 37889999999999999999997 6999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=382.05 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=208.0
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
....++|++++.||+|+||.||+|.+..++.. |+|++.......
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------------- 188 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA----------------------------------- 188 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------------------------
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh-----------------------------------
Confidence 34568899999999999999999999998865 999885332110
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
......+.+|+++++.+.|+ ||+++++++...+.+|+||||++ |+|.+++.... .+++..+..+
T Consensus 189 -------~~~~~~~~~e~~~l~~l~h~------~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~ 253 (446)
T 4ejn_A 189 -------KDEVAHTLTENRVLQNSRHP------FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFY 253 (446)
T ss_dssp -------------------CCCCCSCT------TSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHH
T ss_pred -------hHHHHHHHHHHHHHHhCCCC------eEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence 01112344577777776665 99999999999999999999995 59999998765 4999999999
Q ss_pred HHHHHHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCcc
Q psy17270 175 AFSLVQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 175 ~~qil~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
+.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..|+.++|
T Consensus 254 ~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 331 (446)
T 4ejn_A 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 331 (446)
T ss_dssp HHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS--CEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHH
T ss_pred HHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC--CEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccc
Confidence 9999999999998 9999999999999999988 89999999997532 2234568999999999999999999999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||||++|+|++|+.||.+.+..+....+.......+
T Consensus 332 iwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------------------------------------ 369 (446)
T 4ejn_A 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP------------------------------------------ 369 (446)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------------------------------------
T ss_pred hhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC------------------------------------------
Confidence 99999999999999999999888777666553111111
Q ss_pred ccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKSS 367 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~ 367 (429)
...++.+.+||.+||+.||++|| |+.|+++||||+..
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 12378899999999999999999 99999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=359.01 Aligned_cols=263 Identities=26% Similarity=0.397 Sum_probs=203.8
Q ss_pred hcccccCCeEEE-eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 15 LHDHICYRYEIL-EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 15 ~~~~~~~rY~i~-~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
+...+.++|++. +.||+|+||+||+|.+..++.. |+|++.....
T Consensus 6 ~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------------------------- 51 (316)
T 2ac3_A 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---------------------------------- 51 (316)
T ss_dssp SCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS----------------------------------
T ss_pred cCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc----------------------------------
Confidence 345688999996 7899999999999999888865 8888743211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~ 170 (429)
.....+.+|++++.++ +|+ ||+++++++...+.+|+||||+. ++|.+++.... .+++..
T Consensus 52 -----------~~~~~~~~E~~~l~~~~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 112 (316)
T 2ac3_A 52 -----------HIRSRVFREVEMLYQCQGHR------NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELE 112 (316)
T ss_dssp -----------CCHHHHHHHHHHHHHTCCCT------TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS--SCCHHH
T ss_pred -----------hhHHHHHHHHHHHHHhcCCC------CeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC--CCCHHH
Confidence 1123566799999885 454 99999999999999999999995 79999998765 499999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCC-cceEEeeecccccccC----------cceeeecCccccchhh
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS-SSIKVIDFGSSCYSHQ----------RVYTYIQSRFYRSPEV 239 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~-~~vkl~Dfg~~~~~~~----------~~~~~~~t~~y~aPE~ 239 (429)
+..++.||+.||+|||++||+||||||+||+++.++. ..+||+|||++..... .....+||+.|+|||+
T Consensus 113 ~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 192 (316)
T 2ac3_A 113 ASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192 (316)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHH
Confidence 9999999999999999999999999999999988762 2399999999864321 1223568999999999
Q ss_pred hhC-----CCCCCCccccchhhHHHHHhhCCCCCCCCCHH---------------HHHHHHHHHhCCCcHHHHhhhhhhh
Q psy17270 240 ILG-----LPYGPPIDMWSLGCILAELYTGCPLFPGENEV---------------EQLACIMEILGCPPDEVINTASRRR 299 (429)
Q Consensus 240 ~~~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~ 299 (429)
+.+ ..++.++|||||||++|+|++|+.||.+.+.. .....+.......+.
T Consensus 193 ~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---------- 262 (316)
T 2ac3_A 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD---------- 262 (316)
T ss_dssp HHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCH----------
T ss_pred hhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCc----------
Confidence 975 45789999999999999999999999875421 112222211111111
Q ss_pred hhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 300 LFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
......++.+.+||++||+.||++|||+.|+++||||++..
T Consensus 263 ----------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 263 ----------------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp ----------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ----------------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 11233478899999999999999999999999999998643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=367.84 Aligned_cols=284 Identities=27% Similarity=0.540 Sum_probs=225.7
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.++|++.+.||+|+||+||+|.+..++.. |+|++......
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------------------------- 63 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-------------------------------------- 63 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS--------------------------------------
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc--------------------------------------
Confidence 578999999999999999999999988865 99987543211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCe------EEEEEeecCcCHHHHHHhhCCCCCCHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH------LCISFELMNLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~------~~lv~e~~~g~L~~~i~~~~~~~~~~~~~ 171 (429)
......+.+|+.+++.+.|+ ||+++++++..... +|+||||++++|.+++. ..+++..+
T Consensus 64 -----~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~ 128 (353)
T 3coi_A 64 -----EIFAKRAYRELLLLKHMQHE------NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG----LKFSEEKI 128 (353)
T ss_dssp -----HHHHHHHHHHHHHHHHCCCT------TBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT----SCCCHHHH
T ss_pred -----hHHHHHHHHHHHHHHhcCCC------CcccHhheEecccccccceeEEEEeccccCCHHHHhc----CCCCHHHH
Confidence 12234566799999999876 99999999977653 59999999998877764 24999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC-CCCCCCcc
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPID 250 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D 250 (429)
..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++...........+|+.|+|||++.+ ..++.++|
T Consensus 129 ~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 206 (353)
T 3coi_A 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVD 206 (353)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC--CEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHH
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC--cEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhh
Confidence 99999999999999999999999999999999888 8999999999876665566789999999999987 57899999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||||++|+|++|..||.+.+..+.+..+....+.++.+++...............+ ...........
T Consensus 207 i~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~ 275 (353)
T 3coi_A 207 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP-----------QTPRKDFTQLF 275 (353)
T ss_dssp HHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSC-----------BCSSCCTTTTC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCc-----------CCCCccHHHhc
Confidence 9999999999999999999999999999999999999888765433211100000000 00011122333
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
...++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 276 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 276 PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp TTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred CCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 45689999999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=366.26 Aligned_cols=257 Identities=27% Similarity=0.387 Sum_probs=199.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+.+.++|++.+.||+|+||+||+|.+..++. +|+|++.....
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------------------------- 91 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD------------------------------------- 91 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------------------------------
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-------------------------------------
Confidence 5678899999999999999999999998886 49888753210
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
...+.+|+++++.+.|+ ||+++++++.....+++||||+. ++|.+++.... .+++..+..+
T Consensus 92 ----------~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 153 (349)
T 2w4o_A 92 ----------KKIVRTEIGVLLRLSHP------NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADA 153 (349)
T ss_dssp -----------------CHHHHHCCCT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHH
T ss_pred ----------HHHHHHHHHHHHhCCCC------CCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHH
Confidence 12344599999999876 99999999999999999999995 69999987654 4999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEec---CCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCCc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQ---RGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~---~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
+.|++.||.|||++||+||||||+|||++. ++ .+||+|||++...... ....+||+.|+|||++.+..++.++
T Consensus 154 ~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 231 (349)
T 2w4o_A 154 VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA--PLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEV 231 (349)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTC--CEEECCCC----------------CGGGSCHHHHTTCCCCTHH
T ss_pred HHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCC--CEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCccc
Confidence 999999999999999999999999999986 44 8999999999764432 2346789999999999998999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHH-HHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVE-QLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
|||||||++|+|++|..||.+..... .+..+.......+. .
T Consensus 232 DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~--------------------------------------~ 273 (349)
T 2w4o_A 232 DMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS--------------------------------------P 273 (349)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT--------------------------------------T
T ss_pred chHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC--------------------------------------c
Confidence 99999999999999999997765543 33333221111000 1
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....++.+.+||++||+.||++|||+.|+|+||||+...
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 1123478899999999999999999999999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=364.69 Aligned_cols=285 Identities=30% Similarity=0.524 Sum_probs=215.2
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
..-++|++.+.||+|+||+||+|.+..++.. |+|++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------------------------- 60 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--------------------------------------- 60 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---------------------------------------
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---------------------------------------
Confidence 3457899999999999999999999988864 888763221
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCe-------EEEEEeecCcCHHHHHHhh--CCCCCC
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH-------LCISFELMNLNLYELIKRN--NYQGFS 167 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~-------~~lv~e~~~g~L~~~i~~~--~~~~~~ 167 (429)
.......++++.+..+.|+ ||++++++|..... +++||||++++|.+.+... ....++
T Consensus 61 -------~~~~~~~~~~~~l~~l~h~------niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~ 127 (360)
T 3e3p_A 61 -------RFRNRELQIMQDLAVLHHP------NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP 127 (360)
T ss_dssp -------TCCCHHHHHHHHHHHHCCT------TBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCC
T ss_pred -------cccHHHHHHHHHHHhcCCC------CcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCC
Confidence 1122344577777777776 99999999976543 8999999999887776542 334589
Q ss_pred HHHHHHHHHHHHHHHHHHH--HCCceecccCCCcEEEec-CCCcceEEeeecccccccCc--ceeeecCccccchhhhhC
Q psy17270 168 LGLIRRFAFSLVQCLRLLH--RENIIHCDLKPENVLLKQ-RGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILG 242 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH--~~~ivH~dlkp~Nili~~-~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~ 242 (429)
+..+..++.|++.||.||| ++||+||||||+|||++. ++ .+||+|||++...... .....||+.|+|||++.+
T Consensus 128 ~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 205 (360)
T 3e3p_A 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG 205 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcC
Confidence 9999999999999999999 999999999999999996 66 8999999999764432 334578999999999976
Q ss_pred CC-CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 243 LP-YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 243 ~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...++.++.+.+.........+... . .
T Consensus 206 ~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~-------~ 271 (360)
T 3e3p_A 206 NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLY-------N-------S 271 (360)
T ss_dssp CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGG-------C-------C
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhcccc-------c-------c
Confidence 54 8999999999999999999999999999999999999999999998876553221111000 0 0
Q ss_pred CCchhhhhh----ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy17270 322 GSKDMASVL----RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370 (429)
Q Consensus 322 ~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~~ 370 (429)
......... ...++.+.+||.+||+.||++|||+.|+|+||||++....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 272 KGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp CCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred ccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 000111111 2246789999999999999999999999999999876543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=362.30 Aligned_cols=265 Identities=25% Similarity=0.429 Sum_probs=216.9
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.++|++.+.||+|+||.||+|.+..+|. +|+|++............
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~------------------------------ 139 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL------------------------------ 139 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHH------------------------------
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHH------------------------------
Confidence 3456899999999999999999999988775 499988654322111111
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
..+...+.+|+.+++.+ .|+ ||+++++++......|+||||+. ++|.+++.... .+++..+..
T Consensus 140 -------~~~~~~~~~E~~~l~~l~~hp------~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~ 204 (365)
T 2y7j_A 140 -------EEVREATRRETHILRQVAGHP------HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRS 204 (365)
T ss_dssp -------HHHHHHHHHHHHHHHHHTTCT------TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHH
T ss_pred -------HHHHHHHHHHHHHHHHhcCCC------CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 12234566799999999 566 99999999999999999999996 59999998764 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCC------CC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGL------PY 245 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~ 245 (429)
++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++..... .....+||+.|+|||++.+. .+
T Consensus 205 i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~--~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 282 (365)
T 2y7j_A 205 IMRSLLEAVSFLHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282 (365)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCB
T ss_pred HHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCC
Confidence 999999999999999999999999999999988 899999999876442 33456899999999998742 57
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|||||||++|+|++|..||.+.+....+..+......++...
T Consensus 283 ~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------------------------------- 328 (365)
T 2y7j_A 283 GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE---------------------------------- 328 (365)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH----------------------------------
T ss_pred CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc----------------------------------
Confidence 8899999999999999999999998887776666654222222111
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
+...++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus 329 ----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 ----WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp ----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 1234788999999999999999999999999999973
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=379.72 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=216.6
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.+....++|++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~---------------------------------- 55 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR---------------------------------- 55 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH----------------------------------
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc----------------------------------
Confidence 3456678999999999999999999999988865 99988532111
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.......+.+|+.+++.++|+ ||+++++++.....+|+||||+ +|+|.+++.... .+++..++
T Consensus 56 --------~~~~~~~~~~Ei~~l~~l~Hp------nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~ 119 (476)
T 2y94_A 56 --------SLDVVGKIRREIQNLKLFRHP------HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESR 119 (476)
T ss_dssp --------HTTTHHHHHHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHH
T ss_pred --------CHHHHHHHHHHHHHHHhCCCC------CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 011233566799999988776 9999999999999999999999 569999987654 49999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCC-CCCc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPY-GPPI 249 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~-~~~~ 249 (429)
.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++.+..+ +.++
T Consensus 120 ~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~--~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 197 (476)
T 2y94_A 120 RLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEV 197 (476)
T ss_dssp HHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC--CEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHH
T ss_pred HHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC--CeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcc
Confidence 9999999999999999999999999999999988 899999999976443 2345689999999999998765 6799
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|..||.+.+.......+.......+
T Consensus 198 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----------------------------------------- 236 (476)
T 2y94_A 198 DIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----------------------------------------- 236 (476)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC-----------------------------------------
T ss_pred eehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC-----------------------------------------
Confidence 999999999999999999998877766665543111111
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
...++.+.+||++||+.||++|||+.|+++||||++.
T Consensus 237 -~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 237 -QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 1236889999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=381.45 Aligned_cols=274 Identities=24% Similarity=0.426 Sum_probs=219.8
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
...+.++|+++++||+|+||+||+|.++.++.. |+|++.............
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~---------------------------- 82 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDD---------------------------- 82 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC---------------------------------------
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhccccccccc----------------------------
Confidence 446899999999999999999999999988865 999886543221110000
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
..........+.+|+.+++.++|+ ||+++++++.....+|+|||||. |+|.+.+.... .+++..+..
T Consensus 83 ----~~~~~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~ 150 (504)
T 3q5i_A 83 ----NKNIEKFHEEIYNEISLLKSLDHP------NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAAN 150 (504)
T ss_dssp ---------CTHHHHHHHHHHHHTCCCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHH
T ss_pred ----chhhHHHHHHHHHHHHHHHhCCCC------CCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 000123456778899999999876 99999999999999999999995 69999988765 399999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCC-cceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCcc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS-SSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~-~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
++.||+.||+|||++||+||||||+|||++.++. ..+||+|||++..... .....+||+.|+|||++.+ .++.++|
T Consensus 151 i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~D 229 (504)
T 3q5i_A 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCD 229 (504)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHH
T ss_pred HHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHH
Confidence 9999999999999999999999999999987653 3699999999976443 2345679999999999875 6899999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||+||++|+|++|..||.+.+..+.+..+.......+... +
T Consensus 230 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------------------------------------~ 271 (504)
T 3q5i_A 230 VWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND--------------------------------------W 271 (504)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH--------------------------------------H
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc--------------------------------------c
Confidence 99999999999999999999998888877765332222222 2
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
...++.+.+||++||++||++|||+.|+|+||||+...
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 33478999999999999999999999999999998643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=359.59 Aligned_cols=286 Identities=29% Similarity=0.450 Sum_probs=220.0
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
-+..+.+||++++.||+|+||+||+|.+..++.. |+|++.....
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------------------------------- 49 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP----------------------------------- 49 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH-----------------------------------
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh-----------------------------------
Confidence 4567899999999999999999999999988865 9998753321
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEE--------------EcCeEEEEEeecCcCHHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY--------------FRNHLCISFELMNLNLYELIK 159 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~--------------~~~~~~lv~e~~~g~L~~~i~ 159 (429)
.....+.+|+++++.++|+ ||+++++++. ....+++||||++|+|.+++.
T Consensus 50 ----------~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~ 113 (320)
T 2i6l_A 50 ----------QSVKHALREIKIIRRLDHD------NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE 113 (320)
T ss_dssp ----------HHHHHHHHHHHHHHTCCCT------TBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHT
T ss_pred ----------HHHHHHHHHHHHHHhcCCC------CeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhh
Confidence 1123456699999999876 9999999873 346889999999999999986
Q ss_pred hhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEec-CCCcceEEeeecccccccC------cceeeecCc
Q psy17270 160 RNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQ-RGSSSIKVIDFGSSCYSHQ------RVYTYIQSR 232 (429)
Q Consensus 160 ~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~-~~~~~vkl~Dfg~~~~~~~------~~~~~~~t~ 232 (429)
.. .+++..+..++.|++.||+|||++||+||||||+||+++. ++ .+||+|||++..... ......+|+
T Consensus 114 ~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 188 (320)
T 2i6l_A 114 QG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL--VLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188 (320)
T ss_dssp TC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT--EEEECCCTTCBCC--------CCCGGGSCC
T ss_pred cC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--eEEEccCccccccCCCcccccccccccccc
Confidence 53 4999999999999999999999999999999999999974 44 899999999975432 122345788
Q ss_pred cccchhhhhC-CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccc
Q psy17270 233 FYRSPEVILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311 (429)
Q Consensus 233 ~y~aPE~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (429)
.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.........+......... +...
T Consensus 189 ~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 260 (320)
T 2i6l_A 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVI--------PVYI 260 (320)
T ss_dssp TTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTS--------CHHH
T ss_pred cccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcC--------cccc
Confidence 9999999876 578899999999999999999999999999998888888877766655443321100 0000
Q ss_pred cCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.. ................++.+.+||++||+.||++|||+.|+|+||||+...
T Consensus 261 ~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 261 RN----DMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HH----HTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred cc----cccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 00 000111223444556789999999999999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=366.16 Aligned_cols=267 Identities=25% Similarity=0.404 Sum_probs=212.8
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++++.||+|+||+||+|.+..++.. |+|++........
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------- 67 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI----------------------------------- 67 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC------------------------------------
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhccc-----------------------------------
Confidence 4678999999999999999999999988865 9998754321100
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhC-------------
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNN------------- 162 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~------------- 162 (429)
.......+.+|+++++.++|+ ||+++++++.....+++||||| +|+|.+++....
T Consensus 68 -----~~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~ 136 (345)
T 3hko_A 68 -----NPKDVERIKTEVRLMKKLHHP------NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136 (345)
T ss_dssp -------CHHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEEC
T ss_pred -----CHHHHHHHHHHHHHHHhCCCC------CcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccc
Confidence 011234567799999999876 9999999999999999999999 569999885211
Q ss_pred -------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecc
Q psy17270 163 -------------------------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGS 217 (429)
Q Consensus 163 -------------------------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~ 217 (429)
...+++..++.++.||+.||+|||++||+||||||+||+++.++...+||+|||+
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~ 216 (345)
T 3hko_A 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGL 216 (345)
T ss_dssp CCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTT
T ss_pred ccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccc
Confidence 1114678899999999999999999999999999999999877655799999999
Q ss_pred cccccC-------cceeeecCccccchhhhhC--CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCc
Q psy17270 218 SCYSHQ-------RVYTYIQSRFYRSPEVILG--LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP 288 (429)
Q Consensus 218 ~~~~~~-------~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 288 (429)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......+
T Consensus 217 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 296 (345)
T 3hko_A 217 SKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE 296 (345)
T ss_dssp CEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT
T ss_pred cccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC
Confidence 975322 1234678999999999975 5789999999999999999999999999988877766654221111
Q ss_pred HHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 289 DEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.. .....++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus 297 ~~--------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 297 NP--------------------------------------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp SG--------------------------------------GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred Cc--------------------------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 11 1122478899999999999999999999999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=352.89 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=215.0
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++.+.||+|+||.||+|.+..++.. |+|++......
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------------------------------------- 53 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE------------------------------------- 53 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-------------------------------------
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-------------------------------------
Confidence 4457899999999999999999999988864 99987532111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.......+.+|+++++.++|+ ||+++++++.....+++||||+. ++|.+++.... .+++..+..++
T Consensus 54 -----~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~ 120 (284)
T 2vgo_A 54 -----KEGVEHQLRREIEIQSHLRHP------NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFM 120 (284)
T ss_dssp -----HTTCHHHHHHHHHHHHTCCCT------TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHH
T ss_pred -----hHHHHHHHHHHHHHHhcCCCC------CEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHH
Confidence 112234566799999999876 99999999999999999999995 59999998765 39999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-cceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..... ......||+.|+|||++.+..++.++|||||
T Consensus 121 ~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (284)
T 2vgo_A 121 EELADALHYCHERKVIHRDIKPENLLMGYKG--ELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCA 198 (284)
T ss_dssp HHHHHHHHHHHTTTEECCCCSGGGEEECTTC--CEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHH
T ss_pred HHHHHHHHHHHHCCceecCCCHHHEEEcCCC--CEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhH
Confidence 9999999999999999999999999999888 899999999865443 2344678999999999999889999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|+++|+|++|..||...+..+....+....... +...+
T Consensus 199 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~ 236 (284)
T 2vgo_A 199 GVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF------------------------------------------PPFLS 236 (284)
T ss_dssp HHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC------------------------------------------CTTSC
T ss_pred HHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC------------------------------------------CCcCC
Confidence 999999999999999888766655443210000 11237
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+.+.+||.+||+.||++|||+.++++||||+...
T Consensus 237 ~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 237 DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 8899999999999999999999999999997543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=380.93 Aligned_cols=262 Identities=30% Similarity=0.477 Sum_probs=216.6
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.+||+++++||+|+||+||+|.+..++.. |+|++......
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------------------------ 61 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK------------------------------------ 61 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB------------------------------------
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc------------------------------------
Confidence 35789999999999999999999999988865 99987432110
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
......+.+|+++++.+.|+ ||+++++++.....+|+|||||. ++|.+.+.... .+++..+..+
T Consensus 62 -------~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i 126 (486)
T 3mwu_A 62 -------NKDTSTILREVELLKKLDHP------NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARI 126 (486)
T ss_dssp -------CSCHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHH
T ss_pred -------chHHHHHHHHHHHHHhCCCC------CcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence 11224567799999999876 99999999999999999999995 69999888765 4999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
+.||+.||.|||++||+||||||+|||++..+ ...+||+|||++..... .....+||+.|+|||++.+ .|+.++||
T Consensus 127 ~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di 205 (486)
T 3mwu_A 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDV 205 (486)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHH
T ss_pred HHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhH
Confidence 99999999999999999999999999996532 22799999999975433 2334679999999999987 58999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|.+||.+.+..+.+..+.......+.. .+.
T Consensus 206 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------------------------------------~~~ 247 (486)
T 3mwu_A 206 WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP--------------------------------------QWR 247 (486)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG--------------------------------------GGG
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc--------------------------------------ccC
Confidence 999999999999999999998888877766522211111 123
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
..++.+.+||++||+.||++|||+.|+|+||||+...
T Consensus 248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 3478999999999999999999999999999998654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=352.81 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=206.1
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++.+.||+|+||+||+|.+..++.. |+|++......
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------------------------------------- 61 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ------------------------------------- 61 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-------------------------------------
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-------------------------------------
Confidence 5788999999999999999999999988865 88877433211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhh--CCCCCCHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRN--NYQGFSLGLIRR 173 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~--~~~~~~~~~~~~ 173 (429)
.....+.+|+++++.++|+ ||+++++++......++||||+. ++|.+.+... ....+++..+..
T Consensus 62 -------~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 128 (285)
T 3is5_A 62 -------VPMEQIEAEIEVLKSLDHP------NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128 (285)
T ss_dssp -------SCHHHHHHHHHHHHTCCCT------TBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHH
T ss_pred -------hhHHHHHHHHHHHHhCCCc------hHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHH
Confidence 1123566799999999876 99999999999999999999995 5999988653 224599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCcc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
++.|++.||+|||++||+||||||+||+++.++ ...++|+|||++..... ......+|+.|+|||++.+ .++.++|
T Consensus 129 i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~D 207 (285)
T 3is5_A 129 LMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCD 207 (285)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT-CCCHHHH
T ss_pred HHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc-CCCcccC
Confidence 999999999999999999999999999995421 22799999999975432 2344678999999999864 6888999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||||++|+|++|+.||.+.+..+....+......... ..
T Consensus 208 i~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~ 248 (285)
T 3is5_A 208 IWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV---------------------------------------EC 248 (285)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-----------------------------------------
T ss_pred eehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc---------------------------------------cc
Confidence 999999999999999999998776655443321100000 01
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
...++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 123688999999999999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=362.75 Aligned_cols=259 Identities=26% Similarity=0.347 Sum_probs=214.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+...++|++++.||+|+||+||+|.+..++.. |+|++........
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---------------------------------- 95 (348)
T 1u5q_A 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---------------------------------- 95 (348)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHH----------------------------------
T ss_pred cchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccch----------------------------------
Confidence 34567799999999999999999999888865 9998754322111
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+++++.++|+ ||+++++++......++||||+.|+|.+++.... ..+++..+..++
T Consensus 96 --------~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~ 160 (348)
T 1u5q_A 96 --------EKWQDIIKEVRFLQKLRHP------NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVT 160 (348)
T ss_dssp --------HHHHHHHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHH
T ss_pred --------HHHHHHHHHHHHHHhCCCC------CEeeEEEEEEECCeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHH
Confidence 1123566799999999877 9999999999999999999999999999887654 469999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhh---CCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVIL---GLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Diw 252 (429)
.|++.||+|||++||+||||||+|||++.++ .+||+|||++..... ....+||+.|+|||++. +..++.++|||
T Consensus 161 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diw 237 (348)
T 1u5q_A 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 237 (348)
T ss_dssp HHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSS-BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHH
T ss_pred HHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEeeccCceecCC-CCcccCCcceeCHhhhccccCCCCCcHHHHH
Confidence 9999999999999999999999999999888 999999999976543 33567999999999996 45689999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|..||.+.+..+.+..+........ ....
T Consensus 238 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~ 277 (348)
T 1u5q_A 238 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL----------------------------------------QSGH 277 (348)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----------------------------------------CCTT
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------------------------------------CCCC
Confidence 999999999999999998887766655543110000 0012
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.++.+.+||.+||+.||++|||+.++++||||...
T Consensus 278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 36889999999999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=383.58 Aligned_cols=263 Identities=29% Similarity=0.470 Sum_probs=218.2
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.+..+.+||++.+.||+|+||+||+|.+..++.. |+|++......
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------------------------------- 65 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK---------------------------------- 65 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----------------------------------
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc----------------------------------
Confidence 3467889999999999999999999999988865 88887432110
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.......+.+|+++++.+.|+ ||+++++++.....+|+|||||. ++|.+.+.... .+++..+.
T Consensus 66 --------~~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~ 129 (484)
T 3nyv_A 66 --------QKTDKESLLREVQLLKQLDHP------NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAA 129 (484)
T ss_dssp --------BSSCHHHHHHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHH
T ss_pred --------cchHHHHHHHHHHHHHhCCCC------CCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHH
Confidence 112234567799999998776 99999999999999999999995 69999987654 49999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEec---CCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQ---RGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~---~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
.++.||+.||+|||++||+||||||+|||++. ++ .+||+|||++..... .....+||+.|+|||++.+ .|+.
T Consensus 130 ~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 206 (484)
T 3nyv_A 130 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA--NIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDE 206 (484)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC--CEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCT
T ss_pred HHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCC--cEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCC
Confidence 99999999999999999999999999999953 44 899999999875432 2344679999999999987 6899
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
++|||||||++|+|++|.+||.+.+..+.+..+......++..
T Consensus 207 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------------------- 249 (484)
T 3nyv_A 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP------------------------------------- 249 (484)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG-------------------------------------
T ss_pred cceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc-------------------------------------
Confidence 9999999999999999999999999888877776522211111
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.+...++.+.+||++||+.||++|||+.|+|+||||+...
T Consensus 250 -~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 250 -QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp -GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred -ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 1223478999999999999999999999999999997643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=380.96 Aligned_cols=261 Identities=26% Similarity=0.457 Sum_probs=213.2
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.++|++++.||+|+||+||+|+++.++.. |+|++......
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------------------------------------ 76 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS------------------------------------ 76 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC----------------------------------------
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC------------------------------------
Confidence 35788999999999999999999999988865 88887533211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
......+.+|+++++.+.|+ ||+++++++.....+|+|||||. |+|.+.+.... .+++..+..+
T Consensus 77 -------~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i 141 (494)
T 3lij_A 77 -------TSSNSKLLEEVAVLKLLDHP------NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVI 141 (494)
T ss_dssp --------CTTHHHHHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHH
T ss_pred -------chHHHHHHHHHHHHHhCCCC------CCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence 11133566799999998776 99999999999999999999995 69999888765 3999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
+.||+.||+|||++||+||||||+|||++..+ ...+||+|||++..... .....+||+.|+|||++.+ .|+.++||
T Consensus 142 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~Di 220 (494)
T 3lij_A 142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDV 220 (494)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHH
T ss_pred HHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhH
Confidence 99999999999999999999999999998654 12599999999976443 2345679999999999864 68999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|.+||.+.+..+.+..+......++... +.
T Consensus 221 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------------------------------------~~ 262 (494)
T 3lij_A 221 WSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE--------------------------------------WK 262 (494)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG--------------------------------------GT
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh--------------------------------------cc
Confidence 9999999999999999999998888777765332222111 12
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
..++.+.+||++||+.||++|||+.|+|+||||+..
T Consensus 263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 347889999999999999999999999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=381.73 Aligned_cols=260 Identities=26% Similarity=0.357 Sum_probs=214.8
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.++..++|++++.||+|+||.||+|.++.++.. |+|++.+....
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~----------------------------------- 223 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK----------------------------------- 223 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----------------------------------
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-----------------------------------
Confidence 346678899999999999999999999988865 99988532211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.......+.+|+++++.+.|+ ||+++++++.+...+|+||||+ +|+|.+++.......+++..++.
T Consensus 224 -------~~~~~~~~~~E~~iL~~l~hp------~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~ 290 (576)
T 2acx_A 224 -------KRKGEAMALNEKQILEKVNSR------FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290 (576)
T ss_dssp -------HTTCHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHH
T ss_pred -------hhHHHHHHHHHHHHHHHcCCC------CEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHH
Confidence 111223466799999999876 9999999999999999999999 56999999876655699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++.+..|+.++||
T Consensus 291 i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g--~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~Di 368 (576)
T 2acx_A 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDW 368 (576)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHH
T ss_pred HHHHHHHHHHHHHHCCEeccCCchheEEEeCCC--CeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchH
Confidence 999999999999999999999999999999988 899999999976543 2345689999999999999889999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCH----HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 252 WSLGCILAELYTGCPLFPGENE----VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
|||||++|+|++|..||.+.+. ......+... . .
T Consensus 369 wSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~---~-------------------------------------- 406 (576)
T 2acx_A 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-P---E-------------------------------------- 406 (576)
T ss_dssp HHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-C---C--------------------------------------
T ss_pred HHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-c---c--------------------------------------
Confidence 9999999999999999987642 2222222110 0 0
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKSS 367 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~ 367 (429)
......++++.+||++||+.||++|| ++.|+++||||+..
T Consensus 407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 00122378999999999999999999 79999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=352.02 Aligned_cols=260 Identities=25% Similarity=0.328 Sum_probs=216.2
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
..+...++|++.+.||+|+||+||+|.+..++.. |+|++......
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---------------------------------- 54 (294)
T 2rku_A 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---------------------------------- 54 (294)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC----------------------------------
T ss_pred eCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc----------------------------------
Confidence 3456789999999999999999999999988875 88887543211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.......+.+|+.+++.+.|+ ||+++++++...+..++||||++ ++|.+++.... .+++..+.
T Consensus 55 --------~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~ 118 (294)
T 2rku_A 55 --------KPHQREKMSMEISIHRSLAHQ------HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEAR 118 (294)
T ss_dssp --------SHHHHHHHHHHHHHHHTCCCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHH
T ss_pred --------CHHHHHHHHHHHHHHHhCCCC------CEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHH
Confidence 111223556699999998776 99999999999999999999996 69999988764 49999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.... .......||+.|+|||++.+..++.++
T Consensus 119 ~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 196 (294)
T 2rku_A 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196 (294)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHH
T ss_pred HHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC--CEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchh
Confidence 9999999999999999999999999999999888 89999999997643 223345789999999999988899999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||+++|+|++|+.||.+.+..+....+...... .
T Consensus 197 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~ 234 (294)
T 2rku_A 197 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------------------------------------------I 234 (294)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC------------------------------------------C
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC------------------------------------------C
Confidence 9999999999999999999988776655444321000 0
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
+...++.+.++|.+||+.||++|||+.|+++||||++..
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred ccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 112367889999999999999999999999999997653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=358.88 Aligned_cols=260 Identities=25% Similarity=0.320 Sum_probs=216.9
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
..+...+||++++.||+|+||.||+|.+..++.. |+|++......
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---------------------------------- 80 (335)
T 2owb_A 35 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---------------------------------- 80 (335)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC----------------------------------
T ss_pred cCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc----------------------------------
Confidence 3456688999999999999999999999988865 88887543211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.......+.+|+.+++.+.|+ ||+++++++...+.+++||||+. ++|.+++.... .+++..+.
T Consensus 81 --------~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~ 144 (335)
T 2owb_A 81 --------KPHQREKMSMEISIHRSLAHQ------HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEAR 144 (335)
T ss_dssp --------SHHHHHHHHHHHHHHHTCCCT------TBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHH
T ss_pred --------CHHHHHHHHHHHHHHHhCCCC------CCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHH
Confidence 111233566699999998776 99999999999999999999996 69999988764 49999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++.... .......||+.|+|||++.+..++.++
T Consensus 145 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 222 (335)
T 2owb_A 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222 (335)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHH
T ss_pred HHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC--CEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchh
Confidence 9999999999999999999999999999999988 89999999997543 223346789999999999998899999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||...+..+....+.......
T Consensus 223 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------------------------------ 260 (335)
T 2owb_A 223 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI------------------------------------------ 260 (335)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC------------------------------------------
T ss_pred hHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC------------------------------------------
Confidence 99999999999999999999887766655444311100
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||.+||+.||++|||+.|+++|+||++..
T Consensus 261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 261 PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 112367889999999999999999999999999998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=367.70 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=209.5
Q ss_pred cccCCeEE--EeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 18 HICYRYEI--LEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 18 ~~~~rY~i--~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.+...|++ .+.||+|+||.||+|.+..++.. |+|++......
T Consensus 84 ~~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~----------------------------------- 128 (373)
T 2x4f_A 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK----------------------------------- 128 (373)
T ss_dssp CGGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH-----------------------------------
T ss_pred ccccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc-----------------------------------
Confidence 45667777 67899999999999999988865 88887543211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
....+.+|+++++.++|+ ||+++++++.....+++||||++ ++|.+++.... ..+++..+..
T Consensus 129 ----------~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~ 191 (373)
T 2x4f_A 129 ----------DKEEVKNEISVMNQLDHA------NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES-YNLTELDTIL 191 (373)
T ss_dssp ----------HHHHHHHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHH
T ss_pred ----------cHHHHHHHHHHHHhCCCC------CCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHH
Confidence 122455699999998776 99999999999999999999995 69988887543 3499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
++.||+.||+|||++||+||||||+|||+..++...+||+|||++..... .....+||+.|+|||++.+..++.++||
T Consensus 192 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 271 (373)
T 2x4f_A 192 FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271 (373)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHH
T ss_pred HHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhH
Confidence 99999999999999999999999999999654334899999999976443 2334579999999999998889999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|..||.+.+..+.+..+.......+.+ ...
T Consensus 272 wslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--------------------------------------~~~ 313 (373)
T 2x4f_A 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE--------------------------------------EFQ 313 (373)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG--------------------------------------GGT
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh--------------------------------------hhc
Confidence 999999999999999999999888877776532222111 112
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
..++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 347899999999999999999999999999999763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=356.31 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=209.2
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
.|+..++||+|+||+||+|.+..++.. |+|++.....
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~------------------------------------------ 83 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ------------------------------------------ 83 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------------------------------------------
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch------------------------------------------
Confidence 599999999999999999999877764 8888743211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.....+.+|+.+++.++|+ ||+++++++......++||||+. ++|.+++... .+++..+..++.|++
T Consensus 84 ---~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~ 151 (321)
T 2c30_A 84 ---QRRELLFNEVVIMRDYQHF------NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVL 151 (321)
T ss_dssp ---CSHHHHHHHHHHHTTCCCT------TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHH
T ss_pred ---hHHHHHHHHHHHHHhCCCC------CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHH
Confidence 1123456799999988776 99999999999999999999995 6999988653 499999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
.||.|||++||+||||||+||+++.++ .++|+|||++..... ......||+.|+|||++.+..++.++|||||||
T Consensus 152 ~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ 229 (321)
T 2c30_A 152 QALAYLHAQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229 (321)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred HHHHHHHHCCeecCCCCHHHEEECCCC--cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHH
Confidence 999999999999999999999999888 899999999876443 233467999999999999988999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|+.||.+.+..+....+........ ......++.
T Consensus 230 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~ 270 (321)
T 2c30_A 230 MVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL---------------------------------------KNSHKVSPV 270 (321)
T ss_dssp HHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC---------------------------------------TTGGGSCHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc---------------------------------------CccccCCHH
Confidence 99999999999998887766555443110000 001234788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
+.+||.+||+.||++|||+.|+++||||.+.
T Consensus 271 l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 271 LRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 9999999999999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=350.75 Aligned_cols=264 Identities=22% Similarity=0.313 Sum_probs=211.0
Q ss_pred hhhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 13 QVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 13 ~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
.++++++.+||++++.||+|+||.||+|.+..++.. |+|++......
T Consensus 3 ~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------------------- 50 (294)
T 4eqm_A 3 HMIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE-------------------------------- 50 (294)
T ss_dssp -CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC--------------------------------
T ss_pred cchhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc--------------------------------
Confidence 467889999999999999999999999999988865 88887433221
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHH
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~ 170 (429)
.......+.+|+.+++.++|+ ||+++++++.....+|+||||++ ++|.+++.... .+++..
T Consensus 51 ----------~~~~~~~~~~e~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~ 112 (294)
T 4eqm_A 51 ----------KEETLKRFEREVHNSSQLSHQ------NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDT 112 (294)
T ss_dssp ----------CHHHHHHHHHHHHHHTTCCBT------TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHH
T ss_pred ----------cHHHHHHHHHHHHHHhcCCCC------CCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHH
Confidence 112234566799999998876 99999999999999999999995 59999998765 499999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGLPYG 246 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~ 246 (429)
+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++...... ....+||+.|+|||++.+..++
T Consensus 113 ~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 190 (294)
T 4eqm_A 113 AINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK--TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190 (294)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCSSSTTC-------------CCSSCCHHHHHTCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCC
Confidence 999999999999999999999999999999999888 8999999999764432 2335789999999999999999
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
.++|||||||++|+|++|+.||.+.+..+....... ...+. ..
T Consensus 191 ~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~-----------------------------------~~ 233 (294)
T 4eqm_A 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ--DSVPN-----------------------------------VT 233 (294)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--SCCCC-----------------------------------HH
T ss_pred chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--ccCCC-----------------------------------cc
Confidence 999999999999999999999999877655433321 11110 11
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
.......++.+.++|.+||+.||++||+..+.+.+.|..
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 122234578999999999999999999766666666653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=359.91 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=203.5
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.+++|++++.||+|+||+||+|.+.....+|+|++.......
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------------ 48 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN------------------------------------ 48 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH------------------------------------
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch------------------------------------
Confidence 35678899999999999999999999765556999875432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.....+.+|+++++.+.|+ ++||+++++++.....+++|||+.+++|.+++.... .+++..+..++.
T Consensus 49 -------~~~~~~~~E~~~l~~l~~~----~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~ 115 (343)
T 3dbq_A 49 -------QTLDSYRNEIAYLNKLQQH----SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWK 115 (343)
T ss_dssp -------HHHHHHHHHHHHHHHHTTT----CTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHSC--CCCHHHHHHHHH
T ss_pred -------HHHHHHHHHHHHHHhhhhc----CCceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHH
Confidence 1123566799999999872 359999999999999999999988899999998764 499999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhC---------
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILG--------- 242 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~--------- 242 (429)
||+.||+|||++||+||||||+|||++ ++ .+||+|||++...... ....+||+.|+|||++.+
T Consensus 116 qi~~al~~lH~~~iiHrDikp~NIll~-~~--~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 192 (343)
T 3dbq_A 116 NMLEAVHTIHQHGIVHSDLKPANFLIV-DG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192 (343)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEEE-TT--EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-------
T ss_pred HHHHHHHHHHhCCeecCCCCcceEEEE-CC--cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccc
Confidence 999999999999999999999999997 45 7999999999764322 224579999999999975
Q ss_pred --CCCCCCccccchhhHHHHHhhCCCCCCCCCHH-HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCC
Q psy17270 243 --LPYGPPIDMWSLGCILAELYTGCPLFPGENEV-EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319 (429)
Q Consensus 243 --~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (429)
..++.++|||||||++|+|++|+.||...... ..+..+. .....
T Consensus 193 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~------------------------------ 239 (343)
T 3dbq_A 193 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNHE------------------------------ 239 (343)
T ss_dssp ----CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTTSC------------------------------
T ss_pred cccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh---cCCcc------------------------------
Confidence 56788999999999999999999999875432 2222211 10000
Q ss_pred CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
...+...++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 240 -------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 240 -------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp -------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred -------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 00011225788999999999999999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=354.04 Aligned_cols=286 Identities=23% Similarity=0.424 Sum_probs=214.0
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++++.||+|+||+||+|.+..++.. |+|++....
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------------------------- 73 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------------------------------------- 73 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---------------------------------------
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---------------------------------------
Confidence 3468999999999999999999999888865 888874221
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEE--cCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYF--RNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
...+.+|+++++.+. |+ ||+++++++.. ....++||||+. ++|.+++.. +++..+.
T Consensus 74 ---------~~~~~~E~~~l~~l~~~~------~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~ 133 (330)
T 3nsz_A 74 ---------KKKIKREIKILENLRGGP------NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIR 133 (330)
T ss_dssp ---------HHHHHHHHHHHHHHTTST------TBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHH
T ss_pred ---------hHHHHHHHHHHHHcCCCC------CEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHH
Confidence 234566999999997 54 99999999988 568999999996 588887642 8999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhC-CCCCCCc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILG-LPYGPPI 249 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~ 249 (429)
.++.|++.||+|||++||+||||||+|||++.++. .++|+|||++.... .......+|+.|+|||++.+ ..++.++
T Consensus 134 ~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 212 (330)
T 3nsz_A 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL 212 (330)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHH
T ss_pred HHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchh
Confidence 99999999999999999999999999999986542 79999999997543 23344678999999999987 5689999
Q ss_pred cccchhhHHHHHhhCCCCC-CCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 250 DMWSLGCILAELYTGCPLF-PGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
|||||||++|+|++|..|| .+.+..+.+..+...++.+.. ..........+...............+.... ...
T Consensus 213 DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 287 (330)
T 3nsz_A 213 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL--YDYIDKYNIELDPRFNDILGRHSRKRWERFV---HSE 287 (330)
T ss_dssp HHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH--HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGC---CTT
T ss_pred hHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh--hhHHHHhccccccchhhhhhhccccchhhhc---ccc
Confidence 9999999999999999998 555677777777776664221 1111111100000000000000000000000 001
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....++.+.+||.+||++||++|||+.|+|+||||++..
T Consensus 288 ~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 288 NQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp TGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1223588999999999999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=368.77 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=196.7
Q ss_pred cccCCeEEE-eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 18 HICYRYEIL-EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 18 ~~~~rY~i~-~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
.+.++|.+. +.||.|+||+||+|.++.++.. |+|++...
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------------------------------- 98 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------------------------------- 98 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------------------------------------
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------------------------------------
Confidence 355667776 7999999999999999998865 88887321
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE----cCeEEEEEeecC-cCHHHHHHhhCCCCCCHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF----RNHLCISFELMN-LNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~ 170 (429)
..+.+|++++.++. .||||++++++|.. ..++|+|||||. |+|.+++.......+++..
T Consensus 99 -----------~~~~~E~~~~~~~~-----~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~ 162 (400)
T 1nxk_A 99 -----------PKARREVELHWRAS-----QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 162 (400)
T ss_dssp -----------HHHHHHHHHHHHHT-----TSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHH
T ss_pred -----------hhHHHHHHHHHHhc-----CCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHH
Confidence 12344788775553 23599999999976 568999999995 5999999876545699999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
+..++.||+.||.|||++||+||||||+|||++..+ ...+||+|||++..... .....+||+.|+|||++.+..|+.
T Consensus 163 ~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 242 (400)
T 1nxk_A 163 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 242 (400)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSS
T ss_pred HHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCC
Confidence 999999999999999999999999999999999731 12899999999976442 234568899999999999889999
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHH----HHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVE----QLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
++|||||||++|+|++|..||.+.+... ....+.......+
T Consensus 243 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~----------------------------------- 287 (400)
T 1nxk_A 243 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP----------------------------------- 287 (400)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC-----------------------------------
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC-----------------------------------
Confidence 9999999999999999999998754321 1111111000000
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
...+...++++.+||++||+.||++|||+.|+++||||.+..
T Consensus 288 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 288 ---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp ---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 001123478999999999999999999999999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=356.49 Aligned_cols=278 Identities=24% Similarity=0.313 Sum_probs=203.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++.+.||+|+||+||+|.+..++.. |+|++................. +.. ....
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~---------~~~----------~~~~ 70 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP---------RGT----------RPAP 70 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC----------------------------------------
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhccccccccc---------ccc----------cccc
Confidence 3468999999999999999999999988865 9998865432211100000000 000 0000
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--cCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--RNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
............+.+|+++++.++|+ ||+++++++.. ...+++||||++ ++|.+++.. ..+++..+..
T Consensus 71 ~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~ 141 (298)
T 2zv2_A 71 GGCIQPRGPIEQVYQEIAILKKLDHP------NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARF 141 (298)
T ss_dssp ----------CHHHHHHHHHHTCCCT------TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHH
T ss_pred cccccccchHHHHHHHHHHHHhCCCC------CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHH
Confidence 00000112345678899999999876 99999999987 568999999995 577665432 3599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCC---CCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLP---YGP 247 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~---~~~ 247 (429)
++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .....||+.|+|||++.+.. ++.
T Consensus 142 ~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 219 (298)
T 2zv2_A 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGK 219 (298)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESH
T ss_pred HHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC--CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCc
Confidence 999999999999999999999999999999888 8999999999764432 23457899999999998765 367
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
++|||||||++|+|++|+.||.+.+.......+.......+
T Consensus 220 ~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------------------- 260 (298)
T 2zv2_A 220 ALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFP--------------------------------------- 260 (298)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------------------------------
T ss_pred hhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCC---------------------------------------
Confidence 89999999999999999999998776555444432100000
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
.....++.+.+||.+||+.||++|||+.|+++||||+
T Consensus 261 -~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 261 -DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp -SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred -CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 0123478899999999999999999999999999995
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=389.82 Aligned_cols=257 Identities=27% Similarity=0.368 Sum_probs=216.3
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
-.++|++++.||+|+||+||+|.++.+++. |+|++.+....
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-------------------------------------- 380 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-------------------------------------- 380 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH--------------------------------------
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc--------------------------------------
Confidence 357899999999999999999999998874 99988543211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.......+..|.+++..+.+ |++|+.++++|.+...+|+||||+. |+|.+++.... .+++..++.|+.
T Consensus 381 ----~~~~~~~~~~E~~~l~~~~~-----~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ 449 (674)
T 3pfq_A 381 ----QDDDVECTMVEKRVLALPGK-----PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAA 449 (674)
T ss_dssp ----HTTTTHHHHHHHHHHTCTTC-----CTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHH
T ss_pred ----cHHHHHHHHHHHHHHHhccC-----CCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHH
Confidence 01122345568888877643 4599999999999999999999995 69999998765 399999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccc---cCcceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS---HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
||+.||+|||++||+||||||+|||++.++ .+||+|||++... .......+||+.|+|||++.+..|+.++||||
T Consensus 450 qi~~aL~~LH~~gIiHrDLKp~NILl~~~g--~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwS 527 (674)
T 3pfq_A 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 527 (674)
T ss_dssp HHHHHHHHHHHTSEECCCCCSTTEEECSSS--CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHH
T ss_pred HHHHHHHHHHhCCeEeccCChhhEEEcCCC--cEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEec
Confidence 999999999999999999999999999988 9999999999752 23345578999999999999999999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|||++|+.||.+.+..+.+..|.......+ ...
T Consensus 528 lGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p------------------------------------------~~~ 565 (674)
T 3pfq_A 528 FGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP------------------------------------------KSM 565 (674)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC------------------------------------------TTS
T ss_pred hHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC------------------------------------------ccC
Confidence 99999999999999999988888777754211111 124
Q ss_pred ChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTP-----DEALRHEWLKSSS 368 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta-----~ell~h~~~~~~~ 368 (429)
++++.+||++||+.||++||++ .|+++||||+...
T Consensus 566 s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 7899999999999999999997 9999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=376.54 Aligned_cols=260 Identities=25% Similarity=0.334 Sum_probs=213.2
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..-.++|++++.||+|+||+||+|+++.+++. |+|++.+....
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~------------------------------------ 224 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK------------------------------------ 224 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH------------------------------------
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh------------------------------------
Confidence 45568999999999999999999999988865 99988533211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC--CCCCCHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN--YQGFSLGLIR 172 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~--~~~~~~~~~~ 172 (429)
.......+.+|+++++.+.|+ ||++++++|.....+|+||||+. |+|.+++.... ...+++..++
T Consensus 225 ------~~~~~~~~~~E~~iL~~l~hp------~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~ 292 (543)
T 3c4z_A 225 ------KRKGYQGAMVEKKILAKVHSR------FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292 (543)
T ss_dssp ------HTTCHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHH
T ss_pred ------hhHHHHHHHHHHHHHHhcCCC------CEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHH
Confidence 111223566799999999776 99999999999999999999995 69999987653 3459999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ....+||+.|+|||++.+..|+.++
T Consensus 293 ~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g--~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 370 (543)
T 3c4z_A 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV 370 (543)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHH
T ss_pred HHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC--CEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHH
Confidence 9999999999999999999999999999999988 8999999999764432 2345899999999999999999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCC----HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 250 DMWSLGCILAELYTGCPLFPGEN----EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
|+|||||++|+|++|+.||.+.+ ..+....+.......
T Consensus 371 DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~-------------------------------------- 412 (543)
T 3c4z_A 371 DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY-------------------------------------- 412 (543)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC--------------------------------------
T ss_pred hcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC--------------------------------------
Confidence 99999999999999999998753 233333332210000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSSS 368 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~ 368 (429)
+...++.+.+||++||+.||++||+ +.++++||||+...
T Consensus 413 ----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 413 ----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred ----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 1233789999999999999999996 58999999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=354.03 Aligned_cols=260 Identities=24% Similarity=0.403 Sum_probs=210.1
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.++|++++.||+|+||.||+|.+..++.. |+|++.......
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~------------------------------------- 45 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR------------------------------------- 45 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH-------------------------------------
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc-------------------------------------
Confidence 568999999999999999999999888864 999875432110
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEE--EcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY--FRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.......+.+|+++++.++|+ ||+++++++. .....++||||++++|.+++.......+++..+..++
T Consensus 46 ----~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~ 115 (305)
T 2wtk_C 46 ----IPNGEANVKKEIQLLRRLRHK------NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115 (305)
T ss_dssp ----STTHHHHHHHHHHHHTTCCCT------TBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHH
T ss_pred ----cchhHHHHHHHHHHHHhcCCC------CeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHH
Confidence 011223566799999998776 9999999984 4468999999999889999887766679999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----cceeeecCccccchhhhhCCC--CCCC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RVYTYIQSRFYRSPEVILGLP--YGPP 248 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~--~~~~ 248 (429)
.|++.||.|||++|++||||||+||+++.++ .++|+|||++..... ......||+.|+|||++.+.. ++.+
T Consensus 116 ~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 193 (305)
T 2wtk_C 116 CQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFK 193 (305)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHH
T ss_pred HHHHHHHHHHHHCCeeecCCCcccEEEcCCC--cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcch
Confidence 9999999999999999999999999999888 899999999975432 223456899999999998754 3679
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++|..||.+.+..+....+......
T Consensus 194 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~------------------------------------------ 231 (305)
T 2wtk_C 194 VDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA------------------------------------------ 231 (305)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC------------------------------------------
T ss_pred hhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC------------------------------------------
Confidence 99999999999999999999988776665554431100
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
.....++.+.+||.+||+.||++|||+.|+++||||+....
T Consensus 232 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 01123788999999999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=348.62 Aligned_cols=265 Identities=26% Similarity=0.421 Sum_probs=215.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++++.||+|+||+||+|.+..++.. |+|++........
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----------------------------------- 46 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSS----------------------------------- 46 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTC-----------------------------------
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccc-----------------------------------
Confidence 4667899999999999999999999988765 8887743321100
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
........+.+|+.+++.++|+ ||+++++++......++||||+. ++|.+++.... .+++..+..++
T Consensus 47 ----~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~ 114 (283)
T 3bhy_A 47 ----RRGVSREEIEREVNILREIRHP------NIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFL 114 (283)
T ss_dssp ----SSSBCHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred ----ccchHHHHHHHHHHHHHhCCCC------CeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHH
Confidence 0111234677799999999876 99999999999999999999995 79999998764 49999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCC--CcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRG--SSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~--~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.|++.||.|||++|++|+||||+||+++.++ ...++|+|||++..... ......+|+.|+|||++.+..++.++||
T Consensus 115 ~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 194 (283)
T 3bhy_A 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 194 (283)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHH
T ss_pred HHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhh
Confidence 9999999999999999999999999998764 23699999999976443 2234568999999999998899999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
||||+++|+|++|..||.+.+..+.+..+.......+.+ ...
T Consensus 195 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~ 236 (283)
T 3bhy_A 195 WSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE--------------------------------------YFS 236 (283)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH--------------------------------------HHT
T ss_pred hhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch--------------------------------------hcc
Confidence 999999999999999999988877666554322222221 223
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
..++.+.+||.+||+.||++|||+.|+++||||+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 447889999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=358.90 Aligned_cols=261 Identities=22% Similarity=0.325 Sum_probs=208.1
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.+||++++.||+|+||+||+|.+..++.. |+|++.......
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------- 52 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD----------------------------------- 52 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS-----------------------------------
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC-----------------------------------
Confidence 56889999999999999999999999888865 999875432211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC----eEEEEEeecC-cCHHHHHHhhCCCCCCHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN----HLCISFELMN-LNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~ 170 (429)
......+.+|+++++.++|+ ||+++++++.... ..|+||||++ ++|.+++.... .+++..
T Consensus 53 -------~~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~ 117 (311)
T 3ork_A 53 -------PSFYLRFRREAQNAAALNHP------AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKR 117 (311)
T ss_dssp -------HHHHHHHHHHHTTCCCCCCT------TBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHH
T ss_pred -------HHHHHHHHHHHHHHHcCCCC------CcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHH
Confidence 11223455677777777665 9999999987664 3599999995 69999998765 499999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhhCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~ 244 (429)
+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++...... .....||+.|+|||++.+..
T Consensus 118 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 195 (311)
T 3ork_A 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS--CEEECCCSCC------------------CCTTCCHHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC--CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCC
Confidence 999999999999999999999999999999999988 8999999999754322 22356899999999999999
Q ss_pred CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
++.++|||||||++|+|++|+.||.+.+..+....+......++.
T Consensus 196 ~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------------------- 240 (311)
T 3ork_A 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS----------------------------------- 240 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH-----------------------------------
T ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc-----------------------------------
Confidence 999999999999999999999999998877666555432221111
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
......++++.+||.+||+.||++||++.+++.|+|++..
T Consensus 241 ---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 241 ---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1122347889999999999999999999999999999753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=354.34 Aligned_cols=259 Identities=24% Similarity=0.383 Sum_probs=213.5
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
...+.++|++++.||+|+||+||+|.+..+++. |+|++......
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------------- 48 (304)
T 2jam_A 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF----------------------------------- 48 (304)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------------------------------
T ss_pred ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-----------------------------------
Confidence 346788999999999999999999999988865 88887533110
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
....+.+|+++++.++|+ ||+++++++.....+++||||+. ++|.+++.... .+++..+..
T Consensus 49 ----------~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 110 (304)
T 2jam_A 49 ----------RDSSLENEIAVLKKIKHE------NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASL 110 (304)
T ss_dssp -------------HHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHH
T ss_pred ----------chHHHHHHHHHHHhCCCC------CeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHH
Confidence 112455699999999876 99999999999999999999995 69999998765 399999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEE---ecCCCcceEEeeecccccccCc-ceeeecCccccchhhhhCCCCCCCc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLL---KQRGSSSIKVIDFGSSCYSHQR-VYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili---~~~~~~~vkl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
++.|++.||.|||++|++|+||||+||++ +.++ .++|+|||++...... .....||+.|+|||++.+..++.++
T Consensus 111 ~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 188 (304)
T 2jam_A 111 VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS--KIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAV 188 (304)
T ss_dssp HHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC--CEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHH
T ss_pred HHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC--CEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchh
Confidence 99999999999999999999999999999 4455 8999999998754432 2345689999999999998899999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|..||.+.+..+....+.......+. ..
T Consensus 189 Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--------------------------------------~~ 230 (304)
T 2jam_A 189 DCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES--------------------------------------PF 230 (304)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT--------------------------------------TT
T ss_pred hHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc--------------------------------------cc
Confidence 9999999999999999999998877766665542111110 01
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
....++.+.+||.+||+.||++|||+.|+++||||+..
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 12347889999999999999999999999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=345.71 Aligned_cols=268 Identities=27% Similarity=0.397 Sum_probs=216.7
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhh-HHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEF-ERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~-~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
...+.++|++.+.||+|+||.||+|.++.++.. |+|++....... ...+
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------------- 62 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEE----------------------------- 62 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHH-----------------------------
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHH-----------------------------
Confidence 346789999999999999999999999988865 999885442110 0000
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
.......+.+|+++++.+. |+ ||+++++++......++||||++ ++|.+++.... .+++..+
T Consensus 63 --------~~~~~~~~~~e~~~l~~l~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 126 (298)
T 1phk_A 63 --------VQELREATLKEVDILRKVSGHP------NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKET 126 (298)
T ss_dssp --------HHHHHHHHHHHHHHHHHHTTCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHH
T ss_pred --------HHHHHHHHHHHHHHHHHhcCCC------CEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHH
Confidence 1122345677999999996 65 99999999999999999999996 69999998764 4999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhh------CC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVIL------GL 243 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~------~~ 243 (429)
..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..... ......+|+.|+|||++. ..
T Consensus 127 ~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 204 (298)
T 1phk_A 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 204 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSC
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC--cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccc
Confidence 99999999999999999999999999999999988 899999999876432 234467899999999986 34
Q ss_pred CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
.++.++|||||||++|+|++|..||.+.+.......+.......+.
T Consensus 205 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------------- 250 (298)
T 1phk_A 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS---------------------------------- 250 (298)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------------------------------
T ss_pred cCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc----------------------------------
Confidence 6788999999999999999999999988877666555442111110
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
......++.+.+||.+||+.||++|||+.|+++||||++..
T Consensus 251 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 251 ----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp ----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ----ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 01123478899999999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=352.77 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=198.4
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.++|++++.||+|+||.||+|++..++.. |+|++......
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-------------------------------------- 45 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-------------------------------------- 45 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--------------------------------------
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--------------------------------------
Confidence 457899999999999999999999988864 99987543221
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC------------------------------------
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN------------------------------------ 141 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~------------------------------------ 141 (429)
.....+.+|+++++.++|+ ||++++++|....
T Consensus 46 ------~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 113 (332)
T 3qd2_B 46 ------LAREKVMREVKALAKLEHP------GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIR 113 (332)
T ss_dssp ------THHHHHHHHHHHHTSCCCT------TBCCEEEEEEECCSCHHHHHHHC--------------------------
T ss_pred ------hHHHHHHHHHHHHHhCCCC------CEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCccccccccee
Confidence 1223566799999999776 9999999986543
Q ss_pred ---------------------eEEEEEeecC-cCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCC
Q psy17270 142 ---------------------HLCISFELMN-LNLYELIKRNNY-QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPE 198 (429)
Q Consensus 142 ---------------------~~~lv~e~~~-g~L~~~i~~~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~ 198 (429)
.+++|||||. ++|.+++..... ...++..+..++.||+.||+|||++||+||||||+
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 193 (332)
T 3qd2_B 114 RMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPS 193 (332)
T ss_dssp ------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred eccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcc
Confidence 3899999995 599999987543 22566779999999999999999999999999999
Q ss_pred cEEEecCCCcceEEeeecccccccCc---------------ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh
Q psy17270 199 NVLLKQRGSSSIKVIDFGSSCYSHQR---------------VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT 263 (429)
Q Consensus 199 Nili~~~~~~~vkl~Dfg~~~~~~~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 263 (429)
||+++.++ .+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 194 NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 271 (332)
T 3qd2_B 194 NIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271 (332)
T ss_dssp GEEECTTC--CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHS
T ss_pred cEEEeCCC--CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHH
Confidence 99999888 8999999999764432 123568999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHH
Q psy17270 264 GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQ 343 (429)
Q Consensus 264 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 343 (429)
|..|+.. ....+........+. .....++.+.+||.+
T Consensus 272 ~~~~~~~-----~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~li~~ 308 (332)
T 3qd2_B 272 SFSTQME-----RVRIITDVRNLKFPL--------------------------------------LFTQKYPQEHMMVQD 308 (332)
T ss_dssp CCCCHHH-----HHHHHHHHHTTCCCH--------------------------------------HHHHHCHHHHHHHHH
T ss_pred cCCChhH-----HHHHHHHhhccCCCc--------------------------------------ccccCChhHHHHHHH
Confidence 8665421 111111111111111 112226778899999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCC
Q psy17270 344 CFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 344 ~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
||+.||++|||+.|+++||||++
T Consensus 309 ~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 309 MLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HccCCCCcCCCHHHHhhchhhhc
Confidence 99999999999999999999976
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=362.89 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=203.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
...++|++++.||+|+||+||+|.+.....+|+|++......
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-------------------------------------- 94 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------------------------------------- 94 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC--------------------------------------
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc--------------------------------------
Confidence 345679999999999999999999987445699987543221
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
......+.+|+++++.+.| .|+||+++++++.....+|+|||+.+++|.+++.... .+++..+..++.|
T Consensus 95 -----~~~~~~~~~Ei~~l~~l~~----~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~~--~~~~~~~~~i~~q 163 (390)
T 2zmd_A 95 -----NQTLDSYRNEIAYLNKLQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKN 163 (390)
T ss_dssp -----HHHHHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHCS--SCCHHHHHHHHHH
T ss_pred -----HHHHHHHHHHHHHHHHccc----CCCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHH
Confidence 1122356679999999986 2459999999999999999999977889999998765 4999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhC----------
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILG---------- 242 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~---------- 242 (429)
|+.||.|||++||+||||||+|||++ ++ .+||+|||++...... ....+||+.|+|||++.+
T Consensus 164 i~~aL~~lH~~~ivHrDlkp~NIll~-~~--~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 240 (390)
T 2zmd_A 164 MLEAVHTIHQHGIVHSDLKPANFLIV-DG--MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240 (390)
T ss_dssp HHHHHHHHHTTTCCCCCCCGGGEEES-SS--CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC---------
T ss_pred HHHHHHHHHHCCeeecCCCHHHEEEE-CC--eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhcccccccccc
Confidence 99999999999999999999999996 45 8999999999764322 234579999999999976
Q ss_pred -CCCCCCccccchhhHHHHHhhCCCCCCCCCHH-HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCC
Q psy17270 243 -LPYGPPIDMWSLGCILAELYTGCPLFPGENEV-EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRK 320 (429)
Q Consensus 243 -~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (429)
..++.++|||||||++|+|++|+.||...... ..+..+.. ....
T Consensus 241 ~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~---~~~~------------------------------- 286 (390)
T 2zmd_A 241 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---PNHE------------------------------- 286 (390)
T ss_dssp ---CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC---TTSC-------------------------------
T ss_pred ccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC---cccc-------------------------------
Confidence 35788999999999999999999999875432 22222221 0000
Q ss_pred CCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 321 PGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
...+...++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 287 ------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 287 ------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp ------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 00011126788999999999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=371.71 Aligned_cols=253 Identities=16% Similarity=0.140 Sum_probs=199.4
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..++|++.+.||+|+||+||+|++..++.. |+|++......
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-------------------------------------- 112 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-------------------------------------- 112 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C--------------------------------------
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc--------------------------------------
Confidence 368899999999999999999999887754 99987532111
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEE-------EEEEEcC-----------------eEEEEEeecCcC
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHML-------EYFYFRN-----------------HLCISFELMNLN 153 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~-------~~~~~~~-----------------~~~lv~e~~~g~ 153 (429)
.......+.+|+++++.+... .||||++++ +++...+ ..|+||||++|+
T Consensus 113 ----~~~~~~~~~~E~~~l~~l~~l---~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~ 185 (377)
T 3byv_A 113 ----PSNAIKQMKEEVLRLRLLRGI---KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185 (377)
T ss_dssp ----CTTHHHHHHHHHHGGGGSTTC---CSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEE
T ss_pred ----chHHHHHHHHHHHHHHhcccc---CCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCC
Confidence 111234566788766666533 466999988 7776553 389999999999
Q ss_pred HHHHHHhhCCCCCCH-------HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce
Q psy17270 154 LYELIKRNNYQGFSL-------GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY 226 (429)
Q Consensus 154 L~~~i~~~~~~~~~~-------~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~ 226 (429)
|.+++..... +++ ..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 186 L~~~l~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~DFG~a~~~~~~~~ 261 (377)
T 3byv_A 186 LQTFGEVLLS--HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--GVFLTGFEHLVRDGARVV 261 (377)
T ss_dssp HHHHHHHHHH--TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCGGGCEETTCEEE
T ss_pred HHHHHHhccc--cccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEechhheecCCccc
Confidence 9999987532 444 88888999999999999999999999999999999888 899999999987776666
Q ss_pred eeecCccccchhhhhCC-----------CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhh
Q psy17270 227 TYIQSRFYRSPEVILGL-----------PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTA 295 (429)
Q Consensus 227 ~~~~t~~y~aPE~~~~~-----------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 295 (429)
..+| +.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 262 ~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~--------------- 325 (377)
T 3byv_A 262 SSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI--------------- 325 (377)
T ss_dssp CCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG---------------
T ss_pred CCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh---------------
Confidence 6778 999999999987 7999999999999999999999999765432111000
Q ss_pred hhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 296 SRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.......++.+.+||.+||+.||++|||+.|+++||||++.
T Consensus 326 -------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 326 -------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp -------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred -------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 00012347889999999999999999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=348.91 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=186.2
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-++|++.+.||+|+||.||+|.+..++.. |+|++......
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------------------- 50 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY--------------------------------------- 50 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---------------------------------------
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh---------------------------------------
Confidence 36799999999999999999999888764 99987432111
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.......+.+|+++++.++|+ ||+++++++......++||||++ ++|.+++.... ..+++..+..++.|
T Consensus 51 ---~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~q 120 (278)
T 3cok_A 51 ---KAGMVQRVQNEVKIHCQLKHP------SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQ 120 (278)
T ss_dssp ---HTTCHHHHHHHHHHHTTBCCT------TBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHH
T ss_pred ---hhhHHHHHHHHHHHHHhCCCC------CeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHH
Confidence 112234566799999988776 99999999999999999999995 69999988653 45999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
++.||.|||++|++|+||||+||+++.++ .++|+|||++..... ......||+.|+|||++.+..++.++|||||
T Consensus 121 i~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (278)
T 3cok_A 121 IITGMLYLHSHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSL 198 (278)
T ss_dssp HHHHHHHHHHTTEECSSCCGGGEEECTTC--CEEECCCTTCEECC----------------------------CTHHHHH
T ss_pred HHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHH
Confidence 99999999999999999999999999888 899999999876432 2234678999999999998889999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||++|+|++|+.||...+..+.+..+.. . . ...+...+
T Consensus 199 G~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------~-----------~-----------~~~~~~~~ 236 (278)
T 3cok_A 199 GCMFYTLLIGRPPFDTDTVKNTLNKVVL--------------------A-----------D-----------YEMPSFLS 236 (278)
T ss_dssp HHHHHHHHHSSCSSCCCSCC-----CCS--------------------S-----------C-----------CCCCTTSC
T ss_pred HHHHHHHHhCCCCCCChhHHHHHHHHhh--------------------c-----------c-----------cCCccccC
Confidence 9999999999999987554322211100 0 0 00112347
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
..+.+||.+||+.||++|||+.++++||||....
T Consensus 237 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 8899999999999999999999999999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=346.21 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=206.2
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
-+.+..++|++.+.||+|+||.||+|.+..++.. |+|++......
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------------- 50 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR---------------------------------- 50 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH----------------------------------
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc----------------------------------
Confidence 3556789999999999999999999999987754 99987432110
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.......+.+|+++++.++|+ ||+++++++.....+++||||+. ++|.+++.... .+++..+.
T Consensus 51 --------~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 114 (276)
T 2h6d_A 51 --------SLDVVGKIKREIQNLKLFRHP------HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEAR 114 (276)
T ss_dssp --------HTTCHHHHHHHHHHHHTCCCT------TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHH
T ss_pred --------chhHHHHHHHHHHHHhcCCCC------CEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHH
Confidence 112234566799999988776 99999999999999999999995 69999998765 39999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhCCCC-CCCc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPY-GPPI 249 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~-~~~~ 249 (429)
.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...... .....+|+.|+|||++.+..+ +.++
T Consensus 115 ~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 192 (276)
T 2h6d_A 115 RLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEV 192 (276)
T ss_dssp HHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS--CEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHH
T ss_pred HHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC--CEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccc
Confidence 9999999999999999999999999999999888 8999999998765432 234578999999999988765 5799
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||+++|+|++|..||...+.......+.......
T Consensus 193 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------------------ 230 (276)
T 2h6d_A 193 DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI------------------------------------------ 230 (276)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------------------------------------
T ss_pred hHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC------------------------------------------
Confidence 99999999999999999999877766555443311100
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
+...++.+.++|.+||+.||++|||+.|+++||||++.
T Consensus 231 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 231 PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred chhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 11236788999999999999999999999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=348.64 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=193.1
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
++..++|++++.||+|+||+||+|.+..++.. |+|++...........
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~------------------------------- 51 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKR------------------------------- 51 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHH-------------------------------
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHH-------------------------------
Confidence 35678999999999999999999999888865 9998864432211111
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhh--CCCCCCHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRN--NYQGFSLGLIRR 173 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~--~~~~~~~~~~~~ 173 (429)
.+..+...++.+. ||||+++++++......++||||++|+|.+++... ....+++..+..
T Consensus 52 ------------~~~~~~~~~~~~~------h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~ 113 (290)
T 3fme_A 52 ------------LLMDLDISMRTVD------CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK 113 (290)
T ss_dssp ------------HHHHHHHHHTTCC------CTTBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHH
T ss_pred ------------HHHHHHHHHHhCC------CCeEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHH
Confidence 1112333344444 45999999999999999999999999998887652 334599999999
Q ss_pred HHHHHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhh----hCCCCC
Q psy17270 174 FAFSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVI----LGLPYG 246 (429)
Q Consensus 174 i~~qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~----~~~~~~ 246 (429)
++.|++.||+|||++ |++||||||+||+++.++ .++|+|||++...... .....||+.|+|||++ .+..++
T Consensus 114 i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 191 (290)
T 3fme_A 114 IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYS 191 (290)
T ss_dssp HHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC---------------CCCCCCSCHHHHSCCTTC--CC
T ss_pred HHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCC
Confidence 999999999999998 999999999999999888 8999999999754432 2335789999999997 455688
Q ss_pred CCccccchhhHHHHHhhCCCCCCCC-CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGE-NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
.++|||||||++|+|++|..||... .....+..+........
T Consensus 192 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------------------------- 234 (290)
T 3fme_A 192 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL------------------------------------- 234 (290)
T ss_dssp HHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC-------------------------------------
T ss_pred cHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc-------------------------------------
Confidence 8999999999999999999999864 33333333322000000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.....++.+.+||.+||+.||++|||+.|+++||||+.
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 235 ---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 00123788999999999999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=359.54 Aligned_cols=297 Identities=21% Similarity=0.315 Sum_probs=213.6
Q ss_pred hhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 14 ~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
.++++..++|++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--------------------------------- 72 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--------------------------------- 72 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH---------------------------------
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH---------------------------------
Confidence 45677899999999999999999999999988865 88887543221
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
.....+.+|+++++.++|+ ||+++++++.....+++||||+. ++|.+++.... .+++..+
T Consensus 73 -----------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 133 (360)
T 3eqc_A 73 -----------AIRNQIIRELQVLHECNSP------YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQIL 133 (360)
T ss_dssp -----------HHHHHHHHHHGGGGGCCCT------TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHH
T ss_pred -----------HHHHHHHHHHHHHHHCCCC------CEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHH
Confidence 1223456689998888766 99999999999999999999995 59999998765 3999999
Q ss_pred HHHHHHHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeeccccccc-CcceeeecCccccchhhhhCCCCCCCc
Q psy17270 172 RRFAFSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-QRVYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
..++.|++.||+|||++ ||+||||||+||+++.++ .++|+|||++.... .......||+.|+|||++.+..++.++
T Consensus 134 ~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 211 (360)
T 3eqc_A 134 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 211 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--CEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHH
T ss_pred HHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC--CEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchh
Confidence 99999999999999996 999999999999999988 89999999986533 223446799999999999998999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhc---cCCCCCcc--ccCCCCCCCCCCCc
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFF---DSKGTPRC--ITNSKGRKRKPGSK 324 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~~ 324 (429)
|||||||++|+|++|+.||...+..+....+.....................+ .....+.. ...........
T Consensus 212 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 288 (360)
T 3eqc_A 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP--- 288 (360)
T ss_dssp HHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSC---
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccC---
Confidence 99999999999999999999887665433322111110000000000000000 00000000 00000000000
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.........++++.+||++||+.||++|||+.|+|+||||+..
T Consensus 289 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 289 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 0000011247889999999999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=344.43 Aligned_cols=258 Identities=20% Similarity=0.268 Sum_probs=203.2
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
...+.++|++++.||+|+||+||+|.+..++.. |+|++........
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------------------------------- 52 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV--------------------------------- 52 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH---------------------------------
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH---------------------------------
Confidence 345778999999999999999999999988765 9998754322211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC--CCCCHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY--QGFSLGL 170 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~--~~~~~~~ 170 (429)
....+.+|+.++..+ .|+ ||+++++++.....+++||||++ ++|.+++..... ..+++..
T Consensus 53 ----------~~~~~~~e~~~~~~l~~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 116 (289)
T 1x8b_A 53 ----------DEQNALREVYAHAVLGQHS------HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116 (289)
T ss_dssp ----------HHHHHHHHHHHHHHSCSCT------TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHH
T ss_pred ----------HHHHHHHHHHHHHHhCCCC------CeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHH
Confidence 123455688888888 555 99999999999999999999995 599999986522 4599999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-----------------CcceEEeeecccccccCcceeeecCcc
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-----------------SSSIKVIDFGSSCYSHQRVYTYIQSRF 233 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-----------------~~~vkl~Dfg~~~~~~~~~~~~~~t~~ 233 (429)
+..++.||+.||+|||++||+||||||+||+++.++ ...++|+|||.+....... ...||+.
T Consensus 117 ~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~ 195 (289)
T 1x8b_A 117 LKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-VEEGDSR 195 (289)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC-CCCCCGG
T ss_pred HHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc-ccCCCcc
Confidence 999999999999999999999999999999998542 2368999999997665433 3468999
Q ss_pred ccchhhhhCC-CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 234 YRSPEVILGL-PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 234 y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
|+|||++.+. .++.++|||||||++|+|++|.+++...+... .+.. +.
T Consensus 196 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~--~~-------------------------- 244 (289)
T 1x8b_A 196 FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIRQ--GR-------------------------- 244 (289)
T ss_dssp GCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHHT--TC--------------------------
T ss_pred ccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHHc--CC--------------------------
Confidence 9999999876 56679999999999999999998876543221 1111 00
Q ss_pred CCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
....+...++.+.+||.+||+.||++|||+.|+++||||++.
T Consensus 245 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 245 -------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp -------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred -------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 000112347899999999999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=358.06 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=208.0
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.++|++++.||+|+||+||+|.+..++.. |+|++........
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~---------------------------------- 65 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLED---------------------------------- 65 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTT----------------------------------
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccc----------------------------------
Confidence 45788999999999999999999999988865 8888743311000
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-Cc-CHHHHHHhhCCCCCCHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NL-NLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g-~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.+........+.+|+++++.++|+ ||+++++++.....+++|||++ .| +|.+++.... .+++..+..
T Consensus 66 ---~~~~~~~~~~~~~E~~~l~~l~h~------~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~ 134 (335)
T 3dls_A 66 ---CWIEDPKLGKVTLEIAILSRVEHA------NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASY 134 (335)
T ss_dssp ---SEEEETTTEEEEHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHH
T ss_pred ---cccchHHHHHHHHHHHHHHhCCCC------CEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHH
Confidence 000111233456699999999876 9999999999999999999998 45 9999998764 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCC-CCCcc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPY-GPPID 250 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~-~~~~D 250 (429)
++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++.+..+ +.++|
T Consensus 135 i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 212 (335)
T 3dls_A 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELE 212 (335)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHH
T ss_pred HHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC--cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCccc
Confidence 999999999999999999999999999999988 899999999976543 2345679999999999998876 77999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||||++|+|++|..||...... .. ... ..+
T Consensus 213 iwslG~il~el~~g~~pf~~~~~~-----------------~~----------------------~~~---------~~~ 244 (335)
T 3dls_A 213 MWSLGVTLYTLVFEENPFCELEET-----------------VE----------------------AAI---------HPP 244 (335)
T ss_dssp HHHHHHHHHHHHHSSCSCSSGGGG-----------------TT----------------------TCC---------CCS
T ss_pred chhHHHHHHHHHhCCCchhhHHHH-----------------Hh----------------------hcc---------CCC
Confidence 999999999999999999752210 00 000 001
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
...++.+.+||.+||+.||++|||+.|+++||||++.
T Consensus 245 ~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 1247889999999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=360.45 Aligned_cols=266 Identities=12% Similarity=0.088 Sum_probs=195.2
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
...|++++.||+|+||+||+|.+..++.. |+|++........
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------------------------------- 103 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR------------------------------------- 103 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHH-------------------------------------
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccc-------------------------------------
Confidence 34599999999999999999999988865 9999865432111
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEE-------EEEEEc-----------------CeEEEEEeecCcCH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHML-------EYFYFR-----------------NHLCISFELMNLNL 154 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~-------~~~~~~-----------------~~~~lv~e~~~g~L 154 (429)
.....+.+|+.+++.|.+ .||||++++ +++... .++|+|||||+++|
T Consensus 104 -----~~~~~~~~E~~~~~~l~~----~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L 174 (371)
T 3q60_A 104 -----SELERLHEATFAAARLLG----ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174 (371)
T ss_dssp -----HHHHHHHHHHHHHHHHHC--------------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEH
T ss_pred -----cHHHHHHHHHHHHHHhcc----cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCH
Confidence 112245568887888763 344877754 555544 34899999999999
Q ss_pred HHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceee
Q psy17270 155 YELIKRNNYQGFSLGLI------RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTY 228 (429)
Q Consensus 155 ~~~i~~~~~~~~~~~~~------~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~ 228 (429)
.+++..... .++...+ ..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..........
T Consensus 175 ~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~DFG~a~~~~~~~~~~ 251 (371)
T 3q60_A 175 ELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG--RLMLGDVSALWKVGTRGPAS 251 (371)
T ss_dssp HHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTS--CEEECCGGGEEETTCEEEGG
T ss_pred HHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCC--CEEEEecceeeecCCCccCc
Confidence 999987532 2455555 67779999999999999999999999999999988 89999999998776655456
Q ss_pred ecCccccchhhhhC--CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 229 IQSRFYRSPEVILG--LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 229 ~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
.+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.... ..
T Consensus 252 ~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------------~~--------------- 303 (371)
T 3q60_A 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK-------------GS--------------- 303 (371)
T ss_dssp GSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT-------------TC---------------
T ss_pred cCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc-------------cc---------------
Confidence 77899999999987 6789999999999999999999999987643100 00
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
....... ...............++.+.+||.+||+.||++|||+.|+|+||||++.
T Consensus 304 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 304 WKRPSLR-----VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CCBCCTT-----SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred hhhhhhh-----hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 0000000 0000000011123458899999999999999999999999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=367.79 Aligned_cols=266 Identities=27% Similarity=0.428 Sum_probs=201.1
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+.++|++.+.||+|+||+||+|.+..++.. |+|++..........
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~-------------------------------- 178 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA-------------------------------- 178 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC----------------------------------
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccccc--------------------------------
Confidence 45689999999999999999999999998865 998875432111000
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
........+.+|+++++.++|+ ||+++++++. ...+++||||+. ++|.+++.... .+++..+..+
T Consensus 179 -----~~~~~~~~~~~E~~~l~~l~hp------niv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i 244 (419)
T 3i6u_A 179 -----READPALNVETEIEILKKLNHP------CIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLY 244 (419)
T ss_dssp -----------CCHHHHHHHHHHCCCT------TBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHH
T ss_pred -----ccchhHHHHHHHHHHHHhCCCC------CEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHH
Confidence 0011223467799999999877 9999999875 556899999995 68988876543 4999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccCc--ceeeecCccccchhhhhC---CCCCCC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILG---LPYGPP 248 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~---~~~~~~ 248 (429)
+.|++.||+|||++||+||||||+|||++.++ ...+||+|||++...... ....+||+.|+|||++.+ ..++.+
T Consensus 245 ~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 324 (419)
T 3i6u_A 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 324 (419)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHH
T ss_pred HHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCch
Confidence 99999999999999999999999999997654 125999999999765433 235679999999999864 467889
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHH-HHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLA-CIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|||||||++|+|++|..||.+......+. .+....... ..
T Consensus 325 ~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~--------------------------------------~~ 366 (419)
T 3i6u_A 325 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF--------------------------------------IP 366 (419)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC--------------------------------------CH
T ss_pred hhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC--------------------------------------Cc
Confidence 999999999999999999998754332222 111111111 12
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
..+...++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 223445889999999999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=347.46 Aligned_cols=251 Identities=21% Similarity=0.233 Sum_probs=202.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+++++|++++.||+|+||+||+|.+..++.. |+|++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------------------------- 46 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--------------------------------------- 46 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---------------------------------------
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---------------------------------------
Confidence 4678999999999999999999999888865 888763211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+++++.+ .|+ ||+++++++......++||||++++|.+++.... ..+++..+..++
T Consensus 47 --------~~~~~~~E~~~l~~l~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~ 111 (330)
T 2izr_A 47 --------RAPQLHLEYRFYKQLGSGD------GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIA 111 (330)
T ss_dssp --------SSCCHHHHHHHHHHHCSCT------TSCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred --------chHHHHHHHHHHHHhhCCC------CCCEEEEEEecCCccEEEEEeCCCCHHHHHHHcC-CCCCHHHHHHHH
Confidence 122466799999999 665 9999999999999999999999889999998753 469999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCC---cceEEeeecccccccCc----------ceeeecCccccchhhhhC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGS---SSIKVIDFGSSCYSHQR----------VYTYIQSRFYRSPEVILG 242 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~---~~vkl~Dfg~~~~~~~~----------~~~~~~t~~y~aPE~~~~ 242 (429)
.|++.||+|||++||+||||||+|||++.++. ..++|+|||++...... ....+||+.|+|||++.+
T Consensus 112 ~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (330)
T 2izr_A 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG 191 (330)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC
Confidence 99999999999999999999999999998761 11999999999754321 235679999999999999
Q ss_pred CCCCCCccccchhhHHHHHhhCCCCCCCCC---HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYTGCPLFPGEN---EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (429)
..++.++|||||||++|+|++|..||.+.+ ..+.+..+.......+.+.
T Consensus 192 ~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~---------------------------- 243 (330)
T 2izr_A 192 KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV---------------------------- 243 (330)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH----------------------------
T ss_pred CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH----------------------------
Confidence 999999999999999999999999998854 3333444332211111111
Q ss_pred CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
. ....+.+.+++.+||+.||.+||++.++++
T Consensus 244 ---------~-~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 244 ---------L-CENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ---------H-TTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ---------H-hccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 111348899999999999999999988876
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=343.62 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=208.6
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
+..+.++|++++.||+|+||+||+|.+..++.. |+|++.....
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------------------------------------ 57 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE------------------------------------ 57 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----------------------------------------
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH------------------------------------
Confidence 345789999999999999999999999988865 8887643211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.....+.+|+++++.+.|+ ||+++++++.....+++||||+. ++|.+++.... ..+++..+..
T Consensus 58 ---------~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~ 121 (302)
T 2j7t_A 58 ---------EELEDYIVEIEILATCDHP------YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQV 121 (302)
T ss_dssp ---------CCHHHHHHHHHHHHHCCCT------TBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHH
T ss_pred ---------HHHHHHHHHHHHHhcCCCC------CEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHH
Confidence 1123566799999998776 99999999999999999999995 58998887654 4599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhh-----CCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVIL-----GLPY 245 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~-----~~~~ 245 (429)
++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.... .......||+.|+|||++. +..+
T Consensus 122 ~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 199 (302)
T 2j7t_A 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG--DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 199 (302)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS--CEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTT
T ss_pred HHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC--CEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCC
Confidence 999999999999999999999999999999888 89999999875322 1223457899999999984 5578
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|||||||++|+|++|..||...+....+..+.... .+.
T Consensus 200 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~------------------------------------ 241 (302)
T 2j7t_A 200 DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPT------------------------------------ 241 (302)
T ss_dssp TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCC------------------------------------
T ss_pred chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--Ccc------------------------------------
Confidence 899999999999999999999999988776655544311 000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.......+..+.+||.+||+.||++|||+.++++||||+...
T Consensus 242 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 242 -LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp -CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred -cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 000123377899999999999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=344.81 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=205.8
Q ss_pred eeehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhccccccccccccc
Q psy17270 9 SFAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESL 87 (429)
Q Consensus 9 ~~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~ 87 (429)
.+....+.....++|++++.||+|+||.||+|.+..++.. |+|++....
T Consensus 17 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------------------------ 66 (314)
T 3com_A 17 KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------------------------------ 66 (314)
T ss_dssp -------------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------------------------------
T ss_pred hcCchhhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------------------------------
Confidence 3444555677889999999999999999999999988865 888764221
Q ss_pred ccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCC
Q psy17270 88 SQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGF 166 (429)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~ 166 (429)
....+.+|+++++.+.|+ ||+++++++.....+++||||++ ++|.+++.... ..+
T Consensus 67 -----------------~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~ 122 (314)
T 3com_A 67 -----------------DLQEIIKEISIMQQCDSP------HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTL 122 (314)
T ss_dssp -----------------CCHHHHHHHHHHHTCCCT------TBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-CCC
T ss_pred -----------------HHHHHHHHHHHHHhCCCC------CCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC-CCC
Confidence 123466799999998776 99999999999999999999996 49999987543 459
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL 243 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~ 243 (429)
++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...... .....||+.|+|||++.+.
T Consensus 123 ~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 200 (314)
T 3com_A 123 TEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG--HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200 (314)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSS
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC--CEEEeecccchhhhhhccccCccCCCCCccChhhcCCC
Confidence 9999999999999999999999999999999999999888 8999999999654432 3345789999999999998
Q ss_pred CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
.++.++|||||||++|+|++|..||...+.......+.... .+.
T Consensus 201 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~---------------------------------- 244 (314)
T 3com_A 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--PPT---------------------------------- 244 (314)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCC----------------------------------
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--Ccc----------------------------------
Confidence 89999999999999999999999999877665544332210 000
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.......++.+.+||.+||+.||++|||+.++++||||+...
T Consensus 245 ---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 245 ---FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp ---CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred ---cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 000122378899999999999999999999999999998643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=347.68 Aligned_cols=279 Identities=19% Similarity=0.274 Sum_probs=206.7
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
+..+++||++.+.||+|+||+||+|.+..++.. |+|++......
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------- 48 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----------------------------------- 48 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-----------------------------------
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-----------------------------------
Confidence 346789999999999999999999999988865 88887532211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC--eEEEEEeecC-cCHHHHHHhhCC-CCCCHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN--HLCISFELMN-LNLYELIKRNNY-QGFSLGL 170 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~-g~L~~~i~~~~~-~~~~~~~ 170 (429)
.....+.+|+++++.++|+ ||+++++++.... .+++||||+. ++|.+++..... ..+++..
T Consensus 49 ---------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 113 (319)
T 4euu_A 49 ---------RPVDVQMREFEVLKKLNHK------NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113 (319)
T ss_dssp ---------SCHHHHHHHHHHHHHCCCT------TBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHH
T ss_pred ---------chHHHHHHHHHHHHhcCCC------CcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHH
Confidence 1123455699999999876 9999999998765 8899999995 699999986543 2399999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEE----ecCCCcceEEeeecccccccC--cceeeecCccccchhhhh---
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLL----KQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVIL--- 241 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili----~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~--- 241 (429)
+..++.|++.||+|||++||+||||||+|||+ +.++ .+||+|||++..... ......||+.|+|||++.
T Consensus 114 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 191 (319)
T 4euu_A 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191 (319)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCceecCCCCceeecccCCCccCHHHhhhcc
Confidence 99999999999999999999999999999998 4444 799999999976443 233467999999999987
Q ss_pred -----CCCCCCCccccchhhHHHHHhhCCCCCCCCCH----HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 242 -----GLPYGPPIDMWSLGCILAELYTGCPLFPGENE----VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 242 -----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
+..++.++|||||||++|+|++|+.||...+. .+.+..+.. ..+...+...... ......+..
T Consensus 192 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~-----~~~~~~~~~ 263 (319)
T 4euu_A 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT---GKPSGAISGVQKA-----ENGPIDWSG 263 (319)
T ss_dssp SCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH---HCCTTCCEEEECS-----TTCCEEEES
T ss_pred ccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc---CCCcccchhhhcc-----cCCccccCc
Confidence 46789999999999999999999999975432 333333332 1221111110000 000000000
Q ss_pred CCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy17270 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~ 363 (429)
..+ .........++.+.+||++||+.||++|||+.|+|+||=
T Consensus 264 ------~~~---~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 264 ------DMP---VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp ------SCC---TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred ------cCC---cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 000 001112334678899999999999999999999999873
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=339.32 Aligned_cols=255 Identities=21% Similarity=0.326 Sum_probs=204.7
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
-+.+|++.+.||+|+||+||+|.+..++.. |+|++.......
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~------------------------------------- 66 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK------------------------------------- 66 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-------------------------------------
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-------------------------------------
Confidence 456799999999999999999999988865 888775332211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc----CeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR----NHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|+.+++.++|+ ||+++++++... ..+++||||++ ++|.+++.... .+++..+.
T Consensus 67 ------~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 132 (290)
T 1t4h_A 67 ------SERQRFKEEAEMLKGLQHP------NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLR 132 (290)
T ss_dssp ------HHHHHHHHHHHHHTTCCCT------TBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHH
T ss_pred ------HHHHHHHHHHHHHHhCCCC------CeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHH
Confidence 1123456699999998776 999999998763 56899999995 59999998765 39999999
Q ss_pred HHHHHHHHHHHHHHHCC--ceecccCCCcEEEe-cCCCcceEEeeecccccccCc-ceeeecCccccchhhhhCCCCCCC
Q psy17270 173 RFAFSLVQCLRLLHREN--IIHCDLKPENVLLK-QRGSSSIKVIDFGSSCYSHQR-VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~~vkl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
.++.|++.||.|||++| ++|+||||+||+++ .++ .++|+|||++...... .....||+.|+|||++.+ .++.+
T Consensus 133 ~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ 209 (290)
T 1t4h_A 133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDES 209 (290)
T ss_dssp HHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTH
T ss_pred HHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC--CEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCc
Confidence 99999999999999999 99999999999997 566 8999999999754433 344678999999998875 58999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++|+.||.+............. +..+ ..
T Consensus 210 ~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--------------------------------------~~ 250 (290)
T 1t4h_A 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP--------------------------------------AS 250 (290)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC--------------------------------------GG
T ss_pred chHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc-cCCc--------------------------------------cc
Confidence 99999999999999999999886554443322210 0000 11
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.....++.+.+||.+||+.||++|||+.|+++||||++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 12234678999999999999999999999999999976
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=350.04 Aligned_cols=268 Identities=28% Similarity=0.416 Sum_probs=206.0
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
...+.++|++.+.||+|+||.||+|.+..++.. |+|++..........
T Consensus 5 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~------------------------------- 53 (322)
T 2ycf_A 5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSA------------------------------- 53 (322)
T ss_dssp CHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------------------------------
T ss_pred hhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhccc-------------------------------
Confidence 345778999999999999999999999988864 999875432211000
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
........+.+|+++++.+.|+ ||+++++++... .+|+||||+. ++|.+++.... .+++..+..
T Consensus 54 ------~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~ 118 (322)
T 2ycf_A 54 ------READPALNVETEIEILKKLNHP------CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK--RLKEATCKL 118 (322)
T ss_dssp -------------CHHHHHHHHHHCCCT------TBCCEEEEEESS-SEEEEEECCTTEETHHHHSTTC--CCCHHHHHH
T ss_pred ------ccchhhhhHHHHHHHHHhCCCC------CCceEeeEEcCC-ceEEEEecCCCCcHHHHHhccC--CCCHHHHHH
Confidence 0011223466799999999876 999999998655 4899999995 59999887654 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCC-cceEEeeecccccccCcc--eeeecCccccchhhhh---CCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS-SSIKVIDFGSSCYSHQRV--YTYIQSRFYRSPEVIL---GLPYGP 247 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~-~~vkl~Dfg~~~~~~~~~--~~~~~t~~y~aPE~~~---~~~~~~ 247 (429)
++.||+.||.|||++|++||||||+||+++.++. ..++|+|||++....... ....||+.|+|||++. ...++.
T Consensus 119 ~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 198 (322)
T 2ycf_A 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 198 (322)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTT
T ss_pred HHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCc
Confidence 9999999999999999999999999999987651 249999999997654432 2356899999999985 456889
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHH-HHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQL-ACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
++|||||||++|+|++|..||........+ ..+....... .
T Consensus 199 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------------------~ 240 (322)
T 2ycf_A 199 AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF--------------------------------------I 240 (322)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC--------------------------------------C
T ss_pred hhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc--------------------------------------C
Confidence 999999999999999999999775433222 2222111111 1
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.......++.+.+||.+||+.||++|||+.|+++||||+..
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 12233457899999999999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=342.26 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=206.5
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.++|++++.||+|+||.||+|.+..++.. |+|++......
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------------------------- 46 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------------------------------------- 46 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--------------------------------------
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--------------------------------------
Confidence 567899999999999999999999988764 88887433211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.....+.+|+.+++.++|+ ||+++++++......++||||++ ++|.+++.... .+++..+..++.
T Consensus 47 ------~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ 112 (276)
T 2yex_A 47 ------DCPENIKKEICINKMLNHE------NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFH 112 (276)
T ss_dssp ------THHHHHHHHHHHHHTCCCT------TBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHH
T ss_pred ------hhhHHHHHHHHHHHhcCCC------CceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHH
Confidence 1123456699999988776 99999999999999999999996 59988886543 499999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----cceeeecCccccchhhhhCCCC-CCCcc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RVYTYIQSRFYRSPEVILGLPY-GPPID 250 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~D 250 (429)
|++.||.|||++|++|+||||+||+++.++ .++|+|||.+..... ......||+.|+|||++.+..+ +.++|
T Consensus 113 ~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 190 (276)
T 2yex_A 113 QLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190 (276)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHH
T ss_pred HHHHHHHHHHhCCeeccCCChHHEEEccCC--CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcch
Confidence 999999999999999999999999999888 899999999865321 2234578999999999987765 67899
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHH-HHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQ-LACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||++|+|++|..||.+.+.... +..+... .. ....
T Consensus 191 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------------------~~~~ 230 (276)
T 2yex_A 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KT---------------------------------------YLNP 230 (276)
T ss_dssp HHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CT---------------------------------------TSTT
T ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-cc---------------------------------------ccCc
Confidence 99999999999999999987654321 1111100 00 0001
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||.+||+.||++|||+.|+++||||++..
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 123478899999999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=346.14 Aligned_cols=263 Identities=24% Similarity=0.409 Sum_probs=206.5
Q ss_pred eehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 10 FAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 10 ~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
+.+..+. ...++|++++.||+|+||.||+|.+..++.. |+|++.....
T Consensus 14 ~~~~~l~-~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------------------------ 62 (326)
T 2x7f_A 14 IDLSALR-DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------------------------------ 62 (326)
T ss_dssp --CCCCC-CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------------------------
T ss_pred ccchhcc-CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------------------------------
Confidence 3344343 3689999999999999999999999888865 8887643211
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEE------cCeEEEEEeecC-cCHHHHHHh
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYF------RNHLCISFELMN-LNLYELIKR 160 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~------~~~~~lv~e~~~-g~L~~~i~~ 160 (429)
....+.+|+.+++.+ .|+ ||+++++++.. ...+++||||++ ++|.+++..
T Consensus 63 ----------------~~~~~~~e~~~l~~l~~h~------~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 120 (326)
T 2x7f_A 63 ----------------EEEEIKQEINMLKKYSHHR------NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120 (326)
T ss_dssp ----------------TTHHHHHHHHHHHHHCCST------TBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHH
T ss_pred ----------------cHHHHHHHHHHHHhccCCC------CeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHh
Confidence 123456699999998 455 99999999987 468999999996 599999987
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccch
Q psy17270 161 NNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSP 237 (429)
Q Consensus 161 ~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aP 237 (429)
.....+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++..... ......||+.|+||
T Consensus 121 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 198 (326)
T 2x7f_A 121 TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198 (326)
T ss_dssp SGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCTTTC-------------CCGGGCCH
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC--CEEEeeCcCceecCcCccccccccCCccccCh
Confidence 6545699999999999999999999999999999999999999888 899999999876432 23345789999999
Q ss_pred hhhh-----CCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 238 EVIL-----GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 238 E~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
|++. +..++.++|||||||++|+|++|..||.+.+....+..+... ..+.
T Consensus 199 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~----------------------- 253 (326)
T 2x7f_A 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--PAPR----------------------- 253 (326)
T ss_dssp HHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCC-----------------------
T ss_pred hhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccc-----------------------
Confidence 9997 456889999999999999999999999888776655443320 0000
Q ss_pred CCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
......++.+.+||.+||..||++|||+.++++||||+..
T Consensus 254 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 254 ---------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ---------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ---------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 0012237889999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=342.97 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=214.0
Q ss_pred hhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 14 ~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
.+.....++|++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------- 61 (303)
T 3a7i_A 15 NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--------------------------------- 61 (303)
T ss_dssp TCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---------------------------------
T ss_pred cCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---------------------------------
Confidence 34455788999999999999999999999888864 88887433211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
.....+.+|+.+++.+.|+ ||+++++++.....+++||||++ ++|.+++... .+++..+
T Consensus 62 -----------~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~ 121 (303)
T 3a7i_A 62 -----------DEIEDIQQEITVLSQCDSP------YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQI 121 (303)
T ss_dssp -----------TTHHHHHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS---CCCHHHH
T ss_pred -----------HHHHHHHHHHHHHHhCCCC------CEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHH
Confidence 1123566799999998776 99999999999999999999996 5999998753 4999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...... .....||+.|+|||++.+..++.+
T Consensus 122 ~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 199 (303)
T 3a7i_A 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199 (303)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC--CEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCch
Confidence 99999999999999999999999999999999888 8999999999764432 334578999999999999889999
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++|..||...+.......+... .++ .
T Consensus 200 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---------------------------------------~ 238 (303)
T 3a7i_A 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NPP---------------------------------------T 238 (303)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCC---------------------------------------C
T ss_pred hhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CCC---------------------------------------C
Confidence 99999999999999999999988776555443320 000 0
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.....++.+.+||.+||+.||++|||+.|+++||||...
T Consensus 239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 112337889999999999999999999999999999653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=337.30 Aligned_cols=256 Identities=19% Similarity=0.232 Sum_probs=206.5
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
+.++.++|++++.||+|+||+||+|.+..++.. |+|++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------------------------------- 46 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-------------------------------------- 46 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--------------------------------------
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--------------------------------------
Confidence 567899999999999999999999999888865 88876321
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.....+.+|+++++.+.+ |++++++++++......++||||++++|.+++.... ..+++..+..+
T Consensus 47 ---------~~~~~~~~e~~~~~~l~~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i 111 (298)
T 1csn_A 47 ---------SDAPQLRDEYRTYKLLAG-----CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMA 111 (298)
T ss_dssp ---------TTSCCHHHHHHHHHHTTT-----CTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHH
T ss_pred ---------CccHHHHHHHHHHHHHhc-----CCCCCeEEeecCCCceeEEEEEecCCCHHHHHHHhc-cCCCHHHHHHH
Confidence 112346669999999843 248999999999999999999999889999998754 35999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCC---cceEEeeecccccccCc----------ceeeecCccccchhhhh
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS---SSIKVIDFGSSCYSHQR----------VYTYIQSRFYRSPEVIL 241 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~---~~vkl~Dfg~~~~~~~~----------~~~~~~t~~y~aPE~~~ 241 (429)
+.|++.||+|||++||+||||||+||+++.++. ..++|+|||++...... .....||+.|+|||++.
T Consensus 112 ~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 191 (298)
T 1csn_A 112 AKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 191 (298)
T ss_dssp HHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhc
Confidence 999999999999999999999999999987651 13999999999754322 23457899999999999
Q ss_pred CCCCCCCccccchhhHHHHHhhCCCCCCCCC---HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCC
Q psy17270 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGEN---EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318 (429)
Q Consensus 242 ~~~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (429)
+..++.++|||||||++|+|++|+.||.+.+ ....+..+......++
T Consensus 192 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------------ 241 (298)
T 1csn_A 192 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP------------------------------ 241 (298)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC------------------------------
T ss_pred CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc------------------------------
Confidence 9899999999999999999999999998743 3444444433211111
Q ss_pred CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
........++.+.+|+.+||+.||++|||+.++++.
T Consensus 242 -------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 242 -------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp -------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred -------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 112223447899999999999999999999998763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=345.32 Aligned_cols=259 Identities=25% Similarity=0.300 Sum_probs=201.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
++..++|++.+.||+|+||+||+|.+. ...+|+|++.......
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~------------------------------------ 75 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHA------------------------------------ 75 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSH------------------------------------
T ss_pred cCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCH------------------------------------
Confidence 456789999999999999999999874 3346888875432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC-CCCCHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY-QGFSLGLIRRF 174 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~-~~~~~~~~~~i 174 (429)
.....+.+|+++++.++|+ ||+++++++.....+++||||+. ++|.+++..... ..+++..+..+
T Consensus 76 -------~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i 142 (309)
T 3p86_A 76 -------ERVNEFLREVAIMKRLRHP------NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142 (309)
T ss_dssp -------HHHHHHHHHHHHHHHCCCT------TBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHH
T ss_pred -------HHHHHHHHHHHHHHhCCCC------CEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHH
Confidence 1123566799999999876 99999999999999999999995 599999976431 12899999999
Q ss_pred HHHHHHHHHHHHHCC--ceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCCCc
Q psy17270 175 AFSLVQCLRLLHREN--IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 175 ~~qil~~l~~lH~~~--ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
+.|++.||+|||++| |+||||||+||+++.++ .+||+|||++...... .....||+.|+|||++.+..++.++
T Consensus 143 ~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 220 (309)
T 3p86_A 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY--TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220 (309)
T ss_dssp HHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC--CEEECCCC-----------------CCTTSCHHHHTTCCCCTTH
T ss_pred HHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC--cEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchh
Confidence 999999999999999 99999999999999988 8999999999754332 3346789999999999999999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||.+.+..+....+...... ...
T Consensus 221 DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----------------------------------------~~~ 260 (309)
T 3p86_A 221 DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR----------------------------------------LEI 260 (309)
T ss_dssp HHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC----------------------------------------CCC
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------------------------------CCC
Confidence 9999999999999999999998877665544321000 001
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALR--HEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~--h~~~~~~ 367 (429)
+...++.+.+||.+||+.||++|||+.++++ .+++++.
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1234788999999999999999999999988 5666553
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=341.22 Aligned_cols=264 Identities=29% Similarity=0.471 Sum_probs=214.4
Q ss_pred hhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 14 VLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 14 ~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
.....+.+||++++.||+|+||+||+|.+..++.. |+|++......
T Consensus 15 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--------------------------------- 61 (287)
T 2wei_A 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--------------------------------- 61 (287)
T ss_dssp HHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS---------------------------------
T ss_pred hHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc---------------------------------
Confidence 34567889999999999999999999999887764 88887432211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
......+.+|+++++.++|+ ||+++++++.....+++|||++. ++|.+.+.... .+++..+
T Consensus 62 ----------~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 123 (287)
T 2wei_A 62 ----------NKDTSTILREVELLKKLDHP------NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDA 123 (287)
T ss_dssp ----------SSCHHHHHHHHHHHHTCCCT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHH
T ss_pred ----------hHHHHHHHHHHHHHHhccCC------CccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHH
Confidence 11223566799999998776 99999999999999999999995 69999887765 4999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccCc--ceeeecCccccchhhhhCCCCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
..++.|++.||.|||++|++|+||||+||+++.++ ...++|+|||++...... .....+|+.|+|||++.+ .++.+
T Consensus 124 ~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ 202 (287)
T 2wei_A 124 ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEK 202 (287)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTH
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCc
Confidence 99999999999999999999999999999997654 236999999998754432 233468899999999876 48899
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+||||||+++|+|++|..||.+.+..+.+..+.......+. .
T Consensus 203 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~ 244 (287)
T 2wei_A 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--------------------------------------P 244 (287)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--------------------------------------G
T ss_pred hhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--------------------------------------h
Confidence 99999999999999999999998877766555431111000 0
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.....++.+.+||++||+.||++|||+.|+++||||++.
T Consensus 245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 112347889999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=349.08 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=201.5
Q ss_pred cCCeEEEeEeeccccceEEEEEec---CCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDH---KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~---~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
.++|++++.||+|+||+||+|++. .++. +|+|++.......
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----------------------------------- 97 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ----------------------------------- 97 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-----------------------------------
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-----------------------------------
Confidence 379999999999999999999984 3454 4888874321100
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.......+.+|+++++.+. |+ ||+++++++.....+++||||+. ++|.+++.... .+++..+..
T Consensus 98 ------~~~~~~~~~~E~~~l~~l~~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 163 (355)
T 1vzo_A 98 ------KAKTTEHTRTERQVLEHIRQSP------FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQI 163 (355)
T ss_dssp ------EESSGGGCCCHHHHHHHHHTCT------TBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHH
T ss_pred ------hhhHHHHHHHHHHHHHHccCCC------ceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHH
Confidence 0111233445999999996 44 99999999999999999999995 59999998765 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC----cceeeecCccccchhhhhCC--CCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----RVYTYIQSRFYRSPEVILGL--PYGP 247 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~--~~~~ 247 (429)
++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++.+. .++.
T Consensus 164 ~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 241 (355)
T 1vzo_A 164 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 241 (355)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CT
T ss_pred HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCc
Confidence 999999999999999999999999999999888 899999999875322 23345799999999999863 4788
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHH----HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEV----EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
++|||||||++|+|++|+.||...+.. .....+......
T Consensus 242 ~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------------------- 284 (355)
T 1vzo_A 242 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP------------------------------------- 284 (355)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-------------------------------------
T ss_pred hhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC-------------------------------------
Confidence 999999999999999999999754322 222111110000
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKSS 367 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~ 367 (429)
.+...++.+.+||.+||..||++|| |+.|+++|+||+..
T Consensus 285 -----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 285 -----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 0122367889999999999999999 99999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.71 Aligned_cols=269 Identities=24% Similarity=0.382 Sum_probs=190.3
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
..+..++|++.+.||+|+||.||+|.+..++.. |+|++......
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------------- 54 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----------------------------------- 54 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------------------------------
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-----------------------------------
Confidence 346688999999999999999999999877754 88887433211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhh------CCCCCC
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRN------NYQGFS 167 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~------~~~~~~ 167 (429)
.....+.+|+++++.+.|+ ||+++++++......++||||+ +++|.+++... ....++
T Consensus 55 ---------~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 119 (303)
T 2vwi_A 55 ---------TSMDELLKEIQAMSQCHHP------NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119 (303)
T ss_dssp --------------------CCCCCCCT------TBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSC
T ss_pred ---------hhHHHHHHHHHHHhhcCCC------CEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCC
Confidence 0112344577777776655 9999999999999999999999 46999998752 224499
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--------cceeeecCccccchhh
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--------RVYTYIQSRFYRSPEV 239 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--------~~~~~~~t~~y~aPE~ 239 (429)
+..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..... ......||+.|+|||+
T Consensus 120 ~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 197 (303)
T 2vwi_A 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG--SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCHHHHHCC---------------CCCTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC--CEEEEeccchheeccCCCccchhhhcccCCCccccCHHH
Confidence 999999999999999999999999999999999999888 899999999864332 1233578999999999
Q ss_pred hhC-CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCC
Q psy17270 240 ILG-LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318 (429)
Q Consensus 240 ~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (429)
+.+ ..++.++|||||||++|+|++|..||.+.+....+..... +.++. .
T Consensus 198 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~-----------------~----------- 247 (303)
T 2vwi_A 198 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDPPS-----------------L----------- 247 (303)
T ss_dssp HHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SSCCC-----------------T-----------
T ss_pred hccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--cCCCc-----------------c-----------
Confidence 976 4689999999999999999999999988766544332221 10000 0
Q ss_pred CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.............++.+.+||.+||+.||++|||+.|+++||||++..
T Consensus 248 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 248 --ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp --TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred --ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 000001112234578899999999999999999999999999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=346.47 Aligned_cols=266 Identities=24% Similarity=0.421 Sum_probs=208.0
Q ss_pred eeeehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccc
Q psy17270 8 LSFAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEES 86 (429)
Q Consensus 8 ~~~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~ 86 (429)
..+.....++.+.++|++++.||+|+||+||+|.+..++.. |+|++.......
T Consensus 30 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------------- 83 (320)
T 3a99_A 30 TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD-------------------------- 83 (320)
T ss_dssp ----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCC--------------------------
T ss_pred hccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchh--------------------------
Confidence 34445566788999999999999999999999999888864 888874331110
Q ss_pred cccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC--cCHHHHHHhhCCC
Q psy17270 87 LSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN--LNLYELIKRNNYQ 164 (429)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~--g~L~~~i~~~~~~ 164 (429)
.........+.+|+.+++.+.| .|+||+++++++.....+++|||++. ++|.+++....
T Consensus 84 -------------~~~~~~~~~~~~E~~~l~~l~~----~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-- 144 (320)
T 3a99_A 84 -------------WGELPNGTRVPMEVVLLKKVSS----GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-- 144 (320)
T ss_dssp -------------EEECTTCCEEEHHHHHHHHHCS----SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--
T ss_pred -------------hhhhhhhhHHHHHHHHHHhhcc----CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--
Confidence 0000112345569999999976 35699999999999999999999995 79999998764
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEe-cCCCcceEEeeecccccccCc-ceeeecCccccchhhhhC
Q psy17270 165 GFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLK-QRGSSSIKVIDFGSSCYSHQR-VYTYIQSRFYRSPEVILG 242 (429)
Q Consensus 165 ~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~-~~~~~~vkl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~ 242 (429)
.+++..+..++.|++.||+|||++||+||||||+|||++ .++ .+||+|||++...... .....||+.|+|||++.+
T Consensus 145 ~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (320)
T 3a99_A 145 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 222 (320)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC--CEEEeeCccccccccccccCCCCCccCCChHHhcc
Confidence 499999999999999999999999999999999999998 556 8999999999765433 334678999999999987
Q ss_pred CCC-CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 243 LPY-GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 243 ~~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
..+ +.++|||||||++|+|++|+.||...+. +.. +.. .
T Consensus 223 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~~-------------~-------------------- 261 (320)
T 3a99_A 223 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQV-------------F-------------------- 261 (320)
T ss_dssp SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CCC-------------C--------------------
T ss_pred CCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--ccc-------------c--------------------
Confidence 765 6789999999999999999999976321 110 000 0
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 262 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 262 -------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp -------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 0112378899999999999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=350.65 Aligned_cols=264 Identities=24% Similarity=0.343 Sum_probs=180.7
Q ss_pred hcccccCCeEEEe-EeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 15 LHDHICYRYEILE-VIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 15 ~~~~~~~rY~i~~-~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
....+.++|++++ .||+|+||+||+|.+..+++. |+|++.....
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------------------------- 67 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---------------------------------- 67 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----------------------------------
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----------------------------------
Confidence 3446789999976 699999999999999988865 9998743211
Q ss_pred CCCCCCCcchhhhhhhHHHHHH-HHHHHhcCCCCCCCceeEEEEEEEE----cCeEEEEEeecC-cCHHHHHHhhCCCCC
Q psy17270 93 FDDENGSYNKKRFHHQALIEVR-ILDHLRKKDADSSYNVIHMLEYFYF----RNHLCISFELMN-LNLYELIKRNNYQGF 166 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~-il~~l~h~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~-g~L~~~i~~~~~~~~ 166 (429)
..+|+. .++.+.| +||+++++++.. ...+++||||+. |+|.+++.......+
T Consensus 68 ----------------~~~e~~~~~~~~~h------~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l 125 (336)
T 3fhr_A 68 ----------------ARQEVDHHWQASGG------PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF 125 (336)
T ss_dssp ----------------HHHHHHHHHHHTTS------TTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCC
T ss_pred ----------------HHHHHHHHHHhcCC------CChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCC
Confidence 111222 2344444 499999999976 456899999995 599999988765679
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccC-cceeeecCccccchhhhhCCC
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~ 244 (429)
++..++.++.||+.||.|||++||+||||||+||+++.++ ...++|+|||++..... ......+|+.|+|||++.+..
T Consensus 126 ~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 205 (336)
T 3fhr_A 126 TEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEK 205 (336)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------CH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCC
Confidence 9999999999999999999999999999999999998644 22599999999976543 234467899999999998888
Q ss_pred CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
++.++|||||||++|+|++|..||.+.+.......+..... . .....
T Consensus 206 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------~-----~~~~~----------------- 252 (336)
T 3fhr_A 206 YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR-----------L-----GQYGF----------------- 252 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHSSCCC-------------------------------------CC-----------------
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh-----------c-----ccccc-----------------
Confidence 89999999999999999999999977654332111110000 0 00000
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
........++.+.+||.+||+.||++|||+.|+++||||++..
T Consensus 253 -~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 253 -PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred -CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0001123478999999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=335.71 Aligned_cols=247 Identities=19% Similarity=0.288 Sum_probs=206.2
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-.++|++++.||+|+||+||+|.+..+..+|+|++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------------------- 48 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--------------------------------------- 48 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---------------------------------------
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---------------------------------------
Confidence 45789999999999999999999987777799987533211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
...+.+|+++++.++|+ ||+++++++......++||||++ ++|.+++.... ..+++..+..++.|
T Consensus 49 -------~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~ 114 (269)
T 4hcu_A 49 -------EEDFIEEAEVMMKLSHP------KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLD 114 (269)
T ss_dssp -------HHHHHHHHHHHHTCCCT------TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHH
T ss_pred -------HHHHHHHHHHHHhCCCC------CEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHH
Confidence 13456699999999876 99999999999999999999995 59999997654 45999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
++.||+|||++|++||||||+||+++.++ .++|+|||++...... .....+|+.|+|||++.+..++.++||||
T Consensus 115 i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 192 (269)
T 4hcu_A 115 VCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192 (269)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECGGG--CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHHhCCeecCCcchheEEEcCCC--CEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHH
Confidence 99999999999999999999999999888 8999999999754432 12234567899999999889999999999
Q ss_pred hhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 254 LGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 254 lG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||++|+|++ |..||.+.+..+....+........ +..
T Consensus 193 lG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~ 231 (269)
T 4hcu_A 193 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----------------------------------------PRL 231 (269)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-----------------------------------------CTT
T ss_pred HHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC-----------------------------------------CCc
Confidence 9999999999 9999999888776665543111100 112
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.++.+.+++.+||+.||++|||+.|+++|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 36889999999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=351.67 Aligned_cols=263 Identities=19% Similarity=0.241 Sum_probs=211.9
Q ss_pred hhhhcccccCCeEEEeEeeccccceEEEEEec-----CCCc-chheeccccchhhHHHHHHHHHHHHHhccccccccccc
Q psy17270 12 FQVLHDHICYRYEILEVIGKGSFGQVIRALDH-----KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEE 85 (429)
Q Consensus 12 ~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~-----~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~ 85 (429)
...+.++..++|++++.||+|+||+||+|.+. .++. +|+|++.......
T Consensus 62 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------- 116 (367)
T 3l9p_A 62 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ------------------------- 116 (367)
T ss_dssp GGGSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH-------------------------
T ss_pred CcchhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh-------------------------
Confidence 34556777899999999999999999999954 3443 4888875332221
Q ss_pred ccccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCC-
Q psy17270 86 SLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNY- 163 (429)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~- 163 (429)
....+.+|+.+++.++|+ ||+++++++......++||||| +|+|.+++.....
T Consensus 117 -------------------~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~ 171 (367)
T 3l9p_A 117 -------------------DELDFLMEALIISKFNHQ------NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR 171 (367)
T ss_dssp -------------------HHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCC
T ss_pred -------------------hHHHHHHHHHHHHhCCCC------CCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccc
Confidence 122456699999999876 9999999999989999999999 5699999987642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeeccccccc-----CcceeeecCcc
Q psy17270 164 ----QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSH-----QRVYTYIQSRF 233 (429)
Q Consensus 164 ----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~-----~~~~~~~~t~~ 233 (429)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ ...+||+|||++.... .......+|+.
T Consensus 172 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~ 251 (367)
T 3l9p_A 172 PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251 (367)
T ss_dssp SSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGG
T ss_pred cCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCccc
Confidence 3489999999999999999999999999999999999998654 1259999999996432 22233567889
Q ss_pred ccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 234 YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 234 y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+........
T Consensus 252 y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~------------------------ 307 (367)
T 3l9p_A 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP------------------------ 307 (367)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC------------------------
T ss_pred EECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------------------
Confidence 999999999899999999999999999998 9999999888776655543111000
Q ss_pred CCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
....++.+.+||.+||+.||++|||+.+++++.++-
T Consensus 308 -----------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 308 -----------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp -----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112367899999999999999999999999997764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=333.43 Aligned_cols=248 Identities=17% Similarity=0.250 Sum_probs=205.8
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+..++|++++.||+|+||.||+|.+..+..+|+|++......
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------------------------------- 46 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-------------------------------------- 46 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--------------------------------------
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--------------------------------------
Confidence 457899999999999999999999887667798887432211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
...+.+|+++++.++|+ ||+++++++.....+++||||++ ++|.+++.... ..+++..+..++.
T Consensus 47 --------~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ 111 (268)
T 3sxs_A 47 --------EDEFFQEAQTMMKLSHP------KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCY 111 (268)
T ss_dssp --------HHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHH
T ss_pred --------HHHHHHHHHHHHhCCCC------CEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHH
Confidence 23456699999999876 99999999999999999999995 68999998764 3599999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
|++.||+|||++|++||||||+||+++.++ .++|+|||++........ ...+|+.|+|||++.+..++.++|||
T Consensus 112 qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 189 (268)
T 3sxs_A 112 DVCEGMAFLESHQFIHRDLAARNCLVDRDL--CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189 (268)
T ss_dssp HHHHHHHHHHHTTEEESSCSGGGEEECTTC--CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHH
T ss_pred HHHHHHHHHHHCCeecCCcCcceEEECCCC--CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhH
Confidence 999999999999999999999999999988 899999999975443322 23456679999999988899999999
Q ss_pred chhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 253 SLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 253 SlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
||||++|+|++ |..||...+..+....+........ +.
T Consensus 190 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~ 228 (268)
T 3sxs_A 190 AFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-----------------------------------------PH 228 (268)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-----------------------------------------CT
T ss_pred HHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC-----------------------------------------CC
Confidence 99999999999 9999998887766555432111000 11
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..++.+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 236789999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=344.57 Aligned_cols=251 Identities=20% Similarity=0.231 Sum_probs=205.9
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
.++..++|++.+.||+|+||+||+|.+..++. +|+|++.......
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------- 92 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER------------------------------- 92 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH-------------------------------
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH-------------------------------
Confidence 35668899999999999999999999986664 5888875432221
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHH
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~ 170 (429)
....+.+|+++++.++|+ ||+++++++.....+++||||++ ++|.+++.... ..+++..
T Consensus 93 -------------~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 152 (325)
T 3kul_A 93 -------------QRRDFLSEASIMGQFDHP------NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQ 152 (325)
T ss_dssp -------------HHHHHHHHHHHHTTCCCT------TBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHH
T ss_pred -------------HHHHHHHHHHHHHhCCCC------CCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHH
Confidence 123466699999998776 99999999999999999999995 59999997654 4599999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~ 244 (429)
+..++.|++.||+|||++||+||||||+|||++.++ .++|+|||++....... ....+|+.|+|||++.+..
T Consensus 153 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 230 (325)
T 3kul_A 153 LVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL--VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230 (325)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC--CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC
Confidence 999999999999999999999999999999999888 89999999997644321 1234567899999999888
Q ss_pred CCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 245 YGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 231 ~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------------ 274 (325)
T 3kul_A 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP------------------------------------ 274 (325)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC------------------------------------
T ss_pred CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC------------------------------------
Confidence 9999999999999999999 999999988877666554311111
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.....++.+.+||.+||..||++|||+.++++
T Consensus 275 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 -----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01234788999999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=344.75 Aligned_cols=271 Identities=15% Similarity=0.194 Sum_probs=201.9
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecC---CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHK---TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~---~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
+.+...++|++++.||+|+||+||+|.+.. ++. +|+|++......... +....
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~-e~~~~---------------------- 87 (345)
T 2v62_A 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFY---------------------- 87 (345)
T ss_dssp EECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHH-HHHHH----------------------
T ss_pred eccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHH-HHHHH----------------------
Confidence 455667899999999999999999999986 444 488888655332211 11110
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE----cCeEEEEEeecCcCHHHHHHhhCCCCC
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF----RNHLCISFELMNLNLYELIKRNNYQGF 166 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~g~L~~~i~~~~~~~~ 166 (429)
.......+.+|+.+++.+.|+ ||+++++++.. ...+|+||||++++|.+++.... .+
T Consensus 88 -----------~~~~~~~~~~e~~~~~~l~h~------ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~ 148 (345)
T 2v62_A 88 -----------QRVAKKDCIKKWIERKQLDYL------GIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TF 148 (345)
T ss_dssp -----------HHHCCHHHHHHHHHHHTCSCC------CCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BC
T ss_pred -----------HHHhhhHHHHHHHhhcccccc------CcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CC
Confidence 111223456688888888776 99999999988 67899999999889999998765 49
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----------ceeeecCccccc
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----------VYTYIQSRFYRS 236 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----------~~~~~~t~~y~a 236 (429)
++..+..++.||+.||+|||++||+||||||+|||++.++...+||+|||++...... .....||+.|+|
T Consensus 149 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a 228 (345)
T 2v62_A 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS 228 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccC
Confidence 9999999999999999999999999999999999999876558999999999653211 134578999999
Q ss_pred hhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCC--CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCC
Q psy17270 237 PEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGE--NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314 (429)
Q Consensus 237 PE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (429)
||++.+..++.++|||||||++|+|++|+.||.+. +...............+........
T Consensus 229 PE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------ 290 (345)
T 2v62_A 229 LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAP------------------ 290 (345)
T ss_dssp HHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSC------------------
T ss_pred HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhcc------------------
Confidence 99999988999999999999999999999999652 3332222222222223322211000
Q ss_pred CCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
....++.+.+||.+||+.||++|||+.++++
T Consensus 291 ---------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 291 ---------------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp ---------------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ---------------ccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0134789999999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=344.26 Aligned_cols=263 Identities=19% Similarity=0.226 Sum_probs=189.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCC----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTN----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
.+..++|++++.||+|+||+||+|.+..++ .+|+|++.......
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------- 66 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-------------------------------- 66 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C--------------------------------
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH--------------------------------
Confidence 356889999999999999999999998776 35888874332111
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeE------EEEEeecC-cCHHHHHHhhCCC-
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHL------CISFELMN-LNLYELIKRNNYQ- 164 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~------~lv~e~~~-g~L~~~i~~~~~~- 164 (429)
.....+.+|+++++.++|+ ||+++++++...... ++||||+. ++|.+++......
T Consensus 67 -----------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~ 129 (323)
T 3qup_A 67 -----------SDIEEFLREAACMKEFDHP------HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129 (323)
T ss_dssp -----------HHHHHHHHHHHHHTTCCCT------TBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC--
T ss_pred -----------HHHHHHHHHHHHHHHCCCC------ceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccc
Confidence 1123566799999998776 999999999876654 99999995 5999999755321
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccc
Q psy17270 165 ---GFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRS 236 (429)
Q Consensus 165 ---~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~a 236 (429)
.+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++...... .....+|+.|+|
T Consensus 130 ~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~a 207 (323)
T 3qup_A 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207 (323)
T ss_dssp -CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC-----------------CCGGGCC
T ss_pred cccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--CEEEeeccccccccccccccccccccCcccccC
Confidence 489999999999999999999999999999999999999888 8999999999754322 122346778999
Q ss_pred hhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCC
Q psy17270 237 PEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315 (429)
Q Consensus 237 PE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (429)
||++.+..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 208 PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------- 258 (323)
T 3qup_A 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL----------------------------- 258 (323)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----------------------------
T ss_pred chhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC-----------------------------
Confidence 999999999999999999999999999 99999988776655544321000
Q ss_pred CCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCC-------HHHHhcCCCCCCCCCCC
Q psy17270 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT-------PDEALRHEWLKSSSSSS 371 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------a~ell~h~~~~~~~~~~ 371 (429)
......++.+.+||.+||+.||++||| +.++++|+|+......+
T Consensus 259 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 259 ------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp ------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred ------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 001223688999999999999999999 78889999998754443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.01 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=202.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCC-------C-cchheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKT-------N-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~-------~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
.-.++|++++.||+|+||+||+|.+... + .+|+|++......
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------------ 127 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE------------------------------ 127 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH------------------------------
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH------------------------------
Confidence 4468999999999999999999997532 2 2488877543221
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC----
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY---- 163 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~---- 163 (429)
.....+.+|+++++.+ +|+ ||+++++++.....+|+||||+. |+|.+++.....
T Consensus 128 --------------~~~~~~~~E~~~l~~l~~hp------nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 187 (370)
T 2psq_A 128 --------------KDLSDLVSEMEMMKMIGKHK------NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187 (370)
T ss_dssp --------------HHHHHHHHHHHHHHHSCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC---
T ss_pred --------------HHHHHHHHHHHHHHHhcCCC------CEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCcccc
Confidence 1123566799999999 565 99999999999999999999995 599999987542
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceee
Q psy17270 164 ----------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTY 228 (429)
Q Consensus 164 ----------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~ 228 (429)
..++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~ 265 (370)
T 2psq_A 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLARDINNIDYYKKTTNG 265 (370)
T ss_dssp --------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCSSCEETTCCCTTCTTTTT
T ss_pred ccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC--CEEEccccCCcccCcccceecccCC
Confidence 3489999999999999999999999999999999999999888 8999999999754322 1223
Q ss_pred ecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCC
Q psy17270 229 IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT 307 (429)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (429)
.+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+.+..+....+.....
T Consensus 266 ~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---------------------- 323 (370)
T 2psq_A 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR---------------------- 323 (370)
T ss_dssp TSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------------
T ss_pred CcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----------------------
Confidence 56788999999999999999999999999999999 9999998776555443332100
Q ss_pred CccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 308 PRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
...+...++.+.+||.+||+.||++|||+.|++++
T Consensus 324 -------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 324 -------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112347889999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=333.47 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=208.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..++|++++.||+|+||+||+|.+..+++. |+|++.......
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------- 46 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE------------------------------------- 46 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-------------------------------------
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-------------------------------------
Confidence 457899999999999999999999988865 888875432211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--cCeEEEEEeecC-cCHHHHHHhhC--CCCCCHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--RNHLCISFELMN-LNLYELIKRNN--YQGFSLGLIR 172 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~-g~L~~~i~~~~--~~~~~~~~~~ 172 (429)
.....+.+|+++++.++|+ ||+++++++.. ...+++||||++ ++|.+++.... ...+++..+.
T Consensus 47 ------~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 114 (279)
T 2w5a_A 47 ------AEKQMLVSEVNLLRELKHP------NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114 (279)
T ss_dssp ------HHHHHHHHHHHHHHHCCCT------TBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHH
T ss_pred ------HHHHHHHHHHHHHHhcCCC------CCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHH
Confidence 1123466699999999876 99999998865 468999999996 59999997643 2349999999
Q ss_pred HHHHHHHHHHHHHHHCC-----ceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCC
Q psy17270 173 RFAFSLVQCLRLLHREN-----IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~-----ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~ 244 (429)
.++.|++.||+|||++| ++|+||||+||+++.++ .++|+|||++...... .....+|+.|+|||++.+..
T Consensus 115 ~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 192 (279)
T 2w5a_A 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS 192 (279)
T ss_dssp HHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS--CEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-
T ss_pred HHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC--CEEEecCchheeeccccccccccCCCccccChHHhccCC
Confidence 99999999999999999 99999999999999888 8999999998764432 22356899999999999988
Q ss_pred CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
++.++|||||||++|+|++|..||...+..+....+......
T Consensus 193 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-------------------------------------- 234 (279)
T 2w5a_A 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-------------------------------------- 234 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------------------------------------
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc--------------------------------------
Confidence 999999999999999999999999998876665555431100
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
......++.+.++|.+||+.||++|||+.|+++|+|+.+.
T Consensus 235 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 235 ---RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ---cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 0011237889999999999999999999999999999764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=347.61 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=206.7
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCC--------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTN--------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~--------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
++..++|++.++||+|+||+||+|.+..++ .+|+|++......
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------------- 115 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE----------------------------- 115 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-----------------------------
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-----------------------------
Confidence 566789999999999999999999986443 2477776543222
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC---
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY--- 163 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~--- 163 (429)
.....+.+|+++++.+ +|+ ||+++++++.....+++||||+. |+|.+++.....
T Consensus 116 ---------------~~~~~~~~E~~~l~~l~~hp------nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 174 (382)
T 3tt0_A 116 ---------------KDLSDLISEMEMMKMIGKHK------NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174 (382)
T ss_dssp ---------------HHHHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSS
T ss_pred ---------------HHHHHHHHHHHHHHHhcCCc------hhhhheeeeccCCceEEEEEecCCCcHHHHHHHhccccc
Confidence 1123566799999999 666 99999999999999999999995 599999987642
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----cee
Q psy17270 164 -----------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYT 227 (429)
Q Consensus 164 -----------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~ 227 (429)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ...
T Consensus 175 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~~~~~~~ 252 (382)
T 3tt0_A 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN--VMKIADFGLARDIHHIDYYKKTTN 252 (382)
T ss_dssp SSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECSCSCCCCSSCCCTTCCCTT
T ss_pred ccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC--cEEEcccCcccccccccccccccC
Confidence 3499999999999999999999999999999999999999888 8999999999754321 223
Q ss_pred eecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
..+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 253 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------------- 312 (382)
T 3tt0_A 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM-------------------- 312 (382)
T ss_dssp CCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC--------------------
T ss_pred CCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence 456788999999999999999999999999999999 99999998876655544321100
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......++.+.+||.+||+.||++|||+.|++++
T Consensus 313 ---------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 313 ---------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp ---------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012347889999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=351.24 Aligned_cols=293 Identities=22% Similarity=0.328 Sum_probs=214.5
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.++.+.++|++++.||+|+||.||+|.+ ....+|+|++......... .. ..
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~------------------~~----------~~ 75 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKR------------------DF----------TK 75 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCE------------------EE----------CC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchh------------------hh----------cc
Confidence 3456679999999999999999999999 3334599987533211000 00 00
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHH------HHhhCCCCCC
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYEL------IKRNNYQGFS 167 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~------i~~~~~~~~~ 167 (429)
..............+.+|+++++.++|+ ||+++++++...+.+++||||+++ +|.++ +.......++
T Consensus 76 ~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~ 149 (348)
T 2pml_X 76 SNNDKISIKSKYDDFKNELQIITDIKNE------YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149 (348)
T ss_dssp CSSSSCCEEEHHHHHHHHHHHHTTCCCT------TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCC
T ss_pred ccchhhhHHhHHHHHHHHHHHHHhCCCC------CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCC
Confidence 0000001112225778899999999776 999999999999999999999965 99888 6554345699
Q ss_pred HHHHHHHHHHHHHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeecccccccC-cceeeecCccccchhhhhCC-C
Q psy17270 168 LGLIRRFAFSLVQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGL-P 244 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~ 244 (429)
+..+..++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||.+..... ......+|+.|+|||++.+. .
T Consensus 150 ~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (348)
T 2pml_X 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESS 227 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS--CEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCC
T ss_pred HHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC--cEEEeccccccccccccccCCCCCcCccCchhhcCCCC
Confidence 99999999999999999999 9999999999999999888 899999999976433 33446789999999999887 5
Q ss_pred CCC-CccccchhhHHHHHhhCCCCCCCCCH-HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 245 YGP-PIDMWSLGCILAELYTGCPLFPGENE-VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 245 ~~~-~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
++. ++|||||||++|+|++|..||.+.+. .+....+.......+... ........
T Consensus 228 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~-----------------------~~~~~~~~ 284 (348)
T 2pml_X 228 YNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR-----------------------NHFLYPLT 284 (348)
T ss_dssp EEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS-----------------------SSSTTTTC
T ss_pred CCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch-----------------------hhhhcccc
Confidence 666 99999999999999999999988766 444444332111111000 00000000
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
...........++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 285 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 285 NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 011112224558899999999999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=336.47 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=204.3
Q ss_pred eehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 10 FAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 10 ~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
+.|..+. +..++|++++.||+|+||.||+|.+.....+|+|++.......
T Consensus 18 ~~~~~~~-~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------- 67 (313)
T 3cek_A 18 LYFQSMS-VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN----------------------------- 67 (313)
T ss_dssp --CCEEE-ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH-----------------------------
T ss_pred CCeeeee-eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc-----------------------------
Confidence 3344333 5678899999999999999999999765556999875432211
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHH
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~ 169 (429)
.....+.+|+++++.+.|. ++||+++++++.....+++|||+.+++|.+++.... .+++.
T Consensus 68 --------------~~~~~~~~E~~~l~~l~~~----~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~ 127 (313)
T 3cek_A 68 --------------QTLDSYRNEIAYLNKLQQH----SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK--SIDPW 127 (313)
T ss_dssp --------------HHHHHHHHHHHHHHHHGGG----CTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHCS--SCCHH
T ss_pred --------------cchHHHHHHHHHHHhcccc----CCceEEEEEEeecCCEEEEEEecCCCcHHHHHHhcC--CCCHH
Confidence 1123456699999999862 359999999999999999999977889999998764 49999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhC--
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILG-- 242 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~-- 242 (429)
.+..++.|++.||.|||++|++||||||+||++++ + .+||+|||++...... .....||+.|+|||++.+
T Consensus 128 ~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 204 (313)
T 3cek_A 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC--------------CCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcc
Confidence 99999999999999999999999999999999964 5 8999999999754322 223568999999999976
Q ss_pred ---------CCCCCCccccchhhHHHHHhhCCCCCCCCCHH-HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 243 ---------LPYGPPIDMWSLGCILAELYTGCPLFPGENEV-EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 243 ---------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
..++.++|||||||++|+|++|..||...... ..+..+. .... .
T Consensus 205 ~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~------------------~----- 258 (313)
T 3cek_A 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNH------------------E----- 258 (313)
T ss_dssp ----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTTS------------------C-----
T ss_pred cccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH---hccc------------------c-----
Confidence 36788999999999999999999999775432 2221111 0000 0
Q ss_pred CCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.......++.+.+||.+||+.||++|||+.|+++||||+..
T Consensus 259 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 259 --------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp --------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred --------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 00011226789999999999999999999999999999764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=344.19 Aligned_cols=269 Identities=13% Similarity=0.128 Sum_probs=196.2
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCC------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTN------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
++..++|++++.||+|+||+||+|.+..++ .+|+|++......... ++...
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-e~~~~---------------------- 87 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT-ELKFY---------------------- 87 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHH-HHHHH----------------------
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHH-HHHHH----------------------
Confidence 455679999999999999999999997763 3488887554322111 11100
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc----CeEEEEEeecCcCHHHHHHhhCCCCC
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR----NHLCISFELMNLNLYELIKRNNYQGF 166 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~g~L~~~i~~~~~~~~ 166 (429)
..........|+..++.+. |+||+++++++... .+.|+||||++++|.+++.... ..+
T Consensus 88 -----------~~~~~~~~~~e~~~~~~l~------h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l 149 (364)
T 3op5_A 88 -----------QRAAKPEQIQKWIRTRKLK------YLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRF 149 (364)
T ss_dssp -----------HHHCCHHHHHHHHHHTTCS------CCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCC
T ss_pred -----------HhhhhhHHHHHHHHHhhcc------CCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCC
Confidence 0111122333444444444 55999999998775 4689999999889999998753 459
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEe--cCCCcceEEeeecccccccCc----------ceeeecCccc
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLK--QRGSSSIKVIDFGSSCYSHQR----------VYTYIQSRFY 234 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~--~~~~~~vkl~Dfg~~~~~~~~----------~~~~~~t~~y 234 (429)
++..+..++.||+.||+|||++||+||||||+|||++ .++ .+||+|||++...... ....+||+.|
T Consensus 150 ~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y 227 (364)
T 3op5_A 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD--QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEF 227 (364)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT--CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTT
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC--eEEEEECCcceecccCCcccccccCcccccCCCCCc
Confidence 9999999999999999999999999999999999999 555 8999999999653321 1234599999
Q ss_pred cchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHH-HHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccC
Q psy17270 235 RSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQ-LACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313 (429)
Q Consensus 235 ~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (429)
+|||++.+..++.++|||||||++|+|+||+.||.+...... .............++.....
T Consensus 228 ~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------- 290 (364)
T 3op5_A 228 TSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCF----------------- 290 (364)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHS-----------------
T ss_pred cCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhc-----------------
Confidence 999999998999999999999999999999999986433222 22222111111111111000
Q ss_pred CCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.....++.+.+|+..||+.||++||++.++++
T Consensus 291 ---------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 291 ---------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp ---------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ---------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 00234789999999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=337.20 Aligned_cols=251 Identities=16% Similarity=0.251 Sum_probs=201.2
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCc--------chheeccccchhhHHHHHHHHHHHHHhcccccccccccc
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNT--------HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEES 86 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~--------~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~ 86 (429)
..++..++|++.+.||+|+||+||+|.+..++. +|+|++....
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----------------------------- 52 (289)
T 4fvq_A 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----------------------------- 52 (289)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-----------------------------
T ss_pred eEEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-----------------------------
Confidence 456778999999999999999999999988774 4666653221
Q ss_pred cccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCC
Q psy17270 87 LSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQG 165 (429)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~ 165 (429)
......+.+|+++++.++|+ ||+++++++......++||||+. ++|.+++.... ..
T Consensus 53 ----------------~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~ 109 (289)
T 4fvq_A 53 ----------------RNYSESFFEAASMMSKLSHK------HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NC 109 (289)
T ss_dssp ----------------GGGHHHHHHHHHHHHTSCCT------TBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTG-GG
T ss_pred ----------------HHHHHHHHHHHHHHHhCCCC------CEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CC
Confidence 12234567799999999876 99999999999999999999996 69999998754 34
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCc------ceEEeeecccccccCcceeeecCccccchhh
Q psy17270 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSS------SIKVIDFGSSCYSHQRVYTYIQSRFYRSPEV 239 (429)
Q Consensus 166 ~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~------~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~ 239 (429)
+++..+..++.||+.||.|||++||+||||||+|||++.++.. .++|+|||++...... ....+|+.|+|||+
T Consensus 110 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~ 188 (289)
T 4fvq_A 110 INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-DILQERIPWVPPEC 188 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-HHHHHTTTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc-cccCCcCcccCHHH
Confidence 9999999999999999999999999999999999999987721 1999999998755433 23468899999999
Q ss_pred hhC-CCCCCCccccchhhHHHHHhhC-CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCC
Q psy17270 240 ILG-LPYGPPIDMWSLGCILAELYTG-CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317 (429)
Q Consensus 240 ~~~-~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (429)
+.+ ..++.++|||||||++|+|++| .+||...+.......... ...
T Consensus 189 ~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~-~~~------------------------------- 236 (289)
T 4fvq_A 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED-RHQ------------------------------- 236 (289)
T ss_dssp HHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCC-------------------------------
T ss_pred hCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc-cCC-------------------------------
Confidence 987 5689999999999999999995 566666555433322211 000
Q ss_pred CCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+...++.+.+||.+||+.||++|||+.|++++
T Consensus 237 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 -----------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp -----------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 011225678899999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=336.47 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=200.6
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.++|++.+.||+|+||+||+|.+..++.. |+|++.....
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~---------------------------------------- 48 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE---------------------------------------- 48 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH----------------------------------------
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH----------------------------------------
Confidence 57899999999999999999999988865 8887643211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.....+.+|+++++.++|+ ||+++++++......++||||+. ++|.+++.... ..+++..+..++.|
T Consensus 49 -----~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~q 116 (310)
T 3s95_A 49 -----ETQRTFLKEVKVMRCLEHP------NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKD 116 (310)
T ss_dssp -----HHHHHHHHHHHHHTTCCCT------TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHH
T ss_pred -----HHHHHHHHHHHHHHhCCCc------CcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHH
Confidence 1223566699999998776 99999999999999999999995 59999998754 45999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----------------eeeecCccccchhhh
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----------------YTYIQSRFYRSPEVI 240 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----------------~~~~~t~~y~aPE~~ 240 (429)
++.||+|||++||+||||||+||+++.++ .+||+|||++....... ...+||+.|+|||++
T Consensus 117 i~~al~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 194 (310)
T 3s95_A 117 IASGMAYLHSMNIIHRDLNSHNCLVRENK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194 (310)
T ss_dssp HHHHHHHHHHTTEECSCCSTTSEEECTTS--CEEECCCTTCEECC--------------------CCCCSCGGGCCHHHH
T ss_pred HHHHHHHHHhCCccCCCCCcCeEEECCCC--CEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHh
Confidence 99999999999999999999999999888 89999999996543221 145789999999999
Q ss_pred hCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCC
Q psy17270 241 LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRK 320 (429)
Q Consensus 241 ~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (429)
.+..++.++|||||||++|+|++|..||.......... ........
T Consensus 195 ~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------~~~~~~~~---------------------------- 240 (310)
T 3s95_A 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------GLNVRGFL---------------------------- 240 (310)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------SBCHHHHH----------------------------
T ss_pred cCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------hhhhhccc----------------------------
Confidence 99999999999999999999999999987643210000 00000000
Q ss_pred CCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 321 PGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
........++.+.+++.+||+.||++|||+.++++ |++
T Consensus 241 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~ 278 (310)
T 3s95_A 241 -----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE 278 (310)
T ss_dssp -----HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred -----cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence 00011234778999999999999999999999987 554
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=331.45 Aligned_cols=253 Identities=21% Similarity=0.267 Sum_probs=195.4
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.-.+.++|++.+.||+|+||+||+|.+..++.. |+|++...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------------------------------- 45 (296)
T 4hgt_A 4 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------------------------------------- 45 (296)
T ss_dssp -------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------------------------------------
T ss_pred ccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--------------------------------------
Confidence 345789999999999999999999999888865 88865321
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.....+.+|+++++.+.|++ ++..+..++......++||||++++|.+++.... ..+++..+..+
T Consensus 46 ---------~~~~~~~~e~~~l~~l~~~~-----~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i 110 (296)
T 4hgt_A 46 ---------TKHPQLHIESKIYKMMQGGV-----GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLL 110 (296)
T ss_dssp -----------CCCHHHHHHHHHHHTTST-----TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT-SCCCHHHHHHH
T ss_pred ---------ccchHHHHHHHHHHHhcCCC-----CCCeeeeecCCCCceEEEEEccCCCHHHHHHHhc-CCCCHHHHHHH
Confidence 11234667999999999873 4555556667778999999999889999998654 35999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEE---ecCCCcceEEeeecccccccCc----------ceeeecCccccchhhhh
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLL---KQRGSSSIKVIDFGSSCYSHQR----------VYTYIQSRFYRSPEVIL 241 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili---~~~~~~~vkl~Dfg~~~~~~~~----------~~~~~~t~~y~aPE~~~ 241 (429)
+.|++.||+|||++||+||||||+|||+ +.++ .+||+|||++...... .....||+.|+|||++.
T Consensus 111 ~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (296)
T 4hgt_A 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188 (296)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhc
Confidence 9999999999999999999999999999 5666 8999999999754322 22457899999999999
Q ss_pred CCCCCCCccccchhhHHHHHhhCCCCCCCCCHH---HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCC
Q psy17270 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEV---EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318 (429)
Q Consensus 242 ~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (429)
+..++.++|||||||++|+|++|+.||.+.+.. ..+..+.......+
T Consensus 189 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------------ 238 (296)
T 4hgt_A 189 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------------------------------ 238 (296)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC------------------------------
T ss_pred CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch------------------------------
Confidence 999999999999999999999999999875432 22222221111111
Q ss_pred CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
........++.+.+||.+||+.||++|||+.++++
T Consensus 239 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 -------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11122334789999999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=337.32 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=194.2
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.++|++++.||+|+||+||+|.+..++.. |+|++.....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------------------- 44 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE--------------------------------------- 44 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHH---------------------------------------
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHH---------------------------------------
Confidence 567899999999999999999999888865 9998743211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE-------------cCeEEEEEeecC-cCHHHHHHhhCC
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-------------RNHLCISFELMN-LNLYELIKRNNY 163 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~-------------~~~~~lv~e~~~-g~L~~~i~~~~~ 163 (429)
....+.+|+++++.++|+ ||+++++++.. ...+|+||||+. ++|.+++....
T Consensus 45 -------~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 110 (303)
T 1zy4_A 45 -------KLSTILSEVMLLASLNHQ------YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN- 110 (303)
T ss_dssp -------HHHHHHHHHHHHTTCCCT------TBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-
T ss_pred -------HHHHHHHHHHHHHhcCch------HHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-
Confidence 112455699999988776 99999998865 457899999995 59999998654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----------------cce
Q psy17270 164 QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----------------RVY 226 (429)
Q Consensus 164 ~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----------------~~~ 226 (429)
..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... ...
T Consensus 111 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (303)
T 1zy4_A 111 LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188 (303)
T ss_dssp GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCCCSCTTC--------------------
T ss_pred cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC--CEEEeeCcchhhcccccchhccccccccccccccc
Confidence 3588999999999999999999999999999999999999888 899999999875432 123
Q ss_pred eeecCccccchhhhhCC-CCCCCccccchhhHHHHHhhCCCCCCCCC-HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccC
Q psy17270 227 TYIQSRFYRSPEVILGL-PYGPPIDMWSLGCILAELYTGCPLFPGEN-EVEQLACIMEILGCPPDEVINTASRRRLFFDS 304 (429)
Q Consensus 227 ~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 304 (429)
...||+.|+|||++.+. .++.++|||||||++|+|++ ||.... .......+.......+.
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~--------------- 250 (303)
T 1zy4_A 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPP--------------- 250 (303)
T ss_dssp -----CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCT---------------
T ss_pred cCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCc---------------
Confidence 45689999999999865 68999999999999999998 554322 22222222110000000
Q ss_pred CCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 305 KGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
......++.+.+||++||+.||++|||+.++++||||+..
T Consensus 251 -----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 251 -----------------------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp -----------------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred -----------------------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 0112236778999999999999999999999999999753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=334.50 Aligned_cols=249 Identities=18% Similarity=0.268 Sum_probs=204.1
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+-.++|++++.||+|+||+||+|.+..+..+|+|++.....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------------------------------- 61 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-------------------------------------- 61 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--------------------------------------
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--------------------------------------
Confidence 456789999999999999999999998666779888743221
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+++++.+.|+ ||+++++++.....+++||||+ +++|.+++.... ..+++..+..++
T Consensus 62 --------~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~ 126 (283)
T 3gen_A 62 --------SEDEFIEEAKVMMNLSHE------KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMC 126 (283)
T ss_dssp --------CHHHHHHHHHHHHTCCCT------TBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHH
T ss_pred --------CHHHHHHHHHHHhcCCCC------CEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHH
Confidence 123456699999999876 9999999999999999999999 569999998643 359999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.|++.||.|||++|++||||||+||+++.++ .++|+|||++....... ....+|+.|+|||++.+..++.++||
T Consensus 127 ~qi~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 204 (283)
T 3gen_A 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204 (283)
T ss_dssp HHHHHHHHHHHHTTCCCSSCSGGGEEECTTS--CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHH
T ss_pred HHHHHHHHHHHHCCccCCCCccceEEEcCCC--CEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhH
Confidence 9999999999999999999999999999888 89999999997544321 12345678999999998889999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||++|+|+| |+.||...+..+....+........ +
T Consensus 205 ~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~ 243 (283)
T 3gen_A 205 WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-----------------------------------------P 243 (283)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-----------------------------------------C
T ss_pred HHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC-----------------------------------------C
Confidence 999999999998 9999999888776665543211111 0
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
...++.+.++|.+||+.||++|||+.++++|
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1226789999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=332.82 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=193.7
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
.++..+||++.+.||+|+||+||+|.+..++. +|+|++......
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-------------------------------- 57 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-------------------------------- 57 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--------------------------------
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH--------------------------------
Confidence 35678999999999999999999999976542 477776432211
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHH
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~ 170 (429)
.....+.+|+.+++.++|+ ||+++++++ ..+..++||||+. ++|.+++.... ..+++..
T Consensus 58 ------------~~~~~~~~e~~~l~~l~h~------~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 117 (281)
T 1mp8_A 58 ------------SVREKFLQEALTMRQFDHP------HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK-YSLDLAS 117 (281)
T ss_dssp ------------HHHHHHHHHHHHHHTCCCT------TBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHH
T ss_pred ------------HHHHHHHHHHHHHHhCCCC------ccceEEEEE-ccCccEEEEecCCCCCHHHHHHhcC-CCCCHHH
Confidence 1223566699999998776 999999997 4567899999996 59999998654 3599999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGLPYG 246 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~ 246 (429)
+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...... .....+|+.|+|||++.+..++
T Consensus 118 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (281)
T 1mp8_A 118 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195 (281)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC-------------------CCGGGCCHHHHHHCCCS
T ss_pred HHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC--CEEECccccccccCcccccccccCCCcccccChhhcccCCCC
Confidence 999999999999999999999999999999999888 8999999999764432 1223567789999999988999
Q ss_pred CCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 247 PPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 247 ~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 196 ~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~--------------------------------------- 236 (281)
T 1mp8_A 196 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--------------------------------------- 236 (281)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---------------------------------------
T ss_pred CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---------------------------------------
Confidence 99999999999999996 99999988776655544321000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......++.+.++|.+||+.||++|||+.|++++
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 237 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112347889999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.11 Aligned_cols=253 Identities=21% Similarity=0.258 Sum_probs=200.2
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.-.+.++|++.+.||+|+||+||+|.+..+++. |+|++....
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------------------------- 46 (296)
T 3uzp_A 4 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------------------------------------- 46 (296)
T ss_dssp -CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-------------------------------------
T ss_pred cceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-------------------------------------
Confidence 445789999999999999999999999888865 888763221
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
....+.+|+++++.+.|++ ++..+..++......++||||++++|.+++.... ..+++..+..+
T Consensus 47 ----------~~~~~~~e~~~l~~l~~~~-----~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i 110 (296)
T 3uzp_A 47 ----------KHPQLHIESKIYKMMQGGV-----GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLL 110 (296)
T ss_dssp ----------SCCHHHHHHHHHHHHTTST-----TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHH
T ss_pred ----------chhHHHHHHHHHHHhhcCC-----CCCccccccCCCCceEEEEEecCCCHHHHHHhhc-cCCCHHHHHHH
Confidence 1234667999999999873 4445555556778899999999889999998544 45999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEe---cCCCcceEEeeecccccccCc----------ceeeecCccccchhhhh
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLK---QRGSSSIKVIDFGSSCYSHQR----------VYTYIQSRFYRSPEVIL 241 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~---~~~~~~vkl~Dfg~~~~~~~~----------~~~~~~t~~y~aPE~~~ 241 (429)
+.|++.||+|||++||+||||||+||+++ .++ .+||+|||++...... .....||+.|+|||++.
T Consensus 111 ~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (296)
T 3uzp_A 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188 (296)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC--eEEEeeCCCcccccccccccccccccccccccccccCChhhhc
Confidence 99999999999999999999999999995 555 8999999999754332 23457899999999999
Q ss_pred CCCCCCCccccchhhHHHHHhhCCCCCCCCCH---HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCC
Q psy17270 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENE---VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318 (429)
Q Consensus 242 ~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (429)
+..++.++|||||||++|+|++|+.||.+.+. .+.+..+.......+
T Consensus 189 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------------ 238 (296)
T 3uzp_A 189 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------------------------------ 238 (296)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC------------------------------
T ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc------------------------------
Confidence 98999999999999999999999999987432 222333322111111
Q ss_pred CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
........++.+.+|+.+||+.||++|||+.++++
T Consensus 239 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 -------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11112334788999999999999999999999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=343.72 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=201.3
Q ss_pred ccccCCeEEEeEeeccccceEEEEEe-----cCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALD-----HKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~-----~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
++-.++|++++.||+|+||.||+|.+ ..++. +|+|++.......
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------ 67 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS------------------------------ 67 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH------------------------------
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH------------------------------
Confidence 45678999999999999999999994 44444 4888875432221
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-eEEEEEeecC-cCHHHHHHhhCC-----
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-HLCISFELMN-LNLYELIKRNNY----- 163 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~-g~L~~~i~~~~~----- 163 (429)
....+.+|++++..+.+ ||||+++++++.... .+++|||||. |+|.+++.....
T Consensus 68 --------------~~~~~~~E~~~l~~l~~-----hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~ 128 (359)
T 3vhe_A 68 --------------EHRALMSELKILIHIGH-----HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128 (359)
T ss_dssp --------------HHHHHHHHHHHHHHHCC-----CTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSC
T ss_pred --------------HHHHHHHHHHHHHhhcC-----CcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhcccccccc
Confidence 12346679999999942 349999999998765 5999999995 699999986542
Q ss_pred -----------------------------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q psy17270 164 -----------------------------------------------------------QGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 164 -----------------------------------------------------------~~~~~~~~~~i~~qil~~l~~ 184 (429)
..+++..+..++.||+.||+|
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~ 208 (359)
T 3vhe_A 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208 (359)
T ss_dssp C------------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHH
Confidence 128899999999999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----cceeeecCccccchhhhhCCCCCCCccccchhhHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILA 259 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 259 (429)
||++||+||||||+|||++.++ .++|+|||++..... ......+|+.|+|||++.+..++.++|||||||++|
T Consensus 209 LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 286 (359)
T 3vhe_A 209 LASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 286 (359)
T ss_dssp HHHTTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHCCcccCCCChhhEEEcCCC--cEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHH
Confidence 9999999999999999999888 899999999975432 122356788999999999989999999999999999
Q ss_pred HHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 260 ELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 260 ~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
+|+| |..||.+.+..+.+.........+. .+...++.+.
T Consensus 287 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~l~ 326 (359)
T 3vhe_A 287 EIFSLGASPYPGVKIDEEFCRRLKEGTRMR----------------------------------------APDYTTPEMY 326 (359)
T ss_dssp HHTTTSCCSSTTCCCSHHHHHHHHHTCCCC----------------------------------------CCTTCCHHHH
T ss_pred HHHhcCCCCCCccchhHHHHHHHHcCCCCC----------------------------------------CCCCCCHHHH
Confidence 9998 9999988765444333332111000 0112378899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q psy17270 339 DFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 339 ~li~~~L~~dP~~Rpta~ell~h 361 (429)
++|.+||+.||++|||+.|+++|
T Consensus 327 ~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 327 QTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHHHH
Confidence 99999999999999999999886
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=338.54 Aligned_cols=254 Identities=19% Similarity=0.240 Sum_probs=196.2
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
....++|++++.||+|+||+||+|.+..++.. ++|+. +|......
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~va-------------------------iK~~~~~~--------- 56 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA-------------------------IKELREAT--------- 56 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEE-------------------------EEEC-------------
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEE-------------------------Eeeccccc---------
Confidence 34578999999999999999999999887753 33332 22111100
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.......+.+|+++++.++|+ ||+++++++.... .++|+|++ +|+|.+++.... ..+++..+..+
T Consensus 57 ------~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~ 122 (327)
T 3poz_A 57 ------SPKANKEILDEAYVMASVDNP------HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNW 122 (327)
T ss_dssp ---------CHHHHHHHHHHHHHCCBT------TBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHH
T ss_pred ------CHHHHHHHHHHHHHHHhCCCC------CEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHH
Confidence 112234677799999999887 9999999998654 77888888 579999998754 45999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCCc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
+.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .....+|+.|+|||++.+..++.++
T Consensus 123 ~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 200 (327)
T 3poz_A 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200 (327)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHhhCCeeCCCCChheEEECCCC--CEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchh
Confidence 99999999999999999999999999999988 8999999999754322 1223457789999999999999999
Q ss_pred cccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 250 DMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 250 DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
|||||||++|+|+| |..||.+.+..+....+......+
T Consensus 201 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------------------- 239 (327)
T 3poz_A 201 DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP----------------------------------------- 239 (327)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----------------------------------------
T ss_pred hhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC-----------------------------------------
Confidence 99999999999999 999999877655443332210000
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.....+..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 012236789999999999999999999999876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=336.48 Aligned_cols=260 Identities=23% Similarity=0.383 Sum_probs=194.8
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.+.+.++|++++.||+|+||.||+|.+..++.. |+|++..........
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~------------------------------- 74 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP------------------------------- 74 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-----------------------------------
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccccc-------------------------------
Confidence 467889999999999999999999999888864 888875432211000
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEee-c-CcCHHHHHHhhCCCCCCHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFEL-M-NLNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~-~-~g~L~~~i~~~~~~~~~~~~~~ 172 (429)
......+.+|+.++..+... ..|+||+++++++......++|||+ + +++|.+++.... .+++..+.
T Consensus 75 --------~~~~~~~~~e~~~l~~l~~~--~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~ 142 (312)
T 2iwi_A 75 --------LSDSVTCPLEVALLWKVGAG--GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSR 142 (312)
T ss_dssp ------------CCCCHHHHHHHHHHSS--CCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHH
T ss_pred --------chhhHHHHHHHHHHHhhccc--CCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHH
Confidence 01112344599999999421 1345999999999999999999999 5 469999998765 49999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEe-cCCCcceEEeeecccccccC-cceeeecCccccchhhhhCCCCC-CCc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLK-QRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGLPYG-PPI 249 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~-~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~-~~~ 249 (429)
.++.||+.||.|||++|++||||||+||+++ .++ .++|+|||++..... ......||+.|+|||++.+..+. .++
T Consensus 143 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 220 (312)
T 2iwi_A 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPA 220 (312)
T ss_dssp HHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHH
T ss_pred HHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccc
Confidence 9999999999999999999999999999998 666 899999999876543 33446789999999999877664 489
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||..... +..... ..
T Consensus 221 Di~slG~il~~l~~g~~pf~~~~~------~~~~~~------------------------------------------~~ 252 (312)
T 2iwi_A 221 TVWSLGILLYDMVCGDIPFERDQE------ILEAEL------------------------------------------HF 252 (312)
T ss_dssp HHHHHHHHHHHHHHSSCSCCSHHH------HHHTCC------------------------------------------CC
T ss_pred hHHHHHHHHHHHHHCCCCCCChHH------Hhhhcc------------------------------------------CC
Confidence 999999999999999999976311 111000 00
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 122378899999999999999999999999999998653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=350.91 Aligned_cols=264 Identities=23% Similarity=0.258 Sum_probs=194.9
Q ss_pred hhhhcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 12 FQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 12 ~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
+-.....+.++|.+.+.||+|+||+||.+.......+|+|++....
T Consensus 6 ~p~~~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---------------------------------- 51 (434)
T 2rio_A 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---------------------------------- 51 (434)
T ss_dssp --CCSCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----------------------------------
T ss_pred ccchhhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----------------------------------
Confidence 3455667899999999999999999987655444456999874321
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCC-----
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQG----- 165 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~----- 165 (429)
...+.+|+++++.+ .|+ ||+++++++.....+|+|||||+|+|.+++.......
T Consensus 52 --------------~~~~~~E~~~l~~l~~Hp------nIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~ 111 (434)
T 2rio_A 52 --------------CDIALMEIKLLTESDDHP------NVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL 111 (434)
T ss_dssp --------------HHHHHHHHHHHHHHTTST------TBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC---------
T ss_pred --------------HHHHHHHHHHHHhccCCC------CcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhh
Confidence 12345599999887 555 9999999999999999999999999999998654211
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-----------CcceEEeeecccccccCc-------cee
Q psy17270 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-----------SSSIKVIDFGSSCYSHQR-------VYT 227 (429)
Q Consensus 166 ~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-----------~~~vkl~Dfg~~~~~~~~-------~~~ 227 (429)
.++..+..++.||+.||+|||++||+||||||+|||++.++ ...+||+|||++...... ...
T Consensus 112 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~ 191 (434)
T 2rio_A 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191 (434)
T ss_dssp ---CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-----------
T ss_pred ccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecC
Confidence 12334578999999999999999999999999999997532 337999999999764432 223
Q ss_pred eecCccccchhhhhC-------CCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhh
Q psy17270 228 YIQSRFYRSPEVILG-------LPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRR 299 (429)
Q Consensus 228 ~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 299 (429)
.+||+.|+|||++.+ ..++.++|||||||++|+|+| |..||.+..... ..+.......+.
T Consensus 192 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~---------- 259 (434)
T 2rio_A 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDE---------- 259 (434)
T ss_dssp ---CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCC----------
T ss_pred CCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCccc----------
Confidence 579999999999976 568899999999999999999 999997754432 122210000000
Q ss_pred hhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 300 LFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
. ... .....++++.+||.+||+.||++|||+.|+++||||..
T Consensus 260 -------~-------------~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 260 -------M-------------KCL-----HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp -------C-------------TTC-----CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred -------c-------------ccc-----ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 0 000 00112578899999999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=331.53 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=198.6
Q ss_pred eEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYN 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~ 101 (429)
|.....||+|+||+||+|.+..++.. |+|++.....
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------------------------------------- 60 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS------------------------------------------- 60 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-------------------------------------------
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-------------------------------------------
Confidence 34444999999999999999888864 8887643211
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC-CCCCHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY-QGFSLGLIRRFAFSLV 179 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~-~~~~~~~~~~i~~qil 179 (429)
.....+.+|+.+++.+.|+ ||+++++++.....+++||||+. ++|.+++..... ..+++..+..++.|++
T Consensus 61 --~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~ 132 (295)
T 2clq_A 61 --RYSQPLHEEIALHKHLKHK------NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132 (295)
T ss_dssp -----HHHHHHHHHHHTCCCT------TBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred --HHHHHHHHHHHHHHhCCCC------CEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHH
Confidence 1223566799999998776 99999999999999999999995 699999987532 2467999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEec-CCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCC--CCCCccccc
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQ-RGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLP--YGPPIDMWS 253 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~-~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~--~~~~~DiwS 253 (429)
.||.|||++|++|+||||+||+++. ++ .++|+|||++...... .....||+.|+|||++.+.. ++.++||||
T Consensus 133 ~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s 210 (295)
T 2clq_A 133 EGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWS 210 (295)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEEETTTC--CEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHH
T ss_pred HHHHHHHhCCEEccCCChhhEEEECCCC--CEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHH
Confidence 9999999999999999999999987 66 8999999999764422 23457899999999998653 788999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|+|++|+.||...+...............+ ..+...
T Consensus 211 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~ 251 (295)
T 2clq_A 211 LGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP---------------------------------------EIPESM 251 (295)
T ss_dssp HHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC---------------------------------------CCCTTS
T ss_pred HHHHHHHHHHCCCCccCCCchhHHHHhhccccccc---------------------------------------cccccC
Confidence 99999999999999976543322111111000000 011234
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 78899999999999999999999999999998643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=333.80 Aligned_cols=258 Identities=26% Similarity=0.321 Sum_probs=187.8
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
--++|++++.||+|+||.||+|.+..++.. |+|++..........
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------------------------------- 68 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK---------------------------------- 68 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHH----------------------------------
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHH----------------------------------
Confidence 357899999999999999999999988764 999886443221111
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
..+..+..+++.+.|+ ||+++++++.....+++||||+++.+..+..... ..+++..+..++.|
T Consensus 69 ---------~~~~~~~~~~~~~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~-~~~~~~~~~~~~~~ 132 (318)
T 2dyl_A 69 ---------RILMDLDVVLKSHDCP------YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVA 132 (318)
T ss_dssp ---------HHHHHHHHHHHTTTCT------TBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHT-SCCCHHHHHHHHHH
T ss_pred ---------HHHHHHHHHHHhcCCC------ceeeEEEEEecCCcEEEEEeccCCcHHHHHHHhc-cCCCHHHHHHHHHH
Confidence 1112234455555555 9999999999999999999999777766665433 45999999999999
Q ss_pred HHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhh-----CCCCCCCc
Q psy17270 178 LVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVIL-----GLPYGPPI 249 (429)
Q Consensus 178 il~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~-----~~~~~~~~ 249 (429)
++.||.|||++ |++|+||||+||+++.++ .++|+|||++..... ......+|+.|+|||++. ...++.++
T Consensus 133 i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 210 (318)
T 2dyl_A 133 IVKALYYLKEKHGVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210 (318)
T ss_dssp HHHHHHHHHHHHCCCCCCCCGGGEEECTTS--CEEECCCTTC--------------CCTTCCHHHHC--------CCTHH
T ss_pred HHHHHHHHHhhCCEEeCCCCHHHEEECCCC--CEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCcccc
Confidence 99999999995 999999999999999888 899999999865432 223457899999999995 44688899
Q ss_pred cccchhhHHHHHhhCCCCCCCC-CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGE-NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
|||||||++|+|++|+.||... +..+.+..+........ +
T Consensus 211 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------------~------- 251 (318)
T 2dyl_A 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL--------------------------------P------- 251 (318)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC--------------------------------C-------
T ss_pred chhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC--------------------------------C-------
Confidence 9999999999999999999874 44444444432100000 0
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.....++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 001237889999999999999999999999999999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=330.55 Aligned_cols=249 Identities=20% Similarity=0.293 Sum_probs=207.6
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
++..++|++.+.||+|+||+||+|.+..++.. |+|++.....
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------------- 51 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------------------------------------- 51 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-------------------------------------
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-------------------------------------
Confidence 45688999999999999999999999988864 8888743221
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
....+.+|+++++.++|+ ||+++++++.....+++||||+. ++|.+++.......+++..+..+
T Consensus 52 ---------~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i 116 (288)
T 3kfa_A 52 ---------EVEEFLKEAAVMKEIKHP------NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116 (288)
T ss_dssp ---------HHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHH
T ss_pred ---------HHHHHHHHHHHHHhCCCC------CEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHH
Confidence 123456699999999876 99999999999999999999996 69999998876667999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhhhCCCCCCCcc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
+.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... ....+|+.|+|||++.+..++.++|
T Consensus 117 ~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 194 (288)
T 3kfa_A 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194 (288)
T ss_dssp HHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG--CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHHHCCccCCCCCcceEEEcCCC--CEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhh
Confidence 99999999999999999999999999999888 89999999997654322 2245677899999999989999999
Q ss_pred ccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 251 MWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 251 iwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||++|+|++ |..||.+.+.......+...... ..
T Consensus 195 i~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~ 233 (288)
T 3kfa_A 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-----------------------------------------ER 233 (288)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-----------------------------------------CC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC-----------------------------------------CC
Confidence 9999999999999 99999987765544433321000 00
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+...++.+.+||++||+.||++|||+.++++
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1233788999999999999999999999976
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=336.10 Aligned_cols=254 Identities=19% Similarity=0.274 Sum_probs=204.2
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecC-----CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHK-----TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
..+...++|++.+.||+|+||.||+|.+.. ++. +|+|++.......
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------- 68 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS---------------------------- 68 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHH----------------------------
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHH----------------------------
Confidence 335568899999999999999999999843 223 4888875432211
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC----
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY---- 163 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~---- 163 (429)
....+.+|+++++.++|+ ||+++++++.....+++||||+. ++|.+++.....
T Consensus 69 ----------------~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 126 (314)
T 2ivs_A 69 ----------------ELRDLLSEFNVLKQVNHP------HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126 (314)
T ss_dssp ----------------HHHHHHHHHHHHTTCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTE
T ss_pred ----------------HHHHHHHHHHHHhhCCCC------ceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCC
Confidence 123456699999988776 99999999999999999999995 799999987542
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-
Q psy17270 164 ------------------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR- 224 (429)
Q Consensus 164 ------------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~- 224 (429)
..+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~--~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR--KMKISDFGLSRDVYEED 204 (314)
T ss_dssp EC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--EEEECCCTTCEECTTTS
T ss_pred cccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCC--CEEEccccccccccccc
Confidence 2389999999999999999999999999999999999999888 8999999999754322
Q ss_pred ----ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhh
Q psy17270 225 ----VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRR 299 (429)
Q Consensus 225 ----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 299 (429)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 205 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------- 270 (314)
T 2ivs_A 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR-------------- 270 (314)
T ss_dssp CEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------------
T ss_pred cceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc--------------
Confidence 122356778999999999889999999999999999999 9999988776554433322000
Q ss_pred hhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 300 LFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.......++.+.++|.+||+.||++|||+.|++++
T Consensus 271 ---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 271 ---------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00012347889999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=352.41 Aligned_cols=253 Identities=21% Similarity=0.223 Sum_probs=191.7
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
..+|++.+.||+|+||+||.........+|||++....
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~------------------------------------------ 60 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC------------------------------------------ 60 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT------------------------------------------
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH------------------------------------------
Confidence 34799999999999999775444444456988873221
Q ss_pred cchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
...+.+|+++++.+ +|+ ||+++++++.....+|+|||+|+|+|.+++.... ..+++..+..++.||
T Consensus 61 ------~~~~~~E~~~l~~l~~Hp------nIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi 127 (432)
T 3p23_A 61 ------FSFADREVQLLRESDEHP------NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKD-FAHLGLEPITLLQQT 127 (432)
T ss_dssp ------EEECHHHHHHHHHSCCCT------TBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSS-CCCCSSCHHHHHHHH
T ss_pred ------HHHHHHHHHHHHhccCCC------CcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcC-CCccchhHHHHHHHH
Confidence 12345699999998 455 9999999999999999999999999999998765 335666778999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEec---CCCcceEEeeecccccccC------cceeeecCccccchhhhhC---CCCC
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQ---RGSSSIKVIDFGSSCYSHQ------RVYTYIQSRFYRSPEVILG---LPYG 246 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~---~~~~~vkl~Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~---~~~~ 246 (429)
+.||+|||++||+||||||+|||++. ++...++|+|||++..... .....+||+.|+|||++.+ ..++
T Consensus 128 ~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t 207 (432)
T 3p23_A 128 TSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPT 207 (432)
T ss_dssp HHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCC
T ss_pred HHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCC
Confidence 99999999999999999999999953 3334688999999976442 2234679999999999984 4577
Q ss_pred CCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 247 PPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 247 ~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
.++|||||||++|+|++ |..||......... .+ .+...... ..
T Consensus 208 ~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~---~~~~~~~~----------------------------~~---- 251 (432)
T 3p23_A 208 YTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-IL---LGACSLDC----------------------------LH---- 251 (432)
T ss_dssp THHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HH---TTCCCCTT----------------------------SC----
T ss_pred cHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HH---hccCCccc----------------------------cC----
Confidence 89999999999999999 99999765443221 11 01000000 00
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.....+..+.+||.+||+.||++|||+.|+++||||..
T Consensus 252 ---~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 252 ---PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ---TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ---ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 00112456789999999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=341.14 Aligned_cols=256 Identities=18% Similarity=0.225 Sum_probs=198.6
Q ss_pred hcccc-cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 15 LHDHI-CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 15 ~~~~~-~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
+.+++ .++|++++.||+|+||+||+|.+..++.. ++|+ |+|......
T Consensus 6 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv-------------------------~~K~~~~~~------ 54 (325)
T 3kex_A 6 LARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPV-------------------------CIKVIEDKS------ 54 (325)
T ss_dssp CCCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEE-------------------------EEEEECCTT------
T ss_pred HHhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEE-------------------------EEEeccccc------
Confidence 33444 67999999999999999999999888764 5444 233221110
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
.......+.+|+.+++.++|+ ||+++++++. ....++||||+. |+|.+++.... ..+++..+
T Consensus 55 ---------~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~ 117 (325)
T 3kex_A 55 ---------GRQSFQAVTDHMLAIGSLDHA------HIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLL 117 (325)
T ss_dssp ---------SCSCBCSCCHHHHHHHTCCCT------TBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHH
T ss_pred ---------cHHHHHHHHHHHHHHhcCCCC------CcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHH
Confidence 011123445699999988776 9999999885 567899999995 79999987653 35999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYG 246 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~ 246 (429)
..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .....+|..|+|||++.+..++
T Consensus 118 ~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (325)
T 3kex_A 118 LNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS--QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS--CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC--eEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCC
Confidence 99999999999999999999999999999999888 8999999999764322 2335677889999999988999
Q ss_pred CCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 247 PPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 247 ~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
.++|||||||++|+|+| |..||.+.+..+....+.......
T Consensus 196 ~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------------- 237 (325)
T 3kex_A 196 HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA-------------------------------------- 237 (325)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC--------------------------------------
T ss_pred hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC--------------------------------------
Confidence 99999999999999999 999999877655444333210000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+...+..+.++|.+||+.||++|||+.|++++
T Consensus 238 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 238 ---QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001125677899999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=346.79 Aligned_cols=249 Identities=20% Similarity=0.328 Sum_probs=203.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+-.++|++.+.||+|+||+||+|.+..++.. |+|++......
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------------------------- 153 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP------------------------------------- 153 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH-------------------------------------
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH-------------------------------------
Confidence 3467999999999999999999999877754 88887533211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+++++.++|+ ||+++++++.....+++||||+. |+|.+++.... ..+++..+..++
T Consensus 154 -------~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~ 219 (377)
T 3cbl_A 154 -------DLKAKFLQEARILKQYSHP------NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMV 219 (377)
T ss_dssp -------HHHTTTTHHHHHHTTCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHH
T ss_pred -------HHHHHHHHHHHHHHhCCCC------CEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHH
Confidence 1123456699999998776 99999999998899999999995 79999998654 349999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCccee-----eecCccccchhhhhCCCCCCCcc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYT-----YIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~-----~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
.|++.||+|||++|++||||||+|||++.++ .+||+|||++......... ..++..|+|||++.+..++.++|
T Consensus 220 ~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~--~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 297 (377)
T 3cbl_A 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297 (377)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHH
T ss_pred HHHHHHHHHHHHCCcCCcccCHHHEEEcCCC--cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhh
Confidence 9999999999999999999999999999888 8999999999764433222 23466799999999888999999
Q ss_pred ccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 251 MWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 251 iwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||++|||++ |..||.+.+..+....+......+ .
T Consensus 298 vwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~ 336 (377)
T 3cbl_A 298 VWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP-----------------------------------------C 336 (377)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC-----------------------------------------C
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------------------C
Confidence 9999999999998 999999987765544433210000 0
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+...++.+.+||.+||+.||++|||+.++++
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1123678999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=338.74 Aligned_cols=252 Identities=19% Similarity=0.240 Sum_probs=205.5
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCC-----C-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKT-----N-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~-----~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
+...++|++++.||+|+||.||+|.+..+ + .+|+|++......
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------------- 91 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA------------------------------- 91 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-------------------------------
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-------------------------------
Confidence 55678999999999999999999999743 3 3488887543221
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC------
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY------ 163 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~------ 163 (429)
.....+.+|+++++.++|+ ||+++++++.....+++||||+. ++|.+++.....
T Consensus 92 -------------~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 152 (343)
T 1luf_A 92 -------------DMQADFQREAALMAEFDNP------NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 152 (343)
T ss_dssp -------------HHHHHHHHHHHHHHTCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC------
T ss_pred -------------HHHHHHHHHHHHHHhCCCC------CEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCccccccc
Confidence 1223566799999999776 99999999999999999999995 599999987431
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---
Q psy17270 164 ----------------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--- 224 (429)
Q Consensus 164 ----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--- 224 (429)
..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 153 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~ 230 (343)
T 1luf_A 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYY 230 (343)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCSCHHHHTGGGCB
T ss_pred ccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCC--eEEEeecCCCcccccCccc
Confidence 4599999999999999999999999999999999999999888 8999999998653321
Q ss_pred --ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhh
Q psy17270 225 --VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLF 301 (429)
Q Consensus 225 --~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 301 (429)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 231 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------- 295 (343)
T 1luf_A 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL--------------- 295 (343)
T ss_dssp C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------------
T ss_pred cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC---------------
Confidence 223567889999999998899999999999999999999 99999988876665544321000
Q ss_pred ccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 302 FDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+...++.+.+||.+||+.||++|||+.+++++
T Consensus 296 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 296 --------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 0012347889999999999999999999999873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=330.44 Aligned_cols=259 Identities=22% Similarity=0.250 Sum_probs=203.3
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
+.....++|++.+.||+|+||+||+|.+..++.. |+|++..........
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~------------------------------ 62 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE------------------------------ 62 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHH------------------------------
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchh------------------------------
Confidence 4456689999999999999999999999888865 888875433221111
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.......+.+|+++++.++|+ ||+++++++.... ++||||+. ++|.+.+.... ..+++..+.
T Consensus 63 --------~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 125 (287)
T 4f0f_A 63 --------MIEKFQEFQREVFIMSNLNHP------NIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKL 125 (287)
T ss_dssp --------HHCCSHHHHHHHHHHTTCCCT------TBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHH
T ss_pred --------HHHHHHHHHHHHHHHHhCCCC------CchhhheeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHH
Confidence 011124567799999999776 9999999985444 79999996 79999887654 469999999
Q ss_pred HHHHHHHHHHHHHHHCC--ceecccCCCcEEEecCCC---cceEEeeecccccccCcceeeecCccccchhhhh--CCCC
Q psy17270 173 RFAFSLVQCLRLLHREN--IIHCDLKPENVLLKQRGS---SSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVIL--GLPY 245 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~--ivH~dlkp~Nili~~~~~---~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~ 245 (429)
.++.|++.||+|||++| ++||||||+||+++.++. ..++|+|||++...........||+.|+|||++. ...+
T Consensus 126 ~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 205 (287)
T 4f0f_A 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESY 205 (287)
T ss_dssp HHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEE
T ss_pred HHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCc
Confidence 99999999999999999 999999999999987651 1299999999987776666778999999999984 3457
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHH--HHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQ--LACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
+.++|||||||++|+|++|+.||...+.... ...+.. .+..
T Consensus 206 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~------------------------------------ 248 (287)
T 4f0f_A 206 TEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGLR------------------------------------ 248 (287)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SCCC------------------------------------
T ss_pred CchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cCCC------------------------------------
Confidence 8899999999999999999999987654322 222111 0000
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.......++.+.+||.+||+.||++|||+.|+++
T Consensus 249 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 ---PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0011234788999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=337.61 Aligned_cols=269 Identities=18% Similarity=0.211 Sum_probs=212.9
Q ss_pred eeeeeehhhhcccccCCeEEEeEeeccccceEEEEEe-----cCCCc-chheeccccchhhHHHHHHHHHHHHHhccccc
Q psy17270 6 RILSFAFQVLHDHICYRYEILEVIGKGSFGQVIRALD-----HKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDAC 79 (429)
Q Consensus 6 ~~~~~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~-----~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~ 79 (429)
...+.++..+.++..++|++++.||+|+||.||+|.+ ..++. +|+|++.......
T Consensus 15 ~~~sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------- 75 (327)
T 2yfx_A 15 AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ------------------- 75 (327)
T ss_dssp TTEEECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHH-------------------
T ss_pred cCCccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchh-------------------
Confidence 3456677788889999999999999999999999994 34443 4888875332211
Q ss_pred ccccccccccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHH
Q psy17270 80 KIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELI 158 (429)
Q Consensus 80 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i 158 (429)
....+.+|+.+++.++|+ ||+++++++......|+||||+ +++|.+++
T Consensus 76 -------------------------~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 124 (327)
T 2yfx_A 76 -------------------------DELDFLMEALIISKFNHQ------NIVRCIGVSLQSLPRFILMELMAGGDLKSFL 124 (327)
T ss_dssp -------------------------HHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTEEHHHHH
T ss_pred -------------------------hHHHHHHHHHHHhhCCCC------CCCeEEEEEcCCCCcEEEEecCCCCcHHHHH
Confidence 122456699999999776 9999999999999999999999 56999999
Q ss_pred HhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccCc-----cee
Q psy17270 159 KRNNY-----QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQR-----VYT 227 (429)
Q Consensus 159 ~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~~-----~~~ 227 (429)
..... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ ...++|+|||++...... ...
T Consensus 125 ~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 204 (327)
T 2yfx_A 125 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204 (327)
T ss_dssp HHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCG
T ss_pred HhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCC
Confidence 87642 3489999999999999999999999999999999999998543 236999999998643221 223
Q ss_pred eecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
..+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+.+..+....+.......
T Consensus 205 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 265 (327)
T 2yfx_A 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD------------------- 265 (327)
T ss_dssp GGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-------------------
T ss_pred cCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC-------------------
Confidence 457889999999998899999999999999999998 999999887766554443210000
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
.....++.+.++|.+||+.||++|||+.+++++.|+-
T Consensus 266 ----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 266 ----------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0122478899999999999999999999999998864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=326.67 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=192.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+-.++|++.+.||+|+||.||+|.+. ...+|+|++.......
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~------------------------------------- 45 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDED------------------------------------- 45 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC--------------------------------------------
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCccc-------------------------------------
Confidence 44689999999999999999999986 3346888875432111
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
.......+.+|+++++.++|+ ||+++++++......++||||+. ++|.+++... .+++..+..++.
T Consensus 46 ----~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ 112 (271)
T 3dtc_A 46 ----ISQTIENVRQEAKLFAMLKHP------NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAV 112 (271)
T ss_dssp -------CHHHHHHHHHHHHHCCCT------TBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHH
T ss_pred ----HHHHHHHHHHHHHHHHhcCCC------CEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHH
Confidence 012234566799999999876 99999999999999999999995 6898888643 499999999999
Q ss_pred HHHHHHHHHHHCC---ceecccCCCcEEEecCC------CcceEEeeecccccccCc-ceeeecCccccchhhhhCCCCC
Q psy17270 177 SLVQCLRLLHREN---IIHCDLKPENVLLKQRG------SSSIKVIDFGSSCYSHQR-VYTYIQSRFYRSPEVILGLPYG 246 (429)
Q Consensus 177 qil~~l~~lH~~~---ivH~dlkp~Nili~~~~------~~~vkl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~ 246 (429)
|++.||+|||++| ++||||||+||+++... ...++|+|||++...... .....||+.|+|||++.+..++
T Consensus 113 ~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 192 (271)
T 3dtc_A 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFS 192 (271)
T ss_dssp HHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCS
T ss_pred HHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCC
Confidence 9999999999999 89999999999998621 127999999999754432 3345789999999999998899
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 193 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------------------- 232 (271)
T 3dtc_A 193 KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA---------------------------------------- 232 (271)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC----------------------------------------
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC----------------------------------------
Confidence 9999999999999999999999988776554433210000
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.......++.+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 00112347889999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=328.51 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=194.5
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
-+++..++|++.++||+|+||+||+|.+.. .+|+|++.......
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~---------------------------------- 61 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTP---------------------------------- 61 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCH----------------------------------
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCH----------------------------------
Confidence 357889999999999999999999998754 47888875432211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.....+.+|+++++.++|+ ||+.++++ ......++||||+. ++|.+++.... ..+++..+..
T Consensus 62 ---------~~~~~~~~E~~~l~~l~h~------~iv~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 124 (289)
T 3og7_A 62 ---------QQLQAFKNEVGVLRKTRHV------NILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLID 124 (289)
T ss_dssp ---------HHHHHHHHHHHHHTTCCCT------TBCCEEEE-ECSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHH
T ss_pred ---------HHHHHHHHHHHHHHhCCCC------cEEEEEee-ccCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHH
Confidence 1123466699999998876 99999995 45677899999996 69999986544 4599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----cceeeecCccccchhhhh---CCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RVYTYIQSRFYRSPEVIL---GLPY 245 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~---~~~~ 245 (429)
++.|++.||+|||++|++||||||+||+++.++ .++|+|||++..... ......||+.|+|||++. +..+
T Consensus 125 i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (289)
T 3og7_A 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC------------------CCCTTCCHHHHC----CCS
T ss_pred HHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCC
Confidence 999999999999999999999999999999988 899999999864332 223356899999999997 5567
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|||||||++|+|++|+.||.+.+..+.+..+.......+.
T Consensus 203 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------------------------ 246 (289)
T 3og7_A 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD------------------------------------ 246 (289)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC------------------------------------
T ss_pred CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc------------------------------------
Confidence 88999999999999999999999887766555444432111110
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
........++.+.+||.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01112234788999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=330.39 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=204.6
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEe-----cCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALD-----HKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~-----~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
..+...++|++.+.||+|+||+||+|.+ ..++. +|+|++........
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--------------------------- 69 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--------------------------- 69 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH---------------------------
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHH---------------------------
Confidence 3456678999999999999999999996 33443 48888754322111
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCC--
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQ-- 164 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~-- 164 (429)
...+.+|+++++.+ +|+ ||+++++++......++||||+. |+|.+++......
T Consensus 70 -----------------~~~~~~E~~~l~~l~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 126 (313)
T 1t46_A 70 -----------------REALMSELKVLSYLGNHM------NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126 (313)
T ss_dssp -----------------HHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-
T ss_pred -----------------HHHHHHHHHHHhhcccCC------CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccc
Confidence 23456699999999 666 99999999999999999999995 5999999876422
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----
Q psy17270 165 --------------GFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----- 225 (429)
Q Consensus 165 --------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----- 225 (429)
.+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++.......
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~ 204 (313)
T 1t46_A 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIKNDSNYVVK 204 (313)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT--EEEECCCGGGSCTTSCTTSEEC
T ss_pred cccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC--CEEEccccccccccccccceec
Confidence 489999999999999999999999999999999999999888 89999999997654322
Q ss_pred eeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccC
Q psy17270 226 YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDS 304 (429)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 304 (429)
....+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+......+..+......+.
T Consensus 205 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 268 (313)
T 1t46_A 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML---------------- 268 (313)
T ss_dssp SSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC----------------
T ss_pred cCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC----------------
Confidence 22456788999999999899999999999999999999 9999988765444433332110000
Q ss_pred CCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 305 KGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.....++.+.++|.+||+.||.+|||+.|++++
T Consensus 269 ------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 269 ------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp ------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 011237889999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.64 Aligned_cols=253 Identities=19% Similarity=0.245 Sum_probs=196.8
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++++.||+|+||+||+|.+..++.. ++|+. +|......
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~-------------------------iK~~~~~~---------- 56 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA-------------------------IKELREAT---------- 56 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEE-------------------------EEEECCCS----------
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEE-------------------------EEeecccc----------
Confidence 4578999999999999999999999888754 55542 22221100
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.......+.+|+++++.++|+ ||+++++++.... .++|+|++ +|+|.+++.... ..+++..+..++
T Consensus 57 -----~~~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~ 123 (327)
T 3lzb_A 57 -----SPKANKEILDEAYVMASVDNP------HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWC 123 (327)
T ss_dssp -----SCCCHHHHHHHHHHHTTCCBT------TBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred -----CHHHHHHHHHHHHHHHhCCCC------CeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHH
Confidence 112344677799999999876 9999999998654 77888888 579999998764 459999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCCcc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
.|++.||.|||++||+||||||+|||++.++ .++|+|||++...... .....+|+.|+|||++.+..++.++|
T Consensus 124 ~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3lzb_A 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC--CEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHH
Confidence 9999999999999999999999999999988 8999999999754322 12234577899999999999999999
Q ss_pred ccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 251 MWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 251 iwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||++|+|++ |..||.+.+..+....+......+ .
T Consensus 202 i~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~ 240 (327)
T 3lzb_A 202 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-----------------------------------------Q 240 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----------------------------------------C
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------------------C
Confidence 9999999999999 999999877665544333211000 0
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
....++.+.+||.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 241 PPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12237789999999999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.12 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=203.2
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
|.+.+.++|+++++||+|+||.||+|.+..++.. |||++...
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~------------------------------------- 43 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK------------------------------------- 43 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT-------------------------------------
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------------------------------------
Confidence 3567899999999999999999999999888865 88865321
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.....+.+|+++++.+.|.+ ++..+..++......++||||++++|.+++.... ..+++..+..
T Consensus 44 ----------~~~~~~~~E~~il~~L~~~~-----~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~-~~l~~~~~~~ 107 (483)
T 3sv0_A 44 ----------TKHPQLLYESKIYRILQGGT-----GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLM 107 (483)
T ss_dssp ----------CSSCCHHHHHHHHHHTTTST-----TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHH
T ss_pred ----------cccHHHHHHHHHHHHhcCCC-----CCCeEEEEEeeCCEEEEEEECCCCCHHHHHHhhc-CCCCHHHHHH
Confidence 11234667999999998763 6666667777788999999999999999998654 4599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEE---ecCCCcceEEeeecccccccCcc----------eeeecCccccchhhh
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLL---KQRGSSSIKVIDFGSSCYSHQRV----------YTYIQSRFYRSPEVI 240 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili---~~~~~~~vkl~Dfg~~~~~~~~~----------~~~~~t~~y~aPE~~ 240 (429)
++.||+.||+|||++||+||||||+|||+ +.++ .+||+|||++....... ....||+.|+|||++
T Consensus 108 i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 185 (483)
T 3sv0_A 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTH 185 (483)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC--eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHh
Confidence 99999999999999999999999999999 4556 89999999997543321 146789999999999
Q ss_pred hCCCCCCCccccchhhHHHHHhhCCCCCCCCCH---HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCC
Q psy17270 241 LGLPYGPPIDMWSLGCILAELYTGCPLFPGENE---VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317 (429)
Q Consensus 241 ~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (429)
.+..++.++|||||||++|+|++|+.||.+... .+.+..+......
T Consensus 186 ~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------------------------------- 234 (483)
T 3sv0_A 186 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA------------------------------- 234 (483)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-------------------------------
T ss_pred cCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-------------------------------
Confidence 999999999999999999999999999987543 2333333221100
Q ss_pred CCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.....+....++++.+||.+||+.||++||++.++++
T Consensus 235 ------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 ------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112223445789999999999999999999987754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=335.75 Aligned_cols=255 Identities=18% Similarity=0.282 Sum_probs=202.3
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecC-----CC-cchheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHK-----TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
.++-.++|++.+.||+|+||+||+|.+.. ++ .+|+|++......
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------------ 89 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS------------------------------ 89 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------------------------------
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH------------------------------
Confidence 34557899999999999999999999832 23 2488887432111
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC----
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY---- 163 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~---- 163 (429)
.....+.+|+++++.+ .|+ ||+++++++.....+++||||+. |+|.+++.....
T Consensus 90 --------------~~~~~~~~E~~~l~~l~~hp------~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 149 (344)
T 1rjb_A 90 --------------SEREALMSELKMMTQLGSHE------NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149 (344)
T ss_dssp ----------------CHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--
T ss_pred --------------HHHHHHHHHHHHHHhhcCCC------CeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccc
Confidence 1234567799999999 666 99999999999999999999995 699999986542
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--
Q psy17270 164 -----------------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-- 224 (429)
Q Consensus 164 -----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-- 224 (429)
..+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~~~~~~~~~~ 227 (344)
T 1rjb_A 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK--VVKICDFGLARDIMSDSN 227 (344)
T ss_dssp -------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTT--EEEECCCGGGSCGGGCTT
T ss_pred cccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCC--cEEeCCCccCcccccCcc
Confidence 2378999999999999999999999999999999999999888 8999999999754322
Q ss_pred ---ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhh
Q psy17270 225 ---VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRL 300 (429)
Q Consensus 225 ---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 300 (429)
.....+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+.+....+..+......+
T Consensus 228 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 294 (344)
T 1rjb_A 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM------------- 294 (344)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC-------------
T ss_pred ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC-------------
Confidence 123456788999999999899999999999999999998 999998876544443333210000
Q ss_pred hccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy17270 301 FFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHE 362 (429)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~ 362 (429)
..+...++.+.+||.+||+.||++|||+.+++++-
T Consensus 295 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 295 ---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 00112378899999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=334.70 Aligned_cols=263 Identities=28% Similarity=0.408 Sum_probs=184.1
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.+.-.++|++++.||+|+||.||+|.+..++.. |+|++.........
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-------------------------------- 64 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ-------------------------------- 64 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHH--------------------------------
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHH--------------------------------
Confidence 345578999999999999999999999988865 99988654322111
Q ss_pred CCCCCcchhhhhhhHHHHHH-HHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhh---CCCCCCHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVR-ILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRN---NYQGFSLGL 170 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~-il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~---~~~~~~~~~ 170 (429)
..+..|+. +++.+. ||||+++++++...+..++||||++++|.+++... ....+++..
T Consensus 65 ------------~~~~~e~~~~~~~~~------h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~ 126 (327)
T 3aln_A 65 ------------KQLLMDLDVVMRSSD------CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126 (327)
T ss_dssp ------------HHHHHHHHHHHSSCC------CTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHH
T ss_pred ------------HHHHHHHHHHHHcCC------CCcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHH
Confidence 12223444 444444 45999999999999999999999999998888642 234599999
Q ss_pred HHHHHHHHHHHHHHHHHC-CceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchhhh----hCC
Q psy17270 171 IRRFAFSLVQCLRLLHRE-NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVI----LGL 243 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~-~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~----~~~ 243 (429)
+..++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++...... .....||+.|+|||++ .+.
T Consensus 127 ~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 204 (327)
T 3aln_A 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT--EEEECCCSSSCC-----------------------------
T ss_pred HHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC--CEEEccCCCceecccccccccCCCCccccCceeeccccCcC
Confidence 999999999999999999 999999999999999888 8999999999764432 2234789999999998 455
Q ss_pred CCCCCccccchhhHHHHHhhCCCCCCCCCHH-HHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELYTGCPLFPGENEV-EQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
.++.++|||||||++|+|++|+.||.+.+.. +.+..+. .+.. ...
T Consensus 205 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-----------------------~~~~---------~~~-- 250 (327)
T 3aln_A 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-----------------------KGDP---------PQL-- 250 (327)
T ss_dssp -CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-----------------------CSCC---------CCC--
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-----------------------cCCC---------CCC--
Confidence 6899999999999999999999999875331 1110000 0000 000
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
........++.+.+||.+||+.||++|||+.|+++||||...
T Consensus 251 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 251 ---SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ---CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 000112347899999999999999999999999999999753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=333.56 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=203.7
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCc------chheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNT------HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
.+...++|++.+.||+|+||+||+|.+..++. +|+|++......
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------------ 90 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA------------------------------ 90 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH------------------------------
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh------------------------------
Confidence 45567899999999999999999999987764 466665433211
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC-----
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN----- 162 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~----- 162 (429)
.....+.+|+++++.+ .|+ ||+++++++.....+++||||+. |+|.+++....
T Consensus 91 --------------~~~~~~~~E~~~l~~l~~h~------~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 150 (333)
T 2i1m_A 91 --------------DEKEALMSELKIMSHLGQHE------NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150 (333)
T ss_dssp --------------HHHHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSC
T ss_pred --------------HHHHHHHHHHHHHHhhcCCC------CeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccc
Confidence 1123566799999999 666 99999999999999999999995 59999997642
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeec
Q psy17270 163 -------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQ 230 (429)
Q Consensus 163 -------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~ 230 (429)
...+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++...... .....+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (333)
T 2i1m_A 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH--VAKIGDFGLARDIMNDSNYIVKGNARL 228 (333)
T ss_dssp C-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG--EEEBCCCGGGCCGGGCTTSEECSSCEE
T ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC--eEEECccccccccccccceeecCCCCC
Confidence 23589999999999999999999999999999999999999888 8999999999754322 122456
Q ss_pred CccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCc
Q psy17270 231 SRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309 (429)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (429)
|+.|+|||++.+..++.++|||||||++|+|+| |..||.+......+..+......+.
T Consensus 229 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------- 287 (333)
T 2i1m_A 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA--------------------- 287 (333)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC---------------------
T ss_pred CccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC---------------------
Confidence 788999999999899999999999999999998 9999988765544444332111000
Q ss_pred cccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 310 CITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+...++.+.++|.+||+.||.+|||+.|++++
T Consensus 288 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 288 -------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 011236789999999999999999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=323.95 Aligned_cols=247 Identities=19% Similarity=0.275 Sum_probs=204.2
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-.++|++++.||+|+||.||+|.+..+..+|+|++......
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--------------------------------------- 46 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--------------------------------------- 46 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---------------------------------------
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---------------------------------------
Confidence 35789999999999999999999986666788887533211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
...+.+|+++++.++|+ ||+++++++......++||||++ ++|.+++.... ..+++..+..++.|
T Consensus 47 -------~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ 112 (267)
T 3t9t_A 47 -------EEDFIEEAEVMMKLSHP------KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLD 112 (267)
T ss_dssp -------HHHHHHHHHHHHTCCCT------TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHH
T ss_pred -------HHHHHHHHHHHHhCCCC------CEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHH
Confidence 13456699999998776 99999999999999999999995 69999998754 45899999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhhhCCCCCCCccccc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
++.||.|||++|++|+||||+||+++.++ .++|+|||++....... ....+|..|+|||++.+..++.++||||
T Consensus 113 i~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 190 (267)
T 3t9t_A 113 VCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190 (267)
T ss_dssp HHHHHHHHHHTTCCCSSCCGGGEEECGGG--CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHHhCCcccCCCchheEEECCCC--CEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhh
Confidence 99999999999999999999999999888 89999999987543321 2234677899999999888999999999
Q ss_pred hhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 254 LGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 254 lG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||+++|+|++ |..||.+.+..+....+........ ...
T Consensus 191 lG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~-----------------------------------------~~~ 229 (267)
T 3t9t_A 191 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----------------------------------------PRL 229 (267)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-----------------------------------------CTT
T ss_pred hHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC-----------------------------------------Ccc
Confidence 9999999999 8999998887766555442111000 112
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.++.+.+++.+||+.||++|||+.+++++
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 36789999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=326.65 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=193.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
..-++|++.+.||+|+||+||+|.+..++.. |+|++.......
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------------------------------------ 74 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD------------------------------------ 74 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS------------------------------------
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC------------------------------------
Confidence 3568899999999999999999999988865 889875432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
......+.+|+.+++.+.|+ ||+++++++.....+++||||++ ++|.+++.... .+++..+..++
T Consensus 75 ------~~~~~~~~~e~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~ 140 (309)
T 2h34_A 75 ------PVFRTRMQREARTAGRLQEP------HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIV 140 (309)
T ss_dssp ------HHHHHHHHHHHHHHTTCCCT------TBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHH
T ss_pred ------HHHHHHHHHHHHHHhhcCCC------CeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHH
Confidence 12234566799999988776 99999999999999999999996 59999998764 49999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.|++.||.|||++||+|+||||+||+++.++ .++|+|||++...... .....+|+.|+|||++.+..++.++||
T Consensus 141 ~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 218 (309)
T 2h34_A 141 RQIGSALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADI 218 (309)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSCCC----------------CCGGGCCGGGTCC----CCCHH
T ss_pred HHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--CEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhH
Confidence 9999999999999999999999999999888 8999999998654432 224578999999999998889999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|+.||.+.+.......+.. .... ......
T Consensus 219 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~--------------------------------------~~~~~~ 259 (309)
T 2h34_A 219 YALTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPR--------------------------------------PSTVRP 259 (309)
T ss_dssp HHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-CCCC--------------------------------------GGGTST
T ss_pred HHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-CCCC--------------------------------------ccccCC
Confidence 9999999999999999988655422222111 0000 111123
Q ss_pred cCChHHHHHHHHhcccCCCCCC-CHHHHhc
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRL-TPDEALR 360 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rp-ta~ell~ 360 (429)
..++.+.++|.+||+.||++|| |+.++++
T Consensus 260 ~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 260 GIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp TCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 4478899999999999999999 7888765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=326.42 Aligned_cols=266 Identities=19% Similarity=0.269 Sum_probs=197.1
Q ss_pred cccccCCeEEEeEeeccccceEEEEE----ecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRAL----DHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~----~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
.....++|++++.||+|+||+||+|+ +..++.. |+|++.....
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------------------------------- 52 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-------------------------------- 52 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--------------------------------
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--------------------------------
Confidence 35678999999999999999999998 5556654 8888753321
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeec-CcCHHHHHHhhCCCCCC
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELM-NLNLYELIKRNNYQGFS 167 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~-~g~L~~~i~~~~~~~~~ 167 (429)
.....+.+|+++++.++|+ ||+++++++... ..+++||||+ +++|.+++.... ..++
T Consensus 53 -------------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 112 (295)
T 3ugc_A 53 -------------EHLRDFEREIEILKSLQHD------NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERID 112 (295)
T ss_dssp -------------HHHHHHHHHHHHHHTCCCT------TBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCC
T ss_pred -------------HHHHHHHHHHHHHHhCCCC------CEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccC
Confidence 1123456699999999876 999999998654 5699999999 569999998764 3599
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhh
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVIL 241 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~ 241 (429)
+..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++...... .....+|..|+|||++.
T Consensus 113 ~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (295)
T 3ugc_A 113 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCSCC-------------CTTCGGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC--eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc
Confidence 999999999999999999999999999999999999988 8999999999764322 11234667799999999
Q ss_pred CCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCC
Q psy17270 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKP 321 (429)
Q Consensus 242 ~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (429)
+..++.++|||||||++|+|+||..||...... . ....+..+................. +
T Consensus 191 ~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~~~-----------~---- 250 (295)
T 3ugc_A 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDKQGQMIVFHLIELLKNNG-----------R---- 250 (295)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTCCTHHHHHHHHHHHHTTC-----------C----
T ss_pred CCCCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCccccchhHHHHHHHHhccC-----------c----
Confidence 999999999999999999999999998763221 1 1111221111100000000000000 0
Q ss_pred CCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 322 GSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...+...++.+.+||.+||+.||++|||+.|+++
T Consensus 251 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 251 -----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp -----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011234789999999999999999999999976
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=323.11 Aligned_cols=250 Identities=18% Similarity=0.240 Sum_probs=200.0
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCC----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTN----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
.+..++|++.+.||+|+||+||+|.+.... .+|+|++.......
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------- 55 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-------------------------------- 55 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH--------------------------------
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch--------------------------------
Confidence 455789999999999999999999976433 25888775432211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
....+.+|+++++.++|+ ||+++++++.. ...++||||+. ++|.+++.... ..+++..+
T Consensus 56 ------------~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~ 115 (281)
T 3cc6_A 56 ------------NKEKFMSEAVIMKNLDHP------HIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNK-NSLKVLTL 115 (281)
T ss_dssp ------------HHHHHHHHHHHHHHHCCT------TBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHH
T ss_pred ------------HHHHHHHHHHHHHhCCCC------CcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHH
Confidence 123566799999999876 99999999764 56789999996 69999998764 45999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhhhCCCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....... ....+|+.|+|||++.+..++.
T Consensus 116 ~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 193 (281)
T 3cc6_A 116 VLYSLQICKAMAYLESINCVHRDIAVRNILVASPE--CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193 (281)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT--EEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC--cEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCc
Confidence 99999999999999999999999999999999988 89999999987644321 2345677899999999888999
Q ss_pred CccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 248 PIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 248 ~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
++|||||||++|+|++ |+.||...+..+....+......+.
T Consensus 194 ~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------------- 235 (281)
T 3cc6_A 194 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-------------------------------------- 235 (281)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC--------------------------------------
T ss_pred hhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC--------------------------------------
Confidence 9999999999999998 9999987766655544432111000
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
....++.+.++|.+||+.||++|||+.|++++
T Consensus 236 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 236 ---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 11236889999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.09 Aligned_cols=252 Identities=18% Similarity=0.229 Sum_probs=204.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecC-----CC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHK-----TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
++..++|++.+.||+|+||+||+|.+.. ++ .+|+|++.......
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------------------ 70 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR------------------------------ 70 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH------------------------------
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH------------------------------
Confidence 5678999999999999999999999873 33 34888875332211
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC-------
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN------- 162 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~------- 162 (429)
....+.+|+++++.++|+ ||+++++++......++||||+. ++|.+++....
T Consensus 71 --------------~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 130 (322)
T 1p4o_A 71 --------------ERIEFLNEASVMKEFNCH------HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 130 (322)
T ss_dssp --------------HHHHHHHHHHHGGGCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCT
T ss_pred --------------HHHHHHHHHHHHHhcCCC------CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCC
Confidence 122456699999988776 99999999999999999999995 69999997642
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-----eeeecCccccc
Q psy17270 163 -YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-----YTYIQSRFYRS 236 (429)
Q Consensus 163 -~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~t~~y~a 236 (429)
...+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++....... ....+|+.|+|
T Consensus 131 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 208 (322)
T 1p4o_A 131 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208 (322)
T ss_dssp TCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCC
T ss_pred CCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC--eEEECcCccccccccccccccccCCCCCCCccC
Confidence 13479999999999999999999999999999999999999988 89999999997543221 23456888999
Q ss_pred hhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCC
Q psy17270 237 PEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315 (429)
Q Consensus 237 PE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (429)
||++.+..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 209 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------- 259 (322)
T 1p4o_A 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL----------------------------- 259 (322)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC-----------------------------
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC-----------------------------
Confidence 999999889999999999999999999 89999988776665544321000
Q ss_pred CCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......++.+.+||.+||+.||++|||+.|++++
T Consensus 260 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 ------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0012347889999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=346.91 Aligned_cols=246 Identities=22% Similarity=0.318 Sum_probs=201.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+-.++|++++.||+|+||+||+|.+.. ..+|+|++....
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~vavK~~~~~~---------------------------------------- 228 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDA---------------------------------------- 228 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-EEEEEEEESSCT----------------------------------------
T ss_pred cChHHeEEEeeecCcCCeeEEEEEecC-CeEEEEEeCCch----------------------------------------
Confidence 456889999999999999999999863 356888774321
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-eEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-HLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+++++.++|+ ||+++++++.... .+++|||||. |+|.+++.......+++..+..++
T Consensus 229 -------~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 295 (450)
T 1k9a_A 229 -------TAQAFLAEASVMTQLRHS------NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295 (450)
T ss_dssp -------TSHHHHHHHHHHHTCCCT------TBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHH
T ss_pred -------HHHHHHHHHHHHHhccCC------CEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHH
Confidence 123567799999999877 9999999987765 7999999995 699999998765558999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
.||+.||+|||++|++||||||+|||++.++ .+||+|||+++..........++..|+|||++.+..++.++||||||
T Consensus 296 ~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG 373 (450)
T 1k9a_A 296 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 373 (450)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEECTTS--CEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCeeCCCCCHhhEEECCCC--CEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHH
Confidence 9999999999999999999999999999888 89999999998655444445678899999999999999999999999
Q ss_pred hHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|++|+|++ |..||.+.+..+....+...... ..+..++
T Consensus 374 ~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-----------------------------------------~~p~~~~ 412 (450)
T 1k9a_A 374 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-----------------------------------------DAPDGCP 412 (450)
T ss_dssp HHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-----------------------------------------CCCTTCC
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------------------------------------CCCCcCC
Confidence 99999998 99999887665555444321000 0112347
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+.+.+||.+||+.||++|||+.++++
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 89999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.33 Aligned_cols=248 Identities=19% Similarity=0.272 Sum_probs=205.2
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+-.++|++.+.||+|+||+||+|.+..+..+|+|++.....
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-------------------------------------- 225 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-------------------------------------- 225 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--------------------------------------
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--------------------------------------
Confidence 455789999999999999999999998766779988743211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+++++.++|+ ||+++++++. ...+++|||||. |+|.+++.......+++..+..++
T Consensus 226 --------~~~~~~~E~~~l~~l~h~------~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 290 (454)
T 1qcf_A 226 --------SVEAFLAEANVMKTLQHD------KLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290 (454)
T ss_dssp --------CHHHHHHHHHHHTTCCCT------TBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHH
T ss_pred --------cHHHHHHHHHHHhhCCCC------CEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHH
Confidence 123566799999999876 9999999886 678999999995 699999986543358999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ....+|..|+|||++.+..++.++||
T Consensus 291 ~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 368 (454)
T 1qcf_A 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368 (454)
T ss_dssp HHHHHHHHHHHHTTCCCSSCSGGGEEECTTC--CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHhCCccCCCCCHHHEEECCCC--cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHH
Confidence 9999999999999999999999999999888 89999999997654321 22345678999999998899999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||++|+|+| |+.||.+.+..+.+..+......+. +
T Consensus 369 wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-----------------------------------------~ 407 (454)
T 1qcf_A 369 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-----------------------------------------P 407 (454)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC-----------------------------------------C
T ss_pred HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----------------------------------------C
Confidence 999999999999 9999999888777665543211110 1
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...++.+.+||.+||+.||++|||+.++++
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 123788999999999999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=337.90 Aligned_cols=264 Identities=24% Similarity=0.299 Sum_probs=192.3
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
.++|++++.||+|+||+||+|.+. ...+|+|++......
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~---------------------------------------- 61 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ---------------------------------------- 61 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH----------------------------------------
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH----------------------------------------
Confidence 578999999999999999999986 345699988543211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC----eEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN----HLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
......|+.+++.++|+ ||+++++++.... .+++|||||. |+|.+++.... +++..+..+
T Consensus 62 ------~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i 126 (322)
T 3soc_A 62 ------SWQNEYEVYSLPGMKHE------NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHI 126 (322)
T ss_dssp ------HHHHHHHHHTSTTCCCT------TBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHHH
T ss_pred ------HHHHHHHHHHHhcCCCC------CchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC---CCHHHHHHH
Confidence 11223377777777665 9999999998754 4799999995 59999998754 999999999
Q ss_pred HHHHHHHHHHHHHC----------CceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhh
Q psy17270 175 AFSLVQCLRLLHRE----------NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEV 239 (429)
Q Consensus 175 ~~qil~~l~~lH~~----------~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~ 239 (429)
+.|++.||+|||+. ||+||||||+|||++.++ .+||+|||++...... .....||+.|+|||+
T Consensus 127 ~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~--~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 204 (322)
T 3soc_A 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL--TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204 (322)
T ss_dssp HHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC--CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHH
T ss_pred HHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC--eEEEccCCcccccccccCccccccCccCccccCHhh
Confidence 99999999999999 999999999999999888 8999999999654322 223578999999999
Q ss_pred hhCC-----CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCC
Q psy17270 240 ILGL-----PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314 (429)
Q Consensus 240 ~~~~-----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (429)
+.+. .++.++|||||||++|+|+||+.||.+................+..+.+...... ..
T Consensus 205 ~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~--------- 270 (322)
T 3soc_A 205 LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVH-----KK--------- 270 (322)
T ss_dssp HTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTT-----SC---------
T ss_pred cccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhc-----cc---------
Confidence 9874 3456889999999999999999999875442221111111122222111111000 00
Q ss_pred CCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+...... .....++.+.+||.+||+.||++|||+.|+++
T Consensus 271 ----~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 271 ----KRPVLRDYW-QKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp ----CCCCCCGGG-GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCCCccccc-cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000000000 00112356899999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=331.26 Aligned_cols=252 Identities=21% Similarity=0.240 Sum_probs=199.7
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCc-----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNT-----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
.++..++|++.+.||+|+||+||+|.+..++. +|+|++.......
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------ 88 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK------------------------------ 88 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH------------------------------
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHH------------------------------
Confidence 35668899999999999999999999876542 5888775432211
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHH
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~ 169 (429)
....+.+|+++++.++|+ ||+++++++.....+++||||+. ++|.+++.... ..+++.
T Consensus 89 --------------~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~ 147 (333)
T 1mqb_A 89 --------------QRVDFLGEAGIMGQFSHH------NIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVL 147 (333)
T ss_dssp --------------HHHHHHHHHHHHHTCCCT------TBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHH
T ss_pred --------------HHHHHHHHHHHHHhCCCC------CCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHH
Confidence 122456699999998776 99999999999899999999996 59999998653 459999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhCC
Q psy17270 170 LIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGL 243 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~ 243 (429)
.+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||++....... ....+|+.|+|||++.+.
T Consensus 148 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (333)
T 1mqb_A 148 QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225 (333)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC-----------------CCCGGGSCHHHHHSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhhccccccccccCCCCccccccCchhcccC
Confidence 9999999999999999999999999999999999888 89999999997644321 123457789999999998
Q ss_pred CCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 244 PYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 244 ~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
.++.++|||||||++|+|++ |..||.+.+..+....+......+.
T Consensus 226 ~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------------- 271 (333)
T 1mqb_A 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---------------------------------- 271 (333)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----------------------------------
T ss_pred CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC----------------------------------
Confidence 99999999999999999999 9999998877666554432110000
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
....++.+.++|.+||+.||++||++.+++++
T Consensus 272 -------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 272 -------PMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11236789999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=339.23 Aligned_cols=259 Identities=11% Similarity=0.105 Sum_probs=198.6
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCC--------C-cchheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKT--------N-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~--------~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
..++|++.+.||+|+||+||+|.+..+ + .+|+|++...
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------------------------------- 86 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------------------------------- 86 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------------------------------
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------------------------------
Confidence 368999999999999999999999874 3 3477776322
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCC---------CCCCceeEEEEEEEE-cCeEEEEEeecCcCHHHHHH
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDA---------DSSYNVIHMLEYFYF-RNHLCISFELMNLNLYELIK 159 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~---------~~~~~i~~~~~~~~~-~~~~~lv~e~~~g~L~~~i~ 159 (429)
..+.+|+++++.+.|+++ ..+.+++.+++++.. ...+++||||++++|.+++.
T Consensus 87 -----------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~ 149 (352)
T 2jii_A 87 -----------------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALD 149 (352)
T ss_dssp -----------------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHH
T ss_pred -----------------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHH
Confidence 245558888888877622 124455668888877 67899999999889999999
Q ss_pred hhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----------ceeee
Q psy17270 160 RNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----------VYTYI 229 (429)
Q Consensus 160 ~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----------~~~~~ 229 (429)
......+++..+..++.||+.||+|||++||+||||||+|||++.++...++|+|||++...... .....
T Consensus 150 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 229 (352)
T 2jii_A 150 VSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE 229 (352)
T ss_dssp HSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTC
T ss_pred hCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccccccccc
Confidence 76445699999999999999999999999999999999999999765447999999999654321 12347
Q ss_pred cCccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCC-HHHHHHHHHHH-hCCCcHHHHhhhhhhhhhccCCCC
Q psy17270 230 QSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGEN-EVEQLACIMEI-LGCPPDEVINTASRRRLFFDSKGT 307 (429)
Q Consensus 230 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 307 (429)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ..+.+...... ...+.. ..
T Consensus 230 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~--------------- 293 (352)
T 2jii_A 230 GDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP-FV--------------- 293 (352)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCC-EE---------------
T ss_pred CCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhh-hh---------------
Confidence 8999999999999899999999999999999999999998764 22222222211 111000 00
Q ss_pred CccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 308 PRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.........++.+.+||.+||+.||++|||+.++++
T Consensus 294 -----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 294 -----------------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp -----------------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -----------------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 000001234789999999999999999999999976
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=330.96 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=203.6
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecC-------CC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHK-------TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-------~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
++-.++|++.+.||+|+||+||+|.+.. ++ .+|+|++......
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------------- 81 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE----------------------------- 81 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-----------------------------
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-----------------------------
Confidence 4557899999999999999999999863 22 2488877543221
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC---
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY--- 163 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~--- 163 (429)
.....+.+|+++++.+ +|+ ||+++++++.....+++||||+. ++|.+++.....
T Consensus 82 ---------------~~~~~~~~E~~~l~~l~~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 140 (334)
T 2pvf_A 82 ---------------KDLSDLVSEMEMMKMIGKHK------NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140 (334)
T ss_dssp ---------------HHHHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTC
T ss_pred ---------------HHHHHHHHHHHHHHHhhcCC------CEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccc
Confidence 1123456699999999 665 99999999999999999999995 599999986542
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----cee
Q psy17270 164 -----------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYT 227 (429)
Q Consensus 164 -----------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~ 227 (429)
..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++...... ...
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~ 218 (334)
T 2pvf_A 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLARDINNIDYYKKTTN 218 (334)
T ss_dssp CSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECTTTSSEECCSC
T ss_pred cccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC--CEEEccccccccccccccccccCC
Confidence 2489999999999999999999999999999999999999888 8999999999754432 122
Q ss_pred eecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 228 YIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
..+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.......
T Consensus 219 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 279 (334)
T 2pvf_A 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD------------------- 279 (334)
T ss_dssp CCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-------------------
T ss_pred CCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC-------------------
Confidence 356778999999998889999999999999999999 999999887766655444311000
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.....++.+.++|.+||+.||.+|||+.|++++
T Consensus 280 ----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 280 ----------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011237889999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=322.97 Aligned_cols=249 Identities=23% Similarity=0.317 Sum_probs=203.1
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
++..+.++|++++.||+|+||.||+|.+..++.. |+|++....
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------------------------ 48 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------------------------------ 48 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------------------------------
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------------------------------
Confidence 4567889999999999999999999999877754 888764221
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE----------------cCeEEEEEeecC-cCHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF----------------RNHLCISFELMN-LNLYE 156 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~~~-g~L~~ 156 (429)
..+.+|+++++.+.|+ ||+++++++.. ...+++||||++ ++|.+
T Consensus 49 -------------~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 109 (284)
T 2a19_B 49 -------------EKAEREVKALAKLDHV------NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109 (284)
T ss_dssp -------------GGGHHHHHHHHHCCCT------TBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHH
T ss_pred -------------HHHHHHHHHHHhCCCC------CEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHH
Confidence 2345699999999876 99999998864 446899999996 59999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccc
Q psy17270 157 LIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFY 234 (429)
Q Consensus 157 ~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y 234 (429)
++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..... ......+|+.|
T Consensus 110 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~y 187 (284)
T 2a19_B 110 WIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDGKRTRSKGTLRY 187 (284)
T ss_dssp HHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEESSCCSCCCCCCSCCTT
T ss_pred HHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC--CEEECcchhheeccccccccccCCcccc
Confidence 99876555699999999999999999999999999999999999999988 899999999876443 23345789999
Q ss_pred cchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCC
Q psy17270 235 RSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314 (429)
Q Consensus 235 ~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (429)
+|||++.+..++.++|||||||++|+|++|..||... ......+.. +.
T Consensus 188 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~--~~---------------------------- 235 (284)
T 2a19_B 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD--GI---------------------------- 235 (284)
T ss_dssp SCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT--TC----------------------------
T ss_pred cChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc--cc----------------------------
Confidence 9999999989999999999999999999998887431 111111100 00
Q ss_pred CCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.....++.+.+||.+||+.||++|||+.|++++.+.-.
T Consensus 236 --------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 --------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 00123678899999999999999999999999977643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=326.93 Aligned_cols=254 Identities=19% Similarity=0.293 Sum_probs=188.7
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
++..+.++|++++.||+|+||+||+|.+. ...+|+|++....
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------------------------------------- 43 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD------------------------------------- 43 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEET-TEEEEEEEECGGG-------------------------------------
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEEC-CEEEEEEEecccc-------------------------------------
Confidence 45788999999999999999999999983 3346999874321
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc----CeEEEEEeecC-cCHHHHHHhhCCCCCCHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR----NHLCISFELMN-LNLYELIKRNNYQGFSLG 169 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~ 169 (429)
...+..|.+++.... ..||||+++++++... ..+++||||+. |+|.++++.. .+++.
T Consensus 44 -----------~~~~~~e~~~~~~~~----l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~ 105 (301)
T 3q4u_A 44 -----------EKSWFRETELYNTVM----LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTV 105 (301)
T ss_dssp -----------HHHHHHHHHHHHHTC----CCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHH
T ss_pred -----------chhhHHHHHHHHHhh----ccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc---ccCHH
Confidence 112334677776621 1344999999987653 46899999995 6999999653 49999
Q ss_pred HHHHHHHHHHHHHHHHH--------HCCceecccCCCcEEEecCCCcceEEeeecccccccCcc-------eeeecCccc
Q psy17270 170 LIRRFAFSLVQCLRLLH--------RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-------YTYIQSRFY 234 (429)
Q Consensus 170 ~~~~i~~qil~~l~~lH--------~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-------~~~~~t~~y 234 (429)
.+..++.|++.||+||| ++||+||||||+|||++.++ .+||+|||++....... ....||+.|
T Consensus 106 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 183 (301)
T 3q4u_A 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183 (301)
T ss_dssp HHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCEEEETTTTEEECCCCCCCCCGGG
T ss_pred HHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC--CEEEeeCCCeeecccccccccccccccccccce
Confidence 99999999999999999 99999999999999999888 89999999986533221 224789999
Q ss_pred cchhhhhCC------CCCCCccccchhhHHHHHhhC----------CCCCCCCCH----HHHHHHHHHHhCCCcHHHHhh
Q psy17270 235 RSPEVILGL------PYGPPIDMWSLGCILAELYTG----------CPLFPGENE----VEQLACIMEILGCPPDEVINT 294 (429)
Q Consensus 235 ~aPE~~~~~------~~~~~~DiwSlG~il~~lltg----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~ 294 (429)
+|||++.+. .++.++|||||||++|+|+|| ..||..... ...+..+.......
T Consensus 184 ~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~------- 256 (301)
T 3q4u_A 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR------- 256 (301)
T ss_dssp CCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-------
T ss_pred eChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCC-------
Confidence 999999876 344689999999999999999 888855321 12221111100000
Q ss_pred hhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 295 ASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+ ..+........++.+.+||.+||+.||++|||+.|+++
T Consensus 257 --------------------------~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 257 --------------------------P-NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp --------------------------C-CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --------------------------C-CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 0 00000011123578999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=324.76 Aligned_cols=248 Identities=20% Similarity=0.280 Sum_probs=202.6
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
++..++|++++.||+|+||+||+|.+.....+|+|++.....
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------------------------- 50 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-------------------------------------- 50 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--------------------------------------
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--------------------------------------
Confidence 456789999999999999999999987655678888743211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+++++.+.|+ ||+++++++. ....++||||+ +++|.+++.......+++..+..++
T Consensus 51 --------~~~~~~~E~~~l~~l~h~------~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 115 (279)
T 1qpc_A 51 --------SPDAFLAEANLMKQLQHQ------RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115 (279)
T ss_dssp --------CHHHHHHHHHHHHHCCCT------TBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHH
T ss_pred --------cHHHHHHHHHHHHhCCCc------CcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHH
Confidence 123456699999999876 9999999875 55789999999 5699999876543359999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........ ...++..|+|||++.+..++.++||
T Consensus 116 ~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 193 (279)
T 1qpc_A 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193 (279)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHH
T ss_pred HHHHHHHHHHHHCCeeccCCCHhhEEEcCCC--CEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhh
Confidence 9999999999999999999999999999887 899999999976543322 2345678999999998889999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||++|+|++ |..||.+.+..+....+....... ..
T Consensus 194 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~ 232 (279)
T 1qpc_A 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-----------------------------------------RP 232 (279)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------------------------------------CC
T ss_pred HHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC-----------------------------------------Cc
Confidence 999999999999 999999988776655443210000 01
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...++.+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 123788999999999999999999999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=347.18 Aligned_cols=254 Identities=21% Similarity=0.276 Sum_probs=204.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
++-.++|++.+.||+|+||+||+|.+..+..+|+|++.....
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------------------------------------- 221 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-------------------------------------- 221 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--------------------------------------
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--------------------------------------
Confidence 355789999999999999999999998777789888743211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+++++.++|+ ||+++++++.. ..+++||||+. |+|.+++.......+++..+..++
T Consensus 222 --------~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~ 286 (452)
T 1fmk_A 222 --------SPEAFLQEAQVMKKLRHE------KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 286 (452)
T ss_dssp --------CHHHHHHHHHHHHHCCCT------TBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHH
T ss_pred --------CHHHHHHHHHHHHhCCCC------CEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHH
Confidence 123466799999999877 99999999865 77899999995 699999986543459999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||++....... ....+|..|+|||++.+..++.++||
T Consensus 287 ~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv 364 (452)
T 1fmk_A 287 AQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364 (452)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHhCCeeCCCCChhhEEECCCC--CEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccH
Confidence 9999999999999999999999999999887 89999999997644321 22345678999999998899999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||++|+|++ |+.||.+.+..+.+..+......+ .+
T Consensus 365 wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-----------------------------------------~~ 403 (452)
T 1fmk_A 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-----------------------------------------CP 403 (452)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------------------------------------CC
T ss_pred HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------------------CC
Confidence 999999999999 999999988777665554211100 01
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcC--CCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRH--EWLKS 366 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h--~~~~~ 366 (429)
...++.+.+||.+||+.||++|||+.++++. .++..
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 2347889999999999999999999999873 55544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=322.14 Aligned_cols=250 Identities=16% Similarity=0.139 Sum_probs=200.6
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+-.++|++.+.||+|+||+||+|++. ...+|+|++.......
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~------------------------------------ 48 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWST------------------------------------ 48 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCH------------------------------------
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCH------------------------------------
Confidence 345688999999999999999999996 3346888875432211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.....+.+|+.+++.++|+ ||+++++++... ..+++||||+. |+|.+++.......+++..+..
T Consensus 49 -------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 115 (271)
T 3kmu_A 49 -------RKSRDFNEECPRLRIFSHP------NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115 (271)
T ss_dssp -------HHHHHHHHHGGGGCCCSCT------TEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHH
T ss_pred -------HHHHHHHHHHHHHHhcCCC------chhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHH
Confidence 1123455688888877665 999999999877 78999999996 6999999877655699999999
Q ss_pred HHHHHHHHHHHHHHCC--ceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCC---C
Q psy17270 174 FAFSLVQCLRLLHREN--IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGP---P 248 (429)
Q Consensus 174 i~~qil~~l~~lH~~~--ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~ 248 (429)
++.|++.||+|||++| ++||||||+||+++.++ .++|+|||++..... ....+|+.|+|||++.+..++. +
T Consensus 116 i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~--~~~l~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~ 191 (271)
T 3kmu_A 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM--TARISMADVKFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRS 191 (271)
T ss_dssp HHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS--CEEEEGGGSCCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHH
T ss_pred HHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc--ceeEEeccceeeecc--cCccCCccccChhhhccCCCCCCCch
Confidence 9999999999999999 99999999999999888 788888887654322 2346899999999999875544 7
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|+|++|+.||.+.+..+....+......+ .
T Consensus 192 ~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------------------~ 231 (271)
T 3kmu_A 192 ADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP----------------------------------------T 231 (271)
T ss_dssp HHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC----------------------------------------C
T ss_pred hhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC----------------------------------------C
Confidence 999999999999999999999888776655444211000 0
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+...++.+.++|.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11234788999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=332.87 Aligned_cols=249 Identities=23% Similarity=0.283 Sum_probs=199.8
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCc---chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNT---HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~---~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.++|++.+.||+|+||.||+|.+..++. +|+|.+.....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-------------------------------------- 65 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------------------------------------- 65 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------------------------------------
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--------------------------------------
Confidence 4789999999999999999999988874 27777643211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC------------
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN------------ 162 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~------------ 162 (429)
......+.+|+++++.+ .|+ ||+++++++.....+++||||++ ++|.+++....
T Consensus 66 ------~~~~~~~~~E~~~l~~l~~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 133 (327)
T 1fvr_A 66 ------KDDHRDFAGELEVLCKLGHHP------NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133 (327)
T ss_dssp ----------CHHHHHHHHHTTCCCCT------TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred ------hHHHHHHHHHHHHHHhccCCC------chhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccc
Confidence 11223566799999988 555 99999999999999999999995 69999997653
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchh
Q psy17270 163 --YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPE 238 (429)
Q Consensus 163 --~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE 238 (429)
...+++..+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||++..... ......+++.|+|||
T Consensus 134 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE 211 (327)
T 1fvr_A 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 211 (327)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEEECCTTCEESSCEECCC----CCTTTCCHH
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC--eEEEcccCcCccccccccccCCCCCccccChh
Confidence 23599999999999999999999999999999999999999888 899999999864332 222345678899999
Q ss_pred hhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCC
Q psy17270 239 VILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317 (429)
Q Consensus 239 ~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (429)
++.+..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 212 ~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~------------------------------- 260 (327)
T 1fvr_A 212 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL------------------------------- 260 (327)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC-------------------------------
T ss_pred hhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC-------------------------------
Confidence 9998888999999999999999998 99999988776554433210000
Q ss_pred CCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
......++.+.+||.+||+.||++|||+.|++++
T Consensus 261 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 261 ----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011237889999999999999999999999886
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=341.44 Aligned_cols=277 Identities=19% Similarity=0.288 Sum_probs=203.2
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
+..+++||++.+.||+|+||+||+|.+..++.. |+|++......
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------------------------------- 48 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----------------------------------- 48 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-----------------------------------
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-----------------------------------
Confidence 356789999999999999999999999988865 99987532211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC--eEEEEEeecC-cCHHHHHHhhCC-CCCCHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN--HLCISFELMN-LNLYELIKRNNY-QGFSLGL 170 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~-g~L~~~i~~~~~-~~~~~~~ 170 (429)
.....+.+|+++++.++|+ ||+++++++.... +.++|||||. |+|.+++..... ..+++..
T Consensus 49 ---------~~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~ 113 (396)
T 4eut_A 49 ---------RPVDVQMREFEVLKKLNHK------NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113 (396)
T ss_dssp ---------SCHHHHHHHHHHHHHCCCT------TBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHH
T ss_pred ---------chHHHHHHHHHHHHhcCCC------CCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHH
Confidence 1123455699999999876 9999999998765 7899999995 699999976542 2399999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEE----ecCCCcceEEeeecccccccCc--ceeeecCccccchhhhhC--
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLL----KQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILG-- 242 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili----~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-- 242 (429)
+..++.||+.||+|||++||+||||||+|||+ +.++ .+||+|||++...... .....||+.|+|||++.+
T Consensus 114 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 191 (396)
T 4eut_A 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191 (396)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE--EEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce--eEEEecCCCceEccCCCccccccCCccccCHHHhhccc
Confidence 99999999999999999999999999999998 4444 7999999999764432 334678999999999875
Q ss_pred ------CCCCCCccccchhhHHHHHhhCCCCCCCCC----HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcccc
Q psy17270 243 ------LPYGPPIDMWSLGCILAELYTGCPLFPGEN----EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312 (429)
Q Consensus 243 ------~~~~~~~DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (429)
..++.++|||||||++|+|++|+.||...+ ..+.+..+.. +.++. .+...... ..+...+..
T Consensus 192 ~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~p~~-~~~~~~~~-----~~~~~~~~~ 263 (396)
T 4eut_A 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPSG-AISGVQKA-----ENGPIDWSG 263 (396)
T ss_dssp C--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--SCCTT-CCEEEECS-----TTCCEEEES
T ss_pred cccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--CCCcc-cchhheec-----cCCCcccCc
Confidence 456789999999999999999999996532 2333333332 22221 11111000 000000000
Q ss_pred CCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+. ...+....++.+.++|++||++||++|||+.|++++
T Consensus 264 ------~~~~---~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 264 ------DMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp ------SCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ------cCCc---ccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 0000 111123346788999999999999999999998553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=350.43 Aligned_cols=248 Identities=20% Similarity=0.298 Sum_probs=205.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+-.++|++.+.||+|+||.||+|.+..++. +|+|++.....
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------------------------------------- 258 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-------------------------------------- 258 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--------------------------------------
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--------------------------------------
Confidence 446789999999999999999999998775 48888743211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+++++.++|+ ||+++++++.....+++|||||. |+|.+++.......+++..+..++
T Consensus 259 --------~~~~~~~E~~~l~~l~hp------niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~ 324 (495)
T 1opk_A 259 --------EVEEFLKEAAVMKEIKHP------NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324 (495)
T ss_dssp --------CHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHH
T ss_pred --------chHHHHHHHHHHHhcCCC------CEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHH
Confidence 123566799999999877 99999999999999999999995 799999987665669999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....... ...++..|+|||++.+..++.++||
T Consensus 325 ~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv 402 (495)
T 1opk_A 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402 (495)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHH
T ss_pred HHHHHHHHHHHhCCcccCCCChhhEEECCCC--cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhH
Confidence 9999999999999999999999999999888 899999999976543222 1335678999999998889999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||++|+|+| |..||.+.+..+....+...... ..+
T Consensus 403 wSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~ 441 (495)
T 1opk_A 403 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-----------------------------------------ERP 441 (495)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-----------------------------------------CCC
T ss_pred HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------------------------------------CCC
Confidence 999999999999 99999987765544433211000 001
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+++.+.+||.+||+.||++|||+.++++
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 234788999999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=338.86 Aligned_cols=250 Identities=21% Similarity=0.263 Sum_probs=193.5
Q ss_pred ccccCCeEEEeEeeccccceEEEEEec---CCC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDH---KTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~---~~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
++..++|++.+.||+|+||+||+|++. .++ .+|+|++.......
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------- 88 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-------------------------------- 88 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHH--------------------------------
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHH--------------------------------
Confidence 445679999999999999999999987 333 35888875432211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~ 171 (429)
....+.+|+++++.+.|+ ||+++++++.....+++||||+ +++|.+++.... ..+++..+
T Consensus 89 ------------~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~ 149 (373)
T 2qol_A 89 ------------QRRDFLGEASIMGQFDHP------NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQL 149 (373)
T ss_dssp ------------HHHHHHHHHHHHTTCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHH
T ss_pred ------------HHHHHHHHHHHHHhCCCC------CCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHH
Confidence 123566799999998776 9999999999989999999999 579999998654 45999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~ 245 (429)
..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....... ....+|..|+|||++.+..+
T Consensus 150 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (373)
T 2qol_A 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL--VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227 (373)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC----------------------CTTSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC--CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCc
Confidence 99999999999999999999999999999999888 89999999997644321 11234677999999999899
Q ss_pred CCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 246 GPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 246 ~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
+.++|||||||++|+|++ |+.||.+.+..+....+......+.
T Consensus 228 ~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~------------------------------------ 271 (373)
T 2qol_A 228 TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------------------------------------ 271 (373)
T ss_dssp CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC------------------------------------
T ss_pred CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------------------------------
Confidence 999999999999999998 9999998887666554432111000
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
....++.+.+++.+||+.||++||++.++++
T Consensus 272 -----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 272 -----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 1123678999999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=332.37 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=182.0
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.-..||++.+.||+|+||.||+|.+..++.. |+|++......
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------------------------- 67 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE------------------------------------- 67 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHH-------------------------------------
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchH-------------------------------------
Confidence 4467999999999999999999999888865 99987433211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEE--------cCeEEEEEeecCcCHHHHHHhh-CCCCC
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYF--------RNHLCISFELMNLNLYELIKRN-NYQGF 166 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~--------~~~~~lv~e~~~g~L~~~i~~~-~~~~~ 166 (429)
....+.+|+.+++.+. |+ ||+++++++.. ...++++|||++|+|.+++... ....+
T Consensus 68 --------~~~~~~~e~~~l~~l~~h~------~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~ 133 (337)
T 3ll6_A 68 --------KNRAIIQEVCFMKKLSGHP------NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133 (337)
T ss_dssp --------HHHHHHHHHHHHHHHTTST------TBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSC
T ss_pred --------HHHHHHHHHHHHHHhccCC------ChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCC
Confidence 1224556999999996 65 99999999953 3458999999999999998763 23459
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCC--ceecccCCCcEEEecCCCcceEEeeecccccccCcc---------------eeee
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHREN--IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV---------------YTYI 229 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~--ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~---------------~~~~ 229 (429)
++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++....... ....
T Consensus 134 ~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (337)
T 3ll6_A 134 SCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211 (337)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS--CEEBCCCTTCBCCSSCC-------------------
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC--CEEEecCccceeccccCcccccccccccchhhcccc
Confidence 99999999999999999999999 99999999999999988 89999999997644321 1346
Q ss_pred cCccccchhhh---hCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCC
Q psy17270 230 QSRFYRSPEVI---LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKG 306 (429)
Q Consensus 230 ~t~~y~aPE~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (429)
+|+.|+|||++ .+..++.++|||||||++|+|++|+.||........+... ...+
T Consensus 212 ~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~------------------- 269 (337)
T 3ll6_A 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK---YSIP------------------- 269 (337)
T ss_dssp ------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------CCCC-------------------
T ss_pred CCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc---ccCC-------------------
Confidence 89999999998 4556888999999999999999999999764432211100 0000
Q ss_pred CCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy17270 307 TPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEW 363 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~ 363 (429)
.....+..+.+||++||+.||++|||+.|++++-+
T Consensus 270 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 270 ----------------------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----------------------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ----------------------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 01122567889999999999999999999999743
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=327.10 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=200.2
Q ss_pred ccccCCeEEEeEeeccccceEEEEEec-----CCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDH-----KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~-----~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
+...++|++++.||+|+||+||+|.+. .++. +|+|++.......
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------ 72 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS------------------------------ 72 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH------------------------------
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH------------------------------
Confidence 456789999999999999999999963 3333 4888875432221
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-eEEEEEeecC-cCHHHHHHhhCC-----
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-HLCISFELMN-LNLYELIKRNNY----- 163 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~-g~L~~~i~~~~~----- 163 (429)
....+.+|++++..+.+ ||||+++++++...+ .+++||||+. ++|.+++.....
T Consensus 73 --------------~~~~~~~E~~~l~~l~~-----hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 133 (316)
T 2xir_A 73 --------------EHRALMSELKILIHIGH-----HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133 (316)
T ss_dssp --------------HHHHHHHHHHHHHHHCC-----CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC
T ss_pred --------------HHHHHHHHHHHHHhccc-----CCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccc
Confidence 12345669999999953 249999999987755 5999999996 599999987542
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeee
Q psy17270 164 ---------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYI 229 (429)
Q Consensus 164 ---------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~ 229 (429)
..+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++...... .....
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~ 211 (316)
T 2xir_A 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDAR 211 (316)
T ss_dssp -------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTTTCTTSEEETTEE
T ss_pred cccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEECCCccccccccCccceeccCCC
Confidence 1288999999999999999999999999999999999999888 8999999999754322 12346
Q ss_pred cCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCC
Q psy17270 230 QSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTP 308 (429)
Q Consensus 230 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (429)
+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+....+.+...........
T Consensus 212 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 271 (316)
T 2xir_A 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-------------------- 271 (316)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC--------------------
T ss_pred cceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCC--------------------
Confidence 7889999999999899999999999999999998 9999988664433322221100000
Q ss_pred ccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 309 RCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.....++.+.++|.+||+.||.+|||+.|+++|
T Consensus 272 --------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 272 --------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011236889999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.81 Aligned_cols=265 Identities=19% Similarity=0.264 Sum_probs=198.6
Q ss_pred ccccCCeEEEeEeeccccceEEEEE----ecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRAL----DHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~----~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
....++|++++.||+|+||.||+|. +..++.. |+|++......
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------------------- 64 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-------------------------------- 64 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------------------------------------
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--------------------------------
Confidence 3456789999999999999999999 4556654 88887533211
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecC-cCHHHHHHhhCCCCCCH
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMN-LNLYELIKRNNYQGFSL 168 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~-g~L~~~i~~~~~~~~~~ 168 (429)
.....+.+|+++++.++|+ ||+++++++... ..+++||||+. ++|.+++.... ..+++
T Consensus 65 ------------~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 125 (302)
T 4e5w_A 65 ------------NHIADLKKEIEILRNLYHE------NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINL 125 (302)
T ss_dssp ------------CCHHHHHHHHHHHHTCCCT------TBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCH
T ss_pred ------------hhHHHHHHHHHHHHhCCCC------CeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCH
Confidence 1123566799999999876 999999999876 67999999995 59999997654 45999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhC
Q psy17270 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILG 242 (429)
Q Consensus 169 ~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~ 242 (429)
..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++....... ....+|..|+|||++.+
T Consensus 126 ~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 203 (302)
T 4e5w_A 126 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203 (302)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC--CEEECcccccccccCCCcceeccCCCCCCccccCCeeecC
Confidence 99999999999999999999999999999999999988 89999999997644321 23457778999999999
Q ss_pred CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
..++.++|||||||++|+|++|..|+.... .......+.................. .
T Consensus 204 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~-~----------------- 260 (302)
T 4e5w_A 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQMTVTRLVNTLKEG-K----------------- 260 (302)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGGGHHHHHHHHHHTT-C-----------------
T ss_pred CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccccCHHHHHHHHhcc-C-----------------
Confidence 889999999999999999999999865421 11222222222221111100000000 0
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
........++.+.+||.+||+.||++|||+.++++
T Consensus 261 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 261 ---RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00011234789999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.58 Aligned_cols=250 Identities=17% Similarity=0.207 Sum_probs=201.0
Q ss_pred cccCCeEEEe-EeeccccceEEEEEecC--CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 18 HICYRYEILE-VIGKGSFGQVIRALDHK--TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 18 ~~~~rY~i~~-~lG~G~~g~Vy~a~~~~--~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
...++|.+++ .||+|+||+||+|.+.. ++. +|+|++......
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---------------------------------- 51 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---------------------------------- 51 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH----------------------------------
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch----------------------------------
Confidence 3467898988 99999999999999753 333 588887543221
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|+++++.++|+ ||+++++++ ....+++|||++. ++|.+++.... ..+++..+.
T Consensus 52 ----------~~~~~~~~E~~~l~~l~h~------~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 113 (287)
T 1u59_A 52 ----------ADTEEMMREAQIMHQLDNP------YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVA 113 (287)
T ss_dssp ----------HHHHHHHHHHHHHHHCCCT------TBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHH
T ss_pred ----------hHHHHHHHHHHHHHhCCCC------CEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHH
Confidence 1223466699999999876 999999999 5667999999996 59999987543 459999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhCCCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGLPYG 246 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~ 246 (429)
.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....... ....+|+.|+|||++.+..++
T Consensus 114 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 191 (287)
T 1u59_A 114 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191 (287)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC--CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCC
Confidence 9999999999999999999999999999999888 89999999997653221 123457889999999988899
Q ss_pred CCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 247 PPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 247 ~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 192 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---------------------------------------- 231 (287)
T 1u59_A 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---------------------------------------- 231 (287)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----------------------------------------
T ss_pred chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc----------------------------------------
Confidence 99999999999999998 9999998877665544432100
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHE 362 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~ 362 (429)
...+...++.+.++|.+||+.||++|||+.+++++.
T Consensus 232 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 232 -MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp -CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 001123478999999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=326.36 Aligned_cols=249 Identities=19% Similarity=0.269 Sum_probs=195.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.-..+|++.+.||+|+||+||+|.+..++. +|+|.+......
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~---------------------------------- 67 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---------------------------------- 67 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH----------------------------------
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH----------------------------------
Confidence 356789999999999999999999865442 377776432211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEE-EcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY-FRNHLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
.....+.+|+++++.++|+ ||+++++++. .+...++||||++ ++|.+++.... ..+++..+
T Consensus 68 ----------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~ 130 (298)
T 3f66_A 68 ----------GEVSQFLTEGIIMKDFSHP------NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDL 130 (298)
T ss_dssp ----------HHHHHHHHHHHHHHTCCCT------TBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHH
T ss_pred ----------HHHHHHHHHHHHHHhCCCC------CEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHH
Confidence 1223566799999999876 9999999864 4568899999996 59999997644 45899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-------ceeeecCccccchhhhhCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-------VYTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~ 244 (429)
..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++...... .....+|+.|+|||++.+..
T Consensus 131 ~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (298)
T 3f66_A 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECcccccccccccchhccccccCCCCCccccChHHhcCCC
Confidence 99999999999999999999999999999999888 8999999999754322 22345678899999999989
Q ss_pred CCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 245 YGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
++.++|||||||++|+|++ |.+||.+.+..+....+........
T Consensus 209 ~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------- 253 (298)
T 3f66_A 209 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ----------------------------------- 253 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC-----------------------------------
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC-----------------------------------
Confidence 9999999999999999999 7788887766555444332111000
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+...++.+.+++.+||+.||++|||+.|+++
T Consensus 254 ------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 254 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1123678999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=324.23 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=192.8
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+..++|++++.||+|+||+||+|.+. ...+|+|++....
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--------------------------------------- 56 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--------------------------------------- 56 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------------------------------------
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---------------------------------------
Confidence 345689999999999999999999885 3345888764321
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-CeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-NHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
..+.+.+|+++++.++|+ ||+++++++... ..+++||||+. ++|.+++.......+++..+..+
T Consensus 57 --------~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 122 (278)
T 1byg_A 57 --------TAQAFLAEASVMTQLRHS------NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122 (278)
T ss_dssp ----------HHHHHTHHHHTTCCCT------TBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHH
T ss_pred --------HHHHHHHHHHHHHhCCCC------CEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHH
Confidence 123456699999988776 999999987554 47999999996 49999998765334899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
+.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...........+++.|+|||++.+..++.++|||||
T Consensus 123 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (278)
T 1byg_A 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 200 (278)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCccccCCCcceEEEeCCC--cEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHH
Confidence 99999999999999999999999999999888 8999999999766655555678889999999998889999999999
Q ss_pred hhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 255 GCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 255 G~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
||++|+|++ |..||...+..+....+..... .......
T Consensus 201 G~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~ 239 (278)
T 1byg_A 201 GILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------------------------------------MDAPDGC 239 (278)
T ss_dssp HHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-----------------------------------------CCCCTTC
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-----------------------------------------CCCcccC
Confidence 999999998 9999988765544433321000 0011234
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
++.+.++|.+||+.||++|||+.|+++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 788999999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=335.62 Aligned_cols=280 Identities=17% Similarity=0.167 Sum_probs=204.9
Q ss_pred eeehhhhcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 9 SFAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 9 ~~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
.|.+..+. ...++|++.+.||+|+||+||+|.+.....+|+|++......
T Consensus 19 ~~~~~~~~-~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------------- 68 (326)
T 3uim_A 19 RFSLRELQ-VASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ----------------------------- 68 (326)
T ss_dssp ECCTHHHH-TTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------------------------------
T ss_pred eecHHHHH-HHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-----------------------------
Confidence 45555444 578999999999999999999998765455698887433211
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC--CC
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY--QG 165 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~--~~ 165 (429)
.....+.+|+++++.+.|+ ||+++++++......++||||+. ++|.+++..... ..
T Consensus 69 ---------------~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 127 (326)
T 3uim_A 69 ---------------GGELQFQTEVEMISMAVHR------NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127 (326)
T ss_dssp ----------------CCCHHHHHHHGGGTCCCT------TBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCC
T ss_pred ---------------hHHHHHHHHHHHHHhccCC------CccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCC
Confidence 1122466799998888776 99999999999999999999995 599999986543 23
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchh
Q psy17270 166 FSLGLIRRFAFSLVQCLRLLHRE---NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPE 238 (429)
Q Consensus 166 ~~~~~~~~i~~qil~~l~~lH~~---~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE 238 (429)
+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .++|+|||++...... .....||+.|+|||
T Consensus 128 ~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (326)
T 3uim_A 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 205 (326)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC--CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC--CEEeccCccccccCcccccccccccCCcCccCHH
Confidence 99999999999999999999999 999999999999999988 8999999999754322 22345899999999
Q ss_pred hhhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCC
Q psy17270 239 VILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318 (429)
Q Consensus 239 ~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (429)
++.+..++.++|||||||++|+|++|..||........ ......++.... +.......
T Consensus 206 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~--------- 263 (326)
T 3uim_A 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-------DDVMLLDWVKGL------LKEKKLEA--------- 263 (326)
T ss_dssp HHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT-------SCSBHHHHHTTT------TSSCCSTT---------
T ss_pred HhccCCCCccccchhHHHHHHHHHhCCCcccccccccc-------cchhHHHHHHHH------hhchhhhh---------
Confidence 99988899999999999999999999999963110000 000000000000 00000000
Q ss_pred CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
..............++.+.+++.+||+.||++|||+.|+++|-.-
T Consensus 264 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 264 -LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp -SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred -hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 000000011112235789999999999999999999999997543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=319.94 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=187.0
Q ss_pred cccccCCeEEE-eEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 16 HDHICYRYEIL-EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 16 ~~~~~~rY~i~-~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
...+.++|.++ +.||+|+||.||+|.+..++.. |+|++...
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------------------------- 54 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------------------------------- 54 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------------------------------
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------------------------------------
Confidence 34566777777 7899999999999999888864 88887321
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE----cCeEEEEEeecC-cCHHHHHHhhCCCCCCH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF----RNHLCISFELMN-LNLYELIKRNNYQGFSL 168 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~ 168 (429)
..+.+|++++.++. .||||+++++++.. ...+++||||+. ++|.+++.......+++
T Consensus 55 -------------~~~~~e~~~~~~~~-----~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 116 (299)
T 3m2w_A 55 -------------PKARREVELHWRAS-----QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 116 (299)
T ss_dssp -------------HHHHHHHHHHHHHT-----TSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBH
T ss_pred -------------HHHHHHHHHHHHhc-----cCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCH
Confidence 13345888874442 23499999999987 678999999996 59999999876567999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccCcceeeecCccccchhhhhCCCCCC
Q psy17270 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 169 ~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
..+..++.|++.||+|||++|++||||||+||+++.++ ...++|+|||++.... +..++.
T Consensus 117 ~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-------------------~~~~~~ 177 (299)
T 3m2w_A 117 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------------GEKYDK 177 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------------------TCGGGG
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-------------------cccCCc
Confidence 99999999999999999999999999999999999832 1289999999985432 234677
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
++|||||||++|+|++|..||.+.+.......+. ............
T Consensus 178 ~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~ 223 (299)
T 3m2w_A 178 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----------------------------------TRIRMGQYEFPN 223 (299)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCC-------CCSC----------------------------------CSSCTTCCSSCH
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH----------------------------------HHHhhccccCCc
Confidence 9999999999999999999998755432110000 000000011112
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
......++++.+||.+||+.||++|||+.|+++||||++...
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 223456899999999999999999999999999999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=319.48 Aligned_cols=247 Identities=19% Similarity=0.265 Sum_probs=197.8
Q ss_pred ccCCeEEEe-EeeccccceEEEEEe--cCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 19 ICYRYEILE-VIGKGSFGQVIRALD--HKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 19 ~~~rY~i~~-~lG~G~~g~Vy~a~~--~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
-.++|++.+ .||+|+||+||+|.+ ..++. +|+|++......
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~----------------------------------- 58 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND----------------------------------- 58 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------------------------------------
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-----------------------------------
Confidence 367899999 999999999999965 44443 488887533211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
......+.+|+++++.++|+ ||+++++++ .....++||||+. ++|.+++.... .+++..+..
T Consensus 59 --------~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 121 (291)
T 1xbb_A 59 --------PALKDELLAEANVMQQLDNP------YIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 121 (291)
T ss_dssp --------CHHHHHHHHHHHHHHTCCCT------TBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHH
T ss_pred --------HHHHHHHHHHHHHHHhCCCC------CEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHH
Confidence 12234566799999999776 999999998 5678999999996 69999998754 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhCCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... ....+|+.|+|||++.+..++.
T Consensus 122 i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 199 (291)
T 1xbb_A 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199 (291)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEH
T ss_pred HHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC--cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCCh
Confidence 999999999999999999999999999999988 89999999997643321 1234567899999999888899
Q ss_pred CccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 248 PIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 248 ~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 200 ~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------------------- 238 (291)
T 1xbb_A 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----------------------------------------- 238 (291)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------------------------------
T ss_pred hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------------------------------
Confidence 9999999999999999 9999999887665544432100
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...+...++.+.++|.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0001234788999999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=321.38 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=188.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+-.++|++.+.||+|+||+||+|.+. ...+|+|++....
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---------------------------------------- 43 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES---------------------------------------- 43 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT----------------------------------------
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh----------------------------------------
Confidence 34678999999999999999999985 3346888764221
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC-CCCCHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY-QGFSLGLIRRFA 175 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~-~~~~~~~~~~i~ 175 (429)
....+.+|+++++.++|+ ||+++++++. +..++||||+. ++|.+++..... ..++...+..++
T Consensus 44 -------~~~~~~~E~~~l~~l~hp------~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 108 (307)
T 2eva_A 44 -------ERKAFIVELRQLSRVNHP------NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108 (307)
T ss_dssp -------HHHHHHHHHHHHHHCCCT------TBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHH
T ss_pred -------HHHHHHHHHHHHhcCCCC------CcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHH
Confidence 123456699999999876 9999999875 56899999995 699999986542 137899999999
Q ss_pred HHHHHHHHHHHH---CCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 176 FSLVQCLRLLHR---ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~---~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.|++.||+|||+ +||+||||||+||+++.++. .+||+|||++...........||+.|+|||++.+..++.++|||
T Consensus 109 ~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 187 (307)
T 2eva_A 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVF 187 (307)
T ss_dssp HHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHH
T ss_pred HHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHH
Confidence 999999999999 89999999999999998762 37999999997766555566799999999999998999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHH--HHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQ--LACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||++|+|++|+.||........ ...+.. +.. ....
T Consensus 188 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~---------------------------------------~~~~ 226 (307)
T 2eva_A 188 SWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTR---------------------------------------PPLI 226 (307)
T ss_dssp HHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCC---------------------------------------CCCB
T ss_pred HHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCC---------------------------------------CCcc
Confidence 999999999999999976433211 111100 000 0011
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
...++.+.++|.+||+.||++|||+.+++++
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 2347889999999999999999999999884
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=321.26 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=192.1
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
++....++|++.+.||+|+||.||+|.+..++.. |+|++......
T Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------------------------------- 71 (310)
T 2wqm_A 26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM---------------------------------- 71 (310)
T ss_dssp GTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC----------------------------------
T ss_pred cccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc----------------------------------
Confidence 4455678899999999999999999999888764 88887532111
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhh--CCCCCCHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRN--NYQGFSLGL 170 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~--~~~~~~~~~ 170 (429)
.......+.+|+++++.++|+ ||+++++++......++||||+. ++|.+++... ....+++..
T Consensus 72 --------~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 137 (310)
T 2wqm_A 72 --------DAKARADCIKEIDLLKQLNHP------NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137 (310)
T ss_dssp --------CHHHHHHHHHHHHHHHTCCCT------TBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHH
T ss_pred --------CHHHHHHHHHHHHHHHhCCCC------CEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHH
Confidence 111233566799999998776 99999999999999999999996 4999998753 234599999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCCCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...... .....+|+.|+|||++.+..++.
T Consensus 138 ~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (310)
T 2wqm_A 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 215 (310)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC------------------CCSSCCHHHHTTCCCCH
T ss_pred HHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--CEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCc
Confidence 999999999999999999999999999999999888 8999999998754332 23356899999999999988999
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCH--HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENE--VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
++|||||||++|+|++|..||.+... ......+.. ...++ .
T Consensus 216 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-------------------------------~----- 258 (310)
T 2wqm_A 216 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPP-------------------------------L----- 258 (310)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSCC-------------------------------C-----
T ss_pred hhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCCC-------------------------------C-----
Confidence 99999999999999999999976432 122211111 00000 0
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.....++.+.+||.+||+.||++|||+.+++++
T Consensus 259 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 259 ---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 001237889999999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=334.13 Aligned_cols=267 Identities=19% Similarity=0.227 Sum_probs=200.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
...++|++.+.||+|+||+||+|.+.....+|+|++.....
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------------------------------- 76 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--------------------------------------- 76 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---------------------------------------
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---------------------------------------
Confidence 36789999999999999999999987555668887643311
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC--CCCCHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY--QGFSLGLIRRF 174 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~--~~~~~~~~~~i 174 (429)
.....+.+|+++++.++|+ ||+++++++......++||||+. ++|.+++..... ..+++..+..+
T Consensus 77 ------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 144 (321)
T 2qkw_B 77 ------QGIEEFETEIETLSFCRHP------HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144 (321)
T ss_dssp ------SHHHHHHHHHHGGGSCCCT------TBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHH
T ss_pred ------HHHHHHHHHHHHHHhCCCC------CEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHH
Confidence 1123456688888888766 99999999999999999999995 699998865432 24899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCCc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
+.|++.||+|||++|++||||||+||+++.++ .+||+|||++...... .....||+.|+|||++.+..++.++
T Consensus 145 ~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 222 (321)
T 2qkw_B 145 CIGAARGLHYLHTRAIIHRDVKSINILLDENF--VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKS 222 (321)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCSTTEEECTTC--CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHH
T ss_pred HHHHHHHHHHhcCCCeecCCCCHHHEEECCCC--CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCccc
Confidence 99999999999999999999999999999888 8999999998753321 2234689999999999988999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||.+....+....+. +.... . ......... .+ ......
T Consensus 223 Di~slG~il~ell~g~~p~~~~~~~~~~~~~~---------~~~~~-~-----~~~~~~~~~--------~~--~~~~~~ 277 (321)
T 2qkw_B 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAE---------WAVES-H-----NNGQLEQIV--------DP--NLADKI 277 (321)
T ss_dssp HHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH---------HTHHH-H-----TTTCCCSSS--------SS--SCTTCS
T ss_pred chHhHHHHHHHHHhCCCcccccCcHHHHHHHH---------Hhhhc-c-----ccccHHHhc--------Ch--hhcccc
Confidence 99999999999999999997654321110000 00000 0 000000000 00 000011
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHE 362 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~ 362 (429)
....+..+.+++.+||+.||++|||+.|++++-
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 122357889999999999999999999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=321.38 Aligned_cols=248 Identities=19% Similarity=0.250 Sum_probs=195.3
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
.-+|++.+.||+|+||+||+|.+..++. +|+|++......
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~------------------------------------ 63 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM------------------------------------ 63 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH------------------------------------
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH------------------------------------
Confidence 3456677999999999999999866553 488876432221
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeE-EEEEeec-CcCHHHHHHhhCCCCCCHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHL-CISFELM-NLNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~-~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.....+.+|+++++.++|+ ||+++++++...... ++||||+ +++|.+++.... ..+++..+..
T Consensus 64 --------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~ 128 (298)
T 3pls_A 64 --------QQVEAFLREGLLMRGLNHP------NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLIS 128 (298)
T ss_dssp --------HHHHHHHHHHHHHHTCCCT------TBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHH
T ss_pred --------HHHHHHHHHHHHHHhCCCC------CeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHH
Confidence 1223556699999999776 999999999876654 9999999 579999997643 4589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-------cceeeecCccccchhhhhCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-------RVYTYIQSRFYRSPEVILGLPYG 246 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~ 246 (429)
++.|++.||+|||++|++||||||+||+++.++ .++|+|||++..... ......+|+.|+|||++.+..++
T Consensus 129 i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 206 (298)
T 3pls_A 129 FGLQVARGMEYLAEQKFVHRDLAARNCMLDESF--TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT 206 (298)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCC
Confidence 999999999999999999999999999999888 899999999964322 12234567889999999998999
Q ss_pred CCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 247 PPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 247 ~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
.++|||||||++|+|++ |.+||...+..+....+......+.
T Consensus 207 ~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------- 249 (298)
T 3pls_A 207 TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ------------------------------------- 249 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC-------------------------------------
T ss_pred hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC-------------------------------------
Confidence 99999999999999999 5666666665544433332110000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
....++.+.+|+.+||+.||.+|||+.++++.
T Consensus 250 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 250 ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11236789999999999999999999998773
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=350.14 Aligned_cols=254 Identities=21% Similarity=0.276 Sum_probs=208.5
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
++..++|++.++||+|+||.||+|.+..+..+|+|++.....
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------------------------------------- 304 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-------------------------------------- 304 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--------------------------------------
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--------------------------------------
Confidence 456789999999999999999999998777789888743211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
..+.+.+|+++++.++|+ ||+++++++.. ..+|+|||||. |+|.+++.......+++..+..++
T Consensus 305 --------~~~~~~~E~~~l~~l~hp------niv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~ 369 (535)
T 2h8h_A 305 --------SPEAFLQEAQVMKKLRHE------KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 369 (535)
T ss_dssp --------CHHHHHHHHHHHHHCCCT------TBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHH
T ss_pred --------CHHHHHHHHHHHHhCCCC------CEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHH
Confidence 123566799999999877 99999999865 77899999995 699999986543459999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||++....... ....++..|+|||++.+..++.++||
T Consensus 370 ~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv 447 (535)
T 2h8h_A 370 AQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447 (535)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC--cEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhH
Confidence 9999999999999999999999999999887 89999999997654321 12345678999999998899999999
Q ss_pred cchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||++|+|++ |+.||.+.+..+.+..+......+ ..
T Consensus 448 wSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-----------------------------------------~~ 486 (535)
T 2h8h_A 448 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-----------------------------------------CP 486 (535)
T ss_dssp HHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC-----------------------------------------CC
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------------------CC
Confidence 999999999999 999999988777665554211100 01
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcC--CCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRH--EWLKS 366 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h--~~~~~ 366 (429)
..+++.+.+||.+||+.||++|||+.++++. .+|..
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 2347889999999999999999999999874 55544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=326.74 Aligned_cols=265 Identities=17% Similarity=0.231 Sum_probs=199.0
Q ss_pred hcccc-cCCeEEEeEeeccccceEEEEE----ecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccc
Q psy17270 15 LHDHI-CYRYEILEVIGKGSFGQVIRAL----DHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLS 88 (429)
Q Consensus 15 ~~~~~-~~rY~i~~~lG~G~~g~Vy~a~----~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~ 88 (429)
+++++ .++|++++.||+|+||.||+|+ +..++. +|+|++......
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------------- 66 (327)
T 3lxl_A 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD----------------------------- 66 (327)
T ss_dssp -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHH-----------------------------
T ss_pred hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHH-----------------------------
Confidence 34445 5799999999999999999999 455665 488887543211
Q ss_pred cCCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--cCeEEEEEeec-CcCHHHHHHhhCCCC
Q psy17270 89 QNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--RNHLCISFELM-NLNLYELIKRNNYQG 165 (429)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~-~g~L~~~i~~~~~~~ 165 (429)
....+.+|+++++.+.|+ ||+++++++.. ...+++||||+ +++|.+++.... ..
T Consensus 67 ----------------~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~ 123 (327)
T 3lxl_A 67 ----------------QQRDFQREIQILKALHSD------FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-AR 123 (327)
T ss_dssp ----------------HHHHHHHHHHHHHTCCCT------TBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG-GG
T ss_pred ----------------HHHHHHHHHHHHHhcCCC------ceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc-cC
Confidence 123456699999999776 99999999874 45799999999 579999998754 34
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhh
Q psy17270 166 FSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEV 239 (429)
Q Consensus 166 ~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~ 239 (429)
+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++....... ....+|+.|+|||+
T Consensus 124 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 201 (327)
T 3lxl_A 124 LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA--HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC--CEEEcccccceecccCCccceeeccCCccccccCHHH
Confidence 99999999999999999999999999999999999999988 89999999997543221 22457778999999
Q ss_pred hhCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCc--HHHHhhhhhhhhhccCCCCCccccCCCCC
Q psy17270 240 ILGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP--DEVINTASRRRLFFDSKGTPRCITNSKGR 317 (429)
Q Consensus 240 ~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (429)
+.+..++.++|||||||++|+|++|..||.......... .......+ ......... ..
T Consensus 202 ~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-------~~----------- 261 (327)
T 3lxl_A 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM--MGCERDVPALSRLLELLEE-------GQ----------- 261 (327)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--CC----CCHHHHHHHHHHT-------TC-----------
T ss_pred hccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh--cccccccccHHHHHHHhhc-------cc-----------
Confidence 999889999999999999999999999997643321110 00000000 000000000 00
Q ss_pred CCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
........++.+.+||.+||+.||++|||+.|++++
T Consensus 262 --------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 262 --------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000112347899999999999999999999999654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=320.30 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=194.1
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecC-CCc---chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHK-TNT---HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-~~~---~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
.+..++|++++.||+|+||+||+|.+.. ++. +|+|++......
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------------------------------- 60 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS--------------------------------- 60 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------------------------------
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC---------------------------------
Confidence 3457899999999999999999999743 332 588877433211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
.......+.+|+++++.++|+ ||+++++++.... .++|||++. ++|.+++.... ..+++..+
T Consensus 61 ---------~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~ 123 (291)
T 1u46_A 61 ---------QPEAMDDFIREVNAMHSLDHR------NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTL 123 (291)
T ss_dssp ----------CHHHHHHHHHHHHHHHCCCT------TBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHH
T ss_pred ---------CHHHHHHHHHHHHHHHhCCCC------CcccEEEEEccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHH
Confidence 112234566799999999776 9999999987654 889999995 69999998754 34999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~ 245 (429)
..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....... ....+|..|+|||++.+..+
T Consensus 124 ~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (291)
T 1u46_A 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201 (291)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC--CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCC
Confidence 99999999999999999999999999999999988 89999999987644321 22456778999999998888
Q ss_pred CCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 246 GPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 246 ~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
+.++|||||||++|+|++ |..||.+.+..+.+..+......++
T Consensus 202 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------------ 245 (291)
T 1u46_A 202 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP------------------------------------ 245 (291)
T ss_dssp EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC------------------------------------
T ss_pred CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC------------------------------------
Confidence 999999999999999999 9999999887766655432100000
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.....++.+.++|.+||+.||++|||+.++++
T Consensus 246 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 246 ----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01234788999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=325.39 Aligned_cols=262 Identities=21% Similarity=0.261 Sum_probs=196.6
Q ss_pred cccCCe-EEEeEeeccccceEEEEEe----cCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 18 HICYRY-EILEVIGKGSFGQVIRALD----HKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 18 ~~~~rY-~i~~~lG~G~~g~Vy~a~~----~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
.+.+|| ++++.||+|+||+||+|.. ..++. +|+|++.......
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------- 75 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ------------------------------- 75 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHH-------------------------------
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChH-------------------------------
Confidence 477888 9999999999999988864 33444 4888875442221
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc--CeEEEEEeecC-cCHHHHHHhhCCCCCCH
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR--NHLCISFELMN-LNLYELIKRNNYQGFSL 168 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~-g~L~~~i~~~~~~~~~~ 168 (429)
....+.+|+++++.++|+ ||+++++++... ..+++||||+. ++|.+++.... +++
T Consensus 76 -------------~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~ 133 (318)
T 3lxp_A 76 -------------HRSGWKQEIDILRTLYHE------HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGL 133 (318)
T ss_dssp -------------HHHHHHHHHHHHHHCCCT------TBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC---CCH
T ss_pred -------------HHHHHHHHHHHHHhCCCc------chhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC---CCH
Confidence 123456699999999876 999999999884 58999999995 59999987654 999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhhC
Q psy17270 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILG 242 (429)
Q Consensus 169 ~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~ 242 (429)
..+..++.|++.||+|||++||+|+||||+||+++.++ .++|+|||++...... .....+|..|+|||++.+
T Consensus 134 ~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 211 (318)
T 3lxp_A 134 AQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC--CEEECCccccccccccccccccccCCCCCceeeChHHhcC
Confidence 99999999999999999999999999999999999888 8999999999765432 223457788999999999
Q ss_pred CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
..++.++|||||||++|+|+||..||...... .....+............... ....
T Consensus 212 ~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~---------------- 268 (318)
T 3lxp_A 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQMTVLRLTELL--ERGE---------------- 268 (318)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHHHHHHHHHHH--HTTC----------------
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccchhHHHHHHHH--hccc----------------
Confidence 88999999999999999999999999764321 111111111111100000000 0000
Q ss_pred CchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
........++.+.+||++||+.||++|||+.|+++
T Consensus 269 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 269 ---RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00011234789999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=321.18 Aligned_cols=251 Identities=18% Similarity=0.208 Sum_probs=192.7
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCC---C-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKT---N-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~---~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
..++|++.+.||+|+||+||+|.+... + .+|+|++.......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------------- 77 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ---------------------------------- 77 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH----------------------------------
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch----------------------------------
Confidence 468999999999999999999988653 2 35888875332111
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-----eEEEEEeecC-cCHHHHHHhh----CCC
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-----HLCISFELMN-LNLYELIKRN----NYQ 164 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~-g~L~~~i~~~----~~~ 164 (429)
.....+.+|+++++.++|+ ||+++++++.... ..++||||+. ++|.+++... ...
T Consensus 78 ---------~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~ 142 (313)
T 3brb_A 78 ---------REIEEFLSEAACMKDFSHP------NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK 142 (313)
T ss_dssp ---------HHHHHHHHHHHHHHTCCCT------TBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCC
T ss_pred ---------hHHHHHHHHHHHHhcCCCC------CeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCc
Confidence 1123456699999999876 9999999987654 4699999995 6999998543 224
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhh
Q psy17270 165 GFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEV 239 (429)
Q Consensus 165 ~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~ 239 (429)
.+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++...... .....+++.|+|||+
T Consensus 143 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 220 (313)
T 3brb_A 143 HIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM--TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 220 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS--CEEECSCSCC----------------CCGGGSCHHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEEeecCcceecccccccCcccccCCCccccCchh
Confidence 599999999999999999999999999999999999999888 8999999998754322 223456788999999
Q ss_pred hhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCC
Q psy17270 240 ILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318 (429)
Q Consensus 240 ~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (429)
+.+..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 221 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------- 268 (313)
T 3brb_A 221 LADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL-------------------------------- 268 (313)
T ss_dssp HHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--------------------------------
T ss_pred hcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC--------------------------------
Confidence 999999999999999999999999 99999887766554443321000
Q ss_pred CCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+...++.+.++|.+||+.||++|||+.+++++
T Consensus 269 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 ---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012346889999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=325.09 Aligned_cols=258 Identities=22% Similarity=0.253 Sum_probs=191.2
Q ss_pred hhhhcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 12 FQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 12 ~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
....+..+.++|++++.||+|+||.||+|.+. ...+|+|++.....
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~--------------------------------- 73 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--------------------------------- 73 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---------------------------------
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---------------------------------
Confidence 34556778899999999999999999999986 34569998743211
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc----CeEEEEEeecC-cCHHHHHHhhCCCCC
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR----NHLCISFELMN-LNLYELIKRNNYQGF 166 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~-g~L~~~i~~~~~~~~ 166 (429)
.....|.+++..+. ..|+||+++++++... ..+++||||+. |+|.+++.... +
T Consensus 74 ---------------~~~~~e~~~~~~~~----~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~ 131 (337)
T 3mdy_A 74 ---------------ASWFRETEIYQTVL----MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---L 131 (337)
T ss_dssp ---------------HHHHHHHHHHTSTT----CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCC---B
T ss_pred ---------------chhhhHHHHHHHHh----hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccC---C
Confidence 11222444444431 2456999999999887 78999999995 59999997653 9
Q ss_pred CHHHHHHHHHHHHHHHHHHHHC--------CceecccCCCcEEEecCCCcceEEeeecccccccCcc-------eeeecC
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRE--------NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV-------YTYIQS 231 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~--------~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~-------~~~~~t 231 (429)
++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++....... ....||
T Consensus 132 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt 209 (337)
T 3mdy_A 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVKFISDTNEVDIPPNTRVGT 209 (337)
T ss_dssp CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTTCEECC---------CCSSCSC
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC--CEEEEeCCCceeeccccccccCCCCCCccC
Confidence 9999999999999999999999 999999999999999888 89999999996543221 235789
Q ss_pred ccccchhhhhCCCCCCC------ccccchhhHHHHHhhC----------CCCCCCCCH----HHHHHHHHHHhCCCcHHH
Q psy17270 232 RFYRSPEVILGLPYGPP------IDMWSLGCILAELYTG----------CPLFPGENE----VEQLACIMEILGCPPDEV 291 (429)
Q Consensus 232 ~~y~aPE~~~~~~~~~~------~DiwSlG~il~~lltg----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~ 291 (429)
+.|+|||++.+..++.. +|||||||++|+|+|| ..||..... .............
T Consensus 210 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----- 284 (337)
T 3mdy_A 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL----- 284 (337)
T ss_dssp GGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC-----
T ss_pred cceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhcc-----
Confidence 99999999988776665 9999999999999999 666654321 1111111100000
Q ss_pred HhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 292 INTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
....+ ........++.+.+||.+||+.||++|||+.|++++
T Consensus 285 -------------------------~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 285 -------------------------RPSFP----NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp -------------------------CCCCC----GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -------------------------Ccccc----ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 00000 000011235678999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=329.58 Aligned_cols=201 Identities=20% Similarity=0.281 Sum_probs=166.9
Q ss_pred cccCCeEEEeEeeccccceEEEEE-----ecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRAL-----DHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~-----~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
.-.++|++.+.||+|+||+||+|. +..++. +|+|++....
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------------------------------- 107 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---------------------------------- 107 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----------------------------------
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----------------------------------
Confidence 457889999999999999999995 455554 4888774321
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhh---CCCCCC
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRN---NYQGFS 167 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~---~~~~~~ 167 (429)
...+..|+++++.+.+. .|+||+.+++++...+..|+|||||. |+|.+++... ....++
T Consensus 108 --------------~~~~~~e~~~~~~l~~~---~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~ 170 (365)
T 3e7e_A 108 --------------PWEFYIGTQLMERLKPS---MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170 (365)
T ss_dssp --------------HHHHHHHHHHHHHSCGG---GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCC
T ss_pred --------------hhHHHHHHHHHHHhhhh---hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCC
Confidence 22445588888887643 45699999999999999999999995 7999999753 234599
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEec-----------CCCcceEEeeeccccccc-----CcceeeecC
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQ-----------RGSSSIKVIDFGSSCYSH-----QRVYTYIQS 231 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~-----------~~~~~vkl~Dfg~~~~~~-----~~~~~~~~t 231 (429)
+..+..++.||+.||+|||++||+||||||+|||++. ++ .+||+|||+++... ......+||
T Consensus 171 ~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~gt 248 (365)
T 3e7e_A 171 QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA--GLALIDLGQSIDMKLFPKGTIFTAKCET 248 (365)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT--TEEECCCTTCEEGGGSCTTEEECCSSCT
T ss_pred HHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC--CEEEeeCchhhhhhccCCCceeeeecCC
Confidence 9999999999999999999999999999999999988 56 89999999996432 223346799
Q ss_pred ccccchhhhhCCCCCCCccccchhhHHHHHhhCCCCCCCC
Q psy17270 232 RFYRSPEVILGLPYGPPIDMWSLGCILAELYTGCPLFPGE 271 (429)
Q Consensus 232 ~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~ 271 (429)
+.|+|||++.+..|+.++|||||||++|+|+||+.||...
T Consensus 249 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp TSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred CCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 9999999999999999999999999999999999999653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=333.84 Aligned_cols=248 Identities=19% Similarity=0.276 Sum_probs=188.1
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCC----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTN----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
..+|++.+.||+|+||+||+|.+..++ .+|+|.+......
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~------------------------------------ 131 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI------------------------------------ 131 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS------------------------------------
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH------------------------------------
Confidence 346899999999999999999986443 2377766432111
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE-cCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-RNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.....+.+|+.+++.++|+ ||+++++++.. +...++||||+. |+|.+++.... ..+++..+..
T Consensus 132 --------~~~~~~~~E~~il~~l~hp------nIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~ 196 (373)
T 3c1x_A 132 --------GEVSQFLTEGIIMKDFSHP------NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIG 196 (373)
T ss_dssp --------HHHHHHHHHHTTSTTCCCT------TBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHH
T ss_pred --------HHHHHHHHHHHHHHhCCCC------CcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHH
Confidence 1223566688888888766 99999998654 568899999995 59999997654 4589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-------ceeeecCccccchhhhhCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-------VYTYIQSRFYRSPEVILGLPYG 246 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~ 246 (429)
++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .....+|+.|+|||++.+..++
T Consensus 197 i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 274 (373)
T 3c1x_A 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 274 (373)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC---------------------CCGGGSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHCCEecCccchheEEECCCC--CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCC
Confidence 999999999999999999999999999999888 8999999999754321 1224567789999999998999
Q ss_pred CCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 247 PPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 247 ~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
.++|||||||++|+|+| |.+||.+.+..+....+.......
T Consensus 275 ~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~-------------------------------------- 316 (373)
T 3c1x_A 275 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-------------------------------------- 316 (373)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC--------------------------------------
T ss_pred cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC--------------------------------------
Confidence 99999999999999999 788998766544433332210000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+...++.+.++|.+||+.||++|||+.|++++
T Consensus 317 ---~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012247889999999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=340.75 Aligned_cols=256 Identities=15% Similarity=0.112 Sum_probs=188.7
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
..|.+.+.||+|+||+||+|.+..+++. |||++........
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~-------------------------------------- 119 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-------------------------------------- 119 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----------------------------------------
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH--------------------------------------
Confidence 3488999999999999999999988865 9998753221111
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCC----------C------CCCCceeEEEEEEEE-----cCeEEEEEeecCcCHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKD----------A------DSSYNVIHMLEYFYF-----RNHLCISFELMNLNLYELI 158 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~----------~------~~~~~i~~~~~~~~~-----~~~~~lv~e~~~g~L~~~i 158 (429)
.....+.+|+.+++.+.|.. . ...++...+..++.. ...++++|+.+.++|.+++
T Consensus 120 ----~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll 195 (413)
T 3dzo_A 120 ----NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195 (413)
T ss_dssp -----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHH
T ss_pred ----HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHH
Confidence 11233555777766666521 0 011112222222222 2368899999999999998
Q ss_pred Hhh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCcc
Q psy17270 159 KRN-----NYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF 233 (429)
Q Consensus 159 ~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~ 233 (429)
... ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.........+| +.
T Consensus 196 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~--~~kL~DFG~a~~~~~~~~~~~g-~~ 272 (413)
T 3dzo_A 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--GVFLTGFEHLVRDGASAVSPIG-RG 272 (413)
T ss_dssp HHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCGGGCEETTEEECCCCC-TT
T ss_pred HHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCC--eEEEEeccceeecCCccccCCC-Cc
Confidence 622 223377889999999999999999999999999999999999998 8999999999877666666778 99
Q ss_pred ccchhhh----------hCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhcc
Q psy17270 234 YRSPEVI----------LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFD 303 (429)
Q Consensus 234 y~aPE~~----------~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 303 (429)
|+|||++ .+..++.++|||||||++|+|+||+.||.+.+..+....+
T Consensus 273 y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~----------------------- 329 (413)
T 3dzo_A 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI----------------------- 329 (413)
T ss_dssp TCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG-----------------------
T ss_pred eeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH-----------------------
Confidence 9999999 4445788999999999999999999999875432111000
Q ss_pred CCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 304 SKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.......++.+.+||.+||+.||++|||+.++++||||+..
T Consensus 330 -----------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 330 -----------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp -----------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -----------------------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 00011336889999999999999999999999999999764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=321.66 Aligned_cols=250 Identities=20% Similarity=0.267 Sum_probs=191.8
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..++|++++.||+|+||.||+|.+..++.. |+|++.....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------------------- 67 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--------------------------------------- 67 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH---------------------------------------
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH---------------------------------------
Confidence 467899999999999999999999888865 9998743211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE----cCeEEEEEeecC-cCHHHHHHhh--CCCCCCHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF----RNHLCISFELMN-LNLYELIKRN--NYQGFSLGL 170 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~-g~L~~~i~~~--~~~~~~~~~ 170 (429)
.....+.+|+++++.++|+ ||+++++++.. ....++||||+. ++|.+++... ....+++..
T Consensus 68 ------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 135 (317)
T 2buj_A 68 ------QDREEAQREADMHRLFNHP------NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ 135 (317)
T ss_dssp ------HHHHHHHHHHHHHHTCCCT------TBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHH
T ss_pred ------HHHHHHHHHHHHHhhcCCC------CeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHH
Confidence 1123455699999998776 99999999873 347899999996 5999999864 224599999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------------eeeecCccccchh
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------------YTYIQSRFYRSPE 238 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------------~~~~~t~~y~aPE 238 (429)
+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++....... ....||+.|+|||
T Consensus 136 ~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 213 (317)
T 2buj_A 136 ILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG--QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213 (317)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGG
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--CEEEEecCcchhcccccccccccccccccccccCCcccCCHh
Confidence 999999999999999999999999999999999888 89999999886533211 1235689999999
Q ss_pred hhhCCC---CCCCccccchhhHHHHHhhCCCCCCCCCHHH-HHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCC
Q psy17270 239 VILGLP---YGPPIDMWSLGCILAELYTGCPLFPGENEVE-QLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314 (429)
Q Consensus 239 ~~~~~~---~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (429)
++.+.. ++.++|||||||++|+|++|+.||....... .+..... . ..
T Consensus 214 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~-------------~~-------------- 264 (317)
T 2buj_A 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--N-------------QL-------------- 264 (317)
T ss_dssp GSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--C-------------C---------------
T ss_pred HhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--c-------------cC--------------
Confidence 997654 6889999999999999999999995311100 0000000 0 00
Q ss_pred CCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+ .....++.+.+||.+||+.||++|||+.+++++
T Consensus 265 ----~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 ----SIP-------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -----CC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCC-------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 000 012337889999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.63 Aligned_cols=280 Identities=22% Similarity=0.304 Sum_probs=202.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
...++|++.+.||.|+||+||+|.+..++.. |+|++.......
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~------------------------------------ 54 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK------------------------------------ 54 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHH------------------------------------
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHH------------------------------------
Confidence 4558999999999999999999999888865 888875432221
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE------cCeEEEEEeec-CcCHHHHHHhhCC-CCCCH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF------RNHLCISFELM-NLNLYELIKRNNY-QGFSL 168 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~------~~~~~lv~e~~-~g~L~~~i~~~~~-~~~~~ 168 (429)
....+.+|+++++.++|+ ||+++++++.. ....++||||| +|+|.+++..... .++++
T Consensus 55 --------~~~~~~~Ei~iL~~L~Hp------nIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse 120 (676)
T 3qa8_A 55 --------NRERWCLEIQIMKKLNHP------NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120 (676)
T ss_dssp --------HHHHHHHHHHHHHHCCBT------TBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCS
T ss_pred --------HHHHHHHHHHHHHhCCCC------CCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCH
Confidence 123456699999999877 99999998755 56889999999 5699999987542 25999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCC-cceEEeeecccccccCc--ceeeecCccccchhhhhCCCC
Q psy17270 169 GLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS-SSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 169 ~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~-~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~ 245 (429)
..+..++.|++.||+|||++||+||||||+||+++.++. ..++|+|||++...... .....||+.|+|||++.+..+
T Consensus 121 ~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 200 (676)
T 3qa8_A 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKY 200 (676)
T ss_dssp SHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCC
T ss_pred HHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCC
Confidence 999999999999999999999999999999999997652 24899999999765432 334678999999999999899
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCC-CCCc
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRK-PGSK 324 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 324 (429)
+.++|||||||++|+|++|..||.+......+.. ......... .... ....+.... ....
T Consensus 201 s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~------~i~~~~~~~-----~~~~--------~~l~g~~~~~~~lp 261 (676)
T 3qa8_A 201 TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG------KVREKSNEH-----IVVY--------DDLTGAVKFSSVLP 261 (676)
T ss_dssp STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST------TCC-----------CCSC--------CCCSSSCCCCSSSC
T ss_pred CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh------hhhcccchh-----hhhh--------hhhccccccccccC
Confidence 9999999999999999999999987654322110 000000000 0000 000000000 0001
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.........++.+.+||.+||.+||++|||+.|+++||||+.
T Consensus 262 ~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 262 TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 111222345688999999999999999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=325.87 Aligned_cols=280 Identities=24% Similarity=0.317 Sum_probs=185.8
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+--++|++++.||+|+||+||+|.+. ...+|+|++......
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-------------------------------------- 50 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ-------------------------------------- 50 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGGHH--------------------------------------
T ss_pred cChHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccchh--------------------------------------
Confidence 34689999999999999999999873 334599987533211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeec-CcCHHHHHHhhCCCCCCHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELM-NLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~ 171 (429)
.+..|.+++.. ....|+||+++++.+... ..+++||||| +|+|.+++.... .++..+
T Consensus 51 ----------~~~~e~~~~~~----~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~ 113 (336)
T 3g2f_A 51 ----------NFINEKNIYRV----PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSS 113 (336)
T ss_dssp ----------HHHHHHHHHTS----TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHH
T ss_pred ----------hHHHHHHHHHH----HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHH
Confidence 11123333221 123455999999866532 3689999999 569999997755 689999
Q ss_pred HHHHHHHHHHHHHHHHC---------CceecccCCCcEEEecCCCcceEEeeecccccccCc-----------ceeeecC
Q psy17270 172 RRFAFSLVQCLRLLHRE---------NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----------VYTYIQS 231 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~---------~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----------~~~~~~t 231 (429)
..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...... ....+||
T Consensus 114 ~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt 191 (336)
T 3g2f_A 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191 (336)
T ss_dssp HHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCTTCEECSSSSCC---------CCTTSC
T ss_pred HHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC--cEEEeeccceeecccccccCccccccccccCCCc
Confidence 99999999999999999 999999999999999888 8999999999754321 1234689
Q ss_pred ccccchhhhhC-------CCCCCCccccchhhHHHHHhhCCCCC-CCCCHHHHHHHHHHHhC-CCcHHHHhhhhhhhhhc
Q psy17270 232 RFYRSPEVILG-------LPYGPPIDMWSLGCILAELYTGCPLF-PGENEVEQLACIMEILG-CPPDEVINTASRRRLFF 302 (429)
Q Consensus 232 ~~y~aPE~~~~-------~~~~~~~DiwSlG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ 302 (429)
+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+....+....+ .+..+........
T Consensus 192 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 267 (336)
T 3g2f_A 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR---- 267 (336)
T ss_dssp GGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTT----
T ss_pred cceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcc----
Confidence 99999999987 34567899999999999999996655 33322111111111111 1111111110000
Q ss_pred cCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHH------hcCCCCCCCCCCCCC
Q psy17270 303 DSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA------LRHEWLKSSSSSSSS 373 (429)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el------l~h~~~~~~~~~~~~ 373 (429)
... +...+ .........++.+.+||.+||+.||++|||+.|+ +-++|-++....+.+
T Consensus 268 -~~~----------~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~~~~~ 330 (336)
T 3g2f_A 268 -EKQ----------RPKFP---EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330 (336)
T ss_dssp -SCC----------CCCCC---TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--------
T ss_pred -ccc----------CCCCC---cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccCCCcc
Confidence 000 00000 0000011124579999999999999999999999 457898876555443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=343.54 Aligned_cols=249 Identities=20% Similarity=0.319 Sum_probs=201.7
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
++..++|++.+.||+|+||+||+|.+..++. +|+|++......
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--------------------------------- 432 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--------------------------------- 432 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH---------------------------------
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH---------------------------------
Confidence 4567899999999999999999999976542 377766432211
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
.....+.+|+.+++.++|+ ||+++++++ .++.+++||||+. |+|.+++.... ..+++..+
T Consensus 433 -----------~~~~~~~~E~~~l~~l~Hp------nIv~l~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~ 493 (656)
T 2j0j_A 433 -----------SVREKFLQEALTMRQFDHP------HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK-FSLDLASL 493 (656)
T ss_dssp -----------HHHHHHHHHHHHHHHCCCT------TBCCEEEEE-CSSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHH
T ss_pred -----------HHHHHHHHHHHHHHhCCCC------CCCeEEEEE-ecCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHH
Confidence 2234566799999999877 999999988 4567899999995 69999998654 35999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhhhCCCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++....... ....+|+.|+|||++.+..++.
T Consensus 494 ~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~--~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 571 (656)
T 2j0j_A 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571 (656)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC--CEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCc
Confidence 99999999999999999999999999999999988 89999999997654322 2245678899999999889999
Q ss_pred CccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 248 PIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 248 ~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 572 ~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------------- 612 (656)
T 2j0j_A 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--------------------------------------- 612 (656)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---------------------------------------
T ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---------------------------------------
Confidence 9999999999999997 999999988877766654311100
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+...++.+.+||.+||+.||++|||+.++++
T Consensus 613 --~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 613 --MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01234788999999999999999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=315.27 Aligned_cols=266 Identities=19% Similarity=0.273 Sum_probs=196.9
Q ss_pred hcccccCCeEEEeEeeccccceEEEEE----ecCCCc-chheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRAL----DHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~----~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
......++|++++.||+|+||.||+|. +..++. +|+|++.....
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------------------------------- 83 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE------------------------------- 83 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-------------------------------
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-------------------------------
Confidence 344567889999999999999999999 455565 48888743211
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC--eEEEEEeecC-cCHHHHHHhhCCCCC
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN--HLCISFELMN-LNLYELIKRNNYQGF 166 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~-g~L~~~i~~~~~~~~ 166 (429)
.....+.+|+++++.++|+ ||+++++++.... .+++||||+. ++|.+++.... ..+
T Consensus 84 --------------~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~ 142 (326)
T 2w1i_A 84 --------------EHLRDFEREIEILKSLQHD------NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERI 142 (326)
T ss_dssp --------------HHHHHHHHHHHHHHTCCCT------TBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST-TSS
T ss_pred --------------HHHHHHHHHHHHHHhCCCC------CeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCC
Confidence 1123466799999999776 9999999986544 7899999995 59999998764 459
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhh
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVI 240 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~ 240 (429)
++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++....... ....++..|+|||++
T Consensus 143 ~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 220 (326)
T 2w1i_A 143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220 (326)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC--cEEEecCcchhhccccccccccccCCCCceeEECchhh
Confidence 9999999999999999999999999999999999999988 89999999997654321 123466779999999
Q ss_pred hCCCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcH-HHHhhhhhhhhhccCCCCCccccCCCCCCC
Q psy17270 241 LGLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPD-EVINTASRRRLFFDSKGTPRCITNSKGRKR 319 (429)
Q Consensus 241 ~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (429)
.+..++.++|||||||++|+|+||..||..... . .....+.... ..........+. ... ..
T Consensus 221 ~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~-~~~-----------~~- 282 (326)
T 2w1i_A 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIGNDKQGQMIVFHLIELLK-NNG-----------RL- 282 (326)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--H---HHHHHCTTCCTHHHHHHHHHHHH-TTC-----------CC-
T ss_pred cCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--H---HHHhhccccchhhhHHHHHHHhh-cCC-----------CC-
Confidence 988889999999999999999999999865321 1 1111222111 111000000000 000 00
Q ss_pred CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
......++.+.+||++||+.||++|||+.|+++
T Consensus 283 --------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 283 --------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp --------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001234789999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=341.45 Aligned_cols=247 Identities=17% Similarity=0.212 Sum_probs=196.1
Q ss_pred ccCCeEEEe-EeeccccceEEEEEecCCC---cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 19 ICYRYEILE-VIGKGSFGQVIRALDHKTN---THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 19 ~~~rY~i~~-~lG~G~~g~Vy~a~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
..++|.+.+ .||+|+||+||+|.+..++ .+|+|++.....
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~------------------------------------ 376 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE------------------------------------ 376 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS------------------------------------
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC------------------------------------
Confidence 356677777 8999999999999886433 258887743211
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
......+.+|+++++.++|+ ||+++++++.. ..+++|||||. |+|.+++.... ..+++..+..
T Consensus 377 --------~~~~~~~~~E~~il~~l~hp------niv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~ 440 (613)
T 2ozo_A 377 --------KADTEEMMREAQIMHQLDNP------YIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAE 440 (613)
T ss_dssp --------STTHHHHHHHHHHHTTCCCT------TBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHH
T ss_pred --------hHHHHHHHHHHHHHHhCCCC------CEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHH
Confidence 11234567799999998776 99999999875 67999999995 69999987543 4599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhCCCCCC
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGLPYGP 247 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~ 247 (429)
++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ....+|+.|+|||++.+..++.
T Consensus 441 i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~ 518 (613)
T 2ozo_A 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518 (613)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC--cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCc
Confidence 999999999999999999999999999999988 99999999997643221 1223467899999999889999
Q ss_pred CccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 248 PIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 248 ~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
++|||||||++|||++ |+.||.+.+..+....+......
T Consensus 519 ~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---------------------------------------- 558 (613)
T 2ozo_A 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---------------------------------------- 558 (613)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC----------------------------------------
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----------------------------------------
Confidence 9999999999999998 99999998877666555421100
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+..+++.+.+||.+||+.||++|||+.++++
T Consensus 559 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 559 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 011234789999999999999999999999854
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=320.69 Aligned_cols=258 Identities=19% Similarity=0.243 Sum_probs=193.6
Q ss_pred hhhhcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 12 FQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 12 ~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
....+..+.++|++.+.||+|+||+||+|.+. ...+|+|++....
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---------------------------------- 77 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---------------------------------- 77 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG----------------------------------
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh----------------------------------
Confidence 34456678899999999999999999999984 3346999874321
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC----eEEEEEeecC-cCHHHHHHhhCCCCC
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN----HLCISFELMN-LNLYELIKRNNYQGF 166 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~-g~L~~~i~~~~~~~~ 166 (429)
...+.+|++++..+. ..||||+++++++.... .+++||||+. |+|.+++... .+
T Consensus 78 --------------~~~~~~e~~~~~~~~----l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~ 136 (342)
T 1b6c_B 78 --------------ERSWFREAEIYQTVM----LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TV 136 (342)
T ss_dssp --------------HHHHHHHHHHHHHSC----CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CB
T ss_pred --------------HHHHHHHHHHHHHhh----cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---Cc
Confidence 123445888888732 13449999999998776 8999999996 5999999764 39
Q ss_pred CHHHHHHHHHHHHHHHHHHH--------HCCceecccCCCcEEEecCCCcceEEeeecccccccCc-------ceeeecC
Q psy17270 167 SLGLIRRFAFSLVQCLRLLH--------RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-------VYTYIQS 231 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH--------~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-------~~~~~~t 231 (429)
++..+..++.|++.||+||| ++||+||||||+||+++.++ .++|+|||++...... .....||
T Consensus 137 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt 214 (342)
T 1b6c_B 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGT 214 (342)
T ss_dssp CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS--CEEECCCTTCEEEETTTTEEEECCCSCCCC
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC--CEEEEECCCceeccccccccccccccCCcC
Confidence 99999999999999999999 89999999999999999888 8999999999654432 2335789
Q ss_pred ccccchhhhhCCC------CCCCccccchhhHHHHHhhC----------CCCCCCCCH----HHHHHHHHHHhCCCcHHH
Q psy17270 232 RFYRSPEVILGLP------YGPPIDMWSLGCILAELYTG----------CPLFPGENE----VEQLACIMEILGCPPDEV 291 (429)
Q Consensus 232 ~~y~aPE~~~~~~------~~~~~DiwSlG~il~~lltg----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~ 291 (429)
+.|+|||++.+.. ++.++|||||||++|+|+|| ..||..... .+.+...... ...
T Consensus 215 ~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~---- 289 (342)
T 1b6c_B 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE-QKL---- 289 (342)
T ss_dssp GGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT-SCC----
T ss_pred cccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHH-HHh----
Confidence 9999999998753 23689999999999999999 778865421 1111111100 000
Q ss_pred HhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 292 INTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+..... .......+.+.+||.+||+.||++|||+.|+++|
T Consensus 290 ----------------------------~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 290 ----------------------------RPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp ----------------------------CCCCCGG-GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCccc-ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 0000000 0001124678899999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=318.81 Aligned_cols=261 Identities=22% Similarity=0.329 Sum_probs=195.5
Q ss_pred eEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
|...+.||+|+||+||+|.+. ...+|+|++...... ..
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-----------------------------------------~~ 70 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDI-----------------------------------------TT 70 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTS-----------------------------------------CT
T ss_pred cccCCccccCCCeEEEEEEEC-CceEEEEEEecccCc-----------------------------------------ch
Confidence 445599999999999999973 345688877432110 01
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhC-CCCCCHHHHHHHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNN-YQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~-~~~~~~~~~~~i~~qil~ 180 (429)
......+.+|+++++.++|+ ||+++++++......++||||+ +++|.+++.... ...+++..+..++.|++.
T Consensus 71 ~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~ 144 (307)
T 2nru_A 71 EELKQQFDQEIKVMAKCQHE------NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN 144 (307)
T ss_dssp TTHHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCC------CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHH
Confidence 22344577799999999876 9999999999999999999999 579999997543 245999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
||.|||++|++||||||+||+++.++ .++|+|||++...... .....||+.|+|||++.+ .++.++||||||
T Consensus 145 ~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG 221 (307)
T 2nru_A 145 GINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFG 221 (307)
T ss_dssp HHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHH
T ss_pred HHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHH
Confidence 99999999999999999999999888 8999999998754332 123468999999999876 578999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|..||........+..+..........+... ++.. ........++
T Consensus 222 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~--------------------~~~~~~~~~~ 274 (307)
T 2nru_A 222 VVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY-------IDKK--------------------MNDADSTSVE 274 (307)
T ss_dssp HHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH-------SCSS--------------------CSCCCHHHHH
T ss_pred HHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh-------cccc--------------------ccccchHHHH
Confidence 999999999999987654333322222111111000000 0000 0000112256
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+.+++.+||+.||++|||+.+++++
T Consensus 275 ~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 275 AMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 78899999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=341.41 Aligned_cols=244 Identities=19% Similarity=0.280 Sum_probs=194.0
Q ss_pred CeEEE-eEeeccccceEEEEEec--CCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 22 RYEIL-EVIGKGSFGQVIRALDH--KTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 22 rY~i~-~~lG~G~~g~Vy~a~~~--~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
.+.+. +.||+|+||+||+|.+. .++. +|+|++......
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------------------------------------- 410 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------------------------------------- 410 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC--------------------------------------
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC--------------------------------------
Confidence 34444 48999999999999664 4443 488887433211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
......+.+|+++++.++|+ ||+++++++. ...+++|||||. |+|.+++.... .+++..+..++.
T Consensus 411 -----~~~~~~~~~E~~il~~l~hp------nIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~ 476 (635)
T 4fl3_A 411 -----PALKDELLAEANVMQQLDNP------YIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVH 476 (635)
T ss_dssp -----GGGHHHHHHHHHHHHHCCCT------TBCCEEEEEE-SSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHH
T ss_pred -----HHHHHHHHHHHHHHHhCCCC------CEeeEEEEEe-cCCEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHH
Confidence 12234677799999999877 9999999986 456899999995 69999997654 499999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhhCCCCCCCcc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .....+|+.|+|||++.+..++.++|
T Consensus 477 qi~~~L~yLH~~~iiHrDLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sD 554 (635)
T 4fl3_A 477 QVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 554 (635)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHCCEeCCCCChHhEEEeCCC--CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHH
Confidence 999999999999999999999999999988 8999999998754322 12234577899999999989999999
Q ss_pred ccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 251 MWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 251 iwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||++|+|++ |+.||.+.+..+....+...... ..
T Consensus 555 vwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-----------------------------------------~~ 593 (635)
T 4fl3_A 555 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-----------------------------------------GC 593 (635)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----------------------------------------CC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------------------------------------CC
Confidence 9999999999998 99999998887766555431110 00
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
+...++++.+||.+||+.||++|||+.++++
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1234789999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=318.35 Aligned_cols=251 Identities=24% Similarity=0.279 Sum_probs=195.7
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
..++..++|++.+.||+|+||.||+|.+.. .+|+|++......
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~----------------------------------- 69 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDN----------------------------------- 69 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCC-----------------------------------
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCC-----------------------------------
Confidence 345668999999999999999999999864 4777776422110
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
......+.+|+.+++.++|+ ||+++++++.....+++||||+. ++|.+++.... ..+++..+..
T Consensus 70 --------~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 134 (319)
T 2y4i_B 70 --------EDQLKAFKREVMAYRQTRHE------NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQ 134 (319)
T ss_dssp --------CCCCCCCCTTGGGGTTCCCT------TBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHH
T ss_pred --------HHHHHHHHHHHHHHhcCCCC------CEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHH
Confidence 01112334488888888766 99999999999999999999995 69999987654 4599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--------CcceeeecCccccchhhhhC---
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--------QRVYTYIQSRFYRSPEVILG--- 242 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--------~~~~~~~~t~~y~aPE~~~~--- 242 (429)
++.||+.||+|||++|++||||||+||+++ ++ .++|+|||++.... .......||+.|+|||++.+
T Consensus 135 i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 211 (319)
T 2y4i_B 135 IAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG--KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211 (319)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSC
T ss_pred HHHHHHHHHHHHHhCCccccCCChhhEEEe-CC--CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccc
Confidence 999999999999999999999999999998 45 89999999976432 12223468899999999975
Q ss_pred ------CCCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCC
Q psy17270 243 ------LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316 (429)
Q Consensus 243 ------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (429)
..++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 212 ~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------- 263 (319)
T 2y4i_B 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL---------------------------- 263 (319)
T ss_dssp C--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC----------------------------
T ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC----------------------------
Confidence 3468899999999999999999999998877665544432100000
Q ss_pred CCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.....++.+.++|.+||..||++|||+.++++
T Consensus 264 ------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 264 ------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00123678899999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=330.81 Aligned_cols=264 Identities=16% Similarity=0.164 Sum_probs=187.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+..++|++++.||+|+||+||+|++. ...+|+|++........
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vAvK~~~~~~~~~~------------------------------------ 59 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLV------------------------------------ 59 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEET-TEEEEEEEEEESCSSCB------------------------------------
T ss_pred cccccchheeeecccCceEEEEEEeC-CceEEEEEEecCCcccc------------------------------------
Confidence 34688999999999999999999982 23458888754321000
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcC---CCCCCCceeEEEEEE-----------------EE-------------cCeEE
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKK---DADSSYNVIHMLEYF-----------------YF-------------RNHLC 144 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~---~~~~~~~i~~~~~~~-----------------~~-------------~~~~~ 144 (429)
..........+.+|+++++.++.. +...|+||+.+.+++ .. ...+|
T Consensus 60 -~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (336)
T 2vuw_A 60 -NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138 (336)
T ss_dssp -TTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEE
T ss_pred -ccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEE
Confidence 000122335677899999998721 111344666655554 32 67899
Q ss_pred EEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecccCCCcEEEecCCC---------------
Q psy17270 145 ISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH-RENIIHCDLKPENVLLKQRGS--------------- 207 (429)
Q Consensus 145 lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH-~~~ivH~dlkp~Nili~~~~~--------------- 207 (429)
+|||||. |++.+.+.. ..+++..++.++.||+.||+||| ++||+||||||+|||++.++.
T Consensus 139 lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~ 215 (336)
T 2vuw_A 139 IVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215 (336)
T ss_dssp EEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEE
T ss_pred EEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCcccccc
Confidence 9999994 555555533 34899999999999999999999 999999999999999998752
Q ss_pred ---cceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhH-HHHHhhCCCCCCCCCH-HHHHHHHHH
Q psy17270 208 ---SSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI-LAELYTGCPLFPGENE-VEQLACIME 282 (429)
Q Consensus 208 ---~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i-l~~lltg~~pf~~~~~-~~~~~~i~~ 282 (429)
..+||+|||+++..... ..+||+.|+|||++.+.. +.++||||+|++ .+++++|..||.+... ......+..
T Consensus 216 ~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~ 292 (336)
T 2vuw_A 216 SCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK 292 (336)
T ss_dssp CTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHH
T ss_pred CCCceEEEeeccccEecCCC--cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhh
Confidence 27999999999865543 458999999999998766 889999998777 7778889999854211 111111111
Q ss_pred HhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHh-cC
Q psy17270 283 ILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEAL-RH 361 (429)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell-~h 361 (429)
..... .......+...++++.+||++||++| ||.|+| +|
T Consensus 293 ~~~~~-----------------------------------~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 293 QMTFK-----------------------------------TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp TCCCS-----------------------------------SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhccC-----------------------------------cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 00000 00011122334788999999999987 999999 99
Q ss_pred CCCC
Q psy17270 362 EWLK 365 (429)
Q Consensus 362 ~~~~ 365 (429)
|||+
T Consensus 333 p~f~ 336 (336)
T 2vuw_A 333 SLFK 336 (336)
T ss_dssp GGGC
T ss_pred CCcC
Confidence 9995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=300.34 Aligned_cols=232 Identities=19% Similarity=0.093 Sum_probs=181.8
Q ss_pred cc-cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 16 HD-HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 16 ~~-~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
++ .+++||++.+.||+|+||.||+|.+..++.. |+|++.......
T Consensus 25 g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~--------------------------------- 71 (286)
T 3uqc_A 25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP--------------------------------- 71 (286)
T ss_dssp TCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC---------------------------------
T ss_pred CCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC---------------------------------
Confidence 44 7889999999999999999999999988765 999885443211
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
......+.+|+.++..+.|+ ||+++++++...+..|+||||++ ++|.+++... ....++.
T Consensus 72 ---------~~~~~~~~~e~~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~ 132 (286)
T 3uqc_A 72 ---------DDVLQETLSRTLRLSRIDKP------GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAI 132 (286)
T ss_dssp ---------HHHHHHHHHHHHHHHTCCCT------TBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHH
T ss_pred ---------HHHHHHHHHHHHHHhcCCCC------CcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHH
Confidence 11224566799998888776 99999999999999999999996 5999998532 5667889
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
.++.|++.||+|||++||+||||||+|||++.++ .++|+++| |++ .++.++|||
T Consensus 133 ~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g--~~kl~~~~-----------------~~~-------~~~~~~Di~ 186 (286)
T 3uqc_A 133 RAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG--DVVLAYPA-----------------TMP-------DANPQDDIR 186 (286)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS--CEEECSCC-----------------CCT-------TCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC--CEEEEecc-----------------ccC-------CCCchhHHH
Confidence 9999999999999999999999999999999988 88887544 333 367899999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|+||+.||.+.+..+.+... .................
T Consensus 187 slG~il~elltg~~Pf~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 187 GIGASLYALLVNRWPLPEAGVRSGLAPA-----------------------------------ERDTAGQPIEPADIDRD 231 (286)
T ss_dssp HHHHHHHHHHHSEECSCCCSBCCCSEEC-----------------------------------CBCTTSCBCCHHHHCTT
T ss_pred HHHHHHHHHHHCCCCCCcCCcchhhHHH-----------------------------------HHHhccCCCChhhcccC
Confidence 9999999999999999885532100000 00000011122334455
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.++.+.+||.+||+.||++| |+.|+++.
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 68999999999999999999 99999883
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.75 Aligned_cols=244 Identities=19% Similarity=0.291 Sum_probs=193.8
Q ss_pred hcccccCCeEEEeEeeccccceEEEEEecC-CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCC
Q psy17270 15 LHDHICYRYEILEVIGKGSFGQVIRALDHK-TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGG 92 (429)
Q Consensus 15 ~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~ 92 (429)
.++.+.+||++++.||+|+||+||+|.+.. ++. +|+|++......
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~--------------------------------- 120 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA--------------------------------- 120 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH---------------------------------
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH---------------------------------
Confidence 456788999999999999999999999976 454 598887543221
Q ss_pred CCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCe-----EEEEEeecC-cCHHHHHHhhCCCCC
Q psy17270 93 FDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH-----LCISFELMN-LNLYELIKRNNYQGF 166 (429)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~-----~~lv~e~~~-g~L~~~i~~~~~~~~ 166 (429)
.....+.+|+++++.++|+ ||+++++++..... .|+||||++ ++|.+++.. .+
T Consensus 121 -----------~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l 179 (681)
T 2pzi_A 121 -----------EAQAMAMAERQFLAEVVHP------SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KL 179 (681)
T ss_dssp -----------HHHHHHHHHHGGGGGCCCT------TBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CC
T ss_pred -----------HHHHHHHHHHHHHHhcCCC------CcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CC
Confidence 1123455689998888776 99999999988765 799999996 588877654 49
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCC
Q psy17270 167 SLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYG 246 (429)
Q Consensus 167 ~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 246 (429)
++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++...... ...+||+.|+|||++.+. ++
T Consensus 180 ~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~ 254 (681)
T 2pzi_A 180 PVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTG-PT 254 (681)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHC-SC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC-CccCCCccccCHHHHcCC-CC
Confidence 999999999999999999999999999999999999864 7999999999766544 456799999999999875 48
Q ss_pred CCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchh
Q psy17270 247 PPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDM 326 (429)
Q Consensus 247 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (429)
.++|||||||++|+|++|.+||.+.... +.+. ...
T Consensus 255 ~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~----------------------------------~~~- 289 (681)
T 2pzi_A 255 VATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPE----------------------------------DDP- 289 (681)
T ss_dssp HHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCT----------------------------------TCH-
T ss_pred CceehhhhHHHHHHHHhCCCCCcccccc----------cccc----------------------------------ccc-
Confidence 8999999999999999999888752110 0000 000
Q ss_pred hhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 327 ASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 327 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
....++.+.+||.+||+.||++||++.+.+.|+|+.
T Consensus 290 ---~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 290 ---VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 011257889999999999999999999999998874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-31 Score=275.02 Aligned_cols=147 Identities=18% Similarity=0.134 Sum_probs=111.1
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~ 184 (429)
.+.+.+|+++|+++.+ |+||++++++++++..+||||||++| +|.+++.+.. ++++. .|+.||+.||+|
T Consensus 285 ~~~~~~E~~~l~~~~~-----~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~y 354 (569)
T 4azs_A 285 KYELHNEIKFLTQPPA-----GFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAA 354 (569)
T ss_dssp HHHHHHHHHHHHSCCT-----TCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCC-----CCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHH
Confidence 4567889999999842 34999999999999999999999965 9999998764 37654 578999999999
Q ss_pred HHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCCCCCccccchhhHHHHH
Q psy17270 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAEL 261 (429)
Q Consensus 185 lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l 261 (429)
+|++|||||||||+|||++.++ .+||+|||+++.... ...+.+||+.|+|||++.+ .+..++|+||+|++++++
T Consensus 355 lH~~GIIHRDIKPeNILL~~dg--~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l 431 (569)
T 4azs_A 355 LEKQGFWHDDVRPWNVMVDARQ--HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNL 431 (569)
T ss_dssp HHHTTCEESCCCGGGEEECTTS--CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCC
T ss_pred HHHCCceeccCchHhEEECCCC--CEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhh
Confidence 9999999999999999999988 899999999975443 2345789999999999977 466789999999999988
Q ss_pred hhCC
Q psy17270 262 YTGC 265 (429)
Q Consensus 262 ltg~ 265 (429)
.++.
T Consensus 432 ~~~~ 435 (569)
T 4azs_A 432 PQPW 435 (569)
T ss_dssp CTTH
T ss_pred cccc
Confidence 7653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-26 Score=233.87 Aligned_cols=188 Identities=17% Similarity=0.162 Sum_probs=138.1
Q ss_pred EEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchh
Q psy17270 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKK 103 (429)
Q Consensus 24 ~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~ 103 (429)
...+.||+|+||+||+|... ...+++|+............ ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~-------------------------------------~~ 380 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLD-------------------------------------EN 380 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHH-------------------------------------HH
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhh-------------------------------------hH
Confidence 45669999999999999443 33457776533211111000 11
Q ss_pred hhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH
Q psy17270 104 RFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCL 182 (429)
Q Consensus 104 ~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l 182 (429)
...+.+.+|++++++++|+ ||+.+..++......|+|||||+ ++|.+++.. +..++.|++.||
T Consensus 381 ~~~~~~~~E~~il~~l~h~------nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL 444 (540)
T 3en9_A 381 IRKSRTAREARYLALVKDF------GIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIV 444 (540)
T ss_dssp HHHHHHHHHHHHHHHGGGG------TCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCC------CcCceEEEEEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHH
Confidence 1234577899999999987 89955555557788899999995 799998775 568999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----------ceeeecCccccchhhhhC--CCCCCCcc
Q psy17270 183 RLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----------VYTYIQSRFYRSPEVILG--LPYGPPID 250 (429)
Q Consensus 183 ~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----------~~~~~~t~~y~aPE~~~~--~~~~~~~D 250 (429)
.|||++||+||||||+|||++. .+||+|||+++..... ....+||+.|+|||++.. ..|+..+|
T Consensus 445 ~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d 520 (540)
T 3en9_A 445 GKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYD 520 (540)
T ss_dssp HHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCT
T ss_pred HHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHh
Confidence 9999999999999999999986 7999999999876542 235689999999999987 56788899
Q ss_pred ccchhhHHHHHhhCCCCCC
Q psy17270 251 MWSLGCILAELYTGCPLFP 269 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~ 269 (429)
+||..+-..+.+.++.+|.
T Consensus 521 ~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 521 RWEIILELMKDVERRARYV 539 (540)
T ss_dssp THHHHHHHHHHHHTCSCCC
T ss_pred HHHHHHHHHHHHHhccccC
Confidence 9999888888877776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.9e-23 Score=191.72 Aligned_cols=174 Identities=20% Similarity=0.193 Sum_probs=117.5
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
...|.+.+.||+|+||.||+|.+ .++. +|+|++.......... +.... .+ ..
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~----------------~~~~~-------~~---~~ 141 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKV----------------KEKRD-------YG---DL 141 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CC----------------CC-----------------
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhh----------------hhhhh-------hc---ch
Confidence 34566779999999999999999 6564 5999885432211000 00000 00 00
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.| .......+.+|+++++.+.| +++..+++ .+..|+||||++ ++|.+ +. . .....++.|
T Consensus 142 ~w-~~~~~~~~~~E~~~l~~l~~------~~v~~~~~----~~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~q 201 (282)
T 1zar_A 142 HF-SVLAIRSARNEFRALQKLQG------LAVPKVYA----WEGNAVLMELIDAKELYR-VR------V--ENPDEVLDM 201 (282)
T ss_dssp CH-HHHHHHHHHHHHHHHHHTTT------SSSCCEEE----EETTEEEEECCCCEEGGG-CC------C--SCHHHHHHH
T ss_pred hh-HHHHHHHHHHHHHHHHhccC------CCcCeEEe----ccceEEEEEecCCCcHHH-cc------h--hhHHHHHHH
Confidence 00 00123457789999999972 24444332 356699999996 48877 31 1 234579999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC----------CCCCC
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG----------LPYGP 247 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~----------~~~~~ 247 (429)
++.||.|||++||+||||||+|||++ ++ .++|+|||++. .+..+.|||++.. ..|+.
T Consensus 202 i~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DFG~a~----------~~~~~~a~e~l~rdv~~i~~~f~~~~~~ 268 (282)
T 1zar_A 202 ILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDFPQSV----------EVGEEGWREILERDVRNIITYFSRTYRT 268 (282)
T ss_dssp HHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCCTTCE----------ETTSTTHHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEECCCCe----------ECCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999 77 89999999985 3455789998864 34555
Q ss_pred Cccccc
Q psy17270 248 PIDMWS 253 (429)
Q Consensus 248 ~~DiwS 253 (429)
.+|+|.
T Consensus 269 ~~~~~~ 274 (282)
T 1zar_A 269 EKDINS 274 (282)
T ss_dssp CCCHHH
T ss_pred CCChHH
Confidence 566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-19 Score=167.91 Aligned_cols=161 Identities=20% Similarity=0.251 Sum_probs=107.3
Q ss_pred eEEEeEeeccccceEEEEEecCCC-c--chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTN-T--HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~-~--~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
|++.+.||+|+||.||+|.+..+| . +|+|+++......... . .+ +...+.... .. .
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~--~-----~~-------~~~~~~~~~------~~-~ 107 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKM--D-----EY-------LYGDERFDM------RR-I 107 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC---------G-----GG-------TTTCTTSCC----------
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhH--H-----Hh-------hcccchhhh------hc-c
Confidence 889999999999999999995555 5 7999875442211110 0 00 000000000 00 0
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC--c----CHHHHHHhhCCCCCCHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN--L----NLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~--g----~L~~~i~~~~~~~~~~~~~~~ 173 (429)
.........+.+|++++..+.|.+. .+|.+ ++. ...++||||++ | +|.++... .++..+..
T Consensus 108 ~~~~~~~~~~~~E~~~l~~l~~~~i-~~p~~---~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~ 174 (258)
T 1zth_A 108 SPKEKVFIWTEKEFRNLERAKEAGV-SVPQP---YTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEG 174 (258)
T ss_dssp -CHHHHHHHHHHHHHHHHHHHHTTC-CCCCE---EEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHH
T ss_pred ChHHHHHHHHHHHHHHHHHHHhCCC-CCCeE---EEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHH
Confidence 0011223457789999999998742 23333 332 36789999994 3 67766432 23557789
Q ss_pred HHHHHHHHHHHHH-HCCceecccCCCcEEEecCCCcceEEeeecccccc
Q psy17270 174 FAFSLVQCLRLLH-RENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYS 221 (429)
Q Consensus 174 i~~qil~~l~~lH-~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~ 221 (429)
++.|++.+|.||| +.||+||||||+|||++. .++|+|||++...
T Consensus 175 i~~qi~~~l~~lH~~~givHrDlkp~NILl~~----~~~liDFG~a~~~ 219 (258)
T 1zth_A 175 IFNDVVENVKRLYQEAELVHADLSEYNIMYID----KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHHHHHHHHTSCEECSSCSTTSEEESS----SEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC----cEEEEECcccccC
Confidence 9999999999999 999999999999999986 6899999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=7.8e-18 Score=163.18 Aligned_cols=158 Identities=16% Similarity=0.186 Sum_probs=100.4
Q ss_pred eEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc-c
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY-N 101 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~-~ 101 (429)
|.+.+.||+|++|.||+|.+.....+|||+++.....+. .++-.+ . +....... .
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr----------------~v~~~r--~------~~~~~~~~~~ 152 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFR----------------TVKANR--D------YLRNRSTGSW 152 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCC----------------CCC--C--E------ECTTSCHHHH
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHH----------------HHHHHH--H------HHHhhccccH
Confidence 999999999999999999997655679998754322110 000000 0 00000000 0
Q ss_pred hhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 102 KKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 102 ~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.......+.+|...|.++.+... .+...++. . ..+|||||++| +|..+ .....+..++.|++.
T Consensus 153 ~~~~rl~A~kE~~nL~rL~~~gv----~vp~p~~~---~-~~~LVME~i~G~~L~~l--------~~~~~~~~l~~qll~ 216 (397)
T 4gyi_A 153 MYLSRLAAIKEFAFMKALYEEGF----PVPEPIAQ---S-RHTIVMSLVDALPMRQV--------SSVPDPASLYADLIA 216 (397)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTC----SCCCEEEE---E-TTEEEEECCSCEEGGGC--------CCCSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhcCC----CCCeeeec---c-CceEEEEecCCccHhhh--------cccHHHHHHHHHHHH
Confidence 00111123458888888866521 12233332 2 23799999976 55332 122345678899999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCc--------ceEEeeeccccc
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSS--------SIKVIDFGSSCY 220 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~--------~vkl~Dfg~~~~ 220 (429)
+|.+||++|||||||||.|||++.++.. .+.|+||+-+..
T Consensus 217 ~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 217 LILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp HHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 9999999999999999999999987631 278999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=5e-11 Score=110.13 Aligned_cols=139 Identities=17% Similarity=0.143 Sum_probs=104.3
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+.|++...+|.|+.+.||++... .+.+++|+......
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~------------------------------------------ 50 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK------------------------------------------ 50 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT------------------------------------------
T ss_pred ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC------------------------------------------
Confidence 35999999999999999999865 45668887632110
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.....+.+|+++++.+... ..+.++++++...+..|+|||+++| +|.+.+. +......++.++.
T Consensus 51 ---~~~~~~~~E~~~l~~l~~~-----~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~ 115 (263)
T 3tm0_A 51 ---GTTYDVEREKDMMLWLEGK-----LPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYA 115 (263)
T ss_dssp ---TSTTCHHHHHHHHHHHTTT-----SCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHHHHHhcC-----CCCCeEEEEEecCCceEEEEEecCCeehhhccC-------CcccHHHHHHHHH
Confidence 1122466799999999642 3577788888888899999999977 7765421 1223346788999
Q ss_pred HHHHHHHH-----------------------------------------------------------CCceecccCCCcE
Q psy17270 180 QCLRLLHR-----------------------------------------------------------ENIIHCDLKPENV 200 (429)
Q Consensus 180 ~~l~~lH~-----------------------------------------------------------~~ivH~dlkp~Ni 200 (429)
.+|+.||+ .+++|+|++|.||
T Consensus 116 ~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Ni 195 (263)
T 3tm0_A 116 ECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNI 195 (263)
T ss_dssp HHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSE
T ss_pred HHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcE
Confidence 99999998 4589999999999
Q ss_pred EEecCCCcceEEeeecccc
Q psy17270 201 LLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 201 li~~~~~~~vkl~Dfg~~~ 219 (429)
+++.++ .+.|+||+.+.
T Consensus 196 l~~~~~--~~~lIDwe~a~ 212 (263)
T 3tm0_A 196 FVKDGK--VSGFIDLGRSG 212 (263)
T ss_dssp EEETTE--EEEECCCTTCE
T ss_pred EEECCc--EEEEEEchhcc
Confidence 997643 45799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.06 E-value=1e-09 Score=100.80 Aligned_cols=135 Identities=14% Similarity=0.046 Sum_probs=93.6
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
..|.+....+.|+.+.||++.......+++|+....
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------------------------------------------- 55 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------------------------------------------- 55 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--------------------------------------------
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--------------------------------------------
Confidence 457776555577779999997643345688775221
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
....+..|+++++.+.+.+ . .+.+++.+....+..++|||+++| ++ . . . ..+ ...++.+++
T Consensus 56 ----~~~~~~~E~~~l~~l~~~~-~---~vP~~~~~~~~~~~~~~v~e~i~G~~l-~-~---~--~~~---~~~~~~~l~ 117 (264)
T 1nd4_A 56 ----ALNELQDEAARLSWLATTG-V---PCAAVLDVVTEAGRDWLLLGEVPGQDL-L-S---S--HLA---PAEKVSIMA 117 (264)
T ss_dssp ----TTSCHHHHHHHHHHHHTTT-C---CBCCEEEEEECSSCEEEEEECCSSEET-T-T---S--CCC---HHHHHHHHH
T ss_pred ----cchhhhHHHHHHHHHHhCC-C---CCCeEEEeccCCCCCEEEEEecCCccc-C-c---C--cCC---HhHHHHHHH
Confidence 0124556999999998651 1 356677777777789999999976 55 2 1 1 122 225667777
Q ss_pred HHHHHHHHCC----------------------------------------------------------ceecccCCCcEE
Q psy17270 180 QCLRLLHREN----------------------------------------------------------IIHCDLKPENVL 201 (429)
Q Consensus 180 ~~l~~lH~~~----------------------------------------------------------ivH~dlkp~Nil 201 (429)
..|..||+.. ++|+|++|.||+
T Consensus 118 ~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil 197 (264)
T 1nd4_A 118 DAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIM 197 (264)
T ss_dssp HHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEE
T ss_pred HHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEE
Confidence 7777777643 999999999999
Q ss_pred EecCCCcceEEeeecccc
Q psy17270 202 LKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 202 i~~~~~~~vkl~Dfg~~~ 219 (429)
++.++ .+.|+|||.+.
T Consensus 198 ~~~~~--~~~liD~~~a~ 213 (264)
T 1nd4_A 198 VENGR--FSGFIDCGRLG 213 (264)
T ss_dssp EETTE--EEEECCCTTCE
T ss_pred EECCc--EEEEEcchhcc
Confidence 97653 55699999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.5e-09 Score=105.08 Aligned_cols=145 Identities=16% Similarity=0.180 Sum_probs=102.9
Q ss_pred eEEEeEeeccccceEEEEEecCCCcchheecc--ccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYG--NQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~--~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
..-++.|+.|.++.||++.... +.+++|+.. ....
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~------------------------------------------ 76 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL------------------------------------------ 76 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSS-CEEEEECCCC-----------------------------------------------
T ss_pred CceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC------------------------------------------
Confidence 3457889999999999998753 566777653 1100
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc---CeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR---NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~---~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
....+.+.+|+++++.+.+.. ..+++++.++.+. +..++|||+++| .+.+. ....++......++.
T Consensus 77 --~~~~~~~~~E~~~l~~L~~~~----vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~ 146 (359)
T 3dxp_A 77 --LPSAHAIEREYRVMDALAGTD----VPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ----SLPGMSPAERTAIYD 146 (359)
T ss_dssp -------CHHHHHHHHHHHTTSS----SCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT----TCTTCCHHHHHHHHH
T ss_pred --CCcHHHHHHHHHHHHHhhcCC----CCCCcEEEECCCCCccCCeEEEEEecCCeecCCC----ccccCCHHHHHHHHH
Confidence 001235667999999998632 2467777777655 458999999977 33221 112377888899999
Q ss_pred HHHHHHHHHHH----------------------------------------------------------CCceecccCCC
Q psy17270 177 SLVQCLRLLHR----------------------------------------------------------ENIIHCDLKPE 198 (429)
Q Consensus 177 qil~~l~~lH~----------------------------------------------------------~~ivH~dlkp~ 198 (429)
+++..|+.||+ .+++|+|++|.
T Consensus 147 ~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~ 226 (359)
T 3dxp_A 147 EMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLD 226 (359)
T ss_dssp HHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGG
T ss_pred HHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCC
Confidence 99999999997 36899999999
Q ss_pred cEEEecCCCcceEEeeeccccc
Q psy17270 199 NVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 199 Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
||+++.++...+.|+||+.+..
T Consensus 227 Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 227 NLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp GEEECSSSSCEEEECCCTTCEE
T ss_pred cEEEeCCCCcEEEEECcccccc
Confidence 9999976532468999998854
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.5e-09 Score=102.62 Aligned_cols=184 Identities=19% Similarity=0.180 Sum_probs=116.5
Q ss_pred EeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchhhh
Q psy17270 26 LEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRF 105 (429)
Q Consensus 26 ~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (429)
++.++.|....||++. +.+++|+-... ..
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----------------------------------------------~~ 53 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----------------------------------------------RG 53 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-----------------------------------------------HH
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-----------------------------------------------ch
Confidence 4569999999999974 45677764321 11
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC---eEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy17270 106 HHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN---HLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQC 181 (429)
Q Consensus 106 ~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~---~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~ 181 (429)
...+.+|+++++.+.+......|.+ +....... ..|+||++++| ++.+.... .++..+...++.+++..
T Consensus 54 ~~~~~~E~~~l~~l~~~~~v~vP~~---~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~ 126 (304)
T 3sg8_A 54 STNLFNEVNILKRIHNKLPLPIPEV---VFTGMPSETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARF 126 (304)
T ss_dssp HHHHHHHHHHHHHHTTSSSSCCCCE---EEECCCCSSCSCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCce---EeecCCCCCCCcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHH
Confidence 2245569999999965433334433 33322222 35889999977 55433221 27778888888888888
Q ss_pred HHHHHH----------------------------------------------------------CCceecccCCCcEEEe
Q psy17270 182 LRLLHR----------------------------------------------------------ENIIHCDLKPENVLLK 203 (429)
Q Consensus 182 l~~lH~----------------------------------------------------------~~ivH~dlkp~Nili~ 203 (429)
++.||+ ..++|+|++|.||+++
T Consensus 127 la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~ 206 (304)
T 3sg8_A 127 LSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFD 206 (304)
T ss_dssp HHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEE
T ss_pred HHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEe
Confidence 888886 1379999999999999
Q ss_pred cCCCcceEEeeecccccccCcceeeecCccc---cchhhhhC--CCCCC------------CccccchhhHHHHHhhCCC
Q psy17270 204 QRGSSSIKVIDFGSSCYSHQRVYTYIQSRFY---RSPEVILG--LPYGP------------PIDMWSLGCILAELYTGCP 266 (429)
Q Consensus 204 ~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y---~aPE~~~~--~~~~~------------~~DiwSlG~il~~lltg~~ 266 (429)
.+....+.++||+.+..... .........+ ..|+.... ..|.. -.+.|++|.++|.+.+|..
T Consensus 207 ~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~ 285 (304)
T 3sg8_A 207 TEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYM 285 (304)
T ss_dssp TTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCH
T ss_pred CCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCH
Confidence 74112678999999865322 1111111111 23332211 01111 2589999999999999976
Q ss_pred CC
Q psy17270 267 LF 268 (429)
Q Consensus 267 pf 268 (429)
+|
T Consensus 286 ~~ 287 (304)
T 3sg8_A 286 DW 287 (304)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=3.2e-06 Score=79.66 Aligned_cols=105 Identities=18% Similarity=0.156 Sum_probs=66.6
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEE-EcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFY-FRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLL 185 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~l 185 (429)
.+.+|+++|+.+.+..... +.+.+.+.. ..+..++|||+++| ++.+..-. .++......++.++...|+.|
T Consensus 55 ~~~~E~~~L~~L~~~~~v~---VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~L 127 (306)
T 3tdw_A 55 ELNKEIQLLPLLVGCVKVN---IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNEL 127 (306)
T ss_dssp HHHHHHHHHHHHTTTCSSB---CCCEEEEEECTTSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCC---CCCeEeecccCCCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHH
Confidence 4556999999998753333 444444443 34567899999977 55442111 134444445555555555555
Q ss_pred HHC------------------------------------------------------------CceecccCCCcEEEec-
Q psy17270 186 HRE------------------------------------------------------------NIIHCDLKPENVLLKQ- 204 (429)
Q Consensus 186 H~~------------------------------------------------------------~ivH~dlkp~Nili~~- 204 (429)
|+. .++|+|++|.||+++.
T Consensus 128 H~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~ 207 (306)
T 3tdw_A 128 SAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLN 207 (306)
T ss_dssp HHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTT
T ss_pred hcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecC
Confidence 432 3599999999999987
Q ss_pred --CCCcceEEeeeccccc
Q psy17270 205 --RGSSSIKVIDFGSSCY 220 (429)
Q Consensus 205 --~~~~~vkl~Dfg~~~~ 220 (429)
++ ..+.|+||+.+..
T Consensus 208 ~~~~-~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 208 SRQT-PLTGIIDFGDAAI 224 (306)
T ss_dssp CSSC-CEEEECCCTTCEE
T ss_pred CCCC-ceEEEEehhhcCC
Confidence 33 1358999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=2e-05 Score=72.42 Aligned_cols=99 Identities=15% Similarity=0.158 Sum_probs=67.7
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLH 186 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH 186 (429)
.+.+|..+|+.+... . -+.+++.+..+.+..++|||+++| ++.+...... .....+..++...|+-||
T Consensus 65 ~~~~E~~~l~~l~~~--v---PVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh 133 (272)
T 4gkh_A 65 DVTDEMVRLNWLTAF--M---PLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLH 133 (272)
T ss_dssp HHHHHHHHHHHHTTT--S---CCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccC--C---CcCeEEEEEEECCeEEEEEEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhc
Confidence 445599999998642 2 266677788888999999999977 6655543211 122234445555555555
Q ss_pred HC----------------------------------------------------------CceecccCCCcEEEecCCCc
Q psy17270 187 RE----------------------------------------------------------NIIHCDLKPENVLLKQRGSS 208 (429)
Q Consensus 187 ~~----------------------------------------------------------~ivH~dlkp~Nili~~~~~~ 208 (429)
.. .++|+|+.+.||+++.++
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-- 211 (272)
T 4gkh_A 134 SIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-- 211 (272)
T ss_dssp TSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE--
T ss_pred CCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCe--
Confidence 31 278999999999998654
Q ss_pred ceEEeeecccc
Q psy17270 209 SIKVIDFGSSC 219 (429)
Q Consensus 209 ~vkl~Dfg~~~ 219 (429)
.+-|+||+.+.
T Consensus 212 ~~~viDwe~a~ 222 (272)
T 4gkh_A 212 LIGCIDVGRVG 222 (272)
T ss_dssp EEEECCCTTCE
T ss_pred EEEEEECcccc
Confidence 56799999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=3.4e-05 Score=73.35 Aligned_cols=30 Identities=33% Similarity=0.433 Sum_probs=26.5
Q ss_pred CCceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
.+++|+|+.+.||+++.++ .+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~--~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE--QIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGG--CEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCC--cEEEEehhhcc
Confidence 5799999999999998766 79999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=3.6e-05 Score=73.89 Aligned_cols=31 Identities=19% Similarity=0.316 Sum_probs=25.5
Q ss_pred CCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
..++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~--~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQ--PVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTE--EEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCc--EEEEEccccccc
Confidence 4689999999999998532 578999998853
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00011 Score=71.69 Aligned_cols=30 Identities=33% Similarity=0.515 Sum_probs=25.5
Q ss_pred CCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
..++|+|+.+.||+++.+ .+.++||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~---~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH---ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS---CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC---CeEEEeCccccc
Confidence 479999999999999765 489999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00055 Score=63.91 Aligned_cols=29 Identities=28% Similarity=0.384 Sum_probs=24.0
Q ss_pred CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.++|+|+.+.||+ ..++ .+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~--~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGE--RMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSS--CEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCC--CEEEEecccccC
Confidence 4899999999999 4455 689999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0017 Score=60.03 Aligned_cols=83 Identities=11% Similarity=0.025 Sum_probs=55.6
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+..+.+..-++.+|.|..+.||+++..+...+++|+-....
T Consensus 11 ~l~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--------------------------------------- 51 (288)
T 3f7w_A 11 ELTGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--------------------------------------- 51 (288)
T ss_dssp HHHCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC---------------------------------------
T ss_pred HhcCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC---------------------------------------
Confidence 34566778899999999999999997655566877642211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN 151 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 151 (429)
.....-+..|++.|+.|.....+..|.++. + +.-++|||++.
T Consensus 52 ------~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~---~----~~~~lv~e~l~ 93 (288)
T 3f7w_A 52 ------PALDGLFRAEALGLDWLGRSFGSPVPQVAG---W----DDRTLAMEWVD 93 (288)
T ss_dssp ------CCCTTHHHHHHHHHHHHTCSTTCCSCCEEE---E----ETTEEEEECCC
T ss_pred ------cchhhHHHHHHHHHHHHHhhCCCCcceEEe---c----cCceEEEEeec
Confidence 111234566999999997654455555443 2 23468999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0019 Score=63.29 Aligned_cols=34 Identities=32% Similarity=0.459 Sum_probs=28.0
Q ss_pred HHCCceecccCCCcEEEecCCCcceEEeeeccccccc
Q psy17270 186 HRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH 222 (429)
Q Consensus 186 H~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~ 222 (429)
+...++|+|++|.||+++.++ +.++||+.+....
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~G~ 263 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSFYGP 263 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCEEEC
T ss_pred CCCeEEecCCCCCcEEEeCCC---CEEEeCcccccCc
Confidence 345799999999999998653 8999999986543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0044 Score=58.19 Aligned_cols=77 Identities=18% Similarity=0.118 Sum_probs=54.4
Q ss_pred EEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchh
Q psy17270 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKK 103 (429)
Q Consensus 24 ~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~ 103 (429)
.-++.|+.|....||++... .+.+++|+....
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~----------------------------------------------- 70 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE-VQTVFVKINERS----------------------------------------------- 70 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS-SCEEEEEEEEGG-----------------------------------------------
T ss_pred eeeEEeCCccceeeeEEEEC-CCeEEEEeCCcc-----------------------------------------------
Confidence 34678999999999999863 456677765321
Q ss_pred hhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc
Q psy17270 104 RFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL 152 (429)
Q Consensus 104 ~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 152 (429)
....+..|++.|+.|...... .+++++.+....+..++|||+++|
T Consensus 71 -~~~~~~~E~~~L~~L~~~~~v---~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 71 -YRSMFRAEADQLALLAKTNSI---NVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp -GHHHHHHHHHHHHHHHHTTSS---BCCCEEEEEECSSEEEEEEECCCC
T ss_pred -cHHHHHHHHHHHHHHHhhCCC---CcceEEEEeecCCceEEEEEeccC
Confidence 112345599999999764222 466667777667889999999965
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0031 Score=55.34 Aligned_cols=98 Identities=14% Similarity=0.077 Sum_probs=63.7
Q ss_pred cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeec
Q psy17270 152 LNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQ 230 (429)
Q Consensus 152 g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~ 230 (429)
.+|.+++.... .++++.+++.++.|.+.+|.-+-. +.-..+=+.|..|++..+| .|.+.+ +.+. ..
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG--~V~f~~-~~s~---------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG--AVTLAP-AADD---------AG 99 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS--CEEECC-C--------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC--ceeccc-cccc---------cc
Confidence 38999998876 689999999999999999887622 1112333457899999988 665543 1110 12
Q ss_pred CccccchhhhhCCCCCCCccccchhhHHHHHhh
Q psy17270 231 SRFYRSPEVILGLPYGPPIDMWSLGCILAELYT 263 (429)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt 263 (429)
...+.|||... ...+.+.=|||||+++|..+-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 23467888763 233456789999999999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0025 Score=60.31 Aligned_cols=33 Identities=24% Similarity=0.372 Sum_probs=26.4
Q ss_pred CCceecccCCCcEEEecCC--CcceEEeeeccccc
Q psy17270 188 ENIIHCDLKPENVLLKQRG--SSSIKVIDFGSSCY 220 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~--~~~vkl~Dfg~~~~ 220 (429)
..++|+|+.+.||+++.+. ...+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4699999999999998641 12789999998854
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0057 Score=57.32 Aligned_cols=146 Identities=14% Similarity=0.129 Sum_probs=79.5
Q ss_pred EEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchh
Q psy17270 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKK 103 (429)
Q Consensus 24 ~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~ 103 (429)
.-++.|+.|....||++... .+.+++|+.....
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g~~vlk~~~~~~---------------------------------------------- 57 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KDPLILTLYEKRV---------------------------------------------- 57 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SCCEEEEEECC------------------------------------------------
T ss_pred eEeeccCCCcccceEEEEeC-CccEEEEEeCCCC----------------------------------------------
Confidence 34567888988999999764 4567888764310
Q ss_pred hhhhhHHHHHHHHHHHhcCCCCCCCceeEEEE---EEEEcCeEEEEEeecCcC-H-----HH------H---HHhhCC--
Q psy17270 104 RFHHQALIEVRILDHLRKKDADSSYNVIHMLE---YFYFRNHLCISFELMNLN-L-----YE------L---IKRNNY-- 163 (429)
Q Consensus 104 ~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~---~~~~~~~~~lv~e~~~g~-L-----~~------~---i~~~~~-- 163 (429)
....+..|+.+++.|..... +.|.++...+ +....+..+++|++++|. + .. . +.....
T Consensus 58 -~~~~l~~e~~~l~~L~~~g~-~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~ 135 (322)
T 2ppq_A 58 -EKNDLPFFLGLMQHLAAKGL-SCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGF 135 (322)
T ss_dssp --CCHHHHHHHHHHHHHHTTC-CCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTC
T ss_pred -CHHHHHHHHHHHHHHHHCCC-CCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccC
Confidence 01234458899999887542 3444443210 122356788999999662 1 10 0 111110
Q ss_pred C-C----CCHHHHHHH---------------HHHHHHHHHHHHH-------CCceecccCCCcEEEecCCCcceEEeeec
Q psy17270 164 Q-G----FSLGLIRRF---------------AFSLVQCLRLLHR-------ENIIHCDLKPENVLLKQRGSSSIKVIDFG 216 (429)
Q Consensus 164 ~-~----~~~~~~~~i---------------~~qil~~l~~lH~-------~~ivH~dlkp~Nili~~~~~~~vkl~Dfg 216 (429)
. . .....-... ...+...+..+.. .+++|+|+.+.||+++.++ .+.++||+
T Consensus 136 ~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~--~~~lIDf~ 213 (322)
T 2ppq_A 136 EIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDE--LSGLIDFY 213 (322)
T ss_dssp CCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTE--EEEECCCT
T ss_pred CCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCc--eEEEecch
Confidence 0 0 011100000 0113334455542 3699999999999998654 45799999
Q ss_pred cccc
Q psy17270 217 SSCY 220 (429)
Q Consensus 217 ~~~~ 220 (429)
.+..
T Consensus 214 ~a~~ 217 (322)
T 2ppq_A 214 FACN 217 (322)
T ss_dssp TCEE
T ss_pred hccC
Confidence 8753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.29 E-value=0.033 Score=52.19 Aligned_cols=29 Identities=17% Similarity=0.229 Sum_probs=24.4
Q ss_pred CCceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 188 ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 188 ~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~---~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D---GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S---SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C---CCEEEECCCCCc
Confidence 3588999999999998 3 689999988743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.26 E-value=0.027 Score=55.32 Aligned_cols=32 Identities=31% Similarity=0.570 Sum_probs=24.6
Q ss_pred CceecccCCCcEEEecCC--------------------------CcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRG--------------------------SSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~--------------------------~~~vkl~Dfg~~~~ 220 (429)
.++|+|+.+.||+++.++ ...+.++||..+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 589999999999998751 02689999988753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.85 E-value=0.014 Score=55.86 Aligned_cols=29 Identities=28% Similarity=0.557 Sum_probs=24.2
Q ss_pred CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
+++|+|+.+.||+++.+ .+.++||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~---~~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK---CLRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC----CEEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCC---cEEEEEecCCCC
Confidence 58999999999999754 589999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.84 E-value=0.03 Score=53.93 Aligned_cols=32 Identities=31% Similarity=0.528 Sum_probs=25.9
Q ss_pred CceecccCCCcEEEecCC--CcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRG--SSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~--~~~vkl~Dfg~~~~ 220 (429)
.++|+|+.+.||+++.+. ...+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 589999999999998761 12789999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.63 E-value=0.044 Score=51.84 Aligned_cols=30 Identities=30% Similarity=0.497 Sum_probs=26.2
Q ss_pred CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
+++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~--~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEE--SIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGG--CEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCC--eEEEEECCCCee
Confidence 699999999999998766 789999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.33 E-value=0.16 Score=50.16 Aligned_cols=29 Identities=17% Similarity=0.327 Sum_probs=19.3
Q ss_pred EEeEeeccccceEEEEEecCC-Ccchheec
Q psy17270 25 ILEVIGKGSFGQVIRALDHKT-NTHALKYY 53 (429)
Q Consensus 25 i~~~lG~G~~g~Vy~a~~~~~-~~~aiK~~ 53 (429)
-++.|+.|-...+|++..... +.+++|+.
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~ 141 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLY 141 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEEC
Confidence 456888899999999987652 34566654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 429 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-56 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-56 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-55 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-54 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-53 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-53 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-51 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-50 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-50 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-50 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-47 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-45 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-31 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-31 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-29 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-29 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-26 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-25 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-24 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-24 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-23 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-23 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-16 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-57
Identities = 67/355 (18%), Positives = 125/355 (35%), Gaps = 60/355 (16%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+E + +G G+ G V + + A K
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARK----------------------------L 38
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
IH E K +Q + E+++L ++ FY
Sbjct: 39 IHLE----------------IKPAIRNQIIRELQVLHECNSP------YIVGFYGAFYSD 76
Query: 141 NHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN-IIHCDLKPE 198
+ I E M +L +++K+ ++ + + ++++ L L ++ I+H D+KP
Sbjct: 77 GEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 199 NVLLKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
N+L+ RG IK+ DFG S +++ +R Y SPE + G Y D+WS+G
Sbjct: 135 NILVNSRGE--IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 192
Query: 258 LAELYTGCPLFPGENEVE-QLACIMEILGCPPDEVINTASRRRLFFDSKGTPR-CITNSK 315
L E+ G P + E +L ++ G + + R R + +
Sbjct: 193 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE 252
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSS 370
F DFV +C + +R + + H ++K S +
Sbjct: 253 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 187 bits (477), Expect = 1e-56
Identities = 77/366 (21%), Positives = 129/366 (35%), Gaps = 92/366 (25%)
Query: 13 QVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIW 72
++ HDH+ Y+I E +G G+FG V R + T +
Sbjct: 18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF----------------------- 54
Query: 73 YLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIH 132
A K S K+ E++ + LR +++
Sbjct: 55 -----AAKFVMTPHESD------------KETVRK----EIQTMSVLRHP------TLVN 87
Query: 133 MLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENII 191
+ + F N + + +E M L+E + + S + + + L +H N +
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYV 146
Query: 192 HCDLKPENVLLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPI 249
H DLKPEN++ + S+ +K+IDFG + + Q V + + +PEV G P G
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309
DMWS+G + L +G F GEN+ E L + D + S
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS------------- 253
Query: 310 CITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369
+ DF+ + D R+T +AL H WL ++
Sbjct: 254 -------------------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288
Query: 370 SSSSSS 375
S
Sbjct: 289 PGRDSQ 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 5e-56
Identities = 75/350 (21%), Positives = 142/350 (40%), Gaps = 64/350 (18%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+YE + IG+G++G+V +A D K ++ A K
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGG---RFV------------------------ALKR 40
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-- 139
++ + EV +L HL + NV+ + +
Sbjct: 41 V--------------RVQTGEEGMPLSTIREVAVLRHLETFEHP---NVVRLFDVCTVSR 83
Query: 140 ---RNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
L + FE ++ +L + + G I+ F L++ L LH ++H DLK
Sbjct: 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 143
Query: 197 PENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
P+N+L+ G + + + + + +YR+PEV+L Y P+D+WS+GC
Sbjct: 144 PQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 203
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
I AE++ PLF G ++V+QL I++++G P +E PR + +
Sbjct: 204 IFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---------------PRDVALPRQ 248
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
++ + + D+ D + +C ++ KR++ AL H + +
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-55
Identities = 85/347 (24%), Positives = 147/347 (42%), Gaps = 66/347 (19%)
Query: 24 EILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHG 83
E L+ +G+G F V +A D TN A K
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIV----------------------------AIKK-- 30
Query: 84 EESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHL 143
+ S K + AL E+++L L N+I +L+ F ++++
Sbjct: 31 ---------IKLGHRSEAKDGINRTALREIKLLQELSHP------NIIGLLDAFGHKSNI 75
Query: 144 CISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLK 203
+ F+ M +L +IK N+ + I+ + +Q L LH+ I+H DLKP N+LL
Sbjct: 76 SLVFDFMETDLEVIIKDNSLV-LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 134
Query: 204 QRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCILA 259
+ G +K+ DFG + ++ + +R+YR+PE++ G YG +DMW++GCILA
Sbjct: 135 ENGV--LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 192
Query: 260 ELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319
EL P PG+++++QL I E LG P +E + K P
Sbjct: 193 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG---------- 242
Query: 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + +D + F ++ R+T +AL+ ++ +
Sbjct: 243 ----IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 5e-54
Identities = 87/350 (24%), Positives = 152/350 (43%), Gaps = 69/350 (19%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
++ +E IG+G++G V +A + T ALK K
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALK----------------------------K 34
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
I + + A+ E+ +L L N++ +L+ +
Sbjct: 35 IRLD---------------TETEGVPSTAIREISLLKELNHP------NIVKLLDVIHTE 73
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
N L + FE ++ +L + + + G L LI+ + F L+Q L H ++H DLKP+N+
Sbjct: 74 NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 201 LLKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGLPY-GPPIDMWSLGC 256
L+ G +IK+ DFG + + + + +YR+PE++LG Y +D+WSLGC
Sbjct: 134 LINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
I AE+ T LFPG++E++QL I LG P + V + + K
Sbjct: 192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-------------GVTSMPDYKP 238
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
K +D + V+ D+ ++Q ++D KR++ AL H + +
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-53
Identities = 96/355 (27%), Positives = 150/355 (42%), Gaps = 65/355 (18%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+YE L IG+G+FG+V +A KT A K
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKV----------------------------ALKK 42
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR- 140
E+ K+ F AL E++IL L+ ++ + + Y R
Sbjct: 43 VLMENE--------------KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88
Query: 141 -NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ + F+ +L L+ N F+L I+R L+ L +HR I+H D+K N
Sbjct: 89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 147
Query: 200 VLLKQRGSSSIKVIDFGSS-------CYSHQRVYTYIQSRFYRSPEVILG-LPYGPPIDM 251
VL+ + G +K+ DFG + R + + +YR PE++LG YGPPID+
Sbjct: 148 VLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL 205
Query: 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311
W GCI+AE++T P+ G E QLA I ++ G EV L+ +
Sbjct: 206 WGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY-------EKL 258
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
KG+KRK + A V D +D + + D +R+ D+AL H++ S
Sbjct: 259 ELVKGQKRKVKDRLKAYVR---DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 4e-53
Identities = 89/347 (25%), Positives = 153/347 (44%), Gaps = 61/347 (17%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y L+ +G G++G V A+D +T A+K K
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK----------------------------K 50
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
++ + + F +A E+R+L H+R ++ +V E
Sbjct: 51 LYRP---------------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ M +L +L+K + I+ + +++ LR +H IIH DLKP N+
Sbjct: 96 TDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL 152
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPIDMWSLGCILA 259
+ + +K++DFG + + + Y+ +R+YR+PEVIL + Y +D+WS+GCI+A
Sbjct: 153 AVNEDCE--LKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210
Query: 260 ELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319
E+ TG LF G + ++QL IM++ G PP E + KG P
Sbjct: 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE-------- 262
Query: 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
KD AS+L V+ + + D+++R+T EAL H + +S
Sbjct: 263 ---KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 8e-53
Identities = 75/350 (21%), Positives = 118/350 (33%), Gaps = 95/350 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+EI +GKG FG V A + ++ A K+
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFIL----------------------------ALKV 38
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ L K HQ EV I HLR N++ + YF+
Sbjct: 39 LFKAQL-------------EKAGVEHQLRREVEIQSHLR------HPNILRLYGYFHDAT 79
Query: 142 HLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + E L +Y +++ + F + L L H + +IH D+KPEN+
Sbjct: 80 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 137
Query: 201 LLKQRGSSSIKVIDFGSSCYS-HQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILA 259
LL G +K+ DFG S ++ R T + Y PE+I G + +D+WSLG +
Sbjct: 138 LLGSAGE--LKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 195
Query: 260 ELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319
E G P F E I + PD V
Sbjct: 196 EFLVGKPPFEANTYQETYKRISRVEFTFPDFV---------------------------- 227
Query: 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369
+ D +++ + +R E L H W+ ++SS
Sbjct: 228 --------------TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 178 bits (451), Expect = 1e-52
Identities = 97/370 (26%), Positives = 161/370 (43%), Gaps = 65/370 (17%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RY ++ +G G F V A D NTH A KI
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHV----------------------------AMKI 45
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLR-----KKDADSSYNVIHMLEY 136
K + A E+++L + K+D+ + +++ +L++
Sbjct: 46 -----------------VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88
Query: 137 FYFRN----HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLR-LLHRENII 191
F + H+ + FE++ NL LIK+ ++G L +++ + L+ L + R II
Sbjct: 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII 148
Query: 192 HCDLKPENVLLKQRG----SSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGP 247
H D+KPENVL++ IK+ D G++C+ + IQ+R YRSPEV+LG P+G
Sbjct: 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGC 208
Query: 248 PIDMWSLGCILAELYTGCPLFPGE------NEVEQLACIMEILGCPPDEVINTASRRRLF 301
D+WS C++ EL TG LF + + + +A I+E+LG P ++ R F
Sbjct: 209 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTF 268
Query: 302 FDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
F+S+G R I+ K + + + K DF++ D +KR + H
Sbjct: 269 FNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328
Query: 362 EWLKSSSSSS 371
WLK +
Sbjct: 329 PWLKDTLGME 338
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 175 bits (444), Expect = 1e-51
Identities = 71/356 (19%), Positives = 134/356 (37%), Gaps = 94/356 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
Y+ILE +G G+FG V R ++ T K
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAK----------------------------F 61
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
I+ L + + E+ I++ L +I++ + F +
Sbjct: 62 INTPYPLDK-----------------YTVKNEISIMNQLHHP------KLINLHDAFEDK 98
Query: 141 NHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+ + E + L++ I +Y+ S + + + L+ +H +I+H D+KPEN
Sbjct: 99 YEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 157
Query: 200 VLLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257
++ + + +SS+K+IDFG + + V + + +PE++ P G DMW++G +
Sbjct: 158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 217
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
L +G F GE+++E L + ++ ++ S
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS--------------------- 256
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSS 373
DF+ + +KRLT +AL H WLK S+ +S
Sbjct: 257 -----------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-51
Identities = 75/347 (21%), Positives = 122/347 (35%), Gaps = 93/347 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+Y I E +G+G FG V R ++ + K
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTY----------------------------MAKF 37
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
K E+ IL+ R + N++H+ E F
Sbjct: 38 -----------------VKVKGTDQVLVKKEISILNIARHR------NILHLHESFESME 74
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L + FE + L+++E I + ++ + I + + + L+ LH NI H D++PEN+
Sbjct: 75 ELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133
Query: 201 LLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
+ + R SS+IK+I+FG + + Y +PEV DMWSLG ++
Sbjct: 134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
Query: 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
L +G F E + + IM +E S
Sbjct: 194 YVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS---------------------- 231
Query: 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
+DFV + + K R+T EAL+H WLK
Sbjct: 232 ----------------IEAMDFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 7e-51
Identities = 87/352 (24%), Positives = 152/352 (43%), Gaps = 69/352 (19%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RY L IG+G++G V A D+ A+K K
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK----------------------------K 40
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
I E + + + L E++IL R ++ ++I
Sbjct: 41 ISPFE----------------HQTYCQRTLREIKILLRFRHENIIGINDIIR-APTIEQM 83
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + LM +LY+L+K Q S I F + +++ L+ +H N++H DLKP N+
Sbjct: 84 KDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 140
Query: 201 LLKQRGSSSIKVIDFGSSCY------SHQRVYTYIQSRFYRSPEVIL-GLPYGPPIDMWS 253
LL +K+ DFG + + Y+ +R+YR+PE++L Y ID+WS
Sbjct: 141 LLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 198
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
+GCILAE+ + P+FPG++ ++QL I+ ILG P E +N + P
Sbjct: 199 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH---- 254
Query: 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
+ + P ++ + D +D + + ++ KR+ ++AL H +L+
Sbjct: 255 ---KNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 170 bits (431), Expect = 2e-50
Identities = 86/348 (24%), Positives = 150/348 (43%), Gaps = 69/348 (19%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+Y LE IG+G++G V +A ++ T ALK KI
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALK----------------------------KI 34
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
E+ + + E+ IL L+ N++ + + + +
Sbjct: 35 RLEK---------------EDEGIPSTTIREISILKELK------HSNIVKLYDVIHTKK 73
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + FE ++ +L +L+ G + F L+ + H ++H DLKP+N+L
Sbjct: 74 RLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL 132
Query: 202 LKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCI 257
+ + G +K+ DFG + ++ I + +YR+P+V++G Y ID+WS+GCI
Sbjct: 133 INREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
AE+ G PLFPG +E +QL I ILG P + + P+ N
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE---------LPKYDPNFTVY 241
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
+ P S L+ D++ +D +++ D +R+T +AL H + K
Sbjct: 242 EPLPWE----SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-50
Identities = 80/345 (23%), Positives = 148/345 (42%), Gaps = 59/345 (17%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RY+ L +G G++G V A D KT A K
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRV----------------------------AVKK 50
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + + E+R+L H++ ++ +V N
Sbjct: 51 L--------------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ + LM +L ++K Q + ++ + +++ L+ +H +IIH DLKP N+
Sbjct: 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 153
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG-LPYGPPIDMWSLGCILAE 260
+ + +K++DFG + ++ + Y+ +R+YR+PE++L + Y +D+WS+GCI+AE
Sbjct: 154 VNEDCE--LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 261 LYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRK 320
L TG LFPG + ++QL I+ ++G P E++ S + +
Sbjct: 212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT-----------Q 260
Query: 321 PGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
+ A+V + VD + + DS KR+T +AL H +
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 8e-50
Identities = 72/345 (20%), Positives = 137/345 (39%), Gaps = 48/345 (13%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
RY+ L+ IG G+ G V A D + + A+K ++ +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK------------KLSR------------- 52
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ + +A E+ ++ + K+ S NV +
Sbjct: 53 ------------------PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ + ELM+ NL ++I+ + + ++ ++ LH IIH DLKP N+
Sbjct: 95 QDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAE 260
++K + I + + + Y+ +R+YR+PEVILG+ Y +D+WS+GCI+ E
Sbjct: 151 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 261 LYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRK 320
+ LFPG + ++Q ++E LG P E + +
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270
Query: 321 PGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
+ + D +++ D KR++ D+AL+H ++
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-49
Identities = 82/358 (22%), Positives = 142/358 (39%), Gaps = 81/358 (22%)
Query: 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDAC 79
Y +VIG GSFG V +A + A+K
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---------------------------- 51
Query: 80 KIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF 139
K+ ++ E++I+ L N++ + +FY
Sbjct: 52 KVLQDKRFKNR---------------------ELQIMRKLDHC------NIVRLRYFFYS 84
Query: 140 ------RNHLCISFELMNLNLYELIKR--NNYQGFSLGLIRRFAFSLVQCLRLLHRENII 191
+L + + + +Y + + Q + ++ + + L + L +H I
Sbjct: 85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 144
Query: 192 HCDLKPENVLLKQRGSSSIKVIDFGSS--CYSHQRVYTYIQSRFYRSPEVILG-LPYGPP 248
H D+KP+N+LL + +K+ DFGS+ + +YI SR+YR+PE+I G Y
Sbjct: 145 HRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 203
Query: 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTP 308
ID+WS GC+LAEL G P+FPG++ V+QL I+++LG P E I + + P
Sbjct: 204 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN---YTEFKFP 260
Query: 309 RCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + + +P + ++ + RLTP EA H +
Sbjct: 261 QIKAHPWTKVFRP----------RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 7e-49
Identities = 74/356 (20%), Positives = 125/356 (35%), Gaps = 99/356 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+EI+ +G G+FG+V +A + +T+ A A K+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLA----------------------------AAKV 44
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ ++E+ IL N++ +L+ FY+ N
Sbjct: 45 I----------------DTKSEEELEDYMVEIDILASCDHP------NIVKLLDAFYYEN 82
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+L I E + + + + I+ + L LH IIH DLK N+L
Sbjct: 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL 142
Query: 202 LKQRGSSSIKVIDFGSSCY---SHQRVYTYIQSRFYRSPEVILGL-----PYGPPIDMWS 253
G IK+ DFG S + QR ++I + ++ +PEV++ PY D+WS
Sbjct: 143 FTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 200
Query: 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
LG L E+ P N + L I + PP L S+ +
Sbjct: 201 LGITLIEMAEIEPPHHELNPMRVLLKIAK--SEPP----------TLAQPSRWSS----- 243
Query: 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369
F DF+ +C + R T + L+H ++ S+
Sbjct: 244 ----------------------NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-47
Identities = 71/354 (20%), Positives = 124/354 (35%), Gaps = 96/354 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+Y E IG+G+ G V A+D T A +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEV----------------------------AIRQ 52
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + K+ + E+ ++ + N+++ L+ + +
Sbjct: 53 MNLQQQPK------------KELIIN----EILVMRENKNP------NIVNYLDSYLVGD 90
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
L + E + L G I +Q L LH +IH D+K +N+L
Sbjct: 91 ELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148
Query: 202 LKQRGSSSIKVIDFGSSC---YSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
L GS +K+ DFG + T + + ++ +PEV+ YGP +D+WSLG +
Sbjct: 149 LGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
E+ G P + EN + L I + G
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIA--------------------------------TNGTP 234
Query: 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSS 372
+ + F DF+ +C + D +KR + E L+H++LK + SS
Sbjct: 235 ELQNPEKL-------SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (408), Expect = 3e-47
Identities = 74/353 (20%), Positives = 118/353 (33%), Gaps = 91/353 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
YE E++G+G V R + T A KI
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEY----------------------------AVKI 35
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + + L EV IL + N+I + + +
Sbjct: 36 I-------DVTGGGSFSAEEVQELREATLKEVDILRKVS-----GHPNIIQLKDTYETNT 83
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ F+LM L++ + S R+ +L++ + LH+ NI+H DLKPEN+
Sbjct: 84 FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENI 141
Query: 201 LLKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILG------LPYGPPIDMW 252
LL + IK+ DFG SC +++ + Y +PE+I YG +DMW
Sbjct: 142 LLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 199
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
S G I+ L G P F ++ L IM + S
Sbjct: 200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS---------------- 243
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
D V++ +KR T +EAL H + +
Sbjct: 244 ----------------------DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-47
Identities = 67/385 (17%), Positives = 131/385 (34%), Gaps = 99/385 (25%)
Query: 12 FQVLHDHICYRYEIL-EVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYL 69
Q+ + I Y++ +V+G G G+V++ + +T ALK
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK------------------ 43
Query: 70 EIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYN 129
+ + + + + R +
Sbjct: 44 ----------MLQ------------------DCPKARREVELHWRASQCP---------H 66
Query: 130 VIHMLEYFY----FRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRL 184
++ +++ + R L I E ++ L+ I+ Q F+ S+ + ++
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 185 LHRENIIHCDLKPENVLL-KQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVIL 241
LH NI H D+KPEN+L +R ++ +K+ DFG + SH + T + +Y +PEV+
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186
Query: 242 GLPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLF 301
Y DMWSLG I+ L G P F + + +
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR------------------ 228
Query: 302 FDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
I + P ++ + + + +R+T E + H
Sbjct: 229 ---------IRMGQYEFPNPEWSEV-------SEEVKMLIRNLLKTEPTQRMTITEFMNH 272
Query: 362 EWLKSSSSSSSSSSHHATDLRKSPS 386
W+ S+ + H + L++
Sbjct: 273 PWIMQSTKVPQTPLHTSRVLKEDKE 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 159 bits (403), Expect = 5e-46
Identities = 68/349 (19%), Positives = 138/349 (39%), Gaps = 64/349 (18%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
Y+++ +G+G + +V A++ N KI
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKV----------------------------VVKI 67
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
K + E++IL++LR N+I + +
Sbjct: 68 L-------------------KPVKKKKIKREIKILENLRG-----GPNIITLADIVKDPV 103
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ ++N + + YQ + IR + + +++ L H I+H D+KP NV+
Sbjct: 104 SRTPALVFEHVNNTDFKQL--YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161
Query: 202 LKQRGSSSIKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGCIL 258
+ +++ID+G + + Q + SR+++ PE+++ Y +DMWSLGC+L
Sbjct: 162 IDHEHRK-LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220
Query: 259 AELYTGC-PLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
A + P F G + +QL I ++LG + + + D + +S+ R
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY--DYIDKYNIELDPRFNDILGRHSRKR 278
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
+ + ++ +DF+ + +D + RLT EA+ H + +
Sbjct: 279 WERFVHSENQHLV---SPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 5e-46
Identities = 74/380 (19%), Positives = 133/380 (35%), Gaps = 95/380 (25%)
Query: 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLG 75
+ I Y+ +V+G G+F +VI A D +T A+K + E + +E
Sbjct: 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMEN-------- 56
Query: 76 LDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLE 135
E+ +L ++ N++ + +
Sbjct: 57 ------------------------------------EIAVLHKIKHP------NIVALDD 74
Query: 136 YFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCD 194
+ HL + +L+ L++ I + ++ R F ++ ++ LH I+H D
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGIVHRD 132
Query: 195 LKPENVLLKQRGSSS-IKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDM 251
LKPEN+L S I + DFG S + T + Y +PEV+ PY +D
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDC 192
Query: 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311
WS+G I L G P F EN+ + I++ + S
Sbjct: 193 WSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS--------------- 237
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
+ DF+ D +KR T ++AL+H W+ ++
Sbjct: 238 -----------------------DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274
Query: 372 SSSSHHATDLRKSPSAHTNM 391
+ ++ K A +
Sbjct: 275 KNIHQSVSEQIKKNFAKSKW 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 1e-45
Identities = 70/354 (19%), Positives = 114/354 (32%), Gaps = 94/354 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+ L IG GSFG V A D + + A K
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVV----------------------------AIKK 47
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+S +G +E + EVR L LR N I + +
Sbjct: 48 -----MSYSGKQSNE--------KWQDIIKEVRFLQKLRHP------NTIQYRGCYLREH 88
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ E + +L++ + + I +Q L LH N+IH D+K N+L
Sbjct: 89 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGL---PYGPPIDMWSLGCIL 258
L + G +K+ DFGS+ +++ + ++ +PEVIL + Y +D+WSLG
Sbjct: 148 LSEPG--LVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
EL P N + L I +
Sbjct: 205 IELAERKPPLFNMNAMSALYHIA---------------------------------QNES 231
Query: 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSS 372
S + F +FV C + R T + L+H ++ +
Sbjct: 232 PALQSGHW-------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-45
Identities = 71/364 (19%), Positives = 120/364 (32%), Gaps = 87/364 (23%)
Query: 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLG 75
+++ Y+ E +G G F V + + T
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQY-------------------------- 38
Query: 76 LDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLE 135
A K + +++ EV IL ++ NVI + E
Sbjct: 39 --AAKFIKKRRT------KSSRRGVSREDIER----EVSILKEIQHP------NVITLHE 80
Query: 136 YFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDL 195
+ + + + EL+ + + F ++ + LH I H DL
Sbjct: 81 VYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDL 139
Query: 196 KPENVLLKQRGSSS--IKVIDFGSSCY--SHQRVYTYIQSRFYRSPEVILGLPYGPPIDM 251
KPEN++L R IK+IDFG + + + +PE++ P G DM
Sbjct: 140 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 199
Query: 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311
WS+G I L +G F G+ + E LA + + DE + S
Sbjct: 200 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS--------------- 244
Query: 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSS 371
DF+ + D KKR+T ++L+H W+K +
Sbjct: 245 -----------------------ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281
Query: 372 SSSS 375
+ SS
Sbjct: 282 ALSS 285
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-45
Identities = 67/351 (19%), Positives = 115/351 (32%), Gaps = 99/351 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
++ +++G+GSF V+ A + T+ A KI
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREY----------------------------AIKI 40
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + K+ E ++ L + + F
Sbjct: 41 LEKRHII-------------KENKVPYVTRERDVMSRLDHP------FFVKLYFTFQDDE 81
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L N L + I++ F R + +V L LH + IIH DLKPEN+
Sbjct: 82 KLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 139
Query: 201 LLKQRGSSSIKVIDFGSSCY-----SHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255
LL + I++ DFG++ R +++ + Y SPE++ D+W+LG
Sbjct: 140 LLNEDMH--IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG 197
Query: 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315
CI+ +L G P F NE I+++ P++
Sbjct: 198 CIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF------------------------ 233
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366
D V + D+ KRL +E + LK+
Sbjct: 234 ------------------FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (396), Expect = 2e-45
Identities = 81/350 (23%), Positives = 149/350 (42%), Gaps = 71/350 (20%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+YE LE IG+G++G V +A + +T+ ALK +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK----------------------------R 34
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ ++ + + AL E+ +L L+ K N++ + + +
Sbjct: 35 VRLDD---------------DDEGVPSSALREICLLKELKHK------NIVRLHDVLHSD 73
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L + FE + +L + N +++ F F L++ L H N++H DLKP+N+
Sbjct: 74 KKLTLVFEFCDQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132
Query: 201 LLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLGC 256
L+ + G +K+ +FG + + + + +YR P+V+ G Y IDMWS GC
Sbjct: 133 LINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190
Query: 257 ILAELYTGC-PLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315
I AEL PLFPG + +QL I +LG P +E + ++ + K
Sbjct: 191 IFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY-------------K 237
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
P + + +V+ + D + + +R++ +EAL+H +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-43
Identities = 64/355 (18%), Positives = 108/355 (30%), Gaps = 104/355 (29%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
YE+L IG GS+G+ + K
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKIL----------------------------VWKEL 37
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-- 140
S+++ K+ EV +L L+ N++ + R
Sbjct: 38 DYGSMTEA----------EKQMLVS----EVNLLRELK------HPNIVRYYDRIIDRTN 77
Query: 141 NHLCISFELM-NLNLYELIKRN--NYQGFSLGLIRRFAFSLVQCLRLLHREN-----IIH 192
L I E +L +I + Q + R L L+ HR + ++H
Sbjct: 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137
Query: 193 CDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPYGPPI 249
DLKP NV L + + +K+ DFG + + ++ + +Y SPE + + Y
Sbjct: 138 RDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKS 195
Query: 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309
D+WSLGC+L EL P F ++ E I E
Sbjct: 196 DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY----------------- 238
Query: 310 CITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364
+ +T+ N R + +E L + +
Sbjct: 239 ------------------------SDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-43
Identities = 54/351 (15%), Positives = 111/351 (31%), Gaps = 99/351 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+++++ +G+G++G+V A++ T A KI
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAV----------------------------AVKI 37
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
D + + E+ I L + NV+ + N
Sbjct: 38 -----------VDMKRAVDCPENIKK----EICINKMLNHE------NVVKFYGHRREGN 76
Query: 142 HLCISFELMNLNL-YELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ E + ++ I+ + G +RF L+ + LH I H D+KPEN+
Sbjct: 77 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 134
Query: 201 LLKQRGSSSIKVIDFGSSCY-----SHQRVYTYIQSRFYRSPEVILGLPY-GPPIDMWSL 254
LL +R ++K+ DFG + + + + Y +PE++ + P+D+WS
Sbjct: 135 LLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 192
Query: 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314
G +L + G + ++ Q + +
Sbjct: 193 GIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-------------------- 232
Query: 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
D A + + + + R+T + + W
Sbjct: 233 -------------------DSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-43
Identities = 65/358 (18%), Positives = 114/358 (31%), Gaps = 93/358 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+Y++ ++G G FG V + N A K
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPV----------------------------AIKH 36
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
++ +S G + + +EV +L + VI +L++F +
Sbjct: 37 VEKDRISDWGELPNGT----------RVPMEVVLLKKVS----SGFSGVIRLLDWFERPD 82
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ E L R F + +++ +R H ++H D+K EN+L
Sbjct: 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 142
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYT-YIQSRFYRSPEVILGLPY-GPPIDMWSLGCILA 259
+ +K+IDFGS VYT + +R Y PE I Y G +WSLG +L
Sbjct: 143 IDLNR-GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLY 201
Query: 260 ELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319
++ G F + E+ R ++FF + + C
Sbjct: 202 DMVCGDIPFEHDEEI---------------------IRGQVFFRQRVSSECQ-------- 232
Query: 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSSSSSSSSHH 377
+ C R T +E H W++ ++ H
Sbjct: 233 -------------------HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (367), Expect = 8e-41
Identities = 65/349 (18%), Positives = 110/349 (31%), Gaps = 97/349 (27%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
++IL +G GSFG+V + A K+
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYY----------------------------AMKVL 37
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
+E + + + E +L + +I M F
Sbjct: 38 KKEIV-------------VRLKQVEHTNDERLMLSIVTHP------FIIRMWGTFQDAQQ 78
Query: 143 LCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLL 202
+ + + + Q F + + +A + L LH ++II+ DLKPEN+LL
Sbjct: 79 IFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 137
Query: 203 KQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELY 262
+ G IK+ DFG + Y YT + Y +PEV+ PY ID WS G ++ E+
Sbjct: 138 DKNGH--IKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 195
Query: 263 TGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322
G F N ++ I+ P
Sbjct: 196 AGYTPFYDSNTMKTYEKILNAELRFPPFF------------------------------- 224
Query: 323 SKDMASVLRCNDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKS 366
++ D +++ D +RL ++ H W K
Sbjct: 225 -----------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-40
Identities = 68/350 (19%), Positives = 119/350 (34%), Gaps = 99/350 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
+ + +++GKGSFG+V A KTN A+K
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIK----------------------------A 34
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ + L + + + + +H + HM F +
Sbjct: 35 LKKDVVLMDDD----------VECTMVEKRVLSLAWEH---------PFLTHMFCTFQTK 75
Query: 141 NHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
+L E + +L I+ F L +A ++ L+ LH + I++ DLK +N
Sbjct: 76 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 133
Query: 200 VLLKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256
+LL + G IK+ DFG + T+ + Y +PE++LG Y +D WS G
Sbjct: 134 ILLDKDGH--IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 191
Query: 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
+L E+ G F G++E E I P +
Sbjct: 192 LLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL------------------------- 226
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT-PDEALRHEWLK 365
+K D + + F + +KRL + +H +
Sbjct: 227 -----------------EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-38
Identities = 55/351 (15%), Positives = 113/351 (32%), Gaps = 99/351 (28%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
+ IG+GSF V + LD +T A
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEV----------------------------AWCEL 42
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--- 139
+ L+++ ++RF E +L L+ N++ + +
Sbjct: 43 QDRKLTKS----------ERQRFKE----EAEMLKGLQ------HPNIVRFYDSWESTVK 82
Query: 140 -RNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHREN--IIHCDL 195
+ + + ELM + L +KR + + ++R + +++ L+ LH IIH DL
Sbjct: 83 GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 140
Query: 196 KPENVLLKQRGSSSIKVIDFGSSCYSHQRV-YTYIQSRFYRSPEVILGLPYGPPIDMWSL 254
K +N+ + + S+K+ D G + I + + +PE+ Y +D+++
Sbjct: 141 KCDNIFITGP-TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAF 198
Query: 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314
G + E+ T + Q+ + P FD P
Sbjct: 199 GMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------FDKVAIPEVK--- 243
Query: 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
+ + C + +R + + L H + +
Sbjct: 244 ------------------------EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 136 bits (343), Expect = 9e-38
Identities = 55/358 (15%), Positives = 102/358 (28%), Gaps = 98/358 (27%)
Query: 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGL 76
H+ RYE+ E++G G +V A D + + A+K
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVK------------------------- 38
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
+ + + F+ + E + L ++ + +
Sbjct: 39 ---VLRADLA--------------RDPSFYLRFRREAQNAAALNHP------AIVAVYDT 75
Query: 137 FYFRNH----LCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENII 191
I E + + L +++ + Q L H+ II
Sbjct: 76 GEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGII 133
Query: 192 HCDLKPENVLLKQRGSSSIKVIDF----GSSCYSHQRVYTYIQSRFYRSPEVILGLPYGP 247
H D+KP N+++ + + S S + I + Y SPE G
Sbjct: 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 193
Query: 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT 307
D++SLGC+L E+ TG P F G++ V + PP S
Sbjct: 194 RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS----------- 242
Query: 308 PRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
V + + + R +R + ++
Sbjct: 243 ---------------------------ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (346), Expect = 1e-37
Identities = 64/351 (18%), Positives = 118/351 (33%), Gaps = 99/351 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+++ ++ +G GSFG+V+ ++ H A KI
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHY----------------------------AMKI 73
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
++ + K + L E RIL + ++ + F +
Sbjct: 74 LDKQKVV-------------KLKQIEHTLNEKRILQAVN------FPFLVKLEFSFKDNS 114
Query: 142 HLC-ISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+L + + ++ ++R FS R +A +V LH ++I+ DLKPEN+
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAE 260
L+ Q+G I+V DFG + R +T + +PE+IL Y +D W+LG ++ E
Sbjct: 173 LIDQQGY--IQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 261 LYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRK 320
+ G P F + ++ I+ P
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFPSHF----------------------------- 261
Query: 321 PGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKS 366
D + D KR ++ H+W +
Sbjct: 262 -------------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 5e-37
Identities = 55/349 (15%), Positives = 106/349 (30%), Gaps = 101/349 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
++L+ IGKG FG V+ D++ N A+K
Sbjct: 8 ELKLLQTIGKGEFGDVMLG-DYRGNKVAVK------------------------------ 36
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-R 140
L E ++ LR N++ +L +
Sbjct: 37 -----------------CIKNDATAQAFLAEASVMTQLRHS------NLVQLLGVIVEEK 73
Query: 141 NHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPEN 199
L I E M +L + ++ + +F+ + + + L N +H DL N
Sbjct: 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 133
Query: 200 VLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILA 259
VL+ + KV DFG + + T + +PE + + D+WS G +L
Sbjct: 134 VLVSEDNV--AKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 191
Query: 260 ELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
E+Y+ G +P + + + + +
Sbjct: 192 EIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-------------------------- 225
Query: 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH-EWLKS 366
A + + C++ D+ R + + E +K+
Sbjct: 226 ---------------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 136 bits (343), Expect = 6e-37
Identities = 61/353 (17%), Positives = 115/353 (32%), Gaps = 95/353 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+ + +IG+G FG+V T A K
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMY----------------------------AMKC 36
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
++ + K+ AL E +L + D ++ M F+ +
Sbjct: 37 LDKKRI-------------KMKQGETLALNERIMLSLVSTGDCP---FIVCMSYAFHTPD 80
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L +LM +L+ + ++ FS +R +A ++ L +H +++ DLKP N+
Sbjct: 81 KLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 138
Query: 201 LLKQRGSSSIKVIDFGSSC-YSHQRVYTYIQSRFYRSPEVIL-GLPYGPPIDMWSLGCIL 258
LL + G +++ D G +C +S ++ + + + Y +PEV+ G+ Y D +SLGC+L
Sbjct: 139 LLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 196
Query: 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
+L G F ++ L + P
Sbjct: 197 FKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL-----------------PDSF------- 232
Query: 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLT-----PDEALRHEWLKS 366
+ D +RL E + +S
Sbjct: 233 ---------------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-35
Identities = 64/356 (17%), Positives = 113/356 (31%), Gaps = 101/356 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+ + + IG GSFG V + H A K+
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDV-------------------------------AVKM 37
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + + F + EV +L R N++ + +
Sbjct: 38 LNVTAPTPQQ----------LQAFKN----EVGVLRKTRHV------NILLFMG-YSTAP 76
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L I + +LY + F + + A Q + LH ++IIH DLK N+
Sbjct: 77 QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNI 135
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF-----YRSPEVILGL---PYGPPIDMW 252
L + + +K+ DFG + + ++ + + +PEVI PY D++
Sbjct: 136 FLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
+ G +L EL TG + N +Q+ ++
Sbjct: 194 AFGIVLYELMTGQLPYSNINNRDQIIFMV------------------------------- 222
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH-EWLKSS 367
R S D++ V KA + +C +R + L E L S
Sbjct: 223 -----GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 128 bits (323), Expect = 9e-35
Identities = 42/285 (14%), Positives = 88/285 (30%), Gaps = 65/285 (22%)
Query: 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGL 76
+ + Y++ IG+GSFG + + N
Sbjct: 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQV--------------------------- 33
Query: 77 DACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEY 136
A K ++ Q E R L + ++ +
Sbjct: 34 -AIKFE------------------PRRSDAPQLRDEYRTYKLLAGCT-----GIPNVYYF 69
Query: 137 FYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLK 196
H + +L+ +L +L+ + FS+ + A ++ ++ +H +++++ D+K
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 128
Query: 197 PENVLLKQRG---SSSIKVIDFGSS----------CYSHQRVYTYIQSRFYRSPEVILGL 243
P+N L+ + ++ I V+DFG ++ + Y S LG
Sbjct: 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR 188
Query: 244 PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPP 288
D+ +LG + G + G I
Sbjct: 189 EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-34
Identities = 65/353 (18%), Positives = 114/353 (32%), Gaps = 102/353 (28%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
++ L+++GKG+FG+VI + T + A KI
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYY----------------------------AMKIL 38
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
+E + K + E R+L + R + + F +
Sbjct: 39 RKEVI-------------IAKDEVAHTVTESRVLQNTR------HPFLTALKYAFQTHDR 79
Query: 143 LCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
LC E N L+ + R + F+ R + +V L LH ++++ D+K EN++
Sbjct: 80 LCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 202 LKQRGSSSIKVIDFGSS---CYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
L + G IK+ DFG + T+ + Y +PEV+ YG +D W LG ++
Sbjct: 138 LDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRK 318
E+ G F ++ I+ P +
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIRFPRTL--------------------------- 228
Query: 319 RKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKS 366
+ D K+RL E + H + S
Sbjct: 229 ---------------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 5e-34
Identities = 55/356 (15%), Positives = 106/356 (29%), Gaps = 102/356 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+ +G+G FG+V + T A+K +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIK----------------------------TL 49
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
G+ + + F E +++ LR ++ +
Sbjct: 50 K--------------PGTMSPEAFLQ----EAQVMKKLR------HEKLVQLYAVVSEEP 85
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
++ + +L + +K + L + A + + + R N +H DL+ N+L
Sbjct: 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 145
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQSR----FYRSPEVILGLPYGPPIDMWSLGCI 257
+ + KV DFG + YT Q + +PE L + D+WS G +
Sbjct: 146 VGENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 203
Query: 258 LAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
L EL T G +PG E L + P
Sbjct: 204 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------------------------ 239
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR--HEWLKSSSSS 370
++ D + QC+ + ++R T + ++ S+
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 3e-33
Identities = 58/362 (16%), Positives = 103/362 (28%), Gaps = 100/362 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
RY + IG GSFG + D A K+
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEV----------------------------AIKL 39
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
K H Q IE +I ++ + + +
Sbjct: 40 E------------------CVKTKHPQLHIESKIYKMMQ-----GGVGIPTIRWCGAEGD 76
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ + EL+ +L +L + + FSL + A ++ + +H +N IH D+KP+N L
Sbjct: 77 YNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL 135
Query: 202 LKQRGSSS-IKVIDFGSS----------CYSHQRVYTYIQSRFYRSPEVILGLPYGPPID 250
+ + + +IDFG + ++ + Y S LG+ D
Sbjct: 136 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDD 195
Query: 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC 310
+ SLG +L G + G + I I KG P
Sbjct: 196 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV--------LCKGYP-- 245
Query: 311 ITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPD---EALRHEWLKSS 367
F ++ C + + + R+ + +
Sbjct: 246 ------------------------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
Query: 368 SS 369
S
Sbjct: 282 FS 283
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-32
Identities = 66/357 (18%), Positives = 122/357 (34%), Gaps = 96/357 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+E+L+V+G G++G+V + Y A K+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLY-------------------------AMKV 59
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ ++ Q K + E ++L+H+R+ ++ + F
Sbjct: 60 LKKATIVQ------------KAKTTEHTRTERQVLEHIRQSP-----FLVTLHYAFQTET 102
Query: 142 HLCISFELMNLN-LYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L + + +N L+ + + + F+ ++ + +V L LH+ II+ D+K EN+
Sbjct: 103 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 160
Query: 201 LLKQRGSSSIKVIDFGSSC----YSHQRVYTYIQSRFYRSPEVILGLP--YGPPIDMWSL 254
LL G + + DFG S +R Y + + Y +P+++ G + +D WSL
Sbjct: 161 LLDSNGH--VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218
Query: 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314
G ++ EL TG F + E A I + S
Sbjct: 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS------------------ 260
Query: 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKS 366
D + + D KKRL DE H + +
Sbjct: 261 --------------------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 7e-31
Identities = 51/345 (14%), Positives = 91/345 (26%), Gaps = 100/345 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
++ IG G FG V + A+K I
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIK----------------------------TI 37
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
G+ +++ F E ++ L ++ + +
Sbjct: 38 R--------------EGAMSEEDFIE----EAEVMMKLSHP------KLVQLYGVCLEQA 73
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+C+ FE M R F+ + + + + L +IH DL N L
Sbjct: 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 133
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQ----SRFYRSPEVILGLPYGPPIDMWSLGCI 257
+ + IKV DFG + + YT + SPEV Y D+WS G +
Sbjct: 134 VGENQ--VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 191
Query: 258 LAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
+ E+++ G + + E + I +
Sbjct: 192 MWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA------------------------ 227
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
+ C+ + R LR
Sbjct: 228 -----------------STHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 9e-31
Identities = 65/351 (18%), Positives = 105/351 (29%), Gaps = 96/351 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+LE +G GSFG V R + + A K
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-------------------------AVKC 43
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ LSQ + EV + L + N+I +
Sbjct: 44 LKPDVLSQ-------------PEAMDDFIREVNAMHSLDHR------NLIRLYGVVL-TP 83
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ + EL L R + F LG + R+A + + + L + IH DL N+L
Sbjct: 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF------YRSPEVILGLPYGPPIDMWSLG 255
L R +K+ DFG Q Y+ + +PE + + D W G
Sbjct: 144 LATRD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 256 CILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNS 314
L E++T G + G N + L I
Sbjct: 202 VTLWEMFTYGQEPWIGLNGSQILHKID--------------------------------- 228
Query: 315 KGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365
K +R P +D + + + QC+ + R T ++L
Sbjct: 229 KEGERLPRPEDC-------PQDIYNVMVQCWAHKPEDRPTFVALR--DFLL 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 3e-29
Identities = 51/344 (14%), Positives = 95/344 (27%), Gaps = 100/344 (29%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
L+ +G G FG V A+K I
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIK----------------------------MIK 37
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
GS ++ F E +++ +L + ++ + +
Sbjct: 38 --------------EGSMSEDEFIE----EAKVMMNLSHE------KLVQLYGVCTKQRP 73
Query: 143 LCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLL 202
+ I E M R F + + + + L + +H DL N L+
Sbjct: 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 133
Query: 203 KQRGSSSIKVIDFGSSCYSHQRVYT----YIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258
+G +KV DFG S Y YT + PEV++ + D+W+ G ++
Sbjct: 134 NDQG--VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 191
Query: 259 AELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317
E+Y+ G + E I + L +
Sbjct: 192 WEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA------------------------- 226
Query: 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
+ + C++ + +R T L +
Sbjct: 227 ----------------SEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 6e-29
Identities = 53/354 (14%), Positives = 106/354 (29%), Gaps = 104/354 (29%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+++E +G G FG+V + A+K +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVK----------------------------SL 45
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
GS + F L E ++ L+ + ++ + +
Sbjct: 46 K--------------QGSMSPDAF----LAEANLMKQLQHQ------RLVRLYAVVT-QE 80
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
+ I E M N +L + +K + ++ + A + + + + N IH DL+ N+
Sbjct: 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSR----FYRSPEVILGLPYGPPIDMWSLGC 256
L+ S K+ DFG + YT + + +PE I + D+WS G
Sbjct: 141 LVSDTL--SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 257 ILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315
+L E+ T G +PG E + + +
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC----------------------- 235
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR--HEWLKSS 367
+ + C+ + R T D ++ ++
Sbjct: 236 ------------------PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (280), Expect = 9e-29
Identities = 56/357 (15%), Positives = 106/357 (29%), Gaps = 102/357 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+ +G G +G+V + K + A K
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTV----------------------------AVKT 49
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
E+++ + L E ++ ++ N++ +L
Sbjct: 50 LKEDTMEVE-----------------EFLKEAAVMKEIKHP------NLVQLLGVCTREP 86
Query: 142 HLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
I E M NL + ++ N Q S ++ A + + L ++N IH DL N
Sbjct: 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSR----FYRSPEVILGLPYGPPIDMWSLGC 256
L+ + +KV DFG S YT + +PE + + D+W+ G
Sbjct: 147 LVGENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 204
Query: 257 ILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315
+L E+ T G +PG + + + + E
Sbjct: 205 LLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC----------------------- 241
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR--HEWLKSSSSS 370
+ + + C+ W+ R + E + + SS S
Sbjct: 242 ------------------PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (280), Expect = 1e-28
Identities = 53/359 (14%), Positives = 96/359 (26%), Gaps = 100/359 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+I +VIG G FG+V + A K
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFV-------------------------AIKT 61
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
++ F E I+ NVIH+
Sbjct: 62 -----------LKSGYTEKQRRDFLS----EASIMGQFDHP------NVIHLEGVVTKST 100
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ I E M + R N F++ + + ++ L N +H DL N+L
Sbjct: 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL 160
Query: 202 LKQRGSSSIKVIDFG--------SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253
+ KV DFG +S ++ + +PE I + D+WS
Sbjct: 161 VNSNL--VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWS 218
Query: 254 LGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCIT 312
G ++ E+ + G + + + I + PP
Sbjct: 219 YGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-------------------- 258
Query: 313 NSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH--EWLKSSSS 369
A + C+ D R + + + +++ +S
Sbjct: 259 ---------------------PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-28
Identities = 49/368 (13%), Positives = 112/368 (30%), Gaps = 113/368 (30%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
E +V+G G+FG+V+ A + + +T + + A K+
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGIS---------------KTGVSIQV--------AVKM 74
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
++ S ++ E++++ L + N++++L
Sbjct: 75 -----------LKEKADSSEREALMS----ELKMMTQLGSHE-----NIVNLLGACTLSG 114
Query: 142 HLCISFELM-NLNLYELIKRNN---------------------YQGFSLGLIRRFAFSLV 179
+ + FE +L ++ + + FA+ +
Sbjct: 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 174
Query: 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY-----SHQRVYTYIQSRFY 234
+ + L ++ +H DL NVL+ +K+ DFG + ++ +
Sbjct: 175 KGMEFLEFKSCVHRDLAARNVLVTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKW 232
Query: 235 RSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVIN 293
+PE + Y D+WS G +L E+++ G +PG ++
Sbjct: 233 MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI------------ 280
Query: 294 TASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRL 353
+ + + + C+ +DS+KR
Sbjct: 281 ---------------------QNGFKMDQPFYA-------TEEIYIIMQSCWAFDSRKRP 312
Query: 354 TPDEALRH 361
+
Sbjct: 313 SFPNLTSF 320
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-27
Identities = 53/345 (15%), Positives = 91/345 (26%), Gaps = 95/345 (27%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
R E+ IG+G FG V + + AL A K
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAV-------------------------AIKT 42
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ +++F E + +++ ++ N
Sbjct: 43 -----------CKNCTSDSVREKFLQ----EALTMRQFDHP------HIVKLIGVIT-EN 80
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ I EL L + L + +A+ L L L + +H D+ NVL
Sbjct: 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 140
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQ----SRFYRSPEVILGLPYGPPIDMWSLGCI 257
+ +K+ DFG S Y Y + +PE I + D+W G
Sbjct: 141 VSSND--CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 198
Query: 258 LAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316
+ E+ G F G + + I P
Sbjct: 199 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC------------------------ 234
Query: 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
+T+C+ +D +R E
Sbjct: 235 -----------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 6e-27
Identities = 58/365 (15%), Positives = 111/365 (30%), Gaps = 98/365 (26%)
Query: 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDA 78
I + E IGKG FG+V R A
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGKWRGEEV------------------------------A 30
Query: 79 CKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFY 138
KI ++ + +A E+ LR + N++ +
Sbjct: 31 VKIFSSRE---------------ERSWFREA--EIYQTVMLRHE------NILGFIAADN 67
Query: 139 FRN----HLCISFELM-NLNLYELIKRNNY-----QGFSLGLIRRFAFSLVQCLRLLHRE 188
N L + + + +L++ + R +L A ++ + +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 189 NIIHCDLKPENVLLKQRGSSSIKVIDFG-------SSCYSHQRVYTYIQSRFYRSPEVIL 241
I H DLK +N+L+K+ G + + D G ++ + ++ Y +PEV+
Sbjct: 128 AIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 242 G------LPYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTA 295
D++++G + E+ C + G +E QL + P E +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMR-- 242
Query: 296 SRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTP 355
+ + K R P LR + +C+ + RLT
Sbjct: 243 -------------KVVCEQKLRPNIPNRWQSCEALRV----MAKIMRECWYANGAARLTA 285
Query: 356 DEALR 360
+
Sbjct: 286 LRIKK 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (261), Expect = 4e-26
Identities = 53/300 (17%), Positives = 93/300 (31%), Gaps = 77/300 (25%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
E + IG+G+FG+V +A L Y + A K+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMV-------------------AVKM 50
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
EE+ E ++ + N++ +L
Sbjct: 51 LKEEA---------------SADMQADFQREAALMAEFD------NPNIVKLLGVCAVGK 89
Query: 142 HLCISFELM-NLNLYELIKRNNYQG----------------------FSLGLIRRFAFSL 178
+C+ FE M +L E ++ + S A +
Sbjct: 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149
Query: 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF----- 233
+ L +H DL N L+ + +K+ DFG S + Y
Sbjct: 150 AAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIR 207
Query: 234 YRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIME--ILGCPPDE 290
+ PE I Y D+W+ G +L E+++ G + G E + + + IL CP +
Sbjct: 208 WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENC 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 7e-26
Identities = 48/346 (13%), Positives = 96/346 (27%), Gaps = 97/346 (28%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
++ ++V+G G+FG V + L + +L E + K
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-------------- 56
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ L E ++ + + +V +L
Sbjct: 57 --------------------------EILDEAYVMASVD------NPHVCRLLGICLTST 84
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
I+ + L + ++ + + + + + + L ++H DL NVL
Sbjct: 85 VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 143
Query: 202 LKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF-----YRSPEVILGLPYGPPIDMWSLGC 256
+K +K+ DFG + Y + + E IL Y D+WS G
Sbjct: 144 VKTPQ--HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 201
Query: 257 ILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315
+ EL T G + G E + + + P +
Sbjct: 202 TVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC----------------------- 238
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
+ +C+ D+ R E +
Sbjct: 239 ------------------TIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 2e-25
Identities = 56/359 (15%), Positives = 104/359 (28%), Gaps = 101/359 (28%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
R + + +G+G+FGQV+ A + K N++T+ A K+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLD----KDKPNRVTKV-----------------AVKM 52
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + + + I H N+I++L
Sbjct: 53 -----------LKSDATEKDLSDLISEMEMMKMIGKH---------KNIINLLGACTQDG 92
Query: 142 HLCISFELM-NLNLYELIKRNNYQG--------------FSLGLIRRFAFSLVQCLRLLH 186
L + E NL E ++ G S + A+ + + + L
Sbjct: 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152
Query: 187 RENIIHCDLKPENVLLKQRGSSSIKVID---FGSSCYSHQRVYTYIQSRFYRSPEVILGL 243
+ IH DL NVL+ + I +++ + +PE +
Sbjct: 153 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212
Query: 244 PYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFF 302
Y D+WS G +L E++T G +PG E + E R+
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE--------------GHRMDK 258
Query: 303 DSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361
S T + C++ +R T + +
Sbjct: 259 PSNCTNELY---------------------------MMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-25
Identities = 59/375 (15%), Positives = 118/375 (31%), Gaps = 109/375 (29%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+ +VIG+G+FGQV++A K A K
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDA--------------------------AIKR 44
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ + + F E+ +L L N+I++L R
Sbjct: 45 -----------MKEYASKDDHRDFAG----ELEVLCKLGHHP-----NIINLLGACEHRG 84
Query: 142 HLCISFELM-NLNLYELIKRNNY--------------QGFSLGLIRRFAFSLVQCLRLLH 186
+L ++ E + NL + ++++ S + FA + + + L
Sbjct: 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144
Query: 187 RENIIHCDLKPENVLLKQRGSSSIKVIDFGSS--CYSHQRVYTYIQSRFYRSPEVILGLP 244
++ IH DL N+L+ + K+ DFG S + + + + E +
Sbjct: 145 QKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV 202
Query: 245 YGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFD 303
Y D+WS G +L E+ + G + G E + + G ++ +N
Sbjct: 203 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--GYRLEKPLNC--------- 251
Query: 304 SKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH-- 361
D D + QC+ +R + + L
Sbjct: 252 ------------------------------DDEVYDLMRQCWREKPYERPSFAQILVSLN 281
Query: 362 EWLKSSSSSSSSSSH 376
L+ + +++ +
Sbjct: 282 RMLEERKTYVNTTLY 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-24
Identities = 47/367 (12%), Positives = 90/367 (24%), Gaps = 102/367 (27%)
Query: 22 RYEILEV-IGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
I ++ +G G+FG V + + A K
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDV--------------------------AIK 42
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR 140
+ + + E +I+ L ++ ++
Sbjct: 43 V-----------LKQGTEKADTEEMMR----EAQIMHQLDNP------YIVRLIGVCQ-A 80
Query: 141 NHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENV 200
L + E+ + + + + ++ L +N +H DL NV
Sbjct: 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 140
Query: 201 LLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSR------FYRSPEVILGLPYGPPIDMWSL 254
LL R K+ DFG S Y + +PE I + D+WS
Sbjct: 141 LLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 198
Query: 255 GCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITN 313
G + E + G + E +A I +
Sbjct: 199 GVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC--------------------- 237
Query: 314 SKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDE---ALRHEWLKSSSSS 370
++ C+ + + R +R + +S
Sbjct: 238 --------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
Query: 371 SSSSSHH 377
HH
Sbjct: 278 EGHHHHH 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-24
Identities = 54/362 (14%), Positives = 97/362 (26%), Gaps = 95/362 (26%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+VIG G FG+V + + ++ A K
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPV------------------------AIKT 43
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
+ F E I+ +N+I +
Sbjct: 44 -----------LKAGYTEKQRVDFLG----EAGIMGQFS------HHNIIRLEGVISKYK 82
Query: 142 HLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVL 201
+ I E M + R FS+ + + ++ L N +H DL N+L
Sbjct: 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 142
Query: 202 LKQRGSSSIKVIDFG-SSCYSHQRVYTYIQSRF-----YRSPEVILGLPYGPPIDMWSLG 255
+ KV DFG S TY S + +PE I + D+WS G
Sbjct: 143 VNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFG 200
Query: 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSK 315
++ E+ T E ++ +
Sbjct: 201 IVMWEVMTYGERPYWELSNHEVMKAI---------------------------------N 227
Query: 316 GRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR--HEWLKSSSSSSSS 373
R P D A + QC+ + +R + + + +++ S +
Sbjct: 228 DGFRLPTPMDCP-------SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280
Query: 374 SS 375
+
Sbjct: 281 AD 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 2e-24
Identities = 50/360 (13%), Positives = 98/360 (27%), Gaps = 103/360 (28%)
Query: 18 HICYRYEILE--VIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLG 75
++ + LE +G G+FG V +
Sbjct: 2 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTV------------------------ 37
Query: 76 LDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLE 135
A KI E+ N + L E ++ L ++ M+
Sbjct: 38 --AVKILKNEA--------------NDPALKDELLAEANVMQQLDNP------YIVRMIG 75
Query: 136 YFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDL 195
+ + + L + +++N + I + ++ L N +H DL
Sbjct: 76 ICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 196 KPENVLLKQRGSSSIKVIDFG------SSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPI 249
NVLL + K+ DFG + ++ + +PE I +
Sbjct: 134 AARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 191
Query: 250 DMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTP 308
D+WS G ++ E ++ G + G E A + +
Sbjct: 192 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC---------------- 235
Query: 309 RCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDE---ALRHEWLK 365
+ D + C+ +D + R LR+ +
Sbjct: 236 -------------------------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 1e-23
Identities = 54/373 (14%), Positives = 112/373 (30%), Gaps = 110/373 (29%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
R + +G G+FG+V+ A + + A K+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLI--------------KSDAAMTV---------AVKM 60
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
++ E+++L +L + N++++L
Sbjct: 61 -----------LKPSAHLTEREALMS----ELKVLSYLG-----NHMNIVNLLGACTIGG 100
Query: 142 HLCISFELM-NLNLYELIKR----------------NNYQGFSLGLIRRFAFSLVQCLRL 184
+ E +L ++R ++ L + F++ + + +
Sbjct: 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF-----YRSPEV 239
L +N IH DL N+LL K+ DFG + ++ + +PE
Sbjct: 161 LASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES 218
Query: 240 ILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRR 298
I Y D+WS G L EL++ G +PG + +++
Sbjct: 219 IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-------------EGF 265
Query: 299 RLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358
R+ D + C++ D KR T +
Sbjct: 266 RMLSPEHAPAEMY---------------------------DIMKTCWDADPLKRPTFKQI 298
Query: 359 LRH--EWLKSSSS 369
++ + + S++
Sbjct: 299 VQLIEKQISESTN 311
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 5e-23
Identities = 44/276 (15%), Positives = 90/276 (32%), Gaps = 61/276 (22%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKI 81
+ + +G+GSFG V + + + A K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPE--------------TRV---------AIKT 57
Query: 82 HGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN 141
++ + F L E ++ ++V+ +L
Sbjct: 58 -----------VNEAASMRERIEF----LNEASVMKEFN------CHHVVRLLGVVSQGQ 96
Query: 142 HLCISFELM-NLNLYELIKRNNYQG--------FSLGLIRRFAFSLVQCLRLLHRENIIH 192
+ ELM +L ++ SL + + A + + L+ +H
Sbjct: 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156
Query: 193 CDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRF-----YRSPEVILGLPYGP 247
DL N ++ + + +K+ DFG + ++ Y + + SPE + +
Sbjct: 157 RDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT 214
Query: 248 PIDMWSLGCILAELYTGC-PLFPGENEVEQLACIME 282
D+WS G +L E+ T + G + + L +ME
Sbjct: 215 YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 7e-23
Identities = 48/291 (16%), Positives = 93/291 (31%), Gaps = 57/291 (19%)
Query: 1 SSLNFRILSFAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEF 60
S+LN ++ V+ EVIG+G FG V + +
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC-------- 58
Query: 61 ERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLR 120
A K + +F L E I+
Sbjct: 59 -----------------AVKS-----------LNRITDIGEVSQF----LTEGIIMKDFS 86
Query: 121 KKDADSSYNVIHMLEYFY-FRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179
NV+ +L + M RN ++ + F +
Sbjct: 87 HP------NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 140
Query: 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSR------- 232
+ ++ L + +H DL N +L ++ ++KV DFG + + + + + ++
Sbjct: 141 KGMKFLASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 233 FYRSPEVILGLPYGPPIDMWSLGCILAELYTGC-PLFPGENEVEQLACIME 282
+ + E + + D+WS G +L EL T P +P N + +++
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 2e-22
Identities = 59/372 (15%), Positives = 115/372 (30%), Gaps = 111/372 (29%)
Query: 22 RYEILEVIGKGSFGQVIRALDHKTN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACK 80
R ++ + +G+G+FGQVI A + T + A K
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV------------------------AVK 49
Query: 81 IHGEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF- 139
+ + + + I + I H NV+++L
Sbjct: 50 M-----------LKEGATHSEHRALMSELKILIHIGHH---------LNVVNLLGACTKP 89
Query: 140 RNHLCISFELM-NLNLYELIKRNNYQG--------------FSLGLIRRFAFSLVQCLRL 184
L + E NL ++ + +L + ++F + + +
Sbjct: 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 149
Query: 185 LHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY-----SHQRVYTYIQSRFYRSPEV 239
L IH DL N+LL ++ +K+ DFG + + R + +PE
Sbjct: 150 LASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 207
Query: 240 ILGLPYGPPIDMWSLGCILAELYTGC-PLFPGENEVEQLACIMEILGCPPDEVINTASRR 298
I Y D+WS G +L E+++ +PG E+ ++
Sbjct: 208 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-------------EGT 254
Query: 299 RLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA 358
R+ TP + C++ + +R T E
Sbjct: 255 RMRAPDYTTPEMY---------------------------QTMLDCWHGEPSQRPTFSEL 287
Query: 359 LRH--EWLKSSS 368
+ H L++++
Sbjct: 288 VEHLGNLLQANA 299
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.8 bits (183), Expect = 2e-16
Identities = 40/242 (16%), Positives = 72/242 (29%), Gaps = 56/242 (23%)
Query: 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIH 82
I +++G+G V K +K++ T F++ + + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKK-------------VKEKRDY 48
Query: 83 GEESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNH 142
G+ S A E R L L+ V + Y + N
Sbjct: 49 GDLHFS--------------VLAIRSARNEFRALQKLQ------GLAVPKV--YAWEGNA 86
Query: 143 LCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLL 202
+ L ELI + +++ + + I+H DL NVL+
Sbjct: 87 V----------LMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV 136
Query: 203 KQRGSSSIKVIDFGSSC-YSHQRVYTYIQSRFYRSPEVIL---GLPYGPPIDMWSLGCIL 258
+ G I +IDF S + R I+ Y D+ S +
Sbjct: 137 SEEG---IWIIDFPQSVEVGEEGWREI----LERDVRNIITYFSRTYRTEKDINSAIDRI 189
Query: 259 AE 260
+
Sbjct: 190 LQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 429 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.16 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.78 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.48 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.59 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.52 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-58 Score=426.96 Aligned_cols=252 Identities=28% Similarity=0.407 Sum_probs=217.0
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|+++.++.. |+|++.+....
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~---------------------------------------- 45 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE---------------------------------------- 45 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH----------------------------------------
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc----------------------------------------
Confidence 5699999999999999999999998865 99987543211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.......+.+|+++++.++|+ ||+++++++.+++.+|+|||||+ |+|.+++..... +++..++.++.||
T Consensus 46 --~~~~~~~~~~E~~il~~l~hp------nIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~--l~e~~~~~i~~qi 115 (263)
T d2j4za1 46 --KAGVEHQLRREVEIQSHLRHP------NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITEL 115 (263)
T ss_dssp --HTTCHHHHHHHHHHHHTCCCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHH
T ss_pred --ChHHHHHHHHHHHHHHhcCCC------CCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCC--CCHHHHHHHHHHH
Confidence 122344677799999999877 99999999999999999999995 699999987653 9999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-cceeeecCccccchhhhhCCCCCCCccccchhhH
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCI 257 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 257 (429)
+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||+
T Consensus 116 ~~al~~lH~~~ivHrDiKp~Nill~~~~--~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvi 193 (263)
T d2j4za1 116 ANALSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 193 (263)
T ss_dssp HHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred HHHHHHHHHCCeeeeeeccccceecCCC--CEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHH
Confidence 9999999999999999999999999988 899999999976543 3455689999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHH
Q psy17270 258 LAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAF 337 (429)
Q Consensus 258 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
+|+|++|+.||.+.+..+.+..+....... +...++++
T Consensus 194 lyell~G~~Pf~~~~~~~~~~~i~~~~~~~------------------------------------------p~~~s~~~ 231 (263)
T d2j4za1 194 CYEFLVGKPPFEANTYQETYKRISRVEFTF------------------------------------------PDFVTEGA 231 (263)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHTTCCCC------------------------------------------CTTSCHHH
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------------------------------------------CccCCHHH
Confidence 999999999999988877776665311111 11237889
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 338 VDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 338 ~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.+||.+||+.||++|||+.|+|+||||++
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=426.30 Aligned_cols=253 Identities=27% Similarity=0.453 Sum_probs=215.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..+||++++.||+|+||+||+|.++.+++. |+|++.....
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--------------------------------------- 58 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--------------------------------------- 58 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---------------------------------------
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---------------------------------------
Confidence 467999999999999999999999998865 8988743211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
...+.+.+|+++++.++|+ ||++++++|.+++++|+|||||. |+|.+++... ++++..++.++.
T Consensus 59 ------~~~~~~~~E~~il~~l~Hp------nIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~ 123 (293)
T d1yhwa1 59 ------PKKELIINEILVMRENKNP------NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCR 123 (293)
T ss_dssp ------SCHHHHHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHH
T ss_pred ------hHHHHHHHHHHHHHhCCCC------CEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHH
Confidence 1123567799999999887 99999999999999999999995 6999987764 399999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..|+.++||||
T Consensus 124 qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 201 (293)
T d1yhwa1 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201 (293)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHH
T ss_pred HHHHHHHHHHHCCCcccCCcHHHeEECCCC--cEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceeh
Confidence 999999999999999999999999999988 89999999997643 2344568999999999999999999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|+|+||+.||.+.+..+.+..+........ ..+...
T Consensus 202 lGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~ 242 (293)
T d1yhwa1 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL---------------------------------------QNPEKL 242 (293)
T ss_dssp HHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------------------------------------SSGGGS
T ss_pred HhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC---------------------------------------CCcccC
Confidence 99999999999999999888777766654211110 011234
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 789999999999999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=424.06 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=208.7
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+-++|++++.||+|+||+||+|+++.+++. |+|++......
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------------------------------------- 44 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------------------------------------- 44 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------------------------------
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--------------------------------------
Confidence 456899999999999999999999998865 99987543211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
...+.+.+|+++++.++|+ ||+++++++.+++.+|+|||||. |+|.+++.... .+++..++.++.
T Consensus 45 ------~~~~~~~~Ei~~l~~l~Hp------nIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~ 110 (271)
T d1nvra_ 45 ------DCPENIKKEICINKMLNHE------NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFH 110 (271)
T ss_dssp ----------CHHHHHHHHHTCCCT------TBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHH
T ss_pred ------hHHHHHHHHHHHHHhCCCC------CEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHH
Confidence 1123567799999999877 99999999999999999999995 69999987543 499999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc-----CcceeeecCccccchhhhhCCCC-CCCcc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-----QRVYTYIQSRFYRSPEVILGLPY-GPPID 250 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~-~~~~D 250 (429)
||+.||+|||++||+||||||+|||++.++ .+||+|||+|+... ......+||+.|+|||++.+..+ +.++|
T Consensus 111 qi~~al~ylH~~~IiHrDiKp~NILl~~~~--~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~D 188 (271)
T d1nvra_ 111 QLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188 (271)
T ss_dssp HHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHH
T ss_pred HHHHHHHHHHHcCCccCcccHHHEEECCCC--CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCcee
Confidence 999999999999999999999999999888 89999999997543 12345689999999999998876 57899
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||||++|+|+||+.||.+.+............... ....
T Consensus 189 iwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~ 229 (271)
T d1nvra_ 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------------------------------LNPW 229 (271)
T ss_dssp HHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------------------------------------STTG
T ss_pred eeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------------------------------CCcc
Confidence 9999999999999999998765433322222100000 0112
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
...++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 3347889999999999999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=423.70 Aligned_cols=268 Identities=26% Similarity=0.417 Sum_probs=224.1
Q ss_pred cccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCC
Q psy17270 16 HDHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFD 94 (429)
Q Consensus 16 ~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~ 94 (429)
.+.+.+||++++.||+|+||+||+|+++.+|+. |+|++.+......
T Consensus 5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~--------------------------------- 51 (293)
T d1jksa_ 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS--------------------------------- 51 (293)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTC---------------------------------
T ss_pred CCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchh---------------------------------
Confidence 345789999999999999999999999998865 8888754321100
Q ss_pred CCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHH
Q psy17270 95 DENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 95 ~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~ 173 (429)
........+.+|++++++++|+ ||++++++|.+..++|+|||||+ |+|.+++.... .+++..++.
T Consensus 52 ------~~~~~~~~~~~E~~il~~l~Hp------nIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~ 117 (293)
T d1jksa_ 52 ------RRGVSREDIEREVSILKEIQHP------NVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 117 (293)
T ss_dssp ------SSSBCHHHHHHHHHHHHHCCCT------TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHH
T ss_pred ------hhhHHHHHHHHHHHHHHhCCCC------CCCcEEEEEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHH
Confidence 0112345678899999999887 99999999999999999999995 69999998765 499999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCC--cceEEeeeccccccc--CcceeeecCccccchhhhhCCCCCCCc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGS--SSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~--~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
++.|++.||+|||++||+||||||+|||++.++. ..+||+|||++.... .......||+.|+|||++.+..++.++
T Consensus 118 ~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~ 197 (293)
T d1jksa_ 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 197 (293)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHH
T ss_pred HHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcc
Confidence 9999999999999999999999999999987653 259999999997654 334456899999999999998999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||+||++|+|++|+.||.+.+..+.+..+.......+.. .
T Consensus 198 DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------------------~ 239 (293)
T d1jksa_ 198 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE--------------------------------------Y 239 (293)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH--------------------------------------H
T ss_pred cchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch--------------------------------------h
Confidence 99999999999999999999999888877776532222222 2
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++.+.+||++||+.||++|||++|+|+||||+...
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 234478999999999999999999999999999998654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-56 Score=430.84 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=222.0
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+.+-++|++++.||+|+||+||+|+++.+|.. |+|++......
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~------------------------------------ 65 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------------------------------------ 65 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH------------------------------------
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh------------------------------------
Confidence 34557999999999999999999999999865 99988544221
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
-.+.+.+|+++++.++|+ ||++++++|.+++++|+|||||. |+|.+++.... +++++..++.+
T Consensus 66 ---------~~~~~~~E~~il~~l~Hp------nIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i 129 (350)
T d1koaa2 66 ---------DKETVRKEIQTMSVLRHP------TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEY 129 (350)
T ss_dssp ---------HHHHHHHHHHHHHHTCCT------TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHH
T ss_pred ---------hHHHHHHHHHHHHhCCCC------CCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHH
Confidence 112456699999999887 99999999999999999999995 69999986543 35999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
+.||+.||+|||++||+||||||+|||++.++...+||+|||+++.... .....+||+.|+|||++.+..|+.++|||
T Consensus 130 ~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~Diw 209 (350)
T d1koaa2 130 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 209 (350)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHH
T ss_pred HHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhh
Confidence 9999999999999999999999999999764334899999999976543 34457899999999999999999999999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|++|+.||.+.+..+.+..+......++.. ....
T Consensus 210 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------------------~~~~ 251 (350)
T d1koaa2 210 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS--------------------------------------AFSG 251 (350)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG--------------------------------------GGGG
T ss_pred hhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--------------------------------------cccC
Confidence 99999999999999999999888888776533222211 1234
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.++++.+||++||+.||++|||+.|+|+||||+...
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 478999999999999999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-57 Score=426.79 Aligned_cols=261 Identities=27% Similarity=0.420 Sum_probs=205.1
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+.+.++|++++.||+|+||+||+|.++.+++. |+|++.......
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----------------------------------- 49 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG----------------------------------- 49 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------------------------------------
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-----------------------------------
Confidence 45789999999999999999999999998875 999885432211
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
....+.+|+++++.++|+ ||++++++|.+++.+|+|||||+ |+|.+++.... .+++..+..+
T Consensus 50 ---------~~~~~~~Ei~il~~l~Hp------nIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~ 112 (307)
T d1a06a_ 50 ---------KEGSMENEIAVLHKIKHP------NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRL 112 (307)
T ss_dssp --------------CHHHHHHHTCCCT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHH
T ss_pred ---------HHHHHHHHHHHHHhCCCC------CCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHH
Confidence 112355699999999877 99999999999999999999996 69999998654 4999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecC-CCcceEEeeeccccccc--CcceeeecCccccchhhhhCCCCCCCccc
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQR-GSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~-~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
+.||+.||+|||++||+||||||+|||+... ....+||+|||++.... ....+.+||+.|+|||++.+..|+.++||
T Consensus 113 ~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~Di 192 (307)
T d1a06a_ 113 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDC 192 (307)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHH
T ss_pred HHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHh
Confidence 9999999999999999999999999999642 12289999999997654 23445789999999999999999999999
Q ss_pred cchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 252 WSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 252 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
|||||++|+|++|+.||.+.+..+....+......++. ....
T Consensus 193 wSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------------------~~~~ 234 (307)
T d1a06a_ 193 WSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS--------------------------------------PYWD 234 (307)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT--------------------------------------TTTT
T ss_pred hhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC--------------------------------------cccc
Confidence 99999999999999999998887777666542111111 1112
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
..++++.+||.+||+.||++|||+.|+++||||++.
T Consensus 235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 347899999999999999999999999999999763
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=421.76 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=214.3
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|.++.+++. |+|++.+....
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------------------------------------- 47 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII---------------------------------------- 47 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----------------------------------------
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc----------------------------------------
Confidence 6799999999999999999999988864 99988543211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.......+.+|++++++++|+ ||++++++|.+++.+|+|||||. |+|.+++.... .+++..++.++.|+
T Consensus 48 --~~~~~~~~~~E~~il~~l~Hp------nIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi 117 (288)
T d1uu3a_ 48 --KENKVPYVTRERDVMSRLDHP------FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEI 117 (288)
T ss_dssp --HTTCHHHHHHHHHHHHHCCST------TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHHHHHHHcCCC------CeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHH
Confidence 112234577799999999887 99999999999999999999995 69999988775 49999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----cceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .....+||+.|+|||++.+..|+.++||||
T Consensus 118 ~~al~ylH~~~iiHrDiKp~NIll~~~~--~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwS 195 (288)
T d1uu3a_ 118 VSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 195 (288)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHH
T ss_pred HHHHHhhccccEEcCcCCccccccCCCc--eEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceeh
Confidence 9999999999999999999999999988 899999999976432 233467999999999999999999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|+|+||+.||.+.+..+.+..|...-...+ ...
T Consensus 196 lGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------------------------------------~~~ 233 (288)
T d1uu3a_ 196 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP------------------------------------------EKF 233 (288)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC------------------------------------------TTC
T ss_pred hhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC------------------------------------------ccC
Confidence 99999999999999999888877776653111111 123
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDE------ALRHEWLKSS 367 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~e------ll~h~~~~~~ 367 (429)
++++.+||++||+.||++|||++| +++||||++.
T Consensus 234 s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 234 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp CHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 788999999999999999999988 5889999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-56 Score=419.10 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=213.4
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.+.|++++.||+|+||+||+|.++.++.. |+|++....
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----------------------------------------- 49 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----------------------------------------- 49 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-----------------------------------------
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-----------------------------------------
Confidence 36799999999999999999999999875 888874321
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
....+.+.+|+++++.++|+ ||+++++++.+++.+|+|||||. |+|.+++.+.. ..+++..++.++.|
T Consensus 50 ----~~~~~~~~~E~~il~~l~Hp------nIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~q 118 (288)
T d2jfla1 50 ----EEELEDYMVEIDILASCDHP------NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQ 118 (288)
T ss_dssp ----SGGGGGTHHHHHHHHHCCCT------TBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHH
T ss_pred ----HHHHHHHHHHHHHHHhCCCC------CCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHH
Confidence 11124567799999999877 99999999999999999999995 69999877654 45999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhh-----CCCCCCCc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVIL-----GLPYGPPI 249 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~-----~~~~~~~~ 249 (429)
|+.||.|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++. +..|+.++
T Consensus 119 i~~gL~ylH~~~ivHrDiKp~NIll~~~~--~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~ 196 (288)
T d2jfla1 119 TLDALNYLHDNKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 196 (288)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHH
T ss_pred HHHHHHHHHHCCEEEeecChhheeECCCC--CEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhh
Confidence 99999999999999999999999999988 899999999965432 233568999999999985 34588999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|+||+.||.+.+..+.+..+....... ...
T Consensus 197 DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------------~~~ 237 (288)
T d2jfla1 197 DVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT---------------------------------------LAQ 237 (288)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC---------------------------------------CSS
T ss_pred hHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---------------------------------------CCc
Confidence 99999999999999999999988877776665411100 001
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
+...++++.+||++||+.||++|||+.|+|+||||+.
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 1234789999999999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.1e-56 Score=429.39 Aligned_cols=261 Identities=25% Similarity=0.432 Sum_probs=220.6
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+.++|++++.||+|+||+||+|+++.+++. |+|++.......
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~------------------------------------ 69 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD------------------------------------ 69 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH------------------------------------
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH------------------------------------
Confidence 3567899999999999999999999998875 999885442211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
...+.+|+++|++++|+ ||++++++|.++.++|+|||||+ |+|.+.+.... .++++.+++.++
T Consensus 70 ---------~~~~~~Ei~il~~l~Hp------nIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~ 133 (352)
T d1koba_ 70 ---------KYTVKNEISIMNQLHHP------KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYM 133 (352)
T ss_dssp ---------HHHHHHHHHHHTTCCST------TBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHH
T ss_pred ---------HHHHHHHHHHHHhCCCC------CCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHH
Confidence 12455699999999876 99999999999999999999995 69988876544 459999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
.||+.||+|||++||+||||||+|||++..+...+||+|||++..... ......||+.|+|||++.+..|+.++||||
T Consensus 134 ~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 213 (352)
T d1koba_ 134 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWA 213 (352)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHH
T ss_pred HHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHH
Confidence 999999999999999999999999999854333899999999986543 345578999999999999999999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|+|+||+.||.+.+..+.+..+......++.. .+...
T Consensus 214 lGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------------------~~~~~ 255 (352)
T d1koba_ 214 IGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED--------------------------------------AFSSV 255 (352)
T ss_dssp HHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS--------------------------------------TTTTS
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--------------------------------------cccCC
Confidence 9999999999999999999988887776532222211 11234
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
++++.+||++||+.||++|||+.|+|+||||+...
T Consensus 256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 78999999999999999999999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-56 Score=419.89 Aligned_cols=281 Identities=29% Similarity=0.526 Sum_probs=224.6
Q ss_pred EEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchh
Q psy17270 25 ILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKK 103 (429)
Q Consensus 25 i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~ 103 (429)
.+++||+|+||+||+|+++.+++. |+|++........ ..
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----------------------------------------~~ 41 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA----------------------------------------KD 41 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------------------------------------
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh----------------------------------------hH
Confidence 578999999999999999998875 9998754322111 12
Q ss_pred hhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy17270 104 RFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCLR 183 (429)
Q Consensus 104 ~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l~ 183 (429)
.....+.+|++++++++|+ ||++++++|..++++|+|||||.+++...+.... ..+++..++.++.||+.||+
T Consensus 42 ~~~~~~~~Ei~il~~l~hp------nIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~ 114 (299)
T d1ua2a_ 42 GINRTALREIKLLQELSHP------NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLE 114 (299)
T ss_dssp --CTHHHHHHHHHHHCCCT------TBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCC------CEeEEEeeeccCCceeehhhhhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHH
Confidence 3345678899999999887 9999999999999999999999876655555433 45999999999999999999
Q ss_pred HHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCC-CCCCCccccchhhHHH
Q psy17270 184 LLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGCILA 259 (429)
Q Consensus 184 ~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ 259 (429)
|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++.+. .|+.++|||||||++|
T Consensus 115 ~lH~~~iiHrDiKp~NIli~~~~--~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 192 (299)
T d1ua2a_ 115 YLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 192 (299)
T ss_dssp HHHHTTCCCCCCCGGGEEECTTC--CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHH
T ss_pred HhhccceecccCCcceEEecCCC--ccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHH
Confidence 99999999999999999999988 899999999976443 23346799999999999755 5799999999999999
Q ss_pred HHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHH
Q psy17270 260 ELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVD 339 (429)
Q Consensus 260 ~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (429)
+|+||.+||.+.+..+++..|...++.+..+.+......... .........+.....+..++++.+
T Consensus 193 el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~s~~~~d 258 (299)
T d1ua2a_ 193 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY--------------VTFKSFPGIPLHHIFSAAGDDLLD 258 (299)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC--------------CCCCCCCCCCHHHHCTTCCHHHHH
T ss_pred HHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh--------------hhhccCCCCChHHhcccCCHHHHH
Confidence 999999999999999999999999998877654322211100 000111123344555667899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 340 FVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 340 li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
||++||+.||++||||.|+|+||||++..
T Consensus 259 ll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 259 LIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 99999999999999999999999998643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=428.88 Aligned_cols=288 Identities=22% Similarity=0.341 Sum_probs=211.0
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+..++|+++++||+|+||+||+|+++.+++. |+|++......
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~------------------------------------- 45 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------------------------------------- 45 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT-------------------------------------
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH-------------------------------------
Confidence 5678999999999999999999999999875 88887543211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+|+.+|+.++|+ ||++++++|.+..++|+|||||. |+|.+++.+.. .+++..++.++
T Consensus 46 -------~~~~~~~~Ei~il~~l~Hp------nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~ 110 (322)
T d1s9ja_ 46 -------AIRNQIIRELQVLHECNSP------YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVS 110 (322)
T ss_dssp -------THHHHHHHHGGGGGGCCCT------TBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHH
T ss_pred -------HHHHHHHHHHHHHHhCCCC------CCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHH
Confidence 2234567799999999876 99999999999999999999996 69999998765 39999999999
Q ss_pred HHHHHHHHHHHH-CCceecccCCCcEEEecCCCcceEEeeeccccccc-CcceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 176 FSLVQCLRLLHR-ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-QRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 176 ~qil~~l~~lH~-~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+|.... ....+.+||+.|+|||++.+..|+.++||||
T Consensus 111 ~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWS 188 (322)
T d1s9ja_ 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188 (322)
T ss_dssp HHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--CEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHH
T ss_pred HHHHHHHHHHHHhCCEEccccCHHHeeECCCC--CEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHH
Confidence 999999999997 4999999999999999988 89999999997543 3345678999999999999999999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHH-HHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh----
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQ-LACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS---- 328 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 328 (429)
+||++|||++|+.||.+.+.... ...+....+............... ....................
T Consensus 189 lGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T d1s9ja_ 189 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP--------LSSYGMDSRPPMAIFELLDYIVNE 260 (322)
T ss_dssp HHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------------------CCCCHHHHHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc--------ccccccccccchhHHHHHhhhhcc
Confidence 99999999999999987654322 222222222211110000000000 00000000000000000000
Q ss_pred ----hh-ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 329 ----VL-RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 329 ----~~-~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.+ ...++++.+||.+||+.||++||||+|+|+||||++.
T Consensus 261 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 261 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00 1247899999999999999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=415.70 Aligned_cols=284 Identities=30% Similarity=0.531 Sum_probs=234.2
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|++..+++. |+|++.....
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----------------------------------------- 40 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----------------------------------------- 40 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------------------------------------------
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-----------------------------------------
Confidence 5899999999999999999999998865 8998743211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
.......+.+|++++++++|+ ||++++++|.++.++|+|||||++++.+++......++++..++.++.||+
T Consensus 41 --~~~~~~~~~~Ei~il~~l~Hp------~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil 112 (298)
T d1gz8a_ 41 --TEGVPSTAIREISLLKELNHP------NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112 (298)
T ss_dssp -----CCHHHHHHHHHHTTCCCT------TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHH
T ss_pred --ChHHHHHHHHHHHHHHhCCCC------cEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHH
Confidence 112335677899999999877 999999999999999999999999888888776667799999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCC-CCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLP-YGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG 255 (429)
.||+|||++|||||||||+|||++.++ .+||+|||.+..... ......||+.|+|||++.... ++.++||||+|
T Consensus 113 ~~L~yLH~~~IiHrDiKpeNIl~~~~~--~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlG 190 (298)
T d1gz8a_ 113 QGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190 (298)
T ss_dssp HHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHHhhcCCEEccccCchheeecccC--cceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccc
Confidence 999999999999999999999999888 899999999975432 333468999999999988776 47899999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|+.||.+.+..+++..+....+.+.+..+........ ....................++
T Consensus 191 vily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~s~ 257 (298)
T d1gz8a_ 191 CIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD-------------YKPSFPKWARQDFSKVVPPLDE 257 (298)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT-------------CCTTSCCCCCCCHHHHSTTCCH
T ss_pred hhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc-------------cccccccccccchhhhccCCCH
Confidence 999999999999999999999999999888877666543322110 0111112223344555567789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
++.+||++||+.||++|||+.|+|+||||++..
T Consensus 258 ~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 258 DGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 999999999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-55 Score=421.14 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=220.6
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|++++.||+|+||+||+|+++.+|+. |+|++.+....
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~---------------------------------------- 43 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV---------------------------------------- 43 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----------------------------------------
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc----------------------------------------
Confidence 3599999999999999999999998875 99988543211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+.+|+.+++.++|+ ||+++++++.+...+|+|||||. |+|..++..... +++..++.++.||
T Consensus 44 --~~~~~~~~~~E~~il~~l~Hp------nIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi 113 (316)
T d1fota_ 44 --RLKQVEHTNDERLMLSIVTHP------FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEV 113 (316)
T ss_dssp --HTTCHHHHHHHHHHHHSCCBT------TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHHHHHHhccCc------ChhheeeeEeeCCeeeeEeeecCCcccccccccccc--ccccHHHHHHHHH
Confidence 112234577799999999887 99999999999999999999995 588888877654 8999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHH
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 258 (429)
+.||+|||++||+||||||+|||++.++ .+||+|||+++.........+||+.|+|||++.+..|+.++|||||||++
T Consensus 114 ~~al~~lH~~~iiHrDiKp~NILl~~~g--~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvil 191 (316)
T d1fota_ 114 CLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 191 (316)
T ss_dssp HHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHH
T ss_pred HHhhhhhccCcEEccccCchheeEcCCC--CEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhH
Confidence 9999999999999999999999999988 89999999999888777788999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 259 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
|+|+||+.||.+.+..+.+..+...-...+ ...++++.
T Consensus 192 yemltG~~Pf~~~~~~~~~~~i~~~~~~~p------------------------------------------~~~s~~~~ 229 (316)
T d1fota_ 192 YEMLAGYTPFYDSNTMKTYEKILNAELRFP------------------------------------------PFFNEDVK 229 (316)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHHCCCCCC------------------------------------------TTSCHHHH
T ss_pred HHHHhCCCCCCCcCHHHHHHHHHcCCCCCC------------------------------------------CCCCHHHH
Confidence 999999999999988888777764211111 12378899
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 339 DFVTQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 339 ~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
++|.+||..||.+|+ |++|+++||||++..
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 999999999999996 899999999998753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-55 Score=414.25 Aligned_cols=288 Identities=28% Similarity=0.511 Sum_probs=231.6
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCC-Cc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKT-NT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~-~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
..+||+++++||+|+||+||+|++..+ ++ +|+|++.....
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-------------------------------------- 46 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-------------------------------------- 46 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC--------------------------------------
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc--------------------------------------
Confidence 357999999999999999999999766 44 48888743321
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-----CeEEEEEeecCcCHHHHHHhhCCCCCCHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-----NHLCISFELMNLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~ 171 (429)
.......+.+|+.+++.|+.. .||||++++++|... .+++++||+|++.+..+........+++..+
T Consensus 47 -----~~~~~~~~~~E~~~l~~l~~~---~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~ 118 (305)
T d1blxa_ 47 -----EEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 118 (305)
T ss_dssp -----TTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHH
T ss_pred -----cchHHHHHHHHHHHHHHHhhc---CCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHH
Confidence 112233566799999888643 456999999998642 4789999999887777666666567999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCCCCCCCc
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
+.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..|+.++
T Consensus 119 ~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~--~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~ 196 (305)
T d1blxa_ 119 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPV 196 (305)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHH
T ss_pred HHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC--CeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhe
Confidence 99999999999999999999999999999999988 89999999986543 334567899999999999999999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||+||++|+|++|++||.+.+..+++..+....+.+....+......... .............
T Consensus 197 DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~ 261 (305)
T d1blxa_ 197 DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ---------------AFHSKSAQPIEKF 261 (305)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGG---------------GSCCCCCCCGGGT
T ss_pred hhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhh---------------hhccccccchhhc
Confidence 9999999999999999999999999999999999998877654322111000 0011112223344
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
....++.+.+||++||++||++||||.|+|+||||++...
T Consensus 262 ~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 262 VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 4566889999999999999999999999999999987643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=422.37 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=217.9
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|++++.||+|+||+||+|+++.+++. |+|++.+....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~---------------------------------------- 44 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII---------------------------------------- 44 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH----------------------------------------
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc----------------------------------------
Confidence 4699999999999999999999999865 99988543211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.......+.+|+++|+.++|+ ||++++++|.+...+|+|||||. |+|.+++..... +++..++.++.||
T Consensus 45 --~~~~~~~~~~E~~il~~l~hp------~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qi 114 (337)
T d1o6la_ 45 --AKDEVAHTVTESRVLQNTRHP------FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEI 114 (337)
T ss_dssp --HTTCHHHHHHHHHHHHSCCCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHHHHHHhCCCC------CEEEEEeeeccccccccceeccCCCchhhhhhcccC--CcHHHHHHHHHHH
Confidence 112234677799999998877 99999999999999999999995 699999988764 9999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
+.||+|||++||+||||||+|||++.+| .+||+|||+|+... ......+||+.|+|||++.+..|+.++||||||
T Consensus 115 l~al~ylH~~~iiHRDlKP~NILl~~~g--~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlG 192 (337)
T d1o6la_ 115 VSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192 (337)
T ss_dssp HHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHH
T ss_pred hhhhhhhhhcCccccccCHHHeEecCCC--CEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchh
Confidence 9999999999999999999999999988 89999999997543 334557899999999999999999999999999
Q ss_pred hHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 256 CILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 256 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
|++|+|++|++||.+.+..+....+.......| ...++
T Consensus 193 vilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p------------------------------------------~~~s~ 230 (337)
T d1o6la_ 193 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFP------------------------------------------RTLSP 230 (337)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------------------------------------TTSCH
T ss_pred hHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC------------------------------------------ccCCH
Confidence 999999999999999998877766654211111 22478
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSS 367 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~ 367 (429)
++.+||++||+.||++|++ +.|+++||||+..
T Consensus 231 ~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 8999999999999999994 9999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-55 Score=426.16 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=221.1
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|+++.+|+. |+|++.+....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~---------------------------------------- 80 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV---------------------------------------- 80 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----------------------------------------
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc----------------------------------------
Confidence 6899999999999999999999998865 99987532211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+.+|+++|+.++|+ ||++++++|.....+++||||+ +|+|...+.... .+++..++.++.||
T Consensus 81 --~~~~~~~~~~E~~il~~l~hp------nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi 150 (350)
T d1rdqe_ 81 --KLKQIEHTLNEKRILQAVNFP------FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQI 150 (350)
T ss_dssp --HTTCHHHHHHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHHHHHHHcCCC------cEeecccccccccccccccccccccchhhhHhhcC--CCCHHHHHHHHHHH
Confidence 112234567799999998876 9999999999999999999999 469999998775 39999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhhHH
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCIL 258 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 258 (429)
+.||.|||++|||||||||+|||++.++ .+||+|||+++.........+||+.|+|||++.+..|+.++|||||||++
T Consensus 151 ~~aL~yLH~~~iiHRDIKP~NILl~~~g--~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvil 228 (350)
T d1rdqe_ 151 VLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228 (350)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred HHHHHHHHhCCEecCcCCHHHcccCCCC--CEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHH
Confidence 9999999999999999999999999988 89999999999887777788999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHH
Q psy17270 259 AELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFV 338 (429)
Q Consensus 259 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
|+|+||+.||.+.+....+..+.......+ ...++++.
T Consensus 229 yemltG~~Pf~~~~~~~~~~~i~~~~~~~p------------------------------------------~~~s~~~~ 266 (350)
T d1rdqe_ 229 YEMAAGYPPFFADQPIQIYEKIVSGKVRFP------------------------------------------SHFSSDLK 266 (350)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------------------------------------TTCCHHHH
T ss_pred HHHHhCCCCCCCcCHHHHHHHHhcCCCCCC------------------------------------------ccCCHHHH
Confidence 999999999999988887777764221111 12378999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy17270 339 DFVTQCFNWDSKKRL-----TPDEALRHEWLKSSS 368 (429)
Q Consensus 339 ~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~~ 368 (429)
+||++||+.||.+|+ |++|+++||||+...
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 999999999999995 999999999998753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=408.30 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=207.6
Q ss_pred cccccCCe-EEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 16 HDHICYRY-EILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 16 ~~~~~~rY-~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
+...++|| ++.++||+|+||+||+|++..++.. |+|++.......
T Consensus 3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~--------------------------------- 49 (270)
T d1t4ha_ 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--------------------------------- 49 (270)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH---------------------------------
T ss_pred CcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH---------------------------------
Confidence 34456777 7888999999999999999988864 888875432111
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE----cCeEEEEEeecC-cCHHHHHHhhCCCCCCH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF----RNHLCISFELMN-LNLYELIKRNNYQGFSL 168 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~ 168 (429)
.....+.+|++++++++|+ ||++++++|.. +..+|+|||||+ |+|.+++.+.. .+++
T Consensus 50 ----------~~~~~~~~E~~il~~l~Hp------nIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~ 111 (270)
T d1t4ha_ 50 ----------SERQRFKEEAEMLKGLQHP------NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKI 111 (270)
T ss_dssp ----------HHHHHHHHHHHHHTTCCCT------TBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCH
T ss_pred ----------HHHHHHHHHHHHHHhCCCC------CeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc--cccH
Confidence 1123466799999999877 99999999976 346899999995 69999998765 3999
Q ss_pred HHHHHHHHHHHHHHHHHHHCC--ceecccCCCcEEEec-CCCcceEEeeeccccccc-CcceeeecCccccchhhhhCCC
Q psy17270 169 GLIRRFAFSLVQCLRLLHREN--IIHCDLKPENVLLKQ-RGSSSIKVIDFGSSCYSH-QRVYTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 169 ~~~~~i~~qil~~l~~lH~~~--ivH~dlkp~Nili~~-~~~~~vkl~Dfg~~~~~~-~~~~~~~~t~~y~aPE~~~~~~ 244 (429)
..++.++.||+.||+|||+++ |+||||||+|||++. ++ .+||+|||+++... ......+||+.|+|||++.+ .
T Consensus 112 ~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~--~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~ 188 (270)
T d1t4ha_ 112 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-K 188 (270)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-C
T ss_pred HHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC--CEEEeecCcceeccCCccCCcccCccccCHHHhCC-C
Confidence 999999999999999999998 999999999999974 56 89999999997544 33456789999999999876 5
Q ss_pred CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
|+.++|||||||++|+|++|+.||.+.+....+...... +..+.
T Consensus 189 ~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~----------------------------------- 232 (270)
T d1t4ha_ 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA----------------------------------- 232 (270)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG-----------------------------------
T ss_pred CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCc-----------------------------------
Confidence 999999999999999999999999876554443322210 11111
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLK 365 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~ 365 (429)
......++++.+||.+||+.||++|||+.|+|+||||+
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 11223478899999999999999999999999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=420.47 Aligned_cols=259 Identities=29% Similarity=0.462 Sum_probs=223.9
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.|.+||++++.||+|+||+||+|.++.+++. |+|++.....+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~------------------------------------- 44 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD------------------------------------- 44 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-------------------------------------
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-------------------------------------
Confidence 3789999999999999999999999999864 99988544221
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
...+.+|+++|+.++|+ ||++++++|++++++|+|||||+ |+|.+++.... ..+++.+++.++
T Consensus 45 ---------~~~~~~Ei~il~~l~Hp------nIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~ 108 (321)
T d1tkia_ 45 ---------QVLVKKEISILNIARHR------NILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYV 108 (321)
T ss_dssp ---------HHHHHHHHHHHHHSCCT------TBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHH
T ss_pred ---------HHHHHHHHHHHHhCCCC------CCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHH
Confidence 12345699999999877 99999999999999999999996 69999997654 359999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
.||+.||+|||++||+||||||+|||++.++...++|+|||++.... ......++|+.|+|||++.+..|+.++||||
T Consensus 109 ~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWS 188 (321)
T d1tkia_ 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWS 188 (321)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhccc
Confidence 99999999999999999999999999987666689999999997644 3345578999999999999999999999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|+|++|..||.+.+..+.+..|......++...+ +..
T Consensus 189 lGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--------------------------------------~~~ 230 (321)
T d1tkia_ 189 LGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------------------------------------KEI 230 (321)
T ss_dssp HHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH--------------------------------------TTS
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc--------------------------------------cCC
Confidence 999999999999999999998888888764444444332 234
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
++++.+||++||..||++|||+.|+|+||||++.
T Consensus 231 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 7889999999999999999999999999999764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.9e-55 Score=407.28 Aligned_cols=264 Identities=28% Similarity=0.399 Sum_probs=220.1
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
|.++|++++.||+|+||+||+|+++.+++. |+|++.+..........
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~-------------------------------- 48 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEE-------------------------------- 48 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHH--------------------------------
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHH--------------------------------
Confidence 568999999999999999999999988865 99988654322111000
Q ss_pred CCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.+...+.+.+|+.+++.+. |+ ||++++++|.+++++|+|||||+ |+|.+++.... ++++..++.++
T Consensus 49 ----~~~~~~~~~~E~~~l~~l~~hp------nIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~ 116 (277)
T d1phka_ 49 ----VQELREATLKEVDILRKVSGHP------NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIM 116 (277)
T ss_dssp ----HHHHHHHHHHHHHHHHHHTTCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred ----HHHHHHHHHHHHHHHHHhcCCC------CeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHH
Confidence 1233456788999999997 66 99999999999999999999995 69999998765 49999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC--cceeeecCccccchhhhhC------CCCCC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ--RVYTYIQSRFYRSPEVILG------LPYGP 247 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~------~~~~~ 247 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++.+ ..++.
T Consensus 117 ~qi~~al~~lH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~ 194 (277)
T d1phka_ 117 RALLEVICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194 (277)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCT
T ss_pred HHHHHHHHHHHHcCCcccccccceEEEcCCC--CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCc
Confidence 9999999999999999999999999999888 899999999986543 3445679999999999873 34688
Q ss_pred CccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 248 PIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 248 ~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
++||||+||++|+|++|+.||.+.+..+....+......++..
T Consensus 195 ~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------------------- 237 (277)
T d1phka_ 195 EVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP------------------------------------- 237 (277)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-------------------------------------
T ss_pred hheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc-------------------------------------
Confidence 9999999999999999999999998888777766521111110
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
.....++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 238 -~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 238 -EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 12234889999999999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-55 Score=417.84 Aligned_cols=256 Identities=26% Similarity=0.329 Sum_probs=212.1
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..++|++++.||+|+||+||+|++..++.. |+|++.......
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------------------------------------- 55 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS------------------------------------- 55 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH-------------------------------------
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC-------------------------------------
Confidence 345799999999999999999999999875 999885443221
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
......+.+|+++++.++|+ ||+++++++.++.++|+|||||.+ +|..++... .++++..++.++.
T Consensus 56 -----~~~~~~~~~Ei~il~~l~Hp------nIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~ 122 (309)
T d1u5ra_ 56 -----NEKWQDIIKEVRFLQKLRHP------NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTH 122 (309)
T ss_dssp -----HHHHHHHHHHHHHHTTCCCT------TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHH
T ss_pred -----HHHHHHHHHHHHHHHHCCCC------CEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHH
Confidence 11223567799999999877 999999999999999999999975 454444443 3599999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhC---CCCCCCccccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILG---LPYGPPIDMWS 253 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwS 253 (429)
||+.||.|||++||+||||||+|||++.++ .+||+|||++..... ....+||+.|+|||++.+ ..|+.++||||
T Consensus 123 qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~~Kl~DFG~a~~~~~-~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwS 199 (309)
T d1u5ra_ 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS 199 (309)
T ss_dssp HHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSS-BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHH
T ss_pred HHHHHHHHHHhCCEeccCCCcceEEECCCC--CEEEeecccccccCC-CCccccCccccCHHHHhccCCCCcCchhhhhh
Confidence 999999999999999999999999999988 999999999976544 345689999999999974 35899999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 254 LGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 254 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
|||++|+|++|..||.+.+..+.+..+......... ....
T Consensus 200 lGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------~~~~ 239 (309)
T d1u5ra_ 200 LGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ----------------------------------------SGHW 239 (309)
T ss_dssp HHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS----------------------------------------CTTS
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----------------------------------------CCCC
Confidence 999999999999999998887777666541110000 0123
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
++.+.+||.+||+.||++|||++|+|+||||++.
T Consensus 240 s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 7889999999999999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=409.89 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=201.5
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
.+.|++++.||+|+||+||+|+++.+++. |+|++.......
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------------------------------------- 44 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-------------------------------------- 44 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH--------------------------------------
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH--------------------------------------
Confidence 36799999999999999999999999875 999885442211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--cCeEEEEEeecC-cCHHHHHHhh--CCCCCCHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--RNHLCISFELMN-LNLYELIKRN--NYQGFSLGLIRR 173 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~-g~L~~~i~~~--~~~~~~~~~~~~ 173 (429)
.....+.+|++++++++|+ ||+++++++.+ +..+|+|||||+ |+|.+++.+. ....+++..++.
T Consensus 45 -----~~~~~~~~E~~il~~l~Hp------nIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~ 113 (269)
T d2java1 45 -----AEKQMLVSEVNLLRELKHP------NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 113 (269)
T ss_dssp -----HHHHHHHHHHHHTTSCCCT------TBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHH
T ss_pred -----HHHHHHHHHHHHHHHCCCC------CEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHH
Confidence 1123456799999998876 99999999865 457899999995 6999998753 234599999999
Q ss_pred HHHHHHHHHHHHHHCC-----ceecccCCCcEEEecCCCcceEEeeecccccccC---cceeeecCccccchhhhhCCCC
Q psy17270 174 FAFSLVQCLRLLHREN-----IIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ---RVYTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 174 i~~qil~~l~~lH~~~-----ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~ 245 (429)
++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++.... .....+||+.|+|||++.+..|
T Consensus 114 i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~--~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 191 (269)
T d2java1 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY 191 (269)
T ss_dssp HHHHHHHHHHHHHHHCC---------CCGGGEEECTTS--CEEECCHHHHHHC-----------CCCSCCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC--cEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCC
Confidence 9999999999999976 99999999999999988 899999999976432 2345789999999999999999
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|||||||++|+|+||+.||.+.+..+....+..... +
T Consensus 192 ~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~--~------------------------------------- 232 (269)
T d2java1 192 NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF--R------------------------------------- 232 (269)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--C-------------------------------------
T ss_pred ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--C-------------------------------------
Confidence 9999999999999999999999999888877766654110 0
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
..+...++++.+||++||+.||++|||+.|+|+|||+
T Consensus 233 --~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 --RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0012247889999999999999999999999999996
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=420.09 Aligned_cols=285 Identities=32% Similarity=0.565 Sum_probs=231.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.+||+++++||+|+||+||+|+++.+++. |+|++......
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------------------------------------- 57 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-------------------------------------- 57 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS--------------------------------------
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC--------------------------------------
Confidence 789999999999999999999999999875 99988543221
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC------eEEEEEeecCcCHHHHHHhhCCCCCCHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN------HLCISFELMNLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~------~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~ 171 (429)
......+.+|+++|+.++|+ ||++++++|...+ ++|+|||||+++|..+++.. ++++..+
T Consensus 58 -----~~~~~~~~~Ei~il~~l~hp------niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~ 123 (346)
T d1cm8a_ 58 -----ELFAKRAYRELRLLKHMRHE------NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRI 123 (346)
T ss_dssp -----HHHHHHHHHHHHHHHHCCBT------TBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHH
T ss_pred -----hHHHHHHHHHHHHHHhcCCC------CeeEEEEEeccCccccccceEEEEEecccccHHHHHHhc---cccHHHH
Confidence 12334677799999999887 9999999997654 67999999988888887654 3999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCC-CCCCCcc
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGL-PYGPPID 250 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~D 250 (429)
+.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..........+||+.|+|||++.+. .++.++|
T Consensus 124 ~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~--~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 201 (346)
T d1cm8a_ 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVD 201 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHH
T ss_pred HHHHHHHHHHHHHHHhCCCcccccCcchhhccccc--ccccccccceeccCCccccccccccccCHHHHcCCCCCCccch
Confidence 99999999999999999999999999999999988 89999999999888777788999999999999875 5689999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||+||++|+|++|++||.+.+..+.+..+....+.++.+++.............. .............
T Consensus 202 iwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ 270 (346)
T d1cm8a_ 202 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG-----------LPELEKKDFASIL 270 (346)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH-----------SCCCCCCCGGGTC
T ss_pred hhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhcc-----------CCcccccchHHhc
Confidence 99999999999999999999999999999999999999887654332111000000 0011122334444
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
...++.+.+||++||..||++||||.|+|+||||++..
T Consensus 271 ~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 271 TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 56689999999999999999999999999999998754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.5e-54 Score=404.25 Aligned_cols=281 Identities=28% Similarity=0.516 Sum_probs=226.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+||+++++||+|+||+||+|+++.+..+|+|++.....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------------------------------------------ 39 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE------------------------------------------ 39 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG------------------------------------------
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc------------------------------------------
Confidence 69999999999999999999997555569998744321
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQ 180 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~ 180 (429)
.......+.+|+.+|++++|+ ||++++++|..+++.+++||++.+.+...+.... +.+++..++.++.||+.
T Consensus 40 -~~~~~~~~~~E~~il~~l~hp------nIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~ 111 (286)
T d1ob3a_ 40 -DEGIPSTTIREISILKELKHS------NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLN 111 (286)
T ss_dssp -GGCCCHHHHHHHHGGGGCCCT------TBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHH
T ss_pred -ChHHHHHHHHHHHHHHhCCCC------cEEeeeeecccCCceeEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHH
Confidence 122345677899999999876 9999999999999999999999887777665544 56999999999999999
Q ss_pred HHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCC-CCCCCccccchhh
Q psy17270 181 CLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGL-PYGPPIDMWSLGC 256 (429)
Q Consensus 181 ~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~ 256 (429)
||+|||++|||||||||+|||++.++ .+||+|||.+...... .....+++.|+|||++.+. .++.++|||||||
T Consensus 112 ~L~~LH~~~IvHrDiKp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv 189 (286)
T d1ob3a_ 112 GIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189 (286)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred HHHHhccCcEEecCCCCceeeEcCCC--CEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCc
Confidence 99999999999999999999999988 8999999999764432 3345789999999999865 4689999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|++|+.||.+.+..+++.++...++.+....+.......... .........+........++.
T Consensus 190 ~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~s~~ 256 (286)
T d1ob3a_ 190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD-------------PNFTVYEPLPWESFLKGLDES 256 (286)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC-------------TTCCCCCCCCGGGTCCSCCHH
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc-------------cccccccCcchhhhcccCCHH
Confidence 9999999999999999999999999999988766654332211100 000111122334445566899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLTPDEALRHEWLKS 366 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpta~ell~h~~~~~ 366 (429)
+.|||++||++||++||||+|+|+||||++
T Consensus 257 ~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 257 GIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 999999999999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-53 Score=414.86 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=208.5
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|+++.+|+. |+|++.+.....
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~--------------------------------------- 44 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--------------------------------------- 44 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---------------------------------------
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch---------------------------------------
Confidence 4699999999999999999999999865 999885432211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......+.+|.++++.+++. .||||++++++|.+.+.+|+|||||. |+|.+++.... .+++..++.++.||
T Consensus 45 ---~~~~~~~~~e~~~~~~l~~~---~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi 116 (364)
T d1omwa3 45 ---KQGETLALNERIMLSLVSTG---DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEI 116 (364)
T ss_dssp ---HTCHHHHHHHHHHHHHHSSS---CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHH
T ss_pred ---hhHHHHHHHHHHHHHHHhcC---CCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHH
Confidence 11122344566666666544 46699999999999999999999995 79999998775 49999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc-CcceeeecCccccchhhhhC-CCCCCCccccchhh
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH-QRVYTYIQSRFYRSPEVILG-LPYGPPIDMWSLGC 256 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~ 256 (429)
+.||.|||++||+||||||+|||++.++ .+||+|||+|+... ......+||+.|+|||++.. ..|+.++|||||||
T Consensus 117 ~~aL~ylH~~~iiHrDlKP~NILl~~~g--~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGv 194 (364)
T d1omwa3 117 ILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 194 (364)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEECSSS--CEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHH
T ss_pred HHHHHHHHHCCccceeeccceeEEcCCC--cEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHH
Confidence 9999999999999999999999999988 89999999998654 33445789999999999975 56899999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCChH
Q psy17270 257 ILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKA 336 (429)
Q Consensus 257 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
++|+|+||+.||.+.+..+...........+ ...+...+++
T Consensus 195 ilyemltG~~Pf~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~s~~ 235 (364)
T d1omwa3 195 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA---------------------------------------VELPDSFSPE 235 (364)
T ss_dssp HHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC---------------------------------------CCCCSSSCHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcccCC---------------------------------------CCCCCCCCHH
Confidence 9999999999998765433221111100000 0011234789
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q psy17270 337 FVDFVTQCFNWDSKKRLT-----PDEALRHEWLKSSS 368 (429)
Q Consensus 337 ~~~li~~~L~~dP~~Rpt-----a~ell~h~~~~~~~ 368 (429)
+.+||.+||+.||++||| |+|+++||||++..
T Consensus 236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 999999999999999999 89999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-54 Score=408.45 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=213.1
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
++|++++.||+|+||+||+|+++.+++. |+|++.+....
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~---------------------------------------- 41 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL---------------------------------------- 41 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH----------------------------------------
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc----------------------------------------
Confidence 5799999999999999999999999975 99988543211
Q ss_pred cchhhhhhhHHHHHHHHH-HHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILD-HLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~-~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.......+..|..++. .++|+ ||+++++++.+.+.+|+|||||+ |+|.+++..... +++..++.++.|
T Consensus 42 --~~~~~~~~~~e~~~l~~~~~hp------~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~--~~e~~~~~~~~q 111 (320)
T d1xjda_ 42 --MDDDVECTMVEKRVLSLAWEHP------FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAE 111 (320)
T ss_dssp --HTTCHHHHHHHHHHHHHHTTCT------TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHH
T ss_pred --ChHHHHHHHHHHHHHHHhCCCC------cEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCC--CCHHHHHHHHHH
Confidence 1112234455766665 56766 99999999999999999999995 699999987754 999999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc---CcceeeecCccccchhhhhCCCCCCCccccch
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH---QRVYTYIQSRFYRSPEVILGLPYGPPIDMWSL 254 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 254 (429)
|+.||+|||++||+||||||+|||++.++ .+||+|||+++... ......+||+.|+|||++.+..|+.++|||||
T Consensus 112 i~~al~ylH~~~iiHrDikp~NiL~~~~~--~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 189 (320)
T d1xjda_ 112 IILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 189 (320)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHhCCeeeccCcccceeecCCC--ceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhh
Confidence 99999999999999999999999999988 89999999997533 33344689999999999999999999999999
Q ss_pred hhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 255 GCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 255 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||++|+|+||+.||.+.+..+.+..+....... +...+
T Consensus 190 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------------------------------------p~~~s 227 (320)
T d1xjda_ 190 GVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY------------------------------------------PRWLE 227 (320)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------------------------------------CTTSC
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------------------------------------CccCC
Confidence 999999999999999998888777665311111 12347
Q ss_pred hHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPD-EALRHEWLKSS 367 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~-ell~h~~~~~~ 367 (429)
+++.+||++||+.||++|||+. |+++||||++.
T Consensus 228 ~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 228 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 8999999999999999999995 89999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=396.72 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=205.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
|.+||++.+.||+|+||+||+|++..++.. |+|++.......
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------------------------------------- 44 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD------------------------------------- 44 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCC-------------------------------------
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccc-------------------------------------
Confidence 678999999999999999999999998865 888874331110
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC--cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN--LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~--g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.........+.+|+.+++++.+ .||||++++++|.+.+.+++|||++. +++.+++.... .+++.+++.++
T Consensus 45 --~~~~~~~~~~~~E~~il~~l~~----~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~ 116 (273)
T d1xwsa_ 45 --WGELPNGTRVPMEVVLLKKVSS----GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 116 (273)
T ss_dssp --EEECTTCCEEEHHHHHHHHHCS----SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHH
T ss_pred --hhhhhHHHHHHHHHHHHHHhcc----CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHH
Confidence 0000112235569999999974 25699999999999999999999995 47888887765 49999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecC-CCcceEEeeecccccccC-cceeeecCccccchhhhhCCCC-CCCcccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQR-GSSSIKVIDFGSSCYSHQ-RVYTYIQSRFYRSPEVILGLPY-GPPIDMW 252 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~-~~~~vkl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~-~~~~Diw 252 (429)
.||+.||+|||++||+||||||+|||++.+ + .+||+|||++..... ...+.+||+.|+|||++.+..+ +.++|||
T Consensus 117 ~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~--~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~Diw 194 (273)
T d1xwsa_ 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 194 (273)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHH
T ss_pred HHHHHHHHHHHHCCCccccCcccceEEecCCC--eEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccc
Confidence 999999999999999999999999999854 4 899999999976443 3445789999999999987765 5689999
Q ss_pred chhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 253 SLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 253 SlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
||||++|+|+||+.||.+.+. +.. +. . .....
T Consensus 195 SlGvilyell~g~~Pf~~~~~------i~~--~~-------------~---------------------------~~~~~ 226 (273)
T d1xwsa_ 195 SLGILLYDMVCGDIPFEHDEE------IIR--GQ-------------V---------------------------FFRQR 226 (273)
T ss_dssp HHHHHHHHHHHSSCSCCSHHH------HHH--CC-------------C---------------------------CCSSC
T ss_pred cceeeehhHhhCCCCCCCchH------Hhh--cc-------------c---------------------------CCCCC
Confidence 999999999999999976321 111 00 0 00112
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
.++++.+||++||+.||++|||++|+|+||||++.
T Consensus 227 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 47899999999999999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=397.39 Aligned_cols=284 Identities=32% Similarity=0.546 Sum_probs=222.3
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-+||+++++||+|+||+||+|++..++++ |||++.....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------------------------------------- 48 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---------------------------------------- 48 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C----------------------------------------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc----------------------------------------
Confidence 38999999999999999999999988875 8888743211
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE--------cCeEEEEEeecCcCHHHHHHhhCCCCCCHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF--------RNHLCISFELMNLNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~--------~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~ 170 (429)
.......+.+|+++|++++|+ ||+++++++.. ..++|+|||+|++.+........ ..+++..
T Consensus 49 ---~~~~~~~~~~E~~il~~l~h~------nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~-~~~~~~~ 118 (318)
T d3blha1 49 ---KEGFPITALREIKILQLLKHE------NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSE 118 (318)
T ss_dssp ---TTSSCHHHHHHHHHHHHCCCT------TBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTT-CCCCHHH
T ss_pred ---chHHHHHHHHHHHHHHHhcCC------CccceEeeeecccccccccCceEEEEEeccCCCccchhhhcc-cccccHH
Confidence 123445677899999999887 99999988754 35789999999887766655443 4699999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-------cceeeecCccccchhhhhCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-------RVYTYIQSRFYRSPEVILGL 243 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-------~~~~~~~t~~y~aPE~~~~~ 243 (429)
++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++.+.
T Consensus 119 ~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 196 (318)
T d3blha1 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196 (318)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC--cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCC
Confidence 999999999999999999999999999999999988 899999999964331 22335799999999999865
Q ss_pred -CCCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC
Q psy17270 244 -PYGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG 322 (429)
Q Consensus 244 -~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (429)
.|+.++||||+||++|+|++|+.||.+.++.+.+..+....+.++.+.+.......... ........
T Consensus 197 ~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~ 264 (318)
T d3blha1 197 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE------------KLELVKGQ 264 (318)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------------------CCSSC
T ss_pred CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhh------------hhcccccc
Confidence 68999999999999999999999999999999999999999988876544332111100 00000011
Q ss_pred Cchhhhhh--ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 323 SKDMASVL--RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 323 ~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
........ ...++.+.|||.+||++||++||||.|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 265 KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 11111111 2347889999999999999999999999999999853
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=408.45 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=207.0
Q ss_pred cccccCCeEEEe-EeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 16 HDHICYRYEILE-VIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 16 ~~~~~~rY~i~~-~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.+.+-++|++++ .||+|+||+||+|++..+++. |+|++...
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------------------------------------- 48 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------------------------------- 48 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------------------------------
T ss_pred CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------------------------------------
Confidence 445667899886 599999999999999988865 89887421
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEE----cCeEEEEEeecC-cCHHHHHHhhCCCCCC
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYF----RNHLCISFELMN-LNLYELIKRNNYQGFS 167 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~-g~L~~~i~~~~~~~~~ 167 (429)
..+.+|++++.++ .|+ ||++++++|++ ..++|+|||||+ |+|.+++......+++
T Consensus 49 -------------~~~~~E~~~~~~~~~hp------nIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~ 109 (335)
T d2ozaa1 49 -------------PKARREVELHWRASQCP------HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 109 (335)
T ss_dssp -------------HHHHHHHHHHHHHTTST------TBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEE
T ss_pred -------------HHHHHHHHHHHHhcCCC------CCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcC
Confidence 1344588887665 455 99999999976 467999999995 6999999876556799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeeccccccc--CcceeeecCccccchhhhhCCC
Q psy17270 168 LGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 168 ~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~ 244 (429)
+.+++.++.||+.||+|||++||+||||||+|||++.++ ...+||+|||+++... ......+||+.|+|||++.+..
T Consensus 110 e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 189 (335)
T d2ozaa1 110 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 189 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGG
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCC
Confidence 999999999999999999999999999999999998643 2379999999997543 3344578999999999999989
Q ss_pred CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCc
Q psy17270 245 YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSK 324 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (429)
|+.++|||||||++|+|+||++||.+.+.......+...... .....
T Consensus 190 y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~-----------------------------~~~~~---- 236 (335)
T d2ozaa1 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-----------------------------GQYEF---- 236 (335)
T ss_dssp GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS-----------------------------CSSSC----
T ss_pred CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc-----------------------------CCCCC----
Confidence 999999999999999999999999876654433322210000 00000
Q ss_pred hhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 325 DMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
........++++.+||++||+.||++|||+.|+++||||++..
T Consensus 237 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 237 -PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp -CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred -CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 0111234588999999999999999999999999999997643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=402.38 Aligned_cols=278 Identities=29% Similarity=0.497 Sum_probs=222.2
Q ss_pred CeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 22 RYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 22 rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+|+.+++||+|+||+||+|+++.+++. |||++....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------------------------------------------- 57 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------------------------------------------- 57 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-------------------------------------------
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-------------------------------------------
Confidence 699999999999999999999998875 888874321
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHh--hCCCCCCHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKR--NNYQGFSLGLIR 172 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~--~~~~~~~~~~~~ 172 (429)
....+|+++|++++|+ ||++++++|... .++|+|||||++++...+.. .....+++.+++
T Consensus 58 ------~~~~~Ei~il~~l~h~------niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~ 125 (350)
T d1q5ka_ 58 ------RFKNRELQIMRKLDHC------NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125 (350)
T ss_dssp ------SSCCHHHHHHHHCCCT------TBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHH
T ss_pred ------hHHHHHHHHHHhcCCC------CCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHH
Confidence 0112499999999877 999999998643 36899999998877666543 233469999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCC-CCCCCc
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGL-PYGPPI 249 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~ 249 (429)
.++.||+.||+|||++||+||||||+|||++.++. .+||+|||++.... ....+.+||+.|+|||++.+. .|+.++
T Consensus 126 ~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 204 (350)
T d1q5ka_ 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI 204 (350)
T ss_dssp HHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCCcccccccccccccChHHhhcccCCCcce
Confidence 99999999999999999999999999999987642 78999999997643 334456899999999998764 689999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||+||++|||++|+.||.+.+..+++..+...++.+..+.+........... .+. ..........
T Consensus 205 DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~---~~~----------~~~~~~~~~~ 271 (350)
T d1q5ka_ 205 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK---FPQ----------IKAHPWTKVF 271 (350)
T ss_dssp HHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC---CCC----------CCCCCGGGTS
T ss_pred eecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc---ccc----------cccCchhhhc
Confidence 999999999999999999999999999999999999999888765432211100 000 0000001111
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
....++++.+||++||++||++||||.|+|+||||++..
T Consensus 272 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 272 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 234578999999999999999999999999999998754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=401.93 Aligned_cols=285 Identities=29% Similarity=0.534 Sum_probs=226.6
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
++.||+++++||+|+||+||+|+++.+++. |+|++.+...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--------------------------------------- 46 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--------------------------------------- 46 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC---------------------------------------
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC---------------------------------------
Confidence 568999999999999999999999999875 9998754321
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC-----eEEEEEeecCcCHHHHHHhhCCCCCCHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN-----HLCISFELMNLNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~ 172 (429)
....+.+.+|+++|+.+.|+ ||+++++++.... ++|+++++++|+|.+++... ++++..++
T Consensus 47 -----~~~~~~~~~Ei~il~~l~hp------~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~ 112 (345)
T d1pmea_ 47 -----QTYCQRTLREIKILLRFRHE------NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHIC 112 (345)
T ss_dssp -----HHHHHHHHHHHHHHHHCCCT------TBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHH
T ss_pred -----hHHHHHHHHHHHHHHHcCCC------CCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC---CCCHHHHH
Confidence 12234567799999999887 9999999987653 47777777789999999765 39999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC------cceeeecCccccchhhhhC-CCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ------RVYTYIQSRFYRSPEVILG-LPY 245 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~-~~~ 245 (429)
.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....+||+.|+|||++.. ..+
T Consensus 113 ~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 190 (345)
T d1pmea_ 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190 (345)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSC
T ss_pred HHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC--CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCC
Confidence 9999999999999999999999999999999988 899999999865332 2344679999999999854 467
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++||||+||++|+|++|+.||.+.+..++.......+..+..+............. .. ........+
T Consensus 191 ~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~----~~~~~~~~~ 259 (345)
T d1pmea_ 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY-------LL----SLPHKNKVP 259 (345)
T ss_dssp STHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHH-------HH----TSCCCCCCC
T ss_pred CchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcc-------cc----cCCccCCCC
Confidence 8899999999999999999999999999999999988888887766543322111000 00 011112233
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSSS 369 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~~ 369 (429)
........++.+.+||.+||+.||++||||.|+|+||||++...
T Consensus 260 ~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 260 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 44555667889999999999999999999999999999986543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=407.73 Aligned_cols=294 Identities=26% Similarity=0.440 Sum_probs=219.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+-+||+++++||+|+||+||+|+|+.++.. |+|++......
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-------------------------------------- 56 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------------------------------------- 56 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS--------------------------------------
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC--------------------------------------
Confidence 458999999999999999999999998876 99988544321
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE------cCeEEEEEeecCcCHHHHHHhhCCCCCCHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF------RNHLCISFELMNLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~------~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~ 171 (429)
......+.+|+.++++++|+ ||++++++|.. ..++|+|||||.+++.+.+. ..+++..+
T Consensus 57 -----~~~~~~~~~Ei~il~~l~hp------nIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i 121 (355)
T d2b1pa1 57 -----QTHAKRAYRELVLMKCVNHK------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERM 121 (355)
T ss_dssp -----HHHHHHHHHHHHHHHHCCCT------TBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHH
T ss_pred -----HHHHHHHHHHHHHHHhcCCC------CeeEEEEEEecccccccCceeEEEEeccchHHHHhhh----cCCCHHHH
Confidence 11123566799999999877 99999999964 36899999999988777663 34999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCCCCCCCc
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLPYGPPI 249 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~ 249 (429)
+.++.||+.||+|||++||+||||||+|||++.++ .++++|||++.... ......++|+.|+|||++.+..++.++
T Consensus 122 ~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~--~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~ 199 (355)
T d2b1pa1 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 199 (355)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC---------------CCTTCCHHHHTTCCCCTTH
T ss_pred HHHHHHHHHHHHHhhhcccccccCCcccccccccc--ceeeechhhhhccccccccccccccccccChhhhcCCCCCCCc
Confidence 99999999999999999999999999999999988 89999999986544 333456799999999999999999999
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||+||++|+|++|++||.+.+...+...+...++.+..+.+.........+...........................
T Consensus 200 DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (355)
T d2b1pa1 200 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279 (355)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHH
T ss_pred ccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccc
Confidence 99999999999999999999999999999999999988888776543321111111100000000000000000111111
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
....++++.+||++||.+||++||||+|+|+||||+..
T Consensus 280 ~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 22346789999999999999999999999999999863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=403.14 Aligned_cols=285 Identities=29% Similarity=0.548 Sum_probs=228.4
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+.+||+++++||+|+||+||+|++..+++. |||++.......
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------------------------------------- 58 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI------------------------------------- 58 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-------------------------------------
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-------------------------------------
Confidence 368999999999999999999999998875 999885432211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc------CeEEEEEeecCcCHHHHHHhhCCCCCCHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR------NHLCISFELMNLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~ 171 (429)
.....+.+|+++|+.++|+ ||++++++|... ..+++++++++|+|.+++... ++++..+
T Consensus 59 ------~~~~~~~~Ei~il~~l~h~------~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~ 123 (348)
T d2gfsa1 59 ------IHAKRTYRELRLLKHMKHE------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHV 123 (348)
T ss_dssp ------HHHHHHHHHHHHHHHCCCT------TBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHH
T ss_pred ------HHHHHHHHHHHHHHhcCCC------CeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc---cccHHHH
Confidence 1123566799999999887 999999998643 245666655578999998653 4999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCC-CCCCcc
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLP-YGPPID 250 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~D 250 (429)
+.++.||+.||+|||++||+||||||+|||++.++ .++++|||.+...........||+.|+|||++.+.. ++.++|
T Consensus 124 ~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~--~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~D 201 (348)
T d2gfsa1 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVD 201 (348)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHH
T ss_pred HHHHHHHHHHHHHHHhCCCcccccCCccccccccc--cccccccchhcccCcccccccccccccCchhhcCCccCCcccc
Confidence 99999999999999999999999999999999988 899999999988777777788999999999988764 688999
Q ss_pred ccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
||||||++|+|++|++||.+.+.......+....+.++.+.............. ...............
T Consensus 202 iwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~ 270 (348)
T d2gfsa1 202 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI-----------QSLTQMPKMNFANVF 270 (348)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHH-----------TTSCCCCCCCHHHHS
T ss_pred hhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhh-----------hhcccCCCcchhhhc
Confidence 999999999999999999999999999999999998887765433221110000 001111223344555
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
...++.+.+||++||+.||++||||.|+|+||||++..
T Consensus 271 ~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 271 IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 66789999999999999999999999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=386.10 Aligned_cols=281 Identities=28% Similarity=0.491 Sum_probs=224.4
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+||+++++||+|+||+||+|+++.+++. |+|+++....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~----------------------------------------- 40 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD----------------------------------------- 40 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-----------------------------------------
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-----------------------------------------
Confidence 6899999999999999999999999876 8988744321
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
......++.+|+.+++.++|+ ||+++++++......+++++++.+ ++..++... +.+++..++.++.|+
T Consensus 41 --~~~~~~~~~~E~~il~~l~h~------niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~ 110 (292)
T d1unla_ 41 --DEGVPSSALREICLLKELKHK------NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQL 110 (292)
T ss_dssp --STTHHHHHHHHHHHHTTCCCT------TBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHH
T ss_pred --ChHHHHHHHHHHHHHHhcCcC------CEEeeccccccccceeEEeeeccccccccccccc--cccchhHHHHHHHHH
Confidence 122345677799999999877 999999999999999999999976 555555443 459999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---ceeeecCccccchhhhhCCC-CCCCccccch
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR---VYTYIQSRFYRSPEVILGLP-YGPPIDMWSL 254 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSl 254 (429)
+.||+|||++||+||||||+|||++.++ .+||+|||.+...... .....+++.|+|||++.+.. ++.++||||+
T Consensus 111 ~~aL~~lH~~~IvHrDiKP~NIli~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSl 188 (292)
T d1unla_ 111 LKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188 (292)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred HHHHHHhhcCCEeeecccCcccccccCC--ceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhcccc
Confidence 9999999999999999999999999888 8999999999765432 23356778899999998765 6899999999
Q ss_pred hhHHHHHhhCCCC-CCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccC
Q psy17270 255 GCILAELYTGCPL-FPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCN 333 (429)
Q Consensus 255 G~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (429)
||++|+|++|+.| |.+.+..+++..+....+.+.+..+......... ...................
T Consensus 189 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~ 255 (292)
T d1unla_ 189 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY-------------KPYPMYPATTSLVNVVPKL 255 (292)
T ss_dssp HHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC-------------CCCCCCCTTCCCTTTSTTC
T ss_pred chHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc-------------cccccccccchhhhccccC
Confidence 9999999999877 5777788888888888888776654433221110 0011111122233334456
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 334 DKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 334 ~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
++.+.+||++||++||++||||+|+|+||||++-
T Consensus 256 s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 8899999999999999999999999999999763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.1e-52 Score=390.04 Aligned_cols=257 Identities=23% Similarity=0.327 Sum_probs=204.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.|++||++++.||+|+||+||+|++..+++. |+|++.......
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------------------------------------ 47 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD------------------------------------ 47 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC------------------------------------
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC------------------------------------
Confidence 5789999999999999999999999998865 999886543221
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcC----eEEEEEeecC-cCHHHHHHhhCCCCCCHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRN----HLCISFELMN-LNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~ 171 (429)
......+.+|+++++.++|+ ||+++++++.... .+|+|||||+ ++|.+++.... .+++.++
T Consensus 48 ------~~~~~~~~~E~~~l~~~~hp------niv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~ 113 (277)
T d1o6ya_ 48 ------PSFYLRFRREAQNAAALNHP------AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRA 113 (277)
T ss_dssp ------HHHHHHHHHHHHHHHTCCCT------TBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHH
T ss_pred ------HHHHHHHHHHHHHHHhcCCC------CCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHH
Confidence 12234567799999998877 9999999998764 4899999996 58999887765 4999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc------CcceeeecCccccchhhhhCCCC
Q psy17270 172 RRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH------QRVYTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~ 245 (429)
+.++.||+.||+|||++||+||||||+|||++.++ .++++|||.+.... ......+||+.|+|||++.+..|
T Consensus 114 ~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 191 (277)
T d1o6ya_ 114 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 191 (277)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS--CEEECCCTTCEECC----------------TTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHhCCccCccccCcccccCccc--cceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCC
Confidence 99999999999999999999999999999999988 89999999875432 12334679999999999999899
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|||||||++|+|+||++||.+.+..+.+..+......++.
T Consensus 192 ~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------------------------------ 235 (277)
T d1o6ya_ 192 DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS------------------------------------ 235 (277)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG------------------------------------
T ss_pred CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc------------------------------------
Confidence 99999999999999999999999998888777666542111111
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWL 364 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~ 364 (429)
......++.+.+||++||+.||++||+..+.+.|+|.
T Consensus 236 --~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 236 --ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp --GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred --hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 1123347899999999999999999954444455654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8e-51 Score=390.52 Aligned_cols=284 Identities=24% Similarity=0.400 Sum_probs=213.9
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
..++|+++++||+|+||+||+|+++.+++. |+|++....
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------------------------------------- 72 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------------------------------------- 72 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----------------------------------------
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----------------------------------------
Confidence 357899999999999999999999999875 888874321
Q ss_pred CCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEc--CeEEEEEeecCc-CHHHHHHhhCCCCCCHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFR--NHLCISFELMNL-NLYELIKRNNYQGFSLGLIRR 173 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g-~L~~~i~~~~~~~~~~~~~~~ 173 (429)
...+.+|+++|+.+. |+ ||++++++|... .++++|||||++ +|..+. +.+++..++.
T Consensus 73 --------~~~~~~Ei~il~~l~~hp------nIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~ 133 (328)
T d3bqca1 73 --------KKKIKREIKILENLRGGP------NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF 133 (328)
T ss_dssp --------HHHHHHHHHHHHHHTTST------TBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHH
T ss_pred --------HHHHHHHHHHHHhccCCC------CCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHH
Confidence 234566999999996 54 999999999854 579999999964 665442 3599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc--CcceeeecCccccchhhhhCCC-CCCCcc
Q psy17270 174 FAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH--QRVYTYIQSRFYRSPEVILGLP-YGPPID 250 (429)
Q Consensus 174 i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~D 250 (429)
++.||+.||+|||++||+||||||+|||++.++. .++|+|||++.... ......++|+.|+|||++.+.. ++.++|
T Consensus 134 i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 212 (328)
T d3bqca1 134 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 212 (328)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHH
T ss_pred HHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccc
Confidence 9999999999999999999999999999987652 68999999997644 3445578999999999988764 799999
Q ss_pred ccchhhHHHHHhhCCCCCCCC-CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCC-Cchhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGE-NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPG-SKDMAS 328 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 328 (429)
|||+||++|+|++|+.||... +..++...+...++.+....+..... ....+.............. ......
T Consensus 213 iwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (328)
T d3bqca1 213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN------IELDPRFNDILGRHSRKRWERFVHSE 286 (328)
T ss_dssp HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT------CCCCGGGGGTCCCCCCCCGGGGCCTT
T ss_pred hhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc------cccCcccchhcccccccchhhccccc
Confidence 999999999999999999654 55667777777777543332221110 0001110000000000000 000111
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSSS 368 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~~ 368 (429)
.....++++.|||++||++||++||||+|+|+||||++..
T Consensus 287 ~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 287 NQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp TGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 2234578999999999999999999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=380.35 Aligned_cols=245 Identities=19% Similarity=0.297 Sum_probs=198.5
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
++|++++.||+|+||+||+|.+..+..+|||++.....
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------------------------------------------ 42 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------------------------------------------ 42 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS------------------------------------------
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC------------------------------------------
Confidence 68999999999999999999998666679998743211
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
..+.+.+|+++++.++|+ ||+++++++..+..+++|||||. |+|.+++.... ..+++..+..++.||+
T Consensus 43 ----~~~~~~~E~~~l~~l~Hp------nIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia 111 (263)
T d1sm2a_ 43 ----SEEDFIEEAEVMMKLSHP------KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVC 111 (263)
T ss_dssp ----CHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHH
T ss_pred ----cHHHHHHHHHHHHhcCCC------CcccccceeccCCceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHH
Confidence 123567799999999887 99999999999999999999994 79999987654 4589999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
.||+|||+++|+||||||+|||++.++ .+||+|||+++..... .....||+.|+|||++.+..|+.++||||||
T Consensus 112 ~gl~~lH~~~iiHrDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~G 189 (263)
T d1sm2a_ 112 EGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 189 (263)
T ss_dssp HHHHHHHHTTCCCTTCSGGGEEECGGG--CEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHH
T ss_pred HHHHhhhccceeecccchhheeecCCC--CeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchH
Confidence 999999999999999999999999988 8999999999754322 2235688999999999999999999999999
Q ss_pred hHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|++|||+| |.+||...+..+.+..+........ +..++
T Consensus 190 vil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~-----------------------------------------p~~~~ 228 (263)
T d1sm2a_ 190 VLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----------------------------------------PRLAS 228 (263)
T ss_dssp HHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC-----------------------------------------CTTSC
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC-----------------------------------------ccccC
Confidence 99999999 6788888777776666554211110 11236
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
+.+.+|+.+||+.||++|||++|+++|
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 889999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-51 Score=384.53 Aligned_cols=248 Identities=20% Similarity=0.282 Sum_probs=203.8
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
+-.++|++.+.||+|+||+||+|+++.++. +|+|++.....
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-------------------------------------- 55 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-------------------------------------- 55 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--------------------------------------
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--------------------------------------
Confidence 456789999999999999999999998886 48888743211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
-.+++.+|++++++++|+ ||+++++++.++..+++|||||. |+|.+++.......+++..+..++
T Consensus 56 --------~~~~~~~E~~il~~l~Hp------nIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~ 121 (287)
T d1opja_ 56 --------EVEEFLKEAAVMKEIKHP------NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121 (287)
T ss_dssp --------CHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHH
T ss_pred --------hHHHHHHHHHHHHhCCCC------CEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHH
Confidence 123567799999999887 99999999999999999999995 799999987766679999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcce----eeecCccccchhhhhCCCCCCCccc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVY----TYIQSRFYRSPEVILGLPYGPPIDM 251 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di 251 (429)
.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....... ...||+.|+|||++.+..|+.++||
T Consensus 122 ~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~--~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~Di 199 (287)
T d1opja_ 122 TQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199 (287)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHH
T ss_pred HHHHHHHHHHHHCCcccCccccCeEEECCCC--cEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhh
Confidence 9999999999999999999999999999988 899999999986543221 2357889999999999999999999
Q ss_pred cchhhHHHHHhhCCCC-CCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhh
Q psy17270 252 WSLGCILAELYTGCPL-FPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVL 330 (429)
Q Consensus 252 wSlG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
|||||++|||++|..| |.+.+.......+..... ...+
T Consensus 200 wS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~-----------------------------------------~~~~ 238 (287)
T d1opja_ 200 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-----------------------------------------MERP 238 (287)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-----------------------------------------CCCC
T ss_pred hhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC-----------------------------------------CCCC
Confidence 9999999999996555 555554443333221000 0011
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 331 RCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 331 ~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...++.+.+||.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 234789999999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=391.65 Aligned_cols=253 Identities=19% Similarity=0.288 Sum_probs=203.6
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCc------chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNT------HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQN 90 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~ 90 (429)
++-.++|+++++||+|+||+||+|++..++. +|+|.+.....
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------------------------------- 80 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------------------------------- 80 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------------------------------
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--------------------------------
Confidence 3445899999999999999999999976653 35555432211
Q ss_pred CCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCC-----
Q psy17270 91 GGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNY----- 163 (429)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~----- 163 (429)
......+.+|+.++.++ +|+ ||+++++++.+.+.+|+|||||+ |+|.+++.....
T Consensus 81 ------------~~~~~~~~~E~~~l~~l~~Hp------nIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~ 142 (325)
T d1rjba_ 81 ------------SSEREALMSELKMMTQLGSHE------NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 142 (325)
T ss_dssp ---------------CHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---
T ss_pred ------------HHHHHHHHHHHHHHHHhcCCC------cEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcch
Confidence 12234567799999998 566 99999999999999999999995 799999976532
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc---
Q psy17270 164 ----------------QGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--- 224 (429)
Q Consensus 164 ----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--- 224 (429)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 143 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~~ 220 (325)
T d1rjba_ 143 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK--VVKICDFGLARDIMSDSNY 220 (325)
T ss_dssp ------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTT--EEEECCCGGGSCGGGCTTS
T ss_pred hhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCC--eEEEeeccccccccCCCce
Confidence 2489999999999999999999999999999999999999988 9999999999754322
Q ss_pred --ceeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhh
Q psy17270 225 --VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLF 301 (429)
Q Consensus 225 --~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 301 (429)
.....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+.+..+...-..+
T Consensus 221 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~-------------- 286 (325)
T d1rjba_ 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM-------------- 286 (325)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC--------------
T ss_pred eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 123567999999999999999999999999999999998 899999877666655554311000
Q ss_pred ccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 302 FDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+...++++.+||.+||+.||++|||++|+++|
T Consensus 287 --------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 287 --------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0112347889999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=382.47 Aligned_cols=253 Identities=24% Similarity=0.309 Sum_probs=201.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+-.++|++++.||+|+||+||+|+... .+|+|+++.....
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~-------------------------------------- 44 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPT-------------------------------------- 44 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCC--------------------------------------
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCC--------------------------------------
Confidence 446889999999999999999998643 5788887533211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
....+.+.+|++++++++|+ ||+++++++ ....+++|||||+ |+|.+++.... ..+++..+..++.
T Consensus 45 -----~~~~~~~~~E~~~l~~l~Hp------nIv~~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~ 111 (276)
T d1uwha_ 45 -----PQQLQAFKNEVGVLRKTRHV------NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIAR 111 (276)
T ss_dssp -----TTHHHHHHHHHHHHTTCCCT------TBCCEEEEE-CSSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHH
T ss_pred -----HHHHHHHHHHHHHHHhCCCC------CEeeeeEEE-eccEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHH
Confidence 11234567799999999877 999999976 4567899999996 69999997654 4599999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----cceeeecCccccchhhhhCC---CCCCC
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RVYTYIQSRFYRSPEVILGL---PYGPP 248 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~---~~~~~ 248 (429)
||+.||+|||++|||||||||+|||++.++ .+||+|||+++.... ......||+.|+|||++.+. .|+.+
T Consensus 112 qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ 189 (276)
T d1uwha_ 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189 (276)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEETTS--SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHH
T ss_pred HHHHHHHHHhcCCEeccccCHHHEEEcCCC--CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCch
Confidence 999999999999999999999999999988 899999999965432 22346789999999999753 47889
Q ss_pred ccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhh
Q psy17270 249 IDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMAS 328 (429)
Q Consensus 249 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
+|||||||++|||+||+.||.+.+....+..+.......+ ....
T Consensus 190 sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p------------------------------------~~~~ 233 (276)
T d1uwha_ 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP------------------------------------DLSK 233 (276)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC------------------------------------CGGG
T ss_pred hhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC------------------------------------cchh
Confidence 9999999999999999999998877666554443211111 0112
Q ss_pred hhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 329 VLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 329 ~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
....+++.+.+||.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 223457899999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-51 Score=385.11 Aligned_cols=250 Identities=22% Similarity=0.273 Sum_probs=197.1
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
+-.++|++.+.||+|+||+||+|.++.++. +|+|++.......
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------------- 69 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--------------------------------- 69 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH---------------------------------
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH---------------------------------
Confidence 446789999999999999999999987764 3667664332221
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
..+.+.+|+++|++++|+ ||+++++++...+.+++|||||. |+|.+++.... ..+++.++.
T Consensus 70 -----------~~~~~~~E~~~l~~l~Hp------nIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~ 131 (299)
T d1jpaa_ 70 -----------QRRDFLSEASIMGQFDHP------NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLV 131 (299)
T ss_dssp -----------HHHHHHHHHHHHTTCCCT------TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHH
T ss_pred -----------HHHHHHHHHHHHHhCCCC------CCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHH
Confidence 223567799999999877 99999999999999999999995 69999887654 359999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc--------eeeecCccccchhhhhCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV--------YTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~ 244 (429)
.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ....+|+.|+|||++.+..
T Consensus 132 ~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 209 (299)
T d1jpaa_ 132 GMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 209 (299)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------------------CGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHHHHhhCCCccCccccceEEECCCC--cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC
Confidence 9999999999999999999999999999999988 89999999997543221 1235788999999999999
Q ss_pred CCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 245 YGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
|+.++|||||||++|||+| |+.||.+.+..+.+..+......+.
T Consensus 210 ~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------------- 254 (299)
T d1jpaa_ 210 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP----------------------------------- 254 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-----------------------------------
T ss_pred CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----------------------------------
Confidence 9999999999999999998 8999999888776665543111110
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
+...++.+.+|+.+||+.||++|||+.|++++
T Consensus 255 ------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 ------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12247889999999999999999999998875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=383.16 Aligned_cols=253 Identities=19% Similarity=0.266 Sum_probs=206.4
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+-.++|++++.||+|+||+||+|.++.+..+|||++.....
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~--------------------------------------- 50 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--------------------------------------- 50 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---------------------------------------
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---------------------------------------
Confidence 45689999999999999999999987655678998743211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
-.+.+.+|++++++++|+ ||+++++++. ++.+++|||||. |+|.+++.......+++..+..++.
T Consensus 51 -------~~~~~~~E~~~l~~l~Hp------nIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~ 116 (272)
T d1qpca_ 51 -------SPDAFLAEANLMKQLQHQ------RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116 (272)
T ss_dssp -------CHHHHHHHHHHHHHCCCT------TBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHH
T ss_pred -------CHHHHHHHHHHHHhCCCC------CEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHH
Confidence 123567799999999887 9999999764 567899999995 7999987655444599999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc----eeeecCccccchhhhhCCCCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV----YTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ....||+.|+|||++.+..++.++|||
T Consensus 117 qi~~gl~~lH~~~ivHrDiKp~NIll~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvw 194 (272)
T d1qpca_ 117 QIAEGMAFIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194 (272)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHHHhCCcccCccchhheeeeccc--ceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhh
Confidence 999999999999999999999999999988 89999999997654322 234678899999999988999999999
Q ss_pred chhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 253 SLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 253 SlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
||||++|||+| |.+||...+..+.+..+......+ .+.
T Consensus 195 S~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-----------------------------------------~p~ 233 (272)
T d1qpca_ 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-----------------------------------------RPD 233 (272)
T ss_dssp HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------------------------------------CCT
T ss_pred hhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------------------------------------Ccc
Confidence 99999999999 566777777766665554311100 012
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALR--HEWLKS 366 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~--h~~~~~ 366 (429)
..++++.+|+.+||+.||++|||+.|+++ ++||.+
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 34788999999999999999999999988 788753
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-50 Score=388.90 Aligned_cols=308 Identities=31% Similarity=0.510 Sum_probs=236.9
Q ss_pred hhccccc-CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 14 VLHDHIC-YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 14 ~~~~~~~-~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
.+|+.|. +||+++++||+|+||+||+|+++.+++. |||+++....
T Consensus 5 ~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--------------------------------- 51 (362)
T d1q8ya_ 5 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--------------------------------- 51 (362)
T ss_dssp CTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---------------------------------
T ss_pred CCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---------------------------------
Confidence 4577775 6899999999999999999999999875 9998854321
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCC-----CCCceeEEEEEEEEc--CeEEEEEeec--CcCHHHHHHhhC
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDAD-----SSYNVIHMLEYFYFR--NHLCISFELM--NLNLYELIKRNN 162 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~-----~~~~i~~~~~~~~~~--~~~~lv~e~~--~g~L~~~i~~~~ 162 (429)
....+.+|+++++.+.|++.. .|+||+++++++... ...+++++++ .++.........
T Consensus 52 -------------~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (362)
T d1q8ya_ 52 -------------YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE 118 (362)
T ss_dssp -------------HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTT
T ss_pred -------------chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccccccccccc
Confidence 223455699999999987654 468999999998654 4666666666 456666666666
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCCCcEEEecCCC----cceEEeeecccccccCcceeeecCccccch
Q psy17270 163 YQGFSLGLIRRFAFSLVQCLRLLHR-ENIIHCDLKPENVLLKQRGS----SSIKVIDFGSSCYSHQRVYTYIQSRFYRSP 237 (429)
Q Consensus 163 ~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~dlkp~Nili~~~~~----~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aP 237 (429)
...+++..++.++.||+.||+|||+ .||+||||||+|||++.++. ..++++|||.+..........+||+.|+||
T Consensus 119 ~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aP 198 (362)
T d1q8ya_ 119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198 (362)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCH
T ss_pred ccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccccccccccccccCh
Confidence 6679999999999999999999998 89999999999999987652 138999999998877777778899999999
Q ss_pred hhhhCCCCCCCccccchhhHHHHHhhCCCCCCCCC------HHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccc
Q psy17270 238 EVILGLPYGPPIDMWSLGCILAELYTGCPLFPGEN------EVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCI 311 (429)
Q Consensus 238 E~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (429)
|++.+..|+.++||||+||++++|++|+.||...+ ..+.+..+...++.++.+++.........++........
T Consensus 199 E~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
T d1q8ya_ 199 EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNI 278 (362)
T ss_dssp HHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSC
T ss_pred hhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhcc
Confidence 99999999999999999999999999999997543 456778888899999988887666666565555444432
Q ss_pred cCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy17270 312 TNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRHEWLKSS 367 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h~~~~~~ 367 (429)
......................++.+.|||.+||.+||.+||||.|+|+||||+..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 279 SKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp CCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred ccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 22221110000000111112346789999999999999999999999999999854
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=377.65 Aligned_cols=254 Identities=21% Similarity=0.274 Sum_probs=205.8
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDEN 97 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~ 97 (429)
+-.++|++++.||+|+||+||+|+++.+.++|||++......
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~-------------------------------------- 55 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------------------------------------- 55 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--------------------------------------
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC--------------------------------------
Confidence 446789999999999999999999988878899987433211
Q ss_pred CCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 98 GSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 98 ~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
...+.+|+.++++++|+ ||+++++++. ++.+++|||||. |+|..++.......+++..+..++.
T Consensus 56 --------~~~~~~E~~~l~~l~h~------nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~ 120 (285)
T d1fmka3 56 --------PEAFLQEAQVMKKLRHE------KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 120 (285)
T ss_dssp --------HHHHHHHHHHHHHCCCT------TBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred --------HHHHHHHHHHHHhcccC------CEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHH
Confidence 13466799999999887 9999999984 566899999995 6899888765545699999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCCCCCCCcccc
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGLPYGPPIDMW 252 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (429)
||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .....||+.|+|||++.+..++.++|||
T Consensus 121 ~i~~gl~~LH~~~ivH~DlKp~NIll~~~~--~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~ 198 (285)
T d1fmka3 121 QIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 198 (285)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHhhhheecccccceEEEECCCC--cEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhh
Confidence 999999999999999999999999999988 8999999999754322 2235689999999999999999999999
Q ss_pred chhhHHHHHhhC-CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhc
Q psy17270 253 SLGCILAELYTG-CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLR 331 (429)
Q Consensus 253 SlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
||||++|||+|| .+|+.+....+.+..+......+ ...
T Consensus 199 S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-----------------------------------------~~~ 237 (285)
T d1fmka3 199 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-----------------------------------------CPP 237 (285)
T ss_dssp HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------------------------------------CCT
T ss_pred cchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------------------------------------CCc
Confidence 999999999995 66667777766665554311100 112
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCCC
Q psy17270 332 CNDKAFVDFVTQCFNWDSKKRLTPDEALR--HEWLKSS 367 (429)
Q Consensus 332 ~~~~~~~~li~~~L~~dP~~Rpta~ell~--h~~~~~~ 367 (429)
.+++++.+||.+||+.||++|||+.++++ ++||...
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 34788999999999999999999999988 8899764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=374.24 Aligned_cols=245 Identities=18% Similarity=0.277 Sum_probs=205.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCc
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSY 100 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~ 100 (429)
+.|+++++||+|+||+||+|+++.+..+|+|+++....
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~------------------------------------------ 41 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------------------------------------------ 41 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS------------------------------------------
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC------------------------------------------
Confidence 57999999999999999999997555679998754321
Q ss_pred chhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy17270 101 NKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLV 179 (429)
Q Consensus 101 ~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil 179 (429)
....+.+|+.++++++|+ ||+++++++.++..+++||||+. |+|.+++.... ..+++..+..++.|++
T Consensus 42 ----~~~~~~~Ev~~~~~l~Hp------nIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~ 110 (258)
T d1k2pa_ 42 ----SEDEFIEEAKVMMNLSHE------KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVC 110 (258)
T ss_dssp ----CHHHHHHHHHHHHTCCCT------TBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHHHhcCCC------ceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHH
Confidence 123566799999999877 99999999999999999999995 78888876554 3589999999999999
Q ss_pred HHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc----ceeeecCccccchhhhhCCCCCCCccccchh
Q psy17270 180 QCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR----VYTYIQSRFYRSPEVILGLPYGPPIDMWSLG 255 (429)
Q Consensus 180 ~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 255 (429)
.||+|||++||+||||||+||+++.++ .+||+|||+++..... .....+|+.|+|||++.+..++.++||||||
T Consensus 111 ~gl~~LH~~~iiH~dlk~~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G 188 (258)
T d1k2pa_ 111 EAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 188 (258)
T ss_dssp HHHHHHHHTTBCCSCCSGGGEEECTTC--CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHhhcCcccccccceeEEEcCCC--cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccc
Confidence 999999999999999999999999988 8999999999754322 2235688999999999999999999999999
Q ss_pred hHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCC
Q psy17270 256 CILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCND 334 (429)
Q Consensus 256 ~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
|++|||+| |+.||.+.+..+....+......+. +...+
T Consensus 189 ~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------------------------------------p~~~~ 227 (258)
T d1k2pa_ 189 VLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-----------------------------------------PHLAS 227 (258)
T ss_dssp HHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-----------------------------------------CTTCC
T ss_pred hhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC-----------------------------------------ccccc
Confidence 99999998 8999999988877766654211111 11236
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 335 KAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 335 ~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
+.+.+||++||+.||++|||+.|+++|
T Consensus 228 ~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 228 EKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 789999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=377.66 Aligned_cols=251 Identities=18% Similarity=0.232 Sum_probs=202.6
Q ss_pred cCCeEEEeE-eeccccceEEEEEecCCCc---chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 20 CYRYEILEV-IGKGSFGQVIRALDHKTNT---HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 20 ~~rY~i~~~-lG~G~~g~Vy~a~~~~~~~---~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
.++|.+.+. ||+|+||+||+|.++.++. +|||++......
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~------------------------------------ 50 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK------------------------------------ 50 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH------------------------------------
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH------------------------------------
Confidence 467889885 9999999999998865542 588887543222
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.....+.+|++++++++|+ ||+++++++.. +.+|+|||||+ |+|.+++.... ..+++..+..+
T Consensus 51 --------~~~~~~~~E~~il~~l~Hp------nIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i 114 (285)
T d1u59a_ 51 --------ADTEEMMREAQIMHQLDNP------YIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAEL 114 (285)
T ss_dssp --------HHHHHHHHHHHHHHHCCCT------TBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHH
T ss_pred --------HHHHHHHHHHHHHHhCCCC------CEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHH
Confidence 1123566799999999887 99999999864 56899999996 69999876543 45999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhhCCCCCCC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
+.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .....||+.|+|||++.+..++.+
T Consensus 115 ~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k 192 (285)
T d1u59a_ 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192 (285)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHhCCeecCcCchhheeeccCC--ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCcc
Confidence 99999999999999999999999999999988 9999999999764432 123467889999999999899999
Q ss_pred ccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|||||||++|||+| |+.||.+.+..+....+......
T Consensus 193 sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~----------------------------------------- 231 (285)
T d1u59a_ 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----------------------------------------- 231 (285)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-----------------------------------------
T ss_pred chhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------------------------------------
Confidence 999999999999998 99999998877666555431100
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHH---hcCCCCC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEA---LRHEWLK 365 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~el---l~h~~~~ 365 (429)
..+...++++.+||.+||+.||++|||+.++ |+|.|+.
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0112347899999999999999999999887 6678763
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=372.81 Aligned_cols=249 Identities=20% Similarity=0.313 Sum_probs=194.7
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
+-.++|++++.||+|+||+||+|++..++. +|+|.+......
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~---------------------------------- 49 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD---------------------------------- 49 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH----------------------------------
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH----------------------------------
Confidence 446899999999999999999999976653 366665432221
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHH
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIR 172 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~ 172 (429)
.....+.+|++++++++|+ ||+++++++. ++.+|+|||||. |+|.+++.... ..+++..+.
T Consensus 50 ----------~~~~~~~~E~~~l~~l~Hp------nIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~ 111 (273)
T d1mp8a_ 50 ----------SVREKFLQEALTMRQFDHP------HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLI 111 (273)
T ss_dssp ----------HHHHHHHHHHHHHHTCCCT------TBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHH
T ss_pred ----------HHHHHHHHHHHHHHhCCCC------CEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHH
Confidence 2233566799999999877 9999999985 578899999995 68888876554 469999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC----cceeeecCccccchhhhhCCCCCCC
Q psy17270 173 RFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ----RVYTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 173 ~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
.++.||+.||+|||++|++||||||+||+++.++ .+||+|||+++.... ......||+.|+|||++.+..|+.+
T Consensus 112 ~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~--~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~ 189 (273)
T d1mp8a_ 112 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189 (273)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC-------------------CCGGGCCHHHHHHCCCSHH
T ss_pred HHHHHHHHHhhhhcccCeeccccchhheeecCCC--cEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCc
Confidence 9999999999999999999999999999999988 899999999976432 2233567899999999999999999
Q ss_pred ccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|||||||++|||+| |.+||.+.+..+.+..+......
T Consensus 190 ~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~----------------------------------------- 228 (273)
T d1mp8a_ 190 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----------------------------------------- 228 (273)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----------------------------------------
T ss_pred cccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------------------------------------
Confidence 999999999999998 89999998887766655431100
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+...++.+.+||.+||+.||++|||+.|+++|
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0112347899999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=372.26 Aligned_cols=243 Identities=20% Similarity=0.305 Sum_probs=194.3
Q ss_pred eEeeccccceEEEEEecCCC--c-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcchh
Q psy17270 27 EVIGKGSFGQVIRALDHKTN--T-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNKK 103 (429)
Q Consensus 27 ~~lG~G~~g~Vy~a~~~~~~--~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~~ 103 (429)
++||+|+||+||+|.+..++ . +|+|++...... .
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------------------------------------------~ 49 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------------------------------------------P 49 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------------------------------------------C
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-------------------------------------------H
Confidence 46999999999999875433 3 488887433211 1
Q ss_pred hhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH
Q psy17270 104 RFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFSLVQCL 182 (429)
Q Consensus 104 ~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l 182 (429)
.....+.+|++++++++|+ ||+++++++. ....++|||||+ |+|.+++.... .+++..+..++.||+.||
T Consensus 50 ~~~~~~~~E~~il~~l~Hp------nIv~~~g~~~-~~~~~lvmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl 120 (277)
T d1xbba_ 50 ALKDELLAEANVMQQLDNP------YIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGM 120 (277)
T ss_dssp HHHHHHHHHHHHHHTCCCT------TBCCEEEEEE-SSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCC------CCceEEEEec-cCCEEEEEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHH
Confidence 2234677799999999877 9999999986 456789999995 69999988764 499999999999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 183 RLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 183 ~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
+|||++||+||||||+|||++.++ .+||+|||+++..... .....||+.|+|||++.+..++.++|||||||
T Consensus 121 ~ylH~~~iiHrDlKp~Nill~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv 198 (277)
T d1xbba_ 121 KYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 198 (277)
T ss_dssp HHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred hhHHhCCcccCCCcchhhcccccC--cccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchh
Confidence 999999999999999999999988 9999999999754322 12246889999999999989999999999999
Q ss_pred HHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 257 ILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 257 il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
++|||+| |+.||.+.+..+....+...... ..+...++
T Consensus 199 ~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-----------------------------------------~~p~~~~~ 237 (277)
T d1xbba_ 199 LMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-----------------------------------------GCPAGCPR 237 (277)
T ss_dssp HHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----------------------------------------CCCTTCCH
T ss_pred hhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC-----------------------------------------CCCcccCH
Confidence 9999998 89999998877665555421000 01123478
Q ss_pred HHHHHHHHhcccCCCCCCCHHHH---hcCCCC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEA---LRHEWL 364 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~el---l~h~~~ 364 (429)
++.+||.+||+.||++|||+.++ |+|+|+
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 99999999999999999999998 456554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=379.04 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=207.6
Q ss_pred CCeEEEeEeeccccceEEEEEecC---CCc-chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHK---TNT-HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~---~~~-~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
++|++++.||+|+||+||+|++.. +|+ +|+|++.+.....
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~------------------------------------ 67 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ------------------------------------ 67 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE------------------------------------
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhcc------------------------------------
Confidence 679999999999999999999743 554 4888874332110
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
.....+.+.+|++++++++|+ |||+++++++.+...++++|||+. |+|.+++..... +++..+..++
T Consensus 68 -----~~~~~~~~~~E~~il~~l~h~-----pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~ 135 (322)
T d1vzoa_ 68 -----KAKTTEHTRTERQVLEHIRQS-----PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYV 135 (322)
T ss_dssp -----EESSGGGCCCHHHHHHHHHTC-----TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHH
T ss_pred -----chHHHHHHHHHHHHHHhccCC-----CeEEEeeeeeccCCceeeeeecccccHHHHHHHhccc--ccHHHHHHHH
Confidence 112234556699999999984 499999999999999999999995 699999988764 8999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeeccccccc----CcceeeecCccccchhhhhCC--CCCCCc
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSH----QRVYTYIQSRFYRSPEVILGL--PYGPPI 249 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~ 249 (429)
.||+.||.|||++||+||||||+|||++.++ .++|+|||++.... .......|++.|+|||.+.+. .++.++
T Consensus 136 ~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ks 213 (322)
T d1vzoa_ 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213 (322)
T ss_dssp HHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHH
T ss_pred HHHHHHHHHhhcCCEEeccCCccceeecCCC--CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchh
Confidence 9999999999999999999999999999988 89999999986543 223446789999999999865 367899
Q ss_pred cccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 250 DMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 250 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
|||||||++|+|++|+.||.+.+..+....+........ ...
T Consensus 214 DIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--------------------------------------~~~ 255 (322)
T d1vzoa_ 214 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--------------------------------------PPY 255 (322)
T ss_dssp HHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--------------------------------------CCC
T ss_pred hhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--------------------------------------CCC
Confidence 999999999999999999988765444444432110000 001
Q ss_pred hccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRL-----TPDEALRHEWLKSS 367 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rp-----ta~ell~h~~~~~~ 367 (429)
+...++.+.+||++||++||++|| ||+|+++||||++.
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 123478999999999999999999 58999999999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=367.18 Aligned_cols=250 Identities=20% Similarity=0.241 Sum_probs=195.6
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCC-----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTN-----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
++--..|++.++||+|+||+||+|.++.++ .+|+|++........
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~------------------------------ 52 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ------------------------------ 52 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH------------------------------
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHH------------------------------
Confidence 344568999999999999999999987665 248887754333211
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHH
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGL 170 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~ 170 (429)
...+.+|++++++++|+ ||+++++++......++|||||. +++.+++.... ..+++..
T Consensus 53 --------------~~~~~~E~~il~~l~H~------nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~ 111 (283)
T d1mqba_ 53 --------------RVDFLGEAGIMGQFSHH------NIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQ 111 (283)
T ss_dssp --------------HHHHHHHHHHHHTCCCT------TBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHH
T ss_pred --------------HHHHHHHHHHHHhcCCC------CEeeeeEEEecCCceEEEEEecccCcchhhhhccc-ccccHHH
Confidence 23466799999999887 99999999999999999999995 57877776554 4699999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc------ceeeecCccccchhhhhCCC
Q psy17270 171 IRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR------VYTYIQSRFYRSPEVILGLP 244 (429)
Q Consensus 171 ~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~ 244 (429)
+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++..... .....||+.|+|||++.+..
T Consensus 112 ~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 189 (283)
T d1mqba_ 112 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189 (283)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC-----------------CCCGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHhhhhccccccccCccccceEEECCCC--eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC
Confidence 999999999999999999999999999999999988 8999999999754321 12245788999999999999
Q ss_pred CCCCccccchhhHHHHHhhC-CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCC
Q psy17270 245 YGPPIDMWSLGCILAELYTG-CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGS 323 (429)
Q Consensus 245 ~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (429)
++.++|||||||++|||++| .+|+.+.+..+.+..+......+
T Consensus 190 ~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~------------------------------------ 233 (283)
T d1mqba_ 190 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------------------------------------ 233 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------------------------------------
T ss_pred CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC------------------------------------
Confidence 99999999999999999995 55566666655554443211000
Q ss_pred chhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 324 KDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+...++.+.+||.+||+.||++|||+.|+++
T Consensus 234 -----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 234 -----TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 01123678999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=373.33 Aligned_cols=250 Identities=19% Similarity=0.263 Sum_probs=194.8
Q ss_pred CCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 21 YRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 21 ~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
+.|++++.||+|+||+||+|.+..+++. ++|+ |+|.+....
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~v-------------------------avK~~~~~~------------- 50 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-------------------------AIKELREAT------------- 50 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEE-------------------------EEEEECC---------------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEE-------------------------EEEEecccc-------------
Confidence 4699999999999999999999888853 3333 222221100
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAFSL 178 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~qi 178 (429)
.....+.+.+|++++++++|+ ||+++++++.++ ..++++|++ +|+|.+.+.... ..+++..+..++.||
T Consensus 51 --~~~~~~~~~~E~~~l~~l~Hp------nIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi 120 (317)
T d1xkka_ 51 --SPKANKEILDEAYVMASVDNP------HVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQI 120 (317)
T ss_dssp ----CTHHHHHHHHHHHHHCCCT------TBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHHHHHHhCCCC------CEeeEEEEEecC-CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHH
Confidence 112344677899999999887 999999999765 456667776 679999887654 469999999999999
Q ss_pred HHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccchhhhhCCCCCCCccccc
Q psy17270 179 VQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSPEVILGLPYGPPIDMWS 253 (429)
Q Consensus 179 l~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 253 (429)
+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .....||+.|+|||++.+..|+.++||||
T Consensus 121 ~~gl~yLH~~~iiHrDlKp~NIll~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS 198 (317)
T d1xkka_ 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 198 (317)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHHcCcccCcchhhcceeCCCC--CeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhh
Confidence 9999999999999999999999999988 9999999999764321 22346799999999999999999999999
Q ss_pred hhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhcc
Q psy17270 254 LGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRC 332 (429)
Q Consensus 254 lG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
|||++|||+| |.+||.+.+..+....+......+ .+..
T Consensus 199 ~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-----------------------------------------~p~~ 237 (317)
T d1xkka_ 199 YGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-----------------------------------------QPPI 237 (317)
T ss_dssp HHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC-----------------------------------------CCTT
T ss_pred HHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------------------CCcc
Confidence 9999999998 899999887766555444311100 0123
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 333 NDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 333 ~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.++.+.+|+.+||+.||++|||+.|+++|
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 47889999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=369.01 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=192.3
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCC------cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTN------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
+-.++|+++++||+|+||+||+|++..++ .+|+|++.......
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~------------------------------- 58 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS------------------------------- 58 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-------------------------------
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-------------------------------
Confidence 44578999999999999999999986543 24777764332211
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-CeEEEEEeecC-cCHHHHHHhhC-------
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-NHLCISFELMN-LNLYELIKRNN------- 162 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~-g~L~~~i~~~~------- 162 (429)
....+.+|..++.++.|+ +||+.+++++... ..+++|||||+ |+|.+++....
T Consensus 59 -------------~~~~~~~e~~~l~~~~~h-----~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~ 120 (299)
T d1ywna1 59 -------------EHRALMSELKILIHIGHH-----LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120 (299)
T ss_dssp -------------HHHHHHHHHHHHHHHCCC-----TTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC--
T ss_pred -------------HHHHHHHHHHHHHhhcCC-----CeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccc
Confidence 123455688888888654 4999999887654 47899999995 79999997543
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----cceeeec
Q psy17270 163 -------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RVYTYIQ 230 (429)
Q Consensus 163 -------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----~~~~~~~ 230 (429)
...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... ......|
T Consensus 121 ~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~g 198 (299)
T d1ywna1 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARL 198 (299)
T ss_dssp ---------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG--CEEECC------CCSCTTSCCTTSCCC
T ss_pred cchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC--cEEEccCcchhhccccccccccCceee
Confidence 13488999999999999999999999999999999999999988 899999999975332 2234578
Q ss_pred CccccchhhhhCCCCCCCccccchhhHHHHHhhC-CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCc
Q psy17270 231 SRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG-CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPR 309 (429)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (429)
|+.|+|||++.+..++.++|||||||++|||+|| .+||.+.+..+.+..+......+
T Consensus 199 t~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~---------------------- 256 (299)
T d1ywna1 199 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------------- 256 (299)
T ss_dssp GGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------
T ss_pred CccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------------------
Confidence 9999999999999999999999999999999986 67898876555444433211100
Q ss_pred cccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 310 CITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
..+...++++.+||.+||+.||++|||+.|+++|
T Consensus 257 ------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 257 ------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0112247889999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=363.27 Aligned_cols=249 Identities=22% Similarity=0.277 Sum_probs=193.9
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCC----cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTN----THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
.++|++++.||+|+||+||+|++..+. .+|+|++......
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~------------------------------------ 50 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS------------------------------------ 50 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------------------------------------
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC------------------------------------
Confidence 466999999999999999999875433 3488877433221
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRF 174 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i 174 (429)
.....+.+.+|+++++.++|+ ||+++++++.+ ..+++|||||+ |++.+.+.... ..+++..+..+
T Consensus 51 ------~~~~~~~~~~Ei~~l~~l~H~------nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~ 116 (273)
T d1u46a_ 51 ------QPEAMDDFIREVNAMHSLDHR------NLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRY 116 (273)
T ss_dssp -------CHHHHHHHHHHHHHHHCCCT------TBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHH
T ss_pred ------CHHHHHHHHHHHHHHHhCCCC------CEEEEEEEEee-cchheeeeeecCcchhhhhhccc-CCCCHHHHHHH
Confidence 112234677899999999887 99999999964 57789999995 68888877654 35999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc------eeeecCccccchhhhhCCCCCCC
Q psy17270 175 AFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV------YTYIQSRFYRSPEVILGLPYGPP 248 (429)
Q Consensus 175 ~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~ 248 (429)
+.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... ....+|..|+|||++.+..++.+
T Consensus 117 ~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~--~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 194 (273)
T d1u46a_ 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA 194 (273)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH
T ss_pred HHHHHHHHHHhhhCCEeeeeecHHHhcccccc--ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcc
Confidence 99999999999999999999999999999988 89999999997653321 12456788999999999999999
Q ss_pred ccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhh
Q psy17270 249 IDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMA 327 (429)
Q Consensus 249 ~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (429)
+|||||||++|||+| |+.||.+.+..+.+..+......+
T Consensus 195 ~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------------- 234 (273)
T d1u46a_ 195 SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---------------------------------------- 234 (273)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC----------------------------------------
T ss_pred hhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC----------------------------------------
Confidence 999999999999998 899999999888776665310000
Q ss_pred hhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 328 SVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 328 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+...++.+.+||.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 011234788999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=365.22 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=194.6
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
-.++|++++.||+|+||.||+|.++. ..+|+|+++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~vAvK~i~~~~----------------------------------------- 42 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDA----------------------------------------- 42 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-EEEEEEECCCCC-----------------------------------------
T ss_pred CHHHeEEeEEEecCCCeEEEEEEECC-eEEEEEEECcHH-----------------------------------------
Confidence 34679999999999999999999853 356888874321
Q ss_pred CcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEE-cCeEEEEEeec-CcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 99 SYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYF-RNHLCISFELM-NLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 99 ~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
..+.+.+|++++++++|+ ||+++++++.. .+.+|+||||+ +|+|.+++.......+++..+..++.
T Consensus 43 ------~~~~~~~E~~~l~~l~Hp------nIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~ 110 (262)
T d1byga_ 43 ------TAQAFLAEASVMTQLRHS------NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 110 (262)
T ss_dssp --------HHHHHTHHHHTTCCCT------TBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred ------HHHHHHHHHHHHHhCCCC------CEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHH
Confidence 123566799999998877 99999998854 46789999999 57999999766544589999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccchhhhhCCCCCCCccccchhh
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSPEVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 256 (429)
||+.||+|||+.+|+||||||+|||++.++ .+||+|||+++..........+|..|+|||++.+..++.++|||||||
T Consensus 111 ~i~~al~ylH~~~ivH~dlkp~Nil~~~~~--~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~ 188 (262)
T d1byga_ 111 DVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 188 (262)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHhhccccccCceeccccchHhheecCCC--CEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHH
Confidence 999999999999999999999999999988 899999999987766666678899999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhhhccCCh
Q psy17270 257 ILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDK 335 (429)
Q Consensus 257 il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
++|||+| |++||...+..+....+..... ...+...++
T Consensus 189 il~el~t~~~~p~~~~~~~~~~~~i~~~~~-----------------------------------------~~~~~~~~~ 227 (262)
T d1byga_ 189 LLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------------------------------------MDAPDGCPP 227 (262)
T ss_dssp HHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-----------------------------------------CCCCTTCCH
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----------------------------------------CCCCccCCH
Confidence 9999998 7999988777665554432000 001123368
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 336 AFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 336 ~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+.+||++||+.||++|||+.|++++
T Consensus 228 ~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=364.35 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=199.3
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCC--------cchheeccccchhhHHHHHHHHHHHHHhccccccccccccccc
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTN--------THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQ 89 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~--------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~ 89 (429)
+-.++|++++.||+|+||.||+|++..++ .+|+|++........
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~---------------------------- 61 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD---------------------------- 61 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH----------------------------
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH----------------------------
Confidence 45789999999999999999999986654 247777754433222
Q ss_pred CCCCCCCCCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC-----
Q psy17270 90 NGGFDDENGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN----- 162 (429)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~----- 162 (429)
...+.+|...+.++ +|+ ||+++++++..+..+++|||||. |+|.+++....
T Consensus 62 ----------------~~~~~~e~~~l~~~~~Hp------nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~ 119 (299)
T d1fgka_ 62 ----------------LSDLISEMEMMKMIGKHK------NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119 (299)
T ss_dssp ----------------HHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC---
T ss_pred ----------------HHHHHHHHHHHHHhcCCC------eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccc
Confidence 23455688888888 455 99999999999999999999994 79999997653
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceee
Q psy17270 163 ---------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTY 228 (429)
Q Consensus 163 ---------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~ 228 (429)
...+++..+..++.||+.||+|||++|||||||||+|||++.++ .+||+|||++...... ....
T Consensus 120 ~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~ 197 (299)
T d1fgka_ 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN--VMKIADFGLARDIHHIDYYKKTTNG 197 (299)
T ss_dssp ---------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSTTCCCCGGGCCTTCCCTTS
T ss_pred cccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC--CeEeccchhhccccccccccccccC
Confidence 23589999999999999999999999999999999999999998 8999999999754322 2235
Q ss_pred ecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCC
Q psy17270 229 IQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGT 307 (429)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (429)
.+|+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+.+..+....+..... +
T Consensus 198 ~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~--~------------------- 256 (299)
T d1fgka_ 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--M------------------- 256 (299)
T ss_dssp CCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--C-------------------
T ss_pred CCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCC--C-------------------
Confidence 68899999999999999999999999999999998 7999998887665544432100 0
Q ss_pred CccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 308 PRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+...++.+.+||.+||+.||++|||+.|+++
T Consensus 257 --------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 257 --------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp --------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 011234788999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-47 Score=361.43 Aligned_cols=262 Identities=20% Similarity=0.256 Sum_probs=202.5
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
.+++||++++.||+|+||+||+|++..+++. |+|++....
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--------------------------------------- 44 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--------------------------------------- 44 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---------------------------------------
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---------------------------------------
Confidence 3678999999999999999999999988865 888753211
Q ss_pred CCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHH
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAF 176 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~ 176 (429)
....+..|+++++.+.|++ +|+.+.+++......++||||+++++.+.+.... ..+++..+..++.
T Consensus 45 --------~~~~~~~E~~i~~~l~~~~-----~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~ 110 (299)
T d1ckia_ 45 --------KHPQLHIESKIYKMMQGGV-----GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLAD 110 (299)
T ss_dssp --------TSCCHHHHHHHHHHSTTST-----TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHH
T ss_pred --------cCHHHHHHHHHHHHccCCC-----cccEEEEEEecCCEEEEEEEEcCCchhhhhhhcc-CCCcHHHHHHHHH
Confidence 1124567999999998762 6777777788888999999999999888877654 4699999999999
Q ss_pred HHHHHHHHHHHCCceecccCCCcEEEecCC-CcceEEeeecccccccC----------cceeeecCccccchhhhhCCCC
Q psy17270 177 SLVQCLRLLHRENIIHCDLKPENVLLKQRG-SSSIKVIDFGSSCYSHQ----------RVYTYIQSRFYRSPEVILGLPY 245 (429)
Q Consensus 177 qil~~l~~lH~~~ivH~dlkp~Nili~~~~-~~~vkl~Dfg~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~ 245 (429)
|++.||+|||++||+||||||+|||++..+ ...++|+|||+|+.... .....+||+.|+|||++.+..+
T Consensus 111 qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 190 (299)
T d1ckia_ 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 190 (299)
T ss_dssp HHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC
T ss_pred HHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCC
Confidence 999999999999999999999999986432 23699999999975432 1234579999999999999999
Q ss_pred CCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCch
Q psy17270 246 GPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKD 325 (429)
Q Consensus 246 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (429)
+.++|||||||++|||+||+.||...........+....... . ..+
T Consensus 191 ~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~---~-------------------------------~~~ 236 (299)
T d1ckia_ 191 SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK---M-------------------------------STP 236 (299)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH---H-------------------------------HSC
T ss_pred CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc---C-------------------------------CCC
Confidence 999999999999999999999998876654443332211000 0 000
Q ss_pred hhhhhccCChHHHHHHHHhcccCCCCCCCHH---HHhcCCCCCC
Q psy17270 326 MASVLRCNDKAFVDFVTQCFNWDSKKRLTPD---EALRHEWLKS 366 (429)
Q Consensus 326 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~---ell~h~~~~~ 366 (429)
........++++.+||.+||+.||++||++. ++|+|+|.+.
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 1222234578999999999999999999986 5577777643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=364.83 Aligned_cols=249 Identities=22% Similarity=0.262 Sum_probs=201.1
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcc---hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTH---ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDE 96 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~---aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~ 96 (429)
-++|++.+.||+|+||+||+|+++.++.. |||.+......
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~------------------------------------- 51 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK------------------------------------- 51 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------------------------------------
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-------------------------------------
Confidence 46899999999999999999999988753 56665322111
Q ss_pred CCCcchhhhhhhHHHHHHHHHHH-hcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhh-------------
Q psy17270 97 NGSYNKKRFHHQALIEVRILDHL-RKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRN------------- 161 (429)
Q Consensus 97 ~~~~~~~~~~~~~~~E~~il~~l-~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~------------- 161 (429)
.....+.+|+++|.++ +|+ ||+++++++...+.+++|||||+ |+|.+++...
T Consensus 52 -------~~~~~~~~E~~~l~~l~~Hp------nIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 118 (309)
T d1fvra_ 52 -------DDHRDFAGELEVLCKLGHHP------NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118 (309)
T ss_dssp ----------CHHHHHHHHHTTCCCCT------TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred -------HHHHHHHHHHHHHHhccCCC------CEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccc
Confidence 1233577799999998 465 99999999999999999999995 7999998754
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc--ceeeecCccccchh
Q psy17270 162 -NYQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR--VYTYIQSRFYRSPE 238 (429)
Q Consensus 162 -~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~--~~~~~~t~~y~aPE 238 (429)
....+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++..... .....||..|+|||
T Consensus 119 ~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~--~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE 196 (309)
T d1fvra_ 119 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 196 (309)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEEECCTTCEESSCEECCC----CCTTTCCHH
T ss_pred cccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC--ceEEccccccccccccccccceecCCcccchH
Confidence 224599999999999999999999999999999999999999988 8999999998754422 23456899999999
Q ss_pred hhhCCCCCCCccccchhhHHHHHhhC-CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCC
Q psy17270 239 VILGLPYGPPIDMWSLGCILAELYTG-CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGR 317 (429)
Q Consensus 239 ~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (429)
.+.+..|+.++|||||||++|||++| .+||.+.+..+....+.....
T Consensus 197 ~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~-------------------------------- 244 (309)
T d1fvra_ 197 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-------------------------------- 244 (309)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--------------------------------
T ss_pred HhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC--------------------------------
Confidence 99999999999999999999999996 568888887766554432100
Q ss_pred CCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 318 KRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
...+...++++.+||.+||+.||++|||+.|++++
T Consensus 245 ---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 ---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 00112347899999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-47 Score=360.60 Aligned_cols=248 Identities=19% Similarity=0.236 Sum_probs=202.2
Q ss_pred cCCeEEEeEeeccccceEEEEEecC-----CC-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHK-----TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGF 93 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~ 93 (429)
.++|++++.||+|+||+||+|+++. ++ .+|||++......
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~---------------------------------- 57 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---------------------------------- 57 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH----------------------------------
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh----------------------------------
Confidence 5689999999999999999999753 23 3588887543322
Q ss_pred CCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhhC----------
Q psy17270 94 DDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRNN---------- 162 (429)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~---------- 162 (429)
.....+.+|++++++++|+ ||+++++++......+++||++. |+|.+++....
T Consensus 58 ----------~~~~~~~~E~~il~~l~h~------niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~ 121 (301)
T d1lufa_ 58 ----------DMQADFQREAALMAEFDNP------NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121 (301)
T ss_dssp ----------HHHHHHHHHHHHHHTCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC---------
T ss_pred ----------HHHHHHHHHHHHHHhcCCC------CcccceeeeccCCceEEEEEecCCCcHHHHHHhcCcccccccccc
Confidence 1234566799999999887 99999999999999999999995 79999987532
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccC-----cc
Q psy17270 163 ------------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-----RV 225 (429)
Q Consensus 163 ------------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-----~~ 225 (429)
...+++..+..++.|++.||+|||++++|||||||+|||++.++ .+||+|||+++.... ..
T Consensus 122 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~--~~Kl~DFGls~~~~~~~~~~~~ 199 (301)
T d1lufa_ 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKAD 199 (301)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCSCHHHHTGGGCBC--
T ss_pred ccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCC--cEEEccchhheeccCCcccccc
Confidence 12488999999999999999999999999999999999999988 899999999864322 22
Q ss_pred eeeecCccccchhhhhCCCCCCCccccchhhHHHHHhhC-CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccC
Q psy17270 226 YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYTG-CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDS 304 (429)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 304 (429)
....+|+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+..+.+..+..... +
T Consensus 200 ~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~--~---------------- 261 (301)
T d1lufa_ 200 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--L---------------- 261 (301)
T ss_dssp --CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--C----------------
T ss_pred CCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC--C----------------
Confidence 345688999999999999999999999999999999998 578999888877766543110 0
Q ss_pred CCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 305 KGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
..+...++++.+||.+||+.||++|||+.|+++
T Consensus 262 -----------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 262 -----------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 011234788999999999999999999999965
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-46 Score=352.63 Aligned_cols=254 Identities=18% Similarity=0.216 Sum_probs=203.3
Q ss_pred ccccCCeEEEeEeeccccceEEEEEecCCCcc-hheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCC
Q psy17270 17 DHICYRYEILEVIGKGSFGQVIRALDHKTNTH-ALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDD 95 (429)
Q Consensus 17 ~~~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~ 95 (429)
+++++||+++++||+|+||+||+|++..+++. |+|++....
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------------------------------------- 42 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-------------------------------------- 42 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--------------------------------------
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--------------------------------------
Confidence 46889999999999999999999999998865 888763221
Q ss_pred CCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHH
Q psy17270 96 ENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFA 175 (429)
Q Consensus 96 ~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~ 175 (429)
....+.+|+++++.+.|. +|++.+++++......++|||+++++|.+++.... ..++...+..++
T Consensus 43 ---------~~~~~~~e~~~~~~l~~~-----~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~ 107 (293)
T d1csna_ 43 ---------DAPQLRDEYRTYKLLAGC-----TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAA 107 (293)
T ss_dssp ---------TSCCHHHHHHHHHHTTTC-----TTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred ---------CcHHHHHHHHHHHHhcCC-----CCCCEEEEEeecCCccEEEEEecCCCHHHHHHhhc-cchhhHHHHHHH
Confidence 122456699999999874 48899999999999999999999999999987654 469999999999
Q ss_pred HHHHHHHHHHHHCCceecccCCCcEEEecCC---CcceEEeeecccccccC----------cceeeecCccccchhhhhC
Q psy17270 176 FSLVQCLRLLHRENIIHCDLKPENVLLKQRG---SSSIKVIDFGSSCYSHQ----------RVYTYIQSRFYRSPEVILG 242 (429)
Q Consensus 176 ~qil~~l~~lH~~~ivH~dlkp~Nili~~~~---~~~vkl~Dfg~~~~~~~----------~~~~~~~t~~y~aPE~~~~ 242 (429)
.|++.||+|||++||+||||||+|||++... ...++|+|||+|+.... .....+||+.|+|||++.+
T Consensus 108 ~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~ 187 (293)
T d1csna_ 108 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187 (293)
T ss_dssp HHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC
Confidence 9999999999999999999999999997531 22799999999975332 1234579999999999999
Q ss_pred CCCCCCccccchhhHHHHHhhCCCCCCCCCH---HHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCC
Q psy17270 243 LPYGPPIDMWSLGCILAELYTGCPLFPGENE---VEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKR 319 (429)
Q Consensus 243 ~~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (429)
..++.++|||||||++|+|+||+.||.+.+. ......+.......
T Consensus 188 ~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-------------------------------- 235 (293)
T d1csna_ 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-------------------------------- 235 (293)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS--------------------------------
T ss_pred CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC--------------------------------
Confidence 9999999999999999999999999986543 22233332211100
Q ss_pred CCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 320 KPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
...++....++++.+++..|+..+|++||+.+.+.+
T Consensus 236 -----~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 -----PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -----CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 012223345788999999999999999999776543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=353.67 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=206.0
Q ss_pred eehhhhcccccCCeEEEeEeeccccceEEEEEecC-----CC-cchheeccccchhhHHHHHHHHHHHHHhccccccccc
Q psy17270 10 FAFQVLHDHICYRYEILEVIGKGSFGQVIRALDHK-----TN-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHG 83 (429)
Q Consensus 10 ~~~~~~~~~~~~rY~i~~~lG~G~~g~Vy~a~~~~-----~~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~ 83 (429)
|.....-++-.++|++.++||+|+||.||+|++.. ++ .+|+|++......
T Consensus 12 ~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~------------------------ 67 (311)
T d1t46a_ 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL------------------------ 67 (311)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH------------------------
T ss_pred CCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH------------------------
Confidence 33333445557899999999999999999998743 22 2488877543221
Q ss_pred ccccccCCCCCCCCCCcchhhhhhhHHHHHHHHHHHh-cCCCCCCCceeEEEEEEEEcCeEEEEEeecC-cCHHHHHHhh
Q psy17270 84 EESLSQNGGFDDENGSYNKKRFHHQALIEVRILDHLR-KKDADSSYNVIHMLEYFYFRNHLCISFELMN-LNLYELIKRN 161 (429)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~L~~~i~~~ 161 (429)
.....+.+|+++++.+. |+ ||+++++++.....+++|||||+ |+|.+++...
T Consensus 68 --------------------~~~~~~~~E~~~~~~l~~Hp------nIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~ 121 (311)
T d1t46a_ 68 --------------------TEREALMSELKVLSYLGNHM------NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121 (311)
T ss_dssp --------------------HHHHHHHHHHHHHHHHCCCT------TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHT
T ss_pred --------------------HHHHHHHHHHHHHHhccCCC------CEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhc
Confidence 11234667999999994 55 99999999999999999999995 6999998764
Q ss_pred C----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcc
Q psy17270 162 N----------------YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRV 225 (429)
Q Consensus 162 ~----------------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~ 225 (429)
. ...+++..+..++.||+.||+|||++|++||||||+||+++.++ .++++|||.++......
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~--~~ki~DfG~~~~~~~~~ 199 (311)
T d1t46a_ 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIKNDS 199 (311)
T ss_dssp TTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT--EEEECCCGGGSCTTSCT
T ss_pred cccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC--cccccccchheeccCCC
Confidence 3 12589999999999999999999999999999999999999988 89999999997644321
Q ss_pred -----eeeecCccccchhhhhCCCCCCCccccchhhHHHHHhh-CCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhh
Q psy17270 226 -----YTYIQSRFYRSPEVILGLPYGPPIDMWSLGCILAELYT-GCPLFPGENEVEQLACIMEILGCPPDEVINTASRRR 299 (429)
Q Consensus 226 -----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 299 (429)
...+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+.+..+...-..+.
T Consensus 200 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~----------- 268 (311)
T d1t46a_ 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML----------- 268 (311)
T ss_dssp TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC-----------
T ss_pred cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-----------
Confidence 22578999999999999899999999999999999998 7788878776666655543211000
Q ss_pred hhccCCCCCccccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy17270 300 LFFDSKGTPRCITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR 360 (429)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~ 360 (429)
.+...++.+.+||.+||+.||++|||+.|+++
T Consensus 269 -----------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 269 -----------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp -----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01123788999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=355.66 Aligned_cols=256 Identities=18% Similarity=0.224 Sum_probs=208.2
Q ss_pred cccCCeEEEeEeeccccceEEEEEecCC-----C-cchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCC
Q psy17270 18 HICYRYEILEVIGKGSFGQVIRALDHKT-----N-THALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNG 91 (429)
Q Consensus 18 ~~~~rY~i~~~lG~G~~g~Vy~a~~~~~-----~-~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~ 91 (429)
+-.++|++++.||+|+||+||+|++..+ + .+|||++.......+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~------------------------------ 66 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE------------------------------ 66 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHH------------------------------
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHH------------------------------
Confidence 4568999999999999999999998632 2 358888754332211
Q ss_pred CCCCCCCCcchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeec-CcCHHHHHHhhC--------
Q psy17270 92 GFDDENGSYNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELM-NLNLYELIKRNN-------- 162 (429)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~g~L~~~i~~~~-------- 162 (429)
...+.+|+++++++.|+ ||+++++++..+...++||||| +|+|.+++....
T Consensus 67 --------------~~~~~~E~~il~~l~h~------nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~ 126 (308)
T d1p4oa_ 67 --------------RIEFLNEASVMKEFNCH------HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 126 (308)
T ss_dssp --------------HHHHHHHHHHGGGCCCT------TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTT
T ss_pred --------------HHHHHHHHHHHHHcCCC------CEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccc
Confidence 22456799999998877 9999999999899999999999 579999886532
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-----ceeeecCccccch
Q psy17270 163 YQGFSLGLIRRFAFSLVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-----VYTYIQSRFYRSP 237 (429)
Q Consensus 163 ~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-----~~~~~~t~~y~aP 237 (429)
...++...+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++..... .....+|+.|+||
T Consensus 127 ~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP 204 (308)
T d1p4oa_ 127 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204 (308)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc--eEEEeecccceeccCCcceeeccceecccccCCH
Confidence 12378899999999999999999999999999999999999888 8999999999754332 2234688999999
Q ss_pred hhhhCCCCCCCccccchhhHHHHHhhC-CCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCC
Q psy17270 238 EVILGLPYGPPIDMWSLGCILAELYTG-CPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKG 316 (429)
Q Consensus 238 E~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (429)
|.+.+..++.++|||||||++|||+|| .+||.+.+..+.+..+.+....+
T Consensus 205 e~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~----------------------------- 255 (308)
T d1p4oa_ 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD----------------------------- 255 (308)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC-----------------------------
T ss_pred HHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC-----------------------------
Confidence 999999999999999999999999997 68999988887776664311100
Q ss_pred CCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCC
Q psy17270 317 RKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALR------HEWLKS 366 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~------h~~~~~ 366 (429)
.+...++.+.++|.+||+.||++|||+.++++ +|+|++
T Consensus 256 ------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 256 ------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred ------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 01234688999999999999999999999988 566643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=348.29 Aligned_cols=244 Identities=18% Similarity=0.237 Sum_probs=189.3
Q ss_pred EEEeEeeccccceEEEEEecCCCc----chheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 24 EILEVIGKGSFGQVIRALDHKTNT----HALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 24 ~i~~~lG~G~~g~Vy~a~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
.+.++||+|+||+||+|++..++. +|+|++......
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~---------------------------------------- 69 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---------------------------------------- 69 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH----------------------------------------
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH----------------------------------------
Confidence 446799999999999999876542 478877533221
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEc-CeEEEEEeecC-cCHHHHHHhhCCCCCCHHHHHHHHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFR-NHLCISFELMN-LNLYELIKRNNYQGFSLGLIRRFAFS 177 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~-g~L~~~i~~~~~~~~~~~~~~~i~~q 177 (429)
.....+.+|++++++++|+ ||+++++++... ..+++|||||+ |+|.+++.... ..+++..+..++.|
T Consensus 70 ----~~~~~~~~E~~~l~~l~Hp------nIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~q 138 (311)
T d1r0pa_ 70 ----GEVSQFLTEGIIMKDFSHP------NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQ 138 (311)
T ss_dssp ----HHHHHHHHHHHHHHTCCCT------TBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHH
T ss_pred ----HHHHHHHHHHHHHHhCCCC------CEeEEeEEEEecCCceEEEEEEeecCchhhhhcccc-ccchHHHHHHHHHH
Confidence 1224567799999999887 999999998764 58999999995 68988877554 45888999999999
Q ss_pred HHHHHHHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCc-------ceeeecCccccchhhhhCCCCCCCcc
Q psy17270 178 LVQCLRLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQR-------VYTYIQSRFYRSPEVILGLPYGPPID 250 (429)
Q Consensus 178 il~~l~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (429)
++.||.|||+.+|+||||||+|||++.++ .+||+|||+++..... .....||+.|+|||++.+..++.++|
T Consensus 139 ia~gL~~lH~~~iiHrDLK~~NILl~~~~--~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksD 216 (311)
T d1r0pa_ 139 VAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 216 (311)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHhhhhhcccCcccCCccHHhEeECCCC--CEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhH
Confidence 99999999999999999999999999887 8999999999754322 11246789999999999999999999
Q ss_pred ccchhhHHHHHhhCCCCCCCC-CHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCccccCCCCCCCCCCCchhhhh
Q psy17270 251 MWSLGCILAELYTGCPLFPGE-NEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRCITNSKGRKRKPGSKDMASV 329 (429)
Q Consensus 251 iwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
||||||++|||+||..||... +..+....+... .. .. .
T Consensus 217 I~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~~------------------------------~~---------~ 255 (311)
T d1r0pa_ 217 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RR------------------------------LL---------Q 255 (311)
T ss_dssp HHHHHHHHHHHHTTSCCSCC------CHHHHHTT--CC------------------------------CC---------C
T ss_pred hhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--CC------------------------------CC---------C
Confidence 999999999999977766543 333322222210 00 00 0
Q ss_pred hccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 330 LRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 330 ~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
+..+++.+.+||.+||+.||++|||+.|+++|
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12347889999999999999999999999988
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=348.90 Aligned_cols=263 Identities=20% Similarity=0.263 Sum_probs=182.4
Q ss_pred ccCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCC
Q psy17270 19 ICYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENG 98 (429)
Q Consensus 19 ~~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~ 98 (429)
|+++|.+.+.||+|+||+||+|++. ...+|||++.....
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~---------------------------------------- 39 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE---------------------------------------- 39 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH----------------------------------------
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch----------------------------------------
Confidence 5788999999999999999999973 33569998753321
Q ss_pred CcchhhhhhhHHHH--HHHHHHHhcCCCCCCCceeEEEEEEEEcC----eEEEEEeec-CcCHHHHHHhhCCCCCCHHHH
Q psy17270 99 SYNKKRFHHQALIE--VRILDHLRKKDADSSYNVIHMLEYFYFRN----HLCISFELM-NLNLYELIKRNNYQGFSLGLI 171 (429)
Q Consensus 99 ~~~~~~~~~~~~~E--~~il~~l~h~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~-~g~L~~~i~~~~~~~~~~~~~ 171 (429)
..+..| +..+..++ ||||+++++++.... .+|+||||| .|+|.+++++.. +++..+
T Consensus 40 --------~~~~~e~ei~~~~~~~------HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---l~~~~~ 102 (303)
T d1vjya_ 40 --------RSWFREAEIYQTVMLR------HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGM 102 (303)
T ss_dssp --------HHHHHHHHHHTSTTCC------CTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHH
T ss_pred --------hHHHHHHHHHHHhhCC------CCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCC---CCHHHH
Confidence 111223 33333444 459999999998654 689999999 569999998754 999999
Q ss_pred HHHHHHHHHHHHHHHH--------CCceecccCCCcEEEecCCCcceEEeeecccccccC-------cceeeecCccccc
Q psy17270 172 RRFAFSLVQCLRLLHR--------ENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQ-------RVYTYIQSRFYRS 236 (429)
Q Consensus 172 ~~i~~qil~~l~~lH~--------~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~-------~~~~~~~t~~y~a 236 (429)
..++.|++.||+|+|+ +||+||||||+|||++.++ .+||+|||++..... ......||+.|+|
T Consensus 103 ~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~--~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~a 180 (303)
T d1vjya_ 103 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180 (303)
T ss_dssp HHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCEEEETTTTEECC----CCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC--CeEEEecCccccccCCCcceeccccceecccCcCC
Confidence 9999999999999996 5999999999999999888 999999999865432 2234679999999
Q ss_pred hhhhhCCC------CCCCccccchhhHHHHHhhCCCCCCCCCHHHHHHHHHHHhCCCcHHHHhhhhhhhhhccCCCCCcc
Q psy17270 237 PEVILGLP------YGPPIDMWSLGCILAELYTGCPLFPGENEVEQLACIMEILGCPPDEVINTASRRRLFFDSKGTPRC 310 (429)
Q Consensus 237 PE~~~~~~------~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (429)
||++.+.. ++.++|||||||++|||+||..||............. ....+..+..... ......
T Consensus 181 PE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~---- 250 (303)
T d1vjya_ 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-VPSDPSVEEMRKV-----VCEQKL---- 250 (303)
T ss_dssp HHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-SCSSCCHHHHHHH-----HTTSCC----
T ss_pred hhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc-ccccchHHHHHHH-----Hhcccc----
Confidence 99987642 5678999999999999999998875433211000000 0000000000000 000000
Q ss_pred ccCCCCCCCCCCCchhhhhhccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy17270 311 ITNSKGRKRKPGSKDMASVLRCNDKAFVDFVTQCFNWDSKKRLTPDEALRH 361 (429)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ell~h 361 (429)
.+....... .......+.+|+.+||+.||++|||+.|++++
T Consensus 251 ---------~p~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 251 ---------RPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp ---------CCCCCGGGG-GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCcccC-ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000000000 00113468899999999999999999999763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=2.2e-24 Score=189.11 Aligned_cols=181 Identities=18% Similarity=0.142 Sum_probs=118.1
Q ss_pred eEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCCcch
Q psy17270 23 YEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGSYNK 102 (429)
Q Consensus 23 Y~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~~~~ 102 (429)
|.+.++||+|+||+||+|++.....+|+|+++........ ++... ........
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~----------------~~~~~-----------~~~~~~~~ 54 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKK----------------VKEKR-----------DYGDLHFS 54 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------C----------------CCC------------------CHH
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhh----------------hhhhh-----------hhccHHHH
Confidence 5689999999999999999975556799987543221000 00000 00000001
Q ss_pred hhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCcCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH
Q psy17270 103 KRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNLNLYELIKRNNYQGFSLGLIRRFAFSLVQCL 182 (429)
Q Consensus 103 ~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~~~~~~~~~~i~~qil~~l 182 (429)
........+|...+.++.+. +++..+++. ..+++||++++... ..++...+..++.|++.+|
T Consensus 55 ~~~~~~~~~e~~~l~~l~~~------~v~~~~~~~----~~~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l 116 (191)
T d1zara2 55 VLAIRSARNEFRALQKLQGL------AVPKVYAWE----GNAVLMELIDAKEL--------YRVRVENPDEVLDMILEEV 116 (191)
T ss_dssp HHHHHHHHHHHHHHHHTTTS------SSCCEEEEE----TTEEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHccCC------CcceEEEec----CCEEEEEeeccccc--------cchhhHHHHHHHHHHHHHH
Confidence 12233455688888888776 777766542 23799999976311 1256666788999999999
Q ss_pred HHHHHCCceecccCCCcEEEecCCCcceEEeeecccccccCcceeeecCccccch------hhhhCCCCCCCccccchhh
Q psy17270 183 RLLHRENIIHCDLKPENVLLKQRGSSSIKVIDFGSSCYSHQRVYTYIQSRFYRSP------EVILGLPYGPPIDMWSLGC 256 (429)
Q Consensus 183 ~~lH~~~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~~~~~~~~~~~t~~y~aP------E~~~~~~~~~~~DiwSlG~ 256 (429)
+|||++||+||||||+|||++.+ .++|+|||.|......... .|... +. ....|+.++|+||+.-
T Consensus 117 ~~lH~~giiHrDiKP~NILv~~~---~~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 117 AKFYHRGIVHGDLSQYNVLVSEE---GIWIIDFPQSVEVGEEGWR-----EILERDVRNIITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp HHHHHTTEECSCCSTTSEEEETT---EEEECCCTTCEETTSTTHH-----HHHHHHHHHHHHH-HHHHHCCCCCHHHHHH
T ss_pred HHHhhCCEEEccCChhheeeeCC---CEEEEECCCcccCCCCCcH-----HHHHHHHHHHHHH-HcCCCCCcccHHHHHH
Confidence 99999999999999999999864 5899999998654422111 12111 12 2346888999999654
Q ss_pred H
Q psy17270 257 I 257 (429)
Q Consensus 257 i 257 (429)
-
T Consensus 188 ~ 188 (191)
T d1zara2 188 R 188 (191)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.16 E-value=7.5e-06 Score=72.73 Aligned_cols=86 Identities=13% Similarity=0.015 Sum_probs=57.2
Q ss_pred cCCeEEEeEeeccccceEEEEEecCCCcchheeccccchhhHHHHHHHHHHHHHhcccccccccccccccCCCCCCCCCC
Q psy17270 20 CYRYEILEVIGKGSFGQVIRALDHKTNTHALKYYGNQLTEFERTEIEKYLEIWYLGLDACKIHGEESLSQNGGFDDENGS 99 (429)
Q Consensus 20 ~~rY~i~~~lG~G~~g~Vy~a~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~~~ 99 (429)
-+.|++++..+.++.+.||++.. ..+.+++|+......
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~----------------------------------------- 50 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK----------------------------------------- 50 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT-----------------------------------------
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc-----------------------------------------
Confidence 35788888877777789999864 344567776532211
Q ss_pred cchhhhhhhHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc-CHHH
Q psy17270 100 YNKKRFHHQALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL-NLYE 156 (429)
Q Consensus 100 ~~~~~~~~~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g-~L~~ 156 (429)
.....+.+|..+++.+... . -+.+++.+...++..++||++++| ++.+
T Consensus 51 ----~~~~~~~~E~~~l~~l~~~--v---pvP~vl~~~~~~~~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 51 ----GTTYDVEREKDMMLWLEGK--L---PVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp ----TSTTCHHHHHHHHHHHTTT--S---CCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred ----cchhhHHHHHHHHHHHhcc--C---CCCcEEEEEecCCceEEEEEecccccccc
Confidence 1122455689999888632 2 255667777788899999999976 5543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.78 E-value=3.1e-05 Score=68.23 Aligned_cols=41 Identities=10% Similarity=-0.078 Sum_probs=30.5
Q ss_pred hHHHHHHHHHHHhcCCCCCCCceeEEEEEEEEcCeEEEEEeecCc
Q psy17270 108 QALIEVRILDHLRKKDADSSYNVIHMLEYFYFRNHLCISFELMNL 152 (429)
Q Consensus 108 ~~~~E~~il~~l~h~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 152 (429)
.+..|+..++.+.... . .+.+++.+....+..++||++++|
T Consensus 50 ~l~~E~~~l~~L~~~g-v---pvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 50 ELQDEAARLSWLATTG-V---PCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CHHHHHHHHHHHHTTT-C---CBCCEEEEEECSSCEEEEEECCSS
T ss_pred HHHHHHHHHHHHHhcC-C---CCCceeeecccccceEEEEEeeec
Confidence 3556999999997653 2 256666777777889999999965
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.48 E-value=0.00018 Score=67.81 Aligned_cols=29 Identities=31% Similarity=0.492 Sum_probs=25.1
Q ss_pred CceecccCCCcEEEecCCCcceEEeeeccccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSCY 220 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~~ 220 (429)
.++|+|+.|.|||++.+ .++++||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~---~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH---ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS---CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC---ceEEechhhccc
Confidence 58999999999999865 589999998754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.59 E-value=0.027 Score=50.25 Aligned_cols=29 Identities=34% Similarity=0.543 Sum_probs=25.5
Q ss_pred CceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
|+||+|+.++||+++.+. ..-++||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~--v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDE--LSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred ccccCCcchhhhhccccc--ceeEecccccc
Confidence 799999999999998765 56899999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.55 E-value=0.012 Score=54.63 Aligned_cols=22 Identities=9% Similarity=-0.068 Sum_probs=17.1
Q ss_pred EEEeEeeccccceEEEEEecCC
Q psy17270 24 EILEVIGKGSFGQVIRALDHKT 45 (429)
Q Consensus 24 ~i~~~lG~G~~g~Vy~a~~~~~ 45 (429)
--+++|+.|-.=.+|++.....
T Consensus 45 l~v~~l~GGltN~~y~v~~~~~ 66 (395)
T d1nw1a_ 45 LRISRIKGGMSNMLFLCRLSEV 66 (395)
T ss_dssp EEEEEECCCTTEEEEEEEECTT
T ss_pred eEEEEcCCccccceEEEEeCCC
Confidence 3457889999999999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.52 E-value=0.02 Score=51.55 Aligned_cols=27 Identities=22% Similarity=0.378 Sum_probs=22.5
Q ss_pred CceecccCCCcEEEecCCCcceEEeeecccc
Q psy17270 189 NIIHCDLKPENVLLKQRGSSSIKVIDFGSSC 219 (429)
Q Consensus 189 ~ivH~dlkp~Nili~~~~~~~vkl~Dfg~~~ 219 (429)
+++|+|+.+.|||++. + ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~-~---~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G---PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESS-S---EEECCCTTCC
T ss_pred eeecCCCCcccEEEeC-C---ceEEechhcc
Confidence 6899999999999963 3 3589999875
|